Citrus Sinensis ID: 013401

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440---
Protein Sequence
MKKSQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPSYSKRSNSTREQ
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEccccccccccccccccccEEccccccccccccHHHHHccccccccccccHHHHHHHHHHccccccccccccHHcHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHcccccccccEEEEcEcccccEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEccccccHHHEEEcHHHcEEEccccHHHccccccEEcccEEEEEEEccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccHHHHccHHHccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHcccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mkksqnplyegrspstgvrstpdrffyspgshyseastvrnrktsKNSLAMAAKAVAGLFvacftppetnsskdfvnsnefkpspvsdasrsrasterrrsssqglyvssnnstrggdqsgnvQITMEEIYRAtrnfspsfkigqggfgtvykgrledgTIVAIKRAKKsvydkhsgaEFQSEIRTLAQVEHLNLVkfhgylefederIVIVeyvpngtlrehLDCLQGNILDLAGRLDIAIDVAHAITYLHmytdhpiihrdikssnilltenFRAKVADFGFARlaadtesgathvstqvkgtagyldpeylktyqlteksdvYSFGVLLVELVtgrrpiepkreLKERITVKWAMkkfsdgdaisildprventaANNLALEKILELALQCLaprrqnrpsmrRCAEILWSVRKDYRELAASdvllqpsyskrsnstreq
Flexible Loop (DISEMBL)
mkksqnplyegrspstgvrstpDRFFYspgshyseastvrnrkTSKNSLAMAAKAVAGLFVACFTPPEtnsskdfvnsnefkpspvsdasrsrasterrrsssqglyvssnnstrggdqsgnvQITMEEIYRATrnfspsfkigQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHgylefederIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAdtesgathvstqvkgtagyldPEYLKTYQLTEKSDVYSFGVLLVElvtgrrpiepkrelkeritvkwamkkfsdgdaisildPRVENTAANNLALEKILELALQCLaprrqnrpsmrrCAEILWSVRKDYRELAasdvllqpsyskrsnstreq
Low Complexity Region (SEG)
MKKSQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVsdasrsrasterrrsssQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPSYSKRSNSTREQ
Disordered region (IsUnstruct)
**************************************************MAAKAVAGLFVACFT***********************************************************ITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRR****SMRRCAEILWSVRKDYRELAASDVL***************
Disordered Region (DISOPRED)
*************************************************AMAAKAVAGLFVACFTPP********************************************************QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAI***************FQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE*****KERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK**************************
Disordered Region (DISEMBL)
*****************VRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNE**************************************QSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPSY**********
Disordered Region (DISPRO)
******************************************KTSKNSLAMAAKAVAGLFVACFTPPETNS************************************************SGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK**************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKKSQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPSYSKRSNSTREQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	443	2.2.26 [Sep-21-2011]
Q8VZJ9	411	Calmodulin-binding recept	yes	no	0.830	0.895	0.636	1e-142
Q9FIL7	470	Calmodulin-binding recept	no	no	0.762	0.719	0.557	1e-108
Q9ASQ5	510	Calmodulin-binding recept	no	no	0.781	0.678	0.497	3e-91
C0LGD7	953	Probable LRR receptor-lik	no	no	0.708	0.329	0.423	1e-61
Q9SA72	849	Probable receptor-like pr	no	no	0.726	0.379	0.395	1e-59
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.652	0.407	0.428	4e-59
Q9SX31	708	Proline-rich receptor-lik	no	no	0.821	0.514	0.369	6e-59
Q9SGY7	718	Putative proline-rich rec	no	no	0.661	0.408	0.414	2e-58
C0LGI2	929	Probable LRR receptor-lik	no	no	0.668	0.318	0.432	2e-58
Q9LX66	830	Receptor-like protein kin	no	no	0.645	0.344	0.435	4e-58

>sp|Q8VZJ9|CRCK2_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 2 OS=Arabidopsis thaliana GN=CRCK2 PE=2 SV=1

 Score =  504 bits (1298), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 243/382 (63%), Positives = 301/382 (78%), Gaps = 14/382 (3%)

Query: 43  KTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSS 102
           +TS ++    A+ ++G+F+ CFTPP++ SS    NS     + +     S  S+  +RS 
Sbjct: 37  RTSTDTTTSIARRISGIFINCFTPPDSVSSNYIDNSKSSSDNNIRSRRSSTGSSSVQRS- 95

Query: 103 SQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIV 162
               Y ++N       ++ + + T +EIY AT+NFSPSF+IGQGGFGTVYK +L DG   
Sbjct: 96  ----YGNAN-------ETEHTRFTFDEIYDATKNFSPSFRIGQGGFGTVYKVKLRDGKTF 144

Query: 163 AIKRAKKSVYDKHSGA--EFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL 220
           A+KRAKKS++D   GA  EF SEI+TLAQV HL+LVK++G++   DE+I++VEYV NGTL
Sbjct: 145 AVKRAKKSMHDDRQGADAEFMSEIQTLAQVTHLSLVKYYGFVVHNDEKILVVEYVANGTL 204

Query: 221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVA 280
           R+HLDC +G  LD+A RLDIA DVAHAITYLHMYT  PIIHRDIKSSNILLTEN+RAKVA
Sbjct: 205 RDHLDCKEGKTLDMATRLDIATDVAHAITYLHMYTQPPIIHRDIKSSNILLTENYRAKVA 264

Query: 281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRR 340
           DFGFARLA DT+SGATHVSTQVKGTAGYLDPEYL TYQLTEKSDVYSFGVLLVEL+TGRR
Sbjct: 265 DFGFARLAPDTDSGATHVSTQVKGTAGYLDPEYLTTYQLTEKSDVYSFGVLLVELLTGRR 324

Query: 341 PIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQ 400
           PIE  R  KERIT++WA+KKF+ GD IS+LDP++E  +ANNLALEK+LE+A QCLAP R+
Sbjct: 325 PIELSRGQKERITIRWAIKKFTSGDTISVLDPKLEQNSANNLALEKVLEMAFQCLAPHRR 384

Query: 401 NRPSMRRCAEILWSVRKDYREL 422
           +RPSM++C+EILW +RKDYREL
Sbjct: 385 SRPSMKKCSEILWGIRKDYREL 406

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FIL7|CRCK1_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 1 OS=Arabidopsis thaliana GN=CRCK1 PE=1 SV=1

 Score =  393 bits (1010), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 189/339 (55%), Positives = 257/339 (75%), Gaps = 1/339 (0%)

Query: 83  PSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFK 142
           PS    ++  + S + R S S+      ++S+      G V  +  E+ RAT NFS   +
Sbjct: 93  PSSFGRSTERKVSGQYRFSGSRFQSPGKDSSSSKSWHQGPVIFSFGELQRATANFSSVHQ 152

Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           IG+GGFGTV+KG+L+DGTIVAIKRA+K+ Y K    EF++EI TL+++EH+NLVK +G+L
Sbjct: 153 IGEGGFGTVFKGKLDDGTIVAIKRARKNNYGKSWLLEFKNEIYTLSKIEHMNLVKLYGFL 212

Query: 203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHR 262
           E  DE++++VEYV NG LREHLD L+GN L++A RL+IAIDVAHA+TYLH YTD PIIHR
Sbjct: 213 EHGDEKVIVVEYVANGNLREHLDGLRGNRLEMAERLEIAIDVAHALTYLHTYTDSPIIHR 272

Query: 263 DIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEK 322
           DIK+SNIL+T   RAKVADFGFARL ++ + GATH+STQVKG+AGY+DP+YL+T+QLT+K
Sbjct: 273 DIKASNILITNKLRAKVADFGFARLVSE-DLGATHISTQVKGSAGYVDPDYLRTFQLTDK 331

Query: 323 SDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNL 382
           SDVYSFGVLLVE++TGRRPIE KR  K+R+TVKWA+++  D +A+ I+DP ++   A   
Sbjct: 332 SDVYSFGVLLVEILTGRRPIELKRPRKDRLTVKWALRRLKDDEAVLIMDPFLKRNRAAIE 391

Query: 383 ALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE 421
             EK+L LA +C+ P R  RP+M+  AE LW++R++ +E
Sbjct: 392 VAEKMLRLASECVTPTRATRPAMKGIAEKLWAIRREMKE 430

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ5|CRCK3_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 3 OS=Arabidopsis thaliana GN=CRCK3 PE=2 SV=1

 Score =  336 bits (861), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 177/356 (49%), Positives = 231/356 (64%), Gaps = 10/356 (2%)

Query: 66  PPETNSSKDFVNSNEFKPS--PVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNV 123
           P E+NS    V+S E  PS   +  +      +  R   S   Y  S   +R     G +
Sbjct: 157 PKESNSVHQ-VSSFEMSPSSEKIPQSPFRAPPSPSRVPQSPSRYAMSPRPSR----LGPL 211

Query: 124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE 183
            +TM +I  AT NF+ S +IG+GGFG V+KG L+DG +VAIKRAKK  ++     EF+SE
Sbjct: 212 NLTMSQINTATGNFADSHQIGEGGFGVVFKGVLDDGQVVAIKRAKKEHFENLR-TEFKSE 270

Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID 243
           +  L+++ H NLVK  GY++  DER++I EYV NGTLR+HLD  +G  L+   RL+I ID
Sbjct: 271 VDLLSKIGHRNLVKLLGYVDKGDERLIITEYVRNGTLRDHLDGARGTKLNFNQRLEIVID 330

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           V H +TYLH Y +  IIHRDIKSSNILLT++ RAKVADFGFAR    T+S  TH+ TQVK
Sbjct: 331 VCHGLTYLHSYAERQIIHRDIKSSNILLTDSMRAKVADFGFAR-GGPTDSNQTHILTQVK 389

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD 363
           GT GYLDPEY+KTY LT KSDVYSFG+LLVE++TGRRP+E KR   ERITV+WA  K+++
Sbjct: 390 GTVGYLDPEYMKTYHLTAKSDVYSFGILLVEILTGRRPVEAKRLPDERITVRWAFDKYNE 449

Query: 364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
           G    ++DP         + L K+  LA QC AP ++ RP M    + LW++R  Y
Sbjct: 450 GRVFELVDPNARERVDEKI-LRKMFSLAFQCAAPTKKERPDMEAVGKQLWAIRSSY 504

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2

 Score =  237 bits (604), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 144/340 (42%), Positives = 192/340 (56%), Gaps = 26/340 (7%)

Query: 94  ASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYK 153
           A   R+RSS   L +            G    T  E+  AT NF+ S +IGQGG+G VYK
Sbjct: 593 AVARRKRSSKASLKIE-----------GVKSFTYAELALATDNFNSSTQIGQGGYGKVYK 641

Query: 154 GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE 213
           G L  GT+VAIKRA++         EF +EI  L+++ H NLV   G+ + E E++++ E
Sbjct: 642 GTLGSGTVVAIKRAQEGSLQGEK--EFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYE 699

Query: 214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE 273
           Y+ NGTLR+++       LD A RL IA+  A  I YLH   + PI HRDIK+SNILL  
Sbjct: 700 YMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDS 759

Query: 274 NFRAKVADFGFARLA--ADTES-GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGV 330
            F AKVADFG +RLA   D E     HVST VKGT GYLDPEY  T+QLT+KSDVYS GV
Sbjct: 760 RFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGV 819

Query: 331 LLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILEL 390
           +L+EL TG +PI   + +   I +      +  G  +S +D R+  ++  +  LEK   L
Sbjct: 820 VLLELFTGMQPITHGKNIVREINI-----AYESGSILSTVDKRM--SSVPDECLEKFATL 872

Query: 391 ALQCLAPRRQNRPSMR---RCAEILWSVRKDYRELAASDV 427
           AL+C       RPSM    R  EI+W +  +      +D+
Sbjct: 873 ALRCCREETDARPSMAEVVRELEIIWELMPESHVAKTADL 912

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  231 bits (588), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 137/346 (39%), Positives = 196/346 (56%), Gaps = 24/346 (6%)

Query: 86  VSDASRSRASTERRRSSSQG---LYVSSNNSTRGGDQSGNV-------------QITMEE 129
           V    + R+ ++  +++  G   L++  NNST     +G               + T+ E
Sbjct: 453 VCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLRLNTLAASTMGRKFTLAE 512

Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           I  AT+NF     IG GGFG VY+G LEDGT++AIKRA  + + +   AEF++EI  L++
Sbjct: 513 IRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRA--TPHSQQGLAEFETEIVMLSR 570

Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H +LV   G+ +  +E I++ EY+ NGTLR HL       L    RL+  I  A  + 
Sbjct: 571 LRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSARGLH 630

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH  ++  IIHRD+K++NILL ENF AK++DFG ++     +   THVST VKG+ GYL
Sbjct: 631 YLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDH--THVSTAVKGSFGYL 688

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           DPEY +  QLTEKSDVYSFGV+L E V  R  I P     +    +WA+      +  SI
Sbjct: 689 DPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLESI 748

Query: 370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV 415
           +D  +    +   +LEK  E+A +CLA   +NRP M    E+LWS+
Sbjct: 749 IDSNLRGNYSPE-SLEKYGEIAEKCLADEGKNRPMM---GEVLWSL 790

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  229 bits (583), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 128/299 (42%), Positives = 177/299 (59%), Gaps = 10/299 (3%)

Query: 120 SGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE 179
           SG    T EE+   T  FS    +G+GGFG VYKG+L DG +VA+K+ K  V       E
Sbjct: 336 SGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLK--VGSGQGDRE 393

Query: 180 FQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD 239
           F++E+  +++V H +LV   GY   + ER++I EYVPN TL  HL      +L+ A R+ 
Sbjct: 394 FKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVR 453

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           IAI  A  + YLH      IIHRDIKS+NILL + F A+VADFG A+L   T+   THVS
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQ---THVS 510

Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA-- 357
           T+V GT GYL PEY ++ +LT++SDV+SFGV+L+EL+TGR+P++  + L E   V+WA  
Sbjct: 511 TRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARP 570

Query: 358 --MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS 414
              K    GD   ++D R+E     N    +++E A  C+      RP M +    L S
Sbjct: 571 LLHKAIETGDFSELVDRRLEKHYVENEVF-RMIETAAACVRHSGPKRPRMVQVVRALDS 628

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  228 bits (582), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 143/387 (36%), Positives = 216/387 (55%), Gaps = 23/387 (5%)

Query: 48  SLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSS---Q 104
           ++A+    + G+FV C    E   S   V+  +  PSP+S  +RS ++  R +SS+    
Sbjct: 287 AVALVVFTLFGIFVWCLRKREKRLSA--VSGGDVTPSPMSSTARSDSAFFRMQSSAPVGA 344

Query: 105 GLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAI 164
                S  S  GG  +     + EE+ +AT  FS    +G+GGFG VYKG L DG +VA+
Sbjct: 345 SKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAV 404

Query: 165 KRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL 224
           K+ K  +       EF++E+ TL+++ H +LV   G+    D R++I +YV N  L  HL
Sbjct: 405 KQLK--IGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHL 462

Query: 225 DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
              + ++LD A R+ IA   A  + YLH      IIHRDIKSSNILL +NF A+V+DFG 
Sbjct: 463 HG-EKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGL 521

Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           ARLA D     TH++T+V GT GY+ PEY  + +LTEKSDV+SFGV+L+EL+TGR+P++ 
Sbjct: 522 ARLALDCN---THITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDT 578

Query: 345 KRELKERITVKWAMKKFSDG----DAISILDPRVENTAANNLALEKILELALQCLAPRRQ 400
            + L +   V+WA    S      +  S+ DP++      +  + +++E A  C+     
Sbjct: 579 SQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVES-EMFRMIEAAGACVRHLAT 637

Query: 401 NRPSMRRCAEILWSVRKDYRELAASDV 427
            RP M +       + + +  LAA D+
Sbjct: 638 KRPRMGQ-------IVRAFESLAAEDL 657

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  227 bits (578), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 126/304 (41%), Positives = 181/304 (59%), Gaps = 11/304 (3%)

Query: 123 VQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS 182
           +  T EE+ + T  F  SF +G+GGFG VYKG L +G  VAIK+ K    + +   EF++
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYR--EFKA 413

Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           E+  +++V H +LV   GY   E  R +I E+VPN TL  HL      +L+ + R+ IAI
Sbjct: 414 EVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIAI 473

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
             A  + YLH      IIHRDIKSSNILL + F A+VADFG ARL    ++  +H+ST+V
Sbjct: 474 GAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARL---NDTAQSHISTRV 530

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA----M 358
            GT GYL PEY  + +LT++SDV+SFGV+L+EL+TGR+P++  + L E   V+WA    +
Sbjct: 531 MGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLI 590

Query: 359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD 418
           +    GD   ++DPR+EN    +  + K++E A  C+      RP M +    L   R D
Sbjct: 591 EAIEKGDISEVVDPRLENDYVES-EVYKMIETAASCVRHSALKRPRMVQVVRAL-DTRDD 648

Query: 419 YREL 422
             +L
Sbjct: 649 LSDL 652

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score =  226 bits (577), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 138/319 (43%), Positives = 187/319 (58%), Gaps = 23/319 (7%)

Query: 95  STERRRSSSQGLYVSSNNSTRGG---DQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTV 151
           STE ++   +GL   S  + RGG   D+     I++  +  AT NFS   K+G+G FG+V
Sbjct: 568 STETKK---KGLVAYS--AVRGGHLLDEGVAYFISLPVLEEATDNFSK--KVGRGSFGSV 620

Query: 152 YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI 211
           Y GR++DG  VA+K         H   +F +E+  L+++ H NLV   GY E  D RI++
Sbjct: 621 YYGRMKDGKEVAVKITADP--SSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILV 678

Query: 212 VEYVPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNIL 270
            EY+ NG+L +HL        LD   RL IA D A  + YLH   +  IIHRD+KSSNIL
Sbjct: 679 YEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNIL 738

Query: 271 LTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGV 330
           L  N RAKV+DFG +R    TE   THVS+  KGT GYLDPEY  + QLTEKSDVYSFGV
Sbjct: 739 LDINMRAKVSDFGLSR---QTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGV 795

Query: 331 LLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALE---KI 387
           +L EL++G++P+  +    E   V WA      GD   I+DP +    A+N+ +E   ++
Sbjct: 796 VLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCI----ASNVKIESVWRV 851

Query: 388 LELALQCLAPRRQNRPSMR 406
            E+A QC+  R  NRP M+
Sbjct: 852 AEVANQCVEQRGHNRPRMQ 870

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  226 bits (575), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 128/294 (43%), Positives = 170/294 (57%), Gaps = 8/294 (2%)

Query: 122 NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ 181
           N +I    +  AT NF  S  IG GGFG VYKG L DGT VA+KR       +   AEF+
Sbjct: 470 NYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPK--SQQGLAEFR 527

Query: 182 SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
           +EI  L+Q  H +LV   GY +  +E I+I EY+ NGT++ HL       L    RL+I 
Sbjct: 528 TEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEIC 587

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           I  A  + YLH     P+IHRD+KS+NILL ENF AKVADFG ++   + +   THVST 
Sbjct: 588 IGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQ--THVSTA 645

Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF 361
           VKG+ GYLDPEY +  QLT+KSDVYSFGV+L E++  R  I+P    +     +WAMK  
Sbjct: 646 VKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 705

Query: 362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV 415
             G    I+D  +      + +L K  E   +CLA    +RPSM    ++LW++
Sbjct: 706 KKGQLDQIIDQSLRGNIRPD-SLRKFAETGEKCLADYGVDRPSM---GDVLWNL 755

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	443
147773362	442	hypothetical protein VITISV_007757 [Viti	0.990	0.993	0.743	0.0
297745358	1079	unnamed protein product [Vitis vinifera]	0.990	0.406	0.741	0.0
225454361	442	PREDICTED: probable leucine-rich repeat	0.990	0.993	0.741	0.0
224127718	439	predicted protein [Populus trichocarpa]	0.943	0.952	0.744	1e-179
357504419	440	Receptor-like protein kinase ANXUR2 [Med	0.970	0.977	0.704	1e-173
351727172	438	calmodulin-binding receptor-like cytopla	0.979	0.990	0.685	1e-171
255541648	427	ATP binding protein, putative [Ricinus c	0.923	0.957	0.744	1e-170
356520390	439	PREDICTED: probable leucine-rich repeat	0.984	0.993	0.676	1e-168
224064051	366	predicted protein [Populus trichocarpa]	0.760	0.920	0.792	1e-160
449432138	452	PREDICTED: calmodulin-binding receptor-l	0.927	0.909	0.678	1e-155

>gi|147773362|emb|CAN75716.1| hypothetical protein VITISV_007757 [Vitis vinifera]

 Score =  681 bits (1757), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/441 (74%), Positives = 378/441 (85%), Gaps = 2/441 (0%)

Query: 3   KSQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVA 62
           K+ N +Y  R+  +G R TPDR  YSP +   +AS+++  ++ +N + MA K+VAG+FV+
Sbjct: 2   KNPNLMYGNRNHGSGARRTPDRLTYSPSTVDYDASSIQKSRSGRNPMMMAVKSVAGVFVS 61

Query: 63  CFTPPETNSSKDFVNSNEFK-PSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSG 121
           CFTPPET SSK+F +S+EF+ PS  SD SR+ +   R   SS G+Y +S NST G  + G
Sbjct: 62  CFTPPETTSSKNFGDSDEFRAPSVASDVSRAGSVRRRVSGSSHGIYANSYNSTHG-REPG 120

Query: 122 NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ 181
           +V+ T+EEIY+ATRNFSPS+KIGQGGFGTVYKGRLEDGT+VA+KRAKKS+YDKH G EFQ
Sbjct: 121 SVKFTLEEIYKATRNFSPSWKIGQGGFGTVYKGRLEDGTLVAVKRAKKSLYDKHLGVEFQ 180

Query: 182 SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
           SEI+TLAQVEHLNLV+F+GYLE  DERIV+VEYVPNGTLREHLDC+QGNILD A RLD+A
Sbjct: 181 SEIQTLAQVEHLNLVRFYGYLEHGDERIVVVEYVPNGTLREHLDCVQGNILDFAARLDVA 240

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           IDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN RAKVADFGFARLAADTESGATHVSTQ
Sbjct: 241 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENLRAKVADFGFARLAADTESGATHVSTQ 300

Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF 361
           VKGTAGYLDPEYL+TYQLTEKSDVYSFGVLLVELVTGRRPIE KREL ERIT KWAMKKF
Sbjct: 301 VKGTAGYLDPEYLRTYQLTEKSDVYSFGVLLVELVTGRRPIEAKRELPERITAKWAMKKF 360

Query: 362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE 421
           +DGDAI  LDPR+E  AANNLALEKILELALQCLAP++QNRPSMRRCAEILWS+RKD+RE
Sbjct: 361 TDGDAIFTLDPRLERNAANNLALEKILELALQCLAPQKQNRPSMRRCAEILWSIRKDHRE 420

Query: 422 LAASDVLLQPSYSKRSNSTRE 442
           L+ASD     S+S++S   RE
Sbjct: 421 LSASDTRSLSSHSQKSIQLRE 441

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297745358|emb|CBI40438.3| unnamed protein product [Vitis vinifera]

 Score =  679 bits (1752), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/441 (74%), Positives = 377/441 (85%), Gaps = 2/441 (0%)

Query: 3    KSQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVA 62
            K+ N +Y  R+  +G R TPDR  YSP +   +AS+++  ++ +N + MA K+VAG+FV+
Sbjct: 639  KNPNLMYGNRNHGSGARRTPDRLTYSPSTVDYDASSIQKSRSGRNPMMMAVKSVAGVFVS 698

Query: 63   CFTPPETNSSKDFVNSNEFK-PSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSG 121
            CFTPPET SSK+F +S+EF+ PS  SD SR+ +   R   SS G+Y +S NST G  + G
Sbjct: 699  CFTPPETTSSKNFGDSDEFRAPSVASDVSRAGSVRRRVSGSSHGIYANSYNSTHG-REPG 757

Query: 122  NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ 181
            +V+ T+EEIY+ATRNFSPS+KIGQGGFGTVYKGRLEDGT+VA+KRAKKS+YDKH G EFQ
Sbjct: 758  SVKFTLEEIYKATRNFSPSWKIGQGGFGTVYKGRLEDGTLVAVKRAKKSLYDKHLGVEFQ 817

Query: 182  SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
            SEI+TLAQVEHLNLV+F+GYLE  DERIV+VEYVPNGTLREHLDC+QGNILD A RLD+A
Sbjct: 818  SEIQTLAQVEHLNLVRFYGYLEHGDERIVVVEYVPNGTLREHLDCVQGNILDFAARLDVA 877

Query: 242  IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
            IDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN RAKVADFGFARLAADTESGATHVSTQ
Sbjct: 878  IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENLRAKVADFGFARLAADTESGATHVSTQ 937

Query: 302  VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF 361
            VKGTAGYLDPEYL+TYQLTEKSDVYSFGVLLVELVTGR PIE KREL ERIT KWAMKKF
Sbjct: 938  VKGTAGYLDPEYLRTYQLTEKSDVYSFGVLLVELVTGRCPIEAKRELPERITAKWAMKKF 997

Query: 362  SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE 421
            +DGDAI  LDPR+E  AANNLALEKILELALQCLAP++QNRPSMRRCAEILWS+RKD+RE
Sbjct: 998  TDGDAIFTLDPRLERNAANNLALEKILELALQCLAPQKQNRPSMRRCAEILWSIRKDHRE 1057

Query: 422  LAASDVLLQPSYSKRSNSTRE 442
            L+ASD     S+S++S   RE
Sbjct: 1058 LSASDTRSLSSHSQKSIQLRE 1078

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225454361|ref|XP_002278521.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330 [Vitis vinifera]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/441 (74%), Positives = 377/441 (85%), Gaps = 2/441 (0%)

Query: 3   KSQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVA 62
           K+ N +Y  R+  +G R TPDR  YSP +   +AS+++  ++ +N + MA K+VAG+FV+
Sbjct: 2   KNPNLMYGNRNHGSGARRTPDRLTYSPSTVDYDASSIQKSRSGRNPMMMAVKSVAGVFVS 61

Query: 63  CFTPPETNSSKDFVNSNEFK-PSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSG 121
           CFTPPET SSK+F +S+EF+ PS  SD SR+ +   R   SS G+Y +S NST G  + G
Sbjct: 62  CFTPPETTSSKNFGDSDEFRAPSVASDVSRAGSVRRRVSGSSHGIYANSYNSTHG-REPG 120

Query: 122 NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ 181
           +V+ T+EEIY+ATRNFSPS+KIGQGGFGTVYKGRLEDGT+VA+KRAKKS+YDKH G EFQ
Sbjct: 121 SVKFTLEEIYKATRNFSPSWKIGQGGFGTVYKGRLEDGTLVAVKRAKKSLYDKHLGVEFQ 180

Query: 182 SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
           SEI+TLAQVEHLNLV+F+GYLE  DERIV+VEYVPNGTLREHLDC+QGNILD A RLD+A
Sbjct: 181 SEIQTLAQVEHLNLVRFYGYLEHGDERIVVVEYVPNGTLREHLDCVQGNILDFAARLDVA 240

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           IDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN RAKVADFGFARLAADTESGATHVSTQ
Sbjct: 241 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENLRAKVADFGFARLAADTESGATHVSTQ 300

Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF 361
           VKGTAGYLDPEYL+TYQLTEKSDVYSFGVLLVELVTGR PIE KREL ERIT KWAMKKF
Sbjct: 301 VKGTAGYLDPEYLRTYQLTEKSDVYSFGVLLVELVTGRCPIEAKRELPERITAKWAMKKF 360

Query: 362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE 421
           +DGDAI  LDPR+E  AANNLALEKILELALQCLAP++QNRPSMRRCAEILWS+RKD+RE
Sbjct: 361 TDGDAIFTLDPRLERNAANNLALEKILELALQCLAPQKQNRPSMRRCAEILWSIRKDHRE 420

Query: 422 LAASDVLLQPSYSKRSNSTRE 442
           L+ASD     S+S++S   RE
Sbjct: 421 LSASDTRSLSSHSQKSIQLRE 441

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127718|ref|XP_002320146.1| predicted protein [Populus trichocarpa] gi|222860919|gb|EEE98461.1| predicted protein [Populus trichocarpa]

 Score =  634 bits (1635), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 317/426 (74%), Positives = 359/426 (84%), Gaps = 8/426 (1%)

Query: 3   KSQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVA 62
           KS    Y  R+P++GV  TPD   YSP S    + +   ++   N L++AAK++AG+FVA
Sbjct: 2   KSPYSRYARRTPASGVGHTPDCVPYSPTSSSHSSGSTLKKR---NPLSVAAKSMAGVFVA 58

Query: 63  CFTPPET--NSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQS 120
           CFTPPE   NSSKDF  S E K   V  AS +    ERRRSS +G+Y S  NS  G  + 
Sbjct: 59  CFTPPEPEPNSSKDFGYSEELKAPSV--ASSTSGGNERRRSSRRGIYSSPANSVHG-REP 115

Query: 121 GNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEF 180
           G+V  TMEEI  ATRNFSP+FKIGQGGFGTVYKGR +DGT+VAIKRAKKSVYDKH G EF
Sbjct: 116 GSVNFTMEEINAATRNFSPTFKIGQGGFGTVYKGRFQDGTVVAIKRAKKSVYDKHLGVEF 175

Query: 181 QSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI 240
           QSEIRTLAQVEHLNLVKF+GYLE EDERIV+VEYV NGTLREHLDC+ GN++DLA RLDI
Sbjct: 176 QSEIRTLAQVEHLNLVKFYGYLEHEDERIVLVEYVANGTLREHLDCIHGNVIDLAVRLDI 235

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
           AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD++SGATHVST
Sbjct: 236 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADSDSGATHVST 295

Query: 301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK 360
           QVKGTAGYLDPEYL+TYQLTEKSDVYSFGVLLVELVTGRRPIE KRE+KERIT KWA+KK
Sbjct: 296 QVKGTAGYLDPEYLRTYQLTEKSDVYSFGVLLVELVTGRRPIEAKREIKERITAKWAIKK 355

Query: 361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
           F++G+A+ ILDP+++ TAANNLALEKILELALQCLAP RQ+RPSMR+CAEILWS+RKDY+
Sbjct: 356 FAEGNAVLILDPKLKCTAANNLALEKILELALQCLAPHRQSRPSMRKCAEILWSIRKDYK 415

Query: 421 ELAASD 426
           E +ASD
Sbjct: 416 EQSASD 421

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357504419|ref|XP_003622498.1| Receptor-like protein kinase ANXUR2 [Medicago truncatula] gi|355497513|gb|AES78716.1| Receptor-like protein kinase ANXUR2 [Medicago truncatula]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 305/433 (70%), Positives = 364/433 (84%), Gaps = 3/433 (0%)

Query: 12  RSPSTGVRSTPDRFFYSPG-SHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFTPPETN 70
           RS  +G RSTPDR   S   S   +++T  +   S+N +  AA +VAGLF ACFTPP+++
Sbjct: 9   RSQHSGHRSTPDRMSRSSDFSTSVQSTTSSSSSGSRNPVVAAAMSVAGLFAACFTPPDSS 68

Query: 71  SSKDFVNSNEFKPSPVSDASR-SRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEE 129
           +SK  V+S EFK +  S AS  SRA ++R R S++G  +   N+ +G ++SG V+ TMEE
Sbjct: 69  NSKSVVDSEEFKSTSTSVASNASRAGSQRGRGSNRGTNIGLYNTIQG-NESGIVKYTMEE 127

Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           I +ATRNFSPSFKIGQGGFG VYK +L DGTIVA+KRAKKSV++K+ G+EFQSE++TL++
Sbjct: 128 IIQATRNFSPSFKIGQGGFGAVYKTKLLDGTIVAVKRAKKSVHEKNLGSEFQSEVQTLSR 187

Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           VEHLNLVKF+GYLE  DERIV+VEYVPNGTLREHLDC+ GN+LDLA RLDIAIDV+HA+T
Sbjct: 188 VEHLNLVKFYGYLEQGDERIVVVEYVPNGTLREHLDCIHGNVLDLAARLDIAIDVSHALT 247

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLHMY DHPIIHRDIKSSNILLTE+FRAKVADFGFAR A D++SG THVSTQVKGTAGYL
Sbjct: 248 YLHMYMDHPIIHRDIKSSNILLTEHFRAKVADFGFARQAPDSDSGMTHVSTQVKGTAGYL 307

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK ELKERITVKWAMK+F DG+AIS+
Sbjct: 308 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKFELKERITVKWAMKRFIDGNAISV 367

Query: 370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLL 429
           LD R++ T+ANNLALEKILELALQCLAP RQNRP+M+RCAEILW++RKDYRE++AS+   
Sbjct: 368 LDTRLDQTSANNLALEKILELALQCLAPHRQNRPNMKRCAEILWAIRKDYREISASNFRS 427

Query: 430 QPSYSKRSNSTRE 442
             + S+RS S RE
Sbjct: 428 YSTTSQRSASLRE 440

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351727172|ref|NP_001235360.1| calmodulin-binding receptor-like cytoplasmic kinase [Glycine max] gi|223452470|gb|ACM89562.1| calmodulin-binding receptor-like cytoplasmic kinase [Glycine max]

 Score =  608 bits (1567), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 301/439 (68%), Positives = 356/439 (81%), Gaps = 5/439 (1%)

Query: 6   NPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFT 65
           +P    R  S+  R+ P+R   SPG   SE ST       +NS++  AK+ AG+F  CF+
Sbjct: 3   SPYTPRRRSSSDHRTRPERAPPSPGYASSEFSTSSTVSAHRNSVSAVAKSFAGIFAGCFS 62

Query: 66  PPETNSSKDFVNSNEFKPSP-VSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQ 124
           PP++++SK   +S EFK S  VS+ASR  A ++R   S +G  +SS N      + G+V+
Sbjct: 63  PPDSDNSKSLGDSEEFKSSSTVSNASR--AGSQRGHGSKRGTSISSYN-ILPAKEPGSVE 119

Query: 125 ITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
            TMEEI+R TRNFSPSFKIGQGGFG VY+ +L DGT+VA+KRAKKSVY+KH G EFQSEI
Sbjct: 120 FTMEEIFRVTRNFSPSFKIGQGGFGAVYRAKLLDGTVVAVKRAKKSVYEKHLGVEFQSEI 179

Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDV 244
           +TL++VEHLNLVKF GYLE EDERI++VEYVPNGTLREHLDC+ G++LDLA RLDIAIDV
Sbjct: 180 QTLSRVEHLNLVKFFGYLEQEDERIIVVEYVPNGTLREHLDCIHGSVLDLAARLDIAIDV 239

Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKG 304
           +HAITYLHMY DHPIIHRDIKSSNILLTENFRAKVADFGFAR A D++SG THVSTQVKG
Sbjct: 240 SHAITYLHMYIDHPIIHRDIKSSNILLTENFRAKVADFGFARQAPDSDSGMTHVSTQVKG 299

Query: 305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG 364
           TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK ELKERIT +WAMK+F +G
Sbjct: 300 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKFELKERITARWAMKRFIEG 359

Query: 365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE-LA 423
           DAIS+LDPR++  AAN LALEKILELALQCLAPRRQ+RP+M+RCAEILWS+RKD RE L+
Sbjct: 360 DAISVLDPRLDQIAANTLALEKILELALQCLAPRRQSRPTMKRCAEILWSIRKDIREQLS 419

Query: 424 ASDVLLQPSYSKRSNSTRE 442
           AS+     + S+RS S +E
Sbjct: 420 ASNFRSFSTSSQRSTSLKE 438

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255541648|ref|XP_002511888.1| ATP binding protein, putative [Ricinus communis] gi|223549068|gb|EEF50557.1| ATP binding protein, putative [Ricinus communis]

 Score =  603 bits (1555), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 315/423 (74%), Positives = 350/423 (82%), Gaps = 14/423 (3%)

Query: 4   SQNPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVAC 63
           S N +Y  R+  +  RSTPD   YSP S YS+ASTV   K  +N LA AAK++AG+FVAC
Sbjct: 3   SPNYMYGRRNARSVTRSTPDHLQYSPSSSYSDASTV---KKQQNPLAAAAKSLAGVFVAC 59

Query: 64  FTPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNV 123
           FTPPE  SS ++ +S    PS VSD SR R  +  R +    +Y S  NSTRG      +
Sbjct: 60  FTPPEPTSSTNYGDSG--PPSVVSDGSRDRRRSSGRGT----IYGSPQNSTRG-----RI 108

Query: 124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE 183
           + TM+EIY+ATRNFSPS KIGQGGFGTVYKGRL DGT VAIKRAKKSVYDKH G EFQSE
Sbjct: 109 KFTMDEIYKATRNFSPSSKIGQGGFGTVYKGRLNDGTFVAIKRAKKSVYDKHLGVEFQSE 168

Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID 243
           IRTLAQVEHLNLV  +G+LE EDERIV+VEYVPNGTLREHLDC+  ++LDLA RLDIAID
Sbjct: 169 IRTLAQVEHLNLVNLYGFLEHEDERIVVVEYVPNGTLREHLDCMHRDVLDLATRLDIAID 228

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           VAHA+TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD ESGATHVSTQVK
Sbjct: 229 VAHAVTYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADAESGATHVSTQVK 288

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD 363
           GTAGYLDPEYLKTYQLT+KSDVYSFGVLLVELVTGRRPIEPKRELKERIT +WAMKKFS+
Sbjct: 289 GTAGYLDPEYLKTYQLTDKSDVYSFGVLLVELVTGRRPIEPKRELKERITARWAMKKFSE 348

Query: 364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA 423
           GDAIS LDPR+E T  NNL LEKILELALQCLA RRQ+RPSM++C EILW +RKD +E+A
Sbjct: 349 GDAISTLDPRLERTPVNNLLLEKILELALQCLALRRQSRPSMKQCVEILWGIRKDCKEIA 408

Query: 424 ASD 426
            SD
Sbjct: 409 GSD 411

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520390|ref|XP_003528845.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Glycine max]

 Score =  598 bits (1541), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 297/439 (67%), Positives = 354/439 (80%), Gaps = 3/439 (0%)

Query: 6   NPLYEGRSPSTGVRSTPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFT 65
           +P    R  S+  R+TP R   SP    SE ST     T +N ++  AK+ AG+F  CF 
Sbjct: 3   SPYAPRRRSSSDHRTTPGRAPPSPSFASSELSTSSTVSTHRNPVSAVAKSFAGIFAGCFA 62

Query: 66  PPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQI 125
            P+ ++SK   +S EFK S  S ++ SRA ++R R S++G+ +SS N      + G V+ 
Sbjct: 63  RPDFDNSKSLGDSEEFKSS-SSVSNASRAGSQRGRGSNRGISISSYN-ILPAKEPGIVKF 120

Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIR 185
           TMEEI+R TRNFSPSFKIGQGGFG VYK +L DGT+VA+KRAKKS+Y+KH G EFQSEI+
Sbjct: 121 TMEEIFRVTRNFSPSFKIGQGGFGAVYKAKLLDGTVVAVKRAKKSMYEKHLGVEFQSEIQ 180

Query: 186 TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVA 245
           TL++VEHLNLVKF GYLE EDERI++VE+VPNGTLREHLDC+ G++LDLA RLDIAIDV+
Sbjct: 181 TLSRVEHLNLVKFFGYLEQEDERIIVVEHVPNGTLREHLDCIHGSVLDLAARLDIAIDVS 240

Query: 246 HAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
           HAITYLHMY DHPIIHRDIKSSNILLTENFRAKVADFGFAR A D++SG TH+STQ+KGT
Sbjct: 241 HAITYLHMYIDHPIIHRDIKSSNILLTENFRAKVADFGFARQAPDSDSGMTHISTQIKGT 300

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD 365
           AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK EL+ERIT KWAMK+F DGD
Sbjct: 301 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKFELRERITAKWAMKRFIDGD 360

Query: 366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE-LAA 424
           AIS+LDPR++ T AN LALEKILELALQCLAPRRQ RP+M+RCAEILWS+RKD+RE L+A
Sbjct: 361 AISVLDPRLDQTTANTLALEKILELALQCLAPRRQIRPTMKRCAEILWSIRKDFREQLSA 420

Query: 425 SDVLLQPSYSKRSNSTREQ 443
           S+     + S+RS S +E+
Sbjct: 421 SNFRSFSTSSQRSTSIKEK 439

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224064051|ref|XP_002301367.1| predicted protein [Populus trichocarpa] gi|222843093|gb|EEE80640.1| predicted protein [Populus trichocarpa]

 Score =  570 bits (1470), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 268/338 (79%), Positives = 307/338 (90%), Gaps = 1/338 (0%)

Query: 89  ASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGF 148
            S +  S+ERR+ S++G+Y S  NS R   + G+V  TMEEIY ATRNFSP+FKIGQG F
Sbjct: 11  VSNTSGSSERRQGSNRGIYSSPFNSVRE-REPGSVNFTMEEIYTATRNFSPTFKIGQGDF 69

Query: 149 GTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER 208
           GTVYKGRL+DGT VAIKRAKKSV DKH G EFQSEIRTLAQVEHL+LVKF+GYLE EDER
Sbjct: 70  GTVYKGRLQDGTAVAIKRAKKSVNDKHLGEEFQSEIRTLAQVEHLHLVKFYGYLEHEDER 129

Query: 209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSN 268
           IV++EYVPNGTLREHLDC+ GN++DLA R+DIAIDVAHA+TYLHMYTDHPIIHRDIKSSN
Sbjct: 130 IVLMEYVPNGTLREHLDCMHGNVIDLAVRVDIAIDVAHAVTYLHMYTDHPIIHRDIKSSN 189

Query: 269 ILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSF 328
           ILLTENFRAKVADFGFARLAAD +SGATHVSTQVKGTAGYLDPEY++TYQLTEKSDVYSF
Sbjct: 190 ILLTENFRAKVADFGFARLAADRDSGATHVSTQVKGTAGYLDPEYMRTYQLTEKSDVYSF 249

Query: 329 GVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKIL 388
           GVLLVEL+TGRRP+EP+RE+KER+T KWA+KKF++G+AI ILDP++E TAANNLALEKIL
Sbjct: 250 GVLLVELMTGRRPVEPEREIKERLTAKWAIKKFAEGNAIVILDPKLERTAANNLALEKIL 309

Query: 389 ELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
           ELALQCLAP RQ+RPSMR+CAE+LWS+RKDY+E + SD
Sbjct: 310 ELALQCLAPGRQSRPSMRKCAEVLWSIRKDYKEQSTSD 347

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449432138|ref|XP_004133857.1| PREDICTED: calmodulin-binding receptor-like cytoplasmic kinase 2-like [Cucumis sativus] gi|449480223|ref|XP_004155834.1| PREDICTED: calmodulin-binding receptor-like cytoplasmic kinase 2-like [Cucumis sativus]

 Score =  554 bits (1428), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 287/423 (67%), Positives = 336/423 (79%), Gaps = 12/423 (2%)

Query: 21  TPDRFFYSPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNE 80
           TP  F YSP    S     R+R    N +  AA++VAG F +CFTPPE  +       +E
Sbjct: 40  TPVYFPYSPSPDVSVGMESRSRL---NPVKAAARSVAGAFTSCFTPPEKETPPSLGFGSE 96

Query: 81  FKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPS 140
           F+ S  SDAS   +   RR   S+    SS+N +    + G+++I +EEI +AT+NFS S
Sbjct: 97  FRNS--SDAS---SHNGRRNQGSRREPRSSSNLSHD-REPGSLRINIEEIRKATKNFSVS 150

Query: 141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            KIGQGGFG+VYKG+L DG +VAIKRAKKSVYD + G EF+SEI+TLAQVEHLNLVKF+G
Sbjct: 151 SKIGQGGFGSVYKGKL-DGVLVAIKRAKKSVYDNNLGLEFKSEIQTLAQVEHLNLVKFYG 209

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           YLE +DERIVIVEYVPNGTLREHL+C+ G +LDLA RL IA DVAHAITYLHMYTD PII
Sbjct: 210 YLEHQDERIVIVEYVPNGTLREHLECIHGTVLDLATRLAIATDVAHAITYLHMYTDRPII 269

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRDIKSSNILLTEN+RAKVADFGFARLAAD +  ATHVSTQVKGTAGYLDPEYLKTYQLT
Sbjct: 270 HRDIKSSNILLTENYRAKVADFGFARLAADGD--ATHVSTQVKGTAGYLDPEYLKTYQLT 327

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           EKSD+YSFGVLLVELVTGRRPIEPKREL++RIT KWAMKKFS+G+A +ILDP +E T AN
Sbjct: 328 EKSDIYSFGVLLVELVTGRRPIEPKRELEQRITPKWAMKKFSEGEASAILDPNLEQTEAN 387

Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPSYSKRSNST 440
           +LA+EKILELALQCLAPRR +RPSMRRCAEILW +RKD+R+L+A D     + S+RS S 
Sbjct: 388 HLAVEKILELALQCLAPRRHSRPSMRRCAEILWRIRKDHRDLSAPDFRSFSTNSQRSASV 447

Query: 441 REQ 443
           RE+
Sbjct: 448 REK 450

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	443
TAIR|locus:2126011	411	CRCK2 "calmodulin-binding rece	0.830	0.895	0.628	1.3e-125
TAIR|locus:2154563	470	CRCK1 "calmodulin-binding rece	0.735	0.693	0.575	5.8e-98
TAIR|locus:2041735	510	CRCK3 "calmodulin-binding rece	0.668	0.580	0.545	1.7e-84
TAIR|locus:2156992	946	AT5G49770 [Arabidopsis thalian	0.647	0.303	0.456	1e-59
TAIR|locus:2157042	953	AT5G49760 [Arabidopsis thalian	0.659	0.306	0.451	1.8e-59
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.659	0.300	0.453	7.3e-59
TAIR|locus:2157002	857	AT5G49780 [Arabidopsis thalian	0.654	0.338	0.443	1.7e-57
TAIR|locus:2078196	871	AT3G46350 [Arabidopsis thalian	0.629	0.320	0.420	4.8e-56
TAIR|locus:2204564	849	HERK2 "hercules receptor kinas	0.634	0.330	0.444	6.2e-56
UNIPROTKB|O24585	901	CR4 "Putative receptor protein	0.641	0.315	0.424	7.3e-56

TAIR|locus:2126011 CRCK2 "calmodulin-binding receptor-like cytoplasmic kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1234 (439.4 bits), Expect = 1.3e-125, P = 1.3e-125
 Identities = 240/382 (62%), Positives = 296/382 (77%)

Query:    43 KTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVXXXXXXXXXXXXXXXX 102
             +TS ++    A+ ++G+F+ CFTPP++ SS    NS     + +                
Sbjct:    37 RTSTDTTTSIARRISGIFINCFTPPDSVSSNYIDNSKSSSDNNIRSRRSSTGSSSV---- 92

Query:   103 XQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIV 162
              Q  Y ++N       ++ + + T +EIY AT+NFSPSF+IGQGGFGTVYK +L DG   
Sbjct:    93 -QRSYGNAN-------ETEHTRFTFDEIYDATKNFSPSFRIGQGGFGTVYKVKLRDGKTF 144

Query:   163 AIKRAKKSVYDKHSGA--EFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL 220
             A+KRAKKS++D   GA  EF SEI+TLAQV HL+LVK++G++   DE+I++VEYV NGTL
Sbjct:   145 AVKRAKKSMHDDRQGADAEFMSEIQTLAQVTHLSLVKYYGFVVHNDEKILVVEYVANGTL 204

Query:   221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVA 280
             R+HLDC +G  LD+A RLDIA DVAHAITYLHMYT  PIIHRDIKSSNILLTEN+RAKVA
Sbjct:   205 RDHLDCKEGKTLDMATRLDIATDVAHAITYLHMYTQPPIIHRDIKSSNILLTENYRAKVA 264

Query:   281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRR 340
             DFGFARLA DT+SGATHVSTQVKGTAGYLDPEYL TYQLTEKSDVYSFGVLLVEL+TGRR
Sbjct:   265 DFGFARLAPDTDSGATHVSTQVKGTAGYLDPEYLTTYQLTEKSDVYSFGVLLVELLTGRR 324

Query:   341 PIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQ 400
             PIE  R  KERIT++WA+KKF+ GD IS+LDP++E  +ANNLALEK+LE+A QCLAP R+
Sbjct:   325 PIELSRGQKERITIRWAIKKFTSGDTISVLDPKLEQNSANNLALEKVLEMAFQCLAPHRR 384

Query:   401 NRPSMRRCAEILWSVRKDYREL 422
             +RPSM++C+EILW +RKDYREL
Sbjct:   385 SRPSMKKCSEILWGIRKDYREL 406

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

TAIR|locus:2154563 CRCK1 "calmodulin-binding receptor-like cytoplasmic kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
 Identities = 190/330 (57%), Positives = 257/330 (77%)

Query:   111 NNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKS 170
             ++S++   Q G V  +  E+ RAT NFS   +IG+GGFGTV+KG+L+DGTIVAIKRA+K+
Sbjct:   122 SSSSKSWHQ-GPVIFSFGELQRATANFSSVHQIGEGGFGTVFKGKLDDGTIVAIKRARKN 180

Query:   171 VYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN 230
              Y K    EF++EI TL+++EH+NLVK +G+LE  DE++++VEYV NG LREHLD L+GN
Sbjct:   181 NYGKSWLLEFKNEIYTLSKIEHMNLVKLYGFLEHGDEKVIVVEYVANGNLREHLDGLRGN 240

Query:   231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
              L++A RL+IAIDVAHA+TYLH YTD PIIHRDIK+SNIL+T   RAKVADFGFARL ++
Sbjct:   241 RLEMAERLEIAIDVAHALTYLHTYTDSPIIHRDIKASNILITNKLRAKVADFGFARLVSE 300

Query:   291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE 350
              + GATH+STQVKG+AGY+DP+YL+T+QLT+KSDVYSFGVLLVE++TGRRPIE KR  K+
Sbjct:   301 -DLGATHISTQVKGSAGYVDPDYLRTFQLTDKSDVYSFGVLLVEILTGRRPIELKRPRKD 359

Query:   351 RITVKWAMKKFSDGDAISILDPRVE-NTAANNLALEKILELALQCLAPRRQNRPSMRRCA 409
             R+TVKWA+++  D +A+ I+DP ++ N AA  +A EK+L LA +C+ P R  RP+M+  A
Sbjct:   360 RLTVKWALRRLKDDEAVLIMDPFLKRNRAAIEVA-EKMLRLASECVTPTRATRPAMKGIA 418

Query:   410 EILWSVRKDYRELAASDVLLQPSYSKRSNS 439
             E LW++R++ +E          S S  ++S
Sbjct:   419 EKLWAIRREMKETMICSSASNSSCSSTTHS 448

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0042542 "response to hydrogen peroxide" evidence=IEP

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2041735 CRCK3 "calmodulin-binding receptor-like cytoplasmic kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
 Identities = 163/299 (54%), Positives = 212/299 (70%)

Query:   121 GNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEF 180
             G + +TM +I  AT NF+ S +IG+GGFG V+KG L+DG +VAIKRAKK  ++ +   EF
Sbjct:   209 GPLNLTMSQINTATGNFADSHQIGEGGFGVVFKGVLDDGQVVAIKRAKKEHFE-NLRTEF 267

Query:   181 QSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI 240
             +SE+  L+++ H NLVK  GY++  DER++I EYV NGTLR+HLD  +G  L+   RL+I
Sbjct:   268 KSEVDLLSKIGHRNLVKLLGYVDKGDERLIITEYVRNGTLRDHLDGARGTKLNFNQRLEI 327

Query:   241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
              IDV H +TYLH Y +  IIHRDIKSSNILLT++ RAKVADFGFAR    T+S  TH+ T
Sbjct:   328 VIDVCHGLTYLHSYAERQIIHRDIKSSNILLTDSMRAKVADFGFAR-GGPTDSNQTHILT 386

Query:   301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK 360
             QVKGT GYLDPEY+KTY LT KSDVYSFG+LLVE++TGRRP+E KR   ERITV+WA  K
Sbjct:   387 QVKGTVGYLDPEYMKTYHLTAKSDVYSFGILLVEILTGRRPVEAKRLPDERITVRWAFDK 446

Query:   361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
             +++G    ++DP         + L K+  LA QC AP ++ RP M    + LW++R  Y
Sbjct:   447 YNEGRVFELVDPNARERVDEKI-LRKMFSLAFQCAAPTKKERPDMEAVGKQLWAIRSSY 504

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)]

 Score = 617 (222.3 bits), Expect = 1.0e-59, P = 1.0e-59
 Identities = 136/298 (45%), Positives = 186/298 (62%)

Query:   121 GNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA-E 179
             G    T EE+ + T NFS +  +G GG+G VYKG L +G ++AIKRA++       GA E
Sbjct:   618 GTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG---SMQGAFE 674

Query:   180 FQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD 239
             F++EI  L++V H N+VK  G+   + E++++ EY+PNG+LR+ L    G  LD   RL 
Sbjct:   675 FKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLK 734

Query:   240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
             IA+     + YLH   D PIIHRD+KS+NILL E+  AKVADFG ++L  D E    HV+
Sbjct:   735 IALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKA--HVT 792

Query:   300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP-KRELKERITVKWAM 358
             TQVKGT GYLDPEY  T QLTEKSDVY FGV+++EL+TG+ PI+     +KE   VK  M
Sbjct:   793 TQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKE---VKKKM 849

Query:   359 KKFSD-GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV 415
              K  +  D   +LD  +   + N    EK +++ALQC+ P   NRP+M    + L S+
Sbjct:   850 DKSRNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESI 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)]

 Score = 615 (221.5 bits), Expect = 1.8e-59, P = 1.8e-59
 Identities = 134/297 (45%), Positives = 183/297 (61%)

Query:   109 SSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAK 168
             +S +S       G    T EE+ + T NFS +  +G GG+G VY+G L +G ++AIKRA+
Sbjct:   603 TSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQ 662

Query:   169 KSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ 228
             +       G EF++EI  L++V H N+V+  G+    +E++++ EY+ NG+L++ L    
Sbjct:   663 QG--SLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKS 720

Query:   229 GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA 288
             G  LD   RL IA+     + YLH   D PIIHRDIKS+NILL EN  AKVADFG ++L 
Sbjct:   721 GIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLV 780

Query:   289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKREL 348
              D E   THV+TQVKGT GYLDPEY  T QLTEKSDVY FGV+L+EL+TGR PIE  + +
Sbjct:   781 GDPEK--THVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYV 838

Query:   349 KERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSM 405
                +  K   K  S  D   +LD  +  ++ N    EK ++LAL+C+     NRPSM
Sbjct:   839 VREVKTKMN-KSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSM 894

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0044242 "cellular lipid catabolic process" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 610 (219.8 bits), Expect = 7.3e-59, P = 7.3e-59
 Identities = 137/302 (45%), Positives = 185/302 (61%)

Query:   107 YVSSNNSTRGGDQ-SGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIK 165
             + SS   + G  Q  G    + EE+ + T NFS S ++G GG+G VYKG L+DG +VAIK
Sbjct:   607 WASSGKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIK 666

Query:   166 RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLD 225
             RA++       G EF++EI  L++V H NLV   G+   + E+I++ EY+ NG+L++ L 
Sbjct:   667 RAQQG--STQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLT 724

Query:   226 CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA 285
                G  LD   RL +A+  A  + YLH   D PIIHRD+KS+NILL EN  AKVADFG +
Sbjct:   725 GRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLS 784

Query:   286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK 345
             +L +D   G  HVSTQVKGT GYLDPEY  T +LTEKSDVYSFGV+++EL+T ++PIE  
Sbjct:   785 KLVSDCTKG--HVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKG 842

Query:   346 RELKERITVKWAMKKFSDGDAISILDP--RVENTAANNLALEKILELALQCLAPRRQNRP 403
             + +   I  K  M K SD D   + D   R          L + +ELAL+C+      RP
Sbjct:   843 KYIVREI--KLVMNK-SDDDFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADERP 899

Query:   404 SM 405
             +M
Sbjct:   900 TM 901

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)]

 Score = 593 (213.8 bits), Expect = 1.7e-57, P = 1.7e-57
 Identities = 133/300 (44%), Positives = 180/300 (60%)

Query:   109 SSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAK 168
             ++ NS       G    T EE+ +   NFS +  +G GG+G VYKG L  G ++AIKRA+
Sbjct:   506 ANQNSVDAPQLMGTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQ 565

Query:   169 KSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ 228
                       EF++EI  L++V H N+VK  G+     E++++ EY+PNG+LR+ L    
Sbjct:   566 PG--SLQGALEFKTEIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKS 623

Query:   229 GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA 288
             G  LD   RL IA+     + YLH   D PIIHRD+KSSN+LL E+  AKVADFG ++L 
Sbjct:   624 GIRLDWTRRLRIALGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQLV 683

Query:   289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP-KRE 347
              D E    +V+ QVKGT GYLDPEY  T QLTEKSDVY FGV+++EL+TG+ PIE  K  
Sbjct:   684 EDAEKA--NVTAQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYV 741

Query:   348 LKERITVKWAMKKFSD-GDAISILDPRVENTAANNL-ALEKILELALQCLAPRRQNRPSM 405
             +KE   +K  M K  +  D    LD  +  T+  NL   EK +++AL+C+ P    RPSM
Sbjct:   742 VKE---MKMKMNKSKNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSM 798

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2078196 AT3G46350 [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
 Identities = 122/290 (42%), Positives = 178/290 (61%)

Query:   124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE 183
             + +  E+ + T NF  +  +G+GGFGTVY G L+    VA+K   +S    +   EF++E
Sbjct:   553 KFSYSEVMKMTNNFQRA--LGEGGFGTVYHGDLDSSQQVAVKLLSQSSTQGYK--EFKAE 608

Query:   184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQG-NILDLAGRLDIAI 242
             +  L +V H+NL+   GY +  D   +I EY+ NG L+ HL    G ++L    RL IA+
Sbjct:   609 VDLLLRVHHINLLNLVGYCDERDHLALIYEYMSNGDLKHHLSGEHGGSVLSWNIRLRIAV 668

Query:   243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
             D A  + YLH+     ++HRD+KS+NILL ENF AK+ADFG +R  +    G +HVST V
Sbjct:   669 DAALGLEYLHIGCRPSMVHRDVKSTNILLDENFMAKIADFGLSR--SFILGGESHVSTVV 726

Query:   303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS 362
              G+ GYLDPEY +T +L E SDVYSFG++L+E++T +R I+  RE K  IT +W     +
Sbjct:   727 AGSLGYLDPEYYRTSRLAEMSDVYSFGIVLLEIITNQRVIDKTRE-KPHIT-EWTAFMLN 784

Query:   363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRC-AEI 411
              GD   I+DP + N   N+ ++ + LELA+ C  P  +NRPSM +  AE+
Sbjct:   785 RGDITRIMDPNL-NGDYNSHSVWRALELAMSCANPSSENRPSMSQVVAEL 833

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 579 (208.9 bits), Expect = 6.2e-56, P = 6.2e-56
 Identities = 131/295 (44%), Positives = 184/295 (62%)

Query:   124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE 183
             + T+ EI  AT+NF     IG GGFG VY+G LEDGT++AIKRA  + + +   AEF++E
Sbjct:   507 KFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRA--TPHSQQGLAEFETE 564

Query:   184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG--RLDIA 241
             I  L+++ H +LV   G+ +  +E I++ EY+ NGTLR HL     N+  L+   RL+  
Sbjct:   565 IVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHL--FGSNLPPLSWKQRLEAC 622

Query:   242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
             I  A  + YLH  ++  IIHRD+K++NILL ENF AK++DFG ++     +   THVST 
Sbjct:   623 IGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDH--THVSTA 680

Query:   302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV-KWAMKK 360
             VKG+ GYLDPEY +  QLTEKSDVYSFGV+L E V  R  I P    K++I + +WA+  
Sbjct:   681 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLP-KDQINLAEWALSW 739

Query:   361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV 415
                 +  SI+D  +    +   +LEK  E+A +CLA   +NRP M    E+LWS+
Sbjct:   740 QKQRNLESIIDSNLRGNYSPE-SLEKYGEIAEKCLADEGKNRPMM---GEVLWSL 790

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)]

 Score = 561 (202.5 bits), Expect = 7.3e-56, Sum P(2) = 7.3e-56
 Identities = 124/292 (42%), Positives = 185/292 (63%)

Query:   124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE 183
             + + EE+ +AT  FS   ++G+G F  V+KG L DGT+VA+KRA K+   K S  EF +E
Sbjct:   492 EFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHNE 551

Query:   184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI---LDLAGRLDI 240
             +  L+++ H +L+   GY E   ER+++ E++ +G+L +HL     N+   L+ A R+ I
Sbjct:   552 LDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTI 611

Query:   241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
             A+  A  I YLH Y   P+IHRDIKSSNIL+ E+  A+VADFG + L    +SG T +S 
Sbjct:   612 AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGP-ADSG-TPLSE 669

Query:   301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK 360
                GT GYLDPEY + + LT KSDVYSFGV+L+E+++GR+ I+   + +E   V+WA+  
Sbjct:   670 LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAID--MQFEEGNIVEWAVPL 727

Query:   361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                GD  +ILDP V +  ++  AL+KI  +A +C+  R ++RPSM +    L
Sbjct:   728 IKAGDIFAILDP-VLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTAL 778

GO:0042803 "protein homodimerization activity" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8VZJ9	CRCK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.6361	0.8306	0.8953	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	443
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-42
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-39
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-37
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-33
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-27
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-27
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-26
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-26
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-25
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-20
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-19
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-15
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.001
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.002
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.002
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.003
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  180 bits (458), Expect = 7e-54
 Identities = 85/279 (30%), Positives = 133/279 (47%), Gaps = 34/279 (12%)

Query: 142 KIGQGGFGTVYKGRLEDG-----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           K+G+G FG VYKG L+         VA+K  K+   ++    EF  E R + +++H N+V
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI-EEFLREARIMRKLDHPNIV 64

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           K  G    E+  ++++EY+P G L ++L   +   L L+  L  A+ +A  + YL     
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N L+ EN   K++DFG +R   D      +     K    ++ PE LK 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPR 373
            + T KSDV+SFGVLL E+ T G  P       E+ E +   + +             P+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL-------------PK 225

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
             N         ++ +L LQC A   ++RP+     EIL
Sbjct: 226 PPNCP------PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (455), Expect = 2e-53
 Identities = 85/279 (30%), Positives = 129/279 (46%), Gaps = 34/279 (12%)

Query: 142 KIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           K+G+G FG VYKG L        T VA+K  K+    +    EF  E   + ++ H N+V
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLSHPNIV 64

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           +  G     +   ++ EY+P G L + L    G  L L   L +A+ +A  + YL     
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGYLDPEYL 314
              +HRD+ + N L+TEN   K++DFG +R   + +        +  +K  A    PE L
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA----PESL 176

Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
           K  + T KSDV+SFGVLL E+ T G +P  P    +E       ++   DG        R
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEE------VLELLEDG-------YR 222

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +          +++ EL LQC A   ++RP+     E L
Sbjct: 223 LP---RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  177 bits (451), Expect = 7e-53
 Identities = 79/280 (28%), Positives = 119/280 (42%), Gaps = 45/280 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G+G FG VY  R  + G +VAIK  KK    K        EI+ L +++H N+V+ + 
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR-ERILREIKILKKLKHPNIVRLYD 64

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E ED+  +++EY   G L + L   +   L           +  A+ YLH      I+
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALEYLH---SKGIV 119

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+K  NILL E+   K+ADFG AR     E     ++T V GT  Y+ PE L      
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGE----KLTTFV-GTPEYMAPEVLLGKGYG 174

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKREL--------KERITVKWAMKKFSDGDAISILDP 372
           +  D++S GV+L EL+TG+ P     +L        K +          S  +A  ++  
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP-EAKDLIR- 232

Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                               + L    + R +     E L
Sbjct: 233 --------------------KLLVKDPEKRLT---AEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (447), Expect = 9e-53
 Identities = 73/196 (37%), Positives = 105/196 (53%), Gaps = 12/196 (6%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+GGFGTVY  R  + G  VAIK  KK         E   EI  L ++ H N+VK +G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGV 59

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
            E E+   +++EY   G+L++ L   +G  L     L I + +   + YLH    + IIH
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 262 RDIKSSNILLTE-NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ-L 319
           RD+K  NILL   N + K+ADFG ++L    +S    +   + GT  Y+ PE L      
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LLKTIVGTPAYMAPEVLLGKGYY 171

Query: 320 TEKSDVYSFGVLLVEL 335
           +EKSD++S GV+L EL
Sbjct: 172 SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  175 bits (446), Expect = 4e-52
 Identities = 83/279 (29%), Positives = 132/279 (47%), Gaps = 35/279 (12%)

Query: 142 KIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           K+G+G FG VYKG+L+         VA+K  K+   ++    EF  E R + +++H N+V
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI-EEFLREARIMRKLDHPNVV 64

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           K  G    E+   +++EY+  G L  +L   +  +  L+  L  A+ +A  + YL     
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL-SLSDLLSFALQIARGMEYLE---S 120

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N L+ EN   K++DFG +R   D      +     K    ++ PE LK 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPR 373
            + T KSDV+SFGVLL E+ T G +P       E+ E +   + +             P+
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-------------PQ 224

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
             N         ++ +L LQC A   ++RP+     EIL
Sbjct: 225 PPNCP------PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  173 bits (440), Expect = 3e-51
 Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 43/287 (14%)

Query: 142 KIGQGGFGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           K+G+G FG VYKG+L+      T VA+K  K+    +    +F  E R + ++ H N+V+
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-ASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHL-------DCLQGNILDLAGRLDIAIDVAHAITY 250
             G    E+   +++EY+  G L ++L          + + L L   L  AI +A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGY 308
           L        +HRD+ + N L+ E+   K++DFG +R   D +        +  ++  A  
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA-- 175

Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKERITVKWAMKKFSDGD 365
             PE LK    T KSDV+SFGVLL E+ T G  P       E+ E +   + + K     
Sbjct: 176 --PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK----- 228

Query: 366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                 P            +++ EL L C     ++RP+     E L
Sbjct: 229 ------PE--------YCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  163 bits (415), Expect = 2e-47
 Identities = 86/275 (31%), Positives = 125/275 (45%), Gaps = 29/275 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G FGTVYK +    G IVA+K  KK           + EIR L ++ H N+V+   
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++EY   G L ++L   +G  L       IA+ +   + YLH    + II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL- 319
           HRD+K  NILL EN   K+ADFG A+        ++ ++T V GT  Y+ PE L      
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176

Query: 320 TEKSDVYSFGVLLVELVTGRRP--IEPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
             K DV+S GV+L EL+TG+ P   E   +  + I                  D    ++
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI--------RRILGPPLEFDEPKWSS 228

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            +         +L  +CL      RP+     EIL
Sbjct: 229 GSEEA-----KDLIKKCLNKDPSKRPT---AEEIL 255

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (380), Expect = 3e-42
 Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 24/210 (11%)

Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+G FG+VY    +D G ++A+K  + S   +      + EIR L+ ++H N+V+++G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 201 YLEFEDERI---VIVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYL 251
             E ++E+    + +EYV  G+L   L           G+L           +   + YL
Sbjct: 67  S-ERDEEKNTLNIFLEYVSGGSLSSLLK--------KFGKLPEPVIRKYTRQILEGLAYL 117

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    + I+HRDIK +NIL+  +   K+ADFG A+   D E+G    +  V+GT  ++ P
Sbjct: 118 H---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE--GTGSVRGTPYWMAP 172

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           E ++  +    +D++S G  ++E+ TG+ P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (377), Expect = 5e-42
 Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 31/243 (12%)

Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           F    KIG+GGFG VYK R    G  VAIK  K    +K    +  +EI+ L + +H N+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE--KIINEIQILKKCKHPNI 59

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAIT 249
           VK++G    +DE  +++E+   G+L++ L             L       +  ++   + 
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLK-------STNQTLTESQIAYVCKELLKGLE 112

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH    + IIHRDIK++NILLT +   K+ DFG +   +DT++  T V     GT  ++
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWM 164

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
            PE +       K+D++S G+  +EL  G+ P      +K       A+ K +      +
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIATNGPPGL 217

Query: 370 LDP 372
            +P
Sbjct: 218 RNP 220

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  141 bits (359), Expect = 3e-39
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 16/206 (7%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G FG VY  R   DG +  +K    S   +    +  +E++ L ++ H N++K++ 
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 201 YLEFEDERIVIV-EYVPNGTLREHL-DCLQGNIL---DLAGRLDIAIDVAHAITYLHMYT 255
             E E  ++ IV EY   G L + +    +       +    LD  + +  A+ YLH   
Sbjct: 67  SFE-EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI--LDWFVQLCLALKYLH--- 120

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
              I+HRDIK  NI LT N   K+ DFG +++ + T   A    T V GT  YL PE  +
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK---TVV-GTPYYLSPELCQ 176

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP 341
                 KSD++S G +L EL T + P
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 2e-37
 Identities = 72/214 (33%), Positives = 109/214 (50%), Gaps = 24/214 (11%)

Query: 136 NFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           N+     IG+G FG VYKG  LE G  VAIK+       + +      EI  L  ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVA---HAI 248
           +VK+ G +E  D   +I+EY  NG+LR         I+   G      +A+ V      +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLR--------QIIKKFGPFPESLVAVYVYQVLQGL 112

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAG 307
            YLH   +  +IHRDIK++NIL T++   K+ADFG A +L   ++         V GT  
Sbjct: 113 AYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-----DASVVGTPY 164

Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           ++ PE ++    +  SD++S G  ++EL+TG  P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (321), Expect = 6e-34
 Identities = 94/283 (33%), Positives = 131/283 (46%), Gaps = 39/283 (13%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+ G     T VA+K  K           F  E + + ++ H  LV+ +  
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
              E+E I IV EY+  G+L + L   +G  L L   +D+A  +A  + YL        I
Sbjct: 70  CS-EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-QVKGTAGYLDPEYLKTYQL 319
           HRD+ + NIL+ EN   K+ADFG ARL  D E  A   +   +K TA    PE     + 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRF 181

Query: 320 TEKSDVYSFGVLLVELVT-GRRPIE--PKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
           T KSDV+SFG+LL E+VT GR P      RE+ E++   + M             PR  N
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------------PRPPN 228

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
                     + +L LQC     + RP+     E L S  +DY
Sbjct: 229 CPEE------LYDLMLQCWDKDPEERPTF----EYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 2e-33
 Identities = 89/307 (28%), Positives = 132/307 (42%), Gaps = 19/307 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQV-EHLNLVKFH 199
           K+G+G FG VY  R  D  +VA+K   K +  K    E F  EI+ LA +    N+VK +
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            + + E    +++EYV  G+L + L    +   L  +  L I   +  A+ YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 259 IIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVK--GTAGYLDPEYLK 315
           IIHRDIK  NILL  +    K+ DFG A+L  D  S ++  +      GT GY+ PE L 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 316 TYQL---TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
              L   +  SD++S G+ L EL+TG  P E ++      T +                 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS--ATSQTLKIILELPTPSLASPL 239

Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPS 432
              N    + A   +L+   + LA   +NR S               +E   SD+L    
Sbjct: 240 SPSNPELISKAASDLLK---KLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296

Query: 433 YSKRSNS 439
            +    S
Sbjct: 297 SAPLRLS 303

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  125 bits (317), Expect = 3e-33
 Identities = 79/283 (27%), Positives = 129/283 (45%), Gaps = 17/283 (6%)

Query: 142 KIGQGGFGTVYKGRLE---DGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG V   R +   D T   VA+K    S  ++H  ++F+ EI  L  ++H N+V
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRTLDHENIV 69

Query: 197 KFHGYLEFEDERI--VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  E    R   +I+EY+P+G+LR++L   +  I +L   L  +  +   + YL   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI-NLKRLLLFSSQICKGMDYLG-- 126

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                IHRD+ + NIL+      K++DFG A+     +    +V    +    +  PE L
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
           +T + +  SDV+SFGV L EL T G     P  E    I +       +    + +L   
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT--RLLELLKEG 242

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR 416
                  +   E + +L   C     Q+RPS      I+  +R
Sbjct: 243 ERLPRPPSCPDE-VYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (307), Expect = 6e-32
 Identities = 73/222 (32%), Positives = 113/222 (50%), Gaps = 23/222 (10%)

Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA--EFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V  G    G  VA+K  K       S A   F +E   +  + H NLV+  G
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKD-----DSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 201 YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            +  +   + IV EY+  G+L ++L      ++ LA +L  A+DV   + YL    +   
Sbjct: 68  -VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNF 123

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           +HRD+ + N+L++E+  AKV+DFG   LA +   G       VK TA    PE L+  + 
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFG---LAKEASQGQDSGKLPVKWTA----PEALREKKF 176

Query: 320 TEKSDVYSFGVLLVELVT-GRRPI--EPKRELKERITVKWAM 358
           + KSDV+SFG+LL E+ + GR P    P +++   +   + M
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM 218

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (305), Expect = 1e-31
 Identities = 73/232 (31%), Positives = 111/232 (47%), Gaps = 22/232 (9%)

Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +GQG  G VYK R    G I A+K+      D+    +   E++TL   E   +VK +G
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 201 YLEFEDERIVIV-EYVPNGTLREHLDCLQGNI--LDLAGRLDIAIDVAHAITYLHMYTDH 257
              +++  I IV EY+  G+L + L  + G I    LA    IA  +   + YLH  T  
Sbjct: 67  AF-YKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLA---YIARQILKGLDYLH--TKR 119

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
            IIHRDIK SN+L+      K+ADFG   ++   E+     +T V GT  Y+ PE ++  
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFG---ISKVLENTLDQCNTFV-GTVTYMSPERIQGE 175

Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA-MKKFSDGDAIS 368
             +  +D++S G+ L+E   G+ P  P  +        +  M+   DG   S
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----FFELMQAICDGPPPS 222

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  120 bits (303), Expect = 2e-31
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 10/203 (4%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V++G  ++   VAIK  K     K    +FQ E++ L ++ H +L+     
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLFAV 70

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
               +   +I E +  G+L   L   +G +L +A  +D+A  VA  + YL    +   IH
Sbjct: 71  CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + NIL+ E+   KVADFG ARL  +    ++      K TA    PE       + 
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----PEAASHGTFST 183

Query: 322 KSDVYSFGVLLVELVT-GRRPIE 343
           KSDV+SFG+LL E+ T G+ P  
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 8e-31
 Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 12/202 (5%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V++G   + T VA+K  K    D     +F +E + + ++ H  L++ +  
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP---KDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              E+   ++ E +  G+L E+L    G  L L   +D+A  VA  + YL        IH
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIH 126

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD+ + N+L+ EN   KVADFG AR+  +    A       +K TA    PE     + +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA----PEAALYNRFS 182

Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  118 bits (297), Expect = 2e-30
 Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 13/206 (6%)

Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG G FG VY    L+ G ++A+K  +    D  +  E   E++ L  ++H NLVK++G
Sbjct: 7   KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 201 YLEFEDERIVI-VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            +E   E++ I +EY   GTL E L+   G ILD        + +   + YLH    H I
Sbjct: 67  -VEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHS---HGI 120

Query: 260 IHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           +HRDIK +NI L  N   K+ DFG A +L  +T +    V +   GT  Y+ PE +   +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAPEVITGGK 179

Query: 319 LTEK---SDVYSFGVLLVELVTGRRP 341
                  +D++S G +++E+ TG+RP
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  114 bits (288), Expect = 2e-29
 Identities = 90/283 (31%), Positives = 136/283 (48%), Gaps = 40/283 (14%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+ G     T VAIK  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +    E I I+ EY+ NG+L + L   +G  L +   +D+A  +A  + ++        I
Sbjct: 70  VT--QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YI 124

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQL 319
           HRD++++NIL++E    K+ADFG ARL  D E  A       +K TA    PE +     
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTF 180

Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKR--ELKERITVKWAMKKFSDGDAISILDPRVEN 376
           T KSDV+SFG+LL E+VT GR P       E+ + +   + M             PR +N
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------PRPDN 227

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
                   E++ EL   C   + + RP+     E L SV +D+
Sbjct: 228 CP------EELYELMRLCWKEKPEERPTF----EYLRSVLEDF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 1e-28
 Identities = 87/269 (32%), Positives = 127/269 (47%), Gaps = 35/269 (13%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG+G FG VYKG L+  T VA+K  + ++       +F  E   L Q +H N+VK  G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG- 59

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +  + + I IV E VP G+L   L   + N L +   L +++D A  + YL        I
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGYLDPEYLKTYQ 318
           HRD+ + N L+ EN   K++DFG +R         +    Q  +K TA    PE L   +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA----PEALNYGR 171

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEP---KRELKERITVKWAMKKFSDGDAISILDPRVE 375
            T +SDV+S+G+LL E  +      P    ++ +ERI   + M             P  +
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-------------PAPQ 218

Query: 376 NTAANNLALEKILELALQCLAPRRQNRPS 404
                 L  E+I  L LQC A   +NRPS
Sbjct: 219 ------LCPEEIYRLMLQCWAYDPENRPS 241

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  110 bits (278), Expect = 1e-27
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 26/219 (11%)

Query: 143 IGQGGFGTVYKGRL-EDGTIVAIKRAKKS--VYDKHSGAEFQSEIRTLAQVE-HLNLVKF 198
           IG+G F TV   +  E     AIK   K   + +K        E   L ++  H  ++K 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-EKEVLTRLNGHPGIIKL 67

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           +   + E+    ++EY PNG L +++    G++ +   R   A ++  A+ YLH      
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAA-EILLALEYLH---SKG 122

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADT--ESGATHVSTQVK------------- 303
           IIHRD+K  NILL ++   K+ DFG A++             +T +              
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 304 -GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            GTA Y+ PE L      + SD+++ G ++ +++TG+ P
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (274), Expect = 2e-27
 Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 12/215 (5%)

Query: 136 NFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           +F    KIG+G FG V+K  R  D  + A+K+   S  ++    E   E R LA+++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 195 LVKFHGYLEF-EDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
           ++++  Y  F +  ++ IV EY  NG L + L   +G  L         I +   + +LH
Sbjct: 61  IIRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 I+HRDIKS N+ L      K+ D G A+L +D     T+ +  + GT  YL PE
Sbjct: 119 ---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----TNFANTIVGTPYYLSPE 171

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
             +     EKSDV++ GV+L E  TG+ P +   +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  108 bits (272), Expect = 4e-27
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 18/218 (8%)

Query: 142 KIGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G+G +G+VYK  RL D    A+K        +    +  +EIR LA V H N++ +  
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 201 YLEFEDERI--VIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
              F D     +++EY P G L + +     +  ++       I I +   +  LH   +
Sbjct: 67  --AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---E 121

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             I+HRD+KS+NILL  N   K+ D G +++     +      TQ+ GT  Y+ PE  K 
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-----KTQI-GTPHYMAPEVWKG 175

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
              + KSD++S G LL E+ T   P E +  ++L+ ++
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  107 bits (269), Expect = 1e-26
 Identities = 74/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       S   F  E + + ++ H  LV+ +  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 70  VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 125

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181

Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 2e-26
 Identities = 76/236 (32%), Positives = 115/236 (48%), Gaps = 18/236 (7%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +D G + A+K  KK    K    E   +E   L+++ H  +VK H 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 201 YLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              F+ E    +++EY P G L  HL   +G   +   R   A ++  A+ YLH      
Sbjct: 61  A--FQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAA-EIVLALEYLH---SLG 113

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           II+RD+K  NILL  +   K+ DFG   LA +  S  +  +T   GT  YL PE L    
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFG---LAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169

Query: 319 LTEKSDVYSFGVLLVELVTGRRP--IEPKRELKERI-TVKWAMKKFSDGDAISILD 371
             +  D +S GVLL E++TG+ P   E ++E+ E+I        +F   +A  ++ 
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLIS 225

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  107 bits (267), Expect = 2e-26
 Identities = 76/221 (34%), Positives = 111/221 (50%), Gaps = 15/221 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+ G     T VA+K  K       S   F  E + + ++ H  LV+ +  
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQLYAV 69

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L   +G  L L   +D+A  VA  + Y+        IH
Sbjct: 70  VS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIH 125

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++S+NIL+ +    K+ADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181

Query: 321 EKSDVYSFGVLLVELVTGRRPIEP---KRELKERITVKWAM 358
            KSDV+SFG+LL ELVT  R   P    RE+ E++   + M
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  106 bits (267), Expect = 2e-26
 Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 38/220 (17%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G+G +G+VYK    E G +VAIK     V  +    E   EI  L Q +   +VK++G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIK----VVPVEEDLQEIIKEISILKQCDSPYIVKYYG 65

Query: 201 YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD-------IAI---DVAHAIT 249
              F++  + IV EY           C  G++ D+    +       IA         + 
Sbjct: 66  SY-FKNTDLWIVMEY-----------CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH    +  IHRDIK+ NILL E  +AK+ADFG +    DT +        V GT  ++
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR----NTVIGTPFWM 166

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKR 346
            PE ++      K+D++S G+  +E+  G+ P   I P R
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 5e-26
 Identities = 71/203 (34%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+G +G V K R    G IVAIK+ K+S  D+        E++ L Q+ H N+V    
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL-- 65

Query: 201 YLEF--EDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             E      R+ +V EYV   TL E L+   G +   A R      +  AI Y H    H
Sbjct: 66  -KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS-YIWQLLQAIAYCH---SH 119

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
            IIHRDIK  NIL++E+   K+ DFGFAR        A+ ++  V  T  Y  PE L   
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARAL--RARPASPLTDYV-ATRWYRAPELLVGD 176

Query: 318 QLTEKS-DVYSFGVLLVELVTGR 339
               K  DV++ G ++ EL+ G 
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  105 bits (264), Expect = 5e-26
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 41/284 (14%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+ G   + T VA+K  K       S   F  E   +  ++H  LV+ +  
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   +I EY+  G+L + L   +G  + L   +D +  +A  + Y+        IH
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIH 126

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++N+L++E+   K+ADFG AR+  D E  A       +K TA    PE +     T
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFT 182

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD-----PRVE 375
            KSDV+SFG+LL E+VT  +   P                 S+ D +S L      PR+E
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGM---------------SNSDVMSALQRGYRMPRME 227

Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
           N        +++ ++   C   + + RP+     + L SV  D+
Sbjct: 228 NCP------DELYDIMKTCWKEKAEERPTF----DYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (263), Expect = 9e-26
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 13/205 (6%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G G  G V K      G I+A+K  +  + ++    +   E+  L +     +V F+G
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNI-LDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 +  + +EY+  G+L + L  +QG I   + G+  IA+ V   +TYLH    H I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--EKHKI 122

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           IHRD+K SNIL+    + K+ DFG +    ++ +  T V     GT+ Y+ PE ++    
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFV-----GTSSYMAPERIQGNDY 176

Query: 320 TEKSDVYSFGVLLVELVTGRRPIEP 344
           + KSD++S G+ L+EL TGR P  P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  104 bits (261), Expect = 2e-25
 Identities = 67/236 (28%), Positives = 102/236 (43%), Gaps = 19/236 (8%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   +  D   + A+K   K+   +K S     +E R L ++ H  LV    
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66

Query: 201 YLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              F+DE    ++V+ +  G LR HL   +    +   +  I  ++  A+ YLH      
Sbjct: 67  -YSFQDEENMYLVVDLLLGGDLRYHLS-QKVKFSEEQVKFWIC-EIVLALEYLH---SKG 120

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRDIK  NILL E     + DF  A            ++T   GT GY+ PE L    
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-----LTTSTSGTPGYMAPEVLCRQG 175

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPK-RELKERITVKWAMKK--FSDGDAISILD 371
            +   D +S GV   E + G+RP     R ++++I  K       +    +   +D
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 2e-25
 Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 32/273 (11%)

Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           +G G FG V+ G+      VAIK  ++      S  +F  E + + ++ H NLV+ +G  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHR 262
             +    ++ EY+ NG L  +L   +G  L     LD+  DV  A+ YL     +  IHR
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHR 124

Query: 263 DIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEK 322
           D+ + N L+ E+   KV+DFG AR   D +  +   S   K    +  PE     + + K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS---SQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 323 SDVYSFGVLLVELVT-GRRPIEPKR--ELKERITVKWAMKKFSDGDAISILDPRVENTAA 379
           SDV+SFGVL+ E+ + G+ P E     E+ E ++  + + +           P+      
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-----------PK------ 224

Query: 380 NNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
             LA  ++  +   C   + ++RP+ ++    L
Sbjct: 225 --LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  103 bits (258), Expect = 3e-25
 Identities = 75/221 (33%), Positives = 111/221 (50%), Gaps = 15/221 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV  +  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYAV 69

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ E++  G+L + L    G  L L   +D+A  +A  + Y+        IH
Sbjct: 70  VS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIH 125

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ +N   K+ADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181

Query: 321 EKSDVYSFGVLLVELVTGRRPIEP---KRELKERITVKWAM 358
            KSDV+SFG+LL ELVT  R   P    RE+ E++   + M
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  103 bits (257), Expect = 5e-25
 Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +     VA+K  K+   +     EF  E   + +++H NLV+  G
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 69

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126

Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182

Query: 320 TEKSDVYSFGVLLVELVT 337
           + KSDV++FGVLL E+ T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (255), Expect = 7e-25
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 34/270 (12%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++      S  +F  E + + ++ H  LV+ +G 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
              E   I +V E++ +G L ++L   +G        L + +DV   + YL       +I
Sbjct: 68  C-TERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLE---SSNVI 122

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+ + N L+ EN   KV+DFG  R   D +  ++  +   K    +  PE     + +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT---KFPVKWSSPEVFSFSKYS 179

Query: 321 EKSDVYSFGVLLVELVT-GRRPIEPKR--ELKERITVKWAMKKFSDGDAISILDPRVENT 377
            KSDV+SFGVL+ E+ + G+ P E +   E+ E I   + + K           PR    
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK-----------PR---- 224

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRR 407
               LA + + EL   C   R ++RPS   
Sbjct: 225 ----LASQSVYELMQHCWKERPEDRPSFSL 250

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  102 bits (255), Expect = 9e-25
 Identities = 69/281 (24%), Positives = 130/281 (46%), Gaps = 34/281 (12%)

Query: 136 NFSPSFKIGQGGFG--TVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL 193
           ++ P   +G+G FG  T+Y+ R ED ++V  K    +   +    +  +EI  L+ ++H 
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 194 NLVKFHGYLEFEDERIVIVE--YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           N++ ++ +  F D+  +++E  Y   GTL + +   +G + +    L     +  A++Y+
Sbjct: 60  NIIAYYNH--FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H      I+HRDIK+ NI LT+    K+ DFG +++     S A      V GT  Y+ P
Sbjct: 118 H---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA----ETVVGTPYYMSP 170

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD 371
           E  +  +   KSD+++ G +L EL+T +R  +    L   + VK     ++   ++   +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN--LVVKIVQGNYTPVVSVYSSE 228

Query: 372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                          ++ L    L    + RP+     E+L
Sbjct: 229 ---------------LISLVHSLLQQDPEKRPT---ADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (254), Expect = 1e-24
 Identities = 74/210 (35%), Positives = 108/210 (51%), Gaps = 18/210 (8%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
            IG+G FG V +G    G  VA+K  K  V    +   F  E   + ++ H NLV+  G 
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +      IV+ E +  G L   L      ++ +   L  ++DVA  + YL       ++H
Sbjct: 68  ILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + NIL++E+  AKV+DFG AR+ +    G  +    VK TA    PE LK  + + 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKLPVKWTA----PEALKHKKFSS 176

Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKE 350
           KSDV+S+GVLL E+ + GR P  PK  LKE
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPY-PKMSLKE 205

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (255), Expect = 1e-24
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 39/225 (17%)

Query: 143 IGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G+G FG V+ G         D  +VA+K   K      +  +F+ E   L   +H N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHL---------------DCLQGNILDLAGRLDIA 241
           KF+G     D  I++ EY+ +G L + L                  +  +  L   L IA
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL---LQIA 128

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           + +A  + YL        +HRD+ + N L+  +   K+ DFG +R    T+        +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD------YYR 179

Query: 302 VKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           V G       ++ PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  101 bits (252), Expect = 2e-24
 Identities = 72/201 (35%), Positives = 99/201 (49%), Gaps = 12/201 (5%)

Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D     +F  E   +    H N++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 200 GY-LEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +     N  + DL G     + VA  + YL     
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEYL---AS 116

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E+F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 317 YQLTEKSDVYSFGVLLVELVT 337
            + T KSDV+SFGVLL EL+T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (251), Expect = 3e-24
 Identities = 84/275 (30%), Positives = 129/275 (46%), Gaps = 40/275 (14%)

Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           IG+G FG V  G    G  VA+K  K       +   F +E   + Q+ H NLV+  G +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 203 EFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
             E   + IV EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N+L++E+  AKV+DFG  + A+ T+         VK TA    PE L+  + + 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTA----PEALREKKFST 178

Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN---T 377
           KSDV+SFG+LL E+ + GR P  P+  LK+ +                   PRVE     
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY-PRIPLKDVV-------------------PRVEKGYKM 218

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            A +     + ++  QC       RPS  +  E L
Sbjct: 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 24/210 (11%)

Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V +GRL    +    VAIK  K    DK    +F +E   + Q +H N+++ 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR-LDFLTEASIMGQFDHPNIIRL 70

Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +      ++I EY+ NG+L    RE+       +  L G L     +A  + YL   
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLR---GIASGMKYL--- 122

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGYLDPE 312
           ++   +HRD+ + NIL+  N   KV+DFG +R   D+E+  T    +  ++ TA    PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTA----PE 178

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +   + T  SDV+SFG+++ E+++ G RP
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  100 bits (251), Expect = 3e-24
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 15/207 (7%)

Query: 142 KIGQGGFGTVY--KGRLEDG--TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           KIG+G FG +Y  K + +     I  I   K  V +K +    + E+  LA+++H N+V 
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVT 63

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
           F    +      +++EY   G L + ++  +G +      L   + ++  + ++H   D 
Sbjct: 64  FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DR 120

Query: 258 PIIHRDIKSSNILLTENFR-AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
            I+HRDIKS NI L++N   AK+ DFG AR   D+      ++    GT  YL PE  + 
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS----MELAYTCVGTPYYLSPEICQN 176

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIE 343
                K+D++S G +L EL T + P E
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 4e-24
 Identities = 75/225 (33%), Positives = 110/225 (48%), Gaps = 43/225 (19%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSG----AEFQSEIRTLAQVEHLNLV 196
            IG+G FG VYK        +VAIK     V D         + Q EI+ L+Q     + 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIK-----VIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 197 KFHG-YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDL--AGRLD---IAI---DVAH 246
           K++G +L+    ++ I+ EY           C  G+ LDL   G+LD   IA    +V  
Sbjct: 63  KYYGSFLK--GSKLWIIMEY-----------CGGGSCLDLLKPGKLDETYIAFILREVLL 109

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            + YLH   +   IHRDIK++NILL+E    K+ADFG   ++    S  +  +T V GT 
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFV-GTP 162

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
            ++ PE +K     EK+D++S G+  +EL  G  P   + P R L
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL 207

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  101 bits (253), Expect = 4e-24
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 40/277 (14%)

Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G  G VYK      G  VAIK+ +  +  ++       EI  +   +H N+V ++ 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIIN-EILIMKDCKHPNIVDYYD 82

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA-GRLD-IAIDVAHAITYLHMYTDHP 258
                DE  V++EY+  G+L + +     N + +   ++  +  +V   + YLH      
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLH---SQN 136

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           +IHRDIKS NILL+++   K+ADFGF   AA      +  ++ V GT  ++ PE +K   
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGF---AAQLTKEKSKRNSVV-GTPYWMAPEVIKRKD 192

Query: 319 LTEKSDVYSFGVLLVELVTGRRP-IE--PKRELKERITVKWAMKKFSDGDAISILDPRVE 375
              K D++S G++ +E+  G  P +   P R L   IT K                P ++
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGI--------------PPLK 237

Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           N      +  +  +   +CL    + RPS     E+L
Sbjct: 238 N--PEKWS-PEFKDFLNKCLVKDPEKRPS---AEELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 61/216 (28%), Positives = 113/216 (52%), Gaps = 30/216 (13%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAK--KSVYDKHSGAE------FQSEIRTLAQVEHL 193
           IG+G +G VY    +  G ++A+K+ +   ++  +H   +       +SEI TL  ++HL
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHA 247
           N+V++ G+   E+   + +EYVP G++        G+ L   GR +          V   
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSI--------GSCLRTYGRFEEQLVRFFTEQVLEG 120

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YLH      I+HRD+K+ N+L+  +   K++DFG ++ + D      ++S Q  G+  
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVF 175

Query: 308 YLDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRP 341
           ++ PE + +Y    + K D++S G +++E+  GRRP
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 31/229 (13%)

Query: 142 KIGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEHLNLVK 197
            IG+G FGTV K  R  DG I+  K      Y   +  E Q   SE+  L +++H N+V+
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEID---YGNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 198 FHGY-LEFEDERIVIV-EYVPNGTL-------REHLDCLQGNILDLAGRLDIAIDVAHAI 248
           ++   ++  ++ + IV EY   G L       ++    ++   +       I   +  A+
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-----WRILTQLLLAL 118

Query: 249 TYLH--MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA-THVSTQVKGT 305
              H      + ++HRD+K +NI L  N   K+ DFG A++     S A T+V     GT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GT 173

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR--ELKERI 352
             Y+ PE L      EKSD++S G L+ EL     P   +   +L  +I
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G GGFG V   +++      A+K  KK  + +        SE   L +  H  +VK + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 201 YLEFEDERIV--IVEYVPNG----TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
              F+D++ +  ++EY   G     LR+      G   +   R  IA  V  A  YLH  
Sbjct: 61  T--FKDKKYIYMLMEYCLGGELWTILRDR-----GLFDEYTARFYIAC-VVLAFEYLH-- 110

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            +  II+RD+K  N+LL  N   K+ DFGFA+     +   T       GT  Y+ PE +
Sbjct: 111 -NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYVAPEII 164

Query: 315 --KTYQLTEKSDVYSFGVLLVELVTGRRP 341
             K Y  +   D +S G+LL EL+TGR P
Sbjct: 165 LNKGYDFS--VDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 98.0 bits (244), Expect = 4e-23
 Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 19/281 (6%)

Query: 143 IGQGGFGTVYKGRLE---DGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G+G FG V     +   DGT  +VA+K  K+    +++   ++ EI  L  + H N+VK
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG-WKKEINILKTLYHENIVK 70

Query: 198 FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + G    +  + +  I+EYVP G+LR   D L  + L+LA  L  A  +   + YLH  +
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLR---DYLPKHKLNLAQLLLFAQQICEGMAYLH--S 125

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            H  IHRD+ + N+LL  +   K+ DFG A+ A         V         +   E LK
Sbjct: 126 QH-YIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP-IEPKRELKERITVKWAMKKFSDGDAISILDPRV 374
             + +  SDV+SFGV L EL+T       P ++ +E I  K    + +    I +L+  +
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK--QGQMTVVRLIELLERGM 241

Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV 415
                 N   E +  L   C     + RP+ R    IL  +
Sbjct: 242 RLPCPKNCPQE-VYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 7e-23
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 36/228 (15%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHG 200
           IG+G +G VYK R  + G +VAIK        +    E + E   L +   H N+  F+G
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 201 -YLE-----FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAI 248
            +++      +D+  +++E    G++ +    L   +     RL       I  +    +
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTD----LVKGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            YLH   ++ +IHRDIK  NILLT+N   K+ DFG +    D+  G  +      GT  +
Sbjct: 127 AYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFI---GTPYW 179

Query: 309 LDPE-----YLKTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
           + PE              +SDV+S G+  +EL  G+ P   + P R L
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL 227

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 9e-23
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVKF 198
           +GQG FG VY    ++ G  +A+K+         +  E  +   EI+ L  ++H  +V++
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 199 HGYLEFEDERIVI-VEYVPNGTLREHLD---CLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +G L  +DE + I +EY+P G++++ L     L   +     R      +   + YLH  
Sbjct: 70  YGCLR-DDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH-- 121

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             + I+HRDIK +NIL       K+ DFG ++      S  T + + V GT  ++ PE +
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVI 179

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP 341
                  K+DV+S G  +VE++T + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 23/211 (10%)

Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V +GRL+        VAIK   KS Y +    +F SE   + Q +H N++  
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIK-TLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      ++I E++ NG L   L    G   ++ L G L     +A  + YL   ++
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---SE 124

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-----QVKGTAGYLDP 311
              +HRD+ + NIL+  N   KV+DFG +R   D  S  T+ S+      ++ TA    P
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA----P 180

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           E +   + T  SDV+S+G+++ E+++ G RP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 83/279 (29%), Positives = 129/279 (46%), Gaps = 32/279 (11%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+       T VA+K  K       S   F +E   +  ++H  LVK H  
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E   I I E++  G+L + L   +G+   L   +D +  +A  + ++        IH
Sbjct: 70  VTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 125

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL++ +   K+ADFG AR+  D E  A       +K TA    PE +     T
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFT 181

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
            KSDV+SFG+LL+E+VT  R   P     E I      +    G  +    PR EN    
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI------RALERGYRM----PRPENCP-- 229

Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
               E++  + ++C   R + RP+     E + SV  D+
Sbjct: 230 ----EELYNIMMRCWKNRPEERPTF----EYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 37/215 (17%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKR---AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G G FG+VY+G  L+DG   A+K    A      + +  + + EI  L++++H N+V++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH------AITYLH 252
            G    ED   + +E VP G+L          +L   G     +   +       + YLH
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLA--------KLLKKYGSFPEPVIRLYTRQILLGLEYLH 119

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAG 307
              D   +HRDIK +NIL+  N   K+ADFG A+           V         KG+  
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAK----------QVVEFSFAKSFKGSPY 166

Query: 308 YLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           ++ PE + +       +D++S G  ++E+ TG+ P
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V++G L+        VAIK  K   Y +    +F SE   + Q  H N+++ 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQG--NILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      ++I EY+ NG L ++L    G  +   L G L     +A  + YL   +D
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SD 125

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + NIL+  N   KV+DFG +R+  D   G T+ ++  K    +  PE +  
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGKIPIRWTAPEAIAY 184

Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRP 341
            + T  SDV+SFG+++ E+++ G RP
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 83/289 (28%), Positives = 124/289 (42%), Gaps = 43/289 (14%)

Query: 143 IGQGGFGTVYKGRLED------GTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           +G G FG VY+G   D      G I VA+K  +K   D+    EF  E   ++   H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHPNI 61

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL-----DCLQGNILDLAGRLDIAIDVAHAITY 250
           VK  G     + + +I+E +  G L  +L     +     +L L   LDI +DVA    Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRA-----KVADFGFARLAADT-ESGATHVSTQVKG 304
           L        IHRD+ + N L++E         K+ DFG AR   D  +S       +   
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLL 175

Query: 305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSD 363
              ++ PE L   + T +SDV+SFGVL+ E++T G++P       +    V       + 
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT------AG 229

Query: 364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           G        R++         +KI +L   C A     RP+  R  EIL
Sbjct: 230 G--------RLQKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 26/221 (11%)

Query: 143 IGQGGFGTVYKG--RLEDGTI---VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FGTVYKG    E   +   VAIK  ++      +  E   E   +A V+H ++V+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVR 73

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G +    +  +I + +P G L +++   + NI      L+  + +A  ++YL      
Sbjct: 74  LLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY-LLNWCVQIAKGMSYLEE---K 128

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG-----YLDPE 312
            ++HRD+ + N+L+      K+ DFG A+L    E        +     G     ++  E
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-------EYHAEGGKVPIKWMALE 181

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKE 350
            +     T KSDV+S+GV + EL+T G +P E  P  E+ +
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + + ++ H  LV+ +G 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 202 LEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
              +    ++ EY+ NG L    REH    Q + L     L++  DV   + YL      
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLE---SK 119

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
             IHRD+ + N L+ +    KV+DFG +R   D E  +   S   K    +  PE L   
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS---SVGSKFPVRWSPPEVLLYS 176

Query: 318 QLTEKSDVYSFGVLLVELVT-GRRPIE 343
           + + KSDV++FGVL+ E+ + G+ P E
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 5e-22
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 47/222 (21%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           +IG+G +G VYK R  + G +VA+K+ +    ++  G    +  EI+ L ++ H N+V+ 
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 199 HG-YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAH------- 246
                      I +V EY+ +               DL G LD   +    +        
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDH---------------DLTGLLDSPEVKFTESQIKCYMKQ 108

Query: 247 ---AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
               + YLH    + I+HRDIK SNIL+  +   K+ADFG AR      S      T   
Sbjct: 109 LLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY---TNRV 162

Query: 304 GTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            T  Y  PE L     Y    + D++S G +L EL  G +PI
Sbjct: 163 ITLWYRPPELLLGATRY--GPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 94.8 bits (236), Expect = 7e-22
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 40/220 (18%)

Query: 143 IGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEHL 193
           +G+G FG VYKG L         T VAIK  K    +        EF+ E   ++ ++H 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLK----ENAEPKVQQEFRQEAELMSDLQHP 68

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           N+V   G    E    ++ EY+ +G L E L              D    + LD +  L 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           IAI +A  + YL   + H  +HRD+ + N L+ E    K++DFG +R         +   
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD------IYSADY 179

Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVEL 335
            +V+  +     ++ PE +   + T +SD++SFGV+L E+
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.1 bits (234), Expect = 7e-22
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 27/215 (12%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAE-------FQSEIRTLAQVEHLN 194
           IG G FG+VY G     G ++A+K+ +       S             EI  L +++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI------DVAHAI 248
           +V++ G     D   + +EYVP G++          +L+  G  +  +       +   +
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVA--------ALLNNYGAFEETLVRNFVRQILKGL 119

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVS-TQVKGTA 306
            YLH      IIHRDIK +NIL+      K++DFG ++ L A++ S  T+ +   ++G+ 
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            ++ PE +K    T K+D++S G L+VE++TG+ P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.9 bits (233), Expect = 8e-22
 Identities = 69/199 (34%), Positives = 103/199 (51%), Gaps = 22/199 (11%)

Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           +G+G FG V+KG L+D T VA+K  K+ +  +    +F SE R L Q +H N+VK  G  
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 203 EFEDERIVIVEYVPNGT----LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
                  +++E VP G     LR+  D L+   L     +  A+D A  + YL       
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLESKN--- 113

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAAD---TESGATHVSTQVKGTAGYLDPEYLK 315
            IHRD+ + N L+ EN   K++DFG +R   D   + SG   +   +K TA    PE L 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTA----PEALN 167

Query: 316 TYQLTEKSDVYSFGVLLVE 334
             + + +SDV+S+G+LL E
Sbjct: 168 YGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 8e-22
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 14/206 (6%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +G VYK R    G IVAIK+ K     +        EI+ L ++ H N++K   
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               + +  ++ E++ +  L + +   +   L  +        +   + + H    H I+
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIK-DRQRGLPESLIKSYLYQLLQGLAFCH---SHGIL 120

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKT-YQ 318
           HRD+K  N+L+      K+ADFG AR         TH V T+      Y  PE L     
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKG 175

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEP 344
            +   D++S G +  EL++ RRP+ P
Sbjct: 176 YSTPVDIWSVGCIFAELLS-RRPLFP 200

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.0 bits (234), Expect = 9e-22
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 29/214 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            IG G    VY    L +   VAIKR         S  E + E++ ++Q  H N+VK++ 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL------AGRLDIAI------DVAHAI 248
                DE  +++ Y              G++LD+       G LD AI      +V   +
Sbjct: 67  SFVVGDELWLVMPY-----------LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            YLH    +  IHRDIK+ NILL E+   K+ADFG +   AD       V     GT  +
Sbjct: 116 EYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 309 LDPEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRP 341
           + PE ++       K+D++SFG+  +EL TG  P
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 65/234 (27%), Positives = 99/234 (42%), Gaps = 57/234 (24%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG G +G VYK R +  G +VAIK  K  +         Q EI  L +  H N+V + G
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHPNIVAYFG 67

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---VAH-------AITY 250
                D+  +++EY           C  G++ D+       +    +A+        + Y
Sbjct: 68  SYLRRDKLWIVMEY-----------CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK------- 303
           LH   +   IHRDIK +NILLTE+   K+ADFG              VS Q+        
Sbjct: 117 LH---ETGKIHRDIKGANILLTEDGDVKLADFG--------------VSAQLTATIAKRK 159

Query: 304 ---GTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
              GT  ++ PE     +      K D+++ G+  +EL   + P   + P R L
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 11/214 (5%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVE 191
             NF    KIG+G F  VYK   L DG +VA+K+ +   + D  +  +   EI  L Q++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAIT 249
           H N++K+       +E  +++E    G L   +     Q  ++         + +  A+ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           ++H      I+HRDIK +N+ +T     K+ D G  R      S  T  +  + GT  Y+
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYM 173

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
            PE +       KSD++S G LL E+   + P  
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.9 bits (228), Expect = 5e-21
 Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 36/279 (12%)

Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V  GRL+        VAIK  K    +K    +F SE   + Q +H N++  
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNIIHL 70

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      +++ EY+ NG+L   L    G   ++ L G L     +A  + YL   +D
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL---SD 124

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  PE +  
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP--R 373
            + T  SDV+S+G+++ E+++ G RP              W M   S+ D I  ++   R
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPY-------------WEM---SNQDVIKAIEEGYR 227

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +        AL    +L L C    R  RP   +   IL
Sbjct: 228 LPAPMDCPAALH---QLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.5 bits (227), Expect = 6e-21
 Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 11/206 (5%)

Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA----EFQSEIRTLAQVEHLNLVKF 198
           +G+G +GTVY G    G ++A+K+ +    +  +      + Q E+  L  ++H+N+V++
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G    ++   + +E+VP G++   L+   G + +          +   + YLH   ++ 
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFC-KYTKQILDGVAYLH---NNC 122

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH--VSTQVKGTAGYLDPEYLKT 316
           ++HRDIK +N++L  N   K+ DFG AR  A      TH  +   + GT  ++ PE +  
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPI 342
                KSD++S G  + E+ TG+ P+
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 93.0 bits (231), Expect = 7e-21
 Identities = 76/248 (30%), Positives = 110/248 (44%), Gaps = 45/248 (18%)

Query: 109 SSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYK------GRLEDGTIV 162
           SS++S+     + +   ++ E+ R  R       IG G  GTVYK      GRL      
Sbjct: 55  SSSSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRL------ 101

Query: 163 AIKRAKKSVYDKHSGA---EFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT 219
               A K +Y  H      +   EI  L  V H N+VK H   +   E  V++E++  G+
Sbjct: 102 ---YALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158

Query: 220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV 279
           L         +I D     D+A  +   I YLH      I+HRDIK SN+L+      K+
Sbjct: 159 LEGT------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKI 209

Query: 280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE------KSDVYSFGVLLV 333
           ADFG +R+ A T       ++ V GT  Y+ PE + T  L          D++S GV ++
Sbjct: 210 ADFGVSRILAQTMDPC---NSSV-GTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSIL 264

Query: 334 ELVTGRRP 341
           E   GR P
Sbjct: 265 EFYLGRFP 272

Length = 353

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 35/211 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV---- 196
            +G+G +G V K +  E G IVAIK+  +S  DK        EIR L Q+ H NLV    
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 197 ------KFHGYLEFEDERIVI-VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
                 + +   EF D  ++  +E  PNG             LD +        +   I 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------------LDESRVRKYLFQILRGIE 114

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGY 308
           + H    H IIHRDIK  NIL++++   K+ DFGFAR LAA  E    +V+T+      Y
Sbjct: 115 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WY 166

Query: 309 LDPEYL-KTYQLTEKSDVYSFGVLLVELVTG 338
             PE L    +     D+++ G L+ E++TG
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 32/212 (15%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL---NLVKF 198
           IG+G +G VY+G+ +  G +VA+K       D    ++ Q E+  L+Q+      N+ K+
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITKY 67

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLH 252
           +G         +I+EY   G++R          L  AG +       I  +V  A+ Y+H
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRT---------LMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 +IHRDIK++NIL+T     K+ DFG   +AA     ++  ST V GT  ++ PE
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFV-GTPYWMAPE 171

Query: 313 YL---KTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +   K Y    K+D++S G+ + E+ TG  P
Sbjct: 172 VITEGKYYD--TKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 16/206 (7%)

Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G FG V+   R  D  +V IK+       K      Q+E + L  + H N++    Y
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---EY 64

Query: 202 LE--FEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            E   ED+ ++IV EY P GTL E++     ++LD    L   + +  A+ ++H      
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKL 121

Query: 259 IIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           I+HRD+K+ NILL ++    K+ DFG +++ +      T     V GT  Y+ PE  +  
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-----VVGTPCYISPELCEGK 176

Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIE 343
              +KSD+++ G +L EL + +R  E
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 24/206 (11%)

Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEI-RTLAQVEHLN---LVK 197
           +G G  G+V K   +  GT++A    KK V+   + +  + +I R L  +       +V 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMA----KKVVH-IGAKSSVRKQILRELQIMHECRSPYIVS 67

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
           F+G    E+   + +E++  G+L           +++ G+  IA+ V   +TYL  Y  H
Sbjct: 68  FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYL--YNVH 123

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA--THVSTQVKGTAGYLDPEYLK 315
            I+HRDIK SNIL+    + K+ DFG         SG     ++    GT+ Y+ PE ++
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGV--------SGELINSIADTFVGTSTYMSPERIQ 175

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP 341
             + T KSDV+S G+ ++EL  G+ P
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 31/219 (14%)

Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEI-RTLA---QVEHLNLV 196
           ++G+G  G+V K RL   G I A+K             + Q +I R L      +   +V
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALK-----TITTDPNPDLQKQILRELEINKSCKSPYIV 62

Query: 197 KFHG-YLEFEDERIVI-VEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAI 248
           K++G +L+     I I +EY   G+L    D +   +    GR+       IA  V   +
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
           +YLH      IIHRDIK SNILLT   + K+ DFG +      E   +   T   GT+ Y
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFT-GTSFY 169

Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
           + PE ++    +  SDV+S G+ L+E+   R P  P+ E
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 36/217 (16%)

Query: 143 IGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEHL 193
           +GQG FG VY+G        E  T VAIK    +V +  S     EF +E   + +    
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIK----TVNENASMRERIEFLNEASVMKEFNCH 69

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHL-----DCLQGNILDLAGRLDI---AIDVA 245
           ++V+  G +      +V++E +  G L+ +L     +      L           A ++A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 246 HAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
             + YL        +HRD+ + N ++ E+   K+ DFG  R   +T+          KG 
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD-------YYRKGG 179

Query: 306 AGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT 337
            G L      PE LK    T KSDV+SFGV+L E+ T
Sbjct: 180 KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 70/219 (31%), Positives = 101/219 (46%), Gaps = 36/219 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV---- 196
           KIG+G +G V+K R  E G IVAIK+  +S  D         EIR L Q++H NLV    
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 197 ------KFHGYLEFEDERIV-IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
                 K H   E+ D  ++  +E  P G     +  +    L        A++  H   
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ-------AVNFCHK-- 118

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT-HVSTQVKGTAGY 308
                  H  IHRD+K  NIL+T+  + K+ DFGFAR+        T +V+T+      Y
Sbjct: 119 -------HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166

Query: 309 LDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR 346
             PE L    Q     DV++ G +  EL+TG +P+ P +
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 62/288 (21%), Positives = 115/288 (39%), Gaps = 47/288 (16%)

Query: 136 NFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           N      +G+G FG V+  +          T+V +K A +   D++  +EF+ E+    +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK-ALQKTKDENLQSEFRRELDMFRK 64

Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI-------LDLAGRLDIAI 242
           + H N+V+  G     +   +I+EY   G L++ L   +          L    ++ +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
            +A  +   H+      +HRD+ + N L++     KV       L+ D  +   +     
Sbjct: 125 QIALGMD--HLSNAR-FVHRDLAARNCLVSSQREVKV---SLLSLSKDVYNSEYYKLRNA 178

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKERI---TVKW 356
                +L PE ++    + KSDV+SFGVL+ E+ T G  P       E+  R+    ++ 
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238

Query: 357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS 404
                          P  E          ++ +L  +C A   ++RPS
Sbjct: 239 ---------------PVPEGCP------SRLYKLMTRCWAVNPKDRPS 265

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 60/213 (28%), Positives = 111/213 (52%), Gaps = 27/213 (12%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIK-----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G G F + Y+ R ++ GT++A+K     R   S  ++      + EIR +A++ H +++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEE-VVEALRKEIRLMARLNHPHII 66

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH------AITY 250
           +  G    +    + VE++  G++         ++L   G    A+ + +       ++Y
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSV--------SHLLSKYGAFKEAVIINYTEQLLRGLSY 118

Query: 251 LHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGY 308
           LH   ++ IIHRD+K +N+L+ +   R ++ADFG A RLAA   +GA     Q+ GT  +
Sbjct: 119 LH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-TGAGEFQGQLLGTIAF 174

Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           + PE L+  Q     DV+S G +++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 83/288 (28%), Positives = 123/288 (42%), Gaps = 49/288 (17%)

Query: 143 IGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAE----FQSEIRTLAQVEHL 193
           +G+G FG+V   R   L+D  G +VA+K+ +      HS AE    F+ EI  L  ++H 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ------HSTAEHLRDFEREIEILKSLQHD 65

Query: 194 NLVKFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNI--LDLAGRLDIAIDVAHAIT 249
           N+VK+ G  Y        +++EY+P G+LR   D LQ +   LD    L  A  +   + 
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLR---DYLQKHRERLDHRKLLLYASQICKGME 122

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAG- 307
           YL        +HRD+ + NIL+    R K+ DFG  + L  D E    +   +  G +  
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE----YYKVREPGESPI 175

Query: 308 -YLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGD 365
            +  PE L   + +  SDV+SFGV+L EL T   +   P  E          M     G 
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM------MGNDKQGQ 229

Query: 366 AISILDPRVENTAANNLAL-------EKILELALQCLAPRRQNRPSMR 406
            I      +     NN  L        +I  +  +C       RPS  
Sbjct: 230 MIVY---HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 92.6 bits (230), Expect = 6e-20
 Identities = 78/294 (26%), Positives = 133/294 (45%), Gaps = 24/294 (8%)

Query: 125 ITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           IT+ +I  + +  +    I +G  G  YKG+        ++   K + D +S     SEI
Sbjct: 683 ITINDILSSLKEEN---VISRGKKGASYKGKSIKN---GMQFVVKEINDVNSIPS--SEI 734

Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDV 244
             + +++H N+VK  G    E    +I EY+    L E L       L    R  IAI +
Sbjct: 735 ADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGI 789

Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKG 304
           A A+ +LH      ++  ++    I++         D    RL+     G     T+   
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIII------DGKDEPHLRLSL---PGLLCTDTKCFI 840

Query: 305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG 364
           ++ Y+ PE  +T  +TEKSD+Y FG++L+EL+TG+ P + +  +   I V+WA   +SD 
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI-VEWARYCYSDC 899

Query: 365 DAISILDPRVE-NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK 417
                +DP +  + + N   + +++ LAL C A     RP      + L S  +
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 88.3 bits (219), Expect = 6e-20
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 10/204 (4%)

Query: 142 KIGQGGFGT--VYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           KIG+G FG   + K + EDG    IK    S        E + E+  L+ ++H N+V++ 
Sbjct: 7   KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E      ++++Y   G L + ++  +G +      LD  + +  A+ ++H   D  I
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKI 122

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           +HRDIKS NI LT++   K+ DFG AR+   T      ++    GT  YL PE  +    
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----VELARTCIGTPYYLSPEICENRPY 178

Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
             KSD+++ G +L E+ T +   E
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 48/234 (20%)

Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLA 188
           R+   F    +IG+G +G VY+ R    G IVA+K+ +    ++  G    S  EI  L 
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD--NERDGIPISSLREITLLL 61

Query: 189 QVEHLNLVKFHGYLEFE--DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------- 239
            + H N+V+    +  +  D   +++EY           C Q    DLA  LD       
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEY-----------CEQ----DLASLLDNMPTPFS 106

Query: 240 ------IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
                 + + +   + YLH   ++ IIHRD+K SN+LLT+    K+ADFG AR       
Sbjct: 107 ESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART---YGL 160

Query: 294 GATHVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            A  ++ +V  T  Y  PE L    TY  T   D+++ G +L EL+   +P+ P
Sbjct: 161 PAKPMTPKVV-TLWYRAPELLLGCTTY--TTAIDMWAVGCILAELLAH-KPLLP 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 38/216 (17%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE---FQSEIRTLAQVEHLNLVKF 198
           +G G FG VYK +  E G   A K          S  E   F  EI  L++ +H N+V  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKII-----QIESEEELEDFMVEIDILSECKHPNIVGL 67

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR-LD------IAIDVAHAITYL 251
           +    +E++  +++E+   G L         +I+    R L       +   +  A+ +L
Sbjct: 68  YEAYFYENKLWILIEFCDGGAL--------DSIMLELERGLTEPQIRYVCRQMLEALNFL 119

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLD 310
           H    H +IHRD+K+ NILLT +   K+ADFG  A+  +  +   T +     GT  ++ 
Sbjct: 120 H---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMA 171

Query: 311 PEYL--KTYQLTE---KSDVYSFGVLLVELVTGRRP 341
           PE +  +T++      K+D++S G+ L+EL     P
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.3 bits (220), Expect = 1e-19
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS----EIRTLAQVEHLNLV 196
           K+G+G +G VYK R  + G IVA+K+ +      +      S    EI  L +++H N+V
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD----NEEEGIPSTALREISLLKELKHPNIV 61

Query: 197 KFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           K    +   + ++ +V EY     L+++LD   G  L       I   +   + Y H   
Sbjct: 62  KLLDVI-HTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCH--- 115

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL- 314
            H I+HRD+K  NIL+  +   K+ADFG AR         TH       T  Y  PE L 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPEILL 171

Query: 315 --KTYQLTEKSDVYSFGVLLVELVTGR 339
             K Y      D++S G +  E++TG+
Sbjct: 172 GSKHYSTA--VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 24/212 (11%)

Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIK-----RAKKSVYDKHSGAEFQSEIRTLAQ 189
           F+   KIG+G FG V+KG +++ T  +VAIK      A+  + D       Q EI  L+Q
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIED------IQQEITVLSQ 58

Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
            +   + K++G    + +  +I+EY+  G+    LD L+   LD      I  ++   + 
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILKGLD 115

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH       IHRDIK++N+LL+E+   K+ADFG A    DT+           GT  ++
Sbjct: 116 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK----RNTFVGTPFWM 168

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            PE +K      K+D++S G+  +EL  G  P
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 54/226 (23%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQV-EHLNLVK 197
           ++G G FG+VY  R  E G +VAIK+ KK  Y      E  +  E+++L ++ EH N+VK
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE---ECMNLREVKSLRKLNEHPNIVK 62

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDL----AGRL-------DIAIDV 244
                    E  V  E   N  L  +   + ++GN+  L     G+         I   +
Sbjct: 63  LK-------E--VFRE---NDEL--YFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI 108

Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH---VSTQ 301
              + ++H    H   HRD+K  N+L++     K+ADFG AR   +  S   +   VST+
Sbjct: 109 LQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR 162

Query: 302 VKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
                 Y  PE L    +Y  +   D+++ G ++ EL T  RP+ P
Sbjct: 163 -----WYRAPEILLRSTSY--SSPVDIWALGCIMAELYTL-RPLFP 200

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 66/196 (33%), Positives = 100/196 (51%), Gaps = 12/196 (6%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G FG V+ GRL  D T VA+K  ++++      A+F  E R L Q  H N+V+  G
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               +    +++E V  G     L   +G  L +   + +  + A  + YL   + H  I
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLE--SKH-CI 116

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGYLDPEYLKTYQ 318
           HRD+ + N L+TE    K++DFG +R   D    +T    Q  VK TA    PE L   +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTA----PEALNYGR 172

Query: 319 LTEKSDVYSFGVLLVE 334
            + +SDV+SFG+LL E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 143 IGQGGFGTVY---KGRLEDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           I +G +G V+   K    D  I AIK  KK+ +  K+   +  +E   L+Q +   +VK 
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 199 HGYLEFEDER-IVIV-EYVPNG---TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
             Y  F+ ++ + +V EY+P G   +L E++  L  ++     R+ IA ++  A+ YLH 
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV----ARIYIA-EIVLALEYLH- 110

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA----DTESGATHVSTQVKGTAGYL 309
              + IIHRD+K  NIL+  N   K+ DFG +++         +       ++ GT  Y+
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            PE +     ++  D +S G +L E + G  P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)

Query: 143 IGQGGFGTV-YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G G  GTV    R+ DG   A+K        +      Q+E+  L   +  ++VK H  
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 202 LEFEDER--------IVIVEYVPNGTLREHLDCLQGNILDL----AGRLDIAIDVA-HAI 248
              +D R         ++++Y   G LR+ +              AG L I + +A H +
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
              HM      IHRDIKS+NILL  N   K+ DFGF+++ A T S    V     GT  Y
Sbjct: 160 HSKHM------IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD--DVGRTFCGTPYY 211

Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           + PE  +    ++K+D++S GVLL EL+T +RP +
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 27/204 (13%)

Query: 151 VYKGRLEDGTIVAIKRAKKSVYDKHSGAE-----FQSEIRTLAQVEHLNLVKFHGY-LEF 204
           +YKG   +   V I+  KK     H G +      ++EI+ L +++  N++K +G+ ++ 
Sbjct: 36  IYKGIF-NNKEVIIRTFKKF----HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90

Query: 205 EDER---IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
            D+     +I+EY   G LRE LD  +   L    +LD+AID    +  L+ YT+ P  +
Sbjct: 91  VDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY--QL 319
           +++ S + L+TEN++ K+   G  ++ +       +V+  V     Y   + L     + 
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPF--KNVNFMV-----YFSYKMLNDIFSEY 199

Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
           T K D+YS GV+L E+ TG+ P E
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAIK+       K       +EI  + + +H N+V +  
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE--LIINEILVMRENKHPNIVNYLD 83

Query: 201 YLEFEDERIVIVEYVPNGTLREHLD--CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
                DE  V++EY+  G+L + +   C+    +    R     +   A+ +LH    + 
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQ 135

Query: 259 IIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           +IHRDIKS NILL  +   K+ DFGF A++  +    +T V     GT  ++ PE +   
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRK 190

Query: 318 QLTEKSDVYSFGVLLVELVTGRRP 341
               K D++S G++ +E+V G  P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 142 KIGQGGFGTVYKGRLED--GTI--VAIKRAKKSVYDKHSGA--EFQSEIRTLAQVEHLNL 195
           K+G G FG V +G      G +  VA+K  K    DK S    +F  E   +  ++H NL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS---DKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           ++ +G +      +++ E  P G+L + L         ++   D A+ +A+ + YL    
Sbjct: 59  IRLYGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES-- 115

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-QVKGTAGYLDPEYL 314
               IHRD+ + NILL  + + K+ DFG  R  A  ++   +V    +K    +  PE L
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMR--ALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +T   +  SDV+ FGV L E+ T G  P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 50/291 (17%)

Query: 128 EEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ---SE 183
           E+++   R      +IG G FG VY  R +    +VAIK  K S   K S  ++Q    E
Sbjct: 14  EKLFTDLR------EIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKE 65

Query: 184 IRTLAQVEHLNLVKFHG-YLEFEDERIVIVEYVPNGTLREHLDCLQGNI--LDLAGRLDI 240
           +R L Q+ H N +++ G YL  E    +++EY   G+  + L+  +  +  +++A    I
Sbjct: 66  VRFLQQLRHPNTIEYKGCYLR-EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA---I 120

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
                  + YLH    H  IHRDIK+ NILLTE    K+ADFG A L +   S       
Sbjct: 121 CHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------- 170

Query: 301 QVKGTAGYLDPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA 357
              GT  ++ PE +      Q   K DV+S G+  +EL   + P+             + 
Sbjct: 171 -FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-------------FN 216

Query: 358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRC 408
           M   S    I+  D    ++   +      ++    CL    Q+RPS    
Sbjct: 217 MNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS---CLQKIPQDRPSSEEL 264

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 22/209 (10%)

Query: 143 IGQGGFGTVYKGRLEDG--TIVAIK---------RAKKSVYDKHSGAEFQSEIRTL-AQV 190
           +G G FG VYK R ++    ++A+K            K   DK  G +  SE+  +  Q+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66

Query: 191 EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAI 248
            H N+V+++      D   ++++ +    L EH + L+            +I + +  A+
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            YLH   +  I+HRD+  +NI+L E+ +  + DFG A+     +       T V GT  Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTILY 179

Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
             PE +K     EK+DV++FG +L ++ T
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.4 bits (211), Expect = 7e-19
 Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 9/158 (5%)

Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH 246
           LA+++H N+V F    E +    +++EY   G L + +   +G +      L   + +  
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA-THVSTQVKGT 305
            + ++H   +  ++HRDIKS NI LT+N + K+ DFG ARL     + A T+V     GT
Sbjct: 112 GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-----GT 163

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
             Y+ PE  +      KSD++S G +L EL T + P +
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.9 bits (213), Expect = 7e-19
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 13/206 (6%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +GTV+K +  E   IVA+KR +    D+   +    EI  L +++H N+V+ + 
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            L  + +  ++ EY  +  L+++ D   G+I D          +   + + H    H ++
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAFCH---SHNVL 121

Query: 261 HRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+K  N+L+ +N   K+ADFG AR         +  V      T  Y  P+ L   +L
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAKL 176

Query: 320 TEKS-DVYSFGVLLVELVTGRRPIEP 344
              S D++S G +  EL    RP+ P
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 143 IGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G+G FG V   R +      G  VA+K  K      H  A+ + EI  L  + H N+VK
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVK 70

Query: 198 FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + G    +    +  I+E++P+G+L+E+L     N ++L  +L  A+ +   + YL    
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYL---G 126

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRD+ + N+L+    + K+ DFG  + A +T+     V   +     +  PE L 
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 316 TYQLTEKSDVYSFGVLLVELVT 337
             +    SDV+SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 34/214 (15%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL-----NLV 196
           IG G  G VYK R +  G ++A+K+ +++        E    I     V         +V
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-----GNKEENKRILMDLDVVLKSHDCPYIV 77

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHL-DCLQGNI-LDLAGRLDIAIDVAHAITYLHMY 254
           K +GY   + +  + +E +   T  + L   +QG I  D+ G++ +AI    A+ YL   
Sbjct: 78  KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAI--VKALHYLK-- 131

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPEY 313
             H +IHRD+K SNILL  +   K+ DFG + RL    +S A    T+  G A Y+ PE 
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL---VDSKA---KTRSAGCAAYMAPER 185

Query: 314 LK------TYQLTEKSDVYSFGVLLVELVTGRRP 341
           +        Y +  ++DV+S G+ LVEL TG+ P
Sbjct: 186 IDPPDPNPKYDI--RADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 83/257 (32%), Positives = 119/257 (46%), Gaps = 36/257 (14%)

Query: 143 IGQGGFGTVYKGR----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +GQG FG V+  R     + G + A+K  KK+          + E   LA+V H  +VK 
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI-----DVAHAITYLHM 253
           H    F+ E          G L   LD L+G   DL  RL   +     DV   +  L +
Sbjct: 64  H--YAFQTE----------GKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELAL 109

Query: 254 YTDH----PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
             DH     II+RD+K  NILL E    K+ DFG ++ + D E  A        GT  Y+
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYM 165

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV----KWAMKKFSDGD 365
            PE +     T+ +D +SFGVL+ E++TG  P + K + KE +T+    K  M +F   +
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-DRKETMTMILKAKLGMPQFLSPE 224

Query: 366 AISILDPRVENTAANNL 382
           A S+L    +   AN L
Sbjct: 225 AQSLLRALFKRNPANRL 241

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 36/221 (16%)

Query: 143 IGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           IGQG FG V++ R       E  T+VA+K  K+        A+FQ E   +A+ +H N+V
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDHPNIV 71

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHL-------------------DCLQGNI-LDLAG 236
           K  G         ++ EY+  G L E L                    C    + L    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESG 294
           +L IA  VA  + YL   ++   +HRD+ + N L+ EN   K+ADFG +R   +AD    
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVEL 335
           + + +  ++    ++ PE +   + T +SDV+++GV+L E+
Sbjct: 189 SENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 31/223 (13%)

Query: 142 KIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+  FG +YKG L     +   +VAIK  K     +  G EFQ E   +A++ H N+V
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG-EFQQEASLMAELHHPNIV 70

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHL---------------DCLQGNILDLAGRLDIA 241
              G +  E    ++ EY+  G L E L               D    + LD    L IA
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVS 299
           I +A  + YL   + H  +H+D+ + NIL+ E    K++D G +R   +AD         
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             ++    ++ PE +   + +  SD++SFGV+L E+ + G +P
Sbjct: 188 LPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 41/260 (15%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFH 199
           KIG+G  G V        G  VA+K+       K    E   +E+  +   +H N+V+ +
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMY 82

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLHM 253
                 DE  V++E++  G L +         +    R++      + + V  A+++LH 
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLAVLKALSFLH- 132

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPE 312
                +IHRDIKS +ILLT + R K++DFGF A+++ +     + V     GT  ++ PE
Sbjct: 133 --AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPE 185

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
            +       + D++S G++++E+V G  P   +  L+       AMK+  D        P
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-------AMKRIRDNLP-----P 233

Query: 373 RVENTAANNLALEKILELAL 392
           +++N    +  L   L+  L
Sbjct: 234 KLKNLHKVSPRLRSFLDRML 253

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 32/210 (15%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V   R +  G   A+K   K+   K    E   +E R L  + H  LV  +G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYLH 252
              F+D+  +  ++EYVP G L  HL          +GR         A  V  A+ YLH
Sbjct: 69  --SFQDDSNLYLVMEYVPGGELFSHLR--------KSGRFPEPVARFYAAQVVLALEYLH 118

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDP 311
                 I++RD+K  N+LL  +   K+ DFGFA R+   T +        + GT  YL P
Sbjct: 119 ---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT--------LCGTPEYLAP 167

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           E + +    +  D ++ G+L+ E++ G  P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 41/221 (18%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKK-SVYDKHSGAEFQS--EIRTLAQVEHLNLVK 197
           K+G+G +  VYK R  E G IVAIK+ K     +   G  F +  EI+ L +++H N++ 
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66

Query: 198 FHGYLEF-EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH---------- 246
                 F     I +V            + ++ ++  +     I +  A           
Sbjct: 67  LLDV--FGHKSNINLV-----------FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            + YLH    + I+HRD+K +N+L+  +   K+ADFG AR         TH   QV  T 
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH---QVV-TR 166

Query: 307 GYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y  PE L   + Y      D++S G +  EL+  R P  P
Sbjct: 167 WYRAPELLFGARHY--GVGVDMWSVGCIFAELLL-RVPFLP 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 71/224 (31%), Positives = 112/224 (50%), Gaps = 27/224 (12%)

Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGT--IVAIK-----RAKKSVYDKHSGAEFQSEIRTL 187
             F+   +IG+G FG VYKG +++ T  +VAIK      A+  + D       Q EI  L
Sbjct: 4   ELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIED------IQQEITVL 56

Query: 188 AQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHA 247
           +Q +   + +++G      +  +I+EY+  G+    LD L+   L+      I  ++   
Sbjct: 57  SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKG 113

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YLH       IHRDIK++N+LL+E    K+ADFG A    DT+      +T V GT  
Sbjct: 114 LDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTFV-GTPF 166

Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
           ++ PE +K      K+D++S G+  +EL  G  P   + P R L
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 210

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 32/223 (14%)

Query: 142 KIGQGGFGTVYKGR------LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++G+G FG V+          +D  +VA+K  K          +FQ E   L  ++H ++
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLTNLQHEHI 69

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDC-------------LQGN-ILDLAGRLDIA 241
           VKF+G     D  I++ EY+ +G L + L                Q    L L+  L IA
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVS 299
             +A  + YL        +HRD+ + N L+  N   K+ DFG +R   + D      H  
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             ++    ++ PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 187 LPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 11/210 (5%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHL 193
           NF    KIG+G F  VY+   L DG  VA+K+ +   + D  + A+   EI  L Q+ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYL 251
           N++K++     ++E  +++E    G L   +     Q  ++         + +  A+ ++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H      ++HRDIK +N+ +T     K+ D G  R      S  T  +  + GT  Y+ P
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSP 175

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           E +       KSD++S G LL E+   + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R    G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D    + + L         +   + + H  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 172

Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 173 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 143 IGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G+G FG V K          + + VA+K  K    +K   ++  SE+  +  + +H N+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKNI 78

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLDIA 241
           +   G    E    V+VEY  +G LR+ L                     L     +  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
             VA  + +L        IHRD+ + N+L+TE+   K+ADFG AR          H+   
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-------DIHHIDYY 188

Query: 302 VKGTAGYLD-----PEYLKTYQLTEKSDVYSFGVLLVELVT 337
            K T G L      PE L     T +SDV+SFGVLL E+ T
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 34/267 (12%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G+      VAIK   +      S  +F  E + + ++ H  LV+ +G 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR---LDIAIDVAHAITYLHMYTDHP 258
              +    ++ E++ NG L  +L   QG +     +   L +  DV   + YL     + 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKL----SKDMLLSMCQDVCEGMEYLER---NS 120

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            IHRD+ + N L++     KV+DFG  R   D E  +   S+  K    +  PE     +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS---SSGAKFPVKWSPPEVFNFSK 177

Query: 319 LTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
            + KSDV+SFGVL+ E+ T G+ P E K   +        ++  S G    +  P+    
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-------VVEMISRGF--RLYRPK---- 224

Query: 378 AANNLALEKILELALQCLAPRRQNRPS 404
               LA   + E+   C   + + RP+
Sbjct: 225 ----LASMTVYEVMYSCWHEKPEGRPT 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.2 bits (205), Expect = 7e-18
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 29/223 (13%)

Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIK-----RAKKSVYDKHSGAEFQSEIRTLAQ 189
           F+   +IG+G FG V+KG +++ T  +VAIK      A+  + D       Q EI  L+Q
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIED------IQQEITVLSQ 58

Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
            +   + K++G      +  +I+EY+  G+    LD L+    D      +  ++   + 
Sbjct: 59  CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATMLKEILKGLD 115

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE-SGATHVSTQVKGTAGY 308
           YLH       IHRDIK++N+LL+E    K+ADFG A    DT+    T V     GT  +
Sbjct: 116 YLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167

Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
           + PE ++      K+D++S G+  +EL  G  P   + P R L
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL 210

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.8 bits (204), Expect = 9e-18
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 29/220 (13%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++G+G FG V+          +D  +VA+K  K +    ++  +F  E   L  ++H ++
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHI 69

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------LQGNI---LDLAGRLDIAIDV 244
           VKF+G     D  I++ EY+ +G L + L           +GN    L  +  L IA  +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVSTQV 302
           A  + YL        +HRD+ + N L+ EN   K+ DFG +R   + D      H    +
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +    ++ PE +   + T +SDV+S GV+L E+ T G++P
Sbjct: 187 R----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.1 bits (205), Expect = 9e-18
 Identities = 90/308 (29%), Positives = 138/308 (44%), Gaps = 68/308 (22%)

Query: 143 IGQGGFGTVYKGRL-EDGTIV--AIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLNLVK 197
           IG+G FG V K R+ +DG  +  AIKR K+ +  D H   +F  E+  L ++  H N++ 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIIN 72

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD------LAGR----------LDIA 241
             G  E      + +EY P+G L + L   +  +L+      +A            L  A
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
            DVA  + YL   +    IHRD+ + NIL+ EN+ AK+ADFG +R               
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVY 177

Query: 302 VKGTAGYLDPEYLKTYQL-----TEKSDVYSFGVLLVELVT-GRRPI--EPKRELKERIT 353
           VK T G L   ++    L     T  SDV+S+GVLL E+V+ G  P       EL E++ 
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237

Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW 413
             + ++K  + D                   +++ +L  QC   +   RPS    A+IL 
Sbjct: 238 QGYRLEKPLNCD-------------------DEVYDLMRQCWREKPYERPSF---AQILV 275

Query: 414 SVRKDYRE 421
           S+ +   E
Sbjct: 276 SLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)

Query: 131 YRATRN-FSPSFKIGQGGFGTVYKG---RLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIR 185
           Y   R   +    IG+G FG VY+G     E+  I VA+K  K          +F  E  
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAY 59

Query: 186 TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVA 245
            + Q +H ++VK  G +  E+   +++E  P G LR +L   +   LDLA  +  +  ++
Sbjct: 60  IMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLS 117

Query: 246 HAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            A+ YL        +HRDI + N+L++     K+ DFG +R   D      + +++ K  
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES---YYKASKGKLP 171

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVE-LVTGRRP 341
             ++ PE +   + T  SDV+ FGV + E L+ G +P
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)

Query: 143 IGQGGFGTVYKGRL--EDGTI--VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG+V +G+L  +DG+   VA+K  K  ++      EF SE   +   +H N++K 
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 199 HGY-LEFEDER-----IVIVEYVPNGTLREHL--DCLQGN--ILDLAGRLDIAIDVAHAI 248
            G   E    +     +VI+ ++ +G L   L    L G    L L   L   +D+A  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV-KGTAG 307
            YL   ++   IHRD+ + N +L E+    VADFG ++      SG  +   ++ K    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK---KIYSGDYYRQGRIAKMPVK 180

Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           ++  E L     T KSDV++FGV + E+ T G+ P
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 57/295 (19%)

Query: 143 IGQGGFGTVYKG--RLEDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEHLNLVK 197
           +G G FG+V KG   ++ G  V +  A K++  +H  A   EF  E   +AQ++H  +V+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEV--AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN-ILDLAGRLDIAIDVAHAITYLHMYTD 256
             G  +  +  ++++E  P G L   L  L+    + ++   ++A  VA  + YL     
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPL---LKYLKKRREIPVSDLKELAHQVAMGMAYLE---S 113

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPEY 313
              +HRD+ + N+LL    +AK++DFG +R L A ++     T     +K  A    PE 
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA----PEC 169

Query: 314 LKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
           +   + + KSDV+S+GV L E  + G +P                  +    + I++L+ 
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKP----------------YGEMKGAEVIAMLE- 212

Query: 373 RVENTAANNLALEK-------ILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
                  +   L +       I  + L C   R ++RP+    +E+  + R+D  
Sbjct: 213 -------SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTF---SELESTFRRDPE 257

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 61/231 (26%), Positives = 110/231 (47%), Gaps = 35/231 (15%)

Query: 135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLA 188
           R+    +++G+G FG V+          +D  +VA+K  K++   + +  +FQ E   L 
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 62

Query: 189 QVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL----REH------LDCLQGNI---LDLA 235
            ++H ++V+F+G        +++ EY+ +G L    R H      L   +      L L 
Sbjct: 63  VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122

Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE--- 292
             L IA  +A  + YL        +HRD+ + N L+ +    K+ DFG +R    T+   
Sbjct: 123 QMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 293 -SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             G T +  +      ++ PE +   + T +SD++SFGV+L E+ T G++P
Sbjct: 180 VGGRTMLPIR------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 88/315 (27%), Positives = 132/315 (41%), Gaps = 72/315 (22%)

Query: 143 IGQGGFGTVYKGRLE-DGTIV--AIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKF 198
           IG+G FG V +  ++ DG  +  AIK  K+    ++   +F  E+  L ++  H N++  
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 199 HGYLEFEDERIVIVEYVPNGTL-----------------REHLDCLQGNILDLAGR--LD 239
            G  E      + +EY P G L                 +EH     G    L  +  L 
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH-----GTASTLTSQQLLQ 123

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A DVA  + YL   ++   IHRD+ + N+L+ EN  +K+ADFG +R             
Sbjct: 124 FASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----------GEE 170

Query: 300 TQVKGTAGYLDPEYLKTYQL-----TEKSDVYSFGVLLVELVT-GRRPI--EPKRELKER 351
             VK T G L   ++    L     T KSDV+SFGVLL E+V+ G  P       EL E+
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230

Query: 352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEI 411
           +   + M+K  + D                   +++ EL  QC   R   RP   + +  
Sbjct: 231 LPQGYRMEKPRNCD-------------------DEVYELMRQCWRDRPYERPPFAQISVQ 271

Query: 412 L---WSVRKDYRELA 423
           L      RK Y  +A
Sbjct: 272 LSRMLEARKAYVNMA 286

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHG 200
           +G G +G VYKGR ++ G + AIK    +  ++    E + EI  L +   H N+  ++G
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRNIATYYG 70

Query: 201 YL------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                     +D+  +++E+   G++ + +   +GN L       I  ++   +++LH  
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H +IHRDIK  N+LLTEN   K+ DFG   ++A  +      +T + GT  ++ PE +
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFI-GTPYWMAPEVI 183

Query: 315 -------KTYQLTEKSDVYSFGVLLVELVTGRRPI---EPKREL 348
                   TY    KSD++S G+  +E+  G  P+    P R L
Sbjct: 184 ACDENPDATYDF--KSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 70/224 (31%), Positives = 100/224 (44%), Gaps = 51/224 (22%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL-------N 194
           IG+G FGTV K   +  GTI+A+KR + +V +K        + R L  ++ +        
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-------EQKRLLMDLDVVMRSSDCPY 64

Query: 195 LVKFHGYLEFE--------------DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI 240
           +VKF+G L  E              D+    V  V    + E        IL   G+  I
Sbjct: 65  IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPE-------EIL---GK--I 112

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
           A+    A+ YL    +  IIHRD+K SNILL  N   K+ DFG +    D  S A    T
Sbjct: 113 AVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIA---KT 165

Query: 301 QVKGTAGYLDPEYLKTYQLTE---KSDVYSFGVLLVELVTGRRP 341
           +  G   Y+ PE +          +SDV+S G+ L E+ TG+ P
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 82.8 bits (204), Expect = 5e-17
 Identities = 57/190 (30%), Positives = 102/190 (53%), Gaps = 21/190 (11%)

Query: 173 DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL--------REHL 224
           D+   A  +SE+  LA  +H  +VK     + +D+ ++I+EY   G L        +EHL
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL 164

Query: 225 DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
              +  +  L  ++ +A+D  H+           ++HRD+KS+NI L      K+ DFGF
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVHS---------RKMMHRDLKSANIFLMPTGIIKLGDFGF 215

Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE- 343
           ++  +D+ S    V++   GT  YL PE  +  + ++K+D++S GV+L EL+T  RP + 
Sbjct: 216 SKQYSDSVS--LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273

Query: 344 -PKRELKERI 352
             +RE+ +++
Sbjct: 274 PSQREIMQQV 283

Length = 478

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)

Query: 143 IGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQV-EHLNLVKFH 199
           +G+G FG V    L     + A+K  KK V  +    E   +E R LA   +H  L + H
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + +D    ++EYV  G L  H+   +    D       A ++   + +LH   +  I
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAEIVLGLQFLH---ERGI 117

Query: 260 IHRDIKSSNILLTENFRAKVADFGFAR---LAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           I+RD+K  N+LL      K+ADFG  +   L   T       ++   GT  Y+ PE L +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-------TSTFCGTPDYIAPEIL-S 169

Query: 317 YQLTEKS-DVYSFGVLLVELVTGRRPIE 343
           YQ    + D ++ GVLL E++ G+ P E
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 30/215 (13%)

Query: 142 KIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   + +    ++
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKEFNCHHV 71

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL----QGN----ILDLAGRLDIAIDVAHA 247
           V+  G +      +VI+E +  G L+ +L  L    + N       L   + +A ++A  
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+          KG  G
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-------KGGKG 181

Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 64/297 (21%)

Query: 143 IGQGGFGTVYKGR------LEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEHL 193
           +G+G FG V K            T VA+K  K++     S +E +   SE   L QV H 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHP 63

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHL----------------------DCLQGNI 231
           +++K +G    +   ++IVEY   G+LR  L                      D      
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 232 LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
           L +   +  A  ++  + YL    +  ++HRD+ + N+L+ E  + K++DFG +R   + 
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKRE 347
           +S       ++     ++  E L  +  T +SDV+SFGVLL E+VT G  P   I P+R 
Sbjct: 181 DSYVKRSKGRIP--VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER- 237

Query: 348 LKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS 404
           L   +   + M+             R EN +      E++  L L C       RP+
Sbjct: 238 LFNLLKTGYRME-------------RPENCS------EEMYNLMLTCWKQEPDKRPT 275

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 16/212 (7%)

Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V K + +   ++    A+K ++ +   A     IR L  +   N 
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 62

Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             +V F+G    + E  + +E++  G+L + L   +    ++ G++ IA  V   + YL 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLR 120

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT  Y+ PE
Sbjct: 121 --EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPE 172

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            L+    + +SD++S G+ LVEL  GR PI P
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 66/237 (27%), Positives = 117/237 (49%), Gaps = 27/237 (11%)

Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G  G V    ++  G +VA+K  K  +  +       +E+  +   +H N+V+ + 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++E++  G L + +   + N   +A    + + V  A++ LH      +I
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHA---QGVI 138

Query: 261 HRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRDIKS +ILLT + R K++DFGF A+++ +     + V     GT  ++ PE +     
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPELISRLPY 193

Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
             + D++S G++++E+V G  P   +  LK       AMK   D      L P+++N
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPKLKN 238

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 80.2 bits (197), Expect = 9e-17
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 17/219 (7%)

Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SE 183
           T+  I    + ++   KIGQG  GTV+    +  G  VAIK+       K    E   +E
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINE 66

Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID 243
           I  + ++++ N+V F       DE  V++EY+  G+L    D +    +D A    +  +
Sbjct: 67  ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT---DVVTETCMDEAQIAAVCRE 123

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQV 302
              A+ +LH    + +IHRDIKS N+LL  +   K+ DFGF A++  +    +T V    
Sbjct: 124 CLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---- 176

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            GT  ++ PE +       K D++S G++ +E+V G  P
Sbjct: 177 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 9e-17
 Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 49/224 (21%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE---HLNLVK- 197
           IG+G +GTVYK R L  G  VA+K+ +  + ++        EI  L Q+E   H N+V+ 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 198 ---FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD----------IAIDV 244
               HG      +R + +  V      EH+D       DLA  L              D+
Sbjct: 67  LDVCHGP---RTDRELKLTLV-----FEHVDQ------DLATYLSKCPKPGLPPETIKDL 112

Query: 245 AH----AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
                  + +LH    H I+HRD+K  NIL+T + + K+ADFG AR+ +   +      T
Sbjct: 113 MRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-----LT 164

Query: 301 QVKGTAGYLDPEYLKTYQLTEKS--DVYSFGVLLVELVTGRRPI 342
            V  T  Y  PE L   Q +  +  D++S G +  EL   RRP+
Sbjct: 165 SVVVTLWYRAPEVL--LQSSYATPVDMWSVGCIFAELFR-RRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 42/216 (19%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           +IG+G  G V+K +  E G  VA+K+   ++     G   Q+  EI+ L   +H  +VK 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 199 HGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRL---DIAIDVAHAITYLHMY 254
                      V+V EY+P+               DL+  L   +  +  A   +Y+ M 
Sbjct: 65  LDVFP-HGSGFVLVMEYMPS---------------DLSEVLRDEERPLPEAQVKSYMRML 108

Query: 255 TD-----HP--IIHRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTA 306
                  H   I+HRD+K +N+L++ +   K+ADFG ARL + +     +H   QV  T 
Sbjct: 109 LKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH---QV-ATR 164

Query: 307 GYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
            Y  PE L   + Y      D+++ G +  EL+ G 
Sbjct: 165 WYRAPELLYGARKY--DPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 51/135 (37%), Positives = 66/135 (48%), Gaps = 25/135 (18%)

Query: 222 EHLDCLQGNILDL----AGRL------DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL 271
           EH+D   G  LD     AGR+       I+I V   +TYL     H I+HRD+K SNIL+
Sbjct: 79  EHMD---GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR--EKHKIMHRDVKPSNILV 133

Query: 272 TENFRAKVADFGFARLAADTESGATHVS--TQVKGTAGYLDPEYLKTYQLTEKSDVYSFG 329
                 K+ DFG         SG    S      GT  Y+ PE L+    T +SD++S G
Sbjct: 134 NSRGEIKLCDFGV--------SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185

Query: 330 VLLVELVTGRRPIEP 344
           + LVE+  GR PI P
Sbjct: 186 LSLVEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 14/200 (7%)

Query: 142 KIGQGGFGTVY----KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           ++G+G FGTVY    K  + +  +  +K       + +   +   E + L++++H  +VK
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYT 255
           FH      D   +I EY     L   L+ L+  G  L      +  I +   + Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
              I+HRD+K+ NI L  N   K+ DFG +RL      G+  ++T   GT  Y+ PE LK
Sbjct: 124 QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM----GSCDLATTFTGTPYYMSPEALK 178

Query: 316 TYQLTEKSDVYSFGVLLVEL 335
                 KSD++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 30/211 (14%)

Query: 143 IGQGGFGTVY--KGRLEDGTIVAIKRAKKSVYD-KHSGAEFQSEIRTL-AQVEHLNLVKF 198
           I +G FG+VY  K R   G   AIK  KKS    K+     ++E   +  Q E   + K 
Sbjct: 4   ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLH 252
           +   + +D   +++EY+  G      DC   +++   G L          +V   +  LH
Sbjct: 63  YYSFQSKDYLYLVMEYLNGG------DC--ASLIKTLGGLPEDWAKQYIAEVVLGVEDLH 114

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 IIHRDIK  N+L+ +    K+ DFG +R            + +  GT  YL PE
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--------NGLENKKFVGTPDYLAPE 163

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
            +      + SD +S G ++ E + G  P  
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 28/216 (12%)

Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEH 192
           F+   +IG G FG VY  R +    +VAIK  K S   K S  ++Q    E++ L +++H
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 193 LNLVKFHGYLEFEDERIVIVEYV---PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
            N +++ G    E    +++EY     +  L  H   LQ   +++A    I       + 
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--VEIAA---ITHGALQGLA 139

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH    H +IHRDIK+ NILLTE  + K+ADFG A +A+   S          GT  ++
Sbjct: 140 YLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS--------FVGTPYWM 188

Query: 310 DPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPI 342
            PE +      Q   K DV+S G+  +EL   + P+
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 28/261 (10%)

Query: 135 RNFSPSF-KIGQGGFGTV-YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH 192
           R +  SF KIG+G  G V        G  VA+K  K  +  +       +E+  +    H
Sbjct: 21  REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHH 78

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            N+V  +      DE  V++E++  G L + +   + N   +A    + + V  A++YLH
Sbjct: 79  ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLH 135

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDP 311
              +  +IHRDIKS +ILLT + R K++DFGF A+++ +     + V     GT  ++ P
Sbjct: 136 ---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAP 187

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD 371
           E +       + D++S G++++E++ G  P   +  L+       AM++  D      L 
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIRDN-----LP 235

Query: 372 PRVENTAANNLALEKILELAL 392
           PRV+++   +  L   L+L L
Sbjct: 236 PRVKDSHKVSSVLRGFLDLML 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 22/219 (10%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDK---HSGAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +     +  EF  E   +A ++H +LV+ 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G       ++V  + +P+G L     EH D +   +L     L+  + +A  + YL   
Sbjct: 75  LGVCLSPTIQLV-TQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE-- 126

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            +  ++HRD+ + N+L+      K+ DFG ARL    E    + +   K    ++  E +
Sbjct: 127 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK--EYNADGGKMPIKWMALECI 183

Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKE 350
              + T +SDV+S+GV + EL+T G +P +  P RE+ +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 15/214 (7%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G+G + TV+KGR +    +VA+K  +   +++ +      E+  L  ++H N+V  H 
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 201 YLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            +  E    ++ EY+ +  L+++LD C  GN++ +         +   ++Y H      I
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YLKTYQ 318
           +HRD+K  N+L+ E    K+ADFG AR     +S  T   +    T  Y  P+  L + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
            +   D++  G +L E+ TG RP+ P   +KE +
Sbjct: 181 YSTPIDMWGVGCILYEMATG-RPMFPGSTVKEEL 213

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)

Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAIK+   ++  +       +EI  + + ++ N+V +  
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 84  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALDFLH---SNQVI 137

Query: 261 HRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRDIKS NILL  +   K+ DFGF A++  +    +T V     GT  ++ PE +     
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAY 192

Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
             K D++S G++ +E+V G  P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 33/285 (11%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G  G V   R +  G  VA+K     +  +       +E+  +   +H N+V+ + 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                +E  V++E++  G L + +   + N   +A    +   V  A+ YLH      +I
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA---TVCESVLQALCYLH---SQGVI 139

Query: 261 HRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRDIKS +ILLT + R K++DFGF A+++ D     + V     GT  ++ PE +     
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPY 194

Query: 320 TEKSDVYSFGVLLVELVTGRRPI--------------EPKRELKERITVKWAMKKFSDGD 365
             + D++S G++++E+V G  P                P  +LK    +   ++ F   +
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFL--E 252

Query: 366 AISILDPRVENTAANNLALEKILELAL-QCLAPR-RQNRPSMRRC 408
            +   +P+   TA   L    +L+  L +CL P  +Q R     C
Sbjct: 253 RMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKRTSTC 297

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 45/250 (18%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHG 200
           +G G +G VYKGR ++ G + AIK    +   +    E + EI  L +   H N+  ++G
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 201 YL------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                     +D+  +++E+   G++ + +   +GN L       I  ++   + +LH  
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA- 139

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H +IHRDIK  N+LLTEN   K+ DFG   ++A  +      +T + GT  ++ PE +
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFI-GTPYWMAPEVI 193

Query: 315 -------KTYQLTEKSDVYSFGVLLVELVTGRRPI--------------EPKRELKERIT 353
                   TY    +SD++S G+  +E+  G  P+               P  +LK +  
Sbjct: 194 ACDENPDATYDY--RSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK-- 249

Query: 354 VKWAMKKFSD 363
            KW+ KKF D
Sbjct: 250 -KWS-KKFID 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 54/204 (26%), Positives = 104/204 (50%), Gaps = 12/204 (5%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVKF 198
           +G G FGTV+KG  + +G  + I  A K++ D+     FQ     +  +  ++H  +V+ 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G       ++V  +  P G+L +H+   + + LD    L+  + +A  + YL    +H 
Sbjct: 75  LGICPGASLQLV-TQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           ++HR++ + NILL  +   ++ADFG A L    +    +  ++ K    ++  E +   +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK--KYFYSEHKTPIKWMALESILFGR 187

Query: 319 LTEKSDVYSFGVLLVELVT-GRRP 341
            T +SDV+S+GV + E+++ G  P
Sbjct: 188 YTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 67/223 (30%), Positives = 97/223 (43%), Gaps = 39/223 (17%)

Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 84

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    L     + 
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 194

Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 143 IGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAE---FQSEIRTLAQVEHLNLVKF 198
           +G+G FG V   RL E G + A+K  KK V  +    E    +  I +LA+  H  L + 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           +   +  D    ++E+V  G L  H+   +    D A     A ++  A+ +LH   D  
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEITSALMFLH---DKG 116

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           II+RD+K  N+LL      K+ADFG  +      +G T  ++   GT  Y+ PE L+   
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKT--TSTFCGTPDYIAPEILQEML 172

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
                D ++ GVLL E++ G  P E + E
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 68/243 (27%), Positives = 109/243 (44%), Gaps = 51/243 (20%)

Query: 133 ATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEF--QSEIRTLAQ 189
             R++    K+G+G FG VYK R ++ G +VA+K  K  ++++  G       EI+ L +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKK 63

Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNIL-----DLAGRL---DIA 241
           ++H N+V     ++      + VE  P+ + R+        +      DL+G L    + 
Sbjct: 64  LKHPNVVPL---ID------MAVER-PDKSKRKRGSVYM--VTPYMDHDLSGLLENPSVK 111

Query: 242 IDVAHA----------ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
           +  +            I YLH   ++ I+HRDIK++NIL+      K+ADFG AR     
Sbjct: 112 LTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 292 -------ESGATHVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRP 341
                    G T   T +  T  Y  PE L   + Y  T   D++  G +  E+ T RRP
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMFT-RRP 225

Query: 342 IEP 344
           I  
Sbjct: 226 ILQ 228

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAE---FQSEIRTLAQVEHLNLVKF 198
           +GQG FG VY     D G  +A+K+ +       +  E    + EI+ L  + H  +V++
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 199 HGYLEFEDERI--VIVEYVPNGTLREHLD---CLQGNILDLAGRLDIAIDVAHAITYLHM 253
           +G L    ER   + +E++P G++++ L     L  N+     R      +   ++YLH 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-----QILEGVSYLH- 123

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPE 312
              + I+HRDIK +NIL       K+ DFG + RL     SG    S  V GT  ++ PE
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSPE 179

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +       K+D++S G  +VE++T + P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 28/215 (13%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEH 192
           NF    K+G+G + TVYKGR    G IVA+K       D   G    +  EI  + +++H
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKH 57

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITY 250
            N+V+ H  +  E++ +++ EY+ +  L++++D   G    LD          +   I +
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR---LAADTESGATHVSTQVKGTAG 307
            H   ++ ++HRD+K  N+L+ +    K+ADFG AR   +  +T       S +V  T  
Sbjct: 116 CH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT------FSNEVV-TLW 165

Query: 308 YLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
           Y  P+ L   +TY  +   D++S G ++ E++TGR
Sbjct: 166 YRAPDVLLGSRTY--STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.9 bits (189), Expect = 7e-16
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 9/205 (4%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G +G V   R   DG    IK+       +      + E + L+Q++H N+V +   
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 202 LEFEDERIVIVE-YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            E ED  + IV  +   G L   L   +G +L     ++  + +A A+ YLH   +  I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+K+ N+ LT     KV D G AR+    E+     ST + GT  Y+ PE        
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARV---LENQCDMASTLI-GTPYYMSPELFSNKPYN 180

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPK 345
            KSDV++ G  + E+ T +     K
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAK 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.9 bits (197), Expect = 7e-16
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 13/195 (6%)

Query: 157 EDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV-EY 214
             G  VAIK  +  +  ++H  A F+ E    A++ H N+V      E     +  V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN 274
           VP  TLRE L    G  L       + + V  A+   H   +  I+HRD+K  NI++++ 
Sbjct: 61  VPGRTLREVLAA-DG-ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115

Query: 275 ---FRAKVADFGFARLAADTESGATH---VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSF 328
                AKV DFG   L              +T+V GT  Y  PE L+   +T  SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 329 GVLLVELVTGRRPIE 343
           G++ +E +TG+R ++
Sbjct: 176 GLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 77.3 bits (191), Expect = 9e-16
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 51/221 (23%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKH-SGAEFQS--EIRTLAQVEHLNLVK 197
           +I +G +G VY+ R  + G IVA+K+ K    +K   G    S  EI  L +++H N+V 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 198 FHGYLEFEDERIV----------IVEYVPNGTLREHLDCLQGNILDLAGRLDIA------ 241
                    + +V          ++EYV      EH D L+  +  +      +      
Sbjct: 69  V--------KEVVVGSNLDKIYMVMEYV------EH-D-LKSLMETMKQPFLQSEVKCLM 112

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           + +   + +LH   D+ I+HRD+K+SN+LL      K+ DFG AR             TQ
Sbjct: 113 LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY----GSPLKPYTQ 165

Query: 302 VKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
           +  T  Y  PE L   K Y  +   D++S G +  EL+T +
Sbjct: 166 LVVTLWYRAPELLLGAKEY--STAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 50/296 (16%)

Query: 142 KIGQGGFGTVY------------KGRLEDG-----TIVAIKRAKKSVYDKHSGAEFQSEI 184
           K+G+G FG V+            K   E+       +VA+K  +      ++  +F  E+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEV 70

Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL---------DCLQGNILDLA 235
           + L+++   N+ +  G    +    +I+EY+ NG L + L                L  +
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
             L +A  +A  + YL        +HRD+ + N L+ +N+  K+ADFG +R      +  
Sbjct: 131 TLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR------NLY 181

Query: 296 THVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE 350
           +    +V+G A     ++  E +   + T KSDV++FGV L E++T  R    P   L +
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ--PYEHLTD 239

Query: 351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMR 406
           +  ++ A   F D D   I  PR  N   +      I EL L+C     ++RP+ R
Sbjct: 240 QQVIENAGHFFRD-DGRQIYLPRPPNCPKD------IYELMLECWRRDEEDRPTFR 288

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 69/225 (30%), Positives = 98/225 (43%), Gaps = 43/225 (19%)

Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K R +    VA+K  K +  DK   A+  SE+  +  + +H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLISEMELMKLIGKHK 78

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI------------- 240
           N++   G    E    VIVEY   G LRE L   +    D     DI             
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYT--FDITKVPEEQLSFKDL 136

Query: 241 ---AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
              A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR       G   
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR-------GVHD 186

Query: 298 VSTQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           +    K + G     ++ PE L     T +SDV+SFG+L+ E+ T
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 32/276 (11%)

Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G G FG + +G L+        VAI   +    DK     F +E  TL Q +H N+V+ 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVRL 71

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL-DIAIDVAHAITYLHMYTDH 257
            G +   +  +++ EY+ NG L   L   +G +  +AG+L  +   +A  + YL   ++ 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL--VAGQLMGMLPGLASGMKYL---SEM 126

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
             +H+ + +  +L+  +   K++  GF RL  D +S A + +   K    +  PE ++ +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKIS--GFRRLQED-KSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 318 QLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
             +  SDV+SFG+++ E+++ G RP              W M   S  D I  ++     
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPY-------------WDM---SGQDVIKAVEDGFRL 227

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            A  N     + +L L C    R  RP   +   IL
Sbjct: 228 PAPRNCP-NLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQ----SEIRTLAQVEHLNLVK 197
           +G G  GTVYK   L    I+A+K     V       E Q    SE+  L + +   ++ 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVK-----VIPLDITVELQKQIMSELEILYKCDSPYIIG 63

Query: 198 FHGYLEFEDERIVI-VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           F+G   F + RI I  E++  G+L    D  +     + GR  IA+ V   +TYL     
Sbjct: 64  FYGAF-FVENRISICTEFMDGGSL----DVYRKIPEHVLGR--IAVAVVKGLTYLWSLK- 115

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             I+HRD+K SN+L+    + K+ DFG +    ++      ++    GT  Y+ PE +  
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------IAKTYVGTNAYMAPERISG 167

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
            Q    SDV+S G+  +EL  GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           ++GQGG+G V+  + +D G IVA+KR KKS ++  +      +E   L   +   LVK  
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL- 66

Query: 200 GYLEFEDERIVIV--EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
               F+D+  + +  EYVP G  R  L    G + +   R  +A     A+  LH     
Sbjct: 67  -LYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFE-AVDALHELG-- 121

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
             IHRD+K  N L+  +   K+ DFG +        G    +  V G+  Y+ PE L+  
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLS-------KGIVTYANSVVGSPDYMAPEVLRGK 173

Query: 318 QLTEKSDVYSFGVLLVELVTGRRP 341
                 D +S G +L E + G  P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 82/298 (27%), Positives = 125/298 (41%), Gaps = 69/298 (23%)

Query: 143 IGQGGFGTVYKGRLE-DGTIV--AIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKF 198
           IG+G FG V K R++ DG  +  AIKR K+    K    +F  E+  L ++  H N++  
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 199 HGYLEFEDERIVIVEYVPNGTL-----------------REHLDCLQGNILDLAGR--LD 239
            G  E      + +EY P+G L                   +          L+ +  L 
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN-----STASTLSSQQLLH 116

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A DVA  + YL   +    IHRD+ + NIL+ EN+ AK+ADFG +R             
Sbjct: 117 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQE 163

Query: 300 TQVKGTAGYLDPEYLKTYQL-----TEKSDVYSFGVLLVELVT-GRRPI--EPKRELKER 351
             VK T G L   ++    L     T  SDV+S+GVLL E+V+ G  P       EL E+
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223

Query: 352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCA 409
           +   + ++K  + D                   +++ +L  QC   +   RPS  +  
Sbjct: 224 LPQGYRLEKPLNCD-------------------DEVYDLMRQCWREKPYERPSFAQIL 262

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)

Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   ++    A+K ++ +   A     IR L  +   N 
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 62

Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 114

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 115 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 166

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 28/216 (12%)

Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEH 192
           FS   +IG G FG VY  R + +  +VAIK  K S   K S  ++Q    E+R L ++ H
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 193 LNLVKFHGYLEFEDERIVIVEYV---PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
            N +++ G    E    +++EY     +  L  H   LQ   +++A    +       + 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--VEIAA---VTHGALQGLA 129

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH    H +IHRD+K+ NILL+E    K+ DFG A + A              GT  ++
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX--------FVGTPYWM 178

Query: 310 DPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPI 342
            PE +      Q   K DV+S G+  +EL   + P+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)

Query: 142 KIGQGGFGTVY-KGRLEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEHLNLVK 197
           +IG G FG VY         +VA+K  K S   K +  ++Q    E++ L Q++H N ++
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVK--KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 198 FHGYLEFEDERIVIVEYV---PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           + G    E    +++EY     +  L  H   LQ   +++A    I       + YLH  
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE--VEIAA---ITHGALQGLAYLH-- 138

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H +IHRDIK+ NILLTE  + K+ADFG A  ++   S          GT  ++ PE +
Sbjct: 139 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS--------FVGTPYWMAPEVI 189

Query: 315 KTY---QLTEKSDVYSFGVLLVELVTGRRPI 342
                 Q   K DV+S G+  +EL   + P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAE---FQSEIRTLAQVEHLNLVKF 198
           +GQG FG VY    ++ G  +A K+ +       +  E    + EI+ L  ++H  +V++
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 199 HGYLEFEDERI--VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           +G L    E+   + +EY+P G++++ L    G + +   R      +   ++YLH    
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTR-KYTRQILEGMSYLH---S 124

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPEYLK 315
           + I+HRDIK +NIL       K+ DFG + RL     SG    S  V GT  ++ PE + 
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWMSPEVIS 182

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP 341
                 K+DV+S G  +VE++T + P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)

Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 71

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HRD+ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-------YYRKGGKG 181

Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)

Query: 142 KIGQGGFGTVYKGR--LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK 197
           K+G+G + TVYKGR  L D  +VA+K  +    +   GA   +  E+  L  ++H N+V 
Sbjct: 13  KLGEGTYATVYKGRSKLTD-NLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
            H  +  E    ++ EY+ +  L+++LD C  GN +++         +   + Y H    
Sbjct: 69  LHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR--- 122

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YLK 315
             ++HRD+K  N+L+ E    K+ADFG AR     +S  T   +    T  Y  P+  L 
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
           +   + + D++  G +  E+ TG RP+ P   ++E++
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 10/215 (4%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   +++  G + A K+  K    K  G +   +E + L +V    +V    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D+  +++  +  G L+ H+  +       A  +  A  +   + +LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+LL ++   +++D G   LA + + G         GT GY+ PE L+     
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLG---LAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYD 172

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVK 355
              D ++ G  L E++ GR P   ++E  E+  +K
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 16/205 (7%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G +G VY  R L     +AIK       D         EI   + ++H N+V++ G 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI-AIDVAHAITYLHMYTDHPII 260
                   + +E VP G+L   L    G + D    +      +   + YLH   D+ I+
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIV 130

Query: 261 HRDIKSSNILL-TENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           HRDIK  N+L+ T +   K++DFG + RLA     G    +    GT  Y+ PE +    
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLA-----GINPCTETFTGTLQYMAPEVIDKGP 185

Query: 319 --LTEKSDVYSFGVLLVELVTGRRP 341
                 +D++S G  +VE+ TG+ P
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 37/228 (16%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G +G V K R    GTI+A+KR + +V     K    +    +R+   V+    V F
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS---VDCPYTVTF 65

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAHAITYLH 252
           +G L  E +  + +E      +   LD     + D    +       IA+ +  A+ YLH
Sbjct: 66  YGALFREGDVWICME-----VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +   +IHRD+K SN+L+  N + K+ DFG +    D+ +      T   G   Y+ PE
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-----KTIDAGCKPYMAPE 173

Query: 313 YL------KTYQLTEKSDVYSFGVLLVELVTGRRPIE----PKRELKE 350
            +      K Y +  KSDV+S G+ ++EL TGR P +    P ++LK+
Sbjct: 174 RINPELNQKGYDV--KSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++   ++  +       +EI  + + ++ N+V +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRDIKS NILL  +   K+ DFGF       +S      + + GT  ++ PE +      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYG 194

Query: 321 EKSDVYSFGVLLVELVTGRRP 341
            K D++S G++ +E++ G  P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 32/238 (13%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQV-EHLNLVKFH 199
           +G+G FG V    L+  G   A+K  KK V       E    E R LA   E+  L   +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYLHM 253
              + ++    ++E++  G L  H       I D  GR D+      A ++   + +LH 
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFH-------IQD-KGRFDLYRATFYAAEIVCGLQFLH- 113

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
                II+RD+K  N++L  +   K+ADFG  +     ++ A+       GT  Y+ PE 
Sbjct: 114 --SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC----GTPDYIAPEI 167

Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITV------KWAMKKFSD 363
           L+  + T   D +SFGVLL E++ G+ P   + + EL E I V      +W  K+  D
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 24/211 (11%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVKF 198
           ++G G FG VYK + ++  ++A  +    V D  S  E +    EI  LA  +H N+VK 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAK----VIDTKSEEELEDYMVEIDILASCDHPNIVKL 67

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
                +E+   +++E+   G +   +  L+  + +   R+ +      A+ YLH   ++ 
Sbjct: 68  LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLH---ENK 123

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---- 314
           IIHRD+K+ NIL T +   K+ADFG +  A +T +     S    GT  ++ PE +    
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDS--FIGTPYWMAPEVVMCET 179

Query: 315 -KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            K      K+DV+S G+ L+E+      IEP
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQ----IEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 36/217 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVK 197
           ++G G FG VYK +  E G + A K     V +  S  E +    EI  LA   H  +VK
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAK-----VIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G   ++ +  +++E+ P G +   +  L   + +   ++ I   +  A+ YLH     
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLH---SM 129

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-----GTAGYLDPE 312
            IIHRD+K+ N+LLT +   K+ADFG +         A +V T  +     GT  ++ PE
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS---------AKNVKTLQRRDSFIGTPYWMAPE 180

Query: 313 Y-----LKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
                 +K      K+D++S G+ L+E+      IEP
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQ----IEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.5 bits (180), Expect = 9e-15
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 142 KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +       VA+K  K    D     E   E   + Q+++  +V+ 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 199 HGYLEFEDERIV--IVEYVP-NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
            G  E E   +V  + E  P N  L+++    + NI +L  +      V+  + YL    
Sbjct: 62  IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQ------VSMGMKYLE--- 112

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPE 312
           +   +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA----PE 168

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +  Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 12/204 (5%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +G VYKGR  + G IVA+K+ +    ++   +    EI  L +++H N+V    
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCL-QGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            L  E    +I E++ +  L+++LD L +G  +D          +   I + H      +
Sbjct: 67  VLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRV 122

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           +HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L     
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPEVLLGSPR 178

Query: 320 -TEKSDVYSFGVLLVELVTGRRPI 342
            +   D++S G +  E+ T ++P+
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAE---FQSEIRTLAQVEHLNLVKF 198
           +G+G FG VY     D G  +A+K+       + +  E    + EI+ L  + H  +V++
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 199 HGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           +G L   +E+   + VEY+P G++++ L        ++  R    I     ++YLH    
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLH---S 124

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           + I+HRDIK +NIL       K+ DFG ++         T + + V GT  ++ PE +  
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVISG 183

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
                K+DV+S    +VE++T + P
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 14/203 (6%)

Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQS-EIRTLA-QVEHLNLVKFH 199
           +G+G FG V    L+      AIK  KK V  +    E    E R LA   EH  L    
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHL-DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              + ++    ++EY+  G L  H+    +    D A     A ++   + +LH      
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLH---KKG 116

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           II+RD+K  N+LL ++   K+ADFG  +   + E  A+       GT  Y+ PE LK  +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC----GTPDYIAPEILKGQK 172

Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
             E  D +SFGVLL E++ G+ P
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 67/220 (30%), Positives = 96/220 (43%), Gaps = 33/220 (15%)

Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +      VA+K  K    DK   ++  SE+  +  + +H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDL-SDLVSEMEMMKMIGKHK 78

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    V+VEY   G LRE+L                L    L     + 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA--ADTESGATH 297
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR     D     T+
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               VK    ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 196 GRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +G VYK R    G IVA+K+ +    D+   +    EI  L ++ H N+V+   
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            +  E++  ++ E++ +  L++++D      LD          +   I Y H    H ++
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVL 121

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---KTY 317
           HRD+K  N+L+      K+ADFG AR         TH   +V  T  Y  PE L   + Y
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGSRQY 177

Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEP 344
             +   D++S G +  E+V  RRP+ P
Sbjct: 178 --STPVDIWSIGCIFAEMVN-RRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 14/209 (6%)

Query: 143 IGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAE-FQSEIRTLA-QVEHLNLVKF 198
           +G+G FG V    L+ GT  + AIK  KK V  +    +   +E R LA   +H  L   
Sbjct: 3   LGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           H   + +D    ++EYV  G L   +   +    D       A +V  A+ +LH    H 
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHR---HG 116

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           +I+RD+K  NILL      K+ADFG  +      +G T  +T   GT  Y+ PE L+  +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVT--TTTFCGTPDYIAPEILQELE 172

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
                D ++ GVL+ E++ G+ P E   E
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 70/275 (25%), Positives = 119/275 (43%), Gaps = 27/275 (9%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHL 193
           NF    KIG+G F  VY+   L D   VA+K+ +   + D  +  +   EI  L Q+ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL--DIAIDVAHAITYL 251
           N++K+      ++E  +++E    G L + +   +     +  R      + +  A+ ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H      ++HRDIK +N+ +T     K+ D G  R  + +++ A H    + GT  Y+ P
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAH---SLVGTPYYMSP 175

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD 371
           E +       KSD++S G LL E+   + P    +           M  FS    I   D
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLFSLCQKIEQCD 224

Query: 372 -PRVENTAANNLALEKILELALQCLAPRRQNRPSM 405
            P +     +    EK+ EL   C+ P    RP +
Sbjct: 225 YPPLPTEHYS----EKLRELVSMCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 18/210 (8%)

Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAK-KSVYDKHSGAEFQSEIRTLAQVEHL 193
           +      +G G FG V+  R        A+K      V          +E R L +V H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 194 NLVKFHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
            +++   +    D+R +  ++EYVP G L  +L    G   +  G    A ++  A+ YL
Sbjct: 62  FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLF-YASEIVCALEYL 117

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H      I++RD+K  NILL +    K+ DFGFA+   D        +  + GT  YL P
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-------TWTLCGTPEYLAP 167

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           E +++    +  D ++ G+L+ E++ G  P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 143 IGQGGFGTVYKGRL-----EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +         D  + VA+K  K + +     A   SE++ ++ +  H N+
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA-LMSELKIMSHLGNHENI 101

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           V   G        +VI EY   G L   L   + + L L   L  +  VA  + +L    
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---A 158

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA----GYLDP 311
               IHRD+ + N+LLT     K+ DFG AR   D  + + +V   VKG A     ++ P
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYV---VKGNARLPVKWMAP 212

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVT 337
           E +     T +SDV+S+G+LL E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 143 IGQGGFGTVY----KGRLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN-- 194
           +G G +G V+     G  + G + A+K  KK ++  K   AE     RT  QV E +   
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE---HTRTERQVLEAVRRC 64

Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             LV  H   + + +  +I++YV  G L  HL   + +  +   R+ IA ++  A+ +LH
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHL-YQREHFTESEVRVYIA-EIVLALDHLH 122

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDP 311
                 II+RDIK  NILL       + DFG ++   A+ E  A        GT  Y+ P
Sbjct: 123 QLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC----GTIEYMAP 175

Query: 312 EYLKTYQLTEKS--DVYSFGVLLVELVTGRRP 341
           E ++          D +S GVL  EL+TG  P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 30/235 (12%)

Query: 125 ITMEEIYRATRNFSPSFKIGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDKHSGA--EFQ 181
           + +E +   T  +     IG+G +G VYK    +DG++ A+K     + D  S    E +
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-----ILDPISDVDEEIE 66

Query: 182 SEIRTLAQV-EHLNLVKFHGYLEFEDERI-----VIVEYVPNGTLREHLDCLQGNILDLA 235
           +E   L  +  H N+VKF+G     D+ +     +++E    G++ E    L   +L   
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE----LVKGLLICG 122

Query: 236 GRLD---IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE 292
            RLD   I+  +  A+  L    ++ IIHRD+K +NILLT     K+ DFG   ++A   
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLT 179

Query: 293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKS-----DVYSFGVLLVELVTGRRPI 342
           S     +T V GT  ++ PE +   Q  + S     DV+S G+  +EL  G  P+
Sbjct: 180 STRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 67/222 (30%), Positives = 99/222 (44%), Gaps = 37/222 (16%)

Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 81

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA------------ 241
           N++   G    +    VIVEY   G LRE+L   +     +    DIA            
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP--PGMEYSYDIARVPDEQMTFKDL 139

Query: 242 ----IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA--ADTESGA 295
                 VA  + YL        IHRD+ + N+L+TEN   K+ADFG AR     D     
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T+    VK    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 197 TNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 25/216 (11%)

Query: 143 IGQGGFGTVYKGRL-EDGTI--VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G FG+V +G+L +D +I  VA+K  K ++  +    +F SE   + + +H N+++  
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 200 GYLEFEDER------IVIVEYVPNGTLREHL------DCLQGNILDLAGRLDIAIDVAHA 247
           G      E       +VI+ ++ +G L   L      DC Q   L     +    D+A  
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ--YLPTQMLVKFMTDIASG 124

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV-KGTA 306
           + YL   +    IHRD+ + N +L EN    VADFG   L+    +G  +   ++ K   
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFG---LSKKIYNGDYYRQGRIAKMPV 178

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            ++  E L     T KSDV+SFGV + E+ T G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 73/232 (31%), Positives = 108/232 (46%), Gaps = 31/232 (13%)

Query: 143 IGQGGFGTVYKG--RLEDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G  R  DG  V ++ A K++ +  S     +F  E   +++  H N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 198 FHGYLEFEDE-RIVIVEYVPNGTL-------REHLDCLQGNILDLAGRLDIAIDVAHAIT 249
             G + FE   R +++E +  G L       R   +  + + L +   L  A DVA    
Sbjct: 74  LIG-VSFERLPRFILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCK 130

Query: 250 YLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR--LAADTESGATHVSTQVKG 304
           YL    +H  IHRDI + N LLT       AK+ADFG AR    A            +K 
Sbjct: 131 YLE--ENH-FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK- 186

Query: 305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPI--EPKRELKERIT 353
              ++ PE       T K+DV+SFGVLL E+ + G  P      +E+ E +T
Sbjct: 187 ---WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 48/234 (20%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSG-AEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V+  R  + G + A+K  +KS   K +  A  ++E   LA  +   +VK + 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILD------LAGRLDIAIDVAHAITYLH 252
              F+DE  +  ++EY+P G L   L  ++ ++            L +A+D  H + +  
Sbjct: 69  S--FQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFYIAELVLALDSVHKLGF-- 122

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-------------------------RL 287
                  IHRDIK  NIL+  +   K+ADFG                            +
Sbjct: 123 -------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                      +    GT  Y+ PE L+      + D +S GV+L E++ G  P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 26/219 (11%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 75  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 126

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            +  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 127 -ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA--LESI 183

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKREL 348
             + Y  T +SDV+S+GV + EL+T G +P +  P  E+
Sbjct: 184 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 20/219 (9%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSG---AEFQSEIRTLAQVEHLNLVKF 198
           +G+GGFG V   ++++ G + A K+  K    K SG   A  + EI  L +V    +V  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
               E +    +++  +  G L+ H+  +    L++   +  +  +   I +LH      
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           I++RD+K  N+LL +    +++D G   LA + + G T   TQ  GT GY+ PE LK   
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLG---LAVELKDGKT--ITQRAGTNGYMAPEILKEEP 170

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIE------PKRELKER 351
            +   D ++ G  + E+V GR P +       K ELK R
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 12/202 (5%)

Query: 143 IGQGGFGTVY-KGRLEDGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQ-VEHLNLVKFH 199
           IG+G FG V    R  DG+  A+K   KK++  K       +E   L + ++H  LV  H
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              +  ++   +++YV  G L  HL   +   L+   R   A +VA AI YLH      I
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHSLN---I 117

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  NILL       + DFG  +   + E      ++   GT  YL PE L+    
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----TTSTFCGTPEYLAPEVLRKEPY 173

Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
               D +  G +L E++ G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 56/216 (25%), Positives = 107/216 (49%), Gaps = 19/216 (8%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           K+G+G + TV+KGR +    +VA+K  +    +   GA   +  E+  L  ++H N+V  
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
           H  +  +    ++ EY+ +  L++++D C  GNI+ +         +   + Y H     
Sbjct: 70  HDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RR 123

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YLKT 316
            ++HRD+K  N+L+ E    K+ADFG AR     +S  T   +    T  Y  P+  L +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGS 179

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
            + + + D++  G +  E+ +G RP+ P   +++ +
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDEL 214

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 14/209 (6%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG V+   L+      AIK  KK V    D       +  + +LA  EH  L   
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHL 61

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           +   + ++    ++EY+  G L  H+        DL      A ++   + +LH      
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLH---SKG 116

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           I++RD+K  NILL  +   K+ADFG  +   +   G     T   GT  Y+ PE L   +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCT-FCGTPDYIAPEILLGQK 172

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
                D +SFGVLL E++ G+ P     E
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 30/220 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G G +G VYK R L  G + A+K  K    D  S    Q EI  + + +H N+V + G
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS--LIQQEIFMVKECKHCNIVAYFG 73

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLHMY 254
                ++  + +EY   G+L++        I  + G L       +  +    + YLH  
Sbjct: 74  SYLSREKLWICMEYCGGGSLQD--------IYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                +HRDIK +NILLT+N   K+ADFG A  A  T + A   S    GT  ++ PE  
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKS--FIGTPYWMAPEVA 178

Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
              K     +  D+++ G+  +EL   + P   + P R L
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 58/209 (27%), Positives = 84/209 (40%), Gaps = 25/209 (11%)

Query: 143 IGQGGFGTV----YKGRLEDGTIVAIKRAKKS-VYDKHSGAEFQSEIR---TLAQVEHLN 194
           +G+G FG V    YK     G + AIK  KK  +  +        E R   T     H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           LV      + ED    ++EY   G L  H+     ++      +  A  V   + YLH  
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSEPRAVFYAACVVLGLQYLH-- 118

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK--GTAGYLDPE 312
            ++ I++RD+K  N+LL      K+ADFG  +       G           GT  +L PE
Sbjct: 119 -ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK------EGMGFGDRTSTFCGTPEFLAPE 171

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            L     T   D +  GVL+ E++ G  P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVE-HLNLVKFH 199
           IG+G +  V   RL+ +  I A+K  KK  V+D       Q+E     Q   +  LV  H
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              +      +++EYV  G L  H+   Q  + +   R   A ++  A+ +LH   +  I
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL  +   K+ D+G  +       G    ++   GT  Y+ PE L+  + 
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGL----GPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
               D ++ GVL+ E++ GR P +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 26/221 (11%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + DG  V I  A K + +  S     E   E   +A V    + + 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G       ++V  + +P G L    RE+ D +    L     L+  + +A  ++YL   
Sbjct: 75  LGICLTSTVQLV-TQLMPYGCLLDYVRENKDRIGSQDL-----LNWCVQIAKGMSYLE-- 126

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            +  ++HRD+ + N+L+      K+ DFG ARL    +TE  A      +K    ++  E
Sbjct: 127 -EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----WMALE 181

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKE 350
            +   + T +SDV+S+GV + EL+T G +P +  P RE+ +
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 47/225 (20%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKFH 199
           IG+G +G VYK R +D G +VA+K+ +  + ++  G    +  EI+ L Q+ H N+V   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 200 -------GYLEFEDER---IVIVEYVPN---GTL--------REHLDCLQGNILDLAGRL 238
                    L+F+ ++    ++ EY+ +   G L         +H+      +L+     
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE----- 127

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
                    + Y H       +HRDIK SNILL    + K+ADFG ARL     S  +  
Sbjct: 128 --------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL---YNSEESRP 173

Query: 299 STQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            T    T  Y  PE  L   +     DV+S G +L EL T ++PI
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 41/218 (18%)

Query: 143 IGQGGFGTVYKGRLEDG-TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN---LVKF 198
           IG+G FG V   R +    + A+K   K    K S + F  E R +  + H N   +V+ 
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIVQL 108

Query: 199 HGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDI--------AIDVAHAI 248
           H    F+D++   +++EY+P G           ++++L    DI          +V  A+
Sbjct: 109 H--YAFQDDKYLYMVMEYMPGG-----------DLVNLMSNYDIPEKWARFYTAEVVLAL 155

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAG 307
             +H       IHRD+K  N+LL ++   K+ADFG   ++ A+   G     T V GT  
Sbjct: 156 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN---GMVRCDTAV-GTPD 208

Query: 308 YLDPEYLKTY----QLTEKSDVYSFGVLLVELVTGRRP 341
           Y+ PE LK+         + D +S GV L E++ G  P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 38/224 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEF---QSEIRTLAQVEHLNLVK 197
           +IG G +G VYK R +  G + AIK     V     G +F   Q EI  +   +H N+V 
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIK-----VIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYL 251
           + G     D+  + +E+   G+L++        I  + G L       ++ +    + YL
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQD--------IYHVTGPLSESQIAYVSRETLQGLYYL 122

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLD 310
           H       +HRDIK +NILLT+N   K+ADFG  A++ A      + +     GT  ++ 
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMA 174

Query: 311 PEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
           PE     +     +  D+++ G+  +EL   + P   + P R L
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 12/204 (5%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQVE-HLNLVKFH 199
           IG+G +  V   RL+    I A+K  KK + +     ++ Q+E     Q   H  LV  H
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + E     ++EYV  G L  H+   Q  + +   R   A +++ A+ YLH   +  I
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH---ERGI 117

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ D+G  +       G T  ++   GT  Y+ PE L+    
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDT--TSTFCGTPNYIAPEILRGEDY 173

Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
               D ++ GVL+ E++ GR P +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.0 bits (168), Expect = 6e-13
 Identities = 54/215 (25%), Positives = 109/215 (50%), Gaps = 16/215 (7%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           K+G+G + TVYKG+ + +G +VA+K  +     +  G  F +  E   L  ++H N+V  
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLL 68

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           H  +  ++   ++ EYV +  L +++D   G +     +L     +   ++Y+H      
Sbjct: 69  HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKL-FLFQLLRGLSYIH---QRY 123

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YLKTY 317
           I+HRD+K  N+L+++    K+ADFG AR     +S  +H  +    T  Y  P+  L + 
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR----AKSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
           + +   D++  G + VE++ G       +++++++
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 41/224 (18%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN---LVK 197
           ++G+G +G+VYK      G  +A+K  +  + +    ++F   I  L  +       +V 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE----SKFNQIIMELDILHKAVSPYIVD 63

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD-----IAIDVAHAITYLH 252
           F+G    E    + +EY+  G+L    D L    +   G  +     I   V   + +L 
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSL----DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG---ATHVSTQVKGTAGYL 309
              +H IIHRD+K +N+L+  N + K+ DFG         SG   A+   T + G   Y+
Sbjct: 120 --EEHNIIHRDVKPTNVLVNGNGQVKLCDFGV--------SGNLVASLAKTNI-GCQSYM 168

Query: 310 DPEYLK--------TYQLTEKSDVYSFGVLLVELVTGRRPIEPK 345
            PE +K        TY  T +SDV+S G+ ++E+  GR P  P+
Sbjct: 169 APERIKSGGPNQNPTY--TVQSDVWSLGLSILEMALGRYPYPPE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 9/214 (4%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G +G V K R  E   IVAIK+ K S  ++        E++ L  ++  N+V+    
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
                +  ++ EYV    L E L+ +   +     R  I   +  AI + H    + I+H
Sbjct: 69  FRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCH---KNDIVH 123

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RDIK  N+L++ N   K+ DFGFAR   +   G+    T+   T  Y  PE L      +
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFAR---NLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180

Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERITVK 355
             D++S G +L EL  G+     + E+ +  T++
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 54/284 (19%)

Query: 143 IGQGGFGTVYKGRLE-------DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLN 194
           +GQG F  +YKG L         G    +    K +   H  +  F      ++Q+ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           LVK +G +   DE I++ EYV  G L   L   + N + L  +LD+A  +A A+ YL   
Sbjct: 63  LVKLYG-VCVRDENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 255 TDHPIIHRDIKSSNILLTEN--------FRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            D  ++H ++   NIL+           F  K++D G                 +V+   
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPF-IKLSDPGIPI-------TVLSREERVE-RI 168

Query: 307 GYLDPEYLKTYQ--LTEKSDVYSFGVLLVELVT-GRRPIEP-KRELKERITVKWAMKKFS 362
            ++ PE ++  Q  LT  +D +SFG  L+E+ + G  P+       KER         + 
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER--------FYQ 220

Query: 363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMR 406
           D   + + D              ++  L  QC       RPS R
Sbjct: 221 DQHRLPMPD------------CAELANLINQCWTYDPTKRPSFR 252

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 25/218 (11%)

Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSE-----IRTLAQV 190
           + P  +IG G +GTVYK R    G  VA+K  +  V     G    +      ++ L   
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAF 59

Query: 191 EHLNLVKF-----HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVA 245
           +H N+V+          + E +  ++ E+V +  LR +LD +    L      D+     
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 246 HAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS-TQVKG 304
             + +LH    + I+HRD+K  NIL+T   + K+ADFG AR+       +  ++ T V  
Sbjct: 119 RGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY------SCQMALTPVVV 169

Query: 305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 12/202 (5%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQ-VEHLNLVKFH 199
           IG+G FG V   +   DG   A+K   KK++  K       +E   L + V+H  LV  H
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              +  D+   +++YV  G L  HL   + +  +   R   A ++A A+ YLH      I
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLHSLN---I 117

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  NILL       + DFG  +   +        ++   GT  YL PE L+    
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK----TTSTFCGTPEYLAPEVLRKQPY 173

Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
               D +  G +L E++ G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 67/219 (30%), Positives = 95/219 (43%), Gaps = 50/219 (22%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK---- 197
           +G G FG V   + +  G   AIK  KK             EI  + QV+H+   K    
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKR------------EILKMKQVQHVAQEKSILM 73

Query: 198 --FHGYL-----EFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRL--DIA----I 242
              H ++      F+DE  V  ++E+V  G L  HL          AGR   D+A     
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--------AGRFPNDVAKFYHA 125

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
           ++  A  YLH      II+RD+K  N+LL      KV DFGFA+   D        +  +
Sbjct: 126 ELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-------TFTL 175

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            GT  YL PE +++    +  D ++ GVLL E + G  P
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKR-AKKSVYDK----HSGAEFQSEIRTLAQVEHLNLV 196
           IG+G FG VY+ R +D   I A+K  +KK +  K    H+  E    +RTL   E   +V
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD-ESPFIV 59

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                 + + +  ++ +Y+  G L  HL   +G   +   +  IA ++  A+ +LH    
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLH---K 114

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL-- 314
           + I++RD+K  NILL       + DFG ++  A+     T  +    GT  YL PE L  
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKT--TNTFCGTTEYLAPEVLLD 170

Query: 315 -KTYQLTEKSDVYSFGVLLVELVTGRRP 341
            K Y  T+  D +S GVL+ E+  G  P
Sbjct: 171 EKGY--TKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 16/217 (7%)

Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHL 193
           +F+    +G+G FG V     +    + AIK  KK V  +    E    E R LA  +  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 194 N-LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             L + H   +  D    ++EYV  G L  H+   Q         +  A +++  + +LH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV-KGTAGYLDP 311
                 II+RD+K  N++L      K+ADFG  +     E     V+T+   GT  Y+ P
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAP 170

Query: 312 EYLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKRE 347
           E +  YQ   KS D +++GVLL E++ G+ P + + E
Sbjct: 171 EII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 62/248 (25%)

Query: 142 KIGQGGFGTVYKGRL---EDGTIVAIKRAKKSVYDKHSGAEF-QSEIRTLA---QVEHLN 194
            IG+G +G VYK +    +DG   AIK+ K    DK       QS  R +A   +++H N
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG---DKEQYTGISQSACREIALLRELKHEN 63

Query: 195 LVKFHG-YLEFEDERIVIV-EY-------------------VPNGTLREHLDCLQGNILD 233
           +V     +LE  D+ + ++ +Y                   +P   ++     L   IL+
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS----LLWQILN 119

Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT----ENFRAKVADFGFARLAA 289
                         + YLH    + ++HRD+K +NIL+     E    K+ D G ARL  
Sbjct: 120 -------------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Query: 290 DTESGATHVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR 346
                   +   V  T  Y  PE L   + Y  T+  D+++ G +  EL+T   PI   R
Sbjct: 164 APLKPLADLDPVVV-TIWYRAPELLLGARHY--TKAIDIWAIGCIFAELLT-LEPIFKGR 219

Query: 347 ELKERITV 354
           E K + + 
Sbjct: 220 EAKIKKSN 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 80/309 (25%), Positives = 135/309 (43%), Gaps = 72/309 (23%)

Query: 142 KIGQGGFGTVY--------------------KGRLEDGTIVAIK--RAKKSVYDKHSGAE 179
           K+G+G FG V+                    KGR     +VA+K  R   +   K++  +
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDAN---KNARND 65

Query: 180 FQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLRE-----HLDCLQGNILDL 234
           F  E++ L++++  N+++  G    ED   +I EY+ NG L +     HLD  + N  D 
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 235 AGR------------LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF 282
                          L +A+ +A  + YL        +HRD+ + N L+ EN   K+ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADF 182

Query: 283 GFAR--LAADTESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           G +R   A D          +++G A     ++  E +   + T  SDV++FGV L E++
Sbjct: 183 GMSRNLYAGDY--------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Query: 337 TGRRPIEPKRELKERITVKWAMKKFSD-GDAISILDPRVENTAANNLALEKILELALQCL 395
              +  +P  EL +   ++ A + F D G  + +  P            + + EL LQC 
Sbjct: 235 MLCKE-QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP--------CPQGLYELMLQCW 285

Query: 396 APRRQNRPS 404
           +   + RPS
Sbjct: 286 SRDCRERPS 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 81/296 (27%), Positives = 129/296 (43%), Gaps = 54/296 (18%)

Query: 143 IGQGGFGTVYKGRL--EDGTI--VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG+V + +L  EDG+   VA+K  K  ++      EF  E   + + +H N++K 
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 199 HGYLEFEDER------IVIVEYVPNGTLREHLDCLQGNI------LDLAGRLDIAIDVAH 246
            G       +      +VI+ ++ +G L  H   L   I      L L   +   ID+A 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVSTQVKG 304
            + YL   +    IHRD+ + N +L EN    VADFG ++   + D           VK 
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK- 180

Query: 305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKRELKERITVKWAMKK 360
              +L  E L     T  SDV++FGV + E++T G+ P   +E   E+   +     +K+
Sbjct: 181 ---WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-NSEIYNYLIKGNRLKQ 236

Query: 361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS---MRRCAEILW 413
             D                    LE + EL  QC +P  + RPS   +R   E++W
Sbjct: 237 PPD-------------------CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 63/246 (25%)

Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           IG+G FG V   RL    + G I A+K+ +KS + +K   A  ++E   LA+ ++  +VK
Sbjct: 9   IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 198 FHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNIL-DLAGRLDI-----AIDVAHAIT 249
              Y  F+DE    +I+EY+P G +   L  ++ +   +   R  I     AID  H + 
Sbjct: 66  L--YYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFG------------FARLAADTESGATH 297
           Y         IHRDIK  N+LL      K++DFG            F R+ +        
Sbjct: 122 Y---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 298 VSTQ----------------------VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVEL 335
                                       GT  Y+ PE        ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 336 VTGRRP 341
           + G  P
Sbjct: 233 LVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)

Query: 143 IGQGGFGTVYKGRLEDGT----IVAIKRAKKS--VYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G+GG+G V++ R   G     I A+K  KK+  V ++   A  ++E   L  V+H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                 +   +  +I+EY+  G L  HL+  +G  ++      ++ +++ A+ +LH    
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLS-EISLALEHLH---Q 118

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             II+RD+K  NILL      K+ DFG  + +   E   TH      GT  Y+ PE L  
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH-EGTVTHTFC---GTIEYMAPEILMR 174

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
               +  D +S G L+ +++TG  P   E +++  ++I
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 16/228 (7%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A K+ +K    K  G     +E + L +V    +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++  +  G L+ H+  +     +    +  A ++   +  LH      I+
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIV 124

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL ++   +++D G   LA     G T +  +V GT GY+ PE +K  + T
Sbjct: 125 YRDLKPENILLDDHGHIRISDLG---LAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 179

Query: 321 EKSDVYSFGVLLVELVTGRRPIEP-----KRELKERITVKWAMKKFSD 363
              D ++ G LL E++ G+ P +      KRE  ER+ VK   +++S+
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVQEEYSE 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 38/219 (17%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +G VYK R       +A+K+ +    D+   +    EI  L +++H N+V+   
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT----- 255
            +   ++R+ +V         E+LD      LDL   +D + D A     +  Y      
Sbjct: 69  VV-HSEKRLYLV--------FEYLD------LDLKKHMDSSPDFAKNPRLIKTYLYQILR 113

Query: 256 ------DHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGY 308
                  H ++HRD+K  N+L+     A K+ADFG AR         TH       T  Y
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWY 169

Query: 309 LDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
             PE L   + Y  +   D++S G +  E+V  ++P+ P
Sbjct: 170 RAPEILLGSRHY--STPVDIWSVGCIFAEMVN-QKPLFP 205

Length = 294

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 10/211 (4%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A KR +K    K  G     +E + L +V    +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++  +  G L+ H+  +     +    L  A ++   +  LH       +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTV 124

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL +    +++D G A    + ES    V     GT GY+ PE L   + T
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAPEVLNNQRYT 179

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKER 351
              D +  G L+ E++ G+ P   ++E  +R
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 37/226 (16%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEH 192
           ++G+  FG VYKG L      E    VAIK  K    DK  G    EF+ E    ++++H
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----DKAEGPLREEFKHEAMMRSRLQH 67

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRL 238
            N+V   G +  E    +I  Y  +  L E L              D    + L+ A  +
Sbjct: 68  PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGAT 296
            I   +A  + +L   + H ++H+D+ + N+L+ +    K++D G  R   AAD      
Sbjct: 128 HIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +    ++    ++ PE +   + +  SD++S+GV+L E+ + G +P
Sbjct: 185 NSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 13/202 (6%)

Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQSEIRT-LAQVEHLNLVKFHG 200
           IG+G FG V + R  D   I A+K  +K+     S        RT LAQV    +V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  ++  +++ ++  G L  HL   +G       R   A ++  A+  LH +    +I
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTA-ELLCALENLHKFN---VI 115

Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           +RD+K  NILL       + DFG  +L   D +   T       GT  YL PE L  +  
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-----GTPEYLAPELLLGHGY 170

Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
           T+  D ++ GVLL E++TG  P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 20/218 (9%)

Query: 135 RNFSPSFKIGQGGFGTVYKGR--LEDGTIVAIKRAKKSVYDKHSGAEFQSEI---RTLAQ 189
           + +    +IG+G +G V+K R     G  VA+KR +    ++        E+   R L  
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 190 VEHLNLVKFH-----GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDV 244
            EH N+V+          + E +  ++ E+V +  L  +LD +    +      D+   +
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKG 304
              + +LH    H ++HRD+K  NIL+T + + K+ADFG AR+ +          T V  
Sbjct: 120 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVV 171

Query: 305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 43/233 (18%)

Query: 136 NFSPSFK----IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQ 189
           +  P ++    IG+G +G V        G  VAIK  K S ++  +  +    EI+ L +
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK--KISPFEHQTFCQRTLREIKILRR 59

Query: 190 VEHLNLVKFH------GYLEFEDERIVIVEYVPNGTLR---------EHLDCLQGNILDL 234
            +H N++          +  F D  IV  E +     +         +H+      IL  
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIV-QELMETDLYKLIKTQHLSNDHIQYFLYQIL-- 116

Query: 235 AGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG 294
                        + Y+H      ++HRD+K SN+LL  N   K+ DFG AR+ AD E  
Sbjct: 117 -----------RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHD 161

Query: 295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKR 346
            T   T+   T  Y  PE +   +   K+ D++S G +L E+++  RP+ P +
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 12/202 (5%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQ-VEHLNLVKFH 199
           IG+G FG V   R + +    A+K   KK++  K       SE   L + V+H  LV  H
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              +  D+   +++Y+  G L  HL   +   L+   R   A ++A A+ YLH      I
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHSLN---I 117

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           ++RD+K  NILL       + DFG  +   + E   T  ++   GT  YL PE L     
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGT--TSTFCGTPEYLAPEVLHKQPY 173

Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
               D +  G +L E++ G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 54/230 (23%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLV-- 196
           KIGQG FG V+K R  +   IVA+K+    + ++  G    +  EI+ L  ++H N+V  
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 197 ------KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAH- 246
                 K   Y  ++    ++ E+       EH         DLAG L    +   ++  
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFC------EH---------DLAGLLSNKNVKFTLSEI 121

Query: 247 ---------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
                     + Y+H    + I+HRD+K++NIL+T++   K+ADFG AR  + +++   +
Sbjct: 122 KKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 298 VSTQVKGTAGYLDPEYLKTYQLTEKS-----DVYSFGVLLVELVTGRRPI 342
             T    T  Y  PE L    L E+      D++  G ++ E+ T R PI
Sbjct: 179 RYTNRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 35/214 (16%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK---- 197
           IG+GGFG VY  R  D G + A+K       DK      Q E   L +   L+LV     
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 198 ---------FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAI 248
                    FH      D+   I++ +  G L  HL   Q  +   A     A ++   +
Sbjct: 57  PFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGL 110

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            ++H   +  +++RD+K +NILL E+   +++D G   LA D      H S    GT GY
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASV---GTHGY 161

Query: 309 LDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           + PE L K       +D +S G +L +L+ G  P
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 65.2 bits (160), Expect = 1e-11
 Identities = 59/223 (26%), Positives = 87/223 (39%), Gaps = 43/223 (19%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH-- 199
           IG G +G V        G  VAIK+      D         EI+ L  + H N++     
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 200 ----GYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLA----GRLDIAIDVAHAITY 250
                  +F D  + IV E +                 DL         +  D      Y
Sbjct: 68  LRPPSPEDFND--VYIVTELME---------------TDLHKVIKSPQPLTDDHIQYFLY 110

Query: 251 ------LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKG 304
                  ++++ + +IHRD+K SNIL+  N   K+ DFG AR     E     ++  V  
Sbjct: 111 QILRGLKYLHSAN-VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV- 168

Query: 305 TAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           T  Y  PE L     Y  T+  D++S G +  EL+T R+P+ P
Sbjct: 169 TRWYRAPELLLSSSRY--TKAIDIWSVGCIFAELLT-RKPLFP 208

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G I A+K  KKSV   + + + F+ E   L+      + +   
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 201 YLEFEDERIVIVEYVPNGTL----REHLDCLQGNILD--LAGRLDIAIDVAHAITYLHMY 254
             + +D   +++EY P G L      + D    ++    LA  L +AI   H + Y    
Sbjct: 69  AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQMGY---- 123

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFG-FARLAADTESGATHVSTQVKGTAGYLDPEY 313
                +HRDIK  N+L+      K+ADFG  ARL A+        S    GT  Y+ PE 
Sbjct: 124 -----VHRDIKPENVLIDRTGHIKLADFGSAARLTAN----KMVNSKLPVGTPDYIAPEV 174

Query: 314 LKTYQLTEKS------DVYSFGVLLVELVTGRRPIE 343
           L T     K       D +S GV+  E++ GR P  
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 35/214 (16%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK---- 197
           IG+GGFG VY  R  D G + A+K       DK      Q E   L +   L+LV     
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 198 ---------FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAI 248
                    FH      D+   I++ +  G L  HL   Q  +         A ++   +
Sbjct: 57  PFIVCMTYAFHT----PDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGL 110

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            ++H   +  +++RD+K +NILL E+   +++D G   LA D      H S    GT GY
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASV---GTHGY 161

Query: 309 LDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           + PE L K       +D +S G +L +L+ G  P
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 39/225 (17%)

Query: 142 KIGQGGFGTVY----KGRLE-----------DGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           K+G+G FG V+    +G  E              +VA+K  +  V  K +  +F  EI+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKI 70

Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLD--------CLQGNI--LDLAG 236
           ++++++ N+++  G    +D   +I EY+ NG L + L             NI  + +A 
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
            L +A+ +A  + YL        +HRD+ + N L+  ++  K+ADFG +R   +  SG  
Sbjct: 131 LLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSR---NLYSGDY 184

Query: 297 HVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           +   +++G A     ++  E +   + T  SDV++FGV L E+ T
Sbjct: 185 Y---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 18/218 (8%)

Query: 143 IGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLN-LVKF 198
           +G+G FG V       GT  + AIK  KK V  +    E    E R LA       L + 
Sbjct: 8   LGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           H   +  D    ++EYV  G L  H+   Q         +  A ++A  + +LH      
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLH---SKG 121

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           II+RD+K  N++L      K+ADFG  +   +   G T  +    GT  Y+ PE +  YQ
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKT--TRTFCGTPDYIAPEII-AYQ 176

Query: 319 LTEKS-DVYSFGVLLVELVTGRRPI--EPKRELKERIT 353
              KS D ++FGVLL E++ G+ P   E + EL + I 
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 64/234 (27%)

Query: 142 KIGQGGFGTVYKGRLED---GTIVAIKRAKKSVYDKHSGAEFQS---------EIRTLAQ 189
           K+G+G +G V+K    D     +VA+K+    ++D      F++         EI  L +
Sbjct: 14  KLGKGAYGIVWKAI--DRRTKEVVALKK----IFDA-----FRNATDAQRTFREIMFLQE 62

Query: 190 V-EHLNLVKFHG----------YLEFE----DERIVIVEYVPNGTLREHLDCLQGNILDL 234
           + +H N+VK             YL FE    D   VI                + NIL+ 
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI----------------RANILED 106

Query: 235 AGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG 294
             +  I   +  A+ Y+H      +IHRD+K SNILL  + R K+ADFG AR  ++ E  
Sbjct: 107 VHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163

Query: 295 ATH-VSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
             + V T    T  Y  PE L     Y  T+  D++S G +L E++ G +P+ P
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLG-KPLFP 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 81/318 (25%), Positives = 125/318 (39%), Gaps = 89/318 (27%)

Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G V      + G  VAIK+  +             E+
Sbjct: 9   TVWEVPDRYQNLSP---VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL 65

Query: 185 RTLAQVEHLNLVK----FHGYLEFEDERIVIVEYVP--------NGTLR------EHLDC 226
           R L  ++H N++     F      ED + V   Y+         N  ++      +H+  
Sbjct: 66  RLLKHMDHENVIGLLDVFTPASSLEDFQDV---YLVTHLMGADLNNIVKCQKLSDDHIQF 122

Query: 227 LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR 286
           L   IL               + Y+H      IIHRD+K SNI + E+   K+ DFG AR
Sbjct: 123 LVYQIL-------------RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Query: 287 LAADTESGATHVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGR------ 339
              D  +G  +V+T+      Y  PE  L      +  D++S G ++ EL+TG+      
Sbjct: 167 HTDDEMTG--YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Query: 340 -------RPIE----PKRELKERITVKWA---------MKK------FSDGDAISI---- 369
                  R +     P  EL ++I+ + A         M K      FS  + ++I    
Sbjct: 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLE 279

Query: 370 ----LDPRVENTAANNLA 383
               LDP    TAA  LA
Sbjct: 280 KMLVLDPDKRITAAEALA 297

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 73/261 (27%), Positives = 113/261 (43%), Gaps = 28/261 (10%)

Query: 143 IGQGGFGTVY-KGRLEDGTIVAIKRAKKSVY-----DKHSGAEFQSEIRTLAQVEHLNLV 196
           IG+G FG V    R  DG   A+K  +K +       KH  AE       L  V+H  LV
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV---LLKNVKHPFLV 59

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   +  ++   ++++V  G L  HL   + +  +   R   A ++A A+ YLH    
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHSIN- 116

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLA---ADTESGATHVSTQVKGTAGYLDPEY 313
             I++RD+K  NILL       + DFG  +     +DT       +T   GT  YL PE 
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-------TTTFCGTPEYLAPEV 167

Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERITVK-WAMKKFSDGDAISIL 370
           ++        D +  G +L E++ G  P   +   E+ + I  K   ++  +   A SIL
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSIL 227

Query: 371 DPRVENTAANNL-ALEKILEL 390
           +  +E      L A E  LE+
Sbjct: 228 EELLEKDRQRRLGAKEDFLEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A K+ +K    K  G     +E R L +V    +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++  +  G L+ H+  +     D    +  A ++   +  L       I+
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIV 124

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL +    +++D G   LA     G T V  +V GT GY+ PE +   + T
Sbjct: 125 YRDLKPENILLDDRGHIRISDLG---LAVQIPEGET-VRGRV-GTVGYMAPEVINNEKYT 179

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW 356
              D +  G L+ E++ G+ P    R+ KER  VK 
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPF---RKRKER--VKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 15/203 (7%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  KK V   K   A   +E R L    H  L     
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             + +D    ++EYV  G L  HL   +  +           ++  A+ YLH      I+
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLS--RERVFSEDRTRFYGAEIVSALDYLH---SGKIV 117

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK--GTAGYLDPEYLKTYQ 318
           +RD+K  N++L ++   K+ DFG  +       G T  +T     GT  YL PE L+   
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAPEVLEDND 171

Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
                D +  GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 142 KIGQGGFGTVYKG--RLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FG V KG  ++    I VAIK   K+  +K    E   E   + Q+++  +V+ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   +V+ E    G L + L   +  I  ++  +++   V+  + YL       
Sbjct: 61  IGVCEAEALMLVM-EMASGGPLNKFLSGKKDEI-TVSNVVELMHQVSMGMKYLE---GKN 115

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
            +HRD+ + N+LL     AK++DFG ++ L AD         +  K    +  PE +   
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD--DSYYKARSAGKWPLKWYAPECINFR 173

Query: 318 QLTEKSDVYSFGVLLVELVT-GRRP 341
           + + +SDV+S+G+ + E  + G++P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 16/228 (7%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A K+  KK +  +   A   +E + L +V    +V    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++  +  G L+ H+  +     D    +  A ++   +  LH      I+
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIV 124

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL +    +++D G   LA +   G T +  +V GT GY+ PE +K  + T
Sbjct: 125 YRDLKPENILLDDYGHIRISDLG---LAVEIPEGET-IRGRV-GTVGYMAPEVVKNERYT 179

Query: 321 EKSDVYSFGVLLVELVTGRRPIEP-----KRELKERITVKWAMKKFSD 363
              D +  G L+ E++ G+ P        KRE  ER  VK   +++S+
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-RVKEDQEEYSE 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 57/226 (25%), Positives = 94/226 (41%), Gaps = 28/226 (12%)

Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLA 188
           ++  T  +     +G G FG V   R    G  VAIK+  K             E++ L 
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64

Query: 189 QVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAI 242
            + H N++          E I  V  +    L   L          +  L+         
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT---------SRPLEKQFIQYFLY 115

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
            +   + Y+H      ++HRD+K SNIL+ EN   K+ DFG AR+     +G  +VST+ 
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG--YVSTRY 170

Query: 303 KGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
                Y  PE + T+Q    + D++S G +  E++ G +P+ P ++
Sbjct: 171 -----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKD 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 11/201 (5%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  KK V   K   A   +E R L    H  L     
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +    +   R   A ++  A+ YLH      ++
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGA-EIVSALGYLH---SCDVV 117

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N++L ++   K+ DFG  +       GAT       GT  YL PE L+     
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK--EGISDGAT--MKTFCGTPEYLAPEVLEDNDYG 173

Query: 321 EKSDVYSFGVLLVELVTGRRP 341
              D +  GV++ E++ GR P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 2/89 (2%)

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY- 317
           +IHRD+K SN+L+ E+   ++ DFG AR  + + +   +  T+   T  Y  PE L +  
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP 187

Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKR 346
           + T   D++S G +  E++ GRR + P +
Sbjct: 188 EYTTAIDMWSVGCIFAEML-GRRQLFPGK 215

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 143 IGQGGFGTVY----KGRLEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLA-QVEHLNLV 196
           +G+G FG V     KG  E   + AIK  KK V  +    E    E R LA   +   L 
Sbjct: 8   LGKGSFGKVMLAERKGTDE---LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + H   +  D    ++EYV  G L   +   Q         +  A ++A  + +LH    
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLH---S 119

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV-KGTAGYLDPEYLK 315
             II+RD+K  N++L      K+ADFG  +     E+    V+T+   GT  Y+ PE + 
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIA 174

Query: 316 TYQLTEKS-DVYSFGVLLVELVTGRRPIEPKRE 347
            YQ   KS D ++FGVLL E++ G+ P E + E
Sbjct: 175 -YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 17/220 (7%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A K+  K    K  G E    E R LA+V    +V    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNI--LDLAGRLDIAIDVAHAITYLHMYTDHP 258
             + + +  +++  +  G LR H+  +                  +   + +LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           II+RD+K  N+LL  +   +++D G A    D +S     +    GT G++ PE L+  +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA----GTPGFMAPELLQGEE 173

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIE------PKRELKERI 352
                D ++ GV L E++  R P          +ELK+RI
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 143 IGQGGFGTVYKGRLEDG-TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G FG V   R +    + A+K   K    K S + F  E R +    +   V    +
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQLF 109

Query: 202 LEFEDER--IVIVEYVPNG---TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             F+D++   +++EY+P G    L  + D  +         + +A+D  H++        
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG------- 162

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             +IHRD+K  N+LL ++   K+ADFG   +  D E+G     T V GT  Y+ PE LK+
Sbjct: 163 --LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMD-ETGMVRCDTAV-GTPDYISPEVLKS 217

Query: 317 Y----QLTEKSDVYSFGVLLVELVTGRRP 341
                    + D +S GV L E++ G  P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 56/217 (25%), Positives = 87/217 (40%), Gaps = 49/217 (22%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFH 199
           KIG+G F  V K +  + G   AIK  KK             EI+ L ++  H N+++  
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLI 64

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL-AGR---------------LDIAID 243
             L F+            G L    + +  N+ +L  GR               L  ++D
Sbjct: 65  EVL-FDR---------KTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
             H          + I HRDIK  NIL+ ++   K+ADFG  R          ++ST+  
Sbjct: 115 HMHR---------NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-- 162

Query: 304 GTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVT 337
               Y  PE L T   Y    K D+++ G +  E+++
Sbjct: 163 ---WYRAPECLLTDGYY--GPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 12/204 (5%)

Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVE-HLNLVKFH 199
           IG+G +  V    L+    I A+K  KK  V D       Q+E         H  LV  H
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + E     ++E+V  G L  H+   Q  + +   R   + +++ A+ +LH   +  I
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARF-YSAEISLALNFLH---ERGI 117

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ D+G  +       G T  ++   GT  Y+ PE L+    
Sbjct: 118 IYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDT--TSTFCGTPNYIAPEILRGEDY 173

Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
               D ++ GVL+ E++ GR P +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 36/237 (15%)

Query: 135 RNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQV 190
           ++F     +G+G  G V+  RL+  G + A+K   K      +K      + EI  LA +
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATL 58

Query: 191 EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNIL-DLAGRLDIAIDVAHAIT 249
           +H  L   +   + E    ++++Y P G L   L    G  L +   R   A +V  A+ 
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALE 117

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT-----------ESGATHV 298
           YLH+     I++RD+K  NILL E+    ++DF  ++ +                 ++  
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 299 STQVK--------------GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           S   +              GT  Y+ PE +         D ++ G+LL E++ G  P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 16/212 (7%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVA---IKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +IG G FG V  G    G   A   +K  + S         F  E++   ++ H N+++ 
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ-LLFLQEVQPYRELNHPNVLQC 60

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR---LDIAIDVAHAITYLHMYT 255
            G        ++++E+ P G L+ +L   +G +  +A +     +A +VA  +  L ++ 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGL--LWLHQ 118

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFA--RLAADTESGATHVSTQVKGTAGYLDPEY 313
               IH D+   N  LT +   K+ D+G A  +   D        +  ++  A  L    
Sbjct: 119 AD-FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 314 ---LKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
              L     T+KS+++S GV + EL T   +P
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 29/224 (12%)

Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTL-AQVEHLNLVKFHG 200
           IG+G +G V+K    ++G+  A+K     ++D     E ++E   L A  +H N+VKF+G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDE--EIEAEYNILKALSDHPNVVKFYG 82

Query: 201 YLEFEDERI-----VIVEYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAHAITYLH 252
               +D +      +++E    G++ +    L    L    R++   IA  +  A+  L 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTD----LVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               +  IHRD+K +NILLT     K+ DFG   ++A   S     +T V GT  ++ PE
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSV-GTPFWMAPE 194

Query: 313 YLKTYQ-----LTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
            +   Q        + DV+S G+  +EL  G  P   + P R L
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 67/294 (22%), Positives = 131/294 (44%), Gaps = 50/294 (17%)

Query: 142 KIGQGGFGTVYKGRLE-----------------DGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           K+G+G FG V+    E                    +VA+K  ++   +K++  +F  EI
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEI 70

Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ---------GNILDLA 235
           + +++++  N+++        D   +I EY+ NG L + L   +            +  +
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
             + +A  +A  + YL        +HRD+ + N L+ +N+  K+ADFG +R   +  SG 
Sbjct: 131 TLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSGD 184

Query: 296 THVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER 351
            +   +++G A     ++  E +   + T  SDV++FGV L E++T  +  +P  +L + 
Sbjct: 185 YY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE-QPYSQLSDE 240

Query: 352 ITVKWAMKKFSD-GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS 404
             ++   + F D G  + +  P         L  + + +L L C     + RPS
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKP--------ALCPDSLYKLMLSCWRRNAKERPS 286

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFH 199
           +G G FG V     ++     VAIKR +KS   K    +   SE + L  + H   V  +
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL--DIAIDVAHAITYLHMYTDH 257
           G  + E    +++E+V  G   E    L+ N      R   D+    A  I  +  Y   
Sbjct: 98  GSFKDESYLYLVLEFVIGG---EFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 258 -PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             I++RD+K  N+LL ++   K+ DFGFA++  DT       +  + GT  Y+ PE L  
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTR------TYTLCGTPEYIAPEILLN 202

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
               + +D ++ G+ + E++ G  P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 20/206 (9%)

Query: 145 QGGFGTVYKGRLEDGTIVAIKRA-KKSVYDKHSGAE---FQSEIRTLAQVEHLNLVK-FH 199
           +G FG ++ G L D      +    K+V D  S  +      E   L  + H N++   H
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 200 GYLEFEDERIVIVEYVPNGTLREHL-DCLQGNI-----LDLAGRLDIAIDVAHAITYLHM 253
             +E  +   V+  Y+  G L+  L  C  G       L     + +AI +A  ++YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVSTQVKGTAGYLDP 311
                +IH+DI + N ++ E  + K+ D   +R     D      + +  VK    ++  
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----WMAL 188

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVT 337
           E L   + +  SDV+SFGVLL EL+T
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G G  G V+     D    VA+K  K  + D  S      EI+ + +++H N+VK +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 202 L-------------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAI 248
           L               E   + IV+      L   L+  QG + +   RL     +   +
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARL-FMYQLLRGL 127

Query: 249 TYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
            Y+H      ++HRD+K +N+ + TE+   K+ DFG AR+     S   ++S  +  T  
Sbjct: 128 KYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKW 183

Query: 308 YLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGR 339
           Y  P   L     T+  D+++ G +  E++TG+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 59.1 bits (144), Expect = 7e-10
 Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 35/191 (18%)

Query: 191 EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDV 244
           ++ N +K +  +      ++I++Y+ +G L    D L+       G+L       I   +
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL---FDLLKKE-----GKLSEAEVKKIIRQL 118

Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVK 303
             A+  LH +    IIH DIK  N+L      R  + D+G  +    T S   +      
Sbjct: 119 VEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPS--CY-----D 167

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP--------IEPKRELKERITVK 355
           GT  Y  PE +K +      D ++ GVL  EL+TG+ P        ++ +  L +R   K
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE-SLLKRQQKK 226

Query: 356 WAMKKFSDGDA 366
               K    +A
Sbjct: 227 LPFIKNVSKNA 237

Length = 267

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 19/220 (8%)

Query: 143 IGQGGFGTVYKG-RLEDG-------TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           +GQG F  ++KG R E G       T V +K   KS   ++    F      ++Q+ H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKH 60

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           LV  +G     DE I++ EYV  G+L  +L     N+++++ +L++A  +A A+ +L   
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLE-- 117

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            D  + H ++ + N+LL      K  +  F +L+    S        +     ++ PE +
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176

Query: 315 KTYQ-LTEKSDVYSFGVLLVELVTG-RRPI---EPKRELK 349
           +  Q L+  +D +SFG  L E+ +G  +P+   + +++L+
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 10/201 (4%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   + +  G   A+K  KK V   K   A   +E R L    H  L     
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH  ++  ++
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLH--SEKNVV 118

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N++L ++   K+ DFG  +     + GAT  +    GT  YL PE L+     
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT--FCGTPEYLAPEVLEDNDYG 174

Query: 321 EKSDVYSFGVLLVELVTGRRP 341
              D +  GV++ E++ GR P
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)

Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 11  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67

Query: 185 RTLAQVEHLNLVKF-------HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C +  + D   +
Sbjct: 68  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKCQK--LTDDHVQ 123

Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             I   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G  +
Sbjct: 124 FLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG--Y 177

Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
           V+T+      Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 178 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 24/211 (11%)

Query: 143 IGQGGFGTVYKGRLEDG-TIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   +L++   + A+K   K  +  +   A F+ E   L   ++  +   H 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR-----LDIAIDVAHAITYLHMYT 255
             + E+   ++++Y   G L   L   +  + +   R     + IAID  H + Y     
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY----- 123

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRDIK  NIL+  N   ++ADFG        E G    S  V GT  Y+ PE L+
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176

Query: 316 TYQ-----LTEKSDVYSFGVLLVELVTGRRP 341
             +        + D +S GV + E++ G  P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 27/158 (17%)

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA----GYLDPEYLK 315
           IHRD+ + NILL+EN   K+ DFG AR   D      +V    KG+A     ++ PE + 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVR---KGSARLPLKWMAPESIF 249

Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV 374
               T +SDV+SFGVLL E+ + G  P  P  ++ E        ++  DG  +       
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQINEEFC-----QRLKDGTRMR------ 297

Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
               A   A  +I  + L C     + RP+     EIL
Sbjct: 298 ----APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 47/248 (18%)

Query: 122 NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEF 180
           N+  ++ E Y           +G+G +G V K      G IVAIK+ K          + 
Sbjct: 1   NMSFSISERYIQKGAH-----LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDR 55

Query: 181 Q------------SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ 228
           Q             E++ + +++H N++     +  E + I +V  +    L++      
Sbjct: 56  QLVGMCGIHFTTLRELKIMNEIKHENIMGLVD-VYVEGDFINLVMDIMASDLKK------ 108

Query: 229 GNILDLAGRLD------IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF 282
             ++D   RL       I + + + +  LH +     +HRD+  +NI +      K+ADF
Sbjct: 109 --VVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163

Query: 283 GFAR-----LAADTESGATHVSTQVKGTAG-----YLDPEYL-KTYQLTEKSDVYSFGVL 331
           G AR       +DT S    +  + + T+      Y  PE L    +     D++S G +
Sbjct: 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223

Query: 332 LVELVTGR 339
             EL+TG+
Sbjct: 224 FAELLTGK 231

Length = 335

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 64/244 (26%), Positives = 102/244 (41%), Gaps = 54/244 (22%)

Query: 143 IGQGGFGTVYKGRLEDGTIV-AIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG G FG V   R  D   + A+K  +K+ V  ++  A  ++E   LA+ ++  +VK   
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL-- 66

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNIL--DLAGRLDIAIDVAHAITYLHMYTD 256
           Y  F+D+  +  +++Y+P G +   L  ++  I   DLA R  IA ++  AI  +H    
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDLA-RFYIA-ELTCAIESVHKMG- 121

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFG---------------------------FARLAA 289
              IHRDIK  NIL+  +   K+ DFG                               + 
Sbjct: 122 --FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 290 DTESGATHVSTQVK------------GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                   +  + K            GT  Y+ PE L     T+  D +S GV+L E++ 
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239

Query: 338 GRRP 341
           G+ P
Sbjct: 240 GQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           K+G+G + TVYKGR +  G +VA+K  +    +   GA F +  E   L  ++H N+V  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
           H  +  +    ++ EY+ +  L++++D C  G  L +         +   + Y H     
Sbjct: 69  HDIIHTKKTLTLVFEYL-DTDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCH---QR 122

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
            ++HRD+K  N+L++E    K+ADFG AR     +S  +   +    T  Y  P+ L   
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR----AKSVPSKTYSNEVVTLWYRPPDVL--L 176

Query: 318 QLTEKS---DVYSFGVLLVELVTGR 339
             TE S   D++  G +  E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 142 KIGQGGFGTVYKG--RLEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK 197
           K+G+G + TVYKG  R+ +G +VA+K           G  F +  E   L  ++H N+V 
Sbjct: 12  KLGEGSYATVYKGISRI-NGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVL 67

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
            H  +  ++    + EY+ +  L +++    G +     RL     +   + Y+H     
Sbjct: 68  LHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQ 122

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL-KT 316
            I+HRD+K  N+L++     K+ADFG AR  A +    T+ S  V  T  Y  P+ L   
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVV--TLWYRPPDVLLGA 178

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              +   D++  G + +E++ G +P  P
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQG-QPAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 41/115 (35%), Positives = 62/115 (53%), Gaps = 14/115 (12%)

Query: 232 LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
           LDL   L  +  VA  + +L        IHRD+ + N+LLT+   AK+ DFG AR   D 
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DI 262

Query: 292 ESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            + + +V   VKG A     ++ PE +     T +SDV+S+G+LL E+ + G+ P
Sbjct: 263 MNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 52/228 (22%)

Query: 142 KIGQGGFGTV----YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           ++GQG +G V          +   VAIK+   +V+ K   A+     R L +++ L   +
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKIT-NVFSKKILAK-----RALRELKLLRHFR 59

Query: 198 FHGYLEFEDERIV------IVEYVP-NGTL--REHLDCLQGNILDLAG--RLDIAIDVAH 246
            H       + I       IV     N      E ++       DL    R    +  AH
Sbjct: 60  GH-------KNITCLYDMDIVFPGNFNELYLYEELMEA------DLHQIIRSGQPLTDAH 106

Query: 247 ----------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGA 295
                      + Y+H      ++HRD+K  N+L+  +   K+ DFG AR  + +    A
Sbjct: 107 FQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKS-DVYSFGVLLVELVTGRRPI 342
             ++  V  T  Y  PE + ++Q   K+ DV+S G +L EL+ GR+P+
Sbjct: 164 GFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +    + A R   A ++  A+ YLH      ++
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGA-EIVSALEYLH---SRDVV 117

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK--GTAGYLDPEYLKTYQ 318
           +RDIK  N++L ++   K+ DFG  +       G +  +T     GT  YL PE L+   
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
                D +  GV++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G FG V   R +    + A+K   K    K S + F  E R +    +   V    +
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQLF 109

Query: 202 LEFEDERIV--IVEYVPNG---TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             F+D+R +  ++EY+P G    L  + D  +         + +A+D  H++ +      
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------ 163

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+K  N+LL ++   K+ADFG        + G     T V GT  Y+ PE LK+
Sbjct: 164 ---IHRDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMVRCDTAV-GTPDYISPEVLKS 217

Query: 317 Y----QLTEKSDVYSFGVLLVELVTGRRP 341
                    + D +S GV L E++ G  P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 13/108 (12%)

Query: 232 LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
           LD    L  +  VA  +++L        IHRD+ + NILLT     K+ DFG AR   D 
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DI 264

Query: 292 ESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVEL 335
            + + +V   VKG A     ++ PE +     T +SDV+S+G+LL E+
Sbjct: 265 RNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)

Query: 142 KIGQGGFGTVYKGRLED---GTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVK 197
            IG+GG G VY     D      VA+K+ ++ + +       F  E +  A + H  +V 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCL-QGNIL--DLAGR------LDIAIDVAHAI 248
            +      D     + Y+   TL+  L  + Q   L  +LA +      L I   +   I
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-----------LAADTESGATH 297
            Y+H      ++HRD+K  NILL       + D+G A            +  D  +    
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 298 VST---QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR 346
             T   ++ GT  Y+ PE L     +E +D+Y+ GV+L +++T   P   K+
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235

Length = 932

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 37/239 (15%)

Query: 136 NFSPSFKIGQGGFGTVYKGRL----EDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV 190
           NF     +G G +G V+  R     + G + A+K  KK ++  K    E     RT  QV
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTE---HTRTERQV 57

Query: 191 -EHLN----LVKFHGYLEFEDERIVIVEYVPNGTLREHLD----CLQGNILDLAGRLDIA 241
            EH+     LV  H   + + +  +I++Y+  G L  HL       +  +   +G + +A
Sbjct: 58  LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA 117

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           ++  H +          II+RDIK  NILL  N    + DFG   L+ +        +  
Sbjct: 118 LEHLHKLG---------IIYRDIKLENILLDSNGHVVLTDFG---LSKEFHEDEVERAYS 165

Query: 302 VKGTAGYLDPEYLKTYQLTEKS--DVYSFGVLLVELVTGRRPI------EPKRELKERI 352
             GT  Y+ P+ ++          D +S GVL+ EL+TG  P         + E+  RI
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI 224

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 63/234 (26%), Positives = 96/234 (41%), Gaps = 44/234 (18%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVE 191
              + P   IG+G +G V   +  E    VAIK+     +D    A+    EI+ L  ++
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD 62

Query: 192 HLNLVKFHGYL------EFEDERIV----------IVEYVPNGTL-REHLDCLQGNILDL 234
           H N++     +       F D  IV          I+    + TL  +H       +L  
Sbjct: 63  HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR--SSQTLSDDHCQYFLYQLL-- 118

Query: 235 AGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG 294
                        + Y+H      ++HRD+K SN+LL  N   K+ DFG AR    T S 
Sbjct: 119 -----------RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR----TTSE 160

Query: 295 ATHVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
                T+   T  Y  PE  L   + T   DV+S G +  EL+ GR+P+ P ++
Sbjct: 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKD 213

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 11/93 (11%)

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH  +   I+HRDIK  N+L+  N   K+ DFG AR+    ES   H++ +V  T  Y 
Sbjct: 118 YLH--SAG-ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES--KHMTQEVV-TQYYR 171

Query: 310 DPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
            PE L   + Y  T   D++S G +  EL+  R
Sbjct: 172 APEILMGSRHY--TSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 50/160 (31%), Positives = 75/160 (46%), Gaps = 30/160 (18%)

Query: 201 YLEFEDER--IVIVEYVPNGTLREHLDC--LQGNI----LDLAGRLDIAIDVAHAITYLH 252
           +  FE +R   +++EYV  G      DC  L  NI    +D+A R+  A  V  A+ YLH
Sbjct: 67  FCSFETKRHLCMVMEYVEGG------DCATLLKNIGALPVDMA-RMYFAETVL-ALEYLH 118

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-----LAADTESGATHVST------Q 301
            Y    I+HRD+K  N+L+T     K+ DFG ++     L  +   G     T      Q
Sbjct: 119 NYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           V GT  Y+ PE +      +  D ++ G++L E + G  P
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 20/209 (9%)

Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLN--- 194
           +G G +G V+  R     + G + A+K  +K+   +   A+     RT   V EH+    
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK--AKTVEHTRTERNVLEHVRQSP 65

Query: 195 -LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
            LV  H   + E +  +I++YV  G +  HL     N  +   R     ++  A+ +LH 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSG-EIILALEHLHK 123

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
                I++RDIK  NILL       + DFG ++     E   T+      GT  Y+ PE 
Sbjct: 124 LG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIEYMAPEI 177

Query: 314 LKTYQLTEKS-DVYSFGVLLVELVTGRRP 341
           ++      K+ D +S G+L+ EL+TG  P
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 51/249 (20%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAK-----KSV----YDKHSGAEFQSEIRTLAQVEH 192
           KIG G FG V+        +V  KR +     K++      +   ++   E+  + +++H
Sbjct: 20  KIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 193 LNLVKF-HGYLEFEDERI-VIVEYVPNGTLREHLD-CLQ--GNILDLAGRLDIAIDVAHA 247
            N+V++   +L   ++++ +++E+   G L  ++  C +  G I + A  +DI   + HA
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA-IVDITRQLLHA 130

Query: 248 ITYLHMYTDHP----IIHRDIKSSNILLTENFR-----------------AKVADFGFAR 286
           + Y H   D P    ++HRD+K  NI L+   R                 AK+ DFG ++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 287 LAADTESGATHVSTQVKGTAGYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
                  G   ++    GT  Y  PE L  +T    +KSD+++ G ++ EL +G+ P   
Sbjct: 191 -----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 345 KRELKERIT 353
                + I+
Sbjct: 246 ANNFSQLIS 254

Length = 1021

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   ++++ G + A+K   K  +  +   A F+ E   L   +   +   H 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNI-LDLA----GRLDIAIDVAHAITYLHMYT 255
             + E+   ++++Y   G L   L   +  +  D+A      + +AID  H + Y     
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY----- 123

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPEYL 314
               +HRDIK  N+LL +N   ++ADFG   RL AD   G    +  V GT  Y+ PE L
Sbjct: 124 ----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---GTVQSNVAV-GTPDYISPEIL 175

Query: 315 KTYQ-----LTEKSDVYSFGVLLVELVTGRRP 341
           +  +        + D +S GV + E++ G  P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 59/264 (22%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V   R  D   + A+K   KK V  ++  A  ++E   LA+ ++  +V+ + 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA----GRLDIAIDVAHAITYLHMYTD 256
             + +D    +++Y+P G +   L  +     DLA      L  A++  H + +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF------ 122

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFA---RLAADTE--SGATHV------------- 298
              IHRDIK  NIL+  +   K+ DFG     R   D++      HV             
Sbjct: 123 ---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179

Query: 299 -------------------------STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLV 333
                                    +  + GT  Y+ PE L     T+  D +S GV+L 
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239

Query: 334 ELVTGRRPIEPKRELKERITV-KW 356
           E++ G+ P   +  L+ ++ V  W
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 24/211 (11%)

Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   +++    I A+K   K  +  +   A F+ E   L   +   +   H 
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNI-LDLA----GRLDIAIDVAHAITYLHMYT 255
             + E+   ++++Y   G L   L   +  +  D+A      + +AI   H + Y     
Sbjct: 69  AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY----- 123

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRDIK  N+LL  N   ++ADFG        + G    S  V GT  Y+ PE L+
Sbjct: 124 ----VHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAV-GTPDYISPEILQ 176

Query: 316 TYQ-----LTEKSDVYSFGVLLVELVTGRRP 341
             +        + D +S GV + E++ G  P
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 34/82 (41%), Positives = 46/82 (56%), Gaps = 10/82 (12%)

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA----GYLDPEYLK 315
           IHRD+ + NILL+EN   K+ DFG AR   D      +V    KG A     ++ PE + 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVR---KGDARLPLKWMAPESIF 248

Query: 316 TYQLTEKSDVYSFGVLLVELVT 337
               T +SDV+SFGVLL E+ +
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 21/159 (13%)

Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           I +G FG VY GR + +  + A+K  KK+ + +K+   + Q+E   LA  +   +V  + 
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD-------IAIDVAHAITYLHM 253
            L+  +   +++EY+  G ++        ++L + G  D       I+ +VA A+ YLH 
Sbjct: 72  SLQSANNVYLVMEYLIGGDVK--------SLLHIYGYFDEEMAVKYIS-EVALALDYLHR 122

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE 292
              H IIHRD+K  N+L++     K+ DFG +++  + E
Sbjct: 123 ---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 142 KIGQGGFGTVYKGRLEDG---TIVAIK--RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +IG G FG V  G +  G     V +K  R   SV ++    +F  E +    ++H NL+
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM---KFLEEAQPYRSLQHSNLL 58

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHL-DCLQGNIL--DLAGRLDIAIDVAHAITYLHM 253
           +  G        ++++E+ P G L+ +L  C +  ++  D      +A ++A  + +LH 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH- 117

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
              +  IH D+   N LLT +   K+ D+G +      +   T    Q+     ++ PE 
Sbjct: 118 --KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT--PDQLWVPLRWIAPEL 173

Query: 314 -------LKTYQLTEKSDVYSFGVLLVEL 335
                  L     T++S+V+S GV + EL
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 28/242 (11%)

Query: 110 SNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAK 168
           S+N+  G D+     I  +      +++     IG G FG VY+   ++    VAIK+  
Sbjct: 41  SHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100

Query: 169 KSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI--------VIVEYVPNGTL 220
           +    K+       E+  +  + H+N++    Y   E  +         V++E++P  T+
Sbjct: 101 QDPQYKN------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TV 153

Query: 221 REHLDCLQGNILDLAGRLD--IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA- 277
            +++     N   L   L    +  +  A+ Y+H      I HRD+K  N+L+  N    
Sbjct: 154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTL 210

Query: 278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELV 336
           K+ DFG A+     +   +++ ++      Y  PE  L     T   D++S G ++ E++
Sbjct: 211 KLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Query: 337 TG 338
            G
Sbjct: 266 LG 267

Length = 440

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 49/223 (21%), Positives = 82/223 (36%), Gaps = 49/223 (21%)

Query: 144 GQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF----- 198
                  + K +    T+VA+K+       K      Q EI T  Q++H N++ +     
Sbjct: 11  EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 199 --------HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY 250
                      + +     ++  + P G L E                 I  DV +A+ Y
Sbjct: 70  VDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAF------------ILKDVLNALDY 116

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA--------RLAADTESGATHVSTQV 302
           +H       IHR +K+S+ILL+ + +  ++   ++        R     +   + V    
Sbjct: 117 IH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL- 172

Query: 303 KGTAGYLDPEYLKTYQ----LTEKSDVYSFGVLLVELVTGRRP 341
                +L PE L   Q      EKSD+YS G+   EL  G  P
Sbjct: 173 ----PWLSPEVL--QQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            I +LH      IIHRD+K SNI++  +   K+ DFG AR A  +     +V T+     
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
            Y  PE +      E  D++S G ++ E++ G 
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 50/238 (21%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   + +D G I A+K  +K+ + +K   A  ++E   L + +   +VK   
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM-- 66

Query: 201 YLEFEDER--IVIVEYVPNG---TLREHLDCLQGNILDL-AGRLDIAIDVAHAITYLHMY 254
           +  F+D+R   +I+E++P G   TL    D L             +AID  H + +    
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFA----------------------------- 285
                IHRDIK  N+LL      K++DFG                               
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 286 --RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
             R A   +     ++    GT  Y+ PE        +  D +S GV++ E++ G  P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 29/191 (15%)

Query: 159 GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG 218
           G  VA+K+  +   ++        E+  L  V H N++             ++  + P  
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIIS------------LLNVFTPQK 93

Query: 219 TLREHLDC-LQGNILDLAGRLDIAIDVAHA-ITYL---------HMYTDHPIIHRDIKSS 267
           +L E  D  L   ++D      I +++ H  ++YL         H+++   IIHRD+K S
Sbjct: 94  SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPS 152

Query: 268 NILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYS 327
           NI++  +   K+ DFG AR A        +V T+      Y  PE +      E  D++S
Sbjct: 153 NIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWS 207

Query: 328 FGVLLVELVTG 338
            G ++ ELV G
Sbjct: 208 VGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 59/248 (23%), Positives = 104/248 (41%), Gaps = 58/248 (23%)

Query: 143 IGQGGFGTV-YKGRLEDGTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V    +++   + A+K   KK V +++  A  ++E   LA+ ++  +VK + 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA----GRLDIAIDVAHAITYLHMYTD 256
             + +D    +++Y+P G +   L  ++     LA      L +AI+  H + +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGF----------------ARLAADT--------- 291
              IHRDIK  NIL+  +   K+ DFG                 + +  D+         
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 292 -------------ESGATH-----VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLV 333
                        E  AT      ++  + GT  Y+ PE L     T+  D +S GV+L 
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 334 ELVTGRRP 341
           E++ G+ P
Sbjct: 240 EMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 40/115 (34%), Positives = 57/115 (49%), Gaps = 13/115 (11%)

Query: 227 LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR 286
           L   +L L   +  +  VA  + +L        IHRD+ + NILL+EN   K+ DFG AR
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 227

Query: 287 LAADTESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              D      +V    KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 228 ---DIYKDPDYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 52/226 (23%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ----SEIRTLAQVEHLNLVK 197
           K+G+G +G VYK + +DG     K  K+    +  G         EI  L +++H N++ 
Sbjct: 8   KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62

Query: 198 FHG-YLEFEDERI-VIVEYV-------------------PNGTLREHLDCLQGNILDLAG 236
               +L   D ++ ++ +Y                    P    R  +  L   ILD   
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD--- 119

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTE 292
                      I YLH    + ++HRD+K +NIL+     E  R K+AD GFARL     
Sbjct: 120 ----------GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 293 SGATHVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVT 337
                +   V  T  Y  PE  L     T+  D+++ G +  EL+T
Sbjct: 167 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 6e-07
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   L+    VAIK+  +   ++        E+  
Sbjct: 15  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++             ++  + P  +L E  D  L   ++D      I +++ 
Sbjct: 70  MKCVNHKNIIS------------LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD 117

Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 118 HERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GT 171

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           + + T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 19/158 (12%)

Query: 136 NFSPSFKIGQGGFGTV-YKGRLEDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHL 193
           +F     IG+G FG V    + + G I A+K   KS ++ K   A  ++E   LA+ +  
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61

Query: 194 NLVKFHGYLEFEDERIV--IVEYVPNGTLREHL---DCLQGNILDL-AGRLDIAIDVAHA 247
            +V    Y  F+D + +  I+E++P G L   L   D    ++         +AI+  H 
Sbjct: 62  WVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA 285
           + +         IHRDIK  NIL+      K++DFG +
Sbjct: 120 LGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 50/238 (21%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   + +D G + A+K  +K+ + +K      ++E   L + + L +VK   
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM-- 66

Query: 201 YLEFEDER--IVIVEYVPNG---TLREHLDCLQGNILDL-AGRLDIAIDVAHAITYLHMY 254
           +  F+D+    +I+E++P G   TL    D L             +AID  H + +    
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFA----------------------------- 285
                IHRDIK  N+LL      K++DFG                               
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 286 --RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
             R A   +     ++    GT  Y+ PE        +  D +S GV++ E++ G  P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 46/222 (20%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +G VYK R    G +VA+K+ +  + ++        EI  L  +     +    
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIV--- 64

Query: 201 YLEFEDERIVIVEYVPNGTLR-------EHLDCLQGNILDLAGR---------------L 238
                  R++ VE+V     +       E+LD      +D  GR                
Sbjct: 65  -------RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTESGATH 297
            +   VAH     H    H ++HRD+K  N+L+  +    K+AD G  R  +      TH
Sbjct: 118 QLLKGVAH----CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170

Query: 298 VSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTG 338
                  T  Y  PE  L +   +   D++S G +  E+   
Sbjct: 171 EIV----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 7/102 (6%)

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           A+ Y+H      + HRD+K  NIL   + + K+ DFG AR+A +    A   +  V  T 
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV-ATR 170

Query: 307 GYLDPEYLKTY--QLTEKSDVYSFGVLLVELVTGRRPIEPKR 346
            Y  PE   ++  + T   D++S G +  E++TG +P+ P +
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGK 211

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 143 IGQGGFGTV-YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G G +GTV        G  VAIK+  +    +        E+R L  ++H N++   G 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVI---GL 79

Query: 202 LE----------FEDERIVIVEYVPN-GTLREHLDCLQGNILDLAGRLDIAIDVAHAITY 250
           L+          F D  +V+     + G L +H    +  I  L  ++         + Y
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM------LKGLKY 133

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           +H      IIHRD+K  N+ + E+   K+ DFG AR   D+E     V      T  Y  
Sbjct: 134 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVV------TRWYRA 183

Query: 311 PEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
           PE +  +   T+  D++S G ++ E++TG+
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 12/107 (11%)

Query: 232 LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAA 289
           L +   L I   +   + YLH      IIHRD+K+ NI + +  +  + D G A+  + A
Sbjct: 154 LPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210

Query: 290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
               G       + GT     PE L   +   K+D++S G++L E++
Sbjct: 211 PAFLG-------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS 182
           T+ E+    +N +P   +G G +G+V   Y  RL     VA+K+  +             
Sbjct: 9   TVWEVPERYQNLTP---VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYR 63

Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD--- 239
           E+R L  ++H N++   G L+       I  +     +   +     NI+      D   
Sbjct: 64  ELRLLKHMKHENVI---GLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120

Query: 240 --IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   ++ DFG AR A D  +G  +
Sbjct: 121 QFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG--Y 175

Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
           V+T+      Y  PE +  +    +  D++S G ++ EL+ G+
Sbjct: 176 VATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   LE    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76

Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++   G L           + P  +L E  D  +   ++D      I +++ 
Sbjct: 77  MKCVNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124

Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GT 178

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
           + + T    T  Y  PE +      E  D++S G ++ E++ G 
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 49/218 (22%)

Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI---------RTLAQVEH 192
           +G G +G+V        G  VAIK+  +          FQSEI           L  ++H
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRP---------FQSEIFAKRAYRELTLLKHMQH 73

Query: 193 LNLVK----------FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
            N++              + +F         Y+    ++  L  + G+ L       +  
Sbjct: 74  ENVIGLLDVFTSAVSGDEFQDF---------YLVMPYMQTDLQKIMGHPLSEDKVQYLVY 124

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
            +   + Y+H      IIHRD+K  N+ + E+   K+ DFG AR  AD E     V    
Sbjct: 125 QMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV---- 176

Query: 303 KGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
             T  Y  PE +  +    +  D++S G ++ E++TG+
Sbjct: 177 --TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 33/99 (33%), Positives = 48/99 (48%), Gaps = 11/99 (11%)

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           A+ YLH      IIHRD+K+ NI L E   A + DFG     A  +  A   + Q  G +
Sbjct: 197 ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFG-----AACKLDAHPDTPQCYGWS 248

Query: 307 GYLD---PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           G L+   PE L       K+D++S G++L E+      +
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 52/226 (23%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ----SEIRTLAQVEHLNLVK 197
           K+G+G +G VYK + +DG     K  +     +  G         EI  L +++H N++ 
Sbjct: 8   KVGRGTYGHVYKAKRKDG-----KDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS 62

Query: 198 FHG-YLEFEDERI-VIVEYV-------------------PNGTLREHLDCLQGNILDLAG 236
               +L   D ++ ++ +Y                    P    R  +  L   ILD   
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD--- 119

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTE 292
                      I YLH    + ++HRD+K +NIL+     E  R K+AD GFARL     
Sbjct: 120 ----------GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 293 SGATHVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVT 337
                +   V  T  Y  PE  L     T+  D+++ G +  EL+T
Sbjct: 167 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 20/150 (13%)

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREH----LDCLQGNILDLAGRLDIAIDVAHAIT 249
           N+V  H Y+  ED   +++++   G L  H    L+  +  +   A  + +A+D  H   
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH--- 102

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
                    I+ RD+  +NILL +    ++  F       D+  G   V         Y 
Sbjct: 103 ------REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA-VENM------YC 149

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
            PE     + TE  D +S G +L EL+TG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 33/102 (32%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
           L I   V  AI YLH   ++ IIHRDIK+ NI +       + DFG A    D  +   +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241

Query: 298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
                 GT     PE L         D++S G++L E+ T  
Sbjct: 242 ---GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 27/162 (16%)

Query: 143 IGQGGFGTVYKGR-----------------LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR 185
           IG GGFG VY+ +                 LE+ TIV       ++YD    A +++   
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN--- 76

Query: 186 TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL--DIAID 243
            +  ++HL + K++G   F+  R +   ++    L E+   +   I     +L  +I  D
Sbjct: 77  -IHNIDHLGIPKYYGCGSFKRCR-MYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA 285
           +   + Y+H   +H I H DIK  NI++  N R  + D+G A
Sbjct: 135 MLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 20/207 (9%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVA---IKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +IG G FG V    +   T VA   +K  K +   K    EF  +      ++H N+++ 
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQC 60

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQ-----GNILDLAGRLDIAIDVAHAITYLHM 253
            G        +++ EY   G L+ +L   Q       +L L     +A ++A  +T++H 
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH- 116

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADF--GFARLAADTESGATHVSTQVKGTAGYLDP 311
              H  +H D+   N  LT +   KV D+  G +R   D           ++  A  L  
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 312 EY---LKTYQLTEKSDVYSFGVLLVEL 335
           E+   L T + T+ S+V++ GV L EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 10/82 (12%)

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA----GYLDPEYLK 315
           +HRD+ + N+L+ E    K+ DFG AR   D    + ++S   KG+      ++ PE + 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLAR---DIMRDSNYIS---KGSTFLPLKWMAPESIF 314

Query: 316 TYQLTEKSDVYSFGVLLVELVT 337
               T  SDV+SFG+LL E+ T
Sbjct: 315 NNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 26/149 (17%), Positives = 51/149 (34%), Gaps = 16/149 (10%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV--KFH 199
            +  G    VY    +D   V +K               + E+  L  +    L   K  
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD----REREVAILQLLARKGLPVPKVL 59

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E +    +++E++   TL E  +  + +I +    L   +   H +  L       +
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKL---HQLPLLV------L 110

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLA 288
            H D+   NIL+ +     + D+ +A   
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 54/236 (22%)

Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH 246
           ++QV H++L   HG      E I++ E+V +G L   L   +G +  +A ++ +A  +A 
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKITVAQQLAS 128

Query: 247 AITYLHMYTDHPIIHRDIKSSNILL--------TENFRAKVADFGFARLAADTESGATHV 298
           A++YL    D  ++H ++ + NILL        T  F  K++D G +  A   E     +
Sbjct: 129 ALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSFTALSREERVERI 184

Query: 299 STQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVEL-------VTGRRPIEPKRELKE 350
                    ++ PE +     L+  +D +SFG  L+E+       +  R P E     KE
Sbjct: 185 P--------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-----KE 231

Query: 351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMR 406
           R   K                 R+   +   LA      L  QCL      RPS R
Sbjct: 232 RFYEK---------------KHRLPEPSCKELA-----TLISQCLTYEPTQRPSFR 267

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 28/82 (34%), Positives = 45/82 (54%), Gaps = 10/82 (12%)

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA----GYLDPEYLK 315
           +HRD+ + N+LL +    K+ DFG AR   D    + +VS   KG+      ++ PE + 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLAR---DIMHDSNYVS---KGSTFLPVKWMAPESIF 312

Query: 316 TYQLTEKSDVYSFGVLLVELVT 337
               T  SDV+S+G+LL E+ +
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 31/153 (20%)

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           ++ +     ++  Y P G      + L GNIL  A R          + YLH    +  I
Sbjct: 80  FMAYGSANSLLKTYFPEGMS----EALIGNILFGALR---------GLNYLH---QNGYI 123

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATH--------VSTQVKGTAGYLDPE 312
           HR+IK+S+IL++ +    V+  G + L +   +G            ST V     +L PE
Sbjct: 124 HRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPE 178

Query: 313 YLKT--YQLTEKSDVYSFGVLLVELVTGRRPIE 343
            L+   Y    KSD+YS G+   EL TGR P +
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 36/106 (33%), Positives = 50/106 (47%), Gaps = 11/106 (10%)

Query: 232 LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
           L LA    +A  +  AI Y+H      IIHRDIK+ N+L+       + DFG A  A  +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 292 ESGATHVSTQVKGTAGYLD---PEYLKTYQLTEKSDVYSFGVLLVE 334
            S   H      G AG +D   PE L     T   D++S G+++ E
Sbjct: 314 WSTPFHY-----GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.5 bits (93), Expect = 0.001
 Identities = 37/168 (22%), Positives = 68/168 (40%), Gaps = 30/168 (17%)

Query: 143 IGQGGFGTVYKGRLEDGTIVAIK-RAKKSVYDKHSGAEFQSEI---RTLAQVEHLNLVKF 198
           I +G    +Y G    G    IK R  KS        E    I   RT  +   L+  + 
Sbjct: 2   IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHP----ELDERIRRERTRNEARLLSRARK 56

Query: 199 HG------YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            G      Y    D + +++EY+    L++ ++          G  ++  ++   +  LH
Sbjct: 57  AGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIE---------EGNDELLREIGRLVGKLH 107

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT--HV 298
                 I+H D+ +SNI++ ++ +  + DFG  + + + E  A   HV
Sbjct: 108 ---KAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIEDKAVDLHV 151

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 35/157 (22%), Positives = 59/157 (37%), Gaps = 20/157 (12%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG- 200
            I QG    +Y         V  +R  K         + + E RT  +   L   +  G 
Sbjct: 3   LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRE-RTRREARILAKAREAGV 61

Query: 201 -----YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
                Y    D  ++++EY+    L++ L+           R D+  +V   +  LH   
Sbjct: 62  PVPIVYDVDPDNGLIVMEYIEGELLKDALE---------EARPDLLREVGRLVGKLH--- 109

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE 292
              I+H D+ +SNI+L+   R    DFG    + + E
Sbjct: 110 KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVE 145

Length = 204

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 38/198 (19%)

Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY-----DKHSGAEFQSEIRTLAQ 189
           R   P   IG+G    + KG       V  +R  K  Y     D+    E     RT A+
Sbjct: 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKG-YRHPELDERLRTE-----RTRAE 386

Query: 190 VEHLNLVKFHGY-------LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
              L+  +  G        ++ E++ IV+ EY+    L++ L+          G  ++  
Sbjct: 387 ARLLSEARRAGVPTPVIYDVDPEEKTIVM-EYIGGKDLKDVLE----------GNPELVR 435

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT--HVST 300
            V   +  LH      I+H D+ +SN ++ ++ R  + DFG  + +   E  A   HV  
Sbjct: 436 KVGEIVAKLH---KAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDLIEDKAVDLHVLK 491

Query: 301 Q-VKGTAGYLDPEYLKTY 317
           Q ++ T    D E L   
Sbjct: 492 QSLESTH--YDFEELWEA 507

Length = 535

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 32/180 (17%)

Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH 246
           + QV H ++V  +G    + E I++ E+V  G L   +   + ++L    +  +A  +A 
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLAS 116

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA----------- 295
           A++YL    D  ++H ++ + NILL             AR   D E G            
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILL-------------AREGIDGECGPFIKLSDPGIPI 160

Query: 296 THVSTQVK-GTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELV-TGRRPIEPKREL-KER 351
           T +S Q       ++ PE ++ +  L+  +D +SFG  L E+   G  P++ K    KER
Sbjct: 161 TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER 220

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 37/160 (23%), Positives = 58/160 (36%), Gaps = 30/160 (18%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIK-------------RAKKSVYDKHSGAEFQSEIRTLA 188
           KIG G    VY      G  VA+K             R +  + DK  G+      R  A
Sbjct: 98  KIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSW-LYVSRLAA 156

Query: 189 QVEHLNLVKFHGYLE-----FEDER-IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           + E   L + +             R  V++EY+    L      L+ ++ +    LD  +
Sbjct: 157 EREFEALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYR----LRLDVENPDEILDKIL 212

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF 282
           +          Y    I+H D+   NIL+TE+    V D+
Sbjct: 213 E-----EVRKAYRRG-IVHGDLSEFNILVTEDGDIVVIDW 246

Length = 304

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	443
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
smart00090	237	RIO RIO-like kinase.	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.29
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.94
COG4248	637	Uncharacterized protein with protein kinase and he	98.88
PRK09902	216	hypothetical protein; Provisional	98.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.79
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.61
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.44
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.42
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.35
PLN02876	822	acyl-CoA dehydrogenase	98.21
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.2
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.15
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.09
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.06
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.04
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.95
PRK10593	297	hypothetical protein; Provisional	97.91
PRK05231	319	homoserine kinase; Provisional	97.86
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.85
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.79
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.56
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.51
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.51
KOG2270	520	consensus Serine/threonine protein kinase involved	97.37
PLN02756	418	S-methyl-5-thioribose kinase	97.29
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.27
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.23
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.14
PRK12396	409	5-methylribose kinase; Reviewed	96.96
PRK11768	325	serine/threonine protein kinase; Provisional	96.86
PLN02236	344	choline kinase	96.76
COG2334	331	Putative homoserine kinase type II (protein kinase	96.71
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.56
PRK06148	1013	hypothetical protein; Provisional	96.5
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.45
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.28
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.26
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.08
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.95
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.02
PTZ00384	383	choline kinase; Provisional	94.97
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.83

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-53  Score=420.73  Aligned_cols=290  Identities=46%  Similarity=0.735  Sum_probs=250.3

Q ss_pred             CCcccCHHHHHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeee
Q 013401          121 GNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG  200 (443)
Q Consensus       121 ~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~  200 (443)
                      ....|+++++..+|++|...+.||+|+||.||+|.+.+|..||||++.......  ..+|.+|+.+|.+++|||||+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence            456789999999999999999999999999999999999999999877543221  456999999999999999999999


Q ss_pred             eeeecC-eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEE
Q 013401          201 YLEFED-ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       201 ~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl  279 (443)
                      ||.+.+ +.+||+|||++|+|.++|.......++|..|++||.++|+||+|||......||||||||+|||||+++.+||
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            999999 5999999999999999997643328899999999999999999999765557999999999999999999999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      +|||+|+.....   ..+......||.+|+|||++.....+.|+|||||||+|+||++|+.|.+...+..+.....|+..
T Consensus       219 sDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  219 SDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             cCccCcccCCcc---ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            999999665531   11111111699999999999988999999999999999999999999987665555557889999


Q ss_pred             hcCCCccccccCccccchhhc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAAN-NLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~-~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .+.++.+.+++|+.+...... .....++..++..|++.+|..||+|.+|++.|..+
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            999999999999998743333 25778899999999999999999999998888544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-54  Score=406.91  Aligned_cols=255  Identities=29%  Similarity=0.419  Sum_probs=211.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcc-----cHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKH-----SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      +.|.+.+.||+|+||.|-+|..+ +|+.||||++.+......     ....+.+|+++|++|+|||||+++++|+..+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45778889999999999999865 899999999977654331     233468999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CceEEeeeccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN---FRAKVADFGFA  285 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DFGla  285 (443)
                      |+||||+.||+|++++..  ++.+.+..-..++.|++.||.|||   ++||+||||||+|||+..+   ..+||+|||+|
T Consensus       252 YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             EEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            999999999999999974  466788888899999999999999   8999999999999999755   78999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCchhH---HHHHHHHHHhh
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRPIEPKREL---KERITVKWAMK  359 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlGvll~elltG~~Pf~~~~~~---~~~~~~~~~~~  359 (443)
                      ++..+.     ....+.||||.|.|||++.+..   +..++|||||||+||.+|+|.+||......   .+++.      
T Consensus       327 K~~g~~-----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~------  395 (475)
T KOG0615|consen  327 KVSGEG-----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL------  395 (475)
T ss_pred             hccccc-----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh------
Confidence            987643     3466789999999999996543   334889999999999999999999765432   22111      


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         .|...       -.+.......++.++||.+||..||++||++.|+++|+|.-
T Consensus       396 ---~G~y~-------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  396 ---KGRYA-------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             ---cCccc-------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence               11110       01123345778999999999999999999999999999975

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-53  Score=399.35  Aligned_cols=268  Identities=26%  Similarity=0.393  Sum_probs=219.8

Q ss_pred             ccCHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeee
Q 013401          124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL  202 (443)
Q Consensus       124 ~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  202 (443)
                      .++..|+.+       +..||+|..|+||++.++ +++.+|+|.+... .+.....++.+|+++++..+|||||.+||+|
T Consensus        75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF  146 (364)
T KOG0581|consen   75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAF  146 (364)
T ss_pred             ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE
Confidence            345555544       447999999999999987 7999999999443 4567778899999999999999999999999


Q ss_pred             eecC-eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEee
Q 013401          203 EFED-ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD  281 (443)
Q Consensus       203 ~~~~-~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~D  281 (443)
                      ..+. ...|+||||.||+|.+.+...  +.+++....+|+.+|++||.|||.  .++||||||||+||||+..|.|||||
T Consensus       147 ~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  147 YSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             EeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecc
Confidence            9999 499999999999999998743  669999999999999999999994  37899999999999999999999999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      ||.+..+.+.      ....++||..|||||.+.+..|+.++||||||++|+||++|+.||....+.  .......+..+
T Consensus       223 FGVS~~lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~--~~~~~~Ll~~I  294 (364)
T KOG0581|consen  223 FGVSGILVNS------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP--YLDIFELLCAI  294 (364)
T ss_pred             ccccHHhhhh------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC--CCCHHHHHHHH
Confidence            9999887754      345678999999999999999999999999999999999999999875110  00111111111


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      .++.     .|.++..    .+++++.+|+..||++||.+||++.++++|+|.......
T Consensus       295 v~~p-----pP~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  295 VDEP-----PPRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             hcCC-----CCCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            1111     1112111    366889999999999999999999999999997754443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-52  Score=415.80  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=221.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-cCCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ..|...+.||+|||++||.+++ .+|..||+|++.+... .....+.+.+||++.++|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999998 6899999999876543 5567788999999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |+|..++|.+++.  ..+.+.+.+++.++.||+.||.|||   +++|||||||..||||+++.+|||+|||||..+..++
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999887  5678999999999999999999999   8889999999999999999999999999999887543


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ...+.||||.|+|||++....++..+||||+||+||.||.|+|||+...-......+.-....++.         
T Consensus       173 E----rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~---------  239 (592)
T KOG0575|consen  173 E----RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS---------  239 (592)
T ss_pred             c----ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc---------
Confidence            2    245678999999999999999999999999999999999999999987644444333321111111         


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                               ..+.+..+||.++|++||.+|||+++|+.|.|.-
T Consensus       240 ---------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  240 ---------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             ---------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                     2346789999999999999999999999999983

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-53  Score=396.79  Aligned_cols=275  Identities=24%  Similarity=0.311  Sum_probs=234.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+|++++.||+|+||+||+++.+ +++.||+|++++..... ........|..+|..++||+||+++..|++.+.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            57999999999999999999876 69999999998765433 35677889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|+.+|.  +.+.+++..+.-++..|+.||.|||   ++|||||||||+|||||.+|+++|+||||++.....+
T Consensus       105 d~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  105 DYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             eccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999999997  4577999988889999999999999   8899999999999999999999999999998654432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ....+|||+.|||||++.+..|+..+|+|||||++|||++|.+||...+.......+....       . ...  
T Consensus       180 ~----~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------~-~~~--  245 (357)
T KOG0598|consen  180 D----ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------L-PLP--  245 (357)
T ss_pred             C----ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------C-CCC--
Confidence            2    3445799999999999999999999999999999999999999999887544333322211       0 000  


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHHhhhhhhhhhhcccCcCCccccc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRP----SMRRCAEILWSVRKDYRELAASDVLLQPSYSK  435 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP----s~~ell~~l~~i~~~~~~~~~~~~~~~~~~~~  435 (443)
                             ......+..+|+.++|..||++|.    ++.++-+|++.-..+|.++.+.++..+..|..
T Consensus       246 -------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~  305 (357)
T KOG0598|consen  246 -------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNV  305 (357)
T ss_pred             -------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCC
Confidence                   111236789999999999999996    78999999999999999998888876655543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.4e-53  Score=386.76  Aligned_cols=271  Identities=26%  Similarity=0.344  Sum_probs=219.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +.|+.+.++|+|+||+||+|+.+ +|+.||||++.....++...+-.+|||++|++|+|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788889999999999999987 69999999998765555666678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+..-| +.|+... ..++.....+++.|++.|+.|||   .+++||||||||||||+.+|.+||||||+|+.+..+. 
T Consensus        82 ~~dhTvL-~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-  155 (396)
T KOG0593|consen   82 YCDHTVL-HELERYP-NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-  155 (396)
T ss_pred             ecchHHH-HHHHhcc-CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence            9976544 4455433 45788889999999999999999   8999999999999999999999999999999887432 


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc-------
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD-------  365 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------  365 (443)
                         ..++.++.|.+|+|||.+.| .+|+..+|||++||++.||++|.+-|.+..+.+....+......+....       
T Consensus       156 ---d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  156 ---DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             ---chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence               35788999999999999977 7899999999999999999999999999888776555543322222110       


Q ss_pred             -c---ccccCccccch--hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          366 -A---ISILDPRVENT--AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       366 -~---~~~~d~~~~~~--~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                       .   ..+-.+.-..+  .-......-+++|+.+||+.||++|++.++++.|...
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence             0   00000000000  0112244579999999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-52  Score=394.46  Aligned_cols=254  Identities=30%  Similarity=0.450  Sum_probs=211.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|....+||.|+||+||+|+++ ++..||||.+.+....+...+.+..||.+|+.++|||||.++++++.++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            57888889999999999999976 68999999998776677778889999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC------CceEEeeeccccc
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN------FRAKVADFGFARL  287 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~------~~vkl~DFGla~~  287 (443)
                      ||+||+|.+||..  .+.+++..++.++.||+.||++||   +++||||||||+||||+.+      -.+||+|||+|+.
T Consensus        90 yC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             eCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999984  457999999999999999999999   8899999999999999864      4699999999999


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      +.+..     ...+.||+|.|||||++...+|+.|+|+||+|+|||+|++|.+||......+....++......      
T Consensus       165 L~~~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~------  233 (429)
T KOG0595|consen  165 LQPGS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV------  233 (429)
T ss_pred             CCchh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc------
Confidence            87543     3567899999999999999999999999999999999999999998776654444332211111      


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ...         .......+.+|+...|+.++.+|-+..+...+..
T Consensus       234 ~~~---------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~  270 (429)
T KOG0595|consen  234 PVL---------PAELSNPLRELLISLLQRNPKDRISFEDFFDHPF  270 (429)
T ss_pred             Cch---------hhhccCchhhhhhHHHhcCccccCchHHhhhhhh
Confidence            111         1112234557777778888888877766665543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-52  Score=379.53  Aligned_cols=257  Identities=27%  Similarity=0.422  Sum_probs=213.9

Q ss_pred             CCCCCceeeeeCceEEEEEEE-cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeee-eeeecCe-EEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG-YLEFEDE-RIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~-~~~~~~~-~~lv~  212 (443)
                      +|.++++||.|.||.||++.. .+|..+|.|.++-...+....+.+..|+.+|++|+|||||++++ -+.++.. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            577778999999999999985 48999999999987777777888999999999999999999999 4555555 89999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      |||.+|+|.+.|...  .++.+++..+++++.|++.||..||+.-. .-|+||||||.||||+.+|.|||+||||++++.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            999999999998643  56789999999999999999999994211 239999999999999999999999999999886


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...    .....++|||+||+||.+.+.+|+.++|||||||++|||+.-++||.+.+-..       ...++..++...+
T Consensus       180 s~~----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~~~  248 (375)
T KOG0591|consen  180 SKT----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYPPL  248 (375)
T ss_pred             chh----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCCCC
Confidence            542    23456789999999999999999999999999999999999999999884322       2223333332211


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                               ....++.++..|+.-|+.+||+.||+...++..+
T Consensus       249 ---------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  249 ---------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ---------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                     2245778899999999999999999965544443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=388.62  Aligned_cols=269  Identities=26%  Similarity=0.371  Sum_probs=229.2

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      .+...+|..++.||+|+|++|++|+.+ +++.||||++.+....+ .....+.+|-.+|.+| .||.||+||..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            344568999999999999999999865 79999999987765433 3345577899999999 79999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +|+|+||+++|+|.++|...  +.+++...+.++.+|+.||+|||   ++|||||||||||||||.|+++||+|||-|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999999854  67999999999999999999999   89999999999999999999999999999998


Q ss_pred             ccccCCCc-------cccc--ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh
Q 013401          288 AADTESGA-------THVS--TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       288 ~~~~~~~~-------~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      +.+.....       ....  ..++||..|++||+|.....+..+|||+||||||+|+.|.+||.+.++......+....
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence            76543321       0112  45899999999999999999999999999999999999999999988765544444433


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      ..+.++                  .++.+.+|+.+.|..||.+|++..+|.+|++.-.-+|..+
T Consensus       304 y~fp~~------------------fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  304 YEFPEG------------------FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             ccCCCC------------------CCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            333332                  2367999999999999999999999999999888787774

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-49  Score=388.90  Aligned_cols=259  Identities=34%  Similarity=0.516  Sum_probs=215.7

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-eEEEEEeecCCC
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-ERIVIVEYVPNG  218 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~gg  218 (443)
                      ...||.|+||+||+|.++....||||++............|.+|+.+|.+++|||||+++|++.+.. .++|||||+++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            3359999999999999985444999999877655555778999999999999999999999999887 799999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCCEEEcCCC-ceEEeeecccccccccCCCcc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP-IIHRDIKSSNILLTENF-RAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~~~~  296 (443)
                      +|.+++.......+++..++.|+.||+.|+.|||   +++ ||||||||+||||+.++ ++||+|||+++......    
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~----  198 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK----  198 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence            9999997645688999999999999999999999   888 99999999999999998 99999999998765432    


Q ss_pred             cccccccCCCCccCccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          297 HVSTQVKGTAGYLDPEYLK--TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                      ...+...||+.|||||++.  ...|+.|+||||||++||||+||..||........  ...-.    ..+     ..+.+
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~~~v~----~~~-----~Rp~~  267 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--ASAVV----VGG-----LRPPI  267 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH----hcC-----CCCCC
Confidence            1223367999999999999  56899999999999999999999999998766221  11110    011     11111


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      +.     .+...+..|+..||+.||..||++.+++..|..+....-.
T Consensus       268 p~-----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  268 PK-----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             Cc-----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            11     1457899999999999999999999999999988765554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=389.82  Aligned_cols=271  Identities=22%  Similarity=0.321  Sum_probs=224.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecC-eEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFED-ERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-~~~lv  211 (443)
                      ++|..+++||.|+||.||+|+.. +|..||||++|++....++ ..-.||++.|++|+ |||||++.+++.+.+ .+++|
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            45677779999999999999865 7999999999988655332 23358999999998 999999999999988 99999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||| ..+|++++..+ ++.+++..+..|+.||++||+|+|   .+|+.||||||||||+..+..+||+|||+|+.+...
T Consensus        89 fE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             HHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999 57999999875 889999999999999999999999   999999999999999998889999999999977643


Q ss_pred             CCCcccccccccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc--
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS--  368 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  368 (443)
                           ..++.++.|.+|+|||+| +...|+.+.|||++|||++|+.+-++-|.+.++.++...+-............+  
T Consensus       164 -----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  164 -----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             -----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence                 357888999999999997 556799999999999999999999999999999887766654444333222211  


Q ss_pred             ----ccCccccc------hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          369 ----ILDPRVEN------TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       369 ----~~d~~~~~------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                          .+.-.++.      ......++.++.+|+.+||..||++|||+.++++|++.-.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~  296 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV  296 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence                11111111      1112236788999999999999999999999999998543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=361.13  Aligned_cols=267  Identities=25%  Similarity=0.349  Sum_probs=228.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+|+.++.||.|+||+|.+++.+ +|..||+|++++... .-.+.+...+|..+|+.+.||+++++++.+.+.+.+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            47888899999999999999977 699999999876543 3455667889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++||.|+.+++.  -+.+++..++.++.+|+.||+|||   .++|++|||||||||||.+|.+||+|||+|+.+... 
T Consensus       124 eyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             eccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999984  456999999999999999999999   788999999999999999999999999999887642 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            ..+.||||.|+|||++....|+.++|+|+|||++|||+.|.+||...++......+-...-.++          
T Consensus       198 ------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP----------  261 (355)
T KOG0616|consen  198 ------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP----------  261 (355)
T ss_pred             ------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC----------
Confidence                  4568899999999999999999999999999999999999999999887554433322111111          


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCC-----CCHHHHHHHHHhhhhhhhhhhcccCcCCc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNR-----PSMRRCAEILWSVRKDYRELAASDVLLQP  431 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R-----Ps~~ell~~l~~i~~~~~~~~~~~~~~~~  431 (443)
                              ......+.+|+..+|+.|-.+|     ....+|..|.|.-.-+|.++..-.+..|-
T Consensus       262 --------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~  317 (355)
T KOG0616|consen  262 --------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPF  317 (355)
T ss_pred             --------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCC
Confidence                    1133568999999999999999     45679999999988888887766665443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.9e-49  Score=383.31  Aligned_cols=276  Identities=22%  Similarity=0.272  Sum_probs=228.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|+.+..||+|+||.||+|+.+ +|..||+|++++... ...++..++.|-.+|...++|+||++|..|.+.+++|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            467999999999999999999876 699999999987653 556778899999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||++||++..+|.  ....|++..+..++.+++.||..||   ..|+|||||||+|+|||..|++||+||||+.-+...
T Consensus       220 MEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999999986  5578999999999999999999999   889999999999999999999999999999532210


Q ss_pred             ----------------------CCCc----cc-----------------ccccccCCCCccCccccccCCCCCchhHHHH
Q 013401          292 ----------------------ESGA----TH-----------------VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSF  328 (443)
Q Consensus       292 ----------------------~~~~----~~-----------------~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSl  328 (443)
                                            +...    ..                 ..-..+|||.|||||++.+..|+..+|+|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  0000    00                 0012479999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC---CH
Q 013401          329 GVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRP---SM  405 (443)
Q Consensus       329 Gvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---s~  405 (443)
                      |||+||||.|.+||....+......+......+...              ......++..+||.+||. ||++|.   .+
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP--------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP--------------EEVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC--------------CcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            999999999999999988766554443322222111              011123779999999999 999997   49


Q ss_pred             HHHHHHHHhhhhhhhhhhcccCcC
Q 013401          406 RRCAEILWSVRKDYRELAASDVLL  429 (443)
Q Consensus       406 ~ell~~l~~i~~~~~~~~~~~~~~  429 (443)
                      .||.+|+|.-.-+|..+-...-++
T Consensus       440 ~EIK~HPfF~~v~W~~l~~~~apf  463 (550)
T KOG0605|consen  440 EEIKKHPFFKGVDWDHLREMPAPF  463 (550)
T ss_pred             HHHhcCCccccCCcchhhcCCCCC
Confidence            999999999988888876555333

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-48  Score=382.59  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=214.7

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC---cccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCe
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD---KHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDE  207 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  207 (443)
                      ...+|...+.||+|+||+|++|.+. ++..||||++.+....   ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3467999999999999999999865 7899999987764222   134556779999999998 9999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CceEEeeecccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGFAR  286 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~  286 (443)
                      .++|||||.||+|++++..  .+.+.+..+..++.|++.|+.|||   .+||+||||||+|||++.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            9999999999999999985  567888999999999999999999   8899999999999999999 999999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCC-CC-CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQ-LT-EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      ....    ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+.+.......+......+   
T Consensus       170 ~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~---  242 (370)
T KOG0583|consen  170 ISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI---  242 (370)
T ss_pred             ccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC---
Confidence            7731    112456778999999999998877 76 78999999999999999999999865433322221111111   


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                        ...+.            ..++.+|+.+||.+||.+|+++.++++|.|...
T Consensus       243 --p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  243 --PSYLL------------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             --CCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence              11110            467999999999999999999999999999764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3e-48  Score=349.49  Aligned_cols=272  Identities=22%  Similarity=0.300  Sum_probs=225.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|..+++||+|.||.||+|++. +|+.||||+++.....+.......|||+.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35777889999999999999865 89999999998876655556678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |++ .+|...|.. +...+....+..++.+++.||+|||   .+.|+||||||.|+||+.+|.+||+|||+++.+..+..
T Consensus        82 fm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            995 688887764 5678999999999999999999999   88999999999999999999999999999999876654


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc--
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL--  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  370 (443)
                      .    .+..+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+-|.+..+.+....+..+.....+.+..++.  
T Consensus       157 ~----~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  157 I----QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             c----cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            3    233368999999999865 579999999999999999999999999998887766665544444333322211  


Q ss_pred             -C-------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 -D-------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 -d-------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       |       |..........+.+++++|+.+||..||.+|+++.++++|.|.-
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~  285 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK  285 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence             1       11111112234567789999999999999999999999999854

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-48  Score=373.81  Aligned_cols=271  Identities=24%  Similarity=0.307  Sum_probs=223.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv  211 (443)
                      ..|+.+.+||+|+||.||+|++. +|+.||+|++..............|||.+|++|+|||||+|.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45777889999999999999864 899999999988877777788889999999999999999999988776  689999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      +|||+. +|.-++.. .+-.|++.++..++.||+.||+|||   .+||+|||||.+|||||.+|.+||+|||||+++...
T Consensus       197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999965 77776653 4567999999999999999999999   899999999999999999999999999999987654


Q ss_pred             CCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...   ..+..+-|.+|.|||+|.| ..|+.++|+||.||||.||+.|++.|.+..+......+..+.....+.. +...
T Consensus       272 ~~~---~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~-W~~~  347 (560)
T KOG0600|consen  272 GSA---PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY-WPVS  347 (560)
T ss_pred             CCc---ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc-cccc
Confidence            432   2555678999999999876 4799999999999999999999999999998877666655444433322 1111


Q ss_pred             C--------cccc----chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          371 D--------PRVE----NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       371 d--------~~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +        +...    ........+...++|+..+|..||++|.|+.+++++.|.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            1        1000    001122345678999999999999999999999999886

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-48  Score=379.31  Aligned_cols=252  Identities=27%  Similarity=0.416  Sum_probs=213.9

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .|....+||+|.-|.||.+... +++.||||++......  ..+-+.+|+.+|+.++|+|||.+++.|..++.+|+||||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4666778999999999999854 7899999998765433  335678999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |+||+|.|.+.   ...+++.++..|+..+++||+|||   .+||||||||.+|||++.+|.+||+||||+..+..... 
T Consensus       352 m~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  352 MEGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             cCCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            99999999885   355999999999999999999999   89999999999999999999999999999988765432 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         .....+|||+|||||++....|++++||||||++++||+-|.+||-..+++.....+.    .-   ..     +.+
T Consensus       425 ---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa----~n---g~-----P~l  489 (550)
T KOG0578|consen  425 ---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----TN---GT-----PKL  489 (550)
T ss_pred             ---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh----hc---CC-----CCc
Confidence               3456789999999999999999999999999999999999999998776655432221    11   11     111


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .   .....+..|.+|+.+||+.|+++|+++.|||+|++.
T Consensus       490 k---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  490 K---NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             C---CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence            1   122345789999999999999999999999999885

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-47  Score=381.76  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=217.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccc-ccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      -|+.++.||.|+-|.|.+|++. +|+.+|||++.+. .........+.+||.+|+.+.||||+++|++|++..++|+|+|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            4777778999999999999975 8999999998765 3444555678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |++||.|++++.  ..+.+++.++.+++.||+.|+.|||   ..+|+||||||+|+|||..+++||+|||+|..-.++. 
T Consensus        93 yv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   93 YVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             ecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            999999999997  4567999999999999999999999   6669999999999999999999999999997655432 


Q ss_pred             CcccccccccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLT-EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                          ...+.||.|.|.+||++.|.+|+ .++||||.|||||.||+|..||++.+-....+.+......+.          
T Consensus       167 ----lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----------  232 (786)
T KOG0588|consen  167 ----LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----------  232 (786)
T ss_pred             ----cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----------
Confidence                35667899999999999999886 689999999999999999999997765555454444332222          


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                              ...+.++.+|+.+||..||..|.|+++|++|+|-.
T Consensus       233 --------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  233 --------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             --------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence                    12446799999999999999999999999999954

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=382.58  Aligned_cols=273  Identities=22%  Similarity=0.332  Sum_probs=231.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  210 (443)
                      ..+|..+.+||+|.||+|+++..+ +++.||||++|+... ....++..+.|-.++.... ||.++.++..|.+.+++++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            468999999999999999999987 689999999988653 5667788889999998875 9999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.||++..++   ....+++..+.-++..|+.||.|||   ++|||+||||.+|||||.+|.+||+|||+++....
T Consensus       447 vmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999944333   4477999999999999999999999   99999999999999999999999999999986543


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      .+    ....++||||.|||||++.+..|+..+|+|+|||+|||||.|..||.+.++.+....+...             
T Consensus       521 ~g----~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------------  583 (694)
T KOG0694|consen  521 QG----DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------------  583 (694)
T ss_pred             CC----CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence            22    2356789999999999999999999999999999999999999999988775543333221             


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhhcccCcCCcccc
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELAASDVLLQPSYS  434 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~~~~~~~~~~~~  434 (443)
                      ++..     ....+.+..+++.++|..+|++|..+     .+|..|++.-..+|.++..-++..+.-|.
T Consensus       584 ~~~y-----P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~  647 (694)
T KOG0694|consen  584 EVRY-----PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPT  647 (694)
T ss_pred             CCCC-----CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcc
Confidence            1111     11245779999999999999999865     89999999999999999887777654443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.4e-48  Score=377.46  Aligned_cols=252  Identities=30%  Similarity=0.414  Sum_probs=218.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+....+.....+.+|+++++.|+|||||.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46777778999999999999876 79999999998877777777889999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.| +|+.+|.  .+..++++.+..|+.+++.||.|||   +++|+|||+||.|||++.+|.+|+||||+|+....   
T Consensus        82 ~a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---  152 (808)
T KOG0597|consen   82 YAVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---  152 (808)
T ss_pred             hhhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc---
Confidence            9977 9999997  5577999999999999999999999   88899999999999999999999999999987654   


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                       .+.+.+.+.|||.|||||++.+.+|+..+|+||||||+|||++|++||....-..       ....+...       +.
T Consensus       153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-------Lv~~I~~d-------~v  217 (808)
T KOG0597|consen  153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-------LVKSILKD-------PV  217 (808)
T ss_pred             -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-------HHHHHhcC-------CC
Confidence             3456677889999999999999999999999999999999999999997543211       11222111       11


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .    +...+...+.+|+...|.+||.+|.+-.+++.|.+-
T Consensus       218 ~----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~  254 (808)
T KOG0597|consen  218 K----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW  254 (808)
T ss_pred             C----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence            1    111456789999999999999999999999999863

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=359.87  Aligned_cols=280  Identities=24%  Similarity=0.340  Sum_probs=229.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +.|+...+||.|.-++||+|... .+..||||++.....+.. ...+++|++.|+.++|||||+++..|..+..+|+||.
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            57899999999999999999854 689999999987665544 7889999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||.+|++.+.+...-...+++..+..|+.+++.||.|||   .+|.||||||+.||||+.+|.|||+|||.+..+.+.+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999998766667999999999999999999999   89999999999999999999999999999988776654


Q ss_pred             CcccccccccCCCCccCccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK--TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .....+..++||++|||||++.  ...|+.|+||||||++..||.+|..||....+.+..+..-...+....   ...++
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---t~~~~  258 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---TSGLD  258 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---cccCC
Confidence            3333346789999999999963  346899999999999999999999999988776544332211111111   11111


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhhccc
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD  426 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~~~~  426 (443)
                           ..........+.+++..||+.||++|||++++++|.|.-....++..+..
T Consensus       259 -----~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~  308 (516)
T KOG0582|consen  259 -----KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKK  308 (516)
T ss_pred             -----hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchh
Confidence                 11222344579999999999999999999999999997655555544433

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-48  Score=341.51  Aligned_cols=255  Identities=27%  Similarity=0.395  Sum_probs=219.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|.||.||+|..+ ++-.||+|++.+... ......++++|+++-..|+||||+++|++|.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            57999999999999999999865 688999999866543 3344567899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||..+|+|+..|.......+++.....++.|++.||.|||   .++||||||||+|+|++.++.+||+|||++...+.. 
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-  177 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-  177 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-
Confidence            9999999999998767778999999999999999999999   888999999999999999999999999999876532 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           .....|||..|++||...+..++..+|+|++|++.||++.|.+||+..........+....-.+.          
T Consensus       178 -----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----------  242 (281)
T KOG0580|consen  178 -----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----------  242 (281)
T ss_pred             -----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----------
Confidence                 24567899999999999999999999999999999999999999987764333332222111111          


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                              ......+.+||.+||..+|.+|....++++|+|...
T Consensus       243 --------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  243 --------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             --------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                    123467899999999999999999999999999753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=363.08  Aligned_cols=261  Identities=26%  Similarity=0.454  Sum_probs=206.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC--eEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED--ERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv  211 (443)
                      .++...+.||+|+||+||++... +|..+|||.+....  ....+.+.+|+.+|++|+|||||+++|......  .++++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            35666778999999999999976 59999999887542  222567899999999999999999999754444  68999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeecccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFARLAAD  290 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~  290 (443)
                      |||+.+|+|.+++....+ .+++..+..++.||++||.|||   ++||||+||||+||||+. ++.+||+|||++.....
T Consensus        95 mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999987665 8999999999999999999999   899999999999999999 79999999999987653


Q ss_pred             cCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHHHHHhhhcCCCcccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPK-RELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                       ............||+.|||||++.. .....++|||||||+++||+||.+||... .......   ++   ......  
T Consensus       171 -~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~---~i---g~~~~~--  241 (313)
T KOG0198|consen  171 -KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL---LI---GREDSL--  241 (313)
T ss_pred             -ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH---HH---hccCCC--
Confidence             1111122345679999999999985 33345999999999999999999999764 1111111   11   111101  


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                         |.+     ....+++..+|+.+|+..||..|||+.++++|+|.....
T Consensus       242 ---P~i-----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  242 ---PEI-----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ---CCC-----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence               111     112457899999999999999999999999999975544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-46  Score=361.67  Aligned_cols=274  Identities=22%  Similarity=0.307  Sum_probs=222.2

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |+..+.||+|+||.||+|... +|+.||||.+.+.... ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            677789999999999999865 7999999998654322 22334578999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+|+|.+++.......+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999998886545557899999999999999999999   8889999999999999999999999999997654322  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||.................   ... .. .    
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~---~~~-~~-~----  224 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK---EDQ-EE-Y----  224 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh---ccc-cc-C----
Confidence               12345699999999999998999999999999999999999999987654322111111111   000 00 0    


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCcCCcc
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVLLQPS  432 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~~~~~  432 (443)
                           ....+..+.+|+.+||+.||.+||+     +.++++|.|.-..+++.+++..+..+-.
T Consensus       225 -----~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~  282 (285)
T cd05631         225 -----SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFC  282 (285)
T ss_pred             -----CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCC
Confidence                 1113467899999999999999997     8999999999999999988776654433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-47  Score=371.44  Aligned_cols=254  Identities=31%  Similarity=0.486  Sum_probs=214.3

Q ss_pred             CCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          138 SPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ..+++||+|.||.||.|.++....||||.++..   ....+.|.+|+++|+.|+|+|||+++++|..++.++||||||+.
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            345579999999999999998779999999875   34456788999999999999999999999998999999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      |+|.+||....+..+.....+.++.||++|++||+   ++++|||||-..||||+++..+||+|||||+...+..   ..
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~---Y~  359 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE---YT  359 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc---ee
Confidence            99999998767788999999999999999999999   8889999999999999999999999999999554433   22


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      ......-...|.|||.+....++.|+|||||||+||||+| |+.||.+....+-...+       ..|..       ++ 
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-------e~GyR-------lp-  424 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-------ERGYR-------LP-  424 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-------hccCc-------CC-
Confidence            2233334667999999999999999999999999999999 99999877654332222       22221       11 


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                        ....|++++.+||..||+.+|++|||++.+...+..+..
T Consensus       425 --~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  425 --RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             --CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence              122477899999999999999999999988888876643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-46  Score=363.07  Aligned_cols=266  Identities=23%  Similarity=0.301  Sum_probs=217.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||.||+|... +++.||||+++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999976 689999999865422 2234456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+|+|.+++..  ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            99999999999974  456889999999999999999999   888999999999999999999999999998765432 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..       +..      
T Consensus       155 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-------~~~------  215 (291)
T cd05612         155 ------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-------GKL------  215 (291)
T ss_pred             ------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCc------
Confidence                  1234699999999999988899999999999999999999999987654332222111       000      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                      .+.     ......+.+|+.+||+.||.+||+     +.++++|.|.-.-++..........+
T Consensus       216 ~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~  273 (291)
T cd05612         216 EFP-----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPP  273 (291)
T ss_pred             CCC-----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCC
Confidence            000     012356899999999999999995     99999999987767766555544433

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-47  Score=356.20  Aligned_cols=276  Identities=21%  Similarity=0.288  Sum_probs=222.1

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-----
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-----  204 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----  204 (443)
                      +.....|..++.||+|+||.|+.+.++ +|+.||||++..........++..||+++|++++|+||+.+++++..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            344556777889999999999999876 79999999998766667777888999999999999999999998865     


Q ss_pred             cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          205 EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      -..+|+|+|+| +.+|...|.  .+..+.......++.|++.||+|+|   +.+|+||||||.|+|++.++.+||||||+
T Consensus        98 f~DvYiV~elM-etDL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHH--cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence            35789999999 678988886  4556999999999999999999999   77899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      |+.....  ......+.++.|.+|.|||++. ...|+.+.||||+||||.|||+|++-|.+.+.......+........+
T Consensus       172 AR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  172 ARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             eeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            9987643  2223357788999999999874 567999999999999999999999999988776554444333222222


Q ss_pred             Ccccccc-------------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          364 GDAISIL-------------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       364 ~~~~~~~-------------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .....+-             .+..........+....++|+.+||..||.+|+|++++|+|++.
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl  313 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL  313 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence            1111111             01111112223455789999999999999999999999999974

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=356.03  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=215.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-cCCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      -+|++.+.||+|.||.|-+|.. ..|+.||||.+++... ++.+...+++||+||..|+||||+.+|++|+..+.++|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3577778999999999999985 5799999999987654 4455667899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||..+|.|+||+.+  .+.+++.++..++.||+.|+.|||   .++|+|||||.+|||||.++++||+||||+-.+.+..
T Consensus       133 EYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  133 EYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999984  466999999999999999999999   8999999999999999999999999999998776543


Q ss_pred             CCcccccccccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLT-EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                           ..+++||+|-|.+||++.|.+|. +.+|-|||||+||.|+.|..||++.+-...       ...+..|...+-  
T Consensus       208 -----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l-------vrQIs~GaYrEP--  273 (668)
T KOG0611|consen  208 -----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL-------VRQISRGAYREP--  273 (668)
T ss_pred             -----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-------HHHhhcccccCC--
Confidence                 45778999999999999998885 789999999999999999999998764332       222333322221  


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                                ..+....-||+.||..+|++|-|+.+|..|-|
T Consensus       274 ----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  274 ----------ETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ----------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                      11234677999999999999999999999988

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-45  Score=355.71  Aligned_cols=272  Identities=24%  Similarity=0.301  Sum_probs=212.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.+.||+|+||.||+|.++ +++.||||+++...........+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999986 68899999987654445556778899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.++.|..+..  ....+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            999877655443  3456889999999999999999999   88899999999999999999999999999987643221


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC---------C
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD---------G  364 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---------~  364 (443)
                         .......||+.|+|||++.+..++.++|||||||++|||++|.+||...........+.........         .
T Consensus       156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         156 ---ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             ---ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence               1223456999999999998888999999999999999999999999876654433333222111110         0


Q ss_pred             ccccccCccccc-----hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          365 DAISILDPRVEN-----TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       365 ~~~~~~d~~~~~-----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .......+....     .......+..+.+|+.+||+.||++||+++++++|+|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000000000000     00011245679999999999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=366.09  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=218.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  210 (443)
                      ...|+..+.||.|.||.||+|+.+ +|+.+|+|.+++.... ......+.+|+.+|+++. |||||.++++|++.+.+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            356788889999999999999987 5999999999776542 335678999999999998 9999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----CCceEEeeecccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE----NFRAKVADFGFAR  286 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~----~~~vkl~DFGla~  286 (443)
                      |||+|.||.|++.|...   .+++..+..++.|++.++.|||   ..||+||||||+|||+..    ++.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999865   3999999999999999999999   788999999999999963    3579999999999


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .....     ......+||++|+|||++....|+..+||||+||++|.|++|.+||+...+......+......+...  
T Consensus       188 ~~~~~-----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~--  260 (382)
T KOG0032|consen  188 FIKPG-----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSE--  260 (382)
T ss_pred             EccCC-----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCC--
Confidence            87752     23556789999999999999999999999999999999999999999988655544333221111111  


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                                  ......+.+.+++..||..||.+|+++.++++|+|.
T Consensus       261 ------------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi  296 (382)
T KOG0032|consen  261 ------------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI  296 (382)
T ss_pred             ------------CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence                        112345789999999999999999999999999993

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.4e-46  Score=365.87  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=213.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+|.+.+.||+|+||.||+|.++ +++.||||++++... .......+.+|+.+|+.++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            47888999999999999999976 689999999875432 2334567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+||||+.++.+||+|||++...... 
T Consensus        98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            99999999999974  456888888999999999999999   888999999999999999999999999999765432 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       .+.. .    
T Consensus       172 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-------~~~~-~----  233 (329)
T PTZ00263        172 ------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-------AGRL-K----  233 (329)
T ss_pred             ------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-------cCCc-C----
Confidence                  123569999999999999899999999999999999999999998765432221111       1110 0    


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYREL  422 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~  422 (443)
                       ++     ......+.+|+.+||+.||.+||+     +.+++.|+|.-..++..+
T Consensus       234 -~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~  282 (329)
T PTZ00263        234 -FP-----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL  282 (329)
T ss_pred             -CC-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence             00     012356889999999999999997     799999999766566554

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-46  Score=357.93  Aligned_cols=265  Identities=25%  Similarity=0.328  Sum_probs=211.6

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC------------cccHHHHHHHHHHHHhcCCccee
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD------------KHSGAEFQSEIRTLAQVEHLNLV  196 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~~Ei~~l~~l~h~niv  196 (443)
                      -.+..++|+++..||+|.||.|.+|... +++.||||++.+....            ....+.+++||.+|++|.|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3455678999999999999999999976 7999999998654211            12236789999999999999999


Q ss_pred             eeeeeeee--cCeEEEEEeecCCCcHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          197 KFHGYLEF--EDERIVIVEYVPNGTLREHLDCLQGNI-LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       197 ~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      +|+++..+  .+.+|||+|||..|.+.+.-   ...+ +.+.++++++.+++.||+|||   .+|||||||||+|+||+.
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcC
Confidence            99999876  46899999999999875321   3445 899999999999999999999   888999999999999999


Q ss_pred             CCceEEeeecccccccccCC-CcccccccccCCCCccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCchhH
Q 013401          274 NFRAKVADFGFARLAADTES-GATHVSTQVKGTAGYLDPEYLKTYQ----LTEKSDVYSFGVLLVELVTGRRPIEPKREL  348 (443)
Q Consensus       274 ~~~vkl~DFGla~~~~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlGvll~elltG~~Pf~~~~~~  348 (443)
                      +|+|||+|||.+..+..... +........+|||.|+|||.+.+..    .+.+.|||||||+||.|+.|+.||-+..+.
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            99999999999986633311 1111223367999999999986622    356889999999999999999999888776


Q ss_pred             HHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          349 KERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .....+...--.+...                .+..+.+.+||.+||++||++|.++.+|..|+|.-+
T Consensus       326 ~l~~KIvn~pL~fP~~----------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  326 ELFDKIVNDPLEFPEN----------------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHhcCcccCCCc----------------ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            5544433221111111                123477999999999999999999999999999654

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.4e-46  Score=363.70  Aligned_cols=254  Identities=23%  Similarity=0.319  Sum_probs=207.6

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      .||+|+||.||+|..+ +|+.||||++++... .......+.+|+.+|+.++||||+++++++...+..++||||+.+|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            6999999999999875 799999999876432 23345567899999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccc
Q 013401          220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS  299 (443)
Q Consensus       220 L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  299 (443)
                      |.+++..  ...+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++......    ...
T Consensus        82 L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~~~  152 (323)
T cd05571          82 LFFHLSR--ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----ATM  152 (323)
T ss_pred             HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----Ccc
Confidence            9999863  467899999999999999999999   8889999999999999999999999999987533221    112


Q ss_pred             ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhh
Q 013401          300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA  379 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  379 (443)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.       ...      ..+.    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~------~~~p----  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEE------IRFP----  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-------cCC------CCCC----
Confidence            34569999999999999899999999999999999999999997654322211111       000      0000    


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhh
Q 013401          380 NNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       380 ~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~  422 (443)
                       .....++.+|+.+||+.||++||     ++.++++|.|.-..++...
T Consensus       216 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         216 -RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence             11346789999999999999999     8999999999765555444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.3e-46  Score=344.41  Aligned_cols=273  Identities=23%  Similarity=0.264  Sum_probs=219.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~l  210 (443)
                      .++|+.+++|++|+||.||+|+++ +++.||+|+++-........-.-.|||.+|.+++|||||.+.++...  -+.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356888889999999999999976 79999999998765444444556799999999999999999887654  467999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |||||+. +|...++... .++...++.-+..|++.||+|||   .+.|+||||||+|+|++..|.+||+|||+|+.+..
T Consensus       155 VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            9999964 8998888654 57888889999999999999999   88899999999999999999999999999998876


Q ss_pred             cCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      +..    ..+..+-|.+|.|||++.+ ..|++.+|+||+|||+.||+++.+-|.+..+.+....+........+......
T Consensus       230 p~k----~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  230 PLK----PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             Ccc----cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            533    3566678999999999876 46999999999999999999999999999988776665543333222111111


Q ss_pred             cCc------cccchhhc--------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDP------RVENTAAN--------NLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~------~~~~~~~~--------~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...      .+.....+        ....+.-.+|+..+|..||.+|.|+.++|+|-|..
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence            000      00000000        01346788999999999999999999999999954

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-45  Score=360.83  Aligned_cols=288  Identities=24%  Similarity=0.350  Sum_probs=219.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+...+||+|+||.||++.+. ++..||+|.++... .......+.+|+++|+.++||||+++++++..++..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            57999999999999999999976 68899999987542 23345678999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||.  .++|+||||||+|||++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            9999999999864  3468899999999999999999993  2469999999999999999999999999987654321 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc-----
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS-----  368 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  368 (443)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....................+....     
T Consensus       159 -----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 -----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             -----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence                 2335699999999999988999999999999999999999999976543221111000000000000000     


Q ss_pred             ----------------------ccC---ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          369 ----------------------ILD---PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       369 ----------------------~~d---~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                                            .++   ..............++.+|+.+||+.||++|||+.++++|+|....+..+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~  313 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEVD  313 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccccccc
Confidence                                  000   0000000011245679999999999999999999999999997766655554


Q ss_pred             cccCcCCccc
Q 013401          424 ASDVLLQPSY  433 (443)
Q Consensus       424 ~~~~~~~~~~  433 (443)
                      ...+.+.++.
T Consensus       314 ~~~~~~~~~~  323 (331)
T cd06649         314 FAGWLCKTLR  323 (331)
T ss_pred             HHHHHHHhhc
Confidence            4444433333

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=362.16  Aligned_cols=265  Identities=27%  Similarity=0.457  Sum_probs=213.4

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ..+.+.+...||+|.||+||+|.+. | .||||++.......+..+.|++|+..|++-+|.||+-+.|++..... .||.
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             CHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            3345566778999999999999986 2 49999998887778888999999999999999999999999988777 9999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      .+|+|-+|+.+|... ...++....++|+.||++|+.|||   .++|||||||..||||.+++.|||+||||+.....-.
T Consensus       467 qwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS  542 (678)
T ss_pred             hhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence            999999999999763 366899999999999999999999   8999999999999999999999999999986543221


Q ss_pred             CCcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                        .........|...|||||+++   ..+|+..+|||||||++|||++|..||... . .+  .+.|   ....|...  
T Consensus       543 --g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~-~d--qIif---mVGrG~l~--  611 (678)
T KOG0193|consen  543 --GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-N-RD--QIIF---MVGRGYLM--  611 (678)
T ss_pred             --cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-C-hh--heEE---EecccccC--
Confidence              111233445888999999995   357899999999999999999999999722 1 11  1111   22222111  


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                        ++  .......+.+++.+|+..||..++++||.+.+|+..|..+....
T Consensus       612 --pd--~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  612 --PD--LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             --cc--chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence              11  11123356678999999999999999999999999887776654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=340.22  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=217.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.+.||+|.|+.||+|.+. +|+.+|+|++..........+++.+|+.+-+.|+|||||++.+.+..+...|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            45666778999999999999876 79999999998777777788999999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCceEEeeecccccccc
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAAD  290 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~~  290 (443)
                      +|.|++|..-|...  ..+++..+-..+.||+.+|.|+|   .++|||||+||+|+|+.   ..-.+||+|||+|..+.+
T Consensus        91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999998877643  56788888899999999999999   89999999999999995   345699999999988763


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..     .....+|||.|||||+++..+|+..+|||+-|||||.||.|.+||++.........+....-.+         
T Consensus       166 g~-----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~---------  231 (355)
T KOG0033|consen  166 GE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY---------  231 (355)
T ss_pred             cc-----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC---------
Confidence            32     3456779999999999999999999999999999999999999999865443333322211111         


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ++     .......++..+|+.+||..||.+|.|+.|.|.|+|.-.+
T Consensus       232 ~~-----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  232 PS-----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             CC-----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            11     0122345789999999999999999999999999996543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-47  Score=362.63  Aligned_cols=252  Identities=29%  Similarity=0.423  Sum_probs=213.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .|..+.+||+|.||.||+|.+. +++.||+|++.... .+...+++++|+.+|.+++++||.++|+.+..+..+|++|||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4667789999999999999975 79999999998753 455678899999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |.||++.+.+.  .+..+++..+.-|+.+++.||.|||   .++.+|||||+.|||+..+|.|||+|||++..+..... 
T Consensus        93 ~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-  166 (467)
T ss_pred             hcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence            99999999986  4556688888889999999999999   88899999999999999999999999999988765432 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ...+++|||.|||||++.+..|+.|+||||||++.+||++|.+|+.+..+..-.    +.++   . .    ..|.+
T Consensus       167 ---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----flIp---k-~----~PP~L  231 (467)
T KOG0201|consen  167 ---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----FLIP---K-S----APPRL  231 (467)
T ss_pred             ---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----Eecc---C-C----CCCcc
Confidence               235678999999999999999999999999999999999999999876552210    0000   0 0    11111


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .    . .+..-+.+|+..||+.||+.||++.++++|-+.
T Consensus       232 ~----~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FI  266 (467)
T KOG0201|consen  232 D----G-DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFI  266 (467)
T ss_pred             c----c-ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHH
Confidence            1    1 345679999999999999999999999999764

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.1e-45  Score=359.93  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=209.4

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      .||+|+||.||++... +|+.||||++++... .......+.+|+.+|+.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            6999999999999976 699999999876532 23445678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccc
Q 013401          220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS  299 (443)
Q Consensus       220 L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  299 (443)
                      |.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.......    ...
T Consensus        82 L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~  152 (328)
T cd05593          82 LFFHLSR--ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----ATM  152 (328)
T ss_pred             HHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----ccc
Confidence            9988863  456899999999999999999999   8889999999999999999999999999987543221    112


Q ss_pred             ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhh
Q 013401          300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA  379 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  379 (443)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       ...      ..++    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~-------~~~------~~~p----  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MED------IKFP----  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc-------cCC------ccCC----
Confidence            34579999999999998899999999999999999999999997654422211110       000      0000    


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhc
Q 013401          380 NNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAA  424 (443)
Q Consensus       380 ~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~  424 (443)
                       .....++.+|+.+||+.||.+|+     ++.++++|.|....++.+...
T Consensus       216 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~  264 (328)
T cd05593         216 -RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD  264 (328)
T ss_pred             -CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence             11236789999999999999997     899999999987766666543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.8e-45  Score=358.68  Aligned_cols=255  Identities=23%  Similarity=0.330  Sum_probs=208.8

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      .||+|+||.||++... +|..||+|+++.... .......+.+|+.+++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            6999999999999975 699999999876432 23345567789999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccc
Q 013401          220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS  299 (443)
Q Consensus       220 L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  299 (443)
                      |.+++..  ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........    ..
T Consensus        82 L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~~  152 (323)
T cd05595          82 LFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TM  152 (323)
T ss_pred             HHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----cc
Confidence            9988863  456899999999999999999999   88899999999999999999999999999875432211    12


Q ss_pred             ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhh
Q 013401          300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA  379 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  379 (443)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+..  .   ..        .++    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~---~~--------~~p----  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--E---EI--------RFP----  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C---CC--------CCC----
Confidence            345699999999999988999999999999999999999999976644322111110  0   00        000    


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhh
Q 013401          380 NNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       380 ~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~  423 (443)
                       ...++.+.+|+.+||+.||++||     ++.++++|.|....++....
T Consensus       216 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  263 (323)
T cd05595         216 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV  263 (323)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence             11346789999999999999998     99999999998776666644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-45  Score=356.71  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=206.1

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      ||+|+||.||+|... +++.||||++++... .......+.+|+.+|..++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 688999999875432 334456678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccc
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST  300 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  300 (443)
                      .+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++......    ....
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~  151 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKTN  151 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----Cccc
Confidence            999864  456899999999999999999999   8889999999999999999999999999987543221    1223


Q ss_pred             cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       301 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       .... .     +     .
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~-------~~~~-~-----~-----~  213 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-------QEPL-R-----F-----P  213 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH-------cCCC-C-----C-----C
Confidence            4579999999999999899999999999999999999999997654322111110       0000 0     0     0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHhhhhhhhhh
Q 013401          381 NLALEKILELALQCLAPRRQNRP---SMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RP---s~~ell~~l~~i~~~~~~~  422 (443)
                      ......+.+|+.+||+.||.+||   ++.+++.|+|.-..++...
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~  258 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKL  258 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHH
Confidence            11336789999999999999997   5799999999766555544

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-45  Score=360.68  Aligned_cols=267  Identities=24%  Similarity=0.339  Sum_probs=216.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++++.... ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999986 5899999998765332 234456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++|++|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            99999999999963  456889999999999999999999   88899999999999999999999999999976543  


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+......+..   ....++
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~  225 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---PVYDDP  225 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC---CCCCcc
Confidence                 223456999999999999889999999999999999999999999876543322222111100000   000000


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                             ....++++.+|+.+||..+|.+||++.++++|+|...-++....
T Consensus       226 -------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~  269 (333)
T cd05600         226 -------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELR  269 (333)
T ss_pred             -------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHh
Confidence                   01234678999999999999999999999999997665555443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.2e-45  Score=350.75  Aligned_cols=269  Identities=23%  Similarity=0.327  Sum_probs=206.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|...++||.|+||+||+|..+ ++..||+|+++... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            46888999999999999999876 68999999987543 22334567799999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+ +|.+++.. .+..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........
T Consensus        84 ~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          84 YLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9975 89988864 3456788899999999999999999   88899999999999999999999999999876432211


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc-------
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD-------  365 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------  365 (443)
                          ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+...........       
T Consensus       159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         159 ----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             ----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence                1233468999999999865 5689999999999999999999999987654333222211111100000       


Q ss_pred             --cccccCccccch---hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          366 --AISILDPRVENT---AANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       366 --~~~~~d~~~~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        ......+.....   ........++.+|+.+||+.||.+|||++++++|+|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence              000000000000   001123457899999999999999999999999988

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.5e-46  Score=334.13  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=219.4

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc------ccHHHHHHHHHHHHhc-CCcceeeeeeee
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK------HSGAEFQSEIRTLAQV-EHLNLVKFHGYL  202 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  202 (443)
                      ...-.+|...+.||.|..++|.+|.++ +|..+|+|++.......      +..+.-.+|+.+|+++ .||||+++.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            334467899999999999999999876 78999999876543211      1223346899999998 599999999999


Q ss_pred             eecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       203 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                      +.+..+++|+|.|+.|.|+|+|.  ..-.+++.+...|+.|+..+++|||   ..+||||||||+|||++++.++||+||
T Consensus        93 es~sF~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence            99999999999999999999997  4467899999999999999999999   888999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKT------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW  356 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~  356 (443)
                      |++..+.+++     .....||||+|+|||.+.+      ..|+..+|+|++|||+|.||.|.+||+..........+..
T Consensus       168 GFa~~l~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime  242 (411)
T KOG0599|consen  168 GFACQLEPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME  242 (411)
T ss_pred             ceeeccCCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence            9999887665     3567899999999999854      3578899999999999999999999987766544433333


Q ss_pred             HhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       357 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      ....+..              +...+......+||.+||+.||.+|.|++|+|.|+|.+.---
T Consensus       243 GkyqF~s--------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  243 GKYQFRS--------------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             cccccCC--------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            2222211              122345577999999999999999999999999999865433

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=349.47  Aligned_cols=273  Identities=22%  Similarity=0.309  Sum_probs=220.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +|+..+.||+|+||.||++... +++.||||++...... ......+.+|+.+++.++|+||+++++.+...+.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778889999999999999875 6899999998654322 2223457789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+|+|.+++.......+++..+..++.|++.||.|||   +++++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999999887545567899999999999999999999   8889999999999999999999999999987654322 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+........    ..     
T Consensus       157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~-----  223 (285)
T cd05605         157 ----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----EE-----  223 (285)
T ss_pred             ----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----cc-----
Confidence                12234689999999999888899999999999999999999999986543222111111111100    00     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                           .....+..+.+|+.+||+.||.+||     ++.++++|.|....+++.+.......+
T Consensus       224 -----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  280 (285)
T cd05605         224 -----YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPP  280 (285)
T ss_pred             -----cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCC
Confidence                 0112346789999999999999999     899999999999888998876555433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.3e-44  Score=352.18  Aligned_cols=272  Identities=21%  Similarity=0.307  Sum_probs=207.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.++||+|+||.||+|... +++.||||+++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            367999999999999999999976 789999999875432 223346778999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+. ++|.+++.. ....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        83 e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          83 EYVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             ECCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9995 688888764 3456888889999999999999999   8889999999999999999999999999987543221


Q ss_pred             CCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH-HHhhhcCCCcc----
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVK-WAMKKFSDGDA----  366 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~----  366 (443)
                          .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......+.+... ...........    
T Consensus       158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 ----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             ----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence                12234568999999999865 458889999999999999999999998765433322211 11100000000    


Q ss_pred             ----------ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          367 ----------ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       367 ----------~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                                .......+............+.+|+.+||+.||.+|||+.++++|.|..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence                      0000000110011111235688999999999999999999999999963

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-44  Score=356.86  Aligned_cols=261  Identities=27%  Similarity=0.409  Sum_probs=203.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecC-
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFED-  206 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~-  206 (443)
                      ++|++.++||+|+||.||+|.+      .++..||||+++... .......+.+|+.+|..+ +|||||++++++...+ 
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            5788899999999999999974      235789999987542 233446788999999999 8999999999887644 


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc----------------------------------------------------------
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ----------------------------------------------------------  228 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~----------------------------------------------------------  228 (443)
                      .+++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            5889999999999999986421                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCC
Q 013401          229 --GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA  306 (443)
Q Consensus       229 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~  306 (443)
                        ...+.+..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++........  .......+++
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~  240 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLPL  240 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCCc
Confidence              124677888899999999999999   888999999999999999999999999999765432111  1122334678


Q ss_pred             CccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHH
Q 013401          307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALE  385 (443)
Q Consensus       307 ~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  385 (443)
                      .|+|||++.+..++.++|||||||+||||++ |..||...........      .+..+....     .     ....+.
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~------~~~~~~~~~-----~-----~~~~~~  304 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ------RLKDGTRMR-----A-----PENATP  304 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH------HHhcCCCCC-----C-----CCCCCH
Confidence            8999999988899999999999999999997 9999986543211111      111111100     0     012346


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          386 KILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       386 ~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .+.+|+.+||+.||.+||++.+|++.|..+..
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            79999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-45  Score=361.74  Aligned_cols=263  Identities=23%  Similarity=0.311  Sum_probs=214.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-C-CcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-D-GTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ++|...+.||+|+||.||+|.++ + +..||||++.+... .......+.+|+.+++.++|||||++++++.+++.+++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            46888899999999999999865 3 46899999865432 234456788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.+|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++......
T Consensus       110 ~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999974  456899999999999999999999   888999999999999999999999999999765421


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                             .....||+.|+|||++.+..++.++|||||||++|||++|.+||...........+.       .+..  .+.
T Consensus       185 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-------~~~~--~~p  248 (340)
T PTZ00426        185 -------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-------EGII--YFP  248 (340)
T ss_pred             -------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCC--CCC
Confidence                   124569999999999998889999999999999999999999998765432211111       1110  001


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccC
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDV  427 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~  427 (443)
                      .         ...+.+.+++.+||+.||.+|+     +++++++|+|.-..++.......+
T Consensus       249 ~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~  300 (340)
T PTZ00426        249 K---------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV  300 (340)
T ss_pred             C---------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCC
Confidence            1         1235688999999999999995     899999999987666665544443

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-44  Score=349.07  Aligned_cols=269  Identities=23%  Similarity=0.293  Sum_probs=206.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc--CCcEEEEEEccccccCcccHHHHHHHHHHHHhc---CCcceeeeeeeee-----ec
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE--DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV---EHLNLVKFHGYLE-----FE  205 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~-----~~  205 (443)
                      +|++.+.||+|+||.||+|.+.  +++.||||+++...........+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6888999999999999999863  478899999876544444445667788887766   6999999999875     34


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      ..+++||||+. ++|.+++.......+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999996 68999987655667899999999999999999999   888999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .......     ......||+.|+|||++.+..++.++|||||||++|||++|.+||...........+..........+
T Consensus       158 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         158 RIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             EeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            7654321     22345689999999999888899999999999999999999999987765443333222111111101


Q ss_pred             ccc-------ccCcccc--chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          366 AIS-------ILDPRVE--NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       366 ~~~-------~~d~~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ...       .+.+...  .........+.+.+|+.+||+.||++||++.++++|+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~  289 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  289 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence            000       0000000  00011123467889999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-45  Score=359.11  Aligned_cols=257  Identities=23%  Similarity=0.399  Sum_probs=223.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe-EEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE-RIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lv~  212 (443)
                      ++|..+++||+|+||.+++++++ +++.|++|.+.............++|+.+++++.|||||.+++.|++++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999876 68899999987766666666678899999999999999999999999998 99999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      +||+||+|.+.|.+.++..+++..++.++.|++.|+.|||   ++.|+|||||+.|||++.++.|||+|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999888889999999999999999999999   8889999999999999999999999999999887654


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ....++||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+-......+....           +. 
T Consensus       161 ~----~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----------~~-  224 (426)
T KOG0589|consen  161 S----LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----------YS-  224 (426)
T ss_pred             h----hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----------CC-
Confidence            1    3456789999999999999999999999999999999999999998876544333333221           01 


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                           +....++.++..||..||..+|..||++.+++.++...
T Consensus       225 -----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  225 -----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             -----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence                 11123457899999999999999999999999996654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-44  Score=357.10  Aligned_cols=274  Identities=21%  Similarity=0.291  Sum_probs=205.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----CeEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----DERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~  209 (443)
                      +|++.++||+|+||.||+|... +|..||||+++...........+.+|+.+++.++||||+++++++...     ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778889999999999999976 689999999875433334456788999999999999999999987543     2579


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|||||. ++|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999994 689888863  356899999999999999999999   8889999999999999999999999999997654


Q ss_pred             ccCCCcccccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh--------
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK--------  359 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--------  359 (443)
                      ..... ........||+.|+|||++.+  ..++.++|||||||++|+|++|.+||...........+.....        
T Consensus       155 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         155 NDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             cccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32211 112234579999999999865  5789999999999999999999999976654322111110000        


Q ss_pred             hcCCCcc---ccccCccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          360 KFSDGDA---ISILDPRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       360 ~~~~~~~---~~~~d~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .+.....   ...+......  ..........+.+|+.+||+.||++||++.++++|+|...
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence            0000000   0000000000  0000112356889999999999999999999999999643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-44  Score=355.24  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=207.2

Q ss_pred             ceeeeeCceEEEEEEE----cCCcEEEEEEcccccc--CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          141 FKIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +.||+|+||.||++..    .+++.||||++++...  .......+.+|+.+|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999985    3588999999876432  123345577899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.|++|.+++..  ...+.+..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            999999999863  456788888899999999999999   88899999999999999999999999999875432221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.       .+.. . +.+  
T Consensus       156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~-------~~~~-~-~~~--  221 (323)
T cd05584         156 ---VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-------KGKL-N-LPP--  221 (323)
T ss_pred             ---cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC-C-CCC--
Confidence               1233569999999999998889999999999999999999999998765432211111       1110 0 001  


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhc
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAA  424 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~  424 (443)
                             ...+.+.+|+.+||+.||++||     ++.++++|.|.-..++.+...
T Consensus       222 -------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~  269 (323)
T cd05584         222 -------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLA  269 (323)
T ss_pred             -------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhc
Confidence                   1235789999999999999999     899999999976655555443

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.3e-45  Score=357.23  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=207.3

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      .||+|+||.||++... +|+.||||++++... .......+.+|++++..++||||+++++++...+..++||||+.+|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            6999999999999875 799999999876532 23345667889999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       220 L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      |.+++.  ....+++..+..++.||+.||.|||   + +||+||||||+|||++.++.+||+|||++........    .
T Consensus        82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~  152 (325)
T cd05594          82 LFFHLS--RERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----T  152 (325)
T ss_pred             HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----c
Confidence            998886  3456899999999999999999999   6 6899999999999999999999999999875432211    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..       ..      ..++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------~~------~~~p---  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------EE------IRFP---  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-------CC------CCCC---
Confidence            2345699999999999988999999999999999999999999976544222111110       00      0000   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~  423 (443)
                        .....++.+|+.+||+.||++|+     ++.++++|.|....++....
T Consensus       217 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~  264 (325)
T cd05594         217 --RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY  264 (325)
T ss_pred             --CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence              01235789999999999999997     99999999997766655543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-44  Score=354.09  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHH---HhcCCcceeeeeeeeeecCeEEEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTL---AQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      |++.+.||+|+||.||+|.+. +++.||||++++... .....+.+.+|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999876 689999999876532 233345667776665   456799999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.|++|..++.   ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++......
T Consensus        81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            99999999988874   356899999999999999999999   888999999999999999999999999998654322


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .    ......+|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..       ...     
T Consensus       155 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------~~~-----  218 (324)
T cd05589         155 G----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEV-----  218 (324)
T ss_pred             C----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC-----
Confidence            1    112346799999999999988999999999999999999999999987654322211111       000     


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~  421 (443)
                       ...     ...+..+.+|+.+||+.||.+||     ++.++++|.|.-..++..
T Consensus       219 -~~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~  267 (324)
T cd05589         219 -RYP-----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD  267 (324)
T ss_pred             -CCC-----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence             000     11236688999999999999999     799999999865544444

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=361.79  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=212.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||+||+|... +|+.||||+++... ........+.+|+.+|..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999976 68999999987642 22344556789999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            99999999999863  456899999999999999999999   8889999999999999999999999999987543221


Q ss_pred             CCcc----------------------------------cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcC
Q 013401          293 SGAT----------------------------------HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG  338 (443)
Q Consensus       293 ~~~~----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG  338 (443)
                      ....                                  ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            1000                                  001124699999999999988999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHhh
Q 013401          339 RRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS---MRRCAEILWSV  415 (443)
Q Consensus       339 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs---~~ell~~l~~i  415 (443)
                      .+||...........+......+      . ...       ....++.+.+|+.+||. +|.+|++   +.++++|.|.-
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~------~-~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETL------Q-FPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCcc------C-CCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            99998765433221111000000      0 000       00123678899999997 9999998   99999999976


Q ss_pred             hhhhhhh
Q 013401          416 RKDYREL  422 (443)
Q Consensus       416 ~~~~~~~  422 (443)
                      ..++...
T Consensus       301 ~~~~~~~  307 (364)
T cd05599         301 GVDWEHI  307 (364)
T ss_pred             CCCHHHH
Confidence            6665543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3e-44  Score=358.74  Aligned_cols=270  Identities=23%  Similarity=0.323  Sum_probs=210.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|+..+.||+|+||+||+|... +++.||||++++... .......+.+|+.++..++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888999999999999999876 689999999875432 2334456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++||+|.+++..  ...+++..+..++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            99999999999974  457899999999999999999999   8899999999999999999999999999987543211


Q ss_pred             CC-------------------------------cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 013401          293 SG-------------------------------ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP  341 (443)
Q Consensus       293 ~~-------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~P  341 (443)
                      ..                               ........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                               00011245799999999999988999999999999999999999999


Q ss_pred             CCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHHHHhhhhhh
Q 013401          342 IEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLA--PRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~--~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      |...........+.......       .+.+..       ...+++.+|+.+|+.  .++..||++.+|++|+|.-..++
T Consensus       236 f~~~~~~~~~~~i~~~~~~~-------~~p~~~-------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         236 FCSETPQETYKKVMNWKETL-------IFPPEV-------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcc-------cCCCcC-------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCH
Confidence            98765433222111100000       001100       123567778877554  23345689999999999877666


Q ss_pred             hhhh
Q 013401          420 RELA  423 (443)
Q Consensus       420 ~~~~  423 (443)
                      ..+.
T Consensus       302 ~~~~  305 (363)
T cd05628         302 EHIR  305 (363)
T ss_pred             HHHH
Confidence            6653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-44  Score=344.61  Aligned_cols=267  Identities=22%  Similarity=0.291  Sum_probs=219.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +.|+.++.||+|.-|+||+|.++ +++.+|+|++.+.... .....+++.|-.||..++||.++.||..++.+...|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            35666778999999999999987 4799999999776543 344566788999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc--
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD--  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~--  290 (443)
                      |||+||+|...+....++.+++..++.++..|+.||+|||   ..|||+||||||||||.++|+|.|+||.|+....-  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999998888999999999999999999999999   77799999999999999999999999999853210  


Q ss_pred             -------------------------------cCCC-------------------cccccccccCCCCccCccccccCCCC
Q 013401          291 -------------------------------TESG-------------------ATHVSTQVKGTAGYLDPEYLKTYQLT  320 (443)
Q Consensus       291 -------------------------------~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~~~~~  320 (443)
                                                     ....                   ....+..++||-.|+|||++.|..++
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0000                   00112346899999999999999999


Q ss_pred             CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCC
Q 013401          321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQ  400 (443)
Q Consensus       321 ~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~  400 (443)
                      .++|+|+|||+|||||.|..||.+.+......++-.....+.+.                ...+..+.+||+++|.+||.
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~----------------~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE----------------PEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC----------------CcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999887655444433222222221                13446799999999999999


Q ss_pred             CCCC----HHHHHHHHHhhhhhhh
Q 013401          401 NRPS----MRRCAEILWSVRKDYR  420 (443)
Q Consensus       401 ~RPs----~~ell~~l~~i~~~~~  420 (443)
                      +|..    +.||.+|++.-.-+|.
T Consensus       378 kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hhhccccchHHhhcCccccCCChh
Confidence            9999    9999999876444443

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3e-44  Score=353.10  Aligned_cols=261  Identities=24%  Similarity=0.330  Sum_probs=210.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCC-cceeeeeeeeeecCeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEH-LNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~  212 (443)
                      +|++++.||+|+||.||+|... +++.||||++++... .......+..|+.++..+.| ++|+.+++++.+.+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999876 588999999876532 23445667889999999975 56888999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++||+|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            99999999998863  356889999999999999999999   8889999999999999999999999999986432211


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                          ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..       ..      .
T Consensus       156 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~------~  218 (324)
T cd05587         156 ----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-------HN------V  218 (324)
T ss_pred             ----CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CC------C
Confidence                112345699999999999998999999999999999999999999987654322211110       00      0


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELA  423 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~  423 (443)
                      .+.     .....++.+|+.+||+.||.+|++.     .++++|+|....++....
T Consensus       219 ~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~  269 (324)
T cd05587         219 SYP-----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLE  269 (324)
T ss_pred             CCC-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            000     1123578999999999999999986     899999997766665543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.5e-44  Score=367.85  Aligned_cols=271  Identities=20%  Similarity=0.290  Sum_probs=201.5

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC------cceeeeeeee
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH------LNLVKFHGYL  202 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h------~niv~l~~~~  202 (443)
                      +....++|++.++||+|+||+||+|.+. +++.||||+++..   ......+..|+++++.++|      .+|+.+++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            3345678999999999999999999875 6889999998643   1223455667777777654      4588999988


Q ss_pred             eec-CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcCCC-----
Q 013401          203 EFE-DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTENF-----  275 (443)
Q Consensus       203 ~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~~~-----  275 (443)
                      ..+ +.+++|||++ |++|.+++..  ...+++..+..|+.||+.||.|||   . .|||||||||+||||+.++     
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccc
Confidence            765 4788889988 7889888864  357899999999999999999999   6 4899999999999998765     


Q ss_pred             -----------ceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 013401          276 -----------RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP  344 (443)
Q Consensus       276 -----------~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~  344 (443)
                                 .+||+|||++.....       .....+||+.|+|||++.+..|+.++|||||||+||||++|++||..
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                       499999998754321       23346799999999999999999999999999999999999999987


Q ss_pred             chhHHHHHHHHHHhhhcCCC--------ccccc------cCccccc----------hhhcHHHHHHHHHHHHHccCCCCC
Q 013401          345 KRELKERITVKWAMKKFSDG--------DAISI------LDPRVEN----------TAANNLALEKILELALQCLAPRRQ  400 (443)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~--------~~~~~------~d~~~~~----------~~~~~~~~~~l~~Li~~cl~~dp~  400 (443)
                      .........+......+...        ....+      +.+....          ..........+.+||.+||+.||.
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            66543332222211111000        00000      0000000          000111235688999999999999


Q ss_pred             CCCCHHHHHHHHHhhh
Q 013401          401 NRPSMRRCAEILWSVR  416 (443)
Q Consensus       401 ~RPs~~ell~~l~~i~  416 (443)
                      +|||+.++++|+|...
T Consensus       428 ~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        428 KRLNARQMTTHPYVLK  443 (467)
T ss_pred             hCCCHHHHhcCccccc
Confidence            9999999999999753

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-44  Score=352.86  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=207.1

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|..+ +++.||||++++... .......+.+|+.++..+ +||||+++++++...+.+++||||+.||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            6999999999999976 689999999876532 234455677888988877 6999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.......    ..
T Consensus        82 ~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~----~~  152 (320)
T cd05590          82 DLMFHIQK--SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KT  152 (320)
T ss_pred             hHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----Cc
Confidence            99998864  456899999999999999999999   8889999999999999999999999999987543211    11


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       .+.. .  .+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-------~~~~-~--~~------  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------NDEV-V--YP------  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-------cCCC-C--CC------
Confidence            234569999999999998899999999999999999999999998765433211111       1110 0  00      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHhhhhhhhhhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSM------RRCAEILWSVRKDYRELA  423 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~------~ell~~l~~i~~~~~~~~  423 (443)
                        .....++.+|+.+||+.||.+||++      ++++.|.|.-..++....
T Consensus       217 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~  265 (320)
T cd05590         217 --TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN  265 (320)
T ss_pred             --CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence              0123678999999999999999998      999999997665555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.2e-44  Score=350.95  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=203.1

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|... +++.||||+++.... .......+..|..++..+ +||||+++++++..++.+++||||++||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999976 688999999876532 223344556677777654 7999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......    ..
T Consensus        82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----~~  152 (316)
T cd05592          82 DLMFHIQS--SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GK  152 (316)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----Cc
Confidence            99998864  356899999999999999999999   8889999999999999999999999999997543322    12


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+....             +.++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------~~~~---  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-------------PHFP---  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------CCCC---
Confidence            334579999999999998899999999999999999999999998765432211111100             0000   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHhhhhhhhhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSMR-RCAEILWSVRKDYREL  422 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~-ell~~l~~i~~~~~~~  422 (443)
                        .....++.+|+.+||+.||.+||++. ++++|.|.-..++...
T Consensus       217 --~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~  259 (316)
T cd05592         217 --RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERL  259 (316)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHHH
Confidence              11235688999999999999999875 7888988765555444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-43  Score=353.50  Aligned_cols=254  Identities=28%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..++||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|+.++|+||+++++++.+.+.+++||||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4556678999999999999976 68999999986542 233456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+.      ...++..+..|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||++........ 
T Consensus       154 ~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        154 MDGGSLEGT------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             CCCCccccc------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            999998643      23566777899999999999999   88899999999999999999999999999986643211 


Q ss_pred             cccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                         ......||..|+|||++..     ...+.++|||||||++|||++|..||................    ...... 
T Consensus       224 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~-  295 (353)
T PLN00034        224 ---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQPPE-  295 (353)
T ss_pred             ---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccCCCC-
Confidence               1234569999999998743     234568999999999999999999997432211111111100    000000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                               .......++.+|+.+||+.||++||++.++++|.|....
T Consensus       296 ---------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        296 ---------APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ---------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                     011234679999999999999999999999999997654

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.5e-44  Score=352.23  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=208.7

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|... +++.||||++++... .......+..|+.++..+ +||||+++++++...+..++||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            6999999999999976 588999999876532 233445677899998876 7999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........    .
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~----~  152 (321)
T cd05591          82 DLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----T  152 (321)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc----c
Confidence            99988863  456889999999999999999999   88899999999999999999999999999875432221    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+......+.       .+..   ..+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~-------~~~~---~~p------  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL-------HDDV---LYP------  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC---CCC------
Confidence            234569999999999998899999999999999999999999998765433221111       1110   000      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHHHhhhhhhhhhhcc
Q 013401          379 ANNLALEKILELALQCLAPRRQNRP-------SMRRCAEILWSVRKDYRELAAS  425 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RP-------s~~ell~~l~~i~~~~~~~~~~  425 (443)
                        .....++.+|+.+||+.||++||       ++.++++|+|.-..++......
T Consensus       217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~  268 (321)
T cd05591         217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQR  268 (321)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence              01235789999999999999999       9999999999876666665443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.9e-44  Score=350.48  Aligned_cols=256  Identities=23%  Similarity=0.339  Sum_probs=205.6

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|.++ +|..||||++++... .......+..|+.++..+ +||||+++++++.+.+.+++||||+.||
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            6999999999999976 689999999876532 123345567788888765 8999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.......    ..
T Consensus        82 ~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~  152 (316)
T cd05620          82 DLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----NR  152 (316)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----Cc
Confidence            99998864  456889999999999999999999   8889999999999999999999999999986432211    12


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+..       .      .+.+..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------~------~~~~~~--  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------D------TPHYPR--  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------C------CCCCCC--
Confidence            2346799999999999998999999999999999999999999986654322111111       0      000000  


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHHhhhhhhhhhhc
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSM-RRCAEILWSVRKDYRELAA  424 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~-~ell~~l~~i~~~~~~~~~  424 (443)
                         ....++.+|+.+||+.||++||++ .++++|.|.-..++.....
T Consensus       218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~~~~  261 (316)
T cd05620         218 ---WITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEK  261 (316)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHHHHh
Confidence               123578999999999999999998 5888899987766665443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-44  Score=354.49  Aligned_cols=265  Identities=25%  Similarity=0.327  Sum_probs=208.2

Q ss_pred             CCCCCceeeeeCceEEEEEEE----cCCcEEEEEEcccccc--CcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDER  208 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  208 (443)
                      +|++.++||+|+||.||++..    .+++.||+|++++...  .....+.+.+|+.++..++ |+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999975    2589999999875432  1233456788999999994 99999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++||||+.+|+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            999999999999999863  456899999999999999999999   888999999999999999999999999999765


Q ss_pred             cccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ......   ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+......       
T Consensus       156 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-------  225 (332)
T cd05614         156 LSEEKE---RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-------  225 (332)
T ss_pred             cccCCC---ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------
Confidence            432211   12245799999999999765 4788999999999999999999999754322111111111100       


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~  422 (443)
                        .++.+.     ......+.+|+.+||+.||++||     ++.++++|.|.-..++...
T Consensus       226 --~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~  278 (332)
T cd05614         226 --CDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEAL  278 (332)
T ss_pred             --CCCCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence              011111     11235689999999999999999     8899999999655444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=358.42  Aligned_cols=267  Identities=23%  Similarity=0.317  Sum_probs=215.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||+||+|... +|+.||||++++... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999976 799999999876533 2245567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++...  ..+++..++.++.||+.||.|||   .+||+||||||+||||+.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999743  67899999999999999999999   8889999999999999999999999999997665432


Q ss_pred             C-------------------------CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchh
Q 013401          293 S-------------------------GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE  347 (443)
Q Consensus       293 ~-------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~  347 (443)
                      .                         ..........||+.|+|||++.+..++.++|||||||+||+|++|..||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            0                         000112345699999999999998999999999999999999999999987664


Q ss_pred             HHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHhhhhhhhh
Q 013401          348 LKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS-MRRCAEILWSVRKDYRE  421 (443)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-~~ell~~l~~i~~~~~~  421 (443)
                      ......+......+   ..     +   .   ....++++.+|+.+||. ||.+||+ +.++++|+|.-.-++..
T Consensus       236 ~~~~~~i~~~~~~~---~~-----p---~---~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~  295 (350)
T cd05573         236 QETYNKIINWKESL---RF-----P---P---DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN  295 (350)
T ss_pred             HHHHHHHhccCCcc---cC-----C---C---CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence            33222211100000   00     0   0   00134679999999997 9999999 99999999976555544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.3e-44  Score=359.25  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=206.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .|..++.||+|+||+||+|.+. +++.||||++.+.. ........+.+|+.+++.++|+|||++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888899999999999999875 68999999987643 233445678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |++||+|.+++..  ...+++..+..++.||+.||.|||   .+||+||||||+||||+.++.+||+|||++........
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999874  356888888999999999999999   88899999999999999999999999999764321100


Q ss_pred             C-------------------------------------------cccccccccCCCCccCccccccCCCCCchhHHHHHH
Q 013401          294 G-------------------------------------------ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGV  330 (443)
Q Consensus       294 ~-------------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGv  330 (443)
                      .                                           ........+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence            0                                           000012357999999999999888999999999999


Q ss_pred             HHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHH--ccCCCCCCCCCHHHH
Q 013401          331 LLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQ--CLAPRRQNRPSMRRC  408 (443)
Q Consensus       331 ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~--cl~~dp~~RPs~~el  408 (443)
                      ++|||++|..||...........+.......      . ...       ......++.+|+.+  |+..++..|+++.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------~-~~~-------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTL------H-IPP-------QVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHcccccc------C-CCC-------CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999998765433222211000000      0 000       00123568889988  445566669999999


Q ss_pred             HHHHHhhhhhh
Q 013401          409 AEILWSVRKDY  419 (443)
Q Consensus       409 l~~l~~i~~~~  419 (443)
                      +.|.|.-.-++
T Consensus       303 l~hp~f~~~~~  313 (381)
T cd05626         303 KAHPFFSEVDF  313 (381)
T ss_pred             hcCcccCCCCh
Confidence            99999654333

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.8e-44  Score=334.99  Aligned_cols=274  Identities=22%  Similarity=0.312  Sum_probs=216.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc-eeeeeeeeeecC------
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN-LVKFHGYLEFED------  206 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~------  206 (443)
                      ..|..+++||+|+||+||+|+.+ +|+.||+|++......+.......+|+.+|+.|+|+| ||.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666678999999999999966 7999999998776443334556789999999999999 999999998877      


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQG--NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      .+++|+||+ .-+|..+++....  ..++...++.++.||+.||.|||   +++|+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            889999999 5799999986543  35777888999999999999999   89999999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      |+...-+.    ...+..++|.+|.|||++.+. .|+...||||+|||++||+++++-|.+..+......+........+
T Consensus       167 Ara~~ip~----~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPM----RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCc----ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence            98655332    235666799999999999776 7999999999999999999999999998886665555443333222


Q ss_pred             Cccccc-----cCccccchh----hcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          364 GDAISI-----LDPRVENTA----ANN---LALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       364 ~~~~~~-----~d~~~~~~~----~~~---~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ......     .+.......    ...   .......+|+.+||+.+|.+|.++..+++|.+...
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~  307 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE  307 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence            211111     111111110    001   11147899999999999999999999999977543

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=360.19  Aligned_cols=268  Identities=22%  Similarity=0.276  Sum_probs=208.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.++||+|+||+||+|... +++.||||++.+.. ........+.+|+++++.++|||||++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888999999999999999875 79999999986532 23344567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++||+|.+++..  ...+++..+..++.|++.||.|||   ++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999863  456888899999999999999999   8889999999999999999999999999996432110


Q ss_pred             CCc-----------c--------------------------------cccccccCCCCccCccccccCCCCCchhHHHHH
Q 013401          293 SGA-----------T--------------------------------HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFG  329 (443)
Q Consensus       293 ~~~-----------~--------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlG  329 (443)
                      ...           .                                ......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            000           0                                000124699999999999988999999999999


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCC---CCHH
Q 013401          330 VLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNR---PSMR  406 (443)
Q Consensus       330 vll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R---Ps~~  406 (443)
                      |+||||++|.+||...........+..   . ..  ....  +      .......++.+|+.+||. +|.+|   +++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~---~-~~--~~~~--p------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIIN---W-RE--TLYF--P------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHc---c-CC--ccCC--C------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999987654322211110   0 00  0000  0      001123568899999998 66665   6999


Q ss_pred             HHHHHHHhhhhhhhhh
Q 013401          407 RCAEILWSVRKDYREL  422 (443)
Q Consensus       407 ell~~l~~i~~~~~~~  422 (443)
                      +++.|+|....++..+
T Consensus       301 ~~l~hp~~~~~~~~~~  316 (377)
T cd05629         301 EIKSHPFFRGVDWDTI  316 (377)
T ss_pred             HHhcCCCcCCCCHHHH
Confidence            9999999765444443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-43  Score=341.43  Aligned_cols=267  Identities=22%  Similarity=0.305  Sum_probs=211.0

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      ||+|+||+||+|.+. +++.||||.+....... .....+..|+.+++.++|+||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999876 78999999986543222 2335677899999999999999999999999999999999999999


Q ss_pred             HHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          221 REHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       221 ~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      .+++...  ....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........    .
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----~  153 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----K  153 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc----c
Confidence            9887432  3456899999999999999999999   88899999999999999999999999999976543321    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............   ........ .          
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~~-~----------  219 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRILNDSV-T----------  219 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---HhhcccCC-C----------
Confidence            234569999999999999899999999999999999999999997653321111111   01111000 0          


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          379 ANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                      .....+..+.+|+.+||+.||++||     +++++++|.|.-..++..+.......+
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~  276 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPP  276 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCC
Confidence            0012346789999999999999999     889999999987766776655544433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9e-44  Score=349.60  Aligned_cols=264  Identities=23%  Similarity=0.314  Sum_probs=211.3

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +|.+.+.||+|+||.||+|... +++.||||++++... .......+..|..++..+ .|++|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788889999999999999876 688999999876532 223344567788888877 5899999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+++|+|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            99999999998864  356889999999999999999999   8889999999999999999999999999987543221


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                          .......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..       ...      
T Consensus       156 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------~~~------  218 (323)
T cd05616         156 ----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNV------  218 (323)
T ss_pred             ----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC------
Confidence                112345799999999999998999999999999999999999999987654322111111       100      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhhccc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELAASD  426 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~~~~  426 (443)
                      .++     .....++.+|+.+||+.||.+|++.     .++++|.|....++.......
T Consensus       219 ~~p-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~  272 (323)
T cd05616         219 AYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE  272 (323)
T ss_pred             CCC-----CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCC
Confidence            000     1134678999999999999999984     899999887666666654333

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.9e-44  Score=352.46  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=207.0

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|.+. +++.||||++++.... ......+.+|+.++..+ +||||+++++++.+.+.+++||||++||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            6999999999999976 6899999999865432 23445678999999998 6999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||+++......    ..
T Consensus        82 ~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~  152 (329)
T cd05588          82 DLMFHMQR--QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG----DT  152 (329)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----Cc
Confidence            99988863  457999999999999999999999   8889999999999999999999999999987532211    12


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH--HHHHHHHHhhhcCCCccccccCccccc
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK--ERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+....+.....      .++ 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p-  225 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC-
Confidence            234579999999999999899999999999999999999999996322111  00011111111111110      011 


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHHhhhhhhhhhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPS------MRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs------~~ell~~l~~i~~~~~~~~  423 (443)
                          ...+.++.+|+.+||+.||.+|++      +.++++|.|....++....
T Consensus       226 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~  274 (329)
T cd05588         226 ----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLE  274 (329)
T ss_pred             ----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence                112356899999999999999987      7999999998766665544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-43  Score=337.29  Aligned_cols=267  Identities=22%  Similarity=0.325  Sum_probs=211.5

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      ||+|+||.||++..+ +|+.||+|.+....... .....+..|+++++.++||||+++++++..+...++||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999876 69999999986543322 2234456799999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccc
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST  300 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  300 (443)
                      .+++.......+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.++|+|||++.......     ...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~  152 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----TIT  152 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----eee
Confidence            99887655566889999999999999999999   8889999999999999999999999999987664322     123


Q ss_pred             cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       301 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..   ........ .         ..
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~-~---------~~  219 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR---RTLEDEVK-F---------EH  219 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---Hhhccccc-c---------cc
Confidence            34689999999999888899999999999999999999999976433211111111   11111100 0         00


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          381 NLALEKILELALQCLAPRRQNRPSM----RRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RPs~----~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                      .....++.+|+.+||+.||.+||++    .+++.|.|.-.-++..++......+
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~  273 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPP  273 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCC
Confidence            1234678999999999999999999    6788999987777777766554433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-43  Score=348.19  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=206.9

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||+||+|.+. +++.||||++++... .......+.+|+.++..+ +||||+++++++...+.+++||||+.||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999876 588999999886532 233455677899999888 6999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......    ..
T Consensus        82 ~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~  152 (318)
T cd05570          82 DLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VT  152 (318)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----Cc
Confidence            99988863  356899999999999999999999   8889999999999999999999999999986532221    11


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       ....      ...   
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-------~~~~------~~~---  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-------EDEV------RYP---  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCC------CCC---
Confidence            234569999999999999899999999999999999999999997665322111111       1000      000   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELA  423 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~  423 (443)
                        ...+..+.+|+.+||+.||.+||++     .++++|.|....++....
T Consensus       217 --~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~  264 (318)
T cd05570         217 --RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLE  264 (318)
T ss_pred             --CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence              1123678999999999999999999     999999998766665443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-44  Score=352.50  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             ceeeeeCceEEEEEEE----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecC
Q 013401          141 FKIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  216 (443)
                      +.||+|+||.||++..    .+|+.||||++++..........+.+|+.+|++++||||+++++++.+++..|+||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999975    358999999998654434445567789999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          217 NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       217 gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      +|+|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........   
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---  153 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---  153 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---
Confidence            9999999863  456899999999999999999999   88899999999999999999999999999876543321   


Q ss_pred             cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       .... . +.     
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~-------~~~~-~-~p-----  218 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL-------KAKL-G-MP-----  218 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH-------cCCC-C-CC-----
Confidence             1234569999999999998889999999999999999999999998665422211111       0000 0 00     


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRE  421 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~  421 (443)
                          ......+.+|+.+||+.||++||+     +.+++.|.|.-..++..
T Consensus       219 ----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~  264 (318)
T cd05582         219 ----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK  264 (318)
T ss_pred             ----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence                112356889999999999999999     78899998875555444

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-43  Score=346.68  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=204.3

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|.+. +++.||||+++.... .......+..|..++..+ +||||+++++++.+.+.+++||||++||
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            6999999999999976 588999999876532 123345566788888764 8999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........    .
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~  152 (316)
T cd05619          82 DLMFHIQS--CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA----K  152 (316)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----c
Confidence            99999864  356888899999999999999999   88899999999999999999999999999875332211    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....             +..+   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------------~~~~---  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-------------PCYP---  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------CCCC---
Confidence            234569999999999998899999999999999999999999998765432211111100             0000   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHhhhhhhhhhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSMR-RCAEILWSVRKDYRELA  423 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~-ell~~l~~i~~~~~~~~  423 (443)
                        .....++.+|+.+||+.||++||++. ++++|.|.-..++....
T Consensus       217 --~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~  260 (316)
T cd05619         217 --RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALE  260 (316)
T ss_pred             --ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHHH
Confidence              01235688999999999999999996 89999887665555443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.3e-43  Score=340.24  Aligned_cols=269  Identities=25%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc---CCcceeeeeeeeee-----cC
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV---EHLNLVKFHGYLEF-----ED  206 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~-----~~  206 (443)
                      +|++.+.||+|+||+||+|..+ +++.||+|.++...........+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788889999999999999876 689999999876543333344566777777665   69999999998764     34


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..++||||+. ++|.+++.......+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999997 48988887655556899999999999999999999   8889999999999999999999999999997


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ......     ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+............
T Consensus       157 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         157 IYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             cccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence            654322     123356899999999998888999999999999999999999999776543332222111100000000


Q ss_pred             c-------cccCccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          367 I-------SILDPRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       367 ~-------~~~d~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .       ..+.+....  ........+++.+|+.+||+.||++||++.+++.|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            0       000000000  0011124467899999999999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.3e-44  Score=359.19  Aligned_cols=267  Identities=23%  Similarity=0.292  Sum_probs=209.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +|++++.||+|+||.||+|... +++.||||++.+... .......+.+|+.+|+.++|+||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999876 689999999865322 23345668899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |++||+|.+++..  ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..+.....
T Consensus        82 ~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999964  456888888999999999999999   88899999999999999999999999999753210000


Q ss_pred             ---------------------------------------CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHH
Q 013401          294 ---------------------------------------GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVE  334 (443)
Q Consensus       294 ---------------------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~e  334 (443)
                                                             .........+||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                   00001123579999999999999899999999999999999


Q ss_pred             HHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 013401          335 LVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRP---SMRRCAEI  411 (443)
Q Consensus       335 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---s~~ell~~  411 (443)
                      |++|..||...........+.......      .  .+      ........+.+|+.+|+ .+|.+|+   ++.+++.|
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~------~--~~------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTL------H--IP------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccc------c--CC------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999998766543322211100000      0  00      00112356788888876 5999999   99999999


Q ss_pred             HHhhhhhhhhh
Q 013401          412 LWSVRKDYREL  422 (443)
Q Consensus       412 l~~i~~~~~~~  422 (443)
                      .|.-..++...
T Consensus       302 ~~~~~~~~~~~  312 (376)
T cd05598         302 PFFKGIDFASL  312 (376)
T ss_pred             CCcCCCCHHHH
Confidence            99765555444

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.5e-43  Score=345.54  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=209.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+..++||+|+||.||++.+. ++..+|+|.++... .......+.+|+++++.++|+||+++++++.+++.+++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            57999999999999999999987 68899999887542 23345678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++..  ...+++..+..++.|++.||.|||.  .++|+|+||||+|||++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999964  3568888999999999999999993  2479999999999999999999999999987654321 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc------
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI------  367 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------  367 (443)
                           .....|+..|+|||++.+..++.++|||||||++|+|++|..||............    .....+...      
T Consensus       159 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  229 (333)
T cd06650         159 -----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF----GCPVEGDPAESETSP  229 (333)
T ss_pred             -----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh----cCcccCCccccccCc
Confidence                 23346899999999999888999999999999999999999999765432111100    000000000      


Q ss_pred             ---------cccCccccc-----------------hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          368 ---------SILDPRVEN-----------------TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       368 ---------~~~d~~~~~-----------------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                               ....+....                 .........++.+|+.+||+.||++||++.++++|.|.-..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                     000000000                 00000134578999999999999999999999999996543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.4e-44  Score=349.81  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=204.1

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHH-HHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIR-TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||+||+|.+. +|+.||||++.+... .......+.+|.. +++.++||||+++++++...+..++||||+.+|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            6999999999999976 799999999875432 2223345555655 457789999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.......    ..
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~  152 (323)
T cd05575          82 ELFFHLQR--ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----KT  152 (323)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----Cc
Confidence            99998863  456889999999999999999999   8889999999999999999999999999987543221    12


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       ... . .+.+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~~-~-~~~~------  217 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL-------NKP-L-RLKP------  217 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH-------cCC-C-CCCC------
Confidence            234579999999999999899999999999999999999999998764322111111       000 0 0111      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHhhhhhhhhhhcc
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSM----RRCAEILWSVRKDYRELAAS  425 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~----~ell~~l~~i~~~~~~~~~~  425 (443)
                         ..+..+.+|+.+||+.||.+||++    .++++|+|.-..++..+...
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~  265 (323)
T cd05575         218 ---NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNK  265 (323)
T ss_pred             ---CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhc
Confidence               123678999999999999999987    69999999766556555433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.9e-44  Score=356.14  Aligned_cols=264  Identities=22%  Similarity=0.279  Sum_probs=210.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|++.+.||+|+||.||+|... ++..||||++++... .......+.+|+.+++.++||||+++++++.+++.+++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            357889999999999999999976 689999999865422 223345577899999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||++||+|.+++..   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998853   35788888899999999999999   888999999999999999999999999999765432


Q ss_pred             CCCcccccccccCCCCccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTY----QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ..   .......||+.|+|||++.+.    .++.++|||||||++|||++|.+||...........+......      .
T Consensus       196 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------~  266 (370)
T cd05596         196 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS------L  266 (370)
T ss_pred             Cc---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc------C
Confidence            11   112345799999999998653    4788999999999999999999999876543322211110000      0


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~~~~~  420 (443)
                      .. .       .....+.++.+|+.+||+.+|.+  |+++.++++|+|....++.
T Consensus       267 ~~-~-------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         267 TF-P-------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             CC-C-------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            00 0       01113467899999999999988  9999999999997654443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.3e-44  Score=359.34  Aligned_cols=266  Identities=21%  Similarity=0.284  Sum_probs=208.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .|+.+++||+|+||.||+|... +++.||||++.+... .......+.+|+.+++.++|+|||++++.+.+++.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888899999999999999875 689999999875422 23345678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+||+|.+++..  ...+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            9999999999864  356888888999999999999999   88899999999999999999999999999753211000


Q ss_pred             -------------------------------------------CcccccccccCCCCccCccccccCCCCCchhHHHHHH
Q 013401          294 -------------------------------------------GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGV  330 (443)
Q Consensus       294 -------------------------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGv  330 (443)
                                                                 .........+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                       0000112357999999999999889999999999999


Q ss_pred             HHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC---HHH
Q 013401          331 LLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS---MRR  407 (443)
Q Consensus       331 ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs---~~e  407 (443)
                      +||||++|.+||...........+.......      .     .+   ......+++.+|+.+|+ .+|.+|++   +.+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------~-----~p---~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSL------H-----IP---PQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCc------C-----CC---CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999998766543322221100000      0     00   01112356788888875 59999997   999


Q ss_pred             HHHHHHhhhhhhhh
Q 013401          408 CAEILWSVRKDYRE  421 (443)
Q Consensus       408 ll~~l~~i~~~~~~  421 (443)
                      +++|.|.-..++..
T Consensus       302 i~~hp~f~~~~~~~  315 (382)
T cd05625         302 IKAHPFFKTIDFSS  315 (382)
T ss_pred             HhcCCCcCCcChHH
Confidence            99999975554443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-43  Score=355.06  Aligned_cols=263  Identities=21%  Similarity=0.280  Sum_probs=207.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|+..+.||+|+||.||++... +++.||+|++++... .......+.+|+.+++.++||||+++++++.+++.+++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999976 689999999865322 233345678999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||++||+|.+++..   ..+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         122 MEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999998853   35788889999999999999999   888999999999999999999999999999865432


Q ss_pred             CCCcccccccccCCCCccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTY----QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ..   ......+||+.|+|||++.+.    .++.++|||||||+||+|++|..||...........+..   ..   ...
T Consensus       196 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~---~~---~~~  266 (370)
T cd05621         196 GM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD---HK---NSL  266 (370)
T ss_pred             Cc---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh---CC---ccc
Confidence            21   112346799999999999654    378899999999999999999999987654322211110   00   000


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~~~~  419 (443)
                      ..     +   ........+.+|+..||..++.+  |+++.++++|+|.-..++
T Consensus       267 ~~-----p---~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         267 NF-----P---EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             CC-----C---CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            00     0   01123466889999999866544  899999999999754433

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.4e-43  Score=339.14  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=202.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC-----------------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED-----------------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK  197 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~  197 (443)
                      .+|.+.++||+|+||.||+|.+++                 +..||||.++... ......++.+|+.+|..++||||++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            468888999999999999997532                 3479999987542 2334567889999999999999999


Q ss_pred             eeeeeeecCeEEEEEeecCCCcHHHHHhhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 013401          198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQ-----------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPII  260 (443)
Q Consensus       198 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  260 (443)
                      +++++.+.+..++||||+.+++|.+++....                 ...+++..++.++.||+.||.|||   +++|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999985421                 123567788899999999999999   88899


Q ss_pred             ecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc--C
Q 013401          261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT--G  338 (443)
Q Consensus       261 HrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt--G  338 (443)
                      ||||||+|||++.++.+||+|||++........  ........++..|+|||++.+..++.++|||||||++|||++  +
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999999999999999976543321  112233456889999999988889999999999999999987  5


Q ss_pred             CCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          339 RRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       339 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ..||..............   .+...........       ...++..+.+|+.+||+.||.+||++.+|.+.|.
T Consensus       239 ~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDEQVIENAGE---FFRDQGRQVYLFR-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHHHHHHHHHH---HhhhccccccccC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            678876543222111111   1111100000000       0113467999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-42  Score=335.74  Aligned_cols=248  Identities=24%  Similarity=0.310  Sum_probs=199.6

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeee----cCeEEEEEee
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEF----EDERIVIVEY  214 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~  214 (443)
                      ...||+|++|.||+|.. +|+.||||+++...... ...+.+.+|+.+|.+++|||||++++++.+    ...+++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35799999999999998 58899999987653222 224678899999999999999999999876    3478999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+|+|.+++..  ...+++...+.++.+++.||.|||.  ..+++||||||+|||++.++.+||+|||++.......  
T Consensus       104 ~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            999999999974  4568888999999999999999993  2478999999999999999999999999987654321  


Q ss_pred             cccccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           ....|+..|+|||++.+  ..++.++|||||||++|||++|..||...........+   ...   +.     ..
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i---~~~---~~-----~~  241 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI---INK---NN-----SL  241 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hhc---CC-----CC
Confidence                 23458999999999976  67899999999999999999999999876432211111   000   00     00


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .++     ..+++.+.+|+.+||+.||++||++.++++.|..+
T Consensus       242 ~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        242 KLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            010     12346799999999999999999999999999765

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.5e-44  Score=351.50  Aligned_cols=266  Identities=24%  Similarity=0.306  Sum_probs=212.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||+||+|... +|+.||||++++... .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999876 699999999876543 2334566889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+++|+|.+++... ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999999999753 356899999999999999999999   8889999999999999999999999999998765332


Q ss_pred             CCcccccccccCCCCccCccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLK------TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .   .......||+.|+|||++.      ...++.++|||||||++|+|++|..||...........+...      ...
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------~~~  227 (330)
T cd05601         157 M---VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF------QRF  227 (330)
T ss_pred             c---eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC------CCc
Confidence            1   1223346999999999986      456788999999999999999999999766543322211110      000


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      ....        .....+..+.+|+..||+ ||.+||++.+++.|.|.-..++...
T Consensus       228 ~~~~--------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         228 LKFP--------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             cCCC--------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence            0000        001134678999999998 9999999999999999765454443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-43  Score=353.55  Aligned_cols=263  Identities=22%  Similarity=0.238  Sum_probs=201.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|.+.++||+|+||.||+|.+. +++.||||....        ..+.+|+++|+.++|||||++++++...+..++|+|
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            57999999999999999999975 689999996542        346789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ++. ++|..++..  ...+++..++.|+.||+.||.|||   .++||||||||+||||+.++.+||+|||++........
T Consensus       164 ~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            994 788888864  356889999999999999999999   88899999999999999999999999999975433211


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH------HHH-HHHHHhhhcCC---
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK------ERI-TVKWAMKKFSD---  363 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~------~~~-~~~~~~~~~~~---  363 (443)
                         .......||+.|+|||++.+..++.++|||||||++|||++|..||.......      ..+ .+.........   
T Consensus       238 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        238 ---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence               12234579999999999998899999999999999999999998875432110      000 00000000000   


Q ss_pred             Cc----ccc---------ccCcccc-chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          364 GD----AIS---------ILDPRVE-NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       364 ~~----~~~---------~~d~~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ..    ...         ...+... ........+.++.+|+.+||+.||.+|||+.++++|.|.
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence            00    000         0000000 001112345679999999999999999999999999996

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=345.42  Aligned_cols=252  Identities=24%  Similarity=0.346  Sum_probs=216.2

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      -|...+.||+|.|.+|.+|++- +|..||||++.+...+......+.+|+..|+.++|||||++|++......+|+|+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            4666668999999999999865 899999999999888888888899999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-cCCCceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl-~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      -.+|+|++||-.. ...+.+..+.+++.||+.||.|||.+|   ||||||||+|+.+ ..-|-|||.|||++-.+.++. 
T Consensus        99 GD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             cCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            9999999999764 456888889999999999999999655   9999999999877 467899999999997776544 


Q ss_pred             CcccccccccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLT-EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                          ..+..||...|-|||++.|..|+ +++||||||||||-|++|++||+..+.-+..-               .++|-
T Consensus       174 ----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDC  234 (864)
T KOG4717|consen  174 ----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDC  234 (864)
T ss_pred             ----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcc
Confidence                35667899999999999999988 57899999999999999999998765533211               12221


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ...   .......+..+||..||..||.+|-+.++|..+.|-
T Consensus       235 KYt---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  235 KYT---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             ccc---CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence            111   123466889999999999999999999999999994

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.4e-43  Score=337.47  Aligned_cols=268  Identities=22%  Similarity=0.338  Sum_probs=214.1

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |+..+.||+|+||.||++... +++.||||.+....... .....+.+|+.+++.++|+||+.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667788999999999999876 68999999986543322 2234567899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.|++|.+++.......+++..++.++.|++.||.|||   .++|+||||||+|||++.++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999986555556899999999999999999999   8889999999999999999999999999987654322  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|..||.....................     ..    
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-----~~----  224 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-----EY----  224 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh-----hc----
Confidence               112346999999999999889999999999999999999999999764321111111111000000     00    


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhccc
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASD  426 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~  426 (443)
                           .......+.+|+.+||+.||.+||+     +.++++|.|.-.-++.......
T Consensus       225 -----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~  276 (285)
T cd05630         225 -----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGM  276 (285)
T ss_pred             -----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCC
Confidence                 0112356899999999999999999     8999999998777777655433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-43  Score=347.02  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=205.5

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|... +++.||+|++++.... ......+.+|+.++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            6999999999999976 6889999998865432 23445677899998877 7999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.......    .
T Consensus        82 ~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~----~  152 (329)
T cd05618          82 DLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----T  152 (329)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC----c
Confidence            99988863  456899999999999999999999   88899999999999999999999999999875432211    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH--HHHHHHHHhhhcCCCccccccCccccc
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK--ERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+..........      .++ 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p-  225 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIP-  225 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCC-
Confidence            234579999999999999899999999999999999999999995321110  00111111111111110      010 


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHHhhhhhhhhhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPS------MRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs------~~ell~~l~~i~~~~~~~~  423 (443)
                          .....++.+|+.+||+.||.+||+      +.++++|+|.-..+|....
T Consensus       226 ----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~  274 (329)
T cd05618         226 ----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLME  274 (329)
T ss_pred             ----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence                112356889999999999999998      6899999997666555443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-43  Score=354.27  Aligned_cols=272  Identities=24%  Similarity=0.287  Sum_probs=207.9

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----eEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----ERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  209 (443)
                      +|++.+.||+|+||.||+|... +|+.||||++............+.+|+.+|+.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999975 7999999998765433445567889999999999999999999998776     789


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|+||+. ++|.+++.  ....+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++....
T Consensus        81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 57888775  3457899999999999999999999   8889999999999999999999999999997654


Q ss_pred             ccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc---
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD---  365 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---  365 (443)
                      ....   .......+++.|+|||++.+. .++.++|||||||++|||++|..||...........+...........   
T Consensus       155 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         155 PDES---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cCcc---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            3221   122344689999999998764 578999999999999999999999987765433222211110000000   


Q ss_pred             ----ccc-c----cCcc-ccc-hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          366 ----AIS-I----LDPR-VEN-TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       366 ----~~~-~----~d~~-~~~-~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                          ... +    ..+. ... ........+++.+|+.+||+.||.+||++.++++|+|.-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                000 0    0000 000 0001112467899999999999999999999999999644

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-43  Score=353.13  Aligned_cols=271  Identities=23%  Similarity=0.310  Sum_probs=213.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|+..+.||+|+||.||+|... +++.||||+++... ........+.+|+.++..++|+||+++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888899999999999999876 68999999987542 23344567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++||+|.+++..  ...+++..+..++.|++.||.|||   ++||+||||||+||||+.++.+||+|||++.......
T Consensus        81 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999863  456899999999999999999999   8889999999999999999999999999987543211


Q ss_pred             CC-------------------------------cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 013401          293 SG-------------------------------ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP  341 (443)
Q Consensus       293 ~~-------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~P  341 (443)
                      ..                               ........+||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                               00011235799999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHhhhhh
Q 013401          342 IEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRP---SMRRCAEILWSVRKD  418 (443)
Q Consensus       342 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---s~~ell~~l~~i~~~  418 (443)
                      |...........+......      . .+.+.       ....+++.+|+.+|+ .||.+|+   ++.++++|+|.-.-+
T Consensus       236 f~~~~~~~~~~~i~~~~~~------~-~~p~~-------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         236 FCSETPQETYRKVMNWKET------L-VFPPE-------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCc------e-ecCCC-------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence            9876553322211100000      0 00000       012356888998876 4999998   589999999977767


Q ss_pred             hhhhhcc
Q 013401          419 YRELAAS  425 (443)
Q Consensus       419 ~~~~~~~  425 (443)
                      |..+...
T Consensus       301 ~~~~~~~  307 (360)
T cd05627         301 WGHIRER  307 (360)
T ss_pred             HHHHhcC
Confidence            7665433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-43  Score=347.11  Aligned_cols=254  Identities=25%  Similarity=0.358  Sum_probs=200.4

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHH-HHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIR-TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|... +++.||||++.+... .......+.+|+. +++.++||||+++++++.+.+..++||||++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            6999999999999976 689999999875432 2223344555654 577889999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..+..++.||+.||.|||   .++|+||||||+||||+.++.+||+|||++........    .
T Consensus        82 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----~  152 (321)
T cd05603          82 ELFFHLQR--ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----T  152 (321)
T ss_pred             CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----c
Confidence            99988863  456888889999999999999999   88899999999999999999999999999875432211    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+   .    ... .. +.       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~----~~~-~~-~~-------  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI---L----HKP-LQ-LP-------  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH---h----cCC-CC-CC-------
Confidence            23456999999999999888999999999999999999999999876432211111   0    000 00 00       


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHhhhhhhhhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSM----RRCAEILWSVRKDYREL  422 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~----~ell~~l~~i~~~~~~~  422 (443)
                        ......+.+++.+||+.||.+||+.    .++++|+|.-..++..+
T Consensus       217 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T cd05603         217 --GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDL  262 (321)
T ss_pred             --CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHH
Confidence              0123568999999999999999865    58888888655555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-43  Score=347.92  Aligned_cols=256  Identities=24%  Similarity=0.348  Sum_probs=202.9

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHH-HHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIR-TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|... +|+.||||++.+... .......+.+|.. +++.++||||+++++++...+..++||||+.||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            6999999999999876 799999999875432 2233345556665 467789999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++.  ....+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........    .
T Consensus        82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~----~  152 (325)
T cd05604          82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD----T  152 (325)
T ss_pred             CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC----C
Confidence            9998886  3457899999999999999999999   88899999999999999999999999999875332211    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       ....  .+.+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~-------~~~~--~~~~------  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL-------HKPL--VLRP------  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH-------cCCc--cCCC------
Confidence            234579999999999999899999999999999999999999998765432211111       1100  0111      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHhhhhhhhhhhc
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSM----RRCAEILWSVRKDYRELAA  424 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~----~ell~~l~~i~~~~~~~~~  424 (443)
                         .....+.+++.+||+.||.+||++    .++++|.|.-..++.++..
T Consensus       218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~  264 (325)
T cd05604         218 ---GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQ  264 (325)
T ss_pred             ---CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence               123568899999999999999977    5899998876555555433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=355.38  Aligned_cols=266  Identities=26%  Similarity=0.323  Sum_probs=215.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Cc-----ceeeeeeeeeecCeE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HL-----NLVKFHGYLEFEDER  208 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~~~~~~  208 (443)
                      +|++++.||+|+||.|-+|.+. +++.||||+++..   +....+...|+.+|..|+ |.     |+|+++++|...+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            7899999999999999999876 7999999999875   455566778999999997 43     899999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCceEEeeecccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE--NFRAKVADFGFAR  286 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~  286 (443)
                      |||+|++ ..+|+++|..++-..++...++.|+.||+.+|.+||   ..+|||.|||||||||.+  ...|||+|||.|.
T Consensus       264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999999 679999999888888999999999999999999999   888999999999999974  3479999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh------
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK------  360 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~------  360 (443)
                      +....      +. .++-+..|+|||++.|.+|+.+.||||||||++||++|.+-|.+.++.+....+......      
T Consensus       340 ~~~q~------vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  340 FESQR------VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccCCc------ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            86542      23 677899999999999999999999999999999999999999998876655444321110      


Q ss_pred             ---------cCC-Cccc------c-----------------ccCcccc-c--hh---hcHHHHHHHHHHHHHccCCCCCC
Q 013401          361 ---------FSD-GDAI------S-----------------ILDPRVE-N--TA---ANNLALEKILELALQCLAPRRQN  401 (443)
Q Consensus       361 ---------~~~-~~~~------~-----------------~~d~~~~-~--~~---~~~~~~~~l~~Li~~cl~~dp~~  401 (443)
                               +.. ....      .                 ..+...+ .  ..   ........+.+|+.+||..||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                     000 0000      0                 0000000 0  00   00122356899999999999999


Q ss_pred             CCCHHHHHHHHHhh
Q 013401          402 RPSMRRCAEILWSV  415 (443)
Q Consensus       402 RPs~~ell~~l~~i  415 (443)
                      |+|..+.++|+|.-
T Consensus       493 R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  493 RITPAQALNHPFLT  506 (586)
T ss_pred             cCCHHHHhcCcccc
Confidence            99999999999965

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=364.20  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=210.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCC-cEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeee-eee------c
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDG-TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGY-LEF------E  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~------~  205 (443)
                      -++++.+.|.+|||+.||+|.+..+ ..||+|++-..  ++.....+.+||.+|+.|. |+|||.+++. ...      .
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4567778899999999999998754 99999997654  5677788999999999996 9999999993 211      1


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      -+++|+||||.||.|-|++..+....|.+.++++|+.|+++|+.+||.+ ...|||||||-|||||+.+|.+||||||.+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            2578999999999999999877777799999999999999999999965 356999999999999999999999999998


Q ss_pred             ccccccCCCcccc-----cccccCCCCccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHH
Q 013401          286 RLAADTESGATHV-----STQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA  357 (443)
Q Consensus       286 ~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~l---~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~  357 (443)
                      ......-.....+     .-...-|+.|+|||++   .+...++|+|||+|||+||-||....||+....          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            6433221111100     1123579999999987   677899999999999999999999999976532          


Q ss_pred             hhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       358 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                               ..+++.....++. ..+.+.|.+||..||++||++||++-++++.+..+..
T Consensus       264 ---------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  264 ---------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                     2223333322222 3467889999999999999999999999999998763

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-42  Score=329.40  Aligned_cols=254  Identities=27%  Similarity=0.419  Sum_probs=211.9

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...+.||+|+||.||+|... +++.|++|.+............+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777889999999999999976 689999999876545556677889999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      ++|++|.+++.......+++..++.++.+++.||.|||   .++++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            99999999998655677899999999999999999999   88899999999999999999999999999876654321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......|++.|+|||++.+..++.++|||||||++++|++|..||...........       ...+.....     
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~-----  221 (256)
T cd08529         157 ---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK-------IIRGVFPPV-----  221 (256)
T ss_pred             ---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcCCCCCC-----
Confidence               12334689999999999988899999999999999999999999976653221111       111111100     


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                           .......+.+++.+||+.+|++||++.+++++.|
T Consensus       222 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         222 -----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             -----ccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence                 0123467999999999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.2e-43  Score=362.50  Aligned_cols=259  Identities=27%  Similarity=0.366  Sum_probs=209.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      .++|.+.+.||+|+||+||+|... +|+.||||++............+.+|+.+|..++|+||+++++.+...+      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            468999999999999999999865 7999999998776555555667889999999999999999988775433      


Q ss_pred             --eEEEEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          207 --ERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       207 --~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                        .+++||||+.+|+|.+++...  ....+++..+..++.|++.||.|||   .++|+||||||+||||+.++.+||+||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEec
Confidence              367999999999999998643  2456889999999999999999999   888999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      |+++.......  .......+||+.|+|||++.+..++.++|||||||+||||++|..||...........       ..
T Consensus       188 Gls~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~-------~~  258 (496)
T PTZ00283        188 GFSKMYAATVS--DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK-------TL  258 (496)
T ss_pred             ccCeecccccc--ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------Hh
Confidence            99986543211  1123346799999999999998999999999999999999999999986543221111       11


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .+.... +         ....+.++.+|+.+||+.||.+||++.+++.++|.
T Consensus       259 ~~~~~~-~---------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~  300 (496)
T PTZ00283        259 AGRYDP-L---------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC  300 (496)
T ss_pred             cCCCCC-C---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence            111100 0         11234679999999999999999999999999763

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.3e-43  Score=344.21  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=211.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +|+..+.||+|+||.||+|... +|+.||||++++... .......+..|+.++..+. |++|+++++++.+.+.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777889999999999999876 689999999876432 2334456778999998886 677888999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++||+|.+++..  ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.......
T Consensus        81 Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999999863  356899999999999999999999   8889999999999999999999999999987543221


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..       ...      
T Consensus       156 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~~------  218 (323)
T cd05615         156 V----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-------HNV------  218 (323)
T ss_pred             c----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC------
Confidence            1    12345699999999999988999999999999999999999999987654322111111       000      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAAS  425 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~  425 (443)
                      ..+     ...+.++.+|+.+||+.||.+|++     ..++++|.|.-..++......
T Consensus       219 ~~p-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~  271 (323)
T cd05615         219 SYP-----KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENR  271 (323)
T ss_pred             CCC-----ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence            000     112356899999999999999997     578999998777777665543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=343.92  Aligned_cols=278  Identities=23%  Similarity=0.295  Sum_probs=235.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHH-HHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGA-EFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +.|..-+.||+|+||.||-|+.+ +|+.||+|.+.++...+...+ -.++|-++|..++.+.||.+-.+|+..+.+++||
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45888889999999999999876 799999999876655444433 3679999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ..|+||+|..+|....+..+++..++.++.+|+.||++||   ..+||.|||||+|||||+.|+++|+|+|||..+.+..
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999998777778999999999999999999999   8889999999999999999999999999999887665


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      ..     ...+||.+|||||++.+..|+...|+|+|||+||||+.|+-||....+-..+..++........         
T Consensus       342 ~~-----~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~---------  407 (591)
T KOG0986|consen  342 PI-----RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE---------  407 (591)
T ss_pred             cc-----ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh---------
Confidence            32     2336999999999999999999999999999999999999999776554333333332221110         


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhhcccCcCCcccc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELAASDVLLQPSYS  434 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~~~~~~~~~~~~  434 (443)
                           ......++++.+|+...|+.||.+|...     .++.+|++.-.-+|+.+.+..+..|.-|+
T Consensus       408 -----ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd  469 (591)
T KOG0986|consen  408 -----EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD  469 (591)
T ss_pred             -----hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC
Confidence                 1123355789999999999999999865     59999999999999999999888766655

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3e-43  Score=346.15  Aligned_cols=254  Identities=25%  Similarity=0.343  Sum_probs=200.4

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHH-HHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIR-TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||+||+|.+. +++.||+|++.+.... ......+.+|.. +++.++|+||+++++++...+..++||||+.|+
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            6999999999999976 6889999998754321 222334445544 467789999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+.+..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........    .
T Consensus        82 ~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~----~  152 (325)
T cd05602          82 ELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----T  152 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----C
Confidence            99998863  456788888899999999999999   88899999999999999999999999999875432211    2


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+.   ....      .+.+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~~~~------~~~~------  217 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL---NKPL------QLKP------  217 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH---hCCc------CCCC------
Confidence            234579999999999999899999999999999999999999998765433211111   1000      0111      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHHhhhhhhhhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSMR----RCAEILWSVRKDYREL  422 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~----ell~~l~~i~~~~~~~  422 (443)
                         .....+.+|+.+||+.||.+||++.    ++++|+|.-..++.++
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~  262 (325)
T cd05602         218 ---NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL  262 (325)
T ss_pred             ---CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHH
Confidence               1235789999999999999999875    8888887655555444

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-43  Score=333.66  Aligned_cols=258  Identities=31%  Similarity=0.492  Sum_probs=207.3

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |+..+.||+|+||+||++... +++.||+|++..............+|+.++++++|+||+++++++.+.+..++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999987 5779999999876444444444567999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .+++|.+++.  ....+++..++.++.||+.||.+||   +++++|+||||+|||++.++.++|+|||++......    
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~----  151 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN----  151 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST----
T ss_pred             cccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc----
Confidence            9999999997  4567899999999999999999999   788999999999999999999999999998754111    


Q ss_pred             ccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          296 THVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                      ........++..|+|||++. +..++.++||||||+++|+|++|..||..........................      
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  225 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ------  225 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc------
Confidence            12234566899999999998 88899999999999999999999999987732222222211111000000000      


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                           .......+.+++.+||+.||++||++.++++|+|.
T Consensus       226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                 00012679999999999999999999999999983

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.3e-43  Score=340.77  Aligned_cols=271  Identities=21%  Similarity=0.323  Sum_probs=206.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|...++||+|+||.||+|..+ +++.||||.++.... ......+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            46888999999999999999876 688999999875432 2334567789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+ +|.+++.. .+..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus        85 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          85 YLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            9975 88888764 3456888889999999999999999   88899999999999999999999999999875433211


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc---
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI---  369 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  369 (443)
                          ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..............+   
T Consensus       160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         160 ----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             ----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence                1223458999999999865 46889999999999999999999999876543332222211111000000000   


Q ss_pred             ---cC---cccc-c--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 ---LD---PRVE-N--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ---~d---~~~~-~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         .+   +... .  .........++.+|+.+||+.||.+|||+.++++|.|.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence               00   0000 0  000112346789999999999999999999999999963

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-42  Score=348.77  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=203.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|++.+.||+|+||.||+|.+      .++..||||+++... .....+.+.+|+.+|..+ +|||||++++++.+.+.
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            4688889999999999999963      246789999987543 223446788999999999 79999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhc-----------------------------------------------------------
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ-----------------------------------------------------------  228 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------------  228 (443)
                      .++|||||+||+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986422                                                           


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          229 --------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       229 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                                    ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........ 
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  269 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-  269 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence                          124678888999999999999999   88899999999999999999999999999976543221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                       ........++..|+|||++.+..++.++|||||||++|||++ |..||..........  ....    .+...  ..+ 
T Consensus       270 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~--~~~~----~~~~~--~~~-  339 (375)
T cd05104         270 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY--KMIK----EGYRM--LSP-  339 (375)
T ss_pred             -ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH--HHHH----hCccC--CCC-
Confidence             111122345678999999998899999999999999999998 899997653322111  1111    11000  000 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                             ...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus       340 -------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         340 -------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                   0123579999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.8e-43  Score=345.84  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=206.5

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|... +++.||||++++... .......+.+|+.++..+ +|+||+.+++++...+.+++||||++||
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            6999999999999976 688999999986533 233455688999999888 5999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......    ..
T Consensus        82 ~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~  152 (327)
T cd05617          82 DLMFHMQR--QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----DT  152 (327)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----Cc
Confidence            99988863  456999999999999999999999   8889999999999999999999999999987533221    11


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....+||+.|+|||++.+..++.++|||||||+||+|++|..||.............+.........      ..++   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p---  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIP---  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCC---
Confidence            2345799999999999998999999999999999999999999964322111111111111111110      0000   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHHhhhhhhhhhhcc
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPS------MRRCAEILWSVRKDYRELAAS  425 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs------~~ell~~l~~i~~~~~~~~~~  425 (443)
                        ...+.++.+++.+||+.||.+|++      +.++++|.|.-..++......
T Consensus       224 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~  274 (327)
T cd05617         224 --RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK  274 (327)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhC
Confidence              112356889999999999999998      579999998766665554433

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5e-43  Score=350.81  Aligned_cols=264  Identities=22%  Similarity=0.284  Sum_probs=207.4

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      +....++|.+.+.||+|+||.||+|..+ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3344578999999999999999999976 689999999865322 22334557889999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +++||||++||+|.+++..   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            9999999999999998853   34788888899999999999999   88899999999999999999999999999986


Q ss_pred             ccccCCCcccccccccCCCCccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTY----QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ......   ......+||+.|+|||++.+.    .++.++|||||||++|||++|..||...........+.   ..   
T Consensus       192 ~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~~---  262 (371)
T cd05622         192 MNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---NH---  262 (371)
T ss_pred             cCcCCc---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH---cC---
Confidence            643221   112345799999999998654    37889999999999999999999998765432221111   00   


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVR  416 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~  416 (443)
                      .......+        ....+..+.+|+.+||..++.+  |+++.++++|+|.-.
T Consensus       263 ~~~~~~~~--------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         263 KNSLTFPD--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             CCcccCCC--------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            00000000        1123467889999999854443  789999999998644

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-44  Score=348.35  Aligned_cols=242  Identities=29%  Similarity=0.486  Sum_probs=203.3

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      ++-||.|+.|.||+|+++ ++.||||+++.-         -..+|+.|++|+|+||+.|.|+|.....+|||||||..|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            335999999999999997 788999987632         1258999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccc
Q 013401          220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS  299 (443)
Q Consensus       220 L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  299 (443)
                      |.+.|.  .++++......+|..+||.|+.|||   .+.|||||||.-||||..+..|||+|||-++...+-.     ..
T Consensus       199 L~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-----Tk  268 (904)
T KOG4721|consen  199 LYEVLK--AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-----TK  268 (904)
T ss_pred             HHHHHh--ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh-----hh
Confidence            999997  5677888888999999999999999   8889999999999999999999999999998765432     12


Q ss_pred             ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhh
Q 013401          300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA  379 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  379 (443)
                      ..+.||..|||||+++..+.++|+|||||||+|||||||..||.+.+.    ..+.|....       ..+     .-+.
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVGs-------NsL-----~Lpv  332 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVGS-------NSL-----HLPV  332 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEeccC-------Ccc-----cccC
Confidence            346799999999999999999999999999999999999999976543    122232111       111     1122


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          380 NNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       380 ~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ...+++-|.-|+++||+-.|.+||++++++.||.....
T Consensus       333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            33467789999999999999999999999999876543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-42  Score=330.48  Aligned_cols=254  Identities=27%  Similarity=0.452  Sum_probs=208.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+..++||+|+||.||+|...++..||+|.++..   ....+.+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            578889999999999999999888888999987653   23456789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++.......+++..++.++.|++.||.|||   .++++|+||||+||+++.++.+||+|||++....+... 
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            99999999997655667888999999999999999999   78899999999999999999999999999987643221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+.....    
T Consensus       159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~~~----  225 (261)
T cd05072         159 --TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-------RGYRMPR----  225 (261)
T ss_pred             --eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-------cCCCCCC----
Confidence              11222346778999999988889999999999999999998 999997654332211111       1100000    


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                            ....+.++.+++.+||+.+|++||++.++++.|..
T Consensus       226 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 ------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                  01133678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.4e-43  Score=348.09  Aligned_cols=270  Identities=21%  Similarity=0.274  Sum_probs=205.2

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  206 (443)
                      ..++|...+.||+|+||.||+|... +|+.||||+++...........+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999875 6899999998765544555667889999999999999999999886543     


Q ss_pred             -eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          207 -ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       207 -~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                       .+++||||+.+ +|.+.+.    ..+++..+..++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999965 5666653    24788888899999999999999   889999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHH--------
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA--------  357 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~--------  357 (443)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+...........        
T Consensus       171 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         171 RTACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             cccccCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            7543221     123456899999999999989999999999999999999999999866543221111000        


Q ss_pred             -------hhhcCCC-------ccccccCcc-cc-chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          358 -------MKKFSDG-------DAISILDPR-VE-NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       358 -------~~~~~~~-------~~~~~~d~~-~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                             ...+...       ...+..... .. ...........+.+|+.+||+.||++|||+.++++|+|..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                   0000000       000000000 00 0000112245789999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-42  Score=333.20  Aligned_cols=267  Identities=22%  Similarity=0.330  Sum_probs=215.2

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |+..+.||+|+||+||+|.+. +++.||+|.+....... .....+.+|+++|+.++|+||+.+++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566778999999999999875 78999999986643322 2334577899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++.......+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999999887555557999999999999999999999   8889999999999999999999999999987653221  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+......+.........     ...   
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~-----~~~---  225 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-----VYS---  225 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-----ccC---
Confidence               123346999999999998888999999999999999999999999876543322222211111110     000   


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcc
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAAS  425 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~  425 (443)
                            ......+.+|+..||+.||.+||+     +.+++.|.|.-..+++....-
T Consensus       226 ------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~  275 (285)
T cd05632         226 ------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAG  275 (285)
T ss_pred             ------ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcC
Confidence                  112356889999999999999999     889999999877777665433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-42  Score=348.42  Aligned_cols=259  Identities=27%  Similarity=0.402  Sum_probs=203.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|...+.||+|+||.||+|...      ++..||||+++.... ......+.+|+.+++.+ +|+|||++++++...+.
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            47888999999999999999742      345799999876432 23356688999999999 89999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhc-----------------------------------------------------------
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ-----------------------------------------------------------  228 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------------  228 (443)
                      +++|||||.+|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999985421                                                           


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccc
Q 013401          229 ---------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS  299 (443)
Q Consensus       229 ---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  299 (443)
                               ...+++..++.|+.||+.||.|||   +++|+||||||+|||+++++.+||+|||++........  ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--~~~~  271 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--YVVK  271 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--eeec
Confidence                     124677888999999999999999   88899999999999999999999999999976543221  1112


Q ss_pred             ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||............   ...   +.  ....+      
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~---~~~---~~--~~~~~------  337 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM---VKR---GY--QMSRP------  337 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH---HHc---cc--CccCC------
Confidence            22345678999999988899999999999999999997 99999765432211111   000   00  00000      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ...+.++.+++.+||+.||.+||++.++++.|..+
T Consensus       338 --~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 --DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              01236799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.1e-43  Score=347.24  Aligned_cols=270  Identities=20%  Similarity=0.265  Sum_probs=206.0

Q ss_pred             HHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----
Q 013401          132 RATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----  205 (443)
Q Consensus       132 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  205 (443)
                      ...++|...+.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999875 689999999876544445556788999999999999999999988643     


Q ss_pred             -CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          206 -DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       206 -~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                       ...++||||+.+ +|.+.+.    ..+++..+..++.|++.||.|||   .+||+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence             357999999965 6766664    24788888999999999999999   88999999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh------
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM------  358 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~------  358 (443)
                      ++......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||................      
T Consensus       166 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         166 ARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cccCCCcc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            97654321     1234568999999999999899999999999999999999999998765433221111000      


Q ss_pred             ---------hhcCCC--cc-----ccccCcc-cc-chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          359 ---------KKFSDG--DA-----ISILDPR-VE-NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       359 ---------~~~~~~--~~-----~~~~d~~-~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                               ..+.+.  ..     ....... .. ...........+.+|+.+||+.||++|||+.++++|+|.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence                     000000  00     0000000 00 000111234578999999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-42  Score=357.05  Aligned_cols=255  Identities=24%  Similarity=0.308  Sum_probs=205.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-C-CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-D-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .|...+.||+|+||.||+|... + +..||+|.+...  .......+.+|+.+|+.++|||||++++++..++.++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            4888889999999999999864 4 678888876543  23344567889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          214 YVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       214 ~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |+.||+|.+++...  ....+++..+..++.||+.||.|||   .++|+||||||+||||+.++.+||+|||++......
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999988542  3456888899999999999999999   888999999999999999999999999999876532


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       .+....   
T Consensus       223 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~-------~~~~~~---  290 (478)
T PTZ00267        223 VS--LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL-------YGKYDP---  290 (478)
T ss_pred             cc--cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCCC---
Confidence            21  112345679999999999998899999999999999999999999997654322111111       111100   


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                        .     .......+.+|+.+||+.||++||++.+++.+.|.
T Consensus       291 --~-----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~  326 (478)
T PTZ00267        291 --F-----PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL  326 (478)
T ss_pred             --C-----CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence              0     01133679999999999999999999999988653

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.1e-43  Score=356.19  Aligned_cols=267  Identities=20%  Similarity=0.277  Sum_probs=199.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-------  205 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------  205 (443)
                      .++|...+.||+|+||.||+|... +++.||||++....      ....+|+.+|+.++|+|||++++++...       
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            357999999999999999999875 68999999875431      2345799999999999999999876432       


Q ss_pred             -CeEEEEEeecCCCcHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEee
Q 013401          206 -DERIVIVEYVPNGTLREHLDC--LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVAD  281 (443)
Q Consensus       206 -~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~D  281 (443)
                       ..+++||||+.+ +|.+++..  ..+..+++..++.++.||+.||.|||   +++|+||||||+||||+.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeec
Confidence             246789999975 67776643  24567899999999999999999999   88899999999999999654 799999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ||+++......     ......||+.|+|||++.+ ..++.++|||||||+||||++|.+||.+.........+......
T Consensus       215 FGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        215 FGSAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             cccchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99998664322     1234568999999999865 46899999999999999999999999877554333222221111


Q ss_pred             cCCCc-------cccccCccccchh----hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          361 FSDGD-------AISILDPRVENTA----ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       361 ~~~~~-------~~~~~d~~~~~~~----~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .....       ...+.-+......    .....+.++.+|+.+||+.||.+||++.++++|+|.-
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence            00000       0000000000000    0111346799999999999999999999999999953

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-42  Score=330.07  Aligned_cols=256  Identities=22%  Similarity=0.374  Sum_probs=204.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++... .......+.+|+.++..++||||+++++++...+..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            46888899999999999999753    36789999987653 23334678899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+++|+|.+++... ...+++..++.++.||+.||.|||   +++++||||||+|||++.++.+||+|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999998753 356889999999999999999999   88899999999999999999999999998765422


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...   .......++..|+|||++.+..++.++|||||||++|||++ |..||...........+       .++.... 
T Consensus       160 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-------~~~~~~~-  228 (266)
T cd05064         160 EAI---YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-------EDGFRLP-  228 (266)
T ss_pred             cch---hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCCCC-
Confidence            111   11112335678999999998899999999999999999775 99999876543221111       1111000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                               ....++..+.+++.+||+.+|.+||++.+|++.+..+
T Consensus       229 ---------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         229 ---------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     0112346799999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-43  Score=345.92  Aligned_cols=273  Identities=20%  Similarity=0.297  Sum_probs=206.4

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec---
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE---  205 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~---  205 (443)
                      .....++|.....||.|+||+||+|... +++.||||+++...........+.+|+.+|+.++|+||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3445678999999999999999999875 688999999876543334456678999999999999999999987543   


Q ss_pred             ---CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          206 ---DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       206 ---~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                         ...++++|++ +++|.+++.   ...+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence               3568999988 788988774   346899999999999999999999   888999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh---
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM---  358 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~---  358 (443)
                      |++......       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....   
T Consensus       163 g~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07878         163 GLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP  235 (343)
T ss_pred             ccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999765432       234568999999999876 568899999999999999999999997654332211111100   


Q ss_pred             -----hhcCCCccccccC--ccccch---hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          359 -----KKFSDGDAISILD--PRVENT---AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       359 -----~~~~~~~~~~~~d--~~~~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                           ..+........+.  +.....   .......+.+.+|+.+||+.||.+|||+.++++|.|...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                 0000000000000  000000   000012345789999999999999999999999999765

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.6e-42  Score=335.87  Aligned_cols=275  Identities=24%  Similarity=0.350  Sum_probs=210.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.++||+|+||.||++.+. ++..||+|.++... ......++.+|++++++++||||+++++++.+++.+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            36888999999999999999876 68899999887542 23345668899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |++|++|.+++..  ...+++..+..++.||+.||.|||.  .++++|+||||+|||++.++.+||+|||++....... 
T Consensus        80 y~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          80 HMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999999974  3568899999999999999999993  2589999999999999999999999999987654321 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc------
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI------  367 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------  367 (443)
                           .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+.....................      
T Consensus       155 -----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 -----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             -----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence                 234568999999999988889999999999999999999999997554222111111000000000000      


Q ss_pred             -----------cccCccc---cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          368 -----------SILDPRV---ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       368 -----------~~~d~~~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                                 ...+...   ...........++.+|+.+||..||++||++.++++++|..+.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                       0000000   0000001134579999999999999999999999999998664433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-42  Score=327.46  Aligned_cols=251  Identities=28%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|...+.||+|+||.||++.++++..+|+|.++..   ......+.+|+.+|+.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            357788899999999999999888888999987654   23346788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++|+|.+++.... ..+++..++.++.|++.||.|||   .++++|+||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            99999999986533 35888999999999999999999   88899999999999999999999999999876543221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+.       .+...  ..+.
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~-------~~~~~--~~~~  224 (256)
T cd05114         156 --TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-------RGFRL--YRPK  224 (256)
T ss_pred             --eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCCC--CCCC
Confidence              11122345678999999988889999999999999999999 999997765433222111       11100  0111


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                              .....+.+|+.+||+.||++||++.++++.|
T Consensus       225 --------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 --------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                    1235689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=340.46  Aligned_cols=268  Identities=21%  Similarity=0.290  Sum_probs=208.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||.||++... +++.||||++.+.. ........+.+|+.++..++|+||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36888999999999999999976 68999999986532 22334556889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++.. .+..+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            99999999999964 2456889999999999999999999   8889999999999999999999999999987654322


Q ss_pred             CCcccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      .   .......||+.|+|||++..     ..++.++|||||||++|+|++|..||...........+.   ..   ....
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~---~~---~~~~  227 (331)
T cd05597         157 T---VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NH---KEHF  227 (331)
T ss_pred             C---ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH---cC---CCcc
Confidence            1   11223469999999999863     457889999999999999999999997654322211111   00   0000


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhhhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~~~~~~~  422 (443)
                      .+ .+      .....++.+.+|+.+||+.++.+  |+++.++++|.|.-.-++...
T Consensus       228 ~~-~~------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~  277 (331)
T cd05597         228 QF-PP------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI  277 (331)
T ss_pred             cC-CC------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence            00 00      01113467889999988665544  889999999999755554443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-42  Score=331.47  Aligned_cols=257  Identities=27%  Similarity=0.430  Sum_probs=206.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      .+|+..+.||+|+||.||+|....      ...||+|.++... .......+.+|+.++..++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            368888899999999999998642      2579999887542 233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013401          209 IVIVEYVPNGTLREHLDCLQG--------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~  274 (443)
                      +++|||+++++|.+++.....              ..+++..++.++.||+.||.|||   .++++|+||||+|||++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence            999999999999999964321              45788889999999999999999   8889999999999999999


Q ss_pred             CceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 013401          275 FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERIT  353 (443)
Q Consensus       275 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~  353 (443)
                      +.+||+|||++........  ........+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus       161 ~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         161 LTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CcEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999876543221  112233457889999999988889999999999999999998 9999976544221111


Q ss_pred             HHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                             +..+.....          ...++.++.+|+.+||+.||.+||++.+|+++|..
T Consensus       239 -------i~~~~~~~~----------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 -------IRSRQLLPC----------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -------HHcCCcCCC----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                   111111110          11245789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.8e-42  Score=330.76  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||+|+||.||+|.+. +++.||||.+.... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            5778889999999999999865 78999999986542 233446788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|..+.      .+++..+..++.|++.||.|||   +++|+|+||||+|||++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9999986542      3678888899999999999999   8889999999999999999999999999997654321  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                          .....||..|+|||++.+..++.++|||||||++|+|++|..||.......................     .+.+
T Consensus       150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  220 (279)
T cd06619         150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL  220 (279)
T ss_pred             ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC
Confidence                2335699999999999988899999999999999999999999975432111110000000000000     0111


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .    ......++.+++.+||+.||++||+++++++++|....+.
T Consensus       221 ~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         221 P----VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             C----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            0    1112356899999999999999999999999999765533

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-42  Score=326.59  Aligned_cols=254  Identities=28%  Similarity=0.429  Sum_probs=207.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+..+.||+|+||.||+|.+.+++.||||.++...   ....++.+|+.+++.++|+||+++++++...+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            4688889999999999999998778889999987542   3356788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++....+..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++.........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            99999999997655567899999999999999999999   888999999999999999999999999999876532211


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                         ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.   ....    ..     
T Consensus       160 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~----~~-----  224 (261)
T cd05068         160 ---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD---QGYR----MP-----  224 (261)
T ss_pred             ---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCC----CC-----
Confidence               1111223457999999998899999999999999999999 999997654332221111   0000    00     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                           .....+..+.+++.+||+.||++||++.++++.|..
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 -----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                 001234679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-43  Score=346.01  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=200.1

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc---CCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV---EHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ||+|+||+||+|... +++.||||++.+... .......+..|..++..+   +||||+++++++.+.+..++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999976 689999999865422 222334455677777655   699999999999999999999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      |+|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........    
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~----  151 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK----  151 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC----
Confidence            999998863  456899999999999999999999   88899999999999999999999999999875432211    


Q ss_pred             ccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.       .+..      .+..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~-------~~~~------~~~~  218 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA-------FGKV------RFPK  218 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH-------cCCC------CCCC
Confidence            12345799999999998654 48899999999999999999999997764322211111       1100      0000


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHHHHhhhhhhhhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRP----SMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RP----s~~ell~~l~~i~~~~~~~  422 (443)
                          ....+.+.+|+.+||+.||.+||    ++.++++|.|....++...
T Consensus       219 ----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~  264 (330)
T cd05586         219 ----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLL  264 (330)
T ss_pred             ----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHH
Confidence                01236788999999999999998    7999999999766555444

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=326.21  Aligned_cols=272  Identities=24%  Similarity=0.304  Sum_probs=224.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|..++.||+|.||+|-+|+-+ +++.||+|++++... .+.....-..|-++|+..+||.+..+...|...+++|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            57888889999999999999866 799999999988764 3444455568899999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||.+||.|+.+|.  ..+.+++.....+-..|+.||.|||   +++||.||||.+|+|+|.+|++||+||||++.-....
T Consensus       248 eyanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  248 EYANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            9999999999997  4567888888888999999999999   8889999999999999999999999999997543222


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                          .....+||||.|+|||++....|+..+|+|.+||++|||++|+.||...+.......+-  +..+.          
T Consensus       323 ----~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~k----------  386 (516)
T KOG0690|consen  323 ----DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDLK----------  386 (516)
T ss_pred             ----ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhcc----------
Confidence                23567899999999999999999999999999999999999999998776533221111  11110          


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCCccc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQPSY  433 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~~~~  433 (443)
                       .+     ....++...|+...|.+||.+|.     ++.||.+|.+...-+|.+.--.....+.-|
T Consensus       387 -FP-----r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKP  446 (516)
T KOG0690|consen  387 -FP-----RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKP  446 (516)
T ss_pred             -CC-----ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCC
Confidence             00     11236788999999999999997     578999999988888888766655544433

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-42  Score=346.05  Aligned_cols=269  Identities=21%  Similarity=0.274  Sum_probs=205.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------  205 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------  205 (443)
                      ..++|...+.||+|+||.||+|.+. .++.||||++............+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3468999999999999999999876 688999999876554455567788999999999999999999987543      


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      ..+++||||+.+ +|.+++.    ..+++..+..++.|++.||.|||   .++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999964 6777664    24788888999999999999999   889999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh-----
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK-----  360 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-----  360 (443)
                      +......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+......     
T Consensus       174 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         174 RTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             cccCCCC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            7654321     123456899999999999989999999999999999999999999876543322221110000     


Q ss_pred             ---c-------CCC----c--cccccCcccc---chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          361 ---F-------SDG----D--AISILDPRVE---NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       361 ---~-------~~~----~--~~~~~d~~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                         +       ...    .  ..+.+.+...   ...........+.+|+.+||+.||.+|||+.++++|+|.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence               0       000    0  0000000000   000011123578999999999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-42  Score=345.69  Aligned_cols=272  Identities=19%  Similarity=0.226  Sum_probs=206.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .+|.+...||+|+||.||+|...   .+..||||.+...       ..+.+|+.+|+.++|||||++++++......++|
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            47999999999999999999754   3678999987643       2346899999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ||++. ++|.+++.  ....+++..++.|+.||+.||.|||   .+|||||||||+||||+.++.+||+|||++......
T Consensus       165 ~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            99995 68888884  4467899999999999999999999   888999999999999999999999999999765443


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC-------CC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS-------DG  364 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------~~  364 (443)
                      ..  ........||+.|+|||++.+..++.++|||||||+||||++|..||.+................+.       ..
T Consensus       239 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        239 PD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cc--cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            21  1112345799999999999988999999999999999999999999976542111111111111000       00


Q ss_pred             cc----------ccccCccccch--hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          365 DA----------ISILDPRVENT--AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       365 ~~----------~~~~d~~~~~~--~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ..          .....+.....  ........++.+|+.+||..||++||++.+++.|+|......+.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence            00          00000000000  00011235688999999999999999999999999986555443

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-42  Score=331.39  Aligned_cols=270  Identities=24%  Similarity=0.331  Sum_probs=206.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...+.||+|+||.||+|... ++..||||+++...........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778889999999999999976 699999999876544444556788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      +. ++|.+++.... +..+++..++.++.||+.||.|||   .++++|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 68888886533 367899999999999999999999   8889999999999999999999999999987553321 


Q ss_pred             CcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc-------
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD-------  365 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-------  365 (443)
                         .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||....+..................       
T Consensus       156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 ---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             ---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence               112234578999999988653 578899999999999999999999987654433222111110000000       


Q ss_pred             --cccccCccc--cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          366 --AISILDPRV--ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       366 --~~~~~d~~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        .........  .........++++.+|+.+||+.||.+|||+.+|++|.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence              000000000  000001123467889999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.4e-42  Score=327.20  Aligned_cols=254  Identities=28%  Similarity=0.398  Sum_probs=206.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...++||+|+||.||+|.++ +++.||+|+++..   .....++.+|+.+++.++|+||+++++++..++..++||||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            5777889999999999999876 5889999998754   33456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++.......+++..++.++.|++.+|.|||   .++++||||||+|||+++++.+||+|||++........ 
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-  159 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  159 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence            99999999997655567899999999999999999999   88899999999999999999999999999977654321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++|||||||++|||++ |..||.............       .+....     
T Consensus       160 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~-----  225 (263)
T cd05052         160 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KGYRME-----  225 (263)
T ss_pred             --eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCCCC-----
Confidence              11112234678999999998899999999999999999998 999997654322111111       100000     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .     ....+..+.+++.+||+.||++||++.++++.|..+
T Consensus       226 ~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 R-----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             C-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            0     011346799999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-42  Score=334.68  Aligned_cols=279  Identities=21%  Similarity=0.282  Sum_probs=222.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||+||+|... +++.||||.+....... .....+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888889999999999999976 59999999987653322 34567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.|++|.+++....+..+++..++.++.||+.+|.|||   ..+++|+||||+|||++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987655567999999999999999999999   7889999999999999999999999999987553221


Q ss_pred             CCcc-------------------------cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchh
Q 013401          293 SGAT-------------------------HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE  347 (443)
Q Consensus       293 ~~~~-------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~  347 (443)
                      ....                         .......||..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            1100                         011234689999999999988899999999999999999999999976654


Q ss_pred             HHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHHHHhhhhhhhhhh
Q 013401          348 LKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS----MRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs----~~ell~~l~~i~~~~~~~~  423 (443)
                      ......+.       ....      ...   .....++.+.+++.+||+.||++||+    +.+++.|.|.-..+|....
T Consensus       238 ~~~~~~~~-------~~~~------~~~---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~  301 (316)
T cd05574         238 DETFSNIL-------KKEV------TFP---GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR  301 (316)
T ss_pred             HHHHHHHh-------cCCc------cCC---CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence            33221111       0000      000   00114578999999999999999999    9999999998777776665


Q ss_pred             cccCcCCcc
Q 013401          424 ASDVLLQPS  432 (443)
Q Consensus       424 ~~~~~~~~~  432 (443)
                      ....+..|.
T Consensus       302 ~~~~~~~~~  310 (316)
T cd05574         302 HTTPPIIPR  310 (316)
T ss_pred             cCCCCCCCC
Confidence            544443333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.3e-42  Score=337.56  Aligned_cols=275  Identities=19%  Similarity=0.228  Sum_probs=205.4

Q ss_pred             CCceeeee--CceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          139 PSFKIGQG--GFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       139 ~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      .+.+||+|  +||+||++..+ +|+.||||+++...........+.+|+.+++.++|||||++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34579999  78999999875 7999999998766444445566788999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      ++|+|.+++.......+++..++.++.|++.||.|||   +++|+||||||+|||++.++.++++|||............
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999997555556899999999999999999999   8889999999999999999999999998765433221111


Q ss_pred             c---cccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH-HhhhcCC------
Q 013401          296 T---HVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW-AMKKFSD------  363 (443)
Q Consensus       296 ~---~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~------  363 (443)
                      .   .......++..|+|||++.+  ..++.++|||||||++|||++|..||.............. ......+      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence            0   01122357788999999975  4688999999999999999999999976443221111100 0000000      


Q ss_pred             Ccc-----ccccC----------------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          364 GDA-----ISILD----------------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       364 ~~~-----~~~~d----------------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...     ....+                ...............+.+|+.+||+.||++|||+.++++|+|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence            000     00000                000000112234567999999999999999999999999999644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.7e-42  Score=340.29  Aligned_cols=268  Identities=21%  Similarity=0.275  Sum_probs=209.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+++.. +++.||||++.+.. ........+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999976 68899999986532 22333455788999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++... ...+++..+..++.|++.||.|||   .++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999753 356888899999999999999999   8889999999999999999999999999997654332


Q ss_pred             CCcccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      .   .......||+.|+|||++.+     ..++.++|||||||+||+|++|..||...........+..   .   ....
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~---~---~~~~  227 (331)
T cd05624         157 T---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN---H---EERF  227 (331)
T ss_pred             c---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc---C---CCcc
Confidence            1   11223569999999999865     4678899999999999999999999986654322111110   0   0000


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhhhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~~~~~~~  422 (443)
                      . +..      .....++.+.+|+.+||..++++  |++++++++|.|.-..++...
T Consensus       228 ~-~p~------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         228 Q-FPS------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             c-CCC------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence            0 000      01123467899999999876655  579999999998765555544

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=323.25  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=207.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc---ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK---HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|...+.||+|+||.||+|... +++.||+|.++......   .....+.+|+.++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999875 68999999886543221   233568899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |+||+++++|.+++..  ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999999874  356888889999999999999999   88899999999999999999999999999876543


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      .... ........|+..|+|||++.+..++.++|||||||++|+|++|..||.............   .....   ..  
T Consensus       157 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~---~~--  227 (263)
T cd06625         157 ICSS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN---PQ--  227 (263)
T ss_pred             cccc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh---ccCCC---CC--
Confidence            2111 111133568899999999998889999999999999999999999997654332211111   00000   00  


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                         +     .......+.+++.+||..+|.+||++.++++++|
T Consensus       228 ---~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         228 ---L-----PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             ---C-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence               0     1123467899999999999999999999999988

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=320.53  Aligned_cols=271  Identities=21%  Similarity=0.338  Sum_probs=216.8

Q ss_pred             CHHHHHHHhcCCCCCceeeeeCceEEEEEE-EcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeeeee
Q 013401          126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLE  203 (443)
Q Consensus       126 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~  203 (443)
                      +++|+|+.+..     .||+|+|+.|--|. +.+|..||||++.+.  ..+...++.||++++.+++ |+||++++++|+
T Consensus        74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            58899998875     59999999999997 568999999999875  5778889999999999996 999999999999


Q ss_pred             ecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CceEEe
Q 013401          204 FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN---FRAKVA  280 (443)
Q Consensus       204 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~vkl~  280 (443)
                      +++..|+|||.|.||.|..+|.  +...+++.++..++.+|+.||.|||   .+||.||||||+|||....   ..||||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ccceEEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeee
Confidence            9999999999999999999997  4567999999999999999999999   9999999999999999654   459999


Q ss_pred             eecccccccccCCC---cccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchh-----
Q 013401          281 DFGFARLAADTESG---ATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE-----  347 (443)
Q Consensus       281 DFGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~-----  347 (443)
                      ||.|..-.......   .+......+|+..|||||+..     ...|+.+.|.||||||||.||+|++||.+.-.     
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            99997654322211   111233568999999999873     34689999999999999999999999965421     


Q ss_pred             ---HHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          348 ---LKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       348 ---~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         ..-+.........+.+|.. ++-|.      .....+.+..+|+...|..|+.+|.++..++.|+|.-
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkY-eFPdk------dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKY-EFPDK------DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCC-cCChh------hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence               1112222223333333321 11111      1234667889999999999999999999999999953

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.3e-42  Score=338.97  Aligned_cols=269  Identities=21%  Similarity=0.281  Sum_probs=209.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.++||+|+||.||++..+ +++.||+|++.+.. ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999976 58899999986532 22333445788999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+|+|.+++... ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999999999753 356888899999999999999999   8889999999999999999999999999987654322


Q ss_pred             CCcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      .   ......+||+.|+|||++.     ...++.++|||||||++|||++|..||...........+.   .....   .
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~---~~~~~---~  227 (332)
T cd05623         157 T---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---NHKER---F  227 (332)
T ss_pred             c---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh---CCCcc---c
Confidence            1   1123356999999999986     3467889999999999999999999998765433222111   00000   0


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhhhhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~~~~~~~~  423 (443)
                             .........+..+.+|+.+||..++.+  |+++.++++|.|.-..++..+.
T Consensus       228 -------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~  278 (332)
T cd05623         228 -------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIR  278 (332)
T ss_pred             -------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHh
Confidence                   000001123467889999988665554  7899999999997766666554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.2e-42  Score=326.86  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=204.8

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec-----
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE-----  205 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-----  205 (443)
                      .+..|+..+.||+|+||.||+|... +++.||+|++...   ......+.+|+.++..+ +|+||+++++++...     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            3456778889999999999999876 6899999998654   23446788999999998 699999999998753     


Q ss_pred             -CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          206 -DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       206 -~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                       ...++||||+.+++|.+++.......+++..++.++.|++.||.|||   +++|+|+||||+||++++++.+||+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence             46899999999999999998655667899999999999999999999   88899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      +........    ......|++.|+|||++.     +..++.++|||||||++|||++|..||.............    
T Consensus       158 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~----  229 (272)
T cd06637         158 SAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP----  229 (272)
T ss_pred             ceecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh----
Confidence            876543211    123456899999999985     3357889999999999999999999997654432222111    


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .   .......+         ...+..+.+|+.+||+.||.+||++.++++|.|.
T Consensus       230 ~---~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         230 R---NPAPRLKS---------KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             c---CCCCCCCC---------CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            0   00000111         1133578999999999999999999999999883

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-41  Score=327.76  Aligned_cols=270  Identities=27%  Similarity=0.329  Sum_probs=208.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+....||+|+||.||+|.++ +|+.||+|++............+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999986 68999999987553333444567899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |++++.|..++.  ....+++..++.++.||+.+|.|||   .++++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999988877765  3346899999999999999999999   78899999999999999999999999999987654321


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC--------C
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD--------G  364 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~  364 (443)
                          ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.........        .
T Consensus       156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         156 ----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             ----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence                1223458889999999865 45788999999999999999999999876554332222111111000        0


Q ss_pred             cc-ccccCcccc----chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          365 DA-ISILDPRVE----NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       365 ~~-~~~~d~~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .. .....+...    ........+..+.+|+.+||++||++||++.+++.|.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence            00 000000000    00001123467899999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-41  Score=322.62  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=207.9

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-cCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-EDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~E  213 (443)
                      .|++.+.||.|+||.||++..+ +++.||||.+............+.+|+.+++.++|+|++++++.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788889999999999999976 68899999987654444556678899999999999999999998764 446789999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++.......+++..++.++.+++.+|.+||   +++++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999997655667899999999999999999999   88899999999999999999999999999976643221


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|++.|+|||++.+..++.++|||||||++++|++|..||...+.........       .+....     
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~-----  221 (257)
T cd08223         158 ----MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-------EGKLPP-----  221 (257)
T ss_pred             ----ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------hcCCCC-----
Confidence                2234568999999999998889999999999999999999999997654322111110       111000     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +     ....+..+.+|+.+||+.||++||++.++++|+|
T Consensus       222 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         222 M-----PKDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             C-----ccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            0     1123467999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-43  Score=329.31  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=205.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----eEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----ERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  209 (443)
                      .|...+.+|.|+||.||+|... ++..||||++.....-.      -+|+++|+.+.|||||++..+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            5777789999999999999976 57999999875542211      27999999999999999988875422     346


Q ss_pred             EEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CceEEeeecccc
Q 013401          210 VIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGFAR  286 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~  286 (443)
                      +|||||+ .+|.+.++..  .+..++...++-+..||.+||.|||   .+||+||||||+|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            8999996 5888888642  3566888888889999999999999   8899999999999999955 999999999999


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .+...+..     ..+.-|..|+|||.+.| ..|+.+.||||.||++.||+-|++-|.+....+....+........+.+
T Consensus       175 ~L~~~epn-----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  175 VLVKGEPN-----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED  249 (364)
T ss_pred             eeccCCCc-----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            88776543     34557889999999865 5799999999999999999999999999876665554443333322221


Q ss_pred             cc-------cccCccccchh----hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          366 AI-------SILDPRVENTA----ANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       366 ~~-------~~~d~~~~~~~----~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +.       +.-.+.+....    .......+.++|+.++|..+|.+|.++.+++.|.+
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f  308 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF  308 (364)
T ss_pred             HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence            11       11112222222    23345578999999999999999999999999976

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.5e-42  Score=333.26  Aligned_cols=270  Identities=22%  Similarity=0.316  Sum_probs=206.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|...++||.|+||.||+|..+ ++..||+|.++.... ......+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            56888999999999999999876 688999999875432 2334567789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+. ++|.+++... ...+++..+..++.||+.||.|||   +++|+|+||||+|||++.++.+||+|||++........
T Consensus        85 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          85 YLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             ccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            996 5898888653 446888899999999999999999   88899999999999999999999999999875433211


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC-
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD-  371 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-  371 (443)
                          ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..............++. 
T Consensus       160 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 ----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             ----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence                1223457899999999865 4578899999999999999999999987654332222211111111110000000 


Q ss_pred             --------ccccch---hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          372 --------PRVENT---AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       372 --------~~~~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                              +.....   ......+..+.+|+.+||+.||.+|||+.++++|.|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                    000000   0011234578999999999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-42  Score=324.07  Aligned_cols=250  Identities=29%  Similarity=0.435  Sum_probs=202.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      +|.+.+.||+|+||.||+|.++++..+|||.+....   .....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            577888999999999999998877789999986542   23456888999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      +|++|.+++.... ..+++..++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++...+...  
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~--  155 (256)
T cd05059          82 ANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--  155 (256)
T ss_pred             CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence            9999999997533 46889999999999999999999   88899999999999999999999999999876543221  


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                       .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+.     ....
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~-----~~~~  222 (256)
T cd05059         156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-------AGY-----RLYR  222 (256)
T ss_pred             -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-------cCC-----cCCC
Confidence             11111224557999999998899999999999999999999 899997654432211111       000     0000


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                           ...++.++.+++.+||+.+|++||++.++++.+
T Consensus       223 -----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 -----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 011346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-41  Score=342.64  Aligned_cols=261  Identities=24%  Similarity=0.346  Sum_probs=205.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  207 (443)
                      ++|.+.+.||+|+||.||+|.+.      .+..||||+++... .....+.+.+|+.+|.++. |||||++++++.+.+.
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            57888899999999999999853      23579999987542 2334567899999999996 9999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhc-----------------------------------------------------------
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ-----------------------------------------------------------  228 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~-----------------------------------------------------------  228 (443)
                      .++|||||++|+|.++|....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886421                                                           


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          229 -----------------------------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       229 -----------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                                                         ...+++..++.++.||+.||.|||   .++|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                               124677788899999999999999   888999999999999999


Q ss_pred             CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 013401          274 NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERI  352 (443)
Q Consensus       274 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~  352 (443)
                      ++.+||+|||+++........  .......+++.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999765432211  11223457788999999988889999999999999999997 999997643221111


Q ss_pred             HHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          353 TVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .      ....+....          .....+..+.+|+.+||+.||++||++.+|.+.|..+.+
T Consensus       351 ~------~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 N------KIKSGYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             H------HHhcCCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1      011110000          011234679999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.9e-41  Score=323.14  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||.||+|... +++.||||.++... ........+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999975 78999999876432 23344456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||+.+++|.+++...  ....+++..++.++.||+.||.|||   +++++|+||||+|||++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999888543  2345788899999999999999999   88999999999999999999999999999876643


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...    ......|++.|+|||++.+..++.++||||||+++|+|++|..||.........  ...   .+.......  
T Consensus       159 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--~~~---~~~~~~~~~--  227 (267)
T cd08228         159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--LCQ---KIEQCDYPP--  227 (267)
T ss_pred             hhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--HHH---HHhcCCCCC--
Confidence            221    122346889999999998888999999999999999999999998654321111  111   111111000  


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                         .    ........+.+++.+||+.+|++||++.+|++.+..++
T Consensus       228 ---~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 ---L----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---C----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               0    01123467999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.3e-42  Score=325.80  Aligned_cols=254  Identities=30%  Similarity=0.481  Sum_probs=209.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .+|...++||.|+||.||+|...++..+|+|.++...  ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            4688888999999999999998889999999987642  23456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++....+..+++..++.++.||+.||.|||   +++++|+||||+|||++.++.+||+|||++........ 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            99999999997656677899999999999999999999   88899999999999999999999999999976643221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                         ......++..|++||++....++.++|||||||++|+|++ |..||...........+   .....    ..     
T Consensus       160 ---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~~~~----~~-----  224 (261)
T cd05148         160 ---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---TAGYR----MP-----  224 (261)
T ss_pred             ---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---HhCCc----CC-----
Confidence               1123346778999999988889999999999999999998 89999765532221111   11110    00     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                           ....+++.+.+++.+||+.||.+||++.++++.|..
T Consensus       225 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 -----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                 011234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.3e-42  Score=330.05  Aligned_cols=270  Identities=22%  Similarity=0.317  Sum_probs=204.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||+|+||.||+|... +|+.||+|+++...........+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778889999999999999976 699999999876544444445678899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +. ++|.+++.. ....+++..++.++.||+.||.|||   .++++||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          81 CD-QDLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            96 578887754 2456899999999999999999999   88899999999999999999999999999876543211 


Q ss_pred             cccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHH-h-----------hhc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA-M-----------KKF  361 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~-~-----------~~~  361 (443)
                         ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.......+....... .           ...
T Consensus       155 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         155 ---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             ---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence               12234578999999998664 4789999999999999999998886443332222111100 0           000


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .......................+++.+|+.+||+.||.+|||+.++++|+|.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00000000000000001112245678999999999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=328.87  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=213.2

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |.++.+||+|+||.||++.++ .|+.+|||.+..    +.+.+++..||.+++++..|+||++||.|.....+|||||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            444558999999999999977 699999998875    456788999999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      ..|++.+.++. .++++.+.++..|+...+.||+|||   ...-||||||..|||++-+|.+||+|||.+..+.+...  
T Consensus       111 GAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  111 GAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             CCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            99999998875 5688999999999999999999999   66689999999999999999999999999988765432  


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                        ....++|||.|||||++....|+.++||||||++..||..|++||.+..+...       +..+... .    .|   
T Consensus       185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMIPT~-P----PP---  247 (502)
T KOG0574|consen  185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMIPTK-P----PP---  247 (502)
T ss_pred             --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEeccCC-C----CC---
Confidence              34567899999999999999999999999999999999999999987655321       1111110 0    01   


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ..--..+.+.++.+++.+||-+.|++|-|+.++++|.+.
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi  286 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFI  286 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence            111133567889999999999999999999999999874

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.1e-42  Score=325.80  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=203.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|++.++||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            47999999999999999999975 78999999986542  2334567899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++..  ...+++..+..++.|++.||.|||   ..+|+||||||+||+++.++.+||+|||++........
T Consensus        87 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          87 YCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999999998863  356899999999999999999999   88899999999999999999999999999976543211


Q ss_pred             CcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                          ......|++.|+|||.+.   ...++.++|||||||++|||++|..||...........       .....   ..
T Consensus       162 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~---~~  227 (267)
T cd06646         162 ----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSN---FQ  227 (267)
T ss_pred             ----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCC---CC
Confidence                112346889999999984   34578899999999999999999999865433221110       00000   00


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .+...   .....+..+.+|+.+||+.||++||++.++++++|
T Consensus       228 ~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         228 PPKLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CCCCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            01110   01123467999999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7.9e-42  Score=327.98  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=205.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|.+.+.||+|+||.||+|...      ++..||||.++.... ......+.+|+++|+.++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            45777889999999999999863      357899999876422 23456889999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013401          209 IVIVEYVPNGTLREHLDCLQ------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR  276 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~  276 (443)
                      ++||||+++++|.+++....            ...+++..+..++.|++.+|.|||   .++++||||||+|||++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999996432            234788888999999999999999   888999999999999999999


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVK  355 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~  355 (443)
                      +||+|||++........  ........+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus       161 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             EEECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999876533211  111223346788999999999899999999999999999998 999997654432211111


Q ss_pred             HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          356 WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                             .+.....          ....+..+.+|+.+||+.||++||++.++++.|.
T Consensus       239 -------~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 -------QGRLLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -------cCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                   1111000          0113467999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.8e-42  Score=323.75  Aligned_cols=251  Identities=29%  Similarity=0.450  Sum_probs=203.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|.+...||+|+||+||+|...++..+|||.++...   .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            3577888999999999999988777779999987542   2346789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++... ...+++..++.++.||+.||.|||   +++++|+||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          81 MSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            9999999998753 336899999999999999999999   88899999999999999999999999999876544321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|++||++.+..++.++|||||||++|+|++ |..||...........+       ..+.....  + 
T Consensus       156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~~~~--~-  223 (256)
T cd05113         156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-------SQGLRLYR--P-  223 (256)
T ss_pred             --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------hcCCCCCC--C-
Confidence              11122335678999999988889999999999999999998 99999765432211111       11110000  0 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                             ......+.+++.+||+.||.+||++.++++.+
T Consensus       224 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         224 -------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             -------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                   01236799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-41  Score=321.45  Aligned_cols=254  Identities=24%  Similarity=0.405  Sum_probs=211.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||.|+||.||.+... +++.+++|.+...........++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5788899999999999999865 689999999876555555667788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++.......+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999997654567899999999999999999999   88899999999999999999999999999976644321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.       .+.....     
T Consensus       157 ---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~~-----  221 (256)
T cd08221         157 ---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------QGNYTPV-----  221 (256)
T ss_pred             ---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCCCCC-----
Confidence               2234568999999999988888999999999999999999999997654322211111       1111110     


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                           ....+.++.+++.+||+.+|++||++.++++++|
T Consensus       222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence                 0123467999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.6e-42  Score=334.03  Aligned_cols=262  Identities=23%  Similarity=0.390  Sum_probs=206.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc----EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|+..+.||+|+||.||+|.+. ++.    .||||.++... ......++.+|+.+++.++||||+++++++... ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            46899999999999999999864 344    38999886532 233456788999999999999999999998764 578


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|+||+.+|+|.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          85 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999999753 345888889999999999999999   8889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ......  ......++..|+|||++.+..++.++|||||||++|||++ |..||...........       ...+....
T Consensus       161 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~~~~  231 (316)
T cd05108         161 ADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGERLP  231 (316)
T ss_pred             CCCcce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhCCCCCC
Confidence            432211  1122335678999999998899999999999999999998 9999976543221110       11111000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      .  +        ..+...+.+++.+||..||.+||++.+++.++..+.++...
T Consensus       232 ~--~--------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~  274 (316)
T cd05108         232 Q--P--------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  274 (316)
T ss_pred             C--C--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCch
Confidence            0  0        11235688999999999999999999999999988766543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.3e-43  Score=358.95  Aligned_cols=258  Identities=27%  Similarity=0.457  Sum_probs=213.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      +....++||+|.||+||+|+..      +...||||.+|... +.....+|+||+.+|..|+|||||+|+|+|.+++.++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            4555668999999999999742      45789999998753 3336789999999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhc--------CCC----CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          210 VIVEYVPNGTLREHLDCLQ--------GNI----LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~--------~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                      +|+|||..|+|.+||....        +..    +...+.+.||.|||.|+.||-   ++.+|||||-..|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            9999999999999997532        223    788899999999999999999   7779999999999999999999


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKW  356 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~  356 (443)
                      ||+||||++.+...+.  ......-.-..+||+||.+....|++++|||||||+|||+++ |..|+.+....+       
T Consensus       643 KIsDfGLsRdiYssDY--Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------  713 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDY--YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------  713 (774)
T ss_pred             Eecccccchhhhhhhh--hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence            9999999987665432  222222334678999999999999999999999999999999 999998765433       


Q ss_pred             HhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       357 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .+..+.++.+.+.          ...++.++++||..||+.+|.+||++.||...|...-
T Consensus       714 VIe~i~~g~lL~~----------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  714 VIECIRAGQLLSC----------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHHHcCCcccC----------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            2233344444322          2236688999999999999999999999999987653

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=322.93  Aligned_cols=257  Identities=27%  Similarity=0.443  Sum_probs=206.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|+..+.||+|+||+||+|.+.    +...||||.++... ......++.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            46888999999999999999874    24579999887543 33445678899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.+++|.+++... ...+++..++.++.|++.||.|||   +++|+|+||||+|||++.++.++|+|||++.....
T Consensus        83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999999753 346889999999999999999999   88899999999999999999999999999987752


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...  ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+       ..+.... 
T Consensus       159 ~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~-------~~~~~~~-  228 (266)
T cd05033         159 SEA--TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV-------EDGYRLP-  228 (266)
T ss_pred             ccc--ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-------HcCCCCC-
Confidence            211  111122345678999999988889999999999999999998 99999765432211111       1110000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         .      ...+++.+.+|+.+||+.+|++||++.+|+++|..+
T Consensus       229 ---~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 ---P------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---C------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0      011346789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-41  Score=333.27  Aligned_cols=265  Identities=22%  Similarity=0.308  Sum_probs=190.6

Q ss_pred             CceeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEEEEEee
Q 013401          140 SFKIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERIVIVEY  214 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~  214 (443)
                      ..+||+|+||+||+|..+   +++.||+|.++...    ....+.+|+.+|+.++||||+++++++..  ...+++||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            357999999999999864   46889999986532    23457789999999999999999998854  4568899999


Q ss_pred             cCCCcHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCceEEeeec
Q 013401          215 VPNGTLREHLDCLQ-------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL----TENFRAKVADFG  283 (443)
Q Consensus       215 ~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFG  283 (443)
                      +. ++|.+++....       ...+++..+..++.||+.||.|||   +++|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            85 58888775321       235888889999999999999999   8889999999999999    456789999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH--------HHH-H
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK--------ERI-T  353 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~--------~~~-~  353 (443)
                      +++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....+..        ... .
T Consensus       158 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         158 FARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             ceeccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99876433211 112234578999999999876 458899999999999999999999996443210        000 0


Q ss_pred             H----------HHHhh-hcCCC-ccccccCcc------ccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          354 V----------KWAMK-KFSDG-DAISILDPR------VEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       354 ~----------~~~~~-~~~~~-~~~~~~d~~------~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +          .|... ..... .....+...      +..  ..........+.+|+.+||+.||.+|||++++++|+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            0          00000 00000 000000000      000  0000011245889999999999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-41  Score=322.61  Aligned_cols=263  Identities=27%  Similarity=0.384  Sum_probs=212.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.+.||.|+||+||+|... ++..+|+|++....... ....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            46888999999999999999865 68899999987543333 56778999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          214 YVPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ++.+++|.+++..... ..+++..+..++.|++.||.|||   +++++|+||||+||++++++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999975332 56899999999999999999999   8889999999999999999999999999998766543


Q ss_pred             CCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ...........|+..|+|||++... .++.++|||||||++|+|++|..||..............  .  .        .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~--~--------~  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ--N--D--------P  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc--C--C--------C
Confidence            3221223445689999999998766 788999999999999999999999976654332221111  0  0        0


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +.+.........+..+.+++.+||+.||++||++.+|++|+|
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence            011111111234467899999999999999999999999987

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.9e-42  Score=366.95  Aligned_cols=261  Identities=21%  Similarity=0.365  Sum_probs=206.7

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERI  209 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~  209 (443)
                      ...+|.++.+||+|+||+||+|.+. ++..||+|++............+.+|+.+|+.|+|||||+++++|..  ...+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999976 68899999987655555556778999999999999999999998855  35689


Q ss_pred             EEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCeEecCCCCCCEEEcC----------
Q 013401          210 VIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYT----DHPIIHRDIKSSNILLTE----------  273 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivHrDlkp~NILl~~----------  273 (443)
                      |||||+.+++|.++|...  ....+++..++.|+.||+.||.|||...    .++||||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998643  2356899999999999999999999432    146999999999999964          


Q ss_pred             -------CCceEEeeecccccccccCCCcccccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 013401          274 -------NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEP  344 (443)
Q Consensus       274 -------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~  344 (443)
                             .+.+||+|||++.......     ......||+.|+|||++.+  ..++.++||||||||||+|++|..||..
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                   2358999999997654321     1234569999999999854  4588999999999999999999999976


Q ss_pred             chhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          345 KRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ............      ..       +.+..    ...+..+.+||..||+.+|.+||++.+++.+.|..
T Consensus       246 ~~~~~qli~~lk------~~-------p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        246 ANNFSQLISELK------RG-------PDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             CCcHHHHHHHHh------cC-------CCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            554332221111      00       00000    01236789999999999999999999999998853

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-41  Score=321.57  Aligned_cols=253  Identities=31%  Similarity=0.457  Sum_probs=203.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++.++||+|+||.||+|...++..||+|.++...   ...+.+.+|+.+++.++|+||+++++++. .+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT---MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC---CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            4688888999999999999998888889999987643   23467899999999999999999999875 4568999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++.......+++..++.++.+++.||.|||   +++++|+||||+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence            99999999997655566899999999999999999999   88899999999999999999999999999976543221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++|||||||++|+|++ |.+||..........   ...    ......     
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~----~~~~~~-----  223 (260)
T cd05070         158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---QVE----RGYRMP-----  223 (260)
T ss_pred             --ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHH----cCCCCC-----
Confidence              11122335678999999988889999999999999999999 899997654322111   111    110000     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .     ....+..+.+|+.+||.+||++||++.++++.|..
T Consensus       224 ~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 C-----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             C-----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0     11234679999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.2e-41  Score=321.65  Aligned_cols=253  Identities=30%  Similarity=0.479  Sum_probs=205.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++.++||+|+||.||+|..++++.||+|.+....   .....+.+|+.+++.++|+||+++++++ ..+..+++|||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~   81 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY   81 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence            4688889999999999999998889999999987543   3456788999999999999999999986 45678999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++....+..+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            99999999987655667899999999999999999999   88899999999999999999999999999876653211 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++|||||||++|+|++ |.+||.............       .+.....    
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~----  224 (260)
T cd05067         158 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RGYRMPR----  224 (260)
T ss_pred             --ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cCCCCCC----
Confidence              11122346778999999988889999999999999999999 999997654322211111       1000000    


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                            ....+.++.+++.+||+.+|++||++++++..|..
T Consensus       225 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                  01123579999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-41  Score=327.31  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=208.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+...  .......+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            46888889999999999999742      3567899988653  233456789999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          209 IVIVEYVPNGTLREHLDCLQ-----------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                      ++||||+.+++|.+++....           ...+++..++.++.||+.||.|||   .+|++||||||+|||+++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence            99999999999999986432           124899999999999999999999   8889999999999999999999


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKW  356 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~  356 (443)
                      ||+|||++........  ........++..|+|||++.+..++.++|||||||++|+|++ |.+||...........+  
T Consensus       160 kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i--  235 (288)
T cd05093         160 KIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI--  235 (288)
T ss_pred             EeccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence            9999999976543211  111223446788999999998889999999999999999998 99999766432211111  


Q ss_pred             HhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       357 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                           ..+......          ...+..+.+|+.+||++||.+||++.+++..+..+.+.
T Consensus       236 -----~~~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         236 -----TQGRVLQRP----------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -----HcCCcCCCC----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                 111111100          01235699999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-41  Score=322.17  Aligned_cols=254  Identities=31%  Similarity=0.466  Sum_probs=204.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .+|.+.++||+|+||.||+|.+.+...||||.++...   .....+.+|+++++.++|+||+++++.+. .+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            4688899999999999999998766779999987532   23467889999999999999999999874 4568999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++....+..+++..++.++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-  157 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  157 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence            99999999997545566889999999999999999999   88899999999999999999999999999976643321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+....     
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~~~~~-----  223 (262)
T cd05071         158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMP-----  223 (262)
T ss_pred             --ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------cCCCCC-----
Confidence              11123346778999999988889999999999999999999 888997654322111111       110000     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                           .....+..+.+|+.+||++||++||++.++++.|...
T Consensus       224 -----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 -----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                 0112346789999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-41  Score=326.07  Aligned_cols=271  Identities=22%  Similarity=0.292  Sum_probs=209.9

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|++.+.||+|+||.||+|.+. +|..||||++............+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778889999999999999975 689999999876654455567889999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      + +++|.+++... ...+++..++.++.||+.+|.|||   +++++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 99999998653 367899999999999999999999   88899999999999999999999999999887654321 


Q ss_pred             cccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh--------hhcCCCc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM--------KKFSDGD  365 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~~  365 (443)
                        .......|+..|+|||++.+. .++.++|||||||++|+|++|.+||...........+....        +.+.+-.
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 --RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             --CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence              112345689999999998654 46889999999999999999998887665433221111100        0000000


Q ss_pred             -cccc-c--CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          366 -AISI-L--DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       366 -~~~~-~--d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                       ...+ .  ..............+.+.+|+.+||+.||.+||+++++++|+|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence             0000 0  00000001111234789999999999999999999999999883

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-41  Score=319.94  Aligned_cols=248  Identities=28%  Similarity=0.449  Sum_probs=197.7

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      .||+|+||.||+|.+. +++.||+|.+.... .......+.+|+++++.++||||+++++++...+..++||||+.+++|
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            6999999999999875 79999999876532 234456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccc
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST  300 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  300 (443)
                      .+++.. .+..+++..++.++.|++.||.|||   .++|+|+||||+|||++.++.+||+|||++....+....  ....
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~  154 (252)
T cd05084          81 LTFLRT-EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGG  154 (252)
T ss_pred             HHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc--ccCC
Confidence            999864 3346889999999999999999999   888999999999999999999999999998754432110  0011


Q ss_pred             cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhh
Q 013401          301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA  379 (443)
Q Consensus       301 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  379 (443)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||..............       ......          
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------~~~~~~----------  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------GVRLPC----------  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-------CCCCCC----------
Confidence            1123457999999988889999999999999999998 9999976544322111111       000000          


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          380 NNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       380 ~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ....+..+.+|+.+||+.||++||++.++++.|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1123467999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-41  Score=320.65  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|++.+.||+|+||.||++... ++..||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+++.++++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            4778889999999999999876 689999998865422 33456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++....+..+++..++.++.||+.||.|||   +++|+|+||||+|||+++++.++|+|||++........ 
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            99999999987655667899999999999999999999   88999999999999999999999999999876543221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......|++.|+|||++.+..++.++||||||+++|+|++|..||............       ..+.....     
T Consensus       156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~-----  220 (255)
T cd08219         156 ---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-------CQGSYKPL-----  220 (255)
T ss_pred             ---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH-------hcCCCCCC-----
Confidence               123456899999999999888999999999999999999999999865432221111       11111100     


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEI  411 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~  411 (443)
                           .......+.+|+.+||+.||++||++.+++..
T Consensus       221 -----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 -----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 01133568999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-41  Score=322.25  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=203.3

Q ss_pred             CCCCceeeeeCceEEEEEEEc-C---CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe-----
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-D---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE-----  207 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  207 (443)
                      |.+.+.||+|+||.||+|.+. +   +..||||+++...........+.+|+..++.++|+||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456778999999999999864 2   4789999987654444556678999999999999999999998866554     


Q ss_pred             -EEEEEeecCCCcHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          208 -RIVIVEYVPNGTLREHLDCL----QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       208 -~~lv~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                       .+++|||+++++|..++...    ....+++..++.++.|++.||.|||   +++++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988543    2236888999999999999999999   888999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhc
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      |+++........  .......++..|+|||++.+..++.++|||||||++|||++ |.+||........   ..+..   
T Consensus       158 g~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~~---  229 (273)
T cd05035         158 GLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYLR---  229 (273)
T ss_pred             cceeeccccccc--cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---
Confidence            999866543211  11112235678999999988889999999999999999999 8999976543221   11111   


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       .+.....          ...+...+.+++.+||+.||++||++.+++++|..+
T Consensus       230 -~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 -HGNRLKQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -cCCCCCC----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             1111110          112346799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-41  Score=336.53  Aligned_cols=264  Identities=19%  Similarity=0.207  Sum_probs=197.2

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ...+|.+.+.||+|+||.||+|... ++..||+|+....        ....|+.+++.++|+||+++++++...+..++|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            3457999999999999999999976 5788999975432        234699999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ||++. ++|.+++.. ....+++..++.|+.||+.||.|||   .++||||||||+|||++.++.+||+|||++......
T Consensus       136 ~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        136 LPHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            99994 688888864 3456899999999999999999999   888999999999999999999999999998754322


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCC-CCCchhHHH------HHHHHHHhhhcC--
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-IEPKRELKE------RITVKWAMKKFS--  362 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~P-f~~~~~~~~------~~~~~~~~~~~~--  362 (443)
                      .     ......||+.|+|||++.+..++.++|||||||++|||+++..| |........      ..........+.  
T Consensus       211 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~  285 (357)
T PHA03209        211 P-----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH  285 (357)
T ss_pred             c-----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence            1     12345699999999999988999999999999999999985544 443211100      000111111100  


Q ss_pred             CCccc---------cccC------ccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          363 DGDAI---------SILD------PRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       363 ~~~~~---------~~~d------~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .....         ..++      .....  ..........+.+||.+||+.||.+|||+.++++|.|.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence            00000         0000      00000  00011223456789999999999999999999999985

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-41  Score=321.37  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=209.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||+|+||.||++... +|+.||+|.+...........++.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788889999999999999875 689999999876544444556789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++.......+++..++.++.|++.+|.|||   +++++|+||+|+|||++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999997655556889999999999999999999   88899999999999999999999999999976543221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......|++.|+|||++.+..++.++|||||||++++|++|..||...........+.       .+....     .
T Consensus       157 ---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~-----~  221 (256)
T cd08218         157 ---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-------RGSYPP-----V  221 (256)
T ss_pred             ---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-------cCCCCC-----C
Confidence               1223468999999999988889999999999999999999999997654322211111       111100     0


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                           .......+.+++.+||+.+|++||++.+|++|.|
T Consensus       222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         222 -----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             -----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence                 1123467999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-41  Score=321.96  Aligned_cols=258  Identities=24%  Similarity=0.427  Sum_probs=206.9

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccC----cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYD----KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      +|...+.||+|+||.||+|...+++.+|||.++.....    ......+.+|+.+|+.++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            46778899999999999999888999999988654221    12235588999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      +||+.+++|.+++..  ...+++..+..++.|++.+|.|||   ..+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            999999999999964  346788889999999999999999   788999999999999999999999999998765321


Q ss_pred             CCC--cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          292 ESG--ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       292 ~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...  .........|+..|+|||++.+..++.++|||||||++|+|++|..||...+...........     .+..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~---  227 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-----RGLM---  227 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-----cCCC---
Confidence            111  111123456899999999999888999999999999999999999999765543322211110     0000   


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        +.+.     ......+.+++.+||+.+|.+||++.+++++.|
T Consensus       228 --~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         228 --PRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             --CCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence              0011     113467899999999999999999999999987

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.5e-41  Score=318.99  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=210.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||.||+|... +|+.||+|.++... ........+.+|+++++.++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999987 79999999886432 23334667899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||+++++|.+++...  ....+++..++.++.+++.||.|||   +.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988643  2455889999999999999999999   88899999999999999999999999999876543


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...    ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..........     ...+..+..... 
T Consensus       159 ~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~-  228 (267)
T cd08224         159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-----CKKIEKCDYPPL-  228 (267)
T ss_pred             CCc----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH-----HhhhhcCCCCCC-
Confidence            221    1223458899999999988889999999999999999999999996543211111     111111111000 


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                              ........+.+++.+||..+|++||++.+|++.+..+.
T Consensus       229 --------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         229 --------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                    01123467999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=334.37  Aligned_cols=261  Identities=27%  Similarity=0.413  Sum_probs=203.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec-C
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE-D  206 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-~  206 (443)
                      ++|++.+.||+|+||.||+|...      +++.||+|+++... .......+.+|+.++.++ +|+||+++++++... .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            46888999999999999999632      35789999987542 223345678899999999 799999999987654 5


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc----------------------------------------------------------
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ----------------------------------------------------------  228 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~----------------------------------------------------------  228 (443)
                      .++++|||+.+++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999999885422                                                          


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCC
Q 013401          229 -GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG  307 (443)
Q Consensus       229 -~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~  307 (443)
                       ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..+.....  ........++..
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~~~~~  240 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLK  240 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc--hhhccCCCCCcc
Confidence             125788889999999999999999   88899999999999999999999999999987643221  111223446778


Q ss_pred             ccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHH
Q 013401          308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEK  386 (443)
Q Consensus       308 y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  386 (443)
                      |+|||++.+..++.++|||||||+||||++ |..||..........      ..+..+.... .         ......+
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~------~~~~~~~~~~-~---------~~~~~~~  304 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC------RRLKEGTRMR-A---------PEYATPE  304 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH------HHHhccCCCC-C---------CccCCHH
Confidence            999999999899999999999999999998 999997643221110      0111111000 0         0123467


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          387 ILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       387 l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      +.+++.+||+.+|++||++.+|+++|..+..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=314.55  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=202.9

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .+.+..||.|+-|.|+++..+ +|..+|||.+.+.. +++...+++..+.++... ++|+||+.+|+|..+..++|+||.
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            334456999999999999976 69999999998753 455566777777777665 499999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |. .-+..++. .-..++++..+-++...++.||.||..  .++|||||+||+|||+|+.|++||||||++..+.+... 
T Consensus       173 Ms-~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-  247 (391)
T KOG0983|consen  173 MS-TCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-  247 (391)
T ss_pred             HH-HHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence            83 23333333 345678988888999999999999997  77999999999999999999999999999988877643 


Q ss_pred             cccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          295 ATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                          .+...|-+.|||||.+.   ...|+.++||||||++|+||.||+.||..-+...+.++..-      + +....++
T Consensus       248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl------n-~ePP~L~  316 (391)
T KOG0983|consen  248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL------N-EEPPLLP  316 (391)
T ss_pred             ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH------h-cCCCCCC
Confidence                23345899999999984   34689999999999999999999999988655444333211      1 0011111


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...       ..+..+.+|+..||.+|+.+||.+.++++|.+.++
T Consensus       317 ~~~-------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  317 GHM-------GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             ccc-------CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence            111       14578999999999999999999999999998654

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.2e-41  Score=320.19  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=198.4

Q ss_pred             eeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      +||+|+||.||+|.++   ++..+|||+++.........+++.+|+.+++.+.|+||+++++++. .+..++||||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5999999999999753   5789999998765444455677899999999999999999999875 55678999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..  ...+++..++.++.|++.||.|||   +++|+||||||.|||++.++.+||+|||++.......... ..
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~  154 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-KA  154 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-ee
Confidence            99999863  356889999999999999999999   8889999999999999999999999999997664332111 11


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccch
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT  377 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  377 (443)
                      .....++..|+|||++....++.++|||||||++|||++ |..||...........+       ..+....     .+  
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-------~~~~~~~-----~~--  220 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-------ESGERME-----CP--  220 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCCCCC-----CC--
Confidence            122235678999999988889999999999999999998 99999865442211111       1111111     00  


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       378 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                         ...+.++.+|+.+||+.||++||++.+|.+.|..
T Consensus       221 ---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 ---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence               1134678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=326.42  Aligned_cols=270  Identities=24%  Similarity=0.322  Sum_probs=211.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||+|+||.||+|.+. +++.||||+++...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6888899999999999999976 688999999876655555667889999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.++.|..++.  ....+++..++.++.||+.||.|||   .++++|+||+|+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99877765554  3355889999999999999999999   88899999999999999999999999999987654432 


Q ss_pred             cccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC---------
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG---------  364 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------  364 (443)
                        .......++..|+|||++.+. .++.++||||||+++|+|++|.+||..................+...         
T Consensus       156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence              123345689999999999887 78899999999999999999999998665443322222211111100         


Q ss_pred             -----ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          365 -----DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       365 -----~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                           ......++...........+.++.+|+.+||..+|++||++++++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence                 0000000000000011123578999999999999999999999999887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.9e-41  Score=323.46  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=203.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|+..++||+|+||+||+|..     .++..||+|.++... .......+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            4577888999999999999984     246789999987532 2334467889999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013401          210 VIVEYVPNGTLREHLDCLQ---------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~  274 (443)
                      +||||+.+++|.+++....               ...+++...+.++.|++.||.|||   +++++||||||+|||++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence            9999999999999985321               234788888999999999999999   8889999999999999999


Q ss_pred             CceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 013401          275 FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERIT  353 (443)
Q Consensus       275 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~  353 (443)
                      +.+||+|||++........  ........++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus       161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         161 LHVKISDLGLSREIYSADY--YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CcEEeccccccccccCCcc--eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999976643321  111233446778999999988889999999999999999998 9999976543211111


Q ss_pred             HHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +       .......          ....++..+.+++.+||+.||.+||++.++++++.
T Consensus       239 ~-------~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         239 V-------RKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             H-------HcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            1       0111000          00113367899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.6e-41  Score=327.02  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=207.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|...+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            47888899999999999999865 68999999887543  2334678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++..   ..+++..++.++.|++.||.|||   ..+|+|+||||+|||++.++.+||+|||++........
T Consensus        98 ~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             ccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999998853   45788899999999999999999   88899999999999999999999999999876543221


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........... .+ .    ...      +.
T Consensus       172 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~~-~----~~~------~~  235 (296)
T cd06654         172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IA-T----NGT------PE  235 (296)
T ss_pred             ----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-Hh-c----CCC------CC
Confidence                12234689999999999888899999999999999999999999976654322111 11 0    000      00


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      +.   ........+.+|+.+||..||++||++.+++++.|...
T Consensus       236 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         236 LQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             CC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            00   01123467899999999999999999999999999653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.2e-41  Score=322.83  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=203.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|...+.||+|+||.||+|... +++.||+|.++...  ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            36777778999999999999875 68999999987542  2334567889999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++..  ...+++..++.++.|++.+|.|||   .+|++|+||||+||+++.++.+||+|||++....... 
T Consensus        87 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          87 FCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999999998864  356899999999999999999999   8889999999999999999999999999987654321 


Q ss_pred             CcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                         .......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+.........  ..+..    ...
T Consensus       161 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~~~----~~~  231 (267)
T cd06645         161 ---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNFQP----PKL  231 (267)
T ss_pred             ---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCCCC----Ccc
Confidence               1123456899999999974   44688899999999999999999999976543322111110  00000    000


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ..       ....+..+.+++.+||+.||++||++.+|++|.|
T Consensus       232 ~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         232 KD-------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             cc-------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            00       0012356889999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-40  Score=336.83  Aligned_cols=266  Identities=21%  Similarity=0.217  Sum_probs=199.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ...|.+.+.||+|+||.||+|.+. +++.||||....        ..+.+|+++|++|+|+|||++++++..++..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            446999999999999999999976 588999996432        23568999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |++. ++|.+++.. ....+++..++.|+.||+.||.|||   .+|||||||||+||||+.++.+||+|||+++......
T Consensus       240 e~~~-~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        240 PKYR-SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EccC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9994 688888864 2346899999999999999999999   8889999999999999999999999999998654321


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchh------HHHH-H-HHHHHhhh---c
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE------LKER-I-TVKWAMKK---F  361 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~------~~~~-~-~~~~~~~~---~  361 (443)
                      .  ........||+.|+|||++.+..++.++|||||||+||||++|..|+.....      .... . .+.+....   +
T Consensus       315 ~--~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        315 S--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             c--cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            1  1112345699999999999998999999999999999999998866532211      0010 0 11111000   0


Q ss_pred             CCC---ccccc--------cCccccchhh--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          362 SDG---DAISI--------LDPRVENTAA--NNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       362 ~~~---~~~~~--------~d~~~~~~~~--~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ...   .....        ..+......+  .......+.+|+.+||+.||.+|||+.|+++|.|.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence            000   00000        0000000000  01123468899999999999999999999999985

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=318.91  Aligned_cols=255  Identities=31%  Similarity=0.451  Sum_probs=208.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .++|.+.+.||+|+||.||+|..++++.||||.+...   .....++.+|+.+++.++|+||+++++++......++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG---TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC---ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3578889999999999999999888888999998754   3345678999999999999999999999999899999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++....+..+++..++.++.+++.||.|||   .++++|+||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999997655567899999999999999999999   88899999999999999999999999999876643211


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                         .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||..........   .....+...        
T Consensus       159 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~~~~~~~~~--------  224 (261)
T cd05034         159 ---TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE---QVERGYRMP--------  224 (261)
T ss_pred             ---hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCCCC--------
Confidence               11122335678999999998889999999999999999998 999997654322111   111111000        


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                       .     ....+..+.+++.+||+.+|++||++.++++.+..
T Consensus       225 -~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 -R-----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -C-----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             0     01123679999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.2e-41  Score=323.72  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=202.3

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      ..++|+..+.||+|+||.||+|.+.      ++..||||.+.... ......++.+|+.+++.++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3467999999999999999999753      35679999876432 1223456889999999999999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceE
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQG--------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAK  278 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vk  278 (443)
                      ..++||||+.+++|.+++.....        ..+++..++.++.|++.||.|||   ..+++|+||||+|||++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence            99999999999999999864321        23567788899999999999999   78899999999999999999999


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHH
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWA  357 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~  357 (443)
                      |+|||++........  ........+++.|+|||++.+..++.++|||||||++|||++ |..||..........   ..
T Consensus       160 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~---~~  234 (277)
T cd05062         160 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR---FV  234 (277)
T ss_pred             ECCCCCccccCCcce--eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HH
Confidence            999999876543221  111122346788999999988889999999999999999999 788987654322111   11


Q ss_pred             hhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       358 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                          ........          ....+..+.+++.+||+.||++||++.++++++.
T Consensus       235 ----~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 ----MEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ----HcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                11110000          0113357999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.7e-41  Score=319.39  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=200.1

Q ss_pred             CCCceeeeeCceEEEEEEEcC-Cc--EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------CeE
Q 013401          138 SPSFKIGQGGFGTVYKGRLED-GT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------DER  208 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~  208 (443)
                      .+.+.||+|+||.||+|.+.+ +.  .||||.++...........+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456789999999999999764 33  589999877654455567788999999999999999999987432      246


Q ss_pred             EEEEeecCCCcHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          209 IVIVEYVPNGTLREHLDCL----QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      +++|||+.+|+|.+++...    ....+++...+.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987422    2345788999999999999999999   88899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      +.........  .......+++.|++||++.+..++.++|||||||++|||++ |..||..........       .+..
T Consensus       159 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-------~~~~  229 (272)
T cd05075         159 SKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD-------YLRQ  229 (272)
T ss_pred             ccccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHc
Confidence            9876543211  11122346778999999998899999999999999999999 889997654322111       1111


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +.....          ....++.+.+++.+||+.||++||++.++++.|..+
T Consensus       230 ~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNRLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111110          011335689999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-43  Score=342.85  Aligned_cols=252  Identities=29%  Similarity=0.426  Sum_probs=210.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      -|..++.||.|+||.||.+.+. +...||||++.... ...+.+.++..||..|++++|||+|.+.|+|-.+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3667779999999999999865 78999999976442 234557789999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||- |+-.|.+.. ..+++.+.++..|+.+.+.||.|||   +++.||||||..|||+++.|.|||+|||.|....+   
T Consensus       107 YCl-GSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHh-ccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            994 567777765 4578999999999999999999999   88899999999999999999999999999876654   


Q ss_pred             CcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                           ...++|||+|||||++.   .++|+-++||||||++..||.-.++|+...+-.....-+.       ..+     
T Consensus       179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-------QNe-----  241 (948)
T KOG0577|consen  179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QNE-----  241 (948)
T ss_pred             -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-------hcC-----
Confidence                 34578999999999984   4689999999999999999999999987665433222111       111     


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .|.+.    ..+.++.|++|+..||++-|..|||..+|+.|.+.+|
T Consensus       242 sPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  242 SPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             CCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            12222    3456788999999999999999999999999988655

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.4e-41  Score=325.31  Aligned_cols=259  Identities=27%  Similarity=0.455  Sum_probs=207.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|...+.||+|+||.||+|...      ++..+++|.++...  ......+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            45777889999999999999742      35678999886532  23345788999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013401          209 IVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~  274 (443)
                      ++||||+++++|.+++....              ...+++..++.++.||+.||.|||   +++|+||||||+|||++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence            99999999999999996432              234788999999999999999999   8889999999999999999


Q ss_pred             CceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 013401          275 FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERIT  353 (443)
Q Consensus       275 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~  353 (443)
                      +.++|+|||++........  ........|+..|+|||++.+..++.++|||||||++|+|++ |..||.........  
T Consensus       160 ~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--  235 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI--  235 (291)
T ss_pred             CcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            9999999999976543211  112233457889999999998899999999999999999999 99998765442211  


Q ss_pred             HHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       ..    ...+.....          ....+..+.+|+.+||+.||++||++.++++.+..+.+
T Consensus       236 -~~----~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         236 -EC----ITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -HH----HhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence             11    111111110          01134679999999999999999999999999998855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.9e-41  Score=319.19  Aligned_cols=256  Identities=24%  Similarity=0.430  Sum_probs=205.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcc-------cHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKH-------SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      +|.+...||+|+||.||+|... +++.||+|.+........       ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999875 688999998765432211       23567899999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+++++|.+++..  ...+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            9999999999999999974  356888889999999999999999   88899999999999999999999999999886


Q ss_pred             ccccCCCc--ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          288 AADTESGA--THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       288 ~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ........  ........|+..|+|||++.+..++.++|||||||++|+|++|..||.............   .    . 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~-  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---E----N-  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh---c----c-
Confidence            65321110  111123458899999999988889999999999999999999999998764433211111   0    0 


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                          ..+.+.     ...+..+.+++.+||++||.+||++.+++++.|
T Consensus       228 ----~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         228 ----ASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             ----CCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence                001111     113467899999999999999999999999887

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.6e-41  Score=317.75  Aligned_cols=253  Identities=30%  Similarity=0.454  Sum_probs=203.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++..+||+|+||.||+|.+.++..+|+|.+...   ......+.+|+.+++.++|+|++++++++. .+..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG---TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC---CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            457888899999999999999877777999987653   233467889999999999999999999875 4568999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++.......+++..+..++.||+.||.|||   +.+++|+||||+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            99999999997655556889999999999999999999   88899999999999999999999999999976643221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++|||||||++|+|++ |..||.........   .+......    ..     
T Consensus       158 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~----~~-----  223 (260)
T cd05069         158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVERGYR----MP-----  223 (260)
T ss_pred             --cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCC----CC-----
Confidence              11122346778999999988889999999999999999999 99999765432211   11111110    00     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                           .....+..+.+++.+||++||.+||++.++++.|..
T Consensus       224 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 -----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 001234679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-41  Score=322.14  Aligned_cols=250  Identities=34%  Similarity=0.536  Sum_probs=195.3

Q ss_pred             CceeeeeCceEEEEEEEc-----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          140 SFKIGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .+.||.|.||.||+|.+.     .+..|+||.++.. ......+.+.+|++.++.++||||++++|++...+..++|+||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccccc
Confidence            457999999999999876     3678999999653 2334467899999999999999999999999988889999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++|+|.++|.......+++..++.|+.||+.||.|||   +++++|+||+++|||++.++.+||+|||++........ 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-  158 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred             cccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc-
Confidence            99999999998765677999999999999999999999   77899999999999999999999999999987632211 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                       ........+...|+|||.+.+..++.++||||||+++|||++ |..||............       .++.....    
T Consensus       159 -~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-------~~~~~~~~----  226 (259)
T PF07714_consen  159 -YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-------KQGQRLPI----  226 (259)
T ss_dssp             -EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-------HTTEETTS----
T ss_pred             -cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccee----
Confidence             122233457788999999988889999999999999999999 78998766432211111       11111110    


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                            ...++..+.+++.+||..||++||++.+|++.|
T Consensus       227 ------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 ------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  111236799999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-42  Score=337.04  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=206.3

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..+.|+++++||+||-+.||++...+.+.||+|++.....+.....-+.+|+..|.+|+ |.+||++|+|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34679999999999999999999888899999988777677777888999999999995 99999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||= ..+|..+|...... .+...+..+..|++.++.++|   .+||||-||||.|+|+-. |.+||+|||+|..+...
T Consensus       439 mE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            9985 57899988764433 333367789999999999999   999999999999999976 58999999999887654


Q ss_pred             CCCcccccccccCCCCccCccccccCC-----------CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQ-----------LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-----------~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ..  .......+||+.||+||.+....           .+.++||||||||||+|+.|++||.........+.       
T Consensus       513 TT--sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~-------  583 (677)
T KOG0596|consen  513 TT--SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH-------  583 (677)
T ss_pred             cc--ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH-------
Confidence            32  22344568999999999984322           56789999999999999999999976543222111       


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                             .+.+|+-..+........++.+++..||+.||++||++.+||+|.+
T Consensus       584 -------aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  584 -------AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             -------hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence                   1122211111111011133999999999999999999999999987

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-41  Score=318.56  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=208.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+..+.||+|+||.||+|... ++..|++|.++...    ..+++.+|+.+++.++|+||+++++++.+....++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            57888899999999999999987 48999999987542    16789999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++.. ....+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.+||+|||++........
T Consensus        79 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          79 YCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             cCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999999864 3467899999999999999999999   78899999999999999999999999999987654321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..            ...+.
T Consensus       155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~~  218 (256)
T cd06612         155 ----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN------------KPPPT  218 (256)
T ss_pred             ----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc------------CCCCC
Confidence                12334588999999999888999999999999999999999999976544322111100            00000


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +.   ........+.+++.+||+.||++||++.+++++.|
T Consensus       219 ~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         219 LS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             CC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence            00   11123467999999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-43  Score=345.36  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             CCCCceeeeeCceEEEEEEEcC-CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |+++..||.|+||.||+|..++ +-..|-|++...  .....+++.-||.||..+.||+||++++.|..++.+||+.|||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            5566689999999999999774 556677877643  3556678889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .||.....+-. -+..+.+..+..+++|++.||.|||   +++|||||||..|||++-+|.++|+|||.+......    
T Consensus       112 ~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----  183 (1187)
T KOG0579|consen  112 GGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----  183 (1187)
T ss_pred             CCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH----
Confidence            99998877765 4678999999999999999999999   888999999999999999999999999998654321    


Q ss_pred             ccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          296 THVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ......++|||+|||||++.     ..+|+.++||||||++|.||..+.+|-...++..-.+.+...       +..-++
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-------ePPTLl  256 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-------EPPTLL  256 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-------CCCccc
Confidence            12345688999999999974     457999999999999999999999998777765544443321       111111


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .        ...+...+.+++.+||.+||+.||++.++++|+|.-
T Consensus       257 q--------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  257 Q--------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             C--------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            1        123456799999999999999999999999999953

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.6e-41  Score=325.43  Aligned_cols=270  Identities=27%  Similarity=0.362  Sum_probs=208.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+..++||+|+||.||+|.++ +++.||+|++..........+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888899999999999999986 58999999987654433445678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.++.|.++...  ...+++..++.++.||+.+|.|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          81 FVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            9999988877653  345899999999999999999999   78899999999999999999999999999876644321


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc-----
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI-----  367 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----  367 (443)
                          ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+......+......     
T Consensus       156 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         156 ----VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             ----ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence                2234568999999999865 347789999999999999999999997665433222222211111100000     


Q ss_pred             ----cccCcccc----chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          368 ----SILDPRVE----NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       368 ----~~~d~~~~----~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                          ....+...    ........+..+.+|+.+||+.||++||++.++++|.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence                00000000    00001123567999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.3e-41  Score=319.46  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=208.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||.||+|... ++..||||.+.... .......++.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46778889999999999999964 79999999876532 22334467889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||+++++|.+++...  ....+++..++.++.||+.||.|||   +++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988642  3456889999999999999999999   88899999999999999999999999999876543


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...    ......|+..|+|||++.+..++.++||||||+++|+|++|..||...........     ..+....     
T Consensus       159 ~~~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~-----  224 (267)
T cd08229         159 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-----KKIEQCD-----  224 (267)
T ss_pred             CCc----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh-----hhhhcCC-----
Confidence            221    12234689999999999888899999999999999999999999965432111110     0111100     


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .+..    .....++.+.+|+.+||+.||++|||+.+|++.+..+
T Consensus       225 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         225 YPPL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            0000    0112456799999999999999999999999988654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.3e-41  Score=320.00  Aligned_cols=260  Identities=23%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc----ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK----HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      +|+..+.||+|+||.||++... +++.||+|.++......    .....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4777889999999999999864 78999999987543211    134678899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeeccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFARLAA  289 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~  289 (443)
                      ||||+.+++|.+++..  ...+++..++.++.||+.||.|||   ++|++|+||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            9999999999999864  356889999999999999999999   88999999999999998765 59999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ..............|+..|+|||++.+..++.++|||||||++++|++|..||...........+.........      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  229 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA------  229 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC------
Confidence            44322222233456899999999998888999999999999999999999999654322111111111000000      


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        +     .........+.+++.+||..+|.+||++.++++|.|
T Consensus       230 --~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         230 --P-----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             --C-----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence              0     011224467999999999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.6e-41  Score=324.22  Aligned_cols=269  Identities=23%  Similarity=0.307  Sum_probs=207.3

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||.|+||.||+|... +|..||||+++...........+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5788899999999999999876 689999999876544444456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +. ++|.+++.......+++..++.++.||+.||.|||   .++++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 68999887656677899999999999999999999   88899999999999999999999999999876543211 


Q ss_pred             cccccccccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC---------
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG---------  364 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------  364 (443)
                         ......+++.|+|||++.+.. ++.++|||||||++|+|++|..||....+.................         
T Consensus       156 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 ---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             ---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence               122335788999999986644 5889999999999999999999997665433222111100000000         


Q ss_pred             ----ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          365 ----DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       365 ----~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                          .........+.  ........++.+++.+||+.||.+||++++++.|+|.
T Consensus       233 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         233 DYKPSFPKWARQDFS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHhhcccccccCHH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                00000000000  0001123568899999999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.4e-41  Score=322.99  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |++.+.||+|+||.||+|... ++..+++|.+....  ......+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            455668999999999999976 58889999886532  334567889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .+++|..++.. ....+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.......   
T Consensus        85 ~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---  157 (282)
T cd06643          85 AGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---  157 (282)
T ss_pred             CCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc---
Confidence            99999888764 3456899999999999999999999   8889999999999999999999999999987654321   


Q ss_pred             ccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          296 THVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                       .......|++.|+|||++.     +..++.++|||||||++|+|++|.+||..............   ...    ....
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~----~~~~  229 (282)
T cd06643         158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEP----PTLA  229 (282)
T ss_pred             -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCC----CCCC
Confidence             1123346899999999983     34577899999999999999999999976654332222111   000    0000


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .        ....+.++.+|+.+||+.||.+||++.++++|+|....
T Consensus       230 ~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         230 Q--------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             C--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            0        11134679999999999999999999999999995543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6e-41  Score=324.23  Aligned_cols=264  Identities=25%  Similarity=0.359  Sum_probs=215.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||.||++.+. +++.||||.++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999976 689999999865432 2234567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++..  ...+++..+..++.||+.||.|||   +++++|+||+|.||||+.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            99999999999874  356899999999999999999999   888999999999999999999999999998776433 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.       .+..      
T Consensus       155 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~------  215 (290)
T cd05580         155 ------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-------EGKV------  215 (290)
T ss_pred             ------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCc------
Confidence                  233468999999999988888999999999999999999999997655322111111       1100      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                      .+.     ......+.+++.+||..||.+|+     +++++++|.|.-.-++-......+.
T Consensus       216 ~~~-----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  271 (290)
T cd05580         216 RFP-----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIE  271 (290)
T ss_pred             cCC-----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCC
Confidence            000     01236789999999999999999     9999999999766665555444443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.4e-41  Score=323.41  Aligned_cols=256  Identities=24%  Similarity=0.377  Sum_probs=205.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+++++||+|+||.||+|.+. ++..|++|.+...  .......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            46888889999999999999976 5899999998654  23445678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|..++... ...+++..++.++.|++.+|.|||   .++++||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          90 FCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             cCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999998877542 356899999999999999999999   8899999999999999999999999999986543221 


Q ss_pred             CcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                         .......+++.|+|||++.     ...++.++|||||||++|+|++|.+||.............       ....  
T Consensus       165 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~--  232 (292)
T cd06644         165 ---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-------KSEP--  232 (292)
T ss_pred             ---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh-------cCCC--
Confidence               1123445889999999984     3457889999999999999999999997655422211110       0000  


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         +...   .......++.+++.+||..||++||++.+++++.|..
T Consensus       233 ---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  273 (292)
T cd06644         233 ---PTLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS  273 (292)
T ss_pred             ---ccCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence               0000   0112335689999999999999999999999999853

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.9e-41  Score=323.13  Aligned_cols=262  Identities=25%  Similarity=0.421  Sum_probs=207.7

Q ss_pred             CHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeee
Q 013401          126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLE  203 (443)
Q Consensus       126 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  203 (443)
                      +..++......|++...||.|+||.||+|.+. +++.||+|++...   ......+..|+.+++.+ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            34444445678899999999999999999975 6899999987643   23345688899999998 6999999999985


Q ss_pred             e------cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          204 F------EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       204 ~------~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                      .      .+..+++|||+.+|+|.+++.......+++..++.++.||+.||.|||   +++++|+||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence            3      467899999999999999997656667888888999999999999999   8889999999999999999999


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI  352 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~  352 (443)
                      +|+|||++........    ......|++.|+|||++.     ...++.++|||||||++|+|++|..||..........
T Consensus       161 ~l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~  236 (282)
T cd06636         161 KLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF  236 (282)
T ss_pred             EEeeCcchhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence            9999999876542211    123356899999999985     3457889999999999999999999997654332221


Q ss_pred             HHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          353 TVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ...+    ...        +.+    ....++..+.+|+.+||+.||.+||++.++++|.|
T Consensus       237 ~~~~----~~~--------~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         237 LIPR----NPP--------PKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             hHhh----CCC--------CCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            1111    000        000    01123467999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.6e-41  Score=317.44  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=209.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||+|+||.||++... ++..+|||.+............+.+|+.+|+.++|+||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788889999999999999875 689999999876555555667889999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~~~~~~  293 (443)
                      +++++|.+++....+..+++..++.++.+++.+|.|||   +++++|+||||+||+++.+ +.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999998655667899999999999999999999   8889999999999999854 4689999999987654321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                           .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..   .    ....+.   
T Consensus       158 -----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~---  222 (256)
T cd08220         158 -----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS---G----TFAPIS---  222 (256)
T ss_pred             -----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh---c----CCCCCC---
Confidence                 2234689999999999888889999999999999999999999976543222111111   0    000000   


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                             ......+.+++.+||+.||++||++.+++.++|
T Consensus       223 -------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~  255 (256)
T cd08220         223 -------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI  255 (256)
T ss_pred             -------CCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence                   113467899999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3e-41  Score=325.10  Aligned_cols=263  Identities=22%  Similarity=0.371  Sum_probs=206.0

Q ss_pred             HHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeee-
Q 013401          127 MEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLE-  203 (443)
Q Consensus       127 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~-  203 (443)
                      ++.+....++|++.+.||+|+||.||+|... +++.||+|+++..   ......+.+|+.+++.+ +|+||+++++++. 
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            4445556789999999999999999999876 6889999987643   22335678899999999 6999999999874 


Q ss_pred             ----ecCeEEEEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          204 ----FEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       204 ----~~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                          .++..++||||++|++|.+++...  ....+++..+..++.|++.||.|||   .++++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                345789999999999999987532  3356888889999999999999999   8889999999999999999999


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI  352 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~  352 (443)
                      ||+|||++........    ......|++.|+|||++..     ..++.++|||||||++|+|++|..||..........
T Consensus       164 kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~  239 (286)
T cd06638         164 KLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF  239 (286)
T ss_pred             EEccCCceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence            9999999876543211    1223468999999999853     347889999999999999999999997664432211


Q ss_pred             HHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          353 TVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ..       .........++        ......+.+|+.+||+.||++||++.++++++|.
T Consensus       240 ~~-------~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         240 KI-------PRNPPPTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             hc-------cccCCCcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            11       01100011111        1123569999999999999999999999999883

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-40  Score=320.32  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=211.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .|...++||.|+||.||+|.+. ++..||||.++... .......+.+|+.+++.+.|+||+++++++.++...++||||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            4667778999999999999976 68899999887542 223456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.|++|.+++..   ..+++.....++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          84 LGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            999999998853   45888889999999999999999   88899999999999999999999999999976543221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......++..|+|||++.+..++.++|||||||++|||++|.+||...........+.       ...     .+  
T Consensus       157 ---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~-----~~--  219 (277)
T cd06640         157 ---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-------KNN-----PP--  219 (277)
T ss_pred             ---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-------cCC-----CC--
Confidence               1223468899999999988889999999999999999999999997654432211110       000     01  


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                         .....++..+.+++.+||+.+|++||++.+++.+.|..+...+.
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06640         220 ---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKT  263 (277)
T ss_pred             ---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhh
Confidence               11123557799999999999999999999999999987766553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-41  Score=320.06  Aligned_cols=255  Identities=28%  Similarity=0.402  Sum_probs=209.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+....||.|+||.||+|.+. +++.||+|.+.... .......+.+|+++++.++|+||+++++++.++..+++|+||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            5778889999999999999976 68999999986542 233456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++..   ..+++..++.++.|++.+|.|||   .++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          81 CGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            999999999864   27899999999999999999999   88899999999999999999999999999987654321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.       ....     +.+
T Consensus       154 ---~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------~~~~-----~~~  218 (274)
T cd06609         154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-------KNNP-----PSL  218 (274)
T ss_pred             ---ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------hcCC-----CCC
Confidence               2234568999999999988889999999999999999999999997655322111111       1100     000


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ..    ...+..+.+++.+||..||++||+++++++|.|....
T Consensus       219 ~~----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         219 EG----NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             cc----cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            00    0034678999999999999999999999999997553

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.7e-41  Score=326.21  Aligned_cols=261  Identities=27%  Similarity=0.372  Sum_probs=205.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      ++|.+.+.||+|+||.||++...        ++..+|+|.++... ......++.+|+.++..+ +|+||+++++++...
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            46888899999999999999752        23579999987542 233446788899999999 799999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +..++||||+.+++|.+++....              ...+++..++.++.|++.||.|||   ++|++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997532              134788889999999999999999   8899999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||++.........  .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            99999999999998765432111  01112234578999999988889999999999999999998 8899876543221


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      .....       .+.....          ......++.+|+.+||..+|++||++.++++.|..+...
T Consensus       252 ~~~~~-------~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         252 FKLLK-------EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHHH-------cCCCCCC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            11111       1110000          112346789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1e-40  Score=322.51  Aligned_cols=270  Identities=21%  Similarity=0.283  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +.+|...+.||+|+||.||+|... +|..||||+++.... ......+.+|+.+++.++|+||+++++++..++..++||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            467899999999999999999875 689999999875432 223346778999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+. ++|.+++.. ....+++..+..++.||+.||.|||   .++|+|+||||+|||++.++.+||+|||++.......
T Consensus        83 e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 677777653 2345778888899999999999999   8889999999999999999999999999987543321


Q ss_pred             CCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc-----
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA-----  366 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----  366 (443)
                      .    ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......+.+...|..........     
T Consensus       158 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         158 Q----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             C----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            1    1223357899999999865 35788999999999999999999999876654444333332111110000     


Q ss_pred             ------cccc----CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          367 ------ISIL----DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       367 ------~~~~----d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                            ....    ...+...+........+.+++.+||+.||.+|||+.+++.|.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence                  0000    0000000000011356889999999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=323.71  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=208.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.++||.|+||.||+|.+. ++..||+|.++..  .......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            46888889999999999999975 6899999998643  23445678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++... +..+++..++.++.|++.+|.|||   +++|+|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          83 FCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999999988653 456899999999999999999999   88899999999999999999999999999876543211


Q ss_pred             CcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                          ......|++.|++||++.     ...++.++|||||||++|+|++|.+||.............       .+... 
T Consensus       159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~-  226 (280)
T cd06611         159 ----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-------KSEPP-  226 (280)
T ss_pred             ----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh-------cCCCC-
Confidence                123346899999999974     3457789999999999999999999998765433222211       11000 


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                          .+.   ........+.+++.+||+.||.+||++.++++|.|....
T Consensus       227 ----~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         227 ----TLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             ----CcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                000   011233578899999999999999999999999996543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.4e-41  Score=320.95  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            357888899999999999999875      35678999876432 23334568899999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---ceEE
Q 013401          208 RIVIVEYVPNGTLREHLDCLQG-----NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF---RAKV  279 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~vkl  279 (443)
                      .++||||+.|++|.+++.....     ..+++..++.++.||+.||.|||   +++++|+||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999965421     25888999999999999999999   88899999999999998654   5999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHh
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      +|||++........  ........++..|+|||++.+..++.++|||||||++|||++ |..||...........+.   
T Consensus       161 ~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~---  235 (277)
T cd05036         161 ADFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT---  235 (277)
T ss_pred             ccCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence            99999986632211  111112234568999999988889999999999999999997 999998654432111111   


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                          ...... .         ....+..+.+++.+||+.||++||++.+|+++|.
T Consensus       236 ----~~~~~~-~---------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 ----GGGRLD-P---------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ----cCCcCC-C---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                000000 0         0112357899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.2e-41  Score=324.04  Aligned_cols=264  Identities=27%  Similarity=0.371  Sum_probs=208.2

Q ss_pred             CHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeee
Q 013401          126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLE  203 (443)
Q Consensus       126 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~  203 (443)
                      ++.++....++|.+...||+|+||.||++... +++.+|+|++...   ......+.+|+.++..+ +||||+++++++.
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            34555556788999999999999999999975 6899999998653   22345678899999999 7999999999987


Q ss_pred             ec-----CeEEEEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013401          204 FE-----DERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR  276 (443)
Q Consensus       204 ~~-----~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~  276 (443)
                      ..     +..++||||++|++|.+++...  .+..+++..++.++.|++.||.|||   .++++|+||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence            54     3589999999999999988632  3456899999999999999999999   888999999999999999999


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-----QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER  351 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~  351 (443)
                      +||+|||++........    ......|+..|+|||++...     .++.++|||||||++|+|++|.+||.........
T Consensus       167 ~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~  242 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL  242 (291)
T ss_pred             EEEeecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence            99999999876543221    12234589999999998543     3678999999999999999999999766543322


Q ss_pred             HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ..+..       .....+.+        .......+.+|+.+||+.||++||++.++++|.|.
T Consensus       243 ~~~~~-------~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  290 (291)
T cd06639         243 FKIPR-------NPPPTLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI  290 (291)
T ss_pred             HHHhc-------CCCCCCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence            21110       00000101        01123569999999999999999999999999884

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-40  Score=326.27  Aligned_cols=265  Identities=22%  Similarity=0.286  Sum_probs=190.2

Q ss_pred             ceeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEEEEEeec
Q 013401          141 FKIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERIVIVEYV  215 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~  215 (443)
                      .+||+|+||.||+|..+   ++..||+|.++...    ....+.+|+.+|+.++||||+++++++..  +...++||||+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            47999999999999865   45789999886532    23457799999999999999999998854  55789999998


Q ss_pred             CCCcHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCceEEeeecc
Q 013401          216 PNGTLREHLDCL-------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL----TENFRAKVADFGF  284 (443)
Q Consensus       216 ~gg~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFGl  284 (443)
                      . ++|.+++...       ....+++..+..++.||+.||.|||   +++|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            6 5777776422       1234788888999999999999999   8889999999999999    4667999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH------HHHHHHH
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE------RITVKWA  357 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~------~~~~~~~  357 (443)
                      ++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|.+||....+...      .......
T Consensus       159 a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         159 ARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             eeccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            9876543211 111234568999999999876 4588999999999999999999999975432100      0000000


Q ss_pred             hhhcC--CCcc----------ccc---c-Cccccch-------hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          358 MKKFS--DGDA----------ISI---L-DPRVENT-------AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       358 ~~~~~--~~~~----------~~~---~-d~~~~~~-------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ...+.  ....          ...   . .......       .........+.+|+.+||+.||.+|||+.++++|+|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00000  0000          000   0 0000000       0000123468899999999999999999999999883

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.1e-41  Score=324.28  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=206.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|+..+.||+|+||.||++...      ....+|+|.++... ......++.+|+.++..+ +|+||+++++++..++.
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            46888889999999999999864      24689999987542 233446688999999999 79999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          208 RIVIVEYVPNGTLREHLDCL--------------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      .+++|||+.+|+|.+++...              ....+++..++.++.|++.||.|||   +++|+||||||+|||++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            99999999999999998642              2456888999999999999999999   888999999999999999


Q ss_pred             CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 013401          274 NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERI  352 (443)
Q Consensus       274 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~  352 (443)
                      ++.+||+|||++........  ........++..|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDY--YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             CCeEEeCccccccccccccc--eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            99999999999987654321  111122235678999999988889999999999999999998 999997654322211


Q ss_pred             HHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          353 TVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...       .+....          ....+...+.+|+.+||..||++|||+.++++.|..+.
T Consensus       246 ~~~-------~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLK-------EGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHH-------cCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            111       110000          00112467999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9.2e-41  Score=323.80  Aligned_cols=271  Identities=22%  Similarity=0.279  Sum_probs=207.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC---cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD---KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      +|...+.||+|+||.||+|... +++.||||.++.....   ......+..|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999976 6899999998765433   22345577899999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+ +++|.+++.... ..+++..++.++.||+.||.|||   +++++|+||||+|||++.++.++|+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999986432 36899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc----
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA----  366 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----  366 (443)
                      ..    ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||........................    
T Consensus       156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NR----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Cc----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            21    1223346888999999854 46788999999999999999998888766543322221111000000000    


Q ss_pred             --ccc----cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          367 --ISI----LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       367 --~~~----~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ...    ..+.............++.+|+.+||++||++||++.+++++.|.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence              000    0000000111123457899999999999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.1e-41  Score=324.60  Aligned_cols=254  Identities=25%  Similarity=0.390  Sum_probs=208.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|...+.||.|+||.||+|... +++.||||.+....  ......+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            36888899999999999999864 79999999886542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++..   ..+++..++.++.+++.+|.|||   +++++|+||||+||+++.++.+||+|||++........
T Consensus        97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          97 YLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             ecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999998853   45899999999999999999999   88899999999999999999999999999876543221


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..............  .....     .    
T Consensus       171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~--~~~~~-----~----  235 (296)
T cd06655         171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTPE-----L----  235 (296)
T ss_pred             ----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCcc-----c----
Confidence                12234689999999999888899999999999999999999999987765433221110  00000     0    


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       .   ........+.+|+.+||..||.+||++.+++.|.|.-
T Consensus       236 -~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         236 -Q---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             -C---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence             0   0112335788999999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-40  Score=316.30  Aligned_cols=248  Identities=29%  Similarity=0.441  Sum_probs=200.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeee-ecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLE-FEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~E  213 (443)
                      ++|.+.+.||+|+||.||++... |..||+|.++..    .....+.+|+.+++.++|+||+++++++. .++..++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            46888899999999999999775 778999988643    23467889999999999999999999764 4567899999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++.......+++..++.++.||+.||.|||   .++++||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999999997655556889999999999999999999   8899999999999999999999999999987543321 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            ....++..|+|||++.+..++.++|||||||++|+|++ |..||...........       +..+.....   
T Consensus       157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---  220 (256)
T cd05082         157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGYKMDA---  220 (256)
T ss_pred             ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HhcCCCCCC---
Confidence                  22335678999999988889999999999999999997 9999975433211111       111100000   


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                             ...++..+.+++.+||+.||++||++.++++.|..
T Consensus       221 -------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 -------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                   11234679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-41  Score=322.02  Aligned_cols=260  Identities=24%  Similarity=0.382  Sum_probs=206.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|++++.||+|+||.||++... ++..||+|.++... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            5788889999999999999976 79999999887542 233446788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      +++++|.+++.... ...+++..+..++.|++.||.|||.  .++|+|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            99999998886421 2368999999999999999999993  2589999999999999999999999999987654321 


Q ss_pred             CcccccccccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTY------QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                           .....|++.|+|||++.+.      .++.++|||||||++|+|++|..||.............    ....+...
T Consensus       158 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~  228 (286)
T cd06622         158 -----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----AIVDGDPP  228 (286)
T ss_pred             -----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----HHhhcCCC
Confidence                 2334588899999998543      35789999999999999999999997543322111111    11111100


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      .     +     ......++.+|+.+||+.+|++||++.+++.+.|....+
T Consensus       229 ~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         229 T-----L-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             C-----C-----CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            0     0     112456789999999999999999999999999965443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.2e-41  Score=326.35  Aligned_cols=275  Identities=21%  Similarity=0.254  Sum_probs=206.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      .++|+...+||+|+||.||+|... +++.||||.+............+.+|+.+++.++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999976 6999999988654333333445678999999999999999999887654      


Q ss_pred             --eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          207 --ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       207 --~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                        ..++||||+. ++|.+++.. ....+++..++.++.||+.||.|||   +++++|+||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              4599999996 578877754 3346899999999999999999999   88899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      +..................++..|+|||++.+. .++.++||||||+++|+|++|.+||...........+......+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            987654332221222344678899999988654 4788999999999999999999999876654433333332221111


Q ss_pred             Cccc-----cccC---------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          364 GDAI-----SILD---------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       364 ~~~~-----~~~d---------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ....     ...+         ...............+.+|+.+||+.||.+||++.++++|.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence            1000     0000         000000000012356789999999999999999999999988

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-40  Score=322.05  Aligned_cols=258  Identities=27%  Similarity=0.384  Sum_probs=203.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      +|...+.||+|+||.||+|...      ....+++|.+..... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            4677889999999999999853      235789998875432 233467889999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 013401          210 VIVEYVPNGTLREHLDCLQ----------------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSS  267 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~  267 (443)
                      +++||+.+++|.+++....                      ...+++..++.++.|++.||.|||   +++++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhh
Confidence            9999999999999986421                      134778888999999999999999   888999999999


Q ss_pred             CEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCch
Q 013401          268 NILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKR  346 (443)
Q Consensus       268 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~  346 (443)
                      |||+++++.+||+|||++.........  .......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999999765432211  11122345778999999988889999999999999999998 999997654


Q ss_pred             hHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          347 ELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .........       ...     ....     ....+..+.+++..||+.||.+||++.++++.|..+.
T Consensus       235 ~~~~~~~~~-------~~~-----~~~~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 PERLFNLLK-------TGY-----RMER-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHHHHh-------CCC-----CCCC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            322111110       000     0000     0123367999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.2e-41  Score=323.77  Aligned_cols=255  Identities=22%  Similarity=0.351  Sum_probs=201.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      +|...++||+|+||.||+|...      ++..||||+++... .......+.+|+.++..++||||+++++++.+.+..+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4666678999999999999863      25789999987542 2233466889999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013401          210 VIVEYVPNGTLREHLDCL--------------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF  275 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~  275 (443)
                      +++||+.+++|.+++...              ....+++..++.++.|++.||.|||   +++|+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998521              1234788888999999999999999   88899999999999999999


Q ss_pred             ceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHH
Q 013401          276 RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITV  354 (443)
Q Consensus       276 ~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~  354 (443)
                      .+||+|||+++.......  ........+++.|+|||++.+..++.++|||||||++|||++ |..||........... 
T Consensus       162 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-  238 (283)
T cd05091         162 NVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM-  238 (283)
T ss_pred             ceEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-
Confidence            999999999876543321  111223446789999999988889999999999999999998 8889876543221111 


Q ss_pred             HHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                            .........          ...++..+.+|+.+||+.||.+||++.+|+..|.
T Consensus       239 ------i~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         239 ------IRNRQVLPC----------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             ------HHcCCcCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence                  111111100          1123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.9e-41  Score=325.18  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=207.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|...+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            57889999999999999999975 79999999986543  2334668899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++..   ..+++..+..++.|++.+|.|||   +.+++||||||+|||++.++.++|+|||++........
T Consensus        97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          97 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999998853   45788899999999999999999   88899999999999999999999999999876543221


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........... .+      ...     .+.
T Consensus       171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~------~~~-----~~~  234 (297)
T cd06656         171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IA------TNG-----TPE  234 (297)
T ss_pred             ----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ec------cCC-----CCC
Confidence                12234689999999999888899999999999999999999999976543221110 00      000     000


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..   ........+.+|+.+||..||++||++.++++|.|..
T Consensus       235 ~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         235 LQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence            00   1112346688999999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-40  Score=323.03  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=206.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|...+.||+|+||.||++...      ++..||||.++.... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            46888899999999999999741      356799998875422 33346788999999999 79999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+.+|+|.+++.......+++..++.++.|++.||.|||   +++|+|+||||+|||++.++.+||+|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997544455899999999999999999999   88899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ......  ........++..|+|||++.+..++.++|||||||++|+|++ |..||...........  ...    .+..
T Consensus       191 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~--~~~----~~~~  262 (302)
T cd05055         191 IMNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK--LIK----EGYR  262 (302)
T ss_pred             ccCCCc--eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH--HHH----cCCc
Confidence            543221  111222346788999999988889999999999999999998 9999976543222111  100    1100


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..          .....++++.+|+.+||+++|++||++.++++.+..+
T Consensus       263 ~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 MA----------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00          0011236799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-40  Score=323.77  Aligned_cols=261  Identities=28%  Similarity=0.405  Sum_probs=203.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc--EEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|.+...||+|+||.||+|.++ ++.  .+++|.++.. ......+.+.+|+.++.++ +||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            46888889999999999999875 343  4788887642 2233456788999999999 69999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013401          211 IVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR  276 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~  276 (443)
                      |+||+++++|.+++....              ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCe
Confidence            999999999999996422              134788899999999999999999   889999999999999999999


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVK  355 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~  355 (443)
                      +||+|||++.......     .......+..|+|||++.+..++.++|||||||++|||++ |..||...........  
T Consensus       158 ~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~--  230 (297)
T cd05089         158 SKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK--  230 (297)
T ss_pred             EEECCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence            9999999986432110     0111223557999999988889999999999999999997 9999976644221111  


Q ss_pred             HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          356 WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                           ...+....     .     ...++..+.+|+.+||+.||.+||++.++++.|..+...++.
T Consensus       231 -----~~~~~~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         231 -----LPQGYRME-----K-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             -----HhcCCCCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                 11110000     0     011336789999999999999999999999999877655543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.4e-41  Score=320.62  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=211.4

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      ||+|+||+||+|... +|+.||+|.+...... ......+.+|+.+|+.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            799999999999866 6899999998654322 22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccc
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST  300 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  300 (443)
                      .+++.......+++..++.++.|++.||.|||   .++++|+||+|+|||++.++.+||+|||++.......     ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~  152 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KIK  152 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----ccc
Confidence            99997655557899999999999999999999   8889999999999999999999999999987654321     122


Q ss_pred             cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       301 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ...++..|+|||++.+..++.++|||||||++|+|++|..||...............   .... ...          ..
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~~----------~~  218 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLEM-AVE----------YP  218 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---cccc-ccc----------CC
Confidence            345888999999998888999999999999999999999999765432111111110   0000 000          01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCc
Q 013401          381 NLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                      ....+.+.+++.+||+.||.+||     ++.+++.|+|...-++....+....
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~  271 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLE  271 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCC
Confidence            11246789999999999999999     8888999999988888777655554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-41  Score=322.82  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=208.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.+.||+|+||+||++... +|+.||+|++.... .......+.+|+++++.++||||+++++++...+.+++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            46777889999999999999876 68999999876542 23345678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++..  ...+++..+..++.+++.+|.|||.  .++++|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            9999999998864  3568899999999999999999993  3589999999999999999999999999986543221 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH----HHHHHHHhhhcCCCccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE----RITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  369 (443)
                           .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......+    ...+...........    
T Consensus       159 -----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         159 -----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             -----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence                 1234689999999999888899999999999999999999999986543211    011101111111110    


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                       .+.+.    ....+.++.+|+.+||+.||++||++.++++++|.+.
T Consensus       230 -~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         230 -PPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             -CCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence             01110    1124467999999999999999999999999998765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7e-41  Score=326.05  Aligned_cols=261  Identities=30%  Similarity=0.425  Sum_probs=203.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc--EEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|++.+.||+|+||.||+|.++ ++.  .+|+|.++.. ........+.+|+.++.++ +|+||+++++++.+++..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            46888889999999999999875 454  4577776542 2234456788999999999 89999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013401          211 IVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR  276 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~  276 (443)
                      ||||+++++|.+++....              ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999996432              235788899999999999999999   889999999999999999999


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVK  355 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~  355 (443)
                      +||+|||++.......     ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........  
T Consensus       163 ~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--  235 (303)
T cd05088         163 AKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK--  235 (303)
T ss_pred             EEeCccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH--
Confidence            9999999986322110     0111224667999999988889999999999999999998 9999976543221111  


Q ss_pred             HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          356 WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                           ...+....     .     ....+..+.+|+.+||+.+|++||++.++++.+..+..+-+.
T Consensus       236 -----~~~~~~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         236 -----LPQGYRLE-----K-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             -----HhcCCcCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence                 11110000     0     011235689999999999999999999999999877555443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=360.08  Aligned_cols=260  Identities=30%  Similarity=0.479  Sum_probs=212.4

Q ss_pred             CCCCceeeeeCceEEEEEEEc--CCc----EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE--DGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~--~g~----~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ....+.||+|.||.||.|...  +|.    .||||.+++. .+.....+|.+|..+|+.++|||||+++|++.+....+|
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            445567999999999999865  344    3899988764 345667889999999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          211 IVEYVPNGTLREHLDCL-----QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      ++|||+||+|..||++.     ....+...+.+.|+.|||+|+.||+   ++++|||||-..|+||+....|||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999864     2456889999999999999999999   788999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +-+.+.+.  ........-...|||||.+....++.|+|||||||+|||++| |..||...+..+-....      ...+
T Consensus       850 rDiy~~~y--yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg  921 (1025)
T KOG1095|consen  850 RDIYDKDY--YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG  921 (1025)
T ss_pred             Hhhhhchh--eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC
Confidence            95443321  112122223468999999999999999999999999999999 99999988765432211      1122


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                              +++   ....+++.+.+||.+||+.+|++||++..|++.+..+....
T Consensus       922 --------RL~---~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  922 --------RLD---PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             --------ccC---CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                    111   12346788999999999999999999999999887765544

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.7e-41  Score=322.49  Aligned_cols=269  Identities=27%  Similarity=0.392  Sum_probs=201.9

Q ss_pred             CCCCceeeeeCceEEEEEEE-----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERI  209 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  209 (443)
                      |...+.||+|+||+||++..     .+++.||+|.++... .......+.+|+++|+.++||||+++++++...  ...+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            47888999999999988652     358899999987642 223456788999999999999999999987653  3588


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+++|.+++..   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus        85 lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999999863   35899999999999999999999   8889999999999999999999999999998665


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ..... ........++..|+|||++.+..++.++|||||||++|+|++|..||.......... ..+.............
T Consensus       159 ~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~  236 (283)
T cd05080         159 EGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMTVVRLIEL  236 (283)
T ss_pred             Ccchh-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccchhhhhhh
Confidence            42211 111222346778999999988889999999999999999999999986543211100 0000000000001111


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ++..... ......+.++.+++.+||++||++||++.++++.+..+
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111100 01122446899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=314.40  Aligned_cols=249  Identities=28%  Similarity=0.466  Sum_probs=205.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+..+.||.|+||.||+|... |+.||||.++....   ...++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            57888899999999999999876 78899999876532   457788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++.......+++..++.++.|++.||.|||   .++++|+||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999997655557899999999999999999999   8889999999999999999999999999997663221  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                           ....++..|+|||++.+..++.++||||||+++|+|++ |..||.............       .+.....    
T Consensus       157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~----  220 (256)
T cd05039         157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-------KGYRMEA----  220 (256)
T ss_pred             -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCCCCC----
Confidence                 12235667999999988889999999999999999997 999997654322111111       0000000    


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                            ....++.+.+++.+||..+|++||++.++++.|..
T Consensus       221 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 ------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                  01134679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=315.15  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=208.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+..+.||.|+||.||+|... +++.+++|.+....  ......+.+|+.+++.++||||+++++++...+.++++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            47888899999999999999875 68899999987543  2355778999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||   .++++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          81 YCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            99999999988652 356889999999999999999999   88899999999999999999999999999876543211


Q ss_pred             CcccccccccCCCCccCccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                          ......++..|+|||++.+.   .++.++|||||||++|+|++|.+||..............  ..+..       
T Consensus       157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--~~~~~-------  223 (262)
T cd06613         157 ----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--SNFPP-------  223 (262)
T ss_pred             ----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCC-------
Confidence                12335689999999999776   788999999999999999999999976654332211110  00000       


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                       +.+.   .....+..+.+++.+||..||..||++.+++.|.|
T Consensus       224 -~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         224 -PKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             -cccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence             0000   11224567999999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-40  Score=313.14  Aligned_cols=247  Identities=30%  Similarity=0.442  Sum_probs=199.2

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHH
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLR  221 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~  221 (443)
                      .||+|+||.||+|...++..||+|.++... .......+.+|+.+++.++||||+++++++...+..++||||+.+++|.
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            699999999999998889999999987543 2333456889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccccc
Q 013401          222 EHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ  301 (443)
Q Consensus       222 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  301 (443)
                      +++... ...+++..++.++.+++.+|.|||   .++++|+||||+||+++.++.+||+|||++........   .....
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~  153 (250)
T cd05085          81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---SSSGL  153 (250)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc---ccCCC
Confidence            988643 345789999999999999999999   88899999999999999999999999999875432211   11112


Q ss_pred             ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       302 ~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+.....          .
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~----------~  216 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-------KGYRMSC----------P  216 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-------cCCCCCC----------C
Confidence            234677999999988889999999999999999998 999997664433221111       1110000          0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          381 NLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ...+..+.+++.+||+.+|++||++.++++.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            113467999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-40  Score=321.87  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=205.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC-----------------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED-----------------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK  197 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~  197 (443)
                      .+|++.++||+|+||.||+|.+.+                 +..||+|.+.... .......+.+|+++++.++|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            478899999999999999997542                 2468999887543 2344567889999999999999999


Q ss_pred             eeeeeeecCeEEEEEeecCCCcHHHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 013401          198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQ---------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSN  268 (443)
Q Consensus       198 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N  268 (443)
                      +++++..++..+++||++.+++|.+++....         ...+++..++.++.|++.||.|||   +++|+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999996533         126889999999999999999999   8889999999999


Q ss_pred             EEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCch
Q 013401          269 ILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT--GRRPIEPKR  346 (443)
Q Consensus       269 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt--G~~Pf~~~~  346 (443)
                      ||++.++.++|+|||++........  ........+++.|+|||++.+..++.++|||||||++|||++  |..||....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDY--YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcc--eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            9999999999999999876543321  112234456789999999988889999999999999999998  778886554


Q ss_pred             hHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          347 ELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ....   .......+...........       ...++.++.+|+.+||+.||.+||++.+|++.|.
T Consensus       239 ~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQQV---IENAGHFFRDDGRQIYLPR-------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hHHH---HHHHHhccccccccccCCC-------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            3221   1111111111111000000       1123367999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-43  Score=315.03  Aligned_cols=267  Identities=26%  Similarity=0.346  Sum_probs=210.3

Q ss_pred             CcccCHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHh-cCCcceeeee
Q 013401          122 NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ-VEHLNLVKFH  199 (443)
Q Consensus       122 ~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~  199 (443)
                      ...|+.+++....       .||.|+||+|++-.++ .|+.+|||++...... ....+++.|...... -+.||||++|
T Consensus        58 ~~~F~~~~Lqdlg-------~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   58 LHTFTSDNLQDLG-------EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             ccccccchHHHHH-------HhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            3455655555444       6999999999999877 6999999999876543 344567777776554 5799999999


Q ss_pred             eeeeecCeEEEEEeecCCCcHHH---HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013401          200 GYLEFEDERIVIVEYVPNGTLRE---HLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR  276 (443)
Q Consensus       200 ~~~~~~~~~~lv~E~~~gg~L~~---~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~  276 (443)
                      |++..++.+||+||+| ..+|..   ++...+...+++...-.|+...+.||.||..  ...|||||+||+||||+..|.
T Consensus       130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~  206 (361)
T KOG1006|consen  130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD  206 (361)
T ss_pred             hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence            9999999999999999 445543   3344566789999888999999999999986  668999999999999999999


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK--TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV  354 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~  354 (443)
                      |||||||++..+.+.-.     -+.-.|-.-|||||.+.  +..|+.++||||||++|||+.||..|+..++...+++..
T Consensus       207 vKLCDFGIcGqLv~SiA-----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~  281 (361)
T KOG1006|consen  207 VKLCDFGICGQLVDSIA-----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ  281 (361)
T ss_pred             EeeecccchHhHHHHHH-----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH
Confidence            99999999987765422     22334788899999994  346899999999999999999999999999887776654


Q ss_pred             HHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..      .++.     |.+.......+....++.++..||.+|.+.||.+.+++++.+..
T Consensus       282 Vv------~gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  282 VV------IGDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             HH------cCCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence            32      1111     11111222234567899999999999999999999999998743

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2e-40  Score=318.96  Aligned_cols=259  Identities=23%  Similarity=0.415  Sum_probs=201.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc----EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|+..+.||+|+||.||+|.+. ++.    .+++|.+... .......++..|+.++..++||||+++++++. ....+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence            46788889999999999999874 455    3666766432 12223456778888999999999999999875 45678


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +++||+.+|+|.+++.. ....+++..++.|+.||+.||.|||   +++++||||||+|||++.++.+||+|||+++...
T Consensus        85 ~i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999999974 3456899999999999999999999   8889999999999999999999999999998664


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....  ........++..|++||++.+..++.++|||||||++|||++ |..||.........   +. .   ..+....
T Consensus       161 ~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~---~~-~---~~~~~~~  231 (279)
T cd05111         161 PDDK--KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP---DL-L---EKGERLA  231 (279)
T ss_pred             CCCc--ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH-H---HCCCcCC
Confidence            3321  112234557789999999988889999999999999999998 99999776432211   11 1   1111111


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                        .+.        .+...+.+++.+||..||.+||++.++++.+..+..+
T Consensus       232 --~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         232 --QPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             --CCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence              010        1234678899999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=337.31  Aligned_cols=263  Identities=29%  Similarity=0.449  Sum_probs=213.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC--C--cE-EEEEEccc-cccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED--G--TI-VAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~--g--~~-vavK~~~~-~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      .+....++||+|+||.||+|.++.  +  .. ||||..+. .........++.+|.++|++++|||||++||++..+..+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            345555799999999999998652  2  23 89999885 335677788999999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      +||||+|.||+|.+||....+ .++..+++.++.+.+.||+|||   .+++|||||-..|+|++.++.+||+||||++..
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            999999999999999986443 6999999999999999999999   899999999999999999999999999998765


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      .....    ......-...|+|||.+....|+.++|||||||++||+.+ |..||.+......+..+..      .+-. 
T Consensus       313 ~~~~~----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~------~~~r-  381 (474)
T KOG0194|consen  313 SQYVM----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK------NGYR-  381 (474)
T ss_pred             cceee----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh------cCcc-
Confidence            31111    1111135678999999999899999999999999999999 8999998876543333311      0000 


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                            +..   ....+.++..++.+||..||+.||+|.++.+.+..+......
T Consensus       382 ------~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  382 ------MPI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ------CCC---CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                  000   012346788999999999999999999999999988766553

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=314.63  Aligned_cols=253  Identities=22%  Similarity=0.294  Sum_probs=205.4

Q ss_pred             HhcCCCCC-ceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeee----c
Q 013401          133 ATRNFSPS-FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEF----E  205 (443)
Q Consensus       133 ~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~  205 (443)
                      .+++|.+. .+||-|-.|.|-.|..+ +|+.+|+|++...       ...++|+++.-.. .|||||.++++|+.    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            34555543 36999999999999876 7999999987643       4567899887666 59999999999864    3


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCceEEeee
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADF  282 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DF  282 (443)
                      ..+.+|||.|+||+|+..|.......+.+.++..|+.||..|+.|||   +.+|.||||||+|+|..   .|..+||+||
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence            46788999999999999999888888999999999999999999999   88899999999999996   4567999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH----HHHHHHHHh
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK----ERITVKWAM  358 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~----~~~~~~~~~  358 (443)
                      |+|+......     .....+-||+|.|||++....|+...|+|||||++|.||+|.+||......-    .+..+....
T Consensus       209 GFAK~t~~~~-----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq  283 (400)
T KOG0604|consen  209 GFAKETQEPG-----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ  283 (400)
T ss_pred             ccccccCCCc-----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence            9998655322     2445678999999999999999999999999999999999999997654311    111111111


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ..|.              .+.....++...++|+.+|..+|.+|.|+.+++.|+|.
T Consensus       284 y~FP--------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  284 YEFP--------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             ccCC--------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            1111              11234567889999999999999999999999999995

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=322.11  Aligned_cols=269  Identities=22%  Similarity=0.348  Sum_probs=202.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+....||+|+||.||+|..+ +++.||||.+...... .....+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            57888999999999999999976 6899999998754322 223456789999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+ +|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus        84 ~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          84 YLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9975 899988653 346889999999999999999999   88899999999999999999999999999875432211


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc-c---
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI-S---  368 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~---  368 (443)
                          ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......+.....+........... .   
T Consensus       159 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 ----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             ----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence                1222347889999999865 458899999999999999999999997665332222211111000000000 0   


Q ss_pred             ----------cc-CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          369 ----------IL-DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       369 ----------~~-d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                                .. ...+...........++.+++.+||+.||++||++.+++++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence                      00 0000000000011256889999999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-40  Score=316.84  Aligned_cols=258  Identities=28%  Similarity=0.461  Sum_probs=204.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CC---cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|...+.||+|+||.||+|.+. ++   ..+|||.++... .......+.+|+.+++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            46778889999999999999875 33   379999887542 23345678899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+++++|.+++.. ....+++..+..++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999999864 3356889999999999999999999   88899999999999999999999999999876643


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      .... .........+..|+|||++.+..++.++|||||||++|||++ |..||...........+.       .+.....
T Consensus       160 ~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-------~~~~~~~  231 (268)
T cd05063         160 DPEG-TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-------DGFRLPA  231 (268)
T ss_pred             cccc-ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-------cCCCCCC
Confidence            2211 111111223567999999988889999999999999999997 999997654322111111       1100000


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                                ....+..+.+|+.+||+.||+.||++.++++.|..+
T Consensus       232 ----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         232 ----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      112346789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.2e-40  Score=314.75  Aligned_cols=250  Identities=22%  Similarity=0.414  Sum_probs=197.0

Q ss_pred             eeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|.+.   ++..||||+++... .....+.+.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            4999999999999764   45679999987542 2344567889999999999999999999875 45789999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++.. ....+++..++.++.||+.||.|||   .++++||||||+|||++.++.+||+|||++.......... ..
T Consensus        80 ~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~  154 (257)
T cd05115          80 PLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KA  154 (257)
T ss_pred             CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-ec
Confidence            99999864 3456899999999999999999999   8889999999999999999999999999997654332211 11


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccch
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT  377 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  377 (443)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+       ..+.... .       
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~~-~-------  219 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-------EQGKRLD-C-------  219 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCCCC-C-------
Confidence            112234678999999988889999999999999999996 99999766443211111       1111100 0       


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       378 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ...+.+++.+++.+||..||++||++.+|++.|..+
T Consensus       220 --~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 --PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              012346799999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=314.34  Aligned_cols=250  Identities=25%  Similarity=0.411  Sum_probs=197.2

Q ss_pred             ceeeeeCceEEEEEEEc-C---CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecC
Q 013401          141 FKIGQGGFGTVYKGRLE-D---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  216 (443)
                      ++||+|+||.||+|... .   +..||+|.++..... .....+.+|+++++.+.|+|||++++++. .+..++||||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            36999999999999753 2   378999998765432 34567889999999999999999999876 556899999999


Q ss_pred             CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          217 NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       217 gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      +++|.+++...  ..+++..++.++.|++.+|.|||   ..+++|+||||+|||++.++.+||+|||++.......... 
T Consensus        79 ~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-  152 (257)
T cd05060          79 LGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-  152 (257)
T ss_pred             CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-
Confidence            99999999743  36899999999999999999999   7889999999999999999999999999998664332111 


Q ss_pred             cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                      .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.........   .+..    ......       
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~---~~~~----~~~~~~-------  218 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI---AMLE----SGERLP-------  218 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHH----cCCcCC-------
Confidence            11111224567999999988889999999999999999998 99999765442211   1111    111000       


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         ....++..+.+++.+||.+||++||++.++++.|..+
T Consensus       219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence               0112336789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-41  Score=347.51  Aligned_cols=277  Identities=20%  Similarity=0.214  Sum_probs=193.5

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc--CCcEEEEEE--------------c-cccccCcccHHHHHHHHHHHHhcCCcce
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE--DGTIVAIKR--------------A-KKSVYDKHSGAEFQSEIRTLAQVEHLNL  195 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~--------------~-~~~~~~~~~~~~~~~Ei~~l~~l~h~ni  195 (443)
                      ...+|+++++||+|+||+||+|.++  ++..+++|.              + +...........+.+|+.+|++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4568999999999999999998754  222222221              1 1111122234567899999999999999


Q ss_pred             eeeeeeeeecCeEEEEEeecCCCcHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013401          196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ---GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT  272 (443)
Q Consensus       196 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~  272 (443)
                      |++++++...+..|+|+|++ +++|.+++....   ........++.|+.||+.||.|||   +++||||||||+||||+
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            99999999999999999998 457777764211   112234566789999999999999   88899999999999999


Q ss_pred             CCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCC-CCCch--hHH
Q 013401          273 ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-IEPKR--ELK  349 (443)
Q Consensus       273 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~P-f~~~~--~~~  349 (443)
                      .++.+||+|||++..+.....   .......||+.|+|||++.+..++.++|||||||+||||++|..+ |....  +..
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            999999999999987654321   112345799999999999998999999999999999999998754 43221  111


Q ss_pred             HHHHHHHHhhh----cCCC--cccccc--------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          350 ERITVKWAMKK----FSDG--DAISIL--------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       350 ~~~~~~~~~~~----~~~~--~~~~~~--------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ....+......    +.+.  .....+        ...+............+.+++.+||+.||.+||++.|++.|+|.-
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            11111111000    0000  000000        000000000111234678899999999999999999999999964


Q ss_pred             h
Q 013401          416 R  416 (443)
Q Consensus       416 ~  416 (443)
                      .
T Consensus       459 ~  459 (501)
T PHA03210        459 A  459 (501)
T ss_pred             c
Confidence            3

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-40  Score=317.17  Aligned_cols=256  Identities=23%  Similarity=0.374  Sum_probs=201.6

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++++.....||+|+||.||+|.+. ++..||+|.+....  ....+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            3456666678999999999999865 68889999876542  33456788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNIL--DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~  288 (443)
                      +||+.+++|.+++.... ..+  ++..+..++.||+.||.|||   .++|+||||||+||+++. ++.++|+|||++...
T Consensus        84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          84 MEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999987432 334  77888899999999999999   888999999999999976 679999999998765


Q ss_pred             cccCCCcccccccccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTY--QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .....    ......|++.|+|||++.+.  .++.++|||||||++|+|++|..||..........   +.......   
T Consensus       160 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~~~---  229 (268)
T cd06624         160 AGINP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMFKI---  229 (268)
T ss_pred             ccCCC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhhcc---
Confidence            43221    12234589999999998654  37889999999999999999999996543221111   11100000   


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                          .+.+     .....+++.+|+.+||+.+|.+||++.++++|+|
T Consensus       230 ----~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         230 ----HPEI-----PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             ----CCCC-----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence                0001     1123467999999999999999999999999988

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=303.49  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=208.7

Q ss_pred             HhcCCCCCceeeeeCceEEEEEE-EcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  206 (443)
                      ..++|++.++||+|||+-||+++ ..+++.||+|++....  ....+..++|++..+.++||||++++++...+.     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            34689999999999999999998 4579999999987653  566788999999999999999999998764433     


Q ss_pred             eEEEEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCceEEeee
Q 013401          207 ERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                      ..||++.|...|+|.+.+...  ++..+++.+.+.|+.+|+.||++||   +..  +.||||||.|||+.+.+.++|.||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEec
Confidence            489999999999999999754  4567999999999999999999999   666  999999999999999999999999


Q ss_pred             cccccccccCCCcccc-----cccccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHH
Q 013401          283 GFARLAADTESGATHV-----STQVKGTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV  354 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~  354 (443)
                      |.+....-.-.+....     .....-|.-|.|||.+..   ...++++|||||||+||+|+.|..||+..-+       
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------  246 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------  246 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence            9987654322111111     112246888999999854   4577899999999999999999999965422       


Q ss_pred             HHHhhhcCCCcc--ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          355 KWAMKKFSDGDA--ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       355 ~~~~~~~~~~~~--~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                              .|..  ..+..+.+..+... ..++.+.+|+..||+.||.+||++.+++.++..+
T Consensus       247 --------~GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 --------QGGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------cCCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                    1211  12222222222112 2678899999999999999999999999998765

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.5e-41  Score=321.32  Aligned_cols=261  Identities=25%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHH-HHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRT-LAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||.||++.+. +|+.||||+++...... ....+..|+.+ ++.++||||+++++++..++..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            36888899999999999999976 69999999987653322 23455566665 56678999999999999999999999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDH-PIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      ||++ ++|.+++...  ....+++..++.++.||+.||.|||   ++ +++||||||+|||++.++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9996 6787777542  2356899999999999999999999   66 89999999999999999999999999987654


Q ss_pred             ccCCCcccccccccCCCCccCcccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKT----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ...     ......|+..|+|||++.+    ..++.++|||||||++|+|++|..||.......+...  ....    +.
T Consensus       156 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~~----~~  224 (283)
T cd06617         156 DSV-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK--QVVE----EP  224 (283)
T ss_pred             ccc-----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH--HHHh----cC
Confidence            321     1123458899999999854    4568899999999999999999999975432211111  1100    00


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      .     +.+.    ....++++.+++.+||..||.+||++.+++++.|.......
T Consensus       225 ~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         225 S-----PQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             C-----CCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            0     0000    11134679999999999999999999999999998766544

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-40  Score=355.96  Aligned_cols=265  Identities=22%  Similarity=0.292  Sum_probs=204.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+|++.++||+|+||.||+|.+. +|+.||||+++..... .....++.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999976 6899999998764322 233467889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeec
Q 013401          213 EYVPNGTLREHLDCLQ---------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFG  283 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG  283 (443)
                      ||++|++|.+++....         ...+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421         123456677899999999999999   8889999999999999999999999999


Q ss_pred             ccccccccCCC--------------cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH
Q 013401          284 FARLAADTESG--------------ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK  349 (443)
Q Consensus       284 la~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~  349 (443)
                      ++.........              ........+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99866211100              0011223579999999999999899999999999999999999999997643321


Q ss_pred             HHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhhh
Q 013401          350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRP-SMRRCAEILWSVRK  417 (443)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~ell~~l~~i~~  417 (443)
                      .... .    ......  . +.       .....+..+.+++.+||+.||++|| +++++++.+..+..
T Consensus       239 i~~~-~----~i~~P~--~-~~-------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYR-D----VILSPI--E-VA-------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhh-h----hccChh--h-cc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1100 0    000000  0 00       0112346788999999999999995 56666666665543

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-40  Score=319.12  Aligned_cols=260  Identities=23%  Similarity=0.376  Sum_probs=204.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc----EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|+..++||+|+||+||+|.+. ++.    .||||+++... .......+.+|+.++..+.|+||+++++++.. ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            46888899999999999999854 454    48999886542 23345678899999999999999999998865 4578


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +++||+++|+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||+++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999998642 346899999999999999999999   8889999999999999999999999999998764


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....  .......+++.|+|||++.+..++.++|||||||++|||++ |..||.........   .+. .   .+....
T Consensus       161 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~-~---~~~~~~  231 (279)
T cd05109         161 IDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP---DLL-E---KGERLP  231 (279)
T ss_pred             cccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHH-H---CCCcCC
Confidence            32211  11122335678999999988889999999999999999998 99999755432211   111 1   111000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .          ....+..+.+++.+||+.||++||++.++++.+..+..+.
T Consensus       232 ~----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 Q----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             C----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            0          0113457899999999999999999999999988776655

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-40  Score=320.77  Aligned_cols=272  Identities=22%  Similarity=0.300  Sum_probs=207.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+....||+|+||.||+|.+. +|+.||||.+............+.+|+++++.++|+||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999976 78999999987654333445678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeecccccccccC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFARLAADTE  292 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~  292 (443)
                      |+. ++|.+++.......+++..++.++.||+.||.|||   +++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 58888886544455678888899999999999999   888999999999999985 5679999999997653321


Q ss_pred             CCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc---
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS---  368 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---  368 (443)
                          .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......+............ .....   
T Consensus       158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  232 (294)
T PLN00009        158 ----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN-EETWPGVT  232 (294)
T ss_pred             ----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hhhccccc
Confidence                11233457899999999865 4578899999999999999999999987655443332211111000 00000   


Q ss_pred             -cc-----Cccc---cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 -IL-----DPRV---ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 -~~-----d~~~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       ..     -+..   ..........+++.+++.+||+.||++||++.+++++.|..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence             00     0000   00001112346789999999999999999999999999864

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-40  Score=320.44  Aligned_cols=255  Identities=25%  Similarity=0.425  Sum_probs=202.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|....+||+|+||.||++...      ++..+|+|.++..  .......+.+|+++++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            46777889999999999999632      4668999987754  234456789999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013401          209 IVIVEYVPNGTLREHLDCLQG-------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF  275 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~  275 (443)
                      +++|||+.+++|.+++.....             ..+++..++.++.||+.||.|||   +++++||||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCC
Confidence            999999999999999864321             34788999999999999999999   88899999999999999999


Q ss_pred             ceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHH
Q 013401          276 RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITV  354 (443)
Q Consensus       276 ~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~  354 (443)
                      .+||+|||++........  ........+++.|+|||++.+..++.++|||||||++|||++ |.+||............
T Consensus       160 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CEEECCCCceeEcCCCce--eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            999999999875532211  111223345788999999998899999999999999999998 99999765443221111


Q ss_pred             HHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .       .+.....          ...++..+.+|+.+||+.||.+||++.++++.|.
T Consensus       238 ~-------~~~~~~~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 T-------QGRELER----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-------cCccCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1       1100000          0113356899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.9e-40  Score=315.39  Aligned_cols=253  Identities=28%  Similarity=0.465  Sum_probs=205.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|...++||+|+||.||++.+.++..+|+|.++..   ......+.+|+.+++.++|+||+++++.+.. ...+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            578889999999999999999877788999988753   3345678899999999999999999999877 778999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++....+..+++..++.++.||+.||.|||   ..+++|+||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            99999999997655667888899999999999999999   78899999999999999999999999999876543221 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++....++.++|||||||++|+|++ |..||...........+.       .+.....    
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~~~----  224 (260)
T cd05073         158 --TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRMPR----  224 (260)
T ss_pred             --ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCCCCCC----
Confidence              11122345678999999988889999999999999999999 999997654322211111       1100000    


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                            ....+..+.+++.+||+++|++||++.++++.|..
T Consensus       225 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  01234679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=313.19  Aligned_cols=248  Identities=31%  Similarity=0.506  Sum_probs=203.3

Q ss_pred             eeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          142 KIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      .||+|+||.||+|....    +..|+||.++...... ....+.+|+.++..++|+||+++++++......++||||+++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            69999999999998763    8899999987654332 467889999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          218 GTLREHLDCLQ-------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       218 g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ++|.+++....       ...+++..++.++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997532       367899999999999999999999   88999999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...  ........++..|+|||.+....++.++|||||||++|+|++ |..||.............       .+.... 
T Consensus       158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~-  227 (262)
T cd00192         158 DDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-------KGYRLP-  227 (262)
T ss_pred             ccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC-
Confidence            321  112234457889999999988889999999999999999999 699998764322111111       111000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                               ....++.++.+++.+||+.||++||++.+++++|
T Consensus       228 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         228 ---------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             ---------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                     0112246799999999999999999999999987

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.5e-41  Score=321.18  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=204.5

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |...+.||+|+||.||+|.+. ++..||||.++.... ......+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            445567999999999999875 688999998875432 234567889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .+++|.+++.   ...+++..+..++.|++.||.|||   .++++|+||+|+||+++.++.++|+|||++........  
T Consensus        85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            9999999885   356888999999999999999999   88999999999999999999999999999876543221  


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                        ......|+..|+|||++.+..++.++|||||||++|||++|..||...........       .....     .+.+ 
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~~-----~~~~-  221 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-------IPKNS-----PPTL-  221 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-------hhcCC-----CCCC-
Confidence              12234588999999999988899999999999999999999999975543221110       10110     0001 


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                          ....+..+.+++.+||+.+|++||++.+++.|.|...
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence                1123466899999999999999999999999999654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-40  Score=322.93  Aligned_cols=259  Identities=26%  Similarity=0.390  Sum_probs=204.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      .+|.+...||+|+||.||+|...        ++..||+|.++... .......+.+|+.+++.+ +||||+++++++...
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            46788889999999999999741        34579999887542 234456788999999999 799999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +..++||||+.+++|.+++....              ...+++..++.++.||+.||.|||   ++||+||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999996532              234677888999999999999999   8899999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||+++........  .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             cCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999866432211  11122346778999999988889999999999999999998 8888875533221


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...       +..+.....          ...++..+.+|+.+||+.+|.+||++.++++.|..+.
T Consensus       249 ~~~-------~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         249 FKL-------LKEGHRMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHH-------HHcCCcCCC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            111       111110000          0123467999999999999999999999999997664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=318.19  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=205.4

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecC----
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFED----  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----  206 (443)
                      ..++|+..+.||+|+||.||+|..+ +++.|++|++...   ......+.+|+.+++.+ .|+||+++++++....    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            3568999999999999999999986 6889999988754   22346788999999999 6999999999987644    


Q ss_pred             --eEEEEEeecCCCcHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          207 --ERIVIVEYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       207 --~~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                        .+++||||+.+++|.+++....  +..+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence              4899999999999999886543  567899999999999999999999   888999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHH
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA  357 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~  357 (443)
                      |++.......    .......|+..|+|||++..     ..++.++|||||||+||+|++|..||...........+.  
T Consensus       158 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--  231 (275)
T cd06608         158 GVSAQLDSTL----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP--  231 (275)
T ss_pred             ccceecccch----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh--
Confidence            9987654321    11233568999999999853     346788999999999999999999997654332222111  


Q ss_pred             hhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       358 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                           ....     +.+.   ......+.+.+|+.+||..||++|||+.++++|.|
T Consensus       232 -----~~~~-----~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         232 -----RNPP-----PTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             -----ccCC-----CCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence                 1100     0011   11124467999999999999999999999999988

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-40  Score=333.07  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=203.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~  207 (443)
                      ++|.+.++||+|+||.||+|.+.      .+..||||+++.... ....+.+.+|+.+|..+. |||||++++++...+.
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            35777789999999999999853      346899999976432 233456889999999997 9999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcC----------------------------------------------------------
Q 013401          208 RIVIVEYVPNGTLREHLDCLQG----------------------------------------------------------  229 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~----------------------------------------------------------  229 (443)
                      .++||||+.+|+|.+++.....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999964321                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          230 --------------------------------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       230 --------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                                                            ..+++..++.|+.||+.||.|||   ..+|+||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence                                                  23566677889999999999999   8899999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      ++++.+||+|||+++........  .......+++.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             eCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            99999999999999765332111  11223457889999999988889999999999999999998 8899875433222


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ......      .+....     .     ...++.++.+|+.+||+.||..||++++|++.|..+
T Consensus       351 ~~~~~~------~~~~~~-----~-----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 FYNAIK------RGYRMA-----K-----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHH------cCCCCC-----C-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111100      010000     0     011346799999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-40  Score=324.40  Aligned_cols=264  Identities=27%  Similarity=0.395  Sum_probs=206.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      .+|.+.++||+|+||.||+|...        ....||+|.++... .......+.+|+.+++.+ +||||+++++++...
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            46788889999999999999742        24579999987542 233456788999999999 599999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +..++||||+.+|+|.+++....              ...+++..++.++.||+.||.|||   ++|++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999996532              235788888999999999999999   8899999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||+++........  .......++..|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYY--KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             cCCCcEEEccccccccccccccc--cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999866432211  01111234567999999988889999999999999999999 8999976543221


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ....       ..+.....          ...++.++.+|+.+||+.||++||++.++++.++.+.....+
T Consensus       246 ~~~~-------~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         246 FKLL-------REGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             HHHH-------HcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence            1111       11111000          011235788999999999999999999999999988654433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-40  Score=318.65  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=208.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcC-----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-cCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-EDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~  207 (443)
                      .++|...+.||+|+||.||+|.+..     +..|++|+++.. ........+.+|+.+++.++|+||+++++++.. ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            3578888999999999999999764     788999988643 234445678899999999999999999998766 567


Q ss_pred             EEEEEeecCCCcHHHHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEee
Q 013401          208 RIVIVEYVPNGTLREHLDCLQG------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD  281 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~D  281 (443)
                      .++++||+.+++|.+++.....      ..+++..++.++.||+.||.|||   +++++|+||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999865322      45889999999999999999999   88899999999999999999999999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhh
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ||+++.......  ........++..|+|||++.+..++.++|||||||++||+++ |..||...+.....   .+..  
T Consensus       161 ~g~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~--  233 (280)
T cd05043         161 NALSRDLFPMDY--HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---AYLK--  233 (280)
T ss_pred             CCCcccccCCce--EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH---HHHH--
Confidence            999976543221  111223346778999999988889999999999999999999 99999766543211   1111  


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                        .+....          ....+++.+.+++.+||..||++||++.++++.|..+.+
T Consensus       234 --~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 --DGYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             --cCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              110000          001134678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=318.78  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=203.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.+.... .......+.+|+.+|..++|+||+++++++...+..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            47888899999999999999864      24689999986542 223345688999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEe
Q 013401          209 IVIVEYVPNGTLREHLDCLQ--------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVA  280 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~  280 (443)
                      ++||||+.+++|.+++....        ...+++..++.++.||+.||.|||   +++++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432        224678888999999999999999   8889999999999999999999999


Q ss_pred             eecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhh
Q 013401          281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       281 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      |||+++.......  ........++..|+|||++.+..++.++|||||||++|||++ |..||.............    
T Consensus       162 dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----  235 (277)
T cd05032         162 DFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----  235 (277)
T ss_pred             CcccchhhccCcc--cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh----
Confidence            9999876543321  112233457889999999988889999999999999999998 999997654322211111    


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                         .+.....     .     ...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus       236 ---~~~~~~~-----~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 ---DGGHLDL-----P-----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---cCCCCCC-----C-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence               1111110     0     012467999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.9e-40  Score=316.57  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=204.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-C---CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-D---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      .+|++.+.||+|+||.||+|.+. +   +..+|+|.++... .......+.+|+.+++.++||||+++++++..++..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46888899999999999999864 2   3479999987543 23345678899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||   +++++||||||+|||++.++.++|+|||++.....
T Consensus        83 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          83 VTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999999753 356888999999999999999999   88899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ..... .......++..|++||++.+..++.++|||||||++|+|++ |..||..........   ...    ++.... 
T Consensus       159 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~---~~~----~~~~~~-  229 (267)
T cd05066         159 DPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK---AIE----EGYRLP-  229 (267)
T ss_pred             cccee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH---HHh----CCCcCC-
Confidence            32111 11112234568999999998889999999999999999887 999997654322111   111    110000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                            .   ....+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       230 ------~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         230 ------A---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------C---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  0   011346789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=320.08  Aligned_cols=263  Identities=24%  Similarity=0.385  Sum_probs=201.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC---------------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED---------------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH  199 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~  199 (443)
                      ++|++.++||+|+||.||+|....               ...||||.++... .......+.+|+++++.++|+||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            478889999999999999997542               2358999987542 233456788999999999999999999


Q ss_pred             eeeeecCeEEEEEeecCCCcHHHHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 013401          200 GYLEFEDERIVIVEYVPNGTLREHLDCLQ----------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNI  269 (443)
Q Consensus       200 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NI  269 (443)
                      +++...+..++||||+.+++|.+++....          ...+++..++.++.|++.||.|||   +++++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999985421          123678888999999999999999   88899999999999


Q ss_pred             EEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCchh
Q 013401          270 LLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT--GRRPIEPKRE  347 (443)
Q Consensus       270 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt--G~~Pf~~~~~  347 (443)
                      |++.++.+||+|||++........  ........++..|+|||++.+..++.++|||||||++|+|++  |..||.....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999976543221  111223346778999999988889999999999999999988  6678876543


Q ss_pred             HHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          348 LKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .........   .+..........       .....+..+.+|+.+||+.||++||++.+|++.|.
T Consensus       239 ~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENTGE---FFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHH---hhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            221111111   111000000000       00112367999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2e-40  Score=320.81  Aligned_cols=272  Identities=21%  Similarity=0.278  Sum_probs=206.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCe-----
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDE-----  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~-----  207 (443)
                      ++|+..+.||+|+||.||+|.+. +++.||||.++...........+.+|+.+++.+. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999976 6999999998765444444567889999999995 6999999999887666     


Q ss_pred             EEEEEeecCCCcHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeec
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ---GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFG  283 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFG  283 (443)
                      .++||||+.+ +|.+++....   +..+++..++.++.||+.||.|||   .++|+||||||+|||++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 7888886432   346899999999999999999999   888999999999999998 8899999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      ++........    ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....+..+...+........
T Consensus       157 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9876533211    1223357889999998854 4578999999999999999999999987665544333221111000


Q ss_pred             CCccccccC-------cccc---chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          363 DGDAISILD-------PRVE---NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       363 ~~~~~~~~d-------~~~~---~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .........       +...   ..........++.+|+.+||.+||.+||++.+++.|.|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~  294 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF  294 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence            000000000       0000   000112245779999999999999999999999999883

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-40  Score=321.71  Aligned_cols=270  Identities=22%  Similarity=0.280  Sum_probs=206.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv  211 (443)
                      ++|+..+.||+|+||.||+|... +++.||||.++...........+.+|+.+++.++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888889999999999999986 689999999876544444445677899999999999999999998877  899999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+. ++|.+++... ...+++..++.++.||+.||.|||   +++++|+||||+|||++.++.+||+|||++......
T Consensus        85 ~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99997 4898888653 346899999999999999999999   888999999999999999999999999998866543


Q ss_pred             CCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh----------
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK----------  360 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~----------  360 (443)
                      ..    ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...........+......          
T Consensus       160 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         160 LK----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             cc----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            21    12234578999999998654 4688999999999999999999999876544332222111000          


Q ss_pred             -cCC---CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          361 -FSD---GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       361 -~~~---~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                       +..   ..........+..........+.+.+|+.+||+.||++||++.++++|.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence             000   00000000000000000013567899999999999999999999999987

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=325.51  Aligned_cols=263  Identities=27%  Similarity=0.389  Sum_probs=214.2

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      ...+.++||+|.||.|.+|....+..||||.++... .++...+|.+||++|.+|+|||||.++|+|..++.+++|+||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            456677999999999999999888999999998753 4555688999999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      ++|+|.+||.+.....+.......|+.||+.|++||.   +.++|||||-+.|+|++.++++||+|||+++.+...+  .
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~--y  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD--Y  692 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC--c
Confidence            9999999998754444455666789999999999999   6669999999999999999999999999999766543  2


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCchhHHHHHHHHHHhhhcCCCcccc-ccCc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT--GRRPIEPKRELKERITVKWAMKKFSDGDAIS-ILDP  372 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~  372 (443)
                      .++-...+-..+|||||.+.-..+++++|||+|||++||+++  ...||.......   .++.....+.+..... ...|
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceeccCC
Confidence            333445567789999999988899999999999999999765  778987654322   2222222233222211 1122


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                              .-++.++++|+..||..|-.+||+++++..+|...
T Consensus       770 --------~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  770 --------PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             --------CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                    23567899999999999999999999999998754

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-41  Score=336.99  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=215.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ...|.+...||+|.|++|.++.+. ++..||||.+.+...+....+.+.+|+++|+.|+|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            357889999999999999999876 7999999999998877777777899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+|.+++|+..  ...+.+..+..++.|++.|++|||   .++|||||||.+||||+.+.++||+|||++.++... 
T Consensus       135 eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-  208 (596)
T ss_pred             EeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc-
Confidence            99999999999984  344556788889999999999999   899999999999999999999999999999887643 


Q ss_pred             CCcccccccccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLT-EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                          .....++|++.|.|||++.+..|+ +++|+|+||++||.|+.|..||++..-...+           +..+...+.
T Consensus       209 ----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~rvl~gk~r  273 (596)
T KOG0586|consen  209 ----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PRVLRGKYR  273 (596)
T ss_pred             ----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------chheeeeec
Confidence                245678899999999999888765 7999999999999999999999865421111           111111110


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                        +.     .....+..+|+.++|-++|.+|+++.++.++-|+-.
T Consensus       274 --Ip-----~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  274 --IP-----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             --cc-----ceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence              00     012245788999999999999999999999999643

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.9e-40  Score=312.22  Aligned_cols=250  Identities=27%  Similarity=0.434  Sum_probs=201.0

Q ss_pred             eeeeeCceEEEEEEEcC--C--cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          142 KIGQGGFGTVYKGRLED--G--TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      .||+|+||.||+|.+.+  +  ..||||.+...... .....+.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            69999999999998642  3  36999998876443 556788999999999999999999999988 889999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      ++|.+++.......+++...+.++.|++.||.|||   .++++|+||||+||+++.++.+||+|||++......... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~  155 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH-YV  155 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc-ee
Confidence            99999997543356899999999999999999999   889999999999999999999999999999876543211 11


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..      .......       
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~~~~~~-------  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EGERLER-------  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cCCcCCC-------
Confidence            1223457889999999998899999999999999999998 9999976544332111111      0000000       


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                         ....+..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               0113467999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.3e-41  Score=331.39  Aligned_cols=281  Identities=20%  Similarity=0.275  Sum_probs=210.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee----cCe
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF----EDE  207 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~  207 (443)
                      ..++|++.+.||+|+||.||+|... +|..||+|++............+.+|+.+|+.++||||+++++++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            3468999999999999999999876 69999999987654444455678899999999999999999998753    346


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+. ++|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            899999995 689888863  355899999999999999999999   88899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh-------
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK-------  359 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-------  359 (443)
                      ................|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            54432222222234578999999999855 4688999999999999999999999976644322111110000       


Q ss_pred             -hcCCCccccc---cCc--cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          360 -KFSDGDAISI---LDP--RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       360 -~~~~~~~~~~---~d~--~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                       ..........   ...  ...........+.++.+++.+||+.||++||++.+++.|+|.-....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence             0000000000   000  00000011224578999999999999999999999999999754333

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=319.60  Aligned_cols=269  Identities=25%  Similarity=0.328  Sum_probs=206.4

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |+..+.||.|++|.||+|.+. +|..||||++............+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999875 7999999998765444444467889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      . ++|.+++.......+++..++.++.|++.||.|||   .++++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999987554457899999999999999999999   78899999999999999999999999999875532211  


Q ss_pred             ccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC---------c
Q 013401          296 THVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG---------D  365 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~  365 (443)
                        ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.......+...+..........         +
T Consensus       155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence              12233578899999988654 57889999999999999999999998766544332221110000000         0


Q ss_pred             ccccc-C-ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          366 AISIL-D-PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       366 ~~~~~-d-~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ....+ . ...............+.+++.+||++||.+||++.+++++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence            00000 0 000000011123367899999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-40  Score=313.95  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~  212 (443)
                      +|++.+.||.|+||.||++... ++..||+|.++.........+.+.+|+++++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778889999999999999865 78999999987655455556778899999999999999999997754  45679999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYT--DHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ||+++++|.+++...  ....+++..++.++.||+.||.|||..+  +.+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998643  2457899999999999999999999553  567999999999999999999999999999876


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....    ......|++.|+|||++.+..++.++||||||+++++|++|..||........  . ..    ...+... 
T Consensus       161 ~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~-~~----~~~~~~~-  228 (265)
T cd08217         161 GHDSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL--A-SK----IKEGKFR-  228 (265)
T ss_pred             cCCcc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH--H-HH----HhcCCCC-
Confidence            54321    12234689999999999888899999999999999999999999987652211  1 11    1111100 


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                          .+     .......+.+|+.+||+.+|++||++.+|++|+|
T Consensus       229 ----~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~  264 (265)
T cd08217         229 ----RI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL  264 (265)
T ss_pred             ----CC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence                00     1123467999999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3e-40  Score=313.91  Aligned_cols=253  Identities=29%  Similarity=0.449  Sum_probs=194.2

Q ss_pred             eeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeee-ecCeEEEEEeecC
Q 013401          142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLE-FEDERIVIVEYVP  216 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~  216 (443)
                      .||+|+||.||+|.+.    ++..||||.+... ........+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            6999999999999853    2457999987542 12334567889999999999999999999765 4556899999999


Q ss_pred             CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          217 NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       217 gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      +++|.+++... ...+.+..++.++.||+.||.|||   ..+++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999999643 334667778899999999999999   88899999999999999999999999999976543221111


Q ss_pred             cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                      .......++..|+|||++.+..++.++|||||||++|||++ |.+||............       ..+.....      
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~------  223 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-------LQGRRLLQ------  223 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------hcCCCCCC------
Confidence            11123446778999999988889999999999999999999 56677655432211111       11100000      


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                          ....++.+.+++.+||+.+|++||++.++++.+..+.
T Consensus       224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                0112357899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-40  Score=312.86  Aligned_cols=251  Identities=29%  Similarity=0.470  Sum_probs=202.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .+|...+.||+|+||.||++.+.++..+|+|.++...   .....+.+|+++++.++||||+++++++......++||||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            3577788999999999999998778899999987543   2345788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++... ...+++..++.++.+++.+|.|||   +.+++|+||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          81 MEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            9999999998642 345788889999999999999999   88899999999999999999999999999876543211 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......++..|+|||++.+..++.++|||||||++|||++ |..||...........       +..+.  ....+.
T Consensus       156 --~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~--~~~~~~  224 (256)
T cd05112         156 --TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET-------INAGF--RLYKPR  224 (256)
T ss_pred             --cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-------HhCCC--CCCCCC
Confidence              11122335678999999988889999999999999999998 9999976543221111       11110  011111


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                      .        .++.+.+|+.+||+.+|++||++.++++.+
T Consensus       225 ~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 L--------ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             C--------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1        236799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.5e-40  Score=322.26  Aligned_cols=271  Identities=21%  Similarity=0.263  Sum_probs=212.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||.||++... +++.||||.+...... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999976 5889999998765321 233456789999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++|++|.+++..  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999999964  356889999999999999999999   8889999999999999999999999999986421110


Q ss_pred             CC-----------cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc
Q 013401          293 SG-----------ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       293 ~~-----------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      ..           .........|+..|+|||++.+..++.++|||||||++|+|++|..||.+............     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~-----  230 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-----  230 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----
Confidence            00           00011234588899999999888899999999999999999999999976543221111111     


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHhhhhhhhhhhcc
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS---MRRCAEILWSVRKDYRELAAS  425 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs---~~ell~~l~~i~~~~~~~~~~  425 (443)
                        +..   ..+.     .....+..+.+++.+||+.||++||+   +.++++++|....++.+..-.
T Consensus       231 --~~~---~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~  287 (305)
T cd05609         231 --DDI---EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQ  287 (305)
T ss_pred             --ccc---CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhc
Confidence              000   0000     00123467899999999999999998   799999999887777775433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-40  Score=323.24  Aligned_cols=275  Identities=26%  Similarity=0.315  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l  210 (443)
                      .++|++.+.||+|+||.||+|... +|+.||+|.++...........+.+|+.+++.++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357999999999999999999976 699999999875543333334567899999999999999999998765  56899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+. ++|.+++... ...+++..++.++.||+.||.|||   ..+++||||||+|||++.++.+||+|||++.....
T Consensus        86 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999996 4788888653 356899999999999999999999   88899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh--------c
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK--------F  361 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~--------~  361 (443)
                      ...    ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+......        +
T Consensus       161 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         161 PAK----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ccC----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            321    1222346888999999865 45789999999999999999999999877654433322221110        0


Q ss_pred             CCCcccccc--Cccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          362 SDGDAISIL--DPRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       362 ~~~~~~~~~--d~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ........+  ......  ........+++.+|+.+||+.||++||++.+++.|.|....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            000000000  000000  00001135678899999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.3e-40  Score=319.17  Aligned_cols=263  Identities=23%  Similarity=0.379  Sum_probs=201.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-----------------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-----------------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK  197 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~  197 (443)
                      ++|++.++||+|+||.||++...                 ++..||||+++... .......+.+|+.+++.++|+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence            46889999999999999998532                 24478999987542 2334567889999999999999999


Q ss_pred             eeeeeeecCeEEEEEeecCCCcHHHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 013401          198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQ---------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSN  268 (443)
Q Consensus       198 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~N  268 (443)
                      +++++...+..++||||+.+++|.+++....         ...+++..++.++.||+.||.|||   +++++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            9999999999999999999999999986432         124667788999999999999999   8889999999999


Q ss_pred             EEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCch
Q 013401          269 ILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT--GRRPIEPKR  346 (443)
Q Consensus       269 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt--G~~Pf~~~~  346 (443)
                      ||++.++.++|+|||++........  ........++..|++||+..+..++.++|||||||++|||++  |..||....
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcc--eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999876543221  111222345678999999888889999999999999999998  778887654


Q ss_pred             hHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          347 ELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ..............   .. .....+.      ...++..+.+|+.+||+.||.+||++.+|++.|.
T Consensus       239 ~~~~~~~~~~~~~~---~~-~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 DEQVIENTGEFFRD---QG-RQVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             hHHHHHHHHHHHhh---cc-ccccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            33221111111100   00 0000000      0113367899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-40  Score=327.37  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=201.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec-C
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE-D  206 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-~  206 (443)
                      ++|++.+.||+|+||.||+|.+      .+++.||||+++.... ......+.+|+.+|.++ +|+||+++++++... .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            4789999999999999999973      2578999999875432 23345688999999999 689999999987654 4


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc----------------------------------------------------------
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ----------------------------------------------------------  228 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~----------------------------------------------------------  228 (443)
                      ..++||||+.+|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986421                                                          


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccccc
Q 013401          229 -------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ  301 (443)
Q Consensus       229 -------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  301 (443)
                             ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........  ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~  240 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGD  240 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc--hhhcCC
Confidence                   123677788899999999999999   88999999999999999999999999999876533211  111122


Q ss_pred             ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       302 ~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||...........      ....+.....     +     
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------~~~~~~~~~~-----~-----  304 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR------RLKEGTRMRA-----P-----  304 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH------HHhccCCCCC-----C-----
Confidence            346678999999988889999999999999999997 9999975432211111      0111111000     0     


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .....++.+++.+||+.||.+||++.+++++|..+..
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0123568999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4e-40  Score=314.23  Aligned_cols=257  Identities=24%  Similarity=0.383  Sum_probs=201.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc---ccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK---HSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~  208 (443)
                      .+|...+.||+|+||.||+|... ++..||+|+++......   .....+.+|+.+++.++|+||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            37888999999999999999875 68999999886543222   234568899999999999999999998875  3578


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++++||+.+++|.+++..  ...+++...+.++.|++.||.|||   +++|+|+||||+||+++.++.+||+|||++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            899999999999999864  345888899999999999999999   888999999999999999999999999998765


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++|..||...........   ...   ...   
T Consensus       157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~---~~~---~~~---  226 (266)
T cd06651         157 QTICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK---IAT---QPT---  226 (266)
T ss_pred             ccccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH---Hhc---CCC---
Confidence            4321111 111234588999999999988899999999999999999999999976543222111   100   000   


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                        .+.+     .....+.+.+++ .||..+|++||++++|++|+|.
T Consensus       227 --~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~  264 (266)
T cd06651         227 --NPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLRHPFA  264 (266)
T ss_pred             --CCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence              1111     112235567777 6888999999999999999883

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=333.07  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=214.7

Q ss_pred             CceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          140 SFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .+.||.|.||+||-|+++ +|+.||||++.+-.+.......+++|+.||+.+.||.||.+...|+..+.+++|||.+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            347999999999999976 79999999998888878888899999999999999999999999999999999999995 5


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CceEEeeecccccccccCCCc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN---FRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~~~~  295 (443)
                      +..++|-....+.+++.....++.||+.||.|||   .++|+|.||||+|||+...   -.+||||||+|+.+.+..   
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence            6666666667778999999999999999999999   8899999999999999643   369999999999987543   


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                        ....++|||.|+|||+++...|+..-|+||.|||+|--|+|..||....+..+++...  ...+...           
T Consensus       722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--aFMyPp~-----------  786 (888)
T KOG4236|consen  722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--AFMYPPN-----------  786 (888)
T ss_pred             --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc--ccccCCC-----------
Confidence              3456789999999999999999999999999999999999999998776666544322  1122111           


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                         ...+.....++||...|+..-.+|.+....+.|+|.
T Consensus       787 ---PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  787 ---PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL  822 (888)
T ss_pred             ---chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence               123455779999999999999999999999999994

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-40  Score=320.91  Aligned_cols=265  Identities=25%  Similarity=0.403  Sum_probs=204.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--Ce
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~  207 (443)
                      +.|.+++.||+|+||.||+|..     .++..||+|.++... .......+.+|+.+++.++|+||+++++++...  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            4578888999999999999974     258899999987542 233456789999999999999999999998775  56


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||++|++|.+++... ...+++..++.++.||+.||.|||   ++|++||||||+|||++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999998643 346899999999999999999999   88899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH--------HHHHHHHhh
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE--------RITVKWAMK  359 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~--------~~~~~~~~~  359 (443)
                      ....... ........|+..|+|||++.+..++.++|||||||++|+|+++..|+........        .........
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         159 IETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             cccCccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            6543221 1122345577889999999888899999999999999999998876543211000        000011111


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ....+....          ....++..+.+|+.+||+.||++||++.++++.+..+
T Consensus       238 ~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRLP----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111000          0112346799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-40  Score=313.54  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=208.3

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...+.||+|+||.||+|... +++.|++|.++...........+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777889999999999999875 789999999876644444677899999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++..  +..+++..+..|+.+++.||.|||   +.+|+|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            999999999863  345788889999999999999999   888999999999999999999999999999876544322


Q ss_pred             cccccccccCCCCccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .........++..|+|||++.+..   ++.++||||||+++++|++|..||.........   .+....   +.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~~~~~---~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFHVGA---GH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HHHHhc---CC-----C
Confidence            211122356889999999997765   888999999999999999999999755321111   111111   00     0


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +.++   ....+...+.+++.+||+.||.+||++.+++.+.|
T Consensus       225 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         225 PPIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             CCCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            0011   01123467889999999999999999999999887

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-40  Score=319.18  Aligned_cols=264  Identities=27%  Similarity=0.401  Sum_probs=200.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~  207 (443)
                      .+|++.+.||+|+||.||+|..+     ++..||||.++..  .......+.+|+++++.++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            46888899999999999999742     5889999998654  23445678899999999999999999998654  346


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +++||||+++++|.+++... ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            89999999999999998642 345889999999999999999999   88899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH-HH--------HHHHh
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER-IT--------VKWAM  358 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~-~~--------~~~~~  358 (443)
                      ....... ........++..|+|||++.+..++.++|||||||++|||++|..|+......... ..        .....
T Consensus       158 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         158 LPQDKEY-YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             ccCCCcc-eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            6543211 11111223455699999998888999999999999999999988775433211000 00        00000


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .......       .+   ......+.++.+|+.+||..+|++|||+.++++.|..+
T Consensus       237 ~~~~~~~-------~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNG-------RL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCC-------cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000000       00   01112346799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5e-40  Score=311.04  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=205.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC---cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD---KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      +|...+.||+|+||.||+|... ++..|++|.+......   ......+.+|+.+++.++|+||+++++++..++.++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667788999999999999976 7999999987654321   23456788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      +||+++++|.+++..  ...+++..++.++.||+.+|.|||   ..+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            999999999999864  345888999999999999999999   788999999999999999999999999998765433


Q ss_pred             CCCcccccccccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      .     ......|+..|++||.+.... ++.++|+|||||++|+|++|..||..............    .  ..... +
T Consensus       156 ~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~--~~~~~-~  223 (258)
T cd06632         156 S-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR----S--KELPP-I  223 (258)
T ss_pred             c-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh----c--ccCCC-c
Confidence            2     123456899999999987666 88999999999999999999999976553222211111    0  00000 0


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .         ......+.+++.+||+.+|.+||++.+++.++|
T Consensus       224 ~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         224 P---------DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             C---------CCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence            0         112367899999999999999999999999886

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.9e-40  Score=327.74  Aligned_cols=275  Identities=20%  Similarity=0.267  Sum_probs=208.7

Q ss_pred             HHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----
Q 013401          132 RATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----  205 (443)
Q Consensus       132 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----  205 (443)
                      ...++|+..+.||+|+||.||+|... +++.||||++.+..........+.+|+.+++.++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34578999999999999999999976 799999999876544444556778999999999999999999987643     


Q ss_pred             -CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          206 -DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       206 -~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                       ...++||||+. ++|.+.+..    .+++..+..++.|++.||.|||   .+||+||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence             35799999995 588887753    2888889999999999999999   88899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh------
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM------  358 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~------  358 (443)
                      +.......     ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....      
T Consensus       165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         165 ARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             ceeCCCCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            97654322     1223458999999999999899999999999999999999999997665432211111000      


Q ss_pred             ---------hhcCCC-------ccccccCccccc---hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          359 ---------KKFSDG-------DAISILDPRVEN---TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       359 ---------~~~~~~-------~~~~~~d~~~~~---~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                               ......       .....+......   ..........+.+|+.+||+.||++||++.++++|.|.. ..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~-~~~  318 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN-VWY  318 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh-hcc
Confidence                     000000       000000000000   000123456789999999999999999999999999944 444


Q ss_pred             h
Q 013401          420 R  420 (443)
Q Consensus       420 ~  420 (443)
                      .
T Consensus       319 ~  319 (353)
T cd07850         319 D  319 (353)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-40  Score=315.49  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=208.2

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||.|+||.||++.++ +++.||+|++..... ......+.+|+++++.++||||+++++++..++..++++||
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            5777889999999999999987 689999999876532 34456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      +.+++|.+++.... ..+++.....++.|++.+|.|||   + .+++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999987533 67889999999999999999999   7 8899999999999999999999999999876543221


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                            ....|+..|+|||++.+..++.++|||||||++|+|++|..||.......+.  .............     +.
T Consensus       157 ------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~-----~~  223 (265)
T cd06605         157 ------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQYIVNEPP-----PR  223 (265)
T ss_pred             ------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHHHhcCCC-----CC
Confidence                  1256889999999998889999999999999999999999999755311110  0001111111110     00


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +.    .......+.+++.+||..||++||++.+++.++|..
T Consensus       224 ~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         224 LP----SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             CC----hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            00    011446799999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.8e-40  Score=317.13  Aligned_cols=262  Identities=21%  Similarity=0.298  Sum_probs=202.6

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccCccc-HHHHHHHHHHHH---hcCCcceeeeeeeeeecCeEEEEEeecC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHS-GAEFQSEIRTLA---QVEHLNLVKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~~Ei~~l~---~l~h~niv~l~~~~~~~~~~~lv~E~~~  216 (443)
                      .||+|+||.||++... +++.||||.+.+....... ...+.+|..+++   ...|+||+.+++++..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999975 6899999988765432222 223344544433   3479999999999999999999999999


Q ss_pred             CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          217 NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       217 gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      +++|.+++..  ...+++..+..++.|++.||.|||   .++|+||||||+|||++.++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            9999998863  356899999999999999999999   8889999999999999999999999999986543321    


Q ss_pred             cccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          297 HVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                        .....|+..|+|||++. +..++.++|||||||++|+|++|..||......... ........         ....+ 
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~---------~~~~~-  218 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT---------VNVEL-  218 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc---------CCcCC-
Confidence              12346899999999986 456889999999999999999999999754321111 11111000         00001 


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcC
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLL  429 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~  429 (443)
                          ....+.++.+++.+||+.||.+||     ++.++++|+|.-..++....-..+..
T Consensus       219 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~  273 (279)
T cd05633         219 ----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPP  273 (279)
T ss_pred             ----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCC
Confidence                112346799999999999999999     69999999999888888865555553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.8e-40  Score=312.33  Aligned_cols=256  Identities=22%  Similarity=0.332  Sum_probs=201.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC---cccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD---KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  208 (443)
                      .+|...+.||+|+||.||+|... ++..||||.+......   ......+.+|+++++.++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999875 6899999987543211   22345688899999999999999999988763  467


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      +++|||++|++|.+++..  ...+++...+.++.|++.+|.|||   +++++|+||||+|||++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            899999999999999864  345788888999999999999999   888999999999999999999999999998765


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ...... ........|+..|+|||++.+..++.++|||||||++|+|++|..||............   .....      
T Consensus       157 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~------  226 (265)
T cd06652         157 QTICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQPT------  226 (265)
T ss_pred             cccccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCCC------
Confidence            422111 11123346899999999998888999999999999999999999999765433221111   10000      


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        .+.     ........+.+++.+||. +|.+||++++|++|.|
T Consensus       227 --~~~-----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         227 --NPV-----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             --CCC-----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence              000     011234678899999985 9999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-40  Score=322.72  Aligned_cols=249  Identities=23%  Similarity=0.387  Sum_probs=201.8

Q ss_pred             CceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          140 SFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      ...||+|+||.||++... ++..||||.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            347999999999999875 68999999886532  234456889999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++..   ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.++|+|||++........    .
T Consensus       105 ~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----~  174 (292)
T cd06658         105 ALTDIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----K  174 (292)
T ss_pred             cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc----c
Confidence            99998742   45888999999999999999999   88899999999999999999999999999876543221    1


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchh
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA  378 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  378 (443)
                      .....|+..|+|||++.+..++.++|||||||++|||++|..||...........+...   +         .+.+..  
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~---------~~~~~~--  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---L---------PPRVKD--  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---C---------CCcccc--
Confidence            22346899999999998888999999999999999999999999865543221111110   0         000000  


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       379 ~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       .......+.+++.+||..||.+||++.+++++.|..
T Consensus       241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             -ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence             111335688999999999999999999999998854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.1e-40  Score=317.44  Aligned_cols=259  Identities=24%  Similarity=0.411  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      ..+|.+.++||+|+||.||+|..+      .+..||+|.++... .......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            457889999999999999999753      25589999876542 22234567889999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEE
Q 013401          208 RIVIVEYVPNGTLREHLDCLQG--------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl  279 (443)
                      .++||||+.+|+|.+++.....        ..+....++.++.||+.||.|||   +++|+||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999965321        23455677889999999999999   889999999999999999999999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHh
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      +|||+++.......  ........++..|+|||.+.+..++.++|||||||++|||++ |..||.........   ..  
T Consensus       161 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~~--  233 (288)
T cd05061         161 GDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---KF--  233 (288)
T ss_pred             CcCCcccccccccc--ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH--
Confidence            99999876543221  111222345778999999988889999999999999999998 78898765432211   11  


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ...+.....          .......+.+++.+||+.||++||++.++++.+...
T Consensus       234 --~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 --VMDGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --HHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence              111111100          011236799999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-40  Score=309.42  Aligned_cols=248  Identities=33%  Similarity=0.461  Sum_probs=199.8

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHH
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLR  221 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~  221 (443)
                      +||+|+||.||+|.+.+++.||+|.++..... .....+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             ccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            69999999999999877999999998765332 34567899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccccc
Q 013401          222 EHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ  301 (443)
Q Consensus       222 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~  301 (443)
                      +++... ...+++..++.++.+++.+|.|||   +++++||||||+|||++.++.+||+|||++........  ......
T Consensus        81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~  154 (251)
T cd05041          81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TVSDGL  154 (251)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc--eecccc
Confidence            998653 346788889999999999999999   88899999999999999999999999999876542111  001112


Q ss_pred             ccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       302 ~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..       .....          ..
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------~~~~~----------~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------GYRMP----------AP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-------CCCCC----------CC
Confidence            234667999999988889999999999999999999 8899976654332222111       00000          01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          381 NLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            123467999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=316.06  Aligned_cols=268  Identities=23%  Similarity=0.284  Sum_probs=209.9

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |...+.||.|++|.||+|... +++.+++|.++...........+.+|+.+|+.++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566778999999999999875 7899999998766544445677889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .+ +|.+++... ...+++..++.++.||+.||.|||   .++|+|+||||+||+++.++.+||+|||.+.......   
T Consensus        81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---  152 (283)
T cd05118          81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---  152 (283)
T ss_pred             CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence            65 888887653 357899999999999999999999   8889999999999999999999999999997765432   


Q ss_pred             ccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc----
Q 013401          296 THVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL----  370 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  370 (443)
                       .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+................    
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence             112234588899999998776 78899999999999999999999998776544332222111110000000000    


Q ss_pred             -------C-ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          371 -------D-PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       371 -------d-~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                             + ............+.++.+++.+||++||.+||++.+++.+.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence                   0 000111112345678999999999999999999999999987

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-40  Score=314.12  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=207.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...+.||+|+||.||+|..+ +|..||+|.+............+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778889999999999999976 688999999876544444556788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~  293 (443)
                      +.+++|.+++.......+++..++.++.|++.||.|||   .++++|+||||+||++++++ .+||+|||.+....+...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999997655556899999999999999999999   78899999999999999875 469999999876643321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|++.|+|||++.+..++.++|||||||++++|++|..||.............       ...... ..  
T Consensus       158 ----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~-~~--  223 (257)
T cd08225         158 ----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-------QGYFAP-IS--  223 (257)
T ss_pred             ----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-------cccCCC-CC--
Confidence                1223458999999999988889999999999999999999999997654322211110       111000 01  


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                             ......+.+++.+||+.+|++||++.+++.+.|
T Consensus       224 -------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         224 -------PNFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             -------CCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence                   112357999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4e-40  Score=317.89  Aligned_cols=257  Identities=29%  Similarity=0.417  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      .++|+....||+|+||.||+|...      ++..||+|.++... ......++.+|+.+++.++||||+++++++.+++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            357889999999999999999863      47889999987542 23345678899999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ--------------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSS  267 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~  267 (443)
                      .++||||+.+++|.+++....                    ...+++..++.++.|++.||.|||   .++++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence            999999999999999996422                    124678888999999999999999   888999999999


Q ss_pred             CEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCch
Q 013401          268 NILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKR  346 (443)
Q Consensus       268 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~  346 (443)
                      |||++.++.++|+|||++........  ........++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             heEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999875532211  111122335677999999988899999999999999999998 888987554


Q ss_pred             hHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          347 ELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ......       .+..+.....          ....+.++.+|+.+||+.||.+||++.++++.|.
T Consensus       238 ~~~~~~-------~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         238 HEEVIY-------YVRDGNVLSC----------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHH-------HHhcCCCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            322111       1111111110          0113367999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-39  Score=313.27  Aligned_cols=253  Identities=28%  Similarity=0.424  Sum_probs=206.3

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |...++||.|+||.||+|... ++..||||.+..... ......+.+|+.++..++|+||+++++++..++..++||||+
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            666778999999999999875 689999998765422 234467889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .+++|.+++.   ...+++..+..++.+++.+|.|||   ..+++|+||||+||+++.++.++|+|||++........  
T Consensus        85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06641          85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence            9999999885   346889999999999999999999   88999999999999999999999999999876543221  


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.       ... ...+.    
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~-~~~~~----  222 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-------KNN-PPTLE----  222 (277)
T ss_pred             --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-------cCC-CCCCC----
Confidence              1223468899999999988888999999999999999999999997654322111110       010 00011    


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                           ...+..+.+++.+||+.+|.+||++.++++|.|..+.
T Consensus       223 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         223 -----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             -----cccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                 1134678999999999999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.4e-40  Score=314.35  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=203.2

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CC---cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .|+..+.||+|+||.||+|.+. ++   ..||||.++... ......++.+|+.+++.++||||+++++++..++..++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            4677889999999999999875 33   369999987542 344456789999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.+++|.+++... ...+++..++.++.|++.||.|||   ++|++|+||||+|||++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999998653 456889999999999999999999   888999999999999999999999999998766443


Q ss_pred             CCCccccccccc--CCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          292 ESGATHVSTQVK--GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       292 ~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....... ....  .+..|+|||++.+..++.++|||||||++|||++ |..||..........   +...    .....
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~---~i~~----~~~~~  231 (269)
T cd05065         160 TSDPTYT-SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN---AIEQ----DYRLP  231 (269)
T ss_pred             ccccccc-cccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH---HHHc----CCcCC
Confidence            2211111 1111  2457999999998899999999999999999887 999998765432211   1110    00000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .          ...++..+.+++.+||+.+|++||++.+++..|..+
T Consensus       232 ~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         232 P----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             C----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0          012345689999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-40  Score=319.45  Aligned_cols=264  Identities=27%  Similarity=0.391  Sum_probs=202.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +|.....||+|+||.||++... +++.||||.+...... .....+.+|+.++.++. |+||+++++++..++..+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            4555668999999999999876 6899999998754322 34567889999999996 9999999999999999999999


Q ss_pred             ecCCCcHHH---HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          214 YVPNGTLRE---HLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       214 ~~~gg~L~~---~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |+.. +|.+   ++.......+++..+..++.+++.||.|||+  ..+++||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9854 5444   3333344678999999999999999999993  35899999999999999999999999999976543


Q ss_pred             cCCCcccccccccCCCCccCccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ...     .....|+..|+|||++.+.   .++.++|||||||++|+|++|..||.......+..      .....+.. 
T Consensus       161 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~-  228 (288)
T cd06616         161 SIA-----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL------TQVVKGDP-  228 (288)
T ss_pred             CCc-----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH------hhhcCCCC-
Confidence            321     1223588999999999765   68899999999999999999999997654221111      11111110 


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                          +.+... .....+.++.+|+.+||+.||.+||++.+++.+.|....+.+
T Consensus       229 ----~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         229 ----PILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             ----CcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence                011100 112245679999999999999999999999999997554433

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=327.79  Aligned_cols=273  Identities=23%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----Ce
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----DE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  207 (443)
                      +++|.+.+.||+|+||.||+|.+. +|+.||||+++... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            468999999999999999999875 78999999986421 233445678899999999999999999987554     35


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++|+||+. ++|.+++.   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          83 VYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            799999996 57877764   356899999999999999999999   88899999999999999999999999999876


Q ss_pred             ccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ....... ........|++.|+|||++.+ ..++.++|||||||++|+|++|++||...+....................
T Consensus       156 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            5433221 112234578999999998754 46889999999999999999999999765432221111110000000000


Q ss_pred             cccc-------------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          367 ISIL-------------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       367 ~~~~-------------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..+.             .+.............++.+|+.+||+.||.+||++.++++|.|..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~  296 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE  296 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence            0000             000000001112346799999999999999999999999998854

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-40  Score=321.99  Aligned_cols=254  Identities=22%  Similarity=0.360  Sum_probs=204.9

Q ss_pred             CCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          139 PSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ....||+|+||.||++... +++.||||.+....  ......+.+|+.++..++||||+++++.+..++..++|+||+++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            3447999999999999875 68999999986542  23346688999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      ++|.+++..   ..+++..++.++.|++.||.|||   +++++|+||||+|||++.++.+||+|||++........    
T Consensus       103 ~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----  172 (297)
T cd06659         103 GALTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----  172 (297)
T ss_pred             CCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc----
Confidence            999987743   45889999999999999999999   88899999999999999999999999999875543211    


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccch
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT  377 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  377 (443)
                      ......|+..|+|||++.+..++.++|||||||++|||++|..||.............    .....   ..     .  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~---~~-----~--  238 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR----DSPPP---KL-----K--  238 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----ccCCC---Cc-----c--
Confidence            1223568999999999988889999999999999999999999997654332211111    00000   00     0  


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       378 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                       ........+.+++.+||+.||.+||++.+++++.|......
T Consensus       239 -~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         239 -NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             -ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence             00112356899999999999999999999999999876554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.9e-40  Score=312.57  Aligned_cols=260  Identities=24%  Similarity=0.442  Sum_probs=203.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc--------ccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK--------HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      +|...+.||+|+||.||+|... +|+.||||.++......        ...+.+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999865 68999999876432111        12345788999999999999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..++||||+.+++|.+++...  ..+++..+..++.||+.||.|||   +++++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999998743  56888999999999999999999   8889999999999999999999999999987


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      ........  .......|+..|+|||++....  ++.++||||||+++|+|++|..||............      ....
T Consensus       157 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~  228 (272)
T cd06629         157 KSDDIYDN--DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------GNKR  228 (272)
T ss_pred             cccccccc--cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh------hccc
Confidence            65432111  1123345889999999987654  788999999999999999999999654432211110      0000


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .. ..+...     .....+..+.+++.+||++||++||++.++++|+|.
T Consensus       229 ~~-~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 SA-PPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cC-CcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            00 000110     011234679999999999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.1e-40  Score=322.14  Aligned_cols=271  Identities=21%  Similarity=0.272  Sum_probs=202.3

Q ss_pred             eeeee--CceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQG--GFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||.|  +||+||++.+. +|+.||||++..........+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999975 7999999998765434444577889999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++.......+++..+..++.||+.||.|||   +++|+||||||+|||++.++.++++|||.+.............
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999987655556899999999999999999999   8889999999999999999999999998654332211111000


Q ss_pred             ---cccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh-------------
Q 013401          299 ---STQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK-------------  360 (443)
Q Consensus       299 ---~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------  360 (443)
                         .....++..|+|||++.+  ..++.++|||||||++|+|++|..||..................             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence               111235667999999976  34789999999999999999999999765432221111000000             


Q ss_pred             --------cC----CCccc-----cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          361 --------FS----DGDAI-----SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       361 --------~~----~~~~~-----~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                              ..    +....     ...+..+. ......+.+.+.+|+.+||+.||++|||+.++++|.|...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                    00    00000     00011111 1122345678999999999999999999999999999643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-39  Score=309.68  Aligned_cols=257  Identities=27%  Similarity=0.388  Sum_probs=210.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..+.||+|+||.||+|... +++.|+||++...... .....+.+|+.++..++|+||+++++++...+.+++||||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            6888899999999999999987 5999999998765322 4457789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      +++++|.+++...  ..+++..++.++.|++.+|.|||   + .+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999743  67899999999999999999999   7 8999999999999999999999999999876654322


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                      .    .....++..|+|||.+.+..++.++||||||+++|+|++|..||.............+..    ...... ... 
T Consensus       156 ~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~-~~~-  225 (264)
T cd06623         156 Q----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPPPS-LPA-  225 (264)
T ss_pred             c----ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCCCC-CCc-
Confidence            1    123458899999999988889999999999999999999999997764211111111111    111100 010 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                             ...+..+.+++.+||.++|+.||++.+++++.|.-
T Consensus       226 -------~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~  260 (264)
T cd06623         226 -------EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK  260 (264)
T ss_pred             -------ccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence                   11346799999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.6e-40  Score=313.64  Aligned_cols=265  Identities=23%  Similarity=0.244  Sum_probs=200.3

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeeeeeec--CeEEEEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFE--DERIVIV  212 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  212 (443)
                      |+..++||+|+||.||+|... +++.||||+++...... ......+|+.++.++. |+||+++++++.+.  +..++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            566788999999999999875 68999999987653222 2234457999999985 99999999999987  8899999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+. ++|.+++.. ....+++..++.++.||+.||.|||   .++++||||||+||+++. +.+||+|||++.......
T Consensus        80 e~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          80 ELMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             ecCC-ccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9996 588887764 2356899999999999999999999   888999999999999999 999999999998664332


Q ss_pred             CCcccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh--------hhcCC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM--------KKFSD  363 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~~~  363 (443)
                      .     .....++..|+|||++. +..++.++|||||||++|||++|.+||...+............        ..+..
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 P-----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             C-----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            1     22345889999999874 4457889999999999999999999998765433222111110        01111


Q ss_pred             CccccccCccc-c--chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          364 GDAISILDPRV-E--NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       364 ~~~~~~~d~~~-~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ........+.. .  ........+..+.+|+.+||++||++||++.++++|.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            00000000000 0  00011234678999999999999999999999999987

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2e-39  Score=309.91  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=190.7

Q ss_pred             eeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .||+|+||.||+|.+.   ++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            5999999999999864   346799998875432 233356889999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          219 TLREHLDCLQ---GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       219 ~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      +|.+++....   ....++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........  
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--  155 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--  155 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence            9999996432   224566777889999999999999   88899999999999999999999999999865432211  


Q ss_pred             ccccccccCCCCccCccccccC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTY-------QLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~-------~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ........|+..|+|||++.+.       .++.++|||||||++|||++ |..||........... ..  .    ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~--~----~~~~  228 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TV--R----EQQL  228 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hh--h----cccC
Confidence            1112234578899999998542       35789999999999999996 9999976544322111 11  0    0111


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                      ...++.+..     ...+.+.+++..|+ .+|++||++.+|+..|
T Consensus       229 ~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l  267 (269)
T cd05087         229 KLPKPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL  267 (269)
T ss_pred             CCCCCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence            111111111     12355888999998 6899999999999775

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.9e-40  Score=323.02  Aligned_cols=261  Identities=27%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      .+|.+.+.||+|+||.||+|...        .+..||+|.++... ......++.+|+++++++ +|+||+++++++...
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            36888899999999999999742        12368999887542 233456788999999999 799999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +..+++|||+.+|+|.+++....              ...+++..++.++.||+.||.|||   .+|++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            99999999999999999996432              234677888899999999999999   8899999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||+++.......  ........++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             cCCCcEEECCcccceecccccc--cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999976543211  111122334578999999998899999999999999999998 8899976543221


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ...+.       .......          ...+...+.+|+.+||+.+|.+||++.++++.|..+...
T Consensus       246 ~~~~~-------~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         246 FKLLK-------EGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHHHH-------cCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            11111       1100000          011235789999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-39  Score=310.45  Aligned_cols=238  Identities=22%  Similarity=0.372  Sum_probs=187.7

Q ss_pred             eeeeeCceEEEEEEEcC-------------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          142 KIGQGGFGTVYKGRLED-------------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      .||+|+||.||+|...+             ...|++|.+....  ......+.+|+.+++.++||||+++++++..+...
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            69999999999998532             2258888876532  33445678899999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-------eEEee
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR-------AKVAD  281 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-------vkl~D  281 (443)
                      ++||||+.+++|..++.. ....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.       ++++|
T Consensus        80 ~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999888764 3456899999999999999999999   889999999999999987664       89999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHH-cCCCCCCCchhHHHHHHHHHHhh
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELV-TGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~ell-tG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      ||++......        ....|+..|+|||++. +..++.++|||||||++|||+ .|..||........    ...  
T Consensus       156 ~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~--  221 (262)
T cd05077         156 PGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERF--  221 (262)
T ss_pred             CCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHH--
Confidence            9998654321        2245788999999986 567889999999999999998 58888865432111    110  


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                        ..... ....          ...+++.+|+.+||+.||++||++.+|++++
T Consensus       222 --~~~~~-~~~~----------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 --YEGQC-MLVT----------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HhcCc-cCCC----------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              00100 0001          1235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-39  Score=317.05  Aligned_cols=255  Identities=29%  Similarity=0.425  Sum_probs=204.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ..|...+.||+|+||.||+|... +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888889999999999999876 689999998864322 2233456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+. |+|.+++.. ....+++..+..++.||+.||.|||   ..+|+|+||+|+||+++.++.+||+|||++...... 
T Consensus        95 e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9996 577776653 3356899999999999999999999   888999999999999999999999999998765322 


Q ss_pred             CCcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                             ....|++.|+|||++.   ...++.++||||||+++|+|++|.+||...........+.+       ...   
T Consensus       169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-------~~~---  231 (307)
T cd06607         169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NDS---  231 (307)
T ss_pred             -------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------CCC---
Confidence                   2345888999999984   35688899999999999999999999976654332221111       000   


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                        +.+    ....+.+.+.+++.+||+.||++||++.+++.++|..+..
T Consensus       232 --~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         232 --PTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             --CCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence              000    0112446799999999999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-39  Score=311.67  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=189.0

Q ss_pred             eeeeeCceEEEEEEEcC---CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLED---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      +||+|+||.||+|...+   ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+.+.+..++||||+.+|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            69999999999997542   4568888776432 2333456789999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          219 TLREHLDCLQG---NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       219 ~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      +|.+++.....   ...++...+.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........  
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--  155 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--  155 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchh--
Confidence            99999975432   23466777899999999999999   88899999999999999999999999999865432211  


Q ss_pred             ccccccccCCCCccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKT-------YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||....+........   .    ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---~----~~~~  228 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV---R----EQDI  228 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh---h----ccCc
Confidence            011123346778999999742       356789999999999999999 788987654432211110   0    0111


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                      ....+.+     .......+.+++..|+ .||++||++.+|++.+
T Consensus       229 ~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         229 KLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            1111111     1123356778888888 5999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-40  Score=326.85  Aligned_cols=272  Identities=21%  Similarity=0.303  Sum_probs=207.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----Ce
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----DE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  207 (443)
                      .++|.+...||+|+||+||+|... +++.||||.++...........+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999875 699999999876544444456778899999999999999999987654     35


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++|+||+. ++|.+++..  ...+++..++.++.||+.||.|||   .++++||||||+|||++.++.+||+|||++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999995 689888863  456899999999999999999999   88899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC---
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD---  363 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---  363 (443)
                      .....    .......++..|+|||++.. ..++.++|||||||++|+|++|.+||...........+........+   
T Consensus       158 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         158 TSEKG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cCCCc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            64322    11234568899999998864 46889999999999999999999999765432222111111110000   


Q ss_pred             -----CccccccC-----ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          364 -----GDAISILD-----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       364 -----~~~~~~~d-----~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                           ......+.     +..........++.++.+|+.+||+.||.+||++.++++|.|.-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~  295 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA  295 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence                 00000000     00000011123457789999999999999999999999999853

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-39  Score=311.59  Aligned_cols=258  Identities=25%  Similarity=0.410  Sum_probs=204.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|...++||+|+||.||+|.+.+    ...||||...... .....+.+.+|+.+++.++|+||+++++++.+ +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            357778899999999999998643    3468999876542 23345678899999999999999999998875 56789


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+++++|.+++... ...+++..++.++.+++.||.|||   +++++|+||||+|||++.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999999653 345899999999999999999999   88899999999999999999999999999876544


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...   .......++..|+|||.+....++.++|||||||++|+|++ |..||...........+.       .+.....
T Consensus       160 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~~~~~~~  229 (270)
T cd05056         160 ESY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------NGERLPM  229 (270)
T ss_pred             ccc---eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------cCCcCCC
Confidence            321   11122234568999999988889999999999999999996 999997665432221111       1111100


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                                ...++..+.+++.+||..+|++||++.++++.|..++.+
T Consensus       230 ----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         230 ----------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                      012346799999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-41  Score=334.99  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=204.5

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      .||+|.||+||.|++. +...+|||-+...  +....+-+..||.+.++|+|.|||+++|.+.+++..-|.||-++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            6999999999999976 4667899988754  345567789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCceEEeeecccccccccCCCccc
Q 013401          221 REHLDCLQGNIL--DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       221 ~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      .++|+. +-+++  ++..+-.+..||++||+|||   ++.|||||||-+|+||+ -.|.+||.|||-++.+..-+    .
T Consensus       660 SsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin----P  731 (1226)
T KOG4279|consen  660 SSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN----P  731 (1226)
T ss_pred             HHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC----c
Confidence            999975 55666  77888889999999999999   88899999999999996 68999999999998765433    2


Q ss_pred             ccccccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          298 VSTQVKGTAGYLDPEYLKTY--QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                      ...++.||..|||||++..+  .|+.++|||||||++.||.||++||-...+-..      ++.....    -..-|.+ 
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFkVGm----yKvHP~i-  800 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFKVGM----YKVHPPI-  800 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhhhcc----eecCCCC-
Confidence            44567799999999999544  589999999999999999999999965443221      1111111    0112222 


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                          ......+..++|.+|+.+||..||++.++++.++-
T Consensus       801 ----Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFl  835 (1226)
T KOG4279|consen  801 ----PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFL  835 (1226)
T ss_pred             ----cHHHHHHHHHHHHHHcCCCcccCccHHHhccCccc
Confidence                23456789999999999999999999999999874

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=312.65  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=206.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc----EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|...+.||+|+||.||+|.++ +|.    .||+|.++.... ......+.+|+.++..++|+||+++++++.. ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            46788889999999999999865 343    589998775532 3345678899999999999999999999887 7889


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+|+|.+++... ...+++..++.++.||+.||.|||   +++++|+||||+|||++.++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999998753 345899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....  .......++..|+|||.+....++.++|||||||++|||++ |..||..........   .    +..+....
T Consensus       161 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~----~~~~~~~~  231 (279)
T cd05057         161 VDEKE--YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---L----LEKGERLP  231 (279)
T ss_pred             Ccccc--eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---H----HhCCCCCC
Confidence            32211  11112234678999999988889999999999999999999 999998764322111   1    11111000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                        .+        ..+...+.+++.+||..||..||++.++++.+..+.++..+
T Consensus       232 --~~--------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05057         232 --QP--------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR  274 (279)
T ss_pred             --CC--------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence              00        01224688999999999999999999999999988665443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=312.32  Aligned_cols=254  Identities=26%  Similarity=0.431  Sum_probs=205.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC---CcceeeeeeeeeecCeEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE---HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv  211 (443)
                      .|+..+.||+|+||.||+|.+. +++.||||.++... ......++.+|+.+++.+.   ||||+++++++..+...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            4677789999999999999975 78999999987542 2344567889999999986   99999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.|++|.+++..   ..+++..++.++.|++.+|.|||   ..+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          81 MEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999998853   36889999999999999999999   888999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..    ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............       ....     
T Consensus       155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~-----  218 (277)
T cd06917         155 SS----KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PKSK-----  218 (277)
T ss_pred             cc----ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------ccCC-----
Confidence            21    1223468999999999864 45788999999999999999999999765432221110       0000     


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .+.+..    .....++.+++.+||+.||++||++.+++.+.|...
T Consensus       219 ~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         219 PPRLED----NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             CCCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence            011110    013467999999999999999999999999999743

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.3e-40  Score=310.16  Aligned_cols=246  Identities=29%  Similarity=0.480  Sum_probs=199.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .+|.+.+.||+|+||.||++.. +++.||+|.++..    .....+.+|+.+++.++||||+++++++..+ ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            4578888999999999999975 5788999988653    2346788999999999999999999998654 57999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++.......+++..++.++.|++.||.|||   .+|++||||||+|||++.++.+||+|||++......   
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999999997655556899999999999999999999   888999999999999999999999999998754322   


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......+..|+|||++.+..++.++|||||||++|+|++ |.+||...........+.       .+....   + 
T Consensus       154 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~~---~-  218 (254)
T cd05083         154 ----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYRME---P-  218 (254)
T ss_pred             ----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCCCC---C-
Confidence                112234568999999988889999999999999999998 999997665432211111       110000   0 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                            ....+..+.+++.+||+.+|++||++.++++.+.
T Consensus       219 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         219 ------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                  0123467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=311.23  Aligned_cols=248  Identities=31%  Similarity=0.450  Sum_probs=194.2

Q ss_pred             eeeeeCceEEEEEEEc-CCc--EEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          142 KIGQGGFGTVYKGRLE-DGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      .||+|+||.||+|.+. ++.  .+++|.++.. ........+.+|+.++..+ +||||+++++++...+..++||||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            5999999999999975 444  4688887643 2234456788999999999 799999999999999999999999999


Q ss_pred             CcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeec
Q 013401          218 GTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFG  283 (443)
Q Consensus       218 g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG  283 (443)
                      ++|.+++....              ...+++..++.++.|++.||+|||   +++++||||||+|||++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986422              124788899999999999999999   8899999999999999999999999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      ++.......     .......+..|+|||++.+..++.++|||||||++|||++ |..||...........       +.
T Consensus       158 l~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-------~~  225 (270)
T cd05047         158 LSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-------LP  225 (270)
T ss_pred             Cccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-------Hh
Confidence            985322110     1111234667999999988889999999999999999997 9999975433211111       11


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .+.....          .......+.+|+.+||..||.+||++.+++..|..+
T Consensus       226 ~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         226 QGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCCCCCC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            1100000          011235689999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-39  Score=313.73  Aligned_cols=270  Identities=23%  Similarity=0.352  Sum_probs=205.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+..++||.|++|.||+|... +|..||||+++.... ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            5788899999999999999986 689999999876532 23345677899999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      +.+ +|.+++.... ...+++..+..++.||+.||.|||   +++++|+||||+||+++.++.++|+|||++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            975 8888886432 246899999999999999999999   88899999999999999999999999999976543211


Q ss_pred             CcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc-----c
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA-----I  367 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----~  367 (443)
                          ......++..|++||++.+. .++.++|||+|||++|+|++|.+||...........+............     .
T Consensus       156 ----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 ----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             ----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence                12234578999999998653 5688999999999999999999999876543322221111000000000     0


Q ss_pred             cccCcccc---c---hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          368 SILDPRVE---N---TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       368 ~~~d~~~~---~---~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ..+.....   .   .......+..+.+++.+||+.||.+||++.+++++.|.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00000000   0   00111235678999999999999999999999999873

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-40  Score=314.36  Aligned_cols=253  Identities=25%  Similarity=0.302  Sum_probs=207.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +|...+.||.|+||.||+|.+. ++..||+|.+.+..... .....+.+|++++++++||||+++++.+..++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778889999999999999976 68999999987643322 456778999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.|++|.+++...  ..+++..+..++.||+++|.|||   .++++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999743  57899999999999999999999   8889999999999999999999999999987665432 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|+..|+|||++.+..++.++|+||||+++|+|++|..||........    .+........  .....  
T Consensus       155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~--~~~~~--  222 (258)
T cd05578         155 ----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQETA--DVLYP--  222 (258)
T ss_pred             ----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhccc--cccCc--
Confidence                12234588999999999888899999999999999999999999986653211    1111111100  00000  


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHH
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSM--RRCAEILW  413 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~--~ell~~l~  413 (443)
                             ...+..+.+++.+||+.||.+||++  .++++|.|
T Consensus       223 -------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~  257 (258)
T cd05578         223 -------ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY  257 (258)
T ss_pred             -------ccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence                   1123679999999999999999999  99988876

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-39  Score=313.59  Aligned_cols=263  Identities=27%  Similarity=0.360  Sum_probs=206.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~  212 (443)
                      +|+..++||.|++|.||+|.+. +++.||+|.+..... ......+.+|+++++.++||||+++++++.+.  +.+++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            5788889999999999999985 689999999875422 23456788999999999999999999988653  4689999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||+++++|.+++...  ....+++..+..++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887542  3456788889999999999999999   88899999999999999999999999999865543


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchh--HHHHHHHHHHhhhcCCCcccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE--LKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ..      .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ........+.....    ...
T Consensus       158 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~  227 (287)
T cd06621         158 SL------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPE  227 (287)
T ss_pred             cc------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chh
Confidence            21      1234578899999999888999999999999999999999999976532  01111112211100    000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                       +.....   ......+.+.+|+.+||..||.+||++.+++++.|...
T Consensus       228 -~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~  271 (287)
T cd06621         228 -LKDEPG---NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA  271 (287)
T ss_pred             -hccCCC---CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence             000000   00123467899999999999999999999999999743

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-39  Score=311.34  Aligned_cols=249  Identities=31%  Similarity=0.475  Sum_probs=197.7

Q ss_pred             eeeeeCceEEEEEEEcC-------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          142 KIGQGGFGTVYKGRLED-------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .||+|+||.||+|+..+       +..+|||.+.... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            59999999999998642       3679999876542 223456788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----ceEEeeecc
Q 013401          215 VPNGTLREHLDCLQ-----GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-----RAKVADFGF  284 (443)
Q Consensus       215 ~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-----~vkl~DFGl  284 (443)
                      +++++|.+++....     ...+++..++.++.||+.||.|||   +.+++|+||||+|||++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432     234788889999999999999999   78899999999999999877     899999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      +........  ........++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~  228 (269)
T cd05044         158 ARDIYKSDY--YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-------A  228 (269)
T ss_pred             ccccccccc--cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-------c
Confidence            976543321  111223346788999999998889999999999999999998 999997655432211111       1


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      +....          .....+..+.+|+.+||..+|.+||++.+|++.|.
T Consensus       229 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 GGRLQ----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CCccC----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            10000          01123467899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-39  Score=316.81  Aligned_cols=273  Identities=25%  Similarity=0.307  Sum_probs=207.5

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  206 (443)
                      ...+|++.+.||+|+||.||+|..+ +|+.||||+++...........+.+|+++++.++||||+++++++.+.+     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567999999999999999999986 6899999998765444445567789999999999999999999987655     


Q ss_pred             -----eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEee
Q 013401          207 -----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD  281 (443)
Q Consensus       207 -----~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~D  281 (443)
                           ..++|+||+.+ +|..++... ...+++..++.++.||+.||.|||   ..+|+|+||||+||++++++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                 78999999976 677766542 346899999999999999999999   88899999999999999999999999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ||++........   .......++..|+|||++.+ ..++.++|||||||++++|++|++||...........+......
T Consensus       160 fg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         160 FGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             ccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999987654321   11222346888999998864 35788999999999999999999999876554433333322111


Q ss_pred             cCCCccccc--------cCccc----cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          361 FSDGDAISI--------LDPRV----ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       361 ~~~~~~~~~--------~d~~~----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ........+        .+...    .........+..+.+|+.+||+.||.+||++.+++++.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            111000000        00000    000001123567999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=313.05  Aligned_cols=270  Identities=25%  Similarity=0.319  Sum_probs=207.0

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEEEEEe
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERIVIVE  213 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~E  213 (443)
                      |++.++||.|+||.||+|... +++.||||+++...........+.+|+.+++.++|+||+++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999976 589999999987643444556788999999999999999999999888  89999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+ +|.+++... ...+++..++.++.||+.||.|||   .++++|+||||+|||+++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9974 888888642 257899999999999999999999   78899999999999999999999999999987654321


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc---
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI---  369 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  369 (443)
                         .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+...............   
T Consensus       156 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         156 ---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             ---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence               11223457889999998764 45789999999999999999999999877654333222221111110000000   


Q ss_pred             -----cCccccc-----hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          370 -----LDPRVEN-----TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       370 -----~d~~~~~-----~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                           ..+....     .......+..+.+++.+||+.||.+||++.+++++.|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                 0000000     00011125679999999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-39  Score=304.34  Aligned_cols=252  Identities=28%  Similarity=0.464  Sum_probs=208.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...+.||+|+||.||++... ++..|++|++.....  .....+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            3677789999999999999986 789999999876432  3557788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++.... ..+++..+..++.|++.+|.+||   .++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          79 CSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999999986532 57899999999999999999999   88899999999999999999999999999977654321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                          .....|+..|++||++.+..++.++||||||+++|+|++|..||..............       ........   
T Consensus       154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~---  219 (253)
T cd05122         154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-------NGPPGLRN---  219 (253)
T ss_pred             ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-------cCCCCcCc---
Confidence                2345689999999999888889999999999999999999999986643322222111       00000000   


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                           .......+.+++.+||+.||++||++.++++|+|
T Consensus       220 -----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         220 -----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                 1112467999999999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-39  Score=312.07  Aligned_cols=262  Identities=26%  Similarity=0.376  Sum_probs=213.6

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..++|+....||+|+||.||+|.+. ++..|++|+++....   ....+.+|+++++.++|+||+++++.+...+..++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            3456888889999999999999987 689999999875422   456788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      +||+++++|.+++.... ..+++..++.++.|++.+|.|||   ..|++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999999997533 47899999999999999999999   889999999999999999999999999998655432


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ..    ......++..|++||++.+..++.++|||||||++|+|++|..||...........+..       ....... 
T Consensus       170 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~-  237 (286)
T cd06614         170 KS----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-------KGIPPLK-  237 (286)
T ss_pred             hh----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------cCCCCCc-
Confidence            21    12234588999999999888899999999999999999999999986655432221111       0000000 


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                             ........+.+|+.+||+.+|..||++.+++++.|......+
T Consensus       238 -------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  279 (286)
T cd06614         238 -------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK  279 (286)
T ss_pred             -------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence                   011134678999999999999999999999999997764433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.6e-39  Score=305.89  Aligned_cols=252  Identities=33%  Similarity=0.501  Sum_probs=201.5

Q ss_pred             CCCCceeeeeCceEEEEEEEcC-----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      |.+.+.||.|+||.||+|...+     +..||+|.++.... ......+.+|+.++..++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            3456789999999999998763     38899999865422 22556888999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.+++|.+++.......+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999997544333899999999999999999999   888999999999999999999999999999776543


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ....   .....+++.|+|||.+.+..++.++|||||||++++|++ |.+||...........+.       ....... 
T Consensus       157 ~~~~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~-  225 (258)
T smart00219      157 DYYK---KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-------KGYRLPK-  225 (258)
T ss_pred             cccc---cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCCCCCC-
Confidence            2111   112237889999999988889999999999999999998 889987643322111111       1110000 


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                               ....+..+.+++.+||..||++||++.++++.|
T Consensus       226 ---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ---------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                     011346799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-39  Score=309.50  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=203.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      .+|.....||.|+||.||+|..+      +.+.|++|.+.... .......+.+|++++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            46888899999999999999864      35679999876432 222456789999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEee
Q 013401          209 IVIVEYVPNGTLREHLDCLQG-------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD  281 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~D  281 (443)
                      ++||||+++++|.+++.....       ..+++..++.++.||+.+|.|||   +++|+||||||+|||++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence            999999999999999975431       15899999999999999999999   88899999999999999999999999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhh
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ||++........   .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.............     
T Consensus       161 ~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-----  232 (275)
T cd05046         161 LSLSKDVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-----  232 (275)
T ss_pred             cccccccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH-----
Confidence            999875432211   11223356788999999988888999999999999999999 888996544322111111     


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        .+......         ...++..+.+++.+||+.||.+||++.+++..++
T Consensus       233 --~~~~~~~~---------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 --AGKLELPV---------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --cCCcCCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence              11100000         0113367999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.2e-40  Score=323.22  Aligned_cols=276  Identities=25%  Similarity=0.351  Sum_probs=206.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecC--eEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFED--ERI  209 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~--~~~  209 (443)
                      .++|...+.||+|+||.||+|.+. +++.||||++............+.+|+.+++++ +|+||+++++++...+  ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            457888889999999999999976 688999998865433344456677899999999 9999999999886543  689


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+. ++|.+++..   ..+++..++.++.||+.||.|||   ++||+|+||||+|||++.++.+||+|||++....
T Consensus        86 lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          86 LVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            9999996 589888853   27888889999999999999999   8899999999999999999999999999998665


Q ss_pred             ccCCCc-ccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC---
Q 013401          290 DTESGA-THVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG---  364 (443)
Q Consensus       290 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---  364 (443)
                      ...... ......+.|+..|+|||++.+ ..++.++|||||||++|+|++|++||...........+..........   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            432211 112334568999999998754 457889999999999999999999997665433322211111100000   


Q ss_pred             --------ccccccC-cc-ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 --------DAISILD-PR-VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 --------~~~~~~d-~~-~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                              ....... .. ..........+.++.+|+.+||+.||++||++.+++++.|.-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence                    0000000 00 0000011113567999999999999999999999999987543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-40  Score=312.02  Aligned_cols=238  Identities=25%  Similarity=0.371  Sum_probs=187.6

Q ss_pred             eeeeeCceEEEEEEEcC--------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          142 KIGQGGFGTVYKGRLED--------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .||+|+||.||+|..+.        ...||+|.+....  ....+.+.+|+.+++.+.||||+++++++..++..++|||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            69999999999998642        2347778765432  3344678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--------eEEeeeccc
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR--------AKVADFGFA  285 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--------vkl~DFGla  285 (443)
                      |+.+|+|.+++... +..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.        ++++|||++
T Consensus        80 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          80 YVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             cCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999998753 346889999999999999999999   888999999999999987765        699999988


Q ss_pred             ccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCC-CCCCCchhHHHHHHHHHHhhhcCC
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGR-RPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ......        ....++..|+|||++.+ ..++.++|||||||++|+|++|. +||........... ..   .   
T Consensus       156 ~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~---~---  220 (258)
T cd05078         156 ITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YE---D---  220 (258)
T ss_pred             cccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HH---c---
Confidence            654321        23458889999999976 45788999999999999999985 66654433221111 10   0   


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                        ...     ++.     ....++.+|+.+||+.||++||+++++++.|
T Consensus       221 --~~~-----~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         221 --RHQ-----LPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --ccc-----CCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              000     000     1125689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-39  Score=311.01  Aligned_cols=238  Identities=26%  Similarity=0.388  Sum_probs=186.7

Q ss_pred             eeeeeCceEEEEEEEcC-------------------------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCccee
Q 013401          142 KIGQGGFGTVYKGRLED-------------------------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV  196 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv  196 (443)
                      +||+|+||.||+|.+..                         ...|++|++....  ......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            69999999999997421                         1358888876532  23345678899999999999999


Q ss_pred             eeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-
Q 013401          197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-  275 (443)
Q Consensus       197 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-  275 (443)
                      ++++++...+..++||||+++|+|..++.. ....+++..++.++.||+.||.|||   +++|+||||||+|||++..+ 
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCc
Confidence            999999999999999999999999988864 3456889999999999999999999   88999999999999998644 


Q ss_pred             ------ceEEeeecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHH-cCCCCCCCchh
Q 013401          276 ------RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELV-TGRRPIEPKRE  347 (443)
Q Consensus       276 ------~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~ell-tG~~Pf~~~~~  347 (443)
                            .+||+|||++......        ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||.....
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             ccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence                  3899999987544321        12347888999998865 56889999999999999985 69999976543


Q ss_pred             HHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          348 LKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                      .........   .           ..+..     .....+.+++.+||+.+|++||++.++++.|
T Consensus       228 ~~~~~~~~~---~-----------~~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 SEKERFYEK---K-----------HRLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHHHHh---c-----------cCCCC-----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            221111100   0           00000     0124689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=309.88  Aligned_cols=268  Identities=25%  Similarity=0.285  Sum_probs=204.2

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc---CCcceeeeeeeeeecCe-----
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV---EHLNLVKFHGYLEFEDE-----  207 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~-----  207 (443)
                      |++.+.||+|+||.||+|.++ +++.||||+++...........+.+|+.+++++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999987 589999999876543333344566788877766   59999999999988877     


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .+++|||+. ++|.+++.......+++..++.++.||+.||.|||   .++++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            999999996 47988887544456899999999999999999999   88899999999999999999999999999877


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC----
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD----  363 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----  363 (443)
                      ......     .....++..|+|||++.+..++.++|||||||++|+|++|.+||....+......+.........    
T Consensus       157 ~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFEMA-----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             ccCCcc-----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence            643321     12335788999999999888999999999999999999999999876543322211110000000    


Q ss_pred             -Cc--cccccCccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          364 -GD--AISILDPRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       364 -~~--~~~~~d~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                       ..  ...........  ..........+.+++.+||+.||.+||++.+++.|.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~  286 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY  286 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence             00  00000000000  1111234577899999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.1e-39  Score=312.84  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=204.5

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |.....||+|+||.||++... +++.+++|+++..  .......+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            444568999999999999865 7899999987643  2233456789999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .|++|.+++..   ..+++..+..++.|++.+|.|||   +++++||||+|+||+++.++.++|+|||++........  
T Consensus        99 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648          99 EGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            99999998864   45888999999999999999999   88899999999999999999999999998875543211  


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                        ......|++.|+|||++.+..++.++|||||||++|+|++|..||...+...........       ..     +.+.
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-------~~-----~~~~  236 (285)
T cd06648         171 --RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-------LP-----PKLK  236 (285)
T ss_pred             --ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-------CC-----CCCc
Confidence              122346899999999998888999999999999999999999999765543222111110       00     0000


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .   .......+.+|+.+||+.+|++||++.++++|.|...
T Consensus       237 ~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         237 N---LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             c---cccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence            0   1113467999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.6e-39  Score=316.07  Aligned_cols=269  Identities=20%  Similarity=0.245  Sum_probs=200.4

Q ss_pred             eeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHHH
Q 013401          143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLRE  222 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~  222 (443)
                      +|.|+++.||++.. +++.||||+++...........+.+|+.+++.++|+||+++++++.+.+..+++|||+.+++|.+
T Consensus        10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED   88 (314)
T ss_pred             hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence            44444444444443 69999999987654455666789999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC---ccccc
Q 013401          223 HLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG---ATHVS  299 (443)
Q Consensus       223 ~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~---~~~~~  299 (443)
                      ++.......+++.....++.||+.||.|||   +++|+||||||+|||++.++.+||+|||.+.........   .....
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence            998655567899999999999999999999   888999999999999999999999999998755432211   11112


Q ss_pred             ccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH-HhhhcCCCcccc--------
Q 013401          300 TQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW-AMKKFSDGDAIS--------  368 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~--------  368 (443)
                      ....++..|+|||++.+  ..++.++|||||||++|||++|..||.............. ............        
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence            33457889999999865  3588999999999999999999999986654332211100 000000000000        


Q ss_pred             ----ccCccc---cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ----ILDPRV---ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ----~~d~~~---~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                          ..++..   ...........++.+|+.+||+.||++||++.++++|+|..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence                000000   00111223456799999999999999999999999999954

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-39  Score=314.55  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=206.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|...+.||+|+||.||++... ++..||+|.+...  .....+.+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            57888999999999999999865 6889999998643  23334678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++++|.+++..   ..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++........
T Consensus        97 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          97 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             cCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999999853   35788889999999999999999   88999999999999999999999999999876543221


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......|++.|++||++.+..++.++|||||||++|+|++|..||...+.........    .  .+ .     +.
T Consensus       171 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~----~--~~-~-----~~  234 (293)
T cd06647         171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----T--NG-T-----PE  234 (293)
T ss_pred             ----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh----c--CC-C-----CC
Confidence                1223468899999999988889999999999999999999999997654432211100    0  00 0     00


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .   .........+.+++.+||+.+|++||++.+++.|.|.-
T Consensus       235 ~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         235 L---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             C---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence            0   01112345688999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-39  Score=310.95  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=201.6

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccCccc-HHHHHHHH---HHHHhcCCcceeeeeeeeeecCeEEEEEeecC
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHS-GAEFQSEI---RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~~Ei---~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  216 (443)
                      .||+|+||.||++... +++.||||.+.+....... ...+..|.   ..++...||||+.+++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999875 6899999998664332222 12233343   34455679999999999999999999999999


Q ss_pred             CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          217 NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       217 gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      |++|.+++..  ...+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......    
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            9999998863  457999999999999999999999   8889999999999999999999999999987553321    


Q ss_pred             cccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          297 HVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                        .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ........         ....+.
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~---------~~~~~~  219 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT---------MAVELP  219 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HHHHHhhc---------cCCCCC
Confidence              123469999999999864 46889999999999999999999999765321110 01110000         001111


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCc
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                      .     ..+.++.+++.+||..||.+||     ++.++++|.|....+++.....++.
T Consensus       220 ~-----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~  272 (278)
T cd05606         220 D-----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYP  272 (278)
T ss_pred             C-----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcccC
Confidence            0     1246799999999999999999     9999999999888777776544443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-39  Score=311.16  Aligned_cols=265  Identities=28%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~  207 (443)
                      +.|...+.||+|+||.||+|.+.     ++..||||+++..... .....+.+|+.+++.+.|+||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            45777789999999999999853     3789999998765332 346789999999999999999999999877  557


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+++++|.+++... ...+++..++.++.||+.||.|||   .++++|+||||+|||++.++.++|+|||++..
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            89999999999999999653 335899999999999999999999   88899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH--------HHHHHHhh
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER--------ITVKWAMK  359 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~--------~~~~~~~~  359 (443)
                      ....... ........++..|++||.+.+..++.++|||||||++|||++|..||.........        ........
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         159 LPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            6532211 11111233566799999998888999999999999999999999998653221100        00000000


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .+......       .   ....++.++.+|+.+||+.+|++||++.+|++.|..+
T Consensus       238 ~~~~~~~~-------~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERL-------P---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcC-------C---CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11010000       0   0112346799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.7e-39  Score=306.46  Aligned_cols=236  Identities=27%  Similarity=0.401  Sum_probs=188.2

Q ss_pred             eeeeeCceEEEEEEEcC-C----------cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          142 KIGQGGFGTVYKGRLED-G----------TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      .||+|+||.||+|.+.+ +          ..+++|.++...   .....+.+|+.+++.++|+||+++++++.. +..++
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            69999999999999763 3          247777765432   125778899999999999999999999888 78899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-------ceEEeeec
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-------RAKVADFG  283 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-------~vkl~DFG  283 (443)
                      ||||+.+|+|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++       .+||+|||
T Consensus        78 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          78 VEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999999753 236889999999999999999999   88899999999999999887       79999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhh
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTY--QLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ++.....        .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...........  +.   
T Consensus       154 ~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--~~---  220 (259)
T cd05037         154 IPITVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--YQ---  220 (259)
T ss_pred             ccccccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--Hh---
Confidence            9876543        1223467789999999776  78899999999999999999 5788866542211111  10   


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                        .....       ...     ....+.+++.+||..+|++||++.++++.|
T Consensus       221 --~~~~~-------~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 --DQHRL-------PMP-----DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --cCCCC-------CCC-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              00000       000     015789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=314.78  Aligned_cols=273  Identities=20%  Similarity=0.244  Sum_probs=201.3

Q ss_pred             CCCCCceeeeeCceEEEEEEEc---CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE---DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  209 (443)
                      +|....+||+|+||.||+|...   ++..||||.+.... ........+.+|+.+++.++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999975   47899999987643 1233346678899999999999999999999988  8899


Q ss_pred             EEEeecCCCcHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC----CCceEEeee
Q 013401          210 VIVEYVPNGTLREHLDCLQ---GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE----NFRAKVADF  282 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~----~~~vkl~DF  282 (443)
                      +||||+.+ +|.+++....   ...+++..++.++.||+.||.|||   +++|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 6777664322   236889999999999999999999   888999999999999999    999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH------HHHHHH
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK------ERITVK  355 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~------~~~~~~  355 (443)
                      |++......... ........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......      ......
T Consensus       157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             ccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876543221 112234568999999998865 457899999999999999999999997554321      000011


Q ss_pred             HHhhhcCCC------------cccc----ccCccccc-hh---hcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          356 WAMKKFSDG------------DAIS----ILDPRVEN-TA---ANN--LALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       356 ~~~~~~~~~------------~~~~----~~d~~~~~-~~---~~~--~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .....+...            +...    ........ ..   ...  ....++.+++.+||+.||++||++.++++|.|
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            110000000            0000    00000000 00   000  23357999999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.7e-39  Score=309.17  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=201.3

Q ss_pred             CCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      |.+.+.||+|+||.||+|.+.    +++.||||+++.........+++.+|+++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556778999999999999853    3688999999876555556677899999999999999999999876532      


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ----GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                      ..++++||+.+|+|.+++....    ...+++...+.++.||+.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2468899999999998874321    124788889999999999999999   888999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhc
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      |+++.......  ........+++.|++||.+.+..++.++|||||||++|+|++ |.+||...........+.      
T Consensus       158 g~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~------  229 (273)
T cd05074         158 GLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI------  229 (273)
T ss_pred             cccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH------
Confidence            99886543211  111223346778999999988889999999999999999999 889997654422211111      


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       .......          ....+..+.+++.+||+.+|++||++.++++.|..+
T Consensus       230 -~~~~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 -KGNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -cCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             1110000          011346799999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-39  Score=317.42  Aligned_cols=273  Identities=23%  Similarity=0.287  Sum_probs=204.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      .++|.+.++||+|+||.||+|... +++.||||++............+.+|+++++.++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999976 6899999998655433334456789999999999999999999875433      


Q ss_pred             --eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          207 --ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       207 --~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                        .+++|+||+.+ +|...+.. ....+++..++.++.||+.||.|||   .++|+|+||||+|||+++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence              46999999964 67776653 3456899999999999999999999   88899999999999999999999999999


Q ss_pred             cccccccCCCcc-------cccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH
Q 013401          285 ARLAADTESGAT-------HVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW  356 (443)
Q Consensus       285 a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~  356 (443)
                      +...........       .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            976543322111       11234567899999998865 3578999999999999999999999987665443322222


Q ss_pred             HhhhcCCCc--------------cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          357 AMKKFSDGD--------------AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       357 ~~~~~~~~~--------------~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ......+..              ......+.+..  ........+.+++.+||+.||.+||++.+++.|.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~  310 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY  310 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence            111110000              00000111100  01123367899999999999999999999999987

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.6e-39  Score=305.61  Aligned_cols=255  Identities=24%  Similarity=0.431  Sum_probs=202.2

Q ss_pred             CCCCCceeeeeCceEEEEEEEcC--CcEEEEEEcccccc--------CcccHHHHHHHHHHHHh-cCCcceeeeeeeeee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLED--GTIVAIKRAKKSVY--------DKHSGAEFQSEIRTLAQ-VEHLNLVKFHGYLEF  204 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~--------~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~  204 (443)
                      +|.+.+.||+|+||.||+|.+..  ++.+|||.+.....        ......++.+|+.++.. ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999764  78899998754321        12234557788888875 689999999999999


Q ss_pred             cCeEEEEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          205 EDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                      ++..++||||++|++|.+++...  ....+++..++.++.|++.+|.|||.  ..+++|+||+|+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988542  34568899999999999999999993  257999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      |++.......     ......|+..|++||++.+..++.++||||||+++|+|++|.+||...........+.       
T Consensus       159 g~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-------  226 (269)
T cd08528         159 GLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV-------  226 (269)
T ss_pred             cceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh-------
Confidence            9997654432     2234568999999999988889999999999999999999999997654322211111       


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ........         .......+.+++.+||+.||++||++.++..++.
T Consensus       227 ~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EAVYEPLP---------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hccCCcCC---------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11111000         0112367999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.7e-39  Score=306.59  Aligned_cols=249  Identities=27%  Similarity=0.335  Sum_probs=202.3

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      ||.|+||.||+|... +++.||+|++.+... .......+.+|+.+++.++|+||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999976 589999999875432 234456789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccc
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST  300 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  300 (443)
                      .+++..  ...+++..+..++.||+.||.|||   +++++|+||+|+||+++.++.++|+|||++.......     ...
T Consensus        81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~~  150 (262)
T cd05572          81 WTILRD--RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTW  150 (262)
T ss_pred             HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----ccc
Confidence            999964  345889999999999999999999   8889999999999999999999999999998765432     122


Q ss_pred             cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       301 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ...|++.|++||++.+..++.++|+||||+++|+|++|..||........... .....   ....     ...     .
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~---~~~~-----~~~-----~  216 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY-NDILK---GNGK-----LEF-----P  216 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH-HHHhc---cCCC-----CCC-----C
Confidence            34689999999999888899999999999999999999999976652111111 00000   0000     000     0


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhh
Q 013401          381 NLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSV  415 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i  415 (443)
                      ....+.+.+++.+||+.||++||+     +.++++|+|.-
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            112467999999999999999999     99999999954

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.2e-39  Score=313.49  Aligned_cols=252  Identities=27%  Similarity=0.413  Sum_probs=202.0

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |...+.||+|+||.||++... ++..||+|++..... .......+.+|+++++.++|+|++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            677789999999999999975 689999999865422 223345788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.| +|.+++.. ....+++..+..++.|++.||.|||   .++|+|+||+|+||+++.++.+||+|||++......   
T Consensus       107 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         107 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            964 77777653 3456899999999999999999999   888999999999999999999999999998654321   


Q ss_pred             cccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          295 ATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                           ....|++.|+|||++.   ...++.++|||||||++|+|++|..||...........+..  ...     .    
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--~~~-----~----  242 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NES-----P----  242 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--ccC-----C----
Confidence                 2345889999999973   45688899999999999999999999976543322211111  000     0    


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       ..    ......+.+.+|+.+||+.+|.+||++.++++++|.+..
T Consensus       243 -~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         243 -TL----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             -CC----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence             00    011234578999999999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-39  Score=319.98  Aligned_cols=274  Identities=22%  Similarity=0.275  Sum_probs=211.2

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----eEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----ERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  209 (443)
                      +|.+.+.||.|+||.||+|... ++..||||++............+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778889999999999999976 5899999998765433455567889999999999999999999988775     789


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+. ++|.+++..  ...+++..++.++.+|+.||.|||   ++||+|+||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 588888863  347899999999999999999999   8889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC----
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG----  364 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----  364 (443)
                      ..... ........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...........+..........    
T Consensus       155 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         155 PDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             ccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            54211 1122345689999999999887 78999999999999999999999998776543322221111110000    


Q ss_pred             ----cccccc---Cccc--cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 ----DAISIL---DPRV--ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ----~~~~~~---d~~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                          .....+   ....  ............+.+|+.+||+.||.+||++.+++.|+|.-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                000000   0000  000001123567899999999999999999999999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.1e-39  Score=314.39  Aligned_cols=261  Identities=24%  Similarity=0.403  Sum_probs=203.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc----EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|+..+.||+|+||.||+|.+. +|.    .||+|.+.... ......++.+|+.+++.++||||+++++++... ..+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            46788889999999999999864 454    46888876532 223344688999999999999999999988654 567


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +++||+++|+|.+++.. ....+++..++.++.|++.||.|||   .++|+|+||||+|||++.++.+||+|||++....
T Consensus        85 ~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            89999999999999864 3345888899999999999999999   8889999999999999999999999999998664


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....  .......++..|+|||++.+..++.++|||||||++|||++ |..||.........   .+..    .+....
T Consensus       161 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~~----~~~~~~  231 (303)
T cd05110         161 GDEKE--YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLLE----KGERLP  231 (303)
T ss_pred             Ccccc--cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH----CCCCCC
Confidence            32211  11222346778999999998899999999999999999997 99999765322211   1110    111000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      .          ...+...+.+++.+||..||++||++.++++.+..+..+..
T Consensus       232 ~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         232 Q----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            0          01123568899999999999999999999999998765544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.6e-39  Score=303.74  Aligned_cols=254  Identities=28%  Similarity=0.451  Sum_probs=211.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...+.||.|+||.||++.+. ++..|++|++............+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778889999999999999976 689999999887655556677889999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          215 VPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       215 ~~gg~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      +++++|.+++....  +..+++..++.++.+++.||.|||   .++++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997543  467899999999999999999999   7889999999999999999999999999997665432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                          .......|++.|+|||.+.+..++.++||||||+++++|++|..||...........  .     .......+   
T Consensus       158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--~-----~~~~~~~~---  223 (258)
T cd08215         158 ----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK--I-----LKGQYPPI---  223 (258)
T ss_pred             ----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH--H-----hcCCCCCC---
Confidence                122335689999999999888899999999999999999999999976643211111  1     11111110   


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        .     ......+.+++.+||..+|++||++.++++++|
T Consensus       224 --~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         224 --P-----SQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             --C-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence              0     023367899999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-39  Score=322.80  Aligned_cols=273  Identities=20%  Similarity=0.301  Sum_probs=206.7

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC---
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED---  206 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---  206 (443)
                      ....++|...+.||+|+||.||+|... ++..||||+++...........+.+|+.+|+.++|+||+++++++..+.   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999865 7999999998654433444566889999999999999999999987654   


Q ss_pred             ---eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeec
Q 013401          207 ---ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFG  283 (443)
Q Consensus       207 ---~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG  283 (443)
                         ..++||||+ +++|.+++.   ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence               458999998 778988774   346899999999999999999999   8889999999999999999999999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh---
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK---  359 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~---  359 (443)
                      ++......       .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....   
T Consensus       164 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07880         164 LARQTDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            98765322       123457899999999865 4588899999999999999999999986654332222111000   


Q ss_pred             -----hcCCCccccccC--ccccc---hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          360 -----KFSDGDAISILD--PRVEN---TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       360 -----~~~~~~~~~~~d--~~~~~---~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                           .+..........  +....   ..........+.+++.+||+.||.+||++.+++.|.|.-..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                 000000000000  00000   00011234568999999999999999999999999996543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-39  Score=321.11  Aligned_cols=277  Identities=21%  Similarity=0.305  Sum_probs=209.1

Q ss_pred             CHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee
Q 013401          126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF  204 (443)
Q Consensus       126 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~  204 (443)
                      ...++....++|...+.||+|+||.||+|... +++.||||+++...........+.+|+.++++++|+||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            44566778899999999999999999999864 79999999987654334445678899999999999999999998764


Q ss_pred             c------CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceE
Q 013401          205 E------DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAK  278 (443)
Q Consensus       205 ~------~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vk  278 (443)
                      .      ...+++++++ +++|.+++..   ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            3      3467788876 7899887752   45899999999999999999999   88899999999999999999999


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH-
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW-  356 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~-  356 (443)
                      |+|||++......       .....|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.. 
T Consensus       161 l~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         161 ILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             Eeccccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999998754321       233568999999999866 4688899999999999999999999976554332221111 


Q ss_pred             -------HhhhcCCCccc---cccCccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          357 -------AMKKFSDGDAI---SILDPRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       357 -------~~~~~~~~~~~---~~~d~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                             ....+......   ..+......  .........++.+|+.+||+.||.+||++.+++.|.|...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence                   11111110000   000000000  0000012457899999999999999999999999999553

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-39  Score=319.74  Aligned_cols=273  Identities=22%  Similarity=0.265  Sum_probs=200.9

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-C--CcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec----Ce
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-D--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE----DE  207 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~  207 (443)
                      +|...+.||+|+||.||++... +  +..||||++............+.+|+.+++.+ +|+||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999975 4  78999999875433334456788999999999 599999999875432    45


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +++++|++. ++|.+++.  ....+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788888885 68988886  3467899999999999999999999   88899999999999999999999999999986


Q ss_pred             ccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC----
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS----  362 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----  362 (443)
                      ................||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+........    
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            65432211111234578999999998765 4688999999999999999999999976543221111111000000    


Q ss_pred             ----CCcccc---cc--CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          363 ----DGDAIS---IL--DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       363 ----~~~~~~---~~--d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                          ......   .+  .+..............+.+|+.+||+.||.+||++.+++.+.|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence                000000   00  00000000011124579999999999999999999999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.6e-39  Score=301.73  Aligned_cols=256  Identities=25%  Similarity=0.439  Sum_probs=209.3

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~  212 (443)
                      +|...+.||+|+||.||+|... ++..|++|++............+.+|+.++++++|+||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677789999999999999987 799999999876543345567889999999999999999999999988  8999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++...  ..+++..++.++.|++.+|.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            999999999999753  37899999999999999999999   7889999999999999999999999999998766543


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      ..  .......++..|++||.+.+..++.++||||||+++|+|++|..||........   ..+....  ......    
T Consensus       156 ~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~--~~~~~~----  224 (260)
T cd06606         156 TG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGS--SGEPPE----  224 (260)
T ss_pred             cc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccc--cCCCcC----
Confidence            21  012335688999999999888899999999999999999999999976652111   1111110  000000    


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                       +     .......+.+++.+||+.||++||++.+++.|+|
T Consensus       225 -~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         225 -I-----PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             -C-----CcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence             0     1112467999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=311.87  Aligned_cols=280  Identities=20%  Similarity=0.308  Sum_probs=217.2

Q ss_pred             CCCcccCHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-C-c---
Q 013401          120 SGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-H-L---  193 (443)
Q Consensus       120 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-~---  193 (443)
                      .|...+...|.  .+++|.+...||+|+||.|-.|.+. .+..||||+++.-   ....+..+-|+++|.++. + |   
T Consensus        76 dGH~v~~~gD~--l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~  150 (415)
T KOG0671|consen   76 DGHYVYQVGDI--LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGK  150 (415)
T ss_pred             CceEEEEeccc--cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCc
Confidence            34344444443  3678999999999999999999876 5789999998753   344556677999999994 2 3   


Q ss_pred             -ceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013401          194 -NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT  272 (443)
Q Consensus       194 -niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~  272 (443)
                       -+|.+.+||+..++.|||+|.+ |-+++++|..+...+++...+..|+.|++++++|||   +.+++|.||||||||+.
T Consensus       151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfv  226 (415)
T KOG0671|consen  151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFV  226 (415)
T ss_pred             eEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEe
Confidence             3788889999999999999999 779999999888888999999999999999999999   88899999999999994


Q ss_pred             C--------------------CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHH
Q 013401          273 E--------------------NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLL  332 (443)
Q Consensus       273 ~--------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll  332 (443)
                      .                    +..|+|+|||.|.+.....       ..++.|..|.|||++.+..++.++||||+||||
T Consensus       227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence            3                    2469999999998765432       456789999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCchhHHHHHHHHHHhhhc--------------CCC-----------ccccccCccc---cchhhcHHHH
Q 013401          333 VELVTGRRPIEPKRELKERITVKWAMKKF--------------SDG-----------DAISILDPRV---ENTAANNLAL  384 (443)
Q Consensus       333 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------------~~~-----------~~~~~~d~~~---~~~~~~~~~~  384 (443)
                      +||.+|..-|......+.....+.+...+              ..+           +.....++..   ......+.+.
T Consensus       300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~  379 (415)
T KOG0671|consen  300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH  379 (415)
T ss_pred             EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence            99999999998776443332222211111              111           0000111111   1111234455


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          385 EKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       385 ~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..|.+|+.+||..||.+|+|+.|++.|+|.-
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~  410 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALSHPFFA  410 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhcCHHhh
Confidence            6799999999999999999999999999864

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-39  Score=319.29  Aligned_cols=273  Identities=21%  Similarity=0.305  Sum_probs=207.9

Q ss_pred             HHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-cC
Q 013401          129 EIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-ED  206 (443)
Q Consensus       129 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~  206 (443)
                      +++..+++|...+.||.|+||.||+|... +++.||||++.+..........+.+|+.+++.++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            44557788999999999999999999866 79999999987654444455678899999999999999999998865 56


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..++|+||+ +++|.+++.   ...+++.....++.||+.||.|||   ..+|+|+||+|+|||++.++.+||+|||++.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999998 568887774   345788888899999999999999   8889999999999999999999999999987


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh------
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK------  359 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~------  359 (443)
                      .....       .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.................      
T Consensus       157 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd07856         157 IQDPQ-------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV  229 (328)
T ss_pred             ccCCC-------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            54321       123457889999999865 5689999999999999999999999976544222111111100      


Q ss_pred             --hcCCCcccccc---C--ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 --KFSDGDAISIL---D--PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 --~~~~~~~~~~~---d--~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ..........+   .  .............+.+.+++.+||+.+|++||++.+++.+.|..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~  292 (328)
T cd07856         230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA  292 (328)
T ss_pred             HHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence              00000000000   0  00000001112346799999999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.7e-39  Score=310.76  Aligned_cols=270  Identities=24%  Similarity=0.337  Sum_probs=210.5

Q ss_pred             CCCCCceeeeeCceEEEEEEE----cCCcEEEEEEcccccc--CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  208 (443)
                      +|+..+.||+|+||.||+|..    .+|..||+|+++....  .....+.+.+|++++..+ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999986    3689999999875432  122345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++||||+++++|.+++..  ...+++..+..++.||+.||.|||   ..+++||||+|+|||++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            999999999999999974  356888888999999999999999   888999999999999999999999999998765


Q ss_pred             cccCCCcccccccccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTY--QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ......   ......|+..|+|||++.+.  .++.++|||||||++|+|++|..||..................   .  
T Consensus       156 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~--  227 (290)
T cd05613         156 HEDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK---S--  227 (290)
T ss_pred             cccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc---c--
Confidence            432211   12235689999999998653  4678999999999999999999999643221111111111000   0  


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccC
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDV  427 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~  427 (443)
                          .+..     .......+.+|+.+||+.||++||     ++.+++.|.|.-+.++.+......
T Consensus       228 ----~~~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  284 (290)
T cd05613         228 ----EPPY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKV  284 (290)
T ss_pred             ----CCCC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhccC
Confidence                0000     111335688999999999999997     899999999988888766654433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-38  Score=305.01  Aligned_cols=255  Identities=20%  Similarity=0.280  Sum_probs=198.4

Q ss_pred             HHHHHHHhcCCCCCcee--eeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeee
Q 013401          127 MEEIYRATRNFSPSFKI--GQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYL  202 (443)
Q Consensus       127 ~~~~~~~~~~f~~~~~L--G~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  202 (443)
                      ..++....++|.+.+.+  |+|+||.||++..+ ++..+|+|.+.......       .|+.....+ +|+||+++++.+
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEE
Confidence            34444555677777766  99999999999875 68999999986542211       122222222 699999999999


Q ss_pred             eecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEee
Q 013401          203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVAD  281 (443)
Q Consensus       203 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~D  281 (443)
                      ...+..++||||+++++|.+++..  ...+++..++.++.||+.||.|||   +.+++||||||+||+++.++ .++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999999964  347899999999999999999999   88899999999999999988 999999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      ||++......        ....|+..|+|||++.+..++.++|||||||++|+|++|..||......... ...+.... 
T Consensus       154 fg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-  223 (267)
T PHA03390        154 YGLCKIIGTP--------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLLKRQ-  223 (267)
T ss_pred             CccceecCCC--------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHHHhh-
Confidence            9998765422        1235899999999999888999999999999999999999999754322110 11111111 


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS-MRRCAEILWSV  415 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-~~ell~~l~~i  415 (443)
                       .. ....          ....+..+.+|+.+||++||.+||+ ++++++|.|..
T Consensus       224 -~~-~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        224 -QK-KLPF----------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             -cc-cCCc----------ccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence             00 0000          1124467999999999999999996 69999999853

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=312.64  Aligned_cols=268  Identities=24%  Similarity=0.320  Sum_probs=221.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .+|..+..||+|+||.|.++..+ +.+.||||++++... ...+.+--+.|-++|... +-|.+++++..|..-+++|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            36899999999999999999877 578999999988764 333333345677777766 578999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.||+|-.+|...  +.+.+..+..+|..|+.||-+||   ++|||.||||.+|||||.+|++||+|||+++.-.-.
T Consensus       429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999754  55788888889999999999999   999999999999999999999999999999754322


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .    .....++|||.|+|||++...+|+..+|+|++||+|||||.|++||++.++......+..-.-.           
T Consensus       504 ~----~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-----------  568 (683)
T KOG0696|consen  504 G----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-----------  568 (683)
T ss_pred             C----cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc-----------
Confidence            2    2345689999999999999999999999999999999999999999998875543332221100           


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhhcccCcC
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELAASDVLL  429 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~~~~~~~  429 (443)
                             .....+.+..+++...|.+.|.+|...     ++|.+|.+.-+.||-.++.-....
T Consensus       569 -------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqP  624 (683)
T KOG0696|consen  569 -------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQP  624 (683)
T ss_pred             -------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCC
Confidence                   122345678899999999999999765     789999999999998887765543

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.2e-39  Score=304.37  Aligned_cols=252  Identities=26%  Similarity=0.404  Sum_probs=208.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|++.++||+|+||.||++... +++.+|+|.++...........+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778889999999999999865 788999999876554455566788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          215 VPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       215 ~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      +++++|.+++...  ....+++..++.++.|++.||.|||   +.|++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998642  2356888999999999999999999   888999999999999999999999999999776543 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           ......|++.|++||.+.+..++.++|+||||+++|+|++|..||.............       .+....    
T Consensus       157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~----  220 (256)
T cd08530         157 -----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------RGKYPP----  220 (256)
T ss_pred             -----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCCCC----
Confidence                 1223458899999999998889999999999999999999999997665422111111       111100    


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                            .......++.+++.+||+.+|++||++.++++|+.
T Consensus       221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~  255 (256)
T cd08530         221 ------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA  255 (256)
T ss_pred             ------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence                  01134467999999999999999999999998863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-39  Score=302.01  Aligned_cols=252  Identities=29%  Similarity=0.466  Sum_probs=209.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|+....||+|+||.||++... +++.|+||.+............+.+|++++.+++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4777889999999999999876 688999999877654445667899999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++...  ..+++..++.++.|++.+|.|||   ++|++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999998743  56899999999999999999999   889999999999999999999999999999876543321


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                          .....|+..|+|||.+.+..++.++|||+||+++|+|++|..||.............    .   .... .+.   
T Consensus       156 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~----~---~~~~-~~~---  220 (254)
T cd06627         156 ----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV----Q---DDHP-PLP---  220 (254)
T ss_pred             ----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh----c---cCCC-CCC---
Confidence                233468999999999988788999999999999999999999998665432221111    0   0000 001   


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                            ....+.+.+++.+||..+|++||++.+++.+.|
T Consensus       221 ------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  253 (254)
T cd06627         221 ------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW  253 (254)
T ss_pred             ------CCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence                  112467899999999999999999999998866

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-39  Score=319.90  Aligned_cols=268  Identities=21%  Similarity=0.321  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      ..+|.....||+|+||.||+|... +|+.||||++++..........+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999975 6999999998765433444566889999999999999999999987543      


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..++|+||+. .+|..++    +..+++..+..++.|++.||.|||   .++++||||||+|||++.++.+||+|||++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4689999985 4666554    245889999999999999999999   8889999999999999999999999999987


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh------
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK------  359 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~------  359 (443)
                      .....       .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....      
T Consensus       166 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         166 HADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CCCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            54321       223457899999999866 4688999999999999999999999987654333222211110      


Q ss_pred             --hcCCCccccccC--ccccch---hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          360 --KFSDGDAISILD--PRVENT---AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       360 --~~~~~~~~~~~d--~~~~~~---~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                        ............  +.....   ........++.+|+.+||+.||.+||++.+++.|.|.-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence              000000000000  000000   000123457899999999999999999999999988643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-39  Score=310.32  Aligned_cols=256  Identities=25%  Similarity=0.332  Sum_probs=208.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  211 (443)
                      ++|...+.||+|+||.||+|... +++.||+|++.+... .......+.+|+.+++.+. |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888889999999999999976 799999999876432 2233466889999999998 99999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ||++.+++|.+++..  ...+++..++.|+.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            999999999999974  347999999999999999999999   888999999999999999999999999998866543


Q ss_pred             CCCc----------------ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 013401          292 ESGA----------------THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVK  355 (443)
Q Consensus       292 ~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~  355 (443)
                      ....                ........|+..|++||++.+..++.++||||||+++++|++|..||.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            2110                012234568899999999988889999999999999999999999998765433221111


Q ss_pred             HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHH
Q 013401          356 WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSM----RRCAEILW  413 (443)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~----~ell~~l~  413 (443)
                      .....         +         ....++.+.+|+.+||+.||.+||++    ++++.|+|
T Consensus       236 ~~~~~---------~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         236 KLEYS---------F---------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             hcCCC---------C---------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            00000         0         01124679999999999999999999    99999887

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=305.01  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=195.7

Q ss_pred             ceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHH-HhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          141 FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTL-AQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      +.||+|+||.||+|... +++.||||.+++.... ......+..|..++ ..++|+||+++++++...+..++|+||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999875 6899999998754321 12223344555544 445899999999999999999999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      ++|.+++..  ...+++..+..++.||+.||.|||   +.+++|+||+|+|||++.++.+||+|||++.....       
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------  149 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------  149 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence            999999864  356889999999999999999999   88899999999999999999999999999875432       


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccch
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT  377 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  377 (443)
                       .....|++.|++||.+.+..++.++||||||+++|+|++|..||....................         ..    
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~----  215 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP---------EE----  215 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC---------Cc----
Confidence             1234588999999999888889999999999999999999999976544322111111000000         00    


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHhhhhh
Q 013401          378 AANNLALEKILELALQCLAPRRQNRP---SMRRCAEILWSVRKD  418 (443)
Q Consensus       378 ~~~~~~~~~l~~Li~~cl~~dp~~RP---s~~ell~~l~~i~~~  418 (443)
                       ....++..+.+++.+||+.||++||   ++.+++.|+|....+
T Consensus       216 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         216 -VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             -ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence             0112346799999999999999999   557999999875433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=356.48  Aligned_cols=260  Identities=26%  Similarity=0.391  Sum_probs=211.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE-cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +-++.....||.|.||.||.|.. .+|...|||-++...........+.+|+.+|..++|||+|++||+=.+.+.++|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            33566677899999999999985 47999999988765444445567889999999999999999999998899999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||.||+|.+.+.  .++..++....-+..|++.||.|||   .+|||||||||+||||+.+|.+|++|||.|+.+.+..
T Consensus      1314 EyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999987  5566777777788999999999999   8999999999999999999999999999999887653


Q ss_pred             CCcccccccccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...........||+.|||||++.+   .....++|||||||++.||+||+.||...+....      ++.....|..   
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a------IMy~V~~gh~--- 1459 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA------IMYHVAAGHK--- 1459 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH------HHhHHhccCC---
Confidence            233333446789999999999965   3466789999999999999999999875543221      1122222221   


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                        |.++..     ...+-.+++.+||+.||++|.++.++++|-+.
T Consensus      1460 --Pq~P~~-----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1460 --PQIPER-----LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             --CCCchh-----hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence              222221     45678899999999999999999999999764

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.6e-39  Score=305.29  Aligned_cols=253  Identities=22%  Similarity=0.319  Sum_probs=188.0

Q ss_pred             eeeeeCceEEEEEEEcCC---cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      +||+|+||.||+|...++   ..+++|.++... .......+.+|+.+++.++||||+++++.+......++||||+.+|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            599999999999975433   345666655432 1233567889999999999999999999999999999999999999


Q ss_pred             cHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          219 TLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       219 ~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      +|.+++....  ....++..++.++.||+.||.|||   +++++||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--~  155 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--I  155 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchh--h
Confidence            9999997532  234566777899999999999999   88899999999999999999999999999864322110  0


Q ss_pred             cccccccCCCCccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          297 HVSTQVKGTAGYLDPEYLKT-------YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .......|+..|+|||++..       ..++.++|||||||++|||++ |..||....+.......   .    .+....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~----~~~~~~  228 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV---I----KDQQVK  228 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----hhcccc
Confidence            11224568899999999843       245779999999999999997 57788654432211111   0    111112


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ..++.+...     ..+.+.+++..|| .+|++||++.+|++.|.
T Consensus       229 ~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222222211     2356888999999 67999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.8e-39  Score=342.10  Aligned_cols=259  Identities=27%  Similarity=0.379  Sum_probs=199.3

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-----
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-----  204 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----  204 (443)
                      .++..+|+++..||+||||.||+++.+ ||+.||||++.... .......+.+|+.+|.+|+|||||++|..|.+     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            567789999999999999999999987 99999999998765 45556678899999999999999999833200     


Q ss_pred             --------------------------------------------------------------------------------
Q 013401          205 --------------------------------------------------------------------------------  204 (443)
Q Consensus       205 --------------------------------------------------------------------------------  204 (443)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------c--------CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 013401          205 --------------------------E--------DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY  250 (443)
Q Consensus       205 --------------------------~--------~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~  250 (443)
                                                +        -.+||.||||+...|.++++..... -.....++++.+|++||.|
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHH
Confidence                                      0        1247889999998888888643211 1467788999999999999


Q ss_pred             HhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc------cc--------CCCcccccccccCCCCccCcccccc
Q 013401          251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA------DT--------ESGATHVSTQVKGTAGYLDPEYLKT  316 (443)
Q Consensus       251 LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~------~~--------~~~~~~~~~~~~gt~~y~aPE~l~~  316 (443)
                      +|   ++|+|||||||.|||++.++.|||+|||+|....      +.        ........+..+||.-|+|||++.+
T Consensus       713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99   8999999999999999999999999999998721      00        0011112455789999999999966


Q ss_pred             CC---CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc---cCccccchhhcHHHHHHHHHH
Q 013401          317 YQ---LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI---LDPRVENTAANNLALEKILEL  390 (443)
Q Consensus       317 ~~---~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~d~~~~~~~~~~~~~~~l~~L  390 (443)
                      ..   |+.|+|||||||||+||+.   ||...   .|+..+-   ..+..+.+..-   .++          ....-..+
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL---~~LR~g~iP~~~~f~~~----------~~~~e~sl  850 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---MERASIL---TNLRKGSIPEPADFFDP----------EHPEEASL  850 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCch---HHHHHHH---HhcccCCCCCCcccccc----------cchHHHHH
Confidence            54   9999999999999999997   45433   2333322   22333333222   222          12446789


Q ss_pred             HHHccCCCCCCCCCHHHHHHHHH
Q 013401          391 ALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       391 i~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      |..||+.||.+|||+.++|..-|
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~s~l  873 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLNSEL  873 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhhccC
Confidence            99999999999999999998755

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=302.67  Aligned_cols=256  Identities=22%  Similarity=0.346  Sum_probs=202.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc---cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~  208 (443)
                      .+|.+.+.||+|+||.||+|.+. +++.||+|.+....   ........+.+|+.+++.++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            36888999999999999999875 69999999875321   1223445788999999999999999999998764  468


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++++||+++++|.+++..  ...+++...+.++.||+.||.|||   +++++|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            899999999999999864  345888889999999999999999   888999999999999999999999999999765


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ...... ........|+..|+|||++.+..++.++|||||||++|+|++|..||.............   ....      
T Consensus       157 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~------  226 (264)
T cd06653         157 QTICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT------  226 (264)
T ss_pred             cccccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC------
Confidence            432111 111234568999999999988889999999999999999999999997654433221111   0000      


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                        .+.+     .....+.+.+++.+||+ +|..||+..+++.|+|
T Consensus       227 --~~~~-----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         227 --KPML-----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             --CCCC-----CcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence              0000     11234679999999999 5799999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-39  Score=307.22  Aligned_cols=267  Identities=23%  Similarity=0.335  Sum_probs=203.4

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |.+.+.||+|+||+||+|... +++.|+||++...... .......+|+..+..++ |+||+++++++..++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            566788999999999999986 5889999998765322 22334557999999998 99999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      + +|+|.+++....+..+++..++.++.|++.+|.|||   +++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence            9 889999887654457899999999999999999999   88899999999999999999999999999976543221 


Q ss_pred             cccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc----------CC
Q 013401          295 ATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF----------SD  363 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------~~  363 (443)
                          .....|+..|+|||++. +..++.++||||||+++++|++|.+||...................          ..
T Consensus       155 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         155 ----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             ----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence                23345889999999884 4457889999999999999999999997665433222111100000          00


Q ss_pred             CccccccCccc--cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          364 GDAISILDPRV--ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       364 ~~~~~~~d~~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ......+....  ............+.+|+.+||+.||++||++.+++.+.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            00000000000  000001112467999999999999999999999999987

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.5e-39  Score=309.86  Aligned_cols=249  Identities=23%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             ceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          141 FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      .+||+|+||.||++..+ +++.||||++....  ......+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            46999999999999875 79999999875432  2344568899999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccccc
Q 013401          220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS  299 (443)
Q Consensus       220 L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  299 (443)
                      |.+++.   ...+++...+.++.|++.+|.|||   ++|++|+||+|+||+++.++.++|+|||++.......    ...
T Consensus       104 L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----~~~  173 (292)
T cd06657         104 LTDIVT---HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PRR  173 (292)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc----ccc
Confidence            998774   345788999999999999999999   8889999999999999999999999999987654321    112


Q ss_pred             ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhh
Q 013401          300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA  379 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  379 (443)
                      ....|++.|++||++.+..++.++|||||||++|+|++|..||..................            .+..   
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~------------~~~~---  238 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------KLKN---  238 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc------------ccCC---
Confidence            3356899999999998888899999999999999999999999866543322222111100            0000   


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          380 NNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       380 ~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .......+.+++.+||+.||.+||++.++++|.|...
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~  275 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK  275 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhc
Confidence            0112356889999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=314.61  Aligned_cols=275  Identities=20%  Similarity=0.242  Sum_probs=204.4

Q ss_pred             cCCCC-CceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcc------------cHHHHHHHHHHHHhcCCcceeeeee
Q 013401          135 RNFSP-SFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKH------------SGAEFQSEIRTLAQVEHLNLVKFHG  200 (443)
Q Consensus       135 ~~f~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~------------~~~~~~~Ei~~l~~l~h~niv~l~~  200 (443)
                      ++|.. .+.||.|+||+||+|.+. +++.||||.++.......            ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45554 456999999999999976 699999999865432211            1124678999999999999999999


Q ss_pred             eeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEe
Q 013401          201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVA  280 (443)
Q Consensus       201 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~  280 (443)
                      ++..++..++||||+. ++|.+++..  ...+++.....++.||+.||.|||   .++++|+||||+|||++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999996 689988863  356889999999999999999999   8889999999999999999999999


Q ss_pred             eecccccccccCCC----------cccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHH
Q 013401          281 DFGFARLAADTESG----------ATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELK  349 (443)
Q Consensus       281 DFGla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~  349 (443)
                      |||++.........          .........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999765421100          01112233578899999998664 46889999999999999999999998776544


Q ss_pred             HHHHHHHHhhhcCCCccccc--------cCccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          350 ERITVKWAMKKFSDGDAISI--------LDPRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~--------~d~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ....+...............        .......  ........+++.+++.+||+.||++||++.+++.|.|.-
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            33222211111111000000        0000000  000112346789999999999999999999999999964

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=276.98  Aligned_cols=270  Identities=24%  Similarity=0.304  Sum_probs=215.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|...++||+|.||+||+|+.+ +++.||+|+++....++.......+||-+|+.+.|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556678999999999999865 699999999987766666667788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      | ..+|..|.+.. ++.++.+....++.|++.||.|+|   +++|.||||||+|+||+.+|.+||+|||+++.+.-+-  
T Consensus        83 c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   83 C-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             h-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            9 56898888764 456888899999999999999999   8889999999999999999999999999998765432  


Q ss_pred             cccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccccc--
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISIL--  370 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  370 (443)
                        ......+-|.+|.+|.++.+. -|++..|+||.|||+.|+.. |++-|.+.+-.+....+.|......+.....+.  
T Consensus       156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence              233445679999999998664 58899999999999999998 777777776666556666655554444332221  


Q ss_pred             -C----ccccchhhc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          371 -D----PRVENTAAN----NLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       371 -d----~~~~~~~~~----~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                       |    |..+.....    ......=.+|+++.|.-+|.+|.+++..++|++.
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf  286 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF  286 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence             1    111111111    1122345789999999999999999999999864

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-39  Score=322.26  Aligned_cols=275  Identities=20%  Similarity=0.290  Sum_probs=209.5

Q ss_pred             HHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe---
Q 013401          132 RATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE---  207 (443)
Q Consensus       132 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~---  207 (443)
                      ...++|.....||+|+||.||+|... +++.||||++............+.+|+.+++.++|+||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999976 68899999987654344445667889999999999999999998876654   


Q ss_pred             ---EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          208 ---RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       208 ---~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                         .++|+||+ +++|.+++..   ..+++..++.++.||+.||.|||   +.||+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999998 6799988853   46899999999999999999999   88899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh----
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK----  359 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~----  359 (443)
                      +......       .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.....    
T Consensus       165 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  237 (343)
T cd07851         165 ARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE  237 (343)
T ss_pred             ccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence            8765432       233468899999999865 3678899999999999999999999976654332222111100    


Q ss_pred             ----hcCCCccccccC---cc--ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          360 ----KFSDGDAISILD---PR--VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       360 ----~~~~~~~~~~~d---~~--~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                          .+........+.   ..  ..........+.++.+|+.+||++||.+|||+.+|++|.|.-.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                000000000000   00  00000001135679999999999999999999999999997654443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=324.80  Aligned_cols=250  Identities=28%  Similarity=0.391  Sum_probs=200.8

Q ss_pred             CceeeeeCceEEEEEEEc-CCcEEEEEEcccccc--CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe--EEEEEee
Q 013401          140 SFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE--RIVIVEY  214 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lv~E~  214 (443)
                      ..+||+|+|-+||+|.+. +|-.||--.++....  .....++|..|+.+|+.|+|+|||++|+.|.+...  ..+|+|+
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            346999999999999876 688888665543333  34455889999999999999999999999988766  7789999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCceEEeeecccccccccCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~  293 (443)
                      +..|+|+.|+.+.  +..+......|+.||+.||.|||+. ..+|||||||-+||||+ ..|.|||+|+|||....... 
T Consensus       125 ~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             ccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            9999999999854  5688888999999999999999974 46899999999999998 56899999999998876542 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                           ...++|||.|||||+.. ..|++.+||||||..++||+|+..||..-..      ...+-++...|.....+.  
T Consensus       201 -----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~--  266 (632)
T KOG0584|consen  201 -----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALS--  266 (632)
T ss_pred             -----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhh--
Confidence                 34578999999999998 5899999999999999999999999854322      111112222222111111  


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                             ..-..++.++|.+||.. ...||++.|||.+.+.-
T Consensus       267 -------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~  300 (632)
T KOG0584|consen  267 -------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFD  300 (632)
T ss_pred             -------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence                   11225799999999999 99999999999998743

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-40  Score=343.59  Aligned_cols=274  Identities=22%  Similarity=0.264  Sum_probs=222.4

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      +.-...+|++++.||+|+||.|.+++++ +++.||+|++.+-. .......-|+.|-.+|..-+.+=|+.++-+|.++++
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3334568999999999999999999986 79999999987633 234455678889999999899999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +|+||||++||+|..++....  .+++..++.++..|+-||.-||   ..|+|||||||+|||||..|++||+|||.+-.
T Consensus       150 LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            999999999999999997543  7999999999999999999999   88899999999999999999999999999877


Q ss_pred             ccccCCCcccccccccCCCCccCccccc----c-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLK----T-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      +...+.   ..+...+|||.|++||++.    + ..|+..+|+|||||++|||+.|..||....-...+-.+..-...+ 
T Consensus       225 m~~dG~---V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l-  300 (1317)
T KOG0612|consen  225 MDADGT---VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL-  300 (1317)
T ss_pred             cCCCCc---EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc-
Confidence            664332   2345568999999999983    2 569999999999999999999999998776555443332211111 


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHhhhhhhhhhhccc
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS---MRRCAEILWSVRKDYRELAASD  426 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs---~~ell~~l~~i~~~~~~~~~~~  426 (443)
                                  ..+ .....+++..+||.+.+. +|+.|..   ++++..|+|....+|..+....
T Consensus       301 ------------~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~  353 (1317)
T KOG0612|consen  301 ------------SFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESV  353 (1317)
T ss_pred             ------------CCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcC
Confidence                        111 112255788899988765 6788888   9999999999999986654443

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1e-38  Score=309.48  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=199.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+|.++ +++.||||+++.... ......+.+|+.++..+. |+||+++++++.+....++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            56888899999999999999987 499999999876432 223455667887777664 999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+. +.|.+++... ...+++..+..++.||+.+|.|||.  .++|+||||+|+||+++.++.+||+|||++.......
T Consensus        94 e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9984 5677666543 3478999999999999999999993  2589999999999999999999999999987654322


Q ss_pred             CCcccccccccCCCCccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQ----LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .     .....++..|+|||++.+..    ++.++||||||+++|+|++|..||.......+..  .....    .....
T Consensus       170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~----~~~~~  238 (296)
T cd06618         170 A-----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL--TKILQ----EEPPS  238 (296)
T ss_pred             c-----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH--HHHhc----CCCCC
Confidence            1     12234788999999986543    7889999999999999999999997543221111  11110    00000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                           +.   ......+++.+|+.+||+.||.+||++.+++++.|..+
T Consensus       239 -----~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         239 -----LP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             -----CC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence                 00   00113467999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.9e-38  Score=307.52  Aligned_cols=251  Identities=27%  Similarity=0.402  Sum_probs=200.5

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |....+||+|+||+||+|+.. ++..|++|++..... .......+.+|+.+++.++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555668999999999999875 689999999865422 223345688999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +. ++|.+++.. ....+++..++.++.||+.+|.|||   .+|++|+||+|+||+++.++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            95 577777754 3456899999999999999999999   88899999999999999999999999999864321    


Q ss_pred             cccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          295 ATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                          .....|+..|+|||++.   ...++.++|||||||++|+|++|.+||..............       ....... 
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~-  241 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NDSPTLQ-  241 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cCCCCCC-
Confidence                12346899999999984   45688899999999999999999999977654332222111       0000110 


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                              .......+.+|+.+||+.+|.+||++.+++.+.|...
T Consensus       242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence                    1112356899999999999999999999999988643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-38  Score=302.80  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      ||.|+||.||++.+. +|+.|++|.++.... .......+.+|+++++.++|+||+++++.+..++..++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 599999999875432 224456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc----c
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA----T  296 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~----~  296 (443)
                      .+++...  ..+++..+..++.||+.+|.|||   .++++|+||+|+||+++.++.++|+|||++..........    .
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9998743  36899999999999999999999   8889999999999999999999999999987544321100    1


Q ss_pred             cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      .......++..|++||.+....++.++||||||+++|+|++|..||.............       .+...      ...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~------~~~  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL-------NGKIE------WPE  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCcC------CCc
Confidence            11233568899999999988888999999999999999999999997655322111111       01000      000


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPSM---RRCAEILWSV  415 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~---~ell~~l~~i  415 (443)
                         ....+..+.+++.+||+.+|++||++   .+++++.|.-
T Consensus       223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~  261 (265)
T cd05579         223 ---DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK  261 (265)
T ss_pred             ---cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence               00024678999999999999999999   9999998864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.1e-38  Score=339.03  Aligned_cols=147  Identities=30%  Similarity=0.459  Sum_probs=132.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.++||+|+||+||+|.+. +++.||||+++... ........+.+|+.++..++|+||+++++++...+.+||||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999987 68999999987543 23334567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ||+.|++|.+++..  ...+++..++.|+.||+.||.|||   .++||||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999864  345888889999999999999999   7889999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=319.04  Aligned_cols=275  Identities=21%  Similarity=0.245  Sum_probs=233.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC-CcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+++.+..||-|+||.|-++..+. ...+|+|++++.- .+..+.+.+..|-.+|..++.|.||++|..|.+..++|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            345566679999999999998764 3358999987654 34556677889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |-|-||.|...|.  ..+.++......++..+++|++|||   .+|||+|||||+|++++.+|-+||.|||+|+.+....
T Consensus       500 EaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  500 EACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            9999999999887  4567888899999999999999999   8999999999999999999999999999999987654


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           ...++||||.|+|||++.+..++.++|.|+||+++||||+|.+||.+.++...+..+-..+..+.-         
T Consensus       575 -----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~---------  640 (732)
T KOG0614|consen  575 -----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF---------  640 (732)
T ss_pred             -----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc---------
Confidence                 355688999999999999999999999999999999999999999999987766554433222211         


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCcCCccccc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVLLQPSYSK  435 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~~~~~~~~  435 (443)
                             .........+|+.+.+..+|.+|..     +.++.+|-|...-||..+.+-.++.|-.+..
T Consensus       641 -------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~v  701 (732)
T KOG0614|consen  641 -------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSV  701 (732)
T ss_pred             -------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccC
Confidence                   1123356889999999999999986     7999999999999999988877776555443

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-39  Score=297.18  Aligned_cols=280  Identities=21%  Similarity=0.254  Sum_probs=206.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc---C--CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-cCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE---D--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-EDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~  208 (443)
                      ..|+.+.+||+|+||.||+|.-+   +  .+.||||.++............-||+.+++.|+|||||.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46888889999999999999633   2  3479999998764434444567799999999999999999999877 7789


Q ss_pred             EEEEeecCCCcHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CceEEee
Q 013401          209 IVIVEYVPNGTLREHLDCL---QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN----FRAKVAD  281 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~----~~vkl~D  281 (443)
                      ++++||.+. +|...|...   ..+.++...+..|+.||+.|+.|||   ++-|+||||||.||||..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999975 787777432   3456888999999999999999999   8889999999999999877    8999999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHH--------HH-
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELK--------ER-  351 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~--------~~-  351 (443)
                      ||+++.+.++-... .....++-|.+|.|||++.|. .|+.+.|||++|||+.|||+-.+-|....+.-        .+ 
T Consensus       180 lGlaR~~~~plkpl-~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  180 LGLARLFNNPLKPL-ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             ccHHHHhhcccccc-ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999887653211 123456789999999998764 68999999999999999999999886543211        11 


Q ss_pred             HHHHHHhhhcCCCccccccCc-------------cccchh-----h--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013401          352 ITVKWAMKKFSDGDAISILDP-------------RVENTA-----A--NNLALEKILELALQCLAPRRQNRPSMRRCAEI  411 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~-------------~~~~~~-----~--~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~  411 (443)
                      ..+..... ......+.-+..             ....+.     .  ...-++..++|+.++|+.||.+|.|+++.++|
T Consensus       259 ~rIf~vLG-~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  259 DRIFEVLG-TPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHcC-CCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            11111111 111111111100             000000     0  00012338899999999999999999999999


Q ss_pred             HHhhhhhhh
Q 013401          412 LWSVRKDYR  420 (443)
Q Consensus       412 l~~i~~~~~  420 (443)
                      .+....+..
T Consensus       338 ~yF~~d~lp  346 (438)
T KOG0666|consen  338 PYFTEDPLP  346 (438)
T ss_pred             cccccCCCC
Confidence            986654444

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4e-38  Score=352.07  Aligned_cols=264  Identities=27%  Similarity=0.432  Sum_probs=208.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ..|.....||+|+||.||+|... ++..||||+++....      ....|++++++++|||||++++++.+++..++|||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            45778889999999999999974 799999998864321      11356889999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++|+|.+++.     .+++..+..|+.||+.||.|||.....+|+||||||+||+++.++..++. ||.......   
T Consensus       764 y~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---  834 (968)
T PLN00113        764 YIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---  834 (968)
T ss_pred             CCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence            999999999985     27889999999999999999996656789999999999999998888875 666543321   


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....|......+.....++|+.
T Consensus       835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHhcCccchhheeCcc
Confidence                 112358999999999999899999999999999999999999995432211 12233433333333334445554


Q ss_pred             ccch-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          374 VENT-AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       374 ~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      +... ........++.+++.+||+.||++||+|.++++.+..+.+..
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            4322 122345567899999999999999999999999998776543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=304.18  Aligned_cols=268  Identities=24%  Similarity=0.316  Sum_probs=207.1

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |+....||+|+||.||+|+.. +++.||+|.++...........+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456678999999999999976 5999999998876434445567889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      . ++|.+++.... ..+++..++.++.|++.+|.|||   +++|+|+||+|+||++++++.+||+|||++........  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            7 58999997532 46899999999999999999999   88899999999999999999999999999976643321  


Q ss_pred             ccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC--------C--
Q 013401          296 THVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD--------G--  364 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------~--  364 (443)
                        ......++..|+|||++.+. .++.++|||||||++|||++|.+||...........+.........        -  
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence              12233467889999998766 7889999999999999999999999876544332222111100000        0  


Q ss_pred             --ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          365 --DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       365 --~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                        ........... ..........+.+++.+||..||++||++.+++.++|.
T Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence              00000000000 00011124679999999999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.8e-38  Score=307.57  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=202.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .|...+.||+|+||.||+|... ++..+|||.+..... ......++.+|+.+++.++|+|++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666678999999999999976 688999998764321 22334567899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+. |+|.+++.. ....+++..++.++.|++.+|.|||   .++++||||||+|||++.++.+||+|||++......  
T Consensus        96 ~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          96 YCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             ccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            996 578777653 3456889999999999999999999   888999999999999999999999999998765421  


Q ss_pred             CcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                            ....|++.|+|||++.   ...++.++|||||||++|+|++|..||.............       ....    
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~----  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QNES----  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-------hcCC----
Confidence                  2345889999999974   3467889999999999999999999987654322211111       0000    


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                       +..    ........+.+|+.+||+.+|.+||++.++++++|.+....
T Consensus       232 -~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         232 -PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             -CCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence             000    01123466899999999999999999999999999776433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=318.56  Aligned_cols=254  Identities=29%  Similarity=0.398  Sum_probs=213.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +.....+||-|.||.||.|.|+ -...||||.+|..   ....++|+.|..+|+.+.|||+|+|+|+|..+...|||.||
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            4556678999999999999987 4778999999865   56678999999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |..|+|.+||.+.....++....+.++.||..|++||.   .+++|||||-..|+|+.++..|||+||||+++...+...
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            99999999999888788888888999999999999999   888999999999999999999999999999988654321


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                      .   .....-...|.|||-+.-..++.|+|||+|||+|||+.| |--||.+.+--.-+.....       +       -+
T Consensus       422 A---HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-------g-------yR  484 (1157)
T KOG4278|consen  422 A---HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-------G-------YR  484 (1157)
T ss_pred             c---ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-------c-------cc
Confidence            1   111223567999999998899999999999999999999 8899987754322111111       1       11


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +.   ....|++++++||++||+..|.+||++.|+.+.+..+
T Consensus       485 M~---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  485 MD---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             cc---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            11   1234678999999999999999999999999988754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9e-38  Score=302.92  Aligned_cols=260  Identities=19%  Similarity=0.239  Sum_probs=185.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccH---------HHHHHHHHHHHhcCCcceeeeeee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSG---------AEFQSEIRTLAQVEHLNLVKFHGY  201 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~---------~~~~~Ei~~l~~l~h~niv~l~~~  201 (443)
                      ++|.+.+.||+|+||+||+|...+    +..+|+|+...........         .....++..+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999998753    4566777543221111000         112233445566789999999997


Q ss_pred             eeecC----eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          202 LEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       202 ~~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                      +....    ..++++|++. .++.+.+..  ....++..++.|+.|++.||.|||   +++|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            66544    3467788773 466665543  233577788899999999999999   8889999999999999999999


Q ss_pred             EEeeecccccccccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-
Q 013401          278 KVADFGFARLAADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT-  353 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~-  353 (443)
                      +|+|||+++..........   .......||+.|+|||++.+..++.++|||||||++|||++|.+||........... 
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            9999999987643221111   111234699999999999999999999999999999999999999986632211111 


Q ss_pred             HH-HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          354 VK-WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       354 ~~-~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                      .. .....+..+.. .           ...+++.+.+++..|+..+|++||++.++++.+
T Consensus       246 ~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRLHEGKI-K-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHhhhhhh-c-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00 11111111110 0           011246799999999999999999999999865

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.5e-39  Score=316.77  Aligned_cols=272  Identities=20%  Similarity=0.257  Sum_probs=202.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-------  205 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------  205 (443)
                      ..+|...+.||.|+||.||+|... +|..||+|.+....  ......+.+|+.+++.++||||+++++++...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            467999999999999999999875 68999999886542  34456788999999999999999999876543       


Q ss_pred             -------CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCce
Q 013401          206 -------DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRA  277 (443)
Q Consensus       206 -------~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~v  277 (443)
                             ...++||||+. ++|.+++.   ...+++..++.++.||+.||.|||   .+||+||||||+|||++ +++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceE
Confidence                   35789999996 58888774   346889999999999999999999   88899999999999997 45678


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW  356 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~  356 (443)
                      ||+|||++.......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....+..+......
T Consensus       155 kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         155 KIGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             EECCcccceecCCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999987654322111 11123458889999998744 5688899999999999999999999987765444333222


Q ss_pred             HhhhcCCCccccc------------cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          357 AMKKFSDGDAISI------------LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       357 ~~~~~~~~~~~~~------------~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..+.....+....            ................++.+|+.+||+.||.+||++.+++.|.|.-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence            1111000000000            0000000000112346789999999999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.7e-38  Score=299.35  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=200.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc---cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      +|.+.++||+|+||.||++.+. .+..+++|.++...   ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778889999999999999875 34556666654322   2233345677899999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          212 VEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||+.+++|.+++...  ....+++..++.++.|++.||.|||   +++++|+||||+||+++. +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642  3456899999999999999999999   889999999999999975 569999999987764


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ....    ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||............       ..+.... 
T Consensus       157 ~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~-------~~~~~~~-  224 (260)
T cd08222         157 GSCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI-------VEGPTPS-  224 (260)
T ss_pred             CCcc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HcCCCCC-
Confidence            3321    223345889999999998888899999999999999999999999765432221111       1111000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                               .......++.+++.+||..||++||++.++++|.|
T Consensus       225 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         225 ---------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             ---------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence                     01234467999999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-38  Score=296.06  Aligned_cols=244  Identities=26%  Similarity=0.358  Sum_probs=200.1

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      ||+|+||.||++... +++.||+|++...... ......+.+|+.+++.++|+||+++++.+..++..++||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999976 5899999998765432 23456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccc
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST  300 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~  300 (443)
                      .+++...  ..+++.....++.|++.+|.|||   ..+++|+||+|+||+++.++.++|+|||++.......    ....
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~  151 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----SRTN  151 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC----Cccc
Confidence            9999743  46899999999999999999999   7889999999999999999999999999987664432    1123


Q ss_pred             cccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhc
Q 013401          301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN  380 (443)
Q Consensus       301 ~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  380 (443)
                      ...++..|++||.+.+..++.++|+|+||+++|+|++|..||...........+..       .. .. +.         
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------~~-~~-~~---------  213 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-------DP-LR-FP---------  213 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-------CC-CC-CC---------
Confidence            45688999999999888889999999999999999999999976653211111110       00 00 00         


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHH
Q 013401          381 NLALEKILELALQCLAPRRQNRPSM---RRCAEILW  413 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RPs~---~ell~~l~  413 (443)
                      ...+..+.+++.+||..||++||++   .++++|+|
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~  249 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF  249 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence            0113678999999999999999999   89998877

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.6e-38  Score=302.94  Aligned_cols=267  Identities=24%  Similarity=0.319  Sum_probs=205.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccC--cccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYD--KHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~  208 (443)
                      +|.+.+.||+|+||.||++...    ++..||||.+++....  ......+.+|++++.++ +|+||+++++.+...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4677889999999999999742    5788999998754221  22345678999999999 599999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++||||+.+++|.+++..  ...+++..++.++.|++.+|.|||   ..+++|+||||.||+++.++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            999999999999998863  356889999999999999999999   888999999999999999999999999998765


Q ss_pred             cccCCCcccccccccCCCCccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .....   .......|+..|++||.+.+..  .+.++||||||+++|+|++|..||..............   .....  
T Consensus       156 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~--  227 (288)
T cd05583         156 LAEEE---ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---RILKS--  227 (288)
T ss_pred             ccccc---cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---HHHcc--
Confidence            43321   1112345899999999987654  77899999999999999999999964322111111100   00000  


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHhhhhhhhhhhc
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSM---RRCAEILWSVRKDYRELAA  424 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~---~ell~~l~~i~~~~~~~~~  424 (443)
                          .+..     .......+.+++.+||+.||++|||+   .++++++|.-..++..+.+
T Consensus       228 ----~~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~  279 (288)
T cd05583         228 ----KPPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAA  279 (288)
T ss_pred             ----CCCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhh
Confidence                0000     01123568899999999999999985   6678888877777766533

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=317.41  Aligned_cols=243  Identities=25%  Similarity=0.302  Sum_probs=199.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      +..|.....||.|+|+.|..|.+. +++.++||++.+...      +..+|+.++... +||||+++.+++.+..+.|+|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            456777888999999999999876 689999999977522      233677666665 699999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE-cCCCceEEeeecccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAAD  290 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl-~~~~~vkl~DFGla~~~~~  290 (443)
                      ||++.|+.|.+.+...   .....++..|+.+|+.|+.|||   .+|||||||||+|||+ +..|+++|+|||+++....
T Consensus       395 ~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             ehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999999999888642   2333677789999999999999   8999999999999999 5899999999999987765


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      .       ....+-|..|.|||++....|++++||||||++||+||+|+.||.......+      +...+..+.     
T Consensus       469 ~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~i~~~~-----  530 (612)
T KOG0603|consen  469 S-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTRIQMPK-----  530 (612)
T ss_pred             h-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHhhcCCc-----
Confidence            4       2334568899999999999999999999999999999999999976543311      111111110     


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                              .....++...+|+.+||+.||.+||+|.++..|.|.
T Consensus       531 --------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 --------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                    113356789999999999999999999999999997

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=324.88  Aligned_cols=263  Identities=27%  Similarity=0.453  Sum_probs=217.7

Q ss_pred             CCCCceeeeeCceEEEEEEEc-C---CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-D---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ..+.+.||.|.||.||+|.++ .   ...||||.+|.. +.+.+..+|+.|..||-+++||||++|.|+......+.||.
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            345668999999999999976 2   457999999976 45667788999999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||++|+|..||+.+.+ .+...+...++..|+.|++||-   ++++|||||-..||||+.+...||+||||++.+.++.
T Consensus       710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999988654 4888889999999999999999   8999999999999999999999999999999876553


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ... .....-.-..+|.|||.+.-..++.++||||+||+|||.++ |..||++..+.+-...+.       ++       
T Consensus       786 ~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-------~g-------  850 (996)
T KOG0196|consen  786 EAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-------QG-------  850 (996)
T ss_pred             Ccc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-------hc-------
Confidence            211 11111223568999999999999999999999999999887 999999886644322222       11       


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      -+++   ..-+++..|.+||+.||++|..+||.+.+|+.+|..+.++=..+
T Consensus       851 yRLP---pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  851 YRLP---PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             cCCC---CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence            1111   11236678999999999999999999999999999887665554

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=318.58  Aligned_cols=268  Identities=28%  Similarity=0.425  Sum_probs=200.3

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------CeEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------DERI  209 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~~  209 (443)
                      +...+.||+|+||.||+|+.+ +|+.||||.++... .....+...+|+++|++|+|+|||+++++=++.      +..+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            334456999999999999965 79999999998754 445567788999999999999999999975543      3568


Q ss_pred             EEEeecCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCC--ceEEeeecc
Q 013401          210 VIVEYVPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT--ENF--RAKVADFGF  284 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~--~vkl~DFGl  284 (443)
                      +|||||.||+|+..++.-. ...+++.+.+.++.++..||.|||   ++|||||||||.||++-  .+|  ..||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999997532 356999999999999999999999   89999999999999994  333  489999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh-cC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK-FS  362 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~  362 (443)
                      |+.+.+..     ....++||+.|++||++. ...|+..+|.|||||++|+++||..||.........-.+.|-... -.
T Consensus       171 Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp  245 (732)
T KOG4250|consen  171 ARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP  245 (732)
T ss_pred             cccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence            99887654     456788999999999998 478999999999999999999999999755433211112221111 11


Q ss_pred             CCccccc---cC------ccccc-hhhcHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHH
Q 013401          363 DGDAISI---LD------PRVEN-TAANNLALEKILELALQCLAPRRQNRP--SMRRCAEILW  413 (443)
Q Consensus       363 ~~~~~~~---~d------~~~~~-~~~~~~~~~~l~~Li~~cl~~dp~~RP--s~~ell~~l~  413 (443)
                      .+.+...   ..      ..++. ..........+...+..+|..+|.+|-  ...++...+.
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~  308 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD  308 (732)
T ss_pred             CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence            1111100   00      01111 111223445677888888999999998  5544444443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=310.81  Aligned_cols=251  Identities=25%  Similarity=0.431  Sum_probs=207.6

Q ss_pred             ceeeeeCceEEEEEEEc--CCc--EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecC
Q 013401          141 FKIGQGGFGTVYKGRLE--DGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  216 (443)
                      ++||+|.||+|++|.|.  .|+  .||||.++...... ...+|++|+.+|.+|+|+|+|+|||+..+ ....+|+|++.
T Consensus       116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            36999999999999876  344  58999998765433 56789999999999999999999999876 67789999999


Q ss_pred             CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          217 NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       217 gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      .|+|.+.|.......|......+++.||+.|+.||.   .+++|||||-..|+||-..-.||||||||++-+...+... 
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y-  269 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY-  269 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce-
Confidence            999999998766778888899999999999999999   8889999999999999988899999999999887654322 


Q ss_pred             cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                      .-.....-...|+|||.++...++.++|||+|||+||||++ |..||-+.+.......++       +++...       
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------~~erLp-------  335 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------AGERLP-------  335 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------ccccCC-------
Confidence            11122334567999999999999999999999999999999 889998876644332222       222111       


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                         -...|++.+++++..||..+|.+||++..|.+.+..
T Consensus       336 ---RPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  336 ---RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ---CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence               123477899999999999999999999999866543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=317.91  Aligned_cols=258  Identities=25%  Similarity=0.394  Sum_probs=212.9

Q ss_pred             HHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeee-----
Q 013401          132 RATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEF-----  204 (443)
Q Consensus       132 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-----  204 (443)
                      .-+..|++...||+|.+|.||+++.+ +++.+|||+....   ....+++..|..+|+.+ .|||++.+|++|..     
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            34567889999999999999999854 7999999987653   34456778899999988 59999999999864     


Q ss_pred             cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          205 EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      +|.+|||||||.||+..|++....+..+.|..+..|++.++.||.+||   .+.+||||||-.|||++.++.|||+|||+
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeee
Confidence            578999999999999999998888899999999999999999999999   78899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-----QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      +..+....    ......+|||.|||||++.+.     .|+.++|+||||++..||.-|.+|+.+.-+....       .
T Consensus       170 SaQldsT~----grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------F  238 (953)
T KOG0587|consen  170 SAQLDSTV----GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------F  238 (953)
T ss_pred             eeeeeccc----ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------c
Confidence            98765432    223456799999999999543     4778999999999999999999999876553321       1


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .+....     .|.+.   -.....+++.++|..||.+|..+||++.++++|++.
T Consensus       239 ~IpRNP-----PPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi  285 (953)
T KOG0587|consen  239 LIPRNP-----PPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI  285 (953)
T ss_pred             cCCCCC-----Ccccc---chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence            111111     11111   133567899999999999999999999999999873

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=307.97  Aligned_cols=255  Identities=26%  Similarity=0.420  Sum_probs=209.1

Q ss_pred             CCCceeeeeCceEEEEEEEc---C--CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          138 SPSFKIGQGGFGTVYKGRLE---D--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ...++||.|.||.||+|...   .  .-.||||..|... +....+.|..|..+|+.++|||||+++|+|.+ ...||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            34457999999999999742   2  3358899888764 45558899999999999999999999999874 4689999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |+++-|.|+.||... ...++......++.||..||.|||   +..+|||||-..|||+.....|||+||||++.+.+..
T Consensus       470 EL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  470 ELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999999864 456888888999999999999999   8889999999999999999999999999999987653


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .   .......-...|||||.+.-..++.++|||-|||.+||++. |..||.+....+       .+..+..|+...   
T Consensus       546 y---YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------VI~~iEnGeRlP---  612 (974)
T KOG4257|consen  546 Y---YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------VIGHIENGERLP---  612 (974)
T ss_pred             h---hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------eEEEecCCCCCC---
Confidence            2   12223334667999999998899999999999999999887 999998754322       122333333222   


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                             ....|+..+..|+.+||..||.+||.+.++...|..+..+
T Consensus       613 -------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  613 -------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             -------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence                   2234667899999999999999999999999999887753

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-39  Score=289.65  Aligned_cols=276  Identities=20%  Similarity=0.248  Sum_probs=213.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--------
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--------  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------  205 (443)
                      ..|+...+||+|.||.||+|+.+ +|+.||+|++--............+|+.+|..|.|+|++.++++|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666778999999999999865 688899987644333344556778999999999999999999987542        


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      ..+|+||.+|+. +|.-.|.. ....+...++.+++.++..||.|+|   ...|+|||+|++|+||+.+|.+||+|||++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            247999999964 77777753 3356888999999999999999999   888999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +.+...+......++..+-|.+|++||.+.|. .|+++.|||..|||+.||+++.+-|.+..+......+......+...
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            87665554444445666779999999998764 69999999999999999999999999988877666665544443332


Q ss_pred             ccccccC---------ccccchhh--------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          365 DAISILD---------PRVENTAA--------NNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       365 ~~~~~~d---------~~~~~~~~--------~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .......         +.+.....        ...-.++.++|+.++|..||.+|+++.+++.|.|..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            2111111         00111000        001124788999999999999999999999999865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=298.71  Aligned_cols=286  Identities=22%  Similarity=0.309  Sum_probs=217.9

Q ss_pred             CCCCCCCCcccCHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC--
Q 013401          115 RGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE--  191 (443)
Q Consensus       115 ~~~~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~--  191 (443)
                      ......|.+.+.+.|.+.. .+|.+.++||.|.|++||+|.+. +.+.||+|+.|..   ....+....||.+|++++  
T Consensus        59 ~dY~kGGYHpV~IGD~F~~-gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~  134 (590)
T KOG1290|consen   59 EDYRKGGYHPVRIGDVFNG-GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREG  134 (590)
T ss_pred             hhhhcCCCceeeccccccC-ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhc
Confidence            3334456677777777653 47999999999999999999865 7889999998864   566677889999999983  


Q ss_pred             ---C---cceeeeeeeeee----cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 013401          192 ---H---LNLVKFHGYLEF----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH  261 (443)
Q Consensus       192 ---h---~niv~l~~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  261 (443)
                         |   .+||+|++.|..    +.++|+|+|++ |.+|..+|.....+.++...++.|+.||+.||.|||.  ..||||
T Consensus       135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIH  211 (590)
T KOG1290|consen  135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIH  211 (590)
T ss_pred             CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccc
Confidence               2   269999999976    44899999999 8899999988888889999999999999999999997  779999


Q ss_pred             cCCCCCCEEEcC--------------------------------------------------------------------
Q 013401          262 RDIKSSNILLTE--------------------------------------------------------------------  273 (443)
Q Consensus       262 rDlkp~NILl~~--------------------------------------------------------------------  273 (443)
                      .||||+|||+..                                                                    
T Consensus       212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~  291 (590)
T KOG1290|consen  212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL  291 (590)
T ss_pred             cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence            999999999942                                                                    


Q ss_pred             --------------------------------------------------------------------------------
Q 013401          274 --------------------------------------------------------------------------------  273 (443)
Q Consensus       274 --------------------------------------------------------------------------------  273 (443)
                                                                                                      
T Consensus       292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~  371 (590)
T KOG1290|consen  292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP  371 (590)
T ss_pred             ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence                                                                                            


Q ss_pred             ------------------CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHH
Q 013401          274 ------------------NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVEL  335 (443)
Q Consensus       274 ------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~el  335 (443)
                                        +.++||+|||-|..+..       .++.-+.|..|+|||++.+..|++.+||||++|+++||
T Consensus       372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k-------hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FEL  444 (590)
T KOG1290|consen  372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK-------HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFEL  444 (590)
T ss_pred             cccccccccCCCCCCCccceeEEEeeccchhhhhh-------hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHh
Confidence                              01256777776665432       24445689999999999999999999999999999999


Q ss_pred             HcCCCCCCCchh------HHHHHHHHHHhhhc----------------CCCcccccc--------CccccchhhcHHHHH
Q 013401          336 VTGRRPIEPKRE------LKERITVKWAMKKF----------------SDGDAISIL--------DPRVENTAANNLALE  385 (443)
Q Consensus       336 ltG~~Pf~~~~~------~~~~~~~~~~~~~~----------------~~~~~~~~~--------d~~~~~~~~~~~~~~  385 (443)
                      +||..-|+....      .+....+......+                ..|++.-+-        +.-.+.-.+..+...
T Consensus       445 aTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~  524 (590)
T KOG1290|consen  445 ATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQ  524 (590)
T ss_pred             hcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHH
Confidence            999999975421      11111121111111                112211111        111111123345567


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          386 KILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       386 ~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ++.+|+.-||+.+|++|||+.+|++|+|-
T Consensus       525 ~fsdFL~PmLef~PeKR~tA~~cl~hPwL  553 (590)
T KOG1290|consen  525 QFSDFLSPMLEFDPEKRPTAAQCLKHPWL  553 (590)
T ss_pred             HHHHHHHHHHhcCccccccHHHHhcCccc
Confidence            89999999999999999999999999994

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=297.11  Aligned_cols=269  Identities=25%  Similarity=0.375  Sum_probs=217.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHh--cCCcceeeeeeeeeecC----e
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ--VEHLNLVKFHGYLEFED----E  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~  207 (443)
                      .++....+.||+|.||.||+|.++ |+.||||++...     +...+.||.++.+.  |+|+||+.|++....+.    +
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            456778889999999999999998 888999998643     33556666666654  69999999999876543    6


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM-----YTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                      +|||.+|.+.|+|+|||..   ..++....++++..++.||.+||.     .+...|.|||||..||||..+|..-|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            8999999999999999963   679999999999999999999996     34456999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccC----CC--CCchhHHHHHHHHHHHHc----------CCCCCCCch
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY----QL--TEKSDVYSFGVLLVELVT----------GRRPIEPKR  346 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~--~~~sDiwSlGvll~ellt----------G~~Pf~~~~  346 (443)
                      |||.................+||.+|||||++...    .+  -..+||||||.++||++.          -++||.+.-
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            99987665543333445567899999999998542    11  236899999999999885          245665443


Q ss_pred             hHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          347 ELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      +.+      .....+.+..+...+.|.++..+....+...+.+||..||..+|..|.|+-.|.+.+..+..
T Consensus       441 p~D------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSD------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCC------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            211      11223445567778889999999999999999999999999999999999999999887764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=300.29  Aligned_cols=274  Identities=23%  Similarity=0.364  Sum_probs=207.0

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHh--cCCcceeeeeeeeeecC----eEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ--VEHLNLVKFHGYLEFED----ERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~~~  209 (443)
                      .......||+|.||.||+|.+. ++.||||++.     ....+.|.+|-.|...  ++|+||++|+++-+..+    .++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            4445557999999999999987 5899999986     3455678888777765  57999999999877666    889


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeEecCCCCCCEEEcCCCceEEeeec
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY------TDHPIIHRDIKSSNILLTENFRAKVADFG  283 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivHrDlkp~NILl~~~~~vkl~DFG  283 (443)
                      ||+||.+.|+|.+||.   ...++|....+|+..+++||.|||.-      +...|+|||||..||||..|++.-|+|||
T Consensus       285 LVt~fh~kGsL~dyL~---~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLK---ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHHH---hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            9999999999999994   56799999999999999999999962      34469999999999999999999999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccCC-CC-----CchhHHHHHHHHHHHHcCCCCCCC--ch----hHHHH
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ-LT-----EKSDVYSFGVLLVELVTGRRPIEP--KR----ELKER  351 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-----~~sDiwSlGvll~elltG~~Pf~~--~~----~~~~~  351 (443)
                      ||..+.........  -..+||.+|||||++.+.- +.     .+.||||+|.|||||++.-.-+..  ..    +....
T Consensus       362 LAl~~~p~~~~~d~--~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  362 LALRLEPGKPQGDT--HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             eeEEecCCCCCcch--hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            99887654332222  2267999999999997642 22     368999999999999984332210  00    00000


Q ss_pred             HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      +..+-....+.+..+.....|.++..+........+.+.+..||..|++.|.|+.=+.+.+|.+..-..
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            000001111111223344556666666656677889999999999999999999999999998765544

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.7e-37  Score=288.40  Aligned_cols=227  Identities=22%  Similarity=0.213  Sum_probs=183.4

Q ss_pred             eCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHHHHH
Q 013401          146 GGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL  224 (443)
Q Consensus       146 G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l  224 (443)
                      |.||.||++.+. +++.||+|+++...       .+.+|...+....||||+++++++...+..++||||+.||+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            899999999976 78999999987642       2334555566667999999999999999999999999999999998


Q ss_pred             hhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccC
Q 013401          225 DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKG  304 (443)
Q Consensus       225 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~g  304 (443)
                      ...  ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++......       .....+
T Consensus        77 ~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~  144 (237)
T cd05576          77 SKF--LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------CDGEAV  144 (237)
T ss_pred             HHh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-------cccCCc
Confidence            643  45899999999999999999999   888999999999999999999999999987655432       122346


Q ss_pred             CCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHH
Q 013401          305 TAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLAL  384 (443)
Q Consensus       305 t~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  384 (443)
                      +..|+|||++.+..++.++|||||||++|||++|..||.......     .       ...     ...++     ....
T Consensus       145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~-------~~~-----~~~~~-----~~~~  202 (237)
T cd05576         145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----N-------THT-----TLNIP-----EWVS  202 (237)
T ss_pred             CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----c-------ccc-----ccCCc-----ccCC
Confidence            778999999988889999999999999999999998875332100     0       000     00000     1133


Q ss_pred             HHHHHHHHHccCCCCCCCCCH-----HHHHHHHH
Q 013401          385 EKILELALQCLAPRRQNRPSM-----RRCAEILW  413 (443)
Q Consensus       385 ~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~  413 (443)
                      ..+.+|+.+||+.||++||++     .+++.|.|
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~  236 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF  236 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence            678999999999999999996     88888877

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-37  Score=304.49  Aligned_cols=266  Identities=23%  Similarity=0.286  Sum_probs=206.4

Q ss_pred             CCCCceeeeeCceEEEEEEE-cCCcEEEEEEcccc-ccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |..++.||-|+||.|.++.. ++...||.|.+.+. .....+...+..|-.||..-+.+-||+||..|.+++.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            55566799999999999974 46889999988553 45566777889999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC--
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE--  292 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--  292 (443)
                      ++||++-.+|..  -..+++..+..++..|..|++++|   ..|+|||||||+|||||.+|++||+||||+.-+.-..  
T Consensus       711 IPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  711 IPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             cCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999998874  467888888888899999999999   8999999999999999999999999999996332110  


Q ss_pred             ------CCc------------------------------ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHH
Q 013401          293 ------SGA------------------------------THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV  336 (443)
Q Consensus       293 ------~~~------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ell  336 (443)
                            ...                              ....-.++||+.|+|||++....|+..+|+||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                  000                              00011247999999999999999999999999999999999


Q ss_pred             cCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHH
Q 013401          337 TGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRP---SMRRCAEILW  413 (443)
Q Consensus       337 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---s~~ell~~l~  413 (443)
                      .|++||-...+...+..+..+...+ +-        ..     ....+.+..+||.++ +.+++.|.   ..++|..|.|
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l-~~--------~~-----~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpf  930 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFL-HI--------PY-----QGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPF  930 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhcc-cc--------cc-----ccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCcc
Confidence            9999998887766554433221111 11        00     111234556666553 24566665   4567999999


Q ss_pred             hhhhhhhhh
Q 013401          414 SVRKDYREL  422 (443)
Q Consensus       414 ~i~~~~~~~  422 (443)
                      .-..||..+
T Consensus       931 FkgIDfssl  939 (1034)
T KOG0608|consen  931 FKGIDFSSL  939 (1034)
T ss_pred             ccccchHhh
Confidence            877776553

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-36  Score=276.21  Aligned_cols=277  Identities=23%  Similarity=0.330  Sum_probs=219.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-ccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ..+|..+..||+|+|.+|.++.++ +.+.||+|++|+...+. +++.=++.|-.+..+- +||.+|-++.+|..+.++++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357999999999999999999875 78999999999887654 3344466777777765 69999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |.||++||+|.-++.  .++.++++.+..+...|.-||.|||   +.|||.||||.+|+|||..|++||.|+|+++.-..
T Consensus       329 vieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            999999999988876  5577999999999999999999999   88999999999999999999999999999975433


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchh-HHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE-LKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      +.    .....++|||.|.|||++++..|+..+|+|+|||+++||+.|+.||+-..- ..+..+.++...-+.+.++   
T Consensus       404 ~g----d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---  476 (593)
T KOG0695|consen  404 PG----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---  476 (593)
T ss_pred             CC----cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc---
Confidence            32    235678999999999999999999999999999999999999999963221 0111122222222222111   


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPS------MRRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs------~~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                         +++..     .+-+...++..-|++||..|..      ++++..|.+.-..||..++...+..+
T Consensus       477 ---riprs-----lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp  535 (593)
T KOG0695|consen  477 ---RIPRS-----LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP  535 (593)
T ss_pred             ---cccce-----eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence               01111     1234567888889999999964      57888998887888888777666544

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-35  Score=310.86  Aligned_cols=270  Identities=20%  Similarity=0.215  Sum_probs=175.8

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-C----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeee------
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-D----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY------  201 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~------  201 (443)
                      ..++|...+.||+|+||.||+|.+. +    +..||||+++...    ..+...+|  .++...+.+++.++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            4568999999999999999999976 5    7899999876421    11111111  1222222233222221      


Q ss_pred             eeecCeEEEEEeecCCCcHHHHHhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 013401          202 LEFEDERIVIVEYVPNGTLREHLDCLQG------------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRD  263 (443)
Q Consensus       202 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrD  263 (443)
                      ...++..++|+||+.+++|.+++.....                  .......+..|+.||+.||.|||   +++|+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCc
Confidence            2456789999999999999998863210                  00112334578999999999999   88899999


Q ss_pred             CCCCCEEEcC-CCceEEeeecccccccccCCCcccccccccCCCCccCccccccC----------------------CCC
Q 013401          264 IKSSNILLTE-NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY----------------------QLT  320 (443)
Q Consensus       264 lkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~  320 (443)
                      |||+|||++. ++.+||+|||+++......   ........||+.|+|||.+...                      .++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~---~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI---NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCcccccccc---ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            9999999985 6899999999997654321   1233456799999999965321                      244


Q ss_pred             CchhHHHHHHHHHHHHcCCCCCCCchhHHH-HHH------HHHHhhhcCCCccccccCccccc-hhhcHHHHHHHHHHHH
Q 013401          321 EKSDVYSFGVLLVELVTGRRPIEPKRELKE-RIT------VKWAMKKFSDGDAISILDPRVEN-TAANNLALEKILELAL  392 (443)
Q Consensus       321 ~~sDiwSlGvll~elltG~~Pf~~~~~~~~-~~~------~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~Li~  392 (443)
                      .++|||||||+||||+++..|+........ .+.      ..|... ... .    ..+.+.. ....+.......+|+.
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~-~----~~~~~~~~~~~~d~~~~~~~dLi~  431 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEP-R----ASPDLRRGFEVLDLDGGAGWELLK  431 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hcc-c----cchhhhhhhhhccccchHHHHHHH
Confidence            567999999999999998777543211110 000      111100 000 0    0000000 0000001134568999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          393 QCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       393 ~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      +||+.||.+|||+.++++|+|.-..+..
T Consensus       432 ~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        432 SMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             HHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            9999999999999999999997654443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=289.49  Aligned_cols=265  Identities=24%  Similarity=0.399  Sum_probs=203.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cC----cccHHHHHHHHHHHHhcCCcceeeeeeeeee-cCeE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YD----KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-EDER  208 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~  208 (443)
                      +|-.+..||+|+|+.||++.+- ..+.||||+-..+. ..    ........+|..|.+.|+||.||++|++|.- .+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            4556668999999999999854 68899999843221 11    1223446789999999999999999999865 5577


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCceEEeeeccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFA  285 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGla  285 (443)
                      |-|+|||+|.+|..||.  .++.+++.++..|+.||+.||.||... ...|||-||||.||||-   .-|.+||.||||+
T Consensus       544 CTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             eeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            89999999999999987  567899999999999999999999854 35799999999999995   4578999999999


Q ss_pred             ccccccCCCc---ccccccccCCCCccCcccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh
Q 013401          286 RLAADTESGA---THVSTQVKGTAGYLDPEYLKT----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       286 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      +...+...+.   ........||-+|++||.+.-    ...+.|+||||+|||+|.++.|+.||.........+....++
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            9876553321   122345679999999998732    246789999999999999999999998765544433332221


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...      ++      ..+.......+..++|++||+.-.++|.+..++..++..+
T Consensus       701 kAt------EV------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  701 KAT------EV------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             cce------ec------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            111      00      0111122346788999999999999999999999887754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=258.71  Aligned_cols=205  Identities=28%  Similarity=0.422  Sum_probs=170.3

Q ss_pred             CCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEeecC
Q 013401          139 PSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~  216 (443)
                      .+..||+|+||.|-+.++. +|...|+|+++.... .....++.+|+.+..+. .+|.+|.+||.+..+..+||+||.| 
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-  127 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-  127 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence            3446999999999888865 799999999987643 44456677899887766 6999999999999999999999999 


Q ss_pred             CCcHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          217 NGTLREHLDC--LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       217 gg~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      ..+|..+..+  ..+..+++.-.-+|+..|++||.|||+  ...|||||+||+||||+.+|+||+||||++..+.+.-. 
T Consensus       128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-  204 (282)
T KOG0984|consen  128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-  204 (282)
T ss_pred             hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence            5677665532  257789999999999999999999997  56799999999999999999999999999988765432 


Q ss_pred             cccccccccCCCCccCccccc----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 013401          295 ATHVSTQVKGTAGYLDPEYLK----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI  352 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~  352 (443)
                          .+...|-.-|||||.+.    ...|+.++||||||+++.||.+++.||+.+....+++
T Consensus       205 ----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL  262 (282)
T KOG0984|consen  205 ----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL  262 (282)
T ss_pred             ----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence                11134777899999984    3478999999999999999999999998776544443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.2e-34  Score=268.44  Aligned_cols=242  Identities=31%  Similarity=0.400  Sum_probs=195.3

Q ss_pred             CceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHHHHHh
Q 013401          147 GFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLD  225 (443)
Q Consensus       147 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~  225 (443)
                      +||.||+|... +|+.+|+|++........ ...+.+|++.++.++|+||+++++.+......++++|++.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999987 589999999876533221 5788999999999999999999999999999999999999999999987


Q ss_pred             hhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCC
Q 013401          226 CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT  305 (443)
Q Consensus       226 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt  305 (443)
                      ...  .+++..++.++.+++.+|.+||   ..+++|+||+|.||+++.++.++|+|||++.......     ......++
T Consensus        80 ~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~  149 (244)
T smart00220       80 KRG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVGT  149 (244)
T ss_pred             hcc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccCC
Confidence            432  3888999999999999999999   7889999999999999999999999999998765432     22345688


Q ss_pred             CCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHH
Q 013401          306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALE  385 (443)
Q Consensus       306 ~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  385 (443)
                      ..|++||.+.+..++.++|||+||+++++|++|..||.........  .....    ......        .........
T Consensus       150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--~~~~~----~~~~~~--------~~~~~~~~~  215 (244)
T smart00220      150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL--FKKIG----KPKPPF--------PPPEWKISP  215 (244)
T ss_pred             cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHh----ccCCCC--------ccccccCCH
Confidence            9999999998888999999999999999999999999763221111  11111    100000        000000336


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          386 KILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       386 ~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ++.+++.+||..+|++||++.+++++.|
T Consensus       216 ~~~~~i~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      216 EAKDLIRKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             HHHHHHHHHccCCchhccCHHHHhhCCC
Confidence            7999999999999999999999999876

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=304.53  Aligned_cols=259  Identities=29%  Similarity=0.454  Sum_probs=207.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEc----C----CcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecC
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE----D----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFED  206 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  206 (443)
                      +..+.+.||+|.||.|++|...    .    ...||||.++..... ...+.+..|+++|+.+ .|+|||.++|++...+
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3445558999999999999743    1    457999999876544 6678899999999999 5999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc--------C------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ--------G------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT  272 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~--------~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~  272 (443)
                      .+++|+||+..|+|.+++....        +      ..+.....+.++.||+.|++||+   +.++|||||-..|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence            9999999999999999997643        0      23888889999999999999999   88899999999999999


Q ss_pred             CCCceEEeeecccccccccCCCccccccccc--CCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 013401          273 ENFRAKVADFGFARLAADTESGATHVSTQVK--GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELK  349 (443)
Q Consensus       273 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~  349 (443)
                      .+..+||+|||+++...+...-   ....-.  -...|||||.+....|+.++|||||||+|||+++ |..||.+.....
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y---~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYY---RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             CCCEEEEccccceeccCCCCce---EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9999999999999865543221   111111  2346999999999999999999999999999999 889998733211


Q ss_pred             HHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      +.      ...+.+|...+.          ...+.+++.++|..||+.+|++||++.++.+.+.....
T Consensus       530 ~l------~~~l~~G~r~~~----------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  530 EL------LEFLKEGNRMEQ----------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HH------HHHHhcCCCCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            11      112333332221          22356789999999999999999999999999988654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=294.47  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=184.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE-----------------cCCcEEEEEEccccccC------------cccHHHHHHHH
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL-----------------EDGTIVAIKRAKKSVYD------------KHSGAEFQSEI  184 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~------------~~~~~~~~~Ei  184 (443)
                      .++|++.++||+|+||+||+|.+                 .+++.||||+++.....            ....+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            46899999999999999999964                 23578999998643211            00112234577


Q ss_pred             HHHHhcCCcce-----eeeeeeeee--------cCeEEEEEeecCCCcHHHHHhhhcC----------------------
Q 013401          185 RTLAQVEHLNL-----VKFHGYLEF--------EDERIVIVEYVPNGTLREHLDCLQG----------------------  229 (443)
Q Consensus       185 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~l~~~~~----------------------  229 (443)
                      .++..++|.++     ++++++|..        ++..++||||+.+++|.+++....+                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     667776643        4568999999999999998863211                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCcc
Q 013401          230 NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL  309 (443)
Q Consensus       230 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~  309 (443)
                      ..+++..++.|+.|++.+|.|||   .++|+||||||+|||++.++.+||+|||++........   .......+|+.|+
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~Y~  377 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPRYS  377 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---cCccccCCCccee
Confidence            12356677889999999999999   78899999999999999999999999999865433211   1111233589999


Q ss_pred             CccccccCC--------------------C--CCchhHHHHHHHHHHHHcCCC-CCCCchhHHHH------HHHHHHhhh
Q 013401          310 DPEYLKTYQ--------------------L--TEKSDVYSFGVLLVELVTGRR-PIEPKRELKER------ITVKWAMKK  360 (443)
Q Consensus       310 aPE~l~~~~--------------------~--~~~sDiwSlGvll~elltG~~-Pf~~~~~~~~~------~~~~~~~~~  360 (443)
                      |||.+....                    +  ..+.||||+|||+|+|++|.. ||.........      ....|..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence            999875321                    1  234799999999999999885 77643322111      1111211  


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHHHhh
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRR---QNRPSMRRCAEILWSV  415 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp---~~RPs~~ell~~l~~i  415 (443)
                      .....    .+  +.   ......+...+|+.+||..+|   .+|+|+.++++|+|..
T Consensus       456 ~~~~~----~~--~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        456 YKGQK----YD--FS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             hcccC----CC--cc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            11110    00  00   111234678899999999766   6899999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=299.78  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=193.1

Q ss_pred             CCCCceeeeeCceE-EEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGT-VYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |...+.+|.|.-|+ ||+|... |+.||||++-..     ....+.+||+.|+.-+ |||||++|+.-.+....||++|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            55556799999987 6999886 789999988643     2345679999999985 99999999998888999999999


Q ss_pred             cCCCcHHHHHhhh-cC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---C--CceEEeeeccccc
Q 013401          215 VPNGTLREHLDCL-QG-NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---N--FRAKVADFGFARL  287 (443)
Q Consensus       215 ~~gg~L~~~l~~~-~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~--~~vkl~DFGla~~  287 (443)
                      | ..+|.++++.. .. ........+.+..|++.||.+||   +.+||||||||+||||+.   +  ..++|+|||+++.
T Consensus       585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            9 57999999753 11 11111344678899999999999   667999999999999975   2  4799999999998


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCchhHHHHHHHHHHhhhcCCCc-
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG-RRPIEPKRELKERITVKWAMKKFSDGD-  365 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  365 (443)
                      +........+ .....||-+|+|||++....-+.++||||||||+|+.++| ..||.+.-+.+.  ++.       .++ 
T Consensus       661 l~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl-------~~~~  730 (903)
T KOG1027|consen  661 LAGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NIL-------TGNY  730 (903)
T ss_pred             cCCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhh-------cCcc
Confidence            8766544444 4456799999999999988888899999999999999995 899987654322  111       111 


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ....+.+.       .++  +..+||.+|+++||..||++.+|+.|+..
T Consensus       731 ~L~~L~~~-------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  731 TLVHLEPL-------PDC--EAKDLISRMLNPDPQLRPSATDVLNHPLF  770 (903)
T ss_pred             ceeeeccC-------chH--HHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence            00111111       011  68899999999999999999999999653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=270.51  Aligned_cols=270  Identities=23%  Similarity=0.307  Sum_probs=206.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----eEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----ERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~  209 (443)
                      +.+..+-||-|+||.||.+++. +|+.||+|++..-...-.....+.+|+++|..++|.|++..++...-..     ++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4556678999999999999875 8999999998765555556678899999999999999999988765432     457


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      ++.|+| ..+|...|.  ....++...++-+++||+.||+|||   +.+|.||||||.|+|++.++.+||||||+++...
T Consensus       134 V~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence            778887 457776665  4566888888899999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH--------Hhhh
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW--------AMKK  360 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~--------~~~~  360 (443)
                      ..+.   ...+..+-|.+|.|||++.|. .|+.++||||.|||+.||+..+.-|....+......+..        .++.
T Consensus       208 ~d~~---~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  208 QRDR---LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             hhhh---hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            4332   223445678999999999764 689999999999999999999999988777655443322        2222


Q ss_pred             cCCCccccccCccccchh--------hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          361 FSDGDAISILDPRVENTA--------ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~--------~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      -.+|...-++....+...        .....-.+.+.+..++|.+||+.|.+..+.+.++..
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            233332222322222111        111223467789999999999999999999998763

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=290.48  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=209.9

Q ss_pred             CCCCceeeeeCceEEEEEEEc-CC----cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-DG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-~g----~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ....++||+|+||+||+|.+- .|    -+||||++.... ......++..|..+|.+|+||||+++++++.... +-||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            344558999999999999863 33    467888765442 2334578899999999999999999999998766 8889


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ++|+++|.|.+|+.. ....+.....+.|..||++|+.|||   ++.+|||||-..||||..-..+||.|||+++.+...
T Consensus       776 tq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999999987 4566888889999999999999999   889999999999999999999999999999988765


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      +.....  ....-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+       +-..+..++..+  
T Consensus       852 ~~ey~~--~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geRLs--  920 (1177)
T KOG1025|consen  852 EKEYSA--PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGERLS--  920 (1177)
T ss_pred             cccccc--cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhccccCC--
Confidence            432222  22234567999999999999999999999999999999 999998764322       112223333211  


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                              ....+..++.-++.+||..|+..||+++++...+...-++-+.-
T Consensus       921 --------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry  964 (1177)
T KOG1025|consen  921 --------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY  964 (1177)
T ss_pred             --------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence                    11235567999999999999999999999999998887777764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.8e-34  Score=280.68  Aligned_cols=281  Identities=20%  Similarity=0.243  Sum_probs=212.9

Q ss_pred             CCCcccCHHHHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC------
Q 013401          120 SGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH------  192 (443)
Q Consensus       120 ~~~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h------  192 (443)
                      .|...+.+.|+  ...+|.+....|+|-|++|..|.+. .|..||||+|..+   ......=++|+++|+.|+.      
T Consensus       419 EGYYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  419 EGYYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             cceEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhh
Confidence            34445555554  3357888888999999999999876 5889999999865   3344455689999999952      


Q ss_pred             cceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       193 ~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      -|+|+|+..|....++|||+|-+ ..+|.+.|.... +-.|....+..++.|+..||..|.   ..||+|.||||.||||
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILV  569 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEe
Confidence            38999999999999999999988 579999997654 334777888899999999999999   7779999999999999


Q ss_pred             cCC-CceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 013401          272 TEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~-~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~  350 (443)
                      ++. ..+||||||.|.++.+.+..+.      .-+..|.|||++.|.+|+...|+||.||+||||.||+.-|.+......
T Consensus       570 NE~k~iLKLCDfGSA~~~~eneitPY------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M  643 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENEITPY------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM  643 (752)
T ss_pred             ccCcceeeeccCccccccccccccHH------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence            864 5699999999988877654332      235569999999999999999999999999999999999988765433


Q ss_pred             HHHHHHHhhhc-----CCCc---------c------------------ccccCc----------cccchhhcHHHHHHHH
Q 013401          351 RITVKWAMKKF-----SDGD---------A------------------ISILDP----------RVENTAANNLALEKIL  388 (443)
Q Consensus       351 ~~~~~~~~~~~-----~~~~---------~------------------~~~~d~----------~~~~~~~~~~~~~~l~  388 (443)
                      .-........+     ..+.         +                  +..+.|          ....+.........|.
T Consensus       644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r  723 (752)
T KOG0670|consen  644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR  723 (752)
T ss_pred             HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence            22211100000     0000         0                  000111          1011122334567899


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          389 ELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       389 ~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +|+.+||..||.+|.+..+.|.|++..
T Consensus       724 dLLdkml~LdP~KRit~nqAL~HpFi~  750 (752)
T KOG0670|consen  724 DLLDKMLILDPEKRITVNQALKHPFIT  750 (752)
T ss_pred             HHHHHHhccChhhcCCHHHHhcCCccc
Confidence            999999999999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=277.47  Aligned_cols=205  Identities=26%  Similarity=0.339  Sum_probs=174.1

Q ss_pred             HHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCccc------HHHHHHHHHHHHhcC---Ccceeee
Q 013401          129 EIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHS------GAEFQSEIRTLAQVE---HLNLVKF  198 (443)
Q Consensus       129 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~------~~~~~~Ei~~l~~l~---h~niv~l  198 (443)
                      ..++...+|..+..||+|+||.|++|.++ +...|+||.+.+...-...      .-.+--||+||..|+   |+||+++
T Consensus       555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            33444567899999999999999999987 5778999988775421111      112457999999997   9999999


Q ss_pred             eeeeeecCeEEEEEeec-CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          199 HGYLEFEDERIVIVEYV-PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       199 ~~~~~~~~~~~lv~E~~-~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                      +++|++++++||+||.- +|-+|+++|+.  ...+.+.++..|+.||+.|+++||   ++||||||||-+|+.++.+|-+
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeE
Confidence            99999999999999975 46799999984  355889999999999999999999   9999999999999999999999


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCC
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT-EKSDVYSFGVLLVELVTGRRPIEP  344 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlGvll~elltG~~Pf~~  344 (443)
                      ||+|||.+.....+      ....++||..|.|||++.|..|- ..-|||+||++||.++....||..
T Consensus       710 klidfgsaa~~ksg------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSG------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEeeccchhhhcCC------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999999776543      35567899999999999998764 568999999999999999999853

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=260.81  Aligned_cols=266  Identities=21%  Similarity=0.250  Sum_probs=202.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------Ce
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------DE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~  207 (443)
                      .+|..+..+|.|.- .|.-+-+. .++.||+|++.....+.....+..+|+.++..+.|+|||+++.+|.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777778888887 55555443 689999999877666666677888999999999999999999988543      36


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .|+|||+| ..+|.+.+.    ..++-..+..|..|++.|++|||   +.||+||||||+||++..++.+||.|||+++.
T Consensus        96 ~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            79999999 568888775    33677788899999999999999   88899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh--------
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK--------  359 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--------  359 (443)
                      ....     ...+.++.|..|.|||++.+..|.+.+||||+||++.||++|..-|.+.+..+....+.....        
T Consensus       168 e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  168 EDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             cCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            5432     345667899999999999998999999999999999999999999987755443322211000        


Q ss_pred             -----------hcCCC---ccccccC-ccccch-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          360 -----------KFSDG---DAISILD-PRVENT-AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       360 -----------~~~~~---~~~~~~d-~~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                                 ...+.   ...+.+. ...+.. .........+.+|+.+||-.||++|.+++++|.|+..
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence                       00000   0001110 000000 0111234568999999999999999999999999874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.1e-33  Score=250.20  Aligned_cols=265  Identities=18%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE-cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecC--eEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFED--ERI  209 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~~  209 (443)
                      .++|++.+++|+|.|+.||.|.. .+++.++||++|.-     ....+.||+.+|..|. ||||++++++..+..  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            45788888999999999999984 46888999998743     3467889999999997 999999999987654  567


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeecccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFARLA  288 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~  288 (443)
                      +|+||+++.+......     .+..-.+...+.+++.||.|||   ++||+|||+||.|++||. .-.++|+|+|||.+.
T Consensus       112 LiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            9999999988776553     3666678889999999999999   899999999999999995 457999999999998


Q ss_pred             cccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCC-chhHHHHHHHHHHh------hh
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEP-KRELKERITVKWAM------KK  360 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~-~~~~~~~~~~~~~~------~~  360 (443)
                      .+...-     .--+.+.+|--||.+... .|+..-|+|||||+|..|+-.+.||-. .+..+....+....      ..
T Consensus       184 Hp~~eY-----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y  258 (338)
T KOG0668|consen  184 HPGKEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY  258 (338)
T ss_pred             CCCcee-----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence            765432     223467889999999664 478899999999999999999988753 33333222222111      00


Q ss_pred             c------CCCccccccCccccch-------hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          361 F------SDGDAISILDPRVENT-------AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       361 ~------~~~~~~~~~d~~~~~~-------~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      +      .+.....+++...+..       .......+++++|+.+.|..|-.+|||++|++.|++...
T Consensus       259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            0      0111111111111111       112234578999999999999999999999999998653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=3.9e-31  Score=240.26  Aligned_cols=212  Identities=37%  Similarity=0.576  Sum_probs=183.9

Q ss_pred             eeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHH
Q 013401          143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLR  221 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~  221 (443)
                      ||+|.+|.||++... +++.++||++....... ....+.+|++.++.+.|++|+++++++......++++|++.|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999986 48999999987653221 3567899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeecccccccccCCCcccccc
Q 013401          222 EHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFARLAADTESGATHVST  300 (443)
Q Consensus       222 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~  300 (443)
                      +++.... ..++...++.++.+++.+|.+||   ..+++|+||+|.||+++. ++.++|+|||.+........    ...
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~~  151 (215)
T cd00180          80 DLLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LLK  151 (215)
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hhh
Confidence            9987432 46888999999999999999999   788999999999999999 89999999999976654321    122


Q ss_pred             cccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhh
Q 013401          301 QVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA  379 (443)
Q Consensus       301 ~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  379 (443)
                      ...+...|++||.+... .++.+.|+|+||+++++|                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            34578899999999877 788899999999999999                                            


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          380 NNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       380 ~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                           ..+.+++.+|++.||++||++.++++++
T Consensus       188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                 3588999999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-33  Score=279.82  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=208.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|+.+.++|.|+||.||++++. +++..|||++|..  ......-++.|+-+++..+|+|||.+++-|...+.+||+||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            47888999999999999999975 7999999999865  34555667899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||.||+|.+...  ...++.+.++..++...+++|+|||   ++|-+|||||-.|||+++.|.+|++|||.+..+...- 
T Consensus        93 ycgggslQdiy~--~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             ecCCCcccceee--ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh-
Confidence            999999987554  4567899999999999999999999   8889999999999999999999999999987654321 


Q ss_pred             CcccccccccCCCCccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                         .....++||++|||||+.   +...|...+|||++|+...|+---++|..+.-+....    +.+.+-       .+
T Consensus       167 ---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l----~LmTkS-------~~  232 (829)
T KOG0576|consen  167 ---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL----FLMTKS-------GF  232 (829)
T ss_pred             ---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH----HHhhcc-------CC
Confidence               234567899999999986   4567999999999999999999999987555443221    111111       01


Q ss_pred             C-ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          371 D-PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       371 d-~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      + +.++.   .....+.+.+|++.||..+|.+||+++.+|.|.+.
T Consensus       233 qpp~lkD---k~kws~~fh~fvK~altknpKkRptaeklL~h~fv  274 (829)
T KOG0576|consen  233 QPPTLKD---KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFV  274 (829)
T ss_pred             CCCcccC---CccchHHHHHHHHHHhcCCCccCCChhhheeceee
Confidence            1 11111   11234679999999999999999999999998764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=253.79  Aligned_cols=267  Identities=22%  Similarity=0.303  Sum_probs=210.6

Q ss_pred             HHHHHHHhcCCCCCceeeeeCceEEEEEEEcC------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeee
Q 013401          127 MEEIYRATRNFSPSFKIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG  200 (443)
Q Consensus       127 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~  200 (443)
                      ..++.....+++....+-+|.||.||.|.+++      .+.|-||.++.. ....+...+..|--.|..+.|||++.+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            44555556678888889999999999997652      455677777654 23455666788998999999999999999


Q ss_pred             eeee-cCeEEEEEeecCCCcHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          201 YLEF-EDERIVIVEYVPNGTLREHLDCLQ------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       201 ~~~~-~~~~~lv~E~~~gg~L~~~l~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      ++.+ .+..++++.++.-|+|..||...+      .+.+...+...++.|++.|+.|||   .++|||.||-..|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence            8765 456788899999999999997322      234566677789999999999999   888999999999999999


Q ss_pred             CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHH
Q 013401          274 NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERI  352 (443)
Q Consensus       274 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~  352 (443)
                      ..+|||+|=.+++-+.+.+.  +...........||+||.+....|+.++|||||||+||||+| |+.|+...++.+...
T Consensus       432 ~LqVkltDsaLSRDLFP~DY--hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~  509 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDY--HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH  509 (563)
T ss_pred             heeEEeccchhccccCcccc--cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence            99999999999987665432  112223346778999999999999999999999999999999 999998887765433


Q ss_pred             HHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          353 TVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ..+       +|-...          ...++++++..++..||..+|++||+.+++..-|....
T Consensus       510 ylk-------dGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  510 YLK-------DGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HHh-------ccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            222       221111          12247789999999999999999999999998886543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=9.8e-32  Score=257.07  Aligned_cols=274  Identities=26%  Similarity=0.366  Sum_probs=201.0

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeeeeee
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEF  204 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~  204 (443)
                      +....+.|...++||+|.|++||++.+.    ..+.||+|.+...    .....+.+|+++|..+. +.||+++.+++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3344567899999999999999999753    4778999988653    34467889999999995 9999999999999


Q ss_pred             cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCceEEeeec
Q 013401          205 EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVADFG  283 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFG  283 (443)
                      ++.+.+|+||++.....+++..     ++...+..++..++.||.++|   .+|||||||||+|||.+ ..+.-.|+|||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEech
Confidence            9999999999999999888853     567788889999999999999   89999999999999998 56789999999


Q ss_pred             ccccccccC-------------CC------------------cccc---------cccccCCCCccCcccccc-CCCCCc
Q 013401          284 FARLAADTE-------------SG------------------ATHV---------STQVKGTAGYLDPEYLKT-YQLTEK  322 (443)
Q Consensus       284 la~~~~~~~-------------~~------------------~~~~---------~~~~~gt~~y~aPE~l~~-~~~~~~  322 (443)
                      ||.......             ..                  ....         .-...||++|.|||++.. ...+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997211000             00                  0000         011359999999999854 467889


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCch-h---HHHHHHHHH--Hhhh--cCCCc--c---------------------cccc-
Q 013401          323 SDVYSFGVLLVELVTGRRPIEPKR-E---LKERITVKW--AMKK--FSDGD--A---------------------ISIL-  370 (443)
Q Consensus       323 sDiwSlGvll~elltG~~Pf~~~~-~---~~~~~~~~~--~~~~--~~~~~--~---------------------~~~~-  370 (443)
                      +||||.|||+..++++..||-... +   ..+...+.-  .+.+  ...+.  +                     ..+. 
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            999999999999999999985332 1   222222110  0000  00000  0                     0000 


Q ss_pred             -C-ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 -D-PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 -d-~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       + ++..........+..+++|+.+||..||.+|.++++.|+|++.=
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence             0 01122222233444799999999999999999999999998753

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=242.23  Aligned_cols=254  Identities=22%  Similarity=0.420  Sum_probs=189.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeee-eeecCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGY-LEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~-~~~~~~~~l  210 (443)
                      .+.|.+.+.||+|.||.+-+|.++ +...+++|.+.+.   .....+|.+|...--.|. |.|||.-|++ |+..+.+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            356788889999999999999988 5788999998875   344578999988776774 9999998874 677888899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCceEEeeecccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT--ENFRAKVADFGFARLA  288 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~  288 (443)
                      ++||++.|+|..-+.   ...+.+.....++.|++.||.|||   ++++||||||.+||||-  +..+|||||||+.+..
T Consensus       100 ~qE~aP~gdL~snv~---~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVE---AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhcC---cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            999999999998774   355788888999999999999999   99999999999999993  3448999999998654


Q ss_pred             cccCCCcccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ...       .....-+..|.+||+...     ....+.+|||+||+|+|.+|+|.+|+.. ..........|..-  ..
T Consensus       174 g~t-------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w--~~  243 (378)
T KOG1345|consen  174 GTT-------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQW--LK  243 (378)
T ss_pred             Cce-------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHH--hc
Confidence            321       112224556999998733     3456789999999999999999999973 33333222222211  11


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHH
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRP---SMRRCAEILW  413 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---s~~ell~~l~  413 (443)
                      +.-.       ..+.......+.++.+..+-|.+++++|-   +.......+|
T Consensus       244 rk~~-------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  244 RKNP-------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             ccCc-------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            1101       01111223457789999999999999994   4444444555

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.3e-29  Score=234.15  Aligned_cols=200  Identities=36%  Similarity=0.526  Sum_probs=171.7

Q ss_pred             CCCCceeeeeCceEEEEEEEcC-CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          137 FSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      |.....||.|+||.||++...+ ++.+++|.+...... .....+.+|+..++.++|+|++++++++...+..++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            4566789999999999999874 899999998765322 24678889999999999999999999999999999999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .+++|.+++..... .+++.....++.+++.+|.+||   .++++|+||+|.||+++.++.++|+|||++......... 
T Consensus        80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       80 EGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            99999999875322 1788899999999999999999   778999999999999999999999999999877554210 


Q ss_pred             ccccccccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 013401          296 THVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP  344 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlGvll~elltG~~Pf~~  344 (443)
                        ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       155 --~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 --LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             --cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence              12334578899999998 666788899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.5e-30  Score=284.42  Aligned_cols=204  Identities=20%  Similarity=0.224  Sum_probs=145.0

Q ss_pred             hcCC-cceeeeeeee-------eecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 013401          189 QVEH-LNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII  260 (443)
Q Consensus       189 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  260 (443)
                      .++| .||+++++++       .+.+.+++++|++ +++|.++|.. ....+++.+++.|+.||+.||.|||   ++|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            3455 5777787776       2334567778887 6799999964 3456999999999999999999999   88999


Q ss_pred             ecCCCCCCEEEcCCC-------------------ceEEeeecccccccccCCC------------cccccccccCCCCcc
Q 013401          261 HRDIKSSNILLTENF-------------------RAKVADFGFARLAADTESG------------ATHVSTQVKGTAGYL  309 (443)
Q Consensus       261 HrDlkp~NILl~~~~-------------------~vkl~DFGla~~~~~~~~~------------~~~~~~~~~gt~~y~  309 (443)
                      ||||||+||||+..+                   .+||+|||+++........            .........||++||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   4555666665432110000            000011246899999


Q ss_pred             CccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHH
Q 013401          310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILE  389 (443)
Q Consensus       310 aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  389 (443)
                      |||++.+..|+.++|||||||+||||++|.+|+...........     ...        +.+..      .....+..+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~-----~~~--------~~~~~------~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLR-----HRV--------LPPQI------LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHH-----Hhh--------cChhh------hhcCHHHHH
Confidence            99999998999999999999999999999998764322111110     000        00100      011234668


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          390 LALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       390 Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ++.+||++||.+||++.++++|+|...
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhchhhhh
Confidence            899999999999999999999999643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=5.1e-28  Score=216.22  Aligned_cols=171  Identities=22%  Similarity=0.294  Sum_probs=130.6

Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      |+|.+++.. .+..+++..++.|+.||+.||.|||   .++      ||+|||++.++.+|+  ||++......      
T Consensus         1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence            689998874 3567999999999999999999999   666      999999999999999  9998765432      


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccch
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT  377 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  377 (443)
                         ...||+.|||||++.+..++.++|||||||++|||++|..||...........  ..........      +.... 
T Consensus        63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~------~~~~~-  130 (176)
T smart00750       63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE--ILLNGMPADD------PRDRS-  130 (176)
T ss_pred             ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH--HHHHHhccCC------ccccc-
Confidence               12589999999999999999999999999999999999999976544322111  1111111110      00000 


Q ss_pred             hhcHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          378 AANNLALE--KILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       378 ~~~~~~~~--~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                       ......+  .+.+++.+||+.||.+||++.++++|+|.+..+-
T Consensus       131 -~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      131 -NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             -cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence             0112222  6999999999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-27  Score=217.72  Aligned_cols=269  Identities=18%  Similarity=0.234  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE-cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  211 (443)
                      +-+|++.++||+|.||.++.|+. -+++.||||.-...    ....+++.|....+.|. .++|..+|-+..++.+-.+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            35899999999999999999984 47999999976543    23456788999888885 89999999888888889999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-----CceEEeeecccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-----FRAKVADFGFAR  286 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-----~~vkl~DFGla~  286 (443)
                      +|++ |.+|.|+.+ +.++.++...++.||+|++.-++|+|   ++.+|.|||||+|+||...     ..+.|+|||+|+
T Consensus       103 idLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            9999 888888765 47889999999999999999999999   8889999999999999753     359999999999


Q ss_pred             cccccCCCccccc---ccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          287 LAADTESGATHVS---TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       287 ~~~~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ...++....+...   ....||.+||+=....|.+.+.+-|+-|||-+++++|-|..||.+..-.......+.+-..-..
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            9998876555443   3467999999999999999999999999999999999999999876432221121111111111


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ..+..+          -...++++..-+.-.-..+-.+-|+++-+...+.++..+..+
T Consensus       258 T~i~~L----------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  258 TPIEVL----------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             CCHHHH----------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            111111          112346677777777778888889998777776665544433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2e-26  Score=226.33  Aligned_cols=264  Identities=23%  Similarity=0.278  Sum_probs=199.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEcC--CcEEEEEEccccccCcccHHHHHHHHHHHHhcCC----cceeeeeeee-eecCeE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH----LNLVKFHGYL-EFEDER  208 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~~~  208 (443)
                      +|.+.++||+|+||.||+|....  ...+|+|..........  ..+..|+.++..+..    .++..+++.. ..++..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            79999999999999999999764  35789998665422221  256778888888862    5888999888 577788


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-----CceEEeeec
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-----FRAKVADFG  283 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-----~~vkl~DFG  283 (443)
                      ++||+.+ |.+|.++......+.++....+.|+.|++.+|++||   +.|+|||||||+|+++...     ..+.|.|||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            9999998 889999876655678999999999999999999999   8889999999999999854     469999999


Q ss_pred             ccc--cccccCCCc---ccc-cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHH
Q 013401          284 FAR--LAADTESGA---THV-STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA  357 (443)
Q Consensus       284 la~--~~~~~~~~~---~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~  357 (443)
                      +++  .........   ... .....||..|+++++..+...+.+.|+||++.++.+|+.|..|+...............
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  332222111   111 22356999999999999999999999999999999999999998665433222222221


Q ss_pred             hhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       358 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ........             .....+..+.+++..+-..+...+|.+..+...++.....
T Consensus       253 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  253 PRKLLTDR-------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hhhhcccc-------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            11111110             0111235677777777779999999999999998766544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-26  Score=206.79  Aligned_cols=265  Identities=19%  Similarity=0.257  Sum_probs=207.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE-cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..+|..+++||.|+||.+|+|.. .+|..||||.-....    ...++..|..+.+.|+ ...|..+..+..+.++-.+|
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            35799999999999999999984 579999999876543    2245678889999887 57888888888889999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~  288 (443)
                      |+++ |.+|.+++.- ..+.++....+.++.|++.-|+|+|   .+++|||||||+|+|+.-   ...+.|+|||+|+..
T Consensus        90 MdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            9999 8888876653 5577899999999999999999999   888999999999999963   346999999999988


Q ss_pred             cccCCCcccc---cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          289 ADTESGATHV---STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       289 ~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .+.....+..   .....||.+|.+=....+...+.+-|+-|+|.+|.++.-|..||.+..........+.+...-....
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            7765544333   3456899999999888888888999999999999999999999998765444333333222221111


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       ++.+-.         ..+.++.-.+..|-..--++-|+..-+.+.+..+..
T Consensus       245 -ie~LC~---------G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  245 -IEVLCK---------GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             -HHHHhC---------CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence             111111         123567788888888888889998777776665544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=2.8e-25  Score=214.43  Aligned_cols=264  Identities=31%  Similarity=0.454  Sum_probs=202.3

Q ss_pred             CCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcc-cHHHHHHHHHHHHhcCCc-ceeeeeeeeeecCeEEEEEee
Q 013401          137 FSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH-SGAEFQSEIRTLAQVEHL-NLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~  214 (443)
                      |.....||.|+||.||++...  ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566778999999999999987  7899999887654443 577899999999999988 799999999777778999999


Q ss_pred             cCCCcHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeecccccccccC
Q 013401          215 VPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFARLAADTE  292 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~  292 (443)
                      +.+++|.+++..... ..+.......++.|++.++.|+|   ..+++||||||+||+++..+ .++++|||++.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999976653221 26888899999999999999999   88899999999999999988 79999999998555433


Q ss_pred             CCcc--cccccccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCchh---HHHHHHHHHHhhhcCCC
Q 013401          293 SGAT--HVSTQVKGTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVTGRRPIEPKRE---LKERITVKWAMKKFSDG  364 (443)
Q Consensus       293 ~~~~--~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlGvll~elltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~  364 (443)
                      ....  .......||..|++||.+.+   ..+....|+|++|++++++++|..||.....   ........+....  . 
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~-  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT--P-  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC--c-
Confidence            2211  12456789999999999987   5788899999999999999999999876653   1111111111100  0 


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ...........     ......+.+++..|+..+|..|.+..+...+.+
T Consensus       234 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~  277 (384)
T COG0515         234 SLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL  277 (384)
T ss_pred             ccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhchH
Confidence            00000011000     122356889999999999999999998888743

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.5e-26  Score=227.76  Aligned_cols=169  Identities=20%  Similarity=0.184  Sum_probs=130.8

Q ss_pred             HHhcCCCCCceeeeeCceEEEEEEEc--CCcEEEEEEcccccc---CcccHHHHHHHHHHHHhcCCcceee-eeeeeeec
Q 013401          132 RATRNFSPSFKIGQGGFGTVYKGRLE--DGTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVEHLNLVK-FHGYLEFE  205 (443)
Q Consensus       132 ~~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~  205 (443)
                      ....+|...+.||+|+||+||+|.++  +++.||||++.....   .......+.+|+++|+.++|+|++. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34568999999999999999999865  578889998653211   2233566899999999999999985 4432    


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCCCceEEeeecc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDI-KSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~NILl~~~~~vkl~DFGl  284 (443)
                      +..++||||++|++|.. +.  .   ..   ...++.+++.+|.|||   .+||+|||| ||+|||++.++.+||+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            46899999999999963 21  1   11   1467889999999999   889999999 99999999999999999999


Q ss_pred             cccccccCCCccc----ccccccCCCCccCcccccc
Q 013401          285 ARLAADTESGATH----VSTQVKGTAGYLDPEYLKT  316 (443)
Q Consensus       285 a~~~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~  316 (443)
                      ++.+.........    ..+...+++.|++||++..
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9977654322111    1235678999999999843

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=6.5e-27  Score=244.66  Aligned_cols=262  Identities=20%  Similarity=0.255  Sum_probs=195.0

Q ss_pred             CCceeeeeCceEEEEEEEc-CCcEEEEEEccc----cccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          139 PSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKK----SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ....+|.|++|.|+.+... ..+.++.|....    ..........+..|+-+-..|.|+|++..+..+.+.+...-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4557999999988877644 455555554331    11111111125567777788899999988888777776666699


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||++ +|+.++..  ...+...++.-++.|++.||.|||   +.||.|||||++|++++.+|.+||+|||.+....-+..
T Consensus       402 ~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9999 99998863  346788888889999999999999   89999999999999999999999999999987765544


Q ss_pred             CcccccccccCCCCccCccccccCCCCC-chhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTE-KSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .........+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+.+..         +.........
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------~~~~~~~~~~  546 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------TNNYSDQRNI  546 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------hhcccccccc
Confidence            4445566788999999999999999986 57999999999999999999865433222110         0000000111


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...........+.....++.+||++||.+|.|+.+|++..|.-
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            1111122334556788999999999999999999999999964

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.5e-26  Score=227.41  Aligned_cols=255  Identities=26%  Similarity=0.303  Sum_probs=202.2

Q ss_pred             eeeeCceEEEEEE----EcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEeecCC
Q 013401          143 IGQGGFGTVYKGR----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       143 LG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      +|+|.||.|+++.    .+.|..||+|+.++..........-..|..++..++ ||.+|++...++.+...++++++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7999999999875    235888999998765443333334557888899887 99999999999999999999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      |+|...+.  ....+.+.........++-+++++|   ..+++|||+|++||+++.+|++++.|||+++...+.+.    
T Consensus        82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            99988775  3455666666777788999999999   78899999999999999999999999999988765432    


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccch
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT  377 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  377 (443)
                          .|||..|||||++.  .+...+|+||||++++||++|..||..  +..     ..+.. .              ..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~-----~~Il~-~--------------~~  204 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTM-----KRILK-A--------------EL  204 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHH-----HHHhh-h--------------cc
Confidence                17999999999998  567789999999999999999999977  111     11000 0              00


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhhcccCcCCcccc
Q 013401          378 AANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELAASDVLLQPSYS  434 (443)
Q Consensus       378 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~~~~~~~~~~~~  434 (443)
                      .........+.+++.+++..+|.+|.-.     .++.+|.+....+|+++..-....++.+.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~  266 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPG  266 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCc
Confidence            1122345678899999999999999755     68888888888889887766666554443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=5.2e-24  Score=192.87  Aligned_cols=142  Identities=17%  Similarity=0.204  Sum_probs=109.4

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCccc------------------------HHHHHHHHHHHHhcCCcce
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS------------------------GAEFQSEIRTLAQVEHLNL  195 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~Ei~~l~~l~h~ni  195 (443)
                      ...||+|+||.||+|...+|+.||||+++........                        .....+|+++|..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999998765321111                        0122359999999987776


Q ss_pred             eeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCCEEEcCC
Q 013401          196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL-HMYTDHPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       196 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDlkp~NILl~~~  274 (443)
                      .....+. . ...+|||||++|++|...+.  ....++....+.++.|++.+|.+| |   ..||+||||||+|||++ +
T Consensus        82 ~~p~~~~-~-~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPIL-L-KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEE-e-cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence            4333222 2 23389999999887765432  335688889999999999999999 7   77899999999999998 4


Q ss_pred             CceEEeeeccccccc
Q 013401          275 FRAKVADFGFARLAA  289 (443)
Q Consensus       275 ~~vkl~DFGla~~~~  289 (443)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.5e-24  Score=194.08  Aligned_cols=173  Identities=15%  Similarity=0.168  Sum_probs=133.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCccc-HH------HHHHHHHHHHhcCCcceeeeeeeeeec-
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS-GA------EFQSEIRTLAQVEHLNLVKFHGYLEFE-  205 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~-~~------~~~~Ei~~l~~l~h~niv~l~~~~~~~-  205 (443)
                      ..+|+..+.||.|+||.||+... ++..+|||.+......... ..      .+.+|++.+.++.|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            56899999999999999999766 5678999998755432221 12      257999999999999999998886643 


Q ss_pred             -------CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceE
Q 013401          206 -------DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAK  278 (443)
Q Consensus       206 -------~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vk  278 (443)
                             ...++||||++|.+|.++..      +++    ....+++.+|..||   ..|++|||+||+||+++.+| ++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                   35789999999999987642      222    24568999999999   88999999999999999988 99


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT  337 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt  337 (443)
                      |+|||..........                -..++....|+.++|||+||+++..+..
T Consensus       175 liDfg~~~~~~e~~a----------------~d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        175 IIDLSGKRCTAQRKA----------------KDRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEECCCcccccchhh----------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence            999998765532210                0013344467789999999999886643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=9e-23  Score=185.06  Aligned_cols=143  Identities=19%  Similarity=0.169  Sum_probs=111.4

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCccc------------------------HHHHHHHHHHHHhcCCcce
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS------------------------GAEFQSEIRTLAQVEHLNL  195 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~~~~~~Ei~~l~~l~h~ni  195 (443)
                      ...||+|+||.||+|.+.+|+.||||+++........                        ...+.+|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4579999999999999878999999998765321110                        1223578999999999887


Q ss_pred             eeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcCC
Q 013401          196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       196 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~~  274 (443)
                      .....+...  ..++||||++|+++...+.  ....++......++.|++.+|.+||   . +||+||||||+|||++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            544443332  2489999999886544322  2345778888999999999999999   6 8899999999999999 7


Q ss_pred             CceEEeeecccccccc
Q 013401          275 FRAKVADFGFARLAAD  290 (443)
Q Consensus       275 ~~vkl~DFGla~~~~~  290 (443)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.3e-22  Score=182.95  Aligned_cols=192  Identities=17%  Similarity=0.138  Sum_probs=141.3

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEcccccc--CcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEeec
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      +...|+.|+||+||++.. ++..++.+.+.....  .......+.+|+++|++|. |++|++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            455799999999997766 577777776654322  1111235789999999995 5889999886    4579999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDI-KSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl-kp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      .|.+|.+.+..         ....++.|++.+|.+||   .+||+|||| ||+|||++.++.++|+|||++.........
T Consensus        81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99998654321         12357789999999999   888999999 799999999999999999999855432210


Q ss_pred             ----c----ccccc-cccCCCCccCccccccC-CCC-CchhHHHHHHHHHHHHcCCCCCCCchh
Q 013401          295 ----A----THVST-QVKGTAGYLDPEYLKTY-QLT-EKSDVYSFGVLLVELVTGRRPIEPKRE  347 (443)
Q Consensus       295 ----~----~~~~~-~~~gt~~y~aPE~l~~~-~~~-~~sDiwSlGvll~elltG~~Pf~~~~~  347 (443)
                          .    .+... ....++.|++|+...-. ..+ ...++++.|+-+|.++|+..++...++
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                0    00000 12368889999865322 233 567999999999999999999876654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-22  Score=184.63  Aligned_cols=247  Identities=19%  Similarity=0.332  Sum_probs=189.0

Q ss_pred             ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcH
Q 013401          141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL  220 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L  220 (443)
                      -+|.+...|..|+|++..+ .+++|+++..........+|..|.-.|+-+.||||+.++++|....++.++..||+.|+|
T Consensus       196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            3689999999999999844 456687766555555567788999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe-cCCCCCCEEEcCCCceEEeeecccccccccCCCccccc
Q 013401          221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH-RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS  299 (443)
Q Consensus       221 ~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH-rDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~  299 (443)
                      +..|....+-..+..++.+++.+++.|+.|||++.  .++- --|....++||++.+.+|. .+-.++...        .
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfq--------e  343 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ--------E  343 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeee--------c
Confidence            99998777777888999999999999999999753  3443 3678889999999887763 222222111        0


Q ss_pred             ccccCCCCccCccccccCCCC---CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          300 TQVKGTAGYLDPEYLKTYQLT---EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       300 ~~~~gt~~y~aPE~l~~~~~~---~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      ....-.|.||+||.+...+-+   .++|+|||+++||||.|...||.+..+.+--..+.           .+-+...++.
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----------leglrv~ipp  412 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----------LEGLRVHIPP  412 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------hccccccCCC
Confidence            111246789999999765533   47899999999999999999998877644322221           1111111111


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                           .....+.+|+.-|++.||.+||.+..++-+|..+
T Consensus       413 -----gis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  413 -----GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             -----CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                 2346689999999999999999999999888765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=3.8e-22  Score=188.88  Aligned_cols=234  Identities=20%  Similarity=0.265  Sum_probs=148.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCC----------cceeeeeeeee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEH----------LNLVKFHGYLE  203 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h----------~niv~l~~~~~  203 (443)
                      .+.....||.|+|+.||.+++. +|+.+|||++.... ......+++++|......+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3445568999999999999987 69999999864332 223345667666655544322          12222222221


Q ss_pred             ---------ecC--------eEEEEEeecCCCcHHHHHhh---hcC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 013401          204 ---------FED--------ERIVIVEYVPNGTLREHLDC---LQG--NILDLAGRLDIAIDVAHAITYLHMYTDHPIIH  261 (443)
Q Consensus       204 ---------~~~--------~~~lv~E~~~gg~L~~~l~~---~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  261 (443)
                               ...        +.+++|+-+ -++|.+++..   ...  ..+....++.+..|+++.+++||   ..|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     111        235667766 4678776542   121  22445556678899999999999   788999


Q ss_pred             cCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCcccccc--------CCCCCchhHHHHHHHHH
Q 013401          262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT--------YQLTEKSDVYSFGVLLV  333 (443)
Q Consensus       262 rDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDiwSlGvll~  333 (443)
                      +||||+|||++.+|.++|+||+.........      .. ...+..|.+||....        ..++.+.|.|+||++||
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY------RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEE------EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCcee------ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            9999999999999999999999876544321      11 235678999998743        25788999999999999


Q ss_pred             HHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCC
Q 013401          334 ELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNR  402 (443)
Q Consensus       334 elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R  402 (443)
                      .|++|..||..........   |                  ...... ..++.+..||..+|+.||.+|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~---~------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPE---W------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSG---G------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCcccccc---c------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999998654321100   0                  011112 456889999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=5.3e-23  Score=216.07  Aligned_cols=246  Identities=23%  Similarity=0.255  Sum_probs=177.3

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHH---HHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEF---QSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~---~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +|...+.||.+.|=+|.+|+++.|. |+||++-+.. +......+   ..|++ ...++|||.+++.-+...+..-|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~-p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQD-PTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccC-CCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            5667778999999999999999887 8899875542 12233333   34555 55568999999998887788888888


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      +|+. -+|+|.|.  .+..+...+.+-|+.||+.||.-+|   ..||+|+|||.|||||+.=.=+.|+||.--+-..-++
T Consensus       101 qyvk-hnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHHh-hhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            8884 48998885  3445677777789999999999999   8889999999999999987678999998654322221


Q ss_pred             CCc---ccccccccCCCCccCcccccc----------CC-CCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH----
Q 013401          293 SGA---THVSTQVKGTAGYLDPEYLKT----------YQ-LTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERIT----  353 (443)
Q Consensus       293 ~~~---~~~~~~~~gt~~y~aPE~l~~----------~~-~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~----  353 (443)
                      .++   ...+.+-..-.+|+|||.+..          .. .+++.||||+||++.||++ |++||.-..-..-+..    
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            111   111222233457999998732          12 5678999999999999998 7999864322111100    


Q ss_pred             HHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013401          354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEI  411 (443)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~  411 (443)
                      ....+..+.                     ...+++|+..|++.||.+|.++++.|+.
T Consensus       255 ~e~~Le~Ie---------------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKIE---------------------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHhCc---------------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            001111111                     1358899999999999999999999987

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.1e-21  Score=174.69  Aligned_cols=136  Identities=21%  Similarity=0.254  Sum_probs=103.5

Q ss_pred             CCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-----CCcceeeeeeeeeecC---eEE
Q 013401          138 SPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-----EHLNLVKFHGYLEFED---ERI  209 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---~~~  209 (443)
                      .....||+|+||.||. .-.++.. +||++....  ......+.+|+.+++.+     .||||++++++++++.   .++
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            3456899999999996 2224444 688876532  22346789999999999     5799999999998874   434


Q ss_pred             -EEEee--cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCCEEEcCC----CceEEee
Q 013401          210 -VIVEY--VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAI-TYLHMYTDHPIIHRDIKSSNILLTEN----FRAKVAD  281 (443)
Q Consensus       210 -lv~E~--~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivHrDlkp~NILl~~~----~~vkl~D  281 (443)
                       +|+||  +.+++|.+++..   ..+++.  ..++.+++.++ +|||   +++||||||||+|||++..    +.++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence             78999  557999999953   235555  34577777777 9999   8889999999999999743    3799999


Q ss_pred             eccc
Q 013401          282 FGFA  285 (443)
Q Consensus       282 FGla  285 (443)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5533

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=1.6e-21  Score=204.81  Aligned_cols=228  Identities=22%  Similarity=0.277  Sum_probs=157.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|+.++.|-.|+||.||+++++ +.+.+|+|+=+++..       +++   +|..-..|.+|                 
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-------lRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-------LRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccchh-------hhc---cccccCCccee-----------------
Confidence            47889999999999999999987 577788854333211       111   22222344433                 


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                          |+-...+..  -+.++..        ++.+++|||   ..||+|||+||+|.||+.-|++|+.|||+++.......
T Consensus       136 ----gDc~tllk~--~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ----GDCATLLKN--IGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ----chhhhhccc--CCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence                222222321  1233332        377899999   77799999999999999999999999999875322111


Q ss_pred             C-----------cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          294 G-----------ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       294 ~-----------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      .           ......+++|||.|.|||++.-+.|+..+|+|+||+|+||++.|..||.+..+....-.+....-.+.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence            0           01123467999999999999999999999999999999999999999998865433221111111111


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHhhhhhhhh
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRP---SMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP---s~~ell~~l~~i~~~~~~  421 (443)
                      ++               ......++.+++.++|+.+|..|.   ..-++.+|-+...-||+.
T Consensus       279 E~---------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~  325 (1205)
T KOG0606|consen  279 EE---------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS  325 (1205)
T ss_pred             cc---------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence            11               111236789999999999999994   556777777777777773

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=4.2e-20  Score=197.66  Aligned_cols=198  Identities=22%  Similarity=0.288  Sum_probs=158.0

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC---CcceeeeeeeeeecCe
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE---HLNLVKFHGYLEFEDE  207 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~  207 (443)
                      ......|.+...||+|+||+||+|...+|+.||+|+-+....=+     |.--.+++.+|+   -+-|..+..++...+.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            33455678888999999999999998889999999876543211     111122333333   3456667777777888


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------CCceEEe
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-------NFRAKVA  280 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-------~~~vkl~  280 (443)
                      .+||+||.+.|+|.+++.  ..+.+++.....++.|++..|+.||   .++|||+||||+|+||..       .-.++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            999999999999999998  6677999999999999999999999   888999999999999953       3459999


Q ss_pred             eecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 013401          281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRR  340 (443)
Q Consensus       281 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~  340 (443)
                      |||-+.-+.....+  ......++|-.+--+|+..|..|+..+|.|.|+.+++-||-|+.
T Consensus       844 DfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99998644322211  34566788999999999999999999999999999999999853

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=2.7e-20  Score=174.27  Aligned_cols=149  Identities=14%  Similarity=0.129  Sum_probs=113.4

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEE--EcCCcEEEEEEccccccCcc----------------------cHHHHHHHHHH
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGR--LEDGTIVAIKRAKKSVYDKH----------------------SGAEFQSEIRT  186 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~~~----------------------~~~~~~~Ei~~  186 (443)
                      ...+.-|.+...||+|+||.||+|.  ..+|+.||||+++.......                      ....+.+|+.+
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3334458888999999999999998  45899999999875432100                      11235689999


Q ss_pred             HHhcCCc--ceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecC
Q 013401          187 LAQVEHL--NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP-IIHRD  263 (443)
Q Consensus       187 l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivHrD  263 (443)
                      +..+.+.  .+.+++++    ...++||||+.|++|...+.  ....+.......++.||+.+|.+||   .+| |+|+|
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~D  174 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGD  174 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCC
Confidence            9999753  23344432    23589999999988866542  2334566667789999999999999   899 99999


Q ss_pred             CCCCCEEEcCCCceEEeeeccccccc
Q 013401          264 IKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       264 lkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      |||+||+++ ++.++|+|||++....
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999 8899999999987544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.7e-19  Score=166.11  Aligned_cols=136  Identities=21%  Similarity=0.368  Sum_probs=112.8

Q ss_pred             ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcc------cHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH------SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +.||+|++|.||+|.. +|..++||+.........      ....+.+|+.++..+.|++|+....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4799999999999987 577799997654322111      124577899999999999988777777778889999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      ++|++|.+++....     . .+..++.+++.+|.+||   ..+++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886321     1 67889999999999999   88899999999999999 78999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.8e-19  Score=164.51  Aligned_cols=148  Identities=20%  Similarity=0.168  Sum_probs=113.8

Q ss_pred             HHHHHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCc--------------------ccHHHHHHHHHH
Q 013401          127 MEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK--------------------HSGAEFQSEIRT  186 (443)
Q Consensus       127 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------~~~~~~~~Ei~~  186 (443)
                      ..++.+....|...+.||+|+||.||++...+|+.||||++.......                    .....+.+|+.+
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            345555655688888999999999999998889999999865432100                    011235678999


Q ss_pred             HHhcCCcc--eeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 013401          187 LAQVEHLN--LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDI  264 (443)
Q Consensus       187 l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl  264 (443)
                      +..+.|++  ++..++    ....++||||++|++|.+....        .....++.+++.++.++|   ..||+|+||
T Consensus        87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl  151 (198)
T cd05144          87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDL  151 (198)
T ss_pred             HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCC
Confidence            99987774  444443    2456899999999998764320        234578899999999999   788999999


Q ss_pred             CCCCEEEcCCCceEEeeeccccccc
Q 013401          265 KSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       265 kp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      ||+||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=6.7e-21  Score=188.10  Aligned_cols=181  Identities=29%  Similarity=0.379  Sum_probs=133.6

Q ss_pred             CeEEEEEeecCCCcHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          206 DERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      .++||.|++|.-.+|.+||.. ......++...+.++.|++.+++|      ++.+|||+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            357899999999999999963 234456777888999999999999      5699999999999999999999999999


Q ss_pred             cccccccCCC--cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhc
Q 013401          285 ARLAADTESG--ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       285 a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      ..........  .....+..+||..||+||.+.+..|+.++|||+||+||+||+. =..+|+...          ....+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence            8766544311  1122356689999999999999999999999999999999998 333332211          12223


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                      .++.+....-.          -..+-..|++++|.+.|.+||++.+..-+.
T Consensus       473 r~g~ip~~~~~----------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~  513 (516)
T KOG1033|consen  473 RDGIIPPEFLQ----------DYPEEYTLLQQLLSPSPEERPSAIEVALHE  513 (516)
T ss_pred             hcCCCChHHhh----------cCcHHHHHHHHhcCCCcccCchHHHHhhhh
Confidence            33332211000          012356799999999999999655554443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.8e-19  Score=181.00  Aligned_cols=220  Identities=28%  Similarity=0.413  Sum_probs=162.2

Q ss_pred             HHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 013401          187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKS  266 (443)
Q Consensus       187 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp  266 (443)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++--...++.+|+.||.|||.  +....|+.|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            4578999999999999999999999999999999999975 45567777778899999999999994  33449999999


Q ss_pred             CCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccC---C----CCCchhHHHHHHHHHHHHcCC
Q 013401          267 SNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY---Q----LTEKSDVYSFGVLLVELVTGR  339 (443)
Q Consensus       267 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~----~~~~sDiwSlGvll~elltG~  339 (443)
                      .|+++|....+||.|||+........  .........-..-|.|||.+.+.   .    .+.+.||||||++++|+++..
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~--~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETA--EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccc--cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999987764310  00011111234469999999663   1    466799999999999999999


Q ss_pred             CCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          340 RPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       340 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      -||...........+......    .....+.|.+..   ..+..+.+..++.+||..+|..||++..+-..+..+.+.
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~----~~~~~~rP~i~~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK----GGSNPFRPSIEL---LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCChHHHHHHHHh----cCCCCcCcchhh---hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            999764332222111111111    111112222221   113445799999999999999999999999988877664

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.3e-19  Score=161.93  Aligned_cols=133  Identities=20%  Similarity=0.351  Sum_probs=106.5

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEEccccccCcc------cHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH------SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      .||+|+||.||+|.+ +|..++||+.........      ...++.+|++++..+.|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 467899998654322111      1355778999999998887655555555677789999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      +|++|.+++....  .       .++.+++.+|.+||   ..+++|+|++|.||+++ ++.++|+|||++...
T Consensus        80 ~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN--D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH--H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998875311  1       78899999999999   88899999999999999 789999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=7.3e-19  Score=184.14  Aligned_cols=140  Identities=23%  Similarity=0.374  Sum_probs=112.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEE-ccccccCc-----ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKR-AKKSVYDK-----HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~-~~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      ...|...+.||+|+||+||+|.+.+.. +++|+ +.+.....     ...+.+.+|+++++.++|++++..+.++...+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345567789999999999999876443 44443 22211111     123567899999999999999888777777778


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||++|++|.+++.          ....++.+++.+|.+||   .++++||||||+|||+ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999998885          34678999999999999   8889999999999999 577899999999865


Q ss_pred             c
Q 013401          288 A  288 (443)
Q Consensus       288 ~  288 (443)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            3

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=9.3e-19  Score=166.85  Aligned_cols=209  Identities=23%  Similarity=0.303  Sum_probs=143.1

Q ss_pred             CCcceeeeeeeeee---------------------------cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHH
Q 013401          191 EHLNLVKFHGYLEF---------------------------EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID  243 (443)
Q Consensus       191 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~  243 (443)
                      .|||||++.++|.+                           ...+|+||... ..+|++++..   +..+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHH
Confidence            59999999887643                           22468888877 4689999863   33555666778999


Q ss_pred             HHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCC--ceEEeeecccccccccCCCccccc--ccccCCCCccCccccccC
Q 013401          244 VAHAITYLHMYTDHPIIHRDIKSSNILLT--ENF--RAKVADFGFARLAADTESGATHVS--TQVKGTAGYLDPEYLKTY  317 (443)
Q Consensus       244 i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~--~vkl~DFGla~~~~~~~~~~~~~~--~~~~gt~~y~aPE~l~~~  317 (443)
                      +++|+.|||   .+||.|||||.+||||.  +|+  .+.|+|||.+-.-....-.....+  ...-|....||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   99999999999999994  333  488999998733222111111111  233588889999997542


Q ss_pred             C------CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHH
Q 013401          318 Q------LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELA  391 (443)
Q Consensus       318 ~------~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li  391 (443)
                      +      .-.++|.|+.|.+.||++....||....+.....      ..+.+.+...+          ...++..+.+|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------r~Yqe~qLPal----------p~~vpp~~rqlV  490 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------RTYQESQLPAL----------PSRVPPVARQLV  490 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------hhhhhhhCCCC----------cccCChHHHHHH
Confidence            2      1247999999999999999999998754421100      11122221111          122446789999


Q ss_pred             HHccCCCCCCCCCHHHHHH----HHHhhhhhhhhh
Q 013401          392 LQCLAPRRQNRPSMRRCAE----ILWSVRKDYREL  422 (443)
Q Consensus       392 ~~cl~~dp~~RPs~~ell~----~l~~i~~~~~~~  422 (443)
                      ...|+.||.+|++..-...    .||....+.+.+
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~  525 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAM  525 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHHHHHhcCchHHHHh
Confidence            9999999999998743333    366655555544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=6.7e-18  Score=152.42  Aligned_cols=139  Identities=18%  Similarity=0.204  Sum_probs=98.8

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHH----------------------HHHHHHHHHhcCCc--ce
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE----------------------FQSEIRTLAQVEHL--NL  195 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~----------------------~~~Ei~~l~~l~h~--ni  195 (443)
                      .+.||+|+||+||+|.+.+++.||||+++...........                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4579999999999999888999999987654321111111                      13566666666433  24


Q ss_pred             eeeeeeeeecCeEEEEEeecCCCcHHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcC
Q 013401          196 VKFHGYLEFEDERIVIVEYVPNGTLREH-LDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTE  273 (443)
Q Consensus       196 v~l~~~~~~~~~~~lv~E~~~gg~L~~~-l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~  273 (443)
                      .+.++.    ...++||||++|+.+... +....   .. .....++.+++.++.++|   . ++|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence            444443    246899999998544321 11111   11 556789999999999999   6 8899999999999999 


Q ss_pred             CCceEEeeecccccccc
Q 013401          274 NFRAKVADFGFARLAAD  290 (443)
Q Consensus       274 ~~~vkl~DFGla~~~~~  290 (443)
                      ++.++|+|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            88999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=2.7e-17  Score=141.87  Aligned_cols=135  Identities=21%  Similarity=0.224  Sum_probs=113.3

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC--cceeeeeeeeeecCeEEEEEeecC
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH--LNLVKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~  216 (443)
                      +.+.||+|.++.||++...+ ..++||.......    ...+.+|+.++..+.|  .++++++.+....+..+++|||+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            34679999999999999864 7799998865422    4678899999999976  589999998888888999999999


Q ss_pred             CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          217 NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       217 gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      |+.+..+         +......++.+++.+|.+||.....+++|+||+|+|||++.++.++++|||++..
T Consensus        77 g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8877543         4455677899999999999965446899999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=8.4e-17  Score=150.95  Aligned_cols=137  Identities=20%  Similarity=0.203  Sum_probs=105.2

Q ss_pred             ceee-eeCceEEEEEEEcCCcEEEEEEcccccc-----------CcccHHHHHHHHHHHHhcCCcce--eeeeeeeeecC
Q 013401          141 FKIG-QGGFGTVYKGRLEDGTIVAIKRAKKSVY-----------DKHSGAEFQSEIRTLAQVEHLNL--VKFHGYLEFED  206 (443)
Q Consensus       141 ~~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~~  206 (443)
                      ..|| .|+.|+||.+... +..++||++.....           .......+.+|+.++..|.|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            3688 8999999999885 67789998754210           11233567899999999988775  66676644332


Q ss_pred             ----eEEEEEeecCC-CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEee
Q 013401          207 ----ERIVIVEYVPN-GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD  281 (443)
Q Consensus       207 ----~~~lv~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~D  281 (443)
                          ..++|||+++| .+|.+++..   ..+++.    .+.+|+.+|.+||   .+||+||||||+|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence                23599999997 688888753   334443    3578999999999   89999999999999999988999999


Q ss_pred             ecccccc
Q 013401          282 FGFARLA  288 (443)
Q Consensus       282 FGla~~~  288 (443)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9988653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=8.2e-19  Score=183.86  Aligned_cols=265  Identities=22%  Similarity=0.257  Sum_probs=196.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEc--CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE--DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .|.....||+|.|+.|-.....  ....+|+|.+...............|..+-+.+. |.|++.+++.....+..++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4666667999999999888753  3556677766544323334455566888888887 999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeeccccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFARLAADT  291 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~  291 (443)
                      ++..|+++++-+........+....-.++.|+..++.|+|.  ..++.||||||+|.+++..+ .+++.|||+|..+..-
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999988832122145555566789999999999994  45699999999999999999 9999999999877652


Q ss_pred             CCCcccccccccC-CCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          292 ESGATHVSTQVKG-TAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       292 ~~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                       .+........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+........ ....|.....        
T Consensus       179 -~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~~--------  248 (601)
T KOG0590|consen  179 -NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNKG--------  248 (601)
T ss_pred             -CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeeccccc--------
Confidence             112223344568 9999999999874 456789999999999999999999875543221 1111111110        


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                          ...............+++.+++..+|..|.+.+++....|-..
T Consensus       249 ----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  249 ----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ----ccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                0000111123356888999999999999999999999999776

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=4e-16  Score=157.16  Aligned_cols=254  Identities=22%  Similarity=0.247  Sum_probs=189.8

Q ss_pred             CCCCCceeee--eCceEEEEEEE--c-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEE
Q 013401          136 NFSPSFKIGQ--GGFGTVYKGRL--E-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       136 ~f~~~~~LG~--G~fg~Vy~~~~--~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~  209 (443)
                      .|.....+|.  |.+|.||.+..  . ++..+|+|+-+...........=.+|+...+.++ |+|.++.+..|+..+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4667778999  99999999976  3 6889999985554433344444457888888885 999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCCEEEcCC-CceEEeeecc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH----AITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGF  284 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGl  284 (443)
                      +.+|+| +.+|..+... ....++....+.+..+...    ||.++|   ..+++|-|+||.||++..+ ...+++|||+
T Consensus       195 iqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            999999 5788887764 3455788888999999999    999999   8889999999999999999 8899999999


Q ss_pred             cccccccCCC-cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCc-hhHHHHHHHHHHhhhcC
Q 013401          285 ARLAADTESG-ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK-RELKERITVKWAMKKFS  362 (443)
Q Consensus       285 a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~-~~~~~~~~~~~~~~~~~  362 (443)
                      ...+.+.... ...+.....|...|++||.+.+ -++...|||+||.++.+..++....-.. ..       .|  ..+.
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W--~~~r  339 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-------SW--SQLR  339 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cc--cccc
Confidence            9888776522 2222333468889999999987 6788999999999999999877654322 11       01  0000


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ...   +-+..      -..-...+..++..|+..+|..|++.+.+..+..
T Consensus       340 ~~~---ip~e~------~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~  381 (524)
T KOG0601|consen  340 QGY---IPLEF------CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNV  381 (524)
T ss_pred             ccc---Cchhh------hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccc
Confidence            000   00000      0011234555899999999999999988776654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=9.4e-15  Score=148.67  Aligned_cols=142  Identities=18%  Similarity=0.238  Sum_probs=99.4

Q ss_pred             ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcc------------------------c--------------HHHHHH
Q 013401          141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH------------------------S--------------GAEFQS  182 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------~--------------~~~~~~  182 (443)
                      +.||.|++|.||+|++++|+.||||+.+.......                        .              .-++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            46999999999999999999999999765421100                        0              012445


Q ss_pred             HHHHHHhc----CCcceeeeeee-eeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHHHhhcCC
Q 013401          183 EIRTLAQV----EHLNLVKFHGY-LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH-AITYLHMYTD  256 (443)
Q Consensus       183 Ei~~l~~l----~h~niv~l~~~-~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~  256 (443)
                      |...+.++    .|.+-|.+-.+ +......++||||++|++|.++...... ..   .+..++..++. .+..+|   .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence            55555554    23322333222 2334567999999999999887643211 12   23456666665 467788   8


Q ss_pred             CCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       257 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      .|++|+|++|.||+++.++.++|+|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            889999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=4e-15  Score=139.17  Aligned_cols=210  Identities=22%  Similarity=0.296  Sum_probs=145.5

Q ss_pred             HHHHHHhcCCcceeeeeeeeeecC-----eEEEEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 013401          183 EIRTLAQVEHLNLVKFHGYLEFED-----ERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYT  255 (443)
Q Consensus       183 Ei~~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~  255 (443)
                      -...|-++.|.|||+++.||.+..     +..++.|||.-|+|..+|.+.  .+..+......+|+.||+.||.|||++ 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            344566678999999999986543     578999999999999999754  345577777789999999999999987 


Q ss_pred             CCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHH
Q 013401          256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVEL  335 (443)
Q Consensus       256 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~el  335 (443)
                      +..|+|+++...-|++..+|-+||+--.....................|-++|.+||.-...+.+.++|||+||...++|
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            47899999999999999999888743221111000000000011123478899999998777788899999999999999


Q ss_pred             HcCCCC-CCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          336 VTGRRP-IEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       336 ltG~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .-|..- -...........+...+....+                     ..-..++.+|++..|..||+|++++.|+-.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~len---------------------~lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIGLEN---------------------GLQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheeeccC---------------------ccccCcCcccccCCCCCCcchhhhhcCcee
Confidence            887643 2111111111111111111111                     113468899999999999999999998643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=2.8e-15  Score=151.07  Aligned_cols=251  Identities=23%  Similarity=0.257  Sum_probs=190.1

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc--CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE--DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~  209 (443)
                      ...+|..+..||.|.|+.|+.+..+  ++..|++|.+.+..........-..|+.+...+. |.+++.++..|...++.|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3446888889999999999998754  6899999999888766665555567888888885 999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CceEEeeecccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLA  288 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~  288 (443)
                      +-.|||+++++...+.  .-..+++..++.+..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||....+
T Consensus       343 ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             CchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            9999999998876663  3456888889999999999999999   8889999999999999876 78999999987532


Q ss_pred             cccCCCcccccccccCCCCcc--CccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          289 ADTESGATHVSTQVKGTAGYL--DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .-.       .....++.++.  +++......+..+.|+++||..+.+.++|.+--+....        |  ..+..+..
T Consensus       418 ~~~-------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~--~~i~~~~~  480 (524)
T KOG0601|consen  418 AFS-------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S--LTIRSGDT  480 (524)
T ss_pred             cee-------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c--eeeecccc
Confidence            211       11112333344  56666778889999999999999999998754322211        0  01111111


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                           ++      .....+.+..+...++.+|+..||.+.++..+...++
T Consensus       481 -----p~------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  481 -----PN------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -----cC------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                 11      1112266888999999999999999999888776554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=1.9e-14  Score=148.31  Aligned_cols=149  Identities=16%  Similarity=0.209  Sum_probs=95.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC-CcEEEEEEccccccCc--------------------------------ccHH---
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDK--------------------------------HSGA---  178 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~--------------------------------~~~~---  178 (443)
                      ..|+. ..||.|++|.||+|++++ |+.||||+.+......                                +...   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 689999999999999987 9999999987542100                                0011   


Q ss_pred             ---HHHHHHHHHHhc----CCcceeeeeeeee-ecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHH-HH
Q 013401          179 ---EFQSEIRTLAQV----EHLNLVKFHGYLE-FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHA-IT  249 (443)
Q Consensus       179 ---~~~~Ei~~l~~l----~h~niv~l~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~-L~  249 (443)
                         ++.+|...+.++    .+.+.|.+-.++. .....++||||+.|+.|.+.... .....+..   .++...+.. +.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~---~la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMK---LLAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHH---HHHHHHHHHHHH
Confidence               134444444444    2333344433332 25567899999999999774221 11112211   222222221 22


Q ss_pred             HHhhcCCCCeEecCCCCCCEEEcCCC----ceEEeeeccccccccc
Q 013401          250 YLHMYTDHPIIHRDIKSSNILLTENF----RAKVADFGFARLAADT  291 (443)
Q Consensus       250 ~LH~~~~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~~~~  291 (443)
                      -+.   ..|++|+|+||.||+++.+|    .++++|||++..+.+.
T Consensus       275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            334   67899999999999999888    9999999999876543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.2e-13  Score=120.64  Aligned_cols=127  Identities=15%  Similarity=0.181  Sum_probs=94.0

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCccee-eeeeeeeecCeEEEEEeecCCC
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV-KFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .+.|+.|.++.||++... +..|++|.......   ....+.+|+.+++.+.+.+++ +++...  .+..++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            346899999999999876 67899998764321   123467899999988655544 444433  33458999999998


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP-----IIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ++.+.       ..   ....++.+++.+|..||   ..+     ++|+|++|.||+++ ++.++|+|||.+.
T Consensus        77 ~l~~~-------~~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE-------DF---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc-------cc---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            87542       01   11245678999999999   555     59999999999999 6689999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=9.3e-13  Score=134.31  Aligned_cols=166  Identities=19%  Similarity=0.242  Sum_probs=127.0

Q ss_pred             EcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHH
Q 013401          156 LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA  235 (443)
Q Consensus       156 ~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~  235 (443)
                      ..++.+|.|+..+...  ......+.+.++.|+.++||||+++++.++.++..|||.|-+  ..|..++....     ..
T Consensus        34 k~~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KE  104 (690)
T ss_pred             eccCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HH
Confidence            3478889998887653  234456788999999999999999999999999999999998  46777775432     45


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccc
Q 013401          236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK  315 (443)
Q Consensus       236 ~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  315 (443)
                      .....+.||+.||.|||.  +++++|++|.-.-|+|+..|..||++|.++........    .....+---.|..|+.+.
T Consensus       105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhcC
Confidence            566678999999999985  77899999999999999999999999998865443221    001111222355666544


Q ss_pred             cCCCCCchhHHHHHHHHHHHHcC
Q 013401          316 TYQLTEKSDVYSFGVLLVELVTG  338 (443)
Q Consensus       316 ~~~~~~~sDiwSlGvll~elltG  338 (443)
                      ...  -..|.|.|||++++++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            322  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=1.8e-12  Score=116.92  Aligned_cols=138  Identities=14%  Similarity=0.174  Sum_probs=99.0

Q ss_pred             ceeeeeCceEEEEEEEcC-------CcEEEEEEcccccc-----------C---------cccHHHHH----HHHHHHHh
Q 013401          141 FKIGQGGFGTVYKGRLED-------GTIVAIKRAKKSVY-----------D---------KHSGAEFQ----SEIRTLAQ  189 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~-----------~---------~~~~~~~~----~Ei~~l~~  189 (443)
                      ..||.|--+.||.|...+       +..+|||+.+....           +         ......+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            469999999999998553       47899997654210           0         01112233    89999999


Q ss_pred             cC--CcceeeeeeeeeecCeEEEEEeecCCCcHHH-HHhhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCC
Q 013401          190 VE--HLNLVKFHGYLEFEDERIVIVEYVPNGTLRE-HLDCLQGNILDLAGRLDIAIDVAHAITYL-HMYTDHPIIHRDIK  265 (443)
Q Consensus       190 l~--h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivHrDlk  265 (443)
                      +.  .-++...+++    ...+|||||+.+..+.. .+   ....++......+..+++.+|..| |   ..|+||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            85  3566666654    46789999997654422 12   222345555667888999999998 8   7889999999


Q ss_pred             CCCEEEcCCCceEEeeeccccccc
Q 013401          266 SSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       266 p~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +.|||+++ +.+.|+|||.+....
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCceeCC
Confidence            99999974 689999999886553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.40  E-value=5.5e-14  Score=148.79  Aligned_cols=268  Identities=17%  Similarity=0.181  Sum_probs=185.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccc-ccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +.|.+.+-+-.|.|+.++.+.-. .|...++|..+.. .......+...++-.++-...+|-++....-+......++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            34666667889999999988644 4555566654322 122233344445555555556787777666666677889999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc-
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT-  291 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-  291 (443)
                      +|+.|++|...+...  ...+.......+..+..+++|||   ...++|+|++|.|+|+..+|..++.|||........ 
T Consensus       884 ~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             HHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            999999998888643  23444445555667889999999   666999999999999999999999999954321110 


Q ss_pred             --------------------CCCcc------cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCc
Q 013401          292 --------------------ESGAT------HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK  345 (443)
Q Consensus       292 --------------------~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~  345 (443)
                                          .....      .......||+.|.+||.+.+......+|+|++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                00000      1122357999999999999999999999999999999999999999887


Q ss_pred             hhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHhhhhhhhhh
Q 013401          346 RELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMR---RCAEILWSVRKDYREL  422 (443)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~---ell~~l~~i~~~~~~~  422 (443)
                      ........       +.        ...+.......+..+...+++...+..+|.+|..+.   ++..|.+.---+|.-+
T Consensus      1039 tpq~~f~n-------i~--------~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1039 TPQQIFEN-------IL--------NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred             chhhhhhc-------cc--------cCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence            65432211       11        111112222233446788999999999999998887   7777766544444443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1.1e-11  Score=108.50  Aligned_cols=133  Identities=23%  Similarity=0.325  Sum_probs=99.5

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEE-ccccccCcccHH-----HHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKR-AKKSVYDKHSGA-----EFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~-~~~~~~~~~~~~-----~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      .|++|+-+.+|.+.+.+ ..+.+|. +++....+..-+     +-.+|..+|..+.--.|..-+=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            58899999999997753 3466664 555444443333     3457889998876444433333445677788999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      +|..|.+++...         ...++..|-..+.-||   ..||||+||.++||++..+. +.++||||+.+.
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999998743         2456777888888999   89999999999999998764 999999998654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=1.3e-11  Score=114.02  Aligned_cols=143  Identities=20%  Similarity=0.230  Sum_probs=108.0

Q ss_pred             ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC--cceeeeeeeeeec---CeEEEEEeec
Q 013401          141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH--LNLVKFHGYLEFE---DERIVIVEYV  215 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~---~~~~lv~E~~  215 (443)
                      ..|+.|.++.||++...+|..|++|........ .....+.+|+.+++.+.+  .++.+++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            468999999999998877788999987654221 234567899999999965  4456677776553   3668999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT----------------------------------------  255 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  255 (443)
                      +|.+|.+.+..   ..++......++.+++.+|..||...                                        
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99888665421   34666677778888888888888431                                        


Q ss_pred             -------------CCCeEecCCCCCCEEEcC--CCceEEeeeccccc
Q 013401          256 -------------DHPIIHRDIKSSNILLTE--NFRAKVADFGFARL  287 (443)
Q Consensus       256 -------------~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~  287 (443)
                                   ...++|+|+.|.|||++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.29  E-value=5.8e-11  Score=103.50  Aligned_cols=146  Identities=23%  Similarity=0.289  Sum_probs=106.6

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEE-ccccccCcc-----cHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKR-AKKSVYDKH-----SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~-~~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+..|-||+-+.|+++.+. |+.+.||. +.+....+.     ...+..+|.++|.++.--.|.--.=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4557889999999999886 77777774 444332222     2234568999998886444443333455566668899


Q ss_pred             eecCC-CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---ceEEeeecccccc
Q 013401          213 EYVPN-GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF---RAKVADFGFARLA  288 (443)
Q Consensus       213 E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~  288 (443)
                      ||++| .++.+++...............++..|-+.|.-||   .+++||+||..+||+|..++   .+.++|||++...
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99977 47888886654444444444788999999999999   89999999999999997554   3589999998543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=6.1e-10  Score=105.88  Aligned_cols=141  Identities=16%  Similarity=0.130  Sum_probs=99.0

Q ss_pred             eeeeCceEEEEEEEcCCcEEEEEEccccccCc---------ccHHHHHHHHHHHHhcCC--cceeeeeeeeee-----cC
Q 013401          143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK---------HSGAEFQSEIRTLAQVEH--LNLVKFHGYLEF-----ED  206 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---------~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~-----~~  206 (443)
                      +-.-....|+++.. +|+.|.||+........         .....+.+|...+..|..  -.....+++.+.     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            44334445667665 47789999753322100         111247789999888843  333444555443     23


Q ss_pred             eEEEEEeecCCC-cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-------CCceE
Q 013401          207 ERIVIVEYVPNG-TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-------NFRAK  278 (443)
Q Consensus       207 ~~~lv~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-------~~~vk  278 (443)
                      .-+||+|++++. +|.+++........+......++.+|+..+.-||   .+||+|+|+++.||||+.       ++.+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEE
Confidence            578999999886 8988886433445566677789999999999999   899999999999999985       46899


Q ss_pred             Eeeeccccc
Q 013401          279 VADFGFARL  287 (443)
Q Consensus       279 l~DFGla~~  287 (443)
                      |+||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=5.3e-10  Score=100.47  Aligned_cols=128  Identities=23%  Similarity=0.301  Sum_probs=82.8

Q ss_pred             EEEEEEEcCCcEEEEEEccccccC-----------cc-------------cHHHHHHHHHHHHhcCCc--ceeeeeeeee
Q 013401          150 TVYKGRLEDGTIVAIKRAKKSVYD-----------KH-------------SGAEFQSEIRTLAQVEHL--NLVKFHGYLE  203 (443)
Q Consensus       150 ~Vy~~~~~~g~~vavK~~~~~~~~-----------~~-------------~~~~~~~Ei~~l~~l~h~--niv~l~~~~~  203 (443)
                      .||.|...+|..+|||+.+.....           ..             ......+|...|..+..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389999988999999986542100           00             112356899999999754  566666542 


Q ss_pred             ecCeEEEEEeecC--CCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCCEEEcCCCceEEe
Q 013401          204 FEDERIVIVEYVP--NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY-LHMYTDHPIIHRDIKSSNILLTENFRAKVA  280 (443)
Q Consensus       204 ~~~~~~lv~E~~~--gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivHrDlkp~NILl~~~~~vkl~  280 (443)
                         ..+|||||+.  |..+..+...    .++......++.+++..+.. +|   ..|+||+||.+.|||++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence               4579999998  6555443321    12234455677788885444 67   8889999999999999988 89999


Q ss_pred             eeccccccc
Q 013401          281 DFGFARLAA  289 (443)
Q Consensus       281 DFGla~~~~  289 (443)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=4.5e-09  Score=104.67  Aligned_cols=214  Identities=16%  Similarity=0.209  Sum_probs=147.9

Q ss_pred             eEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee----cCeEEEEEeecCC-CcHHH
Q 013401          149 GTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF----EDERIVIVEYVPN-GTLRE  222 (443)
Q Consensus       149 g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~g-g~L~~  222 (443)
                      .+.|++... ||..|++|++.-..  .........-+++++++.|+|||++.+++..    +..+++|++|.++ ++|.+
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            467999865 89999999983221  1111122356888999999999999998863    4568999999886 57777


Q ss_pred             HHhhh-------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          223 HLDCL-------------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       223 ~l~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +....             .+...++...|.++.|+..||.++|   +.|+..+-|.|.+||++.+.+++|...|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            55321             2345778999999999999999999   8889999999999999999899998888776554


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...           +       |-+.   -..+-|.=.||.+++.|.||..--...+.... .....             
T Consensus       445 ~d~-----------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-s~~~~-------------  489 (655)
T KOG3741|consen  445 EDP-----------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQS-SHLTR-------------  489 (655)
T ss_pred             CCC-----------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHH-HHHHH-------------
Confidence            321           0       1121   12367999999999999998532111111000 00000             


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL  412 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l  412 (443)
                               -...++.++.+++.......+++ -++.+++.+.
T Consensus       490 ---------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  490 ---------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ---------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                     01124456777777777777776 5777776654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=9.3e-11  Score=120.33  Aligned_cols=157  Identities=22%  Similarity=0.256  Sum_probs=109.5

Q ss_pred             HHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccc-----cccCCCCccCcccccc
Q 013401          242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-----QVKGTAGYLDPEYLKT  316 (443)
Q Consensus       242 ~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~-----~~~gt~~y~aPE~l~~  316 (443)
                      .+++.|+.|+|.  +.++||+.|.|++|.++.++.+||+.|+++.....+..-....+.     -..-...|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345699999996  778999999999999999999999999998766543211111111     1124557999999999


Q ss_pred             CCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHcc
Q 013401          317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCL  395 (443)
Q Consensus       317 ~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl  395 (443)
                      ...+.++|+|||||++|.+.. |..-|.............     ...         ...........+.++++=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-----~~~---------~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-----NLL---------NAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-----ccc---------ccccccccccCcHHHHHHHHHHh
Confidence            888999999999999999995 544444332211111100     000         00111112345678999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHh
Q 013401          396 APRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       396 ~~dp~~RPs~~ell~~l~~  414 (443)
                      ..++..||++..+...++.
T Consensus       250 ~~~~~~rp~~~~l~~~~ff  268 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSIPFF  268 (700)
T ss_pred             cCCcccCcchhhhhccccc
Confidence            9999999999888877763

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=3.9e-09  Score=97.88  Aligned_cols=138  Identities=23%  Similarity=0.214  Sum_probs=98.1

Q ss_pred             CCCCceeeeeCceEEEEEEEcCCcEEEEEEccccc-------cC-------------cccHHHHHHHHHHHHhcCCc--c
Q 013401          137 FSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV-------YD-------------KHSGAEFQSEIRTLAQVEHL--N  194 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-------~~-------------~~~~~~~~~Ei~~l~~l~h~--n  194 (443)
                      ..+...||.|--+.||.|....|..+|||.=+...       ..             ........+|.++|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44567899999999999999999999999522110       00             01123367899999998644  6


Q ss_pred             eeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013401          195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       195 iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~  274 (443)
                      |.+.+++    +...+|||+++|-.|...-       ++....-.|+..|+.-+.-+-   ..|+||+|+.+=|||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence            7777664    5678999999997775321       122333345555555555555   5669999999999999999


Q ss_pred             CceEEeeecccccc
Q 013401          275 FRAKVADFGFARLA  288 (443)
Q Consensus       275 ~~vkl~DFGla~~~  288 (443)
                      |.+.++||--+...
T Consensus       239 g~~~vIDwPQ~v~~  252 (304)
T COG0478         239 GDIVVIDWPQAVPI  252 (304)
T ss_pred             CCEEEEeCcccccC
Confidence            99999999866443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=1e-08  Score=94.07  Aligned_cols=124  Identities=26%  Similarity=0.287  Sum_probs=90.9

Q ss_pred             CcEEEEEEcccccc-----CcccHHHHHHHHHHHHhcC--CcceeeeeeeeeecC----eEEEEEeecCCC-cHHHHHhh
Q 013401          159 GTIVAIKRAKKSVY-----DKHSGAEFQSEIRTLAQVE--HLNLVKFHGYLEFED----ERIVIVEYVPNG-TLREHLDC  226 (443)
Q Consensus       159 g~~vavK~~~~~~~-----~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~----~~~lv~E~~~gg-~L~~~l~~  226 (443)
                      ++.|.+|.......     .........+|...+..|.  .-.+.+.+++.+...    ..+||+|+++|. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            55666665322211     1133456778998888874  334555666655432    458999999884 78888864


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---ceEEeeeccccc
Q 013401          227 LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF---RAKVADFGFARL  287 (443)
Q Consensus       227 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~  287 (443)
                      ...  .+......++.+++..+.-||   .+||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       112 ~~~--~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  112 WEQ--LDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hcc--cchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            322  566677789999999999999   88999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.88  E-value=9.7e-08  Score=93.17  Aligned_cols=264  Identities=18%  Similarity=0.220  Sum_probs=161.8

Q ss_pred             CCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceee--------eeeeeeecCeE
Q 013401          138 SPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVK--------FHGYLEFEDER  208 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~--------l~~~~~~~~~~  208 (443)
                      .....||+|+-+.+|-.---.++  +-|+.....  .....   ..+..|... .||-+-.        ++|- ......
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~--VAKIYh~Pp--pa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i   85 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQ--VAKIYHAPP--PAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI   85 (637)
T ss_pred             CCCccccCCccceeeecchhhch--hheeecCCC--chHHH---HHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence            34557999999999965322122  235544331  11111   233334443 4654322        1221 112225


Q ss_pred             EEEEeecCCCc-HHHHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeec
Q 013401          209 IVIVEYVPNGT-LREHLDC----LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFG  283 (443)
Q Consensus       209 ~lv~E~~~gg~-L~~~l~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG  283 (443)
                      -++|..+.|.. +.+++..    ..-....|.-.+.++..|+.+..-||   .+|.+-+|+.++|||+.+++.|.|+|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccc
Confidence            67788887652 3333321    11223678888899999999999999   8889999999999999999999998855


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcC-CCCCCCchh-------HHH
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTG-RRPIEPKRE-------LKE  350 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG-~~Pf~~~~~-------~~~  350 (443)
                      .-..-     .+.......+|.+.|.+||.-.     +..-+...|.|.|||+|++||.| +.||.+..-       .+.
T Consensus       163 sfqi~-----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         163 SFQIN-----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ceeec-----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            33221     1223445567999999999753     45567789999999999999986 899975421       111


Q ss_pred             HHHHHHHhhhcCCC-ccccccCccccchhhcHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          351 RITVKWAMKKFSDG-DAISILDPRVENTAANNLALEKILELALQCLAPR--RQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       351 ~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~d--p~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      .+.    ...+.+. +...-+.+.. ..+...-....+..|..+|+...  +.-||+++-.+..|-.++.+...-
T Consensus       238 ~Ia----~g~f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C  307 (637)
T COG4248         238 DIA----HGRFAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC  307 (637)
T ss_pred             hhh----cceeeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence            111    1111100 0000011111 11112223456778888888764  568999999999999988877764

>PRK09902 hypothetical protein; Provisional

Probab=98.87  E-value=4.8e-08  Score=88.53  Aligned_cols=155  Identities=15%  Similarity=0.123  Sum_probs=107.7

Q ss_pred             HHHHHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccc----cccCcccHHHHHHHHHHHHhcC--Ccceeeeee
Q 013401          127 MEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKK----SVYDKHSGAEFQSEIRTLAQVE--HLNLVKFHG  200 (443)
Q Consensus       127 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~----~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~  200 (443)
                      ++.+......+-..---|.||-+.|+..... |+.|-||+-..    ...-+.-...|.+|+..|..|.  .-.+.+.. 
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-   87 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-   87 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-
Confidence            4444433333333223567888899987765 44688887542    1111345678999999999985  33344444 


Q ss_pred             eee-e----cCeEEEEEeecCC-CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013401          201 YLE-F----EDERIVIVEYVPN-GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       201 ~~~-~----~~~~~lv~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~  274 (443)
                      ++. .    .-.-+||+|-+.| -+|.+++....-...+...+..+..+|+.+|.-||   ..|+.|+|+-+.|||++.+
T Consensus        88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~  164 (216)
T PRK09902         88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTE  164 (216)
T ss_pred             eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCC
Confidence            322 1    1245799998865 57888875433345577777889999999999999   8999999999999999866


Q ss_pred             Cc--eEEeeecccc
Q 013401          275 FR--AKVADFGFAR  286 (443)
Q Consensus       275 ~~--vkl~DFGla~  286 (443)
                      +.  ++++||.-++
T Consensus       165 g~~~v~lIDlEk~r  178 (216)
T PRK09902        165 GKAEAGFLDLEKSR  178 (216)
T ss_pred             CCeeEEEEEhhccc
Confidence            67  9999998654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.79  E-value=2.8e-08  Score=102.28  Aligned_cols=143  Identities=17%  Similarity=0.256  Sum_probs=95.8

Q ss_pred             ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcc------------------------c----H----------HHHHH
Q 013401          141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH------------------------S----G----------AEFQS  182 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------~----~----------~~~~~  182 (443)
                      .-|+.++-|.||+|++++|+.||||+.+.+.....                        .    .          -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            36899999999999999999999998776421100                        0    0          01345


Q ss_pred             HHHHHHhc----C-CcceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHH-HHHHhhcCC
Q 013401          183 EIRTLAQV----E-HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHA-ITYLHMYTD  256 (443)
Q Consensus       183 Ei~~l~~l----~-h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~~  256 (443)
                      |...+.++    + .++|.--.=+++.....+++|||++|..+.+...... ..++.   ..|+..++++ +.-+-   .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q~~---~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQLL---R  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHHHH---h
Confidence            55555444    2 3333322333445677899999999998887743222 33442   3344444443 22232   5


Q ss_pred             CCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       257 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      .|+.|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            6899999999999999999999999999876654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.61  E-value=7.1e-07  Score=83.06  Aligned_cols=138  Identities=15%  Similarity=0.147  Sum_probs=84.3

Q ss_pred             ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCc--ceeeeeeeeeecCeEEEEEeecCCC
Q 013401          141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL--NLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      ..||+|..+.||+.   .|..+++|.....    .....+.+|.++++.+..-  .+.+.+++....+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            36999999999984   2445778877543    2335578999999988633  3467777777778888999999986


Q ss_pred             c-HHHH--------------H----hhhcC---CCCCHHHHH-HHHH----------HHHH-HHHHHhhc-CCCCeEecC
Q 013401          219 T-LREH--------------L----DCLQG---NILDLAGRL-DIAI----------DVAH-AITYLHMY-TDHPIIHRD  263 (443)
Q Consensus       219 ~-L~~~--------------l----~~~~~---~~l~~~~~~-~i~~----------~i~~-~L~~LH~~-~~~~ivHrD  263 (443)
                      . +.+.              +    .....   ......... .+..          .+.. ...+|... ....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 1111              1    10111   011111110 0000          0111 11222211 133578999


Q ss_pred             CCCCCEEEcCCCceEEeeecccc
Q 013401          264 IKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       264 lkp~NILl~~~~~vkl~DFGla~  286 (443)
                      +.|.||++++++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=7.2e-07  Score=82.20  Aligned_cols=155  Identities=20%  Similarity=0.249  Sum_probs=100.2

Q ss_pred             cCHHHHHHHhcCCCCCceee---eeCceEEEEEEEcCCcEEEEEEccccccCccc-----------------HHH-----
Q 013401          125 ITMEEIYRATRNFSPSFKIG---QGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS-----------------GAE-----  179 (443)
Q Consensus       125 ~~~~~~~~~~~~f~~~~~LG---~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------~~~-----  179 (443)
                      .+...++...+...+....|   .|--+.||+|...++..+|||+.+........                 ...     
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            35566666666666655555   56666899999888999999987654221111                 001     


Q ss_pred             HHHHHHHHHhcC--CcceeeeeeeeeecCeEEEEEeecCCCcH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 013401          180 FQSEIRTLAQVE--HLNLVKFHGYLEFEDERIVIVEYVPNGTL-REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD  256 (443)
Q Consensus       180 ~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~gg~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  256 (443)
                      ..+|+..|.++.  +-.+.+-+.+.    +-.|||||+...-+ .-.|   ..-.+...+...+..++++.+.-|-.  .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~--~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYK--E  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHH--h
Confidence            245777777763  44444444442    35799999954311 1111   22223333455667777877777662  3


Q ss_pred             CCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       257 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      .++||+||..=|||+. ++.+.|+|||-|....
T Consensus       186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7799999999999999 7789999999886554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=1.7e-06  Score=80.16  Aligned_cols=141  Identities=19%  Similarity=0.239  Sum_probs=82.8

Q ss_pred             ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCc--ceeeeeeee---eecCeEEEEEeec
Q 013401          141 FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL--NLVKFHGYL---EFEDERIVIVEYV  215 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~---~~~~~~~lv~E~~  215 (443)
                      +.|+.|..+.||++...+ ..+++|.....    .....+.+|..+++.+...  .+.+++...   ......+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            479999999999999887 58999986542    3456777899998888522  345566533   2334578999999


Q ss_pred             CCCcHHH----------------HHhhhcC-----CCCCHHHH---------HHH------------HHHHHH-HHHHHh
Q 013401          216 PNGTLRE----------------HLDCLQG-----NILDLAGR---------LDI------------AIDVAH-AITYLH  252 (443)
Q Consensus       216 ~gg~L~~----------------~l~~~~~-----~~l~~~~~---------~~i------------~~~i~~-~L~~LH  252 (443)
                      +|..+..                .+.....     ........         ...            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9987776                1111111     11110000         000            111222 233333


Q ss_pred             h----cCCCCeEecCCCCCCEEEc-CCCceEEeeecccc
Q 013401          253 M----YTDHPIIHRDIKSSNILLT-ENFRAKVADFGFAR  286 (443)
Q Consensus       253 ~----~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~  286 (443)
                      .    .....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    1245699999999999999 66667799999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.52  E-value=1.3e-06  Score=79.61  Aligned_cols=135  Identities=19%  Similarity=0.244  Sum_probs=87.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHH---------HHHHHHHHHHhcC---Ccceeeeeeee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA---------EFQSEIRTLAQVE---HLNLVKFHGYL  202 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~~~Ei~~l~~l~---h~niv~l~~~~  202 (443)
                      .+|...+.+-......|.+-..+ |..+.+|..+...  .....         ...+++..+..+.   -..+..++-+.
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~--~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREEN--RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhh--hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            46777777777776667666654 6788999765432  11111         1234444444443   22223333222


Q ss_pred             -----eecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          203 -----EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       203 -----~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                           ......+++|||++|..|.+...      +++    .++..|.+++.-||   ..|+.|+|..|.|++++.++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-E
Confidence                 22335578999999988876542      222    24566788899999   88999999999999999665 9


Q ss_pred             EEeeecccc
Q 013401          278 KVADFGFAR  286 (443)
Q Consensus       278 kl~DFGla~  286 (443)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=2.5e-06  Score=80.21  Aligned_cols=139  Identities=19%  Similarity=0.150  Sum_probs=84.1

Q ss_pred             eeeeeCc-eEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          142 KIGQGGF-GTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       142 ~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      .|-.|.. ..||+.... +..+.||+.....     ...+.+|+++++.+. +--+.+++++....+..++|||+++|..
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            3555555 788998765 4678888775431     335678999988884 4445677777776677899999999977


Q ss_pred             HHHHH----------------hhhcCC-----CCCH--HHHHHHHH--------------------HHHHHHHHHhh---
Q 013401          220 LREHL----------------DCLQGN-----ILDL--AGRLDIAI--------------------DVAHAITYLHM---  253 (443)
Q Consensus       220 L~~~l----------------~~~~~~-----~l~~--~~~~~i~~--------------------~i~~~L~~LH~---  253 (443)
                      |....                ......     .+..  ...+....                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            65331                111110     1100  00000000                    01111122210   


Q ss_pred             -cCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          254 -YTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       254 -~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                       .....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             012348999999999999998778899999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.44  E-value=2.3e-08  Score=102.03  Aligned_cols=183  Identities=19%  Similarity=0.179  Sum_probs=130.9

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc-eeeeeeeeeecCeEEEEEeecCC
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN-LVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ..+.+++|++++++|.+....+....+.+...       ....-++++|.+++||| .+..++-++.++..+++++++.+
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            33458899999999987432333335544332       34556899999999999 77778888888899999999987


Q ss_pred             C-cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc
Q 013401          218 G-TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT  296 (443)
Q Consensus       218 g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~  296 (443)
                      + +-...... ..-.+...+...+...-+.+|++||   +-.-+|+|    |||..+ +..|..||+....+....    
T Consensus       319 ~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----  385 (829)
T KOG0576|consen  319 GRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----  385 (829)
T ss_pred             CccccccCCh-hhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc----
Confidence            7 22111110 1112333334455666677888999   44458998    877766 579999999987665432    


Q ss_pred             cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 013401          297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI  342 (443)
Q Consensus       297 ~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf  342 (443)
                       ......+|+.++|||+.....+....|+|++|+--.+|.-|.+|-
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence             234566999999999999989999999999998888888887774

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.42  E-value=8.8e-06  Score=73.37  Aligned_cols=101  Identities=22%  Similarity=0.163  Sum_probs=81.3

Q ss_pred             HHHHHHHhcCC-cceeeeeeeeeecCeEEEEEeecCCCcHHHH---HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 013401          182 SEIRTLAQVEH-LNLVKFHGYLEFEDERIVIVEYVPNGTLREH---LDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH  257 (443)
Q Consensus       182 ~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  257 (443)
                      .|.-+|+.+.+ +++.+++|+|    ..++|+||...+++...   +.  .-...+|..+.+||.++++.+++|+.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLS--QFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccc--cccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            58888888875 6999999998    34678999987765321   11  113468999999999999999999965446


Q ss_pred             CeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          258 PIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       258 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      .+...|++++||-++++|++|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999999987544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.7e-06  Score=89.00  Aligned_cols=143  Identities=19%  Similarity=0.287  Sum_probs=90.5

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEEccccccCccc-----------------------------H------HHHHHHHHH
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS-----------------------------G------AEFQSEIRT  186 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~-----------------------------~------~~~~~Ei~~  186 (443)
                      -||.-+.|.||+|++++|+.||||+=+........                             .      -+|.+|.+.
T Consensus       168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N  247 (538)
T KOG1235|consen  168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN  247 (538)
T ss_pred             hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence            59999999999999999999999985543211100                             0      013344443


Q ss_pred             HHh----cCCcce---eeeeee-eeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 013401          187 LAQ----VEHLNL---VKFHGY-LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP  258 (443)
Q Consensus       187 l~~----l~h~ni---v~l~~~-~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  258 (443)
                      ..+    +.|-++   |.+=.+ +......+|+||||+|..+.|.-. .....++...   |+..+.++  |+++.-..|
T Consensus       248 ae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~---i~~~l~~~--~~~qIf~~G  321 (538)
T KOG1235|consen  248 AERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA-IDKRGISPHD---ILNKLVEA--YLEQIFKTG  321 (538)
T ss_pred             HHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH-HHHcCCCHHH---HHHHHHHH--HHHHHHhcC
Confidence            333    345551   112222 233456799999999987766432 2223344443   34444443  222222568


Q ss_pred             eEecCCCCCCEEEcC----CCceEEeeecccccccc
Q 013401          259 IIHRDIKSSNILLTE----NFRAKVADFGFARLAAD  290 (443)
Q Consensus       259 ivHrDlkp~NILl~~----~~~vkl~DFGla~~~~~  290 (443)
                      ++|.|=.|.||+++.    ++.+.+-|||+...+..
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999999983    67899999999876653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.35  E-value=1.1e-05  Score=73.18  Aligned_cols=130  Identities=25%  Similarity=0.297  Sum_probs=89.3

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccc--------------cCcccHHHHHHHHHHHHhcC------Ccceeeee
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV--------------YDKHSGAEFQSEIRTLAQVE------HLNLVKFH  199 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~~~~~~Ei~~l~~l~------h~niv~l~  199 (443)
                      ...||+|+.=.||.-  .+.....||+.....              .......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            346999999999864  334446778776543              11122355667777766665      78899999


Q ss_pred             eeeeecCeEEEEEeecCC------CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          200 GYLEFEDERIVIVEYVPN------GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       200 ~~~~~~~~~~lv~E~~~g------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      |+.+++...-+|+|.+.+      .+|.+++.   ...++. .....   +-.-..||-   +++|+.+||+|.||++..
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~---L~~f~~~l~---~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQA---LDEFKRYLL---DHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHH---HHHHHHHHH---HcCCeecCCCcccEEEEe
Confidence            999999999999998754      26777773   234554 33333   334445666   666999999999999964


Q ss_pred             C--C--ceEEee
Q 013401          274 N--F--RAKVAD  281 (443)
Q Consensus       274 ~--~--~vkl~D  281 (443)
                      +  +  .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            3  2  577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.6e-05  Score=87.94  Aligned_cols=79  Identities=14%  Similarity=0.205  Sum_probs=56.9

Q ss_pred             CceeeeeCceEEEEEEEcCC---cEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccce--eeeeeeeeec---CeEEE
Q 013401          140 SFKIGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNL--VKFHGYLEFE---DERIV  210 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~~~~---~~~~l  210 (443)
                      ...|+.|.++.+|+....++   ..+++|+...... ......+.+|+++|+.+. |.+|  .+++.++.+.   +..++
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            45789999999999887653   4677787654321 122356889999999995 6664  6777777654   46789


Q ss_pred             EEeecCCCc
Q 013401          211 IVEYVPNGT  219 (443)
Q Consensus       211 v~E~~~gg~  219 (443)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.21  E-value=9.5e-06  Score=70.99  Aligned_cols=129  Identities=19%  Similarity=0.208  Sum_probs=89.6

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCccee-eeeeeeeecCeEEEEEeecCC
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV-KFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ....||+|++|.||+|.+. |..+|+|+-+.    +.....+..|.++|..+.-.++- ++|.|.+    -.+.|||+.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G   96 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence            4457999999999999997 45788887654    34456788999999988765553 4555433    3345999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC-CCCEEEcCCCceEEeeecccccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIK-SSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk-p~NILl~~~~~vkl~DFGla~~~  288 (443)
                      -.|.+....     .+..    -...+++...-|-   ..||-|..|. |..++|..++.+.|+||.-|.+.
T Consensus        97 ~~L~~~~~~-----~~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          97 RPLGKLEIG-----GDRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cchhhhhhc-----ccHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            888765531     1222    2334555555566   6779999997 55555555558999999988743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.20  E-value=1.3e-05  Score=74.95  Aligned_cols=72  Identities=13%  Similarity=0.125  Sum_probs=45.2

Q ss_pred             ceeeeeCce-EEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCc---ceeeeeeeeeec---CeEEEEEe
Q 013401          141 FKIGQGGFG-TVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL---NLVKFHGYLEFE---DERIVIVE  213 (443)
Q Consensus       141 ~~LG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~---~~~~lv~E  213 (443)
                      ..|+.|+.. .||+.    +..+++|..+..    .....+.+|.++|..+...   .+.++++.....   ...+++||
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            457777776 48876    234777765432    2345788999999887521   234444433332   23588999


Q ss_pred             ecCCCcH
Q 013401          214 YVPNGTL  220 (443)
Q Consensus       214 ~~~gg~L  220 (443)
                      +++|.++
T Consensus        75 ~i~G~~l   81 (235)
T cd05155          75 WLEGETA   81 (235)
T ss_pred             eecCCCC
Confidence            9998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.15  E-value=0.00013  Score=73.32  Aligned_cols=77  Identities=19%  Similarity=0.205  Sum_probs=54.8

Q ss_pred             ceeeeeCceEEEEEEEcCC-cEEEEEEcccccc---C--cccHHHHHHHHHHHHhcC---CcceeeeeeeeeecCeEEEE
Q 013401          141 FKIGQGGFGTVYKGRLEDG-TIVAIKRAKKSVY---D--KHSGAEFQSEIRTLAQVE---HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~---~--~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv  211 (443)
                      +.||.|.+..||++...+| +.|+||.......   .  ....++...|...|..+.   ..++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4699999999999998876 5899998542211   1  124566777888888763   3456777776  34567899


Q ss_pred             EeecCCCc
Q 013401          212 VEYVPNGT  219 (443)
Q Consensus       212 ~E~~~gg~  219 (443)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.09  E-value=1e-05  Score=88.16  Aligned_cols=200  Identities=20%  Similarity=0.200  Sum_probs=137.9

Q ss_pred             HHHHHHHHHHhcCCcceeeeeeeeeecCeEE----EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 013401          179 EFQSEIRTLAQVEHLNLVKFHGYLEFEDERI----VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY  254 (443)
Q Consensus       179 ~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  254 (443)
                      ....|+..+..+.|+|++.++.|-.+....-    +..|+|..-++...+..  -...+....+.+..++..||.|+|  
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h--  303 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLH--  303 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHH--
Confidence            3445677778889999999998865543333    33578888888888763  355777888888999999999999  


Q ss_pred             CCCCeEecCCCCC---CEEEcCCCceEEe--eecccccccccCCCcccccccccCCCCccCccccccCCCCC--chhHHH
Q 013401          255 TDHPIIHRDIKSS---NILLTENFRAKVA--DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE--KSDVYS  327 (443)
Q Consensus       255 ~~~~ivHrDlkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~sDiwS  327 (443)
                       .....|.-|...   +..++..+.+.+.  ||+.+....+.......     .-+..+.++|......+..  ..|+|+
T Consensus       304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~-----~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD-----LLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             -HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh-----cCccccccccccccccchhhhhhHHHH
Confidence             444555544433   4444556677777  89888777665432222     2455678888876655444  469999


Q ss_pred             HHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013401          328 FGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRR  407 (443)
Q Consensus       328 lGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~e  407 (443)
                      +|.++..+..|..+-.......                  ..++..         ....+.++..+|+.-|.+.|+...+
T Consensus       378 lgll~~~~~~~~~i~~~~~~~~------------------~~l~~~---------~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAVPV------------------SLLDVL---------STSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHhhhhhcCcccccccchh------------------hhhccc---------cchhhhhhhhhhcchhhhhccchhh
Confidence            9999999999876533221110                  011110         1115778899999999999999999


Q ss_pred             HHHHHHhh
Q 013401          408 CAEILWSV  415 (443)
Q Consensus       408 ll~~l~~i  415 (443)
                      ++.+.+.-
T Consensus       431 ll~~~f~~  438 (1351)
T KOG1035|consen  431 LLTHPFLR  438 (1351)
T ss_pred             hhhchhcc
Confidence            99999743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.06  E-value=4.9e-05  Score=68.58  Aligned_cols=127  Identities=27%  Similarity=0.448  Sum_probs=88.8

Q ss_pred             cCCCCCceeeeeCc-eEEEEEEEcCCcEEEEEEccccc----------cCc---------ccHHHHHHHHHHHHhcC---
Q 013401          135 RNFSPSFKIGQGGF-GTVYKGRLEDGTIVAIKRAKKSV----------YDK---------HSGAEFQSEIRTLAQVE---  191 (443)
Q Consensus       135 ~~f~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~----------~~~---------~~~~~~~~Ei~~l~~l~---  191 (443)
                      .+++.++.||.|.- |.||++... |+.||+|.++.-.          ...         .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 999999986 7799999933210          000         11234677888777664   


Q ss_pred             Ccce--eeeeeeeeecC------------------eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 013401          192 HLNL--VKFHGYLEFED------------------ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL  251 (443)
Q Consensus       192 h~ni--v~l~~~~~~~~------------------~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~L  251 (443)
                      +.++  |+++||..-..                  ...||.||+....           .+..    .-+.+|.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence            5566  99999873221                  2356777765543           1111    2245677778888


Q ss_pred             hhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       252 H~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      |   ..||+-+|+++.|..     .-||+|||.+
T Consensus       181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---HCCeeeccCcccccc-----CCEEEecccC
Confidence            9   888999999999986     5689999854

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.04  E-value=4.6e-05  Score=71.15  Aligned_cols=73  Identities=15%  Similarity=0.155  Sum_probs=47.6

Q ss_pred             ceeeeeCceEEEEEEEcC--CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc-eeeeeeeeeecCeEEEEEeecCC
Q 013401          141 FKIGQGGFGTVYKGRLED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN-LVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      +.|..|-...+|++...+  +..|++|+.....   .......+|+.+++.+...+ ..++++...  +  .+||||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---ELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---cceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            457788888999998764  6788899765431   11123457888888885333 344444332  2  479999998


Q ss_pred             CcH
Q 013401          218 GTL  220 (443)
Q Consensus       218 g~L  220 (443)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.95  E-value=7.4e-05  Score=72.36  Aligned_cols=141  Identities=20%  Similarity=0.173  Sum_probs=83.0

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCc--ceeeeee------eeeecCeEEEE
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL--NLVKFHG------YLEFEDERIVI  211 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~------~~~~~~~~~lv  211 (443)
                      ...|..|....+|+....++ .+++|+...     .....+..|+.++..+.+.  .+.+++.      +...++..++|
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            44577787789999876544 688887653     2234566788888877432  2444433      12345567899


Q ss_pred             EeecCCCcHHH-----------HHhhhc----C---C-----CCCHHHHH----------HHHHHHHHHHHHHhh----c
Q 013401          212 VEYVPNGTLRE-----------HLDCLQ----G---N-----ILDLAGRL----------DIAIDVAHAITYLHM----Y  254 (443)
Q Consensus       212 ~E~~~gg~L~~-----------~l~~~~----~---~-----~l~~~~~~----------~i~~~i~~~L~~LH~----~  254 (443)
                      +++++|..+..           .+....    +   .     ...+....          .....+..++.++..    .
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99999866421           111000    0   0     00111100          011112333444432    1


Q ss_pred             CCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       255 ~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      -..+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            13579999999999999998777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.91  E-value=0.00019  Score=69.61  Aligned_cols=78  Identities=12%  Similarity=0.115  Sum_probs=56.6

Q ss_pred             CCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-C--cceeeeeeeeee---cCeEEEE
Q 013401          138 SPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-H--LNLVKFHGYLEF---EDERIVI  211 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~---~~~~~lv  211 (443)
                      .....||.|..+.||.....+++ +.+|..+.    ......+.+|...|+.|. +  ..+.++++++..   .+..+||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            34457999999999999776664 66676432    112357889999999885 2  367788877654   3668999


Q ss_pred             EeecCCCcH
Q 013401          212 VEYVPNGTL  220 (443)
Q Consensus       212 ~E~~~gg~L  220 (443)
                      ||+++|+++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>PRK05231 homoserine kinase; Provisional

Probab=97.86  E-value=0.00056  Score=66.98  Aligned_cols=156  Identities=14%  Similarity=0.132  Sum_probs=83.3

Q ss_pred             cCHHHHHHHhcCCCC-----CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC--cceee
Q 013401          125 ITMEEIYRATRNFSP-----SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH--LNLVK  197 (443)
Q Consensus       125 ~~~~~~~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~  197 (443)
                      ++.+++......|..     .+.|+.|....+|+....+| .+++|+.. . .   ....+..|+.++..|..  -.+.+
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~-~---~~~~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R-L---TAEDLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c-C---ChHHhHHHHHHHHHHHHCCCCCCc
Confidence            344555444445544     34566777789999887666 58888765 1 1   22344456666665531  12233


Q ss_pred             eee------eeeecCeEEEEEeecCCCcHH-----------HHHhhh----cCC--------CCCH-HHHHH--------
Q 013401          198 FHG------YLEFEDERIVIVEYVPNGTLR-----------EHLDCL----QGN--------ILDL-AGRLD--------  239 (443)
Q Consensus       198 l~~------~~~~~~~~~lv~E~~~gg~L~-----------~~l~~~----~~~--------~l~~-~~~~~--------  239 (443)
                      .+.      +....+..++++||++|..+.           +.+...    .+.        .+.+ .....        
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            332      123356788999999886431           111111    000        0001 11100        


Q ss_pred             ----HHHH-HHHHHHHHhhc----CCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          240 ----IAID-VAHAITYLHMY----TDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       240 ----i~~~-i~~~L~~LH~~----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                          ...+ +...+..+...    -..++||+|+.|.|||++.+...-|+||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                0111 11112222210    14579999999999999976556899999874

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.85  E-value=1.7e-05  Score=75.80  Aligned_cols=140  Identities=21%  Similarity=0.195  Sum_probs=96.7

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEcccccc---------------Cccc-----HHHHHHHHHHHHhcC-Cc-
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY---------------DKHS-----GAEFQSEIRTLAQVE-HL-  193 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~---------------~~~~-----~~~~~~Ei~~l~~l~-h~-  193 (443)
                      -+...++||-|--+-||.+...+|...++|.=+....               ....     .....+|...|+.|. |- 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            3667789999999999999999999999984221100               0001     112457888888884 33 


Q ss_pred             ceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       194 niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      -|.+.++    .++.++|||++.|-.|.+.-     ...+...   +...+...|.-|-   .+|+||+|..-=||+|++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~-----~v~d~~~---ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVR-----HVEDPPT---LYDDLMGLIVRLA---NHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeee-----ecCChHH---HHHHHHHHHHHHH---HcCceecccchheeEEec
Confidence            2344444    45678999999988875422     1223332   3444555556666   889999999999999999


Q ss_pred             CCceEEeeecccccccc
Q 013401          274 NFRAKVADFGFARLAAD  290 (443)
Q Consensus       274 ~~~vkl~DFGla~~~~~  290 (443)
                      ++.++++||--+.....
T Consensus       238 d~~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVSTSH  254 (465)
T ss_pred             CCCEEEeechHhhccCC
Confidence            99999999987755443

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00015  Score=68.76  Aligned_cols=137  Identities=18%  Similarity=0.191  Sum_probs=75.9

Q ss_pred             eeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEEEeecCCCcHH
Q 013401          143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVIVEYVPNGTLR  221 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~gg~L~  221 (443)
                      +..|-.+.+|+... ++..+++|......  .....+..+|..+++.+....+ .+++...  .  -++||||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            55677788998874 46678888754321  1111235678888888853333 2333332  2  36899999986653


Q ss_pred             H--------------HHhhhcC-----CCCCHHHHH-HHHH---------HHHHHHHHHhhc-----CCCCeEecCCCCC
Q 013401          222 E--------------HLDCLQG-----NILDLAGRL-DIAI---------DVAHAITYLHMY-----TDHPIIHRDIKSS  267 (443)
Q Consensus       222 ~--------------~l~~~~~-----~~l~~~~~~-~i~~---------~i~~~L~~LH~~-----~~~~ivHrDlkp~  267 (443)
                      .              .+.....     ..++....+ ....         .+...+..+-..     ....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            1              1111111     111211111 1110         111112222111     1235899999999


Q ss_pred             CEEEcCCCceEEeeeccccc
Q 013401          268 NILLTENFRAKVADFGFARL  287 (443)
Q Consensus       268 NILl~~~~~vkl~DFGla~~  287 (443)
                      ||++++++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999997743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.79  E-value=0.00083  Score=65.50  Aligned_cols=142  Identities=17%  Similarity=0.145  Sum_probs=80.9

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCc--ceeeeeee------eeecCeEEEE
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL--NLVKFHGY------LEFEDERIVI  211 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~------~~~~~~~~lv  211 (443)
                      +..|+.|....+|+....+| .+++|+....    .....+..|+.++..|...  .+.+++..      ....+..+++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            34567777789999876655 4778876432    1234556677777777422  23444331      1234567899


Q ss_pred             EeecCCCcHH-----------HHHhhh----cCCC--------C-CHHHHH------------HHHHHHHHHHHHHhh--
Q 013401          212 VEYVPNGTLR-----------EHLDCL----QGNI--------L-DLAGRL------------DIAIDVAHAITYLHM--  253 (443)
Q Consensus       212 ~E~~~gg~L~-----------~~l~~~----~~~~--------l-~~~~~~------------~i~~~i~~~L~~LH~--  253 (443)
                      +||++|..+.           ..+...    .+..        . .+....            .....+...+.++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            9999885431           111110    0000        0 000000            001122334444431  


Q ss_pred             --cCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          254 --YTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       254 --~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                        ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence              124689999999999999998877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.77  E-value=6.3e-06  Score=91.66  Aligned_cols=159  Identities=14%  Similarity=0.033  Sum_probs=112.4

Q ss_pred             HHHHHHHHHhcCCcceeeeeeeee--ecCeEEEEEeecCCCcHHHHHhhhcCC--CCCHHHHHHHHHHHHHHHHHHhhcC
Q 013401          180 FQSEIRTLAQVEHLNLVKFHGYLE--FEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYT  255 (443)
Q Consensus       180 ~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~~lv~E~~~gg~L~~~l~~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~  255 (443)
                      ...|...++...|+++...+.-..  +....+.+++|+.+|.++..|-.....  .++..-..-.-.+.+....-+|...
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            344555566678998887765443  244668899999999999988532211  1222212222222255556666543


Q ss_pred             C--CCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHH
Q 013401          256 D--HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLV  333 (443)
Q Consensus       256 ~--~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~  333 (443)
                      .  +-.+|++||+-|.+|..+.++|++++|+.+......    .......+++.|+.|++...-.++.++|+|..|+.+|
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~----sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL----SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchH----hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            2  237999999999999999999999999998332211    1234456889999999998888999999999999999


Q ss_pred             HHHcCCCCC
Q 013401          334 ELVTGRRPI  342 (443)
Q Consensus       334 elltG~~Pf  342 (443)
                      ++..|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            999998886

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.56  E-value=0.00092  Score=64.92  Aligned_cols=74  Identities=30%  Similarity=0.328  Sum_probs=47.0

Q ss_pred             ceeeeeCceEEEEEEEcC-------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEEE
Q 013401          141 FKIGQGGFGTVYKGRLED-------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVIV  212 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  212 (443)
                      +.|..|--..||+....+       ++.|++|+.....   ....+..+|+.++..+....+ .++++.+. +   .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence            346667777899988654       5789999865432   222355688888888753223 34454443 2   3589


Q ss_pred             eecCCCcHH
Q 013401          213 EYVPNGTLR  221 (443)
Q Consensus       213 E~~~gg~L~  221 (443)
                      ||++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.51  E-value=0.001  Score=65.49  Aligned_cols=75  Identities=13%  Similarity=0.153  Sum_probs=50.2

Q ss_pred             eeeeeCceEEEEEEEcCC-cEEEEEEcccccc-----CcccHHHHHHHHHHHHhcC--Cc-ceeeeeeeeeecCeEEEEE
Q 013401          142 KIGQGGFGTVYKGRLEDG-TIVAIKRAKKSVY-----DKHSGAEFQSEIRTLAQVE--HL-NLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~-----~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  212 (443)
                      .||.|....||++...+| +.|+||....-..     -+....+..-|...|+...  -| .+.++|.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999998754 6899998542211     1334456667888887663  34 45555544  455667999


Q ss_pred             eecCCC
Q 013401          213 EYVPNG  218 (443)
Q Consensus       213 E~~~gg  218 (443)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.51  E-value=0.001  Score=63.79  Aligned_cols=30  Identities=27%  Similarity=0.544  Sum_probs=25.0

Q ss_pred             CeEecCCCCCCEEEcCCCc-eEEeeeccccc
Q 013401          258 PIIHRDIKSSNILLTENFR-AKVADFGFARL  287 (443)
Q Consensus       258 ~ivHrDlkp~NILl~~~~~-vkl~DFGla~~  287 (443)
                      .++|+|+.|.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 46999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.37  E-value=0.0011  Score=64.57  Aligned_cols=143  Identities=17%  Similarity=0.197  Sum_probs=91.9

Q ss_pred             CCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHH--------------------H----HHHHHHHHHhcCCc
Q 013401          138 SPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA--------------------E----FQSEIRTLAQVEHL  193 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~--------------------~----~~~Ei~~l~~l~h~  193 (443)
                      .+...|.-|--+.||.+.-.+|..+|||+.+.+...-.+.+                    -    ...|+.-|.+|...
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            34446788889999999999999999998876532111111                    0    23577777777544


Q ss_pred             ceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       194 niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      .|..---++  -...+|||+++.......  ...+...+....+..+-.+++.-+.-|-.  .+++||.||.-=|+|+.+
T Consensus       227 GIP~PePIl--Lk~hVLVM~FlGrdgw~a--PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  227 GIPCPEPIL--LKNHVLVMEFLGRDGWAA--PKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCCcee--eecceEeeeeccCCCCcC--cccccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC
Confidence            332111111  123478999995322110  11134456666666666777777666653  667999999999999965


Q ss_pred             CCceEEeeeccccc
Q 013401          274 NFRAKVADFGFARL  287 (443)
Q Consensus       274 ~~~vkl~DFGla~~  287 (443)
                       |.+.|+|-+-+..
T Consensus       301 -G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 -GKLYIIDVSQSVE  313 (520)
T ss_pred             -CEEEEEEcccccc
Confidence             5799999987754

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.29  E-value=0.0046  Score=62.09  Aligned_cols=75  Identities=13%  Similarity=0.114  Sum_probs=51.5

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEcccccc--Cc---ccHHHHHHHHHHHHhcC---CcceeeeeeeeeecCeEEEE
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY--DK---HSGAEFQSEIRTLAQVE---HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~---~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv  211 (443)
                      .+.||-|....||+.... +..|+||+......  ..   ....+...|...|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            346899999999998875 45689998652221  11   23445556677776653   247778888776  556788


Q ss_pred             EeecCC
Q 013401          212 VEYVPN  217 (443)
Q Consensus       212 ~E~~~g  217 (443)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.27  E-value=0.0051  Score=59.83  Aligned_cols=130  Identities=15%  Similarity=0.190  Sum_probs=76.5

Q ss_pred             EEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC--cceeeeeeeeeecC--eEEEEEeecCCCcHHHHHhh
Q 013401          151 VYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH--LNLVKFHGYLEFED--ERIVIVEYVPNGTLREHLDC  226 (443)
Q Consensus       151 Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~  226 (443)
                      +|..... ++.+++. ...............+|..+|+.+.-  .-+...+++|.++.  ..+.||+|++|..+...+..
T Consensus        41 t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~  118 (321)
T COG3173          41 TFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP  118 (321)
T ss_pred             eEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence            3444333 7778877 33222233445566788888888742  33445566666655  67999999998433221110


Q ss_pred             hcCCCCCHHHHHHHH-HHHHHHH--------------------------------------------------HHHhhc-
Q 013401          227 LQGNILDLAGRLDIA-IDVAHAI--------------------------------------------------TYLHMY-  254 (443)
Q Consensus       227 ~~~~~l~~~~~~~i~-~~i~~~L--------------------------------------------------~~LH~~-  254 (443)
                      ..   ..    ..++ ..++..|                                                  .+|+.. 
T Consensus       119 ~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~  191 (321)
T COG3173         119 ES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR  191 (321)
T ss_pred             cc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence            00   00    0011 1233333                                                  333321 


Q ss_pred             ----CCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          255 ----TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       255 ----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                          +...++|+|+.+.||+|+.++.+=|.||+++..-.
T Consensus       192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                12358999999999999998889999999986543

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.23  E-value=0.00063  Score=68.90  Aligned_cols=166  Identities=22%  Similarity=0.256  Sum_probs=95.1

Q ss_pred             HHHHHHHHHHHhcCCcceeeeeeeeeec-CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 013401          178 AEFQSEIRTLAQVEHLNLVKFHGYLEFE-DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD  256 (443)
Q Consensus       178 ~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  256 (443)
                      ..+.-..++++.+.|+|+..++++-... ...++|||++ +.+|.+.+....   +....      .+           .
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s------~~-----------~   85 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDES------LL-----------A   85 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhh------hc-----------c
Confidence            4566778889999999999999886543 3577889998 678888775321   11110      01           2


Q ss_pred             CCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHH
Q 013401          257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV  336 (443)
Q Consensus       257 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ell  336 (443)
                      +++.|-.            .++++| .++...                      |     ....+|+|||++|.++.++.
T Consensus        86 ~~~~~~~------------~~~~td-~~~t~~----------------------~-----~~~~pKsdVwsl~~i~~el~  125 (725)
T KOG1093|consen   86 HGVLHLN------------IIYITD-HFLTKY----------------------P-----SPIGPKSDVWSLGFIILELY  125 (725)
T ss_pred             cccceeh------------hhhccc-cccccC----------------------C-----CCCCcchhhhhHHHHHHHHH
Confidence            2343332            233344 111000                      0     01114999999999999999


Q ss_pred             cCCCCCCCchhHHHHHHHHHHhhhcC-CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 013401          337 TGRRPIEPKRELKERITVKWAMKKFS-DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEI  411 (443)
Q Consensus       337 tG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~  411 (443)
                      -|..-+....+.+...   .....+. +.....+.    ....-..++.+.++++...|+...|..||...++.++
T Consensus       126 L~~~l~~~~~~s~~l~---~i~k~~~~d~~~~~~a----~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~  194 (725)
T KOG1093|consen  126 LGISLEAELTESEYLE---ILLKYYTDDQELLSTA----MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR  194 (725)
T ss_pred             HhhHHHHHHHHHHHHH---HHHHhccCchhHHHHH----HHHHHHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence            9876654433222111   1111111 11111100    0012234567889999999999999999976555443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.14  E-value=0.011  Score=57.61  Aligned_cols=30  Identities=30%  Similarity=0.421  Sum_probs=25.9

Q ss_pred             CCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          256 DHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       256 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            357999999999999988 578999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.96  E-value=0.0038  Score=62.38  Aligned_cols=76  Identities=20%  Similarity=0.149  Sum_probs=51.5

Q ss_pred             CceeeeeCceEEEEEEEcC-CcEEEEEEcccccc----CcccHHHHHHHHHHHHhcC--Cc-ceeeeeeeeeecCeEEEE
Q 013401          140 SFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVY----DKHSGAEFQSEIRTLAQVE--HL-NLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~----~~~~~~~~~~Ei~~l~~l~--h~-niv~l~~~~~~~~~~~lv  211 (443)
                      ...||.|.-..||++.+.+ ++.|+||....-..    -+....+..-|...|+.+.  .| ++.++|.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3479999999999999753 56799997532221    1344566777888888763  34 45556654  45556788


Q ss_pred             EeecCC
Q 013401          212 VEYVPN  217 (443)
Q Consensus       212 ~E~~~g  217 (443)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.86  E-value=0.038  Score=54.38  Aligned_cols=71  Identities=20%  Similarity=0.134  Sum_probs=46.1

Q ss_pred             eCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC--cceeeee---e--eeeecCeEEEEEeecCCC
Q 013401          146 GGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH--LNLVKFH---G--YLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       146 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~---~--~~~~~~~~~lv~E~~~gg  218 (443)
                      +.-..||+....+|..+++|+....   ......+..|+..+..|..  -.++...   |  +...++..+.++++++|.
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~---~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE---RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc---cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            4456799998888888999987533   2345667778888877732  1223211   1  223356778899999876


Q ss_pred             c
Q 013401          219 T  219 (443)
Q Consensus       219 ~  219 (443)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PLN02236 choline kinase

Probab=96.76  E-value=0.013  Score=58.23  Aligned_cols=138  Identities=16%  Similarity=0.194  Sum_probs=76.6

Q ss_pred             eeeeeCceEEEEEEEcC-----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEEEeec
Q 013401          142 KIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~  215 (443)
                      .|-.|-...+|++...+     ++.|++|+.....  ... -+..+|+.+++.+..-++ .++++.+.. +   .|.||+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            45457778899987532     3678889875532  222 223578888888753333 344555432 2   578998


Q ss_pred             CCCcHHH--------------HHhhhcCCC------CC-HHHHHHHHHH-----------------HHHHHHHH----hh
Q 013401          216 PNGTLRE--------------HLDCLQGNI------LD-LAGRLDIAID-----------------VAHAITYL----HM  253 (443)
Q Consensus       216 ~gg~L~~--------------~l~~~~~~~------l~-~~~~~~i~~~-----------------i~~~L~~L----H~  253 (443)
                      ++.+|..              .+.......      .. +.....+..+                 +...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            7766531              111111111      11 1111122111                 11111111    11


Q ss_pred             -cCCCCeEecCCCCCCEEEcC-CCceEEeeecccc
Q 013401          254 -YTDHPIIHRDIKSSNILLTE-NFRAKVADFGFAR  286 (443)
Q Consensus       254 -~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~  286 (443)
                       .....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             12346899999999999986 4689999999774

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.71  E-value=0.034  Score=54.60  Aligned_cols=138  Identities=21%  Similarity=0.306  Sum_probs=80.1

Q ss_pred             eeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc------eeeeeee--eeecC--eEEEEE
Q 013401          143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN------LVKFHGY--LEFED--ERIVIV  212 (443)
Q Consensus       143 LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~--~~~~~--~~~lv~  212 (443)
                      |.. .-..||+....+|+. ++|+....    ....++..|+..|..|.-..      |..+=|-  ....+  ....++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            444 556799999887776 88877653    34456777888888874221      1111111  11233  778889


Q ss_pred             eecCCCcHHH-----HHh----------hh-cCC---------CCCHH----HH---------HHHHHHHHHHHHHHhh-
Q 013401          213 EYVPNGTLRE-----HLD----------CL-QGN---------ILDLA----GR---------LDIAIDVAHAITYLHM-  253 (443)
Q Consensus       213 E~~~gg~L~~-----~l~----------~~-~~~---------~l~~~----~~---------~~i~~~i~~~L~~LH~-  253 (443)
                      +|++|..+..     .+.          .. .+.         ...|.    ..         .....++...+..+.. 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999877762     110          00 011         11111    00         0122233333443332 


Q ss_pred             ---cCCCC---eEecCCCCCCEEEcCCCc-eEEeeecccc
Q 013401          254 ---YTDHP---IIHRDIKSSNILLTENFR-AKVADFGFAR  286 (443)
Q Consensus       254 ---~~~~~---ivHrDlkp~NILl~~~~~-vkl~DFGla~  286 (443)
                         .-..+   +||+|+.|.|||++.+.. +-++|||.+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               11233   999999999999998874 8999999874

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.56  E-value=0.039  Score=53.81  Aligned_cols=32  Identities=19%  Similarity=0.263  Sum_probs=28.4

Q ss_pred             CCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          256 DHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       256 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      ..+++|+|+.+.|||++.++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            44799999999999999999999999997754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=96.50  E-value=0.034  Score=62.93  Aligned_cols=140  Identities=19%  Similarity=0.217  Sum_probs=78.1

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-------Ccceeeeee-----eeee-cC--
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-------HLNLVKFHG-----YLEF-ED--  206 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-------h~niv~l~~-----~~~~-~~--  206 (443)
                      .|+ |..-.+|+....+|..|++|+.....    ....+..|.+.|..|.       -|.+++-.+     .... ++  
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSE----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCcc----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            453 45678899988888889999987541    2234445566665552       233343221     1111 22  


Q ss_pred             eEEEEEeecCCCcHHHH--------------H---h----hhcC----CCCCHH-----------------HHHHHHHHH
Q 013401          207 ERIVIVEYVPNGTLREH--------------L---D----CLQG----NILDLA-----------------GRLDIAIDV  244 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~--------------l---~----~~~~----~~l~~~-----------------~~~~i~~~i  244 (443)
                      ..+.+++|++|..|.+.              +   .    .+..    ..+.|.                 ....++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            46778999999776541              0   0    0000    011111                 111222223


Q ss_pred             HHHHH-----HHhhcCCCCeEecCCCCCCEEEcCCC--ceE-Eeeeccccc
Q 013401          245 AHAIT-----YLHMYTDHPIIHRDIKSSNILLTENF--RAK-VADFGFARL  287 (443)
Q Consensus       245 ~~~L~-----~LH~~~~~~ivHrDlkp~NILl~~~~--~vk-l~DFGla~~  287 (443)
                      +..+.     .+..+ ..++||.|+.+.|||++.++  .+. |+|||.+..
T Consensus       187 ~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        187 LARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            22221     12221 45799999999999999775  555 999998754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.45  E-value=0.018  Score=56.83  Aligned_cols=72  Identities=14%  Similarity=0.229  Sum_probs=43.2

Q ss_pred             eeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEEEeecC
Q 013401          142 KIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVIVEYVP  216 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~  216 (443)
                      .|-.|--..+|++...+    +..|++|+.....   ...-+-.+|..+++.+..-++ .++++++. .+   +|.+|++
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~   93 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN   93 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence            45456667889887543    2378888765432   122233578888888854444 34555542 22   4788887


Q ss_pred             CCcH
Q 013401          217 NGTL  220 (443)
Q Consensus       217 gg~L  220 (443)
                      |..|
T Consensus        94 g~~l   97 (330)
T PLN02421         94 ARTL   97 (330)
T ss_pred             CCCC
Confidence            7654

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.28  E-value=0.0071  Score=55.45  Aligned_cols=31  Identities=29%  Similarity=0.506  Sum_probs=21.6

Q ss_pred             CCeEecCCCCCCEEE-cCCCceEEeeeccccc
Q 013401          257 HPIIHRDIKSSNILL-TENFRAKVADFGFARL  287 (443)
Q Consensus       257 ~~ivHrDlkp~NILl-~~~~~vkl~DFGla~~  287 (443)
                      ..++|.||.+.|||+ +.++.++|+||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            358999999999999 7889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.26  E-value=0.016  Score=56.78  Aligned_cols=76  Identities=16%  Similarity=0.184  Sum_probs=55.5

Q ss_pred             cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          205 EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      ..+.|++|++- |+.|. .+     ..-.+++...|+.+.+..+.-+..  .-.+-|||+...||||+ +|+|-|+||-+
T Consensus       298 ~~y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence            33556777765 55543 11     234567778888888877777763  44689999999999999 89999999999


Q ss_pred             cccccc
Q 013401          285 ARLAAD  290 (443)
Q Consensus       285 a~~~~~  290 (443)
                      ++.-..
T Consensus       368 sRl~~~  373 (488)
T COG5072         368 SRLSYS  373 (488)
T ss_pred             eecccC
Confidence            985443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.08  E-value=0.02  Score=55.13  Aligned_cols=74  Identities=19%  Similarity=0.360  Sum_probs=46.9

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC---CcceeeeeeeeeecCeEEEEEeec
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE---HLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      ....|+-|....+|+.. .+++.+.||.-...     ....|..|..-|+.|.   --.+.+++++....+..+|||||+
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            34468889999999887 56778999976522     2235677888888773   456778888888888889999999


Q ss_pred             CCC
Q 013401          216 PNG  218 (443)
Q Consensus       216 ~gg  218 (443)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.95  E-value=0.029  Score=55.74  Aligned_cols=61  Identities=13%  Similarity=0.128  Sum_probs=42.7

Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      ..++-+|..|-.+..++..   ...+++-..+++.-.+.||.-+--  -.+++|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence            3556678888888888853   334555566677666666554432  557999999999999953

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.02  E-value=0.095  Score=49.46  Aligned_cols=76  Identities=18%  Similarity=0.145  Sum_probs=52.2

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec-CCCcH
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV-PNGTL  220 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~-~gg~L  220 (443)
                      .+..|..+.|+.+...+|..+++|+.....   ....+. .....|+..+-...|++++.-  .+.-.+++|.+ ++.+|
T Consensus         9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~---~~~~E~-~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L   82 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHA---EAEHEA-RGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSL   82 (253)
T ss_pred             CCCCCcceEEEEEEcCCCCeEEEEecCCcc---cchhhh-hHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCch
Confidence            466788999999999999999999876431   111111 122558888888889999864  33456778888 44466


Q ss_pred             HHH
Q 013401          221 REH  223 (443)
Q Consensus       221 ~~~  223 (443)
                      .+.
T Consensus        83 ~~~   85 (253)
T PF04655_consen   83 ASL   85 (253)
T ss_pred             hhc
Confidence            543

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00384 choline kinase; Provisional

Probab=94.97  E-value=0.29  Score=49.23  Aligned_cols=72  Identities=24%  Similarity=0.298  Sum_probs=42.8

Q ss_pred             eeeeeCceEEEEEEEcCC--cE-----EEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEEEe
Q 013401          142 KIGQGGFGTVYKGRLEDG--TI-----VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g--~~-----vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E  213 (443)
                      .|..|--..+|++...++  ..     |.++....   .....-+-.+|+++++.+...++ .++++.+.    -++|.|
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e  129 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE  129 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence            455677889999976432  22     33333211   11222233578999999865444 44555553    258899


Q ss_pred             ecCCCcH
Q 013401          214 YVPNGTL  220 (443)
Q Consensus       214 ~~~gg~L  220 (443)
                      |++|..|
T Consensus       130 fIeGr~l  136 (383)
T PTZ00384        130 WVEGNTM  136 (383)
T ss_pred             EeccccC
Confidence            9988765

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.83  E-value=0.17  Score=48.69  Aligned_cols=29  Identities=31%  Similarity=0.422  Sum_probs=24.1

Q ss_pred             CeEecCCCCCCEEEcCC--C---ceEEeeecccc
Q 013401          258 PIIHRDIKSSNILLTEN--F---RAKVADFGFAR  286 (443)
Q Consensus       258 ~ivHrDlkp~NILl~~~--~---~vkl~DFGla~  286 (443)
                      -++|+|++..|||+..+  |   .++++||-+++
T Consensus       216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEEcCccCHHhEeEccccccccccceeecccccc
Confidence            38999999999999654  3   69999998764

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	443
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-45
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-45
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-26
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-25
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-25
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-24
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-24
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-24
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-24
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-24
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-24
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-24
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-24
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-24
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-24
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-24
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-24
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-24
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-24
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-24
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-24
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-24
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-24
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-24
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-24
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-24
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-24
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-24
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-24
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-24
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-24
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-24
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-24
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-24
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-24
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-24
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-23
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-23
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-23
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-23
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-22
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-22
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-22
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-22
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-22
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-22
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-22
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-22
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-22
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-22
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-21
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-21
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-21
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-21
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-19
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-18
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-18
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-18
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-16
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-10
3soa_A	444	Full-Length Human Camkii Length = 444		9e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		8e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		8e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		9e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 117/299 (39%), Positives = 167/299 (55%), Gaps = 13/299 (4%)
Query: 124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE 183
           ++ + ++  AT NF   F IG G FG VYKG L DG  VA+KR  ++        EF++E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETE 85
Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIA 241
           I TL+   H +LV   G+ +  +E I+I +Y+ NG L+ HL    L    +    RL+I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           I  A  + YLH      IIHRD+KS NILL ENF  K+ DFG ++    TE G TH+   
Sbjct: 146 IGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXV 200
Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF 361
           VKGT GY+DPEY    +LTEKSDVYSFGV+L E++  R  I      +     +WA++  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
           ++G    I+DP + +      +L K  + A++CLA   ++RPSM    ++LW +    R
Sbjct: 261 NNGQLEQIVDPNLADKIRPE-SLRKFGDTAVKCLALSSEDRPSM---GDVLWKLEYALR 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  177 bits (450), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 116/299 (38%), Positives = 166/299 (55%), Gaps = 13/299 (4%)
Query: 124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE 183
           ++ + ++  AT NF   F IG G FG VYKG L DG  VA+KR  ++        EF++E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR--RTPESSQGIEEFETE 85
Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIA 241
           I TL+   H +LV   G+ +  +E I+I +Y+ NG L+ HL    L    +    RL+I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
           I  A  + YLH      IIHRD+KS NILL ENF  K+ DFG ++    TE   TH+   
Sbjct: 146 IGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXV 200
Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF 361
           VKGT GY+DPEY    +LTEKSDVYSFGV+L E++  R  I      +     +WA++  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
           ++G    I+DP + +      +L K  + A++CLA   ++RPSM    ++LW +    R
Sbjct: 261 NNGQLEQIVDPNLADKIRPE-SLRKFGDTAVKCLALSSEDRPSM---GDVLWKLEYALR 315

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  177 bits (450), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 167/298 (56%), Gaps = 19/298 (6%)
Query: 124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE--FQ 181
           + ++ E+  A+ NFS    +G+GGFG VYKGRL DGT+VA+KR K+   ++  G E  FQ
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE---ERXQGGELQFQ 83
Query: 182 SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI-----LDLAG 236
           +E+  ++   H NL++  G+     ER+++  Y+ NG++     CL+        LD   
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV---ASCLRERPESQPPLDWPK 140
Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
           R  IA+  A  + YLH + D  IIHRD+K++NILL E F A V DFG A+L    +    
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL---MDYKDX 197
Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER--ITV 354
           HV   V+GT G++ PEYL T + +EK+DV+ +GV+L+EL+TG+R  +  R   +   + +
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257
Query: 355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            W      +    +++D  ++    +   +E+++++AL C       RP M     +L
Sbjct: 258 DWVKGLLKEKKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 164/298 (55%), Gaps = 19/298 (6%)
Query: 124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE--FQ 181
           + ++ E+  A+ NF     +G+GGFG VYKGRL DG +VA+KR K+   ++  G E  FQ
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKE---ERTQGGELQFQ 75
Query: 182 SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI-----LDLAG 236
           +E+  ++   H NL++  G+     ER+++  Y+ NG++     CL+        LD   
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA---SCLRERPESQPPLDWPK 132
Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
           R  IA+  A  + YLH + D  IIHRD+K++NILL E F A V DFG A+L    +    
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL---MDYKDX 189
Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER--ITV 354
           HV   V+G  G++ PEYL T + +EK+DV+ +GV+L+EL+TG+R  +  R   +   + +
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            W      +    +++D  ++    +   +E+++++AL C       RP M     +L
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 95/274 (34%), Positives = 160/274 (58%), Gaps = 13/274 (4%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKR--AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           K+G+GGFG VYKG + + T VA+K+  A   +  +    +F  EI+ +A+ +H NLV+  
Sbjct: 38  KMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGN-ILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           G+    D+  ++  Y+PNG+L + L CL G   L    R  IA   A+ I +LH   ++ 
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENH 153
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            IHRDIKS+NILL E F AK++DFG AR  A  +   T + +++ GT  Y+ PE L+  +
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMXSRIVGTTAYMAPEALRG-E 210
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           +T KSD+YSFGV+L+E++TG   ++  RE  + +       +  +      +D ++ +  
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKMND-- 267
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           A++ ++E +  +A QCL  ++  RP +++  ++L
Sbjct: 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 99/293 (33%), Positives = 164/293 (55%), Gaps = 19/293 (6%)
Query: 129 EIYRATRNFSP------SFKIGQGGFGTVYKGRLEDGTIVAIKR--AKKSVYDKHSGAEF 180
           E+   T NF          K+G+GGFG VYKG + + T VA+K+  A   +  +    +F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 181 QSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN-ILDLAGRLD 239
             EI+ +A+ +H NLV+  G+    D+  ++  Y+PNG+L + L CL G   L    R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           IA   A+ I +LH   ++  IHRDIKS+NILL E F AK++DFG AR  A  +   T + 
Sbjct: 138 IAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMX 192
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK 359
            ++ GT  Y+ PE L+  ++T KSD+YSFGV+L+E++TG   ++  RE  + +       
Sbjct: 193 XRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEI 250
Query: 360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +  +      +D ++ +  A++ ++E +  +A QCL  ++  RP +++  ++L
Sbjct: 251 EDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 158/274 (57%), Gaps = 13/274 (4%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKR--AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           K+G+GGFG VYKG + + T VA+K+  A   +  +    +F  EI+ +A+ +H NLV+  
Sbjct: 32  KMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGN-ILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           G+    D+  ++  Y+PNG+L + L CL G   L    R  IA   A+ I +LH   ++ 
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENH 147
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            IHRDIKS+NILL E F AK++DFG AR  A  +     +  ++ GT  Y+ PE L+  +
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQXVMXXRIVGTTAYMAPEALRG-E 204
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           +T KSD+YSFGV+L+E++TG   ++  RE  + +       +  +      +D ++ +  
Sbjct: 205 ITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKMND-- 261
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           A++ ++E +  +A QCL  ++  RP +++  ++L
Sbjct: 262 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 94/274 (34%), Positives = 152/274 (55%), Gaps = 13/274 (4%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKR--AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           K G+GGFG VYKG + + T VA+K+  A   +  +    +F  EI+  A+ +H NLV+  
Sbjct: 29  KXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGN-ILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           G+    D+  ++  Y PNG+L + L CL G   L    R  IA   A+ I +LH   ++ 
Sbjct: 88  GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH---ENH 144
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            IHRDIKS+NILL E F AK++DFG AR  A  +       +++ GT  Y  PE L+  +
Sbjct: 145 HIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQXVXXSRIVGTTAYXAPEALRG-E 201
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           +T KSD+YSFGV+L+E++TG   ++  RE  + +       +  +      +D +  +  
Sbjct: 202 ITPKSDIYSFGVVLLEIITGLPAVDEHRE-PQLLLDIKEEIEDEEKTIEDYIDKKXND-- 258
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           A++ ++E    +A QCL  ++  RP +++  ++L
Sbjct: 259 ADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 107/201 (53%), Gaps = 7/201 (3%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG G FGTV++     G+ VA+K   +  +      EF  E+  + ++ H N+V F G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +       ++ EY+  G+L   L        LD   RL +A DVA  + YLH   + PI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HR++KS N+L+ + +  KV DFG +RL A T       S    GT  ++ PE L+     
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS----SKSAAGTPEWMAPEVLRDEPSN 217
Query: 321 EKSDVYSFGVLLVELVTGRRP 341
           EKSDVYSFGV+L EL T ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 106/201 (52%), Gaps = 7/201 (3%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG G FGTV++     G+ VA+K   +  +      EF  E+  + ++ H N+V F G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +       ++ EY+  G+L   L        LD   RL +A DVA  + YLH   + PI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+KS N+L+ + +  KV DFG +RL A         S    GT  ++ PE L+     
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKA----SXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 321 EKSDVYSFGVLLVELVTGRRP 341
           EKSDVYSFGV+L EL T ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   +++EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 139/289 (48%), Gaps = 33/289 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 19  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL   +    ++   +DIA   A  + YLH  +   IIH
Sbjct: 77  -STKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS---IIH 131
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 319 LTEKSDVYSFGVLLVELVTGRRP---IEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
            + +SDVY+FG++L EL+TG+ P   I  + ++ E +                 L P + 
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-------------GRGSLSPDLS 236
Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAA 424
              +N    +++  L  +CL  +R  RPS  R   IL  + +  REL+ 
Sbjct: 237 KVRSN--CPKRMKRLMAECLKKKRDERPSFPR---ILAEIEELARELSG 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 139/289 (48%), Gaps = 33/289 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 31  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL   +    ++   +DIA   A  + YLH  +   IIH
Sbjct: 89  -STKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 319 LTEKSDVYSFGVLLVELVTGRRP---IEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
            + +SDVY+FG++L EL+TG+ P   I  + ++ E +                 L P + 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-------------GRGSLSPDLS 248
Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAA 424
              +N    +++  L  +CL  +R  RPS  R   IL  + +  REL+ 
Sbjct: 249 KVRSN--CPKRMKRLMAECLKKKRDERPSFPR---ILAEIEELARELSG 292

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   +++EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKIRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 330
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 331 VS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 442
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP 464

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 71
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 72  VS-EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA----PEAALYGRFT 183
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 184 IKSDVWSFGILLTELTTKGRVP 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 73  VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 128
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 184
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 185 IKSDVWSFGILLTELTTKGRVP 206

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   +++EY+  G L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 70
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 71  VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 126
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 182
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 183 IKSDVWSFGILLTELTTKGRVP 204

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 24/265 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 42  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 100 -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 154
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
            + +SDVY+FG++L EL+TG+ P      +  R  + + + +         L P +    
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDLSKVR 262
Query: 379 ANNLALEKILELALQCLAPRRQNRP 403
           +N    + +  L  +CL  +R  RP
Sbjct: 263 SN--CPKAMKRLMAECLKKKRDERP 285

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 24/265 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 43  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 101 -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
            + +SDVY+FG++L EL+TG+ P      +  R  + + + +         L P +    
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDLSKVR 263
Query: 379 ANNLALEKILELALQCLAPRRQNRP 403
           +N    + +  L  +CL  +R  RP
Sbjct: 264 SN--CPKAMKRLMAECLKKKRDERP 286

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 74
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 75  VS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 130
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 186
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 187 IKSDVWSFGILLTELTTKGRVP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 24/265 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 20  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 78  -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
            + +SDVY+FG++L EL+TG+ P      +  R  + + + +         L P +    
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDLSKVR 240
Query: 379 ANNLALEKILELALQCLAPRRQNRP 403
           +N    + +  L  +CL  +R  RP
Sbjct: 241 SN--CPKAMKRLMAECLKKKRDERP 263

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 17  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 75  -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 129
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
            + +SDVY+FG++L EL+TG+ P
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 24/265 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 20  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 78  -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
            + +SDVY+FG++L EL+TG+ P      +  R  + + + +         L P +    
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDLSKVR 240
Query: 379 ANNLALEKILELALQCLAPRRQNRP 403
           +N    + +  L  +CL  +R  RP
Sbjct: 241 SN--CPKAMKRLMAECLKKKRDERP 263

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 116/227 (51%), Gaps = 19/227 (8%)
Query: 118 DQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSG 177
           D S   +I   E+  +TR       IG G FGTVYKG+      V I +      ++   
Sbjct: 26  DSSYYWEIEASEVMLSTR-------IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQA 78
Query: 178 AEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
             F++E+  L +  H+N++ F GY+  +D   ++ ++    +L +HL  +Q     +   
Sbjct: 79  --FRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLH-VQETKFQMFQL 134
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
           +DIA   A  + YLH      IIHRD+KS+NI L E    K+ DFG A + +   SG+  
Sbjct: 135 IDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW-SGSQQ 190
Query: 298 VSTQVKGTAGYLDPEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRP 341
           V  Q  G+  ++ PE ++       + +SDVYS+G++L EL+TG  P
Sbjct: 191 VE-QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 248 VS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 359
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 248 VS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 359
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 73  -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
            + +SDVY+FG++L EL+TG+ P
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 24/265 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 43  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 101 -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
            + +SDVY+FG++L EL+TG+ P      +  R  + + + +         L P +    
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDLSKVR 263
Query: 379 ANNLALEKILELALQCLAPRRQNRP 403
           +N    + +  L  +CL  +R  RP
Sbjct: 264 SN--CPKAMKRLMAECLKKKRDERP 286

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 24/265 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 35  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 93  -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 147
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
            + +SDVY+FG++L EL+TG+ P      +  R  + + + +         L P +    
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDLSKVR 255
Query: 379 ANNLALEKILELALQCLAPRRQNRP 403
           +N    + +  L  +CL  +R  RP
Sbjct: 256 SN--CPKAMKRLMAECLKKKRDERP 278

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 12/203 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              + +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 73  -STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
            + +SDVY+FG++L EL+TG+ P
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 133/277 (48%), Gaps = 31/277 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 31  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
                +  ++ ++    +L  HL   +    ++   +DIA   A  + YLH  +   IIH
Sbjct: 89  -STAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 319 LTEKSDVYSFGVLLVELVTGRRP---IEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
            + +SDVY+FG++L EL+TG+ P   I  + ++ E +                 L P + 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-------------GRGSLSPDLS 248
Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRC-AEI 411
              +N    +++  L  +CL  +R  RPS  R  AEI
Sbjct: 249 KVRSN--CPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
                +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH  +   IIH
Sbjct: 73  -STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A     +    +H   Q+ G+  ++ PE ++      
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLA--TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
            + +SDVY+FG++L EL+TG+ P
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 82  VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD+ ++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 85  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 140
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGTFT 196
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIP 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 83  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 138
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGTFT 194
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIP 216

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 78
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D++  +A  + Y+        +H
Sbjct: 79  VS-EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVH 134
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTA----PEAALYGRFT 190
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 191 IKSDVWSFGILLTELTTKGRVP 212

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 79  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 134
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGTFT 190
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIP 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 86  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 141
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGTFT 197
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIP 219

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/203 (37%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +   +E I IV EY+  G+L + L    G  L L   +D+A  +A  + Y+        +
Sbjct: 248 VS--EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQL 319
           HRD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 358
Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           T KSDV+SFG+LL EL T GR P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP 381

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGTFT 188
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 78  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 133
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGTFT 189
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIP 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGTFT 188
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       +   F  E + + ++ H  LV+ +  
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 78
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D++  +A  + Y+        +H
Sbjct: 79  VS-EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVH 134
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 190
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 191 IKSDVWSFGILLTELTTKGRVP 212

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 83  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 138
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 194
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIP 216

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       S   F  E + + ++ H  LV+ +  
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG---NMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 249 VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 304
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG  RL  D E  A       +K TA    PE     + T
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 360
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL EL T GR P
Sbjct: 361 IKSDVWSFGILLTELTTKGRVP 382

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 82  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 193
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIP 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 87  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 142
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 198
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIP 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 188
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 72  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 183
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIP 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VAIK  K       S   F  E + + +++H  LV+ +  
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES---FLEEAQIMKKLKHDKLVQLYAV 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L   +G  L L   +D+A  VA  + Y+        IH
Sbjct: 73  VS-EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIH 128
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++S+NIL+      K+ADFG ARL  D E  A       +K TA    PE     + T
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTA----PEAALYGRFT 184
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL ELVT GR P
Sbjct: 185 IKSDVWSFGILLTELVTKGRVP 206

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G   + T VA+K  K       S   F  E   +  ++H  LV+ +  
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   +I EY+  G+L + L   +G  + L   +D +  +A  + Y+        IH
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 133
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++N+L++E+   K+ADFG AR+  D E  A       +K TA    PE +     T
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGCFT 189
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
            KSDV+SFG+LL E+VT  +   P R   +       M   S G  +    PRVEN    
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPYPGRTNAD------VMTALSQGYRM----PRVENCP-- 237
Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
               +++ ++   C   + + RP+      +L
Sbjct: 238 ----DELYDIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 73  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 128
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           R+++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 184
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIP 206

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 107/202 (52%), Gaps = 13/202 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G  G V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A       +K TA    PE +     T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTA----PEAINYGTFT 188
Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 37/277 (13%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+ G   + T VA+K  K       +   F  E   +  ++H  LV+ +  
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAV 75
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   +I E++  G+L + L   +G  + L   +D +  +A  + Y+        IH
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++N+L++E+   K+ADFG AR+  D E  A       +K TA    PE +     T
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGCFT 188
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD-----PRVE 375
            KS+V+SFG+LL E+VT  +   P R               ++ D +S L      PR+E
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPYPGR---------------TNADVMSALSQGYRMPRME 233
Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           N        +++ ++   C   + + RP+      +L
Sbjct: 234 NCP------DELYDIMKMCWKEKAEERPTFDYLQSVL 264

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 150
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 259
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 260 -----YCPDPLYEVMLKCWHPKAEMRPSF 283

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 44/285 (15%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+       T VA+K  K       S   F +E   +  ++H  LVK H  
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I E++  G+L + L   +G+   L   +D +  +A  + ++        IH
Sbjct: 79  VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 134
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL++ +   K+ADFG AR+  D E  A       +K TA    PE +     T
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFT 190
Query: 321 EKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD-----PRV 374
            KSDV+SFG+LL+E+VT GR P                    S+ + I  L+     PR 
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIP----------------YPGMSNPEVIRALERGYRMPRP 234
Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
           EN        E++  + ++C     +NRP  R   E + SV  D+
Sbjct: 235 ENCP------EELYNIMMRCW----KNRPEERPTFEYIQSVLDDF 269

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 123/268 (45%), Gaps = 28/268 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 169
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPEY-- 279
Query: 377 TAANNLALEKILELALQCLAPRRQNRPS 404
                   + + E+ L+C  P+ + RPS
Sbjct: 280 ------CPDPLYEVMLKCWHPKAEMRPS 301

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 128/278 (46%), Gaps = 33/278 (11%)
Query: 143 IGQGGFGTVYKGRLEDGT-----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           IG G FG VYKG L+  +      VAIK  K   Y +    +F  E   + Q  H N+++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQG--NILDLAGRLDIAIDVAHAITYLHMYT 255
             G +      ++I EY+ NG L + L    G  ++L L G L     +A  + YL    
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYL---A 164
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
           +   +HRD+ + NIL+  N   KV+DFG +R+  D +  AT+ ++  K    +  PE + 
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPIRWTAPEAIS 223
Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV 374
             + T  SDV+SFG+++ E++T G RP          ++    MK  +DG    +  P  
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPY-------WELSNHEVMKAINDG--FRLPTPMD 274
Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
             +A        I +L +QC    R  RP       IL
Sbjct: 275 CPSA--------IYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 150
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 259
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 260 -----YCPDPLYEVMLKCWHPKAEMRPSF 283

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 146
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 255
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 256 -----YCPDPLYEVMLKCWHPKAEMRPSF 279

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 151
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 260
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 261 -----YCPDPLYEVMLKCWHPKAEMRPSF 284

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 151
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 260
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 261 -----YCPDPLYEVMLKCWHPKAEMRPSF 284

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 170
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPEY-- 280
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 281 ------CPDPLYEVMLKCWHPKAEMRPSF 303

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 143
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPEY-- 253
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 254 ------CPDPLYEVMLKCWHPKAEMRPSF 276

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 149
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 258
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 259 -----YCPDPLYEVMLKCWHPKAEMRPSF 282

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + YL     
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKYL---AS 148
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 257
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 258 -----YCPDPLYEVMLKCWHPKAEMRPSF 281

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + +L     
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFL---AS 210
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 319
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 320 -----YCPDPLYEVMLKCWHPKAEMRPSF 343

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 44/285 (15%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+       T VA+K  K       S   F +E   +  ++H  LVK H  
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I E++  G+L + L   +G+   L   +D +  +A  + ++        IH
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL++ +   K+ADFG AR+  D E  A       +K TA    PE +     T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFT 363
Query: 321 EKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD-----PRV 374
            KSDV+SFG+LL+E+VT GR P                    S+ + I  L+     PR 
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP----------------YPGMSNPEVIRALERGYRMPRP 407
Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY 419
           EN        E++  + ++C     +NRP  R   E + SV  D+
Sbjct: 408 ENCP------EELYNIMMRCW----KNRPEERPTFEYIQSVLDDF 442

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + +L     
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFL---AS 149
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 258
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 259 -----YCPDPLYEVMLKCWHPKAEMRPSF 282

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + +L     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFL---AS 151
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 260
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 261 -----YCPDPLYEVMLKCWHPKAEMRPSF 284

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + +L     
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFL---AS 152
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 261
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 262 -----YCPDPLYEVMLKCWHPKAEMRPSF 285

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 128/260 (49%), Gaps = 18/260 (6%)
Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQVEH 192
           +F     +G+G FG VY  R  +   I+A+K   K+  +K +G E Q   E+   + + H
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEK-AGVEHQLRREVEIQSHLRH 71
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            N+++ +GY        +I+EY P GT+   L  L  +  D         ++A+A++Y H
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SRFDEQRTATYITELANALSYCH 129
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 +IHRDIK  N+LL  N   K+ADFG++  A  +        T + GT  YL PE
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR------RTTLCGTLDYLPPE 180
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDAISI 369
            ++     EK D++S GVL  E + G  P E    +E   RI+ V++    F    A  +
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDL 240
Query: 370 LDPRVENTAANNLALEKILE 389
           +   +++ A+  L L ++LE
Sbjct: 241 ISRLLKHNASQRLTLAEVLE 260

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + +L     
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFL---AS 151
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 260
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 261 -----YCPDPLYEVMLKCWHPKAEMRPSF 284

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + +L     
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFL---AS 152
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 261
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 262 -----YCPDPLYEVMLKCWHPKAEMRPSF 285

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G L D     I  A KS   + D    ++F +E   +    H N++   
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 200 GY-LEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E   +V++ Y+ +G LR  +  +     + DL G     + VA  + +L     
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGMKFL---AS 156
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T  K    ++  E L+T
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
            + T KSDV+SFGVLL EL+T   P  P     + ITV     +        +L P    
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGR-------RLLQPE--- 265
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSM 405
                   + + E+ L+C  P+ + RPS 
Sbjct: 266 -----YCPDPLYEVMLKCWHPKAEMRPSF 289

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG AR+  D +  A + +   K    +  
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 120/217 (55%), Gaps = 28/217 (12%)
Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIK-------RAKKSVYDKHSGAEFQSEIRTLAQVEHL 193
           +IG+GGFG V+KGRL +D ++VAIK         +  + +K    EFQ E+  ++ + H 
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ--EFQREVFIMSNLNHP 83
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
           N+VK +G +   +   +++E+VP G L   L   + + +  + +L + +D+A  I Y+  
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQ- 139
Query: 254 YTDHPIIHRDIKSSNILLT---EN--FRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
             + PI+HRD++S NI L    EN    AKVADFG ++ +  + SG       + G   +
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG-------LLGNFQW 192
Query: 309 LDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRPIE 343
           + PE +   +   TEK+D YSF ++L  ++TG  P +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G FG   K    E G ++ +K   +  +D+ +   F  E++ +  +EH N++KF G 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 202 LEFEDERI-VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           L ++D+R+  I EY+  GTLR  +  +       + R+  A D+A  + YLH      II
Sbjct: 76  L-YKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST----------QVKGTAGYLD 310
           HRD+ S N L+ EN    VADFG ARL  D ++    + +           V G   ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           PE +      EK DV+SFG++L E++ GR   +P
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII-GRVNADP 223

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 118/217 (54%), Gaps = 28/217 (12%)
Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIK-------RAKKSVYDKHSGAEFQSEIRTLAQVEHL 193
           +IG+GGFG V+KGRL +D ++VAIK         +  + +K    EFQ E+  ++ + H 
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ--EFQREVFIMSNLNHP 83
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
           N+VK +G +   +   +++E+VP G L   L   + + +  + +L + +D+A  I Y+  
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQ- 139
Query: 254 YTDHPIIHRDIKSSNILLT---EN--FRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
             + PI+HRD++S NI L    EN    AKVADFG       T   + H  + + G   +
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-------TSQQSVHSVSGLLGNFQW 192
Query: 309 LDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRPIE 343
           + PE +   +   TEK+D YSF ++L  ++TG  P +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 150
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 151 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 206
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 207 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 250
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 251 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 133
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 189
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 233
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 234 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 160
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 161 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 216
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 217 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 260
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 261 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ EY+ NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG  R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 52/296 (17%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+       T VA+K  K       S   F +E   +  ++H  LVK H  
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I E++  G+L + L   +G+   L   +D +  +A  + ++        IH
Sbjct: 246 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 301
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD++++NIL++ +   K+ADFG AR+ A            +K TA    PE +     T 
Sbjct: 302 RDLRAANILVSASLVCKIADFGLARVGA---------KFPIKWTA----PEAINFGSFTI 348
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD-----PRVE 375
           KSDV+SFG+LL+E+VT GR P                    S+ + I  L+     PR E
Sbjct: 349 KSDVWSFGILLMEIVTYGRIP----------------YPGMSNPEVIRALERGYRMPRPE 392
Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQP 431
           N        E++  + ++C     +NRP  R   E + SV  D+     S    QP
Sbjct: 393 NCP------EELYNIMMRCW----KNRPEERPTFEYIQSVLDDFYTATESQXQQQP 438

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 127/260 (48%), Gaps = 18/260 (6%)
Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQVEH 192
           +F     +G+G FG VY  R  +   I+A+K   K+  +K +G E Q   E+   + + H
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEK-AGVEHQLRREVEIQSHLRH 71
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            N+++ +GY        +I+EY P GT+   L  L  +  D         ++A+A++Y H
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SRFDEQRTATYITELANALSYCH 129
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 +IHRDIK  N+LL  N   K+ADFG++  A  +          + GT  YL PE
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT------LCGTLDYLPPE 180
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDAISI 369
            ++     EK D++S GVL  E + G  P E    +E   RI+ V++    F    A  +
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDL 240
Query: 370 LDPRVENTAANNLALEKILE 389
           +   +++ A+  L L ++LE
Sbjct: 241 ISRLLKHNASQRLTLAEVLE 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 128/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T++ GT  YL
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TELCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 90
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 148
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 199
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 260 RDLISRLLKHNPSQRPMLREVLE 282

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 65
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 123
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR------TTLSGTLDYL 174
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLE 257

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 119/217 (54%), Gaps = 28/217 (12%)
Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIK-------RAKKSVYDKHSGAEFQSEIRTLAQVEHL 193
           +IG+GGFG V+KGRL +D ++VAIK         +  + +K    EFQ E+  ++ + H 
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ--EFQREVFIMSNLNHP 83
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
           N+VK +G +   +   +++E+VP G L   L   + + +  + +L + +D+A  I Y+  
Sbjct: 84  NIVKLYGLMH--NPPRMVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEYMQ- 139
Query: 254 YTDHPIIHRDIKSSNILLT---EN--FRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
             + PI+HRD++S NI L    EN    AKVADF  ++ +  + SG       + G   +
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSG-------LLGNFQW 192
Query: 309 LDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRPIE 343
           + PE +   +   TEK+D YSF ++L  ++TG  P +
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 67
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 125
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +   A      + GT  YL
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------LCGTLDYL 176
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLE 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 9/226 (3%)
Query: 120 SGNVQITMEEIY-RATRNFSPSFKIGQGGFG-TVYKGRLEDGTIVAIKRAKKSVYDKHSG 177
           S  V +  E +Y ++   +    KIG+G FG  +     EDG    IK    S       
Sbjct: 8   SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 178 AEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
            E + E+  LA ++H N+V++    E      ++++Y   G L + ++  +G +      
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
           LD  + +  A+ ++H   D  I+HRDIKS NI LT++   ++ DFG AR+   T      
Sbjct: 128 LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST----VE 180
Query: 298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           ++    GT  YL PE  +      KSD+++ G +L EL T +   E
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 81
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 139
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 190
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 191 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 250
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 251 RDLISRLLKHNPSQRPMLREVLE 273

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 69
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 127
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TDLCGTLDYL 178
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLE 261

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 135/293 (46%), Gaps = 43/293 (14%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I+E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNKF 187
Query: 320 TEKSDVYSFGVLLVELVT-GRRP---IEPKR--ELKERITVKWAMKKFSDGDAISILDPR 373
           + KSDV++FGVLL E+ T G  P   I+P +  EL E+                   D R
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK-------------------DYR 228
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
           +E         EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 229 MERPEG---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 275

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 65
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 123
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TDLCGTLDYL 174
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLE 257

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 67
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 125
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 176
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLE 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 69
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 127
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 178
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLE 261

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 91/293 (31%), Positives = 134/293 (45%), Gaps = 43/293 (14%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G FG VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNKF 187
Query: 320 TEKSDVYSFGVLLVELVT-GRRP---IEPKR--ELKERITVKWAMKKFSDGDAISILDPR 373
           + KSDV++FGVLL E+ T G  P   I+P +  EL E+                   D R
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK-------------------DYR 228
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
           +E         EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 229 MERPEG---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 275

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TDLCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TDLCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 69
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 127
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 178
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 239 RDLISRLLKHNPSQRPXLREVLE 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +   A      + GT  YL
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------LCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+ +    VA+K  K+      S  EF  E +T+ ++ H  LVKF+G 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEG---SMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              E    ++ EY+ NG L  +L    G  L+ +  L++  DV   + +L     H  IH
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGYLDPEYLKTYQL 319
           RD+ + N L+  +   KV+DFG  R   D +   + V T+  VK +A    PE    ++ 
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSA----PEVFHYFKY 182
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIE 343
           + KSDV++FG+L+ E+ + G+ P +
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TXLCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 63
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 121
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 172
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 232
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 233 RDLISRLLKHNPSQRPMLREVLE 255

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 69
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P G + + L  L     D         ++A+A++
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYITELANALS 127
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 178
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLE 261

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 128/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R ++   I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +   A      + GT  YL
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA------LCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    ++  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ E + NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 133
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 189
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 190 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 233
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 234 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 68
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 126
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 177
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 237
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 238 RDLISRLLKHNPSQRPMLREVLE 260

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ E + NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 67
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 125
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 176
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLE 259

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 136/288 (47%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I+E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 134
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNKF 190
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 236
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 237 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 278

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 42/289 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV---YDKHSGAEFQSEIRTLAQVEH 192
           N S    +G G FG V  GRL+  +   I  A K++   Y +    +F  E   + Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDIAIDVAHAITY 250
            N+++  G +      +++ E + NG+L   L     Q  ++ L G L     +A  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKY 162
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           L   +D   +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  
Sbjct: 163 L---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTS 218
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
           PE +   + T  SDV+S+G++L E+++ G RP              W M   S+ D I  
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEM---SNQDVIKA 262
Query: 370 LD------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +D      P ++  AA       + +L L C    R NRP   +   IL
Sbjct: 263 VDEGYRLPPPMDCPAA-------LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 201 YLEFEDERIVIVEYVPNGTLREHL-DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
               E    ++ EY+P G L ++L +C +  +  +   L +A  ++ A+ YL        
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVV-LLYMATQISSAMEYLE---KKNF 151
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IHRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L    
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNT 207
Query: 319 LTEKSDVYSFGVLLVELVT-GRRP 341
            + KSDV++FGVLL E+ T G  P
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 130/300 (43%), Gaps = 66/300 (22%)
Query: 124 QITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA--EFQ 181
           ++T+EEI            IG GGFG VY+     G  VA+K A+    +  S      +
Sbjct: 8   ELTLEEI------------IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVR 54
Query: 182 SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
            E +  A ++H N++   G    E    +++E+   G L      L G  +     ++ A
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNR---VLSGKRIPPDILVNWA 111
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTE--------NFRAKVADFGFARLAADTES 293
           + +A  + YLH     PIIHRD+KSSNIL+ +        N   K+ DFG AR       
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------- 164
Query: 294 GATHVSTQVK--GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER 351
              H +T++   G   ++ PE ++    ++ SDV+S+GVLL EL+TG  P          
Sbjct: 165 -EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--------- 214
Query: 352 ITVKWAMKKFSDGDAISILDPRVENTAANNLAL-------EKILELALQCLAPRRQNRPS 404
                   +  DG A++         A N LAL       E   +L   C  P   +RPS
Sbjct: 215 --------RGIDGLAVAY------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPS 260

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 90
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 148
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +          + GT  YL
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------DDLCGTLDYL 199
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 260 RDLISRLLKHNPSQRPMLREVLE 282

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 66
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 124
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+A+FG++  A  +        T + GT  YL
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR------TTLCGTLDYL 175
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 236 RDLISRLLKHNPSQRPMLREVLE 258

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 66
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 124
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +          + GT  YL
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------XXLCGTLDYL 175
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 236 RDLISRLLKHNPSQRPMLREVLE 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 65
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 123
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +          + GT  YL
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT------LCGTLDYL 174
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLE 257

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R  +   I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 61
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 119
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------TTLCGTLDYL 170
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 171 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 230
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 231 RDLISRLLKHNPSQRPMLREVLE 253

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 69
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P G + + L  L     D         ++A+A++
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYITELANALS 127
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +          + GT  YL
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------XXLXGTLDYL 178
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLE 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 67
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 125
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+A+FG++  A  +        T + GT  YL
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR------TTLCGTLDYL 176
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLE 259

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 134/293 (45%), Gaps = 43/293 (14%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTA----PESLAYNKF 187
Query: 320 TEKSDVYSFGVLLVELVT-GRRP---IEPKR--ELKERITVKWAMKKFSDGDAISILDPR 373
           + KSDV++FGVLL E+ T G  P   I+P +  EL E+                   D R
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK-------------------DYR 228
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
           +E         EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 229 MERPEG---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 275

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I+E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 189
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 235
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 236 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 277

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 134
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA----PESLAYNKF 190
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 236
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 237 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 278

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 64
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 122
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +          + GT  YL
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------XXLCGTLDYL 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 234 RDLISRLLKHNPSQRPMLREVLE 256

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I+E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 189
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 235
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 236 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 277

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I+E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 194
Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSDV++FGVLL E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA----PESLAYNKF 191
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 237
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 238 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 279

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 194
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 240
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 241 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 282

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 134/305 (43%), Gaps = 45/305 (14%)
Query: 126 TMEEIYRATRNFSPSFK---------IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVY 172
           T E+  +A R F+             IG G FG V  GRL+        VAIK  K    
Sbjct: 11  TFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT 70
Query: 173 DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQG--N 230
           DK    +F SE   + Q +H N++   G +      ++I EY+ NG+L   L    G   
Sbjct: 71  DKQR-RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
           ++ L G L     +   + YL   +D   +HRD+ + NIL+  N   KV+DFG +R+  D
Sbjct: 130 VIQLVGMLR---GIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELK 349
            +  A + +   K    +  PE +   + T  SDV+S+G+++ E+++ G RP        
Sbjct: 184 -DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------- 235
Query: 350 ERITVKWAMKKFSDGDAISILDP--RVENTAANNLALEKILELALQCLAPRRQNRPSMRR 407
                 W M   S+ D I  ++   R+       +AL    +L L C    R +RP   +
Sbjct: 236 ------WDM---SNQDVIKAIEEGYRLPPPMDCPIALH---QLMLDCWQKERSDRPKFGQ 283
Query: 408 CAEIL 412
              +L
Sbjct: 284 IVNML 288

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 146
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 202
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 203 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 248
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 249 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 290

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 67
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 125
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +          + GT  YL
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------XXLCGTLDYL 176
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLE 259

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQ 189
           A  +F     +G+G FG VY  R +    I+A+K   K+  +K +G E Q   E+   + 
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSH 67
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           + H N+++ +GY        +I+EY P GT+   L  L     D         ++A+A++
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALS 125
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y H      +IHRDIK  N+LL      K+ADFG++  A  +          + GT  YL
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------DDLCGTLDYL 176
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERIT-VKWAMKKFSDGDA 366
            PE ++     EK D++S GVL  E + G+ P E    +E  +RI+ V++    F    A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 367 ISILDPRVENTAANNLALEKILE 389
             ++   +++  +    L ++LE
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLE 259

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V +GRL+      + VAIK  K   Y +    EF SE   + Q EH N+++ 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG-YTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      +++ E++ NG L   L    G   ++ L G L     +A  + YL    +
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYL---AE 134
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-----QVKGTAGYLDP 311
              +HRD+ + NIL+  N   KV+DFG +R   +  S  T+ S+      ++ TA    P
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTA----P 190
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           E +   + T  SD +S+G+++ E+++ G RP
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 191
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 237
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 238 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 279

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 191
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 237
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 238 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 279

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNKF 194
Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSDV++FGVLL E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 134/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 194
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 240
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 241 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 282

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           IG+G FG V  G    G  VA+K  K       +   F +E   + Q+ H NLV+  G +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 203 EFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
             E   + IV EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N+L++E+  AKV+DFG  + A+ T+         VK TA    PE L+  + + 
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTA----PEALREKKFST 365
Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
           KSDV+SFG+LL E+ +  R   P+  LK+ +
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 133/287 (46%), Gaps = 31/287 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HR++ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 435
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA 379
           + KSDV++FGVLL E+ T      P  +L +   +   ++K          D R+E    
Sbjct: 436 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEK----------DYRMERPEG 482
Query: 380 NNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 483 ---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 523

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 134/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 189
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 235
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 236 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 277

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/288 (30%), Positives = 134/288 (46%), Gaps = 33/288 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 189
Query: 320 TEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           + KSDV++FGVLL E+ T G  P  P  +L +   +   ++K          D R+E   
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYEL---LEK----------DYRMERPE 235
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                 EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 236 G---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 277

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  K+      S  +F  E   + ++ H  LV+ +G 
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEG---SMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   +G +      L + +DV   + YL    +  +IH
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIH 146
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ EN   KV+DFG  R   D +  +   ST  K    +  PE     + + 
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSS 203
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           KSDV+SFGVL+ E+ + G+ P E +   E+ E I+  + + K           PR+ +T 
Sbjct: 204 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------PRLAST- 251
Query: 379 ANNLALEKILELALQCLAPRRQNRPS----MRRCAEI 411
                   + ++   C   R ++RP+    +R+ AEI
Sbjct: 252 -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           IG+G FG V  G    G  VA+K  K       +   F +E   + Q+ H NLV+  G +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 203 EFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
             E   + IV EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N+L++E+  AKV+DFG  + A+ T+         VK TA    PE L+  + + 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTA----PEALREKKFST 178
Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
           KSDV+SFG+LL E+ +  R   P+  LK+ +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 16/211 (7%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           IG+G FG V  G    G  VA+K  K       +   F +E   + Q+ H NLV+  G +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 203 EFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
             E   + IV EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N+L++E+  AKV+DFG  + A+ T+         VK TA    PE L+  + + 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTA----PEALREKKFST 193
Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
           KSDV+SFG+LL E+ +  R   P+  LK+ +
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 36/279 (12%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V  GRL+        VAIK  K    DK    +F SE   + Q +H N++  
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNIIHL 74
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQG--NILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      ++I EY+ NG+L   L    G   ++ L G L     +   + YL   +D
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYL---SD 128
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  PE +  
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP--R 373
            + T  SDV+S+G+++ E+++ G RP              W M   S+ D I  ++   R
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGERPY-------------WDM---SNQDVIKAIEEGYR 231
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +       +AL    +L L C    R +RP   +   +L
Sbjct: 232 LPPPMDCPIALH---QLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 36/279 (12%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V  GRL+        VAIK  K    DK    +F SE   + Q +H N++  
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNIIHL 80
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQG--NILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      ++I EY+ NG+L   L    G   ++ L G L     +   + YL   +D
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYL---SD 134
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  PE +  
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP--R 373
            + T  SDV+S+G+++ E+++ G RP              W M   S+ D I  ++   R
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGERPY-------------WDM---SNQDVIKAIEEGYR 237
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +       +AL    +L L C    R +RP   +   +L
Sbjct: 238 LPPPMDCPIALH---QLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 194
Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSDV++FGVLL E+ T G  P
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 31/287 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HR++ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA 379
           + KSDV++FGVLL E+ T      P  +L +   +   ++K          D R+E    
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEK----------DYRMERPEG 443
Query: 380 NNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
                EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 444 ---CPEKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 484

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V +GRL+      + VAIK  K   Y +    EF SE   + Q EH N+++ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG-YTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      +++ E++ NG L   L    G   ++ L G L     +A  + YL    +
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYL---AE 136
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-----QVKGTAGYLDP 311
              +HRD+ + NIL+  N   KV+DFG +R   +  S  T  S+      ++ TA    P
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTA----P 192
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           E +   + T  SD +S+G+++ E+++ G RP
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 137
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 193
Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSDV++FGVLL E+ T G  P
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSP 216

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++      S  +F  E   + ++ H  LV+ +G 
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   +G +      L + +DV   + YL    +  +IH
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIH 124
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ EN   KV+DFG  R   D +  +   ST  K    +  PE     + + 
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSS 181
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           KSDV+SFGVL+ E+ + G+ P E +   E+ E I+  + + K           PR+ +T 
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------PRLAST- 229
Query: 379 ANNLALEKILELALQCLAPRRQNRPS----MRRCAEI 411
                   + ++   C   R ++RP+    +R+ AEI
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY-----DKHSGAEFQSEIRTLAQVEHLNLV 196
           K+G GG  TVY   L + TI+ IK A K+++      + +   F+ E+   +Q+ H N+V
Sbjct: 18  KLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                 E +D   +++EY+   TL E+++      +D A  ++    +   I + H   D
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTA--INFTNQILDGIKHAH---D 129
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             I+HRDIK  NIL+  N   K+ DFG A+  ++T    T+    V GT  Y  PE  K 
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYFSPEQAKG 186
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
               E +D+YS G++L E++ G  P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 133/303 (43%), Gaps = 41/303 (13%)
Query: 126 TMEEIYRATRNFSPSFK---------IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY 172
           T EE  RA R+F+   +         IG G  G V  GRL    +    VAIK A K+ Y
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK-ALKAGY 89
Query: 173 DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN-- 230
            +    +F SE   + Q +H N+++  G +      +++ EY+ NG+L   L    G   
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
           I+ L G L     V   + YL   +D   +HRD+ + N+L+  N   KV+DFG +R+  D
Sbjct: 150 IMQLVGMLR---GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVE-LVTGRRPIEPKRELK 349
            +  A + +T  K    +  PE +     +  SDV+SFGV++ E L  G RP        
Sbjct: 204 -DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------- 255
Query: 350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCA 409
                 W M   ++ D IS ++      A        + +L L C    R  RP   +  
Sbjct: 256 ------WNM---TNRDVISSVEEGYRLPAPMGCP-HALHQLMLDCWHKDRAQRPRFSQIV 305
Query: 410 EIL 412
            +L
Sbjct: 306 SVL 308

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 189
Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSDV++FGVLL E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++      S  +F  E   + ++ H  LV+ +G 
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   +G +      L + +DV   + YL    +  +IH
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIH 126
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ EN   KV+DFG  R   D +  +   ST  K    +  PE     + + 
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSS 183
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           KSDV+SFGVL+ E+ + G+ P E +   E+ E I+  + + K           PR+ +T 
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------PRLAST- 231
Query: 379 ANNLALEKILELALQCLAPRRQNRPS----MRRCAEI 411
                   + ++   C   R ++RP+    +R+ AEI
Sbjct: 232 -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 32/269 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++    +    +F  E   + ++ H  LV+ +G 
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   +G +      L + +DV   + YL    +  +IH
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EASVIH 126
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ EN   KV+DFG  R   D +  +   ST  K    +  PE     + + 
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSS 183
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           KSDV+SFGVL+ E+ + G+ P E +   E+ E I+  + + K           PR+ +T 
Sbjct: 184 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------PRLAST- 231
Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRR 407
                   + ++   C   R ++RP+  R
Sbjct: 232 -------HVYQIMNHCWKERPEDRPAFSR 253

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       ++    L +A  ++ A+ YL        I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARL-AADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL   DT +        +K TA    PE L   + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 189
Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSDV++FGVLL E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++      S  +F  E   + ++ H  LV+ +G 
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   +G +      L + +DV   + YL    +  +IH
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIH 129
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ EN   KV+DFG  R   D +  +   ST  K    +  PE     + + 
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSS 186
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           KSDV+SFGVL+ E+ + G+ P E +   E+ E I+  + + K           PR+ +T 
Sbjct: 187 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------PRLAST- 234
Query: 379 ANNLALEKILELALQCLAPRRQNRPS----MRRCAEI 411
                   + ++   C   R ++RP+    +R+ AEI
Sbjct: 235 -------HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           IG+G FG V  G    G  VA+K  K       +   F +E   + Q+ H NLV+  G +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 203 EFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
             E   + IV EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N+L++E+  AKV+DFG  + A+ T+         VK TA    PE L+    + 
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTA----PEALREAAFST 184
Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
           KSDV+SFG+LL E+ +  R   P+  LK+ +
Sbjct: 185 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++      S  +F  E   + ++ H  LV+ +G 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   +G +      L + +DV   + YL    +  +IH
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLE---EACVIH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ EN   KV+DFG  R   D +  +   ST  K    +  PE     + + 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRYSS 184
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           KSDV+SFGVL+ E+ + G+ P E +   E+ E I+  + + K           PR+ +T 
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-----------PRLAST- 232
Query: 379 ANNLALEKILELALQCLAPRRQNRPS----MRRCAEI 411
                   + ++   C   R ++RP+    +R+ AEI
Sbjct: 233 -------HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G FG V+ GRL  D T+VA+K  ++++      A+F  E R L Q  H N+V+  G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               +    +++E V  G     L   +G  L +   L +  D A  + YL        I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+ + N L+TE    K++DFG +R  AD    A+    QV     +  PE L   + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV--PVKWTAPEALNYGRYS 293
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
            +SDV+SFG+LL E  T      P   L  + T     ++F +                 
Sbjct: 294 SESDVWSFGILLWE--TFSLGASPYPNLSNQQT-----REFVEKGG---------RLPCP 337
Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
            L  + +  L  QC A     RPS     + L S+RK +R
Sbjct: 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 131/303 (43%), Gaps = 41/303 (13%)
Query: 126 TMEEIYRATRNFSPSFK---------IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVY 172
           T E+  RA   F+             IG G FG V  GRL+        VAIK  K   Y
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG-Y 83
Query: 173 DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN-- 230
            +    +F  E   + Q +H N+V   G +      ++++E++ NG L   L    G   
Sbjct: 84  TEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
           ++ L G L     +A  + YL    D   +HRD+ + NIL+  N   KV+DFG +R+  D
Sbjct: 144 VIQLVGMLR---GIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED 197
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELK 349
            +  A + +T  K    +  PE ++  + T  SDV+S+G+++ E+++ G RP        
Sbjct: 198 -DPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY------- 249
Query: 350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCA 409
                 W M   S+ D I  ++      A  +     + +L L C    R  RP   +  
Sbjct: 250 ------WDM---SNQDVIKAIEEGYRLPAPMDCP-AGLHQLMLDCWQKERAERPKFEQIV 299
Query: 410 EIL 412
            IL
Sbjct: 300 GIL 302

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 37/275 (13%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           +G+G FG V K +      VAIK+ +     K     F  E+R L++V H N+VK +G  
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESESERK----AFIVELRQLSRVNHPNIVKLYG-- 69
Query: 203 EFEDERIVIVEYVPNGTLREHLDCLQGN----ILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              +   +++EY   G+L    + L G         A  +   +  +  + YLH      
Sbjct: 70  ACLNPVCLVMEYAEGGSL---YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 259 IIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           +IHRD+K  N+LL       K+ DFG    A D +   TH+ T  KG+A ++ PE  +  
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFG---TACDIQ---THM-TNNKGSAAWMAPEVFEGS 179
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
             +EK DV+S+G++L E++T R+P +       RI   WA+   +    I  L   +E+ 
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRPPLIKNLPKPIES- 236
Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                       L  +C +     RPSM    +I+
Sbjct: 237 ------------LMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 37/275 (13%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           +G+G FG V K +      VAIK+ +     K     F  E+R L++V H N+VK +G  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERK----AFIVELRQLSRVNHPNIVKLYG-- 68
Query: 203 EFEDERIVIVEYVPNGTLREHLDCLQGN----ILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              +   +++EY   G+L    + L G         A  +   +  +  + YLH      
Sbjct: 69  ACLNPVCLVMEYAEGGSL---YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 259 IIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           +IHRD+K  N+LL       K+ DFG    A D +   TH+ T  KG+A ++ PE  +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFG---TACDIQ---THM-TNNKGSAAWMAPEVFEGS 178
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
             +EK DV+S+G++L E++T R+P +       RI   WA+   +    I  L   +E+ 
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGTRPPLIKNLPKPIES- 235
Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                       L  +C +     RPSM    +I+
Sbjct: 236 ------------LMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 118/253 (46%), Gaps = 15/253 (5%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRA-KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G F  VY+   +  G  VAIK   KK++Y        Q+E++   Q++H ++++ + 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           Y E  +   +++E   NG +  +L        +   R      +   + YLH    H I+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLH---SHGIL 134
Query: 261 HRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+  SN+LLT N   K+ADFG A +L    E   T     + GT  Y+ PE       
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-----LCGTPNYISPEIATRSAH 189
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEP---KRELKERITVKWAMKKFSDGDAISILDPRVEN 376
             +SDV+S G +   L+ GR P +    K  L + +   + M  F   +A  ++   +  
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 377 TAANNLALEKILE 389
             A+ L+L  +L+
Sbjct: 250 NPADRLSLSSVLD 262

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 125/280 (44%), Gaps = 24/280 (8%)
Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G FG V+ GRL  D T+VA+K  ++++      A+F  E R L Q  H N+V+  G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               +    +++E V  G     L   +G  L +   L +  D A  + YL        I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+ + N L+TE    K++DFG +R  AD    A+    QV     +  PE L   + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEALNYGRYS 293
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
            +SDV+SFG+LL E  T      P   L  + T     ++F +                 
Sbjct: 294 SESDVWSFGILLWE--TFSLGASPYPNLSNQQT-----REFVEKGG---------RLPCP 337
Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
            L  + +  L  QC A     RPS     + L S+RK +R
Sbjct: 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 132/303 (43%), Gaps = 41/303 (13%)
Query: 126 TMEEIYRATRNFSPSFK---------IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY 172
           T EE  RA R+F+   +         IG G  G V  GRL    +    VAIK A K+ Y
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK-ALKAGY 89
Query: 173 DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN-- 230
            +    +F SE   + Q +H N+++  G +      +++ EY+ NG+L   L    G   
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
           I+ L G L     V   + YL   +D   +HRD+ + N+L+  N   KV+DFG +R+  D
Sbjct: 150 IMQLVGMLR---GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVE-LVTGRRPIEPKRELK 349
            +  A   +T  K    +  PE +     +  SDV+SFGV++ E L  G RP        
Sbjct: 204 -DPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY------- 255
Query: 350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCA 409
                 W M   ++ D IS ++      A        + +L L C    R  RP   +  
Sbjct: 256 ------WNM---TNRDVISSVEEGYRLPAPMGCP-HALHQLMLDCWHKDRAQRPRFSQIV 305
Query: 410 EIL 412
            +L
Sbjct: 306 SVL 308

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 134/310 (43%), Gaps = 53/310 (17%)
Query: 126 TMEEIYRATRNFSPSFKI---------GQGGFGTVYKGRLE----DGTIVAIKRAKKSVY 172
           T E+   A R F+    I         G G FG V  G L+        VAIK   KS Y
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK-TLKSGY 73
Query: 173 DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN-- 230
            +    +F SE   + Q +H N++   G +      ++I E++ NG+L   L    G   
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
           ++ L G L     +A  + YL    D   +HRD+ + NIL+  N   KV+DFG +R   D
Sbjct: 134 VIQLVGMLR---GIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 291 TESGATHVST-----QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEP 344
             S  T+ S       ++ TA    PE ++  + T  SDV+S+G+++ E+++ G RP   
Sbjct: 188 DTSDPTYTSALGGKIPIRWTA----PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-- 241
Query: 345 KRELKERITVKWAMKKFSDGDAISIL--DPRVENTAANNLALEKILELALQCLAPRRQNR 402
                      W M   ++ D I+ +  D R+        AL    +L L C    R +R
Sbjct: 242 -----------WDM---TNQDVINAIEQDYRLPPPMDCPSALH---QLMLDCWQKDRNHR 284
Query: 403 PSMRRCAEIL 412
           P   +    L
Sbjct: 285 PKFGQIVNTL 294

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 18/228 (7%)
Query: 120 SGNVQITMEEIYRATRN----FSPSFKIGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYD 173
           S  V +  E +Y  + +    F+   KIG+G FG V+KG +++ T  +VAIK       +
Sbjct: 8   SSGVDLGTENLYFQSMDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAE 66
Query: 174 KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD 233
                  Q EI  L+Q +   + K++G    + +  +I+EY+  G+    LD L+   LD
Sbjct: 67  DEIEDI-QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPLD 122
Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
                 I  ++   + YLH       IHRDIK++N+LL+E+   K+ADFG A    DT+ 
Sbjct: 123 ETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 178
Query: 294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                +T V GT  ++ PE +K      K+D++S G+  +EL  G  P
Sbjct: 179 --IKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 21/284 (7%)
Query: 142 KIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R +      G +VA+K+ + S  D+    +FQ EI+ L  +    +V
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSDFIV 71
Query: 197 KFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  Y     E  +++EY+P+G LR+ L   +   LD +  L  +  +   + YL   
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--- 127
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                +HRD+ + NIL+      K+ADFG A+L    +     V    +    +  PE L
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDXXVVREPGQSPIFWYAPESL 186
Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
                + +SDV+SFGV+L EL T   +   P  E    +  +  +        +     R
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 246
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCA---EILWS 414
           +    A    + ++++L   C AP  Q+RPS        ++LWS
Sbjct: 247 LPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDMLWS 287

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 111/243 (45%), Gaps = 48/243 (19%)
Query: 128 EEIYRATRNFSPSFK----IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQS 182
           E  Y   + F   FK    IG GGFG V+K +   DG    I+R K      ++  + + 
Sbjct: 1   ETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVK------YNNEKAER 54
Query: 183 EIRTLAQVEHLNLVKFHGYL-------EFEDERI----------------------VIVE 213
           E++ LA+++H+N+V ++G         E  D+ +                      + +E
Sbjct: 55  EVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQME 114
Query: 214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE 273
           +   GTL + ++  +G  LD    L++   +   + Y+H      +IHRD+K SNI L +
Sbjct: 115 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVD 171
Query: 274 NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLV 333
             + K+ DFG       T        T+ KGT  Y+ PE + +    ++ D+Y+ G++L 
Sbjct: 172 TKQVKIGDFGLV-----TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILA 226
Query: 334 ELV 336
           EL+
Sbjct: 227 ELL 229

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V  GRL+        VAIK  K   Y +    +F  E   + Q +H N++  
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      +++ EY+ NG+L   L    G   ++ L G L     ++  + YL   +D
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GISAGMKYL---SD 142
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              +HRD+ + NIL+  N   KV+DFG +R+  D +  A + +   K    +  PE +  
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP--R 373
            + T  SDV+S+G+++ E+V+ G RP              W M   ++ D I  ++   R
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPY-------------WEM---TNQDVIKAVEEGYR 245
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           + +      AL    +L L C    R +RP       +L
Sbjct: 246 LPSPMDCPAAL---YQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 119/253 (47%), Gaps = 26/253 (10%)
Query: 143 IGQGGFGTVYKGRLEDGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +GQG FG V+  +   G+    + A+K  KK+          + E   L +V H  +VK 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLD----CLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           H   + E +  +I++++  G L   L       + ++      L +A+D  H++      
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG----- 146
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               II+RD+K  NILL E    K+ DFG ++ + D E  A        GT  Y+ PE +
Sbjct: 147 ----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVV 198
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV----KWAMKKFSDGDAISIL 370
                T+ +D +SFGVL+ E++TG  P + K + KE +T+    K  M +F   +A S+L
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAKLGMPQFLSPEAQSLL 257
Query: 371 DPRVENTAANNLA 383
               +   AN L 
Sbjct: 258 RMLFKRNPANRLG 270

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           F+   KIG+G FG V+KG +++ T  +VAIK       +       Q EI  L+Q +   
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPY 81
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           + K++G    + +  +I+EY+  G+    LD L+   LD      I  ++   + YLH  
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                IHRDIK++N+LL+E+   K+ADFG A    DT+           GT  ++ PE +
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK----RNXFVGTPFWMAPEVI 191
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           K      K+D++S G+  +EL  G  P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG G FG V  G L+        VAIK   KS Y +    +F SE   + Q +H N++  
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIK-TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
            G +      ++I E++ NG+L   L    G   ++ L G L     +A  + YL    D
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---AD 127
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-----QVKGTAGYLDP 311
              +HR + + NIL+  N   KV+DFG +R   D  S  T+ S       ++ TA    P
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA----P 183
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           E ++  + T  SDV+S+G+++ E+++ G RP
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 26/253 (10%)
Query: 143 IGQGGFGTVYK----GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +GQG FG V+      R + G + A+K  KK+          + E   LA V H  +VK 
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLD----CLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           H   + E +  +I++++  G L   L       + ++      L + +D  H++      
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLG----- 150
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               II+RD+K  NILL E    K+ DFG ++ A D E  A        GT  Y+ PE +
Sbjct: 151 ----IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC----GTVEYMAPEVV 202
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV----KWAMKKFSDGDAISIL 370
                +  +D +S+GVL+ E++TG  P + K + KE +T+    K  M +F   +A S+L
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLPFQGK-DRKETMTLILKAKLGMPQFLSTEAQSLL 261
Query: 371 DPRVENTAANNLA 383
               +   AN L 
Sbjct: 262 RALFKRNPANRLG 274

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G GGFG V +   +D G  VAIK+ ++ +  K+    +  EI+ + ++ H N+V    
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR-ERWCLEIQIMKKLNHPNVVSARE 80
Query: 201 Y------LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI-DVAHAITYLHM 253
                  L   D  ++ +EY   G LR++L+  +       G +   + D++ A+ YLH 
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 139
Query: 254 YTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
             ++ IIHRD+K  NI+L    +    K+ D G+A+     E     + T+  GT  YL 
Sbjct: 140 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-----ELDQGELCTEFVGTLQYLA 192
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           PE L+  + T   D +SFG L  E +TG RP  P
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G GGFG V +   +D G  VAIK+ ++ +  K+    +  EI+ + ++ H N+V    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR-ERWCLEIQIMKKLNHPNVVSARE 79
Query: 201 Y------LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI-DVAHAITYLHM 253
                  L   D  ++ +EY   G LR++L+  +       G +   + D++ A+ YLH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 254 YTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
             ++ IIHRD+K  NI+L    +    K+ D G+A+     E     + T+  GT  YL 
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-----ELDQGELCTEFVGTLQYLA 191
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           PE L+  + T   D +SFG L  E +TG RP  P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  LV+ +G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ +    KV+DFG +R   D E  +   S   K    +  PE L   + + 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS---SVGSKFPVRWSPPEVLMYSKFSS 200
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           KSD+++FGVL+ E+ + G+ P        ER T     +  + G  + +  P        
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG--LRLYRP-------- 243
Query: 381 NLALEKILELALQCLAPRRQNRPSMR 406
           +LA EK+  +   C   +   RP+ +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFK 269

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           F+   KIG+G FG V+KG +++ T  +VAIK       +       Q EI  L+Q +   
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPY 66
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           + K++G    + +  +I+EY+  G+    LD L+   LD      I  ++   + YLH  
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILREILKGLDYLH-- 121
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                IHRDIK++N+LL+E+   K+ADFG A    DT+      +T V GT  ++ PE +
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRNTFV-GTPFWMAPEVI 176
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           K      K+D++S G+  +EL  G  P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           F+   KIG+G FG V+KG +++ T  +VAIK       +       Q EI  L+Q +   
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPY 66
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           + K++G    + +  +I+EY+  G+    LD L+   LD      I  ++   + YLH  
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILREILKGLDYLH-- 121
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                IHRDIK++N+LL+E+   K+ADFG A    DT+           GT  ++ PE +
Sbjct: 122 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK----RNXFVGTPFWMAPEVI 176
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           K      K+D++S G+  +EL  G  P
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  LV+ +G 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ +    KV+DFG +R   D E  ++  S   K    +  PE L   + + 
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGS---KFPVRWSPPEVLMYSKFSS 185
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           KSD+++FGVL+ E+ + G+ P        ER T     +  + G  + +  P        
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG--LRLYRP-------- 228
Query: 381 NLALEKILELALQCLAPRRQNRPSMR 406
           +LA EK+  +   C   +   RP+ +
Sbjct: 229 HLASEKVYTIMYSCWHEKADERPTFK 254

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  LV+ +G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ +    KV+DFG +R   D E  +   S   K    +  PE L   + + 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS---SVGSKFPVRWSPPEVLMYSKFSS 200
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           KSD+++FGVL+ E+ + G+ P        ER T     +  + G  + +  P        
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG--LRLYRP-------- 243
Query: 381 NLALEKILELALQCLAPRRQNRPSMR 406
           +LA EK+  +   C   +   RP+ +
Sbjct: 244 HLASEKVYTIMYSCWHEKADERPTFK 269

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 119/253 (47%), Gaps = 26/253 (10%)
Query: 143 IGQGGFGTVYKGRLEDGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +GQG FG V+  +   G+    + A+K  KK+          + E   L +V H  +VK 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLD----CLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           H   + E +  +I++++  G L   L       + ++      L +A+D  H++      
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG----- 146
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               II+RD+K  NILL E    K+ DFG ++ + D E  A        GT  Y+ PE +
Sbjct: 147 ----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVV 198
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV----KWAMKKFSDGDAISIL 370
                T+ +D +SFGVL+ E++TG  P + K + KE +T+    K  M +F   +A S+L
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAKLGMPQFLSPEAQSLL 257
Query: 371 DPRVENTAANNLA 383
               +   AN L 
Sbjct: 258 RMLFKRNPANRLG 270

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 119/253 (47%), Gaps = 26/253 (10%)
Query: 143 IGQGGFGTVYKGRLEDGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +GQG FG V+  +   G+    + A+K  KK+          + E   L +V H  +VK 
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLD----CLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           H   + E +  +I++++  G L   L       + ++      L +A+D  H++      
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG----- 147
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               II+RD+K  NILL E    K+ DFG ++ + D E  A        GT  Y+ PE +
Sbjct: 148 ----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVV 199
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV----KWAMKKFSDGDAISIL 370
                T+ +D +SFGVL+ E++TG  P + K + KE +T+    K  M +F   +A S+L
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAKLGMPQFLSPEAQSLL 258
Query: 371 DPRVENTAANNLA 383
               +   AN L 
Sbjct: 259 RMLFKRNPANRLG 271

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  LV+ +G 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLH 127
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ +    KV+DFG +R   D E  +   S   K    +  PE L   + + 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS---SVGSKFPVRWSPPEVLMYSKFSS 184
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           KSD+++FGVL+ E+ + G+ P        ER T     +  + G  + +  P        
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG--LRLYRP-------- 227
Query: 381 NLALEKILELALQCLAPRRQNRPSMR 406
           +LA EK+  +   C   +   RP+ +
Sbjct: 228 HLASEKVYTIMYSCWHEKADERPTFK 253

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 21/284 (7%)
Query: 142 KIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R +      G +VA+K+ + S  D+    +FQ EI+ L  +    +V
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSDFIV 87
Query: 197 KFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  Y        +++EY+P+G LR+ L   +   LD +  L  +  +   + YL   
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--- 143
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                +HRD+ + NIL+      K+ADFG A+L    +     V    +    +  PE L
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESL 202
Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
                + +SDV+SFGV+L EL T   +   P  E    +  +  +   S    +     R
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCA---EILWS 414
           +    A    + ++++L   C AP  Q+RPS        ++LWS
Sbjct: 263 LPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDMLWS 303

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  LV+ +G 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLH 134
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ +    KV+DFG +R   D E  +   S   K    +  PE L   + + 
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS---SVGSKFPVRWSPPEVLMYSKFSS 191
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           KSD+++FGVL+ E+ + G+ P        ER T     +  + G  + +  P        
Sbjct: 192 KSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG--LRLYRP-------- 234
Query: 381 NLALEKILELALQCLAPRRQNRPSMR 406
           +LA EK+  +   C   +   RP+ +
Sbjct: 235 HLASEKVYTIMYSCWHEKADERPTFK 260

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  LV+ +G 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLH 123
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ +    KV+DFG +R   D E  +   S   K    +  PE L   + + 
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS---SVGSKFPVRWSPPEVLMYSKFSS 180
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           KSD+++FGVL+ E+ + G+ P        ER T     +  + G  + +  P        
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG--LRLYRP-------- 223
Query: 381 NLALEKILELALQCLAPRRQNRPSMR 406
           +LA EK+  +   C   +   RP+ +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFK 249

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 28/266 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  LV+ +G 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ +    KV+DFG +R   D E  +   S   K    +  PE L   + + 
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS---SVGSKFPVRWSPPEVLMYSKFSS 185
Query: 322 KSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           KSD+++FGVL+ E+ + G+ P        ER T     +  + G  + +  P        
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG--LRLYRP-------- 228
Query: 381 NLALEKILELALQCLAPRRQNRPSMR 406
           +LA EK+  +   C   +   RP+ +
Sbjct: 229 HLASEKVYTIMYSCWHEKADERPTFK 254

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKS---VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG VY G   D     I+ A KS   + +      F  E   +  + H N++   
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 200 G-YLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTD 256
           G  L  E    V++ Y+ +G L + +   Q N  + DL   +   + VA  + YL    +
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYL---AE 142
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT----HVSTQVKGTAGYLDPE 312
              +HRD+ + N +L E+F  KVADFG AR   D E  +     H    VK TA     E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL----E 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            L+TY+ T KSDV+SFGVLL EL+T   P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 21/284 (7%)
Query: 142 KIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R +      G +VA+K+ + S  D+    +FQ EI+ L  +    +V
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSDFIV 74
Query: 197 KFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  Y        +++EY+P+G LR+ L   +   LD +  L  +  +   + YL   
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--- 130
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                +HRD+ + NIL+      K+ADFG A+L    +     V    +    +  PE L
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESL 189
Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
                + +SDV+SFGV+L EL T   +   P  E    +  +  +   S    +     R
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQR 249
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCA---EILWS 414
           +    A    + ++++L   C AP  Q+RPS        ++LWS
Sbjct: 250 LPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDMLWS 290

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 35/223 (15%)
Query: 135 RNFSPSFK----IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + F   FK    IG GGFG V+K +   DG    IKR K      ++  + + E++ LA+
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAK 60
Query: 190 VEHLNLVKFHGY---LEFEDER-------------IVIVEYVPNGTLREHLDCLQGNILD 233
           ++H+N+V ++G     +++ E               + +E+   GTL + ++  +G  LD
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
               L++   +   + Y+H      +I+RD+K SNI L +  + K+ DFG       T  
Sbjct: 121 KVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV-----TSL 172
Query: 294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
                  + KGT  Y+ PE + +    ++ D+Y+ G++L EL+
Sbjct: 173 KNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 23/288 (7%)
Query: 143 IGQGGFGTV---YKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G+G FG V         DGT  +VA+K  K     +H    ++ EI  L  + H +++K
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG-WKQEIDILRTLYHEHIIK 80
Query: 198 FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + G  E + E+ +  ++EYVP G+LR   D L  + + LA  L  A  +   + YLH  +
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLR---DYLPRHSIGLAQLLLFAQQICEGMAYLH--S 135
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG--YLDPEY 313
            H  IHR++ + N+LL  +   K+ DFG A+   +   G  +   +  G +   +  PE 
Sbjct: 136 QH-YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPEC 191
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIE-PKRELKERITVKWAMKKFSDGDAISILDP 372
           LK Y+    SDV+SFGV L EL+T     + P  +  E I +  A  + +      +L+ 
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI--AQGQMTVLRLTELLE- 248
Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
           R E     +    ++  L   C       RP+      IL +V + YR
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYR 296

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 21/284 (7%)
Query: 142 KIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R +      G +VA+K+ + S  D+    +FQ EI+ L  +    +V
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR--DFQREIQILKALHSDFIV 75
Query: 197 KFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  Y        +++EY+P+G LR+ L   +   LD +  L  +  +   + YL   
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYL--- 131
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                +HRD+ + NIL+      K+ADFG A+L    +     V    +    +  PE L
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESL 190
Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
                + +SDV+SFGV+L EL T   +   P  E    +  +  +        +     R
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQR 250
Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCA---EILWS 414
           +    A    + ++++L   C AP  Q+RPS        ++LWS
Sbjct: 251 LPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDMLWS 291

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQVEH 192
           +F     +G+G FG VY  R +    IVA+K   KS  +K  G E Q   EI   A + H
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEK-EGVEHQLRREIEIQAHLHH 82
Query: 193 LNLVKFHGYLEFEDERI-VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
            N+++ + Y  ++  RI +I+EY P G L + L   +    D      I  ++A A+ Y 
Sbjct: 83  PNILRLYNYF-YDRRRIYLILEYAPRGELYKELQ--KSCTFDEQRTATIMEELADALMYC 139
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H      +IHRDIK  N+LL      K+ADFG++  A             + GT  YL P
Sbjct: 140 H---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT------MCGTLDYLPP 190
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           E ++     EK D++  GVL  EL+ G  P E
Sbjct: 191 EMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 23/288 (7%)
Query: 143 IGQGGFGTV---YKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G+G FG V         DGT  +VA+K  K     +H    ++ EI  L  + H +++K
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG-WKQEIDILRTLYHEHIIK 80
Query: 198 FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + G  E + E+ +  ++EYVP G+LR   D L  + + LA  L  A  +   + YLH   
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLR---DYLPRHSIGLAQLLLFAQQICEGMAYLH--A 135
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG--YLDPEY 313
            H  IHR++ + N+LL  +   K+ DFG A+   +   G  +   +  G +   +  PE 
Sbjct: 136 QH-YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPEC 191
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIE-PKRELKERITVKWAMKKFSDGDAISILDP 372
           LK Y+    SDV+SFGV L EL+T     + P  +  E I +  A  + +      +L+ 
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI--AQGQMTVLRLTELLE- 248
Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
           R E     +    ++  L   C       RP+      IL +V + YR
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYR 296

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 37/259 (14%)
Query: 141 FKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            KIG+G  G V    +   G +VA+K  K  +  +       +E+  +   +H N+V+ +
Sbjct: 157 IKIGEGSTGIVCIATVRSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 214
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 DE  V++E++  G L + +   + N   +A    + + V  A++ LH      +
Sbjct: 215 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---V 268
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK------GTAGYLDPEY 313
           IHRDIKS +ILLT + R K++DFGF             VS +V       GT  ++ PE 
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGF----------CAQVSKEVPRRKXLVGTPYWMAPEL 318
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
           +       + D++S G++++E+V G  P   +  LK       AMK   D      L PR
Sbjct: 319 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPR 366
Query: 374 VENTAANNLALEKILELAL 392
           ++N    + +L+  L+  L
Sbjct: 367 LKNLHKVSPSLKGFLDRLL 385

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 133/304 (43%), Gaps = 68/304 (22%)
Query: 143 IGQGGFGTVYKGRLE-DGTIV--AIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKF 198
           IG+G FG V K R++ DG  +  AIKR K+    K    +F  E+  L ++  H N++  
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQ-----------------GNILDLAGRLDIA 241
            G  E      + +EY P+G L   LD L+                  + L     L  A
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNL---LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
            DVA  + YL   +    IHRD+ + NIL+ EN+ AK+ADFG +R               
Sbjct: 139 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVY 185
Query: 302 VKGTAGYLDPEYLKTYQL-----TEKSDVYSFGVLLVELVT-GRRPI--EPKRELKERIT 353
           VK T G L   ++    L     T  SDV+S+GVLL E+V+ G  P       EL E++ 
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 245
Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW 413
             + ++K  + D                   +++ +L  QC   +   RPS    A+IL 
Sbjct: 246 QGYRLEKPLNCD-------------------DEVYDLMRQCWREKPYERPSF---AQILV 283
Query: 414 SVRK 417
           S+ +
Sbjct: 284 SLNR 287

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 133/304 (43%), Gaps = 68/304 (22%)
Query: 143 IGQGGFGTVYKGRLE-DGTIV--AIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKF 198
           IG+G FG V K R++ DG  +  AIKR K+    K    +F  E+  L ++  H N++  
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQ-----------------GNILDLAGRLDIA 241
            G  E      + +EY P+G L   LD L+                  + L     L  A
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNL---LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
            DVA  + YL   +    IHRD+ + NIL+ EN+ AK+ADFG +R               
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVY 195
Query: 302 VKGTAGYLDPEYLKTYQL-----TEKSDVYSFGVLLVELVT-GRRPI--EPKRELKERIT 353
           VK T G L   ++    L     T  SDV+S+GVLL E+V+ G  P       EL E++ 
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW 413
             + ++K  + D                   +++ +L  QC   +   RPS    A+IL 
Sbjct: 256 QGYRLEKPLNCD-------------------DEVYDLMRQCWREKPYERPSF---AQILV 293
Query: 414 SVRK 417
           S+ +
Sbjct: 294 SLNR 297

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 77
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L       +D    L     +   + YL   
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA-HAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 191
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G GG   V+  R L D   VA+K  +  +  D      F+ E +  A + H  +V  + 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 201 YLEFEDER----IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             E E        +++EYV   TLR+ +   +G +      +++  D   A+ + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRA-IEVIADACQALNFSHQ--- 134
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           + IIHRD+K +NI+++     KV DFG AR  AD+ +  T  +  V GTA YL PE  + 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQARG 193
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
             +  +SDVYS G +L E++TG  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G GG   V+  R L D   VA+K  +  +  D      F+ E +  A + H  +V  + 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 201 YLEFEDER----IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             E E        +++EYV   TLR+ +   +G +      +++  D   A+ + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRA-IEVIADACQALNFSHQ--- 134
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           + IIHRD+K +NI+++     KV DFG AR  AD+ +  T  +  V GTA YL PE  + 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQARG 193
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
             +  +SDVYS G +L E++TG  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +G V+K R  D G IVAIK+  +S  D         EIR L Q++H NLV    
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               +    ++ EY  +  L E LD  Q  + +   +  I      A+ + H    H  I
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHE-LDRYQRGVPEHLVK-SITWQTLQAVNFCH---KHNCI 124
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL-KTYQL 319
           HRD+K  NIL+T++   K+ DFGFARL     +G +        T  Y  PE L    Q 
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLL----TGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPKR 346
               DV++ G +  EL++G  P+ P +
Sbjct: 181 GPPVDVWAIGCVFAELLSG-VPLWPGK 206

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 74
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 188
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 74
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 188
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 105
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 161
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 219
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 77
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+E++P G+LRE+L   +  I D    L     +   + YL   
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 133
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 191
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 73
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 129
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 187
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 81
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 82  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 137
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 195
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 80
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 81  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 136
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 194
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 78
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 192
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 92
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 148
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 206
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 77
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 133
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 191
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 72
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 128
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 186
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 79
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 80  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 135
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 193
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 92
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 148
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--XXKVKEPGESPIFWYAPES 206
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 120/259 (46%), Gaps = 37/259 (14%)
Query: 141 FKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            KIG+G  G V    +   G +VA+K  K  +  +       +E+  +   +H N+V+ +
Sbjct: 80  IKIGEGSTGIVCIATVRSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 137
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 DE  V++E++  G L + +   + N   +A    + + V  A++ LH      +
Sbjct: 138 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---V 191
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK------GTAGYLDPEY 313
           IHRDIKS +ILLT + R K++DFGF             VS +V       GT  ++ PE 
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGF----------CAQVSKEVPRRKXLVGTPYWMAPEL 241
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
           +       + D++S G++++E+V G  P   +  LK       AMK   D      L PR
Sbjct: 242 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPR 289
Query: 374 VENTAANNLALEKILELAL 392
           ++N    + +L+  L+  L
Sbjct: 290 LKNLHKVSPSLKGFLDRLL 308

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 76
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L   + + LDLA  +  A  ++ A+ YL       
Sbjct: 77  IGVIT-ENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKR 131
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG-----YLDPEY 313
            +HRDI + N+L++ N   K+ DFG +R   D        ST  K + G     ++ PE 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STXXKASKGKLPIKWMAPES 183
Query: 314 LKTYQLTEKSDVYSFGVLLVE-LVTGRRPIE 343
           +   + T  SDV+ FGV + E L+ G +P +
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 34/224 (15%)
Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++G+G FG V+          +D  +VA+K  K          +FQ E   L  ++H ++
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREAELLTNLQHEHI 79
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL-----DCL----------QGNILDLAGRLDI 240
           VKF+G     D  I++ EY+ +G L + L     D +          +G  L L+  L I
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLHI 138
Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHV 298
           A  +A  + YL        +HRD+ + N L+  N   K+ DFG +R   + D      H 
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
              ++    ++ PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 196 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 27/254 (10%)
Query: 141 FKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            KIG+G  G V    +   G +VA+K  K  +  +       +E+  +   +H N+V+ +
Sbjct: 35  IKIGEGSTGIVCIATVRSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 92
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 DE  V++E++  G L + +   + N   +A    + + V  A++ LH      +
Sbjct: 93  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---V 146
Query: 260 IHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IHRDIKS +ILLT + R K++DFGF A+++ +       V     GT  ++ PE +    
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAPELISRLP 201
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
              + D++S G++++E+V G  P   +  LK       AMK   D      L PR++N  
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPRLKNLH 249
Query: 379 ANNLALEKILELAL 392
             + +L+  L+  L
Sbjct: 250 KVSPSLKGFLDRLL 263

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 122/254 (48%), Gaps = 27/254 (10%)
Query: 141 FKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            KIG+G  G V    +   G +VA+K  K  +  +       +E+  +   +H N+V+ +
Sbjct: 37  IKIGEGSTGIVCIATVRSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 94
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 DE  V++E++  G L + +   + N   +A    + + V  A++ LH      +
Sbjct: 95  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---V 148
Query: 260 IHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IHRDIKS +ILLT + R K++DFGF A+++ +       V     GT  ++ PE +    
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAPELISRLP 203
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
              + D++S G++++E+V G  P   +  LK       AMK   D      L PR++N  
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPRLKNLH 251
Query: 379 ANNLALEKILELAL 392
             + +L+  L+  L
Sbjct: 252 KVSPSLKGFLDRLL 265

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G GG   V+  R L D   VA+K  +  +  D      F+ E +  A + H  +V  + 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 201 YLEFEDER----IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             E E        +++EYV   TLR+ +   +G +      +++  D   A+ + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRA-IEVIADACQALNFSHQ--- 134
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           + IIHRD+K +NIL++     KV DFG AR  AD+ +     +  V GTA YL PE  + 
Sbjct: 135 NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA-VIGTAQYLSPEQARG 193
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
             +  +SDVYS G +L E++TG  P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 11/216 (5%)
Query: 131 YRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLA 188
           Y    NF    KIG+G F  VY+   L DG  VA+K+ +   + D  + A+   EI  L 
Sbjct: 28  YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 189 QVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAH 246
           Q+ H N++K++     ++E  +++E    G L   +     Q  ++         + +  
Sbjct: 88  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           A+ ++H      ++HRDIK +N+ +T     K+ D G  R      S  T  +  + GT 
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTP 200
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            Y+ PE +       KSD++S G LL E+   + P 
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 76
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L  ++   LDLA  +  A  ++ A+ YL       
Sbjct: 77  IGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 188
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++G+G FG V+          +D  +VA+K  K +    ++  +F  E   L  ++H ++
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHI 77
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL-----DCL---QGNI---LDLAGRLDIAIDV 244
           VKF+G     D  I++ EY+ +G L + L     D +   +GN    L  +  L IA  +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVSTQV 302
           A  + YL        +HRD+ + N L+ EN   K+ DFG +R   + D      H    +
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +    ++ PE +   + T +SDV+S GV+L E+ T G++P
Sbjct: 195 R----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 134/308 (43%), Gaps = 68/308 (22%)
Query: 143 IGQGGFGTVYKGRLE-DGTIV--AIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKF 198
           IG+G FG V K R++ DG  +  AIKR K+    K    +F  E+  L ++  H N++  
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQ-----------------GNILDLAGRLDIA 241
            G  E      + +EY P+G L   LD L+                  + L     L  A
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNL---LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
            DVA  + YL   +    IHR++ + NIL+ EN+ AK+ADFG +R               
Sbjct: 146 ADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR----------GQEVY 192
Query: 302 VKGTAGYLDPEYLKTYQL-----TEKSDVYSFGVLLVELVT-GRRPI--EPKRELKERIT 353
           VK T G L   ++    L     T  SDV+S+GVLL E+V+ G  P       EL E++ 
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 252
Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW 413
             + ++K  + D                   +++ +L  QC   +   RPS    A+IL 
Sbjct: 253 QGYRLEKPLNCD-------------------DEVYDLMRQCWREKPYERPSF---AQILV 290
Query: 414 SVRKDYRE 421
           S+ +   E
Sbjct: 291 SLNRMLEE 298

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKL 104
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L  ++   LDLA  +  A  ++ A+ YL       
Sbjct: 105 IGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE---SKR 159
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 216
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 66
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 127 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR--- 180
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 181 ----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 74
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 130
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHRD+ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE--FFKVKEPGESPIFWYAPES 188
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHG 200
           +G G +G VYKGR ++ G + AIK    +  ++    E + EI  L +   H N+  ++G
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE---EIKQEINMLKKYSHHRNIATYYG 88
Query: 201 YL------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                     +D+  +++E+   G++ + +   +GN L       I  ++   +++LH  
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 147
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H +IHRDIK  N+LLTEN   K+ DFG   ++A  +      +T + GT  ++ PE +
Sbjct: 148 --HKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFI-GTPYWMAPEVI 201
Query: 315 -------KTYQLTEKSDVYSFGVLLVELVTGRRPI---EPKREL 348
                   TY    KSD++S G+  +E+  G  P+    P R L
Sbjct: 202 ACDENPDATYDF--KSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 76
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L  ++   LDLA  +  A  ++ A+ YL       
Sbjct: 77  IGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE---SKR 131
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 188
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKL 81
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L  ++   LDLA  +  A  ++ A+ YL       
Sbjct: 82  IGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE---SKR 136
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 193
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 121/251 (48%), Gaps = 27/251 (10%)
Query: 141 FKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            KIG+G  G V    +   G +VA+K  K  +  +       +E+  +   +H N+V+ +
Sbjct: 26  IKIGEGSTGIVCIATVRSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 DE  V++E++  G L + +   + N   +A    + + V  A++ LH      +
Sbjct: 84  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---V 137
Query: 260 IHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IHRDIKS +ILLT + R K++DFGF A+++ +       V     GT  ++ PE +    
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAPELISRLP 192
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
              + D++S G++++E+V G  P   +  LK       AMK   D      L PR++N  
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPRLKNLH 240
Query: 379 ANNLALEKILE 389
             + +L+  L+
Sbjct: 241 KVSPSLKGFLD 251

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 73
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L  ++   LDLA  +  A  ++ A+ YL       
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 185
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKL 79
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L  ++   LDLA  +  A  ++ A+ YL       
Sbjct: 80  IGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE---SKR 134
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 191
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 192 FTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 75
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 136 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR--- 189
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 190 ----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKL 78
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L  ++   LDLA  +  A  ++ A+ YL       
Sbjct: 79  IGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLE---SKR 133
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 190
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 191 FTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 125
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 177
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 178 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 229
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 230 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 39/230 (16%)
Query: 143 IGQGGFGTVYKGR------LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           IG+G FG V++ R       E  T+VA+K  K+        A+FQ E   +A+ ++ N+V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIV 113
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI----------------------LDL 234
           K  G         ++ EY+  G L E L  +  +                       L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 235 AGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTE 292
           A +L IA  VA  + YL   ++   +HRD+ + N L+ EN   K+ADFG +R   +AD  
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
               + +  ++    ++ PE +   + T +SDV+++GV+L E+ + G +P
Sbjct: 231 KADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 119/256 (46%), Gaps = 37/256 (14%)
Query: 141 FKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            KIG+G  G V    +   G +VA+K  K  +  +       +E+  +   +H N+V+ +
Sbjct: 30  IKIGEGSTGIVCIATVRSSGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 87
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 DE  V++E++  G L + +   + N   +A    + + V  A++ LH      +
Sbjct: 88  NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---V 141
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK------GTAGYLDPEY 313
           IHRDIKS +ILLT + R K++DFGF             VS +V       GT  ++ PE 
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGF----------CAQVSKEVPRRKXLVGTPYWMAPEL 191
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
           +       + D++S G++++E+V G  P   +  LK       AMK   D      L PR
Sbjct: 192 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMIRDN-----LPPR 239
Query: 374 VENTAANNLALEKILE 389
           ++N    + +L+  L+
Sbjct: 240 LKNLHKVSPSLKGFLD 255

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           F+   +IG+G FG V+KG +++ T  +VAIK       +       Q EI  L+Q +   
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSSY 82
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           + K++G      +  +I+EY+  G+    LD L+    D      +  ++   + YLH  
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGS---ALDLLRAGPFDEFQIATMLKEILKGLDYLH-- 137
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                IHRDIK++N+LL+E    K+ADFG A    DT+      +T V GT  ++ PE +
Sbjct: 138 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTFV-GTPFWMAPEVI 192
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
           +      K+D++S G+  +EL  G  P   + P R L
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL 229

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 143 IGQGGFGTV---YKGRLEDGT--IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLV 196
           +G+G FG V         DGT  +VA+K  K+    +  SG  +Q EI  L  + H ++V
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHEHIV 74
Query: 197 KFHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  E + E+ V  ++EYVP G+LR++L     + + LA  L  A  +   + YLH  
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP---RHCVGLAQLLLFAQQICEGMAYLH-- 129
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG--YLDPE 312
             H  IHR + + N+LL  +   K+ DFG A+   +   G  +   +  G +   +  PE
Sbjct: 130 AQH-YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPE 185
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT 337
            LK  +    SDV+SFGV L EL+T
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++   ++  +       +EI  + + ++ N+V +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRDIKS NILL  +   K+ DFGF A++  +    +T V     GT  ++ PE +     
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAY 193
Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
             K D++S G++ +E++ G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 19/291 (6%)
Query: 143 IGQGGFGTV---YKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G+G FG V         DGT  +VA+K  K     +H    ++ EI  L  + H +++K
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRTLYHEHIIK 97
Query: 198 FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + G  E      +  ++EYVP G+LR   D L  + + LA  L  A  +   + YLH   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLR---DYLPRHSIGLAQLLLFAQQICEGMAYLH--A 152
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            H  IHRD+ + N+LL  +   K+ DFG A+   +       V         +  PE LK
Sbjct: 153 QH-YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-XYRVREDGDSPVFWYAPECLK 210
Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRPIE-PKRELKERITVKWAMKKFSDGDAISILDPRV 374
            Y+    SDV+SFGV L EL+T     + P  +  E I +  A  + +      +L+ R 
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI--AQGQMTVLRLTELLE-RG 267
Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAAS 425
           E     +    ++  L   C       RP+      IL +V + Y+  A S
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 143 IGQGGFGTV---YKGRLEDGT--IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLV 196
           +G+G FG V         DGT  +VA+K  K+    +  SG  +Q EI  L  + H ++V
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHEHIV 73
Query: 197 KFHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  E + E+ V  ++EYVP G+LR++L     + + LA  L  A  +   + YLH  
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP---RHCVGLAQLLLFAQQICEGMAYLH-- 128
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG--YLDPE 312
             H  IHR + + N+LL  +   K+ DFG A+   +   G  +   +  G +   +  PE
Sbjct: 129 AQH-YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDSPVFWYAPE 184
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT 337
            LK  +    SDV+SFGV L EL+T
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G GG   V+  R   L     V + RA  +  D      F+ E +  A + H  +V  +
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 200 GYLEFEDER----IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
              E E        +++EYV   TLR+ +   +G +      +++  D   A+ + H   
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRA-IEVIADACQALNFSHQ-- 134
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            + IIHRD+K +NI+++     KV DFG AR  AD+ +  T  +  V GTA YL PE  +
Sbjct: 135 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQAR 192
Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP 341
              +  +SDVYS G +L E++TG  P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 17/217 (7%)
Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           F+   +IG+G FG VYKG +++ T  +VAIK       +       Q EI  L+Q +   
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPY 78
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           + ++ G      +  +I+EY+  G+    LD L+   L+      I  ++   + YLH  
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                IHRDIK++N+LL+E    K+ADFG A    DT+           GT  ++ PE +
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK----RNXFVGTPFWMAPEVI 188
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
           K      K+D++S G+  +EL  G  P   + P R L
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 456
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L   + + LDLA  +  A  ++ A+ YL       
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKR 511
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 568
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 90
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 142
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 143 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 194
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 115
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 167
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 115
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 167
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 113/229 (49%), Gaps = 15/229 (6%)
Query: 120 SGNVQITMEEIY-RATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSG 177
           S  V +  E +Y ++   +     +G+G +G V K R +D G IVAIK+  +S  DK   
Sbjct: 9   SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK 68
Query: 178 AEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
                EI+ L Q+ H NLV      + +    ++ E+V + T+ + L+ L  N LD    
Sbjct: 69  KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLE-LFPNGLDYQVV 126
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGAT 296
                 + + I + H    H IIHRDIK  NIL++++   K+ DFGFAR LAA  E    
Sbjct: 127 QKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183
Query: 297 HVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            V+T+      Y  PE L    +  +  DV++ G L+ E+  G  P+ P
Sbjct: 184 EVATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFP 226

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 22/221 (9%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYD---KHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +     +  EF  E   +A ++H +LV+ 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G       ++V  + +P+G L     EH D +   +L     L+  + +A  + YL   
Sbjct: 106 LGVCLSPTIQLV-TQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE-- 157
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            +  ++HRD+ + N+L+      K+ DFG ARL    E    + +   K    ++  E +
Sbjct: 158 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK--EYNADGGKMPIKWMALECI 214
Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKERI 352
              + T +SDV+S+GV + EL+T G +P +  P RE+ + +
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 115
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 167
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 142 KIGQGGFGTVYKGR---LED--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R   L+D  G +VA+K+ + S  ++H   +F+ EI  L  ++H N+V
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHL-RDFEREIEILKSLQHDNIV 75
Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +  I D    L     +   + YL   
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEYL--- 131
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
                IHR++ + NIL+    R K+ DFG  + L  D E     V    +    +  PE 
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPGESPIFWYAPES 189
Query: 314 LKTYQLTEKSDVYSFGVLLVELVT 337
           L   + +  SDV+SFGV+L EL T
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 143 IGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G+G FG V   R +      G  VA+K  K      H  A+ + EI  L  + H N+VK
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVK 87
Query: 198 FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + G    +    +  I+E++P+G+L+E+L     N ++L  +L  A+ +   + YL    
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYL---G 143
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRD+ + N+L+    + K+ DFG  + A +T+     V         +  PE L 
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 316 TYQLTEKSDVYSFGVLLVELVT 337
             +    SDV+SFGV L EL+T
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 115
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 167
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 115
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 167
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR PI P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++   ++  +       +EI  + + ++ N+V +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRDIKS NILL  +   K+ DFGF       +S      +++ GT  ++ PE +      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK----RSEMVGTPYWMAPEVVTRKAYG 194
Query: 321 EKSDVYSFGVLLVELVTGRRP 341
            K D++S G++ +E++ G  P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 143 IGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G+G FG V   R +      G  VA+K  K      H  A+ + EI  L  + H N+VK
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVK 75
Query: 198 FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + G    +    +  I+E++P+G+L+E+L     N ++L  +L  A+ +   + YL    
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYL---G 131
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRD+ + N+L+    + K+ DFG  + A +T+     V         +  PE L 
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 316 TYQLTEKSDVYSFGVLLVELVT 337
             +    SDV+SFGV L EL+T
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G GG   V+  R   L     V + RA  +  D      F+ E +  A + H  +V  +
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 200 GYLEFEDER----IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
              E E        +++EYV   TLR+ +   +G +      +++  D   A+ + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRA-IEVIADACQALNFSHQ-- 134
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            + IIHRD+K +NI+++     KV DFG AR  AD+ +  T  +  V GTA YL PE  +
Sbjct: 135 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQAR 192
Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP 341
              +  +SDVYS G +L E++TG  P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 81
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 142 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 192
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 68
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 129 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 179
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 180 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 74
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 135 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 185
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 186 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 22/221 (9%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYD---KHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +     +  EF  E   +A ++H +LV+ 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G       ++V  + +P+G L     EH D +   +L     L+  + +A  + YL   
Sbjct: 83  LGVCLSPTIQLV-TQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE-- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            +  ++HRD+ + N+L+      K+ DFG ARL    E    + +   K    ++  E +
Sbjct: 135 -ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK--EYNADGGKMPIKWMALECI 191
Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKERI 352
              + T +SDV+S+GV + EL+T G +P +  P RE+ + +
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 72
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 133 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 183
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 184 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G+G +G+VYK    E G IVAIK+    V  +    E   EI  + Q +  ++VK++G
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQ----VPVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                 +  +++EY   G++ + +  L+   L       I       + YLH       I
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIR-LRNKTLTEDEIATILQSTLKGLEYLHFMRK---I 147
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRDIK+ NILL     AK+ADFG A    D  +        V GT  ++ PE ++     
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK----RNXVIGTPFWMAPEVIQEIGYN 203
Query: 321 EKSDVYSFGVLLVELVTGRRP---IEPKREL 348
             +D++S G+  +E+  G+ P   I P R +
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAI 234

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 81
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 142 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 192
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 71
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 132 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 182
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 183 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 75
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 136 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 186
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 187 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 74
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 135 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 185
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 186 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQVEHLNLVKFH 199
           +G+G FG VY  R  ++  I+A+K   KS  +K  G E Q   EI   + + H N+++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            Y        +++E+ P G L + L   +    D         ++A A+ Y H   +  +
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADALHYCH---ERKV 135
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           IHRDIK  N+L+      K+ADFG++  A             + GT  YL PE ++    
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR------RRXMCGTLDYLPPEMIEGKTH 189
Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
            EK D++  GVL  E + G  P +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQVEHLNLVKFH 199
           +G+G FG VY  R  ++  I+A+K   KS  +K  G E Q   EI   + + H N+++ +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMY 81
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            Y        +++E+ P G L + L   +    D         ++A A+ Y H   +  +
Sbjct: 82  NYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADALHYCH---ERKV 136
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           IHRDIK  N+L+      K+ADFG++  A             + GT  YL PE ++    
Sbjct: 137 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLR------RRXMCGTLDYLPPEMIEGKTH 190
Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
            EK D++  GVL  E + G  P +
Sbjct: 191 DEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G G FG V+  R   +G   A+K  KK +  +    E  ++ R  L+ V H  +++  G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +   +  +I++Y+  G L   L   Q     +A     A +V  A+ YLH      II
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVCLALEYLH---SKDII 128
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL +N   K+ DFGFA+   D       V+  + GT  Y+ PE + T    
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPD-------VTYXLCGTPDYIAPEVVSTKPYN 181
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELK 349
           +  D +SFG+L+ E++ G  P      +K
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMK 210

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 120/254 (47%), Gaps = 27/254 (10%)
Query: 141 FKIGQGGFGTV-YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            KIG+G  G V        G  VA+K  K  +  +       +E+  +    H N+V  +
Sbjct: 51  IKIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY 108
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                 DE  V++E++  G L + +   + N   +A    + + V  A++YLH   +  +
Sbjct: 109 SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLH---NQGV 162
Query: 260 IHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IHRDIKS +ILLT + R K++DFGF A+++ +       V     GT  ++ PE +    
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-----GTPYWMAPEVISRLP 217
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
              + D++S G++++E++ G  P   +  L+       AM++  D      L PRV++  
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIRDS-----LPPRVKDLH 265
Query: 379 ANNLALEKILELAL 392
             +  L   L+L L
Sbjct: 266 KVSSVLRGFLDLML 279

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++   ++  +       +EI  + + ++ N+V +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRDIKS NILL  +   K+ DFGF       +S  + +     GT  ++ PE +      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEVVTRKAYG 194
Query: 321 EKSDVYSFGVLLVELVTGRRP 341
            K D++S G++ +E++ G  P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++   ++  +       +EI  + + ++ N+V +  
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 86  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRDIKS NILL  +   K+ DFGF       +S      + + GT  ++ PE +      
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK----RSXMVGTPYWMAPEVVTRKAYG 195
Query: 321 EKSDVYSFGVLLVELVTGRRP 341
            K D++S G++ +E++ G  P
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPP 216

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 103
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+      
Sbjct: 164 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------ 214
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T
Sbjct: 215 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 76
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L   + + LDLA  +  A  ++ A+ YL       
Sbjct: 77  IGVIT-ENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKR 131
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++     K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 188
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++   ++  +       +EI  + + ++ N+V +  
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 86  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 261 HRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HR+IKS NILL  +   K+ DFGF A++  +    +T V     GT  ++ PE +     
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAY 194
Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
             K D++S G++ +E++ G  P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 13/214 (6%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +GTV+K +  E   IVA+KR +    D+   +    EI  L +++H N+V+ H 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            L  + +  ++ E+  +  L+++ D   G+ LD          +   + + H      ++
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 261 HRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+K  N+L+  N   K+ADFG AR         +  V      T  Y  P+ L   +L
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAKL 178
Query: 320 TEKS-DVYSFGVLLVELVTGRRPIEPKRELKERI 352
              S D++S G +  EL    RP+ P  ++ +++
Sbjct: 179 YSTSIDMWSAGCIFAELANAARPLFPGNDVDDQL 212

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G GG   V+  R   L     V + RA  +  D      F+ E +  A + H  +V  +
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 200 GYLEFEDER----IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
              E E        +++EYV   TLR+ +   +G +      +++  D   A+ + H   
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRA-IEVIADACQALNFSHQ-- 151
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            + IIHRD+K +NI+++     KV DFG AR  AD+ +  T  +  V GTA YL PE  +
Sbjct: 152 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQAR 209
Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP 341
              +  +SDVYS G +L E++TG  P
Sbjct: 210 GDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG+G +G VYK +   G   A+K+ +    D+   +    EI  L +++H N+VK +  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  +   +++ E++ +  L++ LD  +G +  +  +    + + + I Y H   D  ++H
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH---DRRVLH 123
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---KTYQ 318
           RD+K  N+L+      K+ADFG AR         TH       T  Y  P+ L   K Y 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYS 179
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEP 344
            T   D++S G +  E+V G  P+ P
Sbjct: 180 TT--IDIWSVGCIFAEMVNG-TPLFP 202

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG+G +G VYK +   G   A+K+ +    D+   +    EI  L +++H N+VK +  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  +   +++ E++ +  L++ LD  +G +  +  +    + + + I Y H   D  ++H
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH---DRRVLH 123
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---KTYQ 318
           RD+K  N+L+      K+ADFG AR         TH       T  Y  P+ L   K Y 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYS 179
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEP 344
            T   D++S G +  E+V G  P+ P
Sbjct: 180 TT--IDIWSVGCIFAEMVNG-APLFP 202

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG+G +G VYK +   G   A+K+ +    D+   +    EI  L +++H N+VK +  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  +   +++ E++ +  L++ LD  +G +  +  +    + + + I Y H   D  ++H
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH---DRRVLH 123
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---KTYQ 318
           RD+K  N+L+      K+ADFG AR         TH       T  Y  P+ L   K Y 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKYS 179
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEP 344
            T   D++S G +  E+V G  P+ P
Sbjct: 180 TT--IDIWSVGCIFAEMVNG-TPLFP 202

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 145/314 (46%), Gaps = 53/314 (16%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           A    + S ++GQG FG VY+G      + E  T VAIK   ++   +    EF +E   
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASV 68
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD--------LAGRL 238
           + +    ++V+  G +      +VI+E +  G L+ +L  L+  + +        L+  +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
            +A ++A  + YL+    +  +HRD+ + N  + E+F  K+ DFG  R   +T+      
Sbjct: 129 QMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD------ 179
Query: 299 STQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
               KG  G     ++ PE LK    T  SDV+SFGV+L E+ T     +P + L     
Sbjct: 180 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGLSNEQV 236
Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW 413
           +++ M+         +LD + +N        + +LEL   C     + RPS     EI+ 
Sbjct: 237 LRFVMEG-------GLLD-KPDNCP------DMLLELMRMCWQYNPKMRPSF---LEIIS 279
Query: 414 SVRKD----YRELA 423
           S++++    +RE++
Sbjct: 280 SIKEEMEPGFREVS 293

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VA+K   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +++EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E    +      G+  Y  PE    K Y  
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 192 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 29/240 (12%)
Query: 126 TMEEIYRATRNFSPS------FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE 179
           +M++    TR+ +P        ++G G FG VYK + ++ +++A  +    V D  S  E
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK----VIDTKSEEE 77
Query: 180 FQS---EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG 236
            +    EI  LA  +H N+VK      +E+   +++E+   G +   +  L+  + +   
Sbjct: 78  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI 137
Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
           ++ +      A+ YLH   D+ IIHRD+K+ NIL T +   K+ADFG +  A +T +   
Sbjct: 138 QV-VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQR 191
Query: 297 HVSTQVKGTAGYLDPEYL-----KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
             S    GT  ++ PE +     K      K+DV+S G+ L+E+     P   + P R L
Sbjct: 192 RDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VA+K   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +++EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E    +      G+  Y  PE    K Y  
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 192 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEF---QSEIRTLAQVE 191
           NF     +G+G FG V   R+ E G + A+K  KK V  +    E    +  I +LA+  
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-N 82
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H  L +     +  D    ++E+V  G L  H+   +    D A     A ++  A+ +L
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEIISALMFL 140
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV-KGTAGYLD 310
           H   D  II+RD+K  N+LL      K+ADFG  +     E     V+T    GT  Y+ 
Sbjct: 141 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYIA 192
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
           PE L+        D ++ GVLL E++ G  P E + E
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VA++   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +++EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E    +   +  G+  Y  PE    K Y  
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 192 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEH 192
           FS   +IG G FG VY  R + +  +VAIK  K S   K S  ++Q    E+R L ++ H
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 193 LNLVKFHGYLEFEDERIVIVEYV---PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
            N +++ G    E    +++EY     +  L  H   LQ   +++A     A+     + 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--VEIAAVTHGAL---QGLA 168
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH    H +IHRD+K+ NILL+E    K+ DFG A + A         +    GT  ++
Sbjct: 169 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANXFVGTPYWM 217
Query: 310 DPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPI 342
            PE +      Q   K DV+S G+  +EL   + P+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVKL 456
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +  E+   +I+E    G LR  L   + + LDLA  +  A  ++ A+ YL       
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SKR 511
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI + N+L++     K+ DFG +R   D+     + +++ K    ++ PE +   +
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRR 568
Query: 319 LTEKSDVYSFGVLLVE-LVTGRRPIE 343
            T  SDV+ FGV + E L+ G +P +
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 82
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 134
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT 
Sbjct: 135 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTR 186
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            Y+ PE L+    + +SD++S G+ LVE+  GR PI
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VA+K   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +++EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E    +      G   Y  PE    K Y  
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 192 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 115/240 (47%), Gaps = 29/240 (12%)
Query: 126 TMEEIYRATRNFSPS------FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE 179
           +M++    TR+ +P        ++G G FG VYK + ++ +++A  +    V D  S  E
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK----VIDTKSEEE 77
Query: 180 FQS---EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG 236
            +    EI  LA  +H N+VK      +E+   +++E+   G +   +  L+  + +   
Sbjct: 78  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI 137
Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
           ++ +      A+ YLH   D+ IIHRD+K+ NIL T +   K+ADFG +  A +T     
Sbjct: 138 QV-VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQR 191
Query: 297 HVSTQVKGTAGYLDPEYL-----KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
             S    GT  ++ PE +     K      K+DV+S G+ L+E+     P   + P R L
Sbjct: 192 RDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 32/276 (11%)
Query: 142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G  G V   R +  G  VA+K     +  +       +E+  +   +H N+V+ + 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                +E  V++E++  G L + +  ++ N   +A    +   V  A+ YLH      +I
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA---TVCEAVLQALAYLHA---QGVI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRDIKS +ILLT + R K++DFGF A+++ D       V     GT  ++ PE +     
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-----GTPYWMAPEVISRSLY 218
Query: 320 TEKSDVYSFGVLLVELVTGRRPI--------------EPKRELKERITVKWAMKKFSDGD 365
             + D++S G++++E+V G  P                P  +LK    V   ++ F   +
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL--E 276
Query: 366 AISILDPRVENTAANNLALEKILELAL-QCLAPRRQ 400
            + + DP+   TA   L    +L+  L +CL P  Q
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQ 312

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 29/240 (12%)
Query: 126 TMEEIYRATRNFSPS------FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE 179
           +M++    TR+ +P        ++G G FG VYK + ++ +++A  +    V D  S  E
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK----VIDTKSEEE 77
Query: 180 FQS---EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG 236
            +    EI  LA  +H N+VK      +E+   +++E+   G +   +  L+  + +   
Sbjct: 78  LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI 137
Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
           ++ +      A+ YLH   D+ IIHRD+K+ NIL T +   K+ADFG +  A +T     
Sbjct: 138 QV-VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRX--I 189
Query: 297 HVSTQVKGTAGYLDPEYL-----KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
                  GT  ++ PE +     K      K+DV+S G+ L+E+     P   + P R L
Sbjct: 190 QRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 249

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VAIK   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +I+EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVH 134
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E           G+  Y  PE    K Y  
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFS-----NEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 190 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 223

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEH 192
           FS   +IG G FG VY  R + +  +VAIK  K S   K S  ++Q    E+R L ++ H
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 193 LNLVKFHGYLEFEDERIVIVEYV---PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
            N +++ G    E    +++EY     +  L  H   LQ   +++A     A+     + 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--VEIAAVTHGAL---QGLA 129
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH    H +IHRD+K+ NILL+E    K+ DFG A + A         +    GT  ++
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANXFVGTPYWM 178
Query: 310 DPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPI 342
            PE +      Q   K DV+S G+  +EL   + P+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 16/222 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           N+     IG+G F  V   R +  G  VA+K   K+  +  S  +   E+R +  + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +E E    +++EY   G + ++L    G + +   R      +  A+ Y H  
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCH-- 131
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               I+HRD+K+ N+LL  +   K+ADFGF+      E    +      G+  Y  PE  
Sbjct: 132 -QKYIVHRDLKAENLLLDGDMNIKIADFGFS-----NEFTVGNKLDTFCGSPPYAAPELF 185
Query: 315 --KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
             K Y   E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 186 QGKKYDGPE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 13/214 (6%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +GTV+K +  E   IVA+KR +    D+   +    EI  L +++H N+V+ H 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            L  + +  ++ E+  +  L+++ D   G+ LD          +   + + H      ++
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 261 HRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+K  N+L+  N   K+A+FG AR         +  V      T  Y  P+ L   +L
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAKL 178
Query: 320 TEKS-DVYSFGVLLVELVTGRRPIEPKRELKERI 352
              S D++S G +  EL    RP+ P  ++ +++
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VA++   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +++EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E    +      G+  Y  PE    K Y  
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 192 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VAIK   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +I+EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVH 137
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E           G   Y  PE    K Y  
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFS-----NEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 193 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN- 194
           +F    ++G G  G V+K   +   +V    A+K ++ +   A     IR L  +   N 
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIHLEIKPAIRNQIIRELQVLHECNS 66
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAH 246
             +V F+G    + E  + +E++  G+L +        +L  AGR+       ++I V  
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIK 118
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            +TYL     H I+HRD+K SNIL+      K+ DFG +    D       ++ +  GT 
Sbjct: 119 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------EMANEFVGTR 170
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            Y+ PE L+    + +SD++S G+ LVE+  GR P  P
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 94
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+ +                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 204
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VA+K   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    +++EY   G + ++L    G + +   R      +  A+ Y H      I+H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYL-VAHGWMKEKEARAKFR-QIVSAVQYCH---QKFIVH 129
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E    +      G+  Y  PE    K Y  
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFS-----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 185 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 142 KIGQGGFGTVYKGRLEDG-TIVAIKRAKKSVYDKHSGA-----------EFQSEIRTLAQ 189
           K+G G +G V   + ++G +  AIK  KKS +DK   +           E  +EI  L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           ++H N++K     E +    ++ E+   G L E +  +  +  D     +I   +   I 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILSGIC 160
Query: 250 YLHMYTDHPIIHRDIKSSNILLTEN---FRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           YLH    H I+HRDIK  NILL         K+ DFG +   +        +     GTA
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-----GTA 212
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            Y+ PE LK  +  EK DV+S GV++  L+ G  P 
Sbjct: 213 YYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 35/231 (15%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLA 188
           R+    +++G+G FG V+          +D  +VA+K  K++   + +  +FQ E   L 
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 98
Query: 189 QVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL-------DCLQG------NILDLA 235
            ++H ++V+F G        +++ EY+ +G L   L         L G        L L 
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE--- 292
             L +A  VA  + YL        +HRD+ + N L+ +    K+ DFG +R    T+   
Sbjct: 159 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215
Query: 293 -SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             G T +  +      ++ PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 216 VGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 28/269 (10%)
Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+ L L      A+ VA  + YL     
Sbjct: 85  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 139
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXV-MQEHRKVPFAWCAPESLKT 198
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
              +  SD + FGV L E+ T G+ P              W     +    +  +D   E
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP--------------WI--GLNGSQILHKIDKEGE 242
Query: 376 NTAANNLALEKILELALQCLAPRRQNRPS 404
                    + I  + +QC A + ++RP+
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 27/227 (11%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLA 188
           R+    +++G+G FG V+          +D  +VA+K  K++   + +  +FQ E   L 
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 75
Query: 189 QVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL-------DCLQG------NILDLA 235
            ++H ++V+F G        +++ EY+ +G L   L         L G        L L 
Sbjct: 76  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
             L +A  VA  + YL        +HRD+ + N L+ +    K+ DFG +R    T+   
Sbjct: 136 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-- 190
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             V  +      ++ PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 191 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+ L L      A+ VA  + YL     
Sbjct: 75  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 129
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXV-MQEHRKVPFAWCAPESLKT 188
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRP 341
              +  SD + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+ L L      A+ VA  + YL     
Sbjct: 79  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 133
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCAPESLKT 192
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRP 341
              +  SD + FGV L E+ T G+ P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 27/227 (11%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLA 188
           R+    +++G+G FG V+          +D  +VA+K  K++   + +  +FQ E   L 
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 69
Query: 189 QVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL-------DCLQG------NILDLA 235
            ++H ++V+F G        +++ EY+ +G L   L         L G        L L 
Sbjct: 70  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
             L +A  VA  + YL        +HRD+ + N L+ +    K+ DFG +R    T+   
Sbjct: 130 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-- 184
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             V  +      ++ PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 185 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 82
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HRD+ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR-------KGGKG 192
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 79
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HRD+ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 140 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR-------KGGKG 189
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 190 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 46/240 (19%)
Query: 143 IGQGGFGTV-------YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEH 192
           +G+G FG V        KGR    T VA+K  K++     S +E +   SE   L QV H
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNH 85
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLR----------------------EHLDCLQGN 230
            +++K +G    +   ++IVEY   G+LR                        LD     
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
            L +   +  A  ++  + YL    +  ++HRD+ + NIL+ E  + K++DFG +R   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKR 346
            +S      +Q +    ++  E L  +  T +SDV+SFGVLL E+VT G  P   I P+R
Sbjct: 203 EDSXVKR--SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 82
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HRD+ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR-------KGGKG 192
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 46/240 (19%)
Query: 143 IGQGGFGTV-------YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEH 192
           +G+G FG V        KGR    T VA+K  K++     S +E +   SE   L QV H
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNH 85
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLR----------------------EHLDCLQGN 230
            +++K +G    +   ++IVEY   G+LR                        LD     
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
            L +   +  A  ++  + YL    +  ++HRD+ + NIL+ E  + K++DFG +R   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKR 346
            +S      +Q +    ++  E L  +  T +SDV+SFGVLL E+VT G  P   I P+R
Sbjct: 203 EDSXVKR--SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 142 KIGQGGFGTVYKGR--LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK 197
           K+G+G + TVYKG+  L D  +VA+K  +    +   GA   +  E+  L  ++H N+V 
Sbjct: 9   KLGEGTYATVYKGKSKLTDN-LVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
            H  +  E    ++ EY+ +  L+++LD C  GNI+++         +   + Y H    
Sbjct: 65  LHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR--- 118
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YLK 315
             ++HRD+K  N+L+ E    K+ADFG AR     +S  T        T  Y  P+  L 
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
           +   + + D++  G +  E+ TG RP+ P   ++E++
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEEQL 210

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 28/269 (10%)
Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+ L L      A+ VA  + YL     
Sbjct: 85  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 139
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCAPESLKT 198
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
              +  SD + FGV L E+ T G+ P              W     +    +  +D   E
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP--------------WI--GLNGSQILHKIDKEGE 242
Query: 376 NTAANNLALEKILELALQCLAPRRQNRPS 404
                    + I  + +QC A + ++RP+
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN---LVKF 198
           ++G G  G V K +     ++    A+K ++ +   A     IR L  +   N   +V F
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIM---ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 79
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           +G    + E  + +E++  G+L + L   +    ++ G++ IA  V   + YL     H 
Sbjct: 80  YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLR--EKHQ 135
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           I+HRD+K SNIL+      K+ DFG +    D+      ++    GT  Y+ PE L+   
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMAPERLQGTH 189
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEP 344
            + +SD++S G+ LVEL  GR PI P
Sbjct: 190 YSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVKF 198
           +G G FGTV+KG  + +G  + I    K + DK     FQ+    +  +  ++H ++V+ 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G       ++V  +Y+P G+L +H+   +G  L     L+  + +A  + YL    +H 
Sbjct: 99  LGLCPGSSLQLV-TQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLE---EHG 153
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           ++HR++ + N+LL    + +VADFG A L    +    +  ++ K    ++  E +   +
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIHFGK 211
Query: 319 LTEKSDVYSFGVLLVELVT 337
            T +SDV+S+GV + EL+T
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           ++   + IG G +G   K R + DG I+  K        +       SE+  L +++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 195 LVKFHGYL--EFEDERIVIVEYVPNGTL----------REHLDCLQGNILDLAGRLDIAI 242
           +V+++  +         +++EY   G L          R++LD  +  +L +  +L +A+
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD--EEFVLRVMTQLTLAL 124
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQ 301
              H  +       H ++HRD+K +N+ L      K+ DFG AR L  DT    T V   
Sbjct: 125 KECHRRSD----GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--- 177
Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
             GT  Y+ PE +      EKSD++S G LL EL     P 
Sbjct: 178 --GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+ L L      A+ VA  + YL     
Sbjct: 79  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 133
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCAPESLKT 192
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRP 341
              +  SD + FGV L E+ T G+ P
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+ L L      A+ VA  + YL     
Sbjct: 75  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 129
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCAPESLKT 188
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRP 341
              +  SD + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 94
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+ +                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 204
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+ L L      A+ VA  + YL     
Sbjct: 75  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLE---S 129
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCAPESLKT 188
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRP 341
              +  SD + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 120/258 (46%), Gaps = 25/258 (9%)
Query: 109 SSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRA 167
           +S+   R  D    + I  +       +  P  ++G+G +G V K R +  G I+A+KR 
Sbjct: 25  TSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI 84
Query: 168 KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT---LREHL 224
           + +V  +           ++  V+    V F+G L  E +  + +E +        ++ +
Sbjct: 85  RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVI 144
Query: 225 DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
           D  Q    D+ G+  IA+ +  A+ +LH  +   +IHRD+K SN+L+    + K+ DFG 
Sbjct: 145 DKGQTIPEDILGK--IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGI 200
Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYL------KTYQLTEKSDVYSFGVLLVELVTG 338
           +    D+ +      T   G   Y+ PE +      K Y +  KSD++S G+ ++EL   
Sbjct: 201 SGYLVDSVA-----KTIDAGCKPYMAPERINPELNQKGYSV--KSDIWSLGITMIELAIL 253
Query: 339 RRPIE----PKRELKERI 352
           R P +    P ++LK+ +
Sbjct: 254 RFPYDSWGTPFQQLKQVV 271

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVKF 198
           +G G FGTV+KG  + +G  + I    K + DK     FQ+    +  +  ++H ++V+ 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G       ++V  +Y+P G+L +H+   +G  L     L+  + +A  + YL    +H 
Sbjct: 81  LGLCPGSSLQLV-TQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLE---EHG 135
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           ++HR++ + N+LL    + +VADFG A L    +    +  ++ K    ++  E +   +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIHFGK 193
Query: 319 LTEKSDVYSFGVLLVELVT 337
            T +SDV+S+GV + EL+T
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 96/188 (51%), Gaps = 12/188 (6%)
Query: 162 VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLR 221
           VAIKR       + S  E   EI+ ++Q  H N+V ++     +DE  ++++ +  G++ 
Sbjct: 43  VAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 222 EHLDCL------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF 275
           + +  +      +  +LD +    I  +V   + YLH    +  IHRD+K+ NILL E+ 
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDG 158
Query: 276 RAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE-KSDVYSFGVLLV 333
             ++ADFG  A LA   +     V     GT  ++ PE ++  +  + K+D++SFG+  +
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 334 ELVTGRRP 341
           EL TG  P
Sbjct: 219 ELATGAAP 226

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 46/240 (19%)
Query: 143 IGQGGFGTV-------YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQ---SEIRTLAQVEH 192
           +G+G FG V        KGR    T VA+K  K++     S +E +   SE   L QV H
Sbjct: 31  LGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNH 85
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLR----------------------EHLDCLQGN 230
            +++K +G    +   ++IVEY   G+LR                        LD     
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
            L +   +  A  ++  + YL    +  ++HRD+ + NIL+ E  + K++DFG +R   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKR 346
            +S      +Q +    ++  E L  +  T +SDV+SFGVLL E+VT G  P   I P+R
Sbjct: 203 EDSYVKR--SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 96/188 (51%), Gaps = 12/188 (6%)
Query: 162 VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLR 221
           VAIKR       + S  E   EI+ ++Q  H N+V ++     +DE  ++++ +  G++ 
Sbjct: 38  VAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 222 EHLDCL------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF 275
           + +  +      +  +LD +    I  +V   + YLH    +  IHRD+K+ NILL E+ 
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDG 153
Query: 276 RAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE-KSDVYSFGVLLV 333
             ++ADFG  A LA   +     V     GT  ++ PE ++  +  + K+D++SFG+  +
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 334 ELVTGRRP 341
           EL TG  P
Sbjct: 214 ELATGAAP 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 94
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+ +                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 204
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 83
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+ +                + 
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 144 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 193
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 79
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+                  + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 140 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 189
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 86
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+ +                + 
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 147 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 196
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 87
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+ +                + 
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 148 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 197
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 94
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+                  + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 204
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   Y+   ++   + A K   KS+  K H   +  +EI     +++ ++V FHG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E +D   V++E            C + ++L+L  R     +             + YL
Sbjct: 110 FFEDDDFVYVVLEI-----------CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H   ++ +IHRD+K  N+ L ++   K+ DFG A ++  D E   T     + GT  Y+ 
Sbjct: 159 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-----LCGTPNYIA 210
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + D++S G +L  L+ G+ P E
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G+G +G VYK +   G IVA+KR +    D+   +    EI  L ++ H N+V     
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E    ++ E++    L++ LD  +  + D   ++ +   +   + + H    H I+H
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLY-QLLRGVAHCH---QHRILH 142
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK-TYQLT 320
           RD+K  N+L+  +   K+ADFG AR         TH       T  Y  P+ L  + + +
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKKYS 198
Query: 321 EKSDVYSFGVLLVELVTGRRPIEP 344
              D++S G +  E++TG +P+ P
Sbjct: 199 TSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K +    T VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 135
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA--------------GRLD 239
           N++   G    +    VIVEY   G LRE+L   +   L+ +                + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR          H+ 
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHID 245
Query: 300 TQVKGTAG-----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              K T G     ++ PE L     T +SDV+SFGVLL E+ T
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           ++   + IG G +G   K R + DG I+  K        +       SE+  L +++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 195 LVKFHGYL--EFEDERIVIVEYVPNGTL----------REHLDCLQGNILDLAGRLDIAI 242
           +V+++  +         +++EY   G L          R++LD  +  +L +  +L +A+
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD--EEFVLRVMTQLTLAL 124
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
              H  +       H ++HRD+K +N+ L      K+ DFG AR+    E  A     + 
Sbjct: 125 KECHRRSD----GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA----KEF 176
Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            GT  Y+ PE +      EKSD++S G LL EL     P 
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G+G +G VYK +   G IVA+KR +    D+   +    EI  L ++ H N+V     
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E    ++ E++    L++ LD  +  + D   ++ +   +   + + H    H I+H
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLY-QLLRGVAHCH---QHRILH 142
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK-TYQLT 320
           RD+K  N+L+  +   K+ADFG AR         TH       T  Y  P+ L  + + +
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKKYS 198
Query: 321 EKSDVYSFGVLLVELVTGRRPIEP 344
              D++S G +  E++TG +P+ P
Sbjct: 199 TSVDIWSIGCIFAEMITG-KPLFP 221

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 152
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +  ES     ++ V GTA Y+ PE L    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFV-GTAQYVSPELLTEKS 210
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
            ++ SD+++ G ++ +LV G  P 
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 82
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HRD+ + N ++  +F  K+ DFG  R   +T       +   KG  G
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET-------AYYRKGGKG 192
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 81
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HRD+ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 142 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-------YYRKGGKG 191
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 192 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 82
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HRD+ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD-------YYRKGGKG 192
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           ++   + IG G +G   K R + DG I+  K        +       SE+  L +++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 195 LVKFHGYL--EFEDERIVIVEYVPNGTL----------REHLDCLQGNILDLAGRLDIAI 242
           +V+++  +         +++EY   G L          R++LD  +  +L +  +L +A+
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD--EEFVLRVMTQLTLAL 124
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQ 301
              H  +       H ++HRD+K +N+ L      K+ DFG AR L  DT      V   
Sbjct: 125 KECHRRSD----GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--- 177
Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
             GT  Y+ PE +      EKSD++S G LL EL     P 
Sbjct: 178 --GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/225 (33%), Positives = 112/225 (49%), Gaps = 32/225 (14%)
Query: 142 KIGQGGFGTVY--KGRLEDGTIVAIKRAKKS--VYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           K+G G +G V   K +L  G   AIK  KKS      +SGA    E+  L Q++H N++K
Sbjct: 28  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGA-LLDEVAVLKQLDHPNIMK 85
Query: 198 FHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI---DVAHAITYLH 252
            + +  FED+R   +++E    G L + +   Q         +D A+    V    TYLH
Sbjct: 86  LYEF--FEDKRNYYLVMEVYRGGELFDEIILRQK-----FSEVDAAVIMKQVLSGTTYLH 138
Query: 253 MYTDHPIIHRDIKSSNILLTENFR---AKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
               H I+HRD+K  N+LL    R    K+ DFG   L+A  E G      +  GTA Y+
Sbjct: 139 ---KHNIVHRDLKPENLLLESKSRDALIKIVDFG---LSAHFEVGGK--MKERLGTAYYI 190
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
            PE L+  +  EK DV+S GV+L  L+ G  P   +  +E+ +R+
Sbjct: 191 APEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 75
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 130
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 188
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTIV--AIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           K+G G +G V   R +  T V  AIK  +K+     S ++   E+  L  ++H N++K +
Sbjct: 44  KLGSGAYGEVLLCR-DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 200 GYLEFEDER--IVIVEYVPNGTL-REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
            +  FED+R   +++E    G L  E +  ++ N +D A    I   V   +TYLH    
Sbjct: 103 DF--FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLH---K 154
Query: 257 HPIIHRDIKSSNILLTENFR---AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
           H I+HRD+K  N+LL    +    K+ DFG + +  + +     +     GTA Y+ PE 
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-----GTAYYIAPEV 209
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           L+  +  EK DV+S GV+L  L+ G  P 
Sbjct: 210 LRK-KYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 74
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 129
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 187
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   Y+   ++   + A K   KS+  K H   +  +EI     +++ ++V FHG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E +D   V++E            C + ++L+L  R     +             + YL
Sbjct: 110 FFEDDDFVYVVLEI-----------CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H   ++ +IHRD+K  N+ L ++   K+ DFG A ++  D E         + GT  Y+ 
Sbjct: 159 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-----KKDLCGTPNYIA 210
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + D++S G +L  L+ G+ P E
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 98
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 153
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +  ES     ++ V GTA Y+ PE L    
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFV-GTAQYVSPELLTEKS 211
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKN--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   Y+   ++   + A K   KS+  K H   +  +EI     +++ ++V FHG
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E +D   V++E            C + ++L+L  R     +             + YL
Sbjct: 110 FFEDDDFVYVVLEI-----------CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H   ++ +IHRD+K  N+ L ++   K+ DFG A ++  D E         + GT  Y+ 
Sbjct: 159 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-----KKXLCGTPNYIA 210
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + D++S G +L  L+ G+ P E
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG VY+G       +   VA+K  KK      +  +F SE   +  ++H ++VK 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +E E+   +I+E  P G L  +L+    N L +   +  ++ +  A+ YL       
Sbjct: 91  IGIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN--- 145
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI   NIL+      K+ DFG +R   D +     V+   +    ++ PE +   +
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESINFRR 202
Query: 319 LTEKSDVYSFGVLLVELVT-GRRP 341
            T  SDV+ F V + E+++ G++P
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 73
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 128
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 186
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VA+K   K+  +  S  +   E+R    + H N+VK    
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +E E    ++ EY   G + ++L    G   +   R      +  A+ Y H      I+H
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYL-VAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQL 319
           RD+K+ N+LL  +   K+ADFGF+      E    +      G   Y  PE    K Y  
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFS-----NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 192 PE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 225

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 72
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 127
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 185
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 147
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 208 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 262
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYK-GRLEDGTIVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   Y+   ++   + A K   KS+  K H   +  +EI     +++ ++V FHG
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E +D   V++E            C + ++L+L  R     +             + YL
Sbjct: 94  FFEDDDFVYVVLEI-----------CRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H   ++ +IHRD+K  N+ L ++   K+ DFG A ++  D E         + GT  Y+ 
Sbjct: 143 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-----KKDLCGTPNYIA 194
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + D++S G +L  L+ G+ P E
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG V+    +      AIK  KK V    D       +  + +LA  EH  L   
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHM 84
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
               + ++    ++EY+  G L  H+        DL+     A ++   + +LH      
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH---SKG 139
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           I++RD+K  NILL ++   K+ADFG  +  +  D ++       +  GT  Y+ PE L  
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT------NEFCGTPDYIAPEILLG 193
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
            +     D +SFGVLL E++ G+ P   + E
Sbjct: 194 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 224

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRL-----EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +        ED  + VA+K  K + +     A   SE++ ++ + +H N+
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENI 104
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTL--------REHLDCLQGNILDLAGRLDIAIDVAHA 247
           V   G        +VI EY   G L           LD   G  L+L   L  +  VA  
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA- 306
           + +L        IHRD+ + N+LLT    AK+ DFG AR   D  + + ++   VKG A 
Sbjct: 165 MAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMNDSNYI---VKGNAR 215
Query: 307 ---GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               ++ PE +     T +SDV+S+G+LL E+ +
Sbjct: 216 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/225 (33%), Positives = 112/225 (49%), Gaps = 32/225 (14%)
Query: 142 KIGQGGFGTVY--KGRLEDGTIVAIKRAKKS--VYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           K+G G +G V   K +L  G   AIK  KKS      +SGA    E+  L Q++H N++K
Sbjct: 11  KLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGA-LLDEVAVLKQLDHPNIMK 68
Query: 198 FHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI---DVAHAITYLH 252
            + +  FED+R   +++E    G L + +   Q         +D A+    V    TYLH
Sbjct: 69  LYEF--FEDKRNYYLVMEVYRGGELFDEIILRQK-----FSEVDAAVIMKQVLSGTTYLH 121
Query: 253 MYTDHPIIHRDIKSSNILLTENFR---AKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
               H I+HRD+K  N+LL    R    K+ DFG   L+A  E G      +  GTA Y+
Sbjct: 122 ---KHNIVHRDLKPENLLLESKSRDALIKIVDFG---LSAHFEVGGK--MKERLGTAYYI 173
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
            PE L+  +  EK DV+S GV+L  L+ G  P   +  +E+ +R+
Sbjct: 174 APEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 217

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 113/239 (47%), Gaps = 19/239 (7%)
Query: 111 NNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKK 169
            +S   G Q+G + I  +       +     ++G G  G V+K R  + G ++A+K+ ++
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 170 SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQ 228
           S   + +          L   +   +V+  G      +  + +E +  GT  E L   +Q
Sbjct: 61  SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQ 118
Query: 229 GNILD-LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL 287
           G I + + G++ +AI    A+ YL     H +IHRD+K SNILL E  + K+ DFG +  
Sbjct: 119 GPIPERILGKMTVAI--VKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174
Query: 288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE-----KSDVYSFGVLLVELVTGRRP 341
             D ++       +  G A Y+ PE +     T+     ++DV+S G+ LVEL TG+ P
Sbjct: 175 LVDDKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 94
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 149
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +  ES     ++ V GTA Y+ PE L    
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANSFV-GTAQYVSPELLTEKS 207
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
             + SD+++ G ++ +LV G  P     E
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRL-----EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +        ED  + VA+K  K + +     A   SE++ ++ + +H N+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENI 112
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTL--------REHLDCLQGNILDLAGRLDIAIDVAHA 247
           V   G        +VI EY   G L           LD   G  L+L   L  +  VA  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA- 306
           + +L        IHRD+ + N+LLT    AK+ DFG AR   D  + + ++   VKG A 
Sbjct: 173 MAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMNDSNYI---VKGNAR 223
Query: 307 ---GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               ++ PE +     T +SDV+S+G+LL E+ +
Sbjct: 224 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 21/238 (8%)
Query: 113 STRGGDQSG-NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV 171
           S  GG Q G   +  M    + + N+    ++G+G F  V   R        ++ A K +
Sbjct: 6   SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVV---RRCVHKTTGLEFAAKII 62
Query: 172 YDKH-SGAEFQS---EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCL 227
             K  S  +FQ    E R   +++H N+V+ H  ++ E    ++ + V  G L E  D +
Sbjct: 63  NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--DIV 120
Query: 228 QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA---KVADFGF 284
                  A        +  +I Y H    + I+HR++K  N+LL    +    K+ADFG 
Sbjct: 121 AREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           A    D+E  A H      GT GYL PE LK    ++  D+++ GV+L  L+ G  P 
Sbjct: 178 AIEVNDSE--AWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 150
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +  ES     +  V GTA Y+ PE L    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLS-PESKQARANAFV-GTAQYVSPELLTEKS 208
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 152
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 210
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 98
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 153
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 211
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 150
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 208
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG VY+G       +   VA+K  KK      +  +F SE   +  ++H ++VK 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +E E+   +I+E  P G L  +L+    N L +   +  ++ +  A+ YL       
Sbjct: 75  IGIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN--- 129
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI   NIL+      K+ DFG +R   D +     V+   +    ++ PE +   +
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESINFRR 186
Query: 319 LTEKSDVYSFGVLLVELVT-GRRP 341
            T  SDV+ F V + E+++ G++P
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 88
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 149 CTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKK--T 203
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 143 IGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG VY+G       +   VA+K  KK      +  +F SE   +  ++H ++VK 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G +E E+   +I+E  P G L  +L+    N L +   +  ++ +  A+ YL       
Sbjct: 79  IGIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN--- 133
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDI   NIL+      K+ DFG +R   D +     V+   +    ++ PE +   +
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESINFRR 190
Query: 319 LTEKSDVYSFGVLLVELVT-GRRP 341
            T  SDV+ F V + E+++ G++P
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 150
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 208
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 152
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 210
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
             + SD+++ G ++ +LV G  P     E
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 152
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 210
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRA-KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V  G  +  G  VA+K   ++ +       + + EI+ L    H +++K + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            +    +  +++EYV  G L +++ C  G + ++  R  +   +  A+ Y H    H ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVV 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQ 318
           HRD+K  N+LL  +  AK+ADFG + + +D E   T       G+  Y  PE +  + Y 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPEVISGRLYA 188
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIE 343
             E  D++S GV+L  L+ G  P +
Sbjct: 189 GPE-VDIWSCGVILYALLCGTLPFD 212

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 90
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 151 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 205
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 93
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 154 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 208
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 100
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 155
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 213
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
             + SD+++ G ++ +LV G  P     E
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   +++ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH-- 120
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G +G VY GR L +   +AIK   +   D         EI     ++H N+V++ G 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI-DVAHAITYLHMYTDHPII 260
                   + +E VP G+L   L    G + D    +      +   + YLH   D+ I+
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 144
Query: 261 HRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT--Y 317
           HRDIK  N+L+ T +   K++DFG ++  A    G    +    GT  Y+ PE +     
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLA----GINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV-EN 376
              + +D++S G  ++E+ TG+ P     EL E     + +  F        + P + E+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFK-------VHPEIPES 250
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            +A   A        L+C  P     P  R CA  L
Sbjct: 251 MSAEAKA------FILKCFEP----DPDKRACANDL 276

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG V+    +      AIK  KK V    D       +  + +LA  EH  L   
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHM 83
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
               + ++    ++EY+  G L  H+        DL+     A ++   + +LH      
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLH---SKG 138
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           I++RD+K  NILL ++   K+ADFG  +  +  D ++          GT  Y+ PE L  
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNX------FCGTPDYIAPEILLG 192
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
            +     D +SFGVLL E++ G+ P   + E
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 152
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 210
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
             + SD+++ G ++ +LV G  P     E
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK + 
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 104
Query: 201 YLEFEDERIVI-VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
             + +DE++   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      I
Sbjct: 105 CFQ-DDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKGI 158
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           IHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L     
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKSA 216
Query: 320 TEKSDVYSFGVLLVELVTGRRPI 342
            + SD+++ G ++ +LV G  P 
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 94
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 149
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 207
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
             + SD+++ G ++ +LV G  P     E
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 83
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HR++ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 144 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD-------YYRKGGKG 193
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 194 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G   D       T VA+K   +S   +    EF +E   +      ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IEFLNEASVMKGFTCHHV 82
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--------LDIAIDVAHA 247
           V+  G +      +V++E + +G L+ +L  L+    +  GR        + +A ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+       +HR++ + N ++  +F  K+ DFG  R   +T+          KG  G
Sbjct: 143 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD-------YYRKGGKG 192
Query: 308 -----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE LK    T  SD++SFGV+L E+ +
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 79
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 134
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 192
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    D   + A K   KS+  K H   +   EI     + H ++V FHG
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E  D   V++E            C + ++L+L  R     +         +     YL
Sbjct: 89  FFEDNDFVFVVLEL-----------CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 137
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H    + +IHRD+K  N+ L E+   K+ DFG A ++  D E   T     + GT  Y+ 
Sbjct: 138 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-----LCGTPNYIA 189
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + DV+S G ++  L+ G+ P E
Sbjct: 190 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F TV   R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 152
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 210
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
             + SD+++ G ++ +LV G  P     E
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 182
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 183 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  P
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 173
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 174 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 206

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    D   + A K   KS+  K H   +   EI     + H ++V FHG
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E  D   V++E            C + ++L+L  R     +         +     YL
Sbjct: 85  FFEDNDFVFVVLEL-----------CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 133
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H    + +IHRD+K  N+ L E+   K+ DFG A ++  D E   T     + GT  Y+ 
Sbjct: 134 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-----LCGTPNYIA 185
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + DV+S G ++  L+ G+ P E
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   ++ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 68  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 124
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 179
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 180 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 209

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 LGXKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 30/229 (13%)
Query: 132 RATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQ 189
           R   +F P   +G+GGFG V++ + + D    AIKR +  + ++    E    E++ LA+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAK 59
Query: 190 VEHLNLVK-FHGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILD-LAGR--------- 237
           +EH  +V+ F+ +LE ++    +    P   L   +  C + N+ D + GR         
Sbjct: 60  LEHPGIVRYFNAWLE-KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 238 --LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
             L I + +A A+ +LH      ++HRD+K SNI  T +   KV DFG        E   
Sbjct: 119 VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 296 THVS--------TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           T ++        T   GT  Y+ PE +     + K D++S G++L EL+
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 204

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    D   + A K   KS+  K H   +   EI     + H ++V FHG
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E  D   V++E            C + ++L+L  R     +         +     YL
Sbjct: 85  FFEDNDFVFVVLEL-----------CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 133
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H    + +IHRD+K  N+ L E+   K+ DFG A ++  D E   T     + GT  Y+ 
Sbjct: 134 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-----LCGTPNYIA 185
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + DV+S G ++  L+ G+ P E
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 182
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 183 LGXKYY--STAVDIWSLGCIFAEMVT-RRALFP 212

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E+V +  L+  +D      + L         +   + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 204

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEHLNLVKF 198
           K+G G FG V+   L +     ++R  K++    S     + ++EI  L  ++H N++K 
Sbjct: 29  KLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTD 256
               E      +++E    G L E +   Q  G  L      ++   + +A+ Y H  + 
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQ 143
Query: 257 HPIIHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
           H ++H+D+K  NIL  +   +   K+ DFG A L    E      ST   GTA Y+ PE 
Sbjct: 144 H-VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-----STNAAGTALYMAPEV 197
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            K   +T K D++S GV++  L+TG  P 
Sbjct: 198 FKR-DVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G +G VY GR L +   +AIK   +   D         EI     ++H N+V++ G 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI-DVAHAITYLHMYTDHPII 260
                   + +E VP G+L   L    G + D    +      +   + YLH   D+ I+
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 130
Query: 261 HRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT--Y 317
           HRDIK  N+L+ T +   K++DFG ++  A    G    +    GT  Y+ PE +     
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLA----GINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV-EN 376
              + +D++S G  ++E+ TG+ P     EL E     + +  F        + P + E+
Sbjct: 187 GYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFK-------VHPEIPES 236
Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            +A   A        L+C  P     P  R CA  L
Sbjct: 237 MSAEAKA------FILKCFEP----DPDKRACANDL 262

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    ++   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIVEY   G LRE+L                +    +     + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 106/242 (43%), Gaps = 21/242 (8%)
Query: 107 YVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIK 165
           ++ S+  TR   Q  NV++    I+    +FS    IG+GGFG VY  R  D G + A+K
Sbjct: 165 FIESDKFTRFC-QWKNVELN---IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 166 RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE----DERIVIVEYVPNGTLR 221
              K       G       R +  +       F   + +     D+   I++ +  G L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 222 EHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD 281
            HL   Q  +   A     A ++   + ++H   +  +++RD+K +NILL E+   +++D
Sbjct: 281 YHLS--QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISD 335
Query: 282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRR 340
            G   LA D      H S    GT GY+ PE L K       +D +S G +L +L+ G  
Sbjct: 336 LG---LACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 341 PI 342
           P 
Sbjct: 390 PF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 106/242 (43%), Gaps = 21/242 (8%)
Query: 107 YVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIK 165
           ++ S+  TR   Q  NV++    I+    +FS    IG+GGFG VY  R  D G + A+K
Sbjct: 165 FIESDKFTRFC-QWKNVELN---IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 166 RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE----DERIVIVEYVPNGTLR 221
              K       G       R +  +       F   + +     D+   I++ +  G L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 222 EHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD 281
            HL   Q  +   A     A ++   + ++H   +  +++RD+K +NILL E+   +++D
Sbjct: 281 YHLS--QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISD 335
Query: 282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRR 340
            G   LA D      H S    GT GY+ PE L K       +D +S G +L +L+ G  
Sbjct: 336 LG---LACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 341 PI 342
           P 
Sbjct: 390 PF 391

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 106/242 (43%), Gaps = 21/242 (8%)
Query: 107 YVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIK 165
           ++ S+  TR   Q  NV++    I+    +FS    IG+GGFG VY  R  D G + A+K
Sbjct: 165 FIESDKFTRFC-QWKNVELN---IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 166 RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE----DERIVIVEYVPNGTLR 221
              K       G       R +  +       F   + +     D+   I++ +  G L 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 222 EHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVAD 281
            HL   Q  +   A     A ++   + ++H   +  +++RD+K +NILL E+   +++D
Sbjct: 281 YHLS--QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISD 335
Query: 282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRR 340
            G   LA D      H S    GT GY+ PE L K       +D +S G +L +L+ G  
Sbjct: 336 LG---LACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 341 PI 342
           P 
Sbjct: 390 PF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 110/251 (43%), Gaps = 39/251 (15%)
Query: 107 YVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIK 165
           ++ S+  TR   Q  NV++    I+    +FS    IG+GGFG VY  R  D G + A+K
Sbjct: 164 FIESDKFTRFC-QWKNVELN---IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 219
Query: 166 RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK-------------FHGYLEFEDERIVIV 212
                  DK      Q E   L +   L+LV              FH      D+   I+
Sbjct: 220 -----CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----PDKLSFIL 270
Query: 213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT 272
           + +  G L  HL   Q  +   A     A ++   + ++H   +  +++RD+K +NILL 
Sbjct: 271 DLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLD 325
Query: 273 ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVL 331
           E+   +++D G   LA D      H S    GT GY+ PE L K       +D +S G +
Sbjct: 326 EHGHVRISDLG---LACDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCM 379
Query: 332 LVELVTGRRPI 342
           L +L+ G  P 
Sbjct: 380 LFKLLRGHSPF 390

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 84  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 135
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 136 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 192
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 193 LHRIY--THQSDVWSYGVTVWELMTFGSKP 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V  G+ E  G  VA+K   ++ +       + + EI+ L    H +++K + 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            +    +  +++EYV  G L +++ C  G + +   R  +   +   + Y H    H ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESR-RLFQQILSGVDYCHR---HMVV 138
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQ 318
           HRD+K  N+LL  +  AK+ADFG + + +D E           G+  Y  PE +  + Y 
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-----GSPNYAAPEVISGRLYA 193
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG 364
             E  D++S GV+L  L+ G  P +          V    KK  DG
Sbjct: 194 GPE-VDIWSSGVILYALLCGTLPFDDDH-------VPTLFKKICDG 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 86  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 194
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKP 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 87  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 138
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 195
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 196 LHRIY--THQSDVWSYGVTVWELMTFGSKP 223

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + DG  V I  A K + +  S     E   E   +A V    + + 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G       ++V  + +P G L +H+   +G  L     L+  + +A  ++YL    D  
Sbjct: 85  LGICLTSTVQLV-TQLMPYGCLLDHVRENRGR-LGSQDLLNWCMQIAKGMSYLE---DVR 139
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPEYLKT 316
           ++HRD+ + N+L+      K+ DFG ARL    +TE  A      +K    ++  E +  
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----WMALESILR 195
Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKE 350
            + T +SDV+S+GV + EL+T G +P +  P RE+ +
Sbjct: 196 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 232

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 85  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 193
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKP 221

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHG 200
           +G+G F T    R L      AIK  +K    K +   + +  R  +++++H   VK   
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 201 YLEFEDERIVI--VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  F+D+  +   + Y  NG L +++  + G+  +   R   A ++  A+ YLH      
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTA-EIVSALEYLH---GKG 150
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+   ++ DFG A++ +     A   +    GTA Y+ PE L    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--ANXFVGTAQYVSPELLTEKS 208
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI 342
             + SD+++ G ++ +LV G  P 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 83  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 191
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKP 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 13/225 (5%)
Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           +  P  ++G+G +G V K R +  G I+A+KR + +V  +           ++  V+   
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGT---LREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
            V F+G L  E +  + +E +        ++ +D  Q    D+ G+  IA+ +  A+ +L
Sbjct: 68  TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHL 125
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H  +   +IHRD+K SN+L+    + K+ DFG +    D  +       +       ++P
Sbjct: 126 H--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE----PKRELKERI 352
           E L     + KSD++S G+ ++EL   R P +    P ++LK+ +
Sbjct: 184 E-LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E+V +  L++ +D      + L         +   + + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 208

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRA-KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V  G  +  G  VA+K   ++ +       + + EI+ L    H +++K + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            +    +  +++EYV  G L +++ C  G + ++  R  +   +  A+ Y H    H ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVV 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQ 318
           HRD+K  N+LL  +  AK+ADFG + + +D E           G+  Y  PE +  + Y 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-----FLRDSCGSPNYAAPEVISGRLYA 188
Query: 319 LTEKSDVYSFGVLLVELVTGRRPIE 343
             E  D++S GV+L  L+ G  P +
Sbjct: 189 GPE-VDIWSCGVILYALLCGTLPFD 212

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIV Y   G LRE+L                +    +     + 
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 78  IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 131
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRD+ + N+LL     AK++DFG ++ A   +       T  K    +  PE +  Y+
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 319 LTEKSDVYSFGVLLVELVT-GRRP 341
            + KSDV+SFGVL+ E  + G++P
Sbjct: 191 FSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 84  LG-ICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 135
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 136 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 192
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 193 LHRIY--THQSDVWSYGVTVWELMTFGSKP 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 93  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 144
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 145 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 201
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 202 LHRIY--THQSDVWSYGVTVWELMTFGSKP 229

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQV-EHLNLVKFH 199
           IG+G +  V   RL+    I A+K  KK + +     ++ Q+E     Q   H  LV  H
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + E     ++EYV  G L  H+   Q  + +   R   + +++ A+ YLH   +  I
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YSAEISLALNYLH---ERGI 142
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ D+G  +       G T  ++   GT  Y+ PE L+    
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDT--TSXFCGTPNYIAPEILRGEDY 198
Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
               D ++ GVL+ E++ GR P +
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 199 HGYLEFEDERIVI--VEYVP-NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
            G  E E   +V+   E  P N  L+++      NI++L  +      V+  + YL    
Sbjct: 94  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLE--- 144
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPE 312
           +   +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PE 200
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +  Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 199 HGYLEFEDERIVI--VEYVP-NGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
            G  E E   +V+   E  P N  L+++      NI++L  +      V+  + YL    
Sbjct: 94  IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLE--- 144
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPE 312
           +   +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE
Sbjct: 145 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PE 200
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +  Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    D   + A K   KS+  K H   +   EI     + H ++V FHG
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E  D   V++E            C + ++L+L  R     +         +     YL
Sbjct: 109 FFEDNDFVFVVLEL-----------CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H    + +IHRD+K  N+ L E+   K+ DFG A ++  D E         + GT  Y+ 
Sbjct: 158 HR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LCGTPNYIA 209
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + DV+S G ++  L+ G+ P E
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 86  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 194
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKP 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 89  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 140
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 141 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 197
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 198 LHRIY--THQSDVWSYGVTVWELMTFGSKP 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 92  IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 145
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPEYLK 315
            +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE + 
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECIN 201
Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRP 341
            Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 90  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKP 226

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 86  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 194
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 85  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 193
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKP 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 86  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 137
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 138 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 194
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKP 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 191
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKP 219

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    D   + A K   KS+  K H   +   EI     + H ++V FHG
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E  D   V++E            C + ++L+L  R     +         +     YL
Sbjct: 107 FFEDNDFVFVVLEL-----------CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 155
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H    + +IHRD+K  N+ L E+   K+ DFG A ++  D E         + GT  Y+ 
Sbjct: 156 HR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LCGTPNYIA 207
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + DV+S G ++  L+ G+ P E
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 207

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 108 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 159
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 160 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 216
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 217 LHRIY--THQSDVWSYGVTVWELMTFGSKP 244

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 80  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAEGMNYLE-- 131
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 132 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 188
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 189 LHRIY--THQSDVWSYGVTVWELMTFGSKP 216

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 191
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKP 219

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 84  IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 137
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPEYLK 315
            +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE + 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECIN 193
Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRP 341
            Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 120 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 173 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 78  IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 131
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPEYLK 315
            +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE + 
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECIN 187
Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRP 341
            Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 208

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 122 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 207

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 173 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 74  IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPEYLK 315
            +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE + 
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECIN 183
Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRP 341
            Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 143 IGQGGFGTVY--------KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHL 193
           +G+G FG V         K + ++   VA+K  K    +K   ++  SE+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 101
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC--------------LQGNILDLAGRLD 239
           N++   G    +    VIV Y   G LRE+L                +    +     + 
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      +
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK--T 216
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           T  +    ++ PE L     T +SDV+SFGVL+ E+ T
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 173 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 176
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 177 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 209

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 173 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 172
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 173 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 77  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 128
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 129 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 185
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 186 LHRIY--THQSDVWSYGVTVWELMTFGSKP 213

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 123 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 208

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 174 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  PE L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 174
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 204

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQV-EHLNLVKFH 199
           IG+G +  V   RL+    I A+K  KK + +     ++ Q+E     Q   H  LV  H
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + E     ++EYV  G L  H+   Q  + +   R   + +++ A+ YLH   +  I
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YSAEISLALNYLH---ERGI 127
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ D+G  +       G T  ++   GT  Y+ PE L+    
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDT--TSXFCGTPNYIAPEILRGEDY 183
Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
               D ++ GVL+ E++ GR P +
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 174 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 83  LG-ICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 191
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKP 219

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 122 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 174
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 207

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 72  IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 125
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPEYLK 315
            +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE + 
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECIN 181
Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRP 341
            Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 208

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L++ +D      + L         +   + + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 121 H---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 174 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+ + +     +   +    EI  L ++ H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 205

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+ + +     +   +    EI  L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR         TH       T  Y  PE L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 204

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 143 IGQGGFGTVY--KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G F  V+  K RL  G + A+K  KKS   + S  E  +EI  L +++H N+V    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVTLED 73
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E      ++++ V  G L + +  L+  +        +   V  A+ YLH   ++ I+
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQQVLSAVKYLH---ENGIV 128
Query: 261 HRDIKSSNIL-LT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           HRD+K  N+L LT  EN +  + DFG +++  +       + +   GT GY+ PE L   
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG------IMSTACGTPGYVAPEVLAQK 182
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
             ++  D +S GV+   L+ G  P   E + +L E+I
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  PE L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 174
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 175 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 204

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 436 IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 489
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRD+ + N+LL     AK++DFG ++ A   +       T  K    +  PE +  Y+
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 319 LTEKSDVYSFGVLLVELVT-GRRP 341
            + KSDV+SFGVL+ E  + G++P
Sbjct: 549 FSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQV-EHLNLVKFH 199
           IG+G +  V   RL+    I A+K  KK + +     ++ Q+E     Q   H  LV  H
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + E     ++EYV  G L  H+   Q  + +   R   + +++ A+ YLH   +  I
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YSAEISLALNYLH---ERGI 131
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ D+G  +       G T  ++   GT  Y+ PE L+    
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDT--TSXFCGTPNYIAPEILRGEDY 187
Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
               D ++ GVL+ E++ GR P +
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDK-HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    D   + A K   KS+  K H   +   EI     + H ++V FHG
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---------VAHAITYL 251
           + E  D   V++E            C + ++L+L  R     +         +     YL
Sbjct: 83  FFEDNDFVFVVLEL-----------CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLD 310
           H    + +IHRD+K  N+ L E+   K+ DFG A ++  D E         + GT  Y+ 
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-----LCGTPNYIA 183
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           PE L     + + DV+S G ++  L+ G+ P E
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++ +  L++ +D      + L         +   + + H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  PE L
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 176
Query: 315 ---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              K Y  +   D++S G +  E+VT RR + P
Sbjct: 177 LGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 206

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRA---KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +   +V        K    D     E  +E   + Q+++  +V+ 
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   ++++E    G L ++L   Q   +     +++   V+  + YL    +  
Sbjct: 437 IGICEAES-WMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESN 490
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR-LAADTE--SGATHVSTQVKGTAGYLDPEYLK 315
            +HRD+ + N+LL     AK++DFG ++ L AD       TH    VK  A    PE + 
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECIN 546
Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRP 341
            Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 42/227 (18%)
Query: 143 IGQGGFGTVYKGRL-----EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +        ED  + VA+K  K + +     A   SE++ ++ + +H N+
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENI 97
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLR---------------------EHLDCLQGNILDL 234
           V   G        +VI EY   G L                      E LD   G  L+L
Sbjct: 98  VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLEL 157
Query: 235 AGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG 294
              L  +  VA  + +L        IHRD+ + N+LLT    AK+ DFG AR   D  + 
Sbjct: 158 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMND 211
Query: 295 ATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           + ++   VKG A     ++ PE +     T +SDV+S+G+LL E+ +
Sbjct: 212 SNYI---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 85  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA--LESI 193
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKP 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 85  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA--LESI 193
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKP 221

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE 191
           +  NF    KIG+G +G VYK R +  G +VA+K+ +     +   +    EI  L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+VK    +  E++  ++ E++ +  L+  +D      + L         +   + + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H ++HRD+K  N+L+      K+ADFG AR          H       T  Y  P
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E L   K Y  +   D++S G +  E+VT RR + P
Sbjct: 176 EILLGCKYY--STAVDIWSLGCIFAEMVT-RRALFP 208

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 87  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 138
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 139 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA--LESI 195
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 196 LHRIY--THQSDVWSYGVTVWELMTFGSKP 223

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 136 NFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS-GAEFQSEIRTLAQVEHL 193
           N+     +G+G FG V        G  VA+K   K V  K       + EI  L  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLH 252
           +++K +  ++ +DE I+++EY  N    E  D  +Q + +           +  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H I+HRD+K  N+LL E+   K+ADFG + +  D     T       G+  Y  PE
Sbjct: 131 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE 182
Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
            +  K Y   E  DV+S GV+L  ++  R P +
Sbjct: 183 VISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 136 NFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS-GAEFQSEIRTLAQVEHL 193
           N+     +G+G FG V        G  VA+K   K V  K       + EI  L  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLH 252
           +++K +  ++ +DE I+++EY  N    E  D  +Q + +           +  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H I+HRD+K  N+LL E+   K+ADFG + +  D     T       G+  Y  PE
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE 181
Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
            +  K Y   E  DV+S GV+L  ++  R P +
Sbjct: 182 VISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 136 NFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS-GAEFQSEIRTLAQVEHL 193
           N+     +G+G FG V        G  VA+K   K V  K       + EI  L  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLH 252
           +++K +  ++ +DE I+++EY  N    E  D  +Q + +           +  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H I+HRD+K  N+LL E+   K+ADFG + +  D     T       G+  Y  PE
Sbjct: 121 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE 172
Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
            +  K Y   E  DV+S GV+L  ++  R P +
Sbjct: 173 VISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 204

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 85  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 136
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 137 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA--LESI 193
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKP 221

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEF-QSEIRTLAQV-EHLNLVKFH 199
           IG+G +  V   RL+    I A++  KK + +     ++ Q+E     Q   H  LV  H
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + E     ++EYV  G L  H+   Q  + +   R   + +++ A+ YLH   +  I
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YSAEISLALNYLH---ERGI 174
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ D+G  +       G T  ++   GT  Y+ PE L+    
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDT--TSTFCGTPNYIAPEILRGEDY 230
Query: 320 TEKSDVYSFGVLLVELVTGRRPIE 343
               D ++ GVL+ E++ GR P +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 90  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA--LESI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKP 226

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/237 (30%), Positives = 113/237 (47%), Gaps = 31/237 (13%)
Query: 120 SGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE 179
           S  V +  E +Y  +          +G FG V+K +L +   VA+K     + DK S  +
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIF--PIQDKQS-WQ 64
Query: 180 FQSEIRTLAQVEHLNLVKFHGY----LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA 235
            + E+ +L  ++H N+++F G        + +  +I  +   G+L    D L+ N++   
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS---DFLKANVVSWN 121
Query: 236 GRLDIAIDVAHAITYLHMYTDHP---------IIHRDIKSSNILLTENFRAKVADFGFA- 285
               IA  +A  + YLH   D P         I HRDIKS N+LL  N  A +ADFG A 
Sbjct: 122 ELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 286 RLAADTESGATHVSTQVKGTAGYLDPEYLK---TYQLTE--KSDVYSFGVLLVELVT 337
           +  A   +G TH   QV GT  Y+ PE L+    +Q     + D+Y+ G++L EL +
Sbjct: 180 KFEAGKSAGDTH--GQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV 190
           R   +F     +GQG FG V K R   D    AIK+ + +   +   +   SE+  LA +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASL 59
Query: 191 EHLNLVKFHG-YLEFED------------ERIVIVEYVPNGTLRE--HLDCLQGNILDLA 235
            H  +V+++  +LE  +               + +EY  NGTL +  H + L     D  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ-RDEY 118
Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--------L 287
            RL     +  A++Y+H      IIHRD+K  NI + E+   K+ DFG A+        L
Sbjct: 119 WRL--FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 288 AADTES--GATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELV 336
             D+++  G++   T   GTA Y+  E L  T    EK D+YS G++  E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    VY +    +F  E   +++  H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR----LAADTESGATHVSTQVKGT 305
              ++  IHRDI + N LLT       AK+ DFG AR     +   + G   +  +    
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 225
Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
             ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 226 --WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA--LESI 191
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKP 219

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 26/230 (11%)
Query: 118 DQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRA-KKSVYDKH 175
           D++ +V     EI RA         IG+G FG V   +  D   + A+K   K+   +++
Sbjct: 7   DENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN 57
Query: 176 SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA 235
                  E++ +  +EH  LV      + E++  ++V+ +  G LR HL   Q N+    
Sbjct: 58  EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKE 114
Query: 236 GRLDIAI-DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG 294
             + + I ++  A+ YL    +  IIHRD+K  NILL E+    + DF  A +       
Sbjct: 115 ETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP----R 167
Query: 295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKS---DVYSFGVLLVELVTGRRP 341
            T ++T + GT  Y+ PE   + +    S   D +S GV   EL+ GRRP
Sbjct: 168 ETQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQ-VEHLNLVKFH 199
           IG+G FG V   R + +    A+K   KK++  K       SE   L + V+H  LV  H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLD---CLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
              +  D+   +++Y+  G L  HL    C     L+   R   A ++A A+ YLH    
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCF----LEPRARF-YAAEIASALGYLHSLN- 159
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             I++RD+K  NILL       + DFG  +   + E  +T  ++   GT  YL PE L  
Sbjct: 160 --IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNST--TSTFCGTPEYLAPEVLHK 213
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPI 342
                  D +  G +L E++ G  P 
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 136 NFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS-GAEFQSEIRTLAQVEHL 193
           N+     +G+G FG V        G  VA+K   K V  K       + EI  L  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLH 252
           +++K +  ++ +DE I+++EY  N    E  D  +Q + +           +  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H I+HRD+K  N+LL E+   K+ADFG + +  D     T       G+  Y  PE
Sbjct: 125 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE 176
Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
            +  K Y   E  DV+S GV+L  ++  R P +
Sbjct: 177 VISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 208

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 116/236 (49%), Gaps = 23/236 (9%)
Query: 118 DQSGNVQITMEEIYRAT-RNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH 175
           + SG ++I+ E+ +  T  +     +IG+G +G+V K      G I+A+KR + +V +K 
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63
Query: 176 SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG--TLREHLDCLQGNIL- 232
                      +   +   +V+F+G L  E +  + +E +        +++  +  +++ 
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123
Query: 233 -DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
            ++ G++ +A     A+   H+  +  IIHRDIK SNILL  +   K+ DFG +    D+
Sbjct: 124 EEILGKITLA--TVKALN--HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179
Query: 292 ESGATHVSTQVKGTAGYLDPEYL------KTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +      T+  G   Y+ PE +      + Y +  +SDV+S G+ L EL TGR P
Sbjct: 180 IA-----KTRDAGCRPYMAPERIDPSASRQGYDV--RSDVWSLGITLYELATGRFP 228

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +  G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I++ +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 90  LG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKP 226

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +G G FGTVYKG  + +G  V I  A   + +  S     E   E   +A V++ ++ + 
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 117 LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 168
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 169 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 225
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 226 LHRIY--THQSDVWSYGVTVWELMTFGSKP 253

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 113/260 (43%), Gaps = 26/260 (10%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGA-EFQSEIRTL 187
           +Y  + +F     +G+G +G V     +  G IVAIK+ +   +DK   A     EI+ L
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKIL 63
Query: 188 AQVEHLNLVKFHGY-----LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
              +H N++           E  +E  +I E +     R     +   +L          
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR----VISTQMLSDDHIQYFIY 119
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL----AADTE--SGAT 296
               A+  LH      +IHRD+K SN+L+  N   KV DFG AR+    AAD    +G  
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 297 HVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVK 355
              T+   T  Y  PE  L + + +   DV+S G +L EL   RRPI P R+ + ++ + 
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLI 235
Query: 356 WAM--KKFSDGDAISILDPR 373
           + +     SD D   I  PR
Sbjct: 236 FGIIGTPHSDNDLRCIESPR 255

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 112/224 (50%), Gaps = 26/224 (11%)
Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           K+G G + TVYKG     G  VA+K  K    D   G    +  EI  + +++H N+V+ 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNI---LDLAGRLDIAIDVAHAITYLHMY 254
           +  +  E++  ++ E++ N  L++++D    GN    L+L         +   + + H  
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-- 125
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEY 313
            ++ I+HRD+K  N+L+ +  + K+ DFG AR       + ++ V      T  Y  P+ 
Sbjct: 126 -ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-----TLWYRAPDV 179
Query: 314 L---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV 354
           L   +TY  +   D++S G +L E++TG +P+ P    +E++ +
Sbjct: 180 LMGSRTY--STSIDIWSCGCILAEMITG-KPLFPGTNDEEQLKL 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 113/260 (43%), Gaps = 26/260 (10%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGA-EFQSEIRTL 187
           +Y  + +F     +G+G +G V     +  G IVAIK+ +   +DK   A     EI+ L
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKIL 63
Query: 188 AQVEHLNLVKFHGY-----LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
              +H N++           E  +E  +I E +     R     +   +L          
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR----VISTQMLSDDHIQYFIY 119
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL----AADTE--SGAT 296
               A+  LH      +IHRD+K SN+L+  N   KV DFG AR+    AAD    +G  
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 297 HVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVK 355
              T+   T  Y  PE  L + + +   DV+S G +L EL   RRPI P R+ + ++ + 
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLI 235
Query: 356 WAM--KKFSDGDAISILDPR 373
           + +     SD D   I  PR
Sbjct: 236 FGIIGTPHSDNDLRCIESPR 255

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +  G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 83  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 134
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 191
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKP 219

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 116/250 (46%), Gaps = 18/250 (7%)
Query: 143 IGQGGFGTVYKGR----LEDGTIVAIKRAKKS--VYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G+GG+G V++ R       G I A+K  KK+  V +    A  ++E   L +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                 +   +  +I+EY+  G L   L+  +G  ++      +A +++ A+ +LH    
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLA-EISMALGHLH---Q 139
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             II+RD+K  NI+L      K+ DFG  + +   +   TH      GT  Y+ PE L  
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-DGTVTHTFC---GTIEYMAPEILMR 195
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPI---EPKRELKERITVKWAMKKFSDGDAISILDPR 373
                  D +S G L+ +++TG  P      K+ + + +  K  +  +   +A  +L   
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKL 255
Query: 374 VENTAANNLA 383
           ++  AA+ L 
Sbjct: 256 LKRNAASRLG 265

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS---GAEFQSEIRTLAQVEHLNLVKF 198
           +  G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++ ++ + 
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 199 HGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            G +       +I + +P G L    REH D +    L     L+  + +A  + YL   
Sbjct: 90  LG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLE-- 141
Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A  L+  
Sbjct: 142 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA--LESI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + Y  T +SDV+S+GV + EL+T G +P
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKP 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 116/250 (46%), Gaps = 18/250 (7%)
Query: 143 IGQGGFGTVYKGR----LEDGTIVAIKRAKKS--VYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G+GG+G V++ R       G I A+K  KK+  V +    A  ++E   L +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                 +   +  +I+EY+  G L   L+  +G  ++      +A +++ A+ +LH    
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIFMEDTACFYLA-EISMALGHLH---Q 139
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             II+RD+K  NI+L      K+ DFG  + +    +    V+    GT  Y+ PE L  
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHXFCGTIEYMAPEILMR 195
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPI---EPKRELKERITVKWAMKKFSDGDAISILDPR 373
                  D +S G L+ +++TG  P      K+ + + +  K  +  +   +A  +L   
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKL 255
Query: 374 VENTAANNLA 383
           ++  AA+ L 
Sbjct: 256 LKRNAASRLG 265

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK--HSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V+K    + T   +K A K +  +      E ++EI  + Q++H NL++ + 
Sbjct: 97  LGGGRFGQVHKC---EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH-MYTDHPI 259
             E +++ ++++EYV  G L + +     N+ +L   L +   +   I ++H MY    I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQMY----I 208
Query: 260 IHRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           +H D+K  NIL    +  + K+ DFG AR     E    +      GT  +L PE +   
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-----GTPEFLAPEVVNYD 263
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPI 342
            ++  +D++S GV+   L++G  P 
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G F TVYKG   + T+ VA    +     K     F+ E   L  ++H N+V+F+ 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 201 YLEF----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             E     +   +++ E   +GTL+ +L   +  +  +         +   + +LH  T 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLK--RFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 257 HPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YL 314
            PIIHRD+K  NI +T      K+ D G A L   + + A      V GT  +  PE Y 
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA------VIGTPEFXAPEXYE 203
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           + Y   E  DVY+FG   +E  T   P
Sbjct: 204 EKYD--ESVDVYAFGXCXLEXATSEYP 228

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH-SGAEFQS---EIRTLAQVE 191
           N+    ++G+G F  V   R        ++ A K +  K  S  +FQ    E R   +++
Sbjct: 7   NYDVKEELGKGAFSVV---RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+V+ H  ++ E    ++ + V  G L E  D +       A        +  +I Y 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFE--DIVAREFYSEADASHCIQQILESIAYC 121
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGY 308
           H    + I+HR++K  N+LL    +    K+ADFG A    D+E  A H      GT GY
Sbjct: 122 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH---GFAGTPGY 173
Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           L PE LK    ++  D+++ GV+L  L+ G  P 
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH-SGAEFQS---EIRTLAQVE 191
           N+    ++G+G F  V   R        ++ A K +  K  S  +FQ    E R   +++
Sbjct: 7   NYDVKEELGKGAFSVV---RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+V+ H  ++ E    ++ + V  G L E  D +       A        +  +I Y 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFE--DIVAREFYSEADASHCIQQILESIAYC 121
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGY 308
           H    + I+HR++K  N+LL    +    K+ADFG A    D+E  A H      GT GY
Sbjct: 122 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH---GFAGTPGY 173
Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           L PE LK    ++  D+++ GV+L  L+ G  P 
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH-SGAEFQS---EIRTLAQVE 191
           N+    ++G+G F  V   R        ++ A K +  K  S  +FQ    E R   +++
Sbjct: 6   NYDVKEELGKGAFSVV---RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N+V+ H  ++ E    ++ + V  G L E  D +       A        +  +I Y 
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFE--DIVAREFYSEADASHCIQQILESIAYC 120
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGY 308
           H    + I+HR++K  N+LL    +    K+ADFG A    D+E  A H      GT GY
Sbjct: 121 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWH---GFAGTPGY 172
Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           L PE LK    ++  D+++ GV+L  L+ G  P 
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 26/260 (10%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGA-EFQSEIRTL 187
           +Y  + +F     +G+G +G V     +  G IVAIK+ +   +DK   A     EI+ L
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKIL 63
Query: 188 AQVEHLNLVKFHGY-----LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
              +H N++           E  +E  +I E +     R     +   +L          
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR----VISTQMLSDDHIQYFIY 119
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL----AADTESGATHV 298
               A+  LH      +IHRD+K SN+L+  N   KV DFG AR+    AAD        
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 299 STQVK--GTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVK 355
           S  V+   T  Y  PE  L + + +   DV+S G +L EL   RRPI P R+ + ++ + 
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLI 235
Query: 356 WAM--KKFSDGDAISILDPR 373
           + +     SD D   I  PR
Sbjct: 236 FGIIGTPHSDNDLRCIESPR 255

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 32/213 (15%)
Query: 145 QGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLE- 203
           +G FG V+K +L +   VA+K     + DK S  + + EI +   ++H NL++F    + 
Sbjct: 25  RGRFGCVWKAQLMN-DFVAVKIF--PLQDKQS-WQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 204 ---FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP-- 258
               E E  +I  +   G+L    D L+GNI+       +A  ++  ++YLH   D P  
Sbjct: 81  GSNLEVELWLITAFHDKGSLT---DYLKGNIITWNELCHVAETMSRGLSYLH--EDVPWC 135
Query: 259 --------IIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYL 309
                   I HRD KS N+LL  +  A +ADFG A R       G TH   QV GT  Y+
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH--GQV-GTRRYM 192
Query: 310 DPEYLK---TYQLTE--KSDVYSFGVLLVELVT 337
            PE L+    +Q     + D+Y+ G++L ELV+
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 143 IGQGGFGTVYKGRL--EDGTI--VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G FG+V +G L  EDGT   VA+K  K     +    EF SE   +    H N+++ 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 199 HGY-LEFEDERI----VIVEYVPNGTLREHLDCLQGNI------LDLAGRLDIAIDVAHA 247
            G  +E   + I    VI+ ++  G L  +L  L   +      + L   L   +D+A  
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYL--LYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV-KGTA 306
           + YL   ++   +HRD+ + N +L ++    VADFG   L+    SG  +   ++ K   
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFG---LSKKIYSGDYYRQGRIAKMPV 213
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
            ++  E L     T KSDV++FGV + E+ T
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDKR----FKNRELQIMRKLDHCNIVRLRY 114
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 173
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAIK+  +       G  F++ E++ + +++H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-------GKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 143 IGQGGFGTVYKGRL-----EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +        ED  + VA+K  K + +     A   SE++ ++ + +H N+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENI 112
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLD------------CLQGNILDLAGRLDIAID 243
           V   G        +VI EY   G L   L              +  + L     L  +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQ 172
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           VA  + +L        IHRD+ + N+LLT    AK+ DFG AR   D  + + ++   VK
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMNDSNYI---VK 223
Query: 304 GTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           G A     ++ PE +     T +SDV+S+G+LL E+ +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI   A + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINAMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDKR----FKNRELQIMRKLDHCNIVRLRY 116
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 175
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 227
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 260

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDKR----FKNRELQIMRKLDHCNIVRLRY 118
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 177
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 229
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 262

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAIK+  +       G  F++ E++ + +++H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-------GKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 23/221 (10%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSE-----IRT 186
           AT  + P  +IG G +GTVYK R    G  VA+K  +  V +   G    +      +R 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRR 59
Query: 187 LAQVEHLNLVKFHGYL-----EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
           L   EH N+V+          + E +  ++ E+V +  LR +LD      L      D+ 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
                 + +LH      I+HRD+K  NIL+T     K+ADFG AR+ +   + A  V   
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-- 173
Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
              T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 174 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 143 IGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G G FG VY+G++           VA+K   + V  +    +F  E   ++++ H N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKLNHQNIV 97
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYL 251
           +  G       R +++E +  G L+  L        Q + L +   L +A D+A    YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 252 HMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR---LAADTESGATHVSTQVKGT 305
               ++  IHRDI + N LLT       AK+ DFG AR    A+    G   +   VK  
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-LPVK-- 211
Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
             ++ PE       T K+D +SFGVLL E+ +
Sbjct: 212 --WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDKR----FKNRELQIMRKLDHCNIVRLRY 108
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 167
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 219
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 252

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 159
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 218
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 219 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 270
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 303

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    V  +    +F  E   ++++ H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR----LAADTESGATHVSTQVKGT 305
              ++  IHRDI + N LLT       AK+ DFG AR     +   + G   +  +    
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 225
Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
             ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 226 --WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 143 IGQGGFGTVYK--GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V K   R+      A+K   K+       +    E+  L +++H N++K   
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            LE      ++ E    G L + +   +      A R  I   V   ITY+H    H I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH---KHNIV 143
Query: 261 HRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVK---GTAGYLDPEYL 314
           HRD+K  NILL    ++   K+ DFG         S     +T++K   GTA Y+ PE L
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGL--------STCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 315 K-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE---LKERITVKWAM 358
           + TY   EK DV+S GV+L  L++G  P   K E   LK   T K+A 
Sbjct: 196 RGTYD--EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 20/223 (8%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGR-LEDG-TIVAIKRAKKSVYDKHSGAEFQSEI--- 184
           + RA + +    +IG+G +G V+K R L++G   VA+KR +    ++        E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 185 RTLAQVEHLNLVKFHGYL-----EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD 239
           R L   EH N+V+          + E +  ++ E+V +  L  +LD +    +      D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           +   +   + +LH    H ++HRD+K  NIL+T + + K+ADFG AR+ +          
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMAL 176
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           T V  T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEIXINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 133/293 (45%), Gaps = 32/293 (10%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQVEHLNLVKF-- 198
           +IG+G +G V+ G+   G  VA+K      +     + F ++EI     + H N++ F  
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVK----VFFTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 199 ---HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH--M 253
               G   +  +  +I +Y  NG+L    D L+   LD    L +A      + +LH  +
Sbjct: 99  ADIKGTGSW-TQLYLITDYHENGSL---YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 254 YTDH---PIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYL 309
           ++      I HRD+KS NIL+ +N    +AD G A +  +DT       +T+V GT  Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213
Query: 310 DPEYLKT------YQLTEKSDVYSFGVLLVEL----VTGRRPIEPKRELKERITVKWAMK 359
            PE L        +Q    +D+YSFG++L E+    V+G    E +    + +    + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
              +   I  L P   N  +++  L ++ +L  +C A    +R +  R  + L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 23/228 (10%)
Query: 143 IGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G G FG VY+G++           VA+K   + V  +    +F  E   +++  H N+V
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIV 137
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYL 251
           +  G       R +++E +  G L+  L        Q + L +   L +A D+A    YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 252 HMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
               ++  IHRDI + N LLT       AK+ DFG AR      +G             +
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 252
Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
           + PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEIXINKMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 20/209 (9%)
Query: 143 IGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G G FG VY+G++           VA+K   + V  +    +F  E   +++  H N+V
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIV 114
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYL 251
           +  G       R +++E +  G L+  L        Q + L +   L +A D+A    YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 252 HMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
               ++  IHRDI + N LLT       AK+ DFG AR      +G             +
Sbjct: 175 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 229
Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           + PE       T K+D +SFGVLL E+ +
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    V  +    +F  E   +++  H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR---LAADTESGATHVSTQVKGTA 306
              ++  IHRDI + N LLT       AK+ DFG AR    A+    G   +   VK   
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-LPVK--- 210
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
            ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 211 -WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVK 197
           ++G G FG VYK +  E G + A K     V +  S  E +    EI  LA  +H  +VK
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAK-----VIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G    + +  +++E+ P G +   +  L   + +   ++ +   +  A+ +LH     
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH---SK 136
Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-----GTAGYLDPE 312
            IIHRD+K+ N+L+T     ++ADFG +         A ++ T  K     GT  ++ PE
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS---------AKNLKTLQKRDSFIGTPYWMAPE 187
Query: 313 YLKTYQLTE-----KSDVYSFGVLLVELVTGRRP---IEPKREL 348
            +    + +     K+D++S G+ L+E+     P   + P R L
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 143 IGQGGFGTVYKGRL-----EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +        ED  + VA+K  K + +     A   SE++ ++ + +H N+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENI 112
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           V   G        +VI EY   G L   L   +  +L+      IA   A     LH  +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 256 D----------HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
                         IHRD+ + N+LLT    AK+ DFG AR   D  + + ++   VKG 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMNDSNYI---VKGN 225
Query: 306 A----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           A     ++ PE +     T +SDV+S+G+LL E+ +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E +    +++  D +  +G + +   R      V  A+ + H 
Sbjct: 76  IRLLDWFERPDSFVLILERME--PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 131
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 132 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 183
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 85
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 144
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 196
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 229

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    V  +    +F  E   +++  H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR---LAADTESGATHVSTQVKGTA 306
              ++  IHRDI + N LLT       AK+ DFG AR    A+    G   +   VK   
Sbjct: 173 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-LPVK--- 225
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
            ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 226 -WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    V  +    +F  E   +++  H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR----LAADTESGATHVSTQVKGT 305
              ++  IHRDI + N LLT       AK+ DFG AR     +   + G   +  +    
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK---- 210
Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
             ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 211 --WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 143 IGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G G FG VY+G++           VA+K   + V  +    +F  E   +++  H N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIV 97
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYL 251
           +  G       R +++E +  G L+  L        Q + L +   L +A D+A    YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 252 HMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR---LAADTESGATHVSTQVKGT 305
               ++  IHRDI + N LLT       AK+ DFG AR    A+    G   +   VK  
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-LPVK-- 211
Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
             ++ PE       T K+D +SFGVLL E+ +
Sbjct: 212 --WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 143 IGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G G FG VY+G++           VA+K   + V  +    +F  E   +++  H N+V
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIV 113
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYL 251
           +  G       R +++E +  G L+  L        Q + L +   L +A D+A    YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 252 HMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAG- 307
               ++  IHRDI + N LLT       AK+ DFG AR            S   KG    
Sbjct: 174 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAM 223
Query: 308 ----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               ++ PE       T K+D +SFGVLL E+ +
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 143 IGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G G FG VY+G++           VA+K   + V  +    +F  E   +++  H N+V
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIV 123
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYL 251
           +  G       R +++E +  G L+  L        Q + L +   L +A D+A    YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 252 HMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAG- 307
               ++  IHRDI + N LLT       AK+ DFG AR            S   KG    
Sbjct: 184 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAM 233
Query: 308 ----YLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
               ++ PE       T K+D +SFGVLL E+ +
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    V  +    +F  E   +++  H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR---LAADTESGATHVSTQVKGTA 306
              ++  IHRDI + N LLT       AK+ DFG AR    A+    G   +   VK   
Sbjct: 165 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-LPVK--- 217
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
            ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 218 -WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 266

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G FG V   R +    + A+K   K    K S + F  E R +    +   V    +
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQLF 141
Query: 202 LEFEDERIV--IVEYVPNG---TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             F+D++ +  ++EY+P G    L  + D  +         + +A+D  H++        
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG------- 194
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             +IHRD+K  N+LL ++   K+ADFG   +  D E+G  H  T V GT  Y+ PE LK+
Sbjct: 195 --LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMD-ETGMVHCDTAV-GTPDYISPEVLKS 249
Query: 317 Y----QLTEKSDVYSFGVLLVELVTGRRPI 342
                    + D +S GV L E++ G  P 
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    V  +    +F  E   +++  H N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR---LAADTESGATHVSTQVKGTA 306
              ++  IHRDI + N LLT       AK+ DFG AR    A+    G   +   VK   
Sbjct: 150 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-LPVK--- 202
Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
            ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 203 -WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 251

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 127 MEEIYRATRNFSPSFKIGQGGFGTVYKGRL--EDGTIV--AIKRAKKSVYDKHSGAEFQS 182
           +E++    + F+    +G+G FG+V + +L  EDG+ V  A+K  K  +       EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDER------IVIVEYVPNGTLREHLDCLQGNI----- 231
           E   + + +H ++ K  G       +      +VI+ ++ +G L   L  L   I     
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPF 132
Query: 232 -LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LA 288
            L L   +   +D+A  + YL   +    IHRD+ + N +L E+    VADFG +R   +
Sbjct: 133 NLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            D           VK    +L  E L     T  SDV++FGV + E++T G+ P
Sbjct: 190 GDYYRQGCASKLPVK----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 88/318 (27%), Positives = 139/318 (43%), Gaps = 59/318 (18%)
Query: 129 EIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHS----GAEFQSE 183
           E + A     P   +G+GGFGTV+ G RL D   VAIK   ++     S          E
Sbjct: 27  EAFEAEYRLGP--LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 184 IRTLAQVE----HLNLVKFHGYLEFEDERIVIVEY-VPNGTLREHLDCLQGNILDLAGRL 238
           +  L +V     H  +++   + E ++  ++++E  +P   L +++   +G + +   R 
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRC 143
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFGFARLAADTESGA 295
                VA AI + H      ++HRDIK  NIL+  + R   AK+ DFG   L  D     
Sbjct: 144 FFGQVVA-AIQHCHSRG---VVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPY-- 195
Query: 296 THVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV 354
               T   GT  Y  PE++  +Q     + V+S G+LL ++V G  P E  +E+ E    
Sbjct: 196 ----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE---- 247
Query: 355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS 414
             A   F              + + +  AL +      +CLAP+  +RPS+    EIL  
Sbjct: 248 --AELHFP------------AHVSPDCCALIR------RCLAPKPSSRPSLE---EIL-- 282
Query: 415 VRKDYRELAASDVLLQPS 432
               + +  A DV L PS
Sbjct: 283 -LDPWMQTPAEDVPLNPS 299

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 36/232 (15%)
Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV 190
           R   +F     +GQG FG V K R   D    AIK+ + +   +   +   SE+  LA +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASL 59
Query: 191 EHLNLVKFHG-YLEFED------------ERIVIVEYVPNGTLRE--HLDCLQGNILDLA 235
            H  +V+++  +LE  +               + +EY  N TL +  H + L     D  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ-RDEY 118
Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--------L 287
            RL     +  A++Y+H      IIHRD+K  NI + E+   K+ DFG A+        L
Sbjct: 119 WRL--FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 288 AADTES--GATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELV 336
             D+++  G++   T   GTA Y+  E L  T    EK D+YS G++  E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 114/257 (44%), Gaps = 35/257 (13%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           ++G G FG V++   +    V + +   + Y  DK++    ++EI  + Q+ H  L+  H
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 114
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL-------- 251
              E + E ++I+E++  G L            D     D  +  A  I Y+        
Sbjct: 115 DAFEDKYEMVLILEFLSGGEL-----------FDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGY 308
           HM+ +H I+H DIK  NI + E  +A   K+ DFG A     T+     +      TA +
Sbjct: 164 HMH-EHSIVHLDIKPENI-MCETKKASSVKIIDFGLA-----TKLNPDEIVKVTTATAEF 216
Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS 368
             PE +    +   +D+++ GVL   L++G  P   + +L+    VK    +F D DA S
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF-DEDAFS 275
Query: 369 ILDPRVENTAANNLALE 385
            + P  ++   N L  E
Sbjct: 276 SVSPEAKDFIKNLLQKE 292

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           IG G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    KVADFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVK 197
           ++G G FG VYK +  E G + A K     V +  S  E +    EI  LA  +H  +VK
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAK-----VIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G    + +  +++E+ P G +   +  L   + +   ++ +   +  A+ +LH     
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH---SK 128
Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-----GTAGYLDPE 312
            IIHRD+K+ N+L+T     ++ADFG +         A ++ T  K     GT  ++ PE
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVS---------AKNLKTLQKRDSFIGTPYWMAPE 179
Query: 313 YLKTYQLTE-----KSDVYSFGVLLVELVTGRRP---IEPKREL 348
            +    + +     K+D++S G+ L+E+     P   + P R L
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEIXINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 143 IGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
           +G G FG VY+G++     +   +    +    V  +    +F  E   +++  H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLD-----CLQGNILDLAGRLDIAIDVAHAITYLH 252
             G       R +++E +  G L+  L        Q + L +   L +A D+A    YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFA----RLAADTESGATHVSTQVKGT 305
              ++  IHRDI + N LLT       AK+ DFG A    R +   + G   +  +    
Sbjct: 159 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK---- 211
Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK--RELKERIT 353
             ++ PE       T K+D +SFGVLL E+ + G  P   K  +E+ E +T
Sbjct: 212 --WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 260

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 93
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 152
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 153 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 204
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 237

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGR-LEDG-TIVAIKRAKKSVYDKHSGAEFQSEI--- 184
           + RA + +    +IG+G +G V+K R L++G   VA+KR +    ++        E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 185 RTLAQVEHLNLVKFHGYLEF-----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD 239
           R L   EH N+V+            E +  ++ E+V +  L  +LD +    +      D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           +   +   + +LH    H ++HRD+K  NIL+T + + K+ADFG AR+ +          
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMAL 176
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           T V  T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDKR----FKNRELQIMRKLDHCNIVRLRY 114
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 173
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 225
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 77  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 132
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 133 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 184
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 92  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 147
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 148 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 199
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 119 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 174
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 175 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 226
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 104 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 159
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 160 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 211
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 91  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 146
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 147 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 198
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 105 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 160
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 161 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 212
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 69
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 124
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGR-LEDG-TIVAIKRAKKSVYDKHSGAEFQSEI--- 184
           + RA + +    +IG+G +G V+K R L++G   VA+KR +    ++        E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 185 RTLAQVEHLNLVKFHGYLEF-----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD 239
           R L   EH N+V+            E +  ++ E+V +  L  +LD +    +      D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           +   +   + +LH    H ++HRD+K  NIL+T + + K+ADFG AR+ +          
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMAL 176
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           T V  T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 92  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 147
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 148 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 199
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 143 IGQGGFGTVYK--GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V K   R+      A+K   K+       +    E+  L +++H N++K   
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            LE      ++ E    G L + +  ++           I   V   ITY+H    H I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 261 HRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVK---GTAGYLDPEYL 314
           HRD+K  NILL    ++   K+ DFG         S     +T++K   GTA Y+ PE L
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGL--------STCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 315 K-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
           + TY   EK DV+S GV+L  L++G  P   K E
Sbjct: 196 RGTYD--EKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 135
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR  AD  +G   
Sbjct: 136 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV- 190
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 191 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 104 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 159
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 160 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 211
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 105 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 160
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 161 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 212
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 105 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 160
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 161 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 212
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 28/228 (12%)
Query: 143 IGQGGFGTVYK--GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V K   R+      A+K   K+       +    E+  L +++H N++K   
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            LE      ++ E    G L + +  ++           I   V   ITY+H    H I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 261 HRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVK---GTAGYLDPEYL 314
           HRD+K  NILL    ++   K+ DFG         S     +T++K   GTA Y+ PE L
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGL--------STCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 315 K-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE---LKERITVKWAM 358
           + TY   EK DV+S GV+L  L++G  P   K E   LK   T K+A 
Sbjct: 196 RGTYD--EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 15/226 (6%)
Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           +  P  ++G+G +G V K R +  G I A+KR + +V  +           +   V+   
Sbjct: 35  DLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPF 94
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTL----REHLDCLQGNILDLAGRLDIAIDVAHAITY 250
            V F+G L F +  + I   + + +L    ++ +D  Q    D+ G+  IA+ +  A+ +
Sbjct: 95  TVTFYGAL-FREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEH 151
Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           LH  +   +IHRD+K SN+L+    + K  DFG +    D  +       +       ++
Sbjct: 152 LH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERIN 209
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE----PKRELKERI 352
           PE L     + KSD++S G+  +EL   R P +    P ++LK+ +
Sbjct: 210 PE-LNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV 254

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 111 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 166
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 218
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 255

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 105 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 160
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 161 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 212
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 104 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 159
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 160 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 211
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRP 341
             E  DV+S G++L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 80
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 135
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR  AD  +G   
Sbjct: 136 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV- 190
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 191 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 77  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 132
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 133 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 184
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 135
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR  AD  +G   
Sbjct: 136 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV- 190
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 191 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 119 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 174
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 175 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 226
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 91  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 146
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 147 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 198
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 124 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 179
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 180 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 231
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 268

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAIK+  +       G  F++ E++ + +++H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ-------GKAFKNRELQIMRKLDHCNIVRLRY 80
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 77  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 132
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 133 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 184
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 104 IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 159
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 160 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 211
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV- 190
           AT  + P  +IG G +GTVYK R    G  VA+K  +        G    S +R +A + 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 191 -----EHLNLVKFHGYL-----EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI 240
                EH N+V+          + E +  ++ E+V +  LR +LD      L      D+
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
                  + +LH      I+HRD+K  NIL+T     K+ADFG AR+ +          T
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALT 177
Query: 301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            V  T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 76  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 131
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 132 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 183
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 136 NFSPSFKIGQGGFGTVY----KGRLEDGTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQV 190
           +F+    +G+G FG V     KG  E   + AIK  KK V  +    E    E R LA +
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEE---LYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 191 EHLN-LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
           +    L + H   +  D    ++EYV  G L  H+   Q         +  A +++  + 
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISIGLF 134
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-QVKGTAGY 308
           +LH      II+RD+K  N++L      K+ADFG  +     E     V+T +  GT  Y
Sbjct: 135 FLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMMDGVTTREFCGTPDY 186
Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
           + PE +      +  D +++GVLL E++ G+ P + + E
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 225

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSE-----IRT 186
           AT  + P  +IG G +GTVYK R    G  VA+K  +  V +   G    +      +R 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRR 59
Query: 187 LAQVEHLNLVKFHGYL-----EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
           L   EH N+V+          + E +  ++ E+V +  LR +LD      L      D+ 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
                 + +LH      I+HRD+K  NIL+T     K+ADFG AR+ +            
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALDP 170
Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           V  T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 92  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 147
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 148 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 199
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDKR----FKNRELQIMRKLDHCNIVRLRY 92
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 151
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 203
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRP 341
             E  DV+S G++L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRP 341
             E  DV+S G++L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRP 341
             E  DV+S G++L  ++ G  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 21/229 (9%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHG 200
           +G+G F    K    +     A+K     +  K   A  Q EI  L   E H N+VK H 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               +    +++E +  G L E +   +           I   +  A++++H   D  ++
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSHMH---DVGVV 128
Query: 261 HRDIKSSNILLTE---NFRAKVADFGFARLAA-DTESGATHVSTQVKGTAGYLDPEYLKT 316
           HRD+K  N+L T+   N   K+ DFGFARL   D +   T   T       Y  PE L  
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT-----LHYAAPELLNQ 183
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD 365
               E  D++S GV+L  +++G+ P +         +    MKK   GD
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 137 FSPSFKIGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           F    ++G+G    VY+ + + GT    A+K  KK+V  K      ++EI  L ++ H N
Sbjct: 55  FEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHPN 109
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           ++K     E   E  +++E V  G L + +  ++          D    +  A+ YLH  
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLH-- 165
Query: 255 TDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            ++ I+HRD+K  N+L      +   K+ADFG +++        T     V GT GY  P
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-----VCGTPGYCAP 219
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR 346
           E L+      + D++S G++   L+ G  P   +R
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 133 ATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSE-----IRT 186
           AT  + P  +IG G +GTVYK R    G  VA+K  +  V +   G    +      +R 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRR 59
Query: 187 LAQVEHLNLVKFHGYL-----EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
           L   EH N+V+          + E +  ++ E+V +  LR +LD      L      D+ 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
                 + +LH      I+HRD+K  NIL+T     K+ADFG AR+ +            
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALFP 170
Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           V  T  Y  PE L         D++S G +  E+   R+P+
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 143 IGQGGFGTV-----YKGRLEDGTIVAIKRAKKSVYDKHS-GAEFQSEIRTLAQVEHLNLV 196
           +G+G FG V     YK + +    VA+K   + +  K       + EI  L  + H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQQK----VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           K +  +    + ++++EY   G L +++   +  + +  GR      +  AI Y H    
Sbjct: 73  KLYDVITTPTDIVMVIEYA-GGELFDYI-VEKKRMTEDEGRRFFQ-QIICAIEYCH---R 126
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL-- 314
           H I+HRD+K  N+LL +N   K+ADFG + +  D     T       G+  Y  PE +  
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPEVING 181
Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           K Y   E  DV+S G++L  ++ GR P +
Sbjct: 182 KLYAGPE-VDVWSCGIVLYVMLVGRLPFD 209

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 92
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 151
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 203
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G +G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 71
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 126
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 320 -TEKSDVYSFGVLLVELVTGRRP 341
             E  DV+S G++L  ++ G  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           IG G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY+P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    KVADFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 72  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 127
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 128 --NXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 179
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 99  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 154
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 155 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 206
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 243

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 72  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 127
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 128 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 179
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 75  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 130
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 131 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 182
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 99
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 158
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 159 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 210
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 88
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 147
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 148 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 199
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 232

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFH 199
           K+G+G +G V+K      G +VA+K+   +  +         EI  L ++  H N+V   
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
             L  +++R V   Y+    +   L   ++ NIL+   +  +   +   I YLH      
Sbjct: 76  NVLRADNDRDV---YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGG 129
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFAR---------------LAADTES--GATHVSTQ 301
           ++HRD+K SNILL      KVADFG +R               +  +TE+      + T 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 302 VKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              T  Y  PE  L + + T+  D++S G +L E++ G +PI P
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFP 232

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           IG G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY+P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    KVADFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNL 195
           +G GGFG+VY G R+ D   VAIK  +K          +G     E+  L +V      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHM 253
           ++   + E  D  ++I+E  P   +++  D +  +G + +   R      V  A+ + H 
Sbjct: 72  IRLLDWFERPDSFVLILER-PE-PVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH- 127
Query: 254 YTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE
Sbjct: 128 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPE 179
Query: 313 YLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +++ ++   +S  V+S G+LL ++V G  P E   E+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 IGQGGFGTVY----KGRLEDGTIVAIKRAKKSVYDKHSGAEF-QSEIRTLA-QVEHLNLV 196
           +G+G FG V     KG  E   + A+K  KK V  +    E    E R LA   +   L 
Sbjct: 349 LGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + H   +  D    ++EYV  G L  H+   Q         +  A ++A  + +L     
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFYAAEIAIGLFFLQ---S 460
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             II+RD+K  N++L      K+ADFG  +   +   G T  +    GT  Y+ PE +  
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVT--TKXFCGTPDYIAPEII-A 515
Query: 317 YQLTEKS-DVYSFGVLLVELVTGRRPIEPKRE 347
           YQ   KS D ++FGVLL E++ G+ P E + E
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 84
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 143
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 144 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 195
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 80
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 81
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 140
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 141 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 192
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 225

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 130 IYRATRNFSPSFK----IGQGGFGTVY--KGRLEDGTIVAIKR-AKKSVYDKHSGAEFQS 182
           +  +T  FS  +K    +G+G FG V   K ++  G   A+K  +K+ V  K        
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           E++ L Q++H N++K + + E +    ++ E    G L + +   +      A R  I  
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIR 133
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVS 299
            V   ITY+H    + I+HRD+K  N+LL   +++   ++ DFG +     T   A+   
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEASKKM 185
Query: 300 TQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
               GTA Y+ PE L  TY   EK DV+S GV+L  L++G  P     E
Sbjct: 186 KDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCPPFNGANE 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVK--- 197
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 80
Query: 198 -FHGYLEFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            F+   E +DE    ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 143 IGQGGFGTVYKGRL-----EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +        ED  + VA+K  K + +     A   SE++ ++ + +H N+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENI 112
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILD------------LAGR--LDIA 241
           V   G        +VI EY   G L   L   +   L+            L+ R  L  +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFS 172
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
             VA  + +L        IHRD+ + N+LLT    AK+ DFG AR   D  + + ++   
Sbjct: 173 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMNDSNYI--- 223
Query: 302 VKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           VKG A     ++ PE +     T +SDV+S+G+LL E+ +
Sbjct: 224 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  K             E+
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL 84
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 140
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 141 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 195
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 196 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 143 IGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G G F  V     ED     +VAIK   K   +   G+  ++EI  L +++H N+V   
Sbjct: 26  LGTGAFSEVILA--EDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKHPNIVALD 82
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E      +I++ V  G L + +  ++           +   V  A+ YLH   D  I
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH---DLGI 137
Query: 260 IHRDIKSSNIL---LTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           +HRD+K  N+L   L E+ +  ++DFG +++    E   + +ST   GT GY+ PE L  
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTAC-GTPGYVAPEVLAQ 192
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK 349
              ++  D +S GV+   L+ G  P   + + K
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 143 IGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G G F  V     ED     +VAIK   K   +   G+  ++EI  L +++H N+V   
Sbjct: 26  LGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGS-MENEIAVLHKIKHPNIVALD 82
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E      +I++ V  G L + +  ++           +   V  A+ YLH   D  I
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH---DLGI 137
Query: 260 IHRDIKSSNIL---LTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           +HRD+K  N+L   L E+ +  ++DFG +++    E   + +ST   GT GY+ PE L  
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTAC-GTPGYVAPEVLAQ 192
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK 349
              ++  D +S GV+   L+ G  P   + + K
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 130 IYRATRNFSPSFK----IGQGGFGTVY--KGRLEDGTIVAIKR-AKKSVYDKHSGAEFQS 182
           +  +T  FS  +K    +G+G FG V   K ++  G   A+K  +K+ V  K        
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 98
Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           E++ L Q++H N++K + + E +    ++ E    G L + +   +      A R  I  
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIR 156
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVS 299
            V   ITY+H    + I+HRD+K  N+LL   +++   ++ DFG +     T   A+   
Sbjct: 157 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEASKKM 208
Query: 300 TQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
               GTA Y+ PE L  TY   EK DV+S GV+L  L++G  P     E
Sbjct: 209 KDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCPPFNGANE 255

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEH 192
           ++G+  FG VYKG L      E    VAIK  K    DK  G    EF+ E    A+++H
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLREEFRHEAMLRARLQH 88
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRL 238
            N+V   G +  +    +I  Y  +G L E L              D    + L+    +
Sbjct: 89  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGAT 296
            +   +A  + YL   + H ++H+D+ + N+L+ +    K++D G  R   AAD      
Sbjct: 149 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +    ++    ++ PE +   + +  SD++S+GV+L E+ + G +P
Sbjct: 206 NSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
           +G G  G V K   E  T   VAIK   K  +   S  E       ++EI  L ++ H  
Sbjct: 17  LGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 75
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI------DVAHAI 248
           ++K   + + ED  IV+ E +  G L    D + GN      RL  A        +  A+
Sbjct: 76  IIKIKNFFDAEDYYIVL-ELMEGGEL---FDKVVGN-----KRLKEATCKLYFYQMLLAV 126
Query: 249 TYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            YLH   ++ IIHRD+K  N+LL+   E+   K+ DFG +++      G T +   + GT
Sbjct: 127 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTLCGT 178
Query: 306 AGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR---ELKERIT 353
             YL PE L    T       D +S GV+L   ++G  P    R    LK++IT
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
           +G G  G V K   E  T   VAIK   K  +   S  E       ++EI  L ++ H  
Sbjct: 18  LGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI------DVAHAI 248
           ++K   + + ED  IV+ E +  G L    D + GN      RL  A        +  A+
Sbjct: 77  IIKIKNFFDAEDYYIVL-ELMEGGEL---FDKVVGN-----KRLKEATCKLYFYQMLLAV 127
Query: 249 TYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            YLH   ++ IIHRD+K  N+LL+   E+   K+ DFG +++      G T +   + GT
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTLCGT 179
Query: 306 AGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR---ELKERIT 353
             YL PE L    T       D +S GV+L   ++G  P    R    LK++IT
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 109/223 (48%), Gaps = 10/223 (4%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSG-AEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A K+ +K    K  G A   +E + L +V    +V    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++  +  G L+ H+  +       A  +  A ++   +  LH      I+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIV 308
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL ++   +++D G   LA     G T +  +V GT GY+ PE +K  + T
Sbjct: 309 YRDLKPENILLDDHGHIRISDLG---LAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 363
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD 363
              D ++ G LL E++ G+ P + +++  +R  V+  +K+  +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 143 IGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G G F  V     ED     +VAIK   K   +   G+  ++EI  L +++H N+V   
Sbjct: 26  LGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGS-MENEIAVLHKIKHPNIVALD 82
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E      +I++ V  G L + +  ++           +   V  A+ YLH   D  I
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH---DLGI 137
Query: 260 IHRDIKSSNIL---LTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           +HRD+K  N+L   L E+ +  ++DFG +++    E   + +ST   GT GY+ PE L  
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTAC-GTPGYVAPEVLAQ 192
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK 349
              ++  D +S GV+   L+ G  P   + + K
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
           +G G  G V K   E  T   VAIK   K  +   S  E       ++EI  L ++ H  
Sbjct: 18  LGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI------DVAHAI 248
           ++K   + + ED  IV+ E +  G L    D + GN      RL  A        +  A+
Sbjct: 77  IIKIKNFFDAEDYYIVL-ELMEGGEL---FDKVVGN-----KRLKEATCKLYFYQMLLAV 127
Query: 249 TYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            YLH   ++ IIHRD+K  N+LL+   E+   K+ DFG +++      G T +   + GT
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTLCGT 179
Query: 306 AGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR---ELKERIT 353
             YL PE L    T       D +S GV+L   ++G  P    R    LK++IT
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
           +G G  G V K   E  T   VAIK   K  +   S  E       ++EI  L ++ H  
Sbjct: 18  LGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI------DVAHAI 248
           ++K   + + ED  IV+ E +  G L    D + GN      RL  A        +  A+
Sbjct: 77  IIKIKNFFDAEDYYIVL-ELMEGGEL---FDKVVGN-----KRLKEATCKLYFYQMLLAV 127
Query: 249 TYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            YLH   ++ IIHRD+K  N+LL+   E+   K+ DFG +++      G T +   + GT
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTLCGT 179
Query: 306 AGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR---ELKERIT 353
             YL PE L    T       D +S GV+L   ++G  P    R    LK++IT
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 130 IYRATRNFSPSFK----IGQGGFGTVY--KGRLEDGTIVAIKR-AKKSVYDKHSGAEFQS 182
           +  +T  FS  +K    +G+G FG V   K ++  G   A+K  +K+ V  K        
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 99
Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           E++ L Q++H N++K + + E +    ++ E    G L + +   +      A R  I  
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIR 157
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVS 299
            V   ITY+H    + I+HRD+K  N+LL   +++   ++ DFG +     T   A+   
Sbjct: 158 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEASKKM 209
Query: 300 TQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
               GTA Y+ PE L  TY   EK DV+S GV+L  L++G  P     E
Sbjct: 210 KDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCPPFNGANE 256

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
           +G G  G V K   E  T   VAIK   K  +   S  E       ++EI  L ++ H  
Sbjct: 24  LGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 82
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI------DVAHAI 248
           ++K   + + ED  IV+ E +  G L    D + GN      RL  A        +  A+
Sbjct: 83  IIKIKNFFDAEDYYIVL-ELMEGGEL---FDKVVGN-----KRLKEATCKLYFYQMLLAV 133
Query: 249 TYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            YLH   ++ IIHRD+K  N+LL+   E+   K+ DFG +++      G T +   + GT
Sbjct: 134 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTLCGT 185
Query: 306 AGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR---ELKERIT 353
             YL PE L    T       D +S GV+L   ++G  P    R    LK++IT
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 239

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 40/226 (17%)
Query: 143 IGQGGFGTVYKGRLE--DGTIVAIKRAKKSVYDKHSGAE---FQSEIRTLAQV-EHLNLV 196
           +G G FG V          T V+I+ A K + +K   +E     SE++ + Q+  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHL---------DCLQG------------NILDLA 235
              G         +I EY   G L  +L         D ++             N+L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
             L  A  VA  + +L        +HRD+ + N+L+T     K+ DFG AR   D  S +
Sbjct: 173 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMSDS 226
Query: 296 THVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
            +V   V+G A     ++ PE L     T KSDV+S+G+LL E+ +
Sbjct: 227 NYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 109/223 (48%), Gaps = 10/223 (4%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSG-AEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A K+ +K    K  G A   +E + L +V    +V    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++  +  G L+ H+  +       A  +  A ++   +  LH      I+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIV 308
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL ++   +++D G   LA     G T +  +V GT GY+ PE +K  + T
Sbjct: 309 YRDLKPENILLDDHGHIRISDLG---LAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 363
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD 363
              D ++ G LL E++ G+ P + +++  +R  V+  +K+  +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEH 192
           ++G+  FG VYKG L      E    VAIK  K    DK  G    EF+ E    A+++H
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLREEFRHEAMLRARLQH 71
Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRL 238
            N+V   G +  +    +I  Y  +G L E L              D    + L+    +
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGAT 296
            +   +A  + YL   + H ++H+D+ + N+L+ +    K++D G  R   AAD      
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +    ++    ++ PE +   + +  SD++S+GV+L E+ + G +P
Sbjct: 189 NSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 130 IYRATRNFSPSFK----IGQGGFGTVY--KGRLEDGTIVAIKR-AKKSVYDKHSGAEFQS 182
           +  +T  FS  +K    +G+G FG V   K ++  G   A+K  +K+ V  K        
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 81
Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           E++ L Q++H N++K + + E +    ++ E    G L + +   +      A R  I  
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIR 139
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVS 299
            V   ITY+H    + I+HRD+K  N+LL   +++   ++ DFG +     T   A+   
Sbjct: 140 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEASKKM 191
Query: 300 TQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
               GTA Y+ PE L  TY   EK DV+S GV+L  L++G  P     E
Sbjct: 192 KDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCPPFNGANE 238

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +       + +    VA+K  K S +     A   SE++ L+ +  H+N+
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 105
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTL-------REHLDCLQGN---------ILDLAGRLD 239
           V   G        +VI EY   G L       R+   C + +          LDL   L 
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILLT     K+ DFG AR   D ++ + +V 
Sbjct: 166 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYV- 218
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             VKG A     ++ PE +     T +SDV+S+G+ L EL + G  P
Sbjct: 219 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 143 IGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G G F  V     ED     +VAIK   K   +   G+  ++EI  L +++H N+V   
Sbjct: 26  LGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGS-MENEIAVLHKIKHPNIVALD 82
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E      +I++ V  G L + +  ++           +   V  A+ YLH   D  I
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH---DLGI 137
Query: 260 IHRDIKSSNIL---LTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           +HRD+K  N+L   L E+ +  ++DFG +++    E   + +ST   GT GY+ PE L  
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTAC-GTPGYVAPEVLAQ 192
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK 349
              ++  D +S GV+   L+ G  P   + + K
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 38/216 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G +G V++G  + G  VA+K    R +KS +        ++E+     + H N++ F
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-------ETELYNTVMLRHENILGF 67
Query: 199 --------HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY 250
                   H   +      +I  Y   G+L ++L   Q   LD    L I + +A  + +
Sbjct: 68  IASDMTSRHSSTQLW----LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAH 120
Query: 251 LHMYT-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
           LH+          I HRD+KS NIL+ +N +  +AD G A + + + +     +    GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 306 AGYLDPEYL-KTYQLT-----EKSDVYSFGVLLVEL 335
             Y+ PE L +T Q+      ++ D+++FG++L E+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVKFHG 200
           IG G FG VY+ +L D G +VAI   KK + DK     F++ E++ + +++H N+V+   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAI---KKVLQDK----RFKNRELQIMRKLDHCNIVRLRY 80
Query: 201 YLEFEDERI------VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
           +     E+       ++++YVP    R   H    +  +  +  +L +   +  ++ Y+H
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH 139
Query: 253 MYTDHPIIHRDIKSSNILLTENFRA-KVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
            +    I HRDIK  N+LL  +    K+ DFG A+     E   + + ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 312 EYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           E +      T   DV+S G +L EL+ G +PI P
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +       + +    VA+K  K S +     A   SE++ L+ +  H+N+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 112
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTL-------REHLDCLQGN---------ILDLAGRLD 239
           V   G        +VI EY   G L       R+   C + +          LDL   L 
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILLT     K+ DFG AR   D ++ + +V 
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYV- 225
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             VKG A     ++ PE +     T +SDV+S+G+ L EL + G  P
Sbjct: 226 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 38/216 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G +G V++G  + G  VA+K    R +KS +        ++E+     + H N++ F
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-------ETELYNTVMLRHENILGF 67
Query: 199 --------HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY 250
                   H   +      +I  Y   G+L    D LQ   LD    L I + +A  + +
Sbjct: 68  IASDMTSRHSSTQLW----LITHYHEMGSL---YDYLQLTTLDTVSCLRIVLSIASGLAH 120
Query: 251 LHMYT-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
           LH+          I HRD+KS NIL+ +N +  +AD G A + + + +     +    GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 306 AGYLDPEYL-KTYQLT-----EKSDVYSFGVLLVEL 335
             Y+ PE L +T Q+      ++ D+++FG++L E+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +       + +    VA+K  K S +     A   SE++ L+ +  H+N+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 89
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTL-------REHLDCLQGN---------ILDLAGRLD 239
           V   G        +VI EY   G L       R+   C + +          LDL   L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILLT     K+ DFG AR   D ++ + +V 
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYV- 202
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             VKG A     ++ PE +     T +SDV+S+G+ L EL + G  P
Sbjct: 203 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   IG G +G+V      + G  VA+K+  +             E+
Sbjct: 21  TIWEVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 133
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 134 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 188
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 189 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 143 IGQGGFGTVY----KGRLEDGTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQV-EHLNLV 196
           +G+G FG V     KG  E   + A+K  KK V  +    E    E R LA   +   L 
Sbjct: 28  LGKGSFGKVMLSERKGTDE---LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + H   +  D    ++EYV  G L  H+   Q         +  A ++A  + +L     
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFYAAEIAIGLFFLQ---S 139
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             II+RD+K  N++L      K+ADFG  +   +   G T  +    GT  Y+ PE +  
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVT--TKXFCGTPDYIAPEII-A 194
Query: 317 YQLTEKS-DVYSFGVLLVELVTGRRPIEPKRE 347
           YQ   KS D ++FGVLL E++ G+ P E + E
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 143 IGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           +G+G  G V        E+   V I   K++V         + EI     + H N+VKF+
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFY 70
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G+    + + + +EY   G L + ++   G     A R      +   + YLH      I
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHGIG---I 125
Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
            HRDIK  N+LL E    K++DFG A +     +    +  ++ GT  Y+ PE LK  + 
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 320 -TEKSDVYSFGVLLVELVTGRRPIE 343
             E  DV+S G++L  ++ G  P +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 41/230 (17%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-----LQG----NILDLA 235
           R L  ++H N++   G L+          + P  +L E  D      L G    NI+  A
Sbjct: 69  RLLKHMKHENVI---GLLDV---------FTPARSLEEFNDVYLVTHLMGADLNNIVKCA 116
Query: 236 GRLD-----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
              D     +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
             +G          T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 174 EMTGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 28/246 (11%)
Query: 104 QGLYVSSNNST-RGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTI 161
           + LY  SN S  R       +  T+ E+    +N SP   +G G +G+V      + G  
Sbjct: 16  ENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLR 72
Query: 162 VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL-------EFEDERIVIVEY 214
           VA+K+  +             E+R L  ++H N++             EF D  + +V +
Sbjct: 73  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTH 130
Query: 215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN 274
           +    L   + C    + D   +  +   +   + Y+H      IIHRD+K SN+ + E+
Sbjct: 131 LMGADLNNIVKC--QKLTDDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 184
Query: 275 FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLV 333
              K+ DFG AR   D   G          T  Y  PE +  +    +  D++S G ++ 
Sbjct: 185 CELKILDFGLARHTDDEMXGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 237
Query: 334 ELVTGR 339
           EL+TGR
Sbjct: 238 ELLTGR 243

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +       + +    VA+K  K S +     A   SE++ L+ +  H+N+
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 107
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTL-------REHLDCLQGN---------ILDLAGRLD 239
           V   G        +VI EY   G L       R+   C + +          LDL   L 
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILLT     K+ DFG AR   D ++ + +V 
Sbjct: 168 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYV- 220
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             VKG A     ++ PE +     T +SDV+S+G+ L EL + G  P
Sbjct: 221 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G+   G  VA+K    R ++S +        ++EI     + H N++ F
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-------EAEIYQTVMLRHENILGF 63
Query: 199 HGYLEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                 ++    +  ++ +Y  +G+L    D L    + + G + +A+  A  + +LHM 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSL---FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 255 T-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-GTAGY 308
                    I HRD+KS NIL+ +N    +AD G A +  D+ +    ++   + GT  Y
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRY 179
Query: 309 LDPEYL------KTYQLTEKSDVYSFGVLLVEL 335
           + PE L      K ++  +++D+Y+ G++  E+
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 38/216 (17%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G +G V++G  + G  VA+K    R +KS +        ++E+     + H N++ F
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-------ETELYNTVMLRHENILGF 96
Query: 199 --------HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY 250
                   H   +      +I  Y   G+L ++L   Q   LD    L I + +A  + +
Sbjct: 97  IASDMTSRHSSTQLW----LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAH 149
Query: 251 LHMYT-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
           LH+          I HRD+KS NIL+ +N +  +AD G A + + + +     +    GT
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209
Query: 306 AGYLDPEYL-KTYQLT-----EKSDVYSFGVLLVEL 335
             Y+ PE L +T Q+      ++ D+++FG++L E+
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G+   G  VA+K    R ++S +        ++EI     + H N++ F
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-------EAEIYQTVMLRHENILGF 68
Query: 199 HGYLEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                 ++    +  ++ +Y  +G+L    D L    + + G + +A+  A  + +LHM 
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSL---FDYLNRYTVTVEGMIKLALSTASGLAHLHME 125
Query: 255 T-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-GTAGY 308
                    I HRD+KS NIL+ +N    +AD G A +  D+ +    ++   + GT  Y
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRY 184
Query: 309 LDPEYL------KTYQLTEKSDVYSFGVLLVEL 335
           + PE L      K ++  +++D+Y+ G++  E+
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
           +G G  G V K   E  T   VAI+   K  +   S  E       ++EI  L ++ H  
Sbjct: 157 LGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 215
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLH 252
           ++K   + + ED  IV+ E +  G L    D + GN  + +   +L     +  A+ YLH
Sbjct: 216 IIKIKNFFDAEDYYIVL-ELMEGGEL---FDKVVGNKRLKEATCKLYF-YQMLLAVQYLH 270
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
              ++ IIHRD+K  N+LL+   E+   K+ DFG +++      G T +   + GT  YL
Sbjct: 271 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTLCGTPTYL 322
Query: 310 DPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR---ELKERIT 353
            PE L    T       D +S GV+L   ++G  P    R    LK++IT
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 372

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G+   G  VA+K    R ++S +        ++EI     + H N++ F
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-------EAEIYQTVMLRHENILGF 62
Query: 199 HGYLEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                 ++    +  ++ +Y  +G+L    D L    + + G + +A+  A  + +LHM 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSL---FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 255 T-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-GTAGY 308
                    I HRD+KS NIL+ +N    +AD G A +  D+ +    ++   + GT  Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRY 178
Query: 309 LDPEYL------KTYQLTEKSDVYSFGVLLVEL 335
           + PE L      K ++  +++D+Y+ G++  E+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 130
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 131 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 185
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 186 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 140
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 141 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 195
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 196 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 27  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 139
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 140 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 194
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 195 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 28  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 140
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 141 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 195
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 196 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 19/234 (8%)
Query: 127 MEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGT---IVAIKRAKKSVYDKHSGAEFQSE 183
           M    R T ++    ++G+G F  V +   +  T      I   KK     H   E ++ 
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREAR 82
Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID 243
           I  L  ++H N+V+ H  +  E    ++ + V  G L E  D +       A        
Sbjct: 83  ICRL--LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE--DIVAREYYSEADASHCIHQ 138
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVST 300
           +  ++ ++H    H I+HRD+K  N+LL    +    K+ADFG   LA + + G      
Sbjct: 139 ILESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFG---LAIEVQ-GEQQAWF 191
Query: 301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
              GT GYL PE L+     +  D+++ GV+L  L+ G  P   E + +L ++I
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 245

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G+   G  VA+K    R ++S +        ++EI     + H N++ F
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-------EAEIYQTVMLRHENILGF 101
Query: 199 HGYLEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                 ++    +  ++ +Y  +G+L    D L    + + G + +A+  A  + +LHM 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSL---FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 255 T-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-GTAGY 308
                    I HRD+KS NIL+ +N    +AD G A +  D+ +    ++   + GT  Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRY 217
Query: 309 LDPEYL------KTYQLTEKSDVYSFGVLLVEL 335
           + PE L      K ++  +++D+Y+ G++  E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 23  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 135
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 136 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 190
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 191 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G+   G  VA+K    R ++S +        ++EI     + H N++ F
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-------EAEIYQTVMLRHENILGF 65
Query: 199 HGYLEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                 ++    +  ++ +Y  +G+L    D L    + + G + +A+  A  + +LHM 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSL---FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 255 T-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-GTAGY 308
                    I HRD+KS NIL+ +N    +AD G A +  D+ +    ++   + GT  Y
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRY 181
Query: 309 LDPEYL------KTYQLTEKSDVYSFGVLLVEL 335
           + PE L      K ++  +++D+Y+ G++  E+
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 148
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 149 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 203
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 204 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 130
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 131 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 185
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 186 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 27  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 139
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 140 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 194
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 195 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 33/230 (14%)
Query: 143 IGQGGFGTVYKGRLEDGTI--VAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
           +G G  G V K   E  T   VAI+   K  +   S  E       ++EI  L ++ H  
Sbjct: 143 LGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLH 252
           ++K   + + ED  IV+ E +  G L    D + GN  + +   +L     +  A+ YLH
Sbjct: 202 IIKIKNFFDAEDYYIVL-ELMEGGEL---FDKVVGNKRLKEATCKLYF-YQMLLAVQYLH 256
Query: 253 MYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
              ++ IIHRD+K  N+LL+   E+   K+ DFG +++      G T +   + GT  YL
Sbjct: 257 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTLCGTPTYL 308
Query: 310 DPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR---ELKERIT 353
            PE L    T       D +S GV+L   ++G  P    R    LK++IT
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 133
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 134 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 188
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 189 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 15  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 71
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 72  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 127
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 128 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 182
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 183 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 130
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 131 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 185
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 186 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 13  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 125
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 126 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 180
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 181 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 35  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 147
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 148 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 202
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 203 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 134
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 135 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 189
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 190 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 133
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 134 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV- 188
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 189 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 124
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 125 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 179
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 180 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 14  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 70
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 71  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 126
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 127 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 181
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 182 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE  L      +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 13  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 69
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 70  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 125
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 126 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 180
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 181 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 21  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 77
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 133
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 134 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 188
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 189 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           IG+G FG V++G+   G  VA+K    R ++S +        ++EI     + H N++ F
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-------EAEIYQTVMLRHENILGF 88
Query: 199 HGYLEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                 ++    +  ++ +Y  +G+L    D L    + + G + +A+  A  + +LHM 
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSL---FDYLNRYTVTVEGMIKLALSTASGLAHLHME 145
Query: 255 T-----DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-GTAGY 308
                    I HRD+KS NIL+ +N    +AD G A +  D+ +    ++   + GT  Y
Sbjct: 146 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRY 204
Query: 309 LDPEYL------KTYQLTEKSDVYSFGVLLVEL 335
           + PE L      K ++  +++D+Y+ G++  E+
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 143 IGQGGFGTVYKGRLEDG-TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G FG V   R +    + A+K   K    K S + F  E R +    +   V    +
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQLF 135
Query: 202 LEFEDERIV--IVEYVPNG---TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             F+D+R +  ++EY+P G    L  + D  +         + +A+D  H++ +      
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------ 189
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+K  N+LL ++   K+ADFG        + G     T V GT  Y+ PE LK+
Sbjct: 190 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAV-GTPDYISPEVLKS 243
Query: 317 Y----QLTEKSDVYSFGVLLVELVTGRRPI 342
                    + D +S GV L E++ G  P 
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 39  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 151
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 152 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 206
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 207 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 143 IGQGGFGTVYKGRLEDG-TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G FG V   R +    + A+K   K    K S + F  E R +    +   V    +
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQLF 140
Query: 202 LEFEDERIV--IVEYVPNG---TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             F+D+R +  ++EY+P G    L  + D  +         + +A+D  H++ +      
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------ 194
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+K  N+LL ++   K+ADFG        + G     T V GT  Y+ PE LK+
Sbjct: 195 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAV-GTPDYISPEVLKS 248
Query: 317 Y----QLTEKSDVYSFGVLLVELVTGRRPI 342
                    + D +S GV L E++ G  P 
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 11/215 (5%)
Query: 131 YRATRNFSPSFKI-GQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTL 187
           +R T N     K+ G+G FG V   + +  G   A+K  KK V   K   A   +E R L
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 188 AQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHA 247
               H  L       +  D    ++EY   G L  HL   +  +           ++  A
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSA 260
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YLH  ++  +++RD+K  N++L ++   K+ DFG  +     + GAT  +    GT  
Sbjct: 261 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT--FCGTPE 314
Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           YL PE L+        D +  GV++ E++ GR P 
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 141 FKIGQGGFGTVYKG--RLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            ++G G FG+V +G  R+    I VAIK  K+   +K    E   E + + Q+++  +V+
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVR 74
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G  + E   ++++E    G L + L   +  I  ++   ++   V+  + YL    + 
Sbjct: 75  LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLE---EK 129
Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
             +HRD+ + N+LL     AK++DFG ++     +S  T  S   K    +  PE +   
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFR 188
Query: 318 QLTEKSDVYSFGVLLVE-LVTGRRP 341
           + + +SDV+S+GV + E L  G++P
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 11/215 (5%)
Query: 131 YRATRNFSPSFKI-GQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTL 187
           +R T N     K+ G+G FG V   + +  G   A+K  KK V   K   A   +E R L
Sbjct: 146 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 205
Query: 188 AQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHA 247
               H  L       +  D    ++EY   G L  HL   +  +           ++  A
Sbjct: 206 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSA 263
Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YLH  ++  +++RD+K  N++L ++   K+ DFG  +     + GAT  +    GT  
Sbjct: 264 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKT--FCGTPE 317
Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           YL PE L+        D +  GV++ E++ GR P 
Sbjct: 318 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 35  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 91
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 147
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 148 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 202
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 203 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 148
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 149 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 203
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 204 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 18  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 130
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 131 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV- 185
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 186 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 134
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 135 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 189
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 190 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 124
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 125 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 179
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 180 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 134
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 135 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV- 189
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 190 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 36  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 148
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D   G   
Sbjct: 149 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV- 203
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 204 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 45/223 (20%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE--IRTLAQVEHLNLVKF-- 198
           IG+G +G VYKG L D   VA+K     V+   +   F +E  I  +  +EH N+ +F  
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVK-----VFSFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 199 -------HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
                   G +E+    ++++EY PNG+L ++L     +  D      +A  V   + YL
Sbjct: 75  GDERVTADGRMEY----LLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYL 127
Query: 252 HMYT---DH---PIIHRDIKSSNILLTENFRAKVADFGFA------RLAADTESGATHVS 299
           H      DH    I HRD+ S N+L+  +    ++DFG +      RL    E     +S
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 300 TQVKGTAGYLDPEYLK-------TYQLTEKSDVYSFGVLLVEL 335
               GT  Y+ PE L+            ++ D+Y+ G++  E+
Sbjct: 188 E--VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 12  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 124
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 125 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV- 179
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 180 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 22  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 134
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 135 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 189
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 190 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWT---LCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 143 IGQGGFGTVYKGRLEDG-TIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   +L++   + A+K   K  +  +   A F+ E   L   +   +   H 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR-----LDIAIDVAHAITYLHMYT 255
             + ++   ++++Y   G L   L   +  + +   R     + IAID  H + Y     
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY----- 196
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRDIK  NIL+  N   ++ADFG        E G    S  V GT  Y+ PE L+
Sbjct: 197 ----VHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAV-GTPDYISPEILQ 249
Query: 316 TYQ-----LTEKSDVYSFGVLLVELVTGRRPI 342
             +        + D +S GV + E++ G  P 
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 143 IGQGGFGTVYKGRLEDG-TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G FG V   R +    + A+K   K    K S + F  E R +    +   V    +
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQLF 140
Query: 202 LEFEDERIV--IVEYVPNG---TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             F+D+R +  ++EY+P G    L  + D  +         + +A+D  H++ +      
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------ 194
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+K  N+LL ++   K+ADFG        + G     T V GT  Y+ PE LK+
Sbjct: 195 ---IHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAV-GTPDYISPEVLKS 248
Query: 317 Y----QLTEKSDVYSFGVLLVELVTGRRPI 342
                    + D +S GV L E++ G  P 
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 24/229 (10%)
Query: 130 IYRATRNFSPSFK----IGQGGFGTVY--KGRLEDGTIVAIKR-AKKSVYDKHSGAEFQS 182
           +  +T  FS  +K    +G+G FG V   K ++  G   A+K  +K+ V  K        
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLR 75
Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           E++ L Q++H N+ K + + E +    ++ E    G L + +   +      A R  I  
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIR 133
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVS 299
            V   ITY H    + I+HRD+K  N+LL   +++   ++ DFG +     T   A+   
Sbjct: 134 QVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS-----THFEASKKX 185
Query: 300 TQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
               GTA Y+ PE L  TY   EK DV+S GV+L  L++G  P     E
Sbjct: 186 KDKIGTAYYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCPPFNGANE 232

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 92
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY--- 250
           +V   G   +     +VIVE+   G L  +L   +   +         + + H I Y   
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 251 ----LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
               +        IHRD+ + NILL+E    K+ DFG AR   D      +V    KG A
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVR---KGDA 206
Query: 307 ----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
                ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 15/217 (6%)
Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G+G F  V +  ++  G   A K             + + E R    ++H N+V+ H 
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            +  E    +I + V  G L E  D +       A        +  A+ + H      ++
Sbjct: 89  SISEEGHHYLIFDLVTGGELFE--DIVAREYYSEADASHCIQQILEAVLHCHQMG---VV 143
Query: 261 HRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           HRD+K  N+LL    +    K+ADFG   LA + E G         GT GYL PE L+  
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFG---LAIEVE-GEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
              +  D+++ GV+L  L+ G  P   E +  L ++I
Sbjct: 200 PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 236

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH      ++
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---SRDVV 130
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +       GAT  +    GT  YL PE L+     
Sbjct: 131 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT--FCGTPEYLAPEVLEDNDYG 186
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPF 208

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-----LQG----NILDLA 235
           R L  ++H N++   G L+          + P  +L E  D      L G    NI+   
Sbjct: 73  RLLKHMKHENVI---GLLDV---------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 236 GRLD-----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
              D     +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD 177
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
             +G          T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 178 EMTGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-----LQG----NILDLA 235
           R L  ++H N++   G L+          + P  +L E  D      L G    NI+   
Sbjct: 73  RLLKHMKHENVI---GLLDV---------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ 120
Query: 236 GRLD-----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
              D     +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
             +G          T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 178 EMTGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N +P   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 26  TIWEVPERYQNLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 82
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 83  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 138
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 139 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 193
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 194 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   + +  G   A+K  KK V   K   A   +E R L    H  L     
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH  ++  ++
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLH--SEKNVV 132
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N++L ++   K+ DFG  +     + GAT       GT  YL PE L+     
Sbjct: 133 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGAT--MKXFCGTPEYLAPEVLEDNDYG 188
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   + +  G   A+K  KK V   K   A   +E R L    H  L     
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH  ++  ++
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLH--SEKNVV 133
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N++L ++   K+ DFG  +     + GAT       GT  YL PE L+     
Sbjct: 134 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGAT--MKXFCGTPEYLAPEVLEDNDYG 189
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ D+G AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH      ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---SRDVV 127
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +       GAT  +    GT  YL PE L+     
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT--FCGTPEYLAPEVLEDNDYG 183
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 149
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWT---LCGTPEYLAPEIILSKGYN 202
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 203 KAVDWWALGVLIYEMAAGYPPF 224

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 93
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID---VAHAITY 250
           +V   G   +     +VIVE+   G L  +L   +   +      D+  D   + H I Y
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 251 -------LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
                  +        IHRD+ + NILL+E    K+ DFG AR   D       V    K
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIXKDPDXVR---K 207
Query: 304 GTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           G A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    KV DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   + +  G   A+K  KK V   K   A   +E R L    H  L     
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH  ++  ++
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLH--SEKNVV 131
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N++L ++   K+ DFG  +     + GAT       GT  YL PE L+     
Sbjct: 132 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGAT--MKXFCGTPEYLAPEVLEDNDYG 187
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPF 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH      ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---SRDVV 127
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +       GAT  +    GT  YL PE L+     
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT--FCGTPEYLAPEVLEDNDYG 183
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 11/202 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH      ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---SRDVV 127
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +       GAT       GT  YL PE L+     
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGAT--MKXFCGTPEYLAPEVLEDNDYG 183
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 11/202 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH      ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---SRDVV 127
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +       GAT       GT  YL PE L+     
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGAT--MKXFCGTPEYLAPEVLEDNDYG 183
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 92
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHLDC----------LQGNILDLAGRLDIAID 243
           +V   G   +     +VIVE+   G L  +L            L  + L L   +  +  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D      +V    K
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR---DIYKDPDYVR---K 203
Query: 304 GTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
           G A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 15/216 (6%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V +  +L  G   A K             + + E R    ++H N+V+ H  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E    ++ + V  G L E  D +       A        +  A+ + H      ++H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFE--DIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 126
Query: 262 RDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           RD+K  N+LL    +    K+ADFG   LA + + G         GT GYL PE L+   
Sbjct: 127 RDLKPENLLLASKCKGAAVKLADFG---LAIEVQ-GDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 319 LTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
             +  D+++ GV+L  L+ G  P   E + +L ++I
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 218

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRA-KKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G F  V     +  G + A+K   KK++  K S  E  +EI  L +++H N+V    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE--NEIAVLRKIKHENIVALED 87
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E  +   ++++ V  G L + +  ++           +   V  A+ YLH      I+
Sbjct: 88  IYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIRQVLDAVYYLHRMG---IV 142
Query: 261 HRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           HRD+K  N+L     E  +  ++DFG +++      G   V +   GT GY+ PE L   
Sbjct: 143 HRDLKPENLLYYSQDEESKIMISDFGLSKM-----EGKGDVMSTACGTPGYVAPEVLAQK 197
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPI 342
             ++  D +S GV+   L+ G  P 
Sbjct: 198 PYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 11/202 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 77
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH      ++
Sbjct: 78  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---SRDVV 132
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +       GAT       GT  YL PE L+     
Sbjct: 133 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGAT--MKXFCGTPEYLAPEVLEDNDYG 188
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G +G V   R    G  VAIK+   + +D  + A+     RTL +++ L   K    
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNA-FDVVTNAK-----RTLRELKILKHFKHDNI 116
Query: 202 LEFEDERIVIVEYVPNGTLREH---LDCLQGNI---------LDLAGRLDIAIDVAHAIT 249
           +  +D   ++   VP G  +     LD ++ ++         L L         +   + 
Sbjct: 117 IAIKD---ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y+H      +IHRD+K SN+L+ EN   K+ DFG AR    + +   +  T+   T  Y 
Sbjct: 174 YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 310 DPE-YLKTYQLTEKSDVYSFGVLLVELVTGRR 340
            PE  L  ++ T+  D++S G +  E++  R+
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV 190
           R   +F     +GQG FG V K R   D    AIK+ + +   +   +   SE+  LA +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVXLLASL 59
Query: 191 EHLNLVKFHG-YLEFED------------ERIVIVEYVPNGTLRE--HLDCLQGNILDLA 235
            H  +V+++  +LE  +               +  EY  N TL +  H + L     D  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQ-RDEY 118
Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--------L 287
            RL     +  A++Y+H      IIHR++K  NI + E+   K+ DFG A+        L
Sbjct: 119 WRL--FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 288 AADTES--GATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELV 336
             D+++  G++   T   GTA Y+  E L  T    EK D YS G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 92
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VIVE+   G L  +L              + L  + L L   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D      +V 
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVR 206
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 207 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 94
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL------------DCLQGNILDLAGRLDIA 241
           +V   G   +     +VIVE+   G L  +L            + L  + L L   +  +
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
             VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D       V   
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR---DIXKDPDXVR-- 206
Query: 302 VKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
            KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 207 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   ++++   I A+K   K  +  +   A F+ E   L   +   +   H 
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 141
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNI-LDLA----GRLDIAIDVAHAITYLHMYT 255
             + E+   ++++Y   G L   L   +  +  D+A    G + +AID  H + Y     
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY----- 196
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRDIK  N+LL  N   ++ADFG      D   G    S  V GT  Y+ PE L+
Sbjct: 197 ----VHRDIKPDNVLLDVNGHIRLADFGSCLKMND--DGTVQSSVAV-GTPDYISPEILQ 249
Query: 316 TYQ-----LTEKSDVYSFGVLLVELVTGRRPI 342
             +        + D +S GV + E++ G  P 
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   ++++   I A+K   K  +  +   A F+ E   L   +   +   H 
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 157
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNI-LDLA----GRLDIAIDVAHAITYLHMYT 255
             + E+   ++++Y   G L   L   +  +  D+A    G + +AID  H + Y     
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY----- 212
Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
               +HRDIK  N+LL  N   ++ADFG      D   G    S  V GT  Y+ PE L+
Sbjct: 213 ----VHRDIKPDNVLLDVNGHIRLADFGSCLKMND--DGTVQSSVAV-GTPDYISPEILQ 265
Query: 316 TYQ-----LTEKSDVYSFGVLLVELVTGRRPI 342
             +        + D +S GV + E++ G  P 
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 11/202 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K V   K   A   +E R L    H  L     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +  +           ++  A+ YLH      ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLH---SRDVV 127
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +       GAT       GT  YL PE L+     
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK--EGISDGAT--MKXFCGTPEYLAPEVLEDNDYG 183
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
              D +  GV++ E++ GR P 
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 94
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VIVE+   G L  +L              + L  + L L   + 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D      +V 
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVR 208
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 209 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +  SP   +G G +G+V     ++ G  +A+K+  +             E+
Sbjct: 45  TIWEVPERYQTLSP---VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYREL 101
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C +  + D   +
Sbjct: 102 RLLKHMKHENVIGLLDVFTPATSLEEFND--VYLVTHLMGADLNNIVKCQK--LTDDHVQ 157
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR   D  +G   
Sbjct: 158 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV- 212
Query: 298 VSTQVKGTAGYLDPEYLKTYQLTEKS-DVYSFGVLLVELVTGR 339
                  T  Y  PE +  +     + D++S G ++ EL+TGR
Sbjct: 213 ------ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 83
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VIVE+   G L  +L              + L  + L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D       V 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIXKDPDXVR 197
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 198 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 21/209 (10%)
Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G+G F  V +  ++  G   A K             + + E R    ++H N+V+ H 
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP-- 258
            +  E    ++ + V  G L E +         +A       D +H I  +    +H   
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDI---------VAREYYSEADASHCIQQILESVNHCHL 121
Query: 259 --IIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
             I+HRD+K  N+LL    +    K+ADFG   LA + + G         GT GYL PE 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFG---LAIEVQ-GDQQAWFGFAGTPGYLSPEV 177
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           L+     +  D+++ GV+L  L+ G  P 
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 129
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VIVE+   G L  +L              + L  + L L   + 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D      +V 
Sbjct: 190 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVR 243
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 244 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 103/232 (44%), Gaps = 34/232 (14%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA---------------EFQSEIRTL 187
           + QG F  +     +D    A+K+ +KS+ +K                   +F++E++ +
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 188 AQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL---REHLDCLQGN---ILDLAGRLDIA 241
             +++   +   G +   DE  +I EY+ N ++    E+   L  N    + +     I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
             V ++ +Y+H   +  I HRD+K SNIL+ +N R K++DFG +    D +   +     
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----- 210
Query: 302 VKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE 350
            +GT  ++ PE+     +Y    K D++S G+ L  +     P   K  L E
Sbjct: 211 -RGTYEFMPPEFFSNESSYN-GAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    KV DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 141 FKIGQGGFGTVYKG--RLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            ++G G FG+V +G  R+    I VAIK  K+   +K    E   E + + Q+++  +V+
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVR 400
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G  + E   ++++E    G L + L   +  I  ++   ++   V+  + YL    + 
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEI-PVSNVAELLHQVSMGMKYLE---EK 455
Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
             +HR++ + N+LL     AK++DFG ++     +S  T  S   K    +  PE +   
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLKWYAPECINFR 514
Query: 318 QLTEKSDVYSFGVLLVE-LVTGRRP 341
           + + +SDV+S+GV + E L  G++P
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 156
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 209
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 210 KAVDWWALGVLIYEMAAGYPPF 231

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 25/232 (10%)
Query: 132 RATRNFSPSFKIGQGGFGTVYK------GRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIR 185
           R T  +    ++G+G F  V +      G+     I+  K+     + K      + E R
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-----LEREAR 62
Query: 186 TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVA 245
               ++H N+V+ H  +  E    +I + V  G L E  D +       A        + 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE--DIVAREYYSEADASHCIQQIL 120
Query: 246 HAITYLHMYTDHPIIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQV 302
            A+ + H      ++HR++K  N+LL    +    K+ADFG   LA + E G        
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG---LAIEVE-GEQQAWFGF 173
Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
            GT GYL PE L+     +  D+++ GV+L  L+ G  P   E +  L ++I
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI 225

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 92
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VIVE+   G L  +L              + L  + L L   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D       V 
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIXKDPDXVR 206
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 207 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNL 195
           +G G FG V +       + +    VA+K  K S +     A   SE++ L+ +  H+N+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMNI 112
Query: 196 VKFHGYLEFEDERIVIVEYVPNGTL-------REHLDCLQGN---------ILDLAGRLD 239
           V   G        +VI EY   G L       R+   C + +          LDL   L 
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILLT     K+ DFG AR     ++ + +V 
Sbjct: 173 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---HIKNDSNYV- 225
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
             VKG A     ++ PE +     T +SDV+S+G+ L EL + G  P
Sbjct: 226 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 121/291 (41%), Gaps = 33/291 (11%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           IG+G FG VY GR      + +   ++   D+     F+ E+    Q  H N+V F G  
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKA--FKREVMAYRQTRHENVVLFMGAC 98
Query: 203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHR 262
                  +I       TL   +   +  +LD+     IA ++   + YLH      I+H+
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHK 154
Query: 263 DIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK-GTAGYLDPEYLKTYQ--- 318
           D+KS N+   +N +  + DFG   ++   ++G      +++ G   +L PE ++      
Sbjct: 155 DLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 319 ------LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
                  ++ SDV++ G +  EL     P   K +  E I   W M         + + P
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAEAII--WQMG--------TGMKP 261
Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA 423
            +          ++I ++ L C A  ++ RP+  +  ++L  + K  R L+
Sbjct: 262 NLSQIGMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 111/239 (46%), Gaps = 20/239 (8%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSV--YDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G +G V K  ++ GT   I+RA K +  Y       F+ EI  +  ++H N+++ + 
Sbjct: 17  IGRGSWGEV-KIAVQKGT--RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E   +  +++E    G L E +  +   +   +    I  DV  A+ Y H      + 
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHKLN---VA 128
Query: 261 HRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           HRD+K  N L    + +   K+ DFG   LAA  + G   + T+V GT  Y+ P+ L+  
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFG---LAARFKPGKM-MRTKV-GTPYYVSPQVLEGL 183
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
              E  D +S GV++  L+ G  P     + +  + ++     F + D +++  P+ E+
Sbjct: 184 YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV-SPQAES 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 101/247 (40%), Gaps = 39/247 (15%)
Query: 108 VSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAI 164
           +SS    R G     V  T  E+    R+  P   +G G +G V     GR   G  VAI
Sbjct: 1   MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQP---VGSGAYGAVCSAVDGRT--GAKVAI 55
Query: 165 KRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL 224
           K+  +    +        E+R L  + H N++   G L+          + P+ TL +  
Sbjct: 56  KKLYRPFQSELFAKRAYRELRLLKHMRHENVI---GLLDV---------FTPDETLDDFT 103
Query: 225 DC-----LQGNIL------DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE 273
           D        G  L      +  G   I   V   +  L       IIHRD+K  N+ + E
Sbjct: 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 163
Query: 274 NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLL 332
           +   K+ DFG AR  AD+E     V      T  Y  PE +  + + T+  D++S G ++
Sbjct: 164 DCELKILDFGLAR-QADSEMXGXVV------TRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 333 VELVTGR 339
            E++TG+
Sbjct: 217 AEMITGK 223

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 111/239 (46%), Gaps = 20/239 (8%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSV--YDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G +G V K  ++ GT   I+RA K +  Y       F+ EI  +  ++H N+++ + 
Sbjct: 34  IGRGSWGEV-KIAVQKGT--RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E   +  +++E    G L E +  +   +   +    I  DV  A+ Y H      + 
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHKLN---VA 145
Query: 261 HRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           HRD+K  N L    + +   K+ DFG   LAA  + G   + T+V GT  Y+ P+ L+  
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFG---LAARFKPGKM-MRTKV-GTPYYVSPQVLEGL 200
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
              E  D +S GV++  L+ G  P     + +  + ++     F + D +++  P+ E+
Sbjct: 201 YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV-SPQAES 257

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G +G V   R    G  VAIK+   + +D  + A+     RTL +++ L   K    
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNA-FDVVTNAK-----RTLRELKILKHFKHDNI 115
Query: 202 LEFEDERIVIVEYVPNGTLREH---LDCLQGNI---------LDLAGRLDIAIDVAHAIT 249
           +  +D   ++   VP G  +     LD ++ ++         L L         +   + 
Sbjct: 116 IAIKD---ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           Y+H      +IHRD+K SN+L+ EN   K+ DFG AR    + +   +  T+   T  Y 
Sbjct: 173 YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 310 DPE-YLKTYQLTEKSDVYSFGVLLVELVTGRR 340
            PE  L  ++ T+  D++S G +  E++  R+
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 92
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VIVE+   G L  +L              + L  + L L   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D       V 
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDXVR 206
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 207 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 21/209 (10%)
Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G+G F  V +  ++  G   A K             + + E R    ++H N+V+ H 
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP-- 258
            +  E    ++ + V  G L E +         +A       D +H I  +    +H   
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDI---------VAREYYSEADASHCIQQILESVNHCHL 121
Query: 259 --IIHRDIKSSNILLTENFRA---KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
             I+HRD+K  N+LL    +    K+ADFG   LA + + G         GT GYL PE 
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFG---LAIEVQ-GDQQAWFGFAGTPGYLSPEV 177
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           L+     +  D+++ GV+L  L+ G  P 
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 156
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 209
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 210 KAVDWWALGVLIYEMAAGYPPF 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+  FG AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYVP G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 184
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 237
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPF 259

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    L K   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    KV DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 107/236 (45%), Gaps = 25/236 (10%)
Query: 143 IGQGGFGT--VYKGRLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG G FG   + + +L    +VA+K  ++ +  D++     Q EI     + H N+V+F 
Sbjct: 28  IGSGNFGVARLMRDKLT-KELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFK 82
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
             +       +I+EY   G L E + C  G   +   R      +   ++Y H      I
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQ-QLLSGVSYCHSMQ---I 137
Query: 260 IHRDIKSSNILL--TENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLKT 316
            HRD+K  N LL  +   R K+ DFG+++      S   H   +   GT  Y+ PE L  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 317 YQLTEK-SDVYSFGVLLVELVTGRRPIEPKRELKE-RITVKWAMK-KFSDGDAISI 369
            +   K +DV+S GV L  ++ G  P E   E ++ R T++  +  K+S  D I I
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 104/244 (42%), Gaps = 45/244 (18%)
Query: 143 IGQGGFGTVYKGRLEDGT--IVAIKRAKKSVYDKHSGAE---FQSEIRTLAQVEHLNLVK 197
           IGQG +G V +  +E+ T  I AIK   K+   + +  +    ++E+R + ++ H N+ +
Sbjct: 34  IGQGSYGVV-RVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHL------------------------DC----LQG 229
            +   E E    +++E    G L + L                        +C    + G
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 230 NI------LDLAGRLDIAIDVAHAI-TYLHMYTDHPIIHRDIKSSNILLTEN--FRAKVA 280
           +I      LD   R  +  ++   I + LH   +  I HRDIK  N L + N  F  K+ 
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT--EKSDVYSFGVLLVELVTG 338
           DFG ++      +G  +  T   GT  ++ PE L T   +   K D +S GVLL  L+ G
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
Query: 339 RRPI 342
             P 
Sbjct: 273 AVPF 276

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 83
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VI E+   G L  +L              + L  + L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D      +V 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVR 197
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 198 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 83
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VI E+   G L  +L              + L  + L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D      +V 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVR 197
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 198 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 14/108 (12%)
Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           A+++LH      I+HRD+K  NILL +N + +++DFGF+      E G      ++ GT 
Sbjct: 212 AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS---CHLEPGEK--LRELCGTP 263
Query: 307 GYLDPEYLKTYQ------LTEKSDVYSFGVLLVELVTGRRPIEPKREL 348
           GYL PE LK           ++ D+++ GV+L  L+ G  P   +R++
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 13/218 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V+  +++  G + A K+  K    K  G +    E + LA+V    +V    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E + +  +++  +  G +R H+  +  +         I    A  ++ L       II
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLEHLHQRNII 311
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+LL ++   +++D G   LA + ++G T  +    GT G++ PE L   +  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLG---LAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPK------RELKERI 352
              D ++ GV L E++  R P   +      +ELK+R+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 13/218 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V+  +++  G + A K+  K    K  G +    E + LA+V    +V    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E + +  +++  +  G +R H+  +  +         I    A  ++ L       II
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLEHLHQRNII 311
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+LL ++   +++D G   LA + ++G T  +    GT G++ PE L   +  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLG---LAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPK------RELKERI 352
              D ++ GV L E++  R P   +      +ELK+R+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 13/218 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V+  +++  G + A K+  K    K  G +    E + LA+V    +V    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E + +  +++  +  G +R H+  +  +         I    A  ++ L       II
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLEHLHQRNII 311
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+LL ++   +++D G   LA + ++G T  +    GT G++ PE L   +  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLG---LAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPK------RELKERI 352
              D ++ GV L E++  R P   +      +ELK+R+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ D G AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 13/218 (5%)
Query: 143 IGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V+  +++  G + A K+  K    K  G +    E + LA+V    +V    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E + +  +++  +  G +R H+  +  +         I    A  ++ L       II
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI-FYTAQIVSGLEHLHQRNII 311
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+LL ++   +++D G   LA + ++G T  +    GT G++ PE L   +  
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLG---LAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 321 EKSDVYSFGVLLVELVTGRRPIEPK------RELKERI 352
              D ++ GV L E++  R P   +      +ELK+R+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G FG     R  +   +VA+K  ++    +   A  + EI     + H N+V+F   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERG---EKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +       +++EY   G L E + C  G   +   R      +   ++Y H      + H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQ-QLISGVSYCHAMQ---VCH 138
Query: 262 RDIKSSNILL--TENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLKTYQ 318
           RD+K  N LL  +   R K+ DFG+++      S   H   +   GT  Y+ PE L   +
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 319 LTEK-SDVYSFGVLLVELVTGRRPIEPKRELK 349
              K +DV+S GV L  ++ G  P E   E K
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPAFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    L K   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    KV DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 144 GQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL 202
           GQG FGTV  G+ +  G  VAIK+  +    +    E Q  ++ LA + H N+V+   Y 
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQI-MQDLAVLHHPNIVQLQSYF 88
Query: 203 EFEDERI-------VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDV-----AHAITY 250
               ER        V++EYVP+   R    C +           I I V       +I  
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPDTLHR----CCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 251 LHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           LH+ + + + HRDIK  N+L+ E +   K+ DFG A+  + +E    ++ ++      Y 
Sbjct: 145 LHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YR 198
Query: 310 DPEYLKTYQ-LTEKSDVYSFGVLLVELVTG 338
            PE +   Q  T   D++S G +  E++ G
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 143 IGQGGFGTVYKG------RLEDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +G+G FG V +       +      VA+K  K+ + + +H      SE++ L  +  HLN
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHHLN 83
Query: 195 LVKFHGYL-EFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VI E+   G L  +L              + L  + L L   + 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR   D       V 
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIXKDPDXVR 197
Query: 300 TQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 198 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    L K   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    KV DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ D G AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ DF  AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 41/230 (17%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-----LQG----NILDLA 235
           R L  ++H N++   G L+          + P  +L E  D      L G    NI+   
Sbjct: 73  RLLKHMKHENVI---GLLDV---------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 236 GRLD-----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD 290
              D     +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG  R   D
Sbjct: 121 KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD 177
Query: 291 TESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
             +G          T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 178 EMTGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 184
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       GAT     + GT  YL PE + +    
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWT---LCGTPEYLAPEIILSKGYN 237
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPF 259

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 109
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  L  HL  +  ++  L     ++ D        +   + Y+H 
Sbjct: 110 I-----RAPTIEQMKDVYLVTHL--MGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 163 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 258

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEI 184
           T+ E+    +N SP   +G G +G+V      + G  VA+K+  +             E+
Sbjct: 16  TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 185 RTLAQVEHLNLVKFHGYL-------EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR 237
           R L  ++H N++             EF D  + +V ++    L   + C    + D   +
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVTHLMGADLNNIVKC--QKLTDDHVQ 128
Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +   + Y+H      IIHRD+K SN+ + E+   K+ D G AR   D  +G   
Sbjct: 129 F-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV- 183
Query: 298 VSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
                  T  Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 184 ------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY- 201
           +G+G +G V++G L  G  VA+K    S  D+ S    ++EI     + H N++ F    
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF--SSRDEQSWFR-ETEIYNTVLLRHDNILGFIASD 71
Query: 202 ---LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT--- 255
                   +  +I  Y  +G+L    D LQ   L+    L +A+  A  + +LH+     
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSL---YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 256 --DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
                I HRD KS N+L+  N +  +AD G A + +         +    GT  Y+ PE 
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 314 L------KTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           L        ++  + +D+++FG++L E+   RR I
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 15/191 (7%)
Query: 183 EIRTLAQVEHLNLVKFHGYLE--FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI 240
           EI  L +++H N+VK    L+   ED   ++ E V  G + E +  L+    D A R   
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQA-RFYF 143
Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
             D+   I YLH      IIHRDIK SN+L+ E+   K+ADFG     ++   G+  + +
Sbjct: 144 Q-DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFG----VSNEFKGSDALLS 195
Query: 301 QVKGTAGYLDPEYLKTYQ--LTEKS-DVYSFGVLLVELVTGRRPIEPKRELKERITVKWA 357
              GT  ++ PE L   +   + K+ DV++ GV L   V G+ P   +R +     +K  
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ 255
Query: 358 MKKFSDGDAIS 368
             +F D   I+
Sbjct: 256 ALEFPDQPDIA 266

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R    V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    KVADFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIKVADFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    KV DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     LE       KR  ++     S  E + E+  L QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E   + ++I+E V  G L + L   Q   L           +   + YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHT--- 133
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +        K+ DFG   LA + E G       + GT  ++ PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 15/217 (6%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 202 LEF----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
           +      + + + IV+ +    L + L C   +   +   L     +   + Y+H     
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFL---YQILRGLKYIHSAN-- 148
Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE-YLKT 316
            ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE  L +
Sbjct: 149 -VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
              T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 242

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKK----SVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R +  G   A K  KK    S     S  E + E+  L ++ H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR-LDIAIDVAHAITYLHMYT 255
             H   E + + ++I+E V  G L + L   +    D A + L   +D  H   YLH   
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH---YLH--- 125
Query: 256 DHPIIHRDIKSSNILLTE----NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
              I H D+K  NI+L +    N R K+ DFG   +A   E+G       + GT  ++ P
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEF--KNIFGTPEFVAP 180
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRE 347
           E +    L  ++D++S GV+   L++G  P   E K+E
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 25/212 (11%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA--------EFQSEIRTLAQVEHL 193
           ++G G F  V K R E  T   ++ A K +  + S A        E + E+  L QV H 
Sbjct: 19  ELGSGQFAIVKKCR-EKST--GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
           N++  H   E   + ++I+E V  G L + L   Q   L           +   + YLH 
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 254 YTDHPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
                I H D+K  NI+L +        K+ DFG   LA + E G       + GT  ++
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEF--KNIFGTPEFV 185
Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            PE +    L  ++D++S GV+   L++G  P
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     LE       KR  ++     S  E + E+  L QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E   + ++I+E V  G L + L   Q   L           +   + YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHT--- 133
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +        K+ DFG   LA + E G       + GT  ++ PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     LE       KR  ++     S  E + E+  L QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E   + ++I+E V  G L + L   Q   L           +   + YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHT--- 133
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +        K+ DFG   LA + E G       + GT  ++ PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKK----SVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R +  G   A K  KK    S     S  E + E+  L ++ H N++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR-LDIAIDVAHAITYLHMYT 255
             H   E + + ++I+E V  G L + L   +    D A + L   +D  H   YLH   
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH---YLH--- 132
Query: 256 DHPIIHRDIKSSNILLTE----NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
              I H D+K  NI+L +    N R K+ DFG   +A   E+G       + GT  ++ P
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEF--KNIFGTPEFVAP 187
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRE 347
           E +    L  ++D++S GV+   L++G  P   E K+E
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     LE       KR  ++     S  E + E+  L QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E   + ++I+E V  G L + L   Q   L           +   + YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHT--- 133
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +        K+ DFG   LA + E G       + GT  ++ PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKK----SVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R +  G   A K  KK    S     S  E + E+  L ++ H N++
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR-LDIAIDVAHAITYLHMYT 255
             H   E + + ++I+E V  G L + L   +    D A + L   +D  H   YLH   
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH---YLH--- 146
Query: 256 DHPIIHRDIKSSNILLTE----NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
              I H D+K  NI+L +    N R K+ DFG   +A   E+G       + GT  ++ P
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEF--KNIFGTPEFVAP 201
Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRE 347
           E +    L  ++D++S GV+   L++G  P   E K+E
Sbjct: 202 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    KV DFG A+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNLVKFHGY 201
           IG G FG V++ +L +   VAI   KK + DK     F++ E++ +  V+H N+V    +
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAI---KKVLQDKR----FKNRELQIMRIVKHPNVVDLKAF 100
Query: 202 L----EFEDERI--VIVEYVPNGTLR--EHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
                + +DE    +++EYVP    R   H   L+  +  L  +L +   +  ++ Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY-QLLRSLAYIHS 159
Query: 254 YTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                I HRDIK  N+LL   +   K+ DFG A++    E   + + ++      Y  PE
Sbjct: 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPE 211
Query: 313 YL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            +      T   D++S G ++ EL+ G +P+ P
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQG-QPLFP 243

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 91
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 92  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 145 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
            L +   T+  D++S G +L E+++  RPI P +   +++
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQL 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 97
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 98  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 151 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 246

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 90  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 143 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 150
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ E    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 151 YRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 203
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 204 KAVDWWALGVLIYEMAAGYPPF 225

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     LE       KR  ++     S  E + E+  L QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E   + ++I+E V  G L + L   Q   L           +   + YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHT--- 133
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +        K+ DFG   LA + E G       + GT  ++ PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEF--KNIFGTPEFVAPE 188
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 136 NFSPSFKIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV- 190
           NF     +G G +G V+  R     + G + A+K  KK+   +   A+     RT  QV 
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK--AKTTEHTRTERQVL 112
Query: 191 EHLN----LVKFHGYLEFEDERIVIVEYVPNGTLREHLD----CLQGNILDLAGRLDIAI 242
           EH+     LV  H   + E +  +I++Y+  G L  HL       +  +    G + +A+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR--LAADTESGATHVST 300
           +  H +          II+RDIK  NILL  N    + DFG ++  +A +TE      + 
Sbjct: 173 EHLHKLG---------IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-----AY 218
Query: 301 QVKGTAGYLDPEYLKTYQLTEKS--DVYSFGVLLVELVTGRRP 341
              GT  Y+ P+ ++          D +S GVL+ EL+TG  P
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 90  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 143 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
            L +   T+  D++S G +L E+++  RPI P +   +++
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQL 237

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 88  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 236

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 90  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
            L +   T+  D++S G +L E+++  RPI P +   +++
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQL 237

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 117 GDQSGNVQITMEEIYRATRNFSPSF----KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSV 171
           G+ S  +Q    +  R    F  SF    ++G G +G V+K R  EDG + A+KR+    
Sbjct: 35  GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF 94
Query: 172 YDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNG-TLREHLDCLQG 229
                 A   +E+ +  +V +H   V+      +E+  I+ ++    G +L++H +   G
Sbjct: 95  RGPKDRARKLAEVGSHEKVGQHPCCVRLE--QAWEEGGILYLQTELCGPSLQQHCEAW-G 151
Query: 230 NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA 289
             L  A       D   A+ +LH      ++H D+K +NI L    R K+ DFG   L  
Sbjct: 152 ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVE 206
Query: 290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              +GA  V    +G   Y+ PE L+    T  +DV+S G+ ++E+  
Sbjct: 207 LGTAGAGEVQ---EGDPRYMAPELLQGSYGT-AADVFSLGLTILEVAC 250

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 90  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 238

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 95  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 243

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 95
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 96  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 149 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 244

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 86
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 87  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 140 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 235

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 94  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 242

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 133
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 186
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 133
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 186
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 94  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 242

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 88  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 236

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 109
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 110 I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 163 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 258

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLXGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 184
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 237
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPF 259

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLAGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 143 IGQGGFGTVYKGRLEDGT-IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G FG     R +    +VA+K  ++    +      + EI     + H N+V+F   
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERG---EKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +       +++EY   G L E + C  G   +   R      +   ++Y H      + H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQ-QLISGVSYAHAMQ---VAH 138
Query: 262 RDIKSSNILL--TENFRAKVADFGFARLAADTESGATHVSTQVK---GTAGYLDPEYLKT 316
           RD+K  N LL  +   R K+ADFG+++        A+ + +Q K   GT  Y+ PE L  
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSK--------ASVLHSQPKSAVGTPAYIAPEVLLK 190
Query: 317 YQLTEK-SDVYSFGVLLVELVTGRRPIEPKRELK 349
            +   K +DV+S GV L  ++ G  P E   E K
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFAEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 9/240 (3%)
Query: 116 GGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK 174
           G    G V++   + +     ++    IG+G +G V         T VAIK+     +  
Sbjct: 24  GPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQT 83
Query: 175 HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL-DCLQGNILD 233
           +     + EI+ L +  H N++     L       +   Y+    +   L   L+   L 
Sbjct: 84  YCQRTLR-EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLS 142
Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
                     +   + Y+H      ++HRD+K SN+L+      K+ DFG AR+ AD E 
Sbjct: 143 NDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARI-ADPEH 198
Query: 294 GATHVSTQVKGTAGYLDPE-YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
             T   T+   T  Y  PE  L +   T+  D++S G +L E+++  RPI P +   +++
Sbjct: 199 DHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQL 257

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFXEPHARF-YAAQIVLTFEYLHSLD---LI 158
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 159 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 211
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 212 KAVDWWALGVLIYEMAAGYPPF 233

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 27/236 (11%)
Query: 113 STRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKK 169
           S R G     +  T+ E+ +  +   P   +G G +G+V   Y  RL     VA+K+  +
Sbjct: 1   SMRAGFYRQELNKTVWEVPQRLQGLRP---VGSGAYGSVCSAYDARLRQK--VAVKKLSR 55
Query: 170 SVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQG 229
                        E+R L  ++H N++   G L+       I ++     +   +     
Sbjct: 56  PFQSLIHARRTYRELRLLKHLKHENVI---GLLDVFTPATSIEDFSEVYLVTTLMGADLN 112
Query: 230 NILDLAGRLD-----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
           NI+      D     +   +   + Y+H      IIHRD+K SN+ + E+   ++ DFG 
Sbjct: 113 NIVKCQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL 169
Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
           AR A +  +G          T  Y  PE +  +    +  D++S G ++ EL+ G+
Sbjct: 170 ARQADEEMTGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDI 93
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 94  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 242

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L    H N++  +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDI 91
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 92  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 145 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
            L +   T+  D++S G +L E+++  RPI P +   +++
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQL 239

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 57/125 (45%), Gaps = 24/125 (19%)
Query: 221 REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVA 280
           REH  CL            I I +A A+ +LH      ++HRD+K SNI  T +   KV 
Sbjct: 161 REHGVCLH-----------IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 206
Query: 281 DFGFARLAADTESGATHVSTQVK---------GTAGYLDPEYLKTYQLTEKSDVYSFGVL 331
           DFG    A D +     V T +          GT  Y+ PE +     + K D++S G++
Sbjct: 207 DFGLVT-AMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265
Query: 332 LVELV 336
           L EL+
Sbjct: 266 LFELL 270

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 90  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 143 AN---VLHRDLKPSNLLLNTTXDLKIXDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 238

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +    L  ++D++S GV+   L++G  P
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + +E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EY P G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    +V DFG A+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           R +S   +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             +++ + Y E  D+ I +V    N  L   L   +   +D   R     ++  A+  +H
Sbjct: 69  DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDP 311
               H I+H D+K +N L+ +    K+ DFG A ++  DT S      +QV GT  Y+ P
Sbjct: 126 ---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK--DSQV-GTVNYMPP 178
Query: 312 EYLKTYQLTEKS-----------DVYSFGVLLVELVTGRRPIE 343
           E +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           R +S   +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             +++ + Y E  D+ I +V    N  L   L   +   +D   R     ++  A+  +H
Sbjct: 116 DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDP 311
               H I+H D+K +N L+ +    K+ DFG A ++  DT S      +QV GT  Y+ P
Sbjct: 173 Q---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK--DSQV-GTVNYMPP 225
Query: 312 EYLKTYQLTEKS-----------DVYSFGVLLVELVTGRRPIE 343
           E +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           R +S   +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +
Sbjct: 12  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             +++ + Y E  D+ I +V    N  L   L   +   +D   R     ++  A+  +H
Sbjct: 72  DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH 128
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDP 311
               H I+H D+K +N L+ +    K+ DFG A ++  DT S      +QV GT  Y+ P
Sbjct: 129 ---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK--DSQV-GTVNYMPP 181
Query: 312 EYLKTYQLTEKS-----------DVYSFGVLLVELVTGRRPIE 343
           E +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 182 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 224

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 130 IYRATRNFSPSFK--IGQGGFGTVYKG-RLEDG-------TIVAIKRAKKSVYDKHSGAE 179
           ++   RN    F   +GQG F  ++KG R E G       T V +K   K+ +  +S + 
Sbjct: 1   VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESF 59
Query: 180 FQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD 239
           F++    ++++ H +LV  +G     DE I++ E+V  G+L  +L     N +++  +L+
Sbjct: 60  FEAA-SMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLE 117
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           +A  +A A   +H   ++ +IH ++ + NILL      K  +  F +L+    S      
Sbjct: 118 VAKQLAWA---MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 300 TQVKGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTG 338
             ++    ++ PE ++  + L   +D +SFG  L E+ +G
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 130 IYRATRNFSPSFK--IGQGGFGTVYKG-RLEDG-------TIVAIKRAKKSVYDKHSGAE 179
           ++   RN    F   +GQG F  ++KG R E G       T V +K   K+ +  +S + 
Sbjct: 1   VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESF 59
Query: 180 FQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD 239
           F++    ++++ H +LV  +G     DE I++ E+V  G+L  +L     N +++  +L+
Sbjct: 60  FEAA-SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLE 117
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           +A  +A A   +H   ++ +IH ++ + NILL      K  +  F +L+    S      
Sbjct: 118 VAKQLAAA---MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 300 TQVKGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTG 338
             ++    ++ PE ++  + L   +D +SFG  L E+ +G
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L    H N++  +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDI 91
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 92  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 145 AN---VLHRDLKPSNLLLNTTSDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
            L +   T+  D++S G +L E+++  RPI P +   +++
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQL 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 164
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 217
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           R +S   +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             +++ + Y E  D+ I +V    N  L   L   +   +D   R     ++  A+  +H
Sbjct: 116 DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDP 311
               H I+H D+K +N L+ +    K+ DFG A ++  DT S      +QV GT  Y+ P
Sbjct: 173 Q---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK--DSQV-GTVNYMPP 225
Query: 312 EYLKTYQLTEKS-----------DVYSFGVLLVELVTGRRPIE 343
           E +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAI++     +  +     + EI+ L +  H N++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 94  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T   T+   T  Y  PE 
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 242

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 78/322 (24%), Positives = 132/322 (40%), Gaps = 49/322 (15%)
Query: 120 SGNVQITMEEIY-RATRNFS-----PSFKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVY 172
           S  V +  E +Y ++  NF+      S ++G+G F  V +   +  G   A K  KK   
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 173 DKHSGAEFQSEIRTLAQVEHL-NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI 231
            +   AE   EI  L   +    ++  H   E   E I+I+EY   G +     CL   +
Sbjct: 68  GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL--CLP-EL 124
Query: 232 LDLAGRLDIA---IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF---RAKVADFGFA 285
            ++    D+      +   + YLH    + I+H D+K  NILL+  +     K+ DFG +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
Query: 286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--E 343
           R     + G      ++ GT  YL PE L    +T  +D+++ G++   L+T   P   E
Sbjct: 182 R-----KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236
Query: 344 PKRELK---ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQ 400
             +E      ++ V ++ + FS               + + LA + I  L    L    +
Sbjct: 237 DNQETYLNISQVNVDYSEETFS---------------SVSQLATDFIQSL----LVKNPE 277
Query: 401 NRPSMRRCAEILWSVRKDYREL 422
            RP+   C    W  + D+  L
Sbjct: 278 KRPTAEICLSHSWLQQWDFENL 299

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 19/212 (8%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G FG     R  +   +VA+K  ++    +      + EI     + H N+V+F   
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +       +++EY   G L E + C  G   +   R      +   ++Y H      + H
Sbjct: 83  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQ-QLISGVSYCHAMQ---VCH 137
Query: 262 RDIKSSNILL--TENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLKTYQ 318
           RD+K  N LL  +   R K+ DFG+++      S   H   +   GT  Y+ PE L   +
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 319 LTEK-SDVYSFGVLLVELVTGRRPIEPKRELK 349
              K +DV+S GV L  ++ G  P E   E K
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 223

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 108/243 (44%), Gaps = 29/243 (11%)
Query: 120 SGNVQITMEEIYRAT-----RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK 174
           S  V +  E +Y  +     R +S   +IG GG   V++   E   I AIK       D 
Sbjct: 8   SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 67
Query: 175 HSGAEFQSEIRTLAQVEHLN--LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNIL 232
            +   +++EI  L +++  +  +++ + Y E  D+ I +V    N  L   L   +   +
Sbjct: 68  QTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSI 124
Query: 233 DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADT 291
           D   R     ++  A+  +H    H I+H D+K +N L+ +    K+ DFG A ++  DT
Sbjct: 125 DPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDT 180
Query: 292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKS-----------DVYSFGVLLVELVTGRR 340
            S      +QV GT  Y+ PE +K    + ++           DV+S G +L  +  G+ 
Sbjct: 181 TSVVK--DSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 341 PIE 343
           P +
Sbjct: 238 PFQ 240

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           R +S   +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +
Sbjct: 8   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             +++ + Y E  D+ I +V    N  L   L   +   +D   R     ++  A+  +H
Sbjct: 68  DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH 124
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDP 311
               H I+H D+K +N L+ +    K+ DFG A ++  DT S      +QV GT  Y+ P
Sbjct: 125 ---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK--DSQV-GTVNYMPP 177
Query: 312 EYLKTYQLTEKS-----------DVYSFGVLLVELVTGRRPIE 343
           E +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 178 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   LE    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++   G L           + P  +L E  D  +   ++D      I +++ 
Sbjct: 77  MKVVNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
           + + T    T  Y  PE +      E  D++S GV++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   LE    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++   G L           + P  +L E  D  +   ++D      I +++ 
Sbjct: 77  MKVVNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
           + + T    T  Y  PE +      E  D++S GV++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 94  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T    +   T  Y  PE 
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 242

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 142 KIGQGGFGTVYKGR-----LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R     L+       KR  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I E V  G L + L   +   L      +    + + + YLH    
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYLHSLQ- 134
Query: 257 HPIIHRDIKSSNILLTENF----RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG   LA   + G       + GT  ++ PE
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            +    L  ++D++S GV+   L++G  P 
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G +G V         + VAIK+     +  +     + EI+ L +  H N++  +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID--------VAHAITYLHM 253
           +     R   +E + +  + +  D ++ ++  L     ++ D        +   + Y+H 
Sbjct: 95  I-----RAPTIEQMKDVYIVQ--DLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE- 312
                ++HRD+K SN+LL      K+ DFG AR+ AD +   T    +   T  Y  PE 
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
            L +   T+  D++S G +L E+++  RPI P +   +++ 
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLN 243

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ ++  G  P 
Sbjct: 217 KAVDWWALGVLIYQMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+++ +    +V DFGFA+       G T     + GT  YL PE + +    
Sbjct: 164 YRDLKPENLIIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPEIIISKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 80  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER 127
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 181
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
            T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 27/244 (11%)
Query: 105 GLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTI 161
           G ++   +  R G     +  T+ E+ +  +   P   +G G +G+V   Y  RL     
Sbjct: 1   GSHMLEMSGPRAGFYRQELNKTVWEVPQRLQGLRP---VGSGAYGSVCSAYDARLRQK-- 55
Query: 162 VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLR 221
           VA+K+  +             E+R L  ++H N++   G L+       I ++     + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI---GLLDVFTPATSIEDFSEVYLVT 112
Query: 222 EHLDCLQGNILDLAGRLD-----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR 276
             +     NI+      D     +   +   + Y+H      IIHRD+K SN+ + E+  
Sbjct: 113 TLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSE 169
Query: 277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVEL 335
            ++ DFG AR A +  +G          T  Y  PE +  +    +  D++S G ++ EL
Sbjct: 170 LRILDFGLARQADEEMTGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 336 VTGR 339
           + G+
Sbjct: 223 LQGK 226

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           R +S   +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 195 --LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
             +++ + Y E  D+ I +V    N  L   L   +   +D   R     ++  A+  +H
Sbjct: 116 DKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDP 311
               H I+H D+K +N L+ +    K+ DFG A ++  DT S      +QV G   Y+ P
Sbjct: 173 Q---HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK--DSQV-GAVNYMPP 225
Query: 312 EYLKTYQLTEKS-----------DVYSFGVLLVELVTGRRPIE 343
           E +K    + ++           DV+S G +L  +  G+ P +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAK---KSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G F TVYK R ++   IVAIK+ K   +S            EI+ L ++ H N++  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
                 +    ++ +++   T  E +      +L  +      +     + YLH    H 
Sbjct: 78  LDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 132
Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           I+HRD+K +N+LL EN   K+ADFG A+          H   QV  T  Y  PE L   +
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH---QVV-TRWYRAPELLFGAR 188
Query: 319 LTEKS-DVYSFGVLLVELVTGRRPIEP 344
           +     D+++ G +L EL+  R P  P
Sbjct: 189 MYGVGVDMWAVGCILAELLL-RVPFLP 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE--FQSEIRTLAQVEHLNLVKFH 199
           ++G G FG V++   E  T      A K V   H   +   + EI+T++ + H  LV  H
Sbjct: 164 ELGTGAFGVVHR-VTERAT--GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E ++E ++I E++  G L E +   + N +     ++    V   + ++H   ++  
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNY 276
Query: 260 IHRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           +H D+K  NI+ T   +   K+ DFG        +S    V+T   GTA +  PE  +  
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT---GTAEFAAPEVAEGK 331
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPI 342
            +   +D++S GVL   L++G  P 
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 134 TRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKS-------VYDKHSGAEFQSEIR 185
           ++ +S    +G G FG V+     E    V +K  KK        + D   G +   EI 
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG-KVTLEIA 81
Query: 186 TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------ 239
            L++VEH N++K     E +    +++E   +G     LD      +D   RLD      
Sbjct: 82  ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-----LDLFA--FIDRHPRLDEPLASY 134
Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           I   +  A+ YL +     IIHRDIK  NI++ E+F  K+ DFG    AA  E G    +
Sbjct: 135 IFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS---AAYLERGKLFYT 188
Query: 300 TQVKGTAGYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRP 341
               GT  Y  PE L    Y+  E  +++S GV L  LV    P
Sbjct: 189 --FCGTIEYCAPEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENP 229

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   LE    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++   G L           + P  +L E  D  +   ++D      I +++ 
Sbjct: 77  MKCVNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
           + + T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   L+    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++             ++  + P  TL E  D  L   ++D      I +++ 
Sbjct: 77  MKXVNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           + + T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 80  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 181
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
            T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   LE    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++   G L           + P  +L E  D  +   ++D      I +++ 
Sbjct: 77  MKVVNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
           + + T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAE--FQSEIRTLAQVEHLNLVKFH 199
           ++G G FG V++   E  T      A K V   H   +   + EI+T++ + H  LV  H
Sbjct: 58  ELGTGAFGVVHR-VTERAT--GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 114
Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              E ++E ++I E++  G L E +   + N +     ++    V   + ++H   ++  
Sbjct: 115 DAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNY 170
Query: 260 IHRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           +H D+K  NI+ T   +   K+ DFG        +S    V+T   GTA +  PE  +  
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT---GTAEFAAPEVAEGK 225
Query: 318 QLTEKSDVYSFGVLLVELVTGRRPI 342
            +   +D++S GVL   L++G  P 
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 80  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 181
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
            T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 85/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT  YL P  + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEYLAPAIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 128 EEIYRATRNFSPSFKIGQGGFGTVYKGRLED---GTIVAIKRAKKSVYDKHSGAEFQSEI 184
           EE++ AT       ++G+G FG V+  R+ED   G   A+K+ +  V+          E+
Sbjct: 90  EEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRA-------EEL 136
Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL--DIAI 242
              A +    +V  +G +       + +E +  G+L        G ++   G L  D A+
Sbjct: 137 MACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL--------GQLVKEQGCLPEDRAL 188
Query: 243 ----DVAHAITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFA-RLAADTESGAT 296
                    + YLH      I+H D+K+ N+LL ++   A + DFG A  L  D    + 
Sbjct: 189 YYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSL 245
Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                + GT  ++ PE +       K DV+S   +++ ++ G  P
Sbjct: 246 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 81  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 128
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 182
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
            T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 37/223 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   LE    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++   G L           + P  +L E  D  +   ++D      I +++ 
Sbjct: 77  MKVVNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAG-IIHRDLKPSNIVVKSDATLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
           + + T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 80  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 181
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
            T    T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 182 MTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   L+    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++             ++  + P  TL E  D  L   ++D      I +++ 
Sbjct: 77  MKXVNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           + + T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   L+    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++             ++  + P  TL E  D  L   ++D      I +++ 
Sbjct: 77  MKCVNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           + + T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 143 IGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G GG G V+     D    VAIK  K  + D  S      EI+ + +++H N+VK    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 202 L-----EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD-----IAIDVAHAITYL 251
           L     +  D+   + E      ++E+++    N+L+    L+         +   + Y+
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYI 136
Query: 252 HMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           H      ++HRD+K +N+ + TE+   K+ DFG AR+     S   H+S  +  T  Y  
Sbjct: 137 HSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRS 192
Query: 311 PEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE 350
           P  L +    T+  D+++ G +  E++TG+       EL++
Sbjct: 193 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+ +   G ++KGR +   IV +K  K   +      +F  E   L    H N++   G 
Sbjct: 17  KLNENHSGELWKGRWQGNDIV-VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 202 LEFED--ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            +        +I  ++P G+L   L      ++D +  +  A+D+A  + +LH  T  P+
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPL 133
Query: 260 IHRD-IKSSNILLTENFRAKV--ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
           I R  + S ++++ E+  A++  AD  F+        G  +    V   A    PE    
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTN- 188
Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPI 342
                 +D++SF VLL ELVT   P 
Sbjct: 189 ---RRSADMWSFAVLLWELVTREVPF 211

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 27/244 (11%)
Query: 105 GLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTI 161
           G ++   +  R G     +  T+ E+ +  +   P   +G G +G+V   Y  RL     
Sbjct: 1   GSHMLEMSGPRAGFYRQELNKTVWEVPQRLQGLRP---VGSGAYGSVCSAYDARLRQK-- 55
Query: 162 VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLR 221
           VA+K+  +             E+R L  ++H N++   G L+       I ++     + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI---GLLDVFTPATSIEDFSEVYLVT 112
Query: 222 EHLDCLQGNILDLAGRLD-----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR 276
             +     NI+      D     +   +   + Y+H      IIHRD+K SN+ + E+  
Sbjct: 113 TLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSE 169
Query: 277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVEL 335
            ++ DFG AR A +  +G          T  Y  PE +  +    +  D++S G ++ EL
Sbjct: 170 LRILDFGLARQADEEMTGYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 336 VTGR 339
           + G+
Sbjct: 223 LQGK 226

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 19/212 (8%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G FG     R  +   +VA+K  ++    +      + EI     + H N+V+F   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +       +++EY   G L E + C  G   +   R      +   ++Y H      + H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQ-QLISGVSYCHAMQ---VCH 138
Query: 262 RDIKSSNILL--TENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLKTYQ 318
           RD+K  N LL  +   R K+  FG+++      S   H   +   GT  Y+ PE L   +
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 319 LTEK-SDVYSFGVLLVELVTGRRPIEPKRELK 349
              K +DV+S GV L  ++ G  P E   E K
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 19/212 (8%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G FG     R  +   +VA+K  ++    +      + EI     + H N+V+F   
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERG---EKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +       +++EY   G L E + C  G   +   R      +   ++Y H      + H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQ-QLISGVSYCHAMQ---VCH 138
Query: 262 RDIKSSNILL--TENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLKTYQ 318
           RD+K  N LL  +   R K+  FG+++      S   H   +   GT  Y+ PE L   +
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 319 LTEK-SDVYSFGVLLVELVTGRRPIEPKRELK 349
              K +DV+S GV L  ++ G  P E   E K
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   L+    VAIK+  +   ++        E+  
Sbjct: 15  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++             ++  + P  TL E  D  L   ++D      I +++ 
Sbjct: 70  MKCVNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD 117
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 118 HERMSYLLYQMLXGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GT 171
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           + + T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 118 VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 165
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 166 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 219
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 81  VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 128
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 182
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 21  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 78
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 79  VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 126
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 127 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 180
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 181 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++                 + P  TL E  D  L   ++D      I +++ H  
Sbjct: 80  VNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 127
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 181
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV---- 196
           KIGQG FG V+K R  + G  VA+K+       +        EI+ L  ++H N+V    
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 197 ----KFHGYLEFEDERIVIVEYVPNGTLREH-LDCLQGNILDLAGRLDIAIDVAHAITYL 251
               K   Y   +    ++ ++       EH L  L  N+L      +I   +   +  L
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           +    + I+HRD+K++N+L+T +   K+ADFG AR  +  ++   +       T  Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 312 EYLKTYQLTEKS-----DVYSFGVLLVELVTGRRPI 342
           E L    L E+      D++  G ++ E+ T R PI
Sbjct: 199 ELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +GQG    V++GR +  G + AIK      + +    + + E   L ++ H N+VK    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFAI 75
Query: 202 LEFEDER--IVIVEYVPNGTLREHLDCLQGNI-LDLAGRLDIAIDVAHAITYLHMYTDHP 258
            E    R  ++I+E+ P G+L   L+       L  +  L +  DV   + +L    ++ 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 259 IIHRDIKSSNIL--LTENFRA--KVADFGFARLAADTESGATHVSTQVKGTAGYLDP--- 311
           I+HR+IK  NI+  + E+ ++  K+ DFG AR   D E   +     + GT  YL P   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-----LYGTEEYLHPDMY 187
Query: 312 -------EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
                  ++ K Y  T   D++S GV      TG  P  P
Sbjct: 188 ERAVLRKDHQKKYGAT--VDLWSIGVTFYHAATGSLPFRP 225

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 81  VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 128
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 129 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 182
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 31/220 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 24  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 81
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 82  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 129
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 130 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 183
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
                 T  Y  PE +      E  D++S G ++ E++ G
Sbjct: 184 MVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 80  VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 127
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 181
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 85/202 (42%), Gaps = 14/202 (6%)
Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ-SEIRTLAQVEHLNLVKFHG 200
           +G G FG V   +  E G   A+K   K    K    E   +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +      +++EYV  G +  HL  + G   +   R   A  +     YLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARF-YAAQIVLTFEYLHSLD---LI 163
Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  N+L+ +    +V DFGFA+       G T     + GT   L PE + +    
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRT---WXLCGTPEALAPEIILSKGYN 216
Query: 321 EKSDVYSFGVLLVELVTGRRPI 342
           +  D ++ GVL+ E+  G  P 
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPF 238

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +GQG    V++GR +  G + AIK      + +    + + E   L ++ H N+VK    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFAI 75
Query: 202 LEFEDER--IVIVEYVPNGTLREHLDCLQGNI-LDLAGRLDIAIDVAHAITYLHMYTDHP 258
            E    R  ++I+E+ P G+L   L+       L  +  L +  DV   + +L    ++ 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 259 IIHRDIKSSNIL--LTENFRA--KVADFGFARLAADTESGATHVSTQVKGTAGYLDP--- 311
           I+HR+IK  NI+  + E+ ++  K+ DFG AR   D E         + GT  YL P   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-----FVXLYGTEEYLHPDMY 187
Query: 312 -------EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
                  ++ K Y  T   D++S GV      TG  P  P
Sbjct: 188 ERAVLRKDHQKKYGAT--VDLWSIGVTFYHAATGSLPFRP 225

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 118 VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 165
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 166 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 219
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 130 IYRATRNFSPSFKIGQGGFGTV---YKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRT 186
           + +  +N  P   IG G  G V   Y   L+    VAIK+  +   ++        E+  
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVA 245
           +  V H N++             ++  + P  TL E  D  L   ++D      I +++ 
Sbjct: 77  MKXVNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 124
Query: 246 HA-ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
           H  ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G 
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDXTLKILDFGLARTA-----GT 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
           + + T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 74  VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 121
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 122 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 175
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 73  VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 121 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 174
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 259 IIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           ++HRDIK  NIL+  N    K+ DFG   L  DT      V T   GT  Y  PE+++ +
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPEWIRYH 231
Query: 318 QLTEKS-DVYSFGVLLVELVTGRRPIEPKREL 348
           +   +S  V+S G+LL ++V G  P E   E+
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   L+    VAIK+  +   ++        E+  +  
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++             ++  + P  TL E  D  L   ++D      I +++ H  
Sbjct: 74  VNHKNIIS------------LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 121
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 122 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 175
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            T    T  Y  PE +      E  D++S G ++ E+V
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 29/243 (11%)
Query: 120 SGNVQITMEEIYRAT-----RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK 174
           S  V +  E +Y  +     R +S   +IG GG   V++   E   I AIK       D 
Sbjct: 8   SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 67
Query: 175 HSGAEFQSEIRTLAQVEHLN--LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNIL 232
            +   +++EI  L +++  +  +++ + Y E  D+ I +V    N  L   L   +   +
Sbjct: 68  QTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWLK--KKKSI 124
Query: 233 DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADT 291
           D   R     ++  A+  +H    H I+H D+K +N L+ +    K+ DFG A ++  D 
Sbjct: 125 DPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDX 180
Query: 292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKS-----------DVYSFGVLLVELVTGRR 340
                   +QV GT  Y+ PE +K    + ++           DV+S G +L  +  G+ 
Sbjct: 181 XXVVK--DSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 341 PIE 343
           P +
Sbjct: 238 PFQ 240

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 110/259 (42%), Gaps = 45/259 (17%)
Query: 104 QGLYVSSNNSTRGGDQSGNVQITMEEI-YRATRNFSPSFKIGQGGFGTVYKGRLEDGTI- 161
           QG+    NN     DQ   VQ+  + + YR    +     IG+G FG V K    D  + 
Sbjct: 69  QGMTGGPNNGGYDDDQGSYVQVPHDHVAYR----YEVLKVIGKGSFGQVVKAY--DHKVH 122
Query: 162 --VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT 219
             VA+K  +         AE   EIR L   EHL         + +D  + ++  + N T
Sbjct: 123 QHVALKMVRNEKRFHRQAAE---EIRIL---EHLRK-------QDKDNTMNVIHMLENFT 169
Query: 220 LREHL----DCLQGNILDLAGR-------LDIAIDVAHAI-TYLHMYTDHPIIHRDIKSS 267
            R H+    + L  N+ +L  +       L +    AH+I   L     + IIH D+K  
Sbjct: 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229
Query: 268 NILLTENFRA--KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDV 325
           NILL +  R+  KV DFG    ++  E    +   Q   +  Y  PE +   +     D+
Sbjct: 230 NILLKQQGRSGIKVIDFG----SSCYEHQRVYTXIQ---SRFYRAPEVILGARYGMPIDM 282
Query: 326 YSFGVLLVELVTGRRPIEP 344
           +S G +L EL+TG  P+ P
Sbjct: 283 WSLGCILAELLTG-YPLLP 300

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 128 EEIYRATRNFSPSFKIGQGGFGTVYKGRLED---GTIVAIKRAKKSVYDKHSGAEFQSEI 184
           EE++ AT       ++G+G FG V+  R+ED   G   A+K+ +  V+          E+
Sbjct: 71  EEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRA-------EEL 117
Query: 185 RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL--DIAI 242
              A +    +V  +G +       + +E +  G+L        G ++   G L  D A+
Sbjct: 118 MACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL--------GQLVKEQGCLPEDRAL 169
Query: 243 ----DVAHAITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFA-RLAADTESGAT 296
                    + YLH      I+H D+K+ N+LL ++   A + DFG A  L  D      
Sbjct: 170 YYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL 226
Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                + GT  ++ PE +       K DV+S   +++ ++ G  P
Sbjct: 227 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 110/259 (42%), Gaps = 45/259 (17%)
Query: 104 QGLYVSSNNSTRGGDQSGNVQITMEEI-YRATRNFSPSFKIGQGGFGTVYKGRLEDGTI- 161
           QG+    NN     DQ   VQ+  + + YR    +     IG+G FG V K    D  + 
Sbjct: 69  QGMTGGPNNGGYDDDQGSYVQVPHDHVAYR----YEVLKVIGKGSFGQVVKAY--DHKVH 122
Query: 162 --VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT 219
             VA+K  +         AE   EIR L   EHL         + +D  + ++  + N T
Sbjct: 123 QHVALKMVRNEKRFHRQAAE---EIRIL---EHLRK-------QDKDNTMNVIHMLENFT 169
Query: 220 LREHL----DCLQGNILDLAGR-------LDIAIDVAHAI-TYLHMYTDHPIIHRDIKSS 267
            R H+    + L  N+ +L  +       L +    AH+I   L     + IIH D+K  
Sbjct: 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229
Query: 268 NILLTENFRA--KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDV 325
           NILL +  R+  KV DFG    ++  E    +   Q   +  Y  PE +   +     D+
Sbjct: 230 NILLKQQGRSGIKVIDFG----SSCYEHQRVYTXIQ---SRFYRAPEVILGARYGMPIDM 282
Query: 326 YSFGVLLVELVTGRRPIEP 344
           +S G +L EL+TG  P+ P
Sbjct: 283 WSLGCILAELLTG-YPLLP 300

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 27  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 84
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 85  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 132
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 133 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 186
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
            T    T  Y  PE +      E  D++S G ++ E+V  +
Sbjct: 187 MTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV-S 299
           +  VA  + +L   +    IHRD+ + NILL+EN   K+ DFG AR   D      +V  
Sbjct: 205 SFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKNPDYVRK 258
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              +    ++ PE +     + KSDV+S+GVLL E+ +
Sbjct: 259 GDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 127 MEEIYRATRNFSPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIR 185
            E++Y+ T        +G+G +  V     L++G   A+K  +K     HS +    E+ 
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQA--GHSRSRVFREVE 62
Query: 186 TLAQVE-HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDV 244
           TL Q + + N+++   + E +    ++ E +  G++  H+   +      A R  +  DV
Sbjct: 63  TLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR--VVRDV 120
Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFGFA---RLAADTESGATHV 298
           A A+ +LH      I HRD+K  NIL     +    K+ DF      +L        T  
Sbjct: 121 AAALDFLHT---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE 177
Query: 299 STQVKGTAGYLDPEYLKTY--QLT---EKSDVYSFGVLLVELVTGRRPI 342
            T   G+A Y+ PE ++ +  Q T   ++ D++S GV+L  +++G  P 
Sbjct: 178 LTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 14/210 (6%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG FG V+K R  + G  VA+K+       +        EI+ L  ++H N+V    
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 201 YLEFED---ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
               +     R     Y+        L  L  N+L      +I   +   +  L+    +
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
            I+HRD+K++N+L+T +   K+ADFG AR  +  ++   +       T  Y  PE L   
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL--- 201
Query: 318 QLTEKS-----DVYSFGVLLVELVTGRRPI 342
            L E+      D++  G ++ E+ T R PI
Sbjct: 202 -LGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 30/208 (14%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G  G V        G  VA+K+  +   ++        E+  L  V H N++     
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 202 LEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA-ITYL-------- 251
                       + P  TL E  D  L   ++D      I +++ H  ++YL        
Sbjct: 90  ------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 137
Query: 252 -HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
            H+++   IIHRD+K SNI++  +   K+ DFG AR A+       +V T+      Y  
Sbjct: 138 KHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRY-----YRA 191
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTG 338
           PE +      E  D++S G ++ ELV G
Sbjct: 192 PEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV---- 196
           KIGQG FG V+K R  + G  VA+K+       +        EI+ L  ++H N+V    
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 197 ----KFHGYLEFEDERIVIVEYVPNGTLREH-LDCLQGNILDLAGRLDIAIDVAHAITYL 251
               K   Y   +    ++ ++       EH L  L  N+L      +I   +   +  L
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           +    + I+HRD+K++N+L+T +   K+ADFG AR  +  ++   +       T  Y  P
Sbjct: 138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 312 EYLKTYQLTEKS-----DVYSFGVLLVELVTGRRPI 342
           E L    L E+      D++  G ++ E+ T R PI
Sbjct: 198 ELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS---------GAEFQSEIRTLAQVEHL 193
           I  G +G V  G   +G  VAIKR   +V D  +               EIR L    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
           N++         +E  +   Y+    +R  L  +  +   +     I   + H +  LH+
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT-ESGATHVSTQVKGTAGYLDPE 312
             +  ++HRD+   NILL +N    + DF  AR   DT ++  TH  T       Y  PE
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH----RWYRAPE 203
Query: 313 YLKTYQ-LTEKSDVYSFGVLLVEL 335
            +  ++  T+  D++S G ++ E+
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 16  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 74  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 121
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A     G + +
Sbjct: 122 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----GTSFM 175
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
            T    T  Y  PE +      E  D++S G ++ E+V  +
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 143 IGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS---------GAEFQSEIRTLAQVEHL 193
           I  G +G V  G   +G  VAIKR   +V D  +               EIR L    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
           N++         +E  +   Y+    +R  L  +  +   +     I   + H +  LH+
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT-ESGATHVSTQVKGTAGYLDPE 312
             +  ++HRD+   NILL +N    + DF  AR   DT ++  TH  T       Y  PE
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTH----RWYRAPE 203
Query: 313 YLKTYQ-LTEKSDVYSFGVLLVEL 335
            +  ++  T+  D++S G ++ E+
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV---- 196
           KIGQG FG V+K R  + G  VA+K+       +        EI+ L  ++H N+V    
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 197 ----KFHGYLEFEDERIVIVEYVPNGTLREH-LDCLQGNILDLAGRLDIAIDVAHAITYL 251
               K   Y   +    ++ ++       EH L  L  N+L      +I   +   +  L
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           +    + I+HRD+K++N+L+T +   K+ADFG AR  +  ++   +       T  Y  P
Sbjct: 139 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 312 EYLKTYQLTEKS-----DVYSFGVLLVELVTGRRPI 342
           E L    L E+      D++  G ++ E+ T R PI
Sbjct: 199 ELL----LGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 110/259 (42%), Gaps = 45/259 (17%)
Query: 104 QGLYVSSNNSTRGGDQSGNVQITMEEI-YRATRNFSPSFKIGQGGFGTVYKGRLEDGTI- 161
           QG+    NN     DQ   VQ+  + + YR    +     IG+G FG V K    D  + 
Sbjct: 69  QGMTGGPNNGGYDDDQGSYVQVPHDHVAYR----YEVLKVIGKGXFGQVVKAY--DHKVH 122
Query: 162 --VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGT 219
             VA+K  +         AE   EIR L   EHL         + +D  + ++  + N T
Sbjct: 123 QHVALKMVRNEKRFHRQAAE---EIRIL---EHLRK-------QDKDNTMNVIHMLENFT 169
Query: 220 LREHL----DCLQGNILDLAGR-------LDIAIDVAHAI-TYLHMYTDHPIIHRDIKSS 267
            R H+    + L  N+ +L  +       L +    AH+I   L     + IIH D+K  
Sbjct: 170 FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229
Query: 268 NILLTENFRA--KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDV 325
           NILL +  R+  KV DFG    ++  E    +   Q   +  Y  PE +   +     D+
Sbjct: 230 NILLKQQGRSGIKVIDFG----SSCYEHQRVYXXIQ---SRFYRAPEVILGARYGMPIDM 282
Query: 326 YSFGVLLVELVTGRRPIEP 344
           +S G +L EL+TG  P+ P
Sbjct: 283 WSLGCILAELLTG-YPLLP 300

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 28/235 (11%)
Query: 123 VQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKK-SVYDKHSGAEF 180
           + + ++E+     +F     IG+G F  V   ++ + G + A+K   K  +  +   + F
Sbjct: 49  IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 181 QSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--- 237
           + E   L   +   + + H   + E+   +++EY   G L   L      I     R   
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 238 --LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA-RLAADTESG 294
             + +AID  H + Y         +HRDIK  NILL      ++ADFG   +L AD    
Sbjct: 169 AEIVMAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRAD---- 215
Query: 295 ATHVSTQVKGTAGYLDPEYLKTYQLTE-------KSDVYSFGVLLVELVTGRRPI 342
            T  S    GT  YL PE L+             + D ++ GV   E+  G+ P 
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 143 IGQGGFGTVYKGRLEDGTI----VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +G+G +G V K  L+  T+    V I + KK     +  A  + EI+ L ++ H N+++ 
Sbjct: 13  LGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 199 HGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
              L  E+++   +++EY   G ++E LD +      +         +   + YLH    
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127
Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY--- 313
             I+H+DIK  N+LLT     K++  G A       +  T  ++Q  G+  +  PE    
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPEIANG 185
Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIE 343
           L T+    K D++S GV L  + TG  P E
Sbjct: 186 LDTFS-GFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 138 SPSFKIGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           SP+  +G G +G+V        G  VAIK+  +          FQSEI        L L+
Sbjct: 46  SPT-HVGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------FQSEIFAKRAYRELLLL 95
Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDC------LQGNILDLAGR-------LDIAID 243
           K   +++ E+   ++  + P  +LR   D       +Q ++  + G          +   
Sbjct: 96  K---HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQ 152
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           +   + Y+H      ++HRD+K  N+ + E+   K+ DFG AR  AD E     V     
Sbjct: 153 MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV----- 203
Query: 304 GTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
            T  Y  PE + ++    +  D++S G ++ E++TG+
Sbjct: 204 -TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGA 295
           +I   +  AI YLH      I HRD+K  N+L T    N   K+ DFGFA+     E+ +
Sbjct: 119 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTS 170
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +  T+   T  Y+ PE L   +  +  D++S GV++  L+ G  P
Sbjct: 171 HNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 12/107 (11%)
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFGFARLAADTESGA 295
           +I  D+  AI +LH    H I HRD+K  N+L T   +    K+ DFGFA+   +T   A
Sbjct: 132 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 185
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
                    T  Y+ PE L   +  +  D++S GV++  L+ G  P 
Sbjct: 186 LQTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 12/107 (11%)
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFGFARLAADTESGA 295
           +I  D+  AI +LH    H I HRD+K  N+L T   +    K+ DFGFA+   +T   A
Sbjct: 113 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNA 166
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
                    T  Y+ PE L   +  +  D++S GV++  L+ G  P 
Sbjct: 167 LQTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 143 IGQGGFGTVYKG-RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G G +G+V        G  VAIK+  +          FQSEI        L L+K   +
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------FQSEIFAKRAYRELLLLK---H 79
Query: 202 LEFEDERIVIVEYVPNGTLREHLDC------LQGNILDLAG------RLD-IAIDVAHAI 248
           ++ E+   ++  + P  +LR   D       +Q ++  + G      ++  +   +   +
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            Y+H      ++HRD+K  N+ + E+   K+ DFG AR  AD E     V      T  Y
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV------TRWY 189
Query: 309 LDPEYLKTY-QLTEKSDVYSFGVLLVELVTGR 339
             PE + ++    +  D++S G ++ E++TG+
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 31/221 (14%)
Query: 130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           + +  +N  P     QG     Y   LE    VAIK+  +   ++        E+  +  
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 190 VEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHA- 247
           V H N++   G L           + P  +L E  D  +   ++D      I +++ H  
Sbjct: 80  VNHKNII---GLLNV---------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 248 ITYL---------HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           ++YL         H+++   IIHRD+K SNI++  +   K+ DFG AR A  +      V
Sbjct: 128 MSYLLYQMLCGIKHLHSAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV 186
Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
            T+      Y  PE +      E  D++S G ++ E+V  +
Sbjct: 187 VTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFR----AKVADFGFARLAADTESGATHVS 299
           +   + YLH      ++HRD+K SNIL  +        ++ DFGFA+     E+G     
Sbjct: 130 IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK-QLRAENGLLMTP 185
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                TA ++ PE LK     E  D++S G+LL  ++ G  P
Sbjct: 186 CY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 11/103 (10%)
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFR----AKVADFGFARLAADTESGATHVS 299
           +   + YLH      ++HRD+K SNIL  +        ++ DFGFA+     E+G     
Sbjct: 130 IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK-QLRAENGLLMTP 185
Query: 300 TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI 342
                TA ++ PE LK     E  D++S G+LL  ++ G  P 
Sbjct: 186 CY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 34/234 (14%)
Query: 132 RATRNFSPSFKIGQGGFGTVYKG--RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           R T  F    KIG G FG+V+K   RL DG I AIKR+KK +           E+   A 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 190 V-EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL-----AGRLDIAID 243
           + +H ++V++      +D  ++  EY   G+L    D +  N   +     A   D+ + 
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL---ADAISENYRIMSYFKEAELKDLLLQ 121
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLT--------------ENFRAKVADFGFARLAA 289
           V   + Y+H  +   ++H DIK SNI ++              +++ +    F    L  
Sbjct: 122 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 178
Query: 290 DTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPI 342
            T   +  V    +G + +L  E L+  Y    K+D+++  + +V    G  P+
Sbjct: 179 VTRISSPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPL 228

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 13/115 (11%)
Query: 227 LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR 286
           L  + L L   +  +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR
Sbjct: 185 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
Query: 287 LAADTESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              D      +V    KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 242 ---DIYKDPDYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 13/115 (11%)
Query: 227 LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR 286
           L  + L L   +  +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR
Sbjct: 183 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 239
Query: 287 LAADTESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              D      +V    KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 240 ---DIYKDPDYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 13/115 (11%)
Query: 227 LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR 286
           L  + L L   +  +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR
Sbjct: 190 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 246
Query: 287 LAADTESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              D      +V    KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 247 ---DIYKDPDYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 56/115 (48%), Gaps = 13/115 (11%)
Query: 227 LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR 286
           L  + L L   +  +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR
Sbjct: 192 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 248
Query: 287 LAADTESGATHVSTQVKGTA----GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT 337
              D      +V    KG A     ++ PE +     T +SDV+SFGVLL E+ +
Sbjct: 249 ---DIYKDPDYVR---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 34/234 (14%)
Query: 132 RATRNFSPSFKIGQGGFGTVYKG--RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           R T  F    KIG G FG+V+K   RL DG I AIKR+KK +           E+   A 
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 190 V-EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL-----AGRLDIAID 243
           + +H ++V++      +D  ++  EY   G+L    D +  N   +     A   D+ + 
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA---DAISENYRIMSYFKEAELKDLLLQ 123
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLT--------------ENFRAKVADFGFARLAA 289
           V   + Y+H  +   ++H DIK SNI ++              +++ +    F    L  
Sbjct: 124 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 290 DTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPI 342
            T   +  V    +G + +L  E L+  Y    K+D+++  + +V    G  P+
Sbjct: 181 VTRISSPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPL 230

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 34/234 (14%)
Query: 132 RATRNFSPSFKIGQGGFGTVYKG--RLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ 189
           R T  F    KIG G FG+V+K   RL DG I AIKR+KK +           E+   A 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 64
Query: 190 V-EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL-----AGRLDIAID 243
           + +H ++V++      +D  ++  EY   G+L    D +  N   +     A   D+ + 
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL---ADAISENYRIMSYFKEAELKDLLLQ 121
Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLT--------------ENFRAKVADFGFARLAA 289
           V   + Y+H  +   ++H DIK SNI ++              +++ +    F    L  
Sbjct: 122 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 178
Query: 290 DTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPI 342
            T   +  V    +G + +L  E L+  Y    K+D+++  + +V    G  P+
Sbjct: 179 VTRISSPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVV-CAAGAEPL 228

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 142 KIGQGGFGTVYKGRLED---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G+G FG V+  R++D   G   A+K+ +  V+          E+   A +    +V  
Sbjct: 65  RVGRGSFGEVH--RMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPL 115
Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL--DIAI----DVAHAITYLH 252
           +G +       + +E +  G+L        G ++   G L  D A+         + YLH
Sbjct: 116 YGAVREGPWVNIFMELLEGGSL--------GQLIKQMGCLPEDRALYYLGQALEGLEYLH 167
Query: 253 MYTDHPIIHRDIKSSNILL-TENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLD 310
                 I+H D+K+ N+LL ++  RA + DFG A  L  D    +      + GT  ++ 
Sbjct: 168 TRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           PE +       K D++S   +++ ++ G  P
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 49/106 (46%), Gaps = 11/106 (10%)
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGA 295
           +I   +  AI YLH      I HRD+K  N+L T    N   K+ DFGFA+      S  
Sbjct: 135 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 191
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           T   T       Y+ PE L   +  +  D++S GV++  L+ G  P
Sbjct: 192 TPCYTPY-----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGA 295
           +I   +  AI YLH      I HRD+K  N+L T    N   K+ DFGFA+     E+ +
Sbjct: 127 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTS 178
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +  T    T  Y+ PE L   +  +  D++S GV++  L+ G  P
Sbjct: 179 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGA 295
           +I   +  AI YLH      I HRD+K  N+L T    N   K+ DFGFA+     E+ +
Sbjct: 126 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTS 177
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +  T    T  Y+ PE L   +  +  D++S GV++  L+ G  P
Sbjct: 178 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGA 295
           +I   +  AI YLH      I HRD+K  N+L T    N   K+ DFGFA+     E+ +
Sbjct: 125 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTS 176
Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +  T    T  Y+ PE L   +  +  D++S GV++  L+ G  P
Sbjct: 177 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	443
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-128
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-112
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-108
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-75
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-64
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-62
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-54
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-45
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-45
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-43
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-43
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-43
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-43
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-42
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-42
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-41
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-41
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-41
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-40
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-37
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-35
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-33
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-33
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-28
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-09
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	5e-06

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  373 bits (960), Expect = e-128
 Identities = 119/317 (37%), Positives = 171/317 (53%), Gaps = 13/317 (4%)

Query: 99  RRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLED 158
            + S     ++   S+       + ++ + ++  AT NF   F IG G FG VYKG L D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 159 GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG 218
           G  VA+KR            EF++EI TL+   H +LV   G+ +  +E I+I +Y+ NG
Sbjct: 63  GAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120

Query: 219 TLREHL--DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR 276
            L+ HL    L    +    RL+I I  A  + YLH      IIHRD+KS NILL ENF 
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFV 177

Query: 277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELV 336
            K+ DFG ++    TE   TH+ST VKGT GY+DPEY    +LTEKSDVYSFGV+L E++
Sbjct: 178 PKITDFGISKKG--TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

Query: 337 TGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLA 396
             R  I      +     +WA++  ++G    I+DP + +      +L K  + A++CLA
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE-SLRKFGDTAVKCLA 294

Query: 397 PRRQNRPSMRRCAEILW 413
              ++RPSM    ++LW
Sbjct: 295 LSSEDRPSM---GDVLW 308

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  331 bits (850), Expect = e-112
 Identities = 103/292 (35%), Positives = 168/292 (57%), Gaps = 14/292 (4%)

Query: 121 GNVQI-TMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA- 178
           G ++  ++ E+  A+ NFS    +G+GGFG VYKGRL DGT+VA+KR K+   ++  G  
Sbjct: 15  GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE---ERTQGGE 71

Query: 179 -EFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL-DCLQGNI-LDLA 235
            +FQ+E+  ++   H NL++  G+     ER+++  Y+ NG++   L +  +    LD  
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131

Query: 236 GRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA 295
            R  IA+  A  + YLH + D  IIHRD+K++NILL E F A V DFG A+L        
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY---KD 188

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT-- 353
           THV+T V+GT G++ PEYL T + +EK+DV+ +GV+L+EL+TG+R  +  R   +     
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSM 405
           + W      +    +++D  ++     +  +E+++++AL C       RP M
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKM 299

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  321 bits (824), Expect = e-108
 Identities = 98/306 (32%), Positives = 167/306 (54%), Gaps = 24/306 (7%)

Query: 119 QSGNVQI-TMEEIYRATRNFSPSF------KIGQGGFGTVYKGRLEDGTIVAIKRAKKSV 171
                   +  E+   T NF          K+G+GGFG VYKG + + T VA+K+   ++
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA-AM 65

Query: 172 YDKHSG---AEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ 228
            D  +     +F  EI+ +A+ +H NLV+  G+    D+  ++  Y+PNG+L + L CL 
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125

Query: 229 GN-ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL 287
           G   L    R  IA   A+ I +LH   ++  IHRDIKS+NILL E F AK++DFG AR 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE 347
           +   +   T +++++ GT  Y+ PE L   ++T KSD+YSFGV+L+E++TG   ++  RE
Sbjct: 183 S--EKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 348 LKERITVKWAMKKFSDGDAIS-ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMR 406
              ++ +    +   +   I   +D ++ +  +   ++E +  +A QCL  ++  RP ++
Sbjct: 240 --PQLLLDIKEEIEDEEKTIEDYIDKKMNDADST--SVEAMYSVASQCLHEKKNKRPDIK 295

Query: 407 RCAEIL 412
           +  ++L
Sbjct: 296 KVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  236 bits (603), Expect = 8e-75
 Identities = 71/316 (22%), Positives = 122/316 (38%), Gaps = 30/316 (9%)

Query: 118 DQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSG 177
             S  V +  E +Y  +          +G FG V+K +L     VA+K       DK S 
Sbjct: 7   HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQS- 62

Query: 178 AEFQSEIRTLAQVEHLNLVKFHGY----LEFEDERIVIVEYVPNGTLREHLDCLQGNILD 233
            + + E+ +L  ++H N+++F G        + +  +I  +   G+L + L   + N++ 
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVS 119

Query: 234 LAGRLDIAIDVAHAITYLHMYTDH-------PIIHRDIKSSNILLTENFRAKVADFGFAR 286
                 IA  +A  + YLH             I HRDIKS N+LL  N  A +ADFG A 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 287 LAADTESGATHVSTQVKGTAGYLDPEYL-----KTYQLTEKSDVYSFGVLLVELVTGRRP 341
                +S     +    GT  Y+ PE L            + D+Y+ G++L EL +    
Sbjct: 180 KFEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

Query: 342 IEPKRELKERITVKWAMKKFSDGDAISI-----LDPRVENTAANNLALEKILELALQCLA 396
            +   +       +   +  S  D   +       P + +    +  +  + E   +C  
Sbjct: 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 397 PRRQNRPSMRRCAEIL 412
              + R S     E +
Sbjct: 298 HDAEARLSAGCVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  214 bits (547), Expect = 1e-66
 Identities = 83/279 (29%), Positives = 123/279 (44%), Gaps = 40/279 (14%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG G FGTV++     G+ VA+K   +  +      EF  E+  + ++ H N+V F G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 202 LEFEDERIVIVEYVPNGTLREHL-DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +       ++ EY+  G+L   L        LD   RL +A DVA  + YLH     PI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIV 161

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HR++KS N+L+ + +  KV DFG +RL A T       S    GT  ++ PE L+     
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS----SKSAAGTPEWMAPEVLRDEPSN 217

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
           EKSDVYSFGV+L EL T ++P                   + + +   +    V      
Sbjct: 218 EKSDVYSFGVILWELATLQQP-------------------WGNLNPAQV----VAAVGFK 254

Query: 381 NLALE-------KILELALQCLAPRRQNRPSMRRCAEIL 412
              LE       ++  +   C       RPS    A I+
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF---ATIM 290

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (528), Expect = 8e-64
 Identities = 77/311 (24%), Positives = 121/311 (38%), Gaps = 48/311 (15%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
            +G+G FG V K +      VAIK+ +     K     F  E+R L++V H N+VK +G 
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIESESERK----AFIVELRQLSRVNHPNIVKLYGA 69

Query: 202 LEFEDERIVIVEYVPNGTLREHL-DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               +   +++EY   G+L   L           A  +   +  +  + YLH      +I
Sbjct: 70  CL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 261 HRDIKSSNILLTENFR-AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           HRD+K  N+LL       K+ DFG A              T  KG+A ++ PE  +    
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-------MTNNKGSAAWMAPEVFEGSNY 180

Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA 379
           +EK DV+S+G++L E++T R+P                   F +   I     R+     
Sbjct: 181 SEKCDVFSWGIILWEVITRRKP-------------------FDE---IGGPAFRIMWAVH 218

Query: 380 NNLAL-------EKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPS 432
           N           + I  L  +C +     RPSM    EI+  +    R    +D  LQ  
Sbjct: 219 NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSM---EEIVKIMTHLMRYFPGADEPLQYP 275

Query: 433 YSKRSNSTREQ 443
                    + 
Sbjct: 276 CQHSLPPGEDG 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  203 bits (518), Expect = 8e-63
 Identities = 54/288 (18%), Positives = 101/288 (35%), Gaps = 49/288 (17%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+ +   G ++KGR   G  + +K  K   +      +F  E   L    H N++   G 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 202 -LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                     ++  ++P G+L   L      ++D +  +  A+D+A  + +LH   +  I
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLI 134

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK---T 316
               + S ++++ E+  A+++               +  S        ++ PE L+    
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF---------SFQSPGRMYAPAWVAPEALQKKPE 185

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
                 +D++SF VLL ELVT   P                   F+D   + I       
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP-------------------FADLSNMEI----GMK 222

Query: 377 TAANNLALE-------KILELALQCLAPRRQNRPSMRRCAEILWSVRK 417
            A   L           + +L   C+      RP       I+  + K
Sbjct: 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKF---DMIVPILEK 267

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  202 bits (517), Expect = 1e-62
 Identities = 81/289 (28%), Positives = 119/289 (41%), Gaps = 53/289 (18%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA--EFQSEIRTLAQVEHLNLVKFH 199
            IG GGFG VY+     G  VA+K A+    +  S      + E +  A ++H N++   
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G    E    +++E+   G L      L G  +     ++ A+ +A  + YLH     PI
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLN---RVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 260 IHRDIKSSNILLTE--------NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           IHRD+KSSNIL+ +        N   K+ DFG AR    T            G   ++ P
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT------KMSAAGAYAWMAP 183

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD 371
           E ++    ++ SDV+S+GVLL EL+TG  P                   F   D +++  
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP-------------------FRGIDGLAV-- 222

Query: 372 PRVENTAANNLALE-------KILELALQCLAPRRQNRPSMRRCAEILW 413
                 A N LAL           +L   C  P   +RPS      IL 
Sbjct: 223 --AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF---TNILD 266

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  203 bits (518), Expect = 1e-62
 Identities = 81/284 (28%), Positives = 132/284 (46%), Gaps = 29/284 (10%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+   G  VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 31  RIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                 ++ IV ++    +L  HL        ++   +DIA   A  + YLH      II
Sbjct: 89  ST--APQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKSII 142

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL- 319
           HRD+KS+NI L E+   K+ DFG A   +           Q+ G+  ++ PE ++     
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ--FEQLSGSILWMAPEVIRMQDSN 200

Query: 320 --TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
             + +SDVY+FG++L EL+TG+ P      +  R  +   + +         L P +   
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIEMVGR-------GSLSPDLSKV 250

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE 421
            +N    +++  L  +CL  +R  RPS      IL  + +  RE
Sbjct: 251 RSN--CPKRMKRLMAECLKKKRDERPSFP---RILAEIEELARE 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (502), Expect = 3e-60
 Identities = 74/294 (25%), Positives = 129/294 (43%), Gaps = 61/294 (20%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSG-----AEFQSEIRTLAQVEHLNL 195
           +IG+GGFG V+KGR ++D ++VAIK       +  +       EFQ E+  ++ + H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 196 VKFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           VK +G +        +V E+VP G L   L   + + +  + +L + +D+A  I Y+   
Sbjct: 86  VKLYGLMH---NPPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ 141

Query: 255 TDHPIIHRDIKSSNILLTE-----NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
              PI+HRD++S NI L          AKVADFG ++ +  +        + + G   ++
Sbjct: 142 N-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-------VSGLLGNFQWM 193

Query: 310 DPEYL----KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD 365
            PE +    ++Y  TEK+D YSF ++L  ++TG  P                   F +  
Sbjct: 194 APETIGAEEESY--TEKADTYSFAMILYTILTGEGP-------------------FDEYS 232

Query: 366 AISILDPRVENTAANNLALE-------KILELALQCLAPRRQNRPSMRRCAEIL 412
              I    +       L          ++  +   C +   + RP     + I+
Sbjct: 233 YGKI--KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF---SYIV 281

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  196 bits (501), Expect = 8e-60
 Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 37/296 (12%)

Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+G FG   K    E G ++ +K   +  +D+ +   F  E++ +  +EH N++KF G
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 201 YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            L  +D+R+  + EY+  GTLR  +     +    + R+  A D+A  + YLH      I
Sbjct: 75  VLY-KDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV----------STQVKGTAGYL 309
           IHRD+ S N L+ EN    VADFG ARL  D ++    +             V G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI 369
            PE +      EK DV+SFG++L E++                 +   ++ F D      
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--NVRGFLDR----- 242

Query: 370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAAS 425
                 N             + ++C     + RPS     ++   +      LA  
Sbjct: 243 --YCPPNC------PPSFFPITVRCCDLDPEKRPSF---VKLEHWLETLRMHLAGH 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  196 bits (501), Expect = 1e-59
 Identities = 67/311 (21%), Positives = 117/311 (37%), Gaps = 47/311 (15%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
            IG+G FG VY GR   G  VAI+       ++     F+ E+    Q  H N+V F G 
Sbjct: 40  LIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
                   +I       TL   +      +LD+     IA ++   + YLH      I+H
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADT-ESGATHVSTQVKGTAGYLDPEYLKTYQL- 319
           +D+KS N+   +N +  + DFG   ++                G   +L PE ++     
Sbjct: 154 KDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 320 --------TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD 371
                   ++ SDV++ G +  EL     P                   F    A +I+ 
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP-------------------FKTQPAEAIIW 253

Query: 372 PRVEN----TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDV 427
            ++        +     ++I ++ L C A  ++ RP+  +  ++L  + K  R L+    
Sbjct: 254 -QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS---- 308

Query: 428 LLQPSYSKRSN 438
              P +  +S 
Sbjct: 309 --HPGHFWKSA 317

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (496), Expect = 7e-59
 Identities = 68/323 (21%), Positives = 124/323 (38%), Gaps = 43/323 (13%)

Query: 123 VQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS 182
           ++    E      N      IG+G +G VYKG L D   VA+K     V+   +   F +
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK-----VFSFANRQNFIN 54

Query: 183 E--IRTLAQVEHLNLVKFHGY-----LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLA 235
           E  I  +  +EH N+ +F         +   E ++++EY PNG+L ++L     +  D  
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWV 111

Query: 236 GRLDIAIDVAHAITYLHMYTDH------PIIHRDIKSSNILLTENFRAKVADFGFARLAA 289
               +A  V   + YLH            I HRD+ S N+L+  +    ++DFG +    
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 290 DTESGAT----HVSTQVKGTAGYLDPEYLK-------TYQLTEKSDVYSFGVLLVELVTG 338
                      + +    GT  Y+ PE L+            ++ D+Y+ G++  E+   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 339 RRPIEPKRELKERITVKWAMKKFSDGDAISILD--------PRV-ENTAANNLALEKILE 389
              + P   + E   + +  +  +      +          P+  E    N+LA+  + E
Sbjct: 232 CTDLFPGESVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 390 LALQCLAPRRQNRPSMRRCAEIL 412
               C     + R + +   E +
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERM 313

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  188 bits (479), Expect = 1e-56
 Identities = 59/292 (20%), Positives = 117/292 (40%), Gaps = 30/292 (10%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE--IRTLAQVEHLNLVKFH 199
            +G+G +G V++G    G  VA+K     ++       +  E  +     + H N++ F 
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 200 GY----LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
                      +  +I  Y   G+L ++L   Q   LD    L I + +A  + +LH+  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 256 DH-----PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
                   I HRD+KS NIL+ +N +  +AD G A + + + +     +    GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 311 PE------YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK----ERITVKWAMKK 360
           PE       +  +   ++ D+++FG++L E+           + K    + +    + + 
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                 +    P + N   ++  L  + +L  +C       R +  R  + L
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  188 bits (479), Expect = 3e-56
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 30/292 (10%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE--IRTLAQVEHLNLVKFH 199
           +IG+G +G V+ G+   G  VA+K     V+     A +  E  I     + H N++ F 
Sbjct: 44  QIGKGRYGEVWMGKW-RGEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 200 GYLEFEDERI----VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
                         +I +Y  NG+L ++L   +   LD    L +A      + +LH   
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 256 DH-----PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
                   I HRD+KS NIL+ +N    +AD G A       +          GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 311 PE------YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK----ERITVKWAMKK 360
           PE          +Q    +D+YSFG++L E+           E +    + +    + + 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
             +   I  L P   N  +++  L ++ +L  +C A    +R +  R  + L
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  184 bits (469), Expect = 1e-54
 Identities = 61/303 (20%), Positives = 118/303 (38%), Gaps = 38/303 (12%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE--IRTLAQVEHLNLVKFH 199
            IG+G FG V++G+   G  VA+K     ++       +  E  I     + H N++ F 
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 200 GYLEFEDERI----VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
                ++       ++ +Y  +G+L ++L       + + G + +A+  A  + +LHM  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 256 DH-----PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
                   I HRD+KS NIL+ +N    +AD G A                  GT  Y+ 
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 311 PEYL------KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG 364
           PE L      K ++  +++D+Y+ G++  E+           + +    + +     SD 
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----LPYYDLVPSDP 275

Query: 365 DAISILD--------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR 416
               +          P + N   +  AL  + ++  +C       R +  R  + L  + 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

Query: 417 KDY 419
           +  
Sbjct: 336 QQE 338

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  166 bits (422), Expect = 2e-47
 Identities = 83/285 (29%), Positives = 125/285 (43%), Gaps = 34/285 (11%)

Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G FG V+ GRL      VA+K  ++++      A+F  E R L Q  H N+V+  G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIG 179

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               +    +++E V  G     L   +G  L +   L +  D A  + YL        I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGYLDPEYLKTYQ 318
           HRD+ + N L+TE    K++DFG +R  AD    A+    Q  VK TA    PE L   +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEALNYGR 291

Query: 319 LTEKSDVYSFGVLLVELVT-GRRPIE--PKRELKERITVKWAMKKFSDGDAISILDPRVE 375
            + +SDV+SFG+LL E  + G  P      ++ +E +     +             P  E
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-------------PCPE 338

Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
                    + +  L  QC A     RPS     + L S+RK +R
Sbjct: 339 LCP------DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  157 bits (399), Expect = 4e-45
 Identities = 67/269 (24%), Positives = 111/269 (41%), Gaps = 31/269 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G F TVYKG   E    VA    +     K     F+ E   L  ++H N+V+F+ 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 201 Y---LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                    + IV+V E + +GTL+ +L   +  ++ +         +   + +LH    
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLH-TRT 149

Query: 257 HPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            PIIHRD+K  NI +T      K+ D G A L   +       +  V GT  ++ PE  +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF------AKAVIGTPEFMAPEMYE 203

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
             +  E  DVY+FG+ ++E+ T   P        E        ++ + G   +    +V 
Sbjct: 204 E-KYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASF-DKVA 255

Query: 376 NTAANNLALEKILELALQCLAPRRQNRPS 404
                      I+E    C+   +  R S
Sbjct: 256 IPEVKE-----IIE---GCIRQNKDERYS 276

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  159 bits (403), Expect = 5e-45
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 10/202 (4%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G FG     +  EDG    IK    S        E + E+  LA ++H N+V++  
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 201 YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
             E E+  + IV +Y   G L + ++  +G +      LD  + +  A+ ++H   D  I
Sbjct: 91  SFE-ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKI 146

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           +HRDIKS NI LT++   ++ DFG AR+   T   A      + GT  YL PE  +    
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR---ACI-GTPYYLSPEICENKPY 202

Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
             KSD+++ G +L EL T +  
Sbjct: 203 NNKSDIWALGCVLYELCTLKHA 224

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  155 bits (395), Expect = 1e-44
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 13/220 (5%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            IG G +G   K R   DG I+  K        +       SE+  L +++H N+V+++ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 201 -YLEFEDERIVIV-EYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLH--MY 254
             ++  +  + IV EY   G L   +         LD    L +   +  A+   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K +N+ L      K+ DFG AR+     S A    T V GT  Y+ PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK---TFV-GTPYYMSPEQM 188

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
                 EKSD++S G LL EL     P      +EL  +I
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  154 bits (390), Expect = 2e-43
 Identities = 82/302 (27%), Positives = 126/302 (41%), Gaps = 39/302 (12%)

Query: 142 KIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
            +G+G FG V     +      G +VA+K  K     +H  + ++ EI  L  + H +++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR-SGWKQEIDILRTLYHEHII 96

Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  E        +++EYVP G+LR   D L  + + LA  L  A  +   + YLH  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLR---DYLPRHSIGLAQLLLFAQQICEGMAYLH-- 151

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLD 310
                IHRD+ + N+LL  +   K+ DFG A+   +       V       V   A    
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVFWYA---- 205

Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVK-WAMKKFSDGDAIS 368
           PE LK Y+    SDV+SFGV L EL+T       P  +  E I +    M   +      
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM---TVLRLTE 262

Query: 369 ILD-----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA 423
           +L+     PR +          ++  L   C       RP+      IL +V + Y+  A
Sbjct: 263 LLERGERLPRPDKCP------AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316

Query: 424 AS 425
            S
Sbjct: 317 PS 318

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (386), Expect = 3e-43
 Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 35/240 (14%)

Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV 190
           R   +F     IG GGFG V+K +   DG    IKR K +        + + E++ LA++
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKL 61

Query: 191 EHLNLVKFHGYLEFEDE-----------------RIVIV-EYVPNGTLREHLDCLQGNIL 232
           +H+N+V ++G   ++                    + I  E+   GTL + ++  +G  L
Sbjct: 62  DHVNIVHYNGC--WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119

Query: 233 DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE 292
           D    L++   +   + Y+H      +I+RD+K SNI L +  + K+ DFG      +  
Sbjct: 120 DKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176

Query: 293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI 352
                      GT  Y+ PE + +    ++ D+Y+ G++L EL+          +    +
Sbjct: 177 KRTRSK-----GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  152 bits (386), Expect = 4e-43
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 12/203 (5%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           K+G GG  TVY          VAIK         + +   F+ E+   +Q+ H N+V   
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 200 GYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              E ED+   +V EY+   TL E+++      L +   ++    +   I + H   D  
Sbjct: 78  DVDE-EDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           I+HRDIK  NIL+  N   K+ DFG A+  A +E+  T  +  V GT  Y  PE  K   
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNH-VLGTVQYFSPEQAKGEA 188

Query: 319 LTEKSDVYSFGVLLVELVTGRRP 341
             E +D+YS G++L E++ G  P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  152 bits (386), Expect = 5e-43
 Identities = 67/276 (24%), Positives = 112/276 (40%), Gaps = 30/276 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAK-KSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           KIG+G F  VY+   L DG  VA+K+ +   + D  + A+   EI  L Q+ H N++K++
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 200 GYLEFEDERIVIV-EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                ED  + IV E    G L   +     Q  ++         + +  A+ ++H    
Sbjct: 99  ASFI-EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             ++HRDIK +N+ +T     K+ D G  R  +   + A    + V GT  Y+ PE +  
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLV-GTPYYMSPERIHE 210

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
                KSD++S G LL E+   + P        +++ +    KK    D   +       
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFY-----GDKMNLYSLCKKIEQCDYPPLPSDHYSE 265

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                        L   C+ P  + RP       + 
Sbjct: 266 ELRQ---------LVNMCINPDPEKRPD---VTYVY 289

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  152 bits (385), Expect = 1e-42
 Identities = 59/292 (20%), Positives = 105/292 (35%), Gaps = 39/292 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G+GGF  V     L DG   A+KR      ++    E Q E        H N+++   
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVA 93

Query: 201 YLEFEDE---RIVIV-EYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMY 254
           Y   E        ++  +   GTL   ++ L+  GN L     L + + +   +  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-----QVKGTAGYL 309
                 HRD+K +NILL +  +  + D G    A     G+    T       + T  Y 
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 310 DPEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS--DG 364
            PE         + E++DV+S G +L  ++ G  P +   +  + + +     + S    
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQNQLSIPQS 269

Query: 365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR 416
              S                  + +L    +      RP +      L +++
Sbjct: 270 PRHS----------------SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  151 bits (384), Expect = 1e-42
 Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 12/206 (5%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            +G GG   V+  R L D   VA+K  +     D      F+ E +  A + H  +V  +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 200 GYLEFEDERIVIV----EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
              E E     +     EYV   TLR+ +       +     +++  D   A+ + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSH--- 133

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            + IIHRD+K +NI+++     KV DFG AR  AD+ +  T  +  V GTA YL PE  +
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQAR 192

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP 341
              +  +SDVYS G +L E++TG  P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  150 bits (381), Expect = 2e-42
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 37/289 (12%)

Query: 142 KIGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
            +G+G FG V   R +      G  VA+K  K      H  A+ + EI  L  + H N+V
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIV 86

Query: 197 KFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G    +  +   +I+E++P+G+L+E+L   +   ++L  +L  A+ +   + YL   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLG-- 143

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLD 310
                +HRD+ + N+L+    + K+ DFG  +     +   T V       V   A    
Sbjct: 144 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT-VKDDRDSPVFWYA---- 197

Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVK-WAMKKFSDGDAIS 368
           PE L   +    SDV+SFGV L EL+T       P     + I      M   +    ++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM---TVTRLVN 254

Query: 369 ILD-----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            L      P   N        +++ +L  +C   +  NR S +   E  
Sbjct: 255 TLKEGKRLPCPPNCP------DEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  154 bits (391), Expect = 2e-42
 Identities = 83/275 (30%), Positives = 123/275 (44%), Gaps = 34/275 (12%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K           F  E + + ++ H  LV+ +  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 247

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTE-SGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E +        +K TA    PE     + T
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 359

Query: 321 EKSDVYSFGVLLVELVT-GRRPIE--PKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
            KSDV+SFG+LL EL T GR P      RE+ +++   + M             P     
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------PCPPEC 406

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                  E + +L  QC     + RP+       L
Sbjct: 407 P------ESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  149 bits (379), Expect = 3e-42
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
            IG+G FG V  G    G  VA+K  K     +     F +E   + Q+ H NLV+  G 
Sbjct: 28  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 82

Query: 202 LEFEDERI-VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +  E   + ++ EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+ + N+L++E+  AKV+DFG  + A+ T+         VK TA    PE L+  + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK---LPVKWTA----PEALREKKFS 192

Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+ + GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  153 bits (387), Expect = 3e-41
 Identities = 83/275 (30%), Positives = 123/275 (44%), Gaps = 34/275 (12%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K           F  E + + ++ H  LV+ +  
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 330

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E+   ++ EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTE-SGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+ EN   KVADFG ARL  D E +        +K TA    PE     + T
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 442

Query: 321 EKSDVYSFGVLLVELVT-GRRPIE--PKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
            KSDV+SFG+LL EL T GR P      RE+ +++   + M             P     
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------PCPPEC 489

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                  E + +L  QC     + RP+       L
Sbjct: 490 P------ESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (383), Expect = 3e-41
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 13/202 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+G G FG V+       T VA+K  K           F +E   +  ++H  LVK H  
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKLHAV 251

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I E++  G+L + L   +G+   L   +D +  +A  + ++        IH
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-QVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL++ +   K+ADFG AR+  D E  A   +   +K TA    PE +     T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFT 363

Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL+E+VT GR P
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP 385

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  146 bits (372), Expect = 3e-41
 Identities = 69/202 (34%), Positives = 108/202 (53%), Gaps = 13/202 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+          F +E   + Q++H  LV+ +  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAV 76

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-QVKGTAGYLDPEYLKTYQLT 320
           RD++++NIL+++    K+ADFG ARL  D E  A   +   +K TA    PE +     T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFT 188

Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+VT GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  152 bits (385), Expect = 3e-41
 Identities = 78/276 (28%), Positives = 120/276 (43%), Gaps = 34/276 (12%)

Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST-QVKGTAGYLDPEYLKTYQL 319
           HR++ + N L+ EN   KVADFG +RL       A   +   +K TA    PE L   + 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 396

Query: 320 TEKSDVYSFGVLLVELVT-GRRPIE--PKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
           + KSDV++FGVLL E+ T G  P       ++ E +   + M              R E 
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-------------ERPEG 443

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                   EK+ EL   C      +RPS     +  
Sbjct: 444 ------CPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  148 bits (375), Expect = 4e-41
 Identities = 80/317 (25%), Positives = 131/317 (41%), Gaps = 38/317 (11%)

Query: 142 KIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R        G +VA+K+ + S  D+    +FQ EI+ L  +    +V
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIV 87

Query: 197 KFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  Y        +++EY+P+G LR+ L   +   LD +  L  +  +   + YL   
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG-- 144

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAGYL 309
                +HRD+ + NIL+      K+ADFG A+L    +    +V  +     +   A   
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--YYVVREPGQSPIFWYA--- 198

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS 368
            PE L     + +SDV+SFGV+L EL T   +   P  E    +  +  +   +    + 
Sbjct: 199 -PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP--ALSRLLE 255

Query: 369 ILD-----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA 423
           +L+     P             ++ EL   C AP  Q+RPS       L  +    R   
Sbjct: 256 LLEEGQRLPAPPACP------AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309

Query: 424 ASDVLLQPSYSKRSNST 440
                  P     S S 
Sbjct: 310 THAFTAHPEGKHHSLSF 326

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  149 bits (377), Expect = 4e-41
 Identities = 93/422 (22%), Positives = 154/422 (36%), Gaps = 73/422 (17%)

Query: 28  SPGSHYSEASTVRNRKTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVS 87
            P  H+      R    +   L                 P  +   D + S E   + + 
Sbjct: 5   DPMGHHHHHHGRRRASVAAGIL----------------VPRGSPGLDGICSIEELSTSLY 48

Query: 88  DASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGG 147
             + S     +  ++      + N       Q   +  +   ++           IG+G 
Sbjct: 49  KKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE-------VIGRGH 101

Query: 148 FGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY-L 202
           FG VY G L D        A+K   +   D    ++F +E   +    H N++   G  L
Sbjct: 102 FGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160

Query: 203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHR 262
             E   +V++ Y+ +G LR  +     N   +   +   + VA  + +L        +HR
Sbjct: 161 RSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL---ASKKFVHR 216

Query: 263 DIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLDPEYLKTYQ 318
           D+ + N +L E F  KVADFG AR   D E  + H  T     VK  A     E L+T +
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LESLQTQK 272

Query: 319 LTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD-----P 372
            T KSDV+SFGVLL EL+T G  P                +   +  D    L       
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPY-------------PDV---NTFDITVYLLQGRRLL 316

Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVL-LQP 431
           + E         + + E+ L+C  P+ + RPS    +E++  +   +        + +  
Sbjct: 317 QPEYC------PDPLYEVMLKCWHPKAEMRPSF---SELVSRISAIFSTFIGEHYVHVNA 367

Query: 432 SY 433
           +Y
Sbjct: 368 TY 369

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  150 bits (381), Expect = 5e-41
 Identities = 69/202 (34%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
            IG+G FG V  G    G  VA+K  K     +     F +E   + Q+ H NLV+  G 
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 254

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +  E   + IV EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 311

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+ + N+L++E+  AKV+DFG  + A+ T+         VK TA    PE L+  + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK---LPVKWTA----PEALREKKFS 364

Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFG+LL E+ + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  147 bits (372), Expect = 5e-41
 Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 142 KIGQGGFGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            IG+G FG VY G   D        AIK   +   +      F  E   +  + H N++ 
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 198 FHGYLEFEDERI-VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             G +   +    V++ Y+ +G L + +   Q N   +   +   + VA  + YL    +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYL---AE 142

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLDPE 312
              +HRD+ + N +L E+F  KVADFG AR   D E  +          VK TA     E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----LE 198

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            L+TY+ T KSDV+SFGVLL EL+T G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  147 bits (372), Expect = 6e-41
 Identities = 60/273 (21%), Positives = 103/273 (37%), Gaps = 26/273 (9%)

Query: 76  VNSNEFKPSPVSDASRSR----ASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIY 131
           ++ +    S V   + +         + R  S     S    + G D S       +   
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS-- 58

Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV 190
                F    ++G G +G V+K R  EDG + A+KR+          A   +E+ +  +V
Sbjct: 59  -----FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 191 -EHLNLVKFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAI 248
            +H   V+     E E   + +  E     +L++H +   G  L  A       D   A+
Sbjct: 114 GQHPCCVRLEQAWE-EGGILYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTLLAL 170

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            +LH      ++H D+K +NI L    R K+ DFG         +G         G   Y
Sbjct: 171 AHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRY 222

Query: 309 LDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           + PE L+       +DV+S G+ ++E+      
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVACNMEL 254

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  147 bits (372), Expect = 6e-41
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 16/205 (7%)

Query: 142 KIGQGGFGTVYKGRLED---GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            +G+GG G VY+    D     IVA+K   ++   D       Q E RT  +++  ++V 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 198 FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
            H + E  D ++ +    +    L   L   +   L     + I   +  A+   H    
Sbjct: 99  IHDFGE-IDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAH---A 152

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
               HRD+K  NIL++ +  A + DFG A   A T+   T +   V GT  Y+ PE    
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTV-GTLYYMAPERFSE 209

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
              T ++D+Y+   +L E +TG  P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  144 bits (366), Expect = 2e-40
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 21/206 (10%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+ +    VA+K  K+    +    EF  E +T+ ++ H  LVKF+G 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              E    ++ EY+ NG L  +L    G  L+ +  L++  DV   + +L     H  IH
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAGYLDPEYLKT 316
           RD+ + N L+  +   KV+DFG  R   D +    +VS+      VK +A    PE    
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSA----PEVFHY 179

Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRP 341
           ++ + KSDV++FG+L+ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  145 bits (369), Expect = 2e-40
 Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 24/248 (9%)

Query: 108 VSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRA 167
           +  ++    G   G   +  + +    R +S   +IG GG   V++   E   I AIK  
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60

Query: 168 KKSVYDKHSGAEFQSEIRTLAQVEHLNL--VKFHGYLEFEDERIVIV-EYVPNGTLREHL 224
                D  +   +++EI  L +++  +   ++ + Y    D+ I +V E   N  L   L
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVMECG-NIDLNSWL 118

Query: 225 DCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
              +   +D   R     ++  A+  +H    H I+H D+K +N L+ +    K+ DFG 
Sbjct: 119 K--KKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGI 172

Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYLK-----------TYQLTEKSDVYSFGVLLV 333
           A       +    V     GT  Y+ PE +K             +++ KSDV+S G +L 
Sbjct: 173 ANQMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230

Query: 334 ELVTGRRP 341
            +  G+ P
Sbjct: 231 YMTYGKTP 238

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  145 bits (367), Expect = 2e-40
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 13/203 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +  ++ VA+K  K+   +     EF  E   + +++H NLV+  G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 76

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLKTYQL 319
           HRD+ + N L+ EN   KVADFG +RL       A   +   +K TA    PE L   + 
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 189

Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSDV++FGVLL E+ T G  P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  144 bits (365), Expect = 3e-40
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++    +    +F  E   + ++ H  LV+ +G 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   +G        L + +DV   + YL    +  +IH
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLKTYQLT 320
           RD+ + N L+ EN   KV+DFG  R   D +  ++  +   VK  +    PE     + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFSRYS 183

Query: 321 EKSDVYSFGVLLVELVT-GRRP 341
            KSDV+SFGVL+ E+ + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (367), Expect = 3e-40
 Identities = 71/210 (33%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 142 KIGQGGFGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            IG+G FG VY G L D        A+K   +   D    ++F +E   +    H N++ 
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 198 FHGY-LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             G  L  E   +V++ Y+ +G LR  +     N   +   +   + VA  + YL     
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYL---AS 146

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLDPE 312
              +HRD+ + N +L E F  KVADFG AR   D E  + H  T     VK  A     E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA----LE 202

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            L+T + T KSDV+SFGVLL EL+T G  P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  144 bits (366), Expect = 3e-40
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 39/298 (13%)

Query: 142 KIGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R +      G +VA+K+ + S  +     +F+ EI  L  ++H N+V
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIV 74

Query: 197 KFHG--YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G  Y        +I+EY+P G+LR++L   +   +D    L     +   + YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLG-- 131

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLD 310
                IHRD+ + NIL+    R K+ DFG  ++    +     V       +   A    
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK-VKEPGESPIFWYA---- 185

Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVK--WAMKKFSDGDAI 367
           PE L   + +  SDV+SFGV+L EL T   +   P  E    I       M        I
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM---IVFHLI 242

Query: 368 SILD-----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
            +L      PR +         ++I  +  +C       RPS R  A  +  +R +  
Sbjct: 243 ELLKNNGRLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  144 bits (365), Expect = 3e-40
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V  G+      VAIK  K+    +    EF  E + +  + H  LV+ +G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    +I EY+ NG L  +L  ++         L++  DV  A+ YL        +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTAGYLDPEYLKTYQL 319
           RD+ + N L+ +    KV+DFG +R   D E  +  V ++  V+ +     PE L   + 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSP----PEVLMYSKF 198

Query: 320 TEKSDVYSFGVLLVELVT-GRRP 341
           + KSD+++FGVL+ E+ + G+ P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  145 bits (368), Expect = 5e-40
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 24/214 (11%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL--VKFH 199
           +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +   ++ +
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
            Y   +    +++E   N  L   L   +   +D   R     ++  A+  +H    H I
Sbjct: 76  DYEITDQYIYMVMECG-NIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 260 IHRDIKSSNILLTENFRAKVADFGFAR-LAADTESGATHVSTQVKGTAGYLDPEYLK--- 315
           +H D+K +N L+ +    K+ DFG A  +  DT S    V     GT  Y+ PE +K   
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS---VVKDSQVGTVNYMPPEAIKDMS 185

Query: 316 --------TYQLTEKSDVYSFGVLLVELVTGRRP 341
                     +++ KSDV+S G +L  +  G+ P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  144 bits (366), Expect = 7e-40
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)

Query: 142 KIGQGGFGTVYKGRLEDG-----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
            +G G FGTVYKG            VAIK  +++     +  E   E   +A V++ ++ 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVC 80

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI--LDLAGRLDIAIDVAHAITYLHMY 254
           +  G         +I + +P G L +++   + NI    L   L+  + +A  + YL   
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL---LNWCVQIAKGMNYLE-- 134

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPE 312
            D  ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A     E
Sbjct: 135 -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----LE 189

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +     T +SDV+S+GV + EL+T G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  144 bits (366), Expect = 9e-40
 Identities = 55/269 (20%), Positives = 102/269 (37%), Gaps = 29/269 (10%)

Query: 83  PSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFK 142
            S  + +  S A T    S+             G   +  ++    E        +   +
Sbjct: 6   SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR 65

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +G+G FG V++ +  + G   A+K+ +  V+          E+   A +    +V  +G 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGA 118

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD---IAI---DVAHAITYLHMY 254
              E   + I  E +  G+L        G ++   G L               + YLH  
Sbjct: 119 -VREGPWVNIFMELLEGGSL--------GQLIKQMGCLPEDRALYYLGQALEGLEYLH-- 167

Query: 255 TDHPIIHRDIKSSNILLTEN-FRAKVADFGFA-RLAADTESGATHVSTQVKGTAGYLDPE 312
               I+H D+K+ N+LL+ +  RA + DFG A  L  D    +      + GT  ++ PE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +       K D++S   +++ ++ G  P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (362), Expect = 1e-39
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 142 KIGQGGFGTVYKGRL--EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG    +     VA+K  K    D     E  +E   + Q+++  +V+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 199 HGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
            G  E   E  ++V E    G L ++L   Q   +     +++   V+  + YL    + 
Sbjct: 84  IGICE--AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAGYLDPE 312
             +HRD+ + N+LL     AK++DFG ++     E+     +       VK  A    PE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYA----PE 190

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +  Y+ + KSDV+SFGVL+ E  + G++P
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (363), Expect = 2e-39
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 33/295 (11%)

Query: 142 KIGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G+G FG+V   R +      G +VA+K+ + S  +     +F+ EI  L  ++H N+V
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIV 105

Query: 197 KFHGYLEFEDER--IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           K+ G       R   +I+EY+P G+LR++L   +   +D    L     +   + YL   
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLG-- 162

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLD 310
                IHRD+ + NIL+    R K+ DFG  ++    +     V       +   A    
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK-VKEPGESPIFWYA---- 216

Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL 370
           PE L   + +  SDV+SFGV+L EL T     +       R+       +      I +L
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 371 D-----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
                 PR +         ++I  +  +C       RPS R  A  +  +R    
Sbjct: 277 KNNGRLPRPDGCP------DEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  142 bits (360), Expect = 2e-39
 Identities = 60/295 (20%), Positives = 113/295 (38%), Gaps = 52/295 (17%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+GGFG V++ +   D    AIKR +    +     +   E++ LA++EH  +V++  
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPGIVRYFN 70

Query: 201 YLEFEDERIV-------------IV-EYVPNGTLREHLDCLQGN-ILDLAGRLDIAIDVA 245
              + ++                I  +      L++ ++        + +  L I + +A
Sbjct: 71  A--WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128

Query: 246 HAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS------ 299
            A+ +LH      ++HRD+K SNI  T +   KV DFG        E   T ++      
Sbjct: 129 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 300 --TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWA 357
             T   GT  Y+ PE +     + K D++S G++L EL+    P   + E          
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR------T 236

Query: 358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +    +     +   +             +++     L+P    RP       I+
Sbjct: 237 LTDVRNLKFPPLFTQKYPC-------EYVMVQ---DMLSPSPMERPE---AINII 278

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  144 bits (366), Expect = 2e-39
 Identities = 59/278 (21%), Positives = 109/278 (39%), Gaps = 30/278 (10%)

Query: 77  NSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRN 136
           +S+   P        + A  ER+   S  L   +++  +    +         IY   + 
Sbjct: 6   HSSGLVPRGSGMKETAAAKFERQHMDSPDL--GTDDDDKASSSANECISVKGRIYSILK- 62

Query: 137 FSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL- 195
                +IG GG   V++   E   I AIK       D  +   +++EI  L +++  +  
Sbjct: 63  -----QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117

Query: 196 -VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            ++ + Y   +    +++E   N  L   L   +   +D   R     ++  A+  +H  
Sbjct: 118 IIRLYDYEITDQYIYMVMECG-NIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIH-- 172

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H I+H D+K +N L+ +    K+ DFG A       +    V     G   Y+ PE +
Sbjct: 173 -QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS--VVKDSQVGAVNYMPPEAI 228

Query: 315 K-----------TYQLTEKSDVYSFGVLLVELVTGRRP 341
           K             +++ KSDV+S G +L  +  G+ P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  142 bits (359), Expect = 5e-39
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 24/217 (11%)

Query: 142 KIGQGGFGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            +G+G FG+V + +L+        VA+K  K  +       EF  E   + + +H ++ K
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 198 FHG------YLEFEDERIVIVEYVPNGTLREHL----DCLQGNILDLAGRLDIAIDVAHA 247
             G              +VI+ ++ +G L   L           L L   +   +D+A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGT 305
           + YL   +    IHRD+ + N +L E+    VADFG +R     +      +++  VK  
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           A     E L     T  SDV++FGV + E++T G+ P
Sbjct: 207 A----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  141 bits (358), Expect = 6e-39
 Identities = 62/246 (25%), Positives = 103/246 (41%), Gaps = 32/246 (13%)

Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV 190
           R   +F     +GQG FG V K R   D    AIK+ + +   +   +   SE+  LA +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASL 59

Query: 191 EHLNLVKFHG-YLEFEDER-----------IVIV-EYVPNGTLREHLDCLQGNILDLAGR 237
            H  +V+++  +LE  +             + I  EY  NGTL + +   +         
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEY 118

Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
             +   +  A++Y+H      IIHRD+K  NI + E+   K+ DFG A+    +      
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 298 VS----------TQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKR 346
            S          T   GTA Y+  E L  T    EK D+YS G++  E++        + 
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235

Query: 347 ELKERI 352
            + +++
Sbjct: 236 NILKKL 241

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  141 bits (358), Expect = 6e-39
 Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 23/216 (10%)

Query: 142 KIGQGGFGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            +G+G FG+V +G L+        VA+K  K     +    EF SE   +    H N+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 198 FHG-----YLEFEDERIVIVEYVPNGTLREHL----DCLQGNILDLAGRLDIAIDVAHAI 248
             G       +   + +VI+ ++  G L  +L           + L   L   +D+A  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ--VKGTA 306
            YL   ++   +HRD+ + N +L ++    VADFG ++     +        +  VK  A
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
                E L     T KSDV++FGV + E+ T G  P
Sbjct: 218 ----IESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (359), Expect = 7e-39
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 142 KIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            IG G  G V  GRL    +    VAIK  K   Y +    +F SE   + Q +H N+++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 198 FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             G +       +IV EY+ NG+L   L    G    +   + +   V   + YL   +D
Sbjct: 115 LEGVV-TRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLDPE 312
              +HRD+ + N+L+  N   KV+DFG +R+  D +  A + +T     ++ TA    PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTA----PE 224

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +     +  SDV+SFGV++ E++  G RP
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  140 bits (356), Expect = 8e-39
 Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 142 KIGQGGFGTVYKGRL--EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FG+V +G        I VAIK  K+   +K    E   E + + Q+++  +V+ 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 199 HGYLEFEDERIVIV-EYVPNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYT 255
            G  +   E +++V E    G L      L G    + ++   ++   V+  + YL    
Sbjct: 76  IGVCQ--AEALMLVMEMAGGGPL---HKFLVGKREEIPVSNVAELLHQVSMGMKYL---E 127

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAGYLD 310
           +   +HRD+ + N+LL     AK++DFG ++     +S   + +       +K  A    
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYA---- 181

Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           PE +   + + +SDV+S+GV + E ++ G++P
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  141 bits (357), Expect = 1e-38
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 18/208 (8%)

Query: 142 KIGQGGFGTVYKGRLEDG-----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
            +G G FGTV+KG            V IK  +     + S       +  +  ++H ++V
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           +  G         ++ +Y+P G+L +H+   +G  L     L+  + +A  + YL    +
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLE---E 133

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPEYL 314
           H ++HR++ + N+LL    + +VADFG A L    D +   +   T +K  A     E +
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA----LESI 189

Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRP 341
              + T +SDV+S+GV + EL+T G  P
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  140 bits (356), Expect = 2e-38
 Identities = 69/309 (22%), Positives = 124/309 (40%), Gaps = 48/309 (15%)

Query: 142 KIGQGGFGTVYKGRLEDG-----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
            +G G FGTVYKG            VAIK  +++     +  E   E   +A V++ ++ 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVC 80

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           +  G         +I + +P G L +++   + N +     L+  + +A  + YL    D
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLE---D 135

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARL--AADTESGATHVSTQVKGTAGYLDPEYL 314
             ++HRD+ + N+L+      K+ DFG A+L  A + E  A      +K  A     E +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----LESI 191

Query: 315 KTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD-- 371
                T +SDV+S+GV + EL+T G +P                +      +  SIL+  
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPY-------------DGI---PASEISSILEKG 235

Query: 372 ---PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD---YRELAAS 425
              P+             +  + ++C      +RP  R        + +D   Y  +   
Sbjct: 236 ERLPQPPI------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 289

Query: 426 DVLLQPSYS 434
           + +  PS +
Sbjct: 290 ERMHLPSPT 298

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  139 bits (352), Expect = 2e-38
 Identities = 67/298 (22%), Positives = 122/298 (40%), Gaps = 53/298 (17%)

Query: 142 KIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            +G+G FG VY+G       +   VA+K  KK      +  +F SE   +  ++H ++VK
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 198 FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             G    E+E   I+ E  P G L  +L+  + + L +   +  ++ +  A+ YL     
Sbjct: 78  LIGI--IEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLE---S 131

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAGYLDP 311
              +HRDI   NIL+      K+ DFG +R   D +    +         +K  +    P
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMS----P 183

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISIL 370
           E +   + T  SDV+ F V + E+++ G++P              + +    + D I +L
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPF-------------FWL---ENKDVIGVL 227

Query: 371 D-----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA 423
           +     P+ +           +  L  +C      +RP        L  V +  +++A
Sbjct: 228 EKGDRLPKPDLCP------PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (358), Expect = 3e-38
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 142 KIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            +G G FG V  GRL    +    VAIK  K   Y +    +F  E   + Q +H N+++
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G +      +++ EY+ NG+L   L         +   + +   +A  + YL   +D 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SDM 166

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ----VKGTAGYLDPEY 313
             +HRD+ + NIL+  N   KV+DFG  R+  D    A + +      ++ T+    PE 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE-AAYTTRGGKIPIRWTS----PEA 221

Query: 314 LKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +   + T  SDV+S+G++L E+++ G RP
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  145 bits (367), Expect = 6e-38
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 25/207 (12%)

Query: 142 KIGQGGFGTVYKGR--LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            I  GG G +Y       +G  V +K    S  D  + A   +E + LA+V H ++V+  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 200 GYLEFEDERIV----IV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
            ++E  D        IV EYV   +L+       G  L +A  +   +++  A++YLH  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               +++ D+K  NI+LTE  + K+ D G          G       + GT G+  PE +
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY------LYGTPGFQAPEIV 249

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           +T   T  +D+Y+ G  L  L      
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPT 275

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  139 bits (353), Expect = 6e-38
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 142 KIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
            IG G FG VYKG L     +    VAIK  K    +K    +F  E   + Q  H N++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNII 109

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           +  G +      ++I EY+ NG L + L    G    +   + +   +A  + YL    +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL---AN 165

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ---VKGTAGYLDPEY 313
              +HRD+ + NIL+  N   KV+DFG +R+  D        S     ++ TA    PE 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEA 221

Query: 314 LKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           +   + T  SDV+SFG+++ E++T G RP
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  137 bits (346), Expect = 2e-37
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 37/225 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
           KIG G FG+V+K     DG I AIKR+KK +           E+   A + +H ++V++ 
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 200 GYLEFEDERIVIV-EYVPNGTLREHLD--CLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                ED+ ++I  EY   G+L + +       +    A   D+ + V   + Y+H    
Sbjct: 78  SA-WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133

Query: 257 HPIIHRDIKSSNILLTEN-------------------FRAKVADFGFARLAADTESGATH 297
             ++H DIK SNI ++                        K+ D G     +  +     
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---- 189

Query: 298 VSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRP 341
                +G + +L  E L+  Y    K+D+++  + +V        
Sbjct: 190 ----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  136 bits (345), Expect = 2e-37
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 142 KIGQGGFGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVK 80

Query: 198 FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             G     +  + I+ E    G LR  L   + + LDLA  +  A  ++ A+ YL     
Sbjct: 81  LIGV--ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL---ES 134

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-VKGTAGYLDPEYLK 315
              +HRDI + N+L++ N   K+ DFG +R   D+           +K  A    PE + 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA----PESIN 190

Query: 316 TYQLTEKSDVYSFGVLLVELVT-GRRP 341
             + T  SDV+ FGV + E++  G +P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP 217

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (346), Expect = 3e-37
 Identities = 63/246 (25%), Positives = 97/246 (39%), Gaps = 27/246 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +GQG    V++GR  + G + AIK      + +        E   L ++ H N+VK   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKKLNHKNIVKLFA 74

Query: 201 YLEFEDER-IVIV-EYVPNGTLREHLDCLQGNILDLAGR--LDIAIDVAHAITYLHMYTD 256
             E    R  V++ E+ P G+L   L+    N   L     L +  DV   + +L    +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130

Query: 257 HPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
           + I+HR+IK  NI+           K+ DFG AR   D E   +     + GT  YL P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-----LYGTEEYLHPD 185

Query: 313 YLKTYQL--------TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG 364
             +   L            D++S GV      TG  P  P    +    V + +      
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 365 DAISIL 370
            AIS +
Sbjct: 246 GAISGV 251

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  137 bits (346), Expect = 4e-37
 Identities = 71/224 (31%), Positives = 98/224 (43%), Gaps = 38/224 (16%)

Query: 142 KIGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVK 197
            IG+G FG V K R++        AIKR K+         +F  E+  L ++  H N++ 
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIIN 90

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLDIAID 243
             G  E      + +EY P+G L + L                   + L     L  A D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           VA  + YL   +    IHRD+ + NIL+ EN+ AK+ADFG +R     E         VK
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQE-------VYVK 197

Query: 304 GTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            T G L       E L     T  SDV+S+GVLL E+V+ G  P
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (342), Expect = 9e-37
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 24/212 (11%)

Query: 142 KIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGA-EFQSEIRTLAQVEHLNLV 196
           K+G G FG V +G           VA+K  K  V  +     +F  E+  +  ++H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 197 KFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
           + +G +      + +V E  P G+L + L   QG+   L      A+ VA  + YL    
Sbjct: 85  RLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLE--- 138

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAGYLD 310
               IHRD+ + N+LL      K+ DFG  R     +        +         A    
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV--MQEHRKVPFAWCA---- 192

Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
           PE LKT   +  SD + FGV L E+ T G+ P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  135 bits (343), Expect = 1e-36
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G        E  T VAIK   ++   +    EF +E   + +    ++
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKEFNCHHV 90

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL--------DCLQGNILDLAGRLDIAIDVAHA 247
           V+  G +      +VI+E +  G L+ +L        +        L+  + +A ++A  
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+          KG  G
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-------YYRKGGKG 200

Query: 308 YL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            L      PE LK    T  SDV+SFGV+L E+ T   +P
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  135 bits (343), Expect = 1e-36
 Identities = 64/242 (26%), Positives = 91/242 (37%), Gaps = 41/242 (16%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLN 194
            +G G FG V +         +    VA+K  K S +         SE++ L+ +  H+N
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHMN 88

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHL----------------DCLQGNILDLAGRL 238
           +V   G        +VI EY   G L   L                       LDL   L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
             +  VA  + +L        IHRD+ + NILLT     K+ DFG AR           V
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIK--NDSNYVV 203

Query: 299 STQ----VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKRELKE 350
                  VK  A    PE +     T +SDV+S+G+ L EL + G  P   +    +  +
Sbjct: 204 KGNARLPVKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 351 RI 352
            I
Sbjct: 260 MI 261

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  137 bits (347), Expect = 1e-36
 Identities = 63/246 (25%), Positives = 96/246 (39%), Gaps = 27/246 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +GQG    V++GR  + G + AIK      + +        E   L ++ H N+VK   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKKLNHKNIVKLFA 74

Query: 201 YLEFEDER-IVIV-EYVPNGTLREHLDCLQGNILDLAGR--LDIAIDVAHAITYLHMYTD 256
             E    R  V++ E+ P G+L   L+    N   L     L +  DV   + +L    +
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130

Query: 257 HPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
           + I+HR+IK  NI+           K+ DFG AR   D E   +       GT  YL P+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-----GTEEYLHPD 185

Query: 313 YLKTYQL--------TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG 364
             +   L            D++S GV      TG  P  P    +    V + +      
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 365 DAISIL 370
            AIS +
Sbjct: 246 GAISGV 251

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (341), Expect = 1e-36
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 32/244 (13%)

Query: 110 SNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAK 168
           S  ST  GD   +    +E  Y    N      +G+G +G VY GR L +   +AIK   
Sbjct: 1   SMRSTEEGDCESD---LLEYDYEYDENGDRVV-LGKGTYGIVYAGRDLSNQVRIAIKEIP 56

Query: 169 KSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ 228
           +   D         EI     ++H N+V++ G         + +E VP G+L      L+
Sbjct: 57  ER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS---ALLR 111

Query: 229 GNILDLAGRLDIAIDVAHAIT--------YLHMYTDHPIIHRDIKSSNILL-TENFRAKV 279
                  G L          T        YLH   D+ I+HRDIK  N+L+ T +   K+
Sbjct: 112 SK----WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKI 164

Query: 280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL--TEKSDVYSFGVLLVELVT 337
           +DFG ++  A         +    GT  Y+ PE +        + +D++S G  ++E+ T
Sbjct: 165 SDFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT 220

Query: 338 GRRP 341
           G+ P
Sbjct: 221 GKPP 224

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  134 bits (340), Expect = 1e-36
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 37/226 (16%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++G+  FG VYKG L      E    VAIK  K          EF+ E    A+++H N+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR-EEFRHEAMLRARLQHPNV 74

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLDIA 241
           V   G +  +    +I  Y  +G L E L              D    + L+    + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
             +A  + YL   + H ++H+D+ + N+L+ +    K++D G  R   +  +   +    
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAADYYKLLG 188

Query: 302 -----VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
                ++  A    PE +   + +  SD++S+GV+L E+ + G +P
Sbjct: 189 NSLLPIRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  135 bits (342), Expect = 2e-36
 Identities = 64/242 (26%), Positives = 96/242 (39%), Gaps = 42/242 (17%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLN 194
            +G+G FG V +              VA+K  K+            SE++ L  +  HLN
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSELKILIHIGHHLN 92

Query: 195 LVKFHGY-LEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLD 239
           +V   G   +     +VIVE+   G L  +L              + L  + L L   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
            +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR             
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------- 202

Query: 300 TQVKGTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKRELKE 350
             V+     L      PE +     T +SDV+SFGVLL E+ + G  P   ++   E   
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262

Query: 351 RI 352
           R+
Sbjct: 263 RL 264

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  133 bits (338), Expect = 3e-36
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 31/222 (13%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG VY  R  +   I+A+K   K+  +K       + E+   + + H N+++ +G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 201 YLEFEDE-RIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLH 252
           Y  F D  R+ ++ EY P GT+   L            + D         ++A+A++Y H
Sbjct: 77  Y--FHDATRVYLILEYAPLGTVYRELQ--------KLSKFDEQRTATYITELANALSYCH 126

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 +IHRDIK  N+LL      K+ADFG++  A  +       +    GT  YL PE
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-----TDLC-GTLDYLPPE 177

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            ++     EK D++S GVL  E + G+ P E    +E  +RI
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (341), Expect = 3e-36
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 40/229 (17%)

Query: 142 KIGQGGFGTVYKGRL--------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EH 192
            +G+G FG V             ++   VA+K  K    +K   ++  SE+  +  + +H
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKH 100

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRL 238
            N++   G    +    VIVEY   G LRE+L              + +    +     +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
                +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID------ 211

Query: 299 STQVKGTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
               K T G L      PE L     T +SDV+SFGVL+ E+ T G  P
Sbjct: 212 -YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  134 bits (340), Expect = 6e-36
 Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 40/307 (13%)

Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G G  G V+K      G ++A K     +       +   E++ L +     +V F+G
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 201 YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLHM 253
              + D  I I  E++  G+L          +L  AGR+       ++I V   +TYL  
Sbjct: 99  AF-YSDGEISICMEHMDGGSLD--------QVLKKAGRIPEQILGKVSIAVIKGLTYLR- 148

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
              H I+HRD+K SNIL+      K+ DFG +    D+ +  + V     GT  Y+ PE 
Sbjct: 149 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFV-----GTRSYMSPER 201

Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
           L+    + +SD++S G+ LVE+  GR PI P    +  +     ++  +         P 
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS----------VRKDYRELA 423
                    +   +    L       +  P +      ++S          + K+  E A
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIV-NEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERA 317

Query: 424 ASDVLLQ 430
               L+ 
Sbjct: 318 DLKQLMV 324

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  138 bits (350), Expect = 8e-36
 Identities = 74/291 (25%), Positives = 117/291 (40%), Gaps = 46/291 (15%)

Query: 142 KIGQGGFGTVYKGRLEDG----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            IG+G FG V++G           VAIK  K          +F  E  T+ Q +H ++VK
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G +  E+   +I+E    G LR  L   + + LDLA  +  A  ++ A+ YL      
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLE---SK 510

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTE-SGATHVSTQVKGTAGYLDPEYLKT 316
             +HRDI + N+L++ N   K+ DFG +R   D+    A+     +K  A    PE +  
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA----PESINF 566

Query: 317 YQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD---- 371
            + T  SDV+ FGV + E++  G +P                +    + D I  ++    
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPF-------------QGV---KNNDVIGRIENGER 610

Query: 372 -PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE 421
            P   N          +  L  +C A     RP      E+   +     E
Sbjct: 611 LPMPPNCP------PTLYSLMTKCWAYDPSRRPRF---TELKAQLSTILEE 652

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (337), Expect = 8e-36
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 45/234 (19%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
            +G+G FG V K            T VA+K  K++        +  SE   L QV H ++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL-RDLLSEFNVLKQVNHPHV 88

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL----------------------DCLQGNILD 233
           +K +G    +   ++IVEY   G+LR  L                      D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
           +   +  A  ++  + YL    +  ++HRD+ + NIL+ E  + K++DFG +R   + + 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED- 204

Query: 294 GATHVSTQVKGTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
                 + VK + G +       E L  +  T +SDV+SFGVLL E+VT G  P
Sbjct: 205 ------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (349), Expect = 9e-36
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 142 KIGQGGFGTVYKGRL--EDGTI-VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FG+V +G        I VAIK  K+   +K    E   E + + Q+++  +V+ 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 199 HGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
            G  +   E +++V E    G L + L   +   + ++   ++   V+  + YL    + 
Sbjct: 402 IGVCQ--AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 455

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAGYLDPE 312
             +HR++ + N+LL     AK++DFG ++     +S   + +       +K  A    PE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYA----PE 509

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
            +   + + +SDV+S+GV + E ++ G++P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  133 bits (337), Expect = 1e-35
 Identities = 52/223 (23%), Positives = 87/223 (39%), Gaps = 24/223 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
            + +GGF  VY+ + +  G   A+KR   +  ++        E+  + ++  H N+V+F 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 200 GYLEFEDER-------IVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYL 251
                  E         +++  +  G L E L        L     L I      A+ ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST--------QVK 303
           H     PIIHRD+K  N+LL+     K+ DFG A   +     +                
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 304 GTAGYLDPEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRPIE 343
            T  Y  PE +  Y    + EK D+++ G +L  L   + P E
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  132 bits (334), Expect = 1e-35
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 38/226 (16%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKK-SVYDKHSGAEFQSEIRTLAQVEHLN 194
           ++G+G FG V+          +D  +VA+K  K  ++  +    +FQ E   L  ++H +
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR---KDFQREAELLTNLQHEH 78

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLDI 240
           +VKF+G     D  I++ EY+ +G L + L                     L L+  L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
           A  +A  + YL        +HRD+ + N L+  N   K+ DFG +R    T+     V  
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD--YYRVGG 193

Query: 301 Q----VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
                ++       PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 194 HTMLPIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  133 bits (337), Expect = 1e-35
 Identities = 60/249 (24%), Positives = 86/249 (34%), Gaps = 48/249 (19%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLN 194
            +G G FG V                VA+K  K+            SE++ + Q+  H N
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER-EALMSELKMMTQLGSHEN 110

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHL---------------------DCLQGNILD 233
           +V   G         +I EY   G L  +L                     +    N+L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
               L  A  VA  + +L        +HRD+ + N+L+T     K+ DFG AR       
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS- 226

Query: 294 GATHVSTQVKGTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEP 344
                   V      L      PE L     T KSDV+S+G+LL E+ + G  P   I  
Sbjct: 227 ------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280

Query: 345 KRELKERIT 353
                + I 
Sbjct: 281 DANFYKLIQ 289

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  134 bits (338), Expect = 2e-35
 Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 40/229 (17%)

Query: 142 KIGQGGFGTVYKGRL--------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EH 192
            +G+G FG V             ++   VA+K  K    +K   ++  SE+  +  + +H
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKH 146

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRL 238
            N++   G    +    VIVEY   G LRE+L              + +    +     +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
                +A  + YL        IHRD+ + N+L+TEN   K+ADFG AR   + +      
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID------ 257

Query: 299 STQVKGTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
               K T G L      PE L     T +SDV+SFGVL+ E+ T G  P
Sbjct: 258 -YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (334), Expect = 2e-35
 Identities = 61/217 (28%), Positives = 92/217 (42%), Gaps = 25/217 (11%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
            +G G FG VY+G++           VA+K   +   ++    +F  E   +++  H N+
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE-LDFLMEALIISKFNHQNI 95

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL-----DCLQGNILDLAGRLDIAIDVAHAITY 250
           V+  G       R +++E +  G L+  L        Q + L +   L +A D+A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 251 LHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQ--VKGT 305
           L    ++  IHRDI + N LLT       AK+ DFG AR                 VK  
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
                PE       T K+D +SFGVLL E+ + G  P
Sbjct: 213 P----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  131 bits (331), Expect = 4e-35
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 29/222 (13%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    +   + A K   K  +   H   +   EI     + H ++V FHG
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLHMY 254
           + E  D   V++E     +L E               L           +     YLH  
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHK--------RRKALTEPEARYYLRQIVLGCQYLH-- 132

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             + +IHRD+K  N+ L E+   K+ DFG   LA   E         + GT  Y+ PE L
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFG---LATKVEYDGERKKV-LCGTPNYIAPEVL 187

Query: 315 --KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
             K +  + + DV+S G ++  L+ G+ P E    +E   RI
Sbjct: 188 SKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (330), Expect = 4e-35
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 32/218 (14%)

Query: 142 KIGQGGFGTVYKGRL--------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL 193
            +GQG F  ++KG             T V +K   K+  +      F      ++++ H 
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLSHK 72

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
           +LV  +G     DE I++ E+V  G+L  +L     N +++  +L++A  +A A+ +L  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-- 129

Query: 254 YTDHPIIHRDIKSSNILLT--------ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
             ++ +IH ++ + NILL              K++D G +      +        ++   
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL----QERIPWV 184

Query: 306 AGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVT-GRRP 341
                PE ++  +     +D +SFG  L E+ + G +P
Sbjct: 185 P----PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  130 bits (330), Expect = 4e-35
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 20/218 (9%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G F  VY+   +  G  VAIK   KK++Y        Q+E++   Q++H ++++ + 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 201 YLEFEDE-RIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           Y  FED   + +V E   NG +  +L        +   R  +   +   + YLH    H 
Sbjct: 79  Y--FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH---SHG 132

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KT 316
           I+HRD+  SN+LLT N   K+ADFG   LA   +       T   GT  Y+ PE      
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFG---LATQLKMPHEKHYTLC-GTPNYISPEIATRSA 188

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
           +    +SDV+S G +   L+ GR P +    +    ++
Sbjct: 189 H--GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  137 bits (345), Expect = 4e-35
 Identities = 75/288 (26%), Positives = 121/288 (42%), Gaps = 33/288 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH- 199
           ++G GGFG V +    + G  VAIK+ ++ +  K+    +  EI+ + ++ H N+V    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSARE 79

Query: 200 -----GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--LDIAIDVAHAITYLH 252
                  L   D  ++ +EY   G LR++L     N   L       +  D++ A+ YLH
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 253 MYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
              ++ IIHRD+K  NI+L    +    K+ D G+A+     E     V     GT  YL
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-----GTLQYL 190

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP-------KRELKERITVKWAMKKFS 362
            PE L+  + T   D +SFG L  E +TG RP  P         +++E+      +    
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 363 DGDAI---SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRR 407
            G       +  P   +       LE+ L+  L     +R   P    
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGK-LERWLQCMLMWHQRQRGTDPQNPN 297

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  132 bits (333), Expect = 4e-35
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 29/222 (13%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIK-RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+GGF   ++    +   + A K   K  +   H   +   EI     + H ++V FHG
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLHMY 254
           + E  D   V++E     +L E               L           +     YLH  
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHK--------RRKALTEPEARYYLRQIVLGCQYLH-- 158

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             + +IHRD+K  N+ L E+   K+ DFG   LA   E         + GT  Y+ PE L
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFG---LATKVEYDGERKKV-LCGTPNYIAPEVL 213

Query: 315 --KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
             K +  + + DV+S G ++  L+ G+ P E    +E   RI
Sbjct: 214 SKKGH--SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  132 bits (334), Expect = 7e-35
 Identities = 68/229 (29%), Positives = 94/229 (41%), Gaps = 40/229 (17%)

Query: 142 KIGQGGFGTVYKGRL--------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EH 192
            +G+G FG V                T VA+K  K    +K   ++  SE+  +  + +H
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKH 134

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRL 238
            N++   G    +    VIVEY   G LRE+L                     L     +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
             A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR     +      
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID------ 245

Query: 299 STQVKGTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
               K T G L      PE L     T +SDV+SFGVLL E+ T G  P
Sbjct: 246 -YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  131 bits (332), Expect = 8e-35
 Identities = 50/232 (21%), Positives = 96/232 (41%), Gaps = 32/232 (13%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS---------------EIRT 186
            + QG F  +     +D    A+K+ +KS+ +K       +               E++ 
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 187 LAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------I 240
           +  +++   +   G +   DE  +I EY+ N ++ +  +       +    +       I
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
              V ++ +Y+H   +  I HRD+K SNIL+ +N R K++DFG +    D       +  
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD-----KKIKG 209

Query: 301 QVKGTAGYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE 350
              GT  ++ PE+   ++     K D++S G+ L  +     P   K  L E
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  129 bits (327), Expect = 9e-35
 Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 35/224 (15%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG VY  R  ++  I+A+K   KS  +K       + EI   + + H N+++ + 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 201 YLEFEDE-RIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLH 252
           Y  F D  RI ++ E+ P G L + L           GR D         ++A A+ Y H
Sbjct: 82  Y--FHDRKRIYLMLEFAPRGELYKELQ--------KHGRFDEQRSATFMEELADALHYCH 131

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
              +  +IHRDIK  N+L+      K+ADFG    +    S          GT  YL PE
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSLRRRTMC---GTLDYLPPE 182

Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            +  KT+   EK D++  GVL  E + G  P +     E   RI
Sbjct: 183 MIEGKTH--DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  131 bits (331), Expect = 1e-34
 Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 25/217 (11%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
            +G G FG VY+G++           VA+K   +    +    +F  E   +++  H N+
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNI 136

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL-----DCLQGNILDLAGRLDIAIDVAHAITY 250
           V+  G       R +++E +  G L+  L        Q + L +   L +A D+A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 251 LHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQ--VKGT 305
           L    ++  IHRDI + N LLT       AK+ DFG AR                 VK  
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
                PE       T K+D +SFGVLL E+ + G  P
Sbjct: 254 P----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  128 bits (325), Expect = 2e-34
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFH 199
           ++G+G +G V K R +  G I+A+KR + +V +         ++  ++  V+    V F+
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 200 GYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLH 252
           G L F +  + I  E +        LD     ++D    +       IA+ +  A+ +LH
Sbjct: 73  GAL-FREGDVWICMELMDTS-----LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +   +IHRD+K SN+L+    + K+ DFG +    D  +          G   Y+ PE
Sbjct: 127 --SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKPYMAPE 179

Query: 313 ------YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
                   K Y  + KSD++S G+ ++EL   R P + 
Sbjct: 180 RINPELNQKGY--SVKSDIWSLGITMIELAILRFPYDS 215

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (328), Expect = 2e-34
 Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 36/225 (16%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLN 194
            +G G FG V +         +    VA+K  K + +         SE++ ++ + +H N
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK-EALMSELKIMSHLGQHEN 111

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHL------------DCLQGNILDLAGRLDIAI 242
           +V   G        +VI EY   G L   L              +  +       L  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ- 301
            VA  + +L        IHRD+ + N+LLT    AK+ DFG AR   D  + + ++    
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMNDSNYIVKGN 225

Query: 302 ----VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
               VK  A    PE +     T +SDV+S+G+LL E+ + G  P
Sbjct: 226 ARLPVKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  129 bits (327), Expect = 3e-34
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 35/224 (15%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++G+G FG V+          +D  +VA+K  K++   + +  +FQ E   L  ++H ++
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHI 105

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL-------------DCLQGNILDLAGRLDIAI 242
           V+F G        +++ EY+ +G L   L             + +    L L   L +A 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ- 301
            VA  + YL        +HRD+ + N L+ +    K+ DFG +R    T+     V  + 
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD--YYRVGGRT 220

Query: 302 ---VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
              ++       PE +   + T +SDV+SFGV+L E+ T G++P
Sbjct: 221 MLPIRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  129 bits (325), Expect = 9e-34
 Identities = 53/357 (14%), Positives = 108/357 (30%), Gaps = 50/357 (14%)

Query: 67  PETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQI- 125
           P+ +S       N    +P  D        +       GL    ++     +    +   
Sbjct: 3   PQMSSLGTVDAPNFIVGNPWDD--------KLIFKLLSGLSKPVSSYPNTFEWQCKLPAI 54

Query: 126 -TMEEIYRATRNFSPSFKIGQGGFGTVYKGR------LEDGTIVAIKRAKKSVYDKHSGA 178
               E    ++       +G+G F  VY+         ++     +K     V    +  
Sbjct: 55  KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK-----VQKPANPW 109

Query: 179 EFQ---SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLD---CLQGNIL 232
           EF      +  L        +KF+    F++  +++ E    GTL   ++        ++
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 233 DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA-----------KVAD 281
                +  A+ + + I  +H   D  IIH DIK  N +L   F              + D
Sbjct: 170 PQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226

Query: 282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            G +        G     T    T+G+   E L       + D +     +  ++ G   
Sbjct: 227 LGQSIDMKLFPKGTI--FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

Query: 342 IEPKRELKERITVKWAMKKFSDGDAIS-----ILDPRVENTAANNLALEKILELALQ 393
               +        +   ++    D  +     +L+    +   +   L + L+   Q
Sbjct: 285 --KVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (323), Expect = 1e-33
 Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 45/234 (19%)

Query: 142 KIGQGGFGTVYKGRLEDG------TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
            IG+G FG V++ R          T+VA+K  K+        A+FQ E   +A+ ++ N+
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNI 112

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHL----------------------DCLQGNILD 233
           VK  G         ++ EY+  G L E L                             L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
            A +L IA  VA  + YL   ++   +HRD+ + N L+ EN   K+ADFG +R     + 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD- 228

Query: 294 GATHVSTQVKGTAGYL-----DPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP 341
                          +      PE +   + T +SDV+++GV+L E+ + G +P
Sbjct: 229 ------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  127 bits (322), Expect = 1e-33
 Identities = 63/254 (24%), Positives = 109/254 (42%), Gaps = 34/254 (13%)

Query: 118 DQSGNVQITMEEIYRATRN-FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKH 175
           + SG ++I+ E+ +  T        +IG+G +G+V K      G I+A+KR + +V D+ 
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEK 62

Query: 176 SGAEFQSEIRT-LAQVEHLNLVKFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILD 233
              +   ++   +   +   +V+F+G L F +    I  E + + +        +     
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGAL-FREGDCWICMELM-STSF---DKFYKYVYSV 117

Query: 234 LAGRLD------IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL 287
           L   +       I +    A+ +L    +  IIHRDIK SNILL  +   K+ DFG +  
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 288 AADTESGATHVSTQVKGTAGYLDPE------YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
             D+ +          G   Y+ PE        + Y    +SDV+S G+ L EL TGR P
Sbjct: 176 LVDSIAKTRDA-----GCRPYMAPERIDPSASRQGY--DVRSDVWSLGITLYELATGRFP 228

Query: 342 ---IEPKRELKERI 352
                   +   ++
Sbjct: 229 YPKWNSVFDQLTQV 242

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (327), Expect = 2e-33
 Identities = 46/217 (21%), Positives = 87/217 (40%), Gaps = 24/217 (11%)

Query: 136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLN 194
           +F P   +G G  GT+    + D   VA+KR     +          E++ L +  EH N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF-----ADREVQLLRESDEHPN 79

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGR--LDIAIDVAHAITYLH 252
           ++++    +    + + +E     TL    + ++       G   + +       + +LH
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATL---QEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135

Query: 253 MYTDHPIIHRDIKSSNILLTE-----NFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
                 I+HRD+K  NIL++        +A ++DFG  +  A      +  S    GT G
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEG 191

Query: 308 YLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRP 341
           ++ PE L        T   D++S G +   +++    
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  127 bits (320), Expect = 2e-33
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 29/245 (11%)

Query: 113 STRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSV 171
           S   G Q+G + I  +       +     ++G G  G V+K R  + G ++A+K+ ++S 
Sbjct: 3   SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62

Query: 172 YDKHSGAEFQSEIRTL-AQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN 230
            +K        ++  +    +   +V+  G      +  + +E +  GT      C +  
Sbjct: 63  -NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GT------CAEKL 113

Query: 231 ILDLAGRLD------IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
              + G +       + + +  A+ YL     H +IHRD+K SNILL E  + K+ DFG 
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171

Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE-----KSDVYSFGVLLVELVTGR 339
           +    D ++          G A Y+ PE +     T+     ++DV+S G+ LVEL TG+
Sbjct: 172 SGRLVDDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

Query: 340 RPIEP 344
            P + 
Sbjct: 227 FPYKN 231

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  125 bits (316), Expect = 5e-33
 Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 39/253 (15%)

Query: 109 SSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRA 167
           + +    G     N++   EE++          KIG+G FG V+KG       +VAIK  
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLE------KIGKGSFGEVFKGIDNRTQKVVAIKII 55

Query: 168 K-KSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDC 226
             +   D+    + Q EI  L+Q +   + K++G    + +  +I+EY            
Sbjct: 56  DLEEAEDEIE--DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY-----------L 102

Query: 227 LQGNILDL--AGRLD---IAI---DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAK 278
             G+ LDL   G LD   IA    ++   + YLH       IHRDIK++N+LL+E+   K
Sbjct: 103 GGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVK 159

Query: 279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG 338
           +ADFG A    DT+       T V GT  ++ PE +K      K+D++S G+  +EL  G
Sbjct: 160 LADFGVAGQLTDTQIKRN---TFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

Query: 339 RRP---IEPKREL 348
             P   + P + L
Sbjct: 216 EPPHSELHPMKVL 228

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  125 bits (316), Expect = 5e-33
 Identities = 66/249 (26%), Positives = 110/249 (44%), Gaps = 35/249 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAK-KSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            IG G    V           VAIKR   +         E   EI+ ++Q  H N+V ++
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD--ELLKEIQAMSQCHHPNIVSYY 79

Query: 200 G-YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD---IAI---DVAHAITYLH 252
             ++  +DE  ++++ +  G++ + +  +       +G LD   IA    +V   + YLH
Sbjct: 80  TSFVV-KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDP 311
               +  IHRD+K+ NILL E+   ++ADFG  A LA   +     V     GT  ++ P
Sbjct: 139 ---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 312 EYL---KTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKR-----------ELKERITV 354
           E +   + Y    K+D++SFG+  +EL TG  P     P +            L+  +  
Sbjct: 196 EVMEQVRGY--DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253

Query: 355 KWAMKKFSD 363
           K  +KK+  
Sbjct: 254 KEMLKKYGK 262

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  125 bits (315), Expect = 6e-33
 Identities = 67/216 (31%), Positives = 104/216 (48%), Gaps = 26/216 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++       K       +EI  + + ++ N+V +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE--LIINEILVMRENKNPNIVNYLD 84

Query: 201 -YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI---DVAHAITYLHMYTD 256
            YL   DE  V++EY+  G+L    D +    +D      IA    +   A+ +LH    
Sbjct: 85  SYLV-GDELWVVMEYLAGGSL---TDVVTETCMD---EGQIAAVCRECLQALEFLH---S 134

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
           + +IHRDIKS NILL  +   K+ DFGF A++  +    +T V     GT  ++ PE + 
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVT 189

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
                 K D++S G++ +E++ G  P     P R L
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  127 bits (321), Expect = 9e-33
 Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 52/298 (17%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHG 200
            +G G  GTV       G  VA+KR      D         EI+ L +  +H N+++++ 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPNVIRYYC 76

Query: 201 YLEFEDERIVIVEYVPNGTL-----REHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
               +    + +E   N  L      +++      +      + +   +A  + +LH   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132

Query: 256 DHPIIHRDIKSSNILLT-------------ENFRAKVADFGFARLAADTESGATHVSTQV 302
              IIHRD+K  NIL++             EN R  ++DFG  +     +S         
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 303 KGTAGYLDPEYLK-------TYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITV 354
            GT+G+  PE L+         +LT   D++S G +   +++ G+ P   K   +  I  
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII- 251

Query: 355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                 FS  +   + D  +   A +         L  Q +      RP+     ++L
Sbjct: 252 ---RGIFSLDEMKCLHDRSLIAEATD---------LISQMIDHDPLKRPT---AMKVL 294

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  124 bits (313), Expect = 2e-32
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 24/215 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G  G V   R    G  VA+K        +       +E+  +   +H N+V+ + 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE--LLFNEVVIMRDYQHFNVVEMYK 109

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI---DVAHAITYLHMYTDH 257
                +E  V++E++  G L    D +    L+      IA     V  A+ YLH     
Sbjct: 110 SYLVGEELWVLMEFLQGGAL---TDIVSQVRLN---EEQIATVCEAVLQALAYLH---AQ 160

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGF-ARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
            +IHRDIKS +ILLT + R K++DFGF A+++ D     + V     GT  ++ PE +  
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISR 215

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
                + D++S G++++E+V G  P     P + +
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  124 bits (313), Expect = 4e-32
 Identities = 35/371 (9%), Positives = 85/371 (22%), Gaps = 55/371 (14%)

Query: 90  SRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIY-RATRNFSPSFKIGQGGF 148
            R        R  +     +   +        N + T++ +  +  R       +  G  
Sbjct: 16  KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75

Query: 149 GTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHGYLEFED 206
             V+  R +E     A+K       +  S  E         A++   +  +         
Sbjct: 76  SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135

Query: 207 ER-------------------------IVIVEYVPNGTLREHLDCLQ-----GNILDLAG 236
                                       +++    +  L      L           +  
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
              +   +      L       ++H      N+ +  + R  + D               
Sbjct: 196 LHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----- 247

Query: 297 HVSTQVKGTAGYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITV 354
                      Y   E+L   T   T   + +  G+ +  +     P        +    
Sbjct: 248 --GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS 414
           + +++              +          + +  L  + L   R+ R       E    
Sbjct: 306 RPSLRVPGTDSLAFGSCTPLP---------DFVKTLIGRFLNFDRRRRLLPLEAMETPE- 355

Query: 415 VRKDYRELAAS 425
             +   E+++S
Sbjct: 356 FLQLQNEISSS 366

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (309), Expect = 2e-31
 Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 21/213 (9%)

Query: 142 KIGQG--GFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
            IG+G     TV   R    G  V ++R              Q E+       H N+V +
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI---DVAHAITYLHMYT 255
                 ++E  V+  ++  G+ +   D +  + +D    L IA     V  A+ Y+H   
Sbjct: 92  RATFIADNELWVVTSFMAYGSAK---DLICTHFMDGMNELAIAYILQGVLKALDYIH--- 145

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG---YLDPE 312
               +HR +K+S+IL++ + +  ++                 V    K +     +L PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 313 ----YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                L+ Y    KSD+YS G+   EL  G  P
Sbjct: 206 VLQQNLQGY--DAKSDIYSVGITACELANGHVP 236

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (303), Expect = 3e-31
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 39/226 (17%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G G FG VYK +  E G + A K  +    ++    ++  EI  LA  +H  +VK  G
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKLLG 83

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL----AGRLD---IAI---DVAHAITY 250
               + +  +++E+           C  G +  +       L    I +    +  A+ +
Sbjct: 84  AYYHDGKLWIMIEF-----------CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           LH      IIHRD+K+ N+L+T     ++ADFG +     T        + + GT  ++ 
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD---SFI-GTPYWMA 185

Query: 311 PEYLKTYQLTE-----KSDVYSFGVLLVELVTGRRP---IEPKREL 348
           PE +    + +     K+D++S G+ L+E+     P   + P R L
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL 231

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  121 bits (304), Expect = 8e-31
 Identities = 35/295 (11%), Positives = 79/295 (26%), Gaps = 56/295 (18%)

Query: 92  SRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIY-RATRNFSPSFKIGQGGFGT 150
           +R      R++S+ +  ++++       +      +E       R       +GQ     
Sbjct: 29  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88

Query: 151 VYKGR-LEDGTIVAIK--------------------------RAKKSVYDKHSGAEFQSE 183
             +    E G    +                           R  K+         F   
Sbjct: 89  YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148

Query: 184 IRTLAQVEHLNLVKFHGYLE-FEDERIVIVEYVPNGTLREHLDCL-----QGNILDLAGR 237
              +   +   +++               +       L+   + L         L    R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208

Query: 238 LDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
           L + + V   +  LH    + ++H  ++  +I+L +     +  F           GA  
Sbjct: 209 LQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARV 260

Query: 298 VSTQVKGTAGYLDPEYLKTYQL-----------TEKSDVYSFGVLLVELVTGRRP 341
           VS+    + G+  PE                  T   D ++ G+++  +     P
Sbjct: 261 VSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  119 bits (300), Expect = 1e-30
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 32/226 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
            +G G +G VYKGR ++ G + AIK             E + EI  L +   H N+  ++
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 200 G-YL----EFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAI---DVAHAITY 250
           G ++       D+++ +V E+   G++ + +   +GN L       IA    ++   +++
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREILRGLSH 144

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           LH    H +IHRDIK  N+LLTEN   K+ DFG +     T        T + GT  ++ 
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN---TFI-GTPYWMA 197

Query: 311 PEYLKTYQLTE-----KSDVYSFGVLLVELVTGRRP---IEPKREL 348
           PE +   +  +     KSD++S G+  +E+  G  P   + P R L
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  121 bits (306), Expect = 2e-30
 Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 23/220 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G V   R        AIK  +K+     S ++   E+  L  ++H N++K + 
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           +  FED+R    ++E    G L + +   +    ++     I   V   +TYLH    H 
Sbjct: 104 F--FEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAA-VIIKQVLSGVTYLH---KHN 156

Query: 259 IIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL- 314
           I+HRD+K  N+LL    ++   K+ DFG + +  + +        +  GTA Y+ PE L 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-----KMKERLGTAYYIAPEVLR 211

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
           K Y   EK DV+S GV+L  L+ G  P   +  +E+  ++
Sbjct: 212 KKY--DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  121 bits (305), Expect = 2e-30
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 24/221 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            +G+G FG V   +    G   A+K  +K+ V  K        E++ L Q++H N++K +
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 200 GYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
            +  FED+     + E    G L + +   +    ++     I   V   ITY+H    +
Sbjct: 93  EF--FEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAA-RIIRQVLSGITYMH---KN 145

Query: 258 PIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            I+HRD+K  N+LL    ++   ++ DFG +     ++           GTA Y+ PE L
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEVL 200

Query: 315 -KTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
             TY   EK DV+S GV+L  L++G  P     + ++ +++
Sbjct: 201 HGTY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV 239

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (302), Expect = 3e-30
 Identities = 35/327 (10%), Positives = 90/327 (27%), Gaps = 67/327 (20%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIK--------------------RAKKSVYDKHSGAEFQ 181
           +GQ       +    E G    +                        + +    +  + +
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 182 SEIRTLAQVEHLNLVKFHGYLEF--EDERIVIVEYV-----PNGTLREHLDCLQGNI--- 231
             +R +   + +   +    +    ++  + ++            L+   + L  +    
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 232 --LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA 289
             L    RL + + V   +  LH    + ++H  ++  +I+L +     +  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 290 DTESGATHVSTQVKGTAGYLDPEYLKTYQ-----LTEKSDVYSFGVLLVELVTGRRPIEP 344
            +         +            L   Q     +T   D ++ G+ +  +     P   
Sbjct: 263 ASAVSPI---GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--- 316

Query: 345 KRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS 404
                            +D  A+   +    +       +  +LE     L   +++R  
Sbjct: 317 ----------------NTDDAALGGSEWIFRSCKNIPQPVRALLE---GFLRYPKEDRLL 357

Query: 405 MRRCAEILWSVRKDYRELAASDVLLQP 431
             +  E      +   EL+A+  L Q 
Sbjct: 358 PLQAMETPE-YEQLRTELSAALPLYQT 383

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  117 bits (295), Expect = 6e-30
 Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 38/230 (16%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH 192
              F    K+G+G +G+VYK    E G IVAIK  +  V       E   EI  + Q + 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQ--EIIKEISIMQQCDS 83

Query: 193 LNLVKFHG-YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL----AGRLD---IAI-- 242
            ++VK++G Y +   +  +++EY           C  G++ D+       L    IA   
Sbjct: 84  PHVVKYYGSYFK-NTDLWIVMEY-----------CGAGSVSDIIRLRNKTLTEDEIATIL 131

Query: 243 -DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
                 + YLH       IHRDIK+ NILL     AK+ADFG A    DT +      T 
Sbjct: 132 QSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN---TV 185

Query: 302 VKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP---IEPKREL 348
           + GT  ++ PE ++       +D++S G+  +E+  G+ P   I P R +
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  118 bits (298), Expect = 2e-29
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 27/222 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+G FG V K +        A+K   K+       +    E+  L +++H N++K   
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNI--LDLAGRLDIAIDVAHAITYLHMYTD 256
               ED      + E    G L + +   +      D A    I   V   ITY+H    
Sbjct: 89  I--LEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA---RIIKQVFSGITYMH---K 139

Query: 257 HPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
           H I+HRD+K  NILL    ++   K+ DFG +                  GTA Y+ PE 
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEV 194

Query: 314 L-KTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
           L  TY   EK DV+S GV+L  L++G  P   + + ++ +R+
Sbjct: 195 LRGTY--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (288), Expect = 1e-28
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 43/226 (19%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSG-AEFQSEIRTLAQVEHLNLVKFH 199
           +IG G FG VY  R + +  +VAIK+   S    +    +   E+R L ++ H N +++ 
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 200 G-YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDL----AGRLD---IAI---DVAHAI 248
           G YL  E    +++EY              G+  DL       L    IA         +
Sbjct: 121 GCYLR-EHTAWLVMEY------------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            YLH    H +IHRD+K+ NILL+E    K+ DFG    A+      + V     GT  +
Sbjct: 168 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANSFV-----GTPYW 216

Query: 309 LDPEYLKTYQLTE---KSDVYSFGVLLVELVTGRRP---IEPKREL 348
           + PE +      +   K DV+S G+  +EL   + P   +     L
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  114 bits (287), Expect = 1e-28
 Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 51/259 (19%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK---RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            IGQG +G V      +   I AIK   + K    +       ++E+R + ++ H N+ +
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 198 FHGYLEFEDERIVIVEYVPNGTL------REHLDCLQGNILDLAGRL------------- 238
            +   E E    +++E    G L             +  +  +  ++             
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 239 -------------------DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT--ENFRA 277
                              +I   +  A+ YLH   +  I HRDIK  N L +  ++F  
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209

Query: 278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL--TEKSDVYSFGVLLVEL 335
           K+ DFG ++      +G  +  T   GT  ++ PE L T       K D +S GVLL  L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 336 VTGRRP--IEPKRELKERI 352
           + G  P       +   ++
Sbjct: 270 LMGAVPFPGVNDADTISQV 288

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  115 bits (290), Expect = 3e-28
 Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 34/231 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKS-----------VYDKHSGAEFQSEIRTLAQ 189
           K+G G +G V   +     +  AIK  KKS              +    E  +EI  L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 190 VEHLNLVKFHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHA 247
           ++H N++K      FED++    + E+   G L E +   +    +     +I   +   
Sbjct: 103 LDHPNIIKLFDV--FEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAA-NIMKQILSG 158

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKG 304
           I YLH    H I+HRDIK  NILL         K+ DFG +   +              G
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-----KLRDRLG 210

Query: 305 TAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
           TA Y+ PE L K Y   EK DV+S GV++  L+ G  P   +  +++ +++
Sbjct: 211 TAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  111 bits (280), Expect = 4e-28
 Identities = 66/256 (25%), Positives = 105/256 (41%), Gaps = 33/256 (12%)

Query: 108 VSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKR 166
           +  ++    G ++   Q T  E Y           +G+G FG V K +        A+K 
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKV 54

Query: 167 AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV--IVEYVPNGTLREHL 224
             K+       +    E+  L +++H N++K       ED      + E    G L    
Sbjct: 55  INKASAKNKDTSTILREVELLKKLDHPNIMKLFEI--LEDSSSFYIVGELYTGGEL---F 109

Query: 225 D--CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKV 279
           D    +    +      I   V   ITY+H    H I+HRD+K  NILL    ++   K+
Sbjct: 110 DEIIKRKRFSEHDAA-RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKI 165

Query: 280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTG 338
            DFG +            +     GTA Y+ PE L  TY   EK DV+S GV+L  L++G
Sbjct: 166 IDFGLSTCFQQNTKMKDRI-----GTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSG 218

Query: 339 RRPI--EPKRELKERI 352
             P   + + ++ +R+
Sbjct: 219 TPPFYGKNEYDILKRV 234

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  112 bits (281), Expect = 6e-28
 Identities = 65/280 (23%), Positives = 103/280 (36%), Gaps = 41/280 (14%)

Query: 87  SDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQG 146
           S       S+      S       N+        G  +  +E  Y+          +G G
Sbjct: 3   SSHHHHHHSSGLVPRGSHM--APCNDLHATKLAPGKEKEPLESQYQVGP------LLGSG 54

Query: 147 GFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS----EIRTLAQVEHL--NLVKFH 199
           GFG+VY G  + D   VAIK  +K            +    E+  L +V      +++  
Sbjct: 55  GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLHM 253
            + E  D  ++I+E       ++  D +        G L           V  A+ + H 
Sbjct: 115 DWFERPDSFVLILERPEPV--QDLFDFITER-----GALQEELARSFFWQVLEAVRHCH- 166

Query: 254 YTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             +  ++HRDIK  NIL+       K+ DFG   L  D     T  +    GT  Y  PE
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFD-GTRVYSPPE 218

Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE 350
           ++    Y     + V+S G+LL ++V G  P E   E+  
Sbjct: 219 WIRYHRYHGRS-AAVWSLGILLYDMVCGDIPFEHDEEIIR 257

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (277), Expect = 1e-27
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 31/227 (13%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQVEHLNLVKFH 199
           +G+G +G V +    E     A+K  KK    +    E     EI+ L ++ H N+++  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 200 GYLEFE-DERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH--------AIT 249
             L  E  +++ +V EY   G ++E LD +         R  +    AH         + 
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCG-MQEMLDSV------PEKRFPV--CQAHGYFCQLIDGLE 123

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH      I+H+DIK  N+LLT     K++  G A       +  T  ++Q  G+  + 
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQ 178

Query: 310 DPEYLKTYQLTE--KSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            PE           K D++S GV L  + TG  P E     +L E I
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  110 bits (277), Expect = 2e-27
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 35/226 (15%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS----EIRTLAQV----EHL 193
           +G+GGFGTV+ G  L D   VAIK   ++     S          E+  L +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHA 247
            +++   + E ++  ++++E       ++  D +        G L           V  A
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEK-----GPLGEGPSRCFFGQVVAA 151

Query: 248 ITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           I + H      ++HRDIK  NIL+      AK+ DFG   L  D        +    GT 
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-----EPYTDFD-GTR 202

Query: 307 GYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE 350
            Y  PE++    Y     + V+S G+LL ++V G  P E  +E+ E
Sbjct: 203 VYSPPEWISRHQYH-ALPATVWSLGILLYDMVCGDIPFERDQEILE 247

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  110 bits (277), Expect = 2e-27
 Identities = 68/221 (30%), Positives = 99/221 (44%), Gaps = 28/221 (12%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG+G F  V   R +  G  VAIK   K+  +  S  +   E+R +  + H N+VK    
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLHMYT 255
           +E E    +I+EY   G   E  D L  +     GR+           +  A+ Y H   
Sbjct: 83  IETEKTLYLIMEYASGG---EVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH--- 131

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL- 314
              I+HRD+K+ N+LL  +   K+ADFGF+                  G   Y  PE   
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAAPELFQ 186

Query: 315 -KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            K Y   E  DV+S GV+L  LV+G  P + +  +EL+ER+
Sbjct: 187 GKKYDGPE-VDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (272), Expect = 5e-27
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 34/227 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE--FQSEIRTLAQVEHLNLVKF 198
           K+G G FG V+       G    IK   K    +        ++EI  L  ++H N++K 
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKD---RSQVPMEQIEAEIEVLKSLDHPNIIKI 85

Query: 199 HGYLEFEDER-IVIV-EYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAHAITY 250
                FED   + IV E    G L E +   Q         L      ++   + +A+ Y
Sbjct: 86  FEV--FEDYHNMYIVMETCEGGELLERIVSAQAR----GKALSEGYVAELMKQMMNALAY 139

Query: 251 LHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
            H      ++H+D+K  NIL      +   K+ DFG A L    E           GTA 
Sbjct: 140 FH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-----GTAL 191

Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
           Y+ PE  K   +T K D++S GV++  L+TG  P       E++++ 
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA 237

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (272), Expect = 6e-27
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 40/229 (17%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G+G F  V +      G   A K             + + E R   +++H N+V+ H 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 201 YLEFEDERIVIVEYVPNGTL------REHL------DCLQGNILDLAGRLDIAIDVAHAI 248
            ++ E    ++ + V  G L      RE         C+Q  IL+             +I
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILE-------------SI 118

Query: 249 TYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            Y H    + I+HR++K  N+LL    +    K+ADFG A    D+E+          GT
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GT 170

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI 352
            GYL PE LK    ++  D+++ GV+L  L+ G  P   E +  L  +I
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  108 bits (272), Expect = 8e-27
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 143 IGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQVEHLNLVKFHG 200
           +G+G F TV   R        AIK  +K    K +   +   E   +++++H   VK + 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYLH 252
              F+D+  +   + Y  NG L +++           G  D         ++  A+ YLH
Sbjct: 98  T--FQDDEKLYFGLSYAKNGELLKYIRK--------IGSFDETCTRFYTAEIVSALEYLH 147

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 IIHRD+K  NILL E+   ++ DFG A++ +     A   ++ V GTA Y+ PE
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFV-GTAQYVSPE 202

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            L      + SD+++ G ++ +LV G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  110 bits (276), Expect = 1e-26
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 38/220 (17%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
            +G G  G V      +    VAI+   K  +   S  E       ++EI  L ++ H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 195 LVKFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAHA 247
           ++K   +  F+ E   IV E +  G L    D + GN      RL           +  A
Sbjct: 202 IIKIKNF--FDAEDYYIVLELMEGGEL---FDKVVGN-----KRLKEATCKLYFYQMLLA 251

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKG 304
           + YLH   ++ IIHRD+K  N+LL+   E+   K+ DFG +++  +T    T       G
Sbjct: 252 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-----G 303

Query: 305 TAGYLDPEYLKTYQL---TEKSDVYSFGVLLVELVTGRRP 341
           T  YL PE L +          D +S GV+L   ++G  P
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  108 bits (272), Expect = 1e-26
 Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 25/211 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL-NLVKFH 199
           ++G+G F  V +      G   A K  KK    +   AE   EI  L   +    ++  H
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAHAITYLHM 253
              E   E I+I+EY   G +          + +LA  +       +   +   + YLH 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLH- 148

Query: 254 YTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
              + I+H D+K  NILL         K+ DFG +R           +   + GT  YL 
Sbjct: 149 --QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LREIM-GTPEYLA 201

Query: 311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           PE L    +T  +D+++ G++   L+T   P
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  109 bits (273), Expect = 2e-26
 Identities = 57/303 (18%), Positives = 107/303 (35%), Gaps = 44/303 (14%)

Query: 65  TPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQ 124
                        + E + + +       + +    + ++ L  +    T          
Sbjct: 20  RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79

Query: 125 ITMEEIYRATRNFSPSFK----IGQGGFGTVYKGR-LEDGTIVAIKRAKKS------VYD 173
                 + A + F   +     IG+G    V +      G   A+K  + +         
Sbjct: 80  EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139

Query: 174 KHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGN 230
           +      + E   L QV  H +++       +E    +  + + +  G L    D     
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDS--YESSSFMFLVFDLMRKGEL---FD----Y 190

Query: 231 ILDLAGRL------DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
           + +    L       I   +  A+++LH    + I+HRD+K  NILL +N + +++DFGF
Sbjct: 191 LTE-KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF 246

Query: 285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL------TEKSDVYSFGVLLVELVTG 338
           +      E           GT GYL PE LK           ++ D+++ GV+L  L+ G
Sbjct: 247 SCHLEPGEKLRELC-----GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

Query: 339 RRP 341
             P
Sbjct: 302 SPP 304

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (268), Expect = 2e-26
 Identities = 54/208 (25%), Positives = 84/208 (40%), Gaps = 25/208 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
            IG+G +G V            A K+  K  V D      F+ EI  +  ++H N+++ +
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDHPNIIRLY 72

Query: 200 GYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
               FED   +  ++E    G L E +   +    +      I  DV  A+ Y H     
Sbjct: 73  ET--FEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAA-RIMKDVLSAVAYCH---KL 125

Query: 258 PIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            + HRD+K  N L      +   K+ DFG A      +   T V     GT  Y+ P+ L
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----GTPYYVSPQVL 180

Query: 315 -KTYQLTEKSDVYSFGVLLVELVTGRRP 341
              Y    + D +S GV++  L+ G  P
Sbjct: 181 EGLY--GPECDEWSAGVMMYVLLCGYPP 206

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  106 bits (266), Expect = 7e-26
 Identities = 49/209 (23%), Positives = 82/209 (39%), Gaps = 27/209 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+G FG V++            K  K    D+      + EI  L    H N++  H 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNIARHRNILHLHE 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL---DIAI---DVAHAITYLHMY 254
             E  +E ++I E++    + E        I   A  L   +I      V  A+ +LH  
Sbjct: 69  SFESMEELVMIFEFISGLDIFER-------INTSAFELNEREIVSYVHQVCEALQFLH-- 119

Query: 255 TDHPIIHRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             H I H DI+  NI+     +   K+ +FG AR     ++              Y  PE
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLF-TAPEYYAPE 173

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
             +   ++  +D++S G L+  L++G  P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (264), Expect = 7e-26
 Identities = 26/205 (12%), Positives = 55/205 (26%), Gaps = 46/205 (22%)

Query: 142 KIGQGGFGTVYKGRLED---GTIVAIK--RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
             G       ++    D      VA+     +  +       E  S    L++++   + 
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVL-PDDVLQETLSRTLRLSRIDKPGVA 94

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           +    +      +V+ E++  G+L+E  D          G +     +A A    H    
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQSLAAAADAAH---R 147

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             +       S + ++ +    +A       A                            
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMPDA---------------------------- 179

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRP 341
                + D+   G  L  L+  R P
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWP 201

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 7e-26
 Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 37/218 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R    G   A K    R   S     S  E + E+  L ++ H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 197 KFHGYLEFEDERIVIVEYVPNGTL------REHL---DCLQGNILDLAGRLDIAIDVAHA 247
             H   E + + ++I+E V  G L      +E L   +                  +   
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA-----------TQFLKQILDG 120

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTESGATHVSTQVK 303
           + YLH      I H D+K  NI+L      N R K+ DFG A                  
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIF- 172

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           GT  ++ PE +    L  ++D++S GV+   L++G  P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  105 bits (265), Expect = 7e-26
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G G F  V+  +    G + A+K  KKS   +   +  ++EI  L +++H N+V    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIVTLED 73

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E      ++++ V  G L + +   +G   +      +   V  A+ YLH   ++ I+
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDAS-LVIQQVLSAVKYLH---ENGIV 128

Query: 261 HRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           HRD+K  N+L     EN +  + DFG +++  +       + +   GT GY+ PE L   
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN------GIMSTACGTPGYVAPEVLAQK 182

Query: 318 QLTEKSDVYSFGVLLVELVTGRRP 341
             ++  D +S GV+   L+ G  P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPP 206

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  106 bits (266), Expect = 1e-25
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 32/275 (11%)

Query: 77  NSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRN 136
             NE K    +     R   + +R+S+  + + +  +          Q  +   Y     
Sbjct: 35  GHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFY----T 90

Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
            S +  +G G FG V+K      G  +A K    + + DK    E ++EI  + Q++H N
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHAN 147

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAHAI 248
           L++ +   E +++ ++++EYV  G L +        I+D +  L           +   I
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDR-------IIDESYNLTELDTILFMKQICEGI 200

Query: 249 TYLHMYTDHPIIHRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            ++H      I+H D+K  NIL    +  + K+ DFG AR     E    +      GT 
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-----GTP 252

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            +L PE +    ++  +D++S GV+   L++G  P
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  104 bits (262), Expect = 1e-25
 Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 36/227 (15%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ--SEIRTLAQVEHLNLVKFH 199
           +G+G +G V           VA+K        +          EI     + H N+VKF+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDM---KRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH--------AITYL 251
           G+    + + + +EY   G L + ++            +      A          + YL
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIE--------PDIGMPE--PDAQRFFHQLMAGVVYL 121

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H      I HRDIK  N+LL E    K++DFG A +     +    ++    GT  Y+ P
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY-NNRERLLNKMC-GTLPYVAP 176

Query: 312 EYL--KTYQLTEKSDVYSFGVLLVELVTGRRP----IEPKRELKERI 352
           E L  + +   E  DV+S G++L  ++ G  P     +  +E  +  
Sbjct: 177 ELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (262), Expect = 2e-25
 Identities = 47/261 (18%), Positives = 90/261 (34%), Gaps = 34/261 (13%)

Query: 161 IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL 220
            +  +     +           +IR +      N V        +    + ++      L
Sbjct: 89  WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENL 148

Query: 221 REHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV 279
           ++ ++        +    L I I +A A+ +LH      ++HRD+K SNI  T +   KV
Sbjct: 149 KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 205

Query: 280 ADFGFARLAADTESGATHVS--------TQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVL 331
            DFG        E   T ++        T   GT  Y+ PE +     + K D++S G++
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265

Query: 332 LVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELA 391
           L EL+             ER+ +   +    +     +   +             +++  
Sbjct: 266 LFELLY------SFSTQMERVRI---ITDVRNLKFPLLFTQKYPQ-------EHMMVQ-- 307

Query: 392 LQCLAPRRQNRPSMRRCAEIL 412
              L+P    RP      +I+
Sbjct: 308 -DMLSPSPTERPE---ATDII 324

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (264), Expect = 2e-25
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 44/248 (17%)

Query: 127 MEEIYRATRNFSPSF----KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ 181
            E +  A+  FS ++    ++G+G F  V +      G   A K             + +
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE 76

Query: 182 SEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTL------REHL------DCLQG 229
            E R   +++H N+V+ H  ++ E    ++ + V  G L      RE         C+Q 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ- 135

Query: 230 NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR 286
            IL+             +I Y H    + I+HR++K  N+LL    +    K+ADFG A 
Sbjct: 136 QILE-------------SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179

Query: 287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EP 344
              D+E+          GT GYL PE LK    ++  D+++ GV+L  L+ G  P   E 
Sbjct: 180 EVNDSEAWHGFA-----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234

Query: 345 KRELKERI 352
           +  L  +I
Sbjct: 235 QHRLYAQI 242

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (260), Expect = 3e-25
 Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 33/219 (15%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-------FQSEIRTLAQV-EH 192
            +G+G    V +          A+K    +     S  E          E+  L +V  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 193 LNLVKFHGYLEFEDERIV--IVEYVPNGTLREHLD--CLQGNILDLAGRLDIAIDVAHAI 248
            N+++      +E       + + +  G L    D    +  + +   R  I   +   I
Sbjct: 84  PNIIQLKDT--YETNTFFFLVFDLMKKGEL---FDYLTEKVTLSEKETR-KIMRALLEVI 137

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
             LH      I+HRD+K  NILL ++   K+ DFGF+      E           GT  Y
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-----GTPSY 189

Query: 309 LDPEYLKTYQL------TEKSDVYSFGVLLVELVTGRRP 341
           L PE ++           ++ D++S GV++  L+ G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (260), Expect = 3e-25
 Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 54/236 (22%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS------------------- 182
           IG+G +G V       D T  A+K   K    + +G   +                    
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 183 -----EIRTLAQVEHLNLVKFHGYLEF-EDERIVIV-EYVPNGTLREHLDCLQGNILDLA 235
                EI  L +++H N+VK    L+   ++ + +V E V  G +   ++          
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPT------L 131

Query: 236 GRL--DIAI----DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA 289
             L  D A     D+   I YLH      IIHRDIK SN+L+ E+   K+ADFG   ++ 
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG---VSN 185

Query: 290 DTESGATHVSTQVKGTAGYLDPEYL----KTYQLTEKSDVYSFGVLLVELVTGRRP 341
           + +     +S  V GT  ++ PE L    K +   +  DV++ GV L   V G+ P
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCP 239

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  103 bits (260), Expect = 4e-25
 Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 40/229 (17%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS----EIRTLAQVEHLNLVK 197
           +G+G +G V           VA+K     + D     +       EI     + H N+VK
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH--------AIT 249
           F+G+    + + + +EY   G L + ++            +      A          + 
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGELFDRIE--------PDIGMPE--PDAQRFFHQLMAGVV 119

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYL 309
           YLH      I HRDIK  N+LL E    K++DFG A +     +    ++    GT  Y+
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY-NNRERLLNKMC-GTLPYV 174

Query: 310 DPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRP----IEPKRELKERI 352
            PE L  + +   E  DV+S G++L  ++ G  P     +  +E  +  
Sbjct: 175 APELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (260), Expect = 5e-25
 Identities = 65/244 (26%), Positives = 97/244 (39%), Gaps = 36/244 (14%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKS------VYDKHSGAEFQSEIRTLAQVEHLNL 195
           +G G FG V+     E    V +K  KK         +     +   EI  L++VEH N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 196 VKFHGYLEFEDERIVIVE-YVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAI 248
           +K     E +    +++E +     L   +D           RLD      I   +  A+
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFID--------RHPRLDEPLASYIFRQLVSAV 143

Query: 249 TYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGY 308
            YL       IIHRDIK  NI++ E+F  K+ DFG A      +   T       GT  Y
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----GTIEY 195

Query: 309 LDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA 366
             PE L    Y+  E  +++S GV L  LV    P     EL+E +            + 
Sbjct: 196 CAPEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENPFC---ELEETVEAAIHPPYLVSKEL 251

Query: 367 ISIL 370
           +S++
Sbjct: 252 MSLV 255

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (259), Expect = 6e-25
 Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 37/218 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R    G   A K    R  ++     S  E + E+  L QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 197 KFHGYLEFEDERIVIVEYVPNGTL------REHL---DCLQGNILDLAGRLDIAIDVAHA 247
             H   E   + ++I+E V  G L      +E L   +                  +   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----------TSFIKQILDG 127

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTESGATHVSTQVK 303
           + YLH      I H D+K  NI+L          K+ DFG A    D           + 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIF 179

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           GT  ++ PE +    L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  102 bits (257), Expect = 1e-24
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 38/211 (18%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE------FQSEIRTLAQVEHLN 194
            +G G  G V      +    VAIK   K  +   S  E       ++EI  L ++ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 195 LVKFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRL------DIAIDVAHA 247
           ++K   +  F+ E   IV E +  G L    D + GN      RL           +  A
Sbjct: 77  IIKIKNF--FDAEDYYIVLELMEGGEL---FDKVVGN-----KRLKEATCKLYFYQMLLA 126

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKG 304
           + YLH   ++ IIHRD+K  N+LL+   E+   K+ DFG +++  +T    T       G
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-----G 178

Query: 305 TAGYLDPEYLKTYQL---TEKSDVYSFGVLL 332
           T  YL PE L +          D +S GV+L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  103 bits (258), Expect = 1e-24
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 37/218 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R    G   A K    R  ++        E + E+  L QV H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 197 KFHGYLEFEDERIVIVEYVPNGTL------REHL---DCLQGNILDLAGRLDIAIDVAHA 247
             H   E   + ++I+E V  G L      +E L   +                  +   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----------TSFIKQILDG 127

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTESGATHVSTQVK 303
           + YLH      I H D+K  NI+L          K+ DFG A    D           + 
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIF 179

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           GT  ++ PE +    L  ++D++S GV+   L++G  P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  102 bits (257), Expect = 2e-24
 Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 28/215 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---EIRTLAQVEHLNLVK 197
            IG+G F  V +    E G   A+K    + +    G   +    E      ++H ++V+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 198 FHGYLEFEDERIV--IVEYVPNGTL------REHLDCLQGNILDLAGRLDIAIDVAHAIT 249
                 +  + ++  + E++    L      R       G +   A        +  A+ 
Sbjct: 91  LLET--YSSDGMLYMVFEFMDGADLCFEIVKRAD----AGFVYSEAVASHYMRQILEALR 144

Query: 250 YLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           Y H   D+ IIHRD+K   +LL     +   K+  FG A    ++      V+    GT 
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL----VAGGRVGTP 197

Query: 307 GYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            ++ PE +K     +  DV+  GV+L  L++G  P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  103 bits (258), Expect = 2e-24
 Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 28/210 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKR-AKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           ++G G FG V++      G +   K        DK      ++EI  + Q+ H  L+  H
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLH 114

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL---DIAI---DVAHAITYLHM 253
              E + E ++I+E++  G L +        I     ++   ++          + ++H 
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFD-------RIAAEDYKMSEAEVINYMRQACEGLKHMH- 166

Query: 254 YTDHPIIHRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
             +H I+H DIK  NI+    +    K+ DFG A      E     +      TA +  P
Sbjct: 167 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFAAP 219

Query: 312 EYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           E +    +   +D+++ GVL   L++G  P
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (255), Expect = 2e-24
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 37/218 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK----RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R    G   A K    R  KS     S  + + E+  L +++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 197 KFHGYLEFEDERIVIVEYVPNGTL------REHL---DCLQGNILDLAGRLDIAIDVAHA 247
             H   E + + I+I+E V  G L      +E L   +             +    + + 
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA-----------TEFLKQILNG 126

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT----ENFRAKVADFGFARLAADTESGATHVSTQVK 303
           + YLH      I H D+K  NI+L        R K+ DFG A                + 
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIF 178

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           GT  ++ PE +    L  ++D++S GV+   L++G  P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (259), Expect = 3e-24
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 41/218 (18%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G+G F  V +   +  G   A               + + E R    ++H N+V+ H 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 201 YLEFEDERIV--IVEYVPNGTL------REHL------DCLQGNILDLAGRLDIAIDVAH 246
                +E     I + V  G L      RE+        C+Q  IL+             
Sbjct: 78  S--ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILE------------- 121

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVK 303
           A+ + H      ++HR++K  N+LL    +    K+ADFG A      E           
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE---VEGEQQAWFGFA- 174

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
           GT GYL PE L+     +  D+++ GV+L  L+ G  P
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (252), Expect = 4e-24
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK- 197
           KIG+G +G V+K R  + G IVAIK+  +S  D     +  +  EIR L Q++H NLV  
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKHPNLVNL 67

Query: 198 ---FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
              F         R+ +V EY  + T+   LD      +       I      A+ + H 
Sbjct: 68  LEVFR-----RKRRLHLVFEYCDH-TVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCH- 119

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPE 312
              H  IHRD+K  NIL+T++   K+ DFGFARL           V+T+      Y  PE
Sbjct: 120 --KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE 172

Query: 313 YL---KTYQLTEKSDVYSFGVLLVELVTGR 339
            L     Y      DV++ G +  EL++G 
Sbjct: 173 LLVGDTQY--GPPVDVWAIGCVFAELLSGV 200

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (255), Expect = 5e-24
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 24/222 (10%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   +  D   + A+K   K    +++       E++ +  +EH  LV    
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              F+DE  +  +V+ +  G LR HL     +  +   +L I  ++  A+ YL    +  
Sbjct: 83  --SFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFIC-ELVMALDYLQ---NQR 135

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           IIHRD+K  NILL E+    + DF  A +        T     + GT  Y+ PE   + +
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-----MAGTKPYMAPEMFSSRK 190

Query: 319 LTEKS---DVYSFGVLLVELVTGRRP-----IEPKRELKERI 352
               S   D +S GV   EL+ GRRP         +E+    
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  100 bits (252), Expect = 6e-24
 Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 31/210 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK- 197
            +G+G +G V K R  + G IVAIK+  +S  DK    +  +  EI+ L Q+ H NLV  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK--MVKKIAMREIKLLKQLRHENLVNL 89

Query: 198 ---FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
                     + +R  +V E+V + T+ + L+ L  N LD          + + I + H 
Sbjct: 90  LEVCK-----KKKRWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCH- 141

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH-VSTQVKGTAGYLDPE 312
              H IIHRDIK  NIL++++   K+ DFGFAR  A         V+T+      Y  PE
Sbjct: 142 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE 194

Query: 313 YL---KTYQLTEKSDVYSFGVLLVELVTGR 339
            L     Y   +  DV++ G L+ E+  G 
Sbjct: 195 LLVGDVKY--GKAVDVWAIGCLVTEMFMGE 222

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (257), Expect = 9e-24
 Identities = 58/286 (20%), Positives = 108/286 (37%), Gaps = 32/286 (11%)

Query: 66  PPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQI 125
            P   ++   +  +E K     D          + + S   Y +             V+I
Sbjct: 92  KPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSN-YDNYVFDIWKQYYPQPVEI 150

Query: 126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKR-AKKSVYDKHSGAEFQSE 183
             + +     ++    ++G G FG V++      G   A K        DK      + E
Sbjct: 151 KHDHV---LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKE 204

Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL---DI 240
           I+T++ + H  LV  H   E ++E ++I E++  G L E        + D   ++   + 
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEK-------VADEHNKMSEDEA 257

Query: 241 AI---DVAHAITYLHMYTDHPIIHRDIKSSNILLT--ENFRAKVADFGFARLAADTESGA 295
                 V   + ++H   ++  +H D+K  NI+ T   +   K+ DFG        +   
Sbjct: 258 VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--- 311

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                   GTA +  PE  +   +   +D++S GVL   L++G  P
Sbjct: 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 99.2 bits (248), Expect = 9e-24
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 33/224 (14%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V  G     G  VA+K   +            + EI+ L    H +++K + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH--------AITYLH 252
            +    +  +++EYV  G L +++           GR++     A         A+ Y H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC--------KHGRVEE--MEARRLFQQILSAVDYCH 128

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H ++HRD+K  N+LL  +  AK+ADFG + + +D E   T       G+  Y  PE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPE 180

Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            +  + Y    + D++S GV+L  L+ G  P + +    L ++I
Sbjct: 181 VISGRLYA-GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.7 bits (244), Expect = 8e-23
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 32/227 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
            +G+G F    K    +     A+K     +  K   A  Q EI  L     H N+VK H
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 200 GYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
               F D+     ++E +  G L E +   + +  +      I   +  A++++H   D 
Sbjct: 73  EV--FHDQLHTFLVMELLNGGELFERI-KKKKHFSETEAS-YIMRKLVSAVSHMH---DV 125

Query: 258 PIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
            ++HRD+K  N+L T   +N   K+ DFGFARL          + T    T  Y  PE L
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL---KPPDNQPLKTPC-FTLHYAAPELL 181

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP---------IEPKRELKERI 352
                 E  D++S GV+L  +++G+ P              E+ ++I
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.9 bits (249), Expect = 8e-23
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 30/245 (12%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V+  +++  G + A K+  K    K  G +    E + LA+V    +V    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYLHMY 254
             E + +  +++  +  G +R H+     N+ +                +   + +LH  
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIY----NVDEDNPGFQEPRAIFYTAQIVSGLEHLH-- 306

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               II+RD+K  N+LL ++   +++D G   LA + ++G T       GT G++ PE L
Sbjct: 307 -QRNIIYRDLKPENVLLDDDGNVRISDLG---LAVELKAGQTKTKGYA-GTPGFMAPELL 361

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP------IEPKRELKERI---TVKWAMKKFSDGD 365
              +     D ++ GV L E++  R P          +ELK+R+    V +   KFS   
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP-DKFSP-A 419

Query: 366 AISIL 370
           +    
Sbjct: 420 SKDFC 424

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   +L++   + A+K   K    K +    F+ E   L   +   +   H 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              F+D+  +  +++Y   G L   L   +  + +   R  +A ++  AI  +H      
Sbjct: 142 --AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH---QLH 195

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDIK  NIL+  N   ++ADFG      +  +  +     V GT  Y+ PE L+  +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS--VAV-GTPDYISPEILQAME 252

Query: 319 LTEKS-----DVYSFGVLLVELVTGRRP 341
             +       D +S GV + E++ G  P
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G+G    VY+ +        A+K  KK+V DK      ++EI  L ++ H N++K   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKI---VRTEIGVLLRLSHPNIIKLKE 115

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E   E  +++E V  G L + +   +G   +     D    +  A+ YLH   ++ I+
Sbjct: 116 IFETPTEISLVLELVTGGELFDRI-VEKGYYSERDAA-DAVKQILEAVAYLH---ENGIV 170

Query: 261 HRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
           HRD+K  N+L      +   K+ADFG +++        T       GT GY  PE L+  
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-----GTPGYCAPEILRGC 225

Query: 318 QLTEKSDVYSFGVLLVELVTGRRP 341
               + D++S G++   L+ G  P
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEP 249

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 29/231 (12%)

Query: 133 ATRNFSPSFK---------IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS 182
           +T +FS  F+         +G+G    V     L      A+K  +K     H  +    
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFR 59

Query: 183 EIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIA 241
           E+  L Q + H N+++   + E ED   ++ E +  G++  H+   + +  +L     + 
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI-HKRRHFNELEAS-VVV 117

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFAR---LAADTESGA 295
            DVA A+ +LH   +  I HRD+K  NIL     +    K+ DF       L  D    +
Sbjct: 118 QDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKS-----DVYSFGVLLVELVTGRRP 341
           T       G+A Y+ PE ++ +           D++S GV+L  L++G  P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 55/227 (24%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK- 197
           KIG+G +GTV+K +  E   IVA+KR +  + D   G    +  EI  L +++H N+V+ 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRL 66

Query: 198 ---FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAH---- 246
               H      D+++ +V E+       +          DL    D     +D       
Sbjct: 67  HDVLHS-----DKKLTLVFEFC------DQ---------DLKKYFDSCNGDLDPEIVKSF 106

Query: 247 ------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
                  + + H      ++HRD+K  N+L+  N   K+A+FG AR         +    
Sbjct: 107 LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--- 160

Query: 301 QVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
           +V  T  Y  P+ L   K Y  +   D++S G +  EL    RP+ P
Sbjct: 161 EVV-TLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPLFP 204

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 33/224 (14%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V  G+    G  VA+K   +            + EI+ L    H +++K + 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVA--------HAITYLH 252
            +    +  +++EYV  G L +++           GRLD     +          + Y H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYIC--------KNGRLDE--KESRRLFQQILSGVDYCH 133

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H ++HRD+K  N+LL  +  AK+ADFG + + +D E     + T   G+  Y  PE
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSC-GSPNYAAPE 185

Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            +  + Y   E  D++S GV+L  L+ G  P +      L ++I
Sbjct: 186 VISGRLYAGPE-VDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 98.3 bits (245), Expect = 3e-22
 Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 17/237 (7%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQVEHLNLVKFHG 200
           +G+GGFG V   ++   G + A K+ +K    K  G     +E + L +V    +V    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E +D   +++  +  G L+ H+  +       A  +  A ++   +  LH      I+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIV 308

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RD+K  NILL ++   +++D G   LA     G T +  +V GT GY+ PE +K  + T
Sbjct: 309 YRDLKPENILLDDHGHIRISDLG---LAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 363

Query: 321 EKSDVYSFGVLLVELVTGRRP------IEPKRELKERI-TVKWAMKKFSDGDAISIL 370
              D ++ G LL E++ G+ P         + E++  +  V     +     A S+ 
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 95.3 bits (238), Expect = 4e-22
 Identities = 66/228 (28%), Positives = 95/228 (41%), Gaps = 28/228 (12%)

Query: 132 RATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS----EI-- 184
            AT  + P  +IG G +GTVYK R    G  VA+K  +        G         E+  
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVREVAL 64

Query: 185 -RTLAQVEHLNLVK----FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRL 238
            R L   EH N+V+            + ++ +V E+V    LR +LD      L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
           D+       + +LH    + I+HRD+K  NIL+T     K+ADFG AR     +   T  
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTP- 178

Query: 299 STQVKGTAGYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
              V  T  Y  PE L   TY      D++S G +  E+   R+P+  
Sbjct: 179 --VVV-TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFR-RKPLFC 220

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 34/224 (15%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V      +    VA+K   + +  K       + EI  L  + H +++K + 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVA--------HAITYLH 252
            +    + ++++EY   G L +++            R+    D           AI Y H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIV--------EKKRMTE--DEGRRFFQQIICAIEYCH 125

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               H I+HRD+K  N+LL +N   K+ADFG + +  D       + T   G+  Y  PE
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSC-GSPNYAAPE 177

Query: 313 YL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERI 352
            +  K Y    + DV+S G++L  ++ GR P + +    L +++
Sbjct: 178 VINGKLYA-GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 20/210 (9%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           IG+G F  V   +++  G + A+K   K    K      F+ E   L   +   + + H 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           +  F+DE  +  ++EY   G L   L      I     R  +A ++  AI  +H      
Sbjct: 128 F-AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVH---RLG 182

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRDIK  NILL      ++ADFG          G       V GT  YL PE L+   
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSC--LKLRADGTVRSLVAV-GTPDYLSPEILQAVG 239

Query: 319 LTEKSDVY-------SFGVLLVELVTGRRP 341
               +  Y       + GV   E+  G+ P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.9 bits (241), Expect = 1e-21
 Identities = 75/346 (21%), Positives = 128/346 (36%), Gaps = 39/346 (11%)

Query: 42  RKTSKNSLAMAAKAVAGLFVACFTPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRS 101
              S+                 F+       +  +   +  P             +  R 
Sbjct: 102 LVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIE--EICQNLRG 159

Query: 102 SSQGLYVSSNNSTRGGDQ---SGNVQITME--EIYRATRNFSPSFKIGQGGFGTVYKGRL 156
                ++ S+  TR         N+ +TM    ++R          IG+GGFG VY  R 
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRI---------IGRGGFGEVYGCRK 210

Query: 157 ED-GTIVAIKRAKKSVYDKHSGAEF-QSEIRTLAQVEHLN---LVKFHGYLEFEDERIVI 211
            D G + A+K   K       G     +E   L+ V   +   +V         D+   I
Sbjct: 211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270

Query: 212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL 271
           ++ +  G L  HL    G   +   R   A ++   + ++H   +  +++RD+K +NILL
Sbjct: 271 LDLMNGGDLHYHLSQ-HGVFSEADMRFYAA-EIILGLEHMH---NRFVVYRDLKPANILL 325

Query: 272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKS-DVYSFGV 330
            E+   +++D G   LA D      H    V GT GY+ PE L+     + S D +S G 
Sbjct: 326 DEHGHVRISDLG---LACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGC 379

Query: 331 LLVELVTGRRP-----IEPKRELKERI-TVKWAMKKFSDGDAISIL 370
           +L +L+ G  P      + K E+     T+   +      +  S+L
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 48/227 (21%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           KIGQG FG V+K R  + G  VA+K+    + ++  G    +  EI+ L  ++H N+V  
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKHENVVNL 81

Query: 199 HGYLEFEDERIVIVEYVPNGTLR-------EHLDCLQGNILDLAGRLD---IAIDVAH-- 246
                     I   +  P    +       +  +       DLAG L    +   ++   
Sbjct: 82  IE--------ICRTKASPYNRCKGSIYLVFDFCE------HDLAGLLSNVLVKFTLSEIK 127

Query: 247 --------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
                    + Y+H    + I+HRD+K++N+L+T +   K+ADFG AR  +  ++   + 
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 299 STQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPI 342
            T    T  Y  PE L   + Y      D++  G ++ E+ T R PI
Sbjct: 185 YTNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWT-RSPI 228

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 37/224 (16%)

Query: 141 FKIGQGGFGTVYKGR---LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            K+G+G +G VYK +    +D    A+K+ + +     +      EI  L +++H N++ 
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPNVIS 82

Query: 198 FHG-YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH--------- 246
               +L   D ++ ++ +Y  +  L   +   + +    A +  + +             
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRAS---KANKKPVQLPRGMVKSLLYQIL 138

Query: 247 -AITYLHMYTDHPIIHRDIKSSNILLTENFRA----KVADFGFARLAADTESGATHVSTQ 301
             I YLH    + ++HRD+K +NIL+          K+AD GFARL          +   
Sbjct: 139 DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 302 VKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPI 342
           V  T  Y  PE L   + Y  T+  D+++ G +  EL+T   PI
Sbjct: 196 VV-TFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLT-SEPI 235

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 54/221 (24%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK-- 197
           K+G+G +G VYK +   G IVA+KR +  +  +  G    +  EI  L ++ H N+V   
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHHPNIVSLI 85

Query: 198 --FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAH----- 246
              H      +  + +V E++      E          DL   LD     +  +      
Sbjct: 86  DVIHS-----ERCLTLVFEFM------EK---------DLKKVLDENKTGLQDSQIKIYL 125

Query: 247 -----AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
                 + + H    H I+HRD+K  N+L+  +   K+ADFG AR         TH   +
Sbjct: 126 YQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---E 179

Query: 302 VKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
           V  T  Y  P+ L   K Y  +   D++S G +  E++TG+
Sbjct: 180 VV-TLWYRAPDVLMGSKKY--STSVDIWSIGCIFAEMITGK 217

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 41/229 (17%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           IG G FG     R      +VA+K  ++           Q EI     + H N+V+F   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH--------AITYLHM 253
           +       +I+EY   G L E         +  AGR     D A          ++Y H 
Sbjct: 85  ILTPTHLAIIMEYASGGELYER--------ICNAGRFS--EDEARFFFQQLLSGVSYCH- 133

Query: 254 YTDHPIIHRDIKSSNILLTENF--RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
                I HRD+K  N LL  +   R K+ DFG+++ +       + V     GT  Y+ P
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIAP 186

Query: 312 EYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIE----PK--RELKERI 352
           E L  + Y   + +DV+S GV L  ++ G  P E    P+  R+  +RI
Sbjct: 187 EVLLRQEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 93.4 bits (233), Expect = 3e-21
 Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 47/224 (20%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHS-GAEFQS--EIRTLAQVEHLNLVK 197
            +G+G F TVYK R      IVAIK+ K     +   G    +  EI+ L ++ H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 198 FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAH------- 246
                      I +V +++      E          DL   +    + +  +H       
Sbjct: 77  LLD-AFGHKSNISLVFDFM------ET---------DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 247 ---AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
               + YLH    H I+HRD+K +N+LL EN   K+ADFG A+         TH   QV 
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV 174

Query: 304 GTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            T  Y  PE L   + Y      D+++ G +L EL+  R P  P
Sbjct: 175 -TRWYRAPELLFGARMY--GVGVDMWAVGCILAELLL-RVPFLP 214

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 70/349 (20%), Positives = 109/349 (31%), Gaps = 105/349 (30%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLN 194
            +G+G FG V +              VA+K  K+            SE++ L  +  HLN
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLN 87

Query: 195 LVKFHGY-LEFEDERIVIVEYVPNGTLREHL---------------------DCLQGNIL 232
           +V   G   +     +VIVE+   G L  +L                     D +    +
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 233 DLAGRLDIAIDVAHAITYLHM----------YTDHPIIHRDIKSSN-------------- 268
           DL  RLD       + +   +                +++D  +                
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 269 ----------------ILLTENFRAKVADFGFARLAADTESGATHVSTQ-----VKGTAG 307
                           ILL+E    K+ DFG AR   D      +V        +K  A 
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKGDARLPLKWMA- 263

Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRP---IEPKRELKERITVKWAMKKFSD 363
              PE +     T +SDV+SFGVLL E+ + G  P   ++   E   R+     M+    
Sbjct: 264 ---PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--- 317

Query: 364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                   P             ++ +  L C       RP+     E L
Sbjct: 318 --------PD--------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 28/227 (12%)

Query: 132 RATRNFSPSFKIGQGGFGTVYKGR--LEDGTIVAIKRAKKSVYDKHSGAEFQS--EI--- 184
           RA + +    +IG+G +G V+K R     G  VA+KR +  V     G    +  E+   
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVL 65

Query: 185 RTLAQVEHLNLVK----FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD 239
           R L   EH N+V+            + ++ +V E+V    L  +LD +    +      D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
           +   +   + +LH    H ++HRD+K  NIL+T + + K+ADFG AR     +   T   
Sbjct: 125 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTS-- 178

Query: 300 TQVKGTAGYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
             V  T  Y  PE L   +Y      D++S G +  E+   R+P+  
Sbjct: 179 -VVV-TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFR-RKPLFR 220

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.0 bits (227), Expect = 7e-21
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 54/221 (24%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK-- 197
           KIG+G +G VYK +   G   A+K+ +  +  +  G    +  EI  L +++H N+VK  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 198 --FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAH----- 246
              H       +R+V+V E++      +          DL   LD     ++        
Sbjct: 67  DVIHT-----KKRLVLVFEHL------DQ---------DLKKLLDVCEGGLESVTAKSFL 106

Query: 247 -----AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQ 301
                 I Y H   D  ++HRD+K  N+L+      K+ADFG AR         TH   +
Sbjct: 107 LQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---E 160

Query: 302 VKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
           +  T  Y  P+ L   K Y  +   D++S G +  E+V G 
Sbjct: 161 IV-TLWYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 55/212 (25%), Positives = 106/212 (50%), Gaps = 31/212 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           K+G G + TVYKG     G  VA+K  K    D   G    +  EI  + +++H N+V+ 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 199 HGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH-------AITY 250
           +  +   + ++ +V E++ N  L++++D     + +    L++ + V +        + +
Sbjct: 69  YD-VIHTENKLTLVFEFMDN-DLKKYMD--SRTVGNTPRGLELNL-VKYFQWQLLQGLAF 123

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
            H   ++ I+HRD+K  N+L+ +  + K+ DFG AR      +  +    +V  T  Y  
Sbjct: 124 CH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRA 176

Query: 311 PEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
           P+ L   +TY  +   D++S G +L E++TG+
Sbjct: 177 PDVLMGSRTY--STSIDIWSCGCILAEMITGK 206

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 30/224 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ-VEHLNLVKFH 199
            IG G +    +          A+K   KS   K    E   EI  L +  +H N++   
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRDPTE---EIEILLRYGQHPNIITLK 82

Query: 200 GYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
               ++D + V  + E +  G L + +   Q    +      +   +   + YLH     
Sbjct: 83  DV--YDDGKYVYVVTELMKGGELLDKI-LRQKFFSEREAS-AVLFTITKTVEYLH---AQ 135

Query: 258 PIIHRDIKSSNILLTENFRA----KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
            ++HRD+K SNIL  +        ++ DFGFA+      +    + T    TA ++ PE 
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ---LRAENGLLMTPC-YTANFVAPEV 191

Query: 314 LKTYQLTEKSDVYSFGVLLVELVTG-----RRPIEPKRELKERI 352
           L+        D++S GVLL  ++TG       P +   E+  RI
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 58/304 (19%), Positives = 100/304 (32%), Gaps = 56/304 (18%)

Query: 78  SNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNF 137
           SN    SP           +    +                   +V+  ++         
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQ---IKKNAI 59

Query: 138 SPSFK-----IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV- 190
              +K     +G G  G V +          A+K  +          + + E+    +  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRAS 112

Query: 191 EHLNLVKFHGYLEFEDERI------VIVEYVPNGTLREHLDCLQGNILDLAGRL------ 238
           +  ++V+      +E+         +++E +  G L          I D   +       
Sbjct: 113 QCPHIVRIVDV--YENLYAGRKCLLIVMECLDGGELFSR-------IQDRGDQAFTEREA 163

Query: 239 -DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESG 294
            +I   +  AI YLH      I HRD+K  N+L T    N   K+ DFGFA+      S 
Sbjct: 164 SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220

Query: 295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP------IEPKREL 348
            T        T  Y+ PE L   +  +  D++S GV++  L+ G  P      +     +
Sbjct: 221 TTPC-----YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275

Query: 349 KERI 352
           K RI
Sbjct: 276 KTRI 279

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 43/218 (19%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
            +G G  G V +      G   A+K    S        + + E+    Q     ++V   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCIL 88

Query: 200 GYLEFEDERI------VIVEYVPNGTLREHLDCLQGNILDLAGRL-------DIAIDVAH 246
               +E+         +I+E +  G L          I +   +        +I  D+  
Sbjct: 89  DV--YENMHHGKRCLLIIMECMEGGELFSR-------IQERGDQAFTEREAAEIMRDIGT 139

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVK 303
           AI +LH    H I HRD+K  N+L T   ++   K+ DFGFA+           + T   
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPC- 190

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            T  Y+ PE L   +  +  D++S GV++  L+ G  P
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 66/264 (25%), Positives = 107/264 (40%), Gaps = 57/264 (21%)

Query: 105 GLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRL-EDGTIVA 163
           G  +S N +    ++S          ++  R        GQG FGTV  G+    G  VA
Sbjct: 3   GSMMSLNAAAAADERSRKEMDR----FQVER------MAGQGTFGTVQLGKEKSTGMSVA 52

Query: 164 IKRAKKSVYDKHSGA--EFQSEIRTLAQVEHLNLVK----FH--GYLEFEDERIVIV-EY 214
           IK+    V         E Q  ++ LA + H N+V+    F+  G  +  D  + +V EY
Sbjct: 53  IKK----VIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107

Query: 215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAH----------AITYLHMYTDHPIIHRDI 264
           VP+ TL                R  +A               +I  LH+ +   + HRDI
Sbjct: 108 VPD-TLH--------RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDI 157

Query: 265 KSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---KTYQLT 320
           K  N+L+   +   K+ DFG A+  + +E    ++ ++      Y  PE +   + Y  T
Sbjct: 158 KPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHY--T 210

Query: 321 EKSDVYSFGVLLVELVTGRRPIEP 344
              D++S G +  E++ G  PI  
Sbjct: 211 TAVDIWSVGCIFAEMMLG-EPIFR 233

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           IG+G FG V   R +    + A+K   K    K S +  F  E   +A      +V+   
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
              F+D+R +  ++EY+P G L   +     ++ +   R   A +V  A+  +H      
Sbjct: 137 --AFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTA-EVVLALDAIH---SMG 188

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            IHRD+K  N+LL ++   K+ADFG        + G     T V GT  Y+ PE LK+  
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245

Query: 319 LTEK----SDVYSFGVLLVELVTGRRP 341
                    D +S GV L E++ G  P
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 48/218 (22%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVKF 198
           K+G+G + TVYKG+      +VA+K  +    +   GA   +  E+  L  ++H N+V  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 199 HGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD---IAIDVAH-------- 246
           H  +   ++ + +V EY+      +          DL   LD     I++ +        
Sbjct: 66  HD-IIHTEKSLTLVFEYL------DK---------DLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 247 --AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKG 304
              + Y H      ++HRD+K  N+L+ E    K+ADFG AR  +       +   +V  
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV- 162

Query: 305 TAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
           T  Y  P+ L     Y  + + D++  G +  E+ TGR
Sbjct: 163 TLWYRPPDILLGSTDY--STQIDMWGVGCIFYEMATGR 198

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 59/289 (20%)

Query: 78  SNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNF 137
           +  F  S       S   + +      G  V++  +T G       +++    Y  T+  
Sbjct: 7   TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVS----YTDTK-- 60

Query: 138 SPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVEHLNL 195
                IG G FG VY+ +L + G +VAIK+  +          F++ E++ + +++H N+
Sbjct: 61  ----VIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHCNI 109

Query: 196 VK----FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH--- 246
           V+    F+   E +DE  +  +++YVP  T+          +     R    + V +   
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY--------RVARHYSRAKQTLPVIYVKL 160

Query: 247 -------AITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHV 298
                  ++ Y+H      I HRDIK  N+LL  +    K+ DFG A+     E   +++
Sbjct: 161 YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 299 STQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEP 344
            ++      Y  PE +     Y  T   DV+S G +L EL+ G +PI P
Sbjct: 218 CSRY-----YRAPELIFGATDY--TSSIDVWSAGCVLAELLLG-QPIFP 258

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 59/226 (26%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS--EIRTLAQVEHLNLVK- 197
           K+G+G +G VYK         VAIKR +  +  +  G    +  E+  L +++H N+++ 
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 198 ---FHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLD--IAIDVAH----- 246
               H      + R+ ++ EY       E+         DL   +D    + +       
Sbjct: 99  KSVIHH-----NHRLHLIFEYA------EN---------DLKKYMDKNPDVSMRVIKSFL 138

Query: 247 -----AITYLHMYTDHPIIHRDIKSSNILLTENFRA-----KVADFGFARLAADTESGAT 296
                 + + H       +HRD+K  N+LL+ +  +     K+ DFG AR         T
Sbjct: 139 YQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 297 HVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGR 339
           H   ++  T  Y  PE L   + Y  +   D++S   +  E++   
Sbjct: 196 H---EII-TLWYRPPEILLGSRHY--STSVDIWSIACIWAEMLMKT 235

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 28/241 (11%)

Query: 143 IGQGGFGTVY----KGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           +GQG FG V+        +   + A+K  KK+          + E   L +V H  +VK 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 199 H------GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
           H      G L        I++++  G L   L        +   +  +A ++A A+ +LH
Sbjct: 92  HYAFQTEGKLYL------ILDFLRGGDLFTRLSKEVMFTEEDV-KFYLA-ELALALDHLH 143

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 II+RD+K  NILL E    K+ DFG ++ + D E  A    +   GT  Y+ PE
Sbjct: 144 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFC-GTVEYMAPE 196

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI-TVKWAMKKFSDGDAISI 369
            +     T+ +D +SFGVL+ E++TG  P   + ++E    I   K  M +F   +A S+
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256

Query: 370 L 370
           L
Sbjct: 257 L 257

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 30/209 (14%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V   + ++ G   A+K   K  V          +E R L  V    LVK   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLD------IAIDVAHAITYLH 252
              F+D   +  ++EYV  G +  HL           GR         A  +     YLH
Sbjct: 109 S--FKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 +I+RD+K  N+L+ +    +V DFGFA+         T   T + GT   L PE
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TW--T-LCGTPEALAPE 208

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
            + +    +  D ++ GVL+ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 20/290 (6%)

Query: 86  VSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQ 145
           V+D  + +A+ E    S      S              ++TM         F     +G+
Sbjct: 106 VADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-------EFEYLKLLGK 158

Query: 146 GGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLE 203
           G FG V   + +  G   A+K  KK  +  K   A   +E R L    H  L       +
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218

Query: 204 FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRD 263
             D    ++EY   G L  HL   +    D A R   A ++  A+ YLH  ++  +++RD
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYGA-EIVSALDYLH--SEKNVVYRD 274

Query: 264 IKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKS 323
           +K  N++L ++   K+ DFG  +      +          GT  YL PE L+        
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC----GTPEYLAPEVLEDNDYGRAV 330

Query: 324 DVYSFGVLLVELVTGRRPI--EPKRELKERI-TVKWAMKKFSDGDAISIL 370
           D +  GV++ E++ GR P   +   +L E I   +    +    +A S+L
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 69/241 (28%), Positives = 107/241 (44%), Gaps = 33/241 (13%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHG 200
           +G G FG V+  R    G   A+K  KK +  +    E    E   L+ V H  +++  G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYLH 252
              F+D + +  I++Y+  G L   L          + R         A +V  A+ YLH
Sbjct: 74  T--FQDAQQIFMIMDYIEGGELFSLLRK--------SQRFPNPVAKFYAAEVCLALEYLH 123

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 II+RD+K  NILL +N   K+ DFGFA+   D     T+  T + GT  Y+ PE
Sbjct: 124 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TY--T-LCGTPDYIAPE 173

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITV-KWAMKKFSDGDAISI 369
            + T    +  D +SFG+L+ E++ G  P       +  E+I   +     F + D   +
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 233

Query: 370 L 370
           L
Sbjct: 234 L 234

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 59/247 (23%), Positives = 104/247 (42%), Gaps = 54/247 (21%)

Query: 119 QSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGA 178
             G      E  Y   +       IG G FG V++ +L +   VAIK+  +         
Sbjct: 30  SDGKTGEQREIAYTNCK------VIGNGSFGVVFQAKLVESDEVAIKKVLQ-------DK 76

Query: 179 EFQS-EIRTLAQVEHLNLVK----FHGYLEFEDERIV--IVEYVPNGTLREHLDCLQGNI 231
            F++ E++ +  V+H N+V     F+   + +DE  +  ++EYVP  T+           
Sbjct: 77  RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY--------RA 127

Query: 232 LDLAGRLDIAIDVAH----------AITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVA 280
                +L   + +            ++ Y+H      I HRDIK  N+LL   +   K+ 
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLI 184

Query: 281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVT 337
           DFG A++    E   +++ ++      Y  PE +     Y  T   D++S G ++ EL+ 
Sbjct: 185 DFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNY--TTNIDIWSTGCVMAELMQ 237

Query: 338 GRRPIEP 344
           G +P+ P
Sbjct: 238 G-QPLFP 243

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 85.5 bits (211), Expect = 6e-18
 Identities = 67/317 (21%), Positives = 114/317 (35%), Gaps = 20/317 (6%)

Query: 65  TPPETNSSKDFVNSNEFKPSPVSDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQ 124
              +      F   ++ +    +       S        +         T+  ++     
Sbjct: 266 ELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANT 325

Query: 125 ITMEEIYRATRNFSPS-FK----IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSG 177
           I+  +          + F     +G+G FG V     +    + A+K  KK  V      
Sbjct: 326 ISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV 385

Query: 178 AEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG 236
                E R LA   +   L + H   +  D    ++EYV  G L  H+   Q        
Sbjct: 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPH 443

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
            +  A ++A  + +L       II+RD+K  N++L      K+ADFG  +          
Sbjct: 444 AVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT- 499

Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITV 354
              T   GT  Y+ PE +      +  D ++FGVLL E++ G+ P   E + EL + I  
Sbjct: 500 --KTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

Query: 355 -KWAMKKFSDGDAISIL 370
              A  K    +A++I 
Sbjct: 557 HNVAYPKSMSKEAVAIC 573

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 50/241 (20%), Positives = 85/241 (35%), Gaps = 53/241 (21%)

Query: 128 EEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS----- 182
            E++     ++    I  G +G V  G   +G  VAIKR   +V D  +           
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74

Query: 183 ----EIRTLAQVEH------LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNIL 232
               EIR L    H       ++             + +V         E +        
Sbjct: 75  RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHK--LYLVT--------ELMRT------ 118

Query: 233 DLAGRL---DIAIDVAH----------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKV 279
           DLA  +    I I   H           +  LH   +  ++HRD+   NILL +N    +
Sbjct: 119 DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITI 175

Query: 280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTG 338
            DF  AR      +   +V+ +      Y  PE +  ++  T+  D++S G ++ E+   
Sbjct: 176 CDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

Query: 339 R 339
           +
Sbjct: 231 K 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 44/219 (20%), Positives = 88/219 (40%), Gaps = 44/219 (20%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVK-- 197
           K+G+G +  V++   + +   V +K  K  V  K    + + EI+ L  +    N++   
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKP-VKKK----KIKREIKILENLRGGPNIITLA 97

Query: 198 --FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGN--------ILDLAGRLDIAIDVAHA 247
                 +       ++ E+V N   ++    L           IL              A
Sbjct: 98  DIVKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------------A 142

Query: 248 ITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           + Y H      I+HRD+K  N+++  E+ + ++ D+G A      +     V+++     
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195

Query: 307 GYLDPEYLKTYQLTEKS-DVYSFGVLLVELVTGRRPIEP 344
            +  PE L  YQ+ + S D++S G +L  ++  + P   
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 14/233 (6%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +G+G FG V   R +  G   A+K  +K  +  K   A   +E R L    H  L     
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             +  D    ++EY   G L  HL   +    + A R   A ++  A+ YLH      ++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGA-EIVSALEYLH---SRDVV 127

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           +RDIK  N++L ++   K+ DFG  +      +      T   GT  YL PE L+     
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFC-GTPEYLAPEVLEDNDYG 183

Query: 321 EKSDVYSFGVLLVELVTGRRPI--EPKRELKERI-TVKWAMKKFSDGDAISIL 370
              D +  GV++ E++ GR P   +    L E I   +    +    +A S+L
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 63/305 (20%), Positives = 111/305 (36%), Gaps = 41/305 (13%)

Query: 93  RASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPS-FK----IGQGG 147
               E   S       +          +   ++    +           F+    +G G 
Sbjct: 7   HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66

Query: 148 FGTVY----KGRLEDGTIVAIKRAKK-SVYDKHSGAEF-QSEIRTLAQVEHLN-LVKFHG 200
           +G V+        + G + A+K  KK ++  K    E  ++E + L  +     LV  H 
Sbjct: 67  YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 126

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYLHMY 254
             + E +  +I++Y+  G L  HL            R           ++  A+ +LH  
Sbjct: 127 AFQTETKLHLILDYINGGELFTHLS--------QRERFTEHEVQIYVGEIVLALEHLH-- 176

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               II+RDIK  NILL  N    + DFG ++     E+   +      GT  Y+ P+ +
Sbjct: 177 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY--DFC-GTIEYMAPDIV 232

Query: 315 KT--YQLTEKSDVYSFGVLLVELVTGRRP------IEPKRELKERI-TVKWAMKKFSDGD 365
           +       +  D +S GVL+ EL+TG  P         + E+  RI   +    +     
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 292

Query: 366 AISIL 370
           A  ++
Sbjct: 293 AKDLI 297

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 62/237 (26%), Positives = 110/237 (46%), Gaps = 18/237 (7%)

Query: 143 IGQGGFGTVYKGRL----EDGTIVAIKRAKKS--VYDKHSGAEFQSEIRTLAQVEHLNLV 196
           +G+GG+G V++ R       G I A+K  KK+  V +    A  ++E   L +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
                 +   +  +I+EY+  G L   L+     + D A    +A +++ A+ +LH    
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYLA-EISMALGHLH---Q 139

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             II+RD+K  NI+L      K+ DFG  + +    +      T   GT  Y+ PE L  
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFC-GTIEYMAPEILMR 195

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI-TVKWAMKKFSDGDAISIL 370
                  D +S G L+ +++TG  P   E +++  ++I   K  +  +   +A  +L
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLL 252

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 57/255 (22%), Positives = 93/255 (36%), Gaps = 61/255 (23%)

Query: 113 STRGGDQSGNVQITM-EEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKS 170
            +R    +    + + +  +   + +     IG G  G V           VAIK     
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK----- 56

Query: 171 VYDKHSGAEFQS---------EIRTLAQVEHLNLVK-------FHGYLEFEDERIVIVEY 214
              K S   FQ+         E+  +  V H N++             EF+D  + IV  
Sbjct: 57  ---KLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD--VYIVM- 109

Query: 215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAH----------AITYLHMYTDHPIIHRDI 264
                  E +D       +L   + + +D              I +LH      IIHRD+
Sbjct: 110 -------ELMDA------NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDL 153

Query: 265 KSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSD 324
           K SNI++  +   K+ DFG AR A  +     +V T+      Y  PE +      E  D
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVD 208

Query: 325 VYSFGVLLVELVTGR 339
           ++S G ++ E++ G 
Sbjct: 209 IWSVGCIMGEMIKGG 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 15/234 (6%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
           +G+G FG V+    +      AIK  KK  V           E R L+   EH  L    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + ++    ++EY+  G L  H+     +  DL+     A ++   + +LH      I
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLH---SKGI 139

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           ++RD+K  NILL ++   K+ADFG  +     ++     +T   GT  Y+ PE L   + 
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFC-GTPDYIAPEILLGQKY 195

Query: 320 TEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITV-KWAMKKFSDGDAISIL 370
               D +SFGVLL E++ G+ P   + + EL   I +      ++ + +A  +L
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 17/242 (7%)

Query: 108 VSSNNSTRGGDQSGNVQITMEEIYRATRNFSPS-FK----IGQGGFGTVYKGRLED-GTI 161
           +    +   G +     +   E  +A+ +     F     IG+G +  V   RL+    I
Sbjct: 20  LYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRI 79

Query: 162 VAIKRAKKS-VYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEYVPNGT 219
            A++  KK  V D       Q+E     Q   H  LV  H   + E     ++EYV  G 
Sbjct: 80  YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 139

Query: 220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV 279
           L  H+   Q  + +   R   A +++ A+ YLH   +  II+RD+K  N+LL      K+
Sbjct: 140 LMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKL 194

Query: 280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
            D+G  +            ST   GT  Y+ PE L+        D ++ GVL+ E++ GR
Sbjct: 195 TDYGMCKEGLRPGDTT---ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

Query: 340 RP 341
            P
Sbjct: 251 SP 252

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 63/240 (26%), Positives = 93/240 (38%), Gaps = 27/240 (11%)

Query: 143 IGQGGFGTVYKGRL-EDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQ-VEHLNLVKFH 199
           IG+G FG V   R   +    A+K  +K  +  K       SE   L + V+H  LV  H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI------AIDVAHAITYLHM 253
              +  D+   +++Y+  G L  HL                      A ++A A+ YLH 
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQ--------RERCFLEPRARFYAAEIASALGYLH- 156

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
                I++RD+K  NILL       + DFG  +   +  S     ST   GT  YL PE 
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT---STFC-GTPEYLAPEV 210

Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERI-TVKWAMKKFSDGDAISIL 370
           L         D +  G +L E++ G  P       E+ + I      +K      A  +L
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 12/202 (5%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
           IG+G +  V   RL+    I A+K  KK  V D       Q+E     Q   H  LV  H
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + E     ++EYV  G L  H+   Q  + +   R   A +++ A+ YLH   +  I
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH---ERGI 131

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ D+G  +            ST   GT  Y+ PE L+    
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFC-GTPNYIAPEILRGEDY 187

Query: 320 TEKSDVYSFGVLLVELVTGRRP 341
               D ++ GVL+ E++ GR P
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSP 209

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 47/236 (19%), Positives = 79/236 (33%), Gaps = 71/236 (30%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
            +G G  G V +          A+K  +          + + E+    +  +  ++V+  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 77

Query: 200 GYLEFEDERI------VIVEYVPNGTLREHLDCLQGNILDLAGRL-------DIAIDVAH 246
               +E+         +++E +  G L          I D   +        +I   +  
Sbjct: 78  DV--YENLYAGRKCLLIVMECLDGGEL---FS----RIQDRGDQAFTEREASEIMKSIGE 128

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVK 303
           AI YLH      I HRD+K  N+L T    N   K+ DFGFA                  
Sbjct: 129 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------ 167

Query: 304 GTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRP------IEPKRELKERI 352
                   E     Y   +  D++S GV++  L+ G  P      +     +K RI
Sbjct: 168 -------KETTGEKY--DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 15/234 (6%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
           +G+G FG V     +    + A+K  KK  V           E R LA   +   L + H
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              +  D    ++EYV  G L  H+   Q         +  A ++A  + +L       I
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQ--QVGRFKEPHAVFYAAEIAIGLFFLQ---SKGI 142

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N++L      K+ADFG  +             T   GT  Y+ PE +     
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT---KTFC-GTPDYIAPEIIAYQPY 198

Query: 320 TEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITV-KWAMKKFSDGDAISIL 370
            +  D ++FGVLL E++ G+ P   E + EL + I     A  K    +A++I 
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 15/234 (6%)

Query: 143 IGQGGFGTVYKGRLED-GTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
           +G+G FG V   R+++ G + A+K  KK  +          +E R L+    H  L +  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              +  D    ++E+V  G L  H+        +   R   A ++  A+ +LH   D  I
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAA-EIISALMFLH---DKGI 145

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  N+LL      K+ADFG  +            +T   GT  Y+ PE L+    
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---ATFC-GTPDYIAPEILQEMLY 201

Query: 320 TEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITV-KWAMKKFSDGDAISIL 370
               D ++ GVLL E++ G  P   E + +L E I   +     +   DA  IL
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 45/231 (19%), Positives = 89/231 (38%), Gaps = 28/231 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEI-RTLAQVEHLNLVKFH 199
           +IG+G FG +++G  L +   VAIK   +           +    + LA      +   +
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG--IPNVY 72

Query: 200 GYLEFEDERIVIVEYV-PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            + +     +++++ + P+  L E L  L G    +      A  +   +  +H   +  
Sbjct: 73  YFGQEGLHNVLVIDLLGPS--L-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKS 126

Query: 259 IIHRDIKSSNILLTENFRAK-----VADFGFARLAADTESGATHV----STQVKGTAGYL 309
           +++RDIK  N L+            V DFG  +   D  +   H+       + GTA Y+
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK-QHIPYREKKNLSGTARYM 185

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-----IEPKRELKERITVK 355
                   + + + D+ + G + +  + G  P         ++  ERI  K
Sbjct: 186 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.9 bits (184), Expect = 9e-15
 Identities = 60/285 (21%), Positives = 99/285 (34%), Gaps = 69/285 (24%)

Query: 91  RSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRA---------TRNFSPSF 141
            S  + + + +  QG     + S      + +      + Y            + +    
Sbjct: 9   CSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLK 68

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---------EIRTLAQVE 191
            IG G  G V           VAIK        K S   FQ+         E+  +  V 
Sbjct: 69  PIGSGAQGIVCAAYDAVLDRNVAIK--------KLSRP-FQNQTHAKRAYRELVLMKCVN 119

Query: 192 HLNLVK-------FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDV 244
           H N++             EF+D  + +V         E +D       +L   + + +D 
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQD--VYLVM--------ELMDA------NLCQVIQMELDH 163

Query: 245 AH----------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG 294
                        I +LH      IIHRD+K SNI++  +   K+ DFG AR A  +   
Sbjct: 164 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220

Query: 295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
             +V T+      Y  PE +      E  D++S G ++ E+V  +
Sbjct: 221 TPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 30/249 (12%)

Query: 121 GNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE 179
           G++++ +   YR  R      KIG G FG +Y G  +  G  VAIK        KH    
Sbjct: 1   GSMELRVGNRYRLGR------KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLH 52

Query: 180 FQSEI-RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRL 238
            +S+I + +     +  +++ G     D  ++++E +  G   E L         L   L
Sbjct: 53  IESKIYKMMQGGVGIPTIRWCG--AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVL 108

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAADTESGA 295
            +A  +   I Y+H       IHRD+K  N L+    +     + DFG A+   D  +  
Sbjct: 109 LLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH- 164

Query: 296 THVSTQVK----GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-----IEPKR 346
            H+  +      GTA Y         + + + D+ S G +L+    G  P        KR
Sbjct: 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224

Query: 347 ELKERITVK 355
           +  ERI+ K
Sbjct: 225 QKYERISEK 233

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 50/234 (21%), Positives = 87/234 (37%), Gaps = 63/234 (26%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---------E 183
            + +     +G G +G+V        G  VAIK        K S   FQS         E
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--------KLSRP-FQSEIFAKRAYRE 73

Query: 184 IRTLAQVEHLNLVK-------FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG 236
           +  L  ++H N++              F D    +V           +        DL  
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYD--FYLVM--------PFMQT------DLQK 117

Query: 237 RLDIAIDVAH----------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR 286
            + +                 + Y+H      ++HRD+K  N+ + E+   K+ DFG AR
Sbjct: 118 IMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

Query: 287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGR 339
            A    +G  +V T+      Y  PE + ++    +  D++S G ++ E++TG+
Sbjct: 175 HADAEMTG--YVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 43/224 (19%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK--RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           K+G G F TV+  + + + T VA+K  R  K  Y + +    + EI+ L   + +N    
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAA----EDEIKLL---QRVNDADN 77

Query: 199 HGYLEFEDERIV-IVEY-VPNGTLREHL----DCLQGNILDLAGRLD-----------IA 241
                     I+ ++++    G    H+    + L  N+L L  + +           I+
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 242 IDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA------KVADFGFARLAADTESGA 295
             +   + Y+H      IIH DIK  N+L+            K+AD G A    +  +  
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-- 193

Query: 296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
             + T+      Y  PE L        +D++S   L+ EL+TG 
Sbjct: 194 NSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 49/267 (18%), Positives = 82/267 (30%), Gaps = 58/267 (21%)

Query: 87  SDASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEE---IYRATRNFSPSFKI 143
           S    + A      +             R    S     +M      ++    +     I
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61

Query: 144 GQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---------EIRTLAQVEHL 193
           G G +G V +     +  +VAIK        K     F+          EI  L ++ H 
Sbjct: 62  GTGSYGHVCEAYDKLEKRVVAIK--------KILRV-FEDLIDCKRILREIAILNRLNHD 112

Query: 194 NLVK----FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG--RLDIAIDVAH- 246
           ++VK           + + + +V         E  D       D     R  + +   H 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVL--------EIADS------DFKKLFRTPVYLTELHI 158

Query: 247 ---------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
                     + Y+H      I+HRD+K +N L+ ++   KV DFG AR     E+G + 
Sbjct: 159 KTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 298 V---STQVKGTAGYLDPEYLKTYQLTE 321
           +     +                QLT 
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTG 242

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 32/221 (14%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE--FQSEIRTLAQV 190
              ++    IG+G +G V       +   VAIK  K S ++  +  +   + EI+ L + 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPFEHQTYCQRTLR-EIKILLRF 82

Query: 191 EHLNLVKFH------GYLEFEDERIVIVEYVPNGTLREHLDC-----LQGNILDLAGRLD 239
            H N++  +         + +D  + IV+        + ++      L+   L       
Sbjct: 83  RHENIIGINDIIRAPTIEQMKD--VYIVQ--------DLMETDLYKLLKTQHLSNDHICY 132

Query: 240 IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVS 299
               +   + Y+H      ++HRD+K SN+LL      K+ DFG AR  AD +   T   
Sbjct: 133 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFL 188

Query: 300 TQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGR 339
           T+   T  Y  PE +   +  T+  D++S G +L E+++ R
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 57/237 (24%), Positives = 93/237 (39%), Gaps = 57/237 (24%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE--FQSEIRTLAQV 190
           + +F     +G+G +G V        G IVAIK  K   +DK   A    + EI+ L   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIEPFDKPLFALRTLR-EIKILKHF 66

Query: 191 EHLNLVKFH------GYLEFEDERIVIVEYVPNGTLREHLDC-----LQGNILDLAGRLD 239
           +H N++          +  F +  + I++        E +       +   +L       
Sbjct: 67  KHENIITIFNIQRPDSFENFNE--VYIIQ--------ELMQTDLHRVISTQMLS------ 110

Query: 240 IAIDVAH----------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA 289
                 H          A+  LH      +IHRD+K SN+L+  N   KV DFG AR+  
Sbjct: 111 ----DDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 290 DTESGATHVSTQVKGTAGYLD------PEYLKTYQL-TEKSDVYSFGVLLVELVTGR 339
           ++ +  +  + Q  G   ++       PE + T    +   DV+S G +L EL   R
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 37/243 (15%), Positives = 92/243 (37%), Gaps = 40/243 (16%)

Query: 142 KIGQGGFGTVYKGR---------LEDGTIVAIKRAKKS--------VYDKHSGAEFQSEI 184
              +   G +Y+                  ++K   K          + + +     ++ 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 185 RTLAQVEHLNLVKFHGYLEFEDE-RIVIVEYV-PNGTLREHLDCLQGNILDLAGRLDIAI 242
           + L     L +    G+   +D+ R +++  +  +  L+  LD    ++L     L +A 
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVAC 166

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV--ADFGFARLAADTESGATHV-- 298
            +  A+ +LH   ++  +H ++ + NI +    +++V  A +GFA     +     HV  
Sbjct: 167 RLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG---KHVAY 220

Query: 299 ----STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-----IEPKRELK 349
                +  +G   ++  +  K    + +SD+ S G  +++ + G  P        +  +K
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMK 280

Query: 350 ERI 352
           ++ 
Sbjct: 281 QKQ 283

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 59/255 (23%), Positives = 95/255 (37%), Gaps = 55/255 (21%)

Query: 108 VSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKR 166
           +SS    R G     V  T  E+      +     +G G +G V        G  VAIK 
Sbjct: 1   MSSPPPARSGFYRQEVTKTAWEV---RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK- 56

Query: 167 AKKSVYDKHSGAEFQS---------EIRTLAQVEHLNLVK-------FHGYLEFEDERIV 210
                  K     FQS         E+R L  + H N++             +F D    
Sbjct: 57  -------KLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD--FY 106

Query: 211 IVEYVPNGTLREHLDC-----LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIK 265
           +V           +       ++   L       +   +   + Y+H      IIHRD+K
Sbjct: 107 LVM--------PFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLK 155

Query: 266 SSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSD 324
             N+ + E+   K+ DFG AR A    +G  +V T+      Y  PE +  +   T+  D
Sbjct: 156 PGNLAVNEDCELKILDFGLARQADSEMTG--YVVTRW-----YRAPEVILNWMRYTQTVD 208

Query: 325 VYSFGVLLVELVTGR 339
           ++S G ++ E++TG+
Sbjct: 209 IWSVGCIMAEMITGK 223

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 47/256 (18%), Positives = 97/256 (37%), Gaps = 63/256 (24%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS-EIRTLAQVE 191
           ++ +S    +G G FG V +   +E G   A+K+  +          +++ E+  +  ++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMKVLD 58

Query: 192 HLNLVK----FHGYLEFEDERIVIVEYVPNGTLREHLDCLQG------------------ 229
           H+N++K    F+   + E +     +       + +                        
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 230 -------NILDLAGRLDIAIDVAH----------AITYLHMYTDHPIIHRDIKSSNILL- 271
                   +L    R   +I +            A+ ++H      I HRDIK  N+L+ 
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175

Query: 272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSF 328
           +++   K+ DFG A+    +E    ++ ++      Y  PE +     Y  T   D++S 
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY--TPSIDLWSI 228

Query: 329 GVLLVELVTGRRPIEP 344
           G +  EL+ G +P+  
Sbjct: 229 GCVFGELILG-KPLFS 243

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 71.4 bits (174), Expect = 2e-13
 Identities = 62/427 (14%), Positives = 126/427 (29%), Gaps = 112/427 (26%)

Query: 59  LFVACFTPPETNSSKDFVNSN-----EFKPSPVSDASRSRASTERRRSSSQGLYVSSNNS 113
           LF       +    + FV        +F  SP+    R  +   R        Y+   + 
Sbjct: 67  LFW-TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM-------YIEQRDR 118

Query: 114 TRGGDQS---GNVQI--TMEEIYRATRNFSPSFKI---GQGGFGTVYKGRLEDGTIVAIK 165
               +Q     NV       ++ +A     P+  +   G  G G   K      T VA+ 
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K------TWVALD 169

Query: 166 RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLD 225
                 Y      +F+        +  LNL          +  + +++      L   +D
Sbjct: 170 VCLS--YKVQCKMDFK--------IFWLNL----KNCNSPETVLEMLQ-----KLLYQID 210

Query: 226 CLQGNILDLAGRLDIAI-DVAHAITYLHMYTDHP---IIHRDIKSSNILLTENFRAKVAD 281
               +  D +  + + I  +   +  L     +    ++  +++++      N   K+  
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI-- 268

Query: 282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVY----SFGVLLVELVT 337
                L          ++T+ K    +L         L   S          +LL     
Sbjct: 269 -----L----------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL--KYL 311

Query: 338 GRRPIEPKRELKE----RITVKWAMKKFSDGDAISILDPRVENTAANNL-ALEKILELAL 392
             RP +  RE+      R+++     +    D ++      +N    N   L  I+E +L
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIR----DGLA----TWDNWKHVNCDKLTTIIESSL 363

Query: 393 QCLAPRRQNRPSMRRCA-------------EILW--SVRKDYRELAASDV---LLQPSYS 434
             L P    R    R +              ++W   ++ D   +        L++    
Sbjct: 364 NVLEPAEY-RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE---- 418

Query: 435 KRSNSTR 441
           K+   + 
Sbjct: 419 KQPKEST 425

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 55/311 (17%), Positives = 96/311 (30%), Gaps = 80/311 (25%)

Query: 104 QGLYVS-SNNSTRGGDQSGNVQITMEEIYRATRNF--SPSFK----IGQGGFGTVYKGRL 156
           Q L      N T   D S N+++ +  I    R    S  ++    +            L
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV------------L 250

Query: 157 EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTL--------------AQVEHLNLVKFH-GY 201
            +            V +  +   F    + L              A   H++L       
Sbjct: 251 LN------------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298

Query: 202 LEFEDERIVIVEYV--PNGTLREHLDCLQGN--ILDLAGRLDIAIDVAHAITYLHMYTDH 257
              E + +++ +Y+      L    + L  N   L +     I   +A    + H+  D 
Sbjct: 299 TPDEVKSLLL-KYLDCRPQDLPR--EVLTTNPRRLSIIAES-IRDGLATWDNWKHVNCDK 354

Query: 258 PIIHRDIKSS-NILLTENFRAKVADFGFARLAADTESGATHVSTQVKGT----AGYLDPE 312
             +   I+SS N+L    +R       F RL+    S   H+ T +           D  
Sbjct: 355 --LTTIIESSLNVLEPAEYRKM-----FDRLSVFPPS--AHIPTILLSLIWFDVIKSDVM 405

Query: 313 Y----LKTYQLTEK---SDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD 365
                L  Y L EK       S   + +EL   +  +E +  L   I   + + K  D D
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLEL---KVKLENEYALHRSIVDHYNIPKTFDSD 462

Query: 366 AISILDPRVEN 376
            +    P ++ 
Sbjct: 463 DLI--PPYLDQ 471

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 63/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)

Query: 127 MEEI----YRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQ 181
           ME      +R  R      KIG G FG +Y G  ++    VAIK        KH    ++
Sbjct: 1   MEPRVGNKFRLGR------KIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYE 52

Query: 182 SEI-RTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDI 240
           S+I R L     +  V++ G     D  +++++ +  G   E L       L L   L +
Sbjct: 53  SKIYRILQGGTGIPNVRWFG--VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLML 108

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAK---VADFGFARLAADTESGATH 297
           A  + + + ++H  +    +HRDIK  N L+    RA    + DFG A+   DT +   H
Sbjct: 109 ADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-QH 164

Query: 298 V----STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-----IEPKREL 348
           +    +  + GTA Y         + + + D+ S G +L+  + G  P        K++ 
Sbjct: 165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224

Query: 349 KERITVK 355
            E+I+ K
Sbjct: 225 YEKISEK 231

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.1 bits (168), Expect = 4e-13
 Identities = 36/218 (16%), Positives = 63/218 (28%), Gaps = 52/218 (23%)

Query: 125 ITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSG------A 178
           +        T       KIG+G FG V++    D T VAIK       D  +G       
Sbjct: 11  VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 179 EFQSEIRTLAQVEHLNLVKFH---GYLEFEDERIV------------------------- 210
           E   EI    ++  L+    +   G++       V                         
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 211 -----------IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
                      ++E+   G     L+ ++  +  LA    I   +  ++           
Sbjct: 129 PDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRF 183

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH 297
            HRD+   N+LL +    K+      + +     G   
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV 221

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 47/216 (21%), Positives = 77/216 (35%), Gaps = 58/216 (26%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---------E 183
             N+     IG+G +G VY          VAIK        K +   F+          E
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--------KVNRM-FEDLIDCKRILRE 75

Query: 184 IRTLAQVEHLNLVKFH------GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG- 236
           I  L +++   +++ +        L+F++  + IV         E  D       DL   
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDE--LYIVL--------EIADS------DLKKL 119

Query: 237 -RLDIAIDVAH----------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA 285
            +  I +   H             ++H   +  IIHRD+K +N LL ++   KV DFG A
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           R     +   T++   ++              QLT 
Sbjct: 177 RTINSEKD--TNIVNDLEENEEPGPHNKNLKKQLTS 210

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 45/241 (18%), Positives = 88/241 (36%), Gaps = 36/241 (14%)

Query: 142 KIGQGGFGTVYKGRLEDGTIV------AIKRAKKS---------VYDKHSGAEFQSEIRT 186
            IGQGGFG +Y   +     V       +K               Y + +  E   +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 187 LAQVEHLNLVKFHGY----LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
             ++++L + K+ G        +  R +I++    G+  + +             L +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV--ADFGFARLAADTESGATHVST 300
            +   + Y+H   +H  +H DIK+SN+LL      +V   D+G A             + 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH-KAYAA 215

Query: 301 QVK----GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-----IEPKRELKER 351
             K    GT  +   +       + + D+   G  +++ +TG  P      +PK     +
Sbjct: 216 DPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSK 275

Query: 352 I 352
           I
Sbjct: 276 I 276

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 45/217 (20%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIK--RAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFH 199
           IG+G FG V K    +    VA+K  R +K  + + +      EIR L   EHL      
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-FHRQA----AEEIRIL---EHLRK---- 152

Query: 200 GYLEFEDERIVIVEYVPNGTLREHL----DCLQGNILDL--AGRL---------DIAIDV 244
              + +D  + ++  + N T R H+    + L  N+ +L    +            A  +
Sbjct: 153 ---QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 245 AHAITYLHMYTDHPIIHRDIKSSNILLTENFRA--KVADFGFARLAADTESGATHVSTQV 302
              +  LH    + IIH D+K  NILL +  R+  KV DFG +          T++ ++ 
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSRF 264

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
                Y  PE +   +     D++S G +L EL+TG 
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 56/231 (24%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS---------E 183
              +     +G G +G+V      + G  VA+K        K S   FQS         E
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--------KLSRP-FQSIIHAKRTYRE 78

Query: 184 IRTLAQVEHLNLVK-------FHGYLEFEDERIVIVEYVPNGTLREHLDC-----LQGNI 231
           +R L  ++H N++             EF D  + +V           +       ++   
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFND--VYLVT--------HLMGADLNNIVKCQK 128

Query: 232 LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD- 290
           L       +   +   + Y+H      IIHRD+K SN+ + E+   K+ DFG AR  AD 
Sbjct: 129 LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 291 -TESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGR 339
            T     +V+T+      Y  PE +  +    +  D++S G ++ EL+TGR
Sbjct: 186 MTG----YVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 49/231 (21%), Positives = 89/231 (38%), Gaps = 43/231 (18%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE--FQSEIRTLAQV 190
              +     +G GG G V+     +    VAIK   K V       +   + EI+ + ++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALR-EIKIIRRL 65

Query: 191 EHLNLVK---------------FHGYLEFEDERIVIVEYVPNGTLREHLDC-----LQGN 230
           +H N+VK                    E     + IV+        E+++      L+  
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNS--VYIVQ--------EYMETDLANVLEQG 115

Query: 231 ILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL-TENFRAKVADFGFARLAA 289
            L           +   + Y+H      ++HRD+K +N+ + TE+   K+ DFG AR   
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR-IM 171

Query: 290 DTESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGR 339
           D         ++   T  Y  P  L +    T+  D+++ G +  E++TG+
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 28/228 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEI-RTLAQVEHLNLVKFH 199
           KIG G FG +  G+ L     VAIK        +      +    + L   + +  V + 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 200 GYLEFEDERIVIVEYV-PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
           G         +++E + P+  L E L  L      L   L IAI +   + Y+H      
Sbjct: 74  G--PCGKYNAMVLELLGPS--L-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKN 125

Query: 259 IIHRDIKSSNILL--TENFRAKVA---DFGFARLAADTESGATHV----STQVKGTAGYL 309
           +I+RD+K  N L+    N   +V    DF  A+   D E+   H+       + GTA Y+
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK-KHIPYREHKSLTGTARYM 184

Query: 310 DPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP-----IEPKRELKERI 352
                   + + + D+ + G + +  + G  P      +  +E  ++I
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 48/241 (19%), Positives = 82/241 (34%), Gaps = 71/241 (29%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK--RAKKSVYDKHSGAEFQS--EIRTLAQV-----E 191
           K+G G FG V   + +++    A+K  R  K            +  E   L ++      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR-------SAKIEADILKKIQNDDIN 94

Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL----DCLQGNILDL---------AGRL 238
           + N+VK+HG   +                 +H+    + L  ++ ++             
Sbjct: 95  NNNIVKYHGKFMY----------------YDHMCLIFEPLGPSLYEIITRNNYNGFHIED 138

Query: 239 --DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
                I++  A+ YL       + H D+K  NILL + +  K                  
Sbjct: 139 IKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195

Query: 297 HVSTQVK----GTAGYLDPEYLKTYQLT---------------EKSDVYSFGVLLVELVT 337
             ST +K    G A +   +Y  +   T                 SD++SFG +L EL T
Sbjct: 196 TKSTGIKLIDFGCATFKS-DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

Query: 338 G 338
           G
Sbjct: 255 G 255

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 31/212 (14%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIK--RAKKSVYDKHSGAEFQSEIRTLAQVEHLN---- 194
            IG+G FG V K     +   VAIK  + KK+ +   +    Q E+R L   E +N    
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA-FLNQA----QIEVRLL---ELMNKHDT 112

Query: 195 -----LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT 249
                +V    +  F    + +V  + +  L + L       + L      A  +  A+ 
Sbjct: 113 EMKYYIVHLKRHFMFR-NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 250 YLHMYTDHPIIHRDIKSSNILLTENFRA--KVADFGFARLAADTESGATHVSTQVKGTAG 307
           +L    +  IIH D+K  NILL    R+  K+ DFG +           ++ ++      
Sbjct: 172 FLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRF----- 223

Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR 339
           Y  PE L         D++S G +LVE+ TG 
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 44/226 (19%), Positives = 82/226 (36%), Gaps = 36/226 (15%)

Query: 142 KIGQGGFGTVYKG-RLEDGTIVAIKRAK------------KSVYDKHSGAEFQSEIRTLA 188
           KIG GGFG +Y           A    K               Y + +  +   +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 189 QVEHLNLVKFHGYLEFEDER-----IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID 243
           Q+++L +  F+G    E +      +V+     +  L++            +  L + I 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKISGQ--NGTFKKSTVLQLGIR 159

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV--ADFGFARLAADTESGATHV--- 298
           +   + Y+H   ++  +H DIK++N+LL      +V  AD+G +           H    
Sbjct: 160 MLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG---NHKQYQ 213

Query: 299 ---STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRP 341
                   GT  +   +  K   L+ +SDV   G  ++  + G+ P
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 83/255 (32%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEI---RTLAQ 189
            R +    K+G+G +G V+K      G +VA+K        K   A FQ+     RT  +
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--------KIFDA-FQNSTDAQRTFRE 58

Query: 190 V-------EHLNLVKFHGYL---EFEDERIVIVEYVPNGTLREHLDC-----LQGNILDL 234
           +        H N+V     L      D  + +V         ++++      ++ NIL+ 
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRD--VYLVF--------DYMETDLHAVIRANILE- 107

Query: 235 AGRLDIAIDVAH----------AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF 284
                      H           I YLH      ++HRD+K SNILL      KVADFG 
Sbjct: 108 ---------PVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155

Query: 285 ARLAADTESGATHVSTQVKGTAGYLD-----------------PEYL---KTYQLTEKSD 324
           +R   +      ++   +       D                 PE L     Y  T+  D
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY--TKGID 213

Query: 325 VYSFGVLLVELVTGR 339
           ++S G +L E++ G+
Sbjct: 214 MWSLGCILGEILCGK 228

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 41/246 (16%), Positives = 76/246 (30%), Gaps = 85/246 (34%)

Query: 142 KIGQGGFGTVYKG--RLEDGTIVAIK--RAKKSVYDKHSGAEFQS--EIRTLAQVEHLN- 194
            +G+G FG V +        + VA+K  R      +        +  EI  L   + +  
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE-------AARLEINVL---KKIKE 75

Query: 195 --------LVKFHGYLEFEDERIVIVEYVPNGTLREHL----DCLQGNILDL-------- 234
                    V    +  F                  H+    + L  N  +         
Sbjct: 76  KDKENKFLCVLMSDWFNF----------------HGHMCIAFELLGKNTFEFLKENNFQP 119

Query: 235 -AGRL--DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
                   +A  + HA+ +LH   ++ + H D+K  NIL   +    + +   +      
Sbjct: 120 YPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC----- 171

Query: 292 ESGATHVSTQVK----GTAGYLDPEYLKTYQLT---------------EKSDVYSFGVLL 332
               +  +T ++    G+A +   E+  T   T               +  DV+S G +L
Sbjct: 172 -EEKSVKNTSIRVADFGSATFDH-EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229

Query: 333 VELVTG 338
            E   G
Sbjct: 230 FEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 48/246 (19%), Positives = 81/246 (32%), Gaps = 85/246 (34%)

Query: 142 KIGQGGFGTVYKG--RLEDGTIVAIK--RAKKSVYDKHSGAEFQS--EIRTLAQVEHLN- 194
            +G+G FG V +       G  VA+K  +      +        +  EI+ L   EHLN 
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE-------AARSEIQVL---EHLNT 70

Query: 195 --------LVKFHGYLEFEDERIVIVEYVPNGTLREHL----DCLQGNILD--------- 233
                    V+   + E                   H+    + L  +  D         
Sbjct: 71  TDPNSTFRCVQMLEWFEH----------------HGHICIVFELLGLSTYDFIKENGFLP 114

Query: 234 LAGRL--DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT 291
                   +A  +  ++ +LH    + + H D+K  NIL  ++      D+  A      
Sbjct: 115 FRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS------DYTEAYNPKIK 165

Query: 292 ESGATHVSTQVK----GTAGYLDPEYLKTYQLT---------------EKSDVYSFGVLL 332
               T ++  +K    G+A Y D E+  T   T               +  DV+S G +L
Sbjct: 166 RDERTLINPDIKVVDFGSATYDD-EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224

Query: 333 VELVTG 338
           +E   G
Sbjct: 225 IEYYLG 230

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 58/280 (20%), Positives = 86/280 (30%), Gaps = 103/280 (36%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVEHLN---- 194
           K+G G F TV+    ++    VA+K     V    +H       EIR L  V + +    
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-----VVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 195 ----LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCL-----QGNILDLAGRLD------ 239
               +V+      F+           NGT   H+ C+       ++L    + +      
Sbjct: 99  NREMVVQLLDD--FKISG-------VNGT---HI-CMVFEVLGHHLLKWIIKSNYQGLPL 145

Query: 240 -----IAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---------------------- 272
                I   V   + YLH  T   IIH DIK  NILL+                      
Sbjct: 146 PCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203

Query: 273 ---------------------------ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
                                      E  + K+AD G A       +    + T+    
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE--DIQTRQ--- 258

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK 345
             Y   E L        +D++S   +  EL TG    EP 
Sbjct: 259 --YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 38/193 (19%), Positives = 76/193 (39%), Gaps = 25/193 (12%)

Query: 123 VQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQS 182
           V++   +  +  +   P   IG+G    + +    D  ++  +R KK   D+      + 
Sbjct: 324 VEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK 383

Query: 183 EIRTLAQVEHLNLVKFHG------YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG 236
             RT  +  +L LVK  G      +    D + +++ Y+     ++ ++           
Sbjct: 384 S-RTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE----------D 432

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
            LDIA  +   +  LH    + +IH D+ +SN +  +     + DFG  +++   E  A 
Sbjct: 433 NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487

Query: 297 --HVSTQ-VKGTA 306
              V  + V  T 
Sbjct: 488 DLIVFKKAVLSTH 500

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	443
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.85
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.65
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.58
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.34
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.99
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.93
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.85
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.76
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.61
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.4
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.29
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.25
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.24
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.11
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.33
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.3
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.0
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.45
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.45
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.33

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-61  Score=472.83  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=215.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+++++||+|+||+||+|++. +|+.||||++++........+.+.+|+.+|+.|+|||||++++++++++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999976 79999999998766666667889999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+||+|.++|....+..+++..++.|+.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999998766677899999999999999999999   8889999999999999999999999999998765321 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                         ......+||+.|||||++.+..|+.++|||||||+||||++|.+||...........+..       +....     
T Consensus       180 ---~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------~~~~~-----  244 (350)
T 4b9d_A          180 ---ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-------GSFPP-----  244 (350)
T ss_dssp             ---HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCCCC-----
T ss_pred             ---ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-------CCCCC-----
Confidence               123456799999999999999999999999999999999999999987765433222211       11100     


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +     ....++++.+|+.+||+.||++|||+.++++|.|..
T Consensus       245 ~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          245 V-----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             C-----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence            0     112346799999999999999999999999999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.9e-60  Score=463.38  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=215.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ..|+..++||+|+||+||+|.++ +|+.||||+++...  ....+.+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            46888999999999999999986 79999999987653  3334568899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+||+|.+++..   ..+++..++.|+.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       152 y~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          152 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            9999999999863   45999999999999999999999   88899999999999999999999999999987754322


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.........+..   ..         .+.
T Consensus       226 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~---------~~~  289 (346)
T 4fih_A          226 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NL---------PPR  289 (346)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SS---------CCC
T ss_pred             ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CC---------CCC
Confidence                23457899999999999999999999999999999999999999987765443222211   10         011


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +..   ....++++.+|+.+||+.||++|||+.|+++|+|.-
T Consensus       290 ~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          290 LKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             CSC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence            110   112346799999999999999999999999999964

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.7e-60  Score=457.47  Aligned_cols=264  Identities=22%  Similarity=0.293  Sum_probs=220.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++++.||+|+||+||+|+++ +|+.||||++.+... .......+.+|+++|+.|+|||||++++++++++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999976 799999999976432 3445678999999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||+||+|.++|..  ...+++..+..++.||+.||.|||   +++||||||||+||||+.+|.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999974  356999999999999999999999   8889999999999999999999999999998775432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .  .......+||+.|||||++.+..|+.++|||||||+||||++|.+||...+.......+...       ..      
T Consensus       187 ~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-------~~------  251 (311)
T 4aw0_A          187 K--QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-------EY------  251 (311)
T ss_dssp             T--CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------CC------
T ss_pred             C--cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------CC------
Confidence            1  12344678999999999999999999999999999999999999999876653322222111       10      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHH------HHHHHHhhhhhhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRR------CAEILWSVRKDYRELA  423 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~e------ll~~l~~i~~~~~~~~  423 (443)
                      .++     ...++++.+|+.+||+.||.+|||+.|      |++|+|.-.-+|..+.
T Consensus       252 ~~p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          252 DFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             CCC-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             CCC-----cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence            000     012367899999999999999999987      5777777666666653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-58  Score=441.39  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=197.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++++... .......+.+|+.+|+.++|||||++++++++++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999976 799999999976543 3344667999999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||| +|+|.+++..  ...+++..++.++.||+.||.|||   ++|||||||||+||||+.++.+||+|||+|+...+..
T Consensus        93 Ey~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 7899999974  467999999999999999999999   8889999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                           .....+||+.|||||++.+..| +.++|||||||+||+|++|.+||...........+......           
T Consensus       167 -----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~-----------  230 (275)
T 3hyh_A          167 -----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT-----------  230 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------
T ss_pred             -----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence                 2345679999999999988776 57999999999999999999999876543222211111000           


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                        ++     ...++++.+|+.+||+.||++|||+.|+++|+|.
T Consensus       231 --~p-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          231 --LP-----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             --CC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             --CC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence              00     1123678999999999999999999999999995

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-59  Score=453.98  Aligned_cols=266  Identities=25%  Similarity=0.333  Sum_probs=216.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|++++.||+|+||+||+|+..    +++.||||++++..........+.+|+.+|++++|||||++++++++++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999863    47899999998765544555678899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |||||+||+|.++|..  ...+++..+..++.||+.||.|||   ++|||||||||+|||++.+|.+||+|||+|+...+
T Consensus       104 vmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            9999999999999974  356999999999999999999999   88899999999999999999999999999987544


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...    .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.......+...       ..    
T Consensus       179 ~~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------~~----  243 (304)
T 3ubd_A          179 HEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-------KL----  243 (304)
T ss_dssp             --C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CC----
T ss_pred             CCc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-------CC----
Confidence            322    234568999999999999999999999999999999999999999887654332222111       00    


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccC
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDV  427 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~  427 (443)
                        .++     ...++++.+|+.+||+.||++|||     ++++++|+|.-.-+|..+..-.+
T Consensus       244 --~~p-----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~  298 (304)
T 3ubd_A          244 --GMP-----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI  298 (304)
T ss_dssp             --CCC-----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             --CCC-----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCC
Confidence              000     113467899999999999999998     58999999987778877655444

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-58  Score=465.42  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=215.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +.|+.+++||+|+||+||+|.++ +|+.||||++....  ....+.+.+|+.+|+.|+|||||+++++|.+++.+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            46999999999999999999986 79999999987543  3344668899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+||+|.+++..   ..+++..+..|+.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus       229 y~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          229 FLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            9999999999853   45999999999999999999999   88899999999999999999999999999987654322


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.........+..   ..         .+.
T Consensus       303 ----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~---------~~~  366 (423)
T 4fie_A          303 ----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NL---------PPR  366 (423)
T ss_dssp             ----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SC---------CCC
T ss_pred             ----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CC---------CCC
Confidence                23457899999999999999999999999999999999999999987765443222211   10         001


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +..   ....++++.+|+.+||+.||++|||+.|+++|.|.-
T Consensus       367 ~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          367 LKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             CSC---TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             Ccc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence            100   012346799999999999999999999999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-58  Score=441.98  Aligned_cols=250  Identities=24%  Similarity=0.417  Sum_probs=206.1

Q ss_pred             CCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee----cCeEEEEE
Q 013401          138 SPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF----EDERIVIV  212 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~  212 (443)
                      +...+||+|+||+||+|.+. ++..||||++..........+.|.+|+.+|+.|+|||||+++++|++    ++.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45568999999999999986 69999999998766666667789999999999999999999999875    35689999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLT-ENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~  289 (443)
                      |||+||+|.++|..  ...+++..++.|+.||+.||.|||   +++  ||||||||+||||+ .+|.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999974  357999999999999999999999   777  99999999999998 48999999999997643


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ..      .....+||+.|||||++.+ .|+.++|||||||+||||++|.+||...........      .+..+.....
T Consensus       184 ~~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~------~i~~~~~~~~  250 (290)
T 3fpq_A          184 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------RVTSGVKPAS  250 (290)
T ss_dssp             TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH------HHTTTCCCGG
T ss_pred             CC------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH------HHHcCCCCCC
Confidence            22      2345689999999999876 699999999999999999999999976543322111      1111111111


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +         ....++++.+|+.+||+.||++|||+.++++|+|.
T Consensus       251 ~---------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~  286 (290)
T 3fpq_A          251 F---------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             G---------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             C---------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            1         11123568999999999999999999999999995

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-58  Score=446.70  Aligned_cols=264  Identities=28%  Similarity=0.482  Sum_probs=208.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|...++||+|+||+||+|++++  .||||+++.........+.|.+|+.+|++++|||||++++++. ++.++|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEc
Confidence            467788899999999999998753  5999999866555566778999999999999999999999875 4678999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |+||+|.++|.. ....+++..++.|+.||+.||.|||   +++||||||||+||||++++.+||+|||+|+....... 
T Consensus       113 ~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~-  187 (307)
T 3omv_A          113 CEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG-  187 (307)
T ss_dssp             CSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc-
Confidence            999999999975 3457999999999999999999999   78899999999999999999999999999987653221 


Q ss_pred             cccccccccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                       .......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.............  ......        
T Consensus       188 -~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~--~~~~~~--------  256 (307)
T 3omv_A          188 -SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV--GRGYAS--------  256 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--HTTCCC--------
T ss_pred             -ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH--hcCCCC--------
Confidence             122345689999999999964   358999999999999999999999998765433221111  111111        


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      +.+.  .....+++.+.+|+.+||+.||++|||+.+|+++|+.++..+
T Consensus       257 p~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          257 PDLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CCST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             CCcc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            1110  011124567999999999999999999999999999886554

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-58  Score=451.68  Aligned_cols=261  Identities=19%  Similarity=0.241  Sum_probs=210.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ..|...++||+|+||+||+|+++ +|+.||||+++....       ..+|+.+|+.|+|||||++++++.+++.+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            45778889999999999999986 799999999976432       2379999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeecccccccccC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFARLAADTE  292 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~  292 (443)
                      ||+||+|.++|..  ...+++..++.|+.||+.||.|||   +++||||||||+||||+.+| .+||+|||+|+.+....
T Consensus       131 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999974  356999999999999999999999   88999999999999999987 69999999998775443


Q ss_pred             CCcc-cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGAT-HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .... .....++||+.|||||++.+..|+.++|||||||+||||++|.+||...........+...       .      
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------~------  272 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-------P------  272 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-------C------
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-------C------
Confidence            2221 1233468999999999999999999999999999999999999999865443222111110       0      


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      +.+  ......+++.+.+|+.+||+.||.+|||+.|++++++....+...+
T Consensus       273 ~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l  321 (336)
T 4g3f_A          273 PPI--REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL  321 (336)
T ss_dssp             CGG--GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred             CCc--hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence            000  0011123467999999999999999999999999998776655543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-57  Score=446.36  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=206.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|...++||+|+||+||+|+++      +++.||||+++..  .....++|.+|+.+|++|+|||||++++++.+.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35677789999999999999864      4789999999754  344567899999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013401          209 IVIVEYVPNGTLREHLDCLQ-------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF  275 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~  275 (443)
                      +||||||++|+|.++|....             ...+++..++.|+.||+.||.|||   +++||||||||+||||+.++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCC
Confidence            99999999999999996532             246899999999999999999999   78899999999999999999


Q ss_pred             ceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHH
Q 013401          276 RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITV  354 (443)
Q Consensus       276 ~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~  354 (443)
                      .+||+|||+++......  ........+||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+
T Consensus       196 ~~Ki~DFGla~~~~~~~--~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTD--YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             EEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             cEEEcccccceeccCCC--cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999998765432  1223345679999999999999999999999999999999999 99999876543322111


Q ss_pred             HHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .       .+....     .     ...+++++.+|+.+||+.||++|||+.+|+++|..+..
T Consensus       274 ~-------~g~~~~-----~-----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          274 T-------QGRELE-----R-----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             H-------HTCCCC-----C-----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             H-------cCCCCC-----C-----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            1       111111     0     11234679999999999999999999999999988754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.8e-58  Score=443.44  Aligned_cols=259  Identities=27%  Similarity=0.433  Sum_probs=212.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|.+.++||+|+||+||+|++.      ++..||||+++..  .....++|.+|+.+|++|+|||||++++++.+++.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            46778889999999999999863      4789999999754  344567899999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCce
Q 013401          209 IVIVEYVPNGTLREHLDCL-----------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRA  277 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~v  277 (443)
                      +||||||+||+|.++|...           ....+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcE
Confidence            9999999999999999653           2356999999999999999999999   7889999999999999999999


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKW  356 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~  356 (443)
                      ||+|||+|+.......  ........||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+. 
T Consensus       168 Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-  244 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-  244 (299)
T ss_dssp             EECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred             EECCcccceecCCCCc--eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            9999999987654321  122334569999999999999999999999999999999999 999998765433221111 


Q ss_pred             HhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       357 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                            .+.....          ...+++++.+|+.+||+.||++|||+.+|++.|..+.+
T Consensus       245 ------~~~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          245 ------QGRVLQR----------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             ------HTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------cCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                  1111110          11234679999999999999999999999998887654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-57  Score=441.21  Aligned_cols=257  Identities=22%  Similarity=0.350  Sum_probs=211.3

Q ss_pred             CCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      +++..++||+|+||+||+|.+.      +++.||||+++... .....++|.+|+.+|++++|||||+++|++.+++.++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            4566778999999999999863      47899999997653 3445678999999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013401          210 VIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF  275 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~  275 (443)
                      ||||||++|+|.++|....              ...+++..++.|+.||+.||.|||   +++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996432              245899999999999999999999   78899999999999999999


Q ss_pred             ceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHH
Q 013401          276 RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITV  354 (443)
Q Consensus       276 ~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~  354 (443)
                      .+||+|||+++.......  .......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+......... 
T Consensus       183 ~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~-  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM-  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH-
T ss_pred             CEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence            999999999987654321  122345679999999999999999999999999999999998 8999987654322111 


Q ss_pred             HHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          355 KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       355 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                            +..+.....          ...++..+.+|+.+||+.||++||++.+|+++|..+
T Consensus       260 ------i~~~~~~~~----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 ------IRNRQVLPC----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ------HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------HHcCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  112211111          112456799999999999999999999999999754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.7e-57  Score=438.30  Aligned_cols=273  Identities=23%  Similarity=0.325  Sum_probs=206.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC----eEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED----ERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~l  210 (443)
                      ++|...++||+|+||+||+|++ +|+.||||+++..   ......+.+|+..+..++|||||++++++.+++    .++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4567778999999999999998 4899999998653   222223345677777899999999999998765    5799


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY-----TDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      |||||+||+|.++|..   ..+++..++.|+.|++.||.|||+.     +..+||||||||+||||+.++.+||+|||+|
T Consensus        79 V~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999964   4589999999999999999999932     1238999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH----H----
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTY------QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE----R----  351 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~----~----  351 (443)
                      +................+||+.|||||++.+.      .++.++|||||||+||||+||.+||........    .    
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            87654433222233456799999999999754      467799999999999999999887753221100    0    


Q ss_pred             HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ..........    ....+++.++.......+++.+.+|+.+||+.||++|||+.+|++.|..|..+
T Consensus       236 ~~~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chHHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0001111111    11223445554455556778899999999999999999999999999887643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-56  Score=445.33  Aligned_cols=275  Identities=22%  Similarity=0.284  Sum_probs=215.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee------cCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF------EDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~  207 (443)
                      ++|++++.||+|+||+||+|.++ +|+.||||++++..........+.+|+.+|+.|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999986 79999999998765555566778899999999999999999998754      367


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +|||||||. |+|.+++.  ....+++..+..|+.||+.||.|||   ++|||||||||+|||++.+|.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999995 68999996  4567999999999999999999999   88899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      +..............+||+.|||||++.+. .|+.++||||||||+|||++|.+||.+.+.......+............
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            654433333345567899999999998775 5689999999999999999999999988765544433322221111100


Q ss_pred             cc-----------ccCccccc--hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          367 IS-----------ILDPRVEN--TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       367 ~~-----------~~d~~~~~--~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..           .+.+....  .......++++.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            00           00000000  000112346789999999999999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9.1e-56  Score=427.90  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=195.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      ..+|++++.||+|+||+||+|.++ +|+.||||+++... .....+.+.+|+.+|+.|+|||||+++++|.+.+      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            356999999999999999999976 79999999987542 2334567899999999999999999999987655      


Q ss_pred             ------eEEEEEeecCCCcHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEE
Q 013401          207 ------ERIVIVEYVPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       207 ------~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl  279 (443)
                            .+|+|||||.||+|.+++..... ...++..++.|+.||+.||.|||   ++|||||||||+||||+.++.+||
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence                  37999999999999999974321 12345567899999999999999   788999999999999999999999


Q ss_pred             eeecccccccccCCCcc--------cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 013401          280 ADFGFARLAADTESGAT--------HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER  351 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~  351 (443)
                      +|||+|+..........        ...+..+||+.|||||++.+..|+.++|||||||+||||++   ||....+....
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            99999987654332111        11234679999999999999999999999999999999996   88654332111


Q ss_pred             HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..  .    ......          +.......+.+.+|+.+||++||.+|||+.++++|.|.-
T Consensus       237 ~~--~----~~~~~~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~  284 (299)
T 4g31_A          237 LT--D----VRNLKF----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE  284 (299)
T ss_dssp             HH--H----HHTTCC----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred             HH--H----HhcCCC----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            11  1    111110          011122345678899999999999999999999999853

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-54  Score=429.16  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=211.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC-cceeeeeeeeeec
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH-LNLVKFHGYLEFE  205 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~  205 (443)
                      ..++|++.++||+|+||+||+|.+.      .++.||||+++... .......|.+|+.+|.++.| ||||+++++|.+.
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            3467899999999999999999864      24689999987653 23345678999999999975 8999999998764


Q ss_pred             -CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013401          206 -DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNIL  270 (443)
Q Consensus       206 -~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL  270 (443)
                       +.++||||||++|+|.++|....              ...+++..++.|+.||+.||.|||   +++||||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence             56899999999999999997532              245889999999999999999999   788999999999999


Q ss_pred             EcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHH
Q 013401          271 LTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELK  349 (443)
Q Consensus       271 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~  349 (443)
                      |+.++.+||+|||+|+.+.....  .......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.....
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999987654321  122345679999999999999999999999999999999998 999998754322


Q ss_pred             HHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .....      +..+....     .+     ..+++++.+|+.+||+.||++|||+.+|+++|..+..
T Consensus       296 ~~~~~------i~~g~~~~-----~p-----~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          296 EFCRR------LKEGTRMR-----AP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             HHHHH------HHHTCCCC-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH------HHcCCCCC-----CC-----ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            21111      11111111     11     1234679999999999999999999999999987754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.5e-53  Score=423.15  Aligned_cols=270  Identities=21%  Similarity=0.329  Sum_probs=204.4

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ..++|++.++||+|+||+||+|+.+    +++.||||++.+.    ....++.+|+++|+.+ +|||||++++++.+.++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            4578999999999999999999863    4789999988653    3346788999999998 69999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CceEEeeecccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGFAR  286 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~  286 (443)
                      +|+|||||+||+|.+++.     .+++..+..++.||+.||.|||   ++|||||||||+||||+.+ +.+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            999999999999999883     4889999999999999999999   8889999999999999876 799999999998


Q ss_pred             cccccCCCc------------------------ccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCC
Q 013401          287 LAADTESGA------------------------THVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRP  341 (443)
Q Consensus       287 ~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~P  341 (443)
                      ...+.....                        .......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            654432110                        0112345799999999999775 589999999999999999999999


Q ss_pred             CCCchhHHHHH-HHHHHh---------hhcC----------CCccccc------cC---cc--------ccchhhcHHHH
Q 013401          342 IEPKRELKERI-TVKWAM---------KKFS----------DGDAISI------LD---PR--------VENTAANNLAL  384 (443)
Q Consensus       342 f~~~~~~~~~~-~~~~~~---------~~~~----------~~~~~~~------~d---~~--------~~~~~~~~~~~  384 (443)
                      |....+..+.+ .+....         ..+.          ..+....      .+   +.        ..........+
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            96543322221 111100         0000          0000000      00   00        00000111234


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          385 EKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       385 ~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +++.+|+.+||+.||.+|||++|+++|+|.
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f  356 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFF  356 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence            678999999999999999999999999995

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-53  Score=445.22  Aligned_cols=273  Identities=21%  Similarity=0.278  Sum_probs=219.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHH---HHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQS---EIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~---Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|++++.||+|+||+||+|+.+ +|+.||||++++.... ......+.+   ++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999987 7999999999764322 222333334   466667789999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      ||||||.||+|.++|..  ...+++..++.++.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+...
T Consensus       269 lVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999974  356999999999999999999999   8899999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ...      ....+||+.|||||++. +..|+.++||||||||||||++|.+||.+.................       
T Consensus       344 ~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-------  410 (689)
T 3v5w_A          344 KKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-------  410 (689)
T ss_dssp             SCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-------
T ss_pred             CCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-------
Confidence            432      23468999999999996 5679999999999999999999999997654322111111111110       


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCcCCccc
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVLLQPSY  433 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~~~~~~  433 (443)
                         ..++     ...+.++.+||.+||+.||.+|++     +.+|++|+|.-.-+|..+..-.+..+.-|
T Consensus       411 ---~~~p-----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P  472 (689)
T 3v5w_A          411 ---VELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP  472 (689)
T ss_dssp             ---CCCC-----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             ---CCCC-----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccC
Confidence               0000     113467999999999999999998     79999999999999998876665544333

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1e-52  Score=440.90  Aligned_cols=257  Identities=22%  Similarity=0.319  Sum_probs=215.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++++.||+|+||+||+|.++ +|+.||||+++...  ....+.+.+|+.+|+.|+|||||++++++.+.+.+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            367999999999999999999986 79999999987642  334567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE--NFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~  290 (443)
                      |||.||+|.++|.. ....+++..+..++.||+.||.|||   +++|+||||||+||||+.  .+.+||+|||+|+.+..
T Consensus       234 E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          234 EFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             ECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             eecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999999999964 3456999999999999999999999   888999999999999985  48999999999988754


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..     .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.........+......+..       
T Consensus       310 ~~-----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------  377 (573)
T 3uto_A          310 KQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------  377 (573)
T ss_dssp             TS-----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-------
T ss_pred             CC-----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-------
Confidence            32     234567999999999999999999999999999999999999999887654432222211000000       


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       .      .....++++.+||.+||+.||.+||++.++++|+|.-
T Consensus       378 -~------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~  415 (573)
T 3uto_A          378 -S------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  415 (573)
T ss_dssp             -G------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred             -c------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence             0      0112346789999999999999999999999999953

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-49  Score=389.96  Aligned_cols=267  Identities=22%  Similarity=0.329  Sum_probs=222.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|+.++.||+|+||+||+|..+ +|+.||||++++... .......+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999986 699999999876432 3445677889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++||+|.+++..  ...+++..++.++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++......
T Consensus        85 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           85 EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999974  356899999999999999999999   7889999999999999999999999999997643322


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+..  ...           
T Consensus       160 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~-----------  222 (337)
T 1o6l_A          160 A----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEI-----------  222 (337)
T ss_dssp             C----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-----------
T ss_pred             C----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC-----------
Confidence            1    23456799999999999998999999999999999999999999987654322211111  000           


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                      .++     ...+.++.+|+.+||+.||.+||     ++.++++|.|....+|..+......
T Consensus       223 ~~p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~  278 (337)
T 1o6l_A          223 RFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL  278 (337)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             CCC-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCC
Confidence            000     01236789999999999999999     9999999999988888877655443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-49  Score=390.72  Aligned_cols=254  Identities=25%  Similarity=0.350  Sum_probs=215.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ..+|.+.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            357999999999999999999985 7999999999876555666778899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++...  ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.......
T Consensus        94 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             ECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999999753  56899999999999999999999   7889999999999999999999999999997665332


Q ss_pred             CCcccccccccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLT-EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                           .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...........+......           
T Consensus       169 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------  232 (328)
T 3fe3_A          169 -----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR-----------  232 (328)
T ss_dssp             -----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             -----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence                 23456799999999999887775 7899999999999999999999877543322222111000           


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ++     ...+..+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       233 --~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          233 --IP-----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             --CC-----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred             --CC-----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence              00     01235688999999999999999999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-48  Score=378.24  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=213.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|+..+.||+|+||+||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            357999999999999999999965 79999999987543  334567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++..   ..+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.......
T Consensus        97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             ECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999999864   35899999999999999999999   7889999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...  ....         
T Consensus       171 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~---------  235 (297)
T 3fxz_A          171 S----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--GTPE---------  235 (297)
T ss_dssp             C----CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH--CSCC---------
T ss_pred             c----ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCC---------
Confidence            2    233457999999999999999999999999999999999999999877654432222111  0000         


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       +.   .....+..+.+|+.+||+.||.+||++.++++|.|.-
T Consensus       236 -~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          236 -LQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             -CS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             -CC---CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence             00   0112346789999999999999999999999999964

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-49  Score=386.74  Aligned_cols=280  Identities=40%  Similarity=0.636  Sum_probs=229.9

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      +...+++|+..+.||+|+||.||+|.+++++.||||++...  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34456799999999999999999999888999999988754  2345678899999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +||||+.+|+|.+++....  ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999986432  235889999999999999999999   78899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ......  ........||+.|+|||++.+..++.++|||||||++|+|++|..||....+........|.......+...
T Consensus       189 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          189 GTELDQ--THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             CSSSSC--CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccc--cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            543221  122334568999999999988899999999999999999999999998655433333334444444444444


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ..+++.+... .....+..+.+|+.+||+.||++||++.+++++|+.+.+
T Consensus       267 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          267 QIVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSSSCTTC-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcChhhccc-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            4555444322 234577889999999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=391.13  Aligned_cols=268  Identities=24%  Similarity=0.324  Sum_probs=218.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++++... .......+.+|+.+|..+ +||||+++++++.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            368999999999999999999986 699999999876432 334556788999999998 69999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.||+|.+++...  ..+++..++.++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++....
T Consensus       102 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            99999999999999743  56999999999999999999999   78899999999999999999999999999975432


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..    ......+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+......+         
T Consensus       177 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~---------  243 (353)
T 3txo_A          177 NG----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---------  243 (353)
T ss_dssp             -------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred             CC----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence            21    12345679999999999998899999999999999999999999998776543322222110000         


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHhhhhhhhhhhcccCc
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSM------RRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~------~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                      .         ......+.+|+.+||+.||.+||++      .++++|+|.-.-+|..+......
T Consensus       244 p---------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~  298 (353)
T 3txo_A          244 P---------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIE  298 (353)
T ss_dssp             C---------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             C---------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCC
Confidence            0         0123568999999999999999999      99999999887788776555444

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-48  Score=381.04  Aligned_cols=266  Identities=25%  Similarity=0.370  Sum_probs=223.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||.||+|..+ +|+.||||++++... .....+.+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57889999999999999999986 799999999876532 2244567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++..  ...+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus        86 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999974  456899999999999999999999   889999999999999999999999999999865432 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+...       ..      
T Consensus       160 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~~------  220 (318)
T 1fot_A          160 ------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-------EL------  220 (318)
T ss_dssp             ------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------CC------
T ss_pred             ------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC------
Confidence                  23457999999999999989999999999999999999999999876553332222110       00      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                      .++     .....++.+|+.+||+.||.+||     ++.++++|+|.-..+|..+.......+
T Consensus       221 ~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p  278 (318)
T 1fot_A          221 RFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP  278 (318)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCS
T ss_pred             CCC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence            000     01236799999999999999999     999999999998888888766555443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-48  Score=388.78  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=215.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc----ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK----HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      .++|.+.+.||+|+||+||+|..+ +|+.||||++++.....    ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457999999999999999999987 69999999987654322    2457899999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----ceEEeeecc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF----RAKVADFGF  284 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~vkl~DFGl  284 (443)
                      ++||||+.||+|.+++..  ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999963  457999999999999999999999   78899999999999998776    799999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +.......     .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+......    
T Consensus       166 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~----  236 (361)
T 2yab_A          166 AHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD----  236 (361)
T ss_dssp             CEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC----
T ss_pred             ceEcCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Confidence            98765432     234467999999999999989999999999999999999999999876543322222110000    


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                           +++     ......++.+.+|+.+||..||.+|||+.++++|+|.-..+
T Consensus       237 -----~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          237 -----FDE-----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             -----CCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             -----CCc-----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence                 000     00112346789999999999999999999999999975433

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-48  Score=379.74  Aligned_cols=273  Identities=21%  Similarity=0.268  Sum_probs=211.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .++|++.++||+|+||+||+|.+.+|+.||||+++...........+.+|+.+|+.++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36799999999999999999999889999999997665455556778899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+ +|.+++.. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........
T Consensus       100 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          100 FMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             CCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            9974 88888865 3456899999999999999999999   78899999999999999999999999999987643321


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC-
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD-  371 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-  371 (443)
                          ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+................+ 
T Consensus       175 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          175 ----SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             -------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             ----cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence                2334568999999999876 5689999999999999999999999987655443333222211111111100000 


Q ss_pred             -----------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          372 -----------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       372 -----------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                                 .............+++.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  305 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK  305 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence                       00000001112346789999999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-48  Score=389.15  Aligned_cols=259  Identities=23%  Similarity=0.368  Sum_probs=215.4

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..++|.+.+.||+|+||.||+|.++ +|+.||||+++.........+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3467999999999999999999986 699999999987655555667889999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN---FRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~  288 (443)
                      |||+.||+|.+++..  ...+++..++.++.||+.||.|||   .+||+||||||+|||++.+   +.+||+|||++...
T Consensus       107 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            999999999999863  456899999999999999999999   7889999999999999864   45999999999876


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....     ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+......+.      
T Consensus       182 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------  250 (362)
T 2bdw_A          182 NDSE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------  250 (362)
T ss_dssp             TTCC-----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred             cCCc-----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            5432     12346799999999999998999999999999999999999999987654332222211100000      


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        .+      .....+..+.+|+.+||+.||.+||++.++++|+|..
T Consensus       251 --~~------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  289 (362)
T 2bdw_A          251 --SP------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  289 (362)
T ss_dssp             --TT------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred             --cc------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence              00      0112346799999999999999999999999999964

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=396.93  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=214.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..++|++.+.||+|+||+||+|... +|+.||+|++............+.+|+.+|+.++|||||++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4567999999999999999999876 799999999877655555567789999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~  288 (443)
                      ||||.||+|.+++..  ...+++..+..++.||+.||.|||   ++||+||||||+|||++   .++.+||+|||++...
T Consensus        89 ~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999974  456999999999999999999999   78899999999999998   4678999999999776


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....    ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+......+..     
T Consensus       164 ~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----  234 (444)
T 3soa_A          164 EGEQQ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS-----  234 (444)
T ss_dssp             CTTCC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred             cCCCc----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc-----
Confidence            54321    233467999999999999989999999999999999999999999876654332222211111100     


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         +      .....++.+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       235 ---~------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          235 ---P------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             ---T------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             ---c------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence               0      0012346799999999999999999999999999964

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-48  Score=381.19  Aligned_cols=256  Identities=21%  Similarity=0.285  Sum_probs=212.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|.++..   ......+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            357899999999999999999986 6899999998753   344567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE--NFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~  290 (443)
                      ||+.|++|.+++.. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.  ++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           81 EFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999999964 3346899999999999999999999   788999999999999987  78999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......+         
T Consensus       157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------  222 (321)
T 1tki_A          157 GD-----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------  222 (321)
T ss_dssp             TC-----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------
T ss_pred             CC-----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC---------
Confidence            32     2334569999999999998889999999999999999999999998765433222221110000         


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +     .......+.++.+|+.+||..||.+|||+.++++|+|..
T Consensus       223 ~-----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  262 (321)
T 1tki_A          223 D-----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             C-----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             C-----hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence            0     000112346799999999999999999999999999964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-48  Score=380.06  Aligned_cols=288  Identities=35%  Similarity=0.613  Sum_probs=233.3

Q ss_pred             CcccCHHHHHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeee
Q 013401          122 NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY  201 (443)
Q Consensus       122 ~~~~~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~  201 (443)
                      ...++..++....++|...+.||+|+||.||+|.+.+|+.||||+++..... .....+.+|+.+++.++||||++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3467888999999999999999999999999999888999999998765322 223368899999999999999999999


Q ss_pred             eeecCeEEEEEeecCCCcHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEE
Q 013401          202 LEFEDERIVIVEYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       202 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl  279 (443)
                      +...+..++||||+.+|+|.+++....  ...+++..++.|+.||+.||.|||.....||+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999997543  334899999999999999999999432228999999999999999999999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhH--HHHHHHHHH
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKREL--KERITVKWA  357 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~--~~~~~~~~~  357 (443)
                      +|||++........   .......||+.|+|||++.+..++.++|||||||++|+|++|..||......  .......|.
T Consensus       176 ~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          176 GDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             CCCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             ccCccccccCcccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            99999987653322   2234456999999999998888999999999999999999999999643211  112233444


Q ss_pred             hhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       358 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .............+..+... .....+..+.+|+.+||+.||.+|||+.+|+++|+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTS-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHhhchhhhhhcChhhccc-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            44444444445555444332 345567889999999999999999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.3e-48  Score=389.53  Aligned_cols=280  Identities=22%  Similarity=0.322  Sum_probs=221.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ++|++++.||+|+||+||+|+.+ +++.||||++++.... ......+.+|+.+|..+ +|||||++++++.+.+.+++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            57999999999999999999987 6899999999765432 33345678999999887 799999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.||+|.+++..  ...+++..++.++.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+++.....
T Consensus       132 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999974  356999999999999999999999   788999999999999999999999999999763322


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH--HHHHHHHhhhcCCCccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE--RITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  369 (443)
                      .    ......+||+.|+|||++.+..++.++|||||||++|||++|.+||........  ..........+.....   
T Consensus       207 ~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  279 (396)
T 4dc2_A          207 G----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  279 (396)
T ss_dssp             T----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred             C----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence            2    123456799999999999999999999999999999999999999964321110  0000111111111100   


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHhhhhhhhhhhcccCcCCcccc
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSM------RRCAEILWSVRKDYRELAASDVLLQPSYS  434 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~------~ell~~l~~i~~~~~~~~~~~~~~~~~~~  434 (443)
                         .++     ...+.++.+|+.+||+.||.+||++      .++++|+|.-.-+|..+....+..+..|.
T Consensus       280 ---~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~  342 (396)
T 4dc2_A          280 ---RIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN  342 (396)
T ss_dssp             ---CCC-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCC
T ss_pred             ---CCC-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCC
Confidence               000     1123678999999999999999984      89999999988888887766655444443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-48  Score=383.68  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=223.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|+.++.||+|+||.||+|... +|+.||||++++... .......+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999986 699999999876432 2345677889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++...  ..+++..++.++.||+.||.|||   .+||+||||||+||||+.+|.+||+|||+++..... 
T Consensus       121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            999999999999753  46899999999999999999999   788999999999999999999999999999866432 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+..       +..      
T Consensus       195 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------~~~------  255 (350)
T 1rdq_E          195 ------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------GKV------  255 (350)
T ss_dssp             ------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC------
T ss_pred             ------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc-------CCC------
Confidence                  2345799999999999998999999999999999999999999987654332222211       100      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCcCCc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVLLQP  431 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~~~~  431 (443)
                      .++     ...+..+.+|+.+||+.||.+||+     +.++++|.|.-..+|..+.......+.
T Consensus       256 ~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~  314 (350)
T 1rdq_E          256 RFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF  314 (350)
T ss_dssp             CCC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred             CCC-----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCC
Confidence            000     012367999999999999999998     999999999988888777655544433

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-48  Score=385.99  Aligned_cols=269  Identities=24%  Similarity=0.360  Sum_probs=221.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~  209 (443)
                      ..++|...+.||+|+||.||+|.++ +|+.||||++++... .......+.+|..+|..+ +||||+++++++.+.+.++
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            3468999999999999999999986 699999999876532 234456788999999987 8999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.||+|.+++...  ..+++..++.++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++...
T Consensus        95 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            999999999999999743  46899999999999999999999   7889999999999999999999999999997643


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ....    .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+....           
T Consensus       170 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-----------  234 (345)
T 1xjd_A          170 LGDA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-----------  234 (345)
T ss_dssp             CTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred             cCCC----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            2221    2345679999999999999899999999999999999999999998765433222221100           


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHhhhhhhhhhhcccCc
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMR-RCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~-ell~~l~~i~~~~~~~~~~~~~  428 (443)
                        +.++     ...+..+.+|+.+||+.||.+||++. ++++|+|.-.-+|..+......
T Consensus       235 --~~~p-----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~  287 (345)
T 1xjd_A          235 --PFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID  287 (345)
T ss_dssp             --CCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSC
T ss_pred             --CCCC-----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCC
Confidence              0000     01236789999999999999999998 9999999888788777554443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-47  Score=373.68  Aligned_cols=262  Identities=31%  Similarity=0.457  Sum_probs=207.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ..+|++.+.||+|+||+||+|.+ +|+.||||++............+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            45788999999999999999987 48889999988765555666788999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          214 YVPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |+.+|+|.+++.... ...+++..++.++.||+.||.|||   .++  |+||||||+|||++.++.+||+|||+++....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999997422 123899999999999999999999   888  99999999999999999999999999976543


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..    .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....   ....     
T Consensus       192 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~---~~~~-----  259 (309)
T 3p86_A          192 TF----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC---KRLE-----  259 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC---CCCC-----
T ss_pred             cc----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC---CCCC-----
Confidence            21    11234569999999999999999999999999999999999999998765543322221110   0000     


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                         +     ....+..+.+|+.+||+.||.+||++.++++.|..+.++.
T Consensus       260 ---~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          260 ---I-----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ---C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ---C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence               0     0112357999999999999999999999999998886653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-48  Score=383.35  Aligned_cols=273  Identities=22%  Similarity=0.296  Sum_probs=223.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ..+|+..+.||+|+||.||+|..+ +|+.||||++++... .......+.+|..+|..+ +||||+++++++.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            367999999999999999999987 589999999876532 234556788999999988 79999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.||+|.+++...  ..+++..++.++.||+.||.|||   .+||+||||||+||||+.+|.+||+|||+++....
T Consensus        99 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999743  46899999999999999999999   78899999999999999999999999999976432


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..    ......+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+..       ...    
T Consensus       174 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------~~~----  238 (353)
T 2i0e_A          174 DG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNV----  238 (353)
T ss_dssp             TT----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC----
T ss_pred             CC----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------CCC----
Confidence            21    123456799999999999998999999999999999999999999987654332222111       000    


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCcCCccc
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVLLQPSY  433 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~~~~~~  433 (443)
                        .++     ...+.++.+|+.+||+.||.+||+     +.++++|+|.-.-+|..+.......+..|
T Consensus       239 --~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p  299 (353)
T 2i0e_A          239 --AYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP  299 (353)
T ss_dssp             --CCC-----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             --CCC-----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCC
Confidence              000     112367999999999999999995     69999999988888888766555444333

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.5e-48  Score=377.72  Aligned_cols=269  Identities=24%  Similarity=0.331  Sum_probs=211.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEE----cCCcEEEEEEcccccc--CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|++.+.||+|+||.||+|..    .+|+.||||++++...  .......+.+|+.+|+.++||||+++++++...+.+
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5799999999999999999987    4799999999876532  223345678999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++||||+.|++|.+++..  ...+++..++.++.||+.||.|||   .+||+||||||+||||+.++.+||+|||+++..
T Consensus        97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999974  356889999999999999999999   788999999999999999999999999998754


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....    .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..   ...  .   
T Consensus       172 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~~--~---  239 (327)
T 3a62_A          172 IHDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK---CKL--N---  239 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---TCC--C---
T ss_pred             ccCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---CCC--C---
Confidence            33221    23345799999999999988999999999999999999999999987654332211111   100  0   


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                       +.+         .....+.+|+.+||+.||.+||     ++.++++|+|.-..++.++.......+
T Consensus       240 -~p~---------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p  296 (327)
T 3a62_A          240 -LPP---------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP  296 (327)
T ss_dssp             -CCT---------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCS
T ss_pred             -CCC---------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCC
Confidence             001         1236789999999999999999     889999999988778877766555433

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-47  Score=373.24  Aligned_cols=271  Identities=23%  Similarity=0.372  Sum_probs=220.8

Q ss_pred             ccCHHHHHHHhcC----------CCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC
Q 013401          124 QITMEEIYRATRN----------FSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH  192 (443)
Q Consensus       124 ~~~~~~~~~~~~~----------f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h  192 (443)
                      .++.+++..+++.          |.....||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++|
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCC
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCC
Confidence            4567777666654          566678999999999999987 79999999987542  3445678899999999999


Q ss_pred             cceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013401          193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT  272 (443)
Q Consensus       193 ~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~  272 (443)
                      |||+++++++...+..++||||+.|++|.+++.   ...+++..++.++.||+.||.|||   .+||+||||||+|||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEC
Confidence            999999999999999999999999999999885   346899999999999999999999   78899999999999999


Q ss_pred             CCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHH
Q 013401          273 ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI  352 (443)
Q Consensus       273 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~  352 (443)
                      .++.+||+|||++........    ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~  251 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK  251 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             CCCcEEEeeeeeeeecccCcc----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999987654321    1234579999999999999899999999999999999999999998765433221


Q ss_pred             HHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          353 TVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      .+.   ... .        +.+.   .....+..+.+|+.+||+.||.+||++.++++|+|.......+
T Consensus       252 ~~~---~~~-~--------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          252 RLR---DSP-P--------PKLK---NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             HHH---HSS-C--------CCCT---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             HHh---cCC-C--------CCcC---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence            111   110 0        0000   0112336789999999999999999999999999987654433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6e-48  Score=371.15  Aligned_cols=272  Identities=22%  Similarity=0.305  Sum_probs=211.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|...+.||+|+||+||+|...+|+.||||+++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999998899999999876544444557788999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+ +|.+++.. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            975 89988865 3456899999999999999999999   78899999999999999999999999999976543211 


Q ss_pred             cccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc-----cc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA-----IS  368 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~  368 (443)
                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+............     ..
T Consensus       156 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          156 ---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             ---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence               2234568999999999976 45899999999999999999999999877654433332221111110000     00


Q ss_pred             ccCcccc------chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ILDPRVE------NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ~~d~~~~------~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..++...      ........++.+.+|+.+||+.||++|||+.++++|+|.-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  285 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence            0111100      0011112346789999999999999999999999999953

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-47  Score=379.42  Aligned_cols=274  Identities=23%  Similarity=0.342  Sum_probs=218.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ++|+..+.||+|+||.||+|+++ +++.||||++++... .......+.+|+.++..+ +|||||++++++.+.+.+++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57889999999999999999986 689999999976543 233456688999999988 899999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.||+|.+++...  ..+++..++.++.||+.||.|||   ++||+||||||+||||+.+|.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            9999999999999743  56899999999999999999999   788999999999999999999999999999764322


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH--HHHHHHHhhhcCCCccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE--RITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  369 (443)
                      .    ......+||+.|+|||++.+..++.++|||||||++|||++|..||........  ..........+.....   
T Consensus       164 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  236 (345)
T 3a8x_A          164 G----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  236 (345)
T ss_dssp             T----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred             C----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence            2    123456799999999999998999999999999999999999999965321100  0000111111111100   


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHhhhhhhhhhhcccCc
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSM------RRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~------~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                         .++     ...+..+.+|+.+||+.||.+||++      .++++|+|.-..+|..+......
T Consensus       237 ---~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~  293 (345)
T 3a8x_A          237 ---RIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV  293 (345)
T ss_dssp             ---CCC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             ---CCC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCC
Confidence               000     1123678999999999999999995      89999999888888776554443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.2e-48  Score=377.69  Aligned_cols=261  Identities=23%  Similarity=0.331  Sum_probs=215.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc----ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK----HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|...+.||+|+||.||+|... +|+.||||+++......    ...+.+.+|+.+|+.++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46888899999999999999986 69999999987654322    24678999999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----ceEEeeeccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF----RAKVADFGFA  285 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~vkl~DFGla  285 (443)
                      +||||+.+++|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++    .+||+|||++
T Consensus        91 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999963  456899999999999999999999   78899999999999999877    7999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......+    
T Consensus       166 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----  236 (326)
T 2y0a_A          166 HKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF----  236 (326)
T ss_dssp             EECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC----
T ss_pred             eECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc----
Confidence            8765332     1234569999999999998899999999999999999999999998765433222221110000    


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                           ..     ......+..+.+|+.+||+.||.+|||+.++++|+|....+.
T Consensus       237 -----~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          237 -----ED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             -----CH-----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             -----Cc-----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence                 00     001123467899999999999999999999999999765544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.8e-48  Score=385.83  Aligned_cols=274  Identities=22%  Similarity=0.312  Sum_probs=224.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+++.||+|+||.||+|... +++.||||++.+.. ........+.+|+.+|+.++|||||++++++.+.+.+++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57899999999999999999976 68999999986543 23445677889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++..  ...+++..++.++.||+.||.|||   .+||+||||||+||||+.+|.+||+|||++.......
T Consensus        95 e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             CCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999973  457999999999999999999999   7889999999999999999999999999998765332


Q ss_pred             CCcccccccccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                           .....+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.....................      
T Consensus       170 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------  238 (384)
T 4fr4_A          170 -----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT------  238 (384)
T ss_dssp             -----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC------
T ss_pred             -----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC------
Confidence                 2345679999999999963   45899999999999999999999999755432221111111111100      


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHhhhhhhhhhhcccCcCCccc
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPS-MRRCAEILWSVRKDYRELAASDVLLQPSY  433 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-~~ell~~l~~i~~~~~~~~~~~~~~~~~~  433 (443)
                          .     ....+..+.+|+.+||+.||.+||+ +.++++|+|.-..+|..+....+..+..|
T Consensus       239 ----~-----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p  294 (384)
T 4fr4_A          239 ----Y-----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIP  294 (384)
T ss_dssp             ----C-----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCC
T ss_pred             ----C-----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCC
Confidence                0     0112367999999999999999998 99999999998888888766665544333

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-47  Score=369.41  Aligned_cols=271  Identities=21%  Similarity=0.299  Sum_probs=209.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.++||+|+||+||+|.+. +++.||||+++...........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47889999999999999999986 69999999998765555556788899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+ +|.+++.. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            9975 66666654 3467999999999999999999999   78899999999999999999999999999987643221


Q ss_pred             CcccccccccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-HHHHhhhcCCCcccccc-
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT-VKWAMKKFSDGDAISIL-  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-  370 (443)
                          ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......+... +................ 
T Consensus       157 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          157 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             ----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             ----cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence                233456899999999997765 89999999999999999998887544333322222 21111111111100000 


Q ss_pred             ----------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          371 ----------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       371 ----------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                                ................+.+|+.+||+.||.+|||+.++++|+|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence                      00000000111234678999999999999999999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.1e-48  Score=390.67  Aligned_cols=272  Identities=22%  Similarity=0.263  Sum_probs=219.1

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ..++|++.+.||+|+||+||+|.++ +++.||||++++... .......+.+|+.+++.++|||||++++++.+.+.+|+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            4568999999999999999999987 689999999875321 22333457899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |||||+||+|.+++..   ..+++..++.++.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+++....
T Consensus       147 V~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             EECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            9999999999999863   35899999999999999999999   78899999999999999999999999999987653


Q ss_pred             cCCCcccccccccCCCCccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQ----LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ..   .......+||+.|+|||++.+..    ++.++|||||||+||||++|.+||...........+......+.... 
T Consensus       221 ~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-  296 (410)
T 3v8s_A          221 EG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-  296 (410)
T ss_dssp             TS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-
T ss_pred             CC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC-
Confidence            32   11233567999999999997655    78999999999999999999999987765443333222111111000 


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhhhhhhhhhcccC
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVRKDYRELAASDV  427 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~~~~~~~~~~~~  427 (443)
                                   ....+.++.+|+.+||+.+|.+  ||++.+|++|+|.-..+|........
T Consensus       297 -------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~  346 (410)
T 3v8s_A          297 -------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT  346 (410)
T ss_dssp             -------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGS
T ss_pred             -------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhccc
Confidence                         0012367999999999999988  99999999999987666654443333

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.8e-48  Score=385.59  Aligned_cols=280  Identities=18%  Similarity=0.231  Sum_probs=215.9

Q ss_pred             hcCCCCCceeeee--CceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          134 TRNFSPSFKIGQG--GFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      .++|++.+.||+|  +||+||+|.+. +|+.||||+++...........+.+|+.+|+.++|||||++++++.+.+.+++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3579999999999  99999999987 79999999998765555666778899999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |||||.+|+|.+++.......+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999998765577999999999999999999999   78899999999999999999999999999875533


Q ss_pred             cCCCc---ccccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH-HhhhcCCC
Q 013401          291 TESGA---THVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW-AMKKFSDG  364 (443)
Q Consensus       291 ~~~~~---~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~  364 (443)
                      .....   ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.............. ......+.
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            22111   111233479999999999987  6799999999999999999999999976543322111000 00000000


Q ss_pred             ------c-------------ccccc--------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 ------D-------------AISIL--------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ------~-------------~~~~~--------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                            .             ....+        .............+..+.+|+.+||+.||.+|||+.++++|+|.-.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                  0             00000        0000000112234567999999999999999999999999999643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-47  Score=379.97  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=211.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc---CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .++|++.+.||+|+||+||+|.++ +|+.||||+++....   .....+.+.+|+.+++.++|||||++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356889999999999999999976 799999999865322   2234678999999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---eEEeeecc
Q 013401          210 VIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFGF  284 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---vkl~DFGl  284 (443)
                      +|||||.|++|.+++...  .+..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999888643  2446899999999999999999999   788999999999999986654   99999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +........    .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ..........  
T Consensus       180 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~i~~~~~~--  250 (351)
T 3c0i_A          180 AIQLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL---FEGIIKGKYK--  250 (351)
T ss_dssp             CEECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH---HHHHHHTCCC--
T ss_pred             eeEecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH---HHHHHcCCCC--
Confidence            987654321    2334579999999999999899999999999999999999999998754311   1111000000  


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                           ..+     ......++.+.+|+.+||+.||.+||++.++++|+|.-.
T Consensus       251 -----~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          251 -----MNP-----RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             -----CCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             -----CCc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence                 000     001123467999999999999999999999999999654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.9e-48  Score=390.85  Aligned_cols=274  Identities=20%  Similarity=0.267  Sum_probs=221.4

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      +....++|++.++||+|+||+||+|+++ +++.||||++++... .......+.+|+.++..++||||+++++++.+.+.
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            3334578999999999999999999987 589999999875321 12223347899999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +++|||||.||+|.+++... ...+++..++.++.||+.||.|||   .++||||||||+||||+.++.+||+|||+++.
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~  224 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  224 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence            99999999999999999752 456999999999999999999999   78899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      ......   ......+||+.|+|||++.     ...++.++|||||||++|||++|.+||...........+......+.
T Consensus       225 ~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          225 LMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  301 (437)
T ss_dssp             CCTTSC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             cccCCC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence            654321   2234467999999999996     45789999999999999999999999987765443333221111111


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHHhhhhhhhhhh
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQN--RPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~--RPs~~ell~~l~~i~~~~~~~~  423 (443)
                      ....             ....++.+.+|+.+||+.+|++  ||++.++++|+|.-.-+|..+.
T Consensus       302 ~p~~-------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          302 FPTQ-------------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             CCSS-------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             CCcc-------------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence            0000             0012367899999999998888  9999999999999877777764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.1e-48  Score=383.90  Aligned_cols=269  Identities=22%  Similarity=0.298  Sum_probs=213.3

Q ss_pred             HHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-----Ccceeeeeeeeeec
Q 013401          132 RATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-----HLNLVKFHGYLEFE  205 (443)
Q Consensus       132 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l~~~~~~~  205 (443)
                      ...++|.+.++||+|+||+||+|.+. +++.||||+++..   ......+.+|+.+++.+.     |||||++++++...
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            34578999999999999999999985 7899999998743   334556778999999986     99999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC------------
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE------------  273 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~------------  273 (443)
                      +..++||||+ +++|.+++.......+++..++.|+.||+.||.|||   ++||+||||||+||||+.            
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhc
Confidence            9999999999 999999998766667999999999999999999999   788999999999999975            


Q ss_pred             -------------CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 013401          274 -------------NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRR  340 (443)
Q Consensus       274 -------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~  340 (443)
                                   ++.+||+|||++......       .....||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  257 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL  257 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence                         789999999999765432       234569999999999999999999999999999999999999


Q ss_pred             CCCCchhHHHHHHHHHHhhhcCCCccc--------cccC-c----cccchhh---------------cHHHHHHHHHHHH
Q 013401          341 PIEPKRELKERITVKWAMKKFSDGDAI--------SILD-P----RVENTAA---------------NNLALEKILELAL  392 (443)
Q Consensus       341 Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~d-~----~~~~~~~---------------~~~~~~~l~~Li~  392 (443)
                      ||...........+......+......        ..++ .    .......               .....+.+.+|+.
T Consensus       258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  337 (360)
T 3llt_A          258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY  337 (360)
T ss_dssp             SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred             CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence            998776544333332222111110000        0000 0    0000000               0001256889999


Q ss_pred             HccCCCCCCCCCHHHHHHHHHh
Q 013401          393 QCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       393 ~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +||+.||.+|||+.++++|+|.
T Consensus       338 ~~L~~dP~~Rpta~elL~hp~f  359 (360)
T 3llt_A          338 SILQIDPTLRPSPAELLKHKFL  359 (360)
T ss_dssp             HHCCSSGGGSCCHHHHTTSGGG
T ss_pred             HHhcCChhhCCCHHHHhcCccc
Confidence            9999999999999999999984

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-48  Score=394.93  Aligned_cols=273  Identities=21%  Similarity=0.261  Sum_probs=215.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||.||+|... +|+.||||+++.... .......+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            57999999999999999999976 799999999876432 3344466789999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ||+.||+|.+++..  ...+++..++.++.||+.||.|||   . +|||||||||+||||+.++.+||+|||+++.....
T Consensus       228 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          228 EYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             CCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             eeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999974  356899999999999999999999   6 78999999999999999999999999999764332


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .    ......+||+.|+|||++.+..++.++|||||||+||||++|..||...........+....  .   .      
T Consensus       303 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~---~------  367 (446)
T 4ejn_A          303 G----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--I---R------  367 (446)
T ss_dssp             --------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C---C------
T ss_pred             C----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--C---C------
Confidence            2    12345679999999999999999999999999999999999999998765433222221100  0   0      


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCCcccc
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQPSYS  434 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~~~~~  434 (443)
                        ++     ...+..+.+|+.+||+.||.+||     ++.++++|+|.-..++..+.......+..|.
T Consensus       368 --~p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~  428 (446)
T 4ejn_A          368 --FP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQ  428 (446)
T ss_dssp             --CC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred             --CC-----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCC
Confidence              00     01236789999999999999999     9999999999988888887666555444443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-47  Score=363.30  Aligned_cols=259  Identities=27%  Similarity=0.467  Sum_probs=214.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++.+.||+|+||.||+|.++++..||||+++..   .....++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG---SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT---TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccC---CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            578899999999999999999988889999998764   33456789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++... +..+++..++.|+.||+.||.|||   .+||+||||||+|||++.++.+||+|||++........ 
T Consensus        85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-  159 (268)
T ss_dssp             CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred             cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence            9999999999753 456899999999999999999999   78899999999999999999999999999987654321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...................         .+ 
T Consensus       160 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------~~-  227 (268)
T 3sxs_A          160 --VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY---------RP-  227 (268)
T ss_dssp             --EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---------CC-
T ss_pred             --hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC---------CC-
Confidence              12233457788999999998889999999999999999999 999998765543322221110000         00 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                             ...++.+.+|+.+||+.||.+||++.+++++|..++...+
T Consensus       228 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k  267 (268)
T 3sxs_A          228 -------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK  267 (268)
T ss_dssp             -------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred             -------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence                   0123579999999999999999999999999999876654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=370.95  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=213.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|...+.||+|+||+||+|.+. +++.||||++...  .......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            57888899999999999999986 6999999987543  34556788999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++.. ....+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           88 YIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999975 3566999999999999999999999   78899999999999999999999999999987654332


Q ss_pred             Ccc----------cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH--HHHHHHhhhc
Q 013401          294 GAT----------HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER--ITVKWAMKKF  361 (443)
Q Consensus       294 ~~~----------~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~--~~~~~~~~~~  361 (443)
                      ...          .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ..........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY  243 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence            111          0111457999999999999999999999999999999999999998654321100  0000000000


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      .                 ...+++.+.+|+.+||+.||++||++.++++.|..++.....
T Consensus       244 ~-----------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          244 C-----------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             C-----------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             C-----------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            0                 011235689999999999999999999999999998876654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.9e-48  Score=378.78  Aligned_cols=269  Identities=23%  Similarity=0.303  Sum_probs=211.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC----eEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED----ERI  209 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~  209 (443)
                      .++|++.+.||+|+||+||+|.+. ++.||||+++..   ......+.+|+.+|+.++|||||++++++....    .++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            368999999999999999999876 789999998654   333445667999999999999999999998754    469


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------CeEecCCCCCCEEEcCCCceEE
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH----------PIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivHrDlkp~NILl~~~~~vkl  279 (443)
                      +||||+.+|+|.+++..   ..+++..++.|+.||+.||.|||   +.          +|+||||||+|||++.++.+||
T Consensus        99 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            99999999999999964   45899999999999999999999   77          9999999999999999999999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT-  353 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~-  353 (443)
                      +|||+++........  .......||+.|+|||++.+     ..++.++|||||||++|||++|..||........... 
T Consensus       173 ~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          173 ADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             CCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             ccCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            999999876543221  12234579999999999976     3556688999999999999999999975432110000 


Q ss_pred             --------HHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          354 --------VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       354 --------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                              ..........    ....+.+.........++.+.+|+.+||+.||.+|||+.+|++.|..+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVH----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhc----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                    0001111111    112222333333445667899999999999999999999999999988654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.8e-47  Score=370.97  Aligned_cols=274  Identities=21%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|+..+.||+|+||.||+|... +|+.||||+++... .......+.+|+.+|+.++|||||++++++.+++..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            57899999999999999999976 69999999987653 23344678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          214 YVPNGTLREHLDCLQ----GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      |+. ++|.+++....    ...+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 59999986543    245889999999999999999999   7889999999999999999999999999998764


Q ss_pred             ccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....    ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..............
T Consensus       160 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVN----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCC----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             CCcc----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            3221    2234568999999999976 4689999999999999999999999987765443322222111111100000


Q ss_pred             -----ccCccccc-----------hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          369 -----ILDPRVEN-----------TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       369 -----~~d~~~~~-----------~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                           ...+.+..           .......+..+.+|+.+||+.||.+|||+.++++|+|.-.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence                 00000000           00001234679999999999999999999999999996543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.5e-48  Score=385.99  Aligned_cols=275  Identities=24%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecC--eE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFED--ER  208 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~  208 (443)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+|+.+. |||||++++++..++  .+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999976 7999999998766555566677889999999997 999999999997654  78


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      |+|||||. ++|.+++..   ..+++..+..++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++..
T Consensus        87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999997 689888864   46899999999999999999999   788999999999999999999999999999865


Q ss_pred             cccCCC-----------------cccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 013401          289 ADTESG-----------------ATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE  350 (443)
Q Consensus       289 ~~~~~~-----------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~  350 (443)
                      ......                 ........+||++|+|||++.+ ..++.++|||||||++|||++|.+||.+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            432110                 1112345689999999999976 6789999999999999999999999988765544


Q ss_pred             HHHHHHHhhhcCCCccccccCc------------------cccch-----------hhcHHHHHHHHHHHHHccCCCCCC
Q 013401          351 RITVKWAMKKFSDGDAISILDP------------------RVENT-----------AANNLALEKILELALQCLAPRRQN  401 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~------------------~~~~~-----------~~~~~~~~~l~~Li~~cl~~dp~~  401 (443)
                      ...+..............+..+                  .....           .....+.+++.+|+.+||+.||.+
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            3333221111100000000000                  00000           000023467999999999999999


Q ss_pred             CCCHHHHHHHHHh
Q 013401          402 RPSMRRCAEILWS  414 (443)
Q Consensus       402 RPs~~ell~~l~~  414 (443)
                      |||+.++++|+|.
T Consensus       320 R~t~~e~l~Hp~~  332 (388)
T 3oz6_A          320 RISANDALKHPFV  332 (388)
T ss_dssp             SCCHHHHTTSTTT
T ss_pred             CCCHHHHhCCHHH
Confidence            9999999999995

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=368.19  Aligned_cols=254  Identities=27%  Similarity=0.343  Sum_probs=202.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc------------------------ccHHHHHHHHHHHHh
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK------------------------HSGAEFQSEIRTLAQ  189 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------------------------~~~~~~~~Ei~~l~~  189 (443)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++.......                        ...+.+.+|+.+|+.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57999999999999999999976 68999999986543211                        123568899999999


Q ss_pred             cCCcceeeeeeeeee--cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 013401          190 VEHLNLVKFHGYLEF--EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSS  267 (443)
Q Consensus       190 l~h~niv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~  267 (443)
                      ++||||+++++++.+  .+..++||||+++++|.+++   ....+++..++.++.||+.||.|||   .++|+||||||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            999999999999987  56899999999999998765   3457999999999999999999999   788999999999


Q ss_pred             CEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 013401          268 NILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRPIEP  344 (443)
Q Consensus       268 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlGvll~elltG~~Pf~~  344 (443)
                      |||++.++.+||+|||++........    ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||..
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HEEECCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999987654321    233457999999999997654   37789999999999999999999987


Q ss_pred             chhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          345 KRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .........+..   ....     ...        ....++.+.+|+.+||+.||++||++.++++|+|.
T Consensus       243 ~~~~~~~~~~~~---~~~~-----~~~--------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          243 ERIMCLHSKIKS---QALE-----FPD--------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             SSHHHHHHHHHH---CCCC-----CCS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             ccHHHHHHHHhc---ccCC-----CCC--------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence            654322111111   0000     000        01123679999999999999999999999999995

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-47  Score=368.82  Aligned_cols=275  Identities=25%  Similarity=0.276  Sum_probs=211.7

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc---CcccHHHHHHHHHHHHhcC---Ccceeeeeeeeeec
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVE---HLNLVKFHGYLEFE  205 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~  205 (443)
                      ..++|++.++||+|+||+||+|.+. +++.||||+++....   .......+.+|+.+++.+.   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3568999999999999999999975 799999999875432   1222356677888877764   99999999999876


Q ss_pred             C-----eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEe
Q 013401          206 D-----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVA  280 (443)
Q Consensus       206 ~-----~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~  280 (443)
                      .     ..++||||+. ++|.+++.......+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5799999996 69999998665556999999999999999999999   7889999999999999999999999


Q ss_pred             eecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       281 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      |||++.......     ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+......
T Consensus       163 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          163 DFGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             SCSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             eCccccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998664332     234457999999999999889999999999999999999999999887665443333322222


Q ss_pred             cCCCcccccc-------Cccc--cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          361 FSDGDAISIL-------DPRV--ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       361 ~~~~~~~~~~-------d~~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ..........       .+..  ..........+.+.+|+.+||+.||.+|||+.++++|.|.-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            2111111000       0000  000011123467899999999999999999999999999643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-47  Score=382.47  Aligned_cols=268  Identities=24%  Similarity=0.317  Sum_probs=212.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHH-HHhcCCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRT-LAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ++|++++.||+|+||.||+|+.+ +++.||||++++.... ......+.+|..+ ++.++|||||++++++.+.+.+|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57999999999999999999987 6899999998765432 3334556677776 4678999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.||+|.+++..  ...+++..++.++.||+.||.|||   .+||+||||||+||||+.+|.+||+|||+++.....
T Consensus       118 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          118 LDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999974  356889999999999999999999   788999999999999999999999999999764332


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ..    .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+...  ..       .+.
T Consensus       193 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~-------~~~  259 (373)
T 2r5t_A          193 NS----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PL-------QLK  259 (373)
T ss_dssp             CC----CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CC-------CCC
T ss_pred             CC----ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cc-------CCC
Confidence            21    234567999999999999999999999999999999999999999876553322222110  00       011


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHhhhhhhhhhhcccCcC
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSM----RRCAEILWSVRKDYRELAASDVLL  429 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~----~ell~~l~~i~~~~~~~~~~~~~~  429 (443)
                      +         .....+.+|+.+||+.||.+||++    .++++|.|.-..+|..+....+..
T Consensus       260 ~---------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~p  312 (373)
T 2r5t_A          260 P---------NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITP  312 (373)
T ss_dssp             S---------SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred             C---------CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCC
Confidence            1         123578999999999999999987    699999998888888876555443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=372.75  Aligned_cols=266  Identities=26%  Similarity=0.402  Sum_probs=213.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      .+|.+.+.||+|+||.||+|.+.    .+..||||+++... .......+.+|+.+|+.++||||+++++++.+.+..++
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            56888899999999999999975    35569999987642 34455678999999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.|++|.+++.. ....+++..++.|+.||+.||.|||   .++|+||||||+||||+.++.+||+|||++.....
T Consensus       128 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            9999999999999964 3456999999999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      .... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..       +.... 
T Consensus       204 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-------~~~~~-  274 (325)
T 3kul_A          204 DPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-------GYRLP-  274 (325)
T ss_dssp             ---C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-------TCCCC-
T ss_pred             Cccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-------CCCCC-
Confidence            3221 112233457889999999998899999999999999999999 9999987655332222211       10000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                          .     ...+++.+.+|+.+||+.||.+||++.+|++.|..+.++...+.
T Consensus       275 ----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~  319 (325)
T 3kul_A          275 ----A-----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR  319 (325)
T ss_dssp             ----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred             ----C-----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence                0     11234679999999999999999999999999999877655543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-47  Score=362.59  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=213.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+..+.||+|+||.||+|.+.+++.||||+++..   ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc---ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            578889999999999999999988899999998765   33446789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++.. ....+++..++.++.|++.||.|||   .++|+||||||+|||++.++.+||+|||++.......  
T Consensus        87 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  160 (269)
T 4hcu_A           87 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--  160 (269)
T ss_dssp             CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred             CCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc--
Confidence            999999999965 3456899999999999999999999   7889999999999999999999999999998654332  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                       ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..   ...      ...+ 
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~---~~~------~~~~-  229 (269)
T 4hcu_A          161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFR------LYKP-  229 (269)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCC------CCCC-
T ss_pred             -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc---Ccc------CCCC-
Confidence             112233457889999999998899999999999999999999 9999987654332222111   000      0000 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                             ...++.+.+|+.+||+.||.+||++.+++++|..+..
T Consensus       230 -------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          230 -------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                   1123679999999999999999999999999998864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.1e-48  Score=376.54  Aligned_cols=259  Identities=24%  Similarity=0.353  Sum_probs=208.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||+||+|.+. +++.||||++..... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            357999999999999999999987 799999999865432 223356889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.|++|.+++.  ....+++..++.++.||+.||.|||   ++||+||||||+||||+.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           85 EYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             ECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EcCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999999986  3456999999999999999999999   7889999999999999999999999999998654322


Q ss_pred             CCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .  .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... ..+......       ..
T Consensus       160 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~-------~~  229 (323)
T 3tki_A          160 R--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKKTY-------LN  229 (323)
T ss_dssp             E--ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHHHTTCTT-------ST
T ss_pred             c--ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHhccccc-------CC
Confidence            1  122345679999999999987665 678999999999999999999997654322111 111111000       00


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +       .......+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       230 ~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          230 P-------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             T-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             c-------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence            0       112346788999999999999999999999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.2e-46  Score=361.91  Aligned_cols=287  Identities=34%  Similarity=0.608  Sum_probs=228.2

Q ss_pred             CCcccCHHHHHHHhcCCCCC------ceeeeeCceEEEEEEEcCCcEEEEEEccccc--cCcccHHHHHHHHHHHHhcCC
Q 013401          121 GNVQITMEEIYRATRNFSPS------FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSV--YDKHSGAEFQSEIRTLAQVEH  192 (443)
Q Consensus       121 ~~~~~~~~~~~~~~~~f~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h  192 (443)
                      ....++..++..++++|...      +.||+|+||.||+|.. +++.||||++....  ........+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999999887      8999999999999987 58899999986543  223446778999999999999


Q ss_pred             cceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       193 ~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      |||+++++++.+.+..++||||+++++|.+++.... ...+++..++.|+.||+.||.|||   .+||+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            999999999999999999999999999999997533 456899999999999999999999   7889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER  351 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~  351 (443)
                      +.++.+||+|||++........  ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSS--CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred             cCCCcEEEeecccccccccccc--cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence            9999999999999986553221  112334579999999999876 5889999999999999999999999865432211


Q ss_pred             HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ..+...... ........++..+.  ......++.+.+|+.+||+.||.+||++.+++++|..+..
T Consensus       244 ~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          244 LDIKEEIED-EEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             THHHHHHHT-TSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHhhh-hhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            111111111 01111222222221  1234566889999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-46  Score=361.03  Aligned_cols=263  Identities=23%  Similarity=0.372  Sum_probs=217.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999976 6999999999776555566678899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---eEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~~~~  289 (443)
                      ||+.+++|.+++...  ..+++..++.++.||+.||.|||   .++|+||||||+|||++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999999988743  56899999999999999999999   788999999999999986655   9999999997665


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.........      
T Consensus       160 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  228 (284)
T 3kk8_A          160 DSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------  228 (284)
T ss_dssp             SSCB-----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------
T ss_pred             cCcc-----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc------
Confidence            4321     23456999999999999989999999999999999999999999876554332222221111100      


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                        +      .....++.+.+|+.+||+.||.+||++.++++|+|.-.....
T Consensus       229 --~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  271 (284)
T 3kk8_A          229 --P------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV  271 (284)
T ss_dssp             --T------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred             --h------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence              0      001133679999999999999999999999999997554433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.4e-47  Score=398.07  Aligned_cols=275  Identities=23%  Similarity=0.338  Sum_probs=225.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|...+.||+|+||.||+|..+ +|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+.+.+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356888999999999999999986 799999999876432 234456788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||++||+|.+++.......+++..++.++.||+.||.|||   .+|||||||||+||||+.+|.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999997655556999999999999999999999   788999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .     .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+......... .    +.
T Consensus       340 ~-----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~-~----~p  409 (576)
T 2acx_A          340 Q-----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE-E----YS  409 (576)
T ss_dssp             C-----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-C----CC
T ss_pred             c-----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-c----CC
Confidence            2     123457999999999999989999999999999999999999999875432111111111111110 0    00


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCC
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQ  430 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~  430 (443)
                               ...+..+.+|+.+||+.||.+||     ++.++++|+|.-.-+|..+.......+
T Consensus       410 ---------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp  464 (576)
T 2acx_A          410 ---------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPP  464 (576)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred             ---------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCC
Confidence                     11236799999999999999999     889999999998888888766554433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.3e-47  Score=377.09  Aligned_cols=260  Identities=26%  Similarity=0.390  Sum_probs=211.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      ++|.+.+.||+|+||.||+|.+.        ++..||||+++... .......+.+|+.+|+.+ +|||||++++++.+.
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            57888999999999999999852        35679999997652 334456789999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +.+++||||+.+|+|.+++....              ...+++..++.++.||+.||.|||   .++|+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997543              235788999999999999999999   7889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||+++........  .......||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             CCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999866543211  12233457899999999999899999999999999999999 9999987543222


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ...+.       .+....     .     ...++..+.+|+.+||+.||.+||++.+++++|..+..
T Consensus       315 ~~~~~-------~~~~~~-----~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          315 FKLLK-------EGHRMD-----K-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             HHHHH-------TTCCCC-----C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHh-------cCCCCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            11111       111000     0     01234679999999999999999999999999998754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.7e-47  Score=375.01  Aligned_cols=269  Identities=22%  Similarity=0.334  Sum_probs=218.3

Q ss_pred             HHhcCCCCC-ceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeE
Q 013401          132 RATRNFSPS-FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDER  208 (443)
Q Consensus       132 ~~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~  208 (443)
                      ...+.|.+. +.||+|+||+||+|... +++.||||+++...........+.+|+.++..+. ||||+++++++.+.+..
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            344567776 78999999999999987 6999999999876666666788999999999995 79999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeeccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFA  285 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFGla  285 (443)
                      ++||||+.+|+|.+++.......+++..++.|+.||+.||.|||   .+||+||||||+||||+.   ++.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            99999999999999986545577999999999999999999999   788999999999999987   789999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.......... 
T Consensus       182 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-  255 (327)
T 3lm5_A          182 RKIGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE-  255 (327)
T ss_dssp             EEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-
T ss_pred             cccCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch-
Confidence            8765432     1234569999999999999899999999999999999999999998776544333322211111100 


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                                   ......+.+.+|+.+||+.||.+||++.++++|+|.-..++..+
T Consensus       256 -------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          256 -------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             -------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             -------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence                         00113367899999999999999999999999999766555544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=366.70  Aligned_cols=273  Identities=26%  Similarity=0.312  Sum_probs=210.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.++||+|+||+||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999986 69999999987665444556678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++.  ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........
T Consensus        83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            999999988876  3456899999999999999999999   78899999999999999999999999999987653321


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC--------CC
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS--------DG  364 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------~~  364 (443)
                          ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+........        ..
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          158 ----YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             ----ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence                2234569999999999976 5789999999999999999999999988765544333322111100        00


Q ss_pred             ccc---cccCcc--ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 DAI---SILDPR--VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ~~~---~~~d~~--~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...   ...++.  ..........+..+.+|+.+||+.||.+|||+.++++|+|.-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  290 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN  290 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence            000   000000  0000011123467899999999999999999999999999643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=384.85  Aligned_cols=274  Identities=22%  Similarity=0.256  Sum_probs=219.8

Q ss_pred             HHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          129 EIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       129 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      ++....++|++.+.||+|+||.||+|..+ +|+.||||++++... .......+.+|+.+|..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            33344578999999999999999999986 799999999875321 2223345789999999999999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      .+|+||||++||+|.+++... +..+++..++.++.||+.||.|||   +++||||||||+||||+.+|.+||+|||+++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            999999999999999999753 357999999999999999999999   7889999999999999999999999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccc-------cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLK-------TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      .......   ......+||+.|+|||++.       +..++.++|||||||++|||++|.+||...........+.....
T Consensus       211 ~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          211 KLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             ECCTTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             eccCCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            7654321   1223467999999999997       35689999999999999999999999987765443322221111


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHHhhhhhhhhhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNR---PSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R---Ps~~ell~~l~~i~~~~~~~~  423 (443)
                      .+...    ..         ....+.++.+|+.+||+ +|.+|   |++.++++|.|.-..+|..+.
T Consensus       288 ~~~~p----~~---------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          288 HLSLP----LV---------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             HCCCC-----------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             CcCCC----cc---------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence            11000    00         01134679999999999 99998   599999999998777777664

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-47  Score=375.27  Aligned_cols=268  Identities=25%  Similarity=0.310  Sum_probs=209.7

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc---CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY---DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      ....++|++.+.||+|+||+||+|... ++..||||+++....   .......+.+|+.+++.++|||||++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            455678999999999999999999976 689999999865432   3455678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc--------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ--------------------------------------GNILDLAGRLDIAIDVAHAI  248 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~i~~~L  248 (443)
                      ..++||||++||+|.+++....                                      ...+++..++.|+.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999999884211                                      12235677788999999999


Q ss_pred             HHHhhcCCCCeEecCCCCCCEEEcCCC--ceEEeeecccccccccCCCcccccccccCCCCccCcccccc--CCCCCchh
Q 013401          249 TYLHMYTDHPIIHRDIKSSNILLTENF--RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT--YQLTEKSD  324 (443)
Q Consensus       249 ~~LH~~~~~~ivHrDlkp~NILl~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sD  324 (443)
                      .|||   +++|+||||||+||||+.++  .+||+|||++..................||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999   78899999999999998766  89999999998765433322223445679999999999965  67899999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC
Q 013401          325 VYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPS  404 (443)
Q Consensus       325 iwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs  404 (443)
                      ||||||++|+|++|..||...........+......+        ..+      .....++.+.+|+.+||+.||.+||+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~------~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF--------ENP------NYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT--------TSG------GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc--------CCc------ccccCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999998766543322211100000        000      11123467999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 013401          405 MRRCAEILWSV  415 (443)
Q Consensus       405 ~~ell~~l~~i  415 (443)
                      +.++++|+|.-
T Consensus       325 ~~~~l~hp~~~  335 (345)
T 3hko_A          325 AMRALQHPWIS  335 (345)
T ss_dssp             HHHHHHSHHHH
T ss_pred             HHHHhcChhhc
Confidence            99999999963

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.3e-48  Score=380.24  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=207.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++.+.... ......+.+|+.+|+.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999975 7999999998754322 233467889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+ +|+|.+++...  ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.......
T Consensus        89 E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             CCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             ECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            999 78999998743  56999999999999999999999   7789999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                           .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........       ......+      .
T Consensus       163 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------~~~i~~~------~  224 (336)
T 3h4j_B          163 -----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------FKKVNSC------V  224 (336)
T ss_dssp             -----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------BCCCCSS------C
T ss_pred             -----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHcC------C
Confidence                 2344579999999999988776 6899999999999999999999975432110       0000000      0


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..+     ....+..+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       225 ~~~-----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          225 YVM-----PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             CCC-----CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCC-----cccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            000     111346789999999999999999999999999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.4e-47  Score=387.87  Aligned_cols=283  Identities=21%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-----cCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-----EDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----~~~~  208 (443)
                      ++|++.+.||+|+||+||+|.+. +++.||||++............+.+|+.+|+.++|||||++++++..     .+.+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            57999999999999999999976 79999999987665555566788999999999999999999999844     3578


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      |+||||+ +++|.+++.  ....+++..++.|+.||+.||.|||   ++|||||||||+||||+.++.+||+|||+++..
T Consensus       133 ~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            9999998 579999886  4467999999999999999999999   788999999999999999999999999999876


Q ss_pred             cccCCCcc-----------------------cccccccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHc-------
Q 013401          289 ADTESGAT-----------------------HVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVT-------  337 (443)
Q Consensus       289 ~~~~~~~~-----------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlGvll~ellt-------  337 (443)
                      ........                       ......+||++|+|||++ .+..++.++||||||||||||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            53321110                       123456799999999986 56679999999999999999999       


Q ss_pred             ----CCCCCCCchhH-------------------HHHHH-HHHHhhhcCCCcc--------c---cccC--ccccchhhc
Q 013401          338 ----GRRPIEPKREL-------------------KERIT-VKWAMKKFSDGDA--------I---SILD--PRVENTAAN  380 (443)
Q Consensus       338 ----G~~Pf~~~~~~-------------------~~~~~-~~~~~~~~~~~~~--------~---~~~d--~~~~~~~~~  380 (443)
                          |.++|.+....                   .+++. +............        .   ..+.  .........
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                67777654311                   01110 0000000000000        0   0000  000000011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       381 ~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                      .....++.+|+.+||..||.+|||+.++++|+|.-.-.+.+.+
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e  409 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE  409 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence            1234679999999999999999999999999997655555443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-47  Score=367.23  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=203.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|+..++||+|+||+||+|.+. +|+.||||++............+.+|+..+..+ +|+||+++++++.+.+.+++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999987 799999999876544444455566777777666 8999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+ +++|.+++... +..+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||++.......
T Consensus       137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            999 77999988754 457999999999999999999999   7889999999999999999999999999987664432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           ......||+.|+|||++.+ .++.++|||||||++|||++|..||........          +..+..    .+
T Consensus       212 -----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----------~~~~~~----~~  271 (311)
T 3p1a_A          212 -----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ----------LRQGYL----PP  271 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH----------HTTTCC----CH
T ss_pred             -----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----------HhccCC----Cc
Confidence                 2334569999999999987 799999999999999999999877765433211          111110    00


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                           ......++.+.+|+.+||+.||++||++.++++|+|.
T Consensus       272 -----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (311)
T 3p1a_A          272 -----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL  308 (311)
T ss_dssp             -----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             -----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence                 0111234679999999999999999999999999995

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=364.27  Aligned_cols=271  Identities=22%  Similarity=0.275  Sum_probs=211.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC--eEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED--ERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv  211 (443)
                      ++|.+.+.||+|+||+||+|.+. +++.||||+++.... ......+.+|+.+|+.++||||+++++++...+  ..++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            56889999999999999999987 599999999876432 334567889999999999999999999988765  78999


Q ss_pred             EeecCCCcHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCceEEeeecccc
Q 013401          212 VEYVPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL----TENFRAKVADFGFAR  286 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~  286 (443)
                      |||+.+++|.+++..... ..+++..++.|+.||+.||.|||   +++|+||||||+||||    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999975432 33899999999999999999999   7889999999999999    778889999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccc--------cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-HHHH
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLK--------TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT-VKWA  357 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~-~~~~  357 (443)
                      .......     .....||+.|+|||++.        +..++.++|||||||++|||++|..||........... ....
T Consensus       165 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          165 ELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             ECCTTCC-----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             ecCCCCc-----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            7654321     23456999999999986        56789999999999999999999999975432211111 1111


Q ss_pred             hhhcCCCcc----------ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          358 MKKFSDGDA----------ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       358 ~~~~~~~~~----------~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .........          ..+.................+.+|+.+||+.||++||++.++++|+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            111111100          000000011112235667889999999999999999999999999974

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-46  Score=372.44  Aligned_cols=276  Identities=20%  Similarity=0.231  Sum_probs=216.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--------c
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--------E  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~  205 (443)
                      .+|++.++||+|+||.||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57999999999999999999985 79999999987665555556778899999999999999999999887        4


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      +..++||||+.+ +|.+.+.. ....+++..++.|+.||+.||.|||   ++||+||||||+||||+.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            468999999975 77777754 3356899999999999999999999   788999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      ..................||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+..........
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            8765443333333455679999999999876 458999999999999999999999999876655444443332222221


Q ss_pred             cccccc-----------C---ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          365 DAISIL-----------D---PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       365 ~~~~~~-----------d---~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ......           .   ..+..........+.+.+|+.+||+.||.+|||+.++++|.|..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            111000           0   00000000011235689999999999999999999999999964

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.8e-47  Score=361.57  Aligned_cols=257  Identities=27%  Similarity=0.445  Sum_probs=211.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+..+.||+|+||.||+|.+.++..||||+++..   .....++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC---CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            578889999999999999999998889999999865   33446789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++... ...+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........ 
T Consensus       101 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          101 MANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             CTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             cCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            9999999999753 345899999999999999999999   78899999999999999999999999999986643321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.......         .+ 
T Consensus       176 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------~~-  243 (283)
T 3gen_A          176 --TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---------RP-  243 (283)
T ss_dssp             --HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---------CC-
T ss_pred             --ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC---------CC-
Confidence              11233457889999999998899999999999999999998 999998765433222221110000         00 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                             ...++.+.+|+.+||+.||.+||++.+++++|+.+..+
T Consensus       244 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          244 -------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                   11236799999999999999999999999999988654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-47  Score=379.19  Aligned_cols=257  Identities=22%  Similarity=0.336  Sum_probs=211.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999986 69999999987542  234457889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE--NFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~  290 (443)
                      ||+.||+|.+++.. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.  ++.+||+|||++.....
T Consensus       128 E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          128 EFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             ECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999998864 3346899999999999999999999   788999999999999974  57899999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......+         
T Consensus       204 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------  269 (387)
T 1kob_A          204 DE-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF---------  269 (387)
T ss_dssp             TS-----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred             Cc-----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence            32     1233469999999999999899999999999999999999999998776543322221110000         


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +..     .....+.++.+|+.+||+.||.+||++.++++|+|..
T Consensus       270 ~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          270 DED-----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             CSS-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             Ccc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence            000     0012346799999999999999999999999999953

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-46  Score=360.59  Aligned_cols=253  Identities=28%  Similarity=0.462  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|++.+.||+|+||.||+|.+. ++..||||++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            357999999999999999999876 688999999865432 223456788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999999753  56899999999999999999999   889999999999999999999999999998654432


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .      .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+......+.         
T Consensus       163 ~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------  227 (279)
T 3fdn_A          163 R------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP---------  227 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---------
T ss_pred             c------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC---------
Confidence            1      2345699999999999998999999999999999999999999987654333222221111100         


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                               ....+.+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       228 ---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          228 ---------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             ---------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             ---------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence                     01235789999999999999999999999999964

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-46  Score=374.66  Aligned_cols=257  Identities=22%  Similarity=0.315  Sum_probs=199.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|.+.+.||+|+||+||+|... +++.||||++....   .....+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            57999999999999999999987 79999999987642   233678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--eEEeeeccccccccc
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR--AKVADFGFARLAADT  291 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~~~~~  291 (443)
                      |+.||+|.+++..  ...+++..++.|+.||+.||.|||   .+||+||||||+||||+.++.  +||+|||+++.....
T Consensus        97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999999964  346999999999999999999999   788999999999999987765  999999998754322


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCc-hhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEK-SDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      .     .....+||+.|+|||++.+..+..+ +|||||||++|+|++|..||..................... .    +
T Consensus       172 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~----~  241 (361)
T 3uc3_A          172 S-----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-S----I  241 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-C----C
T ss_pred             C-----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-C----C
Confidence            1     1234569999999999988777665 89999999999999999999875442222211111111000 0    0


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ..       ....+..+.+|+.+||+.||.+|||+.++++|+|...
T Consensus       242 ~~-------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          242 PD-------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             CT-------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CC-------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            00       0012367899999999999999999999999999753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-46  Score=386.14  Aligned_cols=269  Identities=20%  Similarity=0.243  Sum_probs=206.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------C
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------D  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~  206 (443)
                      .++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|+.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999876 699999999987655556677889999999999999999999998654      4


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      .+|+||||+.+ .|.+.+.    ..+++..+..++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            67999999975 5666664    24889999999999999999999   7889999999999999999999999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC----
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS----  362 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----  362 (443)
                      ......     .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+.......+........    
T Consensus       213 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          213 TAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             ----CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            765322     23456799999999999999999999999999999999999999988765443332221111000    


Q ss_pred             -----------C-------CccccccCccc--cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          363 -----------D-------GDAISILDPRV--ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       363 -----------~-------~~~~~~~d~~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                                 .       ......+...+  ...........++.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                       0       00000000000  00111223467899999999999999999999999999953

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-46  Score=391.58  Aligned_cols=278  Identities=19%  Similarity=0.269  Sum_probs=224.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||.||+|.++ +|+.||||++++... .......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888889999999999999986 699999999876432 2244567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||++||+|.+++....  ...+++..++.++.||+.||.|||   .+||+||||||+||||+.+|.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999997543  456999999999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...    .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...........+......   ... . +
T Consensus       342 ~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~---~~~-~-~  412 (543)
T 3c4z_A          342 GQT----KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE---QAV-T-Y  412 (543)
T ss_dssp             TCC----CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH---CCC-C-C
T ss_pred             CCc----ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh---ccc-C-C
Confidence            321    123457999999999999999999999999999999999999999875421111111111100   000 0 0


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCcCCccc
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVLLQPSY  433 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~~~~~~  433 (443)
                      .         ...+..+.+|+.+||+.||.+||+     +.++++|+|.-.-+|..+.......+..|
T Consensus       413 p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P  471 (543)
T 3c4z_A          413 P---------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVP  471 (543)
T ss_dssp             C---------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             C---------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCC
Confidence            0         112367899999999999999996     48999999998888888776555444333

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.8e-47  Score=372.21  Aligned_cols=257  Identities=21%  Similarity=0.301  Sum_probs=204.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ..++|+..+.||+|+||.||+|.++ +|+.||||++++...      ...+|+++|.++ +||||+++++++.+.+..++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            3457899999999999999999986 699999999876532      234788889888 79999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC----CceEEeeecccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN----FRAKVADFGFAR  286 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~  286 (443)
                      |||||.||+|.+++..  ...+++..++.++.||+.||.|||   ++||+||||||+|||+..+    +.+||+|||++.
T Consensus        94 v~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           94 VTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999999999999973  456999999999999999999999   7889999999999998533    359999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .......    .....+||+.|+|||++.+..++.++|||||||++|+|++|..||................    .+..
T Consensus       169 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~  240 (342)
T 2qr7_A          169 QLRAENG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKF  240 (342)
T ss_dssp             ECBCTTC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCC
T ss_pred             cCcCCCC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCc
Confidence            7654321    2334579999999999988889999999999999999999999997542211111111111    1110


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      . ....      .....++.+.+|+.+||..||.+||++.++++|+|..
T Consensus       241 ~-~~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          241 S-LSGG------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             C-CCST------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             c-cCcc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            0 0000      0012346799999999999999999999999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=371.52  Aligned_cols=258  Identities=22%  Similarity=0.320  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC--cceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH--LNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|++.+.||+|+||.||+|...+++.||||++............+.+|+.+|..++|  +||+++++++...+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            35699999999999999999999889999999987665555556788999999999976  9999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      || +.+++|.+++..  ...+++..++.|+.||+.||.|||   .++|+||||||+||||+ ++.+||+|||++......
T Consensus        88 ~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             Ee-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99 568899999974  457899999999999999999999   78899999999999997 578999999999876543


Q ss_pred             CCCcccccccccCCCCccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKT-----------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ..  .......+||+.|+|||++.+           ..++.++|||||||++|+|++|..||..........  ......
T Consensus       161 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~  236 (343)
T 3dbq_A          161 TT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--HAIIDP  236 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH--HHHHCT
T ss_pred             cc--cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH--HHHhcC
Confidence            21  112334579999999999865           678889999999999999999999997643321111  111100


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ....   . ...         .....+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       237 ~~~~---~-~~~---------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          237 NHEI---E-FPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             TSCC---C-CCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             Cccc---C-Ccc---------cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            0000   0 000         1125689999999999999999999999999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-46  Score=362.62  Aligned_cols=265  Identities=26%  Similarity=0.376  Sum_probs=209.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|++.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357999999999999999999976 699999999865432 233456788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||++|++|.+++...  ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++......
T Consensus        90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999999743  56899999999999999999999   788999999999999999999999999999876433


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ..   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............      ... ....  
T Consensus       165 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~------~~~-~~~~--  232 (294)
T 4eqm_A          165 SL---TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI------QDS-VPNV--  232 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH------SSC-CCCH--
T ss_pred             cc---cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------hcc-CCCc--
Confidence            21   12334569999999999999899999999999999999999999998765433221111      110 0000  


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRP-SMRRCAEILWSVRKDY  419 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~ell~~l~~i~~~~  419 (443)
                          ........++.+.+++.+||+.||.+|| ++.++.+.+..+..+.
T Consensus       233 ----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          233 ----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             ----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             ----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence                0001112346799999999999999998 8888888887765443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.9e-47  Score=369.27  Aligned_cols=259  Identities=23%  Similarity=0.347  Sum_probs=202.7

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-----
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-----  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----  206 (443)
                      ..++|++.+.||+|+||.||+|.++ +|+.||||+++... .....+.+.+|+.+|+.++|||||++++++.+.+     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            3467899999999999999999987 79999999987543 3445678999999999999999999999986644     


Q ss_pred             ----------------------------------------------------eEEEEEeecCCCcHHHHHhhhcC-CCCC
Q 013401          207 ----------------------------------------------------ERIVIVEYVPNGTLREHLDCLQG-NILD  233 (443)
Q Consensus       207 ----------------------------------------------------~~~lv~E~~~gg~L~~~l~~~~~-~~l~  233 (443)
                                                                          ..++|||||.|++|.+++..... ...+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                37999999999999999975322 2245


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcc--------cccccccCC
Q 013401          234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT--------HVSTQVKGT  305 (443)
Q Consensus       234 ~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~--------~~~~~~~gt  305 (443)
                      +..++.|+.||+.||.|||   ++||+||||||+||||+.++.+||+|||++...........        .......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            5567899999999999999   78899999999999999999999999999987655422111        122345799


Q ss_pred             CCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHH
Q 013401          306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALE  385 (443)
Q Consensus       306 ~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  385 (443)
                      +.|+|||++.+..++.++|||||||++|+|++|..|+......     ..    ......          ..........
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-----~~----~~~~~~----------~~~~~~~~~~  300 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-----IT----DVRNLK----------FPLLFTQKYP  300 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-----HH----HHHTTC----------CCHHHHHHCH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-----HH----HhhccC----------CCcccccCCh
Confidence            9999999999989999999999999999999998775322111     00    000110          0111223446


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          386 KILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       386 ~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .+.+|+.+||+.||.+||++.++++|+|.
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhhchhh
Confidence            68999999999999999999999999984

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5e-47  Score=372.05  Aligned_cols=275  Identities=20%  Similarity=0.268  Sum_probs=205.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|.+.++||+|+||+||+|.+. +++.||||+++...........+.+|+.+|+.++||||+++++++.+++..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            467999999999999999999976 7999999999766544445567789999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-----CCCceEEeeeccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-----ENFRAKVADFGFARL  287 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-----~~~~vkl~DFGla~~  287 (443)
                      ||+. |+|.+++..  ...+++..++.|+.||+.||.|||   +++|+||||||+||||+     .++.+||+|||++..
T Consensus       113 e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          113 EYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             ECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             ecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9997 599999874  356899999999999999999999   78899999999999994     455699999999986


Q ss_pred             ccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ......    ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+............
T Consensus       187 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          187 FGIPIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cCCccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            643221    23345689999999999764 5899999999999999999999999887665443333222111111100


Q ss_pred             cc-------------ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          367 IS-------------ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       367 ~~-------------~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      ..             .....+ .........+++.+|+.+||+.||.+|||+.++++|+|.-..++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTL-KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCH-HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhhhccccH-hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            00             000000 00011123467899999999999999999999999999654443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.7e-47  Score=373.56  Aligned_cols=271  Identities=25%  Similarity=0.352  Sum_probs=214.3

Q ss_pred             CHHHHHHHhcCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeee
Q 013401          126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKF  198 (443)
Q Consensus       126 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l  198 (443)
                      ...+.....++|.+.+.||+|+||.||+|.+      .+++.||||+++... .......+.+|+.+|..+ +|||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3444444567899999999999999999974      246899999997642 233456789999999999 79999999


Q ss_pred             eeeeeecCe-EEEEEeecCCCcHHHHHhhhcC------------------------------------------------
Q 013401          199 HGYLEFEDE-RIVIVEYVPNGTLREHLDCLQG------------------------------------------------  229 (443)
Q Consensus       199 ~~~~~~~~~-~~lv~E~~~gg~L~~~l~~~~~------------------------------------------------  229 (443)
                      ++++.+.+. .++||||+.+|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999887654 8999999999999999975432                                                


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          230 ----------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       230 ----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                                      ..+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            12889999999999999999999   78899999999999999999999999999986643321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                        ........||+.|+|||++.+..++.++|||||||++|+|++ |..||..............  .    +.....   
T Consensus       249 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--~----~~~~~~---  317 (359)
T 3vhe_A          249 --YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--E----GTRMRA---  317 (359)
T ss_dssp             --CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH--H----TCCCCC---
T ss_pred             --chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH--c----CCCCCC---
Confidence              122344568999999999999899999999999999999998 9999976543222111111  0    000000   


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                             ....++.+.+|+.+||+.||.+||++.+++++|..+...
T Consensus       318 -------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          318 -------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                   011236799999999999999999999999999988654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-46  Score=369.36  Aligned_cols=255  Identities=26%  Similarity=0.341  Sum_probs=186.9

Q ss_pred             CceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEeecCC
Q 013401          140 SFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      .+.||+|+||+||+|.+. +++.||||++.+.     ....+.+|+.+++.+. ||||+++++++.+.+..++||||+.|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            467999999999999986 6999999998643     3467789999999997 99999999999999999999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---ceEEeeecccccccccCCC
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF---RAKVADFGFARLAADTESG  294 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~~~~~~~  294 (443)
                      |+|.+++..  ...+++..++.|+.||+.||.|||   +++|+||||||+|||++.++   .+||+|||++........ 
T Consensus        91 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  164 (325)
T 3kn6_A           91 GELFERIKK--KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-  164 (325)
T ss_dssp             CBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence            999999974  467999999999999999999999   78899999999999998765   899999999986544321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                         .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..................+..+...      .
T Consensus       165 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~  235 (325)
T 3kn6_A          165 ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------F  235 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------C
T ss_pred             ---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------C
Confidence               2334568999999999999899999999999999999999999998654322111111222222222110      0


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      . .......++++.+|+.+||+.||.+||++.++++|.|.-
T Consensus       236 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          236 E-GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             C-SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             C-cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence            0 001122456799999999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-47  Score=375.89  Aligned_cols=265  Identities=26%  Similarity=0.365  Sum_probs=214.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|.+.+.||+|+||+||+|.+.      +++.||||+++.. ........+.+|+.+++.++|||||++++++.+.+..
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            57888999999999999999843      4778999998753 2344456788999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---ceEEe
Q 013401          209 IVIVEYVPNGTLREHLDCLQG-----NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF---RAKVA  280 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~vkl~  280 (443)
                      ++||||+.||+|.+++.....     ..+++..++.|+.||+.||.|||   ++||+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999976432     45889999999999999999999   78899999999999999555   59999


Q ss_pred             eecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhh
Q 013401          281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       281 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      |||+++.......  ........||+.|+|||++.+..++.++|||||||++|||++ |..||...........+.    
T Consensus       227 DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~----  300 (367)
T 3l9p_A          227 DFGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT----  300 (367)
T ss_dssp             CCHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----
T ss_pred             CCccccccccccc--cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence            9999976543221  112234568999999999998899999999999999999998 999998765433211111    


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                         .+.....          ...++..+.+|+.+||+.||.+||++.+|+++||.+..+....
T Consensus       301 ---~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~  350 (367)
T 3l9p_A          301 ---SGGRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  350 (367)
T ss_dssp             ---TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             ---cCCCCCC----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence               1110000          0112356899999999999999999999999999997766553

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-46  Score=366.12  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=214.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc----ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK----HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||+++......    ...+.+.+|+.+|+.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356888999999999999999986 69999999987654322    2467899999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----ceEEeeecc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF----RAKVADFGF  284 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~vkl~DFGl  284 (443)
                      ++||||+.+++|.+++..  ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999973  456899999999999999999999   78899999999999999887    799999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +.......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...    .. 
T Consensus       166 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~----~~-  235 (321)
T 2a2a_A          166 AHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----SY-  235 (321)
T ss_dssp             CEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT----CC-
T ss_pred             ceecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----cc-
Confidence            98765432     123456999999999999889999999999999999999999999876543322211110    00 


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .    .++.     .....+..+.+|+.+||+.||.+||++.++++|+|....+.
T Consensus       236 ~----~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          236 D----FDEE-----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             C----CCHH-----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             c----cChh-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            0    0000     01123367899999999999999999999999999654333

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=371.08  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=195.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||.||+|.+. +++.||||+++...    ..+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            467999999999999999999987 68899999987542    3456789999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~  289 (443)
                      ||+.+++|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+||||+.   ++.+||+|||++....
T Consensus       128 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          128 ELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999999963  456899999999999999999999   788999999999999975   8899999999998654


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........  ...    .... ..
T Consensus       203 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~i~----~~~~-~~  270 (349)
T 2w4o_A          203 HQV-----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR--RIL----NCEY-YF  270 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH--HHH----TTCC-CC
T ss_pred             ccc-----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH--HHH----hCCC-cc
Confidence            322     22345699999999999998999999999999999999999999976543321111  111    1100 00


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ..+      .....+..+.+|+.+||+.||++||++.++++|+|...
T Consensus       271 ~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          271 ISP------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             CTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCc------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            000      01123467999999999999999999999999999643

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.7e-46  Score=375.61  Aligned_cols=257  Identities=22%  Similarity=0.321  Sum_probs=204.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC--CcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE--HLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||+||+|...+++.||||++............+.+|+.+|+.+.  |||||++++++..++.+++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999999888999999998766555556678999999999996  599999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      | +.+++|.+++..  ...+++..++.|+.||+.||.|||   .++|+||||||+||||+ ++.+||+|||+++......
T Consensus       136 E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 668899999974  357888899999999999999999   88999999999999995 5799999999998765432


Q ss_pred             CCcccccccccCCCCccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKT-----------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      .  .......+||+.|+|||++.+           ..++.++|||||||+||||++|..||...........  ...   
T Consensus       209 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~---  281 (390)
T 2zmd_A          209 T--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--AII---  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHH---
T ss_pred             c--cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH--HHh---
Confidence            1  112335679999999999865           3688899999999999999999999976533211111  111   


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                       .......+..         .....+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       282 -~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          282 -DPNHEIEFPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             -CTTSCCCCCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             -CccccCCCCc---------cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence             1000000000         0135689999999999999999999999999964

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.5e-46  Score=359.38  Aligned_cols=267  Identities=23%  Similarity=0.336  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHh--cCCcceeeeeeeeee----cCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ--VEHLNLVKFHGYLEF----EDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~----~~~  207 (443)
                      .++|.+.+.||+|+||+||+|.+ +++.||||++...     ....+.+|.+++..  ++||||+++++++..    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            46799999999999999999988 5899999998643     33556667777766  789999999998654    346


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY-----TDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                      .++||||+.+|+|.+++.   ...+++..++.|+.||+.||.|||..     +.++|+||||||+||||+.++.+||+||
T Consensus        81 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            899999999999999994   35699999999999999999999932     1457999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHcC----------CCCCCCch
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY------QLTEKSDVYSFGVLLVELVTG----------RRPIEPKR  346 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlGvll~elltG----------~~Pf~~~~  346 (443)
                      |++..................||+.|+|||++.+.      .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            99987654433222223345799999999999776      455789999999999999999          88886543


Q ss_pred             hHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          347 ELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ............. ...     ...+.+.........+..+.+|+.+||+.||.+|||+.++++.|..|
T Consensus       238 ~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSFEDMRKVV-CVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCHHHHHHHH-TTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcchhhhhHHH-hcc-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2111111100000 001     11222223333445678899999999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-46  Score=376.15  Aligned_cols=255  Identities=21%  Similarity=0.304  Sum_probs=197.3

Q ss_pred             cCCCCC-ceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHh-cCCcceeeeeeeeee----cCe
Q 013401          135 RNFSPS-FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ-VEHLNLVKFHGYLEF----EDE  207 (443)
Q Consensus       135 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~----~~~  207 (443)
                      ++|.+. +.||+|+||+||+|.+. +|+.||||+++..       ..+.+|+.++.+ ++||||+++++++..    .+.
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            466665 68999999999999986 6999999998632       456789998855 479999999999876    567


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeecc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGF  284 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFGl  284 (443)
                      +|+|||||.||+|.+++.......+++..++.|+.||+.||.|||   +++|+||||||+||||+.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            899999999999999997655567999999999999999999999   788999999999999997   78999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH--HHHHHHhhhcC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER--ITVKWAMKKFS  362 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~  362 (443)
                      ++......     .....+||+.|+|||++.+..++.++|||||||+||+|++|..||.........  .........+.
T Consensus       211 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~  285 (400)
T 1nxk_A          211 AKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  285 (400)
T ss_dssp             CEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred             ccccCCCC-----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence            98654322     234567999999999999989999999999999999999999999765432110  00000000000


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                            ...+      .....++++.+|+.+||+.||.+|||+.++++|+|...
T Consensus       286 ------~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          286 ------FPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             ------CCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ------CCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence                  0000      01123467999999999999999999999999999754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-46  Score=386.50  Aligned_cols=253  Identities=24%  Similarity=0.396  Sum_probs=211.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||+++.... .......+.+|+.+|+.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999986 799999999875432 2234567899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++.  ....+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.......
T Consensus        96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999986  3456999999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                           .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+.       .+...  . 
T Consensus       171 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------~~~~~--~-  235 (476)
T 2y94_A          171 -----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC-------DGIFY--T-  235 (476)
T ss_dssp             -----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH-------TTCCC--C-
T ss_pred             -----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-------cCCcC--C-
Confidence                 2334579999999999988765 679999999999999999999998765432211111       11000  0 


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +        ......+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       236 p--------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          236 P--------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             C--------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             C--------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence            0        01235689999999999999999999999999964

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.1e-47  Score=379.10  Aligned_cols=261  Identities=30%  Similarity=0.454  Sum_probs=212.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|...+.||+|+||.||+|.+. +++.||||+++... .......+.+|+.+|+.++|||||++++++...+..++|||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            57888899999999999999987 79999999987542 23344568899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++|+|.+++.. .+..+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++...+...
T Consensus       193 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999999975 3456899999999999999999999   78899999999999999999999999999976543211


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                        ........+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.       .+.....   
T Consensus       269 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~~---  336 (377)
T 3cbl_A          269 --AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGRLPC---  336 (377)
T ss_dssp             --ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTCCCCC---
T ss_pred             --eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCCC---
Confidence              001112235778999999988889999999999999999998 999998765432221111       1110000   


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                             ...+++.+.+|+.+||+.||++|||+.++++.|..+++..
T Consensus       337 -------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          337 -------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence                   0113467999999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.9e-46  Score=373.11  Aligned_cols=265  Identities=28%  Similarity=0.457  Sum_probs=204.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      .+|.+.+.||+|+||.||+|.+.    ++..||||+++... .......+.+|+.+|++++||||+++++++.+.+..++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            57999999999999999999865    57789999987642 34455679999999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+++|+|.+++.. .+..+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999975 3456899999999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ..... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.       .+.... 
T Consensus       200 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-------~~~~~~-  270 (373)
T 2qol_A          200 DPEAA-YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-------EGYRLP-  270 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-------TTEECC-
T ss_pred             CCccc-eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC-
Confidence            32111 11122346788999999998899999999999999999998 999998765432211111       110000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                        .       ...++..+.+|+.+||+.||.+||++.+|++.|..+..+....
T Consensus       271 --~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~  314 (373)
T 2qol_A          271 --P-------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL  314 (373)
T ss_dssp             --C-------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGG
T ss_pred             --C-------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcccc
Confidence              0       0123367999999999999999999999999999987765543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-46  Score=368.69  Aligned_cols=279  Identities=26%  Similarity=0.328  Sum_probs=213.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|+..+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357999999999999999999986 5999999998766544555567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.++.|.+++.  ....+++..++.++.||+.||.|||   .+||+||||||+||||+.++.+||+|||++.......
T Consensus       104 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          104 EFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             ECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            9999998888765  3456999999999999999999999   7889999999999999999999999999997654432


Q ss_pred             CCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh-----------
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK-----------  360 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-----------  360 (443)
                      .    ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+......           
T Consensus       179 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          179 E----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             c----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            1    23345699999999999775 7899999999999999999999999877654433222111100           


Q ss_pred             --cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          361 --FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       361 --~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                        ...+.....+.............++.+.+|+.+||+.||.+||++.++++|.|.-..++.+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  317 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE  317 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHH
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhh
Confidence              0011000101111111111112457799999999999999999999999999975554444

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.2e-47  Score=370.13  Aligned_cols=273  Identities=22%  Similarity=0.308  Sum_probs=205.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|.+.++||+|+||+||+|... +++.||||+++.... ......+.+|+.+|+.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            47888999999999999999986 799999999865432 1111234579999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+. |+|.+++.. .+..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++........
T Consensus        81 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           81 YLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            997 589998875 3457899999999999999999999   78899999999999999999999999999976543221


Q ss_pred             CcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                          ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..................
T Consensus       156 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          156 ----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             ----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence                2234568999999999876 56899999999999999999999999887655443333332222111111111000


Q ss_pred             ---------cccc---hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          373 ---------RVEN---TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       373 ---------~~~~---~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                               ....   ..........+.+|+.+||+.||.+|||+.++++|+|....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                     0000   00011234678999999999999999999999999997543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-47  Score=374.42  Aligned_cols=278  Identities=24%  Similarity=0.321  Sum_probs=220.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEE----cCCcEEEEEEcccccc--CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|++.+.||+|+||.||+|..    .+++.||||++++...  .......+.+|+++|+.+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999987    3689999999876432  123345577899999999 69999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+.+++|.+++...  ..+++..++.++.||+.||.|||   .++|+||||||+||||+.++.+||+|||+++.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999753  46899999999999999999999   78899999999999999999999999999986


Q ss_pred             ccccCCCcccccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ......   ......+||+.|+|||++.+  ..++.++|||||||+||+|++|..||...........+........   
T Consensus       209 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  282 (355)
T 1vzo_A          209 FVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---  282 (355)
T ss_dssp             CCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---
T ss_pred             cccCCC---CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC---
Confidence            543321   12334679999999999975  3578999999999999999999999975432221111111111100   


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcCCcccc
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLLQPSYS  434 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~~~~~~  434 (443)
                            +..     .......+.+|+.+||..||.+||     ++.++++|+|....++..+.......+..+.
T Consensus       283 ------~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~  345 (355)
T 1vzo_A          283 ------PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV  345 (355)
T ss_dssp             ------CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             ------CCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCc
Confidence                  000     011235689999999999999999     9999999999988888888777766554443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-46  Score=401.34  Aligned_cols=273  Identities=22%  Similarity=0.299  Sum_probs=225.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ..+|++++.||+|+||.||+|.++ +++.||||++++... .....+.+.+|..+|..+ +||||+++++++.+.+.+||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467999999999999999999976 689999999876432 334456788999999988 69999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.||+|.+++...  ..+++..++.|+.||+.||.|||   +++||||||||+||||+.+|.+||+|||+++....
T Consensus       420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999753  56999999999999999999999   78899999999999999999999999999986433


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...    .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||...+.......+..       ...    
T Consensus       495 ~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-------~~~----  559 (674)
T 3pfq_A          495 DGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNV----  559 (674)
T ss_dssp             TTC----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS-------SCC----
T ss_pred             CCc----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------CCC----
Confidence            221    23456799999999999999999999999999999999999999988765332222211       110    


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHhhhhhhhhhhcccCcCCccc
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSM-----RRCAEILWSVRKDYRELAASDVLLQPSY  433 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~-----~ell~~l~~i~~~~~~~~~~~~~~~~~~  433 (443)
                        .++     ...+.++.+|+.+||+.||.+||++     ++|++|.|.-..+|..+....+..+..|
T Consensus       560 --~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p  620 (674)
T 3pfq_A          560 --AYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP  620 (674)
T ss_dssp             --CCC-----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred             --CCC-----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCC
Confidence              000     1134679999999999999999998     9999999988888888766655444333

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.4e-46  Score=353.54  Aligned_cols=254  Identities=20%  Similarity=0.330  Sum_probs=210.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~  212 (443)
                      ++|...+.||+|+||.||+|.++ +..||||+++...........+.+|+.+++.++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57889999999999999999986 88899999987655556667899999999999999999999999887  7889999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||+++|+|.+++.......+++..++.|+.||+.||.|||   +++  |+||||||+|||++.++.++|+|||++.....
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999998655557999999999999999999999   888  99999999999999999999999998754322


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCC---chhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTE---KSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                               ....||+.|+|||++.+..++.   ++|||||||++|+|++|..||..............      .+.  
T Consensus       166 ---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------~~~--  228 (271)
T 3kmu_A          166 ---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL------EGL--  228 (271)
T ss_dssp             ---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH------SCC--
T ss_pred             ---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh------cCC--
Confidence                     2345899999999998765554   79999999999999999999987654332221111      000  


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                         .+.+.     ...+..+.+|+.+||+.||.+||++.++++.|..+..
T Consensus       229 ---~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 ---RPTIP-----PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---CCCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---CCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence               00010     1133679999999999999999999999999988753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=362.09  Aligned_cols=268  Identities=25%  Similarity=0.345  Sum_probs=205.5

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhc--CCcceeeeeeeeeec----C
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV--EHLNLVKFHGYLEFE----D  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l--~h~niv~l~~~~~~~----~  206 (443)
                      ..++|++.+.||+|+||.||+|.+. ++.||||++...     ....+.+|.+++..+  +||||+++++++...    .
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            4468999999999999999999886 899999998643     233445566666554  899999999999887    7


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC--------CeEecCCCCCCEEEcCCCceE
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH--------PIIHRDIKSSNILLTENFRAK  278 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~ivHrDlkp~NILl~~~~~vk  278 (443)
                      ..++||||+.+|+|.+++..   ..+++..++.++.|++.||.|||   .+        +|+||||||+||||+.++.+|
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            89999999999999999953   36899999999999999999999   66        899999999999999999999


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCccccccCCCCCc------hhHHHHHHHHHHHHcC----------CCCC
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEK------SDVYSFGVLLVELVTG----------RRPI  342 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~------sDiwSlGvll~elltG----------~~Pf  342 (443)
                      |+|||++..................||+.|+|||++.+..+...      +|||||||++|||++|          ..||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999997765443322222335579999999999987766665      9999999999999999          6666


Q ss_pred             CCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          343 EPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ..............  ...    ......+.+........+++.+.+|+.+||+.||.+||++.+|+++|..+..+
T Consensus       263 ~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          263 HDLVPSDPSYEDMR--EIV----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTSCSSCCHHHHH--HHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hhhcCCCCchhhhH--HHH----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            54322111000000  000    01112233333333446778899999999999999999999999999988654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.6e-46  Score=366.86  Aligned_cols=266  Identities=17%  Similarity=0.195  Sum_probs=211.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....    ....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            367999999999999999999975 79999999986542    223578999999999 899999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-----eEEeeecccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR-----AKVADFGFAR  286 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-----vkl~DFGla~  286 (443)
                      |||+ +++|.+++... +..+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.     +||+|||+++
T Consensus        84 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           84 LELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            9999 99999999753 567999999999999999999999   788999999999999998887     9999999998


Q ss_pred             cccccCCCccc---ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          287 LAADTESGATH---VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       287 ~~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ...........   ......||+.|+|||++.+..++.++|||||||++|||++|..||.....................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            76544322111   124567999999999999999999999999999999999999999865322111111111000000


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      ..          ........+ ++.+|+..||+.||.+||++.+|++.+..+....
T Consensus       239 ~~----------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          239 TP----------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             SC----------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CC----------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            00          000000122 7999999999999999999999999998876554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.9e-46  Score=385.91  Aligned_cols=258  Identities=26%  Similarity=0.370  Sum_probs=212.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.+..........+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            357889999999999999999986 7999999998765555556788999999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~  289 (443)
                      |||.||+|.+++...  ..+++..++.|+.||+.||.|||   .+||+||||||+||||+   .++.+||+|||++....
T Consensus       101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999998743  56899999999999999999999   78899999999999995   45679999999998665


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...     .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+......+        
T Consensus       176 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------  241 (486)
T 3mwu_A          176 QNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF--------  241 (486)
T ss_dssp             CC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS--------
T ss_pred             CCC-----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            432     2334579999999999987 59999999999999999999999998776543322221110000        


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                         ..   ......++.+.+|+.+||+.||.+|||+.++++|+|.-.
T Consensus       242 ---~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          242 ---DL---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             ---CS---GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             ---CC---cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence               00   001123467999999999999999999999999999643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=373.29  Aligned_cols=257  Identities=23%  Similarity=0.302  Sum_probs=204.9

Q ss_pred             CCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          139 PSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ..+.||+|+||.||+|... +|+.||||+++...  ....+.+.+|+.+|+.++|||||++++++.+.+..++||||+++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            3567999999999999975 69999999987642  23456789999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE--cCCCceEEeeecccccccccCCCc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL--TENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl--~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      ++|.+++.. ....+++..++.++.||+.||.|||   +++|+||||||+|||+  +.++.+||+|||+++.......  
T Consensus       171 ~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          171 GELFDRIID-ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             CEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            999998864 3346899999999999999999999   7889999999999999  5678899999999987654321  


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE  375 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  375 (443)
                         ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+......+.        ..   
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~--------~~---  310 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE--------DE---  310 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC--------SG---
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--------hh---
Confidence               2345699999999999988899999999999999999999999987765432222211100000        00   


Q ss_pred             chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       376 ~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                         .....++++.+|+.+||+.||.+||++.++++|+|.-.....
T Consensus       311 ---~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~  352 (373)
T 2x4f_A          311 ---EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLH  352 (373)
T ss_dssp             ---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHH
T ss_pred             ---hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchh
Confidence               011234679999999999999999999999999997554443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.5e-46  Score=356.12  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=206.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|.+.++||+|+||.||+|... ++..||||++.... .......+.+|+.+|+.++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            46888889999999999999976 68999999987653 34456789999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCceEEeeecccccc
Q 013401          214 YVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLA  288 (443)
Q Consensus       214 ~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~  288 (443)
                      |+.+++|.+++...  .+..+++..++.|+.||+.||.|||   ++||+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543  3567999999999999999999999   7889999999999999   45678999999999765


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....     ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.....................     
T Consensus       178 ~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  246 (285)
T 3is5_A          178 KSDE-----HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-----  246 (285)
T ss_dssp             --------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-----
T ss_pred             CCcc-----cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc-----
Confidence            5432     2334569999999999864 6889999999999999999999999876543332222221111000     


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      . ..         ...+.+.+|+.+||+.||.+||++.++++|.|.-
T Consensus       247 ~-~~---------~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          247 E-CR---------PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             ---C---------CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             c-cC---------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence            0 00         0235788999999999999999999999999954

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-46  Score=372.87  Aligned_cols=268  Identities=19%  Similarity=0.260  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      .++|...+.||+|+||.||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            357999999999999999999985 7999999998765544555677899999999999999999999987653      


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      .+++||||+ +++|.+++..   ..+++..+..++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 8899998864   46899999999999999999999   7889999999999999999999999999998


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .....       ....+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.........+...........
T Consensus       177 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          177 QADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             ECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            75432       234579999999999877 6799999999999999999999999987765443322221111100000


Q ss_pred             ccc-----------ccCc--cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          366 AIS-----------ILDP--RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       366 ~~~-----------~~d~--~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...           .+..  ..........+...+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence            000           0000  0000001112346799999999999999999999999999964

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.4e-46  Score=354.97  Aligned_cols=255  Identities=21%  Similarity=0.300  Sum_probs=210.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            356889999999999999999986 58899999987653  344678899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~  289 (443)
                      ||+.+++|.+++..  ...+++..++.|+.||+.||.|||   ++||+||||||+|||+   +.++.+||+|||++....
T Consensus        86 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           86 ELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             eccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999874  356899999999999999999999   7889999999999999   788999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...     ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+.       
T Consensus       161 ~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  227 (277)
T 3f3z_A          161 PGK-----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP-------  227 (277)
T ss_dssp             TTS-----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred             Ccc-----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            432     2234569999999999876 489999999999999999999999987655332222211100000       


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                             .......++.+.+|+.+||+.||.+||++.++++|.|.-
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  266 (277)
T 3f3z_A          228 -------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE  266 (277)
T ss_dssp             -------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             -------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence                   000012346799999999999999999999999999953

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.9e-47  Score=366.40  Aligned_cols=268  Identities=26%  Similarity=0.413  Sum_probs=207.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~  207 (443)
                      ++|++.++||+|+||+||+|.+     .+++.||||+++..  .......+.+|+.+|+.++||||+++++++..  ...
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            5789999999999999999984     26899999998754  34445678999999999999999999999855  356


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+.+++|.+++... ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             eEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            89999999999999999753 345899999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHH---------HHHHHh
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI---------TVKWAM  358 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~---------~~~~~~  358 (443)
                      ...... .........|+..|+|||++.+..++.++|||||||++|+|++|..||..........         ......
T Consensus       164 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          164 LPQDKE-FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             ccCCcc-eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            654321 1112233457888999999999899999999999999999999999987653321110         000111


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .....+....          ....+++.+.+|+.+||+.||.+|||+.++++.|..++.+.
T Consensus       243 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          243 ELLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHhccCcCC----------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            1111111000          01123467999999999999999999999999999998765

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-46  Score=366.20  Aligned_cols=264  Identities=25%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe----
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE----  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----  207 (443)
                      .++|++.+.||+|+||.||+|.+. +++.||||+++..... ......+.+|+.+++.++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            357999999999999999999975 7999999998765332 2344678899999999999999999999877553    


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||++|++|.+++...  ..+++..++.++.||+.||.|||   .++|+||||||+||||+.++.+||+|||++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            49999999999999999743  56899999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..............      ...  
T Consensus       166 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------~~~--  236 (311)
T 3ork_A          166 IADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDP--  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------CCC--
T ss_pred             ccccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc------CCC--
Confidence            6543221 1122345699999999999998999999999999999999999999987655332211110      000  


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                            ..........+..+.+|+.+||+.||.+||+..+++.+.|.-..
T Consensus       237 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          237 ------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             ------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                  00000111234679999999999999999999999988885443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.7e-46  Score=368.24  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=207.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      +.|...+.||+|+||+||+|... +|+.||||++..... .......+.+|+.+|+.++|||||++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888899999999999999975 799999999875432 2233467889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+. |+|.+++.. ....+++..++.++.||+.||.|||   .++|+||||||+||||+.++.+||+|||++...... 
T Consensus       134 e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             ECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9997 688888764 3467899999999999999999999   788999999999999999999999999999765432 


Q ss_pred             CCcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                             ....||+.|+|||++.   +..++.++|||||||++|||++|.+||...........+..       ......
T Consensus       208 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~-------~~~~~~  273 (348)
T 1u5q_A          208 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NESPAL  273 (348)
T ss_dssp             -------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SCCCCC
T ss_pred             -------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cCCCCC
Confidence                   2356999999999984   56789999999999999999999999987654332211111       010000


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ..         ...++.+.+|+.+||+.||.+||++.++++|+|..+
T Consensus       274 ~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          274 QS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CC---------CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence            00         112367899999999999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.4e-45  Score=355.35  Aligned_cols=269  Identities=16%  Similarity=0.227  Sum_probs=214.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....    ....+.+|+.+++.+ +|+||+++++++.+....++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            357999999999999999999974 79999999986542    224578899999999 799999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-----eEEeeecccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR-----AKVADFGFAR  286 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-----vkl~DFGla~  286 (443)
                      |||+ +++|.+++... +..+++..++.|+.||+.||.|||   ++||+||||||+|||++.++.     +||+|||++.
T Consensus        85 ~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999 99999999753 456999999999999999999999   889999999999999987776     9999999998


Q ss_pred             cccccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          287 LAADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       287 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ..........   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            7665432211   1234567999999999999989999999999999999999999999874322111111111100000


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ....          .....+++.+.+|+.+||+.||.+||++.+|++.|..+..+.+.
T Consensus       240 ~~~~----------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          240 TPLR----------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             SCHH----------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ccHH----------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            0000          00112346799999999999999999999999999988765543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-46  Score=384.97  Aligned_cols=257  Identities=27%  Similarity=0.386  Sum_probs=207.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|...++||+|+||+||+|... ++..||||++++..........+.+|+.+|+.++|||||++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888999999999999999986 78999999998765555556788999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeecccccccc
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGFARLAAD  290 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~  290 (443)
                      ||.||+|.+++...  ..+++..++.|+.||+.||.|||   .+||+||||||+||||+.   ++.+||+|||++.....
T Consensus       117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            99999999988743  56899999999999999999999   788999999999999975   45599999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..     .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+......+.        
T Consensus       192 ~~-----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------  257 (494)
T 3lij_A          192 QK-----KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD--------  257 (494)
T ss_dssp             TB-----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             Cc-----cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            32     2344579999999999875 699999999999999999999999987765433222221111100        


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .+      .....++.+.+|+.+||+.||.+|||+.++++|+|.-.
T Consensus       258 ~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          258 SP------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             SG------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             ch------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            00      01123467999999999999999999999999999654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-46  Score=365.62  Aligned_cols=266  Identities=27%  Similarity=0.398  Sum_probs=213.8

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      ..++|...+.||+|+||.||+|.+.      +++.||||+++... .......+.+|+.+++.++||||+++++++.+.+
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            3468999999999999999999874      34889999987643 3344567899999999999999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ----------------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDI  264 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl  264 (443)
                      ..++||||+.+|+|.+++....                      ...+++..++.|+.||+.||.|||   +++|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            9999999999999999997532                      256899999999999999999999   788999999


Q ss_pred             CCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 013401          265 KSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE  343 (443)
Q Consensus       265 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~  343 (443)
                      ||+|||++.++.+||+|||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            99999999999999999999976543321  112234568999999999998899999999999999999999 999998


Q ss_pred             CchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          344 PKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ..........+       ..+.....          ...++..+.+|+.+||+.||.+||++.+++++|..+...+..
T Consensus       279 ~~~~~~~~~~~-------~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          279 GMAHEEVIYYV-------RDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             TSCHHHHHHHH-------HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             CCChHHHHHHH-------hCCCcCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            76543221111       11111110          011336799999999999999999999999999988766543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-46  Score=366.89  Aligned_cols=275  Identities=21%  Similarity=0.278  Sum_probs=207.4

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc---ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK---HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ..++|...+.||+|+||.||+|.+. +|+.||||+++......   .....+.+|+.+++.++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3468999999999999999999976 69999999987543221   1234678999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++...
T Consensus        88 ~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            999999975 88888864 3456889999999999999999999   788999999999999999999999999999876


Q ss_pred             cccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      .....    ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+.............
T Consensus       163 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          163 GSPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TSCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             cCCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            54321    23445799999999999654 58899999999999999999999998876544433322221111111100


Q ss_pred             ccc---C-------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          368 SIL---D-------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       368 ~~~---d-------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...   +       +...........++.+.+|+.+||+.||.+|||+.++++|+|.-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence            000   0       000000011223467999999999999999999999999999643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-46  Score=360.55  Aligned_cols=262  Identities=28%  Similarity=0.398  Sum_probs=213.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      .++|.+.+.||+|+||.||+|.+      .++..||||+++... .......+.+|+.+|+.++||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            35788899999999999999986      245889999987542 34455778899999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 013401          208 RIVIVEYVPNGTLREHLDCLQG----------------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIK  265 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk  265 (443)
                      .++||||+.+++|.+++.....                      ..+++..++.++.||+.||.|||   .++|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            9999999999999999975432                      34889999999999999999999   7889999999


Q ss_pred             CCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 013401          266 SSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEP  344 (443)
Q Consensus       266 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~  344 (443)
                      |+|||++.++.+||+|||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             hheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999986654321  112234457899999999998889999999999999999999 9999987


Q ss_pred             chhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          345 KRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      .........+..       +.....          ...+++.+.+|+.+||+.||.+||++.+++++|..+...
T Consensus       256 ~~~~~~~~~~~~-------~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          256 IPPERLFNLLKT-------GHRMER----------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CCGGGHHHHHHT-------TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHhhc-------CCcCCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            654322111111       100000          012346799999999999999999999999999887543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.8e-46  Score=362.32  Aligned_cols=271  Identities=25%  Similarity=0.364  Sum_probs=197.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcC-C---cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE-
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLED-G---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER-  208 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-  208 (443)
                      .++|.+.+.||+|+||.||+|.+.. +   ..||||+++...........+.+|+.+++.++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4579999999999999999998653 3   2799999987655566678899999999999999999999999877655 


Q ss_pred             -----EEEEeecCCCcHHHHHhhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEE
Q 013401          209 -----IVIVEYVPNGTLREHLDCLQG----NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       209 -----~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl  279 (443)
                           ++||||+.+|+|.+++.....    ..+++..++.|+.||+.||.|||   ++||+||||||+||||+.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence                 999999999999999964331    25899999999999999999999   788999999999999999999999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHh
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      +|||++........  ........+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..  
T Consensus       179 ~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~--  254 (323)
T 3qup_A          179 ADFGLSRKIYSGDY--YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG--  254 (323)
T ss_dssp             CCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--
T ss_pred             eecccccccccccc--ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc--
Confidence            99999987654321  112233457889999999999899999999999999999999 9999987654332211111  


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhhccc
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD  426 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~~~~  426 (443)
                           +.....          ....++.+.+|+.+||+.||.+||++.++++.+..+.....-...+.
T Consensus       255 -----~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          255 -----GNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             -----TCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             -----CCCCCC----------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence                 100000          01133679999999999999999999888888887765544433333

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=370.41  Aligned_cols=263  Identities=27%  Similarity=0.366  Sum_probs=214.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      ++|.+.+.||+|+||+||+|.+.        ++..||||+++.. ........+.+|+.+++.+ +|||||++++++.+.
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            57888999999999999999852        2467999998765 2344457788999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +..++||||+.+|+|.+++....              ...+++..++.|+.||+.||.|||   +++|+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997643              245899999999999999999999   7889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||+++.......  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999986654321  112334467899999999999899999999999999999999 9999987654322


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      ...+.       .+.....          ...+++++.+|+.+||+.||.+||++.+|+++|..+.....
T Consensus       303 ~~~~~-------~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          303 FKLLK-------EGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHHHH-------TTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHH-------cCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11111       1110000          01123679999999999999999999999999998875443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-46  Score=364.82  Aligned_cols=266  Identities=27%  Similarity=0.354  Sum_probs=209.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecC
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFED  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  206 (443)
                      .++|...+.||+|+||.||+|.+      .++..||||+++... .......+.+|+.+|..+ +||||+++++++...+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            36788999999999999999986      246789999987543 334457789999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQG---------------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIK  265 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk  265 (443)
                      ..++||||+++|+|.+++.....                     ..+++..++.|+.||+.||.|||   .+||+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999975432                     23789999999999999999999   7889999999


Q ss_pred             CCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 013401          266 SSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEP  344 (443)
Q Consensus       266 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~  344 (443)
                      |+||||+.++.+||+|||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCcc--ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999999987654321  112334557889999999988899999999999999999998 9999976


Q ss_pred             chhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          345 KRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ..........  ......         ...     ....++.+.+|+.+||+.||.+||++.+++++|+.+..+..+
T Consensus       278 ~~~~~~~~~~--~~~~~~---------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          278 IPVDANFYKL--IQNGFK---------MDQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             CCCSHHHHHH--HHTTCC---------CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             CCcHHHHHHH--HhcCCC---------CCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            5432221111  111100         000     011236799999999999999999999999999988766544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.5e-46  Score=377.28  Aligned_cols=282  Identities=19%  Similarity=0.261  Sum_probs=206.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----Ce
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----DE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  207 (443)
                      .++|.+.+.||+|+||.||+|.+. +++.||||+++...........+.+|+.+|+.++|+||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999976 689999999987655555667889999999999999999999999776     57


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +|+||||+. ++|.+++.  ....+++..++.++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            999999985 69999986  4466999999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCc------------------ccccccccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCC--------
Q 013401          288 AADTESGA------------------THVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRR--------  340 (443)
Q Consensus       288 ~~~~~~~~------------------~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlGvll~elltG~~--------  340 (443)
                      ........                  .......+||++|+|||++ .+..++.++|||||||+||||++|..        
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            65432110                  0123567899999999986 56679999999999999999998544        


Q ss_pred             ---CCCCchh----------------HHHHHH-HHHHhhhcC--------CCcccc---ccCcc--ccchhhcHHHHHHH
Q 013401          341 ---PIEPKRE----------------LKERIT-VKWAMKKFS--------DGDAIS---ILDPR--VENTAANNLALEKI  387 (443)
Q Consensus       341 ---Pf~~~~~----------------~~~~~~-~~~~~~~~~--------~~~~~~---~~d~~--~~~~~~~~~~~~~l  387 (443)
                         +|.+...                ...++. +........        ......   .+...  ..........++.+
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence               4433221                001110 000000000        000000   00000  00000011245679


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          388 LELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       388 ~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      .+|+.+||+.||.+|||+.++++|+|.-.-.+..
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            9999999999999999999999999975544433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.7e-46  Score=355.39  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=210.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+|... ++..||||++..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57889999999999999999986 688999999865432 2234567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++...  ..+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.......
T Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            999999999999753  46899999999999999999999   8899999999999999999999999999987654321


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            .....|++.|+|||++.+..++.++||||||+++|+|++|..||...........+..       ..      .
T Consensus       169 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~------~  229 (284)
T 2vgo_A          169 ------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-------VD------L  229 (284)
T ss_dssp             ------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TC------C
T ss_pred             ------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-------cc------c
Confidence                  2345699999999999998999999999999999999999999987654332211111       00      0


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .+.     ...+..+.+|+.+||+.||.+||++.++++|.|.-
T Consensus       230 ~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          230 KFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             CCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            000     11236789999999999999999999999999964

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.3e-46  Score=354.94  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=211.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc----ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK----HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++......    ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999987 69999999987654322    24678999999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----ceEEeeeccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF----RAKVADFGFA  285 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~vkl~DFGla  285 (443)
                      +||||+.+++|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999974  356899999999999999999999   78899999999999998877    8999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .......     ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...    .. .
T Consensus       160 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~-~  229 (283)
T 3bhy_A          160 HKIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----NY-D  229 (283)
T ss_dssp             EECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----CC-C
T ss_pred             eeccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc----cc-C
Confidence            8765432     123456999999999999889999999999999999999999999876543322211110    00 0


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                          ...     ......++.+.+|+.+||+.||.+||++.++++|.|.-....+
T Consensus       230 ----~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          230 ----FDE-----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             ----CCH-----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             ----Ccc-----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                000     0011234679999999999999999999999999996544333

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.6e-46  Score=384.97  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=213.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|+..+.||+|+||.||+|... +|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46888999999999999999987 799999999866543 2455678999999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~  289 (443)
                      ||+.||+|.+++..  ...+++..++.|+.||+.||.|||   .+||+||||||+|||+   +.++.+||+|||++....
T Consensus       106 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          106 EVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             CCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999873  456999999999999999999999   7889999999999999   567899999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...     .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+......+        
T Consensus       181 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------  246 (484)
T 3nyv_A          181 ASK-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF--------  246 (484)
T ss_dssp             CCC-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------
T ss_pred             ccc-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            432     2234569999999999977 79999999999999999999999998876543322222110000        


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                         ..   ......++.+.+|+.+||+.||.+|||+.++++|+|.-.
T Consensus       247 ---~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          247 ---EL---PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             ---CS---GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             ---CC---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence               00   011123467999999999999999999999999999643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-45  Score=361.50  Aligned_cols=262  Identities=23%  Similarity=0.386  Sum_probs=204.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcE----EEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTI----VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|+..+.||+|+||+||+|.+. +++.    ||+|.++... .......+.+|+.+++.++||||+++++++.+.+ .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            57889999999999999999865 4554    5777765432 3345578999999999999999999999998654 78


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|+||+.+|+|.+++.. ....+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++...
T Consensus        93 ~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            99999999999999975 3466899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....  ........||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..       +....
T Consensus       169 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------~~~~~  239 (327)
T 3poz_A          169 AEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GERLP  239 (327)
T ss_dssp             TTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCCCC
T ss_pred             CCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-------CCCCC
Confidence            4332  112233457889999999999999999999999999999999 9999987654322111111       00000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                                ....+...+.+|+.+||+.||.+||++.+++++|..+..+...
T Consensus       240 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~  282 (327)
T 3poz_A          240 ----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             ----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             ----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhh
Confidence                      0011235799999999999999999999999999988776544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.5e-46  Score=371.30  Aligned_cols=276  Identities=23%  Similarity=0.355  Sum_probs=213.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.+.||+|+||.||+|.+. ++..||+|+++... .......+.+|+.+|+.++||||+++++++..++..++|||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            46888999999999999999987 79999999987642 34445678999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH-PIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |+.|++|.+++...  ..+++..+..|+.||+.||.|||   .. +|+||||||+||||+.++.+||+|||++.......
T Consensus       112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            99999999999753  46899999999999999999999   54 89999999999999999999999999997654321


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh-------------
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK-------------  359 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-------------  359 (443)
                            .....||+.|+|||++.+..++.++|||||||++|+|++|..||.................             
T Consensus       187 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          187 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             ------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                  2345699999999999998999999999999999999999999986543221111000000             


Q ss_pred             ----------hcCCCccccccCc---cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          360 ----------KFSDGDAISILDP---RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       360 ----------~~~~~~~~~~~d~---~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                                ..........++.   ...........+..+.+|+.+||+.||.+|||+.++++|+|.-..+..+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence                      0000000000000   00000001113467999999999999999999999999999776555544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.1e-46  Score=351.41  Aligned_cols=256  Identities=28%  Similarity=0.454  Sum_probs=212.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|...+.||+|+||.||+|.+.+++.||||+++...   ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            5688889999999999999999888999999987653   3446789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +++++|.+++.. ....+++..++.++.|++.||.|||   +++++||||||+|||++.++.+||+|||++.......  
T Consensus        85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--  158 (267)
T 3t9t_A           85 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--  158 (267)
T ss_dssp             CTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH--
T ss_pred             CCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc--
Confidence            999999999975 3456899999999999999999999   7889999999999999999999999999998654321  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                       ........|++.|+|||++.+..++.++||||||+++|+|++ |..||...........+.   ....    .  ..+ 
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~---~~~~----~--~~~-  227 (267)
T 3t9t_A          159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---TGFR----L--YKP-  227 (267)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCC----C--CCC-
T ss_pred             -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh---cCCc----C--CCC-
Confidence             111233457889999999998899999999999999999999 899998765432211111   1100    0  000 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                             ...+..+.+|+.+||+.||.+||++.+++++|..+..
T Consensus       228 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          228 -------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                   1123678999999999999999999999999998864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-45  Score=351.32  Aligned_cols=252  Identities=30%  Similarity=0.471  Sum_probs=196.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccC--cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYD--KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+|...+.||+|+||.||+|.+. +..||||+++.....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888899999999999999986 889999998764322  233567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---eEecCCCCCCEEEcC--------CCceEEee
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP---IIHRDIKSSNILLTE--------NFRAKVAD  281 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivHrDlkp~NILl~~--------~~~vkl~D  281 (443)
                      ||+.+++|.+++.   +..+++..++.++.||+.||.|||   .++   |+||||||+|||++.        ++.+||+|
T Consensus        86 e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           86 EFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             ECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999884   457999999999999999999999   666   999999999999986        77899999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF  361 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~  361 (443)
                      ||++.......      .....||+.|+|||++.+..++.++||||||+++|+|++|..||..............  .  
T Consensus       160 fg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~--  229 (271)
T 3dtc_A          160 FGLAREWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM--N--  229 (271)
T ss_dssp             CCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--S--
T ss_pred             CCccccccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--C--
Confidence            99997654332      2234699999999999998999999999999999999999999987654332221111  0  


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                         ...    ...     ...+++.+.+|+.+||+.||.+||++.+++++|..|
T Consensus       230 ---~~~----~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 ---KLA----LPI-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---CCC----CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---CCC----CCC-----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence               000    000     011336799999999999999999999999999753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-45  Score=382.89  Aligned_cols=257  Identities=28%  Similarity=0.377  Sum_probs=208.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc-----------ccHHHHHHHHHHHHhcCCcceeeeeee
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK-----------HSGAEFQSEIRTLAQVEHLNLVKFHGY  201 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~niv~l~~~  201 (443)
                      .++|.+.++||+|+||+||+|... +++.||||++++.....           ...+.+.+|+.+|+.++|||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            468999999999999999999986 68999999987654322           345678999999999999999999999


Q ss_pred             eeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC---ceE
Q 013401          202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF---RAK  278 (443)
Q Consensus       202 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~---~vk  278 (443)
                      +.+.+..++|||||.||+|.+++...  ..+++..++.|+.||+.||.|||   .+||+||||||+|||++.++   .+|
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999998743  56999999999999999999999   78899999999999998776   699


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      |+|||++.......     .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+....
T Consensus       190 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             ECCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             EEECCCCEEcCCCC-----ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            99999998765432     2334569999999999875 69999999999999999999999998776543322222110


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..+         +     .......++++.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       264 ~~~---------~-----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          264 YYF---------D-----FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             CCC---------C-----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCC---------C-----ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence            000         0     000112346799999999999999999999999999964

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-45  Score=353.40  Aligned_cols=260  Identities=26%  Similarity=0.416  Sum_probs=200.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|++.+.||+|+||.||+|.+.    .+..||||+++... .....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            57888999999999999999874    25679999987542 3344567889999999999999999999974 567899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.+++|.+++.. ....+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            9999999999999975 3456899999999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...   .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+.... 
T Consensus       169 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~~~~-  237 (281)
T 1mp8_A          169 STY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLP-  237 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCCCC-
T ss_pred             ccc---cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCCCCC-
Confidence            321   11223457889999999998899999999999999999997 999998765432211111       111000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      +.         ..++..+.+|+.+||+.||.+||++.+++++|..+..+.+
T Consensus       238 ~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          238 MP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            00         1234679999999999999999999999999999876644

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-45  Score=353.30  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=207.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee----cCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF----EDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~  209 (443)
                      +.|.+.+.||+|+||+||+|.+. ++..||+|++............+.+|+.+|+.++||||+++++++..    ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34777778999999999999976 68899999988766666667789999999999999999999999876    35689


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCceEEeeecccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLT-ENFRAKVADFGFAR  286 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~  286 (443)
                      +||||+.+++|.+++...  ..+++..++.|+.||+.||.|||   .++  |+||||||+|||++ .++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999999743  56899999999999999999999   888  99999999999998 78999999999997


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .....      ......||+.|+|||++.+ .++.++|||||||++|+|++|..||............      ...+..
T Consensus       181 ~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~------~~~~~~  247 (290)
T 1t4h_A          181 LKRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR------VTSGVK  247 (290)
T ss_dssp             GCCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH------HTTTCC
T ss_pred             ccccc------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH------HhccCC
Confidence            54432      1234569999999999875 5899999999999999999999999765443222111      111111


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ....         ....+..+.+|+.+||+.||.+||++.++++|+|.
T Consensus       248 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          248 PASF---------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             CGGG---------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             cccc---------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence            1111         11123569999999999999999999999999994

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.5e-46  Score=362.59  Aligned_cols=288  Identities=27%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeee--ecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLE--FEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~  207 (443)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++...  .......+.+|+.+++.++||||+++++++.  ..+.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            5789999999999999999984     36899999998754  2444567899999999999999999999886  4567


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+++++|.+++... ...+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||++..
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            89999999999999999753 346899999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHH--------HHHHHhh
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI--------TVKWAMK  359 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~--------~~~~~~~  359 (443)
                      ...... .........||+.|+|||++.+..++.++|||||||++|+|++|..||..........        .......
T Consensus       177 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          177 LPLDKD-YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             CCTTCS-EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             cccCCc-cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            654321 1122334568999999999998889999999999999999999999987654321100        0001111


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhhcccCcCCccccccccc
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPSYSKRSNS  439 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  439 (443)
                      ....+....          ....+++.+.+|+.+||+.||.+||++.+++++|..+...............|.....+.|
T Consensus       256 ~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p~~~~~~~s  325 (327)
T 3lxl_A          256 LLEEGQRLP----------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLS  325 (327)
T ss_dssp             HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------------------------
T ss_pred             HhhcccCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCcCccccccc
Confidence            111110000          0112346799999999999999999999999999999887777766666666666655544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.2e-46  Score=379.75  Aligned_cols=257  Identities=27%  Similarity=0.461  Sum_probs=212.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .++|...+.||+|+||.||+|.++++..||||+++..   ....+.+.+|+.+|+.++|||||++++++. .+..++|||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC---CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            4578888999999999999999988899999999764   345678999999999999999999999986 667899999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+|+|.+++....+..+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++...... 
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence            999999999997655556889999999999999999999   7889999999999999999999999999998764321 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                        ........+|+.|+|||++....++.++|||||||+||||++ |..||...........+..   ...    ..    
T Consensus       339 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~----~~----  405 (454)
T 1qcf_A          339 --YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYR----MP----  405 (454)
T ss_dssp             --HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH---TCC----CC----
T ss_pred             --eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCC----CC----
Confidence              111223447889999999998899999999999999999999 9999987654332211111   100    00    


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       .     ...+++.+.+|+.+||+.||++||++.+|++.|..+..
T Consensus       406 -~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          406 -R-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -C-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence             0     11234679999999999999999999999999987643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-45  Score=363.60  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=213.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            57888999999999999999986 588999999876533 3345567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++..  ...+++..++.|+.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.......
T Consensus       121 e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          121 ELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             CCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999998874  356899999999999999999999   7889999999999999999999999999998764322


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......            
T Consensus       196 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------  259 (335)
T 2owb_A          196 E----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS------------  259 (335)
T ss_dssp             C----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------------
T ss_pred             c----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCC------------
Confidence            1    123456999999999999888999999999999999999999999876543322222111000            


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                       +.     ......+.+|+.+||+.||.+||++.++++|.|.-.
T Consensus       260 -~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          260 -IP-----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             -CC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             -CC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence             00     012356889999999999999999999999999643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=355.40  Aligned_cols=260  Identities=23%  Similarity=0.305  Sum_probs=207.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc--CcccHHHHHHHHHHHHhcCCcceeeeeeee--eecCeE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVEHLNLVKFHGYL--EFEDER  208 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~--~~~~~~  208 (443)
                      .++|.+.+.||+|+||.||+|.+. +++.||||+++....  .......+.+|+.+++.++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 689999999876432  124457789999999999999999999998  445688


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ++||||+.++ |.+++.......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 888887666778999999999999999999999   788999999999999999999999999999876


Q ss_pred             cccCCCcccccccccCCCCccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ......  .......||+.|+|||++.+..  ++.++|||||||++|+|++|..||...........+..       +..
T Consensus       160 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-------~~~  230 (305)
T 2wtk_C          160 HPFAAD--DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK-------GSY  230 (305)
T ss_dssp             CTTCSS--CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------CCC
T ss_pred             Cccccc--cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc-------CCC
Confidence            432211  1223456999999999997643  37799999999999999999999987654332221111       000


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       . +.         ..+...+.+|+.+||+.||.+||++.++++|.|.-..
T Consensus       231 -~-~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          231 -A-IP---------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             -C-CC---------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             -C-CC---------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence             0 00         0123578999999999999999999999999997543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=367.18  Aligned_cols=248  Identities=27%  Similarity=0.356  Sum_probs=207.2

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc------ccHHHHHHHHHHHHhcCCcceeeeeeeeeec
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK------HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE  205 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  205 (443)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||+++......      .....+.+|+.+|+.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4567999999999999999999975 79999999987653221      1334567899999999999999999999999


Q ss_pred             CeEEEEEeecCCC-cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          206 DERIVIVEYVPNG-TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       206 ~~~~lv~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      +..++||||+.+| +|.+++.  ....+++..++.|+.||+.||.|||   .+||+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999766 9999987  3456999999999999999999999   78899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      +........     .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||........             
T Consensus       177 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------  238 (335)
T 3dls_A          177 AAYLERGKL-----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------  238 (335)
T ss_dssp             CEECCTTCC-----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------
T ss_pred             ceECCCCCc-----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------
Confidence            987654321     234569999999999988776 7899999999999999999999976432110             


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .    .....       ...++.+.+|+.+||++||.+||++.++++|+|.
T Consensus       239 ~----~~~~~-------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          239 A----AIHPP-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             T----CCCCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             h----ccCCC-------cccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            0    00000       0123679999999999999999999999999995

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-45  Score=354.94  Aligned_cols=255  Identities=23%  Similarity=0.344  Sum_probs=212.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            57888999999999999999987 689999999876533 3345567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++..  ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.......
T Consensus        95 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           95 ELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             ECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999998864  356899999999999999999999   7889999999999999999999999999998764322


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...       ..      
T Consensus       170 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~------  232 (294)
T 2rku_A          170 E----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------EY------  232 (294)
T ss_dssp             C----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------CC------
T ss_pred             c----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------cC------
Confidence            1    123456999999999999888999999999999999999999999876543322221110       00      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .+.     ......+.+|+.+||+.||++||++.++++|.|...
T Consensus       233 ~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          233 SIP-----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             CCc-----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence            000     012356899999999999999999999999999654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-45  Score=351.96  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=207.7

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ..++|++.+.||+|+||+||+|.+. +++.||||+++...........+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999987 799999999987655556667888999999999 89999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC--------------
Q 013401          211 IVEYVPNGTLREHLDCLQ--GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN--------------  274 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~--------------  274 (443)
                      ||||+++++|.+++....  ...+++..++.|+.||+.||.|||   .++|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997542  366899999999999999999999   7889999999999999844              


Q ss_pred             -----CceEEeeecccccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhH
Q 013401          275 -----FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKREL  348 (443)
Q Consensus       275 -----~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~  348 (443)
                           ..+||+|||++.......        ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+......
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~  237 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW  237 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH
T ss_pred             ccCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH
Confidence                 479999999998765422        23499999999999765 5668999999999999999999887655332


Q ss_pred             HHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          349 KERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...          ..+.... +..         ..++.+.+|+.+||+.||.+||++.++++|+|...
T Consensus       238 ~~~----------~~~~~~~-~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          238 HEI----------RQGRLPR-IPQ---------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             HHH----------HTTCCCC-CSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             HHH----------HcCCCCC-CCc---------ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            211          0111100 001         12367999999999999999999999999999653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-45  Score=361.88  Aligned_cols=263  Identities=23%  Similarity=0.395  Sum_probs=206.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcE----EEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTI----VAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|+..+.||+|+||+||+|.+. +++.    ||+|.+.... .......+.+|+.+++.++||||+++++++. ++..+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            47888999999999999999975 4554    6777664432 2233345678999999999999999999886 56789


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+|+|.+++... ...+++..++.|+.||+.||.|||   .+||+||||||+|||++.++.+||+|||+++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999999753 356899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..       +....
T Consensus       167 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~~~  237 (325)
T 3kex_A          167 PDDK--QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK-------GERLA  237 (325)
T ss_dssp             CCTT--CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-------TCBCC
T ss_pred             cccc--cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-------CCCCC
Confidence            4332  122344568889999999998899999999999999999999 9999987654322111111       00000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      .  +        ..+...+.+|+.+||+.||.+||++.+++++|..+.++-...
T Consensus       238 ~--~--------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~  281 (325)
T 3kex_A          238 Q--P--------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRY  281 (325)
T ss_dssp             C--C--------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHH
T ss_pred             C--C--------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence            0  0        012245889999999999999999999999999987765543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-45  Score=354.36  Aligned_cols=263  Identities=29%  Similarity=0.482  Sum_probs=200.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .++|.+.++||+|+||+||+|.+.  ..||||+++...........+.+|+.+|+.++||||++++++. ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            357999999999999999999865  3599999887655556667899999999999999999999964 5667899999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++.. ....+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus       100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999999999964 3466899999999999999999999   78899999999999999999999999999976543211


Q ss_pred             CcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                        ........||+.|+|||++.   +..++.++|||||||++|+|++|..||...............  ....... ..+
T Consensus       176 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~-~~~  250 (289)
T 3og7_A          176 --SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR--GSLSPDL-SKV  250 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH--TSCCCCT-TSS
T ss_pred             --cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc--cccCcch-hhc
Confidence              12234457999999999986   567888999999999999999999999875543322221111  1100000 000


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                               ...+++.+.+|+.+||+.||.+||++.++++.|..+.+
T Consensus       251 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          251 ---------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                     11234679999999999999999999999999988754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-45  Score=373.92  Aligned_cols=269  Identities=23%  Similarity=0.249  Sum_probs=210.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc------CCcceeeeeeeeeecC
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV------EHLNLVKFHGYLEFED  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~  206 (443)
                      ..+|++.+.||+|+||+||+|.+. +++.||||+++..   ......+.+|+.+++.+      .|+||+++++++...+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            357999999999999999999876 6899999998753   33445677888888877      5779999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--eEEeeecc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR--AKVADFGF  284 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--vkl~DFGl  284 (443)
                      ..++||||+. ++|.+++.......+++..++.|+.||+.||.|||   .++||||||||+||||+.++.  +||+|||+
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999995 69999998766567999999999999999999999   778999999999999999887  99999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC--
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS--  362 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--  362 (443)
                      +......       ....+||+.|+|||++.+..++.++|||||||+||||++|.+||....+......+........  
T Consensus       249 a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          249 SCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             CEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            9764432       2345799999999999998999999999999999999999999988765443322221110000  


Q ss_pred             -------------CCccc------cccC-----------------ccccchh---hcHHHHHHHHHHHHHccCCCCCCCC
Q 013401          363 -------------DGDAI------SILD-----------------PRVENTA---ANNLALEKILELALQCLAPRRQNRP  403 (443)
Q Consensus       363 -------------~~~~~------~~~d-----------------~~~~~~~---~~~~~~~~l~~Li~~cl~~dp~~RP  403 (443)
                                   .....      ...+                 +.....+   ........+.+|+.+||+.||.+||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence                         00000      0000                 0000000   0001136689999999999999999


Q ss_pred             CHHHHHHHHHhhh
Q 013401          404 SMRRCAEILWSVR  416 (443)
Q Consensus       404 s~~ell~~l~~i~  416 (443)
                      |+.++++|+|...
T Consensus       402 ta~e~L~Hpw~~~  414 (429)
T 3kvw_A          402 TPGQALRHPWLRR  414 (429)
T ss_dssp             CHHHHHTSTTTC-
T ss_pred             CHHHHhCChhhcc
Confidence            9999999999643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.2e-45  Score=356.54  Aligned_cols=262  Identities=25%  Similarity=0.384  Sum_probs=212.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|...+.||+|+||.||+|.+      .+++.||||+++... .....+.+.+|+.+|+.+ +||||+++++++.+.+.
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            5788899999999999999985      257899999987542 233457789999999999 89999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          208 RIVIVEYVPNGTLREHLDCLQG----------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      .++||||+.+|+|.+++.....                ..+++..++.++.||+.||.|||   +++|+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999975432                24899999999999999999999   7889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            9999999999999987654321  112234457889999999988899999999999999999999 9999976543222


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ......  .....     ..         ....+..+.+|+.+||+.||.+||++.+++++|..+..+
T Consensus       257 ~~~~~~--~~~~~-----~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 FYKMIK--EGFRM-----LS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHHH--HTCCC-----CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhc--cCCCC-----CC---------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            111111  00000     00         011236799999999999999999999999999877654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.2e-45  Score=352.57  Aligned_cols=254  Identities=28%  Similarity=0.465  Sum_probs=203.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccH-----HHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSG-----AEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~-----~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|+..+.||+|+||+||+|.+. +++.||||++..........     ..+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            57888999999999999999985 79999999986643322221     67889999999999999999999986655  


Q ss_pred             EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCc-----eEEee
Q 013401          209 IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLTENFR-----AKVAD  281 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~-----vkl~D  281 (443)
                      ++||||+.+++|.+++.. ....+++..++.++.||+.||.|||   .++  |+||||||+|||++.++.     +||+|
T Consensus        97 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            799999999999998865 3457899999999999999999999   888  999999999999988776     99999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCcccc--ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYL--KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      ||++......       .....||+.|+|||++  ....++.++|||||||++|+|++|..||.................
T Consensus       173 fg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          173 FGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             CTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             CCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            9999754331       3345799999999998  445678899999999999999999999976543222111111110


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..         .+.+     ...+++.+.+|+.+||+.||.+||++.++++.|..+
T Consensus       246 ~~---------~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          246 GL---------RPTI-----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CC---------CCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CC---------CCCC-----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            00         0001     012346799999999999999999999999998753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3e-46  Score=372.22  Aligned_cols=268  Identities=21%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------C
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------D  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~  206 (443)
                      .++|...+.||+|+||.||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999975 799999999976554455567788999999999999999999998654      5


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..++|+|++ +++|.+++..   ..+++..++.++.||+.||.|||   ++||+||||||+||||+.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 7899988853   56999999999999999999999   7889999999999999999999999999997


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .....       .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+...........
T Consensus       181 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          181 HTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65432       234579999999999876 6789999999999999999999999988765443332222111110000


Q ss_pred             cccc-----------cC--ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          366 AISI-----------LD--PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       366 ~~~~-----------~d--~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...+           +.  +..............+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence            0000           00  00000001112346789999999999999999999999999954

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.5e-45  Score=352.71  Aligned_cols=255  Identities=28%  Similarity=0.411  Sum_probs=213.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +.|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            46888999999999999999875 699999999876532 3456789999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+++|.+++.   ...+++..++.++.||+.||.|||   .+||+|+||||+|||++.++.+||+|||++........
T Consensus       101 ~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          101 YLGGGSALDLLE---PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             eCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999999985   356899999999999999999999   78899999999999999999999999999977654321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..    .   .. ..+.. 
T Consensus       175 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~---~~-~~~~~-  241 (303)
T 3a7i_A          175 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK----N---NP-PTLEG-  241 (303)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH----S---CC-CCCCS-
T ss_pred             ----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc----C---CC-CCCcc-
Confidence                12345699999999999998999999999999999999999999987654332221111    0   00 00111 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                              ..+..+.+|+.+||+.||.+||++.++++|+|....
T Consensus       242 --------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          242 --------NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             --------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             --------ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                    123569999999999999999999999999997643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-45  Score=354.63  Aligned_cols=261  Identities=27%  Similarity=0.380  Sum_probs=217.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|.+.+.||+|+||.||+|.+. ++..||||+++..   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            467888999999999999999987 5889999998754   445678899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.|++|.+++.......+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999998766677999999999999999999999   7789999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .   .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..............   ....        
T Consensus       166 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---~~~~--------  231 (288)
T 3kfa_A          166 Y---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRM--------  231 (288)
T ss_dssp             S---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCC--------
T ss_pred             c---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---cCCC--------
Confidence            1   12233457889999999998899999999999999999999 9999986654322111111   0000        


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                       ..     ...+++.+.+|+.+||+.||.+||++.++++.|..+..+..
T Consensus       232 -~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          232 -ER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             -CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -CC-----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence             00     01123679999999999999999999999999998766543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.2e-45  Score=358.70  Aligned_cols=268  Identities=19%  Similarity=0.295  Sum_probs=212.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEE-c-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc------eeeeeeeeeec
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRL-E-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN------LVKFHGYLEFE  205 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~  205 (443)
                      .++|++.+.||+|+||.||+|.+ . +++.||||+++..   ......+.+|+.+++.++|++      |+++++++...
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            35799999999999999999987 3 6899999998753   344567889999999887664      99999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC------------
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE------------  273 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~------------  273 (443)
                      +..++||||+ +++|.+++.......+++..++.++.||+.||.|||   ++||+||||||+|||++.            
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999 899999998665567899999999999999999999   788999999999999987            


Q ss_pred             -------CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCch
Q 013401          274 -------NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR  346 (443)
Q Consensus       274 -------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~  346 (443)
                             ++.+||+|||++......       .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                   678999999999764432       234569999999999999899999999999999999999999998766


Q ss_pred             hHHHHHHHHHHhhhcCCC--------cc-----cc-------------ccCccccchhhcHHHHHHHHHHHHHccCCCCC
Q 013401          347 ELKERITVKWAMKKFSDG--------DA-----IS-------------ILDPRVENTAANNLALEKILELALQCLAPRRQ  400 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~--------~~-----~~-------------~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~  400 (443)
                      .......+......+...        ..     ..             ...+............+.+.+|+.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            543332222211111100        00     00             00000001111234567899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 013401          401 NRPSMRRCAEILWSV  415 (443)
Q Consensus       401 ~RPs~~ell~~l~~i  415 (443)
                      +|||+.++++|+|.-
T Consensus       319 ~Rpt~~ell~hp~f~  333 (339)
T 1z57_A          319 KRITLREALKHPFFD  333 (339)
T ss_dssp             TSCCHHHHTTSGGGG
T ss_pred             cccCHHHHhcCHHHH
Confidence            999999999999853

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.8e-45  Score=365.69  Aligned_cols=269  Identities=20%  Similarity=0.249  Sum_probs=202.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      .++|...+.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999976 6999999998765544555677889999999999999999999987665      


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..++||||+. ++|.+++.    ..+++..+..++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999996 57888775    34889999999999999999999   7889999999999999999999999999997


Q ss_pred             cccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh-------
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK-------  359 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~-------  359 (443)
                      ......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....       
T Consensus       176 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          176 TAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            654321     22345799999999999998999999999999999999999999987765433222111000       


Q ss_pred             ------------hcCC---CccccccCccc--cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 ------------KFSD---GDAISILDPRV--ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ------------~~~~---~~~~~~~d~~~--~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                                  ....   ......+....  ............+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                        0000   00000000000  00011223467899999999999999999999999999963

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-45  Score=357.98  Aligned_cols=267  Identities=21%  Similarity=0.267  Sum_probs=201.3

Q ss_pred             cCCCCC-ceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPS-FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      +.|.+. +.||+|+||+||+|... +++.||||+++..  .......+.+|+.+|.++ +||||+++++++.+.+..++|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            467764 67999999999999965 7999999998764  244567889999999995 799999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---eEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~~~  288 (443)
                      |||+.|++|.+++...  ..+++..++.++.||+.||.|||   .++|+||||||+|||++.++.   +||+|||++...
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999999753  56899999999999999999999   788999999999999998766   999999998765


Q ss_pred             cccCCCc---ccccccccCCCCccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH--------HH
Q 013401          289 ADTESGA---THVSTQVKGTAGYLDPEYLKT-----YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE--------RI  352 (443)
Q Consensus       289 ~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-----~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~--------~~  352 (443)
                      .......   .......+||+.|+|||++.+     ..++.++|||||||++|+|++|..||........        ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            4321110   111223569999999999975     4688999999999999999999999976532110        00


Q ss_pred             HHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          353 TVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ........+..+..      .+.. ......+..+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       245 ~~~~~~~~i~~~~~------~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          245 CQNMLFESIQEGKY------EFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHHHHHCCC------CCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             HHHHHHHHHhccCc------ccCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence            00000000101100      0000 00012346799999999999999999999999999964

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=350.51  Aligned_cols=265  Identities=20%  Similarity=0.359  Sum_probs=213.6

Q ss_pred             cCCCCCc-eeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSF-KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|.+.. .||+|+||.||+|.+.   ++..||||+++.. ......+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            3566665 8999999999999854   5888999998764 2344567789999999999999999999999 5667999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.+++|.+++.. ....+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            9999999999999964 3456899999999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      .... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+.... 
T Consensus       163 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-------~~~~~~-  233 (287)
T 1u59_A          163 DDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRME-  233 (287)
T ss_dssp             CSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCCCC-
T ss_pred             Ccce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-------cCCcCC-
Confidence            3211 111233457899999999988889999999999999999998 999998765432211111       111000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                      ..         ..+++.+.+|+.+||+.||.+||++.+++++|+.+..+.....
T Consensus       234 ~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          234 CP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             CC---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             CC---------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence            00         1234679999999999999999999999999999987766543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.1e-45  Score=350.11  Aligned_cols=258  Identities=29%  Similarity=0.469  Sum_probs=211.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++.+.||+|+||.||+|...++..||||+++..   ......+.+|+.+|+.++||||+++++++. .+..++||||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC---cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            578889999999999999999988889999998764   334578899999999999999999999876 5568999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+++|.+++....+..+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++........ 
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            99999999997544446899999999999999999999   78899999999999999999999999999987654321 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+.... .   
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~~-~---  231 (279)
T 1qpc_A          165 --TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMV-R---  231 (279)
T ss_dssp             --ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCC-C---
T ss_pred             --ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-------cccCCC-C---
Confidence              12233457889999999988889999999999999999999 999998765432211111       110000 0   


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                            ....++.+.+|+.+||..||.+||++.++++.|..+....
T Consensus       232 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          232 ------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                  0113367999999999999999999999999998876543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-45  Score=353.46  Aligned_cols=264  Identities=28%  Similarity=0.440  Sum_probs=208.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeee-eecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL-EFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~  209 (443)
                      .+|...+.||+|+||+||+|.+.+    +..||||.++.. ........+.+|+.+++.++||||+++++++ ..++..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            468888899999999999998642    336899988753 2344557788999999999999999999985 4566889


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+|+|.+++.. ....+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus       104 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            99999999999999964 3456889999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ..............||+.|+|||++.+..++.++|||||||++|+|++ |.+||..............       +... 
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~-------~~~~-  251 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------GRRL-  251 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-------TCCC-
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-------CCCC-
Confidence            543322233345568899999999999899999999999999999999 6677765543322111111       0000 


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      ..         ....++.+.+|+.+||+.||.+||++.++++.|..+..++.
T Consensus       252 ~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          252 LQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            00         01123579999999999999999999999999998876653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-45  Score=372.93  Aligned_cols=265  Identities=23%  Similarity=0.351  Sum_probs=200.7

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC------cccHHHHHHHHHHHHhcCCcceeeeeeeeeec
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD------KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE  205 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~  205 (443)
                      ..++|.+.+.||+|+||+||+|.+. +++.||||++.+....      ......+.+|+.+|+.++|||||++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            4578999999999999999999976 6899999998764322      112234789999999999999999999975 5


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CceEEeee
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN---FRAKVADF  282 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DF  282 (443)
                      +..++||||+.+|+|.+++.  ....+++..++.|+.||+.||.|||   +++|+||||||+||||+.+   +.+||+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             CceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence            56899999999999999886  4467999999999999999999999   7889999999999999754   45999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      |+++......     .....+||+.|+|||++.+   ..++.++|||||||++|+|++|.+||.............   .
T Consensus       287 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---~  358 (419)
T 3i6u_A          287 GHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---T  358 (419)
T ss_dssp             STTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH---H
T ss_pred             ccceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH---h
Confidence            9998765432     2345679999999999853   567889999999999999999999997653321111100   0


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                         .+... . .     .......++.+.+|+.+||+.||.+||++.++++|+|.-..++++
T Consensus       359 ---~~~~~-~-~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~  410 (419)
T 3i6u_A          359 ---SGKYN-F-I-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR  410 (419)
T ss_dssp             ---TTCCC-C-C-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHH
T ss_pred             ---cCCCC-C-C-----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHH
Confidence               00000 0 0     000112346799999999999999999999999999975544443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-45  Score=353.66  Aligned_cols=253  Identities=26%  Similarity=0.453  Sum_probs=208.1

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-------
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-------  204 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-------  204 (443)
                      ...+|+..+.||+|+||.||+|.+. +++.||||+++...      ..+.+|+.+++.++||||+++++++..       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            4457999999999999999999987 79999999987542      356789999999999999999998864       


Q ss_pred             ---------cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013401          205 ---------EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF  275 (443)
Q Consensus       205 ---------~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~  275 (443)
                               ....++||||+.+++|.+++.......+++..++.++.||+.||.|||   .+||+|+||||+|||++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence                     455899999999999999998766677999999999999999999999   78899999999999999999


Q ss_pred             ceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHH
Q 013401          276 RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVK  355 (443)
Q Consensus       276 ~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~  355 (443)
                      .+||+|||++........     .....||+.|+|||++.+..++.++|||||||++|+|++|..||........     
T Consensus       160 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----  229 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT-----  229 (284)
T ss_dssp             EEEECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH-----
T ss_pred             CEEECcchhheecccccc-----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH-----
Confidence            999999999987654321     2344699999999999998999999999999999999999998743221110     


Q ss_pred             HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          356 WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                          ....+..    ..         ..+..+.+|+.+||+.||.+||++.+++++|+.+.++...
T Consensus       230 ----~~~~~~~----~~---------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          230 ----DLRDGII----SD---------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             ----HHHTTCC----CT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             ----Hhhcccc----cc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence                1111111    01         1235688999999999999999999999999998765443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.5e-45  Score=357.40  Aligned_cols=275  Identities=23%  Similarity=0.281  Sum_probs=212.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc--CCcEEEEEEccccccCcccHHHHHHHHHHHHhc---CCcceeeeeeeee----
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE--DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV---EHLNLVKFHGYLE----  203 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~----  203 (443)
                      ..++|.+.+.||+|+||.||+|.+.  +|+.||||+++...........+.+|+.+++.+   .||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4568999999999999999999983  688999999876544333344566788877766   8999999999987    


Q ss_pred             -ecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          204 -FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       204 -~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                       .....++||||+. |+|.+++.......+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999997 69999998766667999999999999999999999   788999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      |++.......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........
T Consensus       165 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          165 GLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             CSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            9997654322     23345699999999999988999999999999999999999999987765443322221111100


Q ss_pred             CCcccc-------ccC--ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          363 DGDAIS-------ILD--PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       363 ~~~~~~-------~~d--~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ......       .+.  ............+..+.+|+.+||+.||.+||++.++++|.|.-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  302 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  302 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence            000000       000  000000011223467899999999999999999999999999643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.3e-45  Score=372.89  Aligned_cols=251  Identities=29%  Similarity=0.453  Sum_probs=207.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC-eEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED-ERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~E  213 (443)
                      ++|...+.||+|+||.||+|.+. |+.||||+++..    ...+.+.+|+.+|+.++|||||++++++.+.+ ..++|||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            56788889999999999999886 789999999764    24567899999999999999999999987665 7999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+|+|.+++.......+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999999998765556899999999999999999999   788999999999999999999999999999754321  


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           .....+++.|+|||++.+..++.++|||||||+||||++ |..||...........+.       .+....    
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~~~----  406 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMD----  406 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTCCCC----
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC----
Confidence                 122357899999999999899999999999999999998 999998654322211111       111100    


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       .     ...++..+.+|+.+||+.||.+||++.++++.|..+..
T Consensus       407 -~-----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          407 -A-----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -C-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             0     11234679999999999999999999999999988764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.5e-45  Score=362.82  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=210.4

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC------cccHHHHHHHHHHHHhc-CCcceeeeeeee
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD------KHSGAEFQSEIRTLAQV-EHLNLVKFHGYL  202 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~  202 (443)
                      .....+|.+.+.||+|+||.||+|.+. +|+.||||++......      ......+.+|+.+++.+ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344567999999999999999999986 7999999998654321      11235678999999999 799999999999


Q ss_pred             eecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       203 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                      ...+..++||||+.|++|.+++..  ...+++..++.++.||+.||.|||   .+||+|+||||+|||++.++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999974  356899999999999999999999   788999999999999999999999999


Q ss_pred             cccccccccCCCcccccccccCCCCccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDPEYLKT------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW  356 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~  356 (443)
                      |++.......     ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||...........+..
T Consensus       245 G~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  319 (365)
T 2y7j_A          245 GFSCHLEPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME  319 (365)
T ss_dssp             TTCEECCTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CcccccCCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            9998765432     1234679999999999864      3588899999999999999999999987654322211111


Q ss_pred             HhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       357 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                         .....        .   .......+..+.+|+.+||+.||.+||++.++++|+|.
T Consensus       320 ---~~~~~--------~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          320 ---GQYQF--------S---SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             ---TCCCC--------C---HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             ---CCCCC--------C---CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence               00000        0   00001123569999999999999999999999999995

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-45  Score=367.80  Aligned_cols=267  Identities=25%  Similarity=0.269  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC--------Ccceeeeeeeee-
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE--------HLNLVKFHGYLE-  203 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~-  203 (443)
                      .++|.+.++||+|+||+||+|.+. +++.||||+++..   ......+.+|+.+|+.++        |+||+++++++. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            357999999999999999999875 6899999998753   344567889999999985        788999999987 


Q ss_pred             ---ecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCC----
Q 013401          204 ---FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH-PIIHRDIKSSNILLTENF----  275 (443)
Q Consensus       204 ---~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~~~----  275 (443)
                         .....++||||+ +++|.+++.......+++..++.|+.||+.||.|||   .+ ||+||||||+||||+.++    
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence               456889999999 677877776555567999999999999999999999   76 899999999999998775    


Q ss_pred             ---------------------------------------------ceEEeeecccccccccCCCcccccccccCCCCccC
Q 013401          276 ---------------------------------------------RAKVADFGFARLAADTESGATHVSTQVKGTAGYLD  310 (443)
Q Consensus       276 ---------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~a  310 (443)
                                                                   .+||+|||++......       .....||+.|+|
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~a  261 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCC
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccC
Confidence                                                         7999999999876432       234569999999


Q ss_pred             ccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchh------HHHHHHHHHHhhhc---------------CC-Ccccc
Q 013401          311 PEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE------LKERITVKWAMKKF---------------SD-GDAIS  368 (443)
Q Consensus       311 PE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~------~~~~~~~~~~~~~~---------------~~-~~~~~  368 (443)
                      ||++.+..++.++|||||||+||+|++|..||.....      ......+.......               .. +....
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            9999998999999999999999999999999975432      11111111110000               00 00000


Q ss_pred             ccCcc--------ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          369 ILDPR--------VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       369 ~~d~~--------~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +.+..        .............+.+|+.+||+.||.+|||+.++++|+|.
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence            00000        00011234566789999999999999999999999999994

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.7e-45  Score=358.48  Aligned_cols=276  Identities=20%  Similarity=0.267  Sum_probs=215.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CC-cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc------eeeeeeeeeec
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DG-TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN------LVKFHGYLEFE  205 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~  205 (443)
                      .++|.+.+.||+|+||+||+|.+. ++ +.||||+++..   ......+.+|+.+++.+.|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            368999999999999999999975 44 78999998753   334567889999999997766      89999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE--------------
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL--------------  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl--------------  271 (443)
                      +..++||||+ +++|.+++.......+++..++.|+.||+.||.|||   ++||+||||||+||||              
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999 778888887655567999999999999999999999   8899999999999999              


Q ss_pred             -----cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCch
Q 013401          272 -----TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKR  346 (443)
Q Consensus       272 -----~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~  346 (443)
                           +.++.+||+|||++......       .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                 66889999999999764432       234569999999999999899999999999999999999999998776


Q ss_pred             hHHHHHHHHHHhhhcCCCccc------c--------------------ccCccccchhhcHHHHHHHHHHHHHccCCCCC
Q 013401          347 ELKERITVKWAMKKFSDGDAI------S--------------------ILDPRVENTAANNLALEKILELALQCLAPRRQ  400 (443)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~------~--------------------~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~  400 (443)
                      .......+......+......      .                    ...+..............+.+|+.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            544333332222111100000      0                    00000000011223456899999999999999


Q ss_pred             CCCCHHHHHHHHHhhhhhhhhhh
Q 013401          401 NRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       401 ~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                      +|||+.++++|.|.-.-+..+..
T Consensus       324 ~Rpt~~e~l~hp~f~~~~~~~~~  346 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGLTPEERS  346 (355)
T ss_dssp             TSCCHHHHTTSGGGGGCCHHHHC
T ss_pred             hCcCHHHHhcChhhcCCChhhcc
Confidence            99999999999997765555543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-45  Score=354.97  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=202.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CC-------cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DG-------TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      ++|...+.||+|+||+||+|.+. ++       ..||+|+++..  .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            57888999999999999999865 34       57999998654  2445678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc--------eE
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR--------AK  278 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~--------vk  278 (443)
                      ..++||||+.|++|.+++... ...+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.        +|
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999753 345899999999999999999999   788999999999999998887        99


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCC-CCCCCchhHHHHHHHHH
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGR-RPIEPKRELKERITVKW  356 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~-~Pf~~~~~~~~~~~~~~  356 (443)
                      |+|||++......        ....||+.|+|||++.+ ..++.++|||||||++|+|++|. +||........ .....
T Consensus       162 l~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~  232 (289)
T 4fvq_A          162 LSDPGISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYE  232 (289)
T ss_dssp             ECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHH
T ss_pred             eccCcccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhh
Confidence            9999998655332        23458899999999987 67899999999999999999955 55544333221 11111


Q ss_pred             HhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       357 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ....+         ...         .+.++.+|+.+||+.||.+||++.+++++|..+..
T Consensus       233 ~~~~~---------~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 DRHQL---------PAP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             TTCCC---------CCC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ccCCC---------CCC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            00000         000         12458899999999999999999999999988754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-45  Score=381.01  Aligned_cols=257  Identities=28%  Similarity=0.397  Sum_probs=213.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|...++||+|+||.||+|.++ ++..||||+++..   ....+.+.+|+.+|+.++|||||++++++.+.+..++|||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            45777789999999999999987 4889999999764   3346789999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+|+|.+++.......+++..++.|+.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++...... 
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            999999999998766667999999999999999999999   7889999999999999999999999999998764322 


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                        ........+++.|+|||++.+..++.++|||||||+||||++ |..||...........+.   ...    ...    
T Consensus       373 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~----~~~----  439 (495)
T 1opk_A          373 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDY----RME----  439 (495)
T ss_dssp             --EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTC----CCC----
T ss_pred             --eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCC----CCC----
Confidence              112233457789999999998899999999999999999999 999998765332111111   110    000    


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       .     ...+++.+.+|+.+||+.||.+||++.+|++.|..+..
T Consensus       440 -~-----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          440 -R-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -C-----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             0     11234679999999999999999999999999987643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.8e-45  Score=354.25  Aligned_cols=268  Identities=24%  Similarity=0.374  Sum_probs=203.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+|++.+.||+|+||.||+|... +|+.||||+++... ........+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            57899999999999999999975 79999999987532 23445567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||+.+++|.+++...  ....+++..++.++.||+.||.|||   .++|+|+||||+|||++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999998643  3566899999999999999999999   78899999999999999999999999999876543


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ...    ......|++.|+|||++.+..++.++|||||||++|+|++|..||.............     ..........
T Consensus       189 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~  259 (310)
T 2wqm_A          189 KTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-----IEQCDYPPLP  259 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH-----HHTTCSCCCC
T ss_pred             CCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH-----hhcccCCCCc
Confidence            321    1234568999999999998899999999999999999999999997543211111111     1111111100


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                               ....++.+.+|+.+||..||.+||++.++++++..+.....+..
T Consensus       260 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          260 ---------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             ---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             ---------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence                     01133679999999999999999999999999999987776644

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-45  Score=355.78  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=207.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|.+.+.||+|+||.||+|... +|+.||||+++...  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            357889999999999999999986 79999999987542  223456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~  289 (443)
                      ||+.+++|.+++...  ..+++..++.++.||+.||.|||   .+||+||||||+|||+   +.++.+||+|||++....
T Consensus        86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999998743  46899999999999999999999   7889999999999999   788899999999987544


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ..      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..   ....     .
T Consensus       161 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~---~~~~-----~  226 (304)
T 2jam_A          161 NG------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE---GYYE-----F  226 (304)
T ss_dssp             CB------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---CCCC-----C
T ss_pred             CC------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---CCCC-----C
Confidence            32      12334699999999999998999999999999999999999999987654322211111   0000     0


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..+      .....+..+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       227 ~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          227 ESP------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             CTT------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             Ccc------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence            000      0112346799999999999999999999999999953

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-46  Score=355.50  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=190.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|.+.+.||+|+||.||+|... +|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357889999999999999999975 799999999865432 223456789999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.+++|.+++.. ....+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            999999999999874 3356899999999999999999999   788999999999999999999999999999866432


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ..    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........       ......      +
T Consensus       166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~------~  228 (278)
T 3cok_A          166 HE----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVLA------D  228 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------C
T ss_pred             CC----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhhc------c
Confidence            21    122356999999999999888999999999999999999999999765321110       000000      0


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ....     ...+..+.+|+.+||+.||.+||++.++++|+|...
T Consensus       229 ~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          229 YEMP-----SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             CCCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             cCCc-----cccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence            0010     113367899999999999999999999999999653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-45  Score=366.63  Aligned_cols=275  Identities=17%  Similarity=0.250  Sum_probs=206.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcC------CcEEEEEEccccccCc---------ccHHHHHHHHHHHHhcCCcceeee
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDK---------HSGAEFQSEIRTLAQVEHLNLVKF  198 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~---------~~~~~~~~Ei~~l~~l~h~niv~l  198 (443)
                      .++|.+.+.||+|+||.||+|.+..      ++.||||++.......         .....+.+|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3579999999999999999998764      4789999976542100         011223455666777889999999


Q ss_pred             eeeeeec----CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--
Q 013401          199 HGYLEFE----DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT--  272 (443)
Q Consensus       199 ~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--  272 (443)
                      ++++...    ...++||||+ |++|.+++.. ....+++..++.|+.||+.||.|||   .++|+||||||+||||+  
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            9998775    4589999999 9999999975 3467999999999999999999999   78899999999999999  


Q ss_pred             CCCceEEeeecccccccccCCCccc---ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH
Q 013401          273 ENFRAKVADFGFARLAADTESGATH---VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK  349 (443)
Q Consensus       273 ~~~~vkl~DFGla~~~~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~  349 (443)
                      .++.+||+|||+++...........   ......||+.|+|||++.+..++.++|||||||+||||++|..||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999876544322111   1234569999999999999899999999999999999999999998543222


Q ss_pred             HHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      ........  ... .....+++..+..    ..+++++.+|+..||..||.+||++.+|++.|..+..+..
T Consensus       269 ~~~~~~~~--~~~-~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          269 KYVRDSKI--RYR-ENIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             HHHHHHHH--HHH-HCHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHH--Hhh-hhHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            11111110  000 0111111111110    1124679999999999999999999999999998776543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.2e-45  Score=358.24  Aligned_cols=266  Identities=24%  Similarity=0.368  Sum_probs=213.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CC-----cEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecC
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DG-----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFED  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g-----~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~  206 (443)
                      .++|...+.||+|+||.||+|.+. ++     ..||||.++... .......+.+|+.+|+.+ +||||+++++++.+.+
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            357889999999999999999875 23     479999987642 234456788999999999 8999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN  274 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~  274 (443)
                      ..++||||+++|+|.+++....            ...+++..++.++.||+.||.|||   .+||+||||||+||||+.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            9999999999999999996532            346899999999999999999999   7889999999999999999


Q ss_pred             CceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHH
Q 013401          275 FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERIT  353 (443)
Q Consensus       275 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~  353 (443)
                      +.+||+|||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CeEEECccccccccccccc--eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            9999999999986654321  112233457889999999998899999999999999999999 9999976543222111


Q ss_pred             HHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       354 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ...  ......      .        ....++.+.+|+.+||+.||.+||++.+++++|..+..+.+.
T Consensus       279 ~~~--~~~~~~------~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          279 LVK--DGYQMA------Q--------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             HHH--HTCCCC------C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHh--cCCCCC------C--------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            111  110000      0        001236789999999999999999999999999988766543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1e-45  Score=353.19  Aligned_cols=258  Identities=23%  Similarity=0.373  Sum_probs=209.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv  211 (443)
                      ++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++.+  .+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            57889999999999999999986 79999999998765555566789999999999999999999998754  6789999


Q ss_pred             EeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCCEEEcCCCceEEeeecc
Q 013401          212 VEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHP-----IIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      |||+++++|.+++...  ....+++..++.++.||+.||.|||   .++     |+||||||+|||++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999653  2345899999999999999999999   666     99999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +.......    .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.       .+
T Consensus       163 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-------~~  231 (279)
T 2w5a_A          163 ARILNHDT----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EG  231 (279)
T ss_dssp             HHHC---C----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HT
T ss_pred             heeecccc----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-------hc
Confidence            97654321    11223468999999999998889999999999999999999999998765432211111       11


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .... +.         ...+..+.+|+.+||+.||.+||++.+|++++|.-.
T Consensus       232 ~~~~-~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          232 KFRR-IP---------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             CCCC-CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             cccc-CC---------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            1100 00         113367999999999999999999999999998643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.2e-45  Score=354.89  Aligned_cols=269  Identities=27%  Similarity=0.422  Sum_probs=211.9

Q ss_pred             CCCCceeeeeCceEEEEEEEc-----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--CeEE
Q 013401          137 FSPSFKIGQGGFGTVYKGRLE-----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DERI  209 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~  209 (443)
                      |+..++||+|+||+||++..+     +++.||||+++.. ........+.+|+.+|+.++||||+++++++.+.  ..++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            488899999999999998642     6889999998765 2334456789999999999999999999999884  6789


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+++|.+++..   ..+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus       112 lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999999854   34899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH--------HHHHHHHhhhc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE--------RITVKWAMKKF  361 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~--------~~~~~~~~~~~  361 (443)
                      .... .........||+.|+|||++.+..++.++|||||||++|+|++|..||........        ...........
T Consensus       186 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHE-YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCS-EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccc-ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            4321 11223345688999999999988899999999999999999999999976532210        00111111111


Q ss_pred             CCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          362 SDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       362 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                      ..+....          ....++..+.+|+.+||+.||.+||++.++++.|..+...++...
T Consensus       265 ~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          265 ERGERLP----------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             hcccCCC----------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            1111000          011234679999999999999999999999999999988887643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.8e-45  Score=356.95  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=212.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      ++|.+.+.||+|+||.||+|.+.        ++..||||+++... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            57889999999999999999863        47789999987642 334456788999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQG--------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +..++||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||   .++|+||||||+||||
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999975431              34889999999999999999999   7889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||++........  ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            9999999999999986654321  112233457889999999988889999999999999999999 9999987643322


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ...+..   .    ....     .     ...++..+.+|+.+||+.||.+||++.+++++|..+......
T Consensus       269 ~~~~~~---~----~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          269 FKLLKE---G----HRMD-----K-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             HHHHHH---T----CCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             HHHHhc---C----CCCC-----C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            111111   0    0000     0     011336799999999999999999999999999988665443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.6e-45  Score=351.17  Aligned_cols=266  Identities=26%  Similarity=0.403  Sum_probs=208.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec--Ce
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE--DE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~  207 (443)
                      +.|+..+.||+|+||.||+|.+     .+++.||||+++... .......+.+|+.+|+.++||||+++++++.+.  ..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4588889999999999999983     368999999987653 344567889999999999999999999999876  67


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +++||||+.+++|.+++.. ....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++..
T Consensus       100 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            8999999999999999965 3456899999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH--------HHHHHHhh
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER--------ITVKWAMK  359 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~--------~~~~~~~~  359 (443)
                      ...... .........||..|+|||++.+..++.++|||||||++|+|++|..|+.........        ........
T Consensus       176 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          176 IETDKE-YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             CCTTCC-EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             ccCCCc-ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            654321 112234456899999999999888999999999999999999999987543221100        01111111


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ....+....          .....++.+.+|+.+||+.||.+||++.++++.|..+.
T Consensus       255 ~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEGKRLP----------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCCCC----------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111111000          01123467999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.7e-45  Score=349.56  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=210.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||.||+|... +++.||||+++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            357889999999999999999986 799999999875432 334577889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++.  ....+++..++.++.||+.||.|||   ++||+|+||||+|||++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           85 EYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             ECCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999999886  3456899999999999999999999   7889999999999999999999999999997654322


Q ss_pred             CCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .  ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... ..+.....       ...
T Consensus       160 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~-------~~~  229 (276)
T 2yex_A          160 R--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKKT-------YLN  229 (276)
T ss_dssp             E--ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-HHHHTTCT-------TST
T ss_pred             c--hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHhhhccc-------ccC
Confidence            1  112334579999999999987665 678999999999999999999998654322111 11111000       000


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +       ....+..+.+|+.+||+.||.+||++.++++|.|.-
T Consensus       230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (276)
T 2yex_A          230 P-------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (276)
T ss_dssp             T-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             c-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence            0       112346789999999999999999999999999953

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.9e-46  Score=355.09  Aligned_cols=260  Identities=22%  Similarity=0.349  Sum_probs=194.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++...........+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            357899999999999999999975 7999999998765433333344455555678889999999999999999999999


Q ss_pred             eecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDH-PIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      ||++ |+|.+++...  .+..+++..++.|+.||+.||.|||   .+ ||+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5888877542  4567999999999999999999999   66 89999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCcccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYL----KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ....     .....||+.|+|||++    .+..++.++|||||||++|+|++|..||..............  ...    
T Consensus       162 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~----  230 (290)
T 3fme_A          162 DDVA-----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--EEP----  230 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH--HSC----
T ss_pred             cccc-----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh--ccC----
Confidence            4321     2234699999999996    556788999999999999999999999976433222111111  110    


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .....         ....+..+.+|+.+||+.||.+|||+.++++|+|.-..
T Consensus       231 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          231 SPQLP---------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CCCCC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCcc---------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            00000         01123679999999999999999999999999997543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-45  Score=376.94  Aligned_cols=257  Identities=31%  Similarity=0.448  Sum_probs=206.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .++|...++||+|+||.||+|.++++..||||+++...   ...+.+.+|+.+|+.++||||+++++++.+ +..++|||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            35688888999999999999999888889999998643   345689999999999999999999999876 77899999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+|+|.+++....+..+++..++.++.||+.||.|||   .++|+||||||+||||+.++.+||+|||+++.......
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999999999997655567899999999999999999999   78899999999999999999999999999987654321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                         .......+++.|+|||++.+..++.++|||||||+||||++ |..||...........+.       .+....    
T Consensus       336 ---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~~~----  401 (452)
T 1fmk_A          336 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMP----  401 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCC----
T ss_pred             ---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC----
Confidence               11223457889999999998899999999999999999999 999998765432211111       111000    


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                       .     ...+++.+.+|+.+||+.||++|||+.+|++.|..+..
T Consensus       402 -~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          402 -C-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence             0     11234679999999999999999999999999987653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3e-45  Score=363.61  Aligned_cols=280  Identities=21%  Similarity=0.239  Sum_probs=208.2

Q ss_pred             CHHHHHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCc---------ccHHHHHHHHHHHHhcCCccee
Q 013401          126 TMEEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK---------HSGAEFQSEIRTLAQVEHLNLV  196 (443)
Q Consensus       126 ~~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---------~~~~~~~~Ei~~l~~l~h~niv  196 (443)
                      .+.++....++|.+.+.||+|+||.||+|.+.+|+.||||++.......         .....+.+|+.+|+.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3566777889999999999999999999998889999999986543222         1236789999999999999999


Q ss_pred             eeeeeeee-----cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          197 KFHGYLEF-----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       197 ~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      ++++++..     ...+++||||+. |+|.+++.. ....+++..++.|+.||+.||.|||   .+||+||||||+||||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            99999854     336899999997 688888864 3457899999999999999999999   7889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||++.......     ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             CTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cCCCCEEEEecCccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999997544322     2234569999999999876 6789999999999999999999999987665433


Q ss_pred             HHHHHHHhhhcCCCc--------cccc----cC--ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          351 RITVKWAMKKFSDGD--------AISI----LD--PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~--------~~~~----~d--~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...+...........        ....    ..  +..............+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  321 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE  321 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence            322221111000000        0000    00  00000111112346799999999999999999999999999953

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=355.18  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=203.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeee------
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEF------  204 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~------  204 (443)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...   ......+.+|+.+++.+ +||||+++++++..      
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC---cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            3467999999999999999999985 7999999998754   33456788999999999 79999999999987      


Q ss_pred             cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          205 EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      .+..++||||+.+++|.+++.......+++..++.++.||+.||.|||   .+||+|+||||+|||++.++.+||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            568899999999999999998655567999999999999999999999   78899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      +........    ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+.    
T Consensus       176 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----  247 (326)
T 2x7f_A          176 SAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP----  247 (326)
T ss_dssp             TC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----
T ss_pred             ceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh----
Confidence            876543211    123456999999999986     5578899999999999999999999998765433222111    


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..   ........         ..+..+.+|+.+||..||.+||++.++++|+|.-
T Consensus       248 ~~---~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          248 RN---PAPRLKSK---------KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             HS---CCCCCSCS---------CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             cC---ccccCCcc---------ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            10   00001111         1236799999999999999999999999999954

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.2e-45  Score=349.18  Aligned_cols=252  Identities=22%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57889999999999999999987 799999999865432 2344567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++...  ..+++..++.++.||+.||.|||   .++|+|+||||+|||++.++.+||+|||++.......
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999999753  46899999999999999999999   7789999999999999999999999999997765432


Q ss_pred             CCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                           ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..   ...     . +.
T Consensus       166 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~-----~-~~  231 (276)
T 2h6d_A          166 -----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG---GVF-----Y-IP  231 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCC-----C-CC
T ss_pred             -----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---Ccc-----c-Cc
Confidence                 1234468999999999987665 5799999999999999999999987543322111111   000     0 00


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                               ......+.+|+.+||+.||.+||++.++++|.|.
T Consensus       232 ---------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~  265 (276)
T 2h6d_A          232 ---------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF  265 (276)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             ---------hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence                     0123568999999999999999999999999995

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=354.64  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=202.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++.+.||+|+||+||+|.+. ++.||||++..    ......+.+|+.+|+.++||||+++++++.  +..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEc
Confidence            46888899999999999999886 78899999864    234567899999999999999999999886  458999999


Q ss_pred             cCCCcHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc-eEEeeecccccccccC
Q 013401          215 VPNGTLREHLDCLQG-NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR-AKVADFGFARLAADTE  292 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~-vkl~DFGla~~~~~~~  292 (443)
                      ++|++|.+++..... ..+++..++.++.||+.||.|||..+.++|+||||||+|||++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999974322 23678889999999999999999433388999999999999998886 799999999755432 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ..+....   +.....   
T Consensus       160 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~---~~~~~~---  225 (307)
T 2eva_A          160 ------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN---GTRPPL---  225 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHHT---TCCCCC---
T ss_pred             ------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHhc---CCCCCc---
Confidence                  22345999999999999989999999999999999999999999754322111  1111111   111110   


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                             ....+..+.+|+.+||+.||.+||++.+++++|..+...+...
T Consensus       226 -------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          226 -------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             -------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             -------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence                   0112367899999999999999999999999999988776553

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=355.24  Aligned_cols=266  Identities=27%  Similarity=0.436  Sum_probs=207.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC-----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED-----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|...+.||+|+||.||+|.+..     +..||||+++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            356677899999999999998652     3469999987542 3344567889999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+++|.+++.. ....+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++....
T Consensus       123 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999975 3457899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+....
T Consensus       199 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-------~~~~~~  270 (333)
T 1mqb_A          199 DDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------DGFRLP  270 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCCCC
T ss_pred             ccccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------CCCcCC
Confidence            43211 111223346889999999998899999999999999999999 999997665432211111       110000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA  423 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~~  423 (443)
                      .          ...++..+.+|+.+||+.||.+||++.+++++|..+........
T Consensus       271 ~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~  315 (333)
T 1mqb_A          271 T----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK  315 (333)
T ss_dssp             C----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred             C----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence            0          01133679999999999999999999999999998877665543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.2e-45  Score=363.31  Aligned_cols=274  Identities=22%  Similarity=0.277  Sum_probs=210.5

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----C
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----D  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~  206 (443)
                      ...+|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|+.++||||+++++++...     .
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            3468999999999999999999976 78999999987532 234456788999999999999999999998765     3


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ..++||||+. ++|.+++..   ..+++..++.|+.||+.||.|||   ++||+||||||+||||+.++.+||+|||++.
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            6899999996 589998853   45899999999999999999999   7889999999999999999999999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ........ .......+||+.|+|||++. +..++.++|||||||++|+|++|.+||...........+...........
T Consensus       177 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          177 VADPDHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             ECCGGGCB-CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             ecCCCCCc-cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            76543221 11234467999999999875 44589999999999999999999999987765443333221111111000


Q ss_pred             ccccc-------------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          366 AISIL-------------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       366 ~~~~~-------------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .....             ................+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            00000             000000001112346799999999999999999999999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-44  Score=363.11  Aligned_cols=266  Identities=21%  Similarity=0.270  Sum_probs=203.6

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-------
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-------  204 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-------  204 (443)
                      ..++|.+.+.||+|+||+||+|.+. +|+.||||++......      ..+|+.+|+.++|||||++++++..       
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            4568999999999999999999975 7999999998654221      2379999999999999999999844       


Q ss_pred             -------------------------------cCeEEEEEeecCCCcHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHH
Q 013401          205 -------------------------------EDERIVIVEYVPNGTLREHLDC--LQGNILDLAGRLDIAIDVAHAITYL  251 (443)
Q Consensus       205 -------------------------------~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~L  251 (443)
                                                     ...+++||||+. ++|.+.+..  ..+..+++..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 588777753  2456799999999999999999999


Q ss_pred             hhcCCCCeEecCCCCCCEEEc-CCCceEEeeecccccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHH
Q 013401          252 HMYTDHPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFG  329 (443)
Q Consensus       252 H~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlG  329 (443)
                      |   ++||+||||||+|||++ .++.+||+|||+++.......     .....||+.|+|||++.+. .++.++||||||
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-----CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            9   88999999999999998 688999999999987654332     2345689999999998764 589999999999


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc------------CCCccccccCccccchhhcHHHHHHHHHHHHHccCC
Q 013401          330 VLLVELVTGRRPIEPKRELKERITVKWAMKKF------------SDGDAISILDPRVENTAANNLALEKILELALQCLAP  397 (443)
Q Consensus       330 vll~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~  397 (443)
                      |++|+|++|.+||...........+.......            .+........... ........+..+.+|+.+||+.
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW-RKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH-HHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH-HhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999998876554433322111110            0000000000000 0001112346799999999999


Q ss_pred             CCCCCCCHHHHHHHHHh
Q 013401          398 RRQNRPSMRRCAEILWS  414 (443)
Q Consensus       398 dp~~RPs~~ell~~l~~  414 (443)
                      ||.+|||+.++++|+|.
T Consensus       309 dP~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          309 EPDLRINPYEAMAHPFF  325 (383)
T ss_dssp             SGGGSCCHHHHHTSGGG
T ss_pred             ChhhCCCHHHHhcCHHH
Confidence            99999999999999995

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=349.24  Aligned_cols=263  Identities=25%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-C---CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE-EE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-D---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER-IV  210 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-~l  210 (443)
                      .|...+.||+|+||+||+|.+. +   +..||||+++.. ......+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            4555678999999999999854 2   337999998753 2334557788999999999999999999999876665 99


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.+++|.+++.. ....+++..++.|+.||+.||.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus       101 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999975 3566889999999999999999999   78899999999999999999999999999986654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR-RPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      .............||+.|+|||++.+..++.++|||||||++|+|++|. +||...........+..       +.... 
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-------~~~~~-  248 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-------GRRLP-  248 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-------TCCCC-
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-------CCCCC-
Confidence            4322222334456899999999999999999999999999999999955 44544433221111111       00000 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                          .     ....++.+.+|+.+||+.||.+|||+.++++.|..+...+.
T Consensus       249 ----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          249 ----Q-----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ----C-----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                0     01123679999999999999999999999999998876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=367.02  Aligned_cols=264  Identities=28%  Similarity=0.448  Sum_probs=199.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc--C--CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeee-ecCeEEE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE--D--GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLE-FEDERIV  210 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~l  210 (443)
                      .|...+.||+|+||+||+|.+.  +  +..||||.++.. ........+.+|+.+++.++||||+++++++. .++..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            4666778999999999999864  2  246899988753 23445678999999999999999999999865 4568899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.+|+|.+++.. ....+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++....
T Consensus       169 v~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            9999999999999964 3456888899999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      .............||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+.       .+...  
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~~~~~--  315 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRRL--  315 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------TTCCC--
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------cCCCC--
Confidence            33222222334568889999999999899999999999999999999 778887654322211111       11100  


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      ..        ...++..+.+|+.+||+.||++||++.+++++|..+...+..
T Consensus       316 ~~--------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          316 LQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             CC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             CC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence            00        011336799999999999999999999999999998877654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=352.50  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=207.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...    .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            457999999999999999999986 6999999998753    23467889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++.. ....+++..++.++.||+.||.|||   .+|++|+||||+|||++.++.+||+|||++.......
T Consensus       104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999999864 3567899999999999999999999   7889999999999999999999999999997665432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............    .....        
T Consensus       180 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~--------  243 (314)
T 3com_A          180 A----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP----TNPPP--------  243 (314)
T ss_dssp             S----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HSCCC--------
T ss_pred             c----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----cCCCc--------
Confidence            1    1234569999999999998899999999999999999999999998765433221111    11000        


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ....   ....+..+.+|+.+||..||.+||++.++++|.|.-.
T Consensus       244 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          244 TFRK---PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             CCSS---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             ccCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence            0000   1112367999999999999999999999999999643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=360.05  Aligned_cols=268  Identities=16%  Similarity=0.208  Sum_probs=209.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC---------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceee--------
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED---------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK--------  197 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~--------  197 (443)
                      ++|.+.+.||+|+||.||+|.+..         ++.||||++...       ..+.+|+.+++.++||||++        
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            579999999999999999999763         789999998753       35779999999999999988        


Q ss_pred             -------eeeeeee-cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCE
Q 013401          198 -------FHGYLEF-EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNI  269 (443)
Q Consensus       198 -------l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NI  269 (443)
                             +++++.. .+..++||||+ +++|.+++.......+++..++.|+.||+.||.|||   +++|+||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence                   5666665 67889999999 999999998654567999999999999999999999   78899999999999


Q ss_pred             EEcCCC--ceEEeeecccccccccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 013401          270 LLTENF--RAKVADFGFARLAADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP  344 (443)
Q Consensus       270 Ll~~~~--~vkl~DFGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~  344 (443)
                      |++.++  .+||+|||+++..........   .......||+.|+|||++.+..++.++|||||||+||+|++|..||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  899999999987654332111   112345799999999999998999999999999999999999999986


Q ss_pred             chhHHHH-HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          345 KRELKER-ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       345 ~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      .....+. ...........    ....+....    ....+..+.+|+.+||+.||.+||++.+|++.|..+..+.+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKP----GPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSC----CCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CCcCHHHHHHHHHhccCCh----hhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            5422111 11111111100    011111000    011236799999999999999999999999999988776653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9e-45  Score=352.83  Aligned_cols=266  Identities=23%  Similarity=0.337  Sum_probs=203.6

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC--
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED--  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--  206 (443)
                      ..++|.+.+.||+|+||.||+|.+.    ++..||||+++...........+.+|+.+++.++||||+++++++.+.+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4467888899999999999999864    3558999999876555555677899999999999999999999988765  


Q ss_pred             ---eEEEEEeecCCCcHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEE
Q 013401          207 ---ERIVIVEYVPNGTLREHLDCL----QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       207 ---~~~lv~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl  279 (443)
                         ..++||||+.+++|.+++...    ....+++..++.|+.||+.||.|||   .++|+||||||+|||++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               359999999999999998532    3456899999999999999999999   889999999999999999999999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHh
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      +|||++........  ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.............   
T Consensus       189 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---  263 (313)
T 3brb_A          189 ADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL---  263 (313)
T ss_dssp             CSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred             eecCcceecccccc--cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH---
Confidence            99999986644321  112233457889999999999899999999999999999999 899997665432211111   


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      .    +.....          ...+++.+.+|+.+||..||.+||++.+++++|..+.....
T Consensus       264 ~----~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          264 H----GHRLKQ----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             T----TCCCCC----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             c----CCCCCC----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            1    100000          01233679999999999999999999999999998876554

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.1e-45  Score=355.12  Aligned_cols=271  Identities=25%  Similarity=0.352  Sum_probs=213.5

Q ss_pred             HHHHHHHhcCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeee
Q 013401          127 MEEIYRATRNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH  199 (443)
Q Consensus       127 ~~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~  199 (443)
                      ..+.....++|.+.+.||+|+||.||+|.+      .+++.||||+++... .......+.+|+.++..+ +||||++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            333434457899999999999999999984      257899999987642 233456788999999999 699999999


Q ss_pred             eeeeecC-eEEEEEeecCCCcHHHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 013401          200 GYLEFED-ERIVIVEYVPNGTLREHLDCLQG--------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDI  264 (443)
Q Consensus       200 ~~~~~~~-~~~lv~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl  264 (443)
                      +++...+ ..++||||+.+++|.+++.....              ..+++..++.++.||+.||.|||   .++|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9987755 48999999999999999975432              12788999999999999999999   788999999


Q ss_pred             CCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 013401          265 KSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE  343 (443)
Q Consensus       265 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~  343 (443)
                      ||+|||++.++.+||+|||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccceEEECCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999986644321  112234568899999999998899999999999999999998 999997


Q ss_pred             CchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          344 PKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .............  .    +....     .     ....+..+.+++.+||+.||.+||++.+++++|..+....
T Consensus       253 ~~~~~~~~~~~~~--~----~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          253 GVKIDEEFCRRLK--E----GTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             TCCCSHHHHHHHH--H----TCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHhc--c----CccCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            6543222111110  0    00000     0     0112357999999999999999999999999999886543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=366.26  Aligned_cols=274  Identities=22%  Similarity=0.271  Sum_probs=212.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC--eEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED--ERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv  211 (443)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||+++.... ......+.+|+.+|+.++||||+++++++.+.+  ..++|
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            57889999999999999999987 599999999876432 334567889999999999999999999998765  78999


Q ss_pred             EeecCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCceEEeeecccc
Q 013401          212 VEYVPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL----TENFRAKVADFGFAR  286 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~  286 (443)
                      |||+.||+|.+++.... ...+++..++.|+.||+.||.|||   ++||+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999997543 233899999999999999999999   7889999999999999    777889999999998


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc--------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH-HHHHHH
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT--------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER-ITVKWA  357 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~-~~~~~~  357 (443)
                      ......     ......||+.|+|||++.+        ..++.++|||||||++|||++|..||......... ......
T Consensus       165 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          165 ELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             ECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             EccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            765432     2234569999999999865        56788999999999999999999999653321111 111111


Q ss_pred             hhhcCCCcc----------ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          358 MKKFSDGDA----------ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       358 ~~~~~~~~~----------~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .........          ..+.................+.+|+.+||+.||++||++.++++.+..+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            111111110          000000011112235567889999999999999999999999999987653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.1e-46  Score=374.58  Aligned_cols=247  Identities=14%  Similarity=0.145  Sum_probs=193.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHH---HHHhcCCcceeeee-------eee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIR---TLAQVEHLNLVKFH-------GYL  202 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~---~l~~l~h~niv~l~-------~~~  202 (443)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||+++... ......+.+.+|+.   +|+.++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            57888899999999999999964 79999999987542 23445677889994   55556899999998       555


Q ss_pred             eecC-----------------eEEEEEeecCCCcHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 013401          203 EFED-----------------ERIVIVEYVPNGTLREHLDCLQG-----NILDLAGRLDIAIDVAHAITYLHMYTDHPII  260 (443)
Q Consensus       203 ~~~~-----------------~~~lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  260 (443)
                      .+.+                 ..++||||+ +|+|.+++.....     ..+++..++.|+.||+.||.|||   ++||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            5543                 278999999 6899999975421     12234778889999999999999   78899


Q ss_pred             ecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccC-----------CCCCchhHHHHH
Q 013401          261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-----------QLTEKSDVYSFG  329 (443)
Q Consensus       261 HrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~sDiwSlG  329 (443)
                      ||||||+||||+.++.+||+|||+++....       .....+| +.|+|||++.+.           .++.++||||||
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            999999999999999999999999985332       2334568 999999999887           899999999999


Q ss_pred             HHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 013401          330 VLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCA  409 (443)
Q Consensus       330 vll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell  409 (443)
                      |+||||++|..||.........               ..+....       ...++.+.+|+.+||+.||.+||++.+++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~---------------~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGS---------------EWIFRSC-------KNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHHSSCCC------CCS---------------GGGGSSC-------CCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccch---------------hhhhhhc-------cCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            9999999999999754321110               0000000       11236799999999999999999999999


Q ss_pred             HHHHhh
Q 013401          410 EILWSV  415 (443)
Q Consensus       410 ~~l~~i  415 (443)
                      +|+|.-
T Consensus       359 ~hp~f~  364 (377)
T 3byv_A          359 ETPEYE  364 (377)
T ss_dssp             TSHHHH
T ss_pred             hChHHH
Confidence            999964

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-44  Score=345.83  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=209.1

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .++|...+.||+|+||+||+|.+..    +..||||.++... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            3578889999999999999998642    3469999987642 33455778999999999999999999999864 4578


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+++|.+++.. ....+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999999975 3456899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....   .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..       +....
T Consensus       165 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-------~~~~~  234 (281)
T 3cc6_A          165 DEDY---YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-------GDRLP  234 (281)
T ss_dssp             -----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-------TCCCC
T ss_pred             cccc---cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-------CCCCC
Confidence            4321   11233457889999999998899999999999999999998 9999975543322111111       00000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      .          ....++.+.+|+.+||..||.+||++.+++++|..+....++.
T Consensus       235 ~----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i  278 (281)
T 3cc6_A          235 K----------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI  278 (281)
T ss_dssp             C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred             C----------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhh
Confidence            0          0112367999999999999999999999999999987766553

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=355.14  Aligned_cols=262  Identities=23%  Similarity=0.371  Sum_probs=203.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEE----EEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIV----AIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~v----avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|++.+.||+|+||.||+|.+. +++.|    |+|.+... ........+.+|+.+++.++||||+++++++...+ .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            57999999999999999999975 45544    66665443 23455678999999999999999999999998654 88


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|+|++.+|+|.+++... ...+++..++.|+.||+.||.|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999999753 456899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..       +....
T Consensus       169 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-------~~~~~  239 (327)
T 3lzb_A          169 AEEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GERLP  239 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCCCC
T ss_pred             Ccccc--ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence            43221  12233457889999999999999999999999999999999 9999987654332111111       00000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                       .         ...++..+.+|+.+||+.||.+||++.++++.|..+..+...
T Consensus       240 -~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  282 (327)
T 3lzb_A          240 -Q---------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             -C---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             -C---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence             0         011235799999999999999999999999999998766544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.4e-45  Score=367.85  Aligned_cols=265  Identities=21%  Similarity=0.293  Sum_probs=201.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------Ce
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------DE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~  207 (443)
                      .+|...+.||+|+||.||+|.+. +|+.||||++.....      .+.+|+++|+.++|||||++++++...      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            46888999999999999999986 699999999865421      223799999999999999999988542      23


Q ss_pred             EEEEEeecCCCcHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-CceEEeeecc
Q 013401          208 RIVIVEYVPNGTLREHLDC--LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-FRAKVADFGF  284 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-~~vkl~DFGl  284 (443)
                      +++||||+.+ +|.+.+..  .....+++..++.++.||+.||.|||   ++||+||||||+||||+.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence            6789999975 66665543  24567999999999999999999999   8899999999999999955 6789999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC-
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS-  362 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-  362 (443)
                      ++.......     ....+||+.|+|||++.+. .++.++|||||||+||||++|.+||...........+........ 
T Consensus       204 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          204 AKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR  278 (420)
T ss_dssp             CEECCTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             hhhcccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            987654322     2345799999999999764 799999999999999999999999988765443333222111000 


Q ss_pred             ------CCccccccCccccchhh----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          363 ------DGDAISILDPRVENTAA----NNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       363 ------~~~~~~~~d~~~~~~~~----~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                            ........-+.+.....    ....+.++.+|+.+||+.||.+||++.++++|+|.
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence                  00000000011110000    11234679999999999999999999999999996

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-45  Score=353.83  Aligned_cols=268  Identities=20%  Similarity=0.249  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|.+.+.||+|+||.||+|.+. +++.||||+++..... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            368999999999999999999976 7899999998765332 23346788999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999743  56899999999999999999999   788999999999999999999999999999766543


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ..   .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.   ....   ......
T Consensus       188 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~---~~~~~~  258 (309)
T 2h34_A          188 KL---TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---QAIP---RPSTVR  258 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---SCCC---CGGGTS
T ss_pred             cc---ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---cCCC---CccccC
Confidence            21   12234569999999999998899999999999999999999999998765431111111   0000   000111


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhhhhhhhhhc
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRP-SMRRCAEILWSVRKDYRELAA  424 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~ell~~l~~i~~~~~~~~~  424 (443)
                               ...+..+.+|+.+||+.||++|| +++++++.+..+........+
T Consensus       259 ---------~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~  303 (309)
T 2h34_A          259 ---------PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA  303 (309)
T ss_dssp             ---------TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-------
T ss_pred             ---------CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccch
Confidence                     12335689999999999999999 999999999887666554443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-44  Score=354.62  Aligned_cols=263  Identities=18%  Similarity=0.278  Sum_probs=203.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeeeeee--cCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEF--EDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~l  210 (443)
                      ++|++.+.||+|+||+||+|.+. +++.||||+++..     ....+.+|+.+|+.++ ||||+++++++.+  ....++
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            57899999999999999999875 7999999998642     3467889999999997 9999999999988  667899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeeccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFARLAA  289 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~  289 (443)
                      ||||+.+++|.+++.     .+++..++.++.||+.||.|||   ++||+||||||+||||+.++ .+||+|||++....
T Consensus       111 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            999999999998874     3888999999999999999999   78899999999999999776 89999999998765


Q ss_pred             ccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-HH----------HH
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT-VK----------WA  357 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~-~~----------~~  357 (443)
                      ....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......+.+. +.          +.
T Consensus       183 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCC-----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             CCCc-----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence            4322     234569999999999976 6789999999999999999999999954432211111 00          00


Q ss_pred             hhhcC--CCccccccCc-------cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          358 MKKFS--DGDAISILDP-------RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       358 ~~~~~--~~~~~~~~d~-------~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .....  .......+..       ...........+..+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence            00000  0000000000       0000011122457799999999999999999999999999964

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.5e-44  Score=353.83  Aligned_cols=261  Identities=30%  Similarity=0.433  Sum_probs=208.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEE--EEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIV--AIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~v--avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|...+.||+|+||.||+|.+. ++..+  |||+++.. ........+.+|+.+|+.+ +||||+++++++.+.+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            57899999999999999999875 56654  99988653 2334456788999999999 89999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013401          211 IVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR  276 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~  276 (443)
                      ||||+++++|.+++....              ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999997532              346899999999999999999999   788999999999999999999


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVK  355 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~  355 (443)
                      +||+|||++.......     ......+++.|+|||++.+..++.++|||||||++|+|++ |..||..........   
T Consensus       181 ~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~---  252 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE---  252 (327)
T ss_dssp             EEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---
T ss_pred             EEEcccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH---
Confidence            9999999987443221     1223457889999999998889999999999999999998 999998765432111   


Q ss_pred             HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          356 WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                          .+..+....     .     ....++.+.+|+.+||+.||.+||++.+++++|..+..+.+.
T Consensus       253 ----~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          253 ----KLPQGYRLE-----K-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             ----HGGGTCCCC-----C-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             ----HhhcCCCCC-----C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                111110000     0     011236799999999999999999999999999988776544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-44  Score=361.55  Aligned_cols=266  Identities=19%  Similarity=0.292  Sum_probs=206.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE----
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER----  208 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~----  208 (443)
                      .++|...+.||+|+||.||+|.+. +|+.||||+++...........+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999976 699999999987655555567888999999999999999999999877765    


Q ss_pred             --EEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          209 --IVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       209 --~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                        ++||||+. ++|.+++.    ..+++..++.++.||+.||.|||   .+||+||||||+||||+.++.+||+|||++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999996 68877663    34899999999999999999999   7889999999999999999999999999997


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .....       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......... .
T Consensus       193 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~-~  264 (371)
T 4exu_A          193 HADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT-E  264 (371)
T ss_dssp             --------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH-H
T ss_pred             ccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH-H
Confidence            65432       234568999999999977 68899999999999999999999999877654433222211110000 0


Q ss_pred             cccccC--------------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          366 AISILD--------------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       366 ~~~~~d--------------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ....+.              +..............+.+|+.+||+.||.+|||+.++++|+|.-
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence            000000              00000001112346799999999999999999999999999964

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-44  Score=347.20  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=208.4

Q ss_pred             cCCCCCc-eeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSF-KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|.+.. .||+|+||.||+|.+.   +++.||||+++...........+.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5677777 8999999999999642   478999999987654455567899999999999999999999998 6678899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.+++|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999999974  456899999999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      .... ........|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.       .+.....
T Consensus       170 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~~  241 (291)
T 1xbb_A          170 DENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGC  241 (291)
T ss_dssp             TCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCCC
T ss_pred             CCCc-ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCCC
Confidence            3221 111223457789999999988889999999999999999999 999998765432211111       1111000


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                                ...+++.+.+|+.+||+.||.+||++.++++.|..+-.....
T Consensus       242 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          242 ----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             ----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence                      012346799999999999999999999999999887554433

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=346.43  Aligned_cols=258  Identities=23%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      +|.....||+|+||.||+|.+. +++.||||.++..  .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            4556668999999999999975 6899999998754  234457789999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeecccccccccC
Q 013401          215 VPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFARLAADTE  292 (443)
Q Consensus       215 ~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~  292 (443)
                      +++++|.+++.... ...+++..++.++.||+.||.|||   .+||+|+||||+|||++. ++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999997542 235678888899999999999999   788999999999999987 8999999999998664322


Q ss_pred             CCcccccccccCCCCccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQ--LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      .    ......||+.|+|||++.+..  ++.++|||||||++|+|++|..||............. .....         
T Consensus       178 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~---------  243 (295)
T 2clq_A          178 P----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKV---------  243 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHCC---------
T ss_pred             C----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-ccccc---------
Confidence            1    123456999999999997643  7889999999999999999999997543322111111 00000         


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .+.+.     ...+..+.+|+.+||+.||++||++.++++|.|.-..
T Consensus       244 ~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          244 HPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             CCCCC-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             ccccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            01111     1123678999999999999999999999999996543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-45  Score=368.02  Aligned_cols=263  Identities=10%  Similarity=0.048  Sum_probs=190.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhc--CCcceeeee-------eeee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQV--EHLNLVKFH-------GYLE  203 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~~~  203 (443)
                      .+|...+.||+|+||+||+|.+. +|+.||||+++.... .......+.+|+.+++.|  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888899999999999999976 799999999987543 233455677885555544  699988755       4443


Q ss_pred             ec-----------------CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeE
Q 013401          204 FE-----------------DERIVIVEYVPNGTLREHLDCLQGNILDLAGR------LDIAIDVAHAITYLHMYTDHPII  260 (443)
Q Consensus       204 ~~-----------------~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~iv  260 (443)
                      ..                 ..+++||||+. |+|.+++.... ..+++..+      +.++.||+.||.|||   ++|||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            33                 34899999998 89999997643 34566666      788899999999999   78899


Q ss_pred             ecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcC
Q 013401          261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTG  338 (443)
Q Consensus       261 HrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG  338 (443)
                      ||||||+||||+.++.+||+|||+++.....       .....||+.|+|||++.+  ..++.++|||||||+||+|++|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999866432       113457799999999987  6899999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          339 RRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       339 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ..||.........        .+................ .....++.+.+|+.+||+.||++||++.++++|+|.-...
T Consensus       290 ~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          290 FLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             SCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CCCCCCcCccccc--------chhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            9999766332100        000000000000011000 0112346799999999999999999999999999965443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.3e-45  Score=355.19  Aligned_cols=259  Identities=25%  Similarity=0.361  Sum_probs=201.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC------cccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD------KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++......      ......+.+|+.+|+.++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            457999999999999999999976 6899999998754321      122345789999999999999999999987655


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---eEEeeec
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFG  283 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---vkl~DFG  283 (443)
                       .++||||+.+++|.+++.  ....+++..++.++.||+.||.|||   .+||+||||||+|||++.++.   +||+|||
T Consensus        89 -~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             -EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             -eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence             899999999999999886  3467899999999999999999999   788999999999999987654   9999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ++.......     ......||+.|+|||++.   ...++.++|||||||++|+|++|..||.............  .. 
T Consensus       163 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~-  234 (322)
T 2ycf_A          163 HSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TS-  234 (322)
T ss_dssp             TCEECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH--HH-
T ss_pred             cceeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH--Hh-
Confidence            998764321     123456999999999974   4578899999999999999999999997654321111100  00 


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                         +...  ..+     ......++.+.+|+.+||+.||.+||++.++++|.|.-.
T Consensus       235 ---~~~~--~~~-----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          235 ---GKYN--FIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             ---TCCC--CCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             ---Cccc--cCc-----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence               0000  000     001123467999999999999999999999999999643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.5e-44  Score=359.08  Aligned_cols=270  Identities=23%  Similarity=0.234  Sum_probs=209.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Cc-----ceeeeeeeeeecC
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HL-----NLVKFHGYLEFED  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~~~~  206 (443)
                      .++|.+.+.||+|+||+||+|.+. +++.||||+++..   .....++.+|+.+++.+. |+     +|+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            468999999999999999999976 6899999998753   334566778999988875 54     4999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCceEEeeecc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT--ENFRAKVADFGF  284 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~~vkl~DFGl  284 (443)
                      ..++||||+. ++|.+++.......+++..++.++.||+.||.|||.. ..|||||||||+||||+  .++.+||+|||+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            9999999995 5999999865556799999999999999999999931 36899999999999995  477899999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhc---
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKF---  361 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~---  361 (443)
                      +......       .....||+.|+|||++.+..++.++|||||||++|||++|.+||...........+.......   
T Consensus       208 a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          208 SCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9876432       234579999999999999899999999999999999999999998776544332222111100   


Q ss_pred             ---------------CCCcccc--------ccC-cc-------------------ccchhhcHHHHHHHHHHHHHccCCC
Q 013401          362 ---------------SDGDAIS--------ILD-PR-------------------VENTAANNLALEKILELALQCLAPR  398 (443)
Q Consensus       362 ---------------~~~~~~~--------~~d-~~-------------------~~~~~~~~~~~~~l~~Li~~cl~~d  398 (443)
                                     .++....        ... +.                   ...........+.+.+|+.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                           0000000        000 00                   0000011223457999999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 013401          399 RQNRPSMRRCAEILWSV  415 (443)
Q Consensus       399 p~~RPs~~ell~~l~~i  415 (443)
                      |.+|||+.++++|+|.-
T Consensus       361 P~~Rpta~e~L~hp~f~  377 (382)
T 2vx3_A          361 PKTRIQPYYALQHSFFK  377 (382)
T ss_dssp             TTTSCCHHHHTTSGGGC
T ss_pred             hhhCCCHHHHhcCcccc
Confidence            99999999999999953

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-44  Score=356.66  Aligned_cols=275  Identities=22%  Similarity=0.288  Sum_probs=208.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-----Ce
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-----DE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~  207 (443)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ........+.+|+.+|+.++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            467999999999999999999986 6999999998643 2234456788999999999999999999987654     67


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+. ++|.+++..   ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++..
T Consensus        89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            899999996 689988864   46899999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcc------cccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          288 AADTESGAT------HVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       288 ~~~~~~~~~------~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      .........      .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            654322111      11234579999999998754 67899999999999999999999999887654433322221111


Q ss_pred             cCCCcccc-ccC-------------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          361 FSDGDAIS-ILD-------------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       361 ~~~~~~~~-~~d-------------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ........ ...             +...........+..+.+|+.+||+.||.+||++.++++|+|.-.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            11000000 000             000000011124467899999999999999999999999999643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=9.7e-45  Score=353.81  Aligned_cols=263  Identities=26%  Similarity=0.396  Sum_probs=212.0

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED  206 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~  206 (443)
                      ..++|.+.+.||+|+||.||+|.+.      +++.||||++.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            3467999999999999999999754      37889999987542 2334556889999999999999999999999999


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceE
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ--------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAK  278 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vk  278 (443)
                      ..++||||+.+|+|.+++....        ...+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+|
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~k  178 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  178 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEE
Confidence            9999999999999999996532        145688999999999999999999   78899999999999999999999


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHH
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWA  357 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~  357 (443)
                      |+|||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.  
T Consensus       179 l~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--  254 (322)
T 1p4o_A          179 IGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--  254 (322)
T ss_dssp             ECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH--
T ss_pred             ECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH--
Confidence            999999986644321  112233457899999999998899999999999999999999 899997764432211111  


Q ss_pred             hhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          358 MKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       358 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                           .+.....          ...++..+.+|+.+||+.||.+||++.+++++|..+...
T Consensus       255 -----~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          255 -----EGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             -----TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -----cCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                 1111000          012346799999999999999999999999999876543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-45  Score=356.58  Aligned_cols=275  Identities=23%  Similarity=0.342  Sum_probs=192.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            468999999999999999999865 689999999865432 234567889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          213 EYVPNGTLREHLDCL------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       213 E~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ||+.+++|.+++...      ....+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998642      2456899999999999999999999   7889999999999999999999999999997


Q ss_pred             cccccCCC-cccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          287 LAADTESG-ATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       287 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      ........ .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............   ......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~  246 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL---QNDPPS  246 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH---TSSCCC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh---ccCCCc
Confidence            65433211 1112234579999999999865 568999999999999999999999998765433222111   100000


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      ......++..     ....+..+.+|+.+||+.||.+||++.++++|.|.-....+
T Consensus       247 ~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          247 LETGVQDKEM-----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             TTC-----CC-----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             cccccccchh-----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            0000001110     11123578999999999999999999999999996544433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4e-44  Score=352.19  Aligned_cols=274  Identities=22%  Similarity=0.342  Sum_probs=213.0

Q ss_pred             HHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHh--cCCcceeeeeeeeeecC--
Q 013401          131 YRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQ--VEHLNLVKFHGYLEFED--  206 (443)
Q Consensus       131 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~--  206 (443)
                      ....++|.+.+.||+|+||.||+|.+. |+.||||++...     ....+.+|++++..  ++||||+++++++...+  
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            344568999999999999999999984 899999998643     34567789999887  68999999999998876  


Q ss_pred             --eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCceEE
Q 013401          207 --ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY-----TDHPIIHRDIKSSNILLTENFRAKV  279 (443)
Q Consensus       207 --~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NILl~~~~~vkl  279 (443)
                        ..++||||+.+|+|.+++..   ..+++..++.++.||+.||.|||..     +.++|+||||||+||||+.++.+||
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence              78999999999999999964   4589999999999999999999931     1357999999999999999999999


Q ss_pred             eeecccccccccCCCcccccccccCCCCccCccccccC------CCCCchhHHHHHHHHHHHHcC----------CCCCC
Q 013401          280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY------QLTEKSDVYSFGVLLVELVTG----------RRPIE  343 (443)
Q Consensus       280 ~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~sDiwSlGvll~elltG----------~~Pf~  343 (443)
                      +|||++..................||+.|+|||++.+.      .++.++|||||||++|||++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            99999987654432211123455799999999999765      233689999999999999999          78886


Q ss_pred             CchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          344 PKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .........  .........    ..+.+.+........+.+.+.+|+.+||+.||.+||++.+|+++|..+..+.
T Consensus       269 ~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          269 DLVPSDPSV--EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TTSCSSCCH--HHHHHHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccCcCcccH--HHHHHHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            543211000  000011111    1122233333334467788999999999999999999999999999887654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-45  Score=362.17  Aligned_cols=277  Identities=22%  Similarity=0.349  Sum_probs=215.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCccc---------------HHHHHHHHHHHHhcCCcceeee
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHS---------------GAEFQSEIRTLAQVEHLNLVKF  198 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~---------------~~~~~~Ei~~l~~l~h~niv~l  198 (443)
                      .++|.+.+.||+|+||.||+|.. +|+.||||++.........               ...+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35799999999999999999999 8999999998765432221               1789999999999999999999


Q ss_pred             eeeeeecCeEEEEEeecCCCcHHHH------HhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEecCCCCCCEEE
Q 013401          199 HGYLEFEDERIVIVEYVPNGTLREH------LDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD-HPIIHRDIKSSNILL  271 (443)
Q Consensus       199 ~~~~~~~~~~~lv~E~~~gg~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivHrDlkp~NILl  271 (443)
                      ++++.+.+..++||||+++++|.++      +.......+++..++.++.||+.||.|||   . +||+||||||+|||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      65433678999999999999999999999   6 889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccC-CCCC-chhHHHHHHHHHHHHcCCCCCCCchhHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTE-KSDVYSFGVLLVELVTGRRPIEPKRELK  349 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~sDiwSlGvll~elltG~~Pf~~~~~~~  349 (443)
                      +.++.+||+|||++......      ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||.......
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             cCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999876432      23445699999999999876 6666 9999999999999999999998765422


Q ss_pred             HHHH-HHHHhhhcCCCccccccCcccc--chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          350 ERIT-VKWAMKKFSDGDAISILDPRVE--NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       350 ~~~~-~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                      +... +......+... ......+...  ........+..+.+|+.+||+.||.+||++.++++|+|.-..++.+
T Consensus       260 ~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~  333 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLD-RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED  333 (348)
T ss_dssp             HHHHHHTSCCCCCCCS-SSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHHhccCcCCccc-hhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHH
Confidence            2111 10000000000 0000000000  0000122446799999999999999999999999999976555544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-44  Score=346.65  Aligned_cols=269  Identities=19%  Similarity=0.241  Sum_probs=205.6

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeee-eecCeEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL-EFEDERIV  210 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~l  210 (443)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++.....    ...+.+|+.+++.++|++++..+.++ ...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            4568999999999999999999974 799999998654322    23477899999999988777666655 66778899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCceEEeeeccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARL  287 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~  287 (443)
                      ||||+ +++|.+++.. ....+++..++.++.||+.||.|||   +++|+||||||+||||   +.++.+||+|||++..
T Consensus        83 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEcc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            99999 9999999874 3456999999999999999999999   7889999999999999   7899999999999987


Q ss_pred             ccccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          288 AADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       288 ~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      .........   .......||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            655432111   12235679999999999999899999999999999999999999997643221111111100000000


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      .          ........++.+.+|+.+||+.||.+||++.++++.+..+..+..
T Consensus       238 ~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          238 P----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             C----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             h----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            0          000001124679999999999999999999999999998876554

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-44  Score=353.93  Aligned_cols=265  Identities=26%  Similarity=0.371  Sum_probs=208.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEE------cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|.+.+.||+|+||.||+|.+      .++..||||++.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            5799999999999999999983      257899999986432 344556788999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEe
Q 013401          209 IVIVEYVPNGTLREHLDCLQG-----NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVA  280 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~  280 (443)
                      ++||||+++++|.+++.....     ..+++..++.++.||+.||.|||   .+||+||||||+||||+.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999976432     34888999999999999999999   788999999999999984   4469999


Q ss_pred             eecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhh
Q 013401          281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       281 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      |||++........  ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.    
T Consensus       186 Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----  259 (327)
T 2yfx_A          186 DFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT----  259 (327)
T ss_dssp             CCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----
T ss_pred             ccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh----
Confidence            9999976543221  112234468999999999988899999999999999999998 999998664432211111    


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                         .+....     .     ...++..+.+|+.+||+.||.+||++.+++++||.+..+..-.
T Consensus       260 ---~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~  309 (327)
T 2yfx_A          260 ---SGGRMD-----P-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  309 (327)
T ss_dssp             ---TTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             ---cCCCCC-----C-----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence               110000     0     0112367899999999999999999999999999987765543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-44  Score=348.55  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=211.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-------cccHHHHHHHHHHHHhcC-Ccceeeeeeeeee
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-------KHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEF  204 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~  204 (443)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||+++.....       ....+.+.+|+.+++.+. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999986 6899999998754311       122456789999999995 9999999999999


Q ss_pred             cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecc
Q 013401          205 EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGF  284 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGl  284 (443)
                      .+..++||||+.+++|.+++..  ...+++..++.++.||+.||.|||   .+||+|+||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999974  356899999999999999999999   78899999999999999999999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLK------TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      +.......     ......||+.|+|||++.      ...++.++|||||||++|+|++|..||...........+....
T Consensus       171 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  245 (298)
T 1phk_A          171 SCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  245 (298)
T ss_dssp             CEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             hhhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence            98765432     123456999999999985      4468889999999999999999999998765433221111100


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      ..        ...+      .....+..+.+|+.+||+.||.+||++.++++|.|.-....
T Consensus       246 ~~--------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          246 YQ--------FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             CC--------CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             cc--------cCcc------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            00        0000      01123467999999999999999999999999999654433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-44  Score=346.82  Aligned_cols=259  Identities=26%  Similarity=0.359  Sum_probs=212.2

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..++|++.+.||+|+||.||+|... +++.||||++............+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999986 799999999877655566678899999999999999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC---CceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN---FRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~  288 (443)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||   .+||+|+||||+|||++.+   +.+||+|||++...
T Consensus       100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            9999999999988643  46899999999999999999999   7889999999999999754   47999999999866


Q ss_pred             cccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .....     .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..       +... 
T Consensus       175 ~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~-  240 (287)
T 2wei_A          175 QQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-------GKYA-  240 (287)
T ss_dssp             CCCSS-----CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCC-
T ss_pred             cCCCc-----cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCCC-
Confidence            54321     223458999999999876 589999999999999999999999987654332111111       1000 


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                         ....   .....+..+.+|+.+||+.||.+||++.++++|+|.-.
T Consensus       241 ---~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          241 ---FDLP---QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             ---CCSG---GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             ---CCch---hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence               0000   00123467999999999999999999999999999643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.3e-44  Score=384.36  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=204.9

Q ss_pred             ceeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          141 FKIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ++||+|+||.||+|.+.   +++.||||+++..........++.+|+.+|+.++|||||++++++. .+..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   4688999999876655666788999999999999999999999986 4568999999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      |+|.+++.  ....+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+++....... ...
T Consensus       454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYK  527 (635)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-ccc
Confidence            99999996  4467899999999999999999999   78899999999999999999999999999987654322 111


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      ......||+.|+|||++.+..++.++|||||||+||||++ |..||...........+.       .+.....       
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~~~-------  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMGC-------  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCCC-------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCCC-------
Confidence            2233457889999999999899999999999999999998 999998765533222111       1111100       


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                         ...+++++.+|+.+||+.||++||++.+|++.|..+..+.
T Consensus       594 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          594 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence               0123467999999999999999999999999998776543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=358.51  Aligned_cols=271  Identities=25%  Similarity=0.376  Sum_probs=198.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHH--HHHHHhcCCcceeeeeeeeee-----cCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSE--IRTLAQVEHLNLVKFHGYLEF-----EDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~E--i~~l~~l~h~niv~l~~~~~~-----~~~  207 (443)
                      ++|++.+.||+|+||.||+|.. +++.||||+++..     ....+..|  +..+..++|+||+++++.+..     ...
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            5789999999999999999977 5899999998643     22334444  444556899999999985533     336


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------CeEecCCCCCCEEEcCCCceE
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH---------PIIHRDIKSSNILLTENFRAK  278 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~ivHrDlkp~NILl~~~~~vk  278 (443)
                      +++||||+++|+|.+++..   ...++..++.|+.||+.||.|||   .+         +|+||||||+||||+.++.+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence            7899999999999999964   34588889999999999999999   77         999999999999999999999


Q ss_pred             EeeecccccccccCCC----cccccccccCCCCccCcccccc-------CCCCCchhHHHHHHHHHHHHcCCCCCCCchh
Q 013401          279 VADFGFARLAADTESG----ATHVSTQVKGTAGYLDPEYLKT-------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRE  347 (443)
Q Consensus       279 l~DFGla~~~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~  347 (443)
                      |+|||++.........    .........||+.|+|||++.+       ..++.++|||||||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999999876543211    1112234579999999999976       4566789999999999999999776643221


Q ss_pred             HHHH---H--------HHHHHhhhcCCCccccccCccccch-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          348 LKER---I--------TVKWAMKKFSDGDAISILDPRVENT-AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       348 ~~~~---~--------~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ..+.   .        ..............    .+.+... .....+++.+.+|+.+||+.||.+|||+.++++.|..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            1000   0        00000000001110    1111111 11234667899999999999999999999999999998


Q ss_pred             hhhhhh
Q 013401          416 RKDYRE  421 (443)
Q Consensus       416 ~~~~~~  421 (443)
                      ...|..
T Consensus       317 l~~~~~  322 (336)
T 3g2f_A          317 MMIWER  322 (336)
T ss_dssp             HHCCCC
T ss_pred             HHHHHh
Confidence            876655

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.2e-45  Score=379.66  Aligned_cols=255  Identities=31%  Similarity=0.449  Sum_probs=209.1

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeec
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      +|.+.++||+|+||.||+|.+.++..||||+++...   ...+.|.+|+.+|+.++|+|||++++++.+ +..+|||||+
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            455667899999999999999888889999998643   345789999999999999999999999876 6789999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCc
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGA  295 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~  295 (443)
                      .+|+|.+++....+..+++..++.|+.||+.||.|||   .++||||||||+||||+.++.+||+|||+++......   
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  417 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---  417 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH---
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc---
Confidence            9999999997655567899999999999999999999   7889999999999999999999999999998764321   


Q ss_pred             ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          296 THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       296 ~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                      ........++..|+|||++.+..++.++|||||||+||||++ |..||...........+.       .+.....     
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~~~~-----  485 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRMPC-----  485 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-------TTCCCCC-----
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCCC-----
Confidence            111223457889999999998899999999999999999999 999998765432211111       1110000     


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                           ...+++.+.+||.+||+.||++||++.+|++.|..+..
T Consensus       486 -----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          486 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                 01234679999999999999999999999999987643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-44  Score=363.89  Aligned_cols=266  Identities=20%  Similarity=0.274  Sum_probs=201.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe------E
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE------R  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------~  208 (443)
                      .+|...+.||+|+||+||+|.+..+..||+|++......      ..+|+.+|+.++|||||++++++...+.      +
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            468999999999999999999987667999987543211      2379999999999999999999865443      7


Q ss_pred             EEEEeecCCCcHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCceEEeeecccc
Q 013401          209 IVIVEYVPNGTLREHLD-CLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVADFGFAR  286 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~  286 (443)
                      ++||||+.++.+..... ......+++..++.++.||+.||.|||   .+||+||||||+||||+ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            89999997654433222 123567999999999999999999999   78899999999999999 79999999999998


Q ss_pred             cccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh-------
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM-------  358 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~-------  358 (443)
                      .......     .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+....       
T Consensus       191 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          191 ILIAGEP-----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             ECCTTCC-----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccCCCC-----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            7654332     2345689999999998664 58999999999999999999999998876544333322211       


Q ss_pred             -----hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          359 -----KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       359 -----~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                           ..+............+ ........+.++.+|+.+||+.||.+||++.++++|+|.-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPF-SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCH-HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHhhChhhhhhccccccCCcH-HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence                 1111111100000000 0001112346799999999999999999999999999963

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.5e-45  Score=351.63  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=205.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            467999999999999999999987 6899999998754  2445678899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++.. ....+++..++.++.||+.||.|||   .+|++||||||+|||++.++.+||+|||++.......
T Consensus        96 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           96 EFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             ECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            99999999998865 3456899999999999999999999   7889999999999999999999999999976432211


Q ss_pred             CCcccccccccCCCCccCcccc-----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYL-----KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                          .......||+.|+|||++     .+..++.++|||||||++|+|++|..||..............   .    ...
T Consensus       172 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~----~~~  240 (302)
T 2j7t_A          172 ----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---S----DPP  240 (302)
T ss_dssp             ----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---S----CCC
T ss_pred             ----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---c----CCc
Confidence                112335699999999998     356788999999999999999999999987654332221111   0    000


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...        .....+..+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       241 ~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          241 TLL--------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             CCS--------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             ccC--------CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence            000        0112236799999999999999999999999999854

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.9e-45  Score=366.17  Aligned_cols=271  Identities=22%  Similarity=0.270  Sum_probs=187.7

Q ss_pred             CCCC-CceeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEE
Q 013401          136 NFSP-SFKIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERI  209 (443)
Q Consensus       136 ~f~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~  209 (443)
                      .|++ .++||+|+||+||+|.++   +++.||||+++...    ....+.+|+.+|+.++|||||++++++..  ...++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            3554 457999999999999965   58899999987542    23568899999999999999999999954  67899


Q ss_pred             EEEeecCCCcHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE----cCCCceE
Q 013401          210 VIVEYVPNGTLREHLDCLQ-------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL----TENFRAK  278 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl----~~~~~vk  278 (443)
                      +||||+. ++|.+++....       ...+++..++.|+.||+.||.|||   +++|+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999996 58888775321       224899999999999999999999   7889999999999999    6788999


Q ss_pred             EeeecccccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhH---------
Q 013401          279 VADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKREL---------  348 (443)
Q Consensus       279 l~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~---------  348 (443)
                      |+|||+++....... ........+||+.|+|||++.+. .++.++|||||||+||+|++|.+||....+.         
T Consensus       173 l~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          173 IADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             ECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEECCCceecCCCCc-ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999987654321 11123346799999999999774 5899999999999999999999999755431         


Q ss_pred             HHHHHHHHHhhhcCCCccccccCc--------------cccchhh-------cHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 013401          349 KERITVKWAMKKFSDGDAISILDP--------------RVENTAA-------NNLALEKILELALQCLAPRRQNRPSMRR  407 (443)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~--------------~~~~~~~-------~~~~~~~l~~Li~~cl~~dp~~RPs~~e  407 (443)
                      .....+......... .....+..              .......       .......+.+|+.+||+.||.+|||+.+
T Consensus       252 ~~l~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          252 DQLDRIFNVMGFPAD-KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHCCCCT-TTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHhhCCCCh-hhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            111111111111100 00000000              0000000       0001356889999999999999999999


Q ss_pred             HHHHHHhhh
Q 013401          408 CAEILWSVR  416 (443)
Q Consensus       408 ll~~l~~i~  416 (443)
                      +++|+|...
T Consensus       331 ~L~hp~f~~  339 (405)
T 3rgf_A          331 AMQDPYFLE  339 (405)
T ss_dssp             HHTSGGGTS
T ss_pred             HhcChhhcc
Confidence            999999754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.7e-44  Score=344.42  Aligned_cols=269  Identities=19%  Similarity=0.247  Sum_probs=208.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeee-eecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL-EFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv  211 (443)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....    ....+.+|+.+++.+.|++++..+.++ ...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            468999999999999999999974 79999999976542    224688999999999988766665554 667788999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~  288 (443)
                      |||+ +++|.+++.. ....+++..++.++.||+.||.|||   +++|+||||||+|||+   +.++.+||+|||++...
T Consensus        84 ~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            9999 9999999974 3456999999999999999999999   7889999999999999   48899999999999876


Q ss_pred             cccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          289 ADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       289 ~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ........   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            55432111   112456799999999999998999999999999999999999999976432111101110000000000


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                       ..         .....+++.+.+|+.+||+.||.+||++.++++.|..+..+...
T Consensus       239 -~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          239 -IE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             -HH---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -hH---------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence             00         00011346799999999999999999999999999988665543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=354.58  Aligned_cols=252  Identities=17%  Similarity=0.190  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeeeCceEEEEEE------EcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC---Ccceeeeeeeeee
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGR------LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE---HLNLVKFHGYLEF  204 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~  204 (443)
                      .++|.+.+.||+|+||+||+|.      ..+++.||||+++..     ...++.+|++++..+.   |+||+++++++..
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            3578899999999999999994      346899999998753     3457788888888886   9999999999999


Q ss_pred             cCeEEEEEeecCCCcHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--------
Q 013401          205 EDERIVIVEYVPNGTLREHLDCL---QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE--------  273 (443)
Q Consensus       205 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--------  273 (443)
                      .+..++|||||+||+|.+++...   ....+++..++.|+.||+.||.|||   +++||||||||+||||+.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccc
Confidence            99999999999999999999753   3467999999999999999999999   888999999999999998        


Q ss_pred             ---CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH
Q 013401          274 ---NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE  350 (443)
Q Consensus       274 ---~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~  350 (443)
                         ++.+||+|||+++......  ........+||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFP--KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSC--TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccCCEEEeeCchhhhhhccC--CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence               8999999999997654221  12234556799999999999998999999999999999999999999964432100


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNR-PSMRRCAEILWSVRK  417 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~R-Ps~~ell~~l~~i~~  417 (443)
                                    .    +...+...+    ..+.+.+++..||+.+|.+| |++.++.+.+..+..
T Consensus       294 --------------~----~~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          294 --------------K----PEGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             --------------E----ECSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             --------------e----echhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                          0    001111111    13568889999999999999 677777777765543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=359.24  Aligned_cols=268  Identities=17%  Similarity=0.223  Sum_probs=200.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccC---------cccHHHHHHHHHHHHhcCCcceeeeeee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYD---------KHSGAEFQSEIRTLAQVEHLNLVKFHGY  201 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~---------~~~~~~~~~Ei~~l~~l~h~niv~l~~~  201 (443)
                      ++|.+.+.||+|+||.||+|.+.    ++..||||++......         ......+.+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57899999999999999999975    5788999998654211         0112346678899999999999999999


Q ss_pred             eee----cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC--
Q 013401          202 LEF----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF--  275 (443)
Q Consensus       202 ~~~----~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~--  275 (443)
                      +..    ....++||||+ +++|.+++...  ..+++..++.|+.||+.||.|||   +++|+||||||+||||+.++  
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            988    67899999999 99999998743  37999999999999999999999   78899999999999999877  


Q ss_pred             ceEEeeecccccccccCCCc---ccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHH-H
Q 013401          276 RAKVADFGFARLAADTESGA---THVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKE-R  351 (443)
Q Consensus       276 ~vkl~DFGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~-~  351 (443)
                      .+||+|||+++.........   ........||+.|+|||++.+..++.++|||||||++|||++|..||........ .
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            99999999998765432211   1112445799999999999998999999999999999999999999964321111 1


Q ss_pred             HHH-HHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          352 ITV-KWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       352 ~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ... ......+.. ......        ....+++++.+|+.+||..||.+||++.+|++.|..+..
T Consensus       271 ~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          271 QTAKTNLLDELPQ-SVLKWA--------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHTTTH-HHHHHS--------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHhhcccccH-HHHhhc--------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            111 111111100 000000        000234679999999999999999999999999987654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.1e-45  Score=349.21  Aligned_cols=253  Identities=28%  Similarity=0.439  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec-CeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE-DERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~  212 (443)
                      .++|++.+.||+|+||.||+|... |+.||||+++..    ...+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            357899999999999999999875 889999998753    3456789999999999999999999986544 5789999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.+++|.+++.......+++..++.++.|++.||.|||   .++|+||||||+|||++.++.+||+|||++...... 
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            9999999999997654445889999999999999999999   788999999999999999999999999998755432 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                            .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...........       ...+....   
T Consensus       171 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-------~~~~~~~~---  234 (278)
T 1byg_A          171 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGYKMD---  234 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------HTTTCCCC---
T ss_pred             ------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HhcCCCCC---
Confidence                  122357899999999998899999999999999999998 9999976543221111       11111000   


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                        .     ...++..+.+|+.+||+.||.+||++.++++.|..+...
T Consensus       235 --~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          235 --A-----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             --C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --C-----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence              0     012346799999999999999999999999999988654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.3e-45  Score=353.17  Aligned_cols=263  Identities=21%  Similarity=0.324  Sum_probs=204.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee----cCeE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF----EDER  208 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~  208 (443)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++||||+++++++..    ....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            367999999999999999999974 7999999988653  34456778999999999999999999999873    3478


Q ss_pred             EEEEeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          209 IVIVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      ++||||+.+|+|.+++...  .+..+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            9999999999999999753  3567999999999999999999999   7889999999999999999999999999987


Q ss_pred             cccccCCCcc-----cccccccCCCCccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHh
Q 013401          287 LAADTESGAT-----HVSTQVKGTAGYLDPEYLKTYQ---LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM  358 (443)
Q Consensus       287 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~---~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~  358 (443)
                      ..........     .......||+.|+|||++.+..   ++.++|||||||++|+|++|..||.............  .
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~  260 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA--V  260 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH--H
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH--h
Confidence            6542211100     0012345899999999987543   6889999999999999999999995432211111110  0


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ....     .     ..   .....+..+.+|+.+||+.||.+||++.+++++|+.+.
T Consensus       261 ~~~~-----~-----~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 QNQL-----S-----IP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HCC------------CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hccC-----C-----CC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            0000     0     00   00112367999999999999999999999999998774

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-44  Score=357.40  Aligned_cols=268  Identities=21%  Similarity=0.259  Sum_probs=205.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-----------Ccceeeeeeee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-----------HLNLVKFHGYL  202 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~  202 (443)
                      .+|.+.+.||+|+||+||+|.+. +++.||||++...   ......+.+|+.+++.+.           |+||+++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            57999999999999999999975 7999999998753   334567889999998886           89999999998


Q ss_pred             eecC----eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcC----
Q 013401          203 EFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH-PIIHRDIKSSNILLTE----  273 (443)
Q Consensus       203 ~~~~----~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~----  273 (443)
                      ...+    ..++|||++ +++|.+++.......+++..++.|+.||+.||.|||   .+ ||+||||||+||||+.    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence            8754    789999999 899999998766677999999999999999999999   76 8999999999999953    


Q ss_pred             --CCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhH---
Q 013401          274 --NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKREL---  348 (443)
Q Consensus       274 --~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~---  348 (443)
                        .+.+||+|||++......       .....||+.|+|||++.+..++.++|||||||++|||++|..||......   
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cCcceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence              447999999999766432       23346999999999999989999999999999999999999999865321   


Q ss_pred             ---HHHHHHHHHhhhc---------------CCCcccccc-Ccc--------ccchhhcHHHHHHHHHHHHHccCCCCCC
Q 013401          349 ---KERITVKWAMKKF---------------SDGDAISIL-DPR--------VENTAANNLALEKILELALQCLAPRRQN  401 (443)
Q Consensus       349 ---~~~~~~~~~~~~~---------------~~~~~~~~~-d~~--------~~~~~~~~~~~~~l~~Li~~cl~~dp~~  401 (443)
                         .....+.......               ......... ...        ...........+.+.+|+.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence               1111111111000               000000000 000        0000112456788999999999999999


Q ss_pred             CCCHHHHHHHHHhhh
Q 013401          402 RPSMRRCAEILWSVR  416 (443)
Q Consensus       402 RPs~~ell~~l~~i~  416 (443)
                      |||+.++++|+|.-.
T Consensus       325 Rpt~~ell~hp~f~~  339 (373)
T 1q8y_A          325 RADAGGLVNHPWLKD  339 (373)
T ss_dssp             CBCHHHHHTCGGGTT
T ss_pred             cCCHHHHhhChhhhc
Confidence            999999999999653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=351.89  Aligned_cols=273  Identities=21%  Similarity=0.270  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeee---------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLE---------  203 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~---------  203 (443)
                      .++|...+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.+++.++||||+++++++.         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            357899999999999999999987 5999999998653  3445677889999999999999999999873         


Q ss_pred             -----ecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCce
Q 013401          204 -----FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRA  277 (443)
Q Consensus       204 -----~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~v  277 (443)
                           +.+..++||||+. |+|.+++.   ...+++..++.++.||+.||.|||   .+||+||||||+|||++ .++.+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeE
Confidence                 4467899999997 69999885   356899999999999999999999   78899999999999997 56799


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW  356 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~  356 (443)
                      ||+|||++......... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus       161 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEccCccccccCCCccc-ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999876432211 112234468999999998865 6789999999999999999999999987765433222221


Q ss_pred             HhhhcCCCccccc------------cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          357 AMKKFSDGDAISI------------LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       357 ~~~~~~~~~~~~~------------~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...........+.            ..+...........+..+.+|+.+||+.||.+||++.++++|+|.-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            1111000000000            00000000011123567999999999999999999999999999643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=356.67  Aligned_cols=266  Identities=20%  Similarity=0.295  Sum_probs=204.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe------
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE------  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~------  207 (443)
                      ++|...+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999976 69999999997755445556778899999999999999999999987654      


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+. ++|.+++.    ..+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            499999996 58877663    34899999999999999999999   78899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh------
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK------  360 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~------  360 (443)
                      ....       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+......      
T Consensus       176 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          176 ADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             ---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             CCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            5432       234568999999999876 67899999999999999999999999876543322222111000      


Q ss_pred             --cCCCccc---cccC--ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          361 --FSDGDAI---SILD--PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       361 --~~~~~~~---~~~d--~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        +.+....   ..+.  +...........+..+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence              0000000   0000  00000001112356799999999999999999999999999964

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-44  Score=377.89  Aligned_cols=254  Identities=20%  Similarity=0.383  Sum_probs=202.5

Q ss_pred             eeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      +||+|+||.||+|.++   ++..||||+++... .....+.+.+|+.+|+.++|||||++++++.. +.+++||||+.+|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            7999999999999864   46789999998652 34566889999999999999999999999875 5699999999999


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+++.. ....+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+++......... ..
T Consensus       421 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~  495 (613)
T 2ozo_A          421 PLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TA  495 (613)
T ss_dssp             BHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             cHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee-ee
Confidence            99999964 3456999999999999999999999   7889999999999999999999999999998765432111 11


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccch
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT  377 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  377 (443)
                      .....+|+.|+|||++.+..++.++|||||||+||||++ |..||...........+.       .+.....        
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~~~--------  560 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRMEC--------  560 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------TTCCCCC--------
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCCCCC--------
Confidence            122346789999999998899999999999999999998 999998765433211111       1111110        


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       378 ~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                        ...++..+.+|+.+||+.||.+||++.+|++.|..+..+.
T Consensus       561 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          561 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             --CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence              0123467999999999999999999999999998775544

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.4e-44  Score=343.45  Aligned_cols=265  Identities=24%  Similarity=0.370  Sum_probs=200.5

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-------
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-------  204 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-------  204 (443)
                      ..++|+..+.||+|+||.||+|... +++.||||+++..   ......+.+|+.+++.++||||+++++++.+       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            3467899999999999999999976 7999999998653   3445678899999999999999999998865       


Q ss_pred             ------cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceE
Q 013401          205 ------EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAK  278 (443)
Q Consensus       205 ------~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vk  278 (443)
                            .+..++||||+++++|.+++.. .+..+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+|
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence                  4578999999999999999975 3456788889999999999999999   78899999999999999999999


Q ss_pred             EeeecccccccccCCC----------cccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchh
Q 013401          279 VADFGFARLAADTESG----------ATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRE  347 (443)
Q Consensus       279 l~DFGla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~  347 (443)
                      |+|||++.........          .........||+.|+|||++.+. .++.++|||||||++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999999866432110          01122345699999999999764 68999999999999999998   5544322


Q ss_pred             HHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          348 LKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      ......  . .... ...    +.+.+     ....+..+.+|+.+||+.||.+||++.++++|+|.-.....
T Consensus       234 ~~~~~~--~-~~~~-~~~----~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (303)
T 1zy4_A          234 RVNILK--K-LRSV-SIE----FPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD  293 (303)
T ss_dssp             HHHHHH--H-HHST-TCC----CCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred             HHHHHH--h-cccc-ccc----cCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence            211111  1 1100 000    00111     11233568999999999999999999999999997544333

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-43  Score=362.87  Aligned_cols=265  Identities=18%  Similarity=0.259  Sum_probs=208.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC-cceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH-LNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|++.++||+|+||.||+|.+. +++.||||++.....    ..++.+|+.+++.|.| ++|..+..++.+.+..+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            468999999999999999999975 799999998765432    2347799999999986 5666666677788899999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE---cCCCceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL---TENFRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~  288 (443)
                      |||+ +++|.+++.. ....+++..++.|+.||+.||.|||   .++||||||||+||||   +.++.+||+|||+++..
T Consensus        82 me~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999 9999999975 3457999999999999999999999   7889999999999999   68899999999999877


Q ss_pred             cccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          289 ADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       289 ~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ........   .......||+.|+|||++.+..++.++|||||||+||||++|..||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            65432211   112356799999999999999999999999999999999999999986543221111111111110000


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ...+          ...+++++.+|+..||+.||++||++.+|++.|..+..
T Consensus       237 ~~~l----------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          237 IEAL----------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HHHH----------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHH----------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            0000          01124679999999999999999999999999987754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.8e-44  Score=353.24  Aligned_cols=279  Identities=20%  Similarity=0.246  Sum_probs=198.5

Q ss_pred             HHHHHhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          129 EIYRATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       129 ~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      ......++|.+.+.||+|+||.||+|.+. +|+.||||++...   ......+.+|++.+..++||||+++++++...+.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            34456689999999999999999999986 6999999988654   2233456688888999999999999999876443


Q ss_pred             -------EEEEEeecCCCcHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCce
Q 013401          208 -------RIVIVEYVPNGTLREHLDC--LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRA  277 (443)
Q Consensus       208 -------~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~v  277 (443)
                             +++||||+.+ .|.+.+..  .....+++..++.++.||+.||.|||. +.+||+||||||+||||+. ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcE
Confidence                   7899999976 55444432  245668899999999999999999993 3567999999999999996 8999


Q ss_pred             EEeeecccccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH
Q 013401          278 KVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW  356 (443)
Q Consensus       278 kl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~  356 (443)
                      ||+|||++........     .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..
T Consensus       172 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             EECCCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCCC-----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            9999999987654332     2345689999999998654 489999999999999999999999988765443333221


Q ss_pred             Hhhh--------cCCC-ccccccC-ccccch----hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          357 AMKK--------FSDG-DAISILD-PRVENT----AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       357 ~~~~--------~~~~-~~~~~~d-~~~~~~----~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      ....        .... ......+ ......    ......+..+.+|+.+||+.||.+|||+.++++|+|.-..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence            1110        0000 0000000 000000    0011135789999999999999999999999999996543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.6e-44  Score=346.89  Aligned_cols=259  Identities=22%  Similarity=0.329  Sum_probs=202.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC--CcceeeeeeeeeecCeEEE
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE--HLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~l  210 (443)
                      ..++|.+.+.||+|+||.||+|.+.+++.||||++............+.+|+.+++.++  |+||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34679999999999999999999888999999998765555556678899999999997  5999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||| +.+++|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||+++ +.+||+|||++.....
T Consensus       106 v~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             EEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            999 568899999974  457899999999999999999999   788999999999999965 7999999999987654


Q ss_pred             cCCCcccccccccCCCCccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKT-----------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      ...  ........||+.|+|||++.+           ..++.++|||||||++|+|++|..||...........  ... 
T Consensus       179 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--~~~-  253 (313)
T 3cek_A          179 DTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH--AII-  253 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--HHH-
T ss_pred             ccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH--HHH-
Confidence            321  111234569999999999865           4688899999999999999999999976533221111  110 


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ....... +..         .....+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       254 --~~~~~~~-~~~---------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          254 --DPNHEIE-FPD---------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             --CTTSCCC-CCC---------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             --hcccccC-Ccc---------cchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence              0000000 000         1135789999999999999999999999999964

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=354.70  Aligned_cols=260  Identities=23%  Similarity=0.326  Sum_probs=189.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeeeee--------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLE--------  203 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~--------  203 (443)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.++..+. ||||+++++++.        
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            357999999999999999999976 7999999998554  2444567889999999996 999999999984        


Q ss_pred             ecCeEEEEEeecCCCcHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEcCCCceEEe
Q 013401          204 FEDERIVIVEYVPNGTLREHLDCL-QGNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLTENFRAKVA  280 (443)
Q Consensus       204 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~~~~~vkl~  280 (443)
                      .....++||||+. |+|.+++... ....+++..++.|+.||+.||.|||   .++  |+||||||+||||+.++.+||+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEe
Confidence            3345799999995 7999988643 3456999999999999999999999   888  9999999999999999999999


Q ss_pred             eecccccccccCCCcc--------cccccccCCCCccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH
Q 013401          281 DFGFARLAADTESGAT--------HVSTQVKGTAGYLDPEYL---KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK  349 (443)
Q Consensus       281 DFGla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~l---~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~  349 (443)
                      |||++...........        .......||+.|+|||++   .+..++.++|||||||++|+|++|..||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            9999987654321110        011234699999999998   56678899999999999999999999997543321


Q ss_pred             HHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          350 ERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .           .......  ..       .......+.+|+.+||+.||.+||++.+++++|+.+....
T Consensus       261 ~-----------~~~~~~~--~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 I-----------VNGKYSI--PP-------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ----------------CCC--CT-------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             h-----------hcCcccC--Cc-------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            0           0000000  00       0011234889999999999999999999999999887543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=347.36  Aligned_cols=269  Identities=26%  Similarity=0.413  Sum_probs=211.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEE-----cCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC--e
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRL-----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED--E  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~  207 (443)
                      ++|++.+.||+|+||.||+|..     .+++.||||++...  .......+.+|+.+++.++||||+++++++...+  .
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            5688899999999999999984     36899999998754  3445567899999999999999999999886654  7


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++||||+++++|.+++.. ....+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||++..
T Consensus       119 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHH-STTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEECCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            8999999999999999975 3356899999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH---------HHHHHHh
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER---------ITVKWAM  358 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~---------~~~~~~~  358 (443)
                      ...... .........++..|+|||++.+..++.++|||||||++|+|++|..||.........         .......
T Consensus       195 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          195 LPQDKE-YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CCSSCS-EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccccc-ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            654321 111123345788899999998888999999999999999999999998654221110         0000111


Q ss_pred             hhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       359 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                      ..+..+....          ....++..+.+|+.+||+.||.+||++.++++.|..++..+.
T Consensus       274 ~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          274 ELLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            1111110000          011234679999999999999999999999999999987653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.7e-44  Score=344.30  Aligned_cols=263  Identities=25%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--CCc--EEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--DGT--IVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|++.+.||+|+||+||+|.+.  ++.  .||||+++.... .....+.+.+|+.+++.++||||+++++++...+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57999999999999999999853  333  689999876533 2345677899999999999999999999988665 89


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+++|.+++... ...+++..++.++.||+.||.|||   .++|+|+||||+|||++.++.+||+|||++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            999999999999999753 356899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..      ......
T Consensus       173 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------~~~~~~  245 (291)
T 1u46_A          173 QNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------EGERLP  245 (291)
T ss_dssp             C-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------SCCCCC
T ss_pred             cccc-chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc------cCCCCC
Confidence            4321 1112234457889999999988889999999999999999999 9999987654322211111      000000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                                .....+..+.+|+.+||..||.+||++.+++++|..+....
T Consensus       246 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          246 ----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence                      01123467999999999999999999999999998776543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.6e-44  Score=349.82  Aligned_cols=256  Identities=23%  Similarity=0.294  Sum_probs=178.4

Q ss_pred             hcCCCCCc-eeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHH-HHHhcCCcceeeeeeeeee----cC
Q 013401          134 TRNFSPSF-KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHGYLEF----ED  206 (443)
Q Consensus       134 ~~~f~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~----~~  206 (443)
                      .++|.+.+ .||+|+||+||+|.+. +|+.||||++...       ....+|+. .++.+.||||+++++++..    ..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            46788855 5999999999999987 7999999998643       12233333 4566789999999999876    45


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeec
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFG  283 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFG  283 (443)
                      ..++||||+.||+|.+++.......+++..++.|+.||+.||.|||   .+||+||||||+||||+.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            5899999999999999998765667999999999999999999999   788999999999999976   4559999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ++.......      .....||+.|+|||++.+..++.++|||||||++|+|++|..||..............   ....
T Consensus       177 ~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~  247 (336)
T 3fhr_A          177 FAKETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRL  247 (336)
T ss_dssp             TCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cceeccccc------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhc
Confidence            997654321      2345689999999999888899999999999999999999999976543221100000   0000


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .. .....+      .....+..+.+|+.+||+.||.+||++.++++|+|.-
T Consensus       248 ~~-~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  292 (336)
T 3fhr_A          248 GQ-YGFPNP------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN  292 (336)
T ss_dssp             ----CCCTT------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             cc-cccCch------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            00 000000      0112346799999999999999999999999999964

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.2e-44  Score=349.21  Aligned_cols=263  Identities=23%  Similarity=0.378  Sum_probs=186.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHH-HHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIR-TLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|...+.||+|+||.||+|... +|+.||||+++.... .....++.+|+. +++.++||||+++++++.+.+..++||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            57888999999999999999986 799999999876532 233345556666 667789999999999999999999999


Q ss_pred             eecCCCcHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCceEEeeecccccc
Q 013401          213 EYVPNGTLREHLDC---LQGNILDLAGRLDIAIDVAHAITYLHMYTDH-PIIHRDIKSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       213 E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ||+.+ +|.+++..   .....+++..+..++.|++.||.|||   .+ ||+||||||+|||++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 78777653   23567899999999999999999999   66 8999999999999999999999999999776


Q ss_pred             cccCCCcccccccccCCCCccCcccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYL----KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      .....     .....||+.|+|||++    .+..++.++|||||||++|+|++|..||.......+..      .....+
T Consensus       177 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~  245 (327)
T 3aln_A          177 VDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------TQVVKG  245 (327)
T ss_dssp             ----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCS
T ss_pred             ccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------HHHhcC
Confidence            54321     2234699999999998    45678999999999999999999999998654321110      111111


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      ........      .....+..+.+|+.+||+.||.+||++.++++|+|....+.
T Consensus       246 ~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          246 DPPQLSNS------EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             CCCCCCCC------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             CCCCCCCc------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence            11111000      01123467999999999999999999999999999765443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=349.96  Aligned_cols=266  Identities=24%  Similarity=0.350  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .++|++.+.||+|+||.||+|.+..  .||||+++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3578899999999999999998864  49999987655444555667899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.|++|.+++.. .+..+++..++.++.||+.||.|||   +++|+||||||+|||++ ++.+||+|||++........
T Consensus       110 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~  184 (319)
T 2y4i_B          110 LCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA  184 (319)
T ss_dssp             CCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred             cccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence            9999999999864 3456899999999999999999999   78899999999999998 67999999999876532211


Q ss_pred             C-cccccccccCCCCccCcccccc---------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          294 G-ATHVSTQVKGTAGYLDPEYLKT---------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       294 ~-~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      . .........||+.|+|||++.+         ..++.++|||||||++|+|++|..||...........+.       .
T Consensus       185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~  257 (319)
T 2y4i_B          185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-------T  257 (319)
T ss_dssp             ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH-------T
T ss_pred             cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc-------c
Confidence            1 1112233469999999999864         357889999999999999999999998765432211111       1


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      +........         ..+..+.+|+.+||..||.+||++.++++.|..+.+.....
T Consensus       258 ~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          258 GMKPNLSQI---------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             TCCCCCCCS---------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             CCCCCCCcC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            111111111         12246889999999999999999999999999988776554

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-43  Score=359.58  Aligned_cols=258  Identities=21%  Similarity=0.279  Sum_probs=191.5

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .|...+.||+|+||+||.+...+|+.||||++...     ....+.+|+.+|..+ +|||||++++++.+++..++||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            34456789999999998877778999999998653     235678999999987 899999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCC-------------Cc
Q 013401          215 VPNGTLREHLDCLQGNI-----LDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTEN-------------FR  276 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~-------------~~  276 (443)
                      |. |+|.+++.......     ..+..++.|+.||+.||.|||   +++|+||||||+||||+.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 69999997432111     133345789999999999999   7889999999999999754             48


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCchhH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT-------YQLTEKSDVYSFGVLLVELVT-GRRPIEPKREL  348 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~  348 (443)
                      +||+|||++..................||+.|+|||++.+       ..++.++|||||||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998775543222122334579999999999965       568999999999999999999 99999765432


Q ss_pred             HHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          349 KERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...  +.  .........         ........+.++.+|+.+||+.||.+||++.++++|+|..
T Consensus       247 ~~~--i~--~~~~~~~~~---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          247 ESN--II--RGIFSLDEM---------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             HHH--HH--HTCCCCCCC---------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHH--Hh--cCCCCcccc---------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence            211  11  111100000         0111234567899999999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.1e-44  Score=349.24  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=205.6

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc----ccHHHHHHHHHHHHhcC--Ccceeeeeeeeeec
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK----HSGAEFQSEIRTLAQVE--HLNLVKFHGYLEFE  205 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~  205 (443)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||+++......    .....+.+|+.+++.+.  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3467999999999999999999875 78999999987654322    12245668999999996  59999999999999


Q ss_pred             CeEEEEEeecCC-CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCceEEeeec
Q 013401          206 DERIVIVEYVPN-GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVADFG  283 (443)
Q Consensus       206 ~~~~lv~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~vkl~DFG  283 (443)
                      +..++|||++.+ ++|.+++..  ...+++..++.++.||+.||.|||   +++|+||||||+||||+ .++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            999999999976 899999975  356899999999999999999999   78899999999999999 78999999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcC
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS  362 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  362 (443)
                      ++.......      .....||+.|+|||++.+..+ +.++|||||||++|||++|..||........        ... 
T Consensus       196 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--------~~~-  260 (320)
T 3a99_A          196 SGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR--------GQV-  260 (320)
T ss_dssp             TCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH--------CCC-
T ss_pred             ccccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc--------ccc-
Confidence            998765421      234569999999999977665 6789999999999999999999976532110        000 


Q ss_pred             CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       363 ~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                            ....         ..++++.+|+.+||+.||.+||++.++++|+|.-.
T Consensus       261 ------~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~  299 (320)
T 3a99_A          261 ------FFRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  299 (320)
T ss_dssp             ------CCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             ------cccc---------cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence                  0111         12367899999999999999999999999999643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=344.27  Aligned_cols=259  Identities=22%  Similarity=0.326  Sum_probs=186.6

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|+..+.||+|+||.||+|.+. +|+.||||++............+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357888999999999999999986 7999999998765333333334445556678889999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH-PIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ||+ ++.+..++. .....+++..++.++.||+.||.|||   .+ ||+|+||||+|||++.++.+||+|||++......
T Consensus       104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 555544443 34567999999999999999999999   64 8999999999999999999999999999765443


Q ss_pred             CCCcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      .     ......||+.|+|||++.     ...++.++|||||||++|+|++|..||.......+...  .......    
T Consensus       179 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~----  247 (318)
T 2dyl_A          179 K-----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT--KVLQEEP----  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--HHHHSCC----
T ss_pred             c-----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH--HHhccCC----
Confidence            2     123446999999999984     45688999999999999999999999976433222111  1111100    


Q ss_pred             ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          367 ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       367 ~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ..     +..   ....+..+.+|+.+||+.||.+||++.++++|+|.-.
T Consensus       248 ~~-----~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          248 PL-----LPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             CC-----CCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             CC-----CCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            00     000   0012367999999999999999999999999999643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-44  Score=345.67  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=197.4

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc----ccHHHHHHHHHHHHhc----CCcceeeeeeeee
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK----HSGAEFQSEIRTLAQV----EHLNLVKFHGYLE  203 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~Ei~~l~~l----~h~niv~l~~~~~  203 (443)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||+++......    .....+.+|+.++..+    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            4568999999999999999999875 78999999987653222    1223356799999998    8999999999999


Q ss_pred             ecCeEEEEEee-cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc-CCCceEEee
Q 013401          204 FEDERIVIVEY-VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVAD  281 (443)
Q Consensus       204 ~~~~~~lv~E~-~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~-~~~~vkl~D  281 (443)
                      ..+..++|||+ +.+++|.+++..  ...+++..++.++.||+.||.|||   .++|+||||||+|||++ .++.+||+|
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            99999999999 789999999975  346899999999999999999999   77899999999999999 889999999


Q ss_pred             ecccccccccCCCcccccccccCCCCccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh
Q 013401          282 FGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT-EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK  360 (443)
Q Consensus       282 FGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~  360 (443)
                      ||++.......      .....||+.|+|||++.+..+. .++|||||||++|+|++|..||........        ..
T Consensus       184 fg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~  249 (312)
T 2iwi_A          184 FGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE--------AE  249 (312)
T ss_dssp             CSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH--------TC
T ss_pred             cchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh--------hc
Confidence            99998765432      2345699999999999776664 489999999999999999999976532111        00


Q ss_pred             cCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       361 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .      . +.         ......+.+|+.+||+.||++||++.++++|.|.-.
T Consensus       250 ~------~-~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~  289 (312)
T 2iwi_A          250 L------H-FP---------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT  289 (312)
T ss_dssp             C------C-CC---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred             c------C-Cc---------ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence            0      0 00         112357899999999999999999999999999643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-42  Score=368.64  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=207.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .++|.+.+.||+|+||.||+|.+.    .+..||||+++... .....+.+.+|+.+|+.++|||||++++++. ++..+
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            356888899999999999999874    25679999887532 3344567899999999999999999999985 56789


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +||||+.+|+|.+++.. ....+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            99999999999999975 3456899999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..       +....
T Consensus       543 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-------~~~~~  612 (656)
T 2j0j_A          543 DSTY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GERLP  612 (656)
T ss_dssp             C-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-------TCCCC
T ss_pred             CCcc---eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence            4321   12233457889999999998899999999999999999997 9999987654332211111       11000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                       +.         ..++..+.+|+.+||..||.+||++.++++.|..+..+.
T Consensus       613 -~~---------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          613 -MP---------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -CC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CC---------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence             00         113467999999999999999999999999999886543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=354.05  Aligned_cols=256  Identities=22%  Similarity=0.314  Sum_probs=192.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .+|...+.||+|+||+||.....+|+.||||++.....     ..+.+|+.+|+.+ +|||||++++++.+.+..++|||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            46888889999999997766566799999999865432     2246899999999 79999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----CCceEEeeecccccc
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-----NFRAKVADFGFARLA  288 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-----~~~vkl~DFGla~~~  288 (443)
                      ||. |+|.+++... ...+.+..++.|+.||+.||.|||   +++|+||||||+||||+.     ...+||+|||+++..
T Consensus        99 ~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           99 LCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            996 6999999753 334555567789999999999999   788999999999999953     235889999999876


Q ss_pred             cccCCCcccccccccCCCCccCccccc---cCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          289 ADTESGATHVSTQVKGTAGYLDPEYLK---TYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       289 ~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      ...... .......+||+.|+|||++.   ...++.++|||||||++|||++ |..||..........    ....    
T Consensus       174 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~----~~~~----  244 (432)
T 3p23_A          174 AVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----LLGA----  244 (432)
T ss_dssp             -------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH----HTTC----
T ss_pred             cCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH----Hhcc----
Confidence            543211 11234467999999999997   4567889999999999999999 999996543322111    0000    


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .......       ........+.+|+.+||+.||.+||++.++++|+|...
T Consensus       245 ~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          245 CSLDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CCCTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             CCccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            0000011       11234466889999999999999999999999998643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.5e-41  Score=325.04  Aligned_cols=235  Identities=20%  Similarity=0.283  Sum_probs=185.4

Q ss_pred             cCCCCC-ceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHH-HhcCCcceeeeeeeeee----cCe
Q 013401          135 RNFSPS-FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTL-AQVEHLNLVKFHGYLEF----EDE  207 (443)
Q Consensus       135 ~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~  207 (443)
                      ++|.+. +.||+|+||.||+|... +++.||||+++..       ..+.+|+.++ +.++||||+++++++..    ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            567776 67999999999999975 7999999998642       4567899988 45589999999999987    678


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeecc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFGF  284 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFGl  284 (443)
                      .++||||+.|++|.+++....+..+++..++.|+.||+.||.|||   +++|+||||||+|||++.   ++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            899999999999999998765667999999999999999999999   788999999999999997   78999999999


Q ss_pred             cccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          285 ARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       285 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +....                          +..++.++|||||||++|+|++|..||.........       ..... 
T Consensus       167 a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~-  212 (299)
T 3m2w_A          167 AKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKT-  212 (299)
T ss_dssp             CEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCC-
T ss_pred             ccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHH-
Confidence            86432                          135677999999999999999999999765432110       00000 


Q ss_pred             ccccccCcccc-chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          365 DAISILDPRVE-NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       365 ~~~~~~d~~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                         .+...... ........++.+.+|+.+||+.||.+||++.++++|+|...
T Consensus       213 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          213 ---RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             ---SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ---HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence               00000000 00011224577999999999999999999999999999654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.2e-42  Score=363.28  Aligned_cols=269  Identities=25%  Similarity=0.360  Sum_probs=204.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee------cCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF------EDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~  207 (443)
                      ++|++.++||+|+||+||+|.+. +|+.||||+++.. ........+.+|+.+|+.++||||+++++++..      .+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            57999999999999999999875 6999999998764 234456778999999999999999999998765      677


Q ss_pred             EEEEEeecCCCcHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc---eEEeeec
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ-GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR---AKVADFG  283 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~---vkl~DFG  283 (443)
                      .++||||+.||+|.+++.... ...+++..++.|+.||+.||.|||   .+||+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999997533 235889999999999999999999   788999999999999997765   9999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHH-------HHHH
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERI-------TVKW  356 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~-------~~~~  356 (443)
                      ++.......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........       ....
T Consensus       170 ~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          170 YAKELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred             ccccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence            998765432     2334679999999999999999999999999999999999999997643221100       0000


Q ss_pred             HhhhcCCCccccccCcccc-chhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          357 AMKKFSDGDAISILDPRVE-NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       357 ~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .......+.. . +...+. ........++.+.+|+.+||..||.+||++.++++|.|.
T Consensus       245 ~~~~~l~g~~-~-~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F  301 (676)
T 3qa8_A          245 VVYDDLTGAV-K-FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF  301 (676)
T ss_dssp             CSCCCCSSSC-C-CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred             hhhhhhcccc-c-cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence            0000000000 0 001100 111223356789999999999999999999999988884

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9e-42  Score=345.20  Aligned_cols=246  Identities=14%  Similarity=0.104  Sum_probs=184.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCC-ccee---------------
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEH-LNLV---------------  196 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h-~niv---------------  196 (443)
                      ++|...+.||+|+||+||+|.+. +|+.||||+++... ......+.+.+|+.+++.+.| .|+.               
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45777789999999999999965 79999999987432 223345778999999999976 2211               


Q ss_pred             ee------eeeeee-----cCeEEEEEeecCCCcHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 013401          197 KF------HGYLEF-----EDERIVIVEYVPNGTLREHLDCL-----QGNILDLAGRLDIAIDVAHAITYLHMYTDHPII  260 (443)
Q Consensus       197 ~l------~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  260 (443)
                      .+      ..++..     ....+++|+++ +++|.+++...     .+..+++..++.|+.||+.||.|||   +++||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            11      111111     12356666665 78999988522     2455788889999999999999999   78899


Q ss_pred             ecCCCCCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCcccc----------ccCCCCCchhHHHHHH
Q 013401          261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL----------KTYQLTEKSDVYSFGV  330 (443)
Q Consensus       261 HrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~~~sDiwSlGv  330 (443)
                      ||||||+||||+.++.+||+|||+++.....       ....+| +.|+|||++          .+..++.++|||||||
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            9999999999999999999999998765432       344568 999999999          5556888999999999


Q ss_pred             HHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 013401          331 LLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAE  410 (443)
Q Consensus       331 ll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~  410 (443)
                      ++|||++|..||.........               ..++....       ..++.+.+|+.+||+.||.+||++.++++
T Consensus       306 il~elltg~~Pf~~~~~~~~~---------------~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGS---------------EWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCS---------------GGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCCCCCCCcchhhhH---------------HHHHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999999765432110               00111000       12367999999999999999999999999


Q ss_pred             HHHh
Q 013401          411 ILWS  414 (443)
Q Consensus       411 ~l~~  414 (443)
                      +.|.
T Consensus       364 ~~~~  367 (413)
T 3dzo_A          364 TPEY  367 (413)
T ss_dssp             SHHH
T ss_pred             CHHH
Confidence            9774

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-40  Score=320.20  Aligned_cols=235  Identities=13%  Similarity=0.058  Sum_probs=185.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||.||+|.+. +++.||||+++..... ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            47999999999999999999986 5999999999765432 334467899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||++|++|.+++..   . ....++..|+.||+.||.|||   .+||+||||||+||||+.+|.+||+++|         
T Consensus       111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            99999999999852   2 345568889999999999999   7889999999999999999999998544         


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                                     |++       .++.++|||||||++|+|++|..||..........            ........
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~  220 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG  220 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTS
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhcc
Confidence                           333       36789999999999999999999998654321000            00000000


Q ss_pred             -cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          373 -RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       373 -~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                       ...........++.+.+|+.+||+.||.+| |+.++++.|..+.....
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence             000011112344679999999999999999 99999999998865543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.6e-41  Score=333.55  Aligned_cols=249  Identities=19%  Similarity=0.167  Sum_probs=189.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEcccccc------CcccHHHHHHHHHHHHhcC---------Ccceeee-
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY------DKHSGAEFQSEIRTLAQVE---------HLNLVKF-  198 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~~~Ei~~l~~l~---------h~niv~l-  198 (443)
                      ++|++.+.||+|+||+||+|++ +|+.||||+++....      .......+.+|+.+|+.++         |||||++ 
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4688889999999999999998 689999999876532      2334477889999999886         5555544 


Q ss_pred             ----------------eeeeee-------------cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 013401          199 ----------------HGYLEF-------------EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT  249 (443)
Q Consensus       199 ----------------~~~~~~-------------~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~  249 (443)
                                      ++++.+             .+.+++|||||.+|++.+.+.   ...+++..++.|+.||+.||.
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHHH
Confidence                            444443             788999999999998777663   356899999999999999999


Q ss_pred             HHhhcCCCCeEecCCCCCCEEEcCCC--------------------ceEEeeecccccccccCCCcccccccccCCCCcc
Q 013401          250 YLHMYTDHPIIHRDIKSSNILLTENF--------------------RAKVADFGFARLAADTESGATHVSTQVKGTAGYL  309 (443)
Q Consensus       250 ~LH~~~~~~ivHrDlkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~  309 (443)
                      |||.  +++||||||||+||||+.++                    .+||+|||+++.....         ..+||+.|+
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y~  244 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVSM  244 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCTT
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeeccc
Confidence            9992  24599999999999999887                    8999999999876532         246999999


Q ss_pred             CccccccCCCCCchhHHHHHHH-HHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHH
Q 013401          310 DPEYLKTYQLTEKSDVYSFGVL-LVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKIL  388 (443)
Q Consensus       310 aPE~l~~~~~~~~sDiwSlGvl-l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  388 (443)
                      |||++.+.. +.++||||||++ .+++++|..||........  ............        ...........++++.
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~~--------~~~~~~~~~~~s~~~~  313 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--LTDKMLKQMTFK--------TKCNTPAMKQIKRKIQ  313 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--HHHHHHHTCCCS--------SCCCSHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH--HHHhhhhhhccC--------cccchhhhhhcCHHHH
Confidence            999998766 889999998777 7789999999843211111  111111111000        0011112345678899


Q ss_pred             HHHHHccCCCCCCCCCHHHHH-HHHHh
Q 013401          389 ELALQCLAPRRQNRPSMRRCA-EILWS  414 (443)
Q Consensus       389 ~Li~~cl~~dp~~RPs~~ell-~~l~~  414 (443)
                      +|+.+||+.|     |+.+++ +|+|.
T Consensus       314 dli~~~L~~d-----sa~e~l~~Hp~f  335 (336)
T 2vuw_A          314 EFHRTMLNFS-----SATDLLCQHSLF  335 (336)
T ss_dssp             HHHHHGGGSS-----SHHHHHHHCGGG
T ss_pred             HHHHHHhccC-----CHHHHHhcCCCc
Confidence            9999999987     999999 99984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-40  Score=357.10  Aligned_cols=240  Identities=24%  Similarity=0.338  Sum_probs=193.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe-----
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE-----  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-----  207 (443)
                      ++|++.+.||+|+||.||+|.+.  +|+.||||++.... .......+.+|+.+|..++|||||++++++...+.     
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            68999999999999999999985  68999999986532 23445678899999999999999999999988766     


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .||||||++|++|.+++..    .+++..++.|+.||+.||.|||   ++|||||||||+||||+.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999887642    6999999999999999999999   7889999999999999986 899999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ....        ....||+.|+|||++.+. ++.++|||||||+||+|++|.+||.....               .. . 
T Consensus       231 ~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------~~-~-  284 (681)
T 2pzi_A          231 INSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV---------------DG-L-  284 (681)
T ss_dssp             TTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC---------------SS-C-
T ss_pred             cccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc---------------cc-c-
Confidence            6432        345699999999999764 48899999999999999999998864311               00 0 


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH-HHhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEI-LWSVR  416 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~-l~~i~  416 (443)
                             ..........+.+.+|+.+||+.||.+||+..+.+.+ +..+.
T Consensus       285 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 -------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                   0001111234678999999999999999965555544 44443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=5.9e-35  Score=306.14  Aligned_cols=188  Identities=16%  Similarity=0.098  Sum_probs=132.3

Q ss_pred             eeeeeCceEEEEEEEc-CCcEEEEEEccccccC--------cccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEEE
Q 013401          142 KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD--------KHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv  211 (443)
                      .++.|.+|.+..+... .|+.||||++.+....        ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3667777777766533 5889999998754321        22345689999999999 699999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||++|++|.++|..  +.++++.   .|+.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999974  4566654   48899999999999   888999999999999999999999999999876543


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI  342 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf  342 (443)
                      ..    .....+||+.|||||++.+ .+..++|+|++|+++++|+++..++
T Consensus       393 ~~----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 CS----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -C----CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             Cc----cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            22    2344679999999999987 5677899999999998887765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=3.6e-30  Score=268.34  Aligned_cols=189  Identities=21%  Similarity=0.251  Sum_probs=145.8

Q ss_pred             CCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcc------cHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          138 SPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKH------SGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ...+.||+|+||.||+|.. .+..+++|+.........      ..+.+.+|+.+|++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4456899999999999954 478889998544332211      134578999999999999999766666678888999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      |||++|++|.+++..          ++.|+.||+.+|.|||   +++|+||||||+|||++.  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999998863          4578999999999999   788999999999999999  9999999999887543


Q ss_pred             CCCcc---cccccccCCCCccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCC
Q 013401          292 ESGAT---HVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVTGRRPI  342 (443)
Q Consensus       292 ~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~~~~sDiwSlGvll~elltG~~Pf  342 (443)
                      .....   .......||+.|||||++..  ..|+..+|+|+..+-.++.+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            21110   01235679999999999976  56888899999998888888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.5e-26  Score=221.55  Aligned_cols=164  Identities=15%  Similarity=0.142  Sum_probs=127.0

Q ss_pred             HHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCc----------------ccHHHHHHHHHHHHhcCCc
Q 013401          130 IYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDK----------------HSGAEFQSEIRTLAQVEHL  193 (443)
Q Consensus       130 ~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------~~~~~~~~Ei~~l~~l~h~  193 (443)
                      +......|...+.||+|+||.||+|.+.+|+.||||+++......                .....+.+|+.+|+.++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            344455677778999999999999999779999999986532111                13456889999999999  


Q ss_pred             ceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC
Q 013401          194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE  273 (443)
Q Consensus       194 niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~  273 (443)
                      | +++++++.. +..++||||++|++|.+ +.        ......++.||+.||.|||   .+||+||||||+||||+ 
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence            5 677775544 56799999999999987 32        1234579999999999999   78899999999999999 


Q ss_pred             CCceEEeeecccccccccCCCcccccccccCCCCccCcccccc----------CCCCCchhHHH
Q 013401          274 NFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT----------YQLTEKSDVYS  327 (443)
Q Consensus       274 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----------~~~~~~sDiwS  327 (443)
                      ++.+||+|||+++.                 +..|+|||++..          ..|+..+|+|.
T Consensus       228 ~~~vkl~DFG~a~~-----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          228 EEGIWIIDFPQSVE-----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TTEEEECCCTTCEE-----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCcEEEEECCCCeE-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99999999999853                 345789998753          23455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=5.2e-21  Score=180.62  Aligned_cols=139  Identities=19%  Similarity=0.186  Sum_probs=105.5

Q ss_pred             CCCCceeeeeCceEEEEEEE-cCCcE--EEEEEccccccCc----------------------ccHHHHHHHHHHHHhcC
Q 013401          137 FSPSFKIGQGGFGTVYKGRL-EDGTI--VAIKRAKKSVYDK----------------------HSGAEFQSEIRTLAQVE  191 (443)
Q Consensus       137 f~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~~----------------------~~~~~~~~Ei~~l~~l~  191 (443)
                      |.+...||+|+||.||+|.+ .+|+.  ||||+++......                      .....+.+|+.+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998 68989  9999875432110                      01135789999999998


Q ss_pred             Ccce--eeeeeeeeecCeEEEEEeecCC-C----cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 013401          192 HLNL--VKFHGYLEFEDERIVIVEYVPN-G----TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDI  264 (443)
Q Consensus       192 h~ni--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDl  264 (443)
                      |++|  ..+++.    +..+|||||+.+ |    .|.+++..     .++..+..++.||+.+|.|||.  .+|||||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            8764  333332    357899999942 4    66665432     2345677899999999999993  346999999


Q ss_pred             CCCCEEEcCCCceEEeeecccccc
Q 013401          265 KSSNILLTENFRAKVADFGFARLA  288 (443)
Q Consensus       265 kp~NILl~~~~~vkl~DFGla~~~  288 (443)
                      ||+|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=1e-19  Score=179.69  Aligned_cols=140  Identities=16%  Similarity=0.178  Sum_probs=98.2

Q ss_pred             CCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccC------------cccHHHHH--------HHHHHHHhcCCcce
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYD------------KHSGAEFQ--------SEIRTLAQVEHLNL  195 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~~~~--------~Ei~~l~~l~h~ni  195 (443)
                      -|.+..+||.|+||.||+|...+|+.||||+++.....            .......+        +|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38899999999999999999989999999987643211            11112222        34445555533222


Q ss_pred             eeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC
Q 013401          196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF  275 (443)
Q Consensus       196 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~  275 (443)
                      . ....+.. ...+|||||+.|++|.++..        ......++.||+.+|.+||   .+|||||||||.||||+++|
T Consensus       176 ~-vp~p~~~-~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 P-VPEPIAQ-SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             S-CCCEEEE-ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred             C-CCeeeec-cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence            1 1111111 23379999999988865431        1234568899999999999   78899999999999998876


Q ss_pred             ----------ceEEeeecccccc
Q 013401          276 ----------RAKVADFGFARLA  288 (443)
Q Consensus       276 ----------~vkl~DFGla~~~  288 (443)
                                .+.|+||+-+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=5.6e-13  Score=125.29  Aligned_cols=145  Identities=15%  Similarity=0.113  Sum_probs=112.8

Q ss_pred             HHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEE
Q 013401          132 RATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       132 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l  210 (443)
                      .....|.....++.|+++.||++... +..+++|+......  .....+.+|+.+|+.+. +..+.++++++...+..++
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            34457877788898999999999754 67899999865321  12235889999999985 7778899999998899999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT-----------------------------------  255 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  255 (443)
                      |||+++|.+|.+.+.       +......++.+++.+|..||...                                   
T Consensus        88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999876531       12233467889999999999611                                   


Q ss_pred             ---------------------CCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          256 ---------------------DHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       256 ---------------------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                                           ...++|+|++|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 1458999999999999876566799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=1.5e-12  Score=121.67  Aligned_cols=131  Identities=16%  Similarity=0.140  Sum_probs=96.7

Q ss_pred             eee-eeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc--eeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIG-QGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN--LVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .++ .|..+.||++...+|..++||+....     ....+.+|+.+++.+.+.+  +.+++++....+..++||||++|.
T Consensus        26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~  100 (264)
T 1nd4_A           26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ  100 (264)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             ecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence            344 55569999998777888999986543     1235778999999885434  556888888888899999999998


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT-------------------------------------------  255 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------  255 (443)
                      +|.  ..   .  ..   ...++.+++..|..||...                                           
T Consensus       101 ~l~--~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          101 DLL--SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             ETT--TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             ccC--cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            873  21   1  11   2356777888888888532                                           


Q ss_pred             ------------CCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          256 ------------DHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       256 ------------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                                  ...++|+|++|.|||++.++.+.|+|||.+..
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                        11299999999999998776677999998743

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=3.6e-11  Score=118.32  Aligned_cols=144  Identities=18%  Similarity=0.211  Sum_probs=106.0

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEcc--ccccCcccHHHHHHHHHHHHhcC--Ccceeeeeeeeeec---CeEEEE
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAK--KSVYDKHSGAEFQSEIRTLAQVE--HLNLVKFHGYLEFE---DERIVI  211 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~---~~~~lv  211 (443)
                      ....|+.|.++.||++...+ ..+++|+..  .... ......+.+|+.+++.|.  +..+.+++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            35578999999999998764 568888765  3211 122346788999999996  45678888888766   458999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT------------------------------------  255 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------  255 (443)
                      |||++|..+.+..    -..++...+..++.+++..|..||...                                    
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999998774321    123667778889999999999999631                                    


Q ss_pred             -------------------CCCeEecCCCCCCEEEcCCCc--eEEeeecccccc
Q 013401          256 -------------------DHPIIHRDIKSSNILLTENFR--AKVADFGFARLA  288 (443)
Q Consensus       256 -------------------~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~~  288 (443)
                                         ...++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                               256999999999999997753  689999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=1.3e-10  Score=111.60  Aligned_cols=184  Identities=19%  Similarity=0.163  Sum_probs=121.2

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccc--eeeeeeeeeecC---eEEEEEe
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLN--LVKFHGYLEFED---ERIVIVE  213 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E  213 (443)
                      ...|+.|....||++.    ..+++|+....    .....+.+|..+|+.+. +..  +.+++......+   ..|+|||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4568999999999873    45888875432    33467889999999884 433  334444433333   3488999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT--------------------------------------  255 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  255 (443)
                      +++|..|.+...    ..++..++..++.+++..|..||...                                      
T Consensus        97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999988865332    23566677778888888888888521                                      


Q ss_pred             -----------------CCCeEecCCCCCCEEEcC--CCceEEeeecccccccccCCCcccccccccCCCCc---cCccc
Q 013401          256 -----------------DHPIIHRDIKSSNILLTE--NFRAKVADFGFARLAADTESGATHVSTQVKGTAGY---LDPEY  313 (443)
Q Consensus       256 -----------------~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y---~aPE~  313 (443)
                                       ...++|+|++|.||+++.  ++.+.|+||+.+.......        .......+   ..|+.
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--------Dl~~~~~~~~~~~~~~  244 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--------DFISLMEDDEEYGMEF  244 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--------HHHTTCCTTTSCCHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--------HHHHHHhhccccCHHH
Confidence                             134799999999999998  5568899999986532210        00011111   23332


Q ss_pred             c----ccCCC----------CCchhHHHHHHHHHHHHcCCCCCC
Q 013401          314 L----KTYQL----------TEKSDVYSFGVLLVELVTGRRPIE  343 (443)
Q Consensus       314 l----~~~~~----------~~~sDiwSlGvll~elltG~~Pf~  343 (443)
                      .    ..+..          ....+.|++|+++|.+.+|..+|.
T Consensus       245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            2    11111          112589999999999999988763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.71  E-value=1.3e-07  Score=88.65  Aligned_cols=135  Identities=19%  Similarity=0.240  Sum_probs=98.1

Q ss_pred             eeeeeCce-EEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFG-TVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .+..|..| .||+.... ++..++||+-...     ....+.+|...|+.|. +--+.++++++.+.+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            35556555 68988765 5677899976532     3456889999999885 445778888899999999999999998


Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT-------------------------------------------  255 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------  255 (443)
                      ++.+....      .......++.+++..|.-||...                                           
T Consensus       106 ~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          106 TAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             EHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            88765532      11233456666777777777321                                           


Q ss_pred             ------------CCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          256 ------------DHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       256 ------------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                                  ...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        11279999999999999877777999997743

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=2.6e-07  Score=88.66  Aligned_cols=136  Identities=18%  Similarity=0.175  Sum_probs=91.9

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCc---ceeeeeeeee-ecCeEEEEEeec
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHL---NLVKFHGYLE-FEDERIVIVEYV  215 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~  215 (443)
                      ...++.|....||+.    |..++||+...    ......+.+|..+|+.|.+.   .+.+++.+.. ..+..++|||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            446888999999988    56688887432    23346788999999999642   3455566553 345678999999


Q ss_pred             CCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 013401          216 PNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT----------------------------------------  255 (443)
Q Consensus       216 ~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  255 (443)
                      +|..|.+..-    ..++......++.++...|..||...                                        
T Consensus        96 ~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           96 QGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9988765321    11334444445555555555555321                                        


Q ss_pred             -----------------CCCeEecCCCCCCEEEcC---CCc-eEEeeeccccc
Q 013401          256 -----------------DHPIIHRDIKSSNILLTE---NFR-AKVADFGFARL  287 (443)
Q Consensus       256 -----------------~~~ivHrDlkp~NILl~~---~~~-vkl~DFGla~~  287 (443)
                                       ...++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             235799999999999987   455 48999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=3.7e-07  Score=89.34  Aligned_cols=81  Identities=6%  Similarity=-0.029  Sum_probs=54.0

Q ss_pred             cee-eeeCceEEEEEEEc-------CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcC-C--cceeeeeeeeeec---
Q 013401          141 FKI-GQGGFGTVYKGRLE-------DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVE-H--LNLVKFHGYLEFE---  205 (443)
Q Consensus       141 ~~L-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~---  205 (443)
                      +.| +.|....+|+....       ++..+++|+...... .......+.+|+.+|+.|. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999998764       266788997654320 0001235678888888874 3  3566777776554   


Q ss_pred             CeEEEEEeecCCCcHH
Q 013401          206 DERIVIVEYVPNGTLR  221 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~  221 (443)
                      +..++|||+++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999886543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.34  E-value=3.6e-06  Score=81.30  Aligned_cols=138  Identities=17%  Similarity=0.143  Sum_probs=78.5

Q ss_pred             eeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC--Ccceeeeee------eeeecCeEEEEEe
Q 013401          142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE--HLNLVKFHG------YLEFEDERIVIVE  213 (443)
Q Consensus       142 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~------~~~~~~~~~lv~E  213 (443)
                      .|+.|..+.||++...+|. +++|+....      ...+..|+.+++.|.  .-.+.+++.      +....+..++|||
T Consensus        39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             ECC----CEEEEEEETTEE-EEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eccccccCcEEEEEeCCCC-EEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            4666778999999876554 889987642      234445666665553  112333332      2235677899999


Q ss_pred             ecCCCcHH-----------HHH---hhhcC-C--C---------CCHHHH------------------------------
Q 013401          214 YVPNGTLR-----------EHL---DCLQG-N--I---------LDLAGR------------------------------  237 (443)
Q Consensus       214 ~~~gg~L~-----------~~l---~~~~~-~--~---------l~~~~~------------------------------  237 (443)
                      |++|..+.           ..|   ..... .  +         ..+...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986431           111   11111 0  0         011110                              


Q ss_pred             -HHHHHHHHHHHHHHhh----------cCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          238 -LDIAIDVAHAITYLHM----------YTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       238 -~~i~~~i~~~L~~LH~----------~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                       ..+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             0111123345555542          025679999999999999888889999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.26  E-value=6.7e-06  Score=81.61  Aligned_cols=77  Identities=14%  Similarity=0.111  Sum_probs=50.2

Q ss_pred             CceeeeeCceEEEEEEEc-CCcEEEEEEcccccc--C---cccHHHHHHHHHHHHhcC-C-cc-eeeeeeeeeecCeEEE
Q 013401          140 SFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY--D---KHSGAEFQSEIRTLAQVE-H-LN-LVKFHGYLEFEDERIV  210 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~---~~~~~~~~~Ei~~l~~l~-h-~n-iv~l~~~~~~~~~~~l  210 (443)
                      ...||.|.++.||++... +++.|+||.......  .   ......+.+|..+|+.+. + +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457999999999999764 468899998653211  0   122345678999988874 2 33 4455543  4556789


Q ss_pred             EEeecCCC
Q 013401          211 IVEYVPNG  218 (443)
Q Consensus       211 v~E~~~gg  218 (443)
                      |||++.|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.02  E-value=2.9e-05  Score=77.70  Aligned_cols=75  Identities=13%  Similarity=0.163  Sum_probs=46.1

Q ss_pred             CceeeeeCceEEEEEEEcCCcEEEEEEcccccc--Cc-----ccHHHHHHHHHHHHh-cCCcceeeeeeeeeecCeEEEE
Q 013401          140 SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVY--DK-----HSGAEFQSEIRTLAQ-VEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~-----~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ...||.|..+.||++.. ++..++||.......  ..     .....+..|+..+.. .....+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            45789999999999965 467899995432111  11     122334444443332 2334566676664  5677999


Q ss_pred             Eeec-CC
Q 013401          212 VEYV-PN  217 (443)
Q Consensus       212 ~E~~-~g  217 (443)
                      ||++ +|
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.99  E-value=2.7e-05  Score=74.75  Aligned_cols=76  Identities=17%  Similarity=0.173  Sum_probs=59.7

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC---CcceeeeeeeeeecCeEEEEEeec
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE---HLNLVKFHGYLEFEDERIVIVEYV  215 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~  215 (443)
                      ....|+.|.+..+|+.... +..++||+....     ....+.+|...|+.|.   ...+.+++.+....+..++|||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            3457899999999998764 667888976532     2466888999998884   356788888888888999999999


Q ss_pred             CCCcH
Q 013401          216 PNGTL  220 (443)
Q Consensus       216 ~gg~L  220 (443)
                      +|..+
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.93  E-value=4.9e-05  Score=71.83  Aligned_cols=79  Identities=20%  Similarity=0.294  Sum_probs=56.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-C--cceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-H--LNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~lv  211 (443)
                      ..+.....+|.|..+.||+....||+.|+||+.....  ......|.+|...|+.|. .  --+.+++++    +..++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEE
Confidence            4455667899999999999999999999999865432  222345778999999884 2  234445543    234789


Q ss_pred             EeecCCCc
Q 013401          212 VEYVPNGT  219 (443)
Q Consensus       212 ~E~~~gg~  219 (443)
                      ||++.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.85  E-value=0.00013  Score=69.94  Aligned_cols=158  Identities=15%  Similarity=0.142  Sum_probs=87.9

Q ss_pred             ccCHHHHHHHhcCCCCC-----ceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc--ee
Q 013401          124 QITMEEIYRATRNFSPS-----FKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN--LV  196 (443)
Q Consensus       124 ~~~~~~~~~~~~~f~~~-----~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv  196 (443)
                      .++.+++......|...     ..|+.|....+|+....+| .+++|+....    .....+..|+.+++.|...+  +.
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            35566666666667652     3466788899999987766 5788987642    11234567888877774212  23


Q ss_pred             eeeee------eeecCeEEEEEeecCCCcHH-----------HH---Hhhhc-CCC------CC---HHHHHH-------
Q 013401          197 KFHGY------LEFEDERIVIVEYVPNGTLR-----------EH---LDCLQ-GNI------LD---LAGRLD-------  239 (443)
Q Consensus       197 ~l~~~------~~~~~~~~lv~E~~~gg~L~-----------~~---l~~~~-~~~------l~---~~~~~~-------  239 (443)
                      +++..      ....+..+++|++++|..+.           +.   +.... ...      ..   +.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33321      23346778999999885431           11   11110 000      00   111000       


Q ss_pred             -----HHHHHHHHHHHHhhc----CCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          240 -----IAIDVAHAITYLHMY----TDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       240 -----i~~~i~~~L~~LH~~----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                           +...+...+..+...    ...+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 011133444555421    13469999999999999987656899999764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.76  E-value=6.4e-05  Score=72.56  Aligned_cols=140  Identities=15%  Similarity=0.158  Sum_probs=72.2

Q ss_pred             eeeeeCceE-EEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-C-cceeeeeeeeeecCeEEEEEeecCCC
Q 013401          142 KIGQGGFGT-VYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-H-LNLVKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       142 ~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h-~niv~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      .|+.|.... +|+....+|..+++|......     ...+..|+.+++.+. + -.+.+++.+....+  +++||++.+.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            465555444 667665446777787654321     023446777777664 2 23455666533333  7899999776


Q ss_pred             cHHHHHhhh------------------cC------CCCCHHHHH-------HH-------------HHHHHHHHHHHh--
Q 013401          219 TLREHLDCL------------------QG------NILDLAGRL-------DI-------------AIDVAHAITYLH--  252 (443)
Q Consensus       219 ~L~~~l~~~------------------~~------~~l~~~~~~-------~i-------------~~~i~~~L~~LH--  252 (443)
                      .+.+++...                  ..      ..++.....       .+             ...+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665444210                  00      011111100       00             001111222221  


Q ss_pred             -hcCCCCeEecCCCCCCEEEcCC----CceEEeeecccccc
Q 013401          253 -MYTDHPIIHRDIKSSNILLTEN----FRAKVADFGFARLA  288 (443)
Q Consensus       253 -~~~~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~~  288 (443)
                       ......++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence             1124579999999999999874    67999999988643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.74  E-value=0.0003  Score=67.48  Aligned_cols=157  Identities=15%  Similarity=0.095  Sum_probs=88.4

Q ss_pred             cCHHHHHHHhcCCCC-----CceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC--cceee
Q 013401          125 ITMEEIYRATRNFSP-----SFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH--LNLVK  197 (443)
Q Consensus       125 ~~~~~~~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~  197 (443)
                      ++.+.+......|..     ...|+ |....||++...+|+.+++|+.....   .....+..|..+++.|..  -.+++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            444444444444432     33566 88889999887777779999876331   234567778888887742  22444


Q ss_pred             eeee-----eeecCeEEEEEeecCCCcHH-----------HHH---hhh-cC------CCCCHHHH--------------
Q 013401          198 FHGY-----LEFEDERIVIVEYVPNGTLR-----------EHL---DCL-QG------NILDLAGR--------------  237 (443)
Q Consensus       198 l~~~-----~~~~~~~~lv~E~~~gg~L~-----------~~l---~~~-~~------~~l~~~~~--------------  237 (443)
                      ++..     ....+..+++||+++|..+.           ..+   ... ..      ..++....              
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4432     23356678899999875431           111   110 00      01111110              


Q ss_pred             --------HHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          238 --------LDIAIDVAHAITYLHM-YTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       238 --------~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                              ..++..++..+.-+-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    0111122222222110 0245689999999999999 4 899999997753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.61  E-value=0.00014  Score=69.04  Aligned_cols=72  Identities=8%  Similarity=0.072  Sum_probs=43.8

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEEEeec-C
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVIVEYV-P  216 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~  216 (443)
                      -...|+.|....+|++     ..+++|+.......   .....+|+.+++.+...++ .+++++  +.+.-++|+||+ +
T Consensus        22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~   91 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG   91 (301)
T ss_dssp             SCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred             ceeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence            3668999999999999     44788876543111   1123467777777642222 345543  333457899999 6


Q ss_pred             CCcH
Q 013401          217 NGTL  220 (443)
Q Consensus       217 gg~L  220 (443)
                      |.+|
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.40  E-value=0.00043  Score=69.38  Aligned_cols=72  Identities=17%  Similarity=0.226  Sum_probs=47.9

Q ss_pred             CceeeeeCceEEEEEEEcC--------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEE
Q 013401          140 SFKIGQGGFGTVYKGRLED--------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIV  210 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~l  210 (443)
                      ...|+.|....||++...+        +..|++|+....    .....+.+|..+++.|...++ .++++.+.  +  .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            3468888889999998753        578888887331    112455689999888853333 55666543  2  38


Q ss_pred             EEeecCCCc
Q 013401          211 IVEYVPNGT  219 (443)
Q Consensus       211 v~E~~~gg~  219 (443)
                      |+||++|..
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            899998643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.29  E-value=0.0012  Score=63.80  Aligned_cols=31  Identities=23%  Similarity=0.325  Sum_probs=27.6

Q ss_pred             CCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          257 HPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       257 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.28  E-value=0.0026  Score=56.97  Aligned_cols=103  Identities=12%  Similarity=0.049  Sum_probs=67.2

Q ss_pred             cHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCcccc
Q 013401          219 TLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV  298 (443)
Q Consensus       219 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~  298 (443)
                      +|.+.|.. .+.++++.++|.++.|.+.+|.-+-.  ...-..+=+-|..|+|..+|.|-+.+ +.+.            
T Consensus        34 SL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            78888876 56889999999999999999877621  11111233347899999999988753 1110            


Q ss_pred             cccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 013401          299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI  342 (443)
Q Consensus       299 ~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf  342 (443)
                          .....+.+||... ...+.+.=|||||++||.-+--..|-
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                0223466888764 34567889999999999998855553

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.25  E-value=0.00067  Score=66.77  Aligned_cols=139  Identities=14%  Similarity=0.170  Sum_probs=78.7

Q ss_pred             ceeeeeCceEEEEEEEc--------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEE
Q 013401          141 FKIGQGGFGTVYKGRLE--------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..|..|....+|++...        +++.|++|+....   ......+.+|..+++.|. +.-..++++.+..    .+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            35777888889999864        2478899985332   123456678999998884 3223556655543    289


Q ss_pred             EeecCCCcHHH--------------HHhhhcCC------CCC--HHHHHHHHHHHHH-------------------HHHH
Q 013401          212 VEYVPNGTLRE--------------HLDCLQGN------ILD--LAGRLDIAIDVAH-------------------AITY  250 (443)
Q Consensus       212 ~E~~~gg~L~~--------------~l~~~~~~------~l~--~~~~~~i~~~i~~-------------------~L~~  250 (443)
                      |||++|..|..              .|......      ...  +..+..+..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99998855421              11111111      111  2233333333211                   1222


Q ss_pred             ----Hhhc-CCCCeEecCCCCCCEEEcCC----CceEEeeecccc
Q 013401          251 ----LHMY-TDHPIIHRDIKSSNILLTEN----FRAKVADFGFAR  286 (443)
Q Consensus       251 ----LH~~-~~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~  286 (443)
                          |... ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                2211 13358999999999999876    789999999774

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.24  E-value=0.0011  Score=66.91  Aligned_cols=73  Identities=14%  Similarity=0.023  Sum_probs=46.4

Q ss_pred             ceeeeeCceEEEEEEEcC-CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEEEeecCCC
Q 013401          141 FKIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~gg  218 (443)
                      ..|+.|-...+|++...+ +..|++|+.....  .. ..+..+|..+|+.|...++ .++++.+.  +  .+||||++|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            467888889999998765 5778888764321  11 1112589999998864444 46666652  2  2599999875


Q ss_pred             cH
Q 013401          219 TL  220 (443)
Q Consensus       219 ~L  220 (443)
                      .|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.11  E-value=0.00057  Score=66.86  Aligned_cols=72  Identities=15%  Similarity=0.086  Sum_probs=42.5

Q ss_pred             ceeeeeCceEEEEEEEcC---------CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcc-eeeeeeeeeecCeEEE
Q 013401          141 FKIGQGGFGTVYKGRLED---------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN-LVKFHGYLEFEDERIV  210 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~l  210 (443)
                      ..|+.|....+|++...+         +..+++|+.....   ....+..+|..+++.+...+ +.++++..  .  -++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            357788888999998753         2678888765421   11112357888888774223 34555443  2  268


Q ss_pred             EEeecCCCc
Q 013401          211 IVEYVPNGT  219 (443)
Q Consensus       211 v~E~~~gg~  219 (443)
                      ||||++|..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.30  E-value=0.0043  Score=61.90  Aligned_cols=73  Identities=11%  Similarity=0.017  Sum_probs=46.3

Q ss_pred             ceeeeeCceEEEEEEEcC--------CcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEE
Q 013401          141 FKIGQGGFGTVYKGRLED--------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..|..|--..+|++...+        +..|++++.....   ....+..+|..+++.+. +.-..++++.+  .  -++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I  148 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI  148 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence            457778888999998753        5788998864431   11123457888888774 22234455432  2  2788


Q ss_pred             EeecCCCcH
Q 013401          212 VEYVPNGTL  220 (443)
Q Consensus       212 ~E~~~gg~L  220 (443)
                      |||++|..|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.00  E-value=0.17  Score=49.86  Aligned_cols=29  Identities=31%  Similarity=0.564  Sum_probs=24.5

Q ss_pred             eEecCCCCCCEEE------cCCCceEEeeeccccc
Q 013401          259 IIHRDIKSSNILL------TENFRAKVADFGFARL  287 (443)
Q Consensus       259 ivHrDlkp~NILl------~~~~~vkl~DFGla~~  287 (443)
                      ++|+|+.+.|||+      +++..+.|+||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      3466799999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.45  E-value=0.14  Score=45.61  Aligned_cols=117  Identities=9%  Similarity=0.131  Sum_probs=81.4

Q ss_pred             CCcceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEE
Q 013401          191 EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNIL  270 (443)
Q Consensus       191 ~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NIL  270 (443)
                      .||+++.. .+-++++.+.+.++.-..+.-+..+     ..++...++.++.+|+....+++     .-+|-=|.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            58888877 5666777777777766543333333     23778889999999998876555     2578889999999


Q ss_pred             EcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 013401          271 LTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEP  344 (443)
Q Consensus       271 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~  344 (443)
                      ++.++.++|.=-|+-..+                     +|.     .++..-=+-.+=|++..+++++..|+.
T Consensus       112 f~~~~~p~i~~RGik~~l---------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV---------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             ECTTSCEEESCCEETTTB---------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EcCCCCEEEEEccCccCC---------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999877754322                     221     112222334566789999999988853

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.45  E-value=0.44  Score=42.57  Aligned_cols=115  Identities=11%  Similarity=0.094  Sum_probs=79.4

Q ss_pred             CCcceeeeeeeeeecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCCCE
Q 013401          191 EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAIT-YLHMYTDHPIIHRDIKSSNI  269 (443)
Q Consensus       191 ~h~niv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivHrDlkp~NI  269 (443)
                      .||++  -..+-.+++.+.+.++.-.++.-+..+.     .++...++.++.+|+.... +++     .-+|-=|.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            57777  3444467788888888775554444453     3778888888888888666 444     368889999999


Q ss_pred             EEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 013401          270 LLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIE  343 (443)
Q Consensus       270 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~  343 (443)
                      +++.++.++|.-.|+-..+                     +|.-     ++..-=+-.+=|++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~~l---------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESL---------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTTB---------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCcccC---------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999887764322                     2221     1111223356678888999888874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.33  E-value=0.035  Score=55.92  Aligned_cols=61  Identities=8%  Similarity=0.017  Sum_probs=17.0

Q ss_pred             CCceeeeeCceEEEEEEEcC-CcEEEE------EEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeee
Q 013401          139 PSFKIGQGGFGTVYKGRLED-GTIVAI------KRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYL  202 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~-g~~vav------K~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  202 (443)
                      ..++||   ||.||+|.+.. ...|||      |..+...........+.+|..+++.++|+|+++.+++.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            345677   99999998763 467888      66655444444455678899999999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	443
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-74
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-68
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-67
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-47
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-44
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-41
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 3e-74
 Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 24/279 (8%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FGTVYKG+      VA+K    +         F++E+  L +  H+N++ F GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
                +  ++ ++    +L  HL  ++    ++   +DIA   A  + YLH      IIH
Sbjct: 73  -STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ--- 318
           RD+KS+NI L E+   K+ DFG A + +      +H   Q+ G+  ++ PE ++      
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG--SHQFEQLSGSILWMAPEVIRMQDKNP 185

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
            + +SDVY+FG++L EL+TG+ P      +  R  + + + +         L P +    
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDLSKVR 235

Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK 417
           +N    + +  L  +CL  +R  RP   +    +  + +
Sbjct: 236 SN--CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 7e-68
 Identities = 76/271 (28%), Positives = 122/271 (45%), Gaps = 26/271 (9%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           ++G G FG V+ G     T VA+K  K+      S   F +E   + Q++H  LV+ +  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  ++   +I EY+ NG+L + L    G  L +   LD+A  +A  + ++    +   IH
Sbjct: 77  VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD++++NIL+++    K+ADFG ARL  D E          K    +  PE +     T 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANN 381
           KSDV+SFG+LL E+VT  R   P     E I       +    D                
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP------------- 236

Query: 382 LALEKILELALQCLAPRRQNRPSMRRCAEIL 412
              E++ +L   C   R ++RP+      +L
Sbjct: 237 ---EELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 2e-67
 Identities = 60/296 (20%), Positives = 121/296 (40%), Gaps = 26/296 (8%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
            IG+G FG V++G+   G  VA+K        +      ++EI     + H N++ F   
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 202 LEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM---- 253
              ++    +  ++ +Y  +G+L ++L       + + G + +A+  A  + +LHM    
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 254 -YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 I HRD+KS NIL+ +N    +AD G A                  GT  Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 313 YL------KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK----ERITVKWAMKKFS 362
            L      K ++  +++D+Y+ G++  E+           + +    + +    ++++  
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD 418
                  L P + N   +  AL  + ++  +C       R +  R  + L  + + 
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 7e-65
 Identities = 76/303 (25%), Positives = 125/303 (41%), Gaps = 28/303 (9%)

Query: 122 NVQITMEEIYRATRNFSPSFKIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSG 177
            VQ  +        +F+    IG+G FG VY G L D        A+K   +   D    
Sbjct: 16  AVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEV 72

Query: 178 AEFQSEIRTLAQVEHLNLVKFHGY-LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAG 236
           ++F +E   +    H N++   G  L  E   +V++ Y+ +G LR +    + +   +  
Sbjct: 73  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKD 131

Query: 237 RLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGAT 296
            +   + VA     +        +HRD+ + N +L E F  KVADFG AR   D E  + 
Sbjct: 132 LIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188

Query: 297 HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW 356
           H  T  K    ++  E L+T + T KSDV+SFGVLL EL+T   P  P     +      
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248

Query: 357 AMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR 416
             ++    +                   + + E+ L+C  P+ + RPS       + ++ 
Sbjct: 249 QGRRLLQPEYCP----------------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

Query: 417 KDY 419
             +
Sbjct: 293 STF 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 1e-64
 Identities = 80/271 (29%), Positives = 114/271 (42%), Gaps = 26/271 (9%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           K+GQG FG V+ G     T VAIK  K       S   F  E + + ++ H  LV+ +  
Sbjct: 24  KLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  E   IV  EY+  G+L + L    G  L L   +D+A  +A  + Y+        +H
Sbjct: 81  VSEEPIYIV-TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 136

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD++++NIL+ EN   KVADFG ARL  D E          K    +  PE     + T 
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTI 193

Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANN 381
           KSDV+SFG+LL EL T  R   P    +E +       +                     
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP------------- 240

Query: 382 LALEKILELALQCLAPRRQNRPSMRRCAEIL 412
              E + +L  QC     + RP+       L
Sbjct: 241 ---ESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 2e-64
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 32/277 (11%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
            IG+G FG V  G    G  VA+K  K     +     F +E   + Q+ H NLV+  G 
Sbjct: 14  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 68

Query: 202 LEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +  E   + IV EY+  G+L ++L     ++L     L  ++DV  A+ YL     +  +
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 125

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+ + N+L++E+  AKV+DFG  + A+ T+          K    +  PE L+  + +
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFS 178

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
            KSDV+SFG+LL E+ +  R   P+  LK+ +       K    D               
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP------------ 226

Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK 417
                 + E+   C       RPS  +  E L  ++ 
Sbjct: 227 ----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (524), Expect = 5e-64
 Identities = 79/286 (27%), Positives = 120/286 (41%), Gaps = 29/286 (10%)

Query: 142 KIGQGGFGTVYKGRLED-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           K+G G +G VY+G  +     VA+K  K+   D     EF  E   + +++H NLV+  G
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLG 80

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
               E    +I E++  G L ++L       +     L +A  ++ A+ YL        I
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 137

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+ + N L+ EN   KVADFG +RL               K    +  PE L   + +
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
            KSDV++FGVLL E+ T      P  +L +                  +L+         
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRMERPE 239

Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASD 426
               EK+ EL   C      +RPS    AEI  +    ++E + SD
Sbjct: 240 GCP-EKVYELMRACWQWNPSDRPSF---AEIHQAFETMFQESSISD 281

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 5e-64
 Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 26/271 (9%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           +IG G FG V+ G   +   VAIK  ++      S  +F  E   + ++ H  LV+ +G 
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
              +    ++ E++ +G L ++L   Q  +      L + +DV      +    +  +IH
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEG---MAYLEEACVIH 124

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+ + N L+ EN   KV+DFG  R   D +      ST  K    +  PE     + + 
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANN 381
           KSDV+SFGVL+ E+ +  +     R   E       ++  S G    +  PR+ +     
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTG--FRLYKPRLAS----- 228

Query: 382 LALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                + ++   C   R ++RP+  R    L
Sbjct: 229 ---THVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-63
 Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 26/278 (9%)

Query: 135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           ++ +   ++G G FG V  G+      VAIK  K+      S  EF  E + +  + H  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEK 60

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           LV+ +G    +    +I EY+ NG L  +L  ++         L++  DV  A+ YL   
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES- 118

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
                +HRD+ + N L+ +    KV+DFG +R   D E      S   K    +  PE L
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVL 173

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV 374
              + + KSD+++FGVL+ E+ +  +         ER T     +  + G  +       
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMP------YERFTNSETAEHIAQGLRLYR----- 222

Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                 +LA EK+  +   C   +   RP+ +     +
Sbjct: 223 -----PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 6e-63
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 12/211 (5%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           +F    ++G G  G V+K      G ++A K     +       +   E++ L +     
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPY 65

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +V F+G    + E  + +E++  G+L + L   +   +       ++I V   +TYL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLR-- 121

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H I+HRD+K SNIL+      K+ DFG +    D+      ++    GT  Y+ PE L
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERL 175

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPK 345
           +    + +SD++S G+ LVE+  GR PI P 
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 9e-63
 Identities = 77/316 (24%), Positives = 128/316 (40%), Gaps = 41/316 (12%)

Query: 126 TMEEIYRATRNFSPSF---------KIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVY 172
           T E+   A R F+             IG G FG V  G L    +    VAIK  K    
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 173 DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNIL 232
           +K    +F SE   + Q +H N++   G +      ++I E++ NG+L   L    G   
Sbjct: 68  EKQR-RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 233 DLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE 292
            +   + +   +A  + YL        +HRD+ + NIL+  N   KV+DFG +R   D  
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 293 SGATHVST-QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIE--PKREL 348
           S  T+ S    K    +  PE ++  + T  SDV+S+G+++ E+++ G RP      +++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 349 KERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRC 408
              I   + +    D                       + +L L C    R +RP   + 
Sbjct: 243 INAIEQDYRLPPPMD-------------------CPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 409 AEILWSVRKDYRELAA 424
              L  + ++   L A
Sbjct: 284 VNTLDKMIRNPNSLKA 299

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 8e-62
 Identities = 68/277 (24%), Positives = 116/277 (41%), Gaps = 34/277 (12%)

Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G F TVYKG   E    VA    +     K     F+ E   L  ++H N+V+F+ 
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 201 YLEF---EDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             E      + IV+V E + +GTL+ +L   +  ++ +         +   + +LH    
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR-T 132

Query: 257 HPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            PIIHRD+K  NI +T      K+ D G A L           +  V GT  ++ PE  +
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA------SFAKAVIGTPEFMAPEMYE 186

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
             +  E  DVY+FG+ ++E+ T   P        E        ++ + G   +  D    
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA- 238

Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                   + ++ E+   C+   +  R S+    ++L
Sbjct: 239 --------IPEVKEIIEGCIRQNKDERYSI---KDLL 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (503), Expect = 9e-61
 Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 50/299 (16%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
            IG+G FG V++ R       E  T+VA+K  K+        A+FQ E   +A+ ++ N+
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNI 78

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI----------------------LD 233
           VK  G         ++ EY+  G L E L  +  +                       L 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
            A +L IA  VA  + YL    +   +HRD+ + N L+ EN   K+ADFG +R     + 
Sbjct: 139 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
                         ++ PE +   + T +SDV+++GV+L E+ +                
Sbjct: 196 --YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM------A 247

Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            +  +    DG+ ++  +              ++  L   C +    +RPS      IL
Sbjct: 248 HEEVIYYVRDGNILACPEN----------CPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-60
 Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 28/275 (10%)

Query: 142 KIGQGGFGTVYKGRLED---GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKF 198
           ++G G FGTV KG  +       VA+K  K    D     E  +E   + Q+++  +V+ 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
            G  E E   +V +E    G L ++L   Q   +     +++   V+  + YL       
Sbjct: 74  IGICEAESWMLV-MEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE---SN 127

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
            +HRD+ + N+LL     AK++DFG ++     E+      T  K    +  PE +  Y+
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYK 186

Query: 319 LTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
            + KSDV+SFGVL+ E  + G++P          +           G+ +          
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPY-------RGMKGSEVTAMLEKGERMGCPAG----- 234

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                   ++ +L   C     +NRP        L
Sbjct: 235 -----CPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-60
 Identities = 68/278 (24%), Positives = 112/278 (40%), Gaps = 31/278 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            IG G +G   K R   DG I+  K        +       SE+  L +++H N+V+++ 
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 201 YLEFEDERIV--IVEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYTD 256
            +       +  ++EY   G L   +     +   LD    L +   +  A+   H  +D
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 257 --HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K +N+ L      K+ DFG AR+        T  +    GT  Y+ PE +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----TSFAKAFVGTPYYMSPEQM 186

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV 374
                 EKSD++S G LL EL     P           + K    K  +G     +  R 
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------SQKELAGKIREGK-FRRIPYRY 238

Query: 375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                     +++ E+  + L  +  +RPS+    EIL
Sbjct: 239 S---------DELNEIITRMLNLKDYHRPSV---EEIL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-59
 Identities = 57/290 (19%), Positives = 119/290 (41%), Gaps = 29/290 (10%)

Query: 128 EEIYRATRNFSPS-FKIGQGGFGTVYKGRL---EDGTIVAIKRAKKSVYDKHSGAEFQSE 183
           ++++    N   +  ++G G FG+V +G     +    VAIK  K+   +K    E   E
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMRE 59

Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
            + + Q+++  +V+  G    + E +++V E    G L + L   +   + ++   ++  
Sbjct: 60  AQIMHQLDNPYIVRLIGV--CQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLH 116

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
            V+  + YL        +HRD+ + N+LL     AK++DFG ++     +S      +  
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAG 172

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS 362
           K    +  PE +   + + +SDV+S+GV + E ++  +    K +  E       M    
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIE 226

Query: 363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            G  +                  ++  L   C   + ++RP      + +
Sbjct: 227 QGKRMECPPE----------CPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 4e-59
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)

Query: 142 KIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFH 199
            +G+G FG VY  R  +   I+A+K   K+  +K       + E+   + + H N+++ +
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           GY        +I+EY P GT+   L   + +  D         ++A+A++Y H      +
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH---SKRV 127

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           IHRDIK  N+LL      K+ADFG++  A  +        T + GT  YL PE ++    
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------RTTLCGTLDYLPPEMIEGRMH 181

Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVENT 377
            EK D++S GVL  E + G+ P E    +E  +RI+      +F+  D ++         
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----RVEFTFPDFVT--------- 228

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                  E   +L  + L      RP +R   E+L
Sbjct: 229 -------EGARDLISRLLKHNPSQRPMLR---EVL 253

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (486), Expect = 4e-58
 Identities = 68/309 (22%), Positives = 118/309 (38%), Gaps = 35/309 (11%)

Query: 134 TRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKS-VYDKHSGAEFQSEIRTLAQVE 191
            + FS   +IG G FG VY  R + +  +VAIK+   S         +   E+R L ++ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 192 HLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYL 251
           H N +++ G    E    +++EY            +    L       +       + YL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 252 HMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDP 311
           H    H +IHRD+K+ NILL+E    K+ DFG A + A              GT  ++ P
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--------NSFVGTPYWMAP 180

Query: 312 EYLKTY---QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS 368
           E +      Q   K DV+S G+  +EL   + P+     +        A+   +  ++ +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNESPA 233

Query: 369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVL 428
           +               E        CL    Q+RP+     +  + V ++       D++
Sbjct: 234 LQSGHWS---------EYFRNFVDSCLQKIPQDRPTSEVLLKHRF-VLRERPPTVIMDLI 283

Query: 429 LQPSYSKRS 437
            +   + R 
Sbjct: 284 QRTKDAVRE 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 77/299 (25%), Positives = 123/299 (41%), Gaps = 32/299 (10%)

Query: 134 TRNFSPS-FK----IGQGGFGTVYKGRLEDGT-----IVAIKRAKKSVYDKHSGAEFQSE 183
           T    PS       IG G FG VYKG L+  +      VAIK  K    +K    +F  E
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGE 59

Query: 184 IRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAID 243
              + Q  H N+++  G +      ++I EY+ NG   +     +     +   + +   
Sbjct: 60  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRG 118

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           +A  + YL    +   +HRD+ + NIL+  N   KV+DFG +R+  D    AT+ ++  K
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-ATYTTSGGK 174

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD 363
               +  PE +   + T  SDV+SFG+++ E++T       +    E       MK  +D
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAIND 228

Query: 364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL 422
           G       P   +          I +L +QC    R  RP       IL  + +    L
Sbjct: 229 G----FRLPTPMD------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-57
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 26/276 (9%)

Query: 142 KIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLV 196
           K+G G FG V +G  +        VA+K  K  V  +    + F  E+  +  ++H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
           + +G +     ++V  E  P G+L + L   QG+   L      A+ VA  + YL     
Sbjct: 75  RLYGVVLTPPMKMV-TELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLE---S 129

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
              IHRD+ + N+LL      K+ DFG  R     +     +    K    +  PE LKT
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWCAPESLKT 188

Query: 317 YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
              +  SD + FGV L E+ T  +         +        K   +G+ +    PR E+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGERL----PRPED 239

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                   + I  + +QC A + ++RP+     + L
Sbjct: 240 CP------QDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 1e-56
 Identities = 62/294 (21%), Positives = 109/294 (37%), Gaps = 44/294 (14%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLN 194
            +G G FG V +         +    VA+K  K S +         SE++ L+ +  H+N
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHMN 88

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI----------------LDLAGRL 238
           +V   G        +VI EY   G L   L   + +                 LDL   L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
             +  VA  + +L        IHRD+ + NILLT     K+ DFG AR   +  +    V
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVV 203

Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM 358
               +    ++ PE +     T +SDV+S+G+ L EL +      P   +  +       
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF------ 257

Query: 359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                     ++       +  +    ++ ++   C       RP+ ++  +++
Sbjct: 258 --------YKMIKEGFRMLSPEHAP-AEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 3e-56
 Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 28/273 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+G +G V           VA+K               + EI     + H N+VKF+G
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           +    + + + +EY   G L + ++      +           +   + YLH      I 
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 125

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL- 319
           HRDIK  N+LL E    K++DFG A +          +  ++ GT  Y+ PE LK  +  
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREFH 183

Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA 379
            E  DV+S G++L  ++ G  P +   +  +          + +         ++++   
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLNPWKKIDSAP- 236

Query: 380 NNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                   L L  + L      R ++    +I 
Sbjct: 237 --------LALLHKILVENPSARITI---PDIK 258

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 5e-56
 Identities = 74/311 (23%), Positives = 119/311 (38%), Gaps = 43/311 (13%)

Query: 142 KIGQGGFGTVYKGRLEDG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVK 197
            IG+G FG V K R++        AIKR K+    K    +F  E+  L ++  H N++ 
Sbjct: 17  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHL--------------DCLQGNILDLAGRLDIAID 243
             G  E      + +EY P+G L + L                   + L     L  A D
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 244 VAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVK 303
           VA  + YL        IHRD+ + NIL+ EN+ AK+ADFG +R             T  +
Sbjct: 136 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KTMGR 187

Query: 304 GTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD 363
               ++  E L     T  SDV+S+GVLL E+V+            E         +   
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247

Query: 364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELA 423
                                +++ +L  QC   +   RPS  +    L  + ++ +   
Sbjct: 248 PLNCD----------------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291

Query: 424 ASDVLLQPSYS 434
            + +  + +Y+
Sbjct: 292 NTTLYEKFTYA 302

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-56
 Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 34/277 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G G FG VYK +  E   + A K        +    ++  EI  LA  +H N+VK   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLD 76

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
              +E+   +++E+   G +   +       L  +    +      A+ YLH   D+ II
Sbjct: 77  AFYYENNLWILIEFCAGGAVDAVM-LELERPLTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL- 319
           HRD+K+ NIL T +   K+ADFG +     T            GT  ++ PE +      
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----RRDSFIGTPYWMAPEVVMCETSK 188

Query: 320 ----TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
                 K+DV+S G+ L+E+     P      ++        + K +  +  ++  P   
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRW 241

Query: 376 NTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           ++           +   +CL      R +    +++L
Sbjct: 242 SSNF--------KDFLKKCLEKNVDARWTT---SQLL 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 1e-55
 Identities = 72/316 (22%), Positives = 136/316 (43%), Gaps = 49/316 (15%)

Query: 142 KIGQGGFGTVYKGRL------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
           ++GQG FG VY+G        E  T VAIK   ++   +    EF +E   + +    ++
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEASVMKEFNCHHV 85

Query: 196 VKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNI--------LDLAGRLDIAIDVAHA 247
           V+  G +      +VI+E +  G L+ +L  L+  +          L+  + +A ++A  
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAG 307
           + YL+    +  +HRD+ + N ++ E+F  K+ DFG  R   +T+        +      
Sbjct: 146 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVR 200

Query: 308 YLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI 367
           ++ PE LK    T  SDV+SFGV+L E+ T            + ++ +  ++   +G  +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------QGLSNEQVLRFVMEGGLL 254

Query: 368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDV 427
              D             + + EL   C     + RPS     EI+ S++++         
Sbjct: 255 DKPDN----------CPDMLFELMRMCWQYNPKMRPSFL---EIISSIKEE--------- 292

Query: 428 LLQPSYSKRSNSTREQ 443
            ++P + + S    E+
Sbjct: 293 -MEPGFREVSFYYSEE 307

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 3e-55
 Identities = 60/311 (19%), Positives = 118/311 (37%), Gaps = 27/311 (8%)

Query: 137 FSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSG---AEFQSEIRTLAQVEH 192
           F     +G G FGTVYKG  + +G  V I  A K + +  S     E   E   +A V++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
            ++ +  G       ++ I + +P G L ++      + +     L+  + +A  + YL 
Sbjct: 71  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
                 ++HRD+ + N+L+      K+ DFG A+L    E    + +   K    ++  E
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALE 183

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
            +     T +SDV+S+GV + EL+T            E  ++    ++       +    
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT---- 239

Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPS 432
                         +  + ++C      +RP  R        + +D +         +  
Sbjct: 240 ------------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287

Query: 433 YSKRSNSTREQ 443
               ++S   +
Sbjct: 288 LPSPTDSNFYR 298

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 1e-54
 Identities = 65/301 (21%), Positives = 101/301 (33%), Gaps = 49/301 (16%)

Query: 142 KIGQGGFGTVYKGRLED------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLN 194
            +G G FG V                VA+K  K+   D        SE++ + Q+  H N
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHEN 102

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHL---------------------DCLQGNILD 233
           +V   G         +I EY   G L  +L                     +    N+L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 234 LAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES 293
               L  A  VA  + +L        +HRD+ + N+L+T     K+ DFG AR      +
Sbjct: 163 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT 353
               V    +    ++ PE L     T KSDV+S+G+LL E+ +      P   +     
Sbjct: 220 --YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF- 276

Query: 354 VKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW 413
                          ++    +         E+I  +   C A   + RPS       L 
Sbjct: 277 -------------YKLIQNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

Query: 414 S 414
            
Sbjct: 323 C 323

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-54
 Identities = 67/283 (23%), Positives = 116/283 (40%), Gaps = 29/283 (10%)

Query: 142 KIGQGGFGTVYKGRL----EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVK 197
            IG+G FG V++G           VAIK  K    D     +F  E  T+ Q +H ++VK
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVK 72

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             G +  E+   +I+E    G LR  L   + + LDLA  +  A  ++ A+ YL      
Sbjct: 73  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE---SK 127

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
             +HRDI + N+L++ N   K+ DFG +R   D+     + +++ K    ++ PE +   
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFR 184

Query: 318 QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
           + T  SDV+ FGV + E++          +  + I      ++                 
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP--------- 235

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
                    +  L  +C A     RP        L ++ ++ +
Sbjct: 236 -------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 6e-54
 Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 31/272 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG  GTVY    +  G  VAI++       +       +EI  + + ++ N+V +  
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
                DE  V++EY+  G+L    D +    +D      +  +   A+ +LH    + +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRDIKS NILL  +   K+ DFGF       +       + + GT  ++ PE +      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAAN 380
            K D++S G++ +E++ G  P   +  L+       A+   +      + +P   +    
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTPELQNPEKLSAIFR 247

Query: 381 NLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +           +CL    + R S     E+L
Sbjct: 248 D--------FLNRCLDMDVEKRGSA---KELL 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 9e-53
 Identities = 61/274 (22%), Positives = 104/274 (37%), Gaps = 27/274 (9%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFH 199
            +G+G F TV   R L      AIK  +K    K +       E   +++++H   VK +
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
              + +++    + Y  NG L +++  +     D         ++  A+ YLH      I
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLH---GKGI 129

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           IHRD+K  NILL E+   ++ DFG A++ +         +    GTA Y+ PE L     
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANSFVGTAQYVSPELLTEKSA 187

Query: 320 TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAA 379
            + SD+++ G ++ +LV G  P     E    I  K    ++   +              
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKLEYDFPEKFF----------- 234

Query: 380 NNLALEKILELALQCLAPRRQNRPSMRRCAEILW 413
                 K  +L  + L      R           
Sbjct: 235 -----PKARDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 1e-50
 Identities = 72/294 (24%), Positives = 112/294 (38%), Gaps = 45/294 (15%)

Query: 142 KIGQGGFGTVYKGRL--------EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EH 192
            +G+G FG V                T VA+K  K    +K   ++  SE+  +  + +H
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKH 78

Query: 193 LNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQG--------------NILDLAGRL 238
            N++   G    +    VIVEY   G LRE+L   +                 L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 239 DIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHV 298
             A  VA  + YL        IHRD+ + N+L+TE+   K+ADFG AR     +      
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY--YKK 193

Query: 299 STQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAM 358
           +T  +    ++ PE L     T +SDV+SFGVLL E+ T      P         V+   
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELF 247

Query: 359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           K   +G  +                  ++  +   C       RP+ ++  E L
Sbjct: 248 KLLKEGHRMDKPSN----------CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (435), Expect = 4e-50
 Identities = 57/276 (20%), Positives = 104/276 (37%), Gaps = 35/276 (12%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G G FG V++      G   A K        +      + EI+T++ + H  LV  H 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHD 90

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E ++E ++I E++  G L E +   + N +     ++    V   + ++H   ++  +
Sbjct: 91  AFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYV 146

Query: 261 HRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           H D+K  NI+ T   +   K+ DFG        +S          GTA +  PE  +   
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-----TTGTAEFAAPEVAEGKP 201

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPK--RELKERITVKWAMKKFSDGDAISILDPRVEN 376
           +   +D++S GVL   L++G  P   +   E    +         S    IS        
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS-------- 253

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                   E   +   + L      R ++    + L
Sbjct: 254 --------EDGKDFIRKLLLADPNTRMTI---HQAL 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 9e-50
 Identities = 66/292 (22%), Positives = 104/292 (35%), Gaps = 41/292 (14%)

Query: 142 KIGQGGFGTVYKGR------LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL 195
            +G+G FG V +              VA+K  K+        A        +    HLN+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 196 VKFHGYLEFEDERI-VIVEYVPNGTLREHL--------------DCLQGNILDLAGRLDI 240
           V   G        + VIVE+   G L  +L              + L  + L L   +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
           +  VA  + +L        IHRD+ + NILL+E    K+ DFG AR              
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKG 194

Query: 301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK 360
             +    ++ PE +     T +SDV+SFGVLL E+ +      P  ++ E        ++
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRR 249

Query: 361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
             +G  +   D              ++ +  L C       RP+     E L
Sbjct: 250 LKEGTRMRAPDY----------TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  166 bits (421), Expect = 5e-49
 Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 30/271 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFH 199
            +G GG   V+  R L     VA+K  +  +    S    F+ E +  A + H  +V  +
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 200 GYLEFEDE---RIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
              E E        IV EYV   TLR+ +       +     +++  D   A+ + H   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH--- 128

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
            + IIHRD+K +NI+++     KV DFG AR  AD+ +  T  +  V GTA YL PE  +
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQAR 187

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITVKWAMKKFSDGDAISILDPR 373
              +  +SDVYS G +L E++TG  P   +    +  +   +  +   +  + +S     
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS----- 242

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPS 404
                        +  + L+ LA   +NR  
Sbjct: 243 -----------ADLDAVVLKALAKNPENRYQ 262

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-48
 Identities = 56/276 (20%), Positives = 103/276 (37%), Gaps = 36/276 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G+G FG V++            K  K    D+      + EI  L    H N++  H 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILHLHE 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E  +E ++I E++    + E ++      L+    +     V  A+ +LH    H I 
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 261 HRDIKSSNILLT--ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           H DI+  NI+     +   K+ +FG AR     ++              Y  PE  +   
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-----FTAPEYYAPEVHQHDV 179

Query: 319 LTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITVKWAMKKFSDGDAISILDPRVEN 376
           ++  +D++S G L+  L++G  P   E  +++ E I              IS        
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS-------- 231

Query: 377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                    + ++   + L   R++R +    +E L
Sbjct: 232 --------IEAMDFVDRLLVKERKSRMTA---SEAL 256

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-48
 Identities = 65/295 (22%), Positives = 118/295 (40%), Gaps = 26/295 (8%)

Query: 132 RATRNFSPSFKIGQGGFGTVYKGR--LEDGTIVAIKRAKKSVYDKHSGAEFQSEI---RT 186
           RA + +    +IG+G +G V+K R     G  VA+KR +    ++        E+   R 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 187 LAQVEHLNLVKFHGYLEF----EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           L   EH N+V+            + ++ +V    +  L  +LD +    +      D+  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
            +   + +LH    H ++HRD+K  NIL+T + + K+ADFG AR+ +   +  + V    
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---- 176

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS 362
             T  Y  PE L         D++S G +  E+   +       ++ +   +   +    
Sbjct: 177 -VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 363 DGD-AISILDPRVENTAANNLALEKI--------LELALQCLAPRRQNRPSMRRC 408
           + D    +  PR    + +   +EK          +L L+CL      R S    
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (422), Expect = 3e-48
 Identities = 63/305 (20%), Positives = 122/305 (40%), Gaps = 31/305 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           ++G G FG V++      G +   K               ++EI  + Q+ H  L+  H 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHD 93

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
             E + E ++I+E++  G L + +   +   +  A  ++        + ++H   +H I+
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149

Query: 261 HRDIKSSNILL--TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           H DIK  NI+    +    K+ DFG A      E     +      TA +  PE +    
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREP 204

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
           +   +D+++ GVL   L++G  P   + +L+    VK    +F + DA S + P  ++  
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-DAFSSVSPEAKD-- 261

Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAASDVLLQPSYSKRSN 438
                           L    + R ++    E  W ++ D+  L +   +    Y+K   
Sbjct: 262 -----------FIKNLLQKEPRKRLTVHDALEHPW-LKGDHSNLTSR--IPSSRYNKIRQ 307

Query: 439 STREQ 443
             +E+
Sbjct: 308 KIKEK 312

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  164 bits (415), Expect = 1e-47
 Identities = 66/277 (23%), Positives = 110/277 (39%), Gaps = 38/277 (13%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFH 199
            +G G FG V+  R   +G   A+K  KK +  +    E    E   L+ V H  +++  
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 200 GYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           G  +   +  +I++Y+  G L   L   Q     +A     A +V  A+ YLH      I
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA--KFYAAEVCLALEYLH---SKDI 125

Query: 260 IHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL 319
           I+RD+K  NILL +N   K+ DFGFA+   D           + GT  Y+ PE + T   
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-------YTLCGTPDYIAPEVVSTKPY 178

Query: 320 TEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITVKWAMKKFSDGDAISILDPRVENT 377
            +  D +SFG+L+ E++ G  P       +  E+I       +       +         
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----NAELRFPPFFN--------- 225

Query: 378 AANNLALEKILELALQCLAPRRQNRPSMRR--CAEIL 412
                  E + +L  + +      R    +    ++ 
Sbjct: 226 -------EDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  162 bits (410), Expect = 2e-47
 Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 46/294 (15%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-------FQSEIRTL 187
           N+ P   +G+G    V +          A+K    +     S  E          E+  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 188 AQV-EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAH 246
            +V  H N+++     E      ++ + +  G L ++L   +   L       I   +  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLE 121

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
            I  LH      I+HRD+K  NILL ++   K+ DFGF+      E        +V GT 
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-----LREVCGTP 173

Query: 307 GYLDPEYLKTYQL------TEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITVKWAM 358
            YL PE ++           ++ D++S GV++  L+ G  P     +  +   I      
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233

Query: 359 KKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
               + D  S                + + +L  + L  + Q R +     E L
Sbjct: 234 FGSPEWDDYS----------------DTVKDLVSRFLVVQPQKRYTA---EEAL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-46
 Identities = 62/274 (22%), Positives = 111/274 (40%), Gaps = 32/274 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLA-QVEHLNLVKF 198
            +G+G FG V+     +     AIK  KK V       E    E R L+   EH  L   
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 199 HGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP 258
               + ++    ++EY+  G L  H+     +  DL+     A ++   + +LH      
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLH---SKG 123

Query: 259 IIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ 318
           I++RD+K  NILL ++   K+ADFG  +     ++     +    GT  Y+ PE L   +
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYIAPEILLGQK 179

Query: 319 LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVENTA 378
                D +SFGVLL E++ G+ P   + E +   +++     +     +           
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LE---------- 227

Query: 379 ANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                 ++  +L ++      + R  +R   +I 
Sbjct: 228 ------KEAKDLLVKLFVREPEKRLGVR--GDIR 253

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 40/292 (13%)

Query: 131 YRATRNFSPSF----KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIR 185
           ++   +    +     +G G F  V          +VAIK   K   +       ++EI 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIA 59

Query: 186 TLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVA 245
            L +++H N+V      E      +I++ V  G L + +  ++           +   V 
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVL 117

Query: 246 HAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQV 302
            A+ YLH   D  I+HRD+K  N+L     E+ +  ++DFG +++          V +  
Sbjct: 118 DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----GSVLSTA 169

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPI--EPKRELKERITVKWAMKK 360
            GT GY+ PE L     ++  D +S GV+   L+ G  P   E   +L E+I        
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229

Query: 361 FSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
               D IS                +   +     +    + R +     + L
Sbjct: 230 SPYWDDIS----------------DSAKDFIRHLMEKDPEKRFTC---EQAL 262

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  159 bits (403), Expect = 3e-46
 Identities = 50/288 (17%), Positives = 95/288 (32%), Gaps = 27/288 (9%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           +IG+G FG +++G  L +   VAIK   +    +    + + E RT   +     +    
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
           Y   E    V+V  +  G   E L  L G    +      A  +   +  +H   +  ++
Sbjct: 68  YFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123

Query: 261 HRDIKSSNILLTENFR-----AKVADFGFARLAADTESGAT---HVSTQVKGTAGYLDPE 312
           +RDIK  N L+            V DFG  +   D  +           + GTA Y+   
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
                + + + D+ + G + +  + G  P +  +      T K   ++  +    + L  
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGEKKQSTPLRE 239

Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR 420
                       E+  +             P       +   V +   
Sbjct: 240 LCAGFP------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (403), Expect = 3e-46
 Identities = 52/279 (18%), Positives = 95/279 (34%), Gaps = 27/279 (9%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG G FG +Y G  +  G  VAIK        K    +   E +    ++    +    
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTIR 69

Query: 201 YLEFEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPI 259
           +   E +  V+V E +          C       L   L +A  +   I Y+H       
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNF 124

Query: 260 IHRDIKSSNILLTE---NFRAKVADFGFARLAADTESGA---THVSTQVKGTAGYLDPEY 313
           IHRD+K  N L+          + DFG A+   D  +        +  + GTA Y     
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
               + + + D+ S G +L+    G        +  +  T +   ++ S+    + ++  
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKKMSTPIEVL 240

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
            +          +       C + R  ++P      ++ 
Sbjct: 241 CKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (403), Expect = 2e-45
 Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 36/286 (12%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEF----QSEIRTLAQV 190
           +FS    IG+GGFG VY  R  + G + A+K   K       G       +  +  ++  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 191 EHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITY 250
           +   +V         D+   I++ +  G L  HL                A ++   + +
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM--RFYAAEIILGLEH 122

Query: 251 LHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLD 310
           +H   +  +++RD+K +NILL E+   +++D G A   +  +  A+       GT GY+ 
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMA 173

Query: 311 PEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRPIEPKR-ELKERITVKWAMKKFSDGDAIS 368
           PE L+        +D +S G +L +L+ G  P    + + K  I            D+ S
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRR--CAEIL 412
                            ++  L    L      R         E+ 
Sbjct: 234 ----------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-45
 Identities = 61/285 (21%), Positives = 104/285 (36%), Gaps = 19/285 (6%)

Query: 136 NFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           NF    KIG+G +G VYK R    G +VA+K+ +     +   +    EI  L ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +VK    +  E++  ++ E++    L++ +D      + L         +   + + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
             H ++HRD+K  N+L+      K+ADFG AR            + +V           L
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILL 175

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE---LKERITVKWAMKKFSDGDAISILD 371
                +   D++S G +  E+VT R       E   L           +       S+ D
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 372 PRVENTAANNLALEKI--------LELALQCLAPRRQNRPSMRRC 408
            +            K+          L  Q L      R S +  
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 8e-45
 Identities = 57/295 (19%), Positives = 111/295 (37%), Gaps = 32/295 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIGQG FG V+K R  + G  VA+K+       +        EI+ L  ++H N+V    
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 201 --------YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLH 252
                   Y   +    ++ ++  +       + L    L    R+     +   +  L+
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQMLLNGLY 131

Query: 253 MYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
               + I+HRD+K++N+L+T +   K+ADFG AR  +  ++   +  T    T  Y  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 313 YLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD 371
            L   +      D++  G ++ E+ T    ++   E  +   +       +     ++ +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 372 --------------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                          +V++     +     L+L  + L      R       + L
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS---DDAL 303

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  155 bits (392), Expect = 1e-44
 Identities = 51/282 (18%), Positives = 109/282 (38%), Gaps = 22/282 (7%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGY 201
           KIG+G +G VYK +   G   A+K+ +    D+   +    EI  L +++H N+VK +  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 202 LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIH 261
           +  +   +++ E++     +    C     L+        + + + I Y H   D  ++H
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 262 RDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTE 321
           RD+K  N+L+      K+ADFG AR            + ++           + + + + 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 322 KSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD---------- 371
             D++S G +  E+V G        E  + + +   +   +  +  ++ +          
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 372 -PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
              +   +      E  ++L  + L      R +     + L
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA---KQAL 279

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 2e-44
 Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 27/286 (9%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGA---EFQSEIRTLAQVEHLNLVK 197
            +G+G F TVYK R      IVAIK+ K     +           EI+ L ++ H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 198 FHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
                  +    ++ +++         D     +L  +      +     + YLH    H
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 258 PIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTY 317
            I+HRD+K +N+LL EN   K+ADFG A+             T    T  Y  PE L   
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP----NRAYTHQVVTRWYRAPELLFGA 175

Query: 318 QL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD----- 371
           ++     D+++ G +L EL+     +    +L +   +   +   ++     +       
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 372 -----PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                P +      + A + +L+L           R +     + L
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA---TQAL 278

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-44
 Identities = 58/284 (20%), Positives = 103/284 (36%), Gaps = 24/284 (8%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
           KIG+G +GTV+K +  E   IVA+KR +    D+   +    EI  L +++H N+V+ H 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 201 YLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPII 260
            L  + +  ++ E+      +    C      ++         +   + + H      ++
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLLKGLGFCHS---RNVL 123

Query: 261 HRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLT 320
           HRD+K  N+L+  N   K+A+FG AR            S +V                 +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 321 EKSDVYSFGVLLVELVTGRRPIEPKRELKERIT------------VKWAMKKFSDGDAIS 368
              D++S G +  EL    RP+ P  ++ +++                +M K  D     
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
           +                   +L    L      R S     E L
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA---EEAL 281

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 6e-44
 Identities = 57/286 (19%), Positives = 107/286 (37%), Gaps = 27/286 (9%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            IG+G +G V       +   VAIK+     +  +       EI+ L +  H N++  + 
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC-QRTLREIKILLRFRHENIIGIND 73

Query: 201 YLEFED----ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
            +        + + +V ++      +    L+   L           +   + Y+H    
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGA---DLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 127

Query: 257 HPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
             ++HRD+K SN+LL      K+ DFG AR+A         ++  V  T  Y  PE +  
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLN 186

Query: 317 -YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
               T+  D++S G +L E+++ R     K  L +   +   +   S  D   I++ +  
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 376 NTAANNLALEKI-------------LELALQCLAPRRQNRPSMRRC 408
           N   +     K+             L+L  + L      R  + + 
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 33/293 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVEHLNLV 196
           ++G G F  V K R    G   A K  KK          S  + + E+  L +++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 197 KFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             H   E + + I+I+E V  G L +     +   L      +    + +    ++    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNG---VYYLHS 131

Query: 257 HPIIHRDIKSSNILLTEN----FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPE 312
             I H D+K  NI+L +      R K+ DFG A                + GT  ++ PE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPE 186

Query: 313 YLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
            +    L  ++D++S GV+   L++G  P     + +        +   S  +     D 
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVN-YEFEDE 238

Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRELAAS 425
              NT+          +   + L    + R +++   +  W   KD ++  +S
Sbjct: 239 YFSNTS------ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSS 285

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 4e-43
 Identities = 67/280 (23%), Positives = 103/280 (36%), Gaps = 46/280 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHS----GAEFQSEIRTLAQV--EHLN 194
            +G GGFG+VY G  + D   VAIK  +K           G     E+  L +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 195 LVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
           +++   + E  D  ++I+E              +   L           V  A+ + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCH-- 127

Query: 255 TDHPIIHRDIKSSNILLTEN-FRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
            +  ++HRDIK  NIL+  N    K+ DFG   L  DT        T   GT  Y  PE+
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY------TDFDGTRVYSPPEW 180

Query: 314 LKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP 372
           ++ ++     + V+S G+LL ++V G  P                   F   + I     
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------------FEHDEEIIRGQV 221

Query: 373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
                 ++         L   CLA R  +RP+     EI 
Sbjct: 222 FFRQRVSSECQ-----HLIRWCLALRPSDRPTF---EEIQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 8e-43
 Identities = 58/279 (20%), Positives = 97/279 (34%), Gaps = 37/279 (13%)

Query: 143 IGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHG 200
           +G G  G V +          A+K  +          + + E+    +  +  ++V+   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVD 72

Query: 201 YLE---FEDERIVIV-EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTD 256
             E      + ++IV E +  G L   +              +I   +  AI YLH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129

Query: 257 HPIIHRDIKSSNILLT---ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
             I HRD+K  N+L T    N   K+ DFGFA+      S  T        T  Y+ PE 
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-----PCYTPYYVAPEV 184

Query: 314 LKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR 373
           L   +  +  D++S GV++  L+ G  P      L     +   MK           +P 
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMGQYEFPNPE 240

Query: 374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL 412
               +      E++  L    L      R ++    E +
Sbjct: 241 WSEVS------EEVKMLIRNLLKTEPTQRMTI---TEFM 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 7e-42
 Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 38/292 (13%)

Query: 125 ITMEEIYRATRNFSPSFKIGQGGFGTVYKGR-LEDGTIVAIKRAKKS-VYDKHSGAEFQS 182
           +TM        +F     +G+G FG V   R    G   A+K  +K  +  K   A   +
Sbjct: 2   VTMN-------DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT 54

Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAI 242
           E R L    H  L       +  D    ++EY   G L  HL   +  +           
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGA 112

Query: 243 DVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQV 302
           ++  A   L       +++RDIK  N++L ++   K+ DFG  +      +         
Sbjct: 113 EIVSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT----F 165

Query: 303 KGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFS 362
            GT  YL PE L+        D +  GV++ E++ GR P     +  ER+     M++  
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILMEEIR 223

Query: 363 DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRR--CAEIL 412
               +S                 +   L    L    + R         E++
Sbjct: 224 FPRTLS----------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-41
 Identities = 58/294 (19%), Positives = 112/294 (38%), Gaps = 35/294 (11%)

Query: 136 NFSPSFKIGQGGFGTVYKGRL-EDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLN 194
           +++ +  IG G FG VY+ +L + G +VAIK+  +             E++ + +++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74

Query: 195 LVKFHGYLEFEDER-----IVIV-EYVPNGTLREHLDCLQGN-ILDLAGRLDIAIDVAHA 247
           +V+   +     E+     + +V +YVP    R      +    L +         +  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 248 ITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATHVSTQVKGTA 306
           + Y+H      I HRDIK  N+LL  +    K+ DFG A+     E   +++ ++     
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----- 186

Query: 307 GYLDP-EYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRE-------LKERITVKWAM 358
            Y  P         T   DV+S G +L EL+ G+               +K   T     
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 359 KKFSDGDAISILDPRVENTAANNLALEKI----LELALQCLAPRRQNRPSMRRC 408
            +  + +      P+++      +   +     + L  + L      R +    
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 4e-38
 Identities = 57/255 (22%), Positives = 99/255 (38%), Gaps = 22/255 (8%)

Query: 89  ASRSRASTERRRSSSQGLYVSSNNSTRGGDQSGNVQITMEEIYRATRNFSPSFKIGQGGF 148
           A+ ++  +E+  S  + L  +  +  +  +        +++ +   +       +G G F
Sbjct: 3   AAAAKKGSEQE-SVKEFLAKAKEDFLKKWETPSQNTAQLDQ-FDRIK------TLGTGSF 54

Query: 149 GTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAE-FQSEIRTLAQVEHLNLVKFHGYLEFED 206
           G V   +  E G   A+K   K    K    E   +E R L  V    LVK     +   
Sbjct: 55  GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114

Query: 207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKS 266
              +++EYV  G +  HL   +            A  +     YLH      +I+RD+K 
Sbjct: 115 NLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKP 169

Query: 267 SNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVY 326
            N+L+ +    +V DFGFA+               + GT   L PE + +    +  D +
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRT-------WTLCGTPEALAPEIILSKGYNKAVDWW 222

Query: 327 SFGVLLVELVTGRRP 341
           + GVL+ E+  G  P
Sbjct: 223 ALGVLIYEMAAGYPP 237

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-36
 Identities = 49/301 (16%), Positives = 98/301 (32%), Gaps = 29/301 (9%)

Query: 128 EEIYRATRNFSPSF----KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQS 182
           +E+ +        +     +G G +G V        G  VAIK+  +    +        
Sbjct: 7   QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66

Query: 183 EIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPNGTLREHL--DCLQGNILDLAGRLDI 240
           E+R L  + H N++        ++      ++              ++   L       +
Sbjct: 67  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 126

Query: 241 AIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVST 300
              +   + Y+H      IIHRD+K  N+ + E+   K+ DFG AR         + ++ 
Sbjct: 127 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------QADSEMTG 177

Query: 301 QVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK 360
            V           L   + T+  D++S G ++ E++TG+   +    L +   +      
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 361 FSDGDAISILDPRVENTAANNLALEKI-------------LELALQCLAPRRQNRPSMRR 407
                   +     +N       LEK              + L  + L    + R +   
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 408 C 408
            
Sbjct: 298 A 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-36
 Identities = 67/319 (21%), Positives = 124/319 (38%), Gaps = 45/319 (14%)

Query: 108 VSSNNSTRGGDQSGNVQ-ITMEEIYRATRNFSPSFKIGQGGFGTVYKGRL----EDGTIV 162
           ++  +  R  + +G+ + + +E       NF     +G G +G V+  R     + G + 
Sbjct: 3   LTVKHELRTANLTGHAEKVGIE-------NFELLKVLGTGAYGKVFLVRKISGHDTGKLY 55

Query: 163 AIKRAKKSVYDKHSGA--EFQSEIRTLAQVEHL-NLVKFHGYLEFEDERIVIVEYVPNGT 219
           A+K  KK+   + +      ++E + L  +     LV  H   + E +  +I++Y+  G 
Sbjct: 56  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 115

Query: 220 LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKV 279
           L  HL   +          ++ I V   +  L       II+RDIK  NILL  N    +
Sbjct: 116 LFTHLSQRERFTEH-----EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 170

Query: 280 ADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT--YQLTEKSDVYSFGVLLVELVT 337
            DFG ++     E   T  +    GT  Y+ P+ ++       +  D +S GVL+ EL+T
Sbjct: 171 TDFGLSKEFVADE---TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227

Query: 338 GRRP--IEPKRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCL 395
           G  P  ++ ++  +  I+ +    +      +S                    +L  + L
Sbjct: 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMS----------------ALAKDLIQRLL 271

Query: 396 APRRQNRPSMRRC--AEIL 412
               + R         EI 
Sbjct: 272 MKDPKKRLGCGPRDADEIK 290

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 54/308 (17%), Positives = 110/308 (35%), Gaps = 52/308 (16%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFH 199
           K+G+G +  V++   + +   V +K  K     K      + EI+ L  +    N++   
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLA 96

Query: 200 GYLEFEDERIV--IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDH 257
             ++    R    + E+V N   ++    L               ++  A+ Y H     
Sbjct: 97  DIVKDPVSRTPALVFEHVNNTDFKQLYQTL-----TDYDIRFYMYEILKALDYCH---SM 148

Query: 258 PIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKT 316
            I+HRD+K  N+++  E+ + ++ D+G A      +     V      +  +  PE L  
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-----ASRYFKGPELLVD 203

Query: 317 YQL-TEKSDVYSFGVLLVELVTGRRPIEPK-----------RELKERITVKWAMKKFSDG 364
           YQ+     D++S G +L  ++  + P               + L       +  K   + 
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 365 D---------AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEIL--- 412
           D                R  ++   +L   + L+   + L    Q+R +     E +   
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT---AREAMEHP 320

Query: 413 --WSVRKD 418
             ++V KD
Sbjct: 321 YFYTVVKD 328

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 7e-34
 Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 20/207 (9%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            IG G  G V           VAIK+  +   ++        E+  +  V H N++    
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 201 Y------LEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY 254
                  LE   +  +++E +     +          LD      +   +   I +LH  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLH-- 136

Query: 255 TDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYL 314
               IIHRD+K SNI++  +   K+ DFG AR      +G + + T    T  Y  PE +
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTSFMMTPYVVTRYYRAPEVI 190

Query: 315 KTYQLTEKSDVYSFGVLLVELVTGRRP 341
                 E  D++S G ++ E+V  +  
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-32
 Identities = 52/290 (17%), Positives = 101/290 (34%), Gaps = 34/290 (11%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHG 200
            +G G +G+V      + G  VA+K+  +             E+R L  ++H N++    
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 201 YLE-----FEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT 255
                    E   + +V ++      +  + ++   L       +   +   + Y+H   
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138

Query: 256 DHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLK 315
              IIHRD+K SN+ + E+   K+ DFG AR   D       ++  V           L 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLN 192

Query: 316 TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVE 375
                +  D++S G ++ EL+TGR        + +   +   +          I      
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 376 NTAANNLALEKI-------------LELALQCLAPRRQNRPSMRRCAEIL 412
           N   +   + K+             ++L  + L      R +    A+ L
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQAL 299

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (285), Expect = 6e-29
 Identities = 50/220 (22%), Positives = 81/220 (36%), Gaps = 23/220 (10%)

Query: 142 KIGQGGFGTVYKGR-LEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL----- 195
           K+G G F TV+  + + + T VA+K  +    DK      + EI+ L +V   +      
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 196 ------VKFHGYLEFEDERIVIVEYVPNGTLREHLDCL---QGNILDLAGRLDIAIDVAH 246
                 +K   +   +    V V  V        L  +   +   + L     I+  +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 247 AITYLHMYTDHPIIHRDIKSSNILLT-ENFRAKVADFGFARLAADTESGATHVSTQVKGT 305
            + Y+H      IIH DIK  N+L+   +    +     A L         +  T    T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQT 192

Query: 306 AGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPK 345
             Y  PE L        +D++S   L+ EL+TG    EP 
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 93.3 bits (231), Expect = 7e-23
 Identities = 31/201 (15%), Positives = 64/201 (31%), Gaps = 24/201 (11%)

Query: 142 KIGQGGFGTVYKGRLEDGTIVAIKRAKKS--------VYDKHSGAEFQSEIRTLAQVEHL 193
            +G+G    V+    E      +K  K              +    F       A+ E  
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 194 NLVKFHGYLEFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHM 253
            L K  G    +        +  N  L E +D  +   + +    ++   +   +   + 
Sbjct: 67  ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120

Query: 254 YTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEY 313
                I+H D+   N+L++E     + DF  +      E     +   V+    Y    +
Sbjct: 121 --HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV-EVGEEGWREILERDVRNIITY----F 172

Query: 314 LKTYQLTEKSDVYSFGVLLVE 334
            +TY    + D+ S    +++
Sbjct: 173 SRTY--RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	443
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.28
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.05
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.55
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.33
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.89

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=434.88  Aligned_cols=252  Identities=28%  Similarity=0.444  Sum_probs=214.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||+||+|.++ +++.||||++.+... .......+.+|+.+|+.++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999986 699999999865432 3345677899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||+||+|.+++..  ...+++..++.|+.||+.||.|||   ++|||||||||+||||+.++.+||+|||+|.......
T Consensus        86 Ey~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          86 EYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             eecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            99999999999974  356999999999999999999999   7889999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            ....+||+.|||||++.+..|+.++|||||||+||||++|.+||...........+..       ..      .
T Consensus       161 ------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------~~------~  221 (263)
T d2j4za1         161 ------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------VE------F  221 (263)
T ss_dssp             ------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TC------C
T ss_pred             ------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CC------C
Confidence                  2346799999999999999999999999999999999999999987654332222211       10      0


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .++     ...++++.+|+.+||++||++|||+.++++|+|.-
T Consensus       222 ~~p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         222 TFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             CCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            000     11346799999999999999999999999999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-58  Score=436.11  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=209.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++.++||+|+||+||+|.++ +|+.||||++..... ....+.+.+|+.+|+.++|||||++++++.+++..|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            57899999999999999999986 799999999876432 2334568899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+||+|.++|.  ....+++..++.|+.||+.||.|||   ++|||||||||+||||+.++.+||+|||+|+.......
T Consensus        84 y~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ccCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999986  4467999999999999999999999   78899999999999999999999999999987654321


Q ss_pred             CcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                        .......+||+.|||||++.+..+ +.++|||||||+||||++|.+||.............. .....       .. 
T Consensus       159 --~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~-~~~~~-------~~-  227 (271)
T d1nvra_         159 --ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-EKKTY-------LN-  227 (271)
T ss_dssp             --ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-TTCTT-------ST-
T ss_pred             --cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-cCCCC-------CC-
Confidence              122345689999999999988776 5789999999999999999999976544322211111 00000       00 


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                            .....++++.+|+.+||+.||++|||+.++++|+|.
T Consensus       228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence                  011234678899999999999999999999999994

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-57  Score=434.28  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=213.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+..++||+|+||+||+|.+. +|+.||||+++...  ....+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            47999999999999999999975 79999999987653  3345778999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+||+|.+++..   ..+++..++.|+.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus        98 y~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            9999999988753   46999999999999999999999   78899999999999999999999999999987654321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                          .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+..  .....          
T Consensus       172 ----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~~~~~----------  235 (293)
T d1yhwa1         172 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--NGTPE----------  235 (293)
T ss_dssp             ----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--HCSCC----------
T ss_pred             ----cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCC----------
Confidence                23456799999999999999999999999999999999999999987665432221111  00000          


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +..   ....++.+.+|+.+||++||.+|||+.++++|.|.
T Consensus       236 ~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         236 LQN---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             CSS---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             CCC---cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            000   11234679999999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-58  Score=433.63  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=202.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--cCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--EDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv  211 (443)
                      ++|++++.||+|+||+||+|..+ +|+.||||+++.........+.+.+|+++|++++|||||++++++.+  ++.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999976 79999999998776666667789999999999999999999999864  4568999


Q ss_pred             EeecCCCcHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          212 VEYVPNGTLREHLDCL--QGNILDLAGRLDIAIDVAHAITYLHMYT--DHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      ||||+||+|.+++...  .+..+++..++.|+.||+.||.|||+.+  .++||||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643  3567999999999999999999999432  23599999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ......    .....+||+.|||||++.+..|+.++|||||||++|||++|.+||...........+..       +...
T Consensus       164 ~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-------~~~~  232 (269)
T d2java1         164 LNHDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-------GKFR  232 (269)
T ss_dssp             C---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCCC
T ss_pred             cccCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CCCC
Confidence            654321    23456799999999999999999999999999999999999999987655332221111       1111


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      .     ++     ...++++.+|+.+||+.||.+|||+.++++|+|
T Consensus       233 ~-----~~-----~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         233 R-----IP-----YRYSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             C-----CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             C-----CC-----cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence            1     00     113467999999999999999999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-57  Score=430.51  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=211.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      +.|+++++||+|+||+||+|.+. +|+.||||+++..  .....+.+.+|+++|++++|||||++++++.+++.+++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            45888899999999999999986 7999999998764  23445678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||+||+|.+++.. .+..+++..+..|+.||+.||.|||   ++|||||||||+||||+.++.+||+|||+|+...... 
T Consensus        90 y~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          90 FCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             CCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            9999999998865 3467999999999999999999999   7889999999999999999999999999997654321 


Q ss_pred             CcccccccccCCCCccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLK-----TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                         ......+||+.|+|||++.     +..|+.++|||||||+||||++|.+||...........+..       +... 
T Consensus       165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~-------~~~~-  233 (288)
T d2jfla1         165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-------SEPP-  233 (288)
T ss_dssp             ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH-------SCCC-
T ss_pred             ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CCCC-
Confidence               1233567999999999984     45688999999999999999999999987765433222211       0000 


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                          .+..   ....++++.+|+.+||++||.+|||+.++++|+|.
T Consensus       234 ----~~~~---~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         234 ----TLAQ---PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             ----CCSS---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             ----CCCc---cccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                0000   11234679999999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=441.29  Aligned_cols=275  Identities=24%  Similarity=0.358  Sum_probs=213.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|+++++||+|+||+||+|.+. +|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+++.+++||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            367999999999999999999976 79999999987653 3445678899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||.||+|.+++...  ..+++..+..++.||+.||.|||+  .+|||||||||+||||+.+|.+||+|||+|+...+..
T Consensus        84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             EcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            999999999999743  569999999999999999999993  1479999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHH-HhhhcCC--------
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKW-AMKKFSD--------  363 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~--------  363 (443)
                            ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......... .......        
T Consensus       160 ------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         160 ------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             ------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             ------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence                  3456899999999999999999999999999999999999999976543221111000 0000000        


Q ss_pred             Cc--cccccCccc---------------cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          364 GD--AISILDPRV---------------ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       364 ~~--~~~~~d~~~---------------~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      ..  .....+...               .........+.++.+|+.+||+.||.+|||++++++|+|.-+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence            00  000000000               000000112367899999999999999999999999999755443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-56  Score=423.94  Aligned_cols=263  Identities=27%  Similarity=0.482  Sum_probs=209.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|.+.++||+|+||+||+|+++  ..||||+++.........+.|.+|+.+|++++|||||++++++. ++.+++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEec
Confidence            57899999999999999999865  35999999876666677788999999999999999999999865 5678999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |+||+|.+++.. .+..+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+|+....... 
T Consensus        85 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~-  159 (276)
T d1uwha_          85 CEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-  159 (276)
T ss_dssp             CCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC-
Confidence            999999999975 3456999999999999999999999   78899999999999999999999999999987654321 


Q ss_pred             cccccccccCCCCccCccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTY---QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                       ........||+.|||||++.+.   .|+.++|||||||+||||+||..||.+............  ..........   
T Consensus       160 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~---  233 (276)
T d1uwha_         160 -SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--RGYLSPDLSK---  233 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH--HTSCCCCGGG---
T ss_pred             -cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh--cCCCCCcchh---
Confidence             1233456799999999998643   578999999999999999999999987654332221111  1111111000   


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                             ....+++.+.+|+.+||+.||++|||+.+|+++|+.+.++
T Consensus       234 -------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         234 -------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                   1112346799999999999999999999999999988764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=423.49  Aligned_cols=250  Identities=24%  Similarity=0.417  Sum_probs=205.2

Q ss_pred             CCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee----cCeEEEEE
Q 013401          138 SPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF----EDERIVIV  212 (443)
Q Consensus       138 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~  212 (443)
                      +...+||+|+||+||+|.+. +++.||||++..........+.+.+|+++|++++|||||++++++++    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999986 68999999988765556667789999999999999999999999875    34679999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCEEEc-CCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHP--IIHRDIKSSNILLT-ENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~  289 (443)
                      |||+||+|.+++..  ...+++..++.|+.||+.||.|||   +++  ||||||||+||||+ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999974  356899999999999999999999   777  99999999999996 57899999999997644


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ..      .....+||+.|||||++.+ .++.++|||||||+||||++|..||.......+...      .+..+.....
T Consensus       167 ~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~------~i~~~~~~~~  233 (270)
T d1t4ha_         167 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------RVTSGVKPAS  233 (270)
T ss_dssp             TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH------HHTTTCCCGG
T ss_pred             CC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH------HHHcCCCCcc
Confidence            32      2345679999999999976 699999999999999999999999976543322111      1111111100


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +         ....++++.+|+.+||++||++|||+.|+++|+|.
T Consensus       234 ~---------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         234 F---------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             G---------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             c---------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence            1         11123568999999999999999999999999984

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=429.71  Aligned_cols=264  Identities=22%  Similarity=0.294  Sum_probs=212.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++++... .....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46999999999999999999986 799999999875432 3445677999999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||+||+|.+++..  ...+++..++.++.||+.||.|||   ++|||||||||+||||++++.+||+|||+|+.+....
T Consensus        88 Ey~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            99999999999874  356999999999999999999999   7889999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .  .......+||+.|+|||++.+..|+.++|||||||+||||++|..||...+.......+..       +..      
T Consensus       163 ~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-------~~~------  227 (288)
T d1uu3a_         163 K--QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-------LEY------  227 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-------TCC------
T ss_pred             c--ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc-------CCC------
Confidence            1  1123346799999999999999999999999999999999999999987655332222111       110      


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHH------HHHHhhhhhhhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCA------EILWSVRKDYRELA  423 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell------~~l~~i~~~~~~~~  423 (443)
                      .++     ...++++.+|+.+||+.||.+|||++|++      +|+|.-.-+|..+.
T Consensus       228 ~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         228 DFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  279 (288)
T ss_dssp             CCC-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             CCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence            010     11236789999999999999999999864      45554334454443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-56  Score=420.46  Aligned_cols=256  Identities=28%  Similarity=0.449  Sum_probs=203.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+..++||+|+||+||+|.+.++..||||+++..   ....++|.+|+++++.++|||||++++++.+++..++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            468888999999999999999988899999998764   34457899999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |++|+|.+++.. ....+++..++.|+.||+.||.|||   .++|+||||||+||||+.++.+||+|||+++....... 
T Consensus        82 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-  156 (263)
T d1sm2a_          82 MEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  156 (263)
T ss_dssp             CTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             cCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence            999999999865 4466889999999999999999999   78899999999999999999999999999987654322 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                        .......||+.|+|||++.+..|+.++|||||||+||||+| |.+||...........+..   ...      ...+ 
T Consensus       157 --~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~------~~~p-  224 (263)
T d1sm2a_         157 --TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFR------LYKP-  224 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---TCC------CCCC-
T ss_pred             --eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---cCC------CCCc-
Confidence              12234569999999999999999999999999999999999 5666655443222211111   100      0011 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                             ..+++++.+|+.+||+.||++|||+++|+++|..|..
T Consensus       225 -------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         225 -------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                   1123679999999999999999999999999988754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=431.80  Aligned_cols=266  Identities=22%  Similarity=0.325  Sum_probs=222.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++++.||+|+||+||+|+.+ +|+.||||++++... .......+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999976 799999999976532 3445677899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||+||+|.+++..  ...+++..++.++.||+.||+|||   ++|||||||||+||||+.+|.+||+|||+|+......
T Consensus        85 ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          85 EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999874  456899999999999999999999   8889999999999999999999999999998765432


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                      .    .....+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+.......+..  ..+           
T Consensus       160 ~----~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--~~~-----------  222 (337)
T d1o6la_         160 A----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEI-----------  222 (337)
T ss_dssp             C----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC-----------
T ss_pred             c----ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCC-----------
Confidence            1    23456799999999999999999999999999999999999999988765332211111  000           


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccC
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDV  427 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~  427 (443)
                      .++     ...+.++.+|+.+||++||.+|++     +.++++|+|...-++..+.....
T Consensus       223 ~~p-----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~  277 (337)
T d1o6la_         223 RFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL  277 (337)
T ss_dssp             CCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             CCC-----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCC
Confidence            000     113467899999999999999994     89999999987777776654443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-55  Score=425.72  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=222.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++++.||+|+||+||+|+++ +|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999986 799999999876532 3445678899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      |||.||+|.+++.  ....+++..++.++.||+.||.|||   ++|||||||||+||||+.+|.+||+|||+|+...+. 
T Consensus        84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999887  4566888888999999999999999   889999999999999999999999999999876543 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            ....+||+.|||||++.+..|+.++|||||||+||+|++|..||...+.......+......         +.+
T Consensus       158 ------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------~p~  222 (316)
T d1fota_         158 ------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---------FPP  222 (316)
T ss_dssp             ------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC---------CCT
T ss_pred             ------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---------CCC
Confidence                  23467999999999999999999999999999999999999999887654332222211000         001


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCc
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                               ..++++.+++.+||++||.+|+     +++++++|+|.-..+|..+...+..
T Consensus       223 ---------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~  274 (316)
T d1fota_         223 ---------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIE  274 (316)
T ss_dssp             ---------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSC
T ss_pred             ---------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCC
Confidence                     1236789999999999999996     9999999999876677766544443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=423.76  Aligned_cols=264  Identities=23%  Similarity=0.320  Sum_probs=215.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC----cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD----KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|++++.||+|+||+||+|.++ +|+.||||++++....    ....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999986 7999999998765432    234678999999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC----ceEEeeeccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF----RAKVADFGFA  285 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~----~vkl~DFGla  285 (443)
                      ||||||+||+|.++|...  ..+++..++.++.||+.||.|||   +++||||||||+|||++.++    .+||+|||++
T Consensus        90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999753  56999999999999999999999   88899999999999998776    5999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .......     ......||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+..       ..
T Consensus       165 ~~~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-------~~  232 (293)
T d1jksa_         165 HKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------VN  232 (293)
T ss_dssp             EECTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-------TC
T ss_pred             hhcCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh-------cC
Confidence            8765432     23445799999999999998999999999999999999999999987765433222211       00


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                      .      ... .......+..+.+|+.+||+.||++|||+.++++|.|.-..+.++.
T Consensus       233 ~------~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         233 Y------EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             C------CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred             C------CCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence            0      000 0011123467899999999999999999999999999766665553

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-56  Score=429.87  Aligned_cols=257  Identities=22%  Similarity=0.345  Sum_probs=197.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .+.|++.+.||+|+||+||+|.++ +|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            356899999999999999999986 79999999987654332 3456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCceEEeeeccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLAA  289 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~  289 (443)
                      |||+||+|.++|.  ....+++..+..++.||+.||.|||   ++|||||||||+|||+.   +++.+||+|||+++...
T Consensus        87 E~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          87 QLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             eccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999997  3567999999999999999999999   88899999999999995   57899999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...     .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.........+..       +...  
T Consensus       162 ~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-------~~~~--  227 (307)
T d1a06a_         162 PGS-----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-------AEYE--  227 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT-------TCCC--
T ss_pred             CCC-----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc-------cCCC--
Confidence            432     23446799999999999999999999999999999999999999987655332222111       1000  


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      ...     ......++++.+|+.+||+.||++|||+.|+++|+|.-
T Consensus       228 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         228 FDS-----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             CCT-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             CCC-----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            000     01112346799999999999999999999999999963

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-55  Score=426.95  Aligned_cols=252  Identities=26%  Similarity=0.371  Sum_probs=209.4

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      .|+.+++||+|+||+||+|.+. +|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999976 799999999876543 23345678999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||.+|+|..++.  .+..+++..++.|+.||+.||.|||   ++|||||||||+||||+.++.+||+|||++.....   
T Consensus        96 ~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          96 YCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             CCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            999999876664  4467999999999999999999999   78899999999999999999999999999986543   


Q ss_pred             CcccccccccCCCCccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKT---YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                           ....+||+.|||||++.+   ..|+.++|||||||++|||++|..||...........+..       +......
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~  235 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NESPALQ  235 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SCCCCCS
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------CCCCCCC
Confidence                 234579999999999864   3589999999999999999999999987655432222111       1111111


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .         ...++.+.+|+.+||+.||.+|||+.+|++|+|..+
T Consensus       236 ~---------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         236 S---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             C---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             C---------CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            1         112467999999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.2e-55  Score=432.04  Aligned_cols=257  Identities=22%  Similarity=0.321  Sum_probs=214.2

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++....  ....+.+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            358999999999999999999976 79999999987642  344567899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT--ENFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~~~  290 (443)
                      |||+||+|.+++.. ....+++..++.|+.||+.||.|||   ++|||||||||+||||+  .++.+||+|||+++.+..
T Consensus       103 E~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         103 EFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999999864 3456999999999999999999999   78899999999999996  467899999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..     ......||+.|||||++.+..++.++|||||||++|+|++|..||.+.........+......+..       
T Consensus       179 ~~-----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------  246 (350)
T d1koaa2         179 KQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------  246 (350)
T ss_dssp             TS-----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-------
T ss_pred             cc-----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------
Confidence            32     233467999999999999999999999999999999999999999877554332222211100000       


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                             ......++.+.+|+.+||+.||++|||+.++++|+|.-
T Consensus       247 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~  284 (350)
T d1koaa2         247 -------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  284 (350)
T ss_dssp             -------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred             -------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                   00112346789999999999999999999999999853

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-55  Score=420.63  Aligned_cols=266  Identities=26%  Similarity=0.416  Sum_probs=202.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CC---cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DG---TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      .+|++.+.||+|+||+||+|.++ ++   ..||||.+.... .....++|.+|+.+|++++|||||++++++.+++.+++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            34666789999999999999875 33   368999886542 34455679999999999999999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      |||||+||+|.+++.. ....+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+++....
T Consensus       105 v~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999998874 3456899999999999999999999   78899999999999999999999999999987765


Q ss_pred             cCCCccc-ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          291 TESGATH-VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       291 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....... ......||+.|||||++.+..++.++|||||||+||||+| |.+||...........+.       .+....
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-------~~~~~~  253 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-------QDYRLP  253 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCCCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC
Confidence            4322211 1223468999999999999899999999999999999998 899998765433211111       111000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYREL  422 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~~  422 (443)
                           .     ...+++.+.+|+.+||+.||++|||+.+|++.|..+.++-+.+
T Consensus       254 -----~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~sl  297 (299)
T d1jpaa_         254 -----P-----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL  297 (299)
T ss_dssp             -----C-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             -----C-----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhC
Confidence                 0     1123467999999999999999999999999998876654443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-55  Score=420.88  Aligned_cols=258  Identities=28%  Similarity=0.376  Sum_probs=213.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+..++||+|+||+||+|.++ +|+.||||+++..   ....++|.+|+++|++++|||||++++++.+++..++|||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            46888889999999999999986 6899999998764   3456789999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ||++|+|.+++.......+++..++.|+.||+.||.|||   .++||||||||+||||+.++.+||+|||+|+.......
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            999999999998766778999999999999999999999   78899999999999999999999999999987654321


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                         .......||+.|+|||++.+..|+.++|||||||++|||++|..||...........  ....    +..     +.
T Consensus       171 ---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~--~i~~----~~~-----~~  236 (287)
T d1opja_         171 ---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--LLEK----DYR-----ME  236 (287)
T ss_dssp             ---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH--HHHT----TCC-----CC
T ss_pred             ---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH--HHhc----CCC-----CC
Confidence               223344589999999999999999999999999999999997666543332222111  1111    100     00


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                      .     ...+++++.+|+.+||+.||++|||+.+|++.|..+..
T Consensus       237 ~-----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         237 R-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             C-----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1     01234679999999999999999999999998877643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-55  Score=430.67  Aligned_cols=255  Identities=22%  Similarity=0.340  Sum_probs=213.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|++++.||+|+||+||+|... +|+.||||+++...  ......+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            47999999999999999999976 79999999987643  3345678899999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc--CCCceEEeeeccccccccc
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT--ENFRAKVADFGFARLAADT  291 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~~~~  291 (443)
                      ||+||+|.+++.. .+..+++..++.|+.||+.||.|||   ++|||||||||+||||+  .++.+||+|||+|......
T Consensus       107 ~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         107 FLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             cCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999999988754 3456999999999999999999999   88899999999999998  6789999999999877643


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      .     ......||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.........+......+..     .  
T Consensus       183 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----~--  250 (352)
T d1koba_         183 E-----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-----D--  250 (352)
T ss_dssp             S-----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----S--
T ss_pred             C-----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----c--
Confidence            2     234457999999999999999999999999999999999999999877654332222211111100     0  


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                             .....++++.+|+.+||+.||.+|||+.++++|.|.
T Consensus       251 -------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~  286 (352)
T d1koba_         251 -------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  286 (352)
T ss_dssp             -------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             -------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence                   001234678999999999999999999999999984

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=409.38  Aligned_cols=253  Identities=28%  Similarity=0.437  Sum_probs=213.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+..++||+|+||+||+|++++++.||||++++.   ....++|.+|+.++++++|||||++++++.+++.+++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~---~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS---SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC---cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            589999999999999999999998999999999865   33457899999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.+|+|.+++.. ....+++..++.|+.||++||.|||   ++||+||||||+||||+.++.+||+|||+++........
T Consensus        81 ~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          81 MANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             CTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             cCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            999999998765 3456889999999999999999999   788999999999999999999999999999876543321


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                         ......||+.|+|||++.+..++.++|||||||++|||+| |..||...........+.       .+....  .+ 
T Consensus       157 ---~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~~~~~--~p-  223 (258)
T d1k2pa_         157 ---SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLY--RP-  223 (258)
T ss_dssp             ---CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTCCCC--CC-
T ss_pred             ---eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-------hCCCCC--Cc-
Confidence               2334569999999999999999999999999999999998 899998775433221111       111100  11 


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                             ..+++++.+|+.+||+.||++|||+.+|+++|.+
T Consensus       224 -------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 -------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                   1234679999999999999999999999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-55  Score=413.71  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=207.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++.++||+|+||+||+|.++++..||||+++..   ....+.|.+|+.+|++++|||||++++++. ++..++||||
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey   88 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence            578888999999999999999998899999998764   344578999999999999999999999875 4668999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |++|+|.+++.......+++..++.|+.||+.||.|||   .++|+||||||+||||+.++.+||+|||+|+...+..  
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--  163 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--  163 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc--
Confidence            99999999886655556999999999999999999999   7889999999999999999999999999998775432  


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCchhHHHHHHHHHHhhhcCCCccccccCcc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR-RPIEPKRELKERITVKWAMKKFSDGDAISILDPR  373 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  373 (443)
                       ........||+.|+|||++.+..++.++|||||||+||||+||. +||...........+       ..+...     .
T Consensus       164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-------~~~~~~-----~  230 (272)
T d1qpca_         164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-------ERGYRM-----V  230 (272)
T ss_dssp             -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTCCC-----C
T ss_pred             -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HhcCCC-----C
Confidence             12234457999999999999889999999999999999999965 455444332211111       111100     0


Q ss_pred             ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          374 VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       374 ~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .+     ..+++++.+|+.+||+.||++|||+.+|++.|..+
T Consensus       231 ~p-----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         231 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Cc-----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            00     12346799999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.6e-55  Score=428.42  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=221.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccc-cCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV-YDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      ++|++++.||+|+||.||+|.++ +|+.||||++++.. ......+.+.+|+.+|+.++|||||++++++.+.+.+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999999986 79999999986543 23345677899999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccC
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTE  292 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~  292 (443)
                      ||+.||+|.+++...  ..+++..++.|+.||+.||.|||   +++||||||||+||||+.+|.+||+|||+|+..... 
T Consensus       121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            999999999999743  56999999999999999999999   788999999999999999999999999999876532 


Q ss_pred             CCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          293 SGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       293 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                            ....+||+.|||||++.+..++.++|||||||+||||++|.+||.+.........+......+         . 
T Consensus       195 ------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~---------p-  258 (350)
T d1rdqe_         195 ------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---------P-  258 (350)
T ss_dssp             ------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------C-
T ss_pred             ------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC---------C-
Confidence                  234679999999999999999999999999999999999999998776543322222110000         0 


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccC
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDV  427 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~  427 (443)
                              ...++++.+|+.+||++||.+|+     ++++|++|.|.-..+|..+..-..
T Consensus       259 --------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~  310 (350)
T d1rdqe_         259 --------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKV  310 (350)
T ss_dssp             --------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             --------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCC
Confidence                    11236799999999999999994     999999999987777776654333

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=410.26  Aligned_cols=250  Identities=25%  Similarity=0.418  Sum_probs=199.7

Q ss_pred             ceeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEeecCC
Q 013401          141 FKIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEYVPN  217 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~g  217 (443)
                      ++||+|+||+||+|.++   .++.||||+++....+....++|.+|+.+|++++|||||++++++.. +..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999864   35789999998765555566789999999999999999999999864 567899999999


Q ss_pred             CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCCccc
Q 013401          218 GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESGATH  297 (443)
Q Consensus       218 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~  297 (443)
                      |+|.+++.  ....+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+++....... ...
T Consensus        92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~-~~~  165 (277)
T d1xbba_          92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYK  165 (277)
T ss_dssp             EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS-EEE
T ss_pred             CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccc-ccc
Confidence            99999987  4467999999999999999999999   78899999999999999999999999999987654322 122


Q ss_pred             ccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccccc
Q 013401          298 VSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRVEN  376 (443)
Q Consensus       298 ~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  376 (443)
                      ......||+.|||||++.+..++.++|||||||++|||++ |.+||.+.........+       ..+.....       
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i-------~~~~~~~~-------  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-------  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTCCCCC-------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH-------HcCCCCCC-------
Confidence            2334579999999999999899999999999999999998 89999876543221111       11111111       


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          377 TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       377 ~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                         ...+++++.+|+.+||+.||++|||+.+|++.|..
T Consensus       232 ---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence               01234679999999999999999999999776654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.6e-54  Score=423.88  Aligned_cols=268  Identities=21%  Similarity=0.285  Sum_probs=214.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHH---HHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQS---EIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~---Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.+.... ......+.+   |+.+++.++|||||++++++.+++.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999986 7999999998654321 222233444   466777788999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|||||.||+|.++|..  ...+++..++.++.||+.||.|||   .+|||||||||+||||+.+|.+||+|||+|+...
T Consensus        84 ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999974  356889999999999999999999   8889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLK-TYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ...      ....+||+.|+|||++. +..|+.++|||||||+||||++|..||.............    ......   
T Consensus       159 ~~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~~---  225 (364)
T d1omwa3         159 KKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTMA---  225 (364)
T ss_dssp             SSC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSCC---
T ss_pred             CCc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccCC---
Confidence            432      23457999999999986 4578999999999999999999999998654322111111    111110   


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHHhhhhhhhhhhcccCc
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPS-----MRRCAEILWSVRKDYRELAASDVL  428 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs-----~~ell~~l~~i~~~~~~~~~~~~~  428 (443)
                         ...+     ...++++.+||.+||+.||.+||+     ++++++|+|.-.-+|..+...++.
T Consensus       226 ---~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~  282 (364)
T d1omwa3         226 ---VELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP  282 (364)
T ss_dssp             ---CCCC-----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             ---CCCC-----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCC
Confidence               0000     113467999999999999999999     799999999877777766554443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=406.21  Aligned_cols=258  Identities=21%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             CCCCCc-eeeeeCceEEEEEEEc---CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEE
Q 013401          136 NFSPSF-KIGQGGFGTVYKGRLE---DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       136 ~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      +|.... +||+|+||+||+|.++   ++..||||+++... .....++|.+|+++|++++|||||++++++.. +.+++|
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            455555 5999999999999864   35689999987643 34556789999999999999999999999864 568999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ||||+||+|.+++.. .+..+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+++.....
T Consensus        87 mE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999998854 3457999999999999999999999   788999999999999999999999999999877543


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      .. .........||+.|+|||++.+..++.++|||||||++|||+| |..||...........+       ..+..... 
T Consensus       163 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-------~~~~~~~~-  233 (285)
T d1u59a_         163 DS-YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRMEC-  233 (285)
T ss_dssp             SC-EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTTCCCCC-
T ss_pred             cc-ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCCCCCC-
Confidence            22 1122334569999999999998899999999999999999998 99999876543221111       11211111 


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                               ...+++++.+|+.+||+.||++||++.+|++.|..+-.
T Consensus       234 ---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         234 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     11234679999999999999999999999988875533

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=415.87  Aligned_cols=257  Identities=27%  Similarity=0.358  Sum_probs=205.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC-C-----cEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED-G-----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|++.++||+|+||+||+|++.. +     ..||||.+.... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            468888999999999999998652 2     369999886543 234456788999999998 89999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 013401          208 RIVIVEYVPNGTLREHLDCLQG---------------------NILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKS  266 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp  266 (443)
                      +++|||||+||+|.++|.....                     ..+++..++.|+.||+.||.|||   +++||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            9999999999999999975322                     35889999999999999999999   78899999999


Q ss_pred             CCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCc
Q 013401          267 SNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPK  345 (443)
Q Consensus       267 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~  345 (443)
                      +|||++.++.+||+|||+|+.......  ........||+.|||||++.+..++.++|||||||+||||++ |.+||.+.
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hccccccCCeEEEeeccccccccCCCc--eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999987654332  122334568999999999999999999999999999999998 89999865


Q ss_pred             hhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Q 013401          346 RELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILW  413 (443)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~  413 (443)
                      ........+..      .+.     .+..     ...+++++.+|+.+||+.||++|||+.+|+++|.
T Consensus       271 ~~~~~~~~~~~------~~~-----~~~~-----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDANFYKLIQ------NGF-----KMDQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSHHHHHHHH------TTC-----CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHh------cCC-----CCCC-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            43322111110      000     0000     1123467999999999999999999999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=417.26  Aligned_cols=262  Identities=24%  Similarity=0.367  Sum_probs=215.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEcccccc-CcccHHHHHHHHHHHH-hcCCcceeeeeeeeeecCeEEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVY-DKHSGAEFQSEIRTLA-QVEHLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~lv  211 (443)
                      ++|++++.||+|+||+||+|+++ +|+.||||++++... .....+.+.+|+.++. .++|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            47889999999999999999986 799999999976432 2344566777777765 68999999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADT  291 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~  291 (443)
                      ||||+||+|.+++..  ...+++..++.++.||+.||.|||   +++||||||||+|||++.++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            999999999999974  356899999999999999999999   788999999999999999999999999999865433


Q ss_pred             CCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccC
Q 013401          292 ESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILD  371 (443)
Q Consensus       292 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  371 (443)
                      ..    ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+.........+....             
T Consensus       157 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-------------  219 (320)
T d1xjda_         157 DA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------------  219 (320)
T ss_dssp             TC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------
T ss_pred             cc----cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            21    2344679999999999999999999999999999999999999998776543222222110             


Q ss_pred             ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHHhhhhhhhhhh
Q 013401          372 PRVENTAANNLALEKILELALQCLAPRRQNRPSMR-RCAEILWSVRKDYRELA  423 (443)
Q Consensus       372 ~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~-ell~~l~~i~~~~~~~~  423 (443)
                      +..+     ...+.++.+|+.+||+.||.+||++. +|++|+|.-.-++.++.
T Consensus       220 ~~~p-----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~  267 (320)
T d1xjda_         220 PFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE  267 (320)
T ss_dssp             CCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred             CCCC-----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHH
Confidence            0010     11346799999999999999999995 89999996544454443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-53  Score=404.82  Aligned_cols=256  Identities=22%  Similarity=0.289  Sum_probs=211.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcc-------cHHHHHHHHHHHHhcC-Ccceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKH-------SGAEFQSEIRTLAQVE-HLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-------~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~  205 (443)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++++......       ..+.+.+|+.+|+.++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57899999999999999999975 799999999876543322       2245789999999997 99999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      +..|||||||+||+|.++|..  ...+++..++.++.||+.||+|||   .+|||||||||+||||+.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            999999999999999999974  356999999999999999999999   788999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKT------YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      +......     ......||+.|+|||++.+      ..++.++|||||||+||+|++|+.||...........+..   
T Consensus       158 ~~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~---  229 (277)
T d1phka_         158 CQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS---  229 (277)
T ss_dssp             EECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred             eEccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh---
Confidence            8775432     2345679999999999853      3468899999999999999999999988765432222111   


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                          +... ...+      .....++++.+|+.+||++||++||++.++++|.|.
T Consensus       230 ----~~~~-~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~  273 (277)
T d1phka_         230 ----GNYQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  273 (277)
T ss_dssp             ----TCCC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             ----CCCC-CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence                1000 0000      111244679999999999999999999999999984

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-54  Score=415.85  Aligned_cols=255  Identities=21%  Similarity=0.288  Sum_probs=211.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIV  212 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~  212 (443)
                      .++|++++.||+|+||+||+|.++ +|+.||||+++..   ......+.+|+++|+.++|||||++++++++++.+|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            357999999999999999999986 7999999999765   333456889999999999999999999999999999999


Q ss_pred             eecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC--CCceEEeeecccccccc
Q 013401          213 EYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE--NFRAKVADFGFARLAAD  290 (443)
Q Consensus       213 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~  290 (443)
                      |||.||+|.++|.. .+..+++.+++.|+.||+.||.|||   ++||+||||||+|||++.  .+.+||+|||+++....
T Consensus        81 E~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          81 EFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999999964 3346899999999999999999999   888999999999999985  45899999999987643


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL  370 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (443)
                      ..     ......||+.|+|||.+.+..|+.++|||||||++|+|++|.+||...........+......+         
T Consensus       157 ~~-----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------  222 (321)
T d1tkia_         157 GD-----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------  222 (321)
T ss_dssp             TC-----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------
T ss_pred             CC-----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence            32     2334569999999999999999999999999999999999999998876543322221110000         


Q ss_pred             CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          371 DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       371 d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      +     .......++++.+|+.+||..||.+|||+.++++|+|.
T Consensus       223 ~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         223 D-----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             C-----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             C-----hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            0     00011234678999999999999999999999999995

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=411.36  Aligned_cols=267  Identities=22%  Similarity=0.255  Sum_probs=204.9

Q ss_pred             CCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCc---ccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          139 PSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDK---HSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      .++.||+|+||+||+|.++ +|+.||||+++......   .....+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3568999999999999976 79999999987653322   1234688999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.++.+..++.  .+..+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          82 METDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             CSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             hcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            98887765543  4567899999999999999999999   88899999999999999999999999999987654322 


Q ss_pred             cccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcccccc---
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISIL---  370 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  370 (443)
                         .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||....+......+................   
T Consensus       156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 ---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             ---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             ---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence               2234579999999999864 467999999999999999999999998877655433333222111111100000   


Q ss_pred             -------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          371 -------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       371 -------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                             .+............+++.+|+.+||+.||++|||+.|+++|.|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f  283 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  283 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence                   00000011111234679999999999999999999999999994

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-53  Score=403.13  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=201.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC-C----cEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED-G----TIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~-g----~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ..|+..+.||+|+||.||+|.+++ +    ..||||+++... ......+|.+|+.+|++++|||||++++++.+.+..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            357778899999999999998763 2    479999987543 3344567899999999999999999999999999999


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|||||.++.|.+++.. ....+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+++...
T Consensus        86 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          86 IITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999988764 4467999999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      .... .........||+.|||||++.+..++.++|||||||+||||++|..|+.......+..  ..    +.++.... 
T Consensus       162 ~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~--~~----i~~~~~~~-  233 (283)
T d1mqba_         162 DDPE-ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--KA----INDGFRLP-  233 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HH----HHTTCCCC-
T ss_pred             CCCc-cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH--HH----HhccCCCC-
Confidence            4322 1122334568999999999999999999999999999999999655544332222111  11    11111110 


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                          .     ...++..+.+|+.+||+.||++||++.+|++.|..+.+.
T Consensus       234 ----~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         234 ----T-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             ----C-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----C-----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                0     112346799999999999999999999999999877654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=408.32  Aligned_cols=272  Identities=23%  Similarity=0.319  Sum_probs=210.4

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+++++||+|+||+||+|.+. +|+.||||+++...........+.+|+++|++++|||||++++++.+++.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999975 79999999997765555556789999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+.+ .+.+++.......+++..+..++.||+.||.|||   ++|||||||||+|||++.++.+||+|||+|+...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9965 5556665556677999999999999999999999   7889999999999999999999999999998765432 


Q ss_pred             CcccccccccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccc---
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISI---  369 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  369 (443)
                         .......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.......+........+......   
T Consensus       157 ---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         157 ---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             ---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             ---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence               1234457999999999986655 578999999999999999999999877654433222221111111110000   


Q ss_pred             --cCc---cccc---hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          370 --LDP---RVEN---TAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       370 --~d~---~~~~---~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                        ...   ....   .......++++.+|+.+||++||++|||+.|+++|.|.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence              000   0000   00111234678999999999999999999999999984

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=416.14  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=206.2

Q ss_pred             hcCCCCCc-eeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeee----cC
Q 013401          134 TRNFSPSF-KIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEF----ED  206 (443)
Q Consensus       134 ~~~f~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~  206 (443)
                      .++|.+.. .||+|+||+||+|.+. +++.||||+++..       ..+.+|+.++.++ +|||||+++++|++    ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            35788875 4999999999999975 7999999998643       4577899987655 79999999999876    46


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC---CCceEEeeec
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE---NFRAKVADFG  283 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~---~~~vkl~DFG  283 (443)
                      .+|+|||||+||+|.++|.......+++..++.|+.||+.||.|||   ++||+||||||+|||++.   ++.+||+|||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccc
Confidence            7899999999999999997655567999999999999999999999   888999999999999985   5679999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      +++.......     ....+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.........   .......
T Consensus       160 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~  231 (335)
T d2ozaa1         160 FAKETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRM  231 (335)
T ss_dssp             TCEECCCCCC-----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS
T ss_pred             eeeeccCCCc-----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhc
Confidence            9987654432     3446799999999999999999999999999999999999999976543221111   1111111


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      +.      ..++ .......++++.+|+.+||+.||++|||+.++++|+|..
T Consensus       232 ~~------~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         232 GQ------YEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             CS------SSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             CC------CCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence            11      0000 111223557899999999999999999999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.2e-53  Score=402.73  Aligned_cols=263  Identities=26%  Similarity=0.335  Sum_probs=205.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe----
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE----  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----  207 (443)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++++.... ......+.+|+++|+.++|||||++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357999999999999999999975 7999999999876443 3445678999999999999999999999987653    


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +|+|||||+|++|.+++..  ...+++..++.|+.||+.||.|||   ++|||||||||+||||+.++.++|+|||++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            7899999999999998874  356999999999999999999999   78899999999999999999999999999876


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI  367 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  367 (443)
                      ...... ........+||+.|+|||++.+..++.++|||||||++|||++|.+||...............  .   ....
T Consensus       161 ~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~--~---~~~~  234 (277)
T d1o6ya_         161 IADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--D---PIPP  234 (277)
T ss_dssp             CC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--C---CCCG
T ss_pred             hccccc-cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc--C---CCCC
Confidence            543322 122344567999999999999989999999999999999999999999877654332221110  0   0000


Q ss_pred             cccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHhhh
Q 013401          368 SILDPRVENTAANNLALEKILELALQCLAPRRQNRP-SMRRCAEILWSVR  416 (443)
Q Consensus       368 ~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-s~~ell~~l~~i~  416 (443)
                      ...         ....++++.+|+.+||++||.+|| +++++++.|..++
T Consensus       235 ~~~---------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         235 SAR---------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GGT---------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             chh---------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            011         112346799999999999999999 8899988887664

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-52  Score=402.52  Aligned_cols=271  Identities=20%  Similarity=0.256  Sum_probs=212.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|+.+++||+|+||+||+|.+++|+.||||+++...........+.+|+.+|++++|||||++++++..++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57899999999999999999999999999999977655556678899999999999999999999999999999999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      +.++.+..+..  ....+++..+..|+.||+.||+|||   +++||||||||+||||+.++.+||+|||++........ 
T Consensus        82 ~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          82 LDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            98776666554  4567999999999999999999999   78899999999999999999999999999987654321 


Q ss_pred             cccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccc---cc-
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAI---SI-  369 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~-  369 (443)
                         ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+..+......+.............   .. 
T Consensus       156 ---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         156 ---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             ---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence               22344699999999998654 56899999999999999999999998776554433332221111110000   00 


Q ss_pred             -c------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          370 -L------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       370 -~------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                       .      .............++.+.+|+.+||++||++|||++|+++|+|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f  284 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence             0      00001111112234678999999999999999999999999984

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=401.03  Aligned_cols=256  Identities=30%  Similarity=0.451  Sum_probs=202.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEee
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVEY  214 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  214 (443)
                      ++|++.+.||+|+||.||+|.++++..||||+++..   ....+.|.+|+.+|++++|||||++++++. ++..++||||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey   92 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   92 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc---cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence            578999999999999999999988888999999765   334578999999999999999999999985 5668999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |++|+|..++.......+++..++.|+.||+.||.|||   .++|+||||||+||||+.++.+||+|||+++....... 
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            99999999987656667999999999999999999999   78899999999999999999999999999987654322 


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                        .......||+.|+|||++.+..++.++|||||||+||||++|..||.......+...  ......    ...     .
T Consensus       169 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~--~i~~~~----~~~-----~  235 (285)
T d1fmka3         169 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--QVERGY----RMP-----C  235 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--HHHTTC----CCC-----C
T ss_pred             --eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH--HHHhcC----CCC-----C
Confidence              122345699999999999999999999999999999999996555443332222111  111110    000     0


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                           ...+++++.+|+.+||+.||++||++.+|++.|..+.
T Consensus       236 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         236 -----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -----CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                 1123467999999999999999999999998776543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-52  Score=402.48  Aligned_cols=262  Identities=23%  Similarity=0.381  Sum_probs=206.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc----EEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT----IVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      .+|++++.||+|+||+||+|.+. +|+    .||||+++.. ......++|.+|+.+|++++|||||++++++.++ ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            36999999999999999999875 454    5788887654 2344567899999999999999999999999764 577


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      ++||++.+|+|.+++.. ....+++..++.|+.||+.||.|||   +++||||||||+||||+.++.+||+|||+++...
T Consensus        87 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          87 LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            88999999999998865 4567999999999999999999999   7889999999999999999999999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      ....  ........||+.|+|||++.+..|+.++|||||||+||||+| |.+||...........+..       +....
T Consensus       163 ~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-------~~~~~  233 (317)
T d1xkka_         163 AEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GERLP  233 (317)
T ss_dssp             TTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-------TCCCC
T ss_pred             cccc--cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence            4332  122334569999999999999999999999999999999998 8899976643322111111       11000


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                           .     ...+++.+.+|+.+||+.||.+|||+.+|+++++.+.++...
T Consensus       234 -----~-----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~  276 (317)
T d1xkka_         234 -----Q-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  276 (317)
T ss_dssp             -----C-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHH
T ss_pred             -----C-----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHh
Confidence                 0     012346799999999999999999999999999988776544

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=396.70  Aligned_cols=260  Identities=26%  Similarity=0.414  Sum_probs=201.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|++.+.||+|+||.||+|.+..    +..||||.++.. ......+.+.+|+.+|++++|||||++++++. ++.+++
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            468888999999999999998642    457899988654 23444577999999999999999999999985 567899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAAD  290 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~  290 (443)
                      ||||+.+|+|.+++.. ....+++..++.++.||+.||.|||   +++||||||||+|||++.++.+||+|||+++....
T Consensus        85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            9999999999998764 4567899999999999999999999   78899999999999999999999999999987654


Q ss_pred             cCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccc
Q 013401          291 TESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISI  369 (443)
Q Consensus       291 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (443)
                      ...   .......||+.|+|||++.+..++.++|||||||+||||++ |.+||...........+.       .+.....
T Consensus       161 ~~~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~~~~~~~  230 (273)
T d1mp8a_         161 STY---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLPM  230 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCCCCC
T ss_pred             Ccc---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCCC
Confidence            321   22344568999999999999999999999999999999998 899998765533221111       1111110


Q ss_pred             cCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhh
Q 013401          370 LDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYR  420 (443)
Q Consensus       370 ~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~  420 (443)
                                ...+++++.+|+.+||+.||++|||+.+|+++|..+..+.+
T Consensus       231 ----------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         231 ----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence                      11234679999999999999999999999999998866543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=403.18  Aligned_cols=272  Identities=22%  Similarity=0.265  Sum_probs=210.3

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-C-CcEEEEEEccccccCcccHHHHHHHHHHHHhc---CCcceeeeeeeeee----
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-D-GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV---EHLNLVKFHGYLEF----  204 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~----  204 (443)
                      .++|+++++||+|+||+||+|.+. + ++.||||+++...........+.+|+.+|+.|   +|||||++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 4 67899999877655444455667888887766   79999999999853    


Q ss_pred             -cCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeec
Q 013401          205 -EDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFG  283 (443)
Q Consensus       205 -~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFG  283 (443)
                       ...++++|||+.++.+.... ......+++..++.++.||+.||.|||   +++||||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             34789999999887665443 345667899999999999999999999   8889999999999999999999999999


Q ss_pred             ccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          284 FARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       284 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ++.......     ......||+.|+|||++.+..|+.++|||||||++|||++|.+||...........+.........
T Consensus       162 ~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         162 LARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             SCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            987654332     344567999999999999999999999999999999999999999987665443333322211111


Q ss_pred             Ccccc-------cc-C-ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          364 GDAIS-------IL-D-PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       364 ~~~~~-------~~-d-~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .....       .. . ............++.+.+|+.+||+.||++|||+.|+++|+|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence            00000       00 0 0000001112234678999999999999999999999999994

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=394.10  Aligned_cols=251  Identities=28%  Similarity=0.437  Sum_probs=200.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-cCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-EDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~E  213 (443)
                      ++|+..++||+|+||.||+|.++ |..||||+++..    ...+.+.+|+.+|++++|||||++++++.+ .+.+++|||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            46788889999999999999985 788999999753    345779999999999999999999998854 567899999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      |+++|+|.++|.......+++..++.|+.||+.||.|||   +++||||||||+|||++.++.+||+|||+++.....  
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            999999999997655567899999999999999999999   788999999999999999999999999999865432  


Q ss_pred             CcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCccccccCc
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAISILDP  372 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  372 (443)
                           .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||..........   +    +..+....+   
T Consensus       157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~---~----i~~~~~~~~---  221 (262)
T d1byga_         157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---R----VEKGYKMDA---  221 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH---H----HTTTCCCCC---
T ss_pred             -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH---H----HHcCCCCCC---
Confidence                 223458999999999998899999999999999999998 788887654332211   1    111111111   


Q ss_pred             cccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhh
Q 013401          373 RVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRK  417 (443)
Q Consensus       373 ~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~  417 (443)
                        .     ...++++.+|+.+||+.||.+|||+.+|+++|..++.
T Consensus       222 --~-----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         222 --P-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             --C-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence              1     1123678999999999999999999999999988753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=400.55  Aligned_cols=275  Identities=20%  Similarity=0.220  Sum_probs=211.2

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee--------c
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF--------E  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~  205 (443)
                      ++|+++++||+|+||+||+|++. +|+.||||++............+.+|+.+|+.++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            68999999999999999999975 79999999987765556667788999999999999999999998754        4


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      +.+++||||+.++.+..+..  ....+++..++.|+.||+.||.|||   ++|||||||||+||||+.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            46899999998776654433  4567889999999999999999999   888999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      .................+||+.|+|||++.+. .|+.++|||||||++|||++|++||....+......+......+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            87665443333334456799999999998764 68999999999999999999999998877655544444433332221


Q ss_pred             cccccc--------------CccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          365 DAISIL--------------DPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       365 ~~~~~~--------------d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ......              ................+.+|+.+||++||++|||++|+++|+|.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            111100              00011111111224568899999999999999999999999994

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=397.13  Aligned_cols=245  Identities=28%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcc----cHHHHHHHHHHHHhcC--CcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKH----SGAEFQSEIRTLAQVE--HLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~----~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~  207 (443)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++++......    ...++.+|+.+|++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999976 799999999876543221    1234668999999996  8999999999999999


Q ss_pred             EEEEEeecCC-CcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-CCceEEeeeccc
Q 013401          208 RIVIVEYVPN-GTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-NFRAKVADFGFA  285 (443)
Q Consensus       208 ~~lv~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-~~~vkl~DFGla  285 (443)
                      .++||||+.+ +++.+++..  +..+++..++.++.||+.||.|||   ++|||||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 678888764  356999999999999999999999   888999999999999985 579999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCC
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQL-TEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDG  364 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  364 (443)
                      +.....      ......||+.|+|||++.+..+ +.++|||||||+||||++|..||.......      ..       
T Consensus       159 ~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~------~~-------  219 (273)
T d1xwsa_         159 ALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------RG-------  219 (273)
T ss_dssp             EECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------HC-------
T ss_pred             eecccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh------hc-------
Confidence            865432      2345679999999999987665 567899999999999999999998653211      00       


Q ss_pred             ccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          365 DAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       365 ~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .  ..+...         .++++.+|+.+||+.||++|||++|+++|+|.
T Consensus       220 ~--~~~~~~---------~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  258 (273)
T d1xwsa_         220 Q--VFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  258 (273)
T ss_dssp             C--CCCSSC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             c--cCCCCC---------CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            0  001111         23679999999999999999999999999995

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-51  Score=398.45  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=211.4

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~  207 (443)
                      .++|+++++||+|+||+||+|+++      +++.||||+++... .....++|.+|+.+|++++||||+++++++.+.+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            467999999999999999999864      46789999987542 34446779999999999999999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ----------------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIK  265 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlk  265 (443)
                      .++||||+.+|+|.+++....                      ...+++..++.|+.||+.||.|||   +++|||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            999999999999999986422                      234788899999999999999999   7889999999


Q ss_pred             CCCEEEcCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCC
Q 013401          266 SSNILLTENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR-RPIEP  344 (443)
Q Consensus       266 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~-~Pf~~  344 (443)
                      |+||||+.++.+||+|||+++.......  ........||+.|+|||++.+..|+.++|||||||++|||++|. +||..
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCCCcEEEccchhheeccCCcc--ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            9999999999999999999986644321  22234567899999999999999999999999999999999985 67876


Q ss_pred             chhHHHHHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          345 KRELKERITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      .........+       ..+..... .         ..++.++.+|+.+||+.||++|||+.+|++.|..|.
T Consensus       246 ~~~~e~~~~v-------~~~~~~~~-p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         246 MAHEEVIYYV-------RDGNILAC-P---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             SCHHHHHHHH-------HTTCCCCC-C---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCHHHHHHHH-------HcCCCCCC-C---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            6544322211       12221111 0         123357999999999999999999999999998763

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=403.12  Aligned_cols=273  Identities=23%  Similarity=0.330  Sum_probs=207.0

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC----eEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED----ERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~l  210 (443)
                      ++|...++||+|+||.||+|++ +|+.||||+++..   ........+|+..+..++|||||++++++.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4566778999999999999987 4889999998643   121222334555666789999999999998764    5899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCEEEcCCCceEEeeeccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMY-----TDHPIIHRDIKSSNILLTENFRAKVADFGFA  285 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivHrDlkp~NILl~~~~~vkl~DFGla  285 (443)
                      |||||++|+|.++|..   ..+++..++.++.|++.||.|||..     +.+|||||||||+||||+.++.+||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999964   3589999999999999999999953     3469999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccCCCCccCccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCchhHH----H----H
Q 013401          286 RLAADTESGATHVSTQVKGTAGYLDPEYLKTYQ------LTEKSDVYSFGVLLVELVTGRRPIEPKRELK----E----R  351 (443)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~------~~~~sDiwSlGvll~elltG~~Pf~~~~~~~----~----~  351 (443)
                      +.................||+.|+|||++.+..      ++.++|||||||+||||+||.+||.......    .    .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            877654433333344578999999999987643      5678999999999999999998874322110    0    0


Q ss_pred             HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ..........    ....+++.+............+.+|+.+||+.||.+|||+.+|+++|..+..+
T Consensus       236 ~~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0011111111    11223444444555556778899999999999999999999999999887643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-51  Score=394.30  Aligned_cols=261  Identities=29%  Similarity=0.457  Sum_probs=208.6

Q ss_pred             CceeeeeCceEEEEEEEcC----CcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-cCeEEEEEee
Q 013401          140 SFKIGQGGFGTVYKGRLED----GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-EDERIVIVEY  214 (443)
Q Consensus       140 ~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~  214 (443)
                      .++||+|+||+||+|.+.+    ...||||++++. ......++|.+|+++|++++|||||++++++.+ ++..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            3579999999999998753    236899998753 345556789999999999999999999999876 4588999999


Q ss_pred             cCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCCC
Q 013401          215 VPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTESG  294 (443)
Q Consensus       215 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~  294 (443)
                      |++|+|.+++.. ....+++..++.++.|++.||.|||   .++|+||||||+||||++++.+||+|||+++........
T Consensus       111 ~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         111 MKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             eecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999998864 4456778889999999999999999   788999999999999999999999999999887655444


Q ss_pred             cccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCccccccCccc
Q 013401          295 ATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDAISILDPRV  374 (443)
Q Consensus       295 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  374 (443)
                      .........||+.|+|||++.+..++.++||||||++||||++|..||.......+..  .+    +..+....  .+  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~--~~----i~~g~~~~--~p--  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VY----LLQGRRLL--QP--  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH--HH----HHTTCCCC--CC--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH--HH----HHcCCCCC--Cc--
Confidence            4444455679999999999999999999999999999999999888876543322111  11    11111110  11  


Q ss_pred             cchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhhhh
Q 013401          375 ENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDYRE  421 (443)
Q Consensus       375 ~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~~~  421 (443)
                            ..+++++.+|+.+||+.||++||++.+|+++|..+..++..
T Consensus       257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence                  12346799999999999999999999999999999776544

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=395.13  Aligned_cols=260  Identities=25%  Similarity=0.360  Sum_probs=198.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec-C
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE-D  206 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-~  206 (443)
                      ++|++.++||+|+||.||+|.+.      +++.||||+++... .......+.+|+.++.++ +|+|||.+++++.+. +
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            57899999999999999999863      35789999987643 234456678888888887 689999999987654 4


Q ss_pred             eEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT  272 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~  272 (443)
                      .+++|||||++|+|.++|....              ...+++..++.++.||+.||.|||   +++||||||||+||||+
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            6899999999999999996532              235889999999999999999999   78899999999999999


Q ss_pred             CCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCchhHHHH
Q 013401          273 ENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTG-RRPIEPKRELKER  351 (443)
Q Consensus       273 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG-~~Pf~~~~~~~~~  351 (443)
                      .++.+||+|||+|+.......  ........||+.|+|||++.+..++.++|||||||++|||++| .+||.........
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             GGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999999999987654322  1223456799999999999999999999999999999999996 5678765432221


Q ss_pred             HHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          352 ITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ....      ..+.....     +     ...++++.+|+.+||+.||++|||+.+|++||..+.
T Consensus       247 ~~~~------~~~~~~~~-----~-----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         247 CRRL------KEGTRMRA-----P-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             HHHH------HHTCCCCC-----C-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH------hcCCCCCC-----C-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1111      01111110     0     113367999999999999999999999999998775

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=391.57  Aligned_cols=259  Identities=26%  Similarity=0.415  Sum_probs=198.3

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc--CC--cEEEEEEccccccC-cccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE--DG--TIVAIKRAKKSVYD-KHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERI  209 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~  209 (443)
                      ++|++.+.||+|+||.||+|...  ++  ..||||++++.... ....++|.+|+.+|+.++|||||++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56889999999999999999864  23  37899998765443 3345679999999999999999999999965 5678


Q ss_pred             EEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccccc
Q 013401          210 VIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAA  289 (443)
Q Consensus       210 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~  289 (443)
                      +|||||++|+|.+++.. ....+++..++.++.||+.||.|||   +++|+||||||+||||+.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            99999999999998875 3456999999999999999999999   7889999999999999999999999999998775


Q ss_pred             ccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHHHHHHHHHhhhcCCCcccc
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKERITVKWAMKKFSDGDAIS  368 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (443)
                      .... .........|+..|+|||++.+..++.++|||||||++|||++ |..||.........   .+...   .+....
T Consensus       163 ~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~i~~---~~~~~~  235 (273)
T d1u46a_         163 QNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKIDK---EGERLP  235 (273)
T ss_dssp             C-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHT---SCCCCC
T ss_pred             cCCC-cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HHHHh---CCCCCC
Confidence            4432 1222344568899999999999999999999999999999998 89999876544321   11111   111110


Q ss_pred             ccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          369 ILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       369 ~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                      .          ...++..+.+|+.+||+.||++|||+.+|++.|...
T Consensus       236 ~----------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 R----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            0          112336799999999999999999999999888653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=391.92  Aligned_cols=259  Identities=29%  Similarity=0.409  Sum_probs=205.6

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCc--EEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGT--IVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l  210 (443)
                      ++|++.++||+|+||+||+|.++ +|.  .||||+++... .....+.+.+|+.+|.++ +|||||++++++.+++.+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            57888899999999999999876 455  46778775432 334456799999999999 79999999999999999999


Q ss_pred             EEeecCCCcHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCc
Q 013401          211 IVEYVPNGTLREHLDCL--------------QGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFR  276 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~  276 (443)
                      ||||++||+|.++|...              ....+++..++.++.||+.||.|||   +++||||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence            99999999999998642              2467899999999999999999999   788999999999999999999


Q ss_pred             eEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCchhHHHHHHHH
Q 013401          277 AKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR-RPIEPKRELKERITVK  355 (443)
Q Consensus       277 vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~-~Pf~~~~~~~~~~~~~  355 (443)
                      +||+|||+++.......     .....||..|+|||.+.+..++.++|||||||++|||++|. +||.........   .
T Consensus       166 ~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~---~  237 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E  237 (309)
T ss_dssp             EEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H
T ss_pred             eEEcccccccccccccc-----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH---H
Confidence            99999999976554321     23446899999999999999999999999999999999975 567655432211   1


Q ss_pred             HHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          356 WAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       356 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      .    +..+..     +...     ..+++++.+|+.+||+.||++||++.+|+++|..+..+.
T Consensus       238 ~----i~~~~~-----~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         238 K----LPQGYR-----LEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             H----GGGTCC-----CCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             H----HHhcCC-----CCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            1    111111     1111     113467999999999999999999999999998886543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=390.79  Aligned_cols=262  Identities=25%  Similarity=0.375  Sum_probs=211.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~  207 (443)
                      ++|++.++||+|+||.||+|++.      +++.||||+++... .......+.+|+.+++.+ +|||||++++++.+.+.
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            57888889999999999999852      46789999997653 344556789999999999 69999999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          208 RIVIVEYVPNGTLREHLDCLQ----------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      .++|||||++|+|.+++....                ...+++..++.|+.||+.||.|||   .+++|||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999997532                235889999999999999999999   8889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||+++.......  .......+||+.|+|||++.+..++.++|||||||++|||+| |.+||........
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999987654332  233445689999999999999899999999999999999999 5666655443222


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKD  418 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~  418 (443)
                      ...+.  .....         +..     ....++++.+|+.+||+.||++|||+.+|++.|..+..+
T Consensus       257 ~~~~i--~~~~~---------~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         257 FYKMI--KEGFR---------MLS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHH--HHTCC---------CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHH--hcCCC---------CCC-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            11111  01110         000     011346799999999999999999999999999876554

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=389.34  Aligned_cols=259  Identities=27%  Similarity=0.377  Sum_probs=207.1

Q ss_pred             cCCCCCceeeeeCceEEEEEEEcC--------CcEEEEEEccccccCcccHHHHHHHHHHHHhc-CCcceeeeeeeeeec
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLED--------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQV-EHLNLVKFHGYLEFE  205 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~  205 (443)
                      ++|++.+.||+|+||.||+|+...        +..||||+++... ......++.+|+..+.++ +|||||++++++.++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            478888999999999999998532        3479999997653 334457788999999988 799999999999999


Q ss_pred             CeEEEEEeecCCCcHHHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEE
Q 013401          206 DERIVIVEYVPNGTLREHLDCLQ--------------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILL  271 (443)
Q Consensus       206 ~~~~lv~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl  271 (443)
                      +..++|||||.+|+|.++|....              ...+++..++.++.||+.||.|||   +++||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999996532              245899999999999999999999   7889999999999999


Q ss_pred             cCCCceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCchhHHH
Q 013401          272 TENFRAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVT-GRRPIEPKRELKE  350 (443)
Q Consensus       272 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~ellt-G~~Pf~~~~~~~~  350 (443)
                      +.++.+||+|||+++........  .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||........
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            99999999999999877654322  23445679999999999999999999999999999999998 7899976654322


Q ss_pred             HHHHHHHhhhcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhh
Q 013401          351 RITVKWAMKKFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVR  416 (443)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~  416 (443)
                      ...       +..+.....     +     ...++.+.+|+.+||+.||.+|||+.+|++.|..|.
T Consensus       247 ~~~-------i~~~~~~~~-----p-----~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         247 FKL-------LKEGHRMDK-----P-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHH-------HHTTCCCCC-----C-----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH-------HHcCCCCCC-----C-----ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            111       111111111     0     113367999999999999999999999999998764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=397.74  Aligned_cols=265  Identities=19%  Similarity=0.265  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC------
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED------  206 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------  206 (443)
                      .++|+++++||+|+||+||+|.+. +|+.||||++++........+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357999999999999999999976 6999999999876555666778899999999999999999999997655      


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      .+|+||||| +.+|..++.   ...+++..++.++.||+.||.|||   ++|||||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            579999999 667777664   356999999999999999999999   8889999999999999999999999999998


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .....       .+...||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......................
T Consensus       170 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         170 QADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             ECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccCCc-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            76432       245679999999999876 4578999999999999999999999987765433222221111100000


Q ss_pred             ---------------cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          366 ---------------AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       366 ---------------~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                                     ........+  ........+.+.+|+.+||..||.+|||+.++++|+|.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f  304 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  304 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HhhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence                           000000000  00011234678899999999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-50  Score=383.46  Aligned_cols=271  Identities=20%  Similarity=0.277  Sum_probs=213.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeEEEEEe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDERIVIVE  213 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~E  213 (443)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...........+.+|+.+|+.++|||||++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47999999999999999999976 79999999998766556667889999999999999999999999999999999999


Q ss_pred             ecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeecccccccccCC
Q 013401          214 YVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARLAADTES  293 (443)
Q Consensus       214 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~  293 (443)
                      ++.++.|..++.  ..+.+++..+..++.|++.||+|||   .+|||||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccc--cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            999999888776  4567899999999999999999999   78899999999999999999999999999987654332


Q ss_pred             CcccccccccCCCCccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHH-HHHHhhhcCCCcc-----
Q 013401          294 GATHVSTQVKGTAGYLDPEYLKTYQ-LTEKSDVYSFGVLLVELVTGRRPIEPKRELKERIT-VKWAMKKFSDGDA-----  366 (443)
Q Consensus       294 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~-----  366 (443)
                          ......+++.|+|||++.+.. ++.++|||||||++|||++|..||.......+... +............     
T Consensus       157 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         157 ----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             ----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             ----cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence                223345789999999987654 68999999999999999999998755443333222 2111111111000     


Q ss_pred             ------ccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          367 ------ISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       367 ------~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                            ....................+.+|+.+||+.||.+|||++|+++|+|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f  286 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence                  000000001111112234578999999999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=395.84  Aligned_cols=274  Identities=22%  Similarity=0.282  Sum_probs=205.9

Q ss_pred             HhcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecC----e
Q 013401          133 ATRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFED----E  207 (443)
Q Consensus       133 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~  207 (443)
                      .+.+|+++++||+|+||+||+|.++ +|+.||||++++.. .....+.+.+|+.+|+.++|||||++++++....    .
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            3457999999999999999999875 89999999987542 3444567889999999999999999999987653    3


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .++++|++.||+|.+++..   ..+++..++.++.||+.||.|||   ++|||||||||+||||+.++.+||+|||++..
T Consensus        85 ~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            4556667779999999963   36899999999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYL-KTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ....... .......+||+.|+|||++ .+..++.++||||+||++|+|++|..||........................
T Consensus       159 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         159 ADPDHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             CCGGGCB-CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccCCCcc-ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            6543321 1223456799999999998 4456789999999999999999999999877654332222211111100000


Q ss_pred             ccc-----------cC--ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          367 ISI-----------LD--PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       367 ~~~-----------~d--~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      ...           ..  ..............++.+|+.+||+.||.+|||+.++++|+|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~  298 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  298 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            000           00  0000000011223578999999999999999999999999983

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=390.35  Aligned_cols=264  Identities=21%  Similarity=0.288  Sum_probs=200.6

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeec------CeE
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFE------DER  208 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~  208 (443)
                      +|..+++||+|+||+||+|++. +|+.||||+++....      .+.+|+.+|++++|||||++++++...      .++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            5888889999999999999986 799999999876422      123799999999999999999998543      357


Q ss_pred             EEEEeecCCCcHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeecccc
Q 013401          209 IVIVEYVPNGTLREHLDC-LQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFAR  286 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~  286 (443)
                      ++|||||.++.+...... .....+++..++.|+.||+.||+|||   ++|||||||||+||||+.++ .+||+|||++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            899999976644333321 24567999999999999999999999   88999999999999999765 89999999998


Q ss_pred             cccccCCCcccccccccCCCCccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhh-----
Q 013401          287 LAADTESGATHVSTQVKGTAGYLDPEYLKT-YQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKK-----  360 (443)
Q Consensus       287 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~-----  360 (443)
                      .......     ....+||+.|+|||.+.+ ..++.++|||||||++|||++|.+||...........+......     
T Consensus       172 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         172 QLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  246 (350)
T ss_dssp             ECCTTSC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             hccCCcc-----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence            7654332     334579999999998764 57899999999999999999999999877654433332211110     


Q ss_pred             ---cC----CCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          361 ---FS----DGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       361 ---~~----~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                         ..    ....... .............++++.+|+.+||+.||++|||+.|+++|.|.
T Consensus       247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             HHHHCC---CCCCCCC-CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhccchhhcccccc-ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence               00    0000000 00000001112234679999999999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-50  Score=386.20  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=209.9

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc------CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeeecCeE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE------DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEFEDER  208 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~  208 (443)
                      ++|...++||+|+||+||+|.+.      ++..||||+++... .......+.+|+.++++++|||||++++++..++..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            57888889999999999999863      36789999997542 334456789999999999999999999999999999


Q ss_pred             EEEEeecCCCcHHHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEe
Q 013401          209 IVIVEYVPNGTLREHLDCLQ--------GNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVA  280 (443)
Q Consensus       209 ~lv~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~  280 (443)
                      ++|||||.+|+|.+++....        -..+++..+..++.|++.||.|||   .++|+||||||+||||+.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886432        134688889999999999999999   7889999999999999999999999


Q ss_pred             eecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCchhHHHHHHHHHHhh
Q 013401          281 DFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGR-RPIEPKRELKERITVKWAMK  359 (443)
Q Consensus       281 DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~-~Pf~~~~~~~~~~~~~~~~~  359 (443)
                      |||+++.......  ........||+.|+|||.+.+..++.++|||||||+||||++|. +||...........+     
T Consensus       176 DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i-----  248 (308)
T d1p4oa_         176 DFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-----  248 (308)
T ss_dssp             CTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-----
T ss_pred             ecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence            9999987654432  22234457999999999999999999999999999999999984 777765443322111     


Q ss_pred             hcCCCccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 KFSDGDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                        ..+.....          ...+++.+.+|+.+||+.||++|||+.+|+++|...
T Consensus       249 --~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 --MEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             --HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             --HhCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence              11111111          011336799999999999999999999999998765

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=386.41  Aligned_cols=273  Identities=25%  Similarity=0.318  Sum_probs=216.7

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc----CCcEEEEEEcccccc--CcccHHHHHHHHHHHHhcCC-cceeeeeeeeeecCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE----DGTIVAIKRAKKSVY--DKHSGAEFQSEIRTLAQVEH-LNLVKFHGYLEFEDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~  207 (443)
                      ++|+++++||+|+||+||+|...    +|+.||||++++...  +....+.+.+|+.+|++++| |||+++++++++...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999852    589999999876532  22345668899999999976 899999999999999


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||   +++||||||||+||||+.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999753  45778889999999999999999   78899999999999999999999999999987


Q ss_pred             ccccCCCcccccccccCCCCccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTY--QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      ......   .......|++.|++||.+.+.  .++.++|||||||+||+|++|..||...........+.........  
T Consensus       179 ~~~~~~---~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--  253 (322)
T d1vzoa_         179 FVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--  253 (322)
T ss_dssp             CCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--
T ss_pred             hccccc---ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--
Confidence            654322   123345799999999999654  4788999999999999999999999776543222221111111100  


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHhhhhhhhhhhcccCcC
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRP-----SMRRCAEILWSVRKDYRELAASDVLL  429 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RP-----s~~ell~~l~~i~~~~~~~~~~~~~~  429 (443)
                             ..     ....++++.+|+.+||++||.+||     |++|+++|+|.-..++..+...+.+.
T Consensus       254 -------~~-----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~  310 (322)
T d1vzoa_         254 -------PY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA  310 (322)
T ss_dssp             -------CC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred             -------CC-----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCc
Confidence                   00     012346799999999999999999     58999999997666666666655553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-48  Score=381.87  Aligned_cols=262  Identities=18%  Similarity=0.287  Sum_probs=202.8

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-Ccceeeeeeeeee--cCeEEE
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEF--EDERIV  210 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~l  210 (443)
                      ++|+++++||+|+||+||+|++. +|+.||||+++..     ...++.+|+++|+.+. ||||+++++++..  ...+++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            57999999999999999999985 7999999998743     3467889999999995 9999999999875  456899


Q ss_pred             EEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-ceEEeeeccccccc
Q 013401          211 IVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-RAKVADFGFARLAA  289 (443)
Q Consensus       211 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~  289 (443)
                      |||||.+++|..+.     +.+++..++.++.||+.||.|||   ++|||||||||+||||+.++ .+||+|||+|....
T Consensus       110 v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence            99999999987653     45899999999999999999999   88899999999999998655 69999999998765


Q ss_pred             ccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHH-HHHH----------HH
Q 013401          290 DTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKER-ITVK----------WA  357 (443)
Q Consensus       290 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~-~~~~----------~~  357 (443)
                      ....     ....+||+.|+|||.+.+. .++.++|||||||++|+|++|..||......... ..+.          +.
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         182 PGQE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             TTCC-----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             CCCc-----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence            4332     3445799999999998764 5799999999999999999999999765432211 1111          10


Q ss_pred             hhhcCCC--ccccccC-------ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHh
Q 013401          358 MKKFSDG--DAISILD-------PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWS  414 (443)
Q Consensus       358 ~~~~~~~--~~~~~~d-------~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~  414 (443)
                      .......  .......       .............+++.+|+.+||+.||.+|||++|+++|+|.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            0000000  0000000       0011111122345679999999999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=387.79  Aligned_cols=268  Identities=20%  Similarity=0.234  Sum_probs=201.5

Q ss_pred             cCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee------cCe
Q 013401          135 RNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF------EDE  207 (443)
Q Consensus       135 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~  207 (443)
                      ++|+++++||+|+||+||+|.+. +|+.||||++++.........++.+|+.+|++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999986 79999999998776666666788999999999999999999999864      468


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      +|+|||||.++ |.+.+.    ..+++..++.++.||+.||.|||   .+||+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            89999999765 444442    45899999999999999999999   78899999999999999999999999999876


Q ss_pred             ccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhh--------
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMK--------  359 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~--------  359 (443)
                      .....     .....+||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.........+.....        
T Consensus       169 ~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         169 AGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccc-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            65432     23456799999999999999999999999999999999999999987654333222211000        


Q ss_pred             -----------hcCCC---ccccccCcc--ccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          360 -----------KFSDG---DAISILDPR--VENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       360 -----------~~~~~---~~~~~~d~~--~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                                 .....   .........  ..........+..+.+|+.+||..||++|||++|+++|+|.-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~  315 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  315 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence                       00000   000000000  011112334567899999999999999999999999999964

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=389.03  Aligned_cols=269  Identities=20%  Similarity=0.276  Sum_probs=206.9

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcceeeeeeeeee-----cCe
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNLVKFHGYLEF-----EDE  207 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----~~~  207 (443)
                      .++|+++++||+|+||+||+|.+. +|+.||||++++..........+.+|+.+|+.++|||||++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999975 79999999998766555666788999999999999999999999864     334


Q ss_pred             EEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          208 RIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       208 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                      .+++||++.||+|.+++.   ...+++..++.++.||+.||.|||   ++|||||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            567788888999999884   356999999999999999999999   88899999999999999999999999999976


Q ss_pred             ccccCCCcccccccccCCCCccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCcc
Q 013401          288 AADTESGATHVSTQVKGTAGYLDPEYLKTY-QLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGDA  366 (443)
Q Consensus       288 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  366 (443)
                      ....       .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+............
T Consensus       171 ~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         171 TDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             CTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            5432       3445699999999987665 4688999999999999999999999877654433332221111000000


Q ss_pred             --------c---cccC--ccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          367 --------I---SILD--PRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       367 --------~---~~~d--~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                              .   ..+.  +............+.+.+|+.+||+.||.+|||+.|+++|+|.-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence                    0   0000  00000001112346789999999999999999999999999953

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-47  Score=368.76  Aligned_cols=267  Identities=16%  Similarity=0.232  Sum_probs=210.0

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC-cceeeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH-LNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv  211 (443)
                      .++|++.++||+|+||+||+|++. +|+.||||++....    ....+.+|+++++.|.| +|++.+++++.+....++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            467999999999999999999976 79999999876542    22346789999999974 8999999999999999999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcC-----CCceEEeeecccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTE-----NFRAKVADFGFAR  286 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~-----~~~vkl~DFGla~  286 (443)
                      |||+ +++|.+++.. .+..+++..++.++.|++.||.|||   ++|||||||||+||||+.     ++.+||+|||+|+
T Consensus        80 me~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          80 IDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9999 7899998864 4567999999999999999999999   889999999999999974     5789999999998


Q ss_pred             cccccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCC
Q 013401          287 LAADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSD  363 (443)
Q Consensus       287 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~  363 (443)
                      ...+......   ......+||+.|||||++.+..++.++|||||||++|||++|..||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            8765432221   1233567999999999999999999999999999999999999999755432221111111110000


Q ss_pred             CccccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhhhhhh
Q 013401          364 GDAISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSVRKDY  419 (443)
Q Consensus       364 ~~~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i~~~~  419 (443)
                      ....++          ...+++++.+++..|+..+|++||+++.+.+.+..+..+.
T Consensus       235 ~~~~~l----------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         235 TPLREL----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             SCHHHH----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CChHHh----------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            000000          0113367999999999999999999999988887765444

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-47  Score=369.21  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=199.8

Q ss_pred             hcCCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce-eeeeeeeeecCeEEEE
Q 013401          134 TRNFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL-VKFHGYLEFEDERIVI  211 (443)
Q Consensus       134 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv  211 (443)
                      +++|++.+.||+|+||+||+|.+. +|+.||||++.....    ..++.+|+++++.++|+|+ +.+.+++.+.+..++|
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            357999999999999999999975 699999998765422    2347789999999986665 5555666778889999


Q ss_pred             EeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEc---CCCceEEeeecccccc
Q 013401          212 VEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLT---ENFRAKVADFGFARLA  288 (443)
Q Consensus       212 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~  288 (443)
                      |||+ +++|.+.+.. ....+++..++.++.|++.||+|||   ++|||||||||+|||++   .+..+||+|||+|+..
T Consensus        82 me~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          82 MELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9999 5677666654 4567999999999999999999999   78899999999999986   4567999999999987


Q ss_pred             cccCCCcc---cccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHHHHHHHHHHhhhcCCCc
Q 013401          289 ADTESGAT---HVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELKERITVKWAMKKFSDGD  365 (443)
Q Consensus       289 ~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  365 (443)
                      .+......   ......+||+.|||||++.+..++.++|||||||++|||++|..||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            65433221   123456799999999999999999999999999999999999999976544332222211111000000


Q ss_pred             cccccCccccchhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHhh
Q 013401          366 AISILDPRVENTAANNLALEKILELALQCLAPRRQNRPSMRRCAEILWSV  415 (443)
Q Consensus       366 ~~~~~d~~~~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs~~ell~~l~~i  415 (443)
                                .......+++++.+|+.+||+.||++||++.++.+.|..+
T Consensus       237 ----------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 ----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ----------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ----------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                      0001112346799999999999999999999887776654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-43  Score=347.26  Aligned_cols=268  Identities=21%  Similarity=0.258  Sum_probs=195.8

Q ss_pred             CCCCCceeeeeCceEEEEEEEc-CCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-----------Ccceeeeeeeee
Q 013401          136 NFSPSFKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-----------HLNLVKFHGYLE  203 (443)
Q Consensus       136 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~  203 (443)
                      +|+++++||+|+||+||+|++. +|+.||||++++.   ....+.+.+|+++|+.++           |+|||++++++.
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            5899999999999999999975 7999999999764   334466788999888775           578999999876


Q ss_pred             ec--CeEEEEEeecCCCc-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCC-----
Q 013401          204 FE--DERIVIVEYVPNGT-LREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENF-----  275 (443)
Q Consensus       204 ~~--~~~~lv~E~~~gg~-L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~-----  275 (443)
                      ..  ...+++|+++..+. ............+++..+..++.||+.||.|||+  .+||+||||||+||||+.++     
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            53  46667777765543 3344444456778999999999999999999994  37899999999999998665     


Q ss_pred             -ceEEeeecccccccccCCCcccccccccCCCCccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCchhHH-----
Q 013401          276 -RAKVADFGFARLAADTESGATHVSTQVKGTAGYLDPEYLKTYQLTEKSDVYSFGVLLVELVTGRRPIEPKRELK-----  349 (443)
Q Consensus       276 -~vkl~DFGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDiwSlGvll~elltG~~Pf~~~~~~~-----  349 (443)
                       .++|+|||.+......       ....+||+.|+|||++.+..++.++|||||||++++|++|+.||.......     
T Consensus       169 ~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ceeeEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence             3999999998765432       234569999999999999999999999999999999999999997543211     


Q ss_pred             HH-HHHHHHhhh---------------cCCCccccccCcc----c-----cchhhcHHHHHHHHHHHHHccCCCCCCCCC
Q 013401          350 ER-ITVKWAMKK---------------FSDGDAISILDPR----V-----ENTAANNLALEKILELALQCLAPRRQNRPS  404 (443)
Q Consensus       350 ~~-~~~~~~~~~---------------~~~~~~~~~~d~~----~-----~~~~~~~~~~~~l~~Li~~cl~~dp~~RPs  404 (443)
                      .. ....+....               +............    .     ...........++.+|+.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            11 111111000               0000000000000    0     011112456688999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 013401          405 MRRCAEILWSV  415 (443)
Q Consensus       405 ~~ell~~l~~i  415 (443)
                      ++|+++|+|.-
T Consensus       322 a~e~L~Hp~f~  332 (362)
T d1q8ya_         322 AGGLVNHPWLK  332 (362)
T ss_dssp             HHHHHTCGGGT
T ss_pred             HHHHhcCcccC
Confidence            99999999954

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.1e-26  Score=205.62  Aligned_cols=163  Identities=16%  Similarity=0.171  Sum_probs=119.1

Q ss_pred             CCceeeeeCceEEEEEEEcCCcEEEEEEccccccC----------------cccHHHHHHHHHHHHhcCCcceeeeeeee
Q 013401          139 PSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYD----------------KHSGAEFQSEIRTLAQVEHLNLVKFHGYL  202 (443)
Q Consensus       139 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~  202 (443)
                      +.++||+|+||+||+|.+.+|+.||||+++.....                ......+.+|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            45689999999999999989999999987543211                00112345788999999999999887653


Q ss_pred             eecCeEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCEEEcCCCceEEeee
Q 013401          203 EFEDERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYTDHPIIHRDIKSSNILLTENFRAKVADF  282 (443)
Q Consensus       203 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivHrDlkp~NILl~~~~~vkl~DF  282 (443)
                          ..+++|||+.+..+.+         ++......++.|++.+|.|||   .+||+||||||+|||++++ .++|+||
T Consensus        84 ----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             ----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence                2379999998866532         344556789999999999999   7889999999999999976 4899999


Q ss_pred             cccccccccCCCcccccccccCCCCccCc------cccccCCCCCchhHHHHHHH
Q 013401          283 GFARLAADTESGATHVSTQVKGTAGYLDP------EYLKTYQLTEKSDVYSFGVL  331 (443)
Q Consensus       283 Gla~~~~~~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~~~~sDiwSlGvl  331 (443)
                      |+|+....+..            ..|+..      |.+ ...|+.++|+||+.--
T Consensus       147 G~a~~~~~~~~------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         147 PQSVEVGEEGW------------REILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TTCEETTSTTH------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             CCcccCCCCCc------------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            99976543211            111111      111 2467889999996533

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.70  E-value=5.6e-08  Score=88.47  Aligned_cols=150  Identities=15%  Similarity=0.107  Sum_probs=99.9

Q ss_pred             HHHHHHhcCCCCCceeeeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecC
Q 013401          128 EEIYRATRNFSPSFKIGQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFED  206 (443)
Q Consensus       128 ~~~~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~  206 (443)
                      .++.+....|+..+..+-++.+.||+.... +..+.||+.....  ......+.+|...|..+. +--+.+++.+...++
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~   83 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence            455666667776655444455789988654 5567788765432  222345678999888874 444667788888889


Q ss_pred             eEEEEEeecCCCcHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 013401          207 ERIVIVEYVPNGTLREHLDCLQGNILDLAGRLDIAIDVAHAITYLHMYT-------------------------------  255 (443)
Q Consensus       207 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------  255 (443)
                      ..++||++++|..+.+....       ......++.+++..|..||...                               
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             ceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            99999999999887654321       1112234455555555555211                               


Q ss_pred             -------------------------CCCeEecCCCCCCEEEcCCCceEEeeeccccc
Q 013401          256 -------------------------DHPIIHRDIKSSNILLTENFRAKVADFGFARL  287 (443)
Q Consensus       256 -------------------------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~  287 (443)
                                               ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     11379999999999999876667999997743

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.28  E-value=7.2e-07  Score=80.47  Aligned_cols=73  Identities=14%  Similarity=0.139  Sum_probs=53.3

Q ss_pred             eeeeCc-eEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcC--CcceeeeeeeeeecCeEEEEEeecCCCc
Q 013401          143 IGQGGF-GTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE--HLNLVKFHGYLEFEDERIVIVEYVPNGT  219 (443)
Q Consensus       143 LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~gg~  219 (443)
                      +..|.. +.||+....++..+++|......     ...+.+|...|+.+.  .-.+.+++.+..+++..++|||+++|.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            445553 67999988888888999765432     234667888888774  3345677888888888999999998866


Q ss_pred             H
Q 013401          220 L  220 (443)
Q Consensus       220 L  220 (443)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.05  E-value=8.7e-06  Score=78.45  Aligned_cols=77  Identities=14%  Similarity=0.099  Sum_probs=49.7

Q ss_pred             ceeeeeCceEEEEEEEc-CCcEEEEEEccccc--cC---cccHHHHHHHHHHHHhcC-C--cceeeeeeeeeecCeEEEE
Q 013401          141 FKIGQGGFGTVYKGRLE-DGTIVAIKRAKKSV--YD---KHSGAEFQSEIRTLAQVE-H--LNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~---~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~lv  211 (443)
                      +.||.|....||++... +++.|+||......  ..   .....+...|...|+.+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            36899999999999865 47789999754211  11   123345667888887763 2  345556654  45566899


Q ss_pred             EeecCCCc
Q 013401          212 VEYVPNGT  219 (443)
Q Consensus       212 ~E~~~gg~  219 (443)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.55  E-value=0.00015  Score=67.51  Aligned_cols=68  Identities=13%  Similarity=0.061  Sum_probs=47.1

Q ss_pred             ceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCCcce--eeee-----eeeeecCeEEEEEeecCCC
Q 013401          148 FGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEHLNL--VKFH-----GYLEFEDERIVIVEYVPNG  218 (443)
Q Consensus       148 fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~gg  218 (443)
                      --.||++...+|..|++|+....   ....+++..|...+..|...+|  +..+     ..+..++..+.+++++.|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            35899999999999999987654   3345678889888888742222  1111     1235567788899999764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.33  E-value=0.00078  Score=61.94  Aligned_cols=158  Identities=13%  Similarity=0.084  Sum_probs=85.5

Q ss_pred             ccCHHHHHHHhcCCCCCcee-----eeeCceEEEEEEEcCCcEEEEEEccccccCcccHHHHHHHHHHHHhcCC-----c
Q 013401          124 QITMEEIYRATRNFSPSFKI-----GQGGFGTVYKGRLEDGTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVEH-----L  193 (443)
Q Consensus       124 ~~~~~~~~~~~~~f~~~~~L-----G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-----~  193 (443)
                      .++.+++.....+|......     ..|---+.|+.+..+|+ |++|+.....    ...++..|+.++..|..     |
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC----CHHHHHHHHHHHHhhhhcccccc
Confidence            35677888888888775443     35556788999887666 8899875431    22345567777777642     2


Q ss_pred             ceeeeee---eeeecCeEEEEEeecCCCcHH-----------HHH---hhh-cCC------------------------C
Q 013401          194 NLVKFHG---YLEFEDERIVIVEYVPNGTLR-----------EHL---DCL-QGN------------------------I  231 (443)
Q Consensus       194 niv~l~~---~~~~~~~~~lv~E~~~gg~L~-----------~~l---~~~-~~~------------------------~  231 (443)
                      ..+...+   +....+....++.++.|....           ..+   ... ...                        .
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            2222111   223345566677766653221           000   000 000                        0


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCEEEcCCCceEEeeecccc
Q 013401          232 LDLAGRLDIAIDVAHAITYLHM-YTDHPIIHRDIKSSNILLTENFRAKVADFGFAR  286 (443)
Q Consensus       232 l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivHrDlkp~NILl~~~~~vkl~DFGla~  286 (443)
                      .........+..+...+.-.+. .-..|+||+|+.+.|||++.+...-|+||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111111222222232333221 124579999999999999988777899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.89  E-value=0.0024  Score=60.66  Aligned_cols=72  Identities=17%  Similarity=0.168  Sum_probs=47.3

Q ss_pred             ceeeeeCceEEEEEEEcC--------CcEEEEEEccccccCcccHHHHHHHHHHHHhcC-CcceeeeeeeeeecCeEEEE
Q 013401          141 FKIGQGGFGTVYKGRLED--------GTIVAIKRAKKSVYDKHSGAEFQSEIRTLAQVE-HLNLVKFHGYLEFEDERIVI  211 (443)
Q Consensus       141 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv  211 (443)
                      ..|+-|---.+|++...+        .+.|.+++.-.    ........+|..+++.+. +.-..++++++..    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            468888889999998653        34566665432    223345668999998885 4333466766542    678


Q ss_pred             EeecCCCcH
Q 013401          212 VEYVPNGTL  220 (443)
Q Consensus       212 ~E~~~gg~L  220 (443)
                      +||++|..|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544